<SEC-DOCUMENT>0001213900-18-011631.txt : 20180823
<SEC-HEADER>0001213900-18-011631.hdr.sgml : 20180823
<ACCEPTANCE-DATETIME>20180823161023
ACCESSION NUMBER:		0001213900-18-011631
CONFORMED SUBMISSION TYPE:	F-1/A
PUBLIC DOCUMENT COUNT:		42
FILED AS OF DATE:		20180823
DATE AS OF CHANGE:		20180823

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Tiziana Life Sciences plc
		CENTRAL INDEX KEY:			0001723069
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			X0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		F-1/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-226368
		FILM NUMBER:		181034874

	BUSINESS ADDRESS:	
		STREET 1:		3RD FLOOR, 11-12 ST. JAMES'S SQUARE
		CITY:			LONDON, ENGLAND
		STATE:			X0
		ZIP:			SW1Y 4LB
		BUSINESS PHONE:		0044(0) 207-495-2379

	MAIL ADDRESS:	
		STREET 1:		3RD FLOOR, 11-12 ST. JAMES'S SQUARE
		CITY:			LONDON, ENGLAND
		STATE:			X0
		ZIP:			SW1Y 4LB
</SEC-HEADER>
<DOCUMENT>
<TYPE>F-1/A
<SEQUENCE>1
<FILENAME>ff12018a1_tizianalife.htm
<DESCRIPTION>AMENDMENT NO. 1 TO FORM F-1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <B>As filed with the U.S. Securities
and Exchange Commission on August 23, 2018.</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"> <B>Registration Statement No. 333-226368</B> </P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>UNITED
STATES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WASHINGTON,
D.C. 20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <B>Amendment No. 1<BR>
to</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 16pt"><B>Form
F-1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REGISTRATION
STATEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>UNDER</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
SECURITIES ACT OF 1933</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 16pt"><B>Tiziana
Life Sciences plc</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of Registrant as specified in its charter)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 6pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Not Applicable</B></P>

<P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;(Translation of Registrant&rsquo;s name into English)&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 6pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>England
and Wales</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Jurisdiction
of incorporation or organization)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address,
including zip code, and telephone number, including area code, of Registrant&rsquo;s principal executive offices)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 6pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>England
    and Wales</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2836</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Not
    Applicable</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
        or other Jurisdiction of</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporation
        or Organization)</FONT></P></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Primary
        Standard Industrial</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Classification
        Code Number)</FONT></P></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S.
        Employer</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
        Number)</FONT></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 6pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3rd
Floor,</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>11-12
St James&rsquo;s Square</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>London
SW1 4LB</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>United
Kingdom</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>+44 20 7495 2379</B></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <B>Tiziana Therapeutics, Inc.</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>420
Lexington Avenue, Suite 2525</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>New
York, NY 10170</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(646) 396 4072</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name,
address, including zip code, and telephone number, including area code, of agent for service)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 6pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Copies
to:</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 6pt"><B><I>&nbsp;</I></B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; width: 33%; font: 10pt Times New Roman, Times, Serif; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"> <B>Ryan
                                         Sansom</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"> <B>Divakar Gupta</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"> <B>Alison Haggerty</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"> <B>Cooley LLP</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"> <B>114 Avenue
of the Americas</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"> <B>New York, NY
10036</B> </P>

<P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"> <B>(212) 479 6000</B> </P>



</TD>
    <TD STYLE="width: 34%; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ed
                                         Lukins</B></FONT> </P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Edward
        Dyson</B></FONT> </P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Cooley
        (UK) LLP</B></FONT> </P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Dashwood</B></FONT> </P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>69
        Old Broad Street</B></FONT> </P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>London
        EC2M 1QS</B></FONT> </P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>United
        Kingdom</B></FONT> </P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>+44
        20 7785 9355</B></FONT> </P></TD>
    <TD STYLE="width: 33%; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Jeffrey
                                         Fessler</B></FONT> </P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Justin
        Anslow</B></FONT> </P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Sheppard,
        Mullin, Richter &amp; </B></FONT><BR>
        <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Hampton LLP</B></FONT> </P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>30
        Rockefeller Plaza</B></FONT> </P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>New
        York, NY 10112-0015</B></FONT> </P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(212)
        653 8700 </B></FONT> </P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Approximate
date of commencement of proposed sale to the public: As soon as practicable after this Registration Statement becomes effective.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 6pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under
the Securities Act of 1933, check the following box. &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act of 1933,
check the following box and list the Securities Act of 1933 registration statement number of the earlier effective registration
statement for the same offering. &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act of 1933, check the following box
and list the Securities Act of 1933 registration statement number of the earlier effective registration statement for the same
offering. &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act of 1933, check the following box
and list the Securities Act of 1933 registration statement number of the earlier effective registration statement for the same
offering. &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; width: 20%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large Accelerated
    filer &#9744;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; width: 20%">&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated
    filer &#9744;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; width: 35%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-accelerated
    filer &#9746;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; width: 25%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smaller reporting
    company &#9744;</FONT></TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(Do not check if a smaller reporting company)</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Emerging
growth company &#9746;</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company that prepares its financial statements in accordance with U. S. GAAP, indicate by check mark if the
registrant has elected not to use the extended transition period* for complying with any new or revised financial accounting standards
provided pursuant to Section 7(a)(2)(B) of the Securities Act of 1933. &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CALCULATION
OF REGISTRATION FEE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid"> TITLE OF EACH CLASS OF SECURITIES TO BE REGISTERED </TD><TD STYLE="padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <B>PROPOSED</B> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <B>MAXIMUM</B> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <B>AGGREGATE</B> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <B>OFFERING</B> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <B>PRICE(1)(2)</B> </P></TD><TD STYLE="padding-bottom: 1.5pt"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <B>AMOUNT
                                         OF</B> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <B>REGISTRATION</B> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <B>FEE(3)(4)</B> </P></TD><TD STYLE="padding-bottom: 1.5pt"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%"> Ordinary shares, nominal value &pound;0.03 per share (5) </TD><TD STYLE="width: 1%"> &nbsp; </TD>
    <TD STYLE="width: 1%; text-align: left"> $ </TD><TD STYLE="width: 9%; text-align: right"> 11,500,000 </TD><TD STYLE="width: 1%; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%"> &nbsp; </TD>
    <TD STYLE="width: 1%; text-align: left"> $ </TD><TD STYLE="width: 9%; text-align: right"> 1,432 </TD><TD STYLE="width: 1%; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"> Representative&rsquo;s Warrants (6) </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> -- </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> -- </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt"> Ordinary shares, nominal value &pound;0.30 per share, underlying Representative&rsquo;s
    Warrants (5)(7) </TD><TD STYLE="padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> 276,000 </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> 36 </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 4pt"> Total </TD><TD STYLE="padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"> 11,776,500 </TD><TD STYLE="padding-bottom: 4pt; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"> 1,468 </TD><TD STYLE="padding-bottom: 4pt; text-align: left"> &nbsp; </TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.3in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated
                                         solely for the purpose of calculating the amount of the registration fee pursuant to
                                         Rule 457(o) of the Securities Act of 1933.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
                                         ordinary shares represented by American Depositary Shares, or ADSs, that are issuable
                                         upon exercise of the underwriters&rsquo; over-allotment option to purchase additional shares.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Calculated
                                         pursuant to Rule 457(o) based on an estimate of the proposed maximum aggregate offering
                                         price.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> (4) </TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"> Previously
                                         paid. </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT> </TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
                                         ordinary shares are represented by ADSs, each of which represents ordinary shares of
                                         the registrant. ADSs issuable on deposit of the ordinary shares registered hereby are
                                         being registered pursuant to a separate registration statement on Form F-6 (File No.
                                         333-226368).</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</FONT> </TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
                                         fee pursuant to Rule 457(g) under the Securities Act of 1933.</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</FONT> </TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated
                                         solely for the purpose of calculating the registration fee pursuant to Rule 457(g) under
                                         the Securities Act of 1933. The Representative&rsquo;s Warrants are exercisable at a
                                         per share exercise price equal to 120% of the public offering price per share. As estimated
                                         solely for the purpose of calculating the registration fee pursuant to Rule 457(g) under
                                         the Securities Act of 1933, the proposed maximum aggregate offering price of the Representative&rsquo;s
                                         Warrants is $276,000, which is equal to 120% of $230,000 (2% of $11,500,000).</FONT> </TD></TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; border-bottom: Black 1.5pt solid">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
Registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until
the Registrant shall file a further amendment which specifically states that this registration statement shall thereafter become
effective in accordance with Section 8(a) of the Securities Act of 1933 or until the registration statement shall become effective
on such date as the Commission, acting pursuant to said Section 8(a), may determine.</B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red">The
information in this preliminary prospectus is not complete and may be changed. We may not sell these securities until
the registration statement filed with the Securities and Exchange Commission is effective. This preliminary
prospectus is not an offer to sell these securities and we are not soliciting offers to buy these securities in any
jurisdiction where the offer or sale is not permitted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 33%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red">PRELIMINARY
    PROSPECTUS</FONT> </TD>
    <TD STYLE="width: 33%; font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red">SUBJECT
    TO COMPLETION</FONT> </TD>
    <TD STYLE="width: 34%; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red">DATED
    AUGUST 23, 2018</FONT> </TD>
    </TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><I>American
Depositary Shares</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><I>Representing
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Ordinary Shares</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><IMG SRC="image_001.jpg" ALT="">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This is a firm commitment initial public
offering, or IPO, of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;American Depositary Shares, or ADSs, of Tiziana Life
Sciences plc. Each ADS represents ordinary shares. No public market currently exists for our ADSs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> Prior to this offering, there has been
no public market for our ADSs. We intend to apply to list our ADSs for trading on the Nasdaq Capital Market or Nasdaq, under the
symbol &ldquo;TLSA.&rdquo; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> Our ordinary shares trade on AIM, a
market of the London Stock Exchange plc, or London Stock Exchange, under the symbol &ldquo;TILS.&rdquo; On&nbsp;August 23, 2018,
the last reported sale price of our ordinary shares was &pound;1.12 per share (equivalent to $1.43&nbsp;per ADS based on an exchange
rate of &pound;1.00 to $1.2769). </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investing
in our ADSs involves a high degree of risk. See &ldquo;Risk Factors&rdquo; beginning on page 10 of this prospectus for a
discussion of information that you should consider before investing in our ADSs.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neither
the SEC, nor any state securities commission has approved or disapproved of these securities or determined if this prospectus
is truthful or complete. Any representation to the contrary is a criminal offense.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are an &ldquo;emerging growth company,&rdquo;
or EGC, as defined under applicable Securities and Exchange Commission, or SEC, rules and, as such, have elected to comply with
certain reduced public company reporting requirements for this and future filings.</P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the completion of this offering, we will also qualify as a &ldquo;controlled company&rdquo; within the meaning of the rules of
Nasdaq. Under these rules, a &ldquo;controlled company&rdquo; may elect not to comply with certain corporate governance requirements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<B>Per ADS</B> &nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<B>Total</B> &nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 76%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial public offering price</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underwriting discounts and commissions<SUP>(1)</SUP></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proceeds, before expenses, to us</FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0; font-family: Times New Roman, Times, Serif"><DIV STYLE="font: 1pt Times New Roman, Times, Serif; border-top: Black 1.5pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.3in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    underwriters will receive compensation in addition to the discounts and commissions. See &ldquo;Underwriting&rdquo; for a
    description of compensation payable to the underwriters.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> We have granted the representative
of the underwriters an over-allotment option to purchase up to an additional &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ADSs
from us at the IPO price, less the underwriting discounts and commissions, within 30 days from the date of this prospectus to
cover over-allotments, if any. If the representative of the underwriters exercises their over-allotment option in full, the total
underwriting discounts and commissions payable will be $ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, and the total proceeds to us, before
expenses, will be $ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
underwriters expect to deliver our ADSs to purchasers in this offering on or about &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
2018.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 14pt"><B>Laidlaw &amp; Company (UK) Ltd.</B></FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: center"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
date of this prospectus is&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; , 2018</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="toc"></A>TABLE
OF CONTENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 0.5in; font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><A HREF="#a_001"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">About
    This Prospectus</FONT></A></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#a_002"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Presentation
    of Financial Information</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">1</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#a_003"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prospectus
    Summary</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">2</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#a_004"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk
    Factors</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">10</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#a_005"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cautionary
    Statement Regarding Forward-Looking Statements</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">43</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#a_006"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Market
    and Industry Data</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">44</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#a_007"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trademarks,
    Service Marks and Tradenames</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">45</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#a_008"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange
    Rate Information</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">46</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#a_009"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Price
    Range of Our Ordinary Shares</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">47</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#a_010"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Use
    of Proceeds</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">48</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#a_011"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividend
    Policy</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">49</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#a_012"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalization</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">50</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#a_013"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dilution</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">51</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#a_014"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selected
    Consolidated Financial Data</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">53</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#a_015"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management&rsquo;s
    Discussion and Analysis of Financial Condition and Results of Operations</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">54</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><A HREF="#a_016"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Business</FONT></A></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: center">64</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#a_017"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">93</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#a_018"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
    Relationships and Related Party Transactions</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">103</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#a_019"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal
    Shareholders</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">104</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_020">Description of Share Capital and Articles of Association</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">105</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#a_022"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ADSs
    Eligible For Future Sale</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">132</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#a_023"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Material
    Tax Considerations</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">133</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#a_024"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underwriters</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">140</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#a_025"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expenses
    of This Offering</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">147</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#a_026"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legal
    Matters</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">148</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#a_027"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Experts</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">148</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#a_028"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Service
    of Process and Enforcement of Liabilities</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">148</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#a_029"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where
    You Can Find Additional Information</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">150</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#a_030"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Index to Consolidated Financial Statements</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">F-1</TD></TR>
</TABLE>

<P STYLE="margin: 0; font-family: Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font-family: Times New Roman, Times, Serif"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 0; margin-bottom: 0; font-family: Times New Roman, Times, Serif"><DIV STYLE="font: 1pt Times New Roman, Times, Serif; border-top: Black 1.5pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font-family: Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>We
are responsible for the information contained in this prospectus and any free-writing prospectus we prepare or authorize. We have
not, and the underwriters have not, authorized anyone to provide you with different information, and we and the underwriters take
no responsibility for any other information others may give you. We are not, and the underwriters are not, making an offer to
sell our ADSs in any jurisdiction where the offer or sale is not permitted. For the avoidance of doubt, we are not, and the underwriters
are not, making an offer to sell our ordinary shares in any jurisdiction. You should not assume that the information contained
in this prospectus is accurate as of any date other than the date on the front cover of this prospectus, regardless of the time
of delivery of this prospectus or the sale of any ADSs.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
investors outside the United States, neither we nor the underwriters have done anything that would permit this offering or possession
or distribution of this prospectus in any jurisdiction, other than the United States, where action for that purpose is required.
Persons outside the United States who come into possession of this prospectus must inform themselves about, and observe any restrictions
relating to, this offering and the distribution of this prospectus outside the United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a public limited company incorporated under the laws of England and Wales and a majority of our outstanding securities are
owned by non-U.S. residents. Under the rules of the SEC, we are currently eligible for treatment as a &ldquo;foreign private issuer,&rdquo;
or FPI. As an FPI, we will not be required to file periodic reports and financial statements with the SEC as frequently or as
promptly as domestic registrants whose securities are registered under the Securities Exchange Act of 1934, or Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid; text-align: center">&nbsp;&nbsp;i</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 5pt; border: Black 1.5pt solid; width: 98%; font-family: Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><B><A NAME="a_001"></A>About
This Prospectus</B></FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise indicated or the context otherwise requires, all references in this registration statement to the terms &ldquo;Tiziana,&rdquo;
&ldquo;Tiziana Life Sciences plc,&rdquo; &ldquo;the company,&rdquo; &ldquo;we,&rdquo; &ldquo;us&rdquo; and &ldquo;our&rdquo; refer
to Tiziana Life Sciences plc and its wholly owned subsidiaries, Tiziana Therapeutics, Inc., Tiziana Pharma Limited and Longevia
Genomics S.r.l.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Solely
for convenience, the trademarks, service marks and trade names in this registration statement may be referred to without the &reg;
and &trade; symbols, but such references should not be construed as any indicator that their respective owners will not assert,
to the fullest extent under applicable law, their rights thereto. This registration statement contains additional trademarks,
service marks and trade names of others, which are the property of their respective owners. We do not intend to use or display
other companies&rsquo; trademarks, service marks and trade names to imply a relationship with, or endorsement or sponsorship of
us by, any other companies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
this registration statement, unless otherwise stated, all references to &ldquo;U.S. dollars&rdquo; or &ldquo;US$&rdquo; or &ldquo;$&rdquo;
or &ldquo;cents&rdquo; are to the currency of the United States of America, and all references to &ldquo;Pounds Sterling&rdquo;
or &ldquo;Sterling&rdquo; or &ldquo;&pound;&rdquo; or &ldquo;pence&rdquo; are to the currency of the United Kingdom.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
this registration statement, any reference to any provision of any legislation shall include any amendment, modification, re-enactment
or extension thereof. Words importing the singular shall include the plural and vice versa, and words importing the masculine
gender shall include the feminine or neutral gender.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B><A NAME="a_002"></A>Presentation
of Financial Information</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">This prospectus includes
our audited consolidated financial statements as of and for the years ended December 31, 2017 and 2016, which are prepared
in accordance with International Financial Reporting Standards, or IFRS, as issued by the International Accounting Standards Board,
or IASB. None of our financial statements were prepared in accordance with generally accepted accounting principles in the United
States.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> Our financial
information is presented in Pounds Sterling. For the convenience of the reader, in this prospectus, unless otherwise indicated,
translations from Pounds Sterling into U.S. dollars were made at the rate of &pound;1.00 to $1.2769, which was the noon buying
rate of the Federal Reserve Bank of New York on August 10, 2018. Such U.S. dollar amounts are not necessarily indicative of the
amounts of U.S. dollars that could actually have been purchased upon exchange of Pounds Sterling at the dates indicated. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have made rounding adjustments to some of the figures included in this prospectus. Accordingly, numerical figures shown as totals
in some tables may not be an arithmetic aggregation of the figures that preceded them.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

</DIV>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 5pt; border: Black 1.5pt solid; width: 98%; font-family: Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><A NAME="a_003"></A>PROSPECTUS
SUMMARY<SUP></SUP></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>This
summary highlights information contained elsewhere in this prospectus and does not contain all of the information that you should
consider in making your investment decision. Before investing in our ADSs or ordinary shares, you should carefully read this entire
prospectus, including our consolidated financial statements and the related notes and the information set forth under the sections
titled &ldquo;Risk Factors,&rdquo; &ldquo;Special Note Regarding Forward-Looking Statements,&rdquo; and &ldquo;Management&rsquo;s
Discussion and Analysis of Financial Condition and Results of Operations,&rdquo; in each case included elsewhere in this prospectus.
Unless the context otherwise requires, we use the terms &ldquo;Tiziana,&rdquo; &ldquo;company,&rdquo; &ldquo;our,&rdquo; &ldquo;us,&rdquo;
and &ldquo;we&rdquo; in this prospectus to refer to Tiziana Life Sciences plc and, where appropriate, our consolidated subsidiaries.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Overview</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> We are a biotechnology
company that is focused on the discovery and development of novel molecules and related diagnostics to treat high unmet medical
needs in oncology and immunology. Our lead product candidate in immunology is Foralumab (TZLS-401), which we believe is the only
fully human anti-cluster definition 3, or anti-CD3, monoclonal antibody, or mAb, in clinical development. MAbs represent a single
pure antibody produced by single clones and are an important class of human therapeutics for treating cancers and autoimmune diseases.
Generation of antibodies for use in humans developed in animals, leads to strong, immune responses limiting their effectiveness
and potentially leading to severe side effects. A process known as &ldquo;humanization&rdquo; removes most of the animal components
of the antibody thereby lowering the immune response from the human immune system. The entire omission of other animal material,
as in fully human antibodies, is the optimal goal to avoid incompatibility with the human immune system. Our lead product candidate
in oncology is Milciclib (TZLS-201), which is an orally bioavailable, small molecule broad spectrum inhibitor of cyclin-dependent
kinases, or CDKs, and Sarcoma, or Src, family kinases. CDKs are a highly conserved family of enzymes that phosphorylate a specific
group of proteins that are involved in regulating the cell cycle. The cell cycle is a series of events that takes place in cells
leading to division and duplication of its DNA to produce two daughter cells. Src family kinases are non-receptor tyrosine kinase
proteins encoded by the Src gene also involved in regulating cell growth and potential transformation of normal cells to cancer
cells. We also have a drug discovery pipeline of small molecule new chemical entities, or NCEs, and biologics. We employ a lean
and virtual research and development, or R&amp;D, model using highly experienced teams of experts for each business function to
maximize value accretion by focusing resources on the drug discovery and development processes. Our mission is to design and deliver
next generation therapeutics and diagnostics for oncology and immune diseases of high unmet medical need by combining deep understanding
of disease biology with clinical development expertise. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> We are developing
Foralumab, for which we in-licensed the intellectual property from Novimmune SA, or Novimmune, in December 2014, as a potential
treatment for non-alcoholic steatohepatitis, or NASH, and Crohn&rsquo;s disease as well as neurodegenerative diseases such as
multiple sclerosis, or MS. We believe that oral or nasal administration of Foralumab has the potential to reduce inflammation
while minimizing the toxicity and related side effects. To date, Foralumab has been studied in one Phase 1 and two Phase 2a clinical
trials conducted by Novimmune in 68 patients dosed by the intravenous route of administration. In these trials, Foralumab was
observed to be well-tolerated and produced immunologic effects consistent with potential clinical benefit while demonstrating
mild to moderate infusion related reactions, or IRR. We plan to initially investigate Foralumab for safety and its immunomodulatory
activity in healthy volunteers in two Phase 1 trials. In one of the Phase 1 trials, subjects will be dosed Foralumab in a newly
developed oral formulation (enteric capsule) with an intention to treat patients with NASH and/or Crohn&rsquo;s disease and in
the other Phase 1 trial, Foralumab will be dosed via intranasal administration using a hand held nasal device with an intention
to treat patients with MS. An investigational new drug application, or IND, for the first-in-human evaluation of Foralumab in
healthy human volunteers was filed on June 1, 2018 and we expect to commence a dose ranging trial to evaluate biomarkers of immunomodulation
of clinical responses in the third quarter of 2018. In addition, we expect to initiate a Phase 1 trial in the first quarter of
2019 and a Phase 2 trial for oral Foralumab by the end of 2019, in patients with NASH and/or Crohn&rsquo;s disease. On April 16,
2018 we entered into an exclusive license agreement with The Brigham and Women&rsquo;s Hospital, Inc., or BWH, relating to a novel
formulation of Foralumab in a medical device for nasal administration. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> We are developing
Milciclib, for which we in-licensed the intellectual property from Nerviano Medical Sciences S.r.l., or Nerviano, in January 2015,
as a potential treatment for hepatocellular carcinoma, or HCC. A novel feature of Milciclib is its ability to reduce levels of
microRNAs, miR-221 and miR-222. MicroRNAs are small RNA molecules that play a significant role in the regulation of gene expression.
miR-221 and miR-222 are believed to be linked to the development of blood supply in cancer tumors. Levels of these microRNAs are
consistently elevated in HCC patients and may contribute towards resistance to treatment with Sorafenib, a multikinase inhibitor
(a drug which may inhibit the cellular division and proliferation associated with certain cancers) often prescribed to HCC patients.
To date, Milciclib has been studied in a total of seven completed and ongoing Phase 1 and Phase 2 clinical trials in a total of
296 patients conducted by Nerviano. In these trials, Milciclib was well-tolerated with minimal adverse events. We initiated a
Phase 2a trial for Milciclib as a monotherapy in patients with HCC in the fourth quarter of 2017 and expect to initiate a Phase
2b trial for Milciclib in combination with Sorafenib (a multikinase inhibitor drug, also known under its brand name Nexavar&reg;,
used to treat some types of kidney, liver and thyroid cancers) in patients with HCC in the first quarter of 2019. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In addition, we are
developing a fully human mAb targeting the IL-6R (TZLS-501). We licensed the intellectual property from Novimmune in January 2017.
This fully human mAb has a novel mechanism of action, binding to both the membrane-bound and soluble forms of the IL-6R and depleting
circulating levels of the IL-6 in the blood. Excessive production of IL-6 is regarded as a key driver of chronic inflammation,
associated with autoimmune diseases such as multiple myeloma, oncology indications and rheumatoid arthritis, and we believe that
TZLS-501 may have potential therapeutic value for these indications.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In preclinical studies,
TZLS-501 demonstrated the potential for overcoming the limitations of other IL-6 pathway drugs. Compared to tocilizumab and sarilumab,
TZLS-501 has been observed to have a higher affinity for the soluble IL-6 receptor from antibody binding studies conducted in cell
culture. TZLS-501 also demonstrated the potential to block or reduce IL-6 signaling in mouse models of inflammation. The soluble
form of IL-6 has been implicated to have a larger role in disease progression compared to the receptor bound form (Kallen, K.J.
(2002). &ldquo;The role of transsignalling via the agonistic soluble IL-6 receptor in human diseases.&rdquo; Biochimica et Biophysica
Acta. 1592 (3): 323&ndash;343.).</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif"></FONT></P>

</DIV>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 5pt; border: Black 1.5pt solid; width: 98%; font-family: Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Competitive Strengths</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">Our
mission is to design and deliver next generation therapeutics and diagnostics for oncology and immune diseases of high unmet medical
need by combining deep understanding of disease biology with clinical development expertise. We believe the following strengths
will allow us to continue to pursue this mission:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 34.65pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal"></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Advanced,
                                         novel pipeline. </I></B>We have an advanced pipeline of novel and proprietary drug candidates,
                                         including antibodies and small molecules, to address high unmet medical needs in the
                                         inflammation, autoimmune and oncology markets with significant commercial potential.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Proprietary
                                         technology</I></B><FONT STYLE="font-weight: normal">. Our proprietary technology enables
                                         the development of alternative routes of administration of antibodies, including oral
                                         delivery. We believe oral delivery will alleviate the significant time and cost burden
                                         associated with other routes of administration, including intravenous delivery.</FONT></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Broad
                                         and engaged network of experts</I></B><I><FONT STYLE="font-weight: normal">. </FONT></I>Our
                                         strong relationships with key opinion leaders contribute to our clinical development
                                         efforts and position us well to support our products, if approved. Dr. Napoleone Ferrara,
                                         Dr. Arun Sanyal, Dr. Kevan Herold, and Dr. Howard Weiner are among the thought leaders
                                         on our scientific advisory committee.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Specialized
    expertise and focus on oncology and inflammation</I></B>. Our management team, including Dr. Kunwar Shailubhai, Dr. Fayez
    Hamzeh, Jules Jacob, Dr. Priya Eddy and Dr. Vaseem Palejwala has <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">considerable</FONT>
    experience translating technologies from     bench to market, and managing the global administration of clinical
    trials.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Strong
                                         intellectual property and know-how</I></B><FONT STYLE="font-weight: normal">. We believe
                                         our proprietary intellectual property portfolio, in-licensed from Nerviano and Novimmune,
                                         provides us with a substantial competitive advantage for the commercial development of
                                         small molecule NCEs, and biologics, as well as expanded possibilities for new development
                                         programs in the future. We have retained the worldwide development and commercialization
                                         rights to all of our product candidates.</FONT></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Lean
                                         research and development model, designed to maximize value</I></B><FONT STYLE="font-weight: normal">.
                                         We employ a lean and virtual R&amp;D model using highly experienced teams of experts
                                         for each business function to maximize value accretion by focusing resources on the drug
                                         discovery and development processes.</FONT></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Strategy</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> Our goal is to
become a leading biotechnology company focused on developing and delivering therapies and related diagnostics in both oncology
and immunology. The key elements of our strategy to achieve this goal are to: </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 34.65pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advance the clinical development of orally administered Foralumab for the treatment of NASH and Crohn&rsquo;s
disease using a novel and proprietary oral formulation by initiating a Phase 1 trial in the first quarter of 2019 and a Phase 2
trial by the end of 2019.&nbsp;&nbsp;In addition, a Phase 1 trial for the first-in-human evaluation of the nasal administration
of Foralumab in healthy volunteers, for neurodegenerative disease indications such as MS, is expected to be initiated in the second
half of 2018.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34.65pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Continue
    to advance the clinical development and obtain regulatory approval for our lead oncology product candidate, Milciclib, as
    a monotherapy in HCC and as a combination therapy for the treatment of refractory solid tumors (being cancers which are non-responsive
    or become resistant to treatment) and HCC by continuing to enroll the ongoing Phase 2a trial as a monotherapy and initiating
    a planned Phase 2b trial in combination with Sorafenib.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34.65pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">Continue
                                         to leverage relationships with key opinion leaders to promote clinical trial success
                                         and enhance future commercialization.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Continue preclinical studies and non-clinical development of our product candidate, TZLS-501, a fully human mAb targeting the IL-6R (a biological mAb which may control the proteins involved in cell signaling relevant to many inflammatory diseases and cancers), for treatment of inflammatory and oncology indications.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">Opportunistically
                                         identify and acquire or in-license complimentary product and technology candidates.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">Seek
orphan drug, fast track or breakthrough designation for our product candidates where warranted.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

</DIV>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 5pt; border: Black 1.5pt solid; width: 98%; font-family: Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Product Candidates</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">Our
product candidate pipeline is set forth below:</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><IMG SRC="img_1n.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selected
Risks Affecting Our Business</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
business is subject to a number of risks of which you should be aware before making an investment decision. You should
carefully consider all of the information set forth in this prospectus and, in particular, should evaluate the specific
factors set forth in the section titled &ldquo;Risk Factors&rdquo; before deciding whether to invest in our ADSs. These
important risks include, but are not limited to, the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If we encounter substantial delays in clinical trials of our product candidates, we may be unable to obtain required regulatory approvals, and therefore will be unable to commercialize our product candidates on a timely basis or at all.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We may fail to demonstrate the safety and therapeutic utility of our product candidates to the satisfaction of applicable regulatory authorities, which would prevent or delay regulatory approval and commercialization.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Success in preclinical studies or clinical trials may not be indicative of results in future clinical trials.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We depend on enrollment of patients in our clinical trials for our product candidates and may find it difficult to enroll patients in our clinical trials, which could delay or prevent us from proceeding with clinical trials of our product candidates and could materially adversely affect our R&amp;D efforts and business, financial condition and results of operations.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our product candidates and the process for administering our product candidates may cause undesirable side effects or have other properties that could delay or prevent their regulatory approval, limit their commercial potential or result in significant negative consequences following any potential marketing approval.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any contamination in our manufacturing process, shortages of raw materials or failure of any of our key suppliers to deliver necessary components could result in delays in our clinical development or marketing schedules.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our independent registered public accounting firm has expressed substantial doubt about our ability to continue as a going concern, which may hinder our ability to obtain future financing.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

</DIV>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 5pt; border: Black 1.5pt solid; width: 98%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We need substantial additional funding to complete the development of our product candidates, which may not be available on acceptable terms, if at all. Failure to obtain this necessary capital when needed may force us to delay, limit or terminate certain of our product development, research operations or future commercialization efforts, if any.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our limited operating history and no history of commercializing pharmaceutical products may make it difficult to evaluate the success of our business to date and to assess the prospects for our future viability.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We rely, and expect to continue to rely, on third parties to conduct our preclinical studies and clinical trials. If these third parties do not successfully carry out their contractual duties or meet expected deadlines, we may not be able to obtain regulatory approval for or commercialize our product candidates.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We face significant competition in an environment of rapid technological change and the possibility that our competitors may achieve regulatory approval before us or develop therapies that are more advanced or effective than ours.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The future commercial success of our product candidates will depend upon the degree of each product candidates&rsquo; market acceptance by physicians, patients, third-party payors and others in the medical community.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We may not be able to protect our intellectual property rights throughout the world.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Even if we obtain and maintain approval for our product candidates in a major pharmaceutical market such as the United States, we may never obtain approval for our product candidates in other major markets.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Product liability lawsuits against us could cause us to incur substantial liabilities and could limit commercialization of any product candidate that we may develop.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We do not know whether an active, liquid and orderly trading market will develop for our ADSs or what the market price of our ADSs will be. As a result, it may be difficult for shareholders to sell their ADSs.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We may lose our FPI status, which would then require us to comply with the Exchange Act&rsquo;s domestic reporting regime and cause us to incur significant legal, accounting and other expenses.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If we are a passive foreign investment company, there could be adverse U.S. federal income tax consequences to U.S. holders.</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corporate
Information</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> We were originally
incorporated under the laws of England and Wales on February 11, 1998, with the goal of leveraging the expertise of our management
team as well as Dr. Napoleone Ferrara, Dr. Arun Sanyal, Dr. Howard Weiner and Dr. Kevan Herold, and to acquire and exploit certain
intellectual property in biotechnology. We subsequently changed our name to Tiziana Life Sciences plc in April 2014 as a result
of the acquisition of Tiziana Pharma Limited in April 2014. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> <FONT STYLE="font-size: 7pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> Our registered
office is located at 3rd Floor, 11-12 St James&rsquo;s Square, London SW1Y 4LB and our telephone number is +44 20 7495 2379. Our
website address is www.tizianalifesciences.com. The reference to our website is an inactive textual reference only and the information
contained in, or that can be accessed through, our website is not a part of this registration statement. Our agent for service
of process in the United States is Tiziana Therapeutics, Inc. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Tiziana,&rdquo;
the Tiziana logo and other trademarks or service marks of Tiziana Life Sciences plc appearing in this prospectus are the property
of Tiziana or our subsidiaries. This prospectus contains additional trade names, trademarks and service marks of others, which
are the property of their respective owners. Solely for convenience, trademarks and trade names referred to in this prospectus
may appear without the &reg; or <SUP>TM</SUP> symbols.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Implications
of Being an Emerging Growth Company</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are an EGC as defined in the Jumpstart Our Business Startups Act of 2012, or the JOBS Act. As such, we may take advantage of certain
exemptions from various reporting requirements that are applicable to other publicly traded entities that are not EGCs. These
exemptions include:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         option to present only two years of audited financial statements and related discussion
                                         in the section titled &ldquo;Management&rsquo;s Discussion and Analysis of Financial
                                         Condition and Results of Operations&rdquo; in this prospectus;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">not
                                         being required to comply with the auditor attestation requirements of Section 404 of
                                         the Sarbanes-Oxley Act of 2002, or Sarbanes-Oxley Act;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">not
                                         being required to comply with any requirement that may be adopted by the Public Company
                                         Accounting Oversight Board regarding mandatory audit firm rotation or a supplement to
                                         the auditor&rsquo;s report providing additional information about the audit and the financial
                                         statements (i.e., an auditor discussion and analysis);</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">not
                                         being required to submit certain executive compensation matters to stockholder advisory
                                         votes, such as &ldquo;say-on-pay,&rdquo; &ldquo;say-on-frequency,&rdquo; and &ldquo;say-on-golden
                                         parachutes;&rdquo; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">not
                                         being required to disclose certain executive compensation related items such as the correlation
                                         between executive compensation and performance and comparisons of the chief executive
                                         officer&rsquo;s compensation to median employee compensation.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></P>

</DIV>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 5pt; border: Black 1.5pt solid; width: 98%; font-family: Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result, we do not know if some investors will find our ADSs or ordinary shares less attractive. The result may be a less active
trading market for our ADSs and/or ordinary shares, and the price of ADSs and/or ordinary shares may become more volatile.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
107 of the JOBS Act also provides that an EGC can take advantage of the extended transition period provided in Section 13(a) of
the Exchange Act, for complying with new or revised accounting standards. As a result, an EGC can delay the adoption of certain
accounting standards until those standards would otherwise apply to private companies. We are choosing to opt out of this extended
transition period and will comply with new or revised accounting standards on the relevant dates on which adoption of such standards
is required for non-EGCs. Under federal securities laws, our decision to opt out of the extended transition period is irrevocable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will remain an EGC until the earliest of: (1) the last day of the first fiscal year in which our annual gross revenues exceed
$1.07 billion; (2) the last day of 2023; (3) the date that we become a &ldquo;large accelerated filer&rdquo; as defined in Rule
12b-2 under the Exchange Act, which would occur on the last day of any fiscal year that the aggregate worldwide market value of
our common equity held by non-affiliates exceeds $700 million as of the last business day of our most recently completed second
fiscal quarter; or (iv) the date on which we have issued more than $1.0 billion in non-convertible debt securities during any
three-year period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Implications
of Being a Foreign Private Issuer</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the completion of this offering, we will report under the Exchange Act as a non-U.S. company with FPI status. Even after we no
longer qualify as an EGC, as long as we qualify as an FPI under the Exchange Act we will be exempt from certain provisions of
the Exchange Act that are applicable to U.S. domestic public companies, including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         sections of the Exchange Act regulating the solicitation of proxies, consents or authorizations
                                         in respect of a security registered under the Exchange Act;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         sections of the Exchange Act requiring insiders to file public reports of their stock
                                         ownership and trading activities and liability for insiders who profit from trades made
                                         in a short period of time; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         rules under the Exchange Act requiring the filing with the SEC of quarterly reports on
                                         Form 10-Q containing unaudited financial and other specific information, and current
                                         reports on Form 8-K upon the occurrence of specified significant events.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FPIs
are also exempt from certain more stringent executive compensation disclosure rules. Thus, even if we no longer qualify as an
EGC, but remain an FPI, we will continue to be exempt from the more stringent compensation disclosures required of companies that
are neither an EGC nor an FPI.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</DIV>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 5pt; border: Black 1.5pt solid; width: 98%; font-family: Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">The
Offering</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 48%; text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ADSs offered by us</FONT></TD>
    <TD STYLE="width: 1%; text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 51%; text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ADSs.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary shares to be outstanding after this offering</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ordinary shares (or &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ordinary shares if the underwriters exercise in full their over-allotment option to purchase an additional &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ADSs), including ordinary shares in the form of ADSs.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Over-allotment option</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ADSs.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ADSs</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
ADS represents &nbsp;&nbsp;&nbsp;&nbsp;ordinary shares, nominal value &pound;0.03 per ordinary share. The depositary will hold
the ordinary shares underlying your ADSs and you will have rights as provided in the deposit agreement among us, the depositary,
and holders and beneficial owners of ADSs from time to time. To better understand the terms of our ADSs, see &ldquo;Description
of the American Depositary Shares.&rdquo; We also encourage you to read the deposit agreement, the form of which is filed as an
exhibit to the registration statement of which this prospectus forms a part.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depositary</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">JPMorgan Chase Bank, N.A.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Use of proceeds</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We estimate that the net proceeds
from our sale of ADSs in this offering will be approximately $ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million (or approximately $
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million if the underwriters exercise their over-allotment option in full), assuming
an IPO price of $ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ADS, which reflects the last reported sale price of &pound;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
per ordinary share on AIM on &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2018 equivalent to US$ per ADS based
on an exchange rate of &pound;&nbsp;&nbsp;&nbsp;&nbsp; to $1.00 after deducting the underwriting discounts and commissions and estimated offering expenses
payable by us.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We intend to use the net proceeds we
        receive from this offering to advance the clinical development of Foralumab and Milciclib, and our other research and
        development programs, working capital and other general corporate purposes.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">See &ldquo;Use of Proceeds&rdquo; for additional
        information.</P></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk factors</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">See &ldquo;Risk Factors&rdquo; and the other information included in this prospectus for a discussion of factors you should carefully consider before deciding to invest in our ADSs.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Representative&rsquo;s
    Warrants</FONT> </TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    registration statement of which this prospectus is a part also registers warrants to purchase &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ADSs
    to Laidlaw &amp; Company (UK) Ltd., the representative of the underwriters, or the Representative, as a portion of the underwriting
    compensation payable to the underwriters in connection with this offering. The warrants, or the Representative&rsquo;s Warrants,
    will be exercisable for a four and a half-year period commencing six months following the closing of this offering at an exercise
    price equal to 120% of the IPO price of the ADSs. Please see &ldquo;Underwriting&mdash;Representative&rsquo;s Warrants&rdquo;
    for a description of these warrants.</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposed &nbsp;&nbsp;&nbsp;NASDAQ&nbsp;&nbsp; Capital Market&nbsp;&nbsp;&nbsp;&nbsp;symbol</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;TLSA.&rdquo;</FONT></TD></TR>
</TABLE>


<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

</DIV>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 5pt; border: Black 1.5pt solid; width: 98%; font-family: Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> The number of
shares of our ordinary shares that will be outstanding after this offering is based on 126,904,285 ordinary shares outstanding
as of August 23, 2018, and excludes: </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px; font-size: 10pt"> &nbsp; </TD>
    <TD STYLE="width: 24px; font-size: 10pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font-size: 10pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,010,833
    ordinary shares issuable upon the exercise of share options outstanding as of&nbsp;&nbsp;August 23, 2018 at exercise prices
    of between $0.657 and $3.285&nbsp;per ordinary share;</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"> &nbsp; </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px"> &nbsp; </TD>
    <TD STYLE="width: 24px"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,906,570 ordinary
    shares that may be issued under our existing share option plans, as described in &ldquo;Management&mdash;Equity Compensation
    Arrangements,&rdquo; as of August 23, 2018; and</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"> &nbsp; </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px"> &nbsp; </TD>
    <TD STYLE="width: 24px"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,060,809 ordinary
    shares that may be issued upon the exercise of warrants to purchase ordinary shares outstanding as at August 23, 2018 at exercise
    prices of between $0.197 and $2.44 per ordinary share.</FONT> </TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise indicated, this prospectus reflects and assumes the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">no
                                         exercise of outstanding share options after August 23, 2018;</FONT> </TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">no
                                         exercise of the underwriters&rsquo; over-allotment option;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">no
                                         exercise of the Representative&rsquo;s Warrants; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">no
                                         exercise of the warrants to purchase ordinary shares after August 23, 2018.</FONT> </TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</DIV>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 5pt; border: Black 1.5pt solid; width: 98%; font-family: Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Summary
Consolidated Financial Data<B><SUP></SUP></B></FONT></P>




<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">The following tables
set forth our summary consolidated financial data for the periods indicated. We have derived the consolidated statement of comprehensive
income for the years ended December 31, 2017 and 2016 and the consolidated balance sheet data as of December 31, 2017 from our
audited consolidated financial statements included elsewhere in this prospectus. Our historical results are not necessarily indicative
of the results that should be expected for any future period. You should read the following summary consolidated financial data
together with the audited consolidated financial statements included elsewhere in this prospectus and the sections titled &ldquo;Exchange
Rate Information&rdquo; and &ldquo;Management&rsquo;s Discussion and Analysis of Financial Condition and Results of Operations.&rdquo;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We maintain our books and records in Pounds Sterling, and we prepare our financial statements in accordance
with IFRS as issued by the IASB. We report our financial results in U.S. dollars.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Consolidated
Statement of Operations Data:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 7pt Times New Roman, Times, Serif"><B></B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0"> Years
    Ended <BR>
    December 31, </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0"> 2017 </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0"> 2016 </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font-weight: bold; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; font-family: Times New Roman, Times, Serif; padding-right: 0"> (in
    thousands except share and per share data) </TD><TD STYLE="font-weight: bold; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> Revenue </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> - </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> - </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> Operating expenses: </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 76%; text-align: left; padding-left: 9pt; font-family: Times New Roman, Times, Serif; padding-right: 0"> Research
    and development </TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> $ </TD><TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> (6,015 </TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> ) </TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> $ </TD><TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> (4,007 </TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-left: 9pt; font-family: Times New Roman, Times, Serif; padding-right: 0"> General and
    administrative </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> (4,602 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> ) </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> (5,872 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-left: 9pt; font-family: Times New Roman, Times, Serif; padding-right: 0"> Total operating
    expenses </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> (10,617 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> ) </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> (9,879 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-left: 9pt; font-family: Times New Roman, Times, Serif; padding-right: 0"> Loss from
    operations </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> (10,617 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> ) </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> (9,879 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> Other income (expense), net </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> (12 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> ) </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> (12 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> Tax provision </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> 1,912 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> 121 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> Net loss attributable to ordinary
    shareholders </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> (8,716 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> ) </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> (9,770 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> Other comprehensive loss: </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-left: 9pt; font-family: Times New Roman, Times, Serif; padding-right: 0"> Foreign currency
    translation adjustment </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> 70 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> 650 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> Total comprehensive loss </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> $ </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> (8,646 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> ) </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> $ </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9,
                                         120</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> Basic and diluted net loss per
    ordinary share </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> $ </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> (0.09 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> ) </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> $ </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> (0.11 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> ) </TD></TR>
</TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>&nbsp;&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 7pt Times New Roman, Times, Serif"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Consolidated Balance Sheet Data:</B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 7pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 7pt Times New Roman, Times, Serif"><B></B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD COLSPAN="10" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As of December 31, 2017</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0">Actual</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0">Pro Forma&nbsp;(1)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0">Pro Forma as <BR> adjusted (2)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="font-weight: bold; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD COLSPAN="10" STYLE="font-weight: bold; text-align: center; font-family: Times New Roman, Times, Serif; padding-right: 0">(in thousands)</TD><TD STYLE="font-weight: bold; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 64%; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">Cash and cash equivalents</TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">$</TD><TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0">64</TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">$</TD><TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0">84</TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">$</TD><TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">Working capital</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">$</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0">(2,301</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">)</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">$</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0">(2,301</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">)</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">$</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">Total assets</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">$</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0">2,471</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">$</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0">2,471</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">$</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">Total shareholders&rsquo; equity</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">$</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0">(2,278</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">)</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">$</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0">(2,258</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">)</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">$</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"></TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>&nbsp;</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 7pt Times New Roman, Times, Serif"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(1) On a pro forma
basis giving effect to: (i) the issuance from January 2018 to April 2018 of an aggregate 1,797,917 ordinary shares for cash with
gross proceeds of $2,268,000; (ii)&nbsp;the issuance from January 2018 to April 2018 of an aggregate 833,215 ordinary shares to
our former noteholders in respect of accrued interest; and (iii) the issuance on April 24, 2018 of 51,563 ordinary shares, credited
as fully paid to intermediaries in lieu of commissions in a private placement.&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(2) On a pro forma as adjusted basis to give further effect to the sale of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ADS in this offering at the assumed IPO price of $ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ADS in this offering, which reflects the last reported sale price of &pound;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ordinary share on AIM on &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2018 equivalent to US$&nbsp;&nbsp;&nbsp;per ADS based on an exchange rate of &pound;&nbsp;&nbsp;&nbsp;&nbsp;to $1.00 after deducting the underwriting discounts and commissions and estimated offering expenses payable by us.</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

</DIV>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="a_004"></A>RISK
FACTORS</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>You
should carefully consider the risks described below, together with all of the other information in this registration statement.
The risks and uncertainties below are not the only ones we face. Additional risks and uncertainties not presently known to us
or that we believe to be immaterial may also adversely affect our business. If any of the following risks occur, our business,
financial condition and results of operations could be seriously harmed and potential future investors in our ADSs could lose
all or part of their investment. Further, if we fail to meet the expectations of the public market in any given period, the potential
market price of our ADSs could decline. We operate in a highly competitive environment that involves significant risks and uncertainties,
some of which are outside of our control. If any of these risks actually occurs, our business and financial condition could suffer
and the potential market price of our ADSs could decline.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risks
Related to the Development of our Product Candidates</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
we encounter substantial delays in clinical trials of our product candidates, we may be unable to obtain required regulatory approvals,
and therefore will be unable to commercialize our product candidates on a timely basis or at all.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
obtaining marketing approval from regulatory authorities for the sale of our product candidates, we must conduct extensive clinical
trials to demonstrate the safety and utility of the product candidates. Clinical testing is expensive, time-consuming and uncertain
as to outcome. We cannot guarantee that any clinical trials will be conducted as planned or completed on schedule, if at all,
as a failure of one or more clinical trials can occur at any stage of testing. Events that may prevent successful or timely completion
of clinical development include:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">delays
                                         in reaching a consensus with the U.S. Food and Drug Administration, or FDA, European
                                         Medicines Agency, or EMA, or other regulatory authorities on trial design;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">delays in reaching agreement on acceptable terms with prospective contract research organizations, or
CROs, and clinical trial sites;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">delays
                                         in opening clinical trial sites or obtaining required institutional review board or independent
                                         ethics committee approval at each clinical trial site;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">delays
                                         in recruiting suitable patients to participate in our future clinical trials;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">imposition
                                         of a clinical hold by regulatory authorities as a result of a serious adverse event or
                                         after an inspection of our clinical trial operations or clinical trial sites;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">failure
                                         by us, any CROs we engage or any other third parties to adhere to clinical trial requirements;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">failure
                                         to perform in accordance with good clinical practice, or GCP, or applicable regulatory
                                         guidelines in Europe and other international markets;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">delays
                                         in the testing, validation, manufacturing and delivery of our product candidates to the
                                         clinical trial sites, including delays by third parties with whom we have contracted
                                         to perform certain of those functions;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">delays
                                         in having patients complete participation in a clinical trial or return for post-treatment
                                         follow-up;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">clinical
                                         trial sites or patients dropping out of a clinical trial;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">selection
                                         of clinical endpoints that require prolonged periods of clinical observation or analysis
                                         of the resulting data;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">occurrence
                                         of serious adverse events associated with the product candidate that are viewed to outweigh
                                         its potential benefits;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">occurrence
                                         of serious adverse events in clinical trials of the same class of agents conducted by
                                         other sponsors; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
                                         in regulatory requirements and guidance that require amending or submitting new clinical
                                         protocols.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
inability to successfully complete preclinical and clinical development could result in additional costs to us or impair our ability
to generate revenues from product sales, regulatory and commercialization milestones and royalties. In addition, if we make manufacturing
or formulation changes to our product candidates, we may need to conduct additional studies to bridge our modified product candidates
to earlier versions. Clinical trial delays also could shorten any periods during which we may have the exclusive right to commercialize
our product candidates or allow our competitors to bring products to market before we do, which could impair our ability to successfully
commercialize our product candidates and may harm our business, financial condition, results of operations and prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
may fail to demonstrate the safety and therapeutic utility of our product candidates to the satisfaction of applicable regulatory
authorities, which would prevent or delay regulatory approval and commercialization.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
obtaining regulatory approvals for the commercial sale of our product candidates, we must demonstrate through lengthy, complex
and expensive preclinical testing and clinical trials that our product candidates are both safe and effective for use in each
target indication. Clinical testing is expensive and can take many years to complete, and its outcome is inherently uncertain.
Most product candidates that commence clinical trials are never approved as products. If the results of our registrational trial
or future pivotal trials for our other product candidates do not demonstrate therapeutic utility of our product candidates, or
if there are safety concerns or serious adverse events associated with our product candidates, we may:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">be
                                         delayed in obtaining marketing approval for our product candidates, if at all;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">obtain
                                         approval for indications or patient populations that are not as broad as intended or
                                         desired;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">obtain
                                         approval with labeling that includes significant use or distribution restrictions or
                                         safety warnings;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">be
                                         subject to additional post-marketing testing requirements;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">be
                                         subject to changes in the way the product is administered;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">be
                                         required to perform additional clinical trials to support approval or be subject to additional
                                         post-marketing testing requirements;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">have
                                         regulatory authorities withdraw or suspend their approval of the product or impose restrictions
                                         on its distribution in the form of a modified risk evaluation and mitigation strategy,
                                         or REMS;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">be
                                         subject to the addition of labeling statements, such as warnings or contraindications;
                                         or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">be
                                         sued or experience damage to our reputation.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Success
in preclinical studies or clinical trials may not be indicative of results in future clinical trials.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Success
in preclinical testing and early clinical trials does not ensure that later clinical trials will generate the same results or
otherwise provide adequate data to demonstrate the effectiveness and safety of our product candidate. Frequently, product candidates
that have shown promising results in early clinical trials have subsequently suffered significant setbacks in later clinical trials.
To date, some of our clinical trials have involved small patient populations and because of the small sample size in such trials,
the interim results of these clinical trials may be subject to substantial variability and may not be indicative of either future
interim results or final results. In addition, the design of a clinical trial can determine whether its results will support approval
of a product and flaws in the design of a clinical trial may not become apparent until the clinical trial is well advanced. Because
we have limited experience designing clinical trials, we may be unable to design and execute a clinical trial to support regulatory
approval. In addition, there is a high failure rate for drugs and biologic products proceeding through clinical trials. In fact,
many companies in the pharmaceutical and biotechnology industries have suffered significant setbacks in late-stage clinical trials
even after achieving promising results in preclinical testing and earlier-stage clinical trials. Moreover, data obtained from
preclinical and clinical activities is subject to varying interpretations, which may delay, limit or prevent regulatory approval.
In addition, we may experience regulatory delays or rejections as a result of many factors, including due to changes in regulatory
policy during the period of our product candidate development. Any such delays could negatively impact our business, financial
condition, results of operations and prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
depend on enrollment of patients in our clinical trials for our product candidates and may find it difficult to enroll patients
in our clinical trials, which could delay or prevent us from proceeding with clinical trials of our product candidates and could
materially adversely affect our R&amp;D efforts and business, financial condition and results of operations.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identifying
and qualifying patients to participate in clinical trials of our product candidates is critical to our success. The timing of
our clinical trials depends on our ability to recruit patients to participate, and to see those patients through the completion
of required follow-up periods. If, for any reason, patients are unwilling to enroll in our clinical trials, then the timeline
for recruiting patients, conducting studies and obtaining regulatory approvals for our product candidates may be delayed. These
delays could result in increased costs, delays in advancing our product candidates, delays in testing the effectiveness of our
product candidates or termination of clinical trials altogether.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
current product candidates are being developed to treat oncology and immune diseases of high unmet medical need. However, we may
not be able to initiate or continue clinical trials if we cannot enroll a sufficient number of eligible patients to participate
in the clinical trials required by the FDA, EMA or other regulatory authorities. As a result, we may not be able to identify,
recruit and enroll a sufficient number of patients, or those with required or desired characteristics, to complete our clinical
trials in a timely manner. Patient enrollment can be affected by many factors, including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">size
                                         of the patient population and process for identifying patients;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">eligibility
                                         and exclusion criteria for our clinical trials;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">perceived
                                         risks and benefits of our product candidates;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">severity
                                         of the disease under investigation;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">proximity
                                         and availability of clinical trial sites for prospective patients;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">competition
                                         with other clinical trials for product candidates competing in the same therapeutic areas
                                         as our product candidates;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ability
                                         to obtain and maintain patient consent;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">patient
                                         drop-outs prior to completion of clinical trials;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">patient
                                         referral practices of physicians; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ability
                                         to monitor patients adequately during and after treatment.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
ability to successfully initiate, enroll and complete clinical trials in any foreign country is subject to numerous risks unique
to conducting business in foreign countries, including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">difficulty
                                         in establishing or managing relationships with CROs and physicians;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">different
                                         standards for the conduct of clinical trials;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">absence
                                         in some countries of established groups with sufficient regulatory expertise for review
                                         of certain treatment protocols;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">inability
                                         to locate qualified local consultants, physicians and partners; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         potential burden of complying with a variety of foreign laws, medical standards and regulatory
                                         requirements, including the regulation of pharmaceutical and biotechnology products and
                                         treatment.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we have difficulty enrolling a sufficient number of patients or finding additional clinical trial sites to conduct our clinical
trials as planned, we may need to delay, limit or terminate ongoing or planned clinical trials, any of which could have an adverse
effect on our business, financial condition, results of operations and prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
product candidates and the process for administering our product candidates may cause undesirable side effects or have other properties
that could delay or prevent their regulatory approval, limit their commercial potential or result in significant negative consequences
following any potential marketing approval.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">During the conduct of
clinical trials, patients report changes in their health, including illnesses, injuries and discomforts, to their study doctor.
Often, it is not possible to determine whether the product candidate being studied caused these conditions. Regulatory authorities
may draw different conclusions or require additional testing to confirm these determinations. For Milciclib, the most frequent
drug-related side effects reported across studies, at all doses tested, were gastrointestinal, or GI, adverse events (nausea and
diarrhea, followed by less frequent vomiting), neurological effects (mainly tremor, then ataxia, dizziness and dysgeusia), skin
disorders and asthenia, fatigue, headache and anorexia. For Foralumab, the most frequent drug-related side effects reported following
intravenous administration were infusion related reactions, or IRR, including fever, headaches, chills, nausea, vomiting diarrhea
and hypotension considered the result of cytokine release also known as cytokine release syndrome, or CRS. Other adverse events
included reactivation of Epstein-Barr virus (clinically silent); moderate lymphocytopenia, abnormalities in liver function tests.
Since most of these changes are related to the infusion route of administration and dosage level, such systemic toxicities are
not anticipated when administered orally due to what we assume will be minimal systemic absorption.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, it is possible that as we test our product candidates in larger, longer and more extensive clinical programs, or as
use of these product candidates becomes more widespread if they receive regulatory approval, illnesses, injuries, discomforts
and other adverse events that were observed in earlier trials, as well as conditions that did not occur or went undetected in
previous trials, will be reported by patients. Many times, side effects are only detectable after investigational products are
tested in large-scale, Phase 3 clinical trials or, in some cases, after they are made available to patients on a commercial scale
after approval. If additional clinical experience indicates that our product candidates cause serious or life-threatening side
effects, the development of our product candidates may fail or be delayed, or, if the product candidate has received regulatory
approval, such approval may be revoked, which would harm our business, prospects, operating results and financial condition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
in the future we are unable to demonstrate that such adverse events were caused by the administration process or related procedures,
the FDA, EMA or other regulatory authorities could order us to cease further development of, or deny approval of, our product
candidates for any or all targeted indications. Even if we are able to demonstrate that any serious adverse events are not product-related,
such occurrences could affect patient recruitment or the ability of enrolled patients to complete the clinical trial. Moreover,
if we elect or are required to delay, suspend or terminate any clinical trial of any of our product candidates, the commercial
prospects of such product candidate may be harmed and our ability to generate product revenues from such product candidate may
be delayed or eliminated. Any of these occurrences may harm our ability to develop other product candidates, and may harm our
business, financial condition and prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
if we or others later identify undesirable side effects caused by any of our product candidates, several potentially significant
negative consequences could result, including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">regulatory
                                         authorities may suspend or withdraw approvals of such product candidate;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">regulatory
                                         authorities may require additional warnings on the label;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
                                         may be required to change the way a product candidate is administered or conduct additional
                                         clinical trials;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
                                         could be sued and held liable for harm caused to patients; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                         reputation may suffer.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
of these events could prevent us from achieving or maintaining market acceptance of our product candidates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Any
contamination in our manufacturing process, shortages of raw materials or failure of any of our key suppliers to deliver necessary
components could result in delays in our clinical development or marketing schedules.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Given
the nature of biologics and NCE manufacturing, there is a risk of contamination. Any contamination could adversely affect our
ability to produce product candidates on schedule and could, therefore, harm our results of operations and cause reputational
damage. In addition, some of the raw materials required in our manufacturing process are derived from biologic sources, and are
difficult to procure and may be subject to contamination or recall. A material shortage, contamination, recall or restriction
on the use of biologically derived substances in the manufacture of our product candidates could adversely impact or disrupt the
commercial manufacturing or the production of clinical material, which could adversely affect our development timelines and our
business, financial condition, results of operations and prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risks
Related to Our Financial Position and Need For Capital</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-underline-style: double"><B><I>Our
independent registered public accounting firm has expressed substantial doubt about our ability to continue as a going concern,
which may hinder our ability to obtain future financing.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mazars
LLP, our independent registered public accounting firm for the fiscal year ended December 31, 2017, has included an explanatory
paragraph in their opinion that accompanies our audited consolidated financial statements as of and for the year ended December
31, 2017, indicating that our current liquidity position raises substantial doubt about our ability to continue as a going concern.
If we are unable to improve our liquidity position we may not be able to continue as a going concern. The accompanying consolidated
financial statements do not include any adjustments that might result if we are unable to continue as a going concern and, therefore,
be required to realize our assets and discharge our liabilities other than in the normal course of business which could cause
investors to suffer the loss of all or a substantial portion of their investment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
have incurred net losses in every year since our inception. We anticipate that we will continue to incur losses for the foreseeable
future and may never achieve or maintain profitability.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"> We are a clinical
stage biotechnology company with a limited operating history. Since our inception in May 2013, we have incurred significant net
losses. Our net losses were $8.7 million and $9.8 million for the years ended December 31, 2017 and 2016, respectively. As of
December 31, 2017, we had an accumulated loss of $42.6 million. We have devoted substantially all of our efforts to research and
development of our product candidates, including clinical development of our lead product candidates, Foralumab and Milciclib,
as well as to building out our management team and infrastructure. We expect that it could be several years, if ever, before we
have a commercialized product candidate. We expect to continue to incur significant expenses and increasing operating losses for
the foreseeable future. These net losses will adversely impact our shareholders&rsquo; equity and net assets and may fluctuate
significantly from quarter to quarter and year to year. We anticipate that our expenses will increase substantially if, and as,
we: </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">continue research and development of Foralumab, including the initiation of our Phase 1 trials in normal healthy volunteers with an intent to treat patients with NASH, Crohn&rsquo;s disease and MS;</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"> &nbsp; </TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">continue
    our Phase 2 program for Milciclib as a monotherpay in HCC patients and initiate a Phase 2b trial for Milciclib in combination
    with Sorafenib in HCC patients;</FONT> </TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">

<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">initiate
                                         clinical trials and preclinical studies for any additional product candidates that we
                                         may pursue in the future;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">manufacture
                                         our product candidates in accordance with current good manufacturing practices, or cGMP,
                                         for clinical trials or potential commercial sales;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">establish
                                         a sales, marketing and distribution infrastructure to commercialize any product candidate
                                         for which we may obtain marketing approval;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">develop,
                                         maintain, expand and protect our intellectual property portfolio;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">identify,
                                         assess, and acquire or in-license other product candidates and technologies;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">secure,
                                         maintain or obtain freedom to operate for any in-licensed technologies and products;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">address
                                         any competing technological and market developments; and</FONT></TD></TR>
</TABLE></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&nbsp;<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">expand
                                         our operations in the United States and Europe.</FONT></TD></TR>
</TABLE></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
may never succeed in any or all of these activities and, even if we do, we may never generate revenues that are significant or
large enough to achieve profitability. If we do achieve profitability, we may not be able to sustain or increase profitability
on a quarterly or annual basis. Our failure to become and remain profitable would decrease the value of our company and could
impair our ability to raise capital, maintain our R&amp;D efforts, expand our business or continue our operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B><I>We need substantial additional funding
to complete the development of our product candidates, which may not be available on acceptable terms, if at all. Failure to obtain
this necessary capital when needed may force us to delay, limit or terminate certain of our product development, research operations
or future commercialization efforts, if any.</I></B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
operations have consumed substantial amounts of cash since inception, and we expect our expenses to increase in connection with
our ongoing activities, particularly as we continue the R&amp;D of, initiate further clinical trials of and seek marketing approval
for, our product candidates. In addition, if we obtain marketing approval for our product candidates, we expect to incur significant
expenses related to product sales, marketing, manufacturing and distribution. Furthermore, we expect to incur additional costs
associated with operating as a public company listed on both AIM in the United Kingdom and Nasdaq in the United States. Our future
capital requirements will depend on many factors, including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         scope, progress, results and costs of laboratory testing, manufacturing, preclinical
                                         and clinical development for our current and future product candidates;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         costs, timing and outcome of regulatory review of our product candidates;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         extent to which we acquire or in-license and develop other product candidates and technologies;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                         ability to establish and maintain collaborations and license agreements on favorable
                                         terms, if at all;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         costs, timing and outcome of potential future commercialization activities, including
                                         manufacturing, marketing, sales and distribution for our product candidates for which
                                         we receive marketing approval;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         costs of developing, maintaining and enforcing our intellectual property rights and defending
                                         intellectual property-related claims; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         sales price and availability of adequate third-party coverage and reimbursement for our
                                         product candidates, if and when approved.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Developing
product candidates and conducting preclinical studies and clinical trials is a time-consuming, expensive and uncertain process
that takes years to complete, and we may never generate the necessary data or results required to obtain marketing approval and
achieve product sales. In addition, our product candidates, if approved, may not achieve commercial success. Our product revenues,
if any, will be derived from or based on sales of product candidates that may not be commercially available for many years, if
at all. Accordingly, we will need to continue to rely on additional financing to achieve our business objectives. Adequate additional
financing may not be available to us on acceptable terms, if at all. To the extent that additional capital is raised through the
issuance of equity or equity-linked securities, the issuance of those securities could result in substantial dilution for our
current shareholders and the terms of any future issuance may include liquidation or other preferences that adversely affect the
rights of our current shareholders. Debt financing, if available, may involve covenants restricting our operations or our ability
to incur additional debt. Any debt or additional equity financing that we raise may contain terms that are not favorable to us
or our shareholders. If we raise additional funds through collaboration and licensing arrangements with third parties, it may
be necessary to relinquish some rights to our technologies or our product candidates, or grant licenses on terms that are not
favorable to us. Furthermore, the potential issuance of additional securities in the future, whether equity or debt, by us, or
the possibility of such issuance, may cause the market price of our ADSs to decline and existing shareholders may not agree with
our financing plans or the terms of such financings.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we are unable to obtain adequate funding on a timely basis, we may be required to significantly curtail, delay or discontinue
our R&amp;D programs of our product candidates or any future commercialization efforts, be unable to expand our operations or
be unable to otherwise capitalize on our business opportunities, as desired, which could harm our business and potentially cause
us to discontinue operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
limited operating history and no history of commercializing pharmaceutical products may make it difficult to evaluate the success
of our business to date and to assess the prospects for our future viability.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
our inception, we have devoted substantially all of our resources to developing Foralumab and Milciclib, and our other product
candidates, building our intellectual property portfolio and providing general and administrative support for these operations.
Although our R&amp;D efforts to date have resulted in a pipeline of product candidates, we have not yet demonstrated our ability
to successfully complete Phase 3 or other pivotal clinical trials, obtain regulatory approvals, or commercialize any of our product
candidates. In addition, given our limited operating history, we may encounter unforeseen expenses, difficulties, complications,
delays and other known and unknown factors in achieving our business objectives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
we are not profitable and have incurred losses in each year since our inception, and we expect that our financial condition and
operating results may continue to fluctuate significantly from quarter to quarter and year to year due to a variety of factors,
many of which are beyond our control. Consequently, any predictions you make about our future success or viability may not be
as accurate as they could be if we had a longer operating history.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risks
Related to Our Reliance on Third Parties</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
rely, and expect to continue to rely, on third parties to conduct our preclinical studies and clinical trials. If these third
parties do not successfully carry out their contractual duties or meet expected deadlines, we may not be able to obtain regulatory
approval for or commercialize our product candidates.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have relied upon and plan to continue to rely upon third parties, including independent clinical investigators and third-party
CROs, to conduct our preclinical studies and clinical trials and to monitor and manage data for our ongoing preclinical and clinical
programs. In engaging these third parties, we typically have to, and expect to have to, negotiate budgets and contracts, which
may result in delays to our development timelines and increases costs. Additionally, there is a limited number of qualified third-party
service providers that specialize or have the expertise required to achieve our business objectives, and so it may be challenging
to find alternative investigators or CROs, or do so on commercially reasonable terms. We rely on these parties for execution of
our preclinical studies and clinical trials, and control only certain aspects of their activities. Nevertheless, we are responsible
for ensuring that each of our preclinical studies and clinical trials is conducted in accordance with the applicable protocol
and legal, regulatory and scientific standards, and our reliance on these third parties does not relieve us of our regulatory
responsibilities. We and our third-party contractors and CROs are required to comply with GCP requirements, which are regulations
and guidelines enforced by the FDA, the Competent Authorities of the Member States of the European Economic Area and comparable
foreign regulatory authorities for all of our product candidates in clinical development. Regulatory authorities enforce these
GCP requirements through periodic inspections of trial sponsors, principal investigators and clinical trial sites. If we fail
to exercise adequate oversight over any of our CROs or if we or any of our CROs fail to comply with applicable GCP requirements,
the clinical data generated in our clinical trials may be deemed unreliable and the FDA, EMA or other regulatory authorities may
require us to perform additional clinical trials before approving our marketing applications. We cannot assure you that upon a
regulatory inspection of us or our CROs or other third parties performing services in connection with our clinical trials, such
regulatory authority will determine that any of our clinical trials complies with GCP regulations. In addition, our clinical trials
must be conducted with product produced under applicable cGMP regulations. Our failure to comply with these regulations may require
us to repeat clinical trials, which would delay the regulatory approval process.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
these investigators and CROs are not our employees and we will not be able to control, other than by contract, the amount of resources,
including time, which they devote to our product candidates and clinical trials. If independent investigators or CROs fail to
devote sufficient resources to the development of our product candidates, or if their performance is substandard, it may delay
or compromise the prospects for approval and commercialization of our product candidates. These investigators and CROs may also
have relationships with other commercial entities, including our competitors, for whom they may also be conducting clinical studies
or other drug development activities, which could affect their performance on our behalf. In addition, the use of third-party
service providers requires us to disclose our proprietary information to these parties, which increases the risk that a competitor
will discover them or that this information will be misappropriated or disclosed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any of our relationships with these third-party CROs terminate, we may not be able to enter into arrangements with alternative
CROs or to do so on commercially reasonable terms. If CROs do not successfully carry out their contractual duties or obligations
or meet expected deadlines, if they need to be replaced or if the quality or accuracy of the clinical data they obtain is compromised
due to the failure to adhere to our clinical protocols, regulatory requirements or for other reasons, our clinical trials may
be extended, delayed or terminated and we may not be able to obtain regulatory approval for or successfully commercialize our
product candidates. As a result, our results of operations and commercial prospects would be harmed, our costs could increase
and our ability to generate revenues could be delayed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Repeating
clinical trials or switching or engaging additional CROs involves additional cost and requires our management&rsquo;s time and focus.
In addition, there is a natural transition period when a clinical trial has to be repeated or when a new CRO commences work. As
a result, delays could occur, which could materially impact our ability to meet our desired clinical development timelines.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
reliance on third parties requires us to share our trade secrets, which increases the possibility that a competitor will discover
them or that our trade secrets will be misappropriated or disclosed.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have engaged contract manufacturing organizations, or CMOs, to manufacture Foralumab and Milciclib and to perform quality testing,
and because we collaborate with various organizations and academic institutions for the advancement of our platforms, we must,
at times, share our proprietary technology and confidential information, including trade secrets, with them. We seek to protect
our proprietary technology, in part, by entering into confidentiality agreements and, if applicable, material transfer agreements,
collaborative research agreements, consulting agreements or other similar agreements with our collaborators, advisors, employees
and consultants prior to beginning research or disclosing proprietary information. These agreements typically limit the rights
of the third parties to use or disclose our confidential information. Despite the contractual provisions employed when working
with third parties, the need to share trade secrets and other confidential information increases the risk that such trade secrets
become known by our competitors, are inadvertently incorporated into the technology of others or are disclosed or used in violation
of these agreements. Given that our proprietary position is based, in part, on our know-how and trade secrets, a competitor&rsquo;s
discovery of our proprietary technology and confidential information or other unauthorized use or disclosure of such technology
or information would impair our competitive position and may have an adverse effect on our business, financial condition, results
of operations and prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Despite
our efforts to protect our trade secrets, our competitors may discover our trade secrets, either through breach of these agreements,
independent development or publication of information including our trade secrets by third parties. A competitor&rsquo;s discovery of
our trade secrets would impair our competitive position and have an adverse impact on our business, financial condition, results
of operations and prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
utilize, and expect to continue to utilize, third parties to conduct our product manufacturing for the foreseeable future, and
these third parties may not perform satisfactorily.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
currently rely on CMOs for the manufacturing of clinical batches and intend to continue to rely on third parties to manufacture
our preclinical study and clinical trial product supplies. If our current CMOs, or any future third-party manufacturers, do not
successfully carry out their contractual duties, meet expected deadlines or manufacture our product candidates in accordance with
regulatory requirements, or if there are disagreements between us and our CMOs or any future third-party manufacturers, we will
not be able to complete, or may be delayed in completing, the preclinical studies required to support future IND submissions and
the clinical trials required for approval of our product candidates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to our current CMOs, we may rely on additional third parties to manufacture ingredients of our product candidates in
the future and to perform quality testing, and reliance on these third parties entails risks to which we would not be subject
if we manufactured the product candidates ourselves, including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reduced
                                         control for certain aspects of manufacturing activities;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">termination
                                         or nonrenewal of manufacturing and service agreements with third parties in a manner
                                         or at a time that is costly or damaging to us; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">disruptions
                                         to the operations of our third-party manufacturers and service providers caused by conditions
                                         unrelated to our business or operations, including the bankruptcy of the manufacturer
                                         or service provider.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
of these events could lead to clinical trial delays or failure to obtain regulatory approval, or impact our ability to successfully
commercialize any of our product candidates. Some of these events could be the basis for FDA, EMA or other regulatory authority
action, including injunction, recall, seizure or total or partial suspension of product manufacture.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>To
the extent we rely on a third-party manufacturing facility for commercial supply, that third party will be subject to significant
regulatory oversight with respect to manufacturing our product candidates.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of therapeutics for clinical trials or commercial sale is subject to extensive regulation. Components of a finished
therapeutic product approved for commercial sale or used in late-stage clinical trials must be manufactured in accordance with
cGMP requirements. These regulations govern manufacturing processes and procedures, including record keeping, and the implementation
and operation of quality systems to control and assure the quality of investigational products and products approved for sale.
Poor control of production processes can lead to the introduction of outside agents or other contaminants, or to inadvertent changes
in the properties or stability of a product candidate that may not be detectable in final product testing. To the extent that
we utilize third-party facilities for commercial supply, the third party&rsquo;s facilities and quality systems must pass an inspection
for compliance with the applicable regulations as a condition of regulatory approval. In addition, the regulatory authorities
may, at any time, audit or inspect the third-party manufacturing facility or the associated quality systems for compliance with
the regulations applicable to the activities being conducted. If, for example, these facilities do not pass a plant inspection,
the FDA will not approve the applicable NDA or biologics license application, or BLA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not directly control the manufacturing of, and are completely dependent on, our CMOs for compliance with cGMP requirements.
If our CMOs cannot successfully manufacture material that conforms to our specifications and the strict regulatory requirements
of the FDA, EMA or other regulatory authorities, they will not be able to secure and/or maintain regulatory approval for their
manufacturing facilities. In addition, we have no direct control over the ability of our CMOs to maintain adequate quality control,
quality assurance and qualified personnel. Furthermore, all of our CMOs are engaged with other companies to supply and/or manufacture
materials or products for such companies, which exposes our CMOs to regulatory risks for the production of such materials and
products. As a result, failure to meet the regulatory requirements for the production of those materials and products may generally
affect the regulatory clearance of our CMOs&rsquo; facilities. Our failure, or the failure of third parties, to comply with applicable
regulations could result in sanctions being imposed on us, including clinical holds, fines, injunctions, civil penalties, delays,
suspension or withdrawal of approvals, license revocation, seizures or recalls of product candidates or products, operating restrictions
and criminal prosecutions, any of which could significantly and adversely affect supplies of our products and product candidates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
potential future dependence upon others for the manufacture of our product candidates may adversely affect our future profit margins
and our ability to commercialize any products that receive regulatory approval on a timely and competitive basis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risks
Related to Commercialization of Our Product Candidates</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
currently have no marketing and sales force. If we are unable to establish effective sales, marketing and distribution capabilities
or enter into agreements with third parties to market, sell and distribute our product candidates that may be approved, we may
not be successful in commercializing our product candidates if and when approved, and we may be unable to generate any product
revenue.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
currently do not have a marketing or sales team for the marketing, sales and distribution of any of our product candidates. In
order to commercialize any of our product candidates that may be approved, we intend to build, on a territory-by-territory basis,
marketing, sales, distribution, managerial and other non-technical capabilities or make arrangements with third parties to perform
these services. These efforts will require significant capital expenditures, management resources and time, and we face competition
in search for qualified personnel or third parties to assist with marketing, sales and distribution of any of our product candidates.
We may not be successful in building these capabilities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are risks involved with both establishing our own sales, marketing and distribution capabilities and entering into arrangements
with third parties to perform these services. For example, recruiting and training a sales force is expensive and time consuming
and could delay any product launch. If the commercial launch of a product candidate for which we recruit a sales force and establish
marketing and/or distribution capabilities is delayed or does not occur for any reason, we would have prematurely or unnecessarily
incurred these commercialization expenses. This may be costly and our investment would be lost if we cannot retain or reposition
our sales and marketing personnel.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Factors
that may inhibit our efforts to commercialize our product candidates on our own include:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                         inability to recruit, train and retain adequate numbers of effective sales and marketing
                                         personnel;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         inability of sales personnel to obtain access to physicians or persuade adequate numbers
                                         of physicians to prescribe any future product that we may develop;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         lack of complementary treatments to be offered by sales personnel, which may put us at
                                         a competitive disadvantage relative to companies with more extensive product lines; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">unforeseen
                                         costs and expenses associated with creating an independent sales and marketing organization.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we enter into arrangements with third parties to perform sales, marketing and distribution services, our product revenue or the
profitability to us from these revenue streams is likely to be lower than if we were to market and sell any product candidates
that we develop ourselves. In addition, we may not be successful in entering into arrangements with third parties to sell and
market our product candidates or may be unable to do so on terms that are favorable to us. We likely will have little control
over such third parties and any of them may fail to devote the necessary resources and attention to sell and market our product
candidates effectively. If we do not establish sales and marketing capabilities successfully, either on our own or in collaboration
with third parties, we may not be successful in commercializing our product candidates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
face significant competition in an environment of rapid technological change and the possibility that our competitors may achieve
regulatory approval before us or develop therapies that are more advanced or effective than ours.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
biotechnology and pharmaceutical industries are characterized by rapidly changing technologies, significant competition and a
strong emphasis on intellectual property. We face substantial competition from many different sources, including large and specialty
pharmaceutical and biotechnology companies, academic research institutions, government agencies and public and private research
institutions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 14.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
developments, including the development of other pharmaceutical technologies and methods of treating disease, occur in the pharmaceutical
and life sciences industries at a rapid pace. Developments by competitors may render our product candidates obsolete or noncompetitive.
We anticipate that we will face intense and increasing competition as new treatments enter the market and advanced technologies
become available.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Many
of our potential competitors, alone or with their strategic partners, have substantially greater financial, technical and other
resources, such as larger R&amp;D, clinical, sales and marketing and manufacturing organizations. These third parties also compete
with us in recruiting and retaining qualified scientific and management personnel, establishing clinical trial sites and patient
registration for clinical trials, as well as in acquiring technologies complementary to, or necessary for, the development of
our products. In addition, mergers and acquisitions in the biotechnology and pharmaceutical industries may result in even more
resources being concentrated among a smaller number of competitors. Our commercial opportunity could be reduced or eliminated
if competitors develop and commercialize products that are safer, more effective, have fewer or less severe side effects, are
more convenient or are less expensive than any product candidate that we may develop. Competitors also may obtain FDA, EMA or
other regulatory approval for their products more rapidly or earlier than we may obtain approval for ours, which could result
in our competitors establishing a strong market position before we are able to enter the market. Additionally, technologies developed
by our competitors may render our product candidates uneconomical or obsolete, and we may not be successful in marketing our product
candidates against competitors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, as a result of the expiration or successful challenge of our patent rights, we could face more litigation with respect
to the validity and/or scope of patents relating to our competitors&rsquo; products. The availability of our competitors&rsquo; products could
limit the demand, and the price we are able to charge, for any product candidate that we may develop and commercialize.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
market opportunities for our product candidates may be smaller than we anticipate.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
focus our R&amp;D efforts on treatments for cancer and autoimmune disease. Our understanding of both the number of people who
have these diseases, as well as the subset of people with these diseases who have the potential to benefit from treatment with
our product candidates, is based on estimates. These estimates may prove to be incorrect and new studies may reduce the estimated
incidence or prevalence of these diseases. The number of patients in the United States, the European Union and elsewhere may turn
out to be lower than expected, may not be otherwise amenable to treatment with our product candidates or patients may become increasingly
difficult to identify and access, all of which would adversely affect our business, financial condition, results of operations
and prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
there are several factors that could contribute to making the actual number of patients who receive our potential products, if
and when approved, less than the potentially addressable market. These include, for example, the lack of widespread availability
of, and limited reimbursement for, new therapies in many underdeveloped markets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
future commercial success of our product candidates will depend upon the degree of each product candidates&rsquo; market acceptance
by physicians, patients, third-party payors and others in the medical community.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
product candidates are at varying stages of development, and we may never have a product that is commercially successful. To date,
we have no product authorized for marketing. Due to the inherent risk in the development of pharmaceutical products, we may never
successfully complete development and commercialization of any of our product candidates. Even with the requisite approvals from
the FDA, EMA and other regulatory authorities internationally, the commercial success of our product candidates will depend, in
part, on the acceptance of physicians, patients and third-party payors of our product candidates as medically necessary, cost-effective
and safe. Any product that we commercialize may not gain acceptance by physicians, patients, third-party payors and others in
the medical community. If these products do not achieve an adequate level of acceptance, we may not generate significant product
revenue and may not become profitable. Even if some product candidates achieve market acceptance, the market may not prove to
be large enough to allow us to generate significant revenues. The degree of market acceptance of our product candidates, if approved
for commercial sale, will depend on several factors, including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         effectiveness and safety of our product candidates as demonstrated in clinical trials;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         potential and perceived advantages of our product candidates over alternative treatments;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         availability and cost of treatment relative to alternative treatments;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
                                         in the standard of care for the targeted indications for any product candidate;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         willingness of physicians to prescribe, and the target patient population to try, new
                                         therapies;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         prevalence and severity of any side effects;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">product
                                         labeling or product insert requirements of the FDA, EMA or other regulatory authorities,
                                         including any limitations or warnings contained in a product&rsquo;s approved labeling;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         timing of market introduction of competitive products;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">sales,
                                         distribution and marketing support;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">publicity
                                         concerning our product candidates or competing products and treatments;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">potential
                                         product liability claims;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         restrictions on the use of our products together with other medications; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">favorable
                                         third-party payor coverage and adequate reimbursement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Even
if a potential product displays favorable clinical properties and safety profile in preclinical studies and clinical trials, market
acceptance of the product will not be fully known until after it is launched.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 14.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
insurance coverage and reimbursement status of newly approved products is uncertain. Failure to obtain or maintain adequate coverage
and reimbursement for our product candidates, if approved, could limit our ability to market those products.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect that coverage and adequate reimbursement by government and private payors will be essential for most patients to be able
to afford these treatments. Accordingly, sales of our product candidates will depend substantially, both domestically and abroad,
on the extent to which the costs of our product candidates will be paid by health maintenance, managed care, pharmacy benefit
and similar healthcare management organizations, or will be reimbursed by government authorities, private health coverage insurers
and other third-party payors. Coverage and reimbursement by a third-party payor may depend upon several factors, including the
third-party payor&rsquo;s determination that use of a product is:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                         covered benefit under our health plan;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">safe,
                                         effective and medically necessary;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">appropriate
                                         for the specific patient;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">cost-effective;
                                         and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">neither
                                         experimental nor investigational.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Obtaining
coverage and reimbursement for a product from third-party payors is a time-consuming and costly process that could require us
to provide to the payor supporting scientific, clinical and cost-effectiveness data. We may not be able to provide data sufficient
to gain acceptance with respect to coverage and reimbursement. If coverage and reimbursement are not available, or are available
only at limited levels, we may not be able to successfully commercialize our product candidates. Even if coverage is provided,
the approved reimbursement amount may not be adequate to realize a sufficient return on our investment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is significant uncertainty related to third-party coverage and reimbursement of newly approved products. In the United States,
third-party payors, including government payors such as the Medicare and Medicaid programs, play an important role in determining
the extent to which new drugs and biologics will be covered and reimbursed. The Medicare and Medicaid programs increasingly are
used as models for how private payors develop their coverage and reimbursement policies. However, no uniform policy of coverage
and reimbursement exists among third-party payors. Therefore, coverage and reimbursement for products can differ significantly
from payor to payor. One payor&rsquo;s determination to provide coverage for a product does not assure that other payors will also provide
coverage, and adequate reimbursement. It is difficult to predict what the Centers for Medicare and Medicaid Services, or CMS will
decide with respect to coverage and reimbursement for fundamentally novel products such as ours, as there is no body of established
practices and precedents for these types of products. Moreover, reimbursement agencies in the European Union may be more conservative
than the CMS. For example, several cancer drugs have been approved for reimbursement in the United States and have not been approved
for reimbursement in certain EU member states, or Member States. It is difficult to predict what third-party payors will decide
with respect to the coverage and reimbursement for our product candidates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Also,
the containment of healthcare costs has become a priority of federal, state and foreign governments, and the prices of drugs have
been a focus in this effort. The U.S. government, state legislatures, and foreign governments have shown significant interest
in implementing cost-containment programs to limit the growth of government-paid healthcare costs, including price controls, restrictions
on reimbursement and requirements for substitution of generic products for branded prescription drugs. For example, in the United
States, the Patient Protection and Affordable Care Act of 2010 (as amended by the Health Care and Education Reconciliation Act
of 2010), or the PPACA, contains provisions that may reduce the profitability of products, including, for example, increased rebates
for products sold to Medicaid programs, extension of Medicaid rebates to Medicaid managed care plans, mandatory discounts for
certain Medicare Part D beneficiaries and annual fees based on pharmaceutical companies&rsquo; share of sales to federal health care
programs. Further, there has been heightened governmental scrutiny over the manner in which manufacturers set prices for their
marketed products, which has resulted in several recent congressional inquiries and proposed federal and state legislation designed
to, among other things, bring more transparency to product pricing, contain the cost of drugs, review the relationship between
pricing and manufacturer patient programs, and reform government program reimbursement methodologies for products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outside
the United States, international operations generally are subject to extensive government price controls and other market regulations,
and increasing emphasis on cost-containment initiatives in the European Union, Canada and other countries may put pricing pressure
on us. In many countries, the prices of medical products are subject to varying price control mechanisms as part of national health
systems. In general, the prices of medicines under such systems are substantially lower than in the United States. Other countries
allow companies to fix their own prices for medical products, but monitor and control company profits. Additional foreign price
controls or other changes in pricing regulation could restrict the amount that we are able to charge for our product candidates.
Accordingly, in markets outside the United States, the reimbursement for our product candidates may be reduced compared with the
United States and may be insufficient to generate commercially reasonable product revenues.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, there can be considerable pressure by governments and other stakeholders on prices and reimbursement levels, including
as part of cost containment measures. Political, economic and regulatory developments may further complicate pricing negotiations,
and pricing negotiations may continue after reimbursement has been obtained. Reference pricing used by various Member States and
parallel distribution, or arbitrage between low-priced and high-priced Member States, can further reduce prices. To obtain reimbursement
or pricing approval in some countries, we may be required to conduct a clinical trial that compares the cost-effectiveness of
our product candidates to other available therapies. If reimbursement of our products is unavailable or limited in scope or amount,
or if pricing is set at unsatisfactory levels, our business could be harmed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Moreover,
increasing efforts by government and third-party payors in the United States and abroad to cap or reduce healthcare costs may
cause such organizations to limit both coverage and the level of reimbursement for new products approved and, as a result, they
may not cover or provide adequate payment for our product candidates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Payors
increasingly are considering new metrics as the basis for reimbursement rates, such as average sales price, average manufacturer
price and actual acquisition cost. The existing data for reimbursement based on some of these metrics is relatively limited, although
certain states have begun to survey acquisition cost data for the purpose of setting Medicaid reimbursement rates, and CMS has
begun making pharmacy National Average Drug Acquisition Cost and National Average Retail Price data publicly available on at least
a monthly basis. Therefore, it may be difficult to project the impact of these evolving reimbursement metrics on the willingness
of payors to cover product candidates that we or our partners are able to commercialize. We expect to experience pricing pressures
in connection with the sale of any of our product candidates due to the trend toward managed healthcare, the increasing influence
of health maintenance organizations and additional legislative changes. The downward pressure on healthcare costs in general,
particularly prescription drugs and surgical procedures and other treatments, has become intense. As a result, increasingly high
barriers are being erected to the entry of new products such as ours.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risks
Related to Our Intellectual Property</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
rights to develop and commercialize our product candidates are subject to the terms and conditions of licenses granted to us by
others. If we fail to comply with our obligations under our existing and any future intellectual property licenses with third
parties, we could lose license rights that are important to the business.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not currently own any patents; however, we are heavily reliant upon licenses and sublicenses from Nerviano and Novimmune to
certain patent rights and proprietary technology that are important or necessary to the development of our technology and product
candidates, including the patents and know-how relating to manufacture. These and other licenses may not provide exclusive rights
to use such intellectual property and technology, or may not provide exclusive rights to use such intellectual property and technology
in all relevant fields of use and in all territories in which we may wish to develop or commercialize our technology and product
candidates in the future. As a result, we may not be able to prevent competitors from developing and commercializing competitive
products, including in territories covered by our licenses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
some circumstances, we may not have the right to control the preparation, filing and prosecution of patent applications, or to
maintain the patents, covering technology that we license from third parties. If our licensors fail to maintain such patents or
patent applications, or lose rights to those patents or patent applications, the rights we have licensed may be reduced or eliminated
and our right to develop and commercialize any of our product candidates that are the subject of such licensed rights could be
adversely affected. In addition to the foregoing, the risks associated with patent rights that we license from third parties will
also apply to patent rights we may own in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Licenses
to additional third-party technology and materials that may be required for our development programs, including additional technology
and materials owned by any of our current licensors, may not be available in the future or may not be available on commercially
reasonable terms, or at all, which could have an adverse effect on our business and financial condition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
we are unable to obtain and maintain patent protection for our current product candidates, any future product candidates we may
develop and our technology, or if the scope of the patent protection obtained is not sufficiently broad, our competitors could
develop and commercialize products and technology similar or identical to ours.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
success depends, in large part, on our ability to seek, obtain and maintain patent protection in the United States and other countries
with respect to our product candidates and to future innovation related to our manufacturing technology. Our licensors have sought
and we intend to seek to protect our proprietary position by filing patent applications in the United States, the United Kingdom
and elsewhere, related to certain technologies and our product candidates that are important to our business. Our current patent
portfolio contains a limited number of patent applications, all of which are in-licensed from third parties and relate to either
composition of matter, formulation, method of use or process of manufacturing Foralumab, Milciclib and a fully human anti-interleukin-6
receptor, or IL-6r, mAb. However, the risks associated with patent rights generally apply to patent rights that we in-license
now or in the future, as well as patent rights that we may own in the future. Moreover, the risks apply with respect to patent
rights and other intellectual property applicable to our product candidates, as well as to any intellectual property rights that
we may acquire in the future related to future product candidates, if any. We have filed a new patent application covering the
composition of matter of Foralumab. However, this application is pending and there is no guarantee that the U.S. Patent
and Trademark Office, or USPTO, will grant this application.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
patent prosecution process is expensive, time-consuming and complex, and we may not be able to file, prosecute, maintain, enforce
or license all necessary or desirable patent applications at a reasonable cost or in a timely manner.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
some cases, the work of certain academic researchers in the oncology and immunology fields has entered the public domain, which
we believe precludes our ability to obtain patent protection for certain inventions relating to such work.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consequently,
we will not be able to assert any such patents to prevent others from using our technology for, and developing and marketing competing
products to treat, these indications. It is also possible that we will fail to identify patentable aspects of our R&amp;D output
before it is too late to obtain patent protection.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
existing license agreements impose, and we expect that future license agreements will impose, various due diligence, development
and commercialization timelines, insurance, milestone payments, royalties and other obligations on us. See the description in
the section titled &ldquo;Business-Collaboration and License Agreements&rdquo; herein. If we fail to comply with our obligations
under these agreements, or we are subject to a bankruptcy, or, in some cases, under other circumstances, the licensor may have
the right to terminate the license, in which event we would not be able to market product candidates covered by the license. In
addition, certain of these license agreements are not assignable by us without the consent of the respective licensor, which may
have an adverse effect on our ability to engage in certain transactions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
patent position of biotechnology and pharmaceutical companies generally is highly uncertain, involves complex legal and factual
questions and has, in recent years, been the subject of much litigation. As a result, the issuance, scope, validity, enforceability
and commercial value of any patent rights are highly uncertain. Our licensed patent applications may not result in patents being
issued which protect our technology or product candidates, effectively prevent others from commercializing competitive technologies
and product candidates or otherwise provide any competitive advantage. In fact, patent applications may not issue as patents at
all. Even assuming patents issue from patent applications in which we have rights, changes in either the patent laws or interpretation
of the patent laws in the United States and other countries may diminish the value of our patents or narrow the scope of our patent
protection.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
parties have developed technologies that may be related or competitive to our own and such parties may have filed or may file
patent applications, or may have received or may receive patents, claiming inventions that may overlap or conflict with those
claimed in our own patent applications or issued patents. We may not be aware of all third-party intellectual property rights
potentially relating to our current and future product candidates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Publications
of discoveries in the scientific literature often lag behind the actual discoveries, and patent applications in the United States
and in other jurisdictions are typically not published until 18 months after filing, or, in some cases, not at all. Therefore,
we cannot know with certainty whether the inventors of our licensed patents and applications were the first to make the inventions
claimed in those patents or pending patent applications, or that they were the first to file for patent protection of such inventions.
Similarly, should we own any patents or patent applications in the future, we may not be certain that we were the first to file
for patent protection for the inventions claimed in such patents or patent applications. As a result, the issuance, scope, validity
and commercial value of our patent rights cannot be predicted with any certainty.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
degree of patent protection we require to successfully compete in the marketplace may be unavailable or severely limited in some
cases and may not adequately protect our rights or permit us to gain or keep any competitive advantage. We cannot provide any
assurances that any of our licensed patents have, or that any of our pending licensed patent applications that mature into issued
patents will include, claims with a scope sufficient to protect our product candidates or otherwise provide any competitive advantage.
In addition, the laws of foreign countries may not protect our rights to the same extent as the laws of the United States. Furthermore,
patents have a limited lifespan. In the United States, the natural expiration of a patent is generally 20 years after it is filed.
Various extensions may be available; however, the life of a patent, and the protection it affords, is limited. Given the amount
of time required for the development, testing and regulatory review of new product candidates, patents protecting such candidates
might expire before or shortly after such candidates are commercialized. As a result, our licensed patent portfolio may not provide
us with adequate and continuing patent protection sufficient to exclude others from commercializing products similar to our product
candidates, including &ldquo;highly similar,&rdquo; or biosimilar, versions of such products. In addition, the intellectual property
portfolio licensed to us by Nerviano and Novimmune may be used by them or licensed to third parties, and such third parties may
have certain enforcement rights. Thus, patents licensed to us could be put at risk of being invalidated or interpreted narrowly
in litigation filed by or against our licensors or another licensee or in administrative proceedings brought by or against our
licensors or another licensee in response to such litigation or for other reasons.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Even
if we acquire patent protection that we expect should enable us to maintain some competitive advantage, third parties, including
competitors, may challenge the validity, enforceability or scope thereof, which may result in such patents being narrowed, invalidated
or held unenforceable. In litigation, a competitor could claim that our patents, if issued, are not valid for a number of reasons.
If a court agrees, we would lose our rights to those challenged patents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
issuance of a patent is not conclusive as to its inventorship, scope, validity or enforceability and our licensed patents may
be challenged in courts or patent offices in the United States and abroad. For example, we may be subject to a third-party submission
of prior art to the USPTO challenging the validity of one or more claims of our licensed patents. Such submissions may also be
made prior to a patent&rsquo;s issuance, precluding the granting of a patent based on one of our pending licensed patent applications.
We may become involved in opposition, derivation, re-examination, inter partes review, post-grant review or interference proceedings
challenging the patent rights of others from whom we have obtained licenses to such rights. Competitors may claim that they invented
the inventions claimed in our licensed issued patents or patent applications prior to the inventors of such patents or applications.
A competitor who can establish an earlier filing or invention date may also claim that we are infringing their patents and that
we therefore cannot practice our technology as claimed under our licensed patents, if issued. Competitors may also contest our
licensed patents, if issued, by showing that the invention was not patent-eligible, was not novel, was obvious or that the patent
claims failed any other requirement for patentability.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
adverse determination by former employees or consultants asserting ownership rights to our patents may result in loss of exclusivity
or freedom to operate or in patent claims being narrowed, invalidated or held unenforceable, in whole or in part, which could
limit our ability to stop others from using or commercializing similar technology and therapeutics, without payment to us, or
could limit the duration of the patent protection covering our technology and product candidates. Such challenges may also result
in our inability to manufacture or commercialize our product candidates without infringing third-party patent rights. In addition,
if the breadth or strength of protection provided by our patents and patent applications is threatened, it could dissuade companies
from collaborating with us to license, develop or commercialize current or future product candidates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Even
if they are unchallenged, our licensed patents and pending patent applications, if issued, may not provide us with any meaningful
protection or prevent competitors from designing around our patent claims to circumvent our licensed patents by developing similar
or alternative technologies or therapeutics in a non-infringing manner. For example, a third party may develop a competitive therapeutic
that provides benefits similar to one or more of our product candidates but that uses a different antibody or molecular active
ingredient that falls outside the scope of our patent protection. If the patent protection provided by the patents and patent
applications we hold or pursue with respect to our product candidates is not sufficiently broad to impede such competition, our
ability to successfully commercialize our product candidates could be negatively affected, which would harm our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
intellectual property licenses with third parties may be subject to disagreements over contract interpretation, which could narrow
the scope of our rights to the relevant intellectual property or technology or increase our financial or other obligations to
our licensors.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
currently depend, and will continue to depend, on our license agreements whereby we obtain rights in certain patents and patent
applications owned by them. Further development and commercialization of our current product candidates may, and development of
any future product candidates will, require us to enter into additional license or collaboration agreements. The agreements under
which we currently license intellectual property or technology from third parties are complex, and certain provisions in such
agreements may be susceptible to multiple interpretations. The resolution of any contract interpretation disagreement that may
arise could narrow what we believe to be the scope of our rights to the relevant intellectual property or technology, or increase
what we believe to be our financial or other obligations under the relevant agreement, either of which could have an adverse effect
on our business, financial condition, results of operations and prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any of our licenses or material relationships or any in-licenses upon which our licenses are based are terminated or breached,
we may:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">lose
                                         our rights to develop and market our product candidates;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">lose
                                         patent protection for our product candidates;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">experience
                                         significant delays in the development or commercialization of our product candidates;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">not
                                         be able to obtain any other licenses on acceptable terms, if at all; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">incur
                                         liability for damages.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 14.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, a third party may in the future bring claims that our performance under our license agreements, including our sponsoring
of clinical trials, interferes with such third party&rsquo;s rights under its agreement with one of our licensors. If any such claim
were successful, it may adversely affect our rights and ability to advance our product candidates as clinical candidates or subject
us to liability for monetary damages, any of which would have an adverse effect on our business, financial condition, results
of operations and prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 14.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
risks apply to any agreements that we may enter into in the future for our current or any future product candidates. If we experience
any of the foregoing, it could have a negative impact on our business, financial condition, results or operations and prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
we fail to comply with our obligations in the agreements under which we license intellectual property rights from third parties
or otherwise experience disruptions to our business relationships with our licensors, we could lose license rights that are important
to our business.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have entered into license agreements with third parties and may need to obtain additional licenses from one or more of these same
third parties or from others to advance our research or allow commercialization of our product candidates. It is possible that
we may be unable to obtain additional licenses at a reasonable cost or on reasonable terms, if at all. In that event, we may be
required to expend significant time and resources to redesign our product candidates or the methods for manufacturing them or
to develop or license replacement technology, all of which may not be feasible on a technical or commercial basis. If we are unable
to do so, we may be unable to develop or commercialize our product candidates, which would harm our business. We cannot provide
any assurances that third-party patents or other intellectual property rights do not exist which might be enforced against our
current product candidates or future product candidates, resulting in either an injunction prohibiting our manufacture or sales,
or, with respect to our sales, an obligation on our part to pay royalties and/or other forms of compensation to third parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
each of our existing license agreements, and we expect in our future agreements, patent prosecution of our licensed technology
is controlled solely by the licensor, and we may be required to reimburse the licensor for their costs of patent prosecution.
If our licensors fail to obtain and maintain patent or other protection for the proprietary intellectual property we license from
them, we could lose our rights to the intellectual property or our exclusivity with respect to those rights, and our competitors
could market competing products using the intellectual property. Our license agreements with Nerviano and Novimmune also require
us to meet development thresholds to maintain each license, including establishing a set timeline for developing and commercializing
product candidates. Disputes may arise regarding intellectual property subject to a licensing agreement, including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         scope of rights granted under the license agreement and other interpretation-related
                                         issues;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         extent to which our technology and processes infringe on intellectual property of the
                                         licensor that is not subject to the licensing agreement;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         sublicensing of patent and other rights pursuant to our collaborative development relationships;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                         diligence obligations under the license agreements and what activities satisfy those
                                         diligence obligations;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         inventorship or ownership of inventions and know-how resulting from the joint creation
                                         or use of intellectual property by our licensors and us and our partners; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         priority of invention of patented technology.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
disputes over intellectual property that we have licensed prevent or impair our ability to maintain our current licensing arrangements
on acceptable terms, we may be unable to successfully develop and commercialize our product candidates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
may not be successful in obtaining or maintaining necessary rights to our product candidates through acquisitions and in-licenses.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
currently have certain rights to the intellectual property, through licenses from third parties, to develop our product candidates.
Because our programs may require the use of additional proprietary rights held by these or other third parties, the growth of
our business likely will depend, in part, on our ability to acquire, in-license or use these proprietary rights. We may be unable
to acquire or in-license any compositions, methods of use, processes or other intellectual property rights from third parties
that we identify as necessary for our product candidates. The licensing or acquisition of third-party intellectual property rights
is a competitive area, and several more established companies may pursue strategies to license or acquire third-party intellectual
property rights that we may consider attractive. These established companies may have a competitive advantage over us due to their
size, capital resources and greater clinical development and commercialization capabilities. In addition, companies that perceive
us to be a competitor may be unwilling to assign or license rights to us. We also may be unable to license or acquire third-party
intellectual property rights on terms that would allow us to make an appropriate return on our investment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may collaborate with non-profit and academic institutions to accelerate our preclinical R&amp;D under written agreements with
these institutions. These institutions may provide us with an option to negotiate a license to any of the institution&rsquo;s rights
in technology resulting from the collaboration. Regardless of such option, we may be unable to negotiate a license within the
specified timeframe or under terms that are acceptable to us. If we are unable to do so, the institution may offer the intellectual
property rights to other parties, potentially blocking our ability to pursue our program.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we are unable to successfully obtain rights to required third-party intellectual property or maintain the existing intellectual
property rights we have, we may have to abandon development of our product candidates and our business, financial condition, results
of operations and prospects could suffer. Moreover, to the extent that we seek to develop other product candidates in the future,
we will likely require acquisition or in-license of additional proprietary rights held by third parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Obtaining
and maintaining our patent protection depends on compliance with various procedural, document submission, fee payment and other
requirements imposed by government patent agencies, and our patent protection could be reduced or eliminated as a result of non-compliance
with these requirements.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Periodic
maintenance fees, renewal fees, annuity fees and various other government fees on patents and/or applications will be due to be
paid to the USPTO and various government patent agencies outside of the United States over the lifetime of our licensed patents
and/or applications and any patent rights we may own in the future. We rely on our outside counsel or our licensing partners to
pay these fees due to non-U.S. patent agencies. The USPTO and various non-U.S. government patent agencies require compliance with
several procedural, documentary, fee payment and other similar provisions during the patent application process. We employ reputable
law firms and other professionals to help us comply and we are also dependent on our licensors to take the necessary action to
comply with these requirements with respect to our licensed intellectual property. In many cases, an inadvertent lapse can be
cured by payment of a late fee or by other means in accordance with the applicable rules. There are situations, however, in which
non-compliance can result in abandonment or lapse of the patent or patent application, resulting in partial or complete loss of
patent rights in the relevant jurisdiction. In such an event, potential competitors might be able to enter the market and this
circumstance could have an adverse effect on our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>We
may not be able to protect our intellectual property rights throughout the world.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Filing,
prosecuting and defending patents on product candidates in all countries throughout the world would be prohibitively expensive,
and our intellectual property rights in some countries outside the United States could be less extensive than those in the United
States. In some cases, we may not be able to obtain patent protection for certain licensed technology outside the United States.
In addition, the laws of some foreign countries do not protect intellectual property rights to the same extent as federal and
state laws in the United States, even in jurisdictions where we do pursue patent protection. Consequently, we may not be able
to prevent third parties from practicing our inventions in all countries outside the United States, even in jurisdictions where
we do pursue patent protection or from selling or importing products made using our inventions in and into the United States or
other jurisdictions.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Competitors
may use our technologies in jurisdictions where we have not pursued and obtained patent protection to develop their own products
and, further, may export otherwise infringing products to territories where we have patent protection, but enforcement is not
as strong as that in the United States. These products may compete with our product candidates, and our patents or other intellectual
property rights may not be effective or sufficient to prevent them from competing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Many
companies have encountered significant problems in protecting and defending intellectual property rights in foreign jurisdictions.
The legal systems of certain countries, particularly certain developing countries, do not favor the enforcement of patents, trade
secrets and other intellectual property protection, particularly those relating to biotechnology products, which could make it
difficult for us to stop the infringement of our patents, if pursued and obtained, or marketing of competing products in violation
of our proprietary rights generally. Moreover, many countries have compulsory licensing laws under which a patent owner may be
compelled to grant licenses to third parties. Many countries limit the enforceability of patents against government agencies or
government contractors. In these countries, the patent owner may have limited remedies, which could materially diminish the value
of such patent. If we or any of our licensors is forced to grant a license to third parties with respect to any patents relevant
to our business, our competitive position may be impaired and our business and results of operations may be adversely affected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, proceedings to enforce our patent rights in foreign jurisdictions could result in substantial costs and divert our efforts
and attention from other aspects of our business, could put our patents at risk of being invalidated or interpreted narrowly and
our patent applications at risk of not issuing and could provoke third parties to assert claims against us. We may not prevail
in any lawsuits that we initiate and the damages or other remedies awarded, if any, may not be commercially meaningful. Accordingly,
our efforts to enforce our intellectual property rights around the world may be inadequate to obtain a significant commercial
advantage from the intellectual property that we develop or license.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
may not be able to protect our trade secrets in court.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to the protection afforded by patents, we rely on trade secret protection and confidentiality agreements to protect proprietary
know-how that is not patentable or that we elect not to patent, processes for which patents are difficult to enforce and any other
elements of our product candidate discovery and development processes that involve proprietary know-how, information or technology
that is not covered by patents. However, trade secrets can be difficult to protect and some courts inside and outside the United
States are less willing or unwilling to protect trade secrets. We seek to protect our proprietary technology and processes, in
part, by entering into confidentiality agreements with our employees, consultants, scientific advisors and contractors. However,
we may not be able to prevent the unauthorized disclosure or use of our technical know-how or other trade secrets by the parties
to these agreements, despite the existence generally of confidentiality agreements and other contractual restrictions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Monitoring
unauthorized uses and disclosures is difficult and we do not know whether the steps we have taken to protect our proprietary technologies
will be effective. If any of the collaborators, scientific advisors, employees and consultants who are parties to these agreements
breach or violate the terms of any of these agreements, we may not have adequate remedies for any such breach or violation. As
a result, we could lose our trade secrets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
cannot guarantee that we have entered into such agreements with each party that may have or have had access to our trade secrets
or proprietary technology and processes. We also seek to preserve the integrity and confidentiality of our data and trade secrets
by maintaining physical security of our premises and physical and electronic security of our information technology systems. While
we have confidence in these individuals, organizations and systems, agreements and security measures, they may still be breached,
and we may not have adequate remedies for any breach.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, our trade secrets may otherwise become known or be independently discovered by competitors. Competitors could purchase
our product candidates and attempt to replicate some or all of the competitive advantages we derive from our development efforts,
willfully infringe our intellectual property rights, design around our protected technology or develop their own competitive technologies
that fall outside of our intellectual property rights. If any of our trade secrets were to be lawfully obtained or independently
developed by a competitor, we would have no right to prevent them, or those to whom they communicate such trade secrets, from
using that technology or information to compete with us. If our trade secrets are not adequately protected so as to protect our
market against competitors&rsquo; therapeutics, our competitive position could be adversely affected, as could our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Third
parties may initiate legal proceedings alleging that we are infringing their intellectual property rights.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
commercial success depends upon our ability and the ability of our future collaborators to develop, manufacture, market and sell
our product candidates and use our proprietary technologies without infringing the proprietary rights and intellectual property
of third parties. The biotechnology and pharmaceutical industries are characterized by extensive and complex litigation regarding
patents and other intellectual property rights. We may in the future become party to, or be threatened with, adversarial proceedings
or litigation regarding intellectual property rights with respect to our product candidates and technology, including interference
proceedings, post grant review and inter partes review before the USPTO. Our competitors or other third parties may assert infringement
claims against us, alleging that our therapeutics, manufacturing methods, formulations or administration methods are covered by
their patents. Given the vast number of patents in our field of technology, we cannot be certain or guarantee that we do not infringe
existing patents or that we will not infringe patents that may be granted in the future. Since this area is competitive and of
strong interest to pharmaceutical and biotechnology companies, there will likely be additional patent applications filed and additional
patents granted in the future, as well as additional R&amp;D programs expected in the future. Furthermore, because patent applications
can take many years to issue, may be confidential for 18 months or more after filing and can be revised before issuance, there
may be applications now pending which may later result in issued patents that may be infringed by the manufacture, use, sale or
importation of our product candidates and we may or may not be aware of such patents. If a patent holder believes the manufacture,
use, sale or importation of one of our product candidates infringes its patent, the patent holder may sue us even if we have licensed
other patent protection for our technology. Moreover, we may face patent infringement claims from non-practicing entities that
have no relevant product revenue and against whom our licensed patent portfolio may therefore have no deterrent effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is also possible that we have failed to identify relevant third-party patents or applications. For example, applications filed
before November 29, 2000 and certain applications filed after that date that will not be filed outside the United States may remain
confidential until patents issue. Moreover, it is difficult for industry participants, including us, to identify all third-party
patent rights that may be relevant to our product candidates and technologies because patent searching is imperfect due to differences
in terminology among patents, incomplete databases and the difficulty in assessing the meaning of patent claims. We may fail to
identify relevant patents or patent applications or may identify pending patent applications of potential interest but incorrectly
predict the likelihood that such patent applications may issue with claims of relevance to our technology. In addition, we may
be unaware of one or more issued patents that would be infringed by the manufacture, sale or use of a current or future product
candidate, or we may incorrectly conclude that a third-party patent is invalid, unenforceable or not infringed by our activities.
Additionally, pending patent applications that have been published can, subject to certain limitations, be later amended in a
manner that could cover our technologies, our product candidates or the use of our product candidates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Third
parties may assert infringement claims against us based on existing patents or patents that may be granted in the future, regardless
of their merit. There is a risk that third parties may choose to engage in litigation with us to enforce or to otherwise assert
their patent or other intellectual property rights against us. Even if we believe such claims are without merit, a court of competent
jurisdiction could hold that these third-party patents are valid, enforceable and infringed, which could adversely affect our
ability to commercialize our product candidates. In order to successfully challenge the validity of any such U.S. patent in federal
court, we would need to overcome a presumption of validity. As this burden is a high one requiring us to present clear and convincing
evidence as to the invalidity of any such U.S. patent claim, there is no assurance that a court of competent jurisdiction would
invalidate the claims of any such U.S. patent. Similarly, there is no assurance that a court of competent jurisdiction would find
that product candidates or our technology did not infringe a third-party patent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patent
and other types of intellectual property litigation can involve complex factual and legal questions, and their outcome is uncertain.
If we are found, or believe there is a risk that we may be found, to infringe a third party&rsquo;s valid and enforceable intellectual
property rights, we could be required or may choose to obtain a license from such third party to continue developing, manufacturing
and marketing our product candidates and technology. However, we may not be able to obtain any required license on commercially
reasonable terms or at all. Even if we were able to obtain a license, it could be non-exclusive, thereby giving our competitors
and other third parties access to the same technologies licensed to us, and it could require us to make substantial licensing
and royalty payments. We could be forced, including by court order, to cease developing, manufacturing and commercializing the
infringing technology or product candidate. In addition, we could be found liable for monetary damages, including treble damages
and attorneys&rsquo; fees, if we are found to have willfully infringed a patent or other intellectual property right. A finding of infringement
could prevent us from manufacturing and commercializing our product candidates or force us to cease some or all of our business
operations, which could harm our business. Claims that we have misappropriated the confidential information or trade secrets of
third parties could have a similar negative impact on our business, financial condition, results of operations and prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Intellectual
property litigation could cause us to spend substantial resources and distract our personnel from their normal responsibilities.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Litigation
or other legal proceedings relating to intellectual property claims, with or without merit, are unpredictable and generally expensive
and time-consuming. Competitors may infringe our patents or the patents of our licensing partners, should such patents issue,
or we may be required to defend against claims of infringement. To counter infringement or unauthorized use claims or to defend
against claims of infringement can be expensive and time consuming. Even if resolved in our favor, litigation or other legal proceedings
relating to intellectual property claims may cause us to incur significant expenses, and could distract our technical and management
personnel from their normal responsibilities. Furthermore, because of the substantial amount of discovery required in connection
with intellectual property litigation, there is a risk that some of our confidential information could be compromised by disclosure
during this type of litigation. In addition, there could be public announcements of the results of hearings, motions or other
interim proceedings or developments and if securities analysts or investors perceive these results to be negative, it could have
a substantial adverse effect on us. Such litigation or proceedings could substantially increase our operating losses and reduce
the resources available for development activities or any future sales, marketing or distribution activities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
may not have sufficient financial or other resources to adequately conduct such litigation or proceedings. Some of our competitors
may be able to sustain the costs of such litigation or proceedings more effectively than we can because of their greater financial
resources and more mature and developed intellectual property portfolios.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accordingly,
despite our efforts, we may not be able to prevent third parties from infringing, misappropriating or successfully challenging
our intellectual property rights. Uncertainties resulting from the initiation and continuation of patent litigation or other proceedings
could have a negative impact on our ability to compete in the marketplace.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
may be subject to claims asserting that our employees, consultants or advisors have wrongfully used or disclosed alleged trade
secrets of their current or former employers or claims asserting ownership of what we regard as our own intellectual property.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
of our employees, consultants or advisors are currently, or were previously, employed at universities or other biotechnology or
pharmaceutical companies, including our competitors or potential competitors, as well as our academic partners. Although we try
to ensure that our employees, consultants and advisors do not use the proprietary information or know-how of others in their work
for us, we may be subject to claims that these individuals or we have used or disclosed intellectual property, including trade
secrets or other proprietary information, of any such individual&rsquo;s current or former employer. Litigation may be necessary to
defend against these claims. If we fail in defending any such claims, in addition to paying monetary damages, we may lose valuable
intellectual property rights. An inability to incorporate such technologies or features would harm our business and may prevent
us from successfully obtaining necessary regulatory approvals and commercializing our product candidates. In addition, we may
lose personnel as a result of such claims, and any such litigation or the threat thereof may adversely affect our ability to hire
employees or contract with independent contractors. A loss of key personnel or their work product could hamper or prevent our
ability to obtain necessary regulatory approvals and commercialize our product candidates, which would have an adverse effect
on our business, results of operations and financial condition. Even if we are successful in defending against such claims, litigation
could result in substantial costs and be a distraction to management.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, while it is our policy to require our employees and contractors who may be involved in the conception or development
of intellectual property to execute agreements assigning such intellectual property to us, we may be unsuccessful in executing
such an agreement with each party who, in fact, conceives or develops intellectual property that we regard as our own. Moreover,
even when we obtain agreements assigning intellectual property to us, the assignment of intellectual property rights may not be
self-executing or the assignment agreements may be breached, and we may be forced to bring claims against third parties, or defend
claims that they may bring against us, to determine the ownership of what we regard as our intellectual property. Furthermore,
individuals executing agreements with us may have pre-existing or competing obligations to a third party, such as an academic
institution, and thus an agreement with us may be ineffective in perfecting ownership of inventions developed by that individual.
Disputes about the ownership of intellectual property that we may own may have an adverse effect on our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Changes
in U.S. patent law could diminish the value of patents in general, thereby impairing our ability to protect our product candidates.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recent
patent reform legislation could increase the uncertainties and costs surrounding the prosecution of patent applications and the
enforcement or defense of issued patents. On September 16, 2011, the Leahy-Smith America Invents Act, or the Leahy-Smith Act,
was signed into law. The Leahy-Smith Act includes several significant changes to U.S. patent law. These include provisions that
affect the way patent applications are prosecuted and also may affect patent litigation. These also include provisions that switched
the United States from a &ldquo;first-to-invent&rdquo; system to a &ldquo;first-to-file&rdquo; system, allow third-party submission
of prior art to the USPTO during patent prosecution and set forth additional procedures to attack the validity of a patent through
various post-grant proceedings administered by the USPTO. Under a first-to-file system, assuming the other requirements for patentability
are met, the first inventor to file a patent application generally will be entitled to the patent on an invention regardless of
whether another inventor had made the invention earlier. The USPTO developed new regulations and procedures to govern administration
of the Leahy-Smith Act, and many of the substantive changes to patent law associated with the Leahy-Smith Act, and in particular,
the first-to-file provisions, only became effective on March 16, 2013.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accordingly,
it is not clear what, if any, impact the Leahy-Smith Act will have on the operation of our business. However, the Leahy-Smith
Act and its implementation could increase the uncertainties and costs surrounding the prosecution of our patent applications and
the enforcement or defense of our issued patents, all of which could have a negative impact effect on our business, financial
condition, results of operations and prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
the U.S. Supreme Court has ruled on several patent cases in recent years, either narrowing the scope of patent protection available
in certain circumstances or weakening the rights of patent owners in certain situations. In addition to increasing uncertainty
with regard to our ability to obtain patents in the future, the combination of new federal legislation, federal court decisions,
and guidance from the USPTO has created uncertainty with respect to the value of patents, once obtained. Depending on the decisions
by the U.S. Congress, federal courts, and the USPTO, the laws and regulations governing patents could change in unpredictable
ways that would weaken our ability to obtain new patents or enforce our existing patents and patents we might obtain in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
our trademarks and trade names are not adequately protected, then we may not be able to build name recognition in our markets
of interest.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not currently have any registered trademarks and we have not filed any trademark applications to date. Any trademark applications
in the United States, Europe and in other foreign jurisdictions where we may file may not be allowed or may subsequently be opposed.
Once filed and registered, our trademarks or trade names may be challenged, infringed, circumvented or declared generic or determined
to be infringing on other marks. As a means to enforce our trademark rights and prevent infringement, we may be required to file
trademark claims against third parties or initiate trademark opposition proceedings. This can be expensive and time-consuming,
particularly for a company of our size. We may not be able to protect our rights to these trademarks and trade names, which we
need to build name recognition among potential partners or customers in our markets of interest. At times, competitors may adopt
trade names or trademarks similar to ours, thereby impeding our ability to build brand identity and possibly leading to market
confusion. In addition, there could be potential trade name or trademark infringement claims brought by owners of other registered
trademarks or trademarks that incorporate variations of our registered or unregistered trademarks or trade names. Over the long
term, if we are unable to establish name recognition based on our trademarks and trade names, then we may not be able to compete
effectively and our business may be adversely affected. Our efforts to enforce or protect our proprietary rights related to trademarks,
trade secrets, domain names, copyrights or other intellectual property may be ineffective and could result in substantial costs
and diversion of resources.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Intellectual
property rights and regulatory exclusivity rights do not necessarily address all potential threats</I>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
degree of future protection afforded by our intellectual property rights is uncertain because intellectual property rights have
limitations, and may not adequately protect our business or permit us to maintain our competitive advantage. For example:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">others
                                         may be able to make products that are similar to our product candidates but that are
                                         not covered by the claims of the patents that we license or may own in the future;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">we,
                                         or our license partners or future collaborators, might not have been the first to make
                                         the inventions covered by the issued patent or pending patent applications that we license
                                         or may own in the future;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">we,
                                         or our license partners or future collaborators, might not have been the first to file
                                         patent applications covering certain of our or their inventions;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">others
                                         may independently develop similar or alternative technologies or duplicate any of our
                                         technologies without infringing our owned or licensed intellectual property rights;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">others
                                         may circumvent our regulatory exclusivities, such as by pursuing approval of a competitive
                                         product candidate via the traditional approval pathway based on their own clinical data,
                                         rather than relying on the abbreviated pathway provided for biosimilar applicants;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">it
                                         is possible that our pending licensed patent applications or those that we may own in
                                         the future will not lead to issued patents;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">issued
                                         patents that we hold rights to now or in the future may be held invalid or unenforceable,
                                         including as a result of legal challenges by our competitors;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">others
                                         may have access to the same intellectual property rights licensed to us on a non-exclusive
                                         basis;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                         competitors might conduct R&amp;D activities in countries where we do not have patent
                                         rights and then use the information learned from such activities to develop competitive
                                         products for sale in our major commercial markets;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
                                         may not develop additional proprietary technologies that are patentable;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         patents or other intellectual property rights of others may have an adverse effect on
                                         our business; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
                                         may choose not to file a patent for certain trade secrets or know-how, and a third party
                                         may subsequently file a patent covering such intellectual property.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Should
any of these events occur, they could significantly harm our business, financial condition, results of operations and prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risks
Related to Government Regulation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Even
if we complete the necessary clinical trials, we cannot predict when, or if, we will obtain regulatory approval to commercialize
our product candidates and the approval may be for a more narrow indication than we seek.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
cannot commercialize a product candidate until the appropriate regulatory authorities have reviewed and approved the product candidate.
The FDA must review and approve any new pharmaceutical product before it can be marketed and sold in the United States. The FDA
regulatory review and approval process, which includes evaluation of preclinical studies and clinical trials of a product candidate
and proposed labeling, as well as the evaluation of the manufacturing process and manufacturers&rsquo; facilities, all of which is lengthy,
expensive and uncertain. To obtain approval, we must, among other things, demonstrate with substantial evidence from well-controlled
clinical trials that the product candidate is both safe and effective for each indication where approval is sought. Even if our
product candidates meet the FDA&rsquo;s safety and effectiveness endpoints in clinical trials, the FDA may not complete their review
processes in a timely manner, or we may not be able to obtain regulatory approval. The FDA has substantial discretion in the review
and approval process and may refuse to file our application for substantive review or may determine after review of our data that
our application is insufficient to allow approval of our product candidates. The FDA may require that we conduct additional preclinical
studies, clinical trials or manufacturing validation studies and submit that data before it will reconsider our application. Additional
delays may result if an FDA Advisory Committee or other regulatory authority recommends non-approval or restrictions on approval.
In addition, we may experience delays or rejections based upon additional government regulation from future legislation or administrative
action, or changes in regulatory authority policy during the period of product development, clinical trials and the review process.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
FDA, EMA or other regulatory authorities also may approve a product candidate for more limited indications than requested or may
impose significant limitations in the form of narrow indications, warnings or a REMS. These regulatory authorities may require
precautions or contraindications with respect to conditions of use or may grant approval subject to the performance of costly
post-marketing clinical trials. In addition, the FDA, EMA or other regulatory authorities may not approve the labeling claims
that are necessary or desirable for the successful commercialization of our product candidates. Any of the foregoing scenarios
could harm the commercial prospects for our product candidates and negatively impact our business, financial condition, results
of operations and prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Delays
in obtaining regulatory approval of our manufacturing process and facility or disruptions in our manufacturing process may delay
or disrupt our product development and commercialization efforts.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not currently operate manufacturing facilities for clinical or commercial production of our product candidates. Before we can
begin to commercially manufacture our product candidates, whether in a third-party facility or in our own facility, if and when
established, we must obtain regulatory approval from the FDA for our manufacturing process and facility. A manufacturing authorization
must also be obtained from the appropriate European Union regulatory authorities and from other foreign regulatory authorities,
as applicable. In order to obtain approval, we will need to ensure that all of our processes, methods and equipment are compliant
with cGMP, and perform extensive audits of vendors, contract laboratories and suppliers. If any of our vendors, contract laboratories
or suppliers are found to be non-compliant with cGMP, we may experience delays or disruptions in manufacturing while we work with
these third parties to remedy the violation or while we work to identify suitable replacement vendors. The cGMP requirements govern
quality control of the manufacturing process and documentation policies and procedures. In complying with cGMP, we will be obligated
to expend time, money and effort in production, record keeping and quality control to assure that the product meets applicable
specifications and other requirements. If we fail to comply with these requirements, we would be subject to possible regulatory
action and may not be permitted to sell any product candidate that we may develop.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we or our third-party manufacturers fail to comply with applicable cGMP regulations, the FDA, EMA and other regulatory authorities
can impose regulatory sanctions including, among other things, refusal to approve a pending application for a new product candidate
or suspension or revocation of a pre-existing approval. Such an occurrence may cause our business, financial condition, results
of operations and prospects to be harmed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
if the supply of our products from our third-party manufacturers to us is interrupted for any reason, including due to regulatory
requirements or actions (including recalls), adverse financial developments at or affecting the supplier, failure by the supplier
to comply with cGMPs, contamination, business interruptions or labor shortages or disputes, there could be a significant disruption
in commercial supply of our products. We do not currently have a backup manufacturer of our product candidate supply for clinical
trials or commercial sale. An alternative manufacturer would need to be qualified through a supplement to its regulatory filing,
which could result in further delays. The regulatory authorities also may require additional clinical trials if a new manufacturer
is relied upon for commercial production. Switching manufacturers may involve substantial costs and could result in a delay in
our desired clinical and commercial timelines.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
our competitors are able to obtain orphan drug exclusivity for products that constitute the same drug and treat the same indications
as our product candidates, we may not be able to have competing products approved by applicable regulatory authorities for a significant
period of time. In addition, even if we obtain orphan drug exclusivity for any of our products, such exclusivity may not protect
us from competition.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Regulatory
authorities in some jurisdictions, including the United States and the European Union, may designate products for relatively small
patient populations as orphan drugs. Under the Orphan Drug Act of 1983, the FDA may designate a product candidate as an orphan
drug if it is intended to treat a rare disease or condition, which is generally defined as having a patient population of fewer
than 200,000 individuals in the United States, or a patient population greater than 200,000 in the United States where there is
no reasonable expectation that the cost of developing the drug will be recovered from sales in the United States. In the United
States, orphan drug designation entitles a party to financial incentives such as opportunities for grant funding towards clinical
trial costs, tax advantages and user-fee waivers. In the European Union, the EMA&rsquo;s Committee for Orphan Medicinal Products grants
orphan drug designation to promote the development of products that are intended for the diagnosis, prevention or treatment of
a life-threatening or chronically debilitating condition affecting not more than five in 10,000 persons in the European Union.
Additionally, orphan drug designation is granted for products intended for the diagnosis, prevention or treatment of a life-threatening,
seriously debilitating or serious and chronic condition and when, without incentives, it is unlikely that sales of the drug in
the European Union would be sufficient to justify the necessary investment in developing the drug or biologic product. In Europe,
orphan drug designation entitles a party to a number of incentives, such as protocol assistance and scientific advice specifically
for designated orphan medicines, and potential fee reductions depending on the status of the sponsor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
designation as an orphan product does not guarantee that any regulatory agency will accelerate regulatory review of, or ultimately
approve, that product candidate, nor does it limit the ability of any regulatory agency to grant orphan drug designation to product
candidates of other companies that treat the same indications as our product candidates prior to our product candidates receiving
exclusive marketing approval.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally,
if a product candidate with an orphan drug designation receives the first marketing approval for the indication for which it has
such designation, the product is entitled to a period of marketing exclusivity, which precludes the FDA or the EMA from approving
another marketing application for a product that constitutes the same drug treating the same indication for that marketing exclusivity
period, except in limited circumstances. If another sponsor receives such approval before we do (regardless of our orphan drug
designation), we will be precluded from receiving marketing approval for our product for the applicable exclusivity period. The
applicable period is seven years in the United States and ten years in the European Union. The exclusivity period in the European
Union can be reduced to six years if a product no longer meets the criteria for orphan drug designation or if the product is sufficiently
profitable so that market exclusivity is no longer justified. Orphan drug exclusivity may be revoked if any regulatory agency
determines that the request for designation was materially defective or if the manufacturer is unable to assure sufficient quantity
of the product to meet the needs of patients with the rare disease or condition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Even
if we obtain orphan drug exclusivity for a product candidate, that exclusivity may not effectively protect the product candidate
from competition because different drugs can be approved for the same condition. In the United States, even after an orphan drug
is approved, the FDA may subsequently approve another drug for the same condition if the FDA concludes that the latter drug is
not the same drug or is clinically superior in that it is shown to be safer, more effective or makes a major contribution to patient
care. In the European Union, marketing authorization may be granted to a similar medicinal product for the same orphan indication
if:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         second applicant can establish in its application that its medicinal product, although
                                         similar to the orphan medicinal product already authorized, is safer, more effective
                                         or otherwise clinically superior;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         holder of the marketing authorization for the original orphan medicinal product consents
                                         to a second orphan medicinal product application; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         holder of the marketing authorization for the original orphan medicinal product cannot
                                         supply sufficient quantities of orphan medicinal product.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Even
if we obtain regulatory approval for a product candidate, our product candidates will remain subject to regulatory oversight.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Even
if we obtain regulatory approval for our product candidates, they will be subject to ongoing regulatory requirements for manufacturing,
labeling, packaging, storage, advertising, promotion, sampling, record-keeping and submission of safety and other post-market
information. Any regulatory approvals that we receive for our product candidates may also be subject to limitations on the approved
indicated uses for which the product may be marketed or to the conditions of approval, or contain requirements for potentially
costly post-marketing testing, including Phase 4 clinical trials, and surveillance to monitor the quality, safety and clinical
effectiveness of the product.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Some
of our product candidates are classified as biologics in the United States, and therefore, can only be sold if we obtain a BLA
from the FDA. The holder of an approved BLA also must submit new or supplemental applications and obtain FDA approval for certain
changes to the approved product, product labeling or manufacturing process. In addition, the holder of a BLA must comply with
the FDA&rsquo;s advertising and promotion requirements, such as those related to the prohibition on promoting products for uses or in
patient populations that are not described in the product&rsquo;s approved labeling (known as &ldquo;off-label use&rdquo;). Advertising
and promotional materials must comply with FDA rules and are subject to FDA review, in addition to other potentially applicable
federal and state laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, product manufacturers and their facilities are subject to payment of user fees and continual review and periodic inspections
by the FDA and other regulatory authorities for compliance with cGMP requirements and adherence to commitments made in the BLA
or foreign marketing application. If we, or a regulatory authority, discover previously unknown problems with a product, such
as adverse events of unanticipated severity or frequency, or problems with the facility where the product is manufactured or if
a regulatory authority disagrees with the promotion, marketing or labeling of that product (in addition to our being obligated
as holder of a BLA to monitor and report adverse events and any failure of a product to meet the BLA specifications), a regulatory
authority may impose restrictions relative to that product, the manufacturing facility or us, including requiring recall or withdrawal
of the product from the market or suspension of manufacturing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 14.35pt"></P>

<!-- Field: Page; Sequence: 33 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 14.35pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we fail to comply with applicable regulatory requirements following approval of our product candidates, a regulatory or enforcement
authority may:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 14.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">issue
                                         a warning letter asserting that we are in violation of the law;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">seek
                                         an injunction or impose administrative, civil or criminal penalties or monetary fines;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">suspend
                                         or withdraw regulatory approval;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">suspend
                                         any ongoing clinical trials;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">refuse
                                         to approve a pending BLA or comparable foreign marketing application (or any supplements
                                         thereto) submitted by us or our strategic partners;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">restrict
                                         the marketing or manufacturing of the product;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">seize
                                         or detain the product or otherwise require the withdrawal of the product from the market;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">refuse
                                         to permit the import or export of the product; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">refuse
                                         to allow us to enter into supply contracts, including government contracts.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
government investigation of alleged violations of law could require us to expend significant time and resources in response and
could generate negative publicity. The occurrence of any event or penalty described above may inhibit our ability to commercialize
our product candidates and adversely affect our business, financial condition, results of operations and prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the FDA&rsquo;s policies, and those of the EMA and other regulatory authorities, may change and additional government regulations
may be enacted that could prevent, limit or delay regulatory approval of our product candidates. We cannot predict the likelihood,
nature or extent of government regulation that may arise from future legislation or administrative action, either in the United
States or abroad. If we are slow or unable to adapt to changes in existing requirements or the adoption of new requirements or
policies, or if we are not able to maintain regulatory compliance, we may lose any marketing approval that we may have obtained
and we may not achieve or sustain profitability, which would negatively impact our business, financial condition, results of operations
and prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Even
if we obtain and maintain approval for our product candidates in a major pharmaceutical market such as the United States, we may
never obtain approval for our product candidates in other major markets.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to market any products in a country or territory, we must establish and comply with numerous and varying regulatory requirements
of such countries or territories regarding safety and effectiveness. Clinical trials conducted in one country may not be accepted
by regulatory authorities in other countries, and regulatory approval in one country does not mean that regulatory approval will
be obtained in any other country. Approval procedures vary among countries and can involve additional product testing and validation
and additional administrative review periods. Seeking regulatory approvals in all major markets could result in significant delays,
difficulties and costs for us and may require additional preclinical studies or clinical trials, which would be costly and time
consuming. Regulatory requirements can vary widely from country to country and could delay or prevent the introduction of our
product candidates in those countries. For example, in many jurisdictions outside of the United States, a product candidate must
be approved for reimbursement before it can be approved for sale in that jurisdiction. In some cases, the price that we intend
to charge for our products would also be subject to approval. Satisfying these and other regulatory requirements is costly, time
consuming, uncertain and subject to unanticipated delays. In addition, our failure to obtain regulatory approval in any country
may delay or have negative effects on the process for regulatory approval in other countries. We currently do not have any product
candidates approved for sale in any jurisdiction, whether in the United States, Europe or any other international markets, and
we do not have experience in obtaining regulatory approval in international markets. If we fail to comply with regulatory requirements
in international markets or to obtain and maintain required approvals, our target market will be reduced and our ability to realize
the full market potential of our product candidates will be compromised.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
may seek a conditional marketing authorization in Europe for some or all of our current product candidates, but we may not be
able to obtain or maintain such designation.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
part of its marketing authorization process, the EMA may grant marketing authorizations for certain categories of medicinal products
on the basis of less complete data than is normally required, when doing so may meet unmet medical needs of patients and serve
the interest of public health. In such cases, it is possible for the Committee for Medicinal Products for Human Use, or CHMP,
to recommend the granting of a marketing authorization, subject to certain specific obligations to be reviewed annually, which
is referred to as a conditional marketing authorization.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
may apply to medicinal products for human use that fall under the jurisdiction of the EMA, including those that aim at the treatment,
the prevention, or the medical diagnosis of seriously debilitating or life-threatening diseases and those designated as orphan
medicinal products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 34 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
conditional marketing authorization may be granted when the CHMP finds that, although comprehensive clinical data referring to
the safety and therapeutic utility of the medicinal product have not been supplied, all the following requirements are met:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         risk-benefit balance of the medicinal product is positive;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">it
                                         is likely that the applicant will be in a position to provide the comprehensive clinical
                                         data;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">unmet
                                         medical needs will be fulfilled; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         benefit to public health of the immediate availability on the market of the medicinal
                                         product concerned outweighs the risk inherent in the fact that additional data is still
                                         required.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
granting of a conditional marketing authorization is restricted to situations in which only the clinical part of the application
is not yet fully complete. Incomplete preclinical or quality data may only be accepted if duly justified and only in the case
of a product intended to be used in emergency situations in response to public health threats. Conditional marketing authorizations
are valid for one year, on a renewable basis. The holder will be required to complete ongoing trials or to conduct new trials
with a view to confirming that the benefit-risk balance is positive. In addition, specific obligations may be imposed in relation
to the collection of pharmacovigilance data.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granting
a conditional marketing authorization allows medicines to reach patients with unmet medical needs earlier than might otherwise
be the case and will ensure that additional data on a product is generated, submitted, assessed and acted upon.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Healthcare
legislative reform measures may have a negative impact on our business and results of operations.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the United States and some foreign jurisdictions, there have been, and continue to be, several legislative and regulatory changes
and proposed changes regarding the healthcare system that could prevent or delay marketing approval of our product candidates,
restrict or regulate post-approval activities and affect our ability to profitably sell any product candidates for which we obtain
marketing approval.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the United States, the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, or the MMA, changed the way Medicare
covers and pays for pharmaceutical products. The MMA expanded Medicare coverage for outpatient drug purchases by adding a new
Medicare Part D program and introduced a new reimbursement methodology based on average sales prices for Medicare Part B physician-administered
drugs. In addition, the MMA authorized Medicare Part D prescription drug plans to limit the number of drugs that will be covered
in any therapeutic class in their formularies. The MMA&rsquo;s cost reduction initiatives and other provisions could decrease the coverage
and price that we receive for any approved products. While the MMA applies only to drug benefits for Medicare beneficiaries, private
payors often follow Medicare coverage policy and payment limitations in setting their own reimbursement rates. Therefore, any
reduction in reimbursement that results from the MMA may result in a similar reduction in payments from private payors. Similar
regulations or reimbursement policies may be enacted in international markets, which could similarly impact our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">More
recently, in March 2010, the PPACA (as amended by the Health Care and Education Reconciliation Act of 2010) was passed, which
substantially changes the way healthcare is financed by both the government and private insurers, and significantly impacts the
U.S. pharmaceutical industry. The PPACA, among other things: (i) addresses a new methodology by which rebates owed by manufacturers
under the Medicaid Drug Rebate Program are calculated for drugs that are inhaled, infused, instilled, implanted or injected; (ii)
increases the minimum Medicaid rebates owed by manufacturers under the Medicaid Drug Rebate Program and extends the rebate program
to individuals enrolled in Medicaid managed care organizations; (iii) establishes annual fees and taxes on manufacturers of certain
branded prescription drugs; (iv) expands the availability of lower pricing under the 340B drug pricing program by adding new entities
to the program; and (v) establishes a new Medicare Part D coverage gap discount program, in which manufacturers must agree to
offer 50% point-of-sale discounts off negotiated prices of applicable brand drugs to eligible beneficiaries during their coverage
gap period, as a condition for the manufacturer&rsquo;s outpatient drugs to be covered under Medicare Part D. Additionally, in the United
States, the Biologics Price Competition and Innovation Act of 2009 created an abbreviated approval pathway for biologic products
that are demonstrated to be biosimilar or &ldquo;interchangeable&rdquo; with an FDA-approved biologic product. This new pathway
could allow competitors to reference data from biologic products already approved after 12 years from the time of approval. This
could expose us to potential competition by lower-cost biosimilars even if we commercialize a product candidate faster than our
competitors. Moreover, the creation of this abbreviated approval pathway does not preclude or delay a third party from pursuing
approval of a competitive product candidate via the traditional approval pathway based on their own clinical trial data.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional
changes that may affect our business include those governing enrollment in federal healthcare programs, reimbursement changes,
rules regarding prescription drug benefits under the health insurance exchanges and fraud and abuse and enforcement. Continued
implementation of the PPACA and the passage of additional laws and regulations may result in the expansion of new programs such
as Medicare payment for performance initiatives, and may impact existing government healthcare programs, such as by improving
the physician quality reporting system and feedback program.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
each state that does not choose to expand its Medicaid program, there likely will be fewer insured patients overall, which could
impact the sales, business and financial condition of manufacturers of branded prescription drugs. Where patients receive insurance
coverage under any of the new options made available through the PPACA, manufacturers may be required to pay Medicaid rebates
on that resulting drug utilization. The U.S. federal government also has announced delays in the implementation of key provisions
of the PPACA. The implications of these delays for our and our potential partners&rsquo; business and financial condition, if any, are
not yet clear.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 35 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
addition, there have been judicial and congressional challenges to certain aspects of the PPACA, and we expect the current administration
and Congress will likely continue to seek legislative and regulatory changes, including repeal and replacement of certain provisions
of the PPACA. In January 2017, President Trump signed an Executive Order directing federal agencies with authorities and responsibilities
under the PPACA to waive, defer, grant exemptions from, or delay the implementation of any provision of the PPACA that would impose
a fiscal or regulatory burden on states, individuals, healthcare providers, health insurers, or manufacturers of pharmaceuticals
or medical devices. More recently, the U.S. House of Representatives passed legislation known as the American Health Care Act
of 2017, and Senate Republicans have released a draft bill known as the Better Care Reconciliation Act of 2017, each of which
would repeal certain aspects of the PPACA if ultimately enacted. The prospects for enactment of these legislative initiatives
remain uncertain. Further, Congress also could consider other legislation to replace elements of the PPACA. We cannot know how
efforts to repeal and replace the PPACA or any future healthcare reform legislation will impact our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect that the PPACA, as well as other healthcare reform measures that may be adopted in the future, may result in more rigorous
coverage criteria and in additional downward pressure on the price that we receive for any approved product. Any reduction in
reimbursement from Medicare or other government programs may result in a similar reduction in payments from private payors. The
implementation of cost containment measures or other healthcare reforms may prevent us from being able to generate revenue, attain
profitability, or commercialize our products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect that additional state and federal healthcare reform measures will be adopted in the future, any of which could limit the
amounts that federal and state governments will pay for healthcare products and services, which could result in reduced demand
for our product candidates or additional pricing pressures.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
are subject to the U.K. Bribery Act, the U.S. Foreign Corrupt Practices Act and other anti-corruption laws, as well as export
control laws, import and customs laws, trade and economic sanctions laws and other laws governing our operations.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
operations are subject to anti-corruption laws, including the U.K. Bribery Act 2010, or the U.K. Bribery Act, the U.S. Foreign
Corrupt Practices Act of 1977, or the FCPA, the U.S. domestic bribery statute contained in 18 &sect;201, the U.S. Travel Act,
and other anti-corruption laws that apply in countries where we do business. The U.K. Bribery Act, the FCPA and these other laws
generally prohibit us and our employees and intermediaries from authorizing, promising, offering, or providing, directly or indirectly,
improper or prohibited payments, or anything else of value, to government officials or other persons to obtain or retain business
or gain some other business advantage. Under the U.K. Bribery Act, we may also be liable for failing to prevent a person associated
with us from committing a bribery offense. We and our commercial partners operate in a number of jurisdictions that pose a high
risk of potential U.K. Bribery Act or FCPA violations, and we participate in collaborations and relationships with third parties
whose corrupt or illegal activities could potentially subject us to liability under the U.K. Bribery Act, FCPA or local anti-corruption
laws, even if we do not explicitly authorize or have actual knowledge of such activities. In addition, we cannot predict the nature,
scope or effect of future regulatory requirements to which our international operations might be subject or the manner in which
existing laws might be administered or interpreted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are also subject to other laws and regulations governing our international operations, including regulations administered by the
governments of the United Kingdom and the United States, and authorities in the European Union, including applicable export control
regulations, economic sanctions and embargoes on certain countries and persons, anti-money laundering laws, import and customs
requirements and currency exchange regulations, collectively referred to as the Trade Control laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is no assurance that we will be completely effective in ensuring our compliance with all applicable anti-corruption laws, including
the U.K. Bribery Act, the FCPA or other legal requirements, including Trade Control laws. If we are not in compliance with the
U.K. Bribery Act, the FCPA and other anti-corruption laws or Trade Control laws, we may be subject to criminal and civil penalties,
disgorgement and other sanctions and remedial measures, and legal expenses, which could have an adverse impact on our business,
financial condition, results of operations and liquidity. Likewise, any investigation of any potential violations of the U.K.
Bribery Act, the FCPA, other anti-corruption laws or Trade Control laws by United Kingdom, United States or other authorities
could also have an adverse impact on our reputation, our business, results of operations and financial condition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 36 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
relationships with customers, physicians and third-party payors will be subject, directly or indirectly, to federal and state
healthcare fraud and abuse laws, false claims laws, health information privacy and security laws and other healthcare laws and
regulations. If we are found in violation of these laws and regulations, we may be required to pay a penalty or be suspended from
participation in federal or state healthcare programs, which may adversely affect our business, financial condition and results
of operations.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we obtain FDA approval for our product candidates and begin commercializing them in the United States, our operations will be
directly, or indirectly through our prescribers, customers and purchasers, subject to various federal and state fraud and abuse
laws and regulations, including, without limitation, the federal Anti-Kickback Statute, the federal civil and criminal laws and
Physician Payments Sunshine Act of 2010 and regulations. These laws will impact, among other things, our proposed sales, marketing
and educational programs. In addition, we may be subject to patient privacy laws by both the U.S. federal government and the states
in which we conduct our business. The laws that will affect our operations include, but are not limited to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         federal Anti-Kickback Statute, which prohibits, among other things, persons or entities
                                         from knowingly and willfully soliciting, receiving, offering or paying any remuneration
                                         (including any kickback, bribe or rebate), directly or indirectly, overtly or covertly,
                                         in cash or in kind, in return for either the referral of an individual, or the purchase,
                                         leasing, furnishing or arranging for the purchase, lease or order of a good, facility,
                                         item or service reimbursable under a federal healthcare program, such as the Medicare
                                         and Medicaid programs. This statute has been interpreted to apply to arrangements between
                                         pharmaceutical manufacturers on the one hand, and prescribers, purchasers and formulary
                                         managers on the other. The PPACA amended the intent requirement of the federal Anti-Kickback
                                         Statute, such that a person or entity no longer needs to have actual knowledge of this
                                         statute or specific intent to violate it;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">federal
                                         civil and criminal false claims laws and civil monetary penalty laws which prohibit,
                                         among other things, individuals or entities from knowingly presenting, or causing to
                                         be presented, claims for payment or approval from Medicare, Medicaid or other government
                                         payors that are false or fraudulent. The PPACA provides, and recent government cases
                                         against pharmaceutical and medical device manufacturers support the view that federal
                                         Anti-Kickback Statute violations and certain marketing practices, including off-label
                                         promotion, may implicate the False Claims Act of 1863;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         federal Health Insurance Portability and Accountability Act of 1996, or HIPAA, which
                                         created new federal criminal statutes that prohibit, among other things, a person from
                                         knowingly and willfully executing a scheme or from making false or fraudulent statements
                                         to defraud any healthcare benefit program, regardless of the payor (e.g., public or private);</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">HIPAA
                                         (as amended by the Health Information Technology for Economic and Clinical Health Act
                                         of 2009), and their implementing regulations, which impose certain requirements relating
                                         to the privacy, security and transmission of individually identifiable health information
                                         without appropriate authorization by entities subject to the rule, such as health plans,
                                         health care clearinghouses and health care providers, and their respective business associates
                                         that perform certain functions or activities that involve the use or disclosure of protected
                                         health information on their behalf;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">federal
                                         transparency laws, including the federal Physician Payment Sunshine Act, that require
                                         certain manufacturers of drugs, devices, biologics and medical supplies for which payment
                                         is available under Medicare, Medicaid or the Children&rsquo;s Health Insurance Program, with
                                         specific exceptions, to report annually to the CMS information related to: (i) payments
                                         or other &ldquo;transfers of value&rdquo; made to physicians and teaching hospitals and
                                         (ii) ownership and investment interests held by physicians and their immediate family
                                         members;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">federal
                                         consumer protection and unfair competition laws, which broadly regulate marketplace activities
                                         and activities that potentially harm consumers; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">state
                                         and foreign law equivalents of each of the above federal laws, state and local laws that
                                         require drug manufacturers to report information related to payments and other transfers
                                         of value to physicians and other healthcare providers or marketing expenditures, and
                                         state and foreign laws governing the privacy and security of health information in certain
                                         circumstances, many of which differ from each other in significant ways and may not have
                                         the same effect, thus complicating compliance efforts.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Efforts
to ensure that our business arrangements with third parties will comply with applicable healthcare laws and regulations will involve
substantial costs. Because of the breadth of these laws and the narrowness of the statutory exceptions and safe harbors available,
it is possible that some of our business activities could be subject to challenge under one or more of such laws. It is possible
that governmental authorities will conclude that our business practices may not comply with current or future statutes, regulations
or case law involving applicable fraud and abuse or other healthcare laws and regulations. If our operations are found to be in
violation of any of these laws or any other governmental regulations that may apply to us, we may be subject to significant criminal,
civil and administrative sanctions including monetary penalties, damages, fines, disgorgement, individual imprisonment, and exclusion
from participation in government funded healthcare programs, such as Medicare and Medicaid, additional reporting requirements
and oversight if we become subject to a corporate integrity agreement or similar agreement to resolve allegations of non-compliance
with these laws, reputational harm, and we may be required to curtail or restructure our operations, any of which could adversely
affect our ability to operate our business and our results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
risk of our being found in violation of these laws is increased by the fact that many of them have not been fully interpreted
by the regulatory authorities or the courts, and their provisions are open to a variety of interpretations. Any action against
us for violation of these laws, even if we successfully defend against it, could cause us to incur significant legal expenses
and divert our management&rsquo;s attention from the operation of our business. The shifting compliance environment and the need to
build and maintain robust and expandable systems to comply with multiple jurisdictions with different compliance and/or reporting
requirements increases the possibility that a healthcare company may run afoul of one or more of the requirements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 37 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
we fail to comply with environmental, health and safety laws and regulations, we could become subject to fines or penalties or
incur substantial costs.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to numerous environmental, health and safety laws and regulations, including those governing laboratory procedures
and the generation, handling, use, storage, treatment, manufacture, transportation and disposal of, and exposure to, hazardous
materials and wastes, as well as laws and regulations relating to occupational health and safety. We contract with third parties
that conduct operations on our behalf that involve the use of hazardous and flammable materials, including chemicals and biologic
materials. Our contractors also produce and dispose of hazardous waste products. We cannot eliminate the risk of contamination
or injury from these materials. In the event of contamination or injury resulting from our contractors&rsquo; use of hazardous
materials, we could be held liable for any resulting damages and any liability could exceed our resources, and our clinical trials
or regulatory approvals could be suspended. We also could incur significant costs associated with civil or criminal fines and
penalties. Our third-party contractors may not carry specific biological or hazardous waste insurance coverage, and their property,
casualty and general liability insurance policies specifically exclude coverage for damages and fines arising from biological
or hazardous waste exposure or contamination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
we maintain workers&rsquo; compensation insurance for certain costs and expenses we may incur due to injuries to our employees resulting
from the use of hazardous materials or other work-related injuries, this insurance may not provide adequate coverage against potential
liabilities. We do not maintain insurance for toxic tort claims that may be asserted against us in connection with our storage
or disposal of biologic, hazardous or radioactive materials.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, we may incur substantial costs in order to comply with current or future environmental, health and safety laws and regulations,
which have tended to become more stringent over time. These current or future laws and regulations may impair our research, development
or production efforts. Failure to comply with these laws and regulations also may result in substantial fines, penalties or other
sanctions or liabilities, which could adversely affect our business, financial condition, results of operations and prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risks
Related to our Business Operations</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
may not be successful in our efforts to identify or discover additional product candidates and may fail to capitalize on programs
or product candidates that may be a greater commercial opportunity or for which there is a greater likelihood of success.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
success of our business depends upon our ability to identify, develop and commercialize product candidates. Research programs
to identify new product candidates require substantial technical, financial and human resources. Although a substantial amount
of our efforts will focus on the continued preclinical and clinical testing and potential approval of our product candidates,
a key element of our long-term growth strategy is to develop and market additional products and product candidates. However, we
may fail to identify other potential product candidates for clinical development for several reasons. For example, our research
may be unsuccessful in identifying potential product candidates or our potential product candidates may be shown to have harmful
side effects, may be commercially impracticable to manufacture or may have other characteristics that may make the products unmarketable
or unlikely to receive marketing approval.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
because we have limited resources, we may forego or delay pursuit of opportunities with certain programs or product candidates
or for indications that later prove to have greater commercial potential. Our spending on current and future R&amp;D programs
may not yield any commercially viable products. If we do not accurately evaluate the commercial potential for a particular product
candidate, we may relinquish valuable rights to that product candidate through strategic collaboration, licensing or other arrangements
in cases in which it would have been more advantageous for us to retain sole development and commercialization rights to such
product candidate. Alternatively, we may allocate internal resources to a product candidate in a therapeutic area in which it
would have been more advantageous to enter into a partnering arrangement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
long-term growth strategy to develop and market additional products and product candidates is heavily dependent on precise, accurate
and reliable scientific data to identify, select and develop promising pharmaceutical product candidates and products. Our business
decisions may therefore be adversely influenced by improper or fraudulent scientific data sourced from third parties. Any irregularities
in the scientific data used by us to determine our focus in R&amp;D of product candidates and products could have a material adverse
effect on our business, prospects, financial condition and results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any of these events occur, we may be forced to abandon our development efforts with respect to a particular product candidate
or fail to develop a potentially successful product candidate, which could have a negative impact on our business, financial condition,
results of operations and prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
future success depends on our ability to retain key employees, consultants and advisors and to recruit, retain and motivate qualified
personnel.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
ability to compete in the highly competitive biotechnology and pharmaceutical industries depends upon our ability to attract and
retain highly qualified managerial, scientific and medical personnel. While we have entered into employment agreements with each
of our executive officers, any of them could leave our employment at any time. We currently do not have &ldquo;key person&rdquo;
insurance on any of our employees. The loss of the services of one or more of our current employees might impede the achievement
of our research, development and commercialization objectives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 38 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recruiting
and retaining other qualified employees, consultants and advisors for our business, including scientific and technical personnel,
also will be critical to our success. We may not be able to attract and retain personnel on acceptable terms given the competition
among numerous pharmaceutical and biotechnology companies and academic institutions for individuals with similar skill sets. In
addition, failure to succeed in preclinical studies or clinical trials or applications for marketing approval may make it more
challenging to recruit and retain qualified personnel. The inability to recruit, or loss of services of certain executives, key
employees, consultants or advisors, may impede the progress of our research, development and commercialization objectives and
have an adverse effect on our business, financial condition, results of operations and prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
we are unable to manage expected growth in the scale and complexity of our operations, our performance may suffer</I>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">At December 31, 2017,
we had 5 full-time employees, who were engaged in R&amp;D activities. If we are successful in executing our business strategy,
we will need to expand our managerial, operational, financial and other systems and resources to manage our operations, continue
our R&amp;D activities and, in the longer term, build a commercial infrastructure to support commercialization of any of our product
candidates that are approved for sale. Future growth would impose significant added responsibilities on members of management
and, to a potentially significant extent, divert our management and business development resources away from their current uses.
It is likely that our management, finance, development personnel, systems and facilities currently in place may not be adequate
to support this future growth. Our need to effectively manage our operations, growth and any future product candidates requires
that we continue to develop more robust business processes and improve our systems and procedures in each of these areas, to attract
and retain sufficient numbers of talented employees and to expand the group of contractors we use.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may be unable to successfully implement these tasks on a larger scale and, accordingly, may not achieve our research, development
and growth goals.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
employees, principal investigators, consultants and commercial partners may engage in misconduct or other improper activities,
including non-compliance with regulatory standards and requirements and insider trading, which could have a material adverse impact
on our business.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are exposed to the risk of fraud or other misconduct by our employees, principal investigators, consultants and commercial partners.
Misconduct by these parties could include intentional failures to: comply with FDA or EMA regulations or the regulations applicable
in other jurisdictions, provide accurate information to the FDA, EMA and other regulatory authorities, comply with healthcare
fraud and abuse laws and regulations in the United States and abroad, report financial information or data accurately or disclose
unauthorized activities to us. In particular, sales, marketing and business arrangements in the healthcare industry are subject
to extensive laws and regulations intended to prevent fraud, misconduct, kickbacks, self-dealing and other abusive practices.
These laws and regulations restrict or prohibit a wide range of pricing, discounting, marketing and promotion, sales commission,
customer incentive programs and other business arrangements. Such misconduct also could involve the improper use of information
obtained in the course of clinical trials or interactions with the FDA, EMA or other regulatory authorities, which could result
in regulatory sanctions and cause serious harm to our reputation. Additional, we are subject to the risk that a person could allege
fraud or other misconduct, even in none occurred. We have adopted a code of conduct applicable to all of our employees, but it
is not always possible to identify and deter employee misconduct, and the precautions we take to detect and prevent these activities
may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from government investigations or
other actions or lawsuits stemming from a failure to comply with these laws or regulations. If any such actions are instituted
against us, and we are not successful in defending ourselves or asserting our rights, those actions could have a significant impact
on our business, financial condition, results of operations and prospects, including the imposition of significant criminal, civil
and administrative sanctions, such as monetary penalties, damages, fines, disgorgement, individual imprisonment, and exclusion
from participation in government funded healthcare programs, such as Medicare and Medicaid, additional reporting requirements
and oversight if we become subject to a corporate integrity agreement or similar agreement to resolve allegations of non-compliance
with these laws, reputational harm, and we may be required to curtail or restructure our operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Product
liability lawsuits against us could cause us to incur substantial liabilities and could limit commercialization of any product
candidate that we may develop.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
face an inherent risk of product liability exposure related to the testing of our current and future product candidates in clinical
trials and may face an even greater risk if we commercialize any product candidate that we may develop. For example, we may be
sued if our current or future product candidates cause or are perceived to cause injury or are found to be otherwise unsuitable
during clinical testing, manufacturing, marketing or sale. Any such product liability claims may include allegations of defects
in manufacturing, defects in design, a failure to warn of dangers inherent in the product, negligence, strict liability or a breach
of warranties. Claims could also be asserted under state consumer protection acts. If we cannot successfully defend ourselves
against product liability claims, we could incur substantial liabilities. Regardless of merit or eventual outcome, liability claims
may result in:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">decreased
                                         demand for any product candidate that we may develop;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 39 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">loss
                                         of revenue;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">substantial
                                         monetary awards to trial participants or patients;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">significant
                                         time and costs to defend the related litigation;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">withdrawal
                                         of clinical trial participants;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         inability to commercialize any product candidates that we may develop; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">injury
                                         to our reputation and significant negative media attention.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
we maintain product liability insurance coverage, such insurance may not be adequate to cover all liabilities that we may incur.
We anticipate that we will need to increase our insurance coverage each time we commence a clinical trial and if we successfully
commercialize any product candidate. Insurance coverage is increasingly expensive. We may not be able to maintain insurance coverage
at a reasonable cost or in an amount adequate to satisfy any liability that may arise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
United Kingdom&rsquo;s vote in favor of withdrawing from the European Union may have a negative effect on global economic conditions,
financial markets and our business, which could reduce the potential value of our ADSs and make it more difficult to do business
in Europe.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2016, a majority of the eligible members of the electorate in the United Kingdom voted to withdraw from the European Union
in a national referendum (commonly referred to as Brexit). The withdrawal of the United Kingdom from the European Union will take
effect either on the effective date of the withdrawal agreement or, in the absence of agreement, two years after the United Kingdom
provides a notice of withdrawal pursuant to Article 50 of the EU Treaty, unless the European Council, in agreement with the United
Kingdom, unanimously decides to extend this period. On March 29, 2017, the U.K. Prime Minister formally delivered the notice of
withdrawal. It appears likely that this withdrawal will involve a process of lengthy negotiations between the United Kingdom and
Member States to determine the future terms of the United Kingdom&rsquo;s relationship with the European Union.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
developments, or the perception that any of them could occur, have had and may continue to have a significant adverse effect on
global economic conditions and the stability of global financial markets, and could significantly reduce global market liquidity
and restrict the ability of key market participants to operate in certain financial markets. In particular, it could also lead
to a period of considerable uncertainty in relation to the U.K. financial and banking markets, as well as on the regulatory process
in Europe. As a result of this uncertainty, global financial markets could experience significant volatility, which could adversely
affect the potential value of our ADSs. Asset valuations, currency exchange rates and credit ratings may also be subject to increased
market volatility. Lack of clarity about future U.K. laws and regulations as the United Kingdom determines which European Union
rules and regulations to replace or replicate in the event of a withdrawal, including financial laws and regulations, tax and
free trade agreements, intellectual property rights, supply chain logistics, environmental, health and safety laws and regulations,
immigration laws and employment laws, could decrease foreign direct investment in the United Kingdom, increase costs, depress
economic activity and restrict our access to capital. If the United Kingdom and the European Union are unable to negotiate acceptable
withdrawal terms or if other Member States pursue withdrawal, barrier-free access between the United Kingdom and other Member
States or among the European Economic Area overall could be diminished or eliminated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may also face new regulatory costs and challenges that could have an adverse effect on our operations. Depending on the terms
of Brexit, the United Kingdom could lose the benefits of global trade agreements negotiated by the European Union on behalf of
its members, which may result in increased trade barriers that could make our doing business in Europe more difficult. In addition,
currency exchange rates in Pounds Sterling and the euro with respect to each other and the U.S. dollar have already been adversely
affected by Brexit. Furthermore, at present, there are no indications of the effect Brexit will have on the pathway to obtaining
marketing approval for any of our product candidates in the United Kingdom, or what, if any, role the EMA may have in the approval
process.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Exchange
rate fluctuations may materially affect our results of operations and financial condition.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Owing
to the international scope of our operations, fluctuations in exchange rates, particularly between Pounds Sterling and the U.S.
dollar, may adversely affect us. Although we are based in the United Kingdom, we may source R&amp;D, manufacturing, consulting
and other services from the United States and the European Union. Further, potential future revenue may be derived from abroad,
particularly from the United States. As a result, our business and the potential value of our ADSs may be affected by fluctuations
in foreign exchange rates not only between the Pounds Sterling and the U.S. dollar, but also the euro, which may have a significant
impact on our results of operations and cash flows from period to period. Currently, we do not have any exchange rate hedging
arrangements in place.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 40 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
internal computer systems, or those of our collaborators or other contractors or consultants, may fail or suffer security breaches,
which could result in a material disruption of our product development programs.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
internal computer systems and those of our current and any future collaborators and other contractors or consultants are vulnerable
to damage from computer viruses, unauthorized access, natural disasters, terrorism, war and telecommunication and electrical failures.
While we have not experienced any such material system failure, accident or security breach to date, if such an event were to
occur and cause interruptions in our operations, it could result in a material disruption of our development programs and our
business operations, whether due to a loss of our trade secrets or other proprietary information or other similar disruptions.
For example, the loss of clinical trial data from completed or future clinical trials could result in delays in our regulatory
approval efforts and significantly increase our costs to recover or reproduce the data. To the extent that any disruption or security
breach were to result in a loss of, or damage to, our data or applications, or inappropriate disclosure of confidential or proprietary
information, we could incur liability, our competitive position could be harmed and the further development and commercialization
of our product candidates could be delayed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risks
Related to the Ownership of Our Securities</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
do not know whether an active, liquid and orderly trading market will develop for our ADSs or what the market price of our ADSs
will be. As a result, it may be difficult for shareholders to sell their ADSs.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to this offering, there has been no public market for our ADSs, although our ordinary shares have traded on AIM. We cannot predict
the extent to which an active market for our ADSs will develop or be sustained after this offering, or how the development of
such a market might affect the market price for our ADSs. The IPO price of our ADSs in this offering will be determined by negotiations
between us and the underwriters taking into account the most recent closing price of our ordinary shares on AIM prior to the pricing
date and prevailing market conditions, among other factors, and may not be indicative of the price at which our ADSs will trade
following completion of this offering. Investors may not be able to sell their ADSs at or above the IPO price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
this offering and after our ADSs begin trading on Nasdaq, our ordinary shares will continue to be admitted to trading on AIM.
We cannot predict the effect of this dual listing on the value of our ADSs and ordinary shares. However, the dual listing of our
ADSs and ordinary shares may dilute the liquidity of these securities in one or both markets and may adversely affect the development
of an active trading market for our ADSs. The price of our ADSs could also be adversely affected by trading in our ordinary shares
on AIM.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
you purchase ADSs in this offering, you will suffer immediate dilution of your investment.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The IPO price of our
ADSs is substantially higher than the pro forma as adjusted net tangible book value per ADS. Therefore, if you purchase ADSs in
this offering, you will pay a price per ADS that substantially exceeds our pro forma as adjusted net tangible book value per ADS
after this offering. Based on an assumed IPO price of $ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;per ADS in this offering,
which reflects the last reported sale price of &pound;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;  per ordinary share on AIM on &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
2018 equivalent to US$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp; per ADS based on an exchange rate of &pound;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; to $1.00, you will experience immediate dilution of $ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per
ADS, representing the difference between our pro forma as adjusted net tangible book value per ADS after this offering and the
IPO price per ADS. After this offering, we will also have outstanding options to purchase ordinary shares with exercise prices
lower than the IPO price. To the extent these outstanding options are exercised, there will be further dilution to investors in
this offering. For further information regarding the dilution resulting from this offering, see the section titled &ldquo;Dilution&rdquo;
in this prospectus.</P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Holders
of our ADSs have fewer rights than our shareholders and must act through the depositary to exercise their rights.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders
of our ADSs do not have the same rights as our shareholders and may only exercise their voting rights with respect to the underlying
ordinary shares in accordance with the provisions of the deposit agreement. Holders of the ADSs will appoint the depositary or
its nominee as their representative to exercise the voting rights attaching to the ordinary shares represented by the ADSs. When
a general meeting is convened, if you hold ADSs, you may not receive sufficient notice of a shareholders&rsquo; meeting to permit
you to withdraw the ordinary shares underlying your ADSs to allow you to vote with respect to any specific matter. We will make
all commercially reasonable efforts to cause the depositary to extend voting rights to you in a timely manner, but we cannot assure
you that you will receive voting materials in time to instruct the depositary to vote, and it is possible that you, or persons
who hold their ADSs through brokers, dealers or other third parties, will not have the opportunity to exercise a right to vote.
Furthermore, the depositary will not be liable for any failure to carry out any instructions to vote, for the manner in which
any vote is cast or for the effect of any such vote. As a result, you may not be able to exercise your right to vote and you may
lack recourse if your ADSs are not voted as you request. In addition, in your capacity as an ADS holder, you will not be able
to call a shareholders&rsquo; meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
rights of our shareholders may differ from the rights typically offered to shareholders of a U.S. corporation.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are incorporated under English law. The rights of holders of ordinary shares and, therefore, certain of the rights of any potential
future holders of ADSs, are governed by English law, including the provisions of the U.K. Companies Act 2006, or the Companies
Act, and by our Articles of Association, or Articles. These rights differ in certain respects from the rights of shareholders
in typical U.S. corporations. See &ldquo;Description of Share Capital and Articles of Association-Differences in Corporate Law&rdquo;
in this report for a description of the principal differences between the provisions of the Companies Act applicable to us and,
for example, the Delaware General Corporation Law relating to stockholders&rsquo; rights and protections.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 41 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
we engage in future acquisitions or strategic partnerships, this may increase our capital requirements, dilute our AIM shareholders,
cause us to incur debt or assume contingent liabilities and subject us to other risks.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
intend to continue to evaluate various acquisitions and strategic partnerships, including licensing or acquiring complementary
drugs, intellectual property rights, technologies or businesses. Any potential acquisition or strategic partnership may entail
numerous risks, including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">increased
                                         operating expenses and cash requirements;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         assumption of additional indebtedness or contingent liabilities;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">assimilation
                                         of operations, intellectual property and drugs of an acquired company, including difficulties
                                         associated with integrating new personnel;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         diversion of our management&rsquo;s attention from our existing drug programs and initiatives
                                         in pursuing such a strategic partnership, merger or acquisition;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">retention
                                         of key employees, the loss of key personnel and uncertainties in our ability to maintain
                                         key business relationships;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">risks
                                         and uncertainties associated with the other party to such a transaction, including the
                                         prospects of that party and their existing drugs or drug candidates and regulatory approvals;
                                         and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                         inability to generate revenue from acquired technology and/or drugs sufficient to meet
                                         our objectives in undertaking the acquisition or even to offset the associated acquisition
                                         and maintenance costs.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>As
an FPI, we are exempt from a number of rules under the U.S. securities laws and are permitted to file less information with the
SEC than U.S. public companies</I>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are an FPI, as defined in the SEC rules and regulations and, consequently, we are not subject to all of the disclosure requirements
applicable to companies organized within the United States. For example, we are exempt from certain rules under the Exchange Act,
that regulate disclosure obligations and procedural requirements related to the solicitation of proxies, consents or authorizations
applicable to a security registered under the Exchange Act. In addition, our officers and directors are exempt from the reporting
and &ldquo;short-swing&rdquo; profit recovery provisions of Section 16 of the Exchange Act and related rules with respect to their
purchases and sales of our securities. Moreover, we are not required to file periodic reports and financial statements with the
SEC as frequently or as promptly as U.S. public companies. Accordingly, there may be less publicly available information concerning
our company than there is for U.S. public companies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">As an FPI, we will file
an annual report on Form 20-F within four months of the close of each fiscal year ended December 31 and reports on Form 6-K relating
to certain material events promptly after we publicly announce these events. However, because of the above exemptions for FPIs,
our ADS holders will not be afforded the same protections or information generally available to investors holding shares in public
companies organized in the United States.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>While
we are an FPI, we are not subject to certain Nasdaq corporate governance rules applicable to U.S. listed companies.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are entitled to rely on a provision in Nasdaq&rsquo;s corporate governance rules that allows us to follow English corporate law
and the Companies Act with regard to certain aspects of corporate governance. This allows us to follow certain corporate governance
practices that differ in significant respects from the corporate governance requirements applicable to U.S. companies listed on
Nasdaq.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
example, we are exempt from Nasdaq regulations that require a listed U.S. company to (i) have a majority of the board of directors
consist of independent directors, (ii) require non-management directors to meet on a regular basis without management present
and (iii) promptly disclose any waivers of the code for directors or executive officers that should address certain specified
items.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with our Nasdaq listing, our audit committee is required to comply with the provisions of Section 301 of the Sarbanes-Oxley
Act and Rule 10A-3 of the Exchange Act, both of which are also applicable to Nasdaq-listed U.S. companies. Because we are an FPI,
however, our audit committee is not subject to additional Nasdaq requirements applicable to listed U.S. companies, including an
affirmative determination that all members of the audit committee are &ldquo;independent,&rdquo; using more stringent criteria than
those applicable to us as an FPI. Furthermore, Nasdaq&rsquo;s corporate governance rules require listed U.S. companies to, among other
things, seek shareholder approval for the implementation of certain equity compensation plans and issuances of ordinary shares,
which we are not required to follow as an FPI.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 42 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
may lose our FPI status, which would then require us to comply with the Exchange Act&rsquo;s domestic reporting regime and cause us
to incur significant legal, accounting and other expenses.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
an FPI, we are not required to comply with all of the periodic disclosure and current reporting requirements of the Exchange Act
applicable to U.S. domestic issuers. We may no longer be an FPI as early as June 30, 2019 (the end of our second fiscal quarter
in the fiscal year following this Nasdaq listing), which would require us to comply with all of the periodic disclosure and current
reporting requirements of the Exchange Act applicable to U.S. domestic issuers as of January 1, 2019. In order to maintain our
current status as an FPI, either (a) a majority of our ADSs must be either directly or indirectly owned of record by non-residents
of the United States or (b)(i) a majority of our executive officers or directors cannot be U.S. citizens or residents, (ii) more
than 50% of our assets must be located outside the United States and (iii) our business must be administered principally outside
the United States. If we lose our status as an FPI, we would be required to comply with the Exchange Act reporting and other requirements
applicable to U.S. domestic issuers, which are more detailed and extensive than the requirements for FPIs. We may also be required
to make changes in our corporate governance practices in accordance with various SEC and Nasdaq rules. The regulatory and compliance
costs to us under U.S. securities laws if we are required to comply with the reporting requirements applicable to a U.S. domestic
issuer may be significantly higher than the cost we would incur as an FPI. As a result, we expect that a loss of FPI status would
increase our legal and financial compliance costs and is likely to make some activities highly time consuming and costly. We also
expect that if we were required to comply with the rules and regulations applicable to U.S. domestic issuers, it would make it
more difficult and expensive for us to obtain director and officer liability insurance, and we may be required to accept reduced
coverage or incur substantially higher costs to obtain coverage. These rules and regulations could also make it more difficult
for us to attract and retain qualified members of our board of directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
are an emerging growth company within the meaning of the Securities Act of 1933 and will take advantage of certain reduced reporting
requirements.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are an EGC, as defined in the JOBS Act. For as long as we continue to be an EGC, we may take advantage of exemptions from various
reporting requirements that are applicable to other public companies that are not EGCs, including not being required to comply
with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, or Section 404, exemptions from the requirements
of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not
previously approved. As an EGC, we are required to report only two years of financial results and selected financial data compared
to three and five years, respectively, for comparable data reported by other public companies. We may take advantage of these
exemptions until we are no longer an EGC. We could be an EGC for up to five years, although circumstances could cause us to lose
that status earlier, including if the aggregate market value of our ADSs held by non-affiliates exceeds $700 million as of any
June 30 (the end of our second fiscal quarter) before that time, in which case we would no longer be an EGC as of the following
December 31 (our fiscal year-end). We cannot predict if investors will find our ADSs less attractive because we may rely on these
exemptions. If some investors find our ADSs less attractive as a result, there may be a less active trading market for our ADSs
and the price of our ADSs may be more volatile in the event that we decide to make an offering of our ADSs following our Nasdaq
listing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.05in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
we fail to establish and maintain proper internal controls, our ability to produce accurate financial statements or comply with
applicable regulations could be impaired.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.05in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
404(a) of the Sarbanes-Oxley Act, or Section 404(a), requires that beginning with our second annual report following our IPO,
management assess and report annually on the effectiveness of our internal control over financial reporting and identify any material
weaknesses in our internal control over financial reporting. Although Section 404(b) of the Sarbanes-Oxley Act, or Section 404(b),
requires our independent registered public accounting firm to issue an annual report that addresses the effectiveness of our internal
control over financial reporting, we have opted to rely on the exemptions provided in the JOBS Act, and consequently will not
be required to comply with SEC rules that implement Section 404(b) until such time as we are no longer an EGC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect our first Section 404(a) assessment will take place for our annual report for the fiscal year ending December 31, 2018.
The presence of material weaknesses could result in financial statement errors which, in turn, could lead to errors in our financial
reports, delays in our financial reporting, which could require us to restate our operating results or our auditors may be required
to issue a qualified audit report. We might not identify one or more material weaknesses in our internal controls in connection
with evaluating our compliance with Section 404 (a). In order to maintain and improve the effectiveness of our disclosure controls
and procedures and internal control over financial reporting, we will need to expend significant resources and provide significant
management oversight.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Implementing
any appropriate changes to our internal control may require specific compliance training of our directors and employees, entail
substantial costs in order to modify our existing accounting systems, take a significant period of time to complete and divert
management&rsquo;s attention from other business concerns. These changes may not, however, be effective in maintaining the adequacy
of our internal control.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
either we are unable to conclude that we have effective internal control over financial reporting or, at the appropriate time,
our independent auditors are unwilling or unable to provide us with an unqualified report on the effectiveness of our internal
control over financial reporting as required by Section 404(b), then in the event we have decided to make an offering of our ADSs
following our Nasdaq listing, investors may lose confidence in our operating results, the price of our ADSs could decline and
we may be subject to litigation or regulatory enforcement actions. In addition, if we are unable to meet the requirements of Section
404, we may not be able to remain listed on Nasdaq.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 43 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
will incur significant increased costs as a result of operating as a company that publicly listed on Nasdaq in the United States,
and our management will be required to devote substantial time to new compliance initiatives.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a U.S. public company, and particularly after we no longer qualify as an EGC, we will incur significant legal, accounting and
other expenses that we did not incur previously. The Sarbanes-Oxley Act, the Dodd-Frank Wall Street Reform and Consumer Protection
Act of 1987, the listing requirements of Nasdaq and other applicable securities rules and regulations impose various requirements
on non-U.S. reporting public companies, including the establishment and maintenance of effective disclosure and financial controls
and corporate governance practices. Our senior management and other personnel will need to devote a substantial amount of time
to these compliance initiatives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Moreover,
these rules and regulations will increase our legal and financial compliance costs and will make some activities more time-consuming
and costly. For example, we expect that these rules and regulations may make it more difficult and more expensive for us to obtain
director and officer liability insurance, which in turn could make it more difficult for us to attract and retain qualified senior
management personnel or members for our board of directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">However,
these rules and regulations are often subject to varying interpretations, in many cases due to their lack of specificity, and,
as a result, their application in practice may evolve over time as new guidance is provided by regulatory and governing bodies.
This could result in continuing uncertainty regarding compliance matters and higher costs necessitated by ongoing revisions to
disclosure and governance practices.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to Section 404, we will be required to furnish a report by our senior management on our internal control over financial reporting.
However, while we remain an EGC, we will not be required to include an attestation report on internal control over financial reporting
issued by our independent registered public accounting firm. To prepare for eventual compliance with Section 404, once we no longer
qualify as an EGC, we will be engaged in a process to document and evaluate our internal control over financial reporting, which
is both costly and challenging. In this regard, we will need to continue to dedicate internal resources, potentially engage outside
consultants and adopt a detailed work plan to assess and document the adequacy of internal control over financial reporting, continue
steps to improve control processes as appropriate, validate through testing that controls are functioning as documented and implement
a continuous reporting and improvement process for internal control over financial reporting. Despite our efforts, there is a
risk that we will not be able to conclude, within the prescribed timeframe or at all, that our internal control over financial
reporting is effective as required by Section 404. If we identify one or more material weaknesses, it could result in an adverse
reaction in the financial markets due to a loss of confidence in the reliability of our financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>ADSs
holders may not be entitled to a jury trial with respect to claims arising under the deposit agreement, which could augur less
favorable results to the plaintiff(s) in any such action.</I></B>&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT>The deposit agreement governing the ADSs representing our ordinary
shares provides that holders and beneficial owners of ADSs irrevocably waive the right to a trial by jury in any legal proceeding
arising out of or relating to the deposit agreement or the ADSs, including claims under federal securities laws, against us
or the depositary to the fullest extent permitted by applicable law. If this jury trial waiver provision is prohibited by
applicable law, an action could nevertheless proceed under the terms of the deposit agreement with a jury trial. To our knowledge,
the enforceability of a jury trial waiver under the federal securities laws has not been finally adjudicated by a federal
court. However, we believe that a jury trial waiver provision is generally enforceable under the laws of the State of New
York, which govern the deposit agreement, by a court of the State of New York or a federal court, which have non-exclusive
jurisdiction over matters arising under the deposit agreement, applying such law. In determining whether to enforce a jury
trial waiver provision, New York courts and federal courts will consider whether the visibility of the jury trial waiver provision
within the agreement is sufficiently prominent such that a party has knowingly waived any right to trial by jury. We believe
that this is the case with respect to the deposit agreement and the ADSs. In addition, New York courts will not enforce a
jury trial waiver provision in order to bar a viable setoff or counterclaim sounding in fraud or one which is based upon a
creditor&rsquo;s negligence in failing to liquidate collateral upon a guarantor&rsquo;s demand, or in the case of an intentional tort
claim (as opposed to a contract dispute), none of which we believe are applicable in the case of the deposit agreement or
the ADSs. No condition, stipulation or provision of the deposit agreement or ADSs serves as a waiver by any holder or beneficial
owner of ADSs or by us or the depositary of compliance with any provision of the federal securities laws. If you or any other
holder or beneficial owner of ADSs brings a claim against us or the depositary in connection with matters arising under the
deposit agreement or the ADSs, you or such other holder or beneficial owner may not be entitled to a jury trial with respect
to such claims, which may have the effect of limiting and discouraging lawsuits against us and / or the depositary. If a lawsuit
is brought against us and / or the depositary under the deposit agreement, it may be heard only by a judge or justice of the
applicable trial court, which would be conducted according to different civil procedures and may augur different results than
a trial by jury would have had, including results that could be less favorable to the plaintiff(s) in any such action, depending
on, among other things, the nature of the claims, the judge or justice hearing such claims, and the venue of the hearing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Claims
of U.S. civil liabilities may not be enforceable against us.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are incorporated under English law. Certain members of our board of directors and senior management are non-residents of the United
States, and all or a substantial portion of our assets and the assets of such persons are located outside the United States. As
a result, it may not be possible to serve process on such persons or us in the United States or to enforce judgments obtained
in U.S. courts against them or us based on civil liability provisions of the securities laws of the United States. As a result,
it may not be possible for investors to effect service of process within the United States upon such persons or to enforce judgments
obtained in U.S. courts against them or us, including judgments predicated upon the civil liability provisions of the U.S. federal
securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 44 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
United States and the United Kingdom do not currently have a treaty providing for recognition and enforcement of judgments (other
than arbitration awards) in civil and commercial matters. Consequently, a final judgment for payment given by a court in the United
States, whether or not predicated solely upon U.S. securities laws, would not automatically be recognized or enforceable in the
United Kingdom. In addition, uncertainty exists as to whether U.K. courts would entertain original actions brought in the United
Kingdom against us or our directors or senior management predicated upon the securities laws of the United States or any state
in the United States. Any final and conclusive monetary judgment for a definite sum obtained against us in U.S. courts would be
treated by the courts of the United Kingdom as a cause of action in itself and sued upon as a debt at common law so that no retrial
of the issues would be necessary, provided that certain requirements are met. Whether these requirements are met in respect of
a judgment based upon the civil liability provisions of the U.S. securities laws, including whether the award of monetary damages
under such laws would constitute a penalty, is an issue for the court making such decision. If an English court gives judgment
for the sum payable under a U.S. judgment, the English judgment will be enforceable by methods generally available for this purpose.
These methods generally permit the English court discretion to prescribe the manner of enforcement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">As
a result, U.S. investors may not be able to enforce against us or our senior management, board of directors or certain experts
named herein who are residents of the United Kingdom or countries other than the United States any judgments obtained in U.S.
courts in civil and commercial matters, including judgments under the U.S. federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>If
we are a passive foreign investment company, there could be adverse U.S. federal income tax consequences to U.S. holders.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Under
the Internal Revenue Code of 1986, or the Internal Revenue Code, we will be a PFIC for any taxable year in which (1) 75% or
more of our gross income consists of passive income or (2) 50% or more of the average quarterly value of our assets consists
of assets that produce, or are held for the production of, passive income. For purposes of these tests, passive income
includes dividends, interest, gains from the sale or exchange of investment property and certain rents and royalties. In
addition, for purposes of the above calculations, a non-U.S. corporation that directly or indirectly owns at least 25% by
value of the shares of another corporation is treated as if it held its proportionate share of the assets and received
directly its proportionate share of the income of such other corporation. If we are a PFIC for any taxable year during which
a U.S. Holder (as defined below under &ldquo;Material Income Tax Considerations-Material U.S. Federal Income Tax
Considerations for U.S. Holders&rdquo;) holds our shares, the U.S. Holder may be subject to adverse tax consequences
regardless of whether we continue to qualify as a PFIC, including ineligibility for any preferred tax rates on capital gains
or on actual or deemed dividends, interest charges on certain taxes treated as deferred, and additional reporting
requirements.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">We believe that we were
a PFIC for our taxable year ended December 31, 2017, but cannot provide any assurances regarding our PFIC status for any past,
current or future taxable years. The determination of whether we are a PFIC is a fact-intensive determination made on an annual
basis applying principles and methodologies which in some circumstances are unclear and subject to varying interpretation. In
particular, the characterization of our assets as active or passive may depend in part on our current and intended future business
plans, which are subject to change. In addition, for our current and future taxable years, the total value of our assets for PFIC
testing purposes may be determined in part by reference to the market price of our ordinary shares or ADSs from time to time,
which may fluctuate considerably. Under the income test, our status as a PFIC depends on the composition of our income which will
depend on the transactions we enter into in the future and our corporate structure. The composition of our income and assets is
also affected by how, and how quickly, we spend the cash we raise in any offering.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
certain circumstances, a U.S. Holder of shares in a PFIC may alleviate some of the adverse tax consequences described above by
making a qualified electing fund, or QEF, election to include in income its pro rata share of the corporation&rsquo;s income on a current
basis. However, a U.S. Holder may make a QEF election with respect to our ordinary shares or ADSs only if we agree to furnish
such U.S. Holder annually with a PFIC annual information statement as specified in the applicable U.S. Treasury Regulations. We
currently do not intend to prepare or provide the information that would enable U.S. Holders to make a QEF election if we are
treated as a PFIC for any taxable year, and prospective investors should assume that a QEF election will not be available.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
further discussion of the PFIC rules and the adverse U.S. federal income tax consequences in the event we are classified as a
PFIC, see the section of this report entitled &ldquo;Material Income Tax Considerations-Material U.S. Federal Income Considerations
For U.S. Holders.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 45 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
may be unable to use net operating loss and tax credit carryforwards and certain built-in losses to reduce future tax payments
or benefit from favorable U.K. tax legislation.<SUP></SUP></I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">As a U.K. resident trading
entity, we are subject to U.K. corporate taxation. Due to the nature of our business, we have generated losses since inception.
As of December 31, 2017, we had cumulative carryforward tax losses of $12.4 million. Subject to any relevant restrictions, we
expect these to be available to carry forward and offset against future operating profits. As a company that carries out extensive
research and development activities, we benefit from the U.K. research and development tax credit regime for small and medium-sized
companies, whereby we are able to surrender the trading losses that arise from our qualifying research and development activities
for a payable tax credit of up to 33.35% of eligible research and development expenditures. Qualifying expenditures largely comprise
employment costs for research staff, consumables and certain internal overhead costs incurred as part of research projects. Certain
subcontracted qualifying research expenditures are eligible for a cash rebate of up to 21.67%. The majority of our pipeline research,
clinical trials management and manufacturing development activities are eligible for inclusion within these tax credit cash rebate
claims. Our ability to continue to claim payable research and development tax credits in the future may be limited because we
may no longer qualify as a small or medium-sized company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may benefit in the future from the United Kingdom&rsquo;s &ldquo;patent box&rdquo; regime, which allows certain profits attributable to
revenues from patented products to be taxed at an effective rate of 10%. We are the exclusive licensee or owner of several patent
applications which, if issued, would cover our product candidates, and accordingly, future upfront fees, milestone fees, product
revenues and royalties could be taxed at this tax rate. When taken in combination with the enhanced relief available on our research
and development expenditures, we expect a long-term lower rate of corporation tax to apply to us. If, however, there are unexpected
adverse changes to the U.K. research and development tax credit regime or the &ldquo;patent box&rdquo; regime, or for any reason
we are unable to qualify for such advantageous tax legislation, or we are unable to use net operating loss and tax credit</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Changes and uncertainties in the
tax system in the countries in which we have operations could materially adversely affect our financial condition and results
of operations, and reduce net returns to our shareholders.</I></B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our tax position could
be adversely impacted by changes in tax rates, tax laws, tax practice, tax treaties or tax regulations or changes in the interpretation
thereof by the tax authorities in the United Kingdom, the United States and other jurisdictions as well as being affected by certain
changes currently proposed by the Organisation for Economic Co-operation and Development and their action plan on Base Erosion
and Profit Shifting. Such changes may become more likely as a result of recent economic trends in the jurisdictions in which we
operate, particularly if such trends continue.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our actual effective
tax rate may vary from our expectation and that variance may be material. A number of factors may increase our future effective
tax rates, including: (1) the jurisdictions in which profits are determined to be earned and taxed; (2) the resolution of issues
arising from any future tax audits with various tax authorities; (3) changes in the valuation of our deferred tax assets and liabilities;
(4) increases in expenses not deductible for tax purposes, including transaction costs and impairments of goodwill in connection
with acquisitions; (5) changes in the taxation of share-based compensation; (6) changes in tax laws or the interpretation of such
tax laws, and changes in generally accepted accounting principles; and (7) challenges to the transfer pricing policies related
to our structure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">A tax authority may
disagree with tax positions that we have taken, which could result in increased tax liabilities. For example, Her Majesty&rsquo;s
Revenue &amp; Customs, or HMRC, the U.S. Internal Revenue Service, or IRS, or another tax authority could challenge our allocation
of income by tax jurisdiction and the amounts paid between our affiliated companies pursuant to our intercompany arrangements and
transfer pricing policies, including methodologies for valuing developed technology and amounts paid with respect to our intellectual
property development. Similarly, a tax authority could assert that we are subject to tax in a jurisdiction where we believe we
have not established a taxable connection, often referred to as a &ldquo;permanent establishment&rdquo; under international tax
treaties, and such an assertion, if successful, could increase our expected tax liability in one or more jurisdictions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">A tax authority may take the position that material income tax liabilities, interest and penalties are
payable by us, for example where there has been a technical violation of contradictory laws and regulations that are relatively
new and have not been subject to extensive review or interpretation, in which case we expect that we might contest such assessment.
High-profile companies can be particularly vulnerable to aggressive application of unclear requirements. Many companies must negotiate
their tax bills with tax inspectors who may demand higher taxes than applicable law appears to provide. Contesting such an assessment
may be lengthy and costly and if we were unsuccessful in disputing the assessment, the implications could increase our anticipated
effective tax rate, where applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 46 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_005"></A>CAUTIONARY
STATEMENT REGARDING FORWARD-LOOKING STATEMENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus contains statements that constitute forward-looking statements. Many of the forward-looking statements contained in
this prospectus can be identified by the use of forward-looking words such as &ldquo;anticipate,&rdquo; &ldquo;believe,&rdquo;
&ldquo;could,&rdquo; &ldquo;estimate,&rdquo; &ldquo;expect,&rdquo; &ldquo;intend,&rdquo; &ldquo;plan,&rdquo; &ldquo;potential&rdquo;
and &ldquo;should,&rdquo; among others.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forward-looking
statements appear in a number of places in this prospectus and include, but are not limited to, statements regarding our intent,
belief, or current expectations. Forward-looking statements are based on our management&rsquo;s beliefs and assumptions and on
information currently available to our management. Such statements are subject to substantial risks and uncertainties, and actual
results may differ materially from those expressed or implied in the forward-looking statements due to various important factors,
including, but not limited to, those identified under &ldquo;Risk Factors.&rdquo; In light of the significant uncertainties in
these forward-looking statements, you should not regard these statements as a guarantee by us or any other person that we will
achieve our objectives and plans in any specified time frame, or at all.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Forward-looking statements
include, but are not limited to, statements about:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the development of product candidates, including statements regarding the timing of initiation, completion and the outcome of clinical studies or trials and related preparatory work, the period during which the results of the trials will become available and our research and development programs;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to obtain and maintain regulatory approval of our product candidates in the indications for which we plan to develop them, and any related restrictions, limitations or warnings in the label of an approved drug or therapy;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">our plans to research, develop,
manufacture and commercialize our product candidates;</P></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the timing of our regulatory filings for our product candidates;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the size and growth potential of the markets for our product candidates;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to raise additional capital;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our commercialization, marketing and manufacturing capabilities and strategy;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our expectations regarding our ability to obtain and maintain intellectual property protection;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to attract and retain qualified employees and key personnel;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to contract with third party suppliers and manufacturers and their ability to perform adequately;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our estimates regarding future revenue, expenses and needs for additional financing; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">regulatory developments in the United States, European Union and other jurisdictions.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forward-looking
statements speak only as of the date they are made, and we do not undertake any obligation to update them in light of new information
or future developments or to release publicly any revisions to these statements in order to reflect later events or circumstances
or to reflect the occurrence of unanticipated events.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, statements that &ldquo;we believe&rdquo; and similar statements reflect our beliefs and opinions on the relevant subject.
These statements are based upon information available to us as of the date of this prospectus, and while we believe such information
forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not be
read to indicate that we have conducted an exhaustive inquiry into, or review of, all relevant information. These statements are
inherently uncertain and investors are cautioned not to unduly rely upon these statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should read this prospectus and the documents that we reference in this prospectus and have filed as exhibits to the registration
statement, of which this prospectus is a part, completely and with the understanding that our actual future results may be materially
different from what we expect. We qualify all of our forward-looking statements by these cautionary statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 47 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="a_006"></A>MARKET
and industry DATA</FONT></P>




<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
industry data and market data included in this prospectus were obtained from independent third-party surveys, market research,
publicly available information, reports of governmental agencies, and industry publications and surveys. All of the market data
used in this prospectus involves a number of assumptions and limitations, and you are cautioned not to give undue weight to such
estimates. We believe that the information from these industry publications and surveys included in this prospectus is reliable.
The industry in which we operate is subject to a high degree of uncertainty and risk due to a variety of factors, including those
described in &ldquo;Risk Factors.&rdquo; These and other factors could cause results to differ materially from those expressed
in the estimates made by the independent parties and by us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 48 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_007"></A>TRADEMARKS,
SERVICE MARKS AND TRADENAMES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Solely
for convenience, the trademarks, service marks, logos and trade names referred to in this prospectus are without the &reg; and
&trade; symbols, but such references are not intended to indicate, in any way, that we will not assert, to the fullest extent
under applicable law, our rights or the rights of the applicable licensors to these trademarks, service marks, and trade names.
For the avoidance of doubt, &ldquo;Tiziana,&rdquo; the Tiziana logo and other trademarks or service marks of Tiziana Life Sciences
plc appearing in this prospectus are the property of Tiziana or our subsidiaries. This prospectus contains additional trademarks,
service marks, and trade names of others, which are the property of their respective owners. All trademarks, service marks, and
trade names appearing in this prospectus are, to our knowledge, the property of their respective owners. We do not intend our
use or display of other companies&rsquo; trademarks, service marks, copyrights, or trade names to imply a relationship with, or
endorsement or sponsorship of us by, any other companies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 49 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B><A NAME="a_008"></A>EXCHANGE
RATE INFORMATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fluctuations
in the exchange rate between Pounds Sterling and the U.S. dollar will affect the U.S. dollar amounts received by potential future
owners of our ADSs on conversion of dividends, if any, paid in Pounds Sterling on the ordinary shares and will affect the potential
future U.S. dollar price of our ADSs on Nasdaq.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below shows the period end, average, high and low exchange rates of U.S. dollars per Pound Sterling for the periods shown.
Average rates are computed by using the noon buying rate of the Federal Reserve Bank of New York for the U.S. dollar on the last
business day of each month during the relevant year indicated or each business day during the relevant month indicated. The rates
set forth below are provided solely for your convenience and may differ from the actual rates used in the preparation of our consolidated
financial statements included in this registration statement and other financial data appearing in this registration statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="14" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">Noon Buying Rate</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Period</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Average<BR>
Rate&nbsp;for</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1.5pt solid">Year Ended December 31,</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">End</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">Period</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">High</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">Low</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="15" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>(U.S. dollars per Pound Sterling)</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%; font: 10pt Times New Roman, Times, Serif; text-align: left">2012</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right">1.6262</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right">1.5853</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right">1.5301</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right">1.6275</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">2013</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1.6574</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1.5641</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1.4837</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1.6574</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">2014</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1.5578</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1.6484</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1.5517</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1.7165</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">2015</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1.4746</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1.5284</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1.4648</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1.5882</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">2016</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1.2337</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1.3555</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1.2155</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1.4800</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">2017</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1.3515</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1.2875</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1.2052</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1.3597</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Month,
    2018</B></FONT> </TD>
    <TD> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Period
    </B></FONT><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>End</B></FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>High</B></FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Low</B></FONT> </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD COLSPAN="10" STYLE="text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(U.S.
    dollars per Pound Sterling)</B></FONT> </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">January 2018</FONT> </TD>
    <TD STYLE="width: 1%"> &nbsp; </TD>
    <TD STYLE="width: 1%"> &nbsp; </TD>
    <TD STYLE="width: 9%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.4190</FONT> </TD>
    <TD STYLE="width: 1%"> &nbsp; </TD>
    <TD STYLE="width: 1%"> &nbsp; </TD>
    <TD STYLE="width: 1%"> &nbsp; </TD>
    <TD STYLE="width: 9%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.4346</FONT> </TD>
    <TD STYLE="width: 1%"> &nbsp; </TD>
    <TD STYLE="width: 1%"> &nbsp; </TD>
    <TD STYLE="width: 1%"> &nbsp; </TD>
    <TD STYLE="width: 9%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3457</FONT> </TD>
    <TD STYLE="width: 1%"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">February 2018</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3794</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.4278</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3756</FONT> </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 2018</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.4027</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.4246</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3713</FONT> </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">April 2018</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3751</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.4379</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3714</FONT> </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 2018</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3289</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3776</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3205</FONT> </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 2018</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3197</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3427</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3089</FONT> </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">July 2018 </FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3140</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3266</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2987</FONT> </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">August 2018 (through August 10, 2018)</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2769</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2769</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3120</FONT> </TD>
    <TD> &nbsp; </TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> <B>On August 10,
2018 the exchange rate published by the Federal Reserve Bank of New York was $1.2769 per &pound;1.00.</B> </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
presented on a constant currency basis in this prospectus is calculated by translating current year results at prior year average
exchange rates. Management reviews and analyzes business results excluding the effect of foreign currency translation because
they believe this better represents our underlying business trends.<BR STYLE="clear: both">
<B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B></B></FONT></P>

<!-- Field: Page; Sequence: 50 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><A NAME="a_009"></A>PRICE RANGE OF OUR ORDINARY SHARES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Our ordinary shares have been trading
on AIM under the symbol &ldquo;TILS&rdquo; since April 24, 2014.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> The following
table presents, for the periods indicated, the reported high and low sale prices, including intra-day sales, of our ordinary shares
on AIM in Pounds Sterling and U.S. dollars. For the convenience of the reader, we have translated Pounds Sterling amounts in the
table below into U.S. dollars at the noon buying rate of the Federal Reserve Bank of New York on August 10, 2018, which was &pound;1.00
to $1.2769.&nbsp; </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"> &nbsp; </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> Price Per<BR> Ordinary
    Share &pound; </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> &nbsp; </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> Price Per<BR> Ordinary
    Share $ </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"> &nbsp; </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> High </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> &nbsp; </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> Low </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> &nbsp; </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> High </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> &nbsp; </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> Low </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD> &nbsp; </TD><TD> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="text-align: center"> &nbsp; </TD><TD> &nbsp; </TD><TD> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="text-align: center"> &nbsp; </TD><TD> &nbsp; </TD><TD> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="text-align: center"> &nbsp; </TD><TD> &nbsp; </TD><TD> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="text-align: center"> &nbsp; </TD><TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold"> Year Ended December 31, 2018 </TD><TD> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="text-align: center"> &nbsp; </TD><TD> &nbsp; </TD><TD> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="text-align: center"> &nbsp; </TD><TD> &nbsp; </TD><TD> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="text-align: center"> &nbsp; </TD><TD> &nbsp; </TD><TD> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="text-align: center"> &nbsp; </TD><TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%; text-align: left"> First Quarter </TD><TD STYLE="width: 1%"> &nbsp; </TD>
    <TD STYLE="width: 1%; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; text-align: right"> 1.49 </TD><TD STYLE="width: 1%; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%"> &nbsp; </TD>
    <TD STYLE="width: 1%; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; text-align: right"> 0.82 </TD><TD STYLE="width: 1%; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%"> &nbsp; </TD>
    <TD STYLE="width: 1%; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; text-align: right"> 1.90 </TD><TD STYLE="width: 1%; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%"> &nbsp; </TD>
    <TD STYLE="width: 1%; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; text-align: right"> 1.05 </TD><TD STYLE="width: 1%; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"> Second Quarter </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 0.88 </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 0.37 </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 1.12 </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 0.47 </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD> Third Quarter (through August 10, 2018) </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 1.10 </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 0.37 </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 1.40 </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 0.47 </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &nbsp; </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &nbsp; </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &nbsp; </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &nbsp; </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD> Year Ended December 31, 2017 </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &nbsp; </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &nbsp; </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &nbsp; </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &nbsp; </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"> First Quarter </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 2.10 </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 1.66 </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 2.68 </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 2.12 </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"> Second Quarter </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 2.40 </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 1.65 </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 3.06 </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 2.11 </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"> Third Quarter </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 1.75 </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 1.42 </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 2.23 </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 1.81 </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"> Fourth Quarter </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 1.80 </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 1.39 </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 2.30 </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 1.77 </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &nbsp; </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &nbsp; </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &nbsp; </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &nbsp; </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD> Year Ended December 31, 2016 </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &nbsp; </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &nbsp; </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &nbsp; </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &nbsp; </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"> First Quarter </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 2.15 </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 1.22 </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 2.75 </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 1.56 </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"> Second Quarter </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 1.61 </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 1.23 </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 2.06 </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 1.57 </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"> Third Quarter </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 2.02 </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 1.35 </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 2.58 </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 1.72 </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"> Fourth Quarter </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 2.16 </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 1.75 </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 2.76 </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 2.23 </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> On August 23,&nbsp;2018,
the last reported sale price of our ordinary shares on AIM was &pound;1.12 per ordinary share ($1.43 per ordinary share based
on the exchange rate set forth above).&nbsp; </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 51 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_010"></A>USE
OF PROCEEDS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We estimate that
the net proceeds from this offering will be approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; million, or approximately $ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million
if the underwriters exercise their over-allotment option in full, assuming an IPO price of $ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per
ADS, which reflects the last reported sale price of &pound;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per ordinary share on AIM on &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
2018 equivalent to US$ per ADS based on an exchange rate of &pound;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; to $1.00, after deducting the underwriting discounts and
commissions and estimated offering expenses payable by us.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Each $1.00 increase
(decrease) in the public offering price per ADS would increase (decrease) our net proceeds, after deducting estimated underwriting
discounts and commissions and offering expenses, by approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million
(assuming no exercise of the over-allotment option by the underwriters).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> We intend to use
the net proceeds to fund our planned clinical trials, manufacturing and process development, analytical testing, regulatory expenses
and for general corporate purposes, including working capital, as follows: </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> &nbsp; </P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> &#9679; </TD><TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif">approximately
                                         $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; to advance the clinical development of Milciclib, which we expect will be sufficient
                                         to complete our ongoing Phase 2a study with Milciclib as a single therapy, or monotherapy,
                                         in HCC patients, and to commence a Phase 2b clinical trial for the combination of Milciclib
                                         with Sorafenib in na&iuml;ve HCC patients (which would exclude costs associated with
                                         protocol development, which have already been paid, but include the cost of purchasing
                                         sufficient quantities of Nexavar&reg; from Bayer and the cost of activation of clinical
                                         sites);</FONT> </TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> &#9679; </TD><TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif">approximately
                                         $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; to advance the clinical development of Foralumab, which we expect will be sufficient
                                         to complete Phase 1 trials evaluating both oral and nasal administration of Foralumab
                                         in healthy volunteers, and to commence Phase 2 trials for treatment of NASH with Foralumab
                                         and nasal administration of Foralumab for treatment of progressive MS patients, respectively;
                                         and</FONT> </TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> &#9679; </TD><TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif">and
                                         the remainder to fund our other research and development programs (including the development
                                         of the <FONT STYLE="text-underline-style: double; background-color: white">StemPrintER&trade;
                                         program)</FONT>, working capital and other general corporate purposes.</FONT> </TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> &nbsp; </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
expected use of the net proceeds from this offering represents our intentions based upon our current plans and business conditions.
We may also use a portion of the net proceeds to in-license, acquire, or invest in additional products or assets, businesses,
or technologies, although currently we have no specific agreements, commitments, or understandings in this regard. As of the date
of this prospectus, we cannot predict with certainty all of the particular uses for the net proceeds to be received upon the closing
of this offering or the amounts that we will actually spend on the uses set forth above. Predicting the costs necessary to develop
product candidates can be difficult. The amounts and timing of our actual expenditures and the extent of clinical development
may vary significantly depending on numerous factors, including the progress of our development efforts, the status of and results
from ongoing clinical trials or clinical trials we may commence in the future, as well as any collaborations that we may enter
into with third parties and any unforeseen cash needs. As a result, our management will retain broad discretion over the allocation
of the net proceeds from this offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> We anticipate
that our existing cash resources, together with the net proceeds from the offering, will enable us to fund our operating expenses
and capital expenditure requirements to the end of 2019. We have based this estimate on assumptions that may prove to be incorrect,
and we could use our available capital resources sooner than we currently expect. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> Pending their
use, we plan to invest the net proceeds from the offering in&nbsp;short-&nbsp;and&nbsp;intermediate-term&nbsp;interest-bearing
obligations and certificates of deposit. The goal with respect to the investment of these net proceeds is capital preservation
and liquidity so that such funds are readily available to fund our operations. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 52 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_011"></A>DIVIDEND
POLICY</B></FONT></P>




<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have never paid or declared any cash dividends on our ordinary shares, and we do not anticipate paying any cash dividends on our
ordinary shares in the foreseeable future. We intend to retain all available funds and any future earnings to fund the development
and expansion of our business. Under English law, among other things, we may only pay dividends if we have sufficient distributable
reserves (on a non-consolidated basis), which are our accumulated realized profits that have not been previously distributed or
capitalized less our accumulated realized losses, so far as such losses have not been previously written off in a reduction or
reorganization of capital.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 53 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="a_012"></A>CAPITALIZATION</FONT></P>




<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should read the information in this &ldquo;Capitalization&rdquo; section together with &ldquo;Selected Consolidated Financial
Data,&rdquo; &ldquo;Management&rsquo;s Discussion and Analysis of Financial Condition and Results of Operations&rdquo; and
our consolidated financial statements and the related notes appearing elsewhere in this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below sets forth our cash and short-term deposits and short-term investments and capitalization as of December 31, 2017
derived from our audited consolidated financial statements included elsewhere in this prospectus:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">on an actual basis; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">on a pro forma basis giving effect to: (i) the issuance from January 2018 to April 2018 of an aggregate
1,797,917 ordinary shares for cash with gross proceeds of $2,268,000 (&pound;1,675,000); (ii)&nbsp;the issuance from January 2018
to April 2018 of an aggregate 833,215 ordinary shares to our former noteholders in respect of accrued interest; and (iii) the issuance
on April 24, 2018 of 51,563 ordinary shares, credited as fully paid to intermediaries in lieu of commissions in a private placement;
and</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">on a pro forma as adjusted basis to give further effect to the sale of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ADS in this offering at the assumed IPO price of $ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ADS in this offering, which reflects the last reported sale price of &pound;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ordinary share on AIM on &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2018 equivalent to US$&nbsp;&nbsp;&nbsp;per ADS based on an exchange rate of  &pound;&nbsp;&nbsp;&nbsp;&nbsp;to $1.00 after deducting the estimated underwriting discounts and commissions and estimated offering expenses payable by us in connection with this offering.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0"> As
    of December 31, 2017 </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<B>Actual</B></FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;<B>Pro
    Forma</B></FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; border-bottom: Black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif; padding-right: 0"> Pro
    Forma As Adjusted(1) </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font-weight: bold; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; font-family: Times New Roman, Times, Serif; padding-right: 0"> (in thousands) </TD><TD STYLE="font-weight: bold; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 64%; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> Cash and short-term
    deposits and short-term investments </TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> $ </TD><TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> 64 </TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> 84 </TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> $ </TD><TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> Total interest bearing loans
    and borrowings </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> $ </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> - </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> - </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> $ </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp;&nbsp;&nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> Warrant liability </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> $ </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> - </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> - </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> $ </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp;&nbsp;&nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> Equity: </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> Issued capital </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> 8,141 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> 8,217 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> Share premium </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> 31,284 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> 33,559 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> Other capital reserves </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> Other reserves </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> 910 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> (3,294 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> ) </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> Accumulated loss </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> (42,613 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> ) </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> (40,740 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> ) </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> Total equity </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> (2,278 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> ) </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> (2,258 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> ) </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> Total capitalization </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> $ </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> (2,214 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> ) </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> (2,174 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> ) </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> $ </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 29px; text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Each $1.00 increase or decrease in the
        assumed IPO price of $ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;per ADS in this offering, would increase or decrease the
        pro forma as adjusted total equity and total capitalization by approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; million after deducting the estimated underwriting
        discounts and commissions and estimated offering expenses payable by us.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">An increase (decrease) of 1,000,000 in
        the number of ADSs offered by us in this offering, as set forth on the cover page of this prospectus, would increase (decrease)
        the pro forma as adjusted total equity and total capitalization by $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; million, assuming no change in the assumed IPO price per ADS
        and after deducting the estimated underwriting discounts and commissions payable by us.</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The table above excludes:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> &nbsp; </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px; font-size: 10pt"> &nbsp; </TD>
    <TD STYLE="width: 24px; font-size: 10pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font-size: 10pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,010,833
    ordinary shares issuable upon the exercise of share options outstanding as of&nbsp;&nbsp;August 23, 2018 at exercise prices
    of between $0.657 and $3.285&nbsp;per ordinary share;</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.25in"> &nbsp; </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px"> &nbsp; </TD>
    <TD STYLE="width: 24px"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,906,570 ordinary
    shares that may be issued under our existing share option plans, as described in &ldquo;Management&mdash;Equity Compensation
    Arrangements,&rdquo; as of August 23, 2018; and</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.25in"> &nbsp; </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px"> &nbsp; </TD>
    <TD STYLE="width: 24px"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,060,809 ordinary
    shares that may be issued upon the exercise of warrants to purchase ordinary shares outstanding as at August 23, 2018 at exercise
    prices of between $0.197 and $2.44 per ordinary share.</FONT> </TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> &nbsp; </P>


<!-- Field: Page; Sequence: 54 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="a_013"></A>DILUTION</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">If you invest in our
ADSs in this offering, your interest will be diluted to the extent of the difference between the IPO price per ADS paid by purchasers
in this offering and our pro forma as adjusted net tangible book value per ADS after completion of this offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">At December 31,
2017, we had a historical net tangible book value of $0.0197 per ordinary share (equal to $0.0958&nbsp;&nbsp;per ADS). Net
tangible book value per ordinary share represents the amount of our total assets less our total liabilities, excluding
goodwill and other intangible assets, divided by the total number of our ordinary shares outstanding as of December 31,
2017.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Pro forma net tangible book value as of December 31, 2017 would have been $0.0199&nbsp;per ordinary share,
or $0.0995&nbsp;per ADS. Pro forma net tangible book value represents the amount of our total tangible assets less our total liabilities
after giving effect to: (i) the issuance from January 2018 to April 2018 of an aggregate 1,797,917 ordinary shares for cash with
gross proceeds of $2,268,000 (&pound;1,675,000); (ii)&nbsp;&nbsp;the issuance from January 2018 to April 2018 of an aggregate 833,215
ordinary shares to our former noteholders in respect of accrued interest; and (iii) the issuance on April 24, 2018 of 51,563 ordinary
shares, credited as fully paid to intermediaries in lieu of commissions in a private placement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">After giving further
effect to the sale by us of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ADSs (representing&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ordinary
shares) at an assumed IPO price of $ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;per ADS in this offering, which reflects
the last reported sale price of &pound;  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ordinary share on AIM on &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
2018 equivalent to US$  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ADS based on an exchange rate of &pound;  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to $1.00 after deducting the estimated underwriting discounts
and commissions and estimated offering expenses payable by us in connection with this offering, our pro forma as adjusted net tangible
book value as of December 31, 2017 would have been $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; million, (equal to $ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per
ADS). This represents an immediate increase in net tangible book value of $ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ordinary share (equal
to $ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ADS) to existing shareholders and an immediate dilution of $ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per
ordinary share (equal to $ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ADS) to new investors purchasing ADSs in this offering.
Dilution per ADS or ordinary share to new investors is determined by subtracting the pro forma as adjusted net tangible book value
per ADS or ordinary share after this offering from the assumed IPO price per ADS paid by new investors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The following table
illustrates this dilution to new investors purchasing ADSs in this offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0">As of<BR>
 December&nbsp;31, 2017</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0">per ADS ($)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 88%; text-indent: -10pt; padding-left: 10pt; font-family: Times New Roman, Times, Serif; padding-right: 0">Assumed IPO price</TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">$</TD><TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;&nbsp;&nbsp;</TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 10pt; font-family: Times New Roman, Times, Serif; padding-right: 0">Pro forma net tangible book value per ADS</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10pt; font-family: Times New Roman, Times, Serif; padding-right: 0">Increase in pro forma net tangible book value per ADS attributable to this offering</TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10pt; font-family: Times New Roman, Times, Serif; padding-right: 0">Pro forma as adjusted net tangible book value per ADS after this offering</TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-bottom: 4pt; text-indent: -10pt; padding-left: 10pt; font-family: Times New Roman, Times, Serif; padding-right: 0">Dilution per ADS to new investors in this offering</TD><TD STYLE="padding-bottom: 4pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="padding-bottom: 4pt; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">If the underwriters
exercise in full their over-allotment option to purchase an additional &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ADSs,
our pro forma as adjusted net tangible book value after this offering would be $ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ordinary share
(equal to $ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ADS), representing an immediate increase in pro forma as adjusted net tangible book
value of $ &nbsp;&nbsp;&nbsp;&nbsp;per ordinary share (equal to $ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ADS) to existing shareholders
and immediate dilution of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per ordinary share (equal to $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per ADS).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Each $1.00 increase
(decrease) in the assumed IPO price of $ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;per ADS in this offering, which reflects
the last reported sale price of &pound; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per ordinary share on AIM on &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
2018 equivalent to US$ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per ADS based on an exchange rate of &pound; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; to $1.00 would increase (decrease) the pro forma as adjusted
net tangible book value after this offering by $ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ADS and the dilution to new investors
in this offering by $ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ADS, assuming that the number of ADSs offered by us in
this offering, as set forth on the cover page of this prospectus, remains the same and after deducting the estimated underwriting
discounts and commissions and estimated offering expenses payable by us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">An increase of 1,000,000
in the number of ADSs offered by us in this offering, as set forth on the cover page of this prospectus, would increase the pro
forma as adjusted net tangible book value after this offering by $ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ADS and decrease the
dilution to new investors participating in this offering by $ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ADS, assuming no change in the
assumed IPO price per ADS and after deducting the estimated underwriting discounts and commissions and estimated offering expenses
payable by us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">A decrease of 1,000,000 in the number of ADSs offered by us in this offering, as set forth on the cover
page of this prospectus, would decrease the pro forma as adjusted net tangible book value after this offering by $ &nbsp;&nbsp;&nbsp;&nbsp;per
ADS, and increase the dilution to new investors participating in this offering by $ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ADS, assuming
no change in the assumed IPO price per ADS and after deducting the estimated underwriting discounts and commissions and estimated
offering expenses payable by us.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 55 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The following table
summarizes, as of December 31, 2017, on the pro forma as adjusted basis described above, the number of ADSs purchased from us,
the total consideration paid to us and the average price paid by new investors purchasing ADSs in this offering. The table below
is based on an assumed IPO price of $ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;per ADS in this offering, which reflects
the last reported sale price of &pound; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per ordinary share on AIM on &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
2018 equivalent to US$  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ADS based on an exchange rate of &pound; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; to $1.00 before deducting the estimated underwriting discounts
and commissions and estimated offering expenses payable by us in connection with this offering.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0">Ordinary Shares<BR>

    Purchased(1)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0">Total &nbsp;Consideration</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Average</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Price per</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Ordinary</B></P></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0">Average &nbsp;Price per</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0">Number</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0">Percent</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0">Amount</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0">Percent</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0">Share</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0">ADS</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="font-weight: bold; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD COLSPAN="22" STYLE="font-weight: bold; text-align: center; font-family: Times New Roman, Times, Serif; padding-right: 0">(in thousands, except percentages and per share data)</TD><TD STYLE="font-weight: bold; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 28%; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">Existing shareholders</TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">%</TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">$</TD><TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">%</TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&pound;</TD><TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">$</TD><TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0">New investors</TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="padding-bottom: 4pt; font-family: Times New Roman, Times, Serif; padding-right: 0">Total</TD><TD STYLE="padding-bottom: 4pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 4pt double; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 4pt double; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="text-align: left; padding-bottom: 4pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="padding-bottom: 4pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 4pt double; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 4pt double; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;&nbsp;&nbsp;</TD><TD STYLE="text-align: left; padding-bottom: 4pt; font-family: Times New Roman, Times, Serif; padding-right: 0">%</TD><TD STYLE="padding-bottom: 4pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 4pt double; font-family: Times New Roman, Times, Serif; padding-right: 0">$</TD><TD STYLE="text-align: right; border-bottom: Black 4pt double; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="text-align: left; padding-bottom: 4pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="padding-bottom: 4pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 4pt double; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 4pt double; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="text-align: left; padding-bottom: 4pt; font-family: Times New Roman, Times, Serif; padding-right: 0">%</TD><TD STYLE="padding-bottom: 4pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 4pt double; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 4pt double; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="text-align: left; padding-bottom: 4pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="padding-bottom: 4pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 4pt double; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 4pt double; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="text-align: left; padding-bottom: 4pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0; font-family: Times New Roman, Times, Serif"><DIV STYLE="font: 1pt Times New Roman, Times, Serif; border-top: Black 1.5pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.3in; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Including ordinary shares in the form of ADSs.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Each $1.00 increase
(decrease) in the assumed IPO price of $ &nbsp;&nbsp;&nbsp;&nbsp;per ADS, which reflects the last reported sale price of &pound; &nbsp;&nbsp;&nbsp;&nbsp;
per ordinary share on AIM on &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2018 equivalent to US$ per ADS based
on an exchange rate of &pound; &nbsp;&nbsp;&nbsp;&nbsp; to $1.00 , would increase (decrease) the total consideration paid by new investors by $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
million (&pound; &nbsp;&nbsp;&nbsp;&nbsp; million) and would increase (decrease) the percentage of total consideration paid by new investors by __%, assuming
that the number of ordinary shares (including ordinary shares in the form of ADSs) offered by us in this offering, as set forth
on the cover page of this prospectus, remains the same.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">An increase (decrease)
of 1,000,000 in the number of ADSs offered by us, as set forth on the cover page of this prospectus, would increase (decrease)
the total consideration paid by new investors by $ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million and would increase or decrease the percentage
of total consideration paid by new investors by &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;%, assuming no change in the assumed IPO price</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The table above assumes
no exercise of the underwriters&rsquo; over-allotment option in this offering. If the underwriters exercise in full their over-allotment
option to purchase an additional &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ADSs, the following will occur:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the percentage of our ordinary shares held by existing shareholders will decrease to &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;% of the total number of our ordinary shares outstanding after this offering; and</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the percentage of our ordinary shares held by new investors will increase to approximately &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;% of the total number of our ordinary shares outstanding after this offering.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -31pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The tables above are based on 125,054,805&nbsp;ordinary shares outstanding as of December 31, 2017. The
tables above exclude:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> &nbsp; </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px; font-size: 10pt"> &nbsp; </TD>
    <TD STYLE="width: 24px; font-size: 10pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font-size: 10pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,010,833
    ordinary shares issuable upon the exercise of share options outstanding as of&nbsp;&nbsp;August 23, 2018 at exercise prices
    of between $0.657 and $3.285&nbsp;per ordinary share;</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> &nbsp; </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px"> &nbsp; </TD>
    <TD STYLE="width: 24px"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,906,570 ordinary
    shares that may be issued under our existing share option plans, as described in &ldquo;Management&mdash;Equity Compensation
    Arrangements,&rdquo; as of August 23, 2018; and</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> &nbsp; </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px"> &nbsp; </TD>
    <TD STYLE="width: 24px"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,060,809 ordinary
    shares that may be issued upon the exercise of warrants to purchase ordinary shares outstanding as at August 23, 2018 at exercise
    prices of between $0.197 and $2.44 per ordinary share.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> &nbsp; </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px"> &nbsp; </TD>
    <TD STYLE="width: 24px"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,010,833 ordinary
    shares issuable upon the exercise of share options outstanding as of&nbsp;&nbsp;August 23, 2018 at exercise prices of between
    $0.657 and $3.285&nbsp;per ordinary share;</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> &nbsp; </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px"> &nbsp; </TD>
    <TD STYLE="width: 24px"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,906,570 ordinary
    shares that may be issued under our existing share option plans, as described in &ldquo;Management&mdash;Equity Compensation
    Arrangements,&rdquo; as of August 23, 2018; and</FONT> </TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 13.5pt">To the extent that
share options or warrants are exercised, or we issue additional ADSs or ordinary shares in the future, there will be further dilution
to investors participating in this offering. In addition, we may choose to raise additional capital because of market conditions
or strategic considerations, even if we believe that we have sufficient funds for our current or future operating plans. If we
raise additional capital through the sale of equity or convertible debt securities, the issuance of these securities could result
in further dilution to our shareholders.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 13.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 56 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_014"></A>SELECTED
CONSOLIDATED FINANCIAL DATA</B></FONT></P>




<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">The following tables
set forth our selected consolidated financial data for the periods indicated. We have derived the consolidated statement of comprehensive
income for the years ended December 31, 2017 and 2016 and the consolidated balance sheet data as of December 31, 2017 and 2016
from our audited consolidated financial statements included elsewhere in this prospectus.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">We maintain our books and records in Pounds Sterling, and we prepare our financial statements in accordance
with IFRS as issued by the IASB. We report our financial results in U.S. dollars.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; padding-right: 0"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; padding-right: 0"> &nbsp; </TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 0"> Years Ended
    December&nbsp;31, </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; padding-right: 0"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; padding-right: 0"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; padding-right: 0"> &nbsp; </TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid; padding-right: 0"> (in
    thousands except share and per share data) </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; padding-right: 0"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-right: 0"></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-right: 0"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid; padding-right: 0"> 2017 </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-right: 0"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-right: 0"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid; padding-right: 0"> 2016 </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-right: 0"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> <B>Consolidated statement of operations data:</B> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> Research and development
    expenses </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 0"> (6,015 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> ) </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 0"> (4,007 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-right: 0"> General
    and Administrative expenses </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1.5pt solid; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 1.5pt solid; padding-right: 0"> (4,602 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-right: 0"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1.5pt solid; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 1.5pt solid; padding-right: 0"> (5,872 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-right: 0"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> Operating Loss </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 0"> (10,617 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 0"> (9,879 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-right: 0"> Finance
    costs </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1.5pt solid; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 1.5pt solid; padding-right: 0"> (12 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-right: 0"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1.5pt solid; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 1.5pt solid; padding-right: 0"> (12 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-right: 0"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> Loss Before taxation </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 0"> (10,628 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 0"> (9,891 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-right: 0"> Tax credits </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1.5pt solid; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 1.5pt solid; padding-right: 0"> 1,912 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1.5pt solid; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 1.5pt solid; padding-right: 0"> 121 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-right: 0"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt; padding-right: 0"> Total Loss </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 4pt double; padding-right: 0"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 4pt double; padding-right: 0"> (8,716 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt; padding-right: 0"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 4pt double; padding-right: 0"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 4pt double; padding-right: 0"> (9,770 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt; padding-right: 0"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt; padding-right: 0"> Basic and
    diluted loss per share </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 4pt double; padding-right: 0"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 4pt double; padding-right: 0"> (0.09 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt; padding-right: 0"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 4pt double; padding-right: 0"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 4pt double; padding-right: 0"> (0.11 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt; padding-right: 0"> ) </TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; padding-right: 0"><P STYLE="margin: 0pt 0; text-align: left; font-family: Times New Roman, Times, Serif"></P>


</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; padding-right: 0"> &nbsp; </TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 0"> As of December
    31, </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; padding-right: 0"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; padding-right: 0"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; padding-right: 0"> &nbsp; </TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid; padding-right: 0"> (in
    thousands) </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; padding-right: 0"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-right: 0"></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; padding-right: 0"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid; padding-right: 0"> 2017 </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; padding-right: 0"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; padding-right: 0"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid; padding-right: 0"> 2016 </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; padding-right: 0"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> <B>Consolidated balance sheet:</B> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> Cash and cash equivalents </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 0"> 64 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 0"> 5,802 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> Total assets </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 0"> 2,471 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 0"> 6,231 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> Total Liabilities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 0"> 4,749 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 0"> 2,143 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> Share capital </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 0"> 8,141 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 0"> 6,903 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> Share premium </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 0"> 31,284 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 0"> 8,943 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> Other reserves </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 0"> 910 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 0"> 17,969 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> Retained earnings </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 0"> (42,613 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 0"> (29,726 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> Total Equity </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 0"> (2,278 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 0"> 4,088 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 57 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="a_015"></A>MANAGEMENT&rsquo;S
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION</FONT></P>




<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AND
RESULTS OF OPERATIONS<B><SUP>8</SUP></B></FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>The
following discussion of our financial condition and results of operations should be read in conjunction with the consolidated
historical financial statements as at December 31, 2017 and 2016 and for the two years ended December 31, 2017.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>The
following discussion includes forward-looking statements that reflect our plans, estimates and beliefs and involves risks and
uncertainties. Our actual results could differ materially from those discussed in these statements. Factors that could cause or
contribute to these differences include, but are not limited to, those discussed below and elsewhere in this registration statement,
particularly in &ldquo;Risk Factors&rdquo; and elsewhere in this prospectus.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>References
below to &ldquo;2017&rdquo; and &ldquo;2016&rdquo; are to the financial years ended December 31, 2017 and December 31, 2016, respectively.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Overview</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 7pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We are a biotechnology company that is focused on the discovery and development of novel molecules and
related diagnostics to treat high unmet medical needs in oncology and immunology. Our lead product candidate in immunology is Foralumab
(TZLS-401), which we believe is the only fully human anti-CD3 monoclonal antibody, or mAb, in clinical development. MAbs represent
a single pure antibody produced by single clones and are an important class of human therapeutics for treating cancers and autoimmune
diseases. Generation of antibodies for use in humans developed in animals, leads to strong, immune responses limiting their effectiveness
and potentially leading to severe side effects. A process known as &ldquo;humanization&rdquo; removes most of the animal components
of the antibody thereby lowering the immune response from the human immune system. The entire omission of other animal material,
as in fully human antibodies, is the optimal goal to avoid incompatibility with the human immune system. Our lead product candidate
in oncology is Milciclib (TZLS-201), which is an orally bioavailable, small molecule broad spectrum inhibitor of cyclin-dependent
kinases, or CDKs, and Src family kinases. CDKs are a highly conserved family of enzymes that phosphorylate a specific group of
proteins that are involved in regulating the cell cycle. The cell cycle is a series of events that takes place in cells leading
to division and duplication of its DNA to produce two daughter cells. Src family kinases are non-receptor tyrosine kinase proteins
encoded by the Src gene also involved in regulating cell growth and potential transformation of normal cells to cancer cells. We
also have a drug discovery pipeline of small molecule NCEs, and biologics. We employ a lean and virtual research and development,
or R&amp;D, model using highly experienced teams of experts for each business function to maximize value accretion by focusing
resources on the drug discovery and development processes. Our mission is to design and deliver next generation therapeutics and
diagnostics for oncology and immune diseases of high unmet medical need by combining deep understanding of disease biology with
clinical development expertise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We are developing
Foralumab, for which we in-licensed the intellectual property from Novimmune SA, or Novimmune, in December 2014, as a potential
treatment for NASH, and Crohn&rsquo;s disease as well as neurodegenerative diseases such a MS. We believe that oral or nasal administration
of Foralumab has the potential to reduce inflammation while minimizing the toxicity and related side effects. To date, Foralumab
has been studied in one Phase 1 and two Phase 2a clinical trials conducted by Novimmune in 68 patients dosed by the intravenous
route of administration. In these trials, Foralumab was observed to be well-tolerated and produced immunologic effects consistent
with potential clinical benefit while demonstrating mild to moderate IRR.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We plan to
initially investigate Foralumab for safety and its immunomodulatory activity in healthy volunteers in two Phase 1 trials. In
one of the Phase 1 trials, subjects will be dosed Foralumab in a newly developed oral formulation (enteric capsule) with an
intention to treat patients with NASH and/or Crohn&rsquo;s disease and in the other Phase 1 trial, Foralumab will be dosed
via intranasal administration using a hand held nasal device with an intention to treat patients with MS. An IND for the
first-in-human evaluation of Foralumab in healthy human volunteers was filed on June 1, 2018 and we expect to commence a dose
ranging trial to evaluate biomarkers of immunomodulation of clinical responses in the third quarter of 2018. In addition, we
expect to initiate a Phase 1 trial in the first quarter of 2019 and a Phase 2 trial for oral Foralumab by the end of 2019, in
patients with NASH and/or Crohn&rsquo;s disease. On April 16, 2018 we entered into an exclusive license agreement with BWH
relating to a novel formulation of Foralumab in a medical device for nasal administration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> We are developing
Milciclib, for which we in-licensed the intellectual property from Nerviano, in January 2015, as a potential treatment for HCC.
A novel feature of Milciclib is its ability to reduce levels of microRNAs, miR-221 and miR-222. MicroRNAs are small RNA molecules
that play a significant role in the regulation of gene expression. miR-221 and miR-222 are believed to be linked to the development
of blood supply in cancer tumors. Levels of these microRNAs are consistently elevated in HCC patients and may contribute towards
resistance to treatment with Sorafenib, a multikinase inhibitor (a drug which may inhibit the cellular division and proliferation
associated with certain cancers) often prescribed to HCC patients. To date, Milciclib has been studied in a total of seven completed
and ongoing Phase 1 and Phase 2 clinical trials in a total of 296 patients conducted by Nerviano. In these trials, Milciclib was
well-tolerated with minimal adverse events. We initiated a Phase 2a trial for Milciclib as a monotherapy in patients with HCC
in the fourth quarter of 2017 and expect to initiate a Phase 2b trial for Milciclib in combination with Sorafenib (a multikinase
inhibitor drug, also known under its brand name Nexavar&reg;, used to treat some types of kidney, liver and thyroid cancers) in
patients with HCC in the first quarter of 2019. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 58 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Cumulative
Patient Exposure in Completed and Ongoing Milciclib Clinical Studies:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<B>Clinical
    Study</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Drug</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Indication</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number
    of </B><BR>
    <B>Patients Treated</B></FONT></TD></TR>
<TR STYLE="background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: bottom; text-align: center; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CDKO-125a-001
    Phase 1</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 12%; text-align: center; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Milciclib</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 30%; text-align: center; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Solid
    tumors</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 18%; text-align: center; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">37</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; padding-right: 0; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CDKO-125a-002
    Phase 1 / Phase 2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; padding-right: 0; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Milciclib</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Malignant
    glioma (Phase 1) Glioblastoma (Phase 2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">62</FONT></TD></TR>
<TR STYLE="background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: bottom; text-align: center; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CDKO-125a-003
    Phase 1</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Milciclib</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Solid
    tumors</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</FONT></TD></TR>
<TR STYLE="background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; text-align: center; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CDKO-125a-004
    Phase 1</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Milciclib
    + gemcitabine</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Solid
    tumors</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</FONT></TD></TR>
<TR STYLE="background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; text-align: center; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CDKO-125a-005/-0061/-0071
    Phase 2</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Milciclib</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Malignant
                                         Pleural Mesothelioma (-005)</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thymic
        carcinoma and malignant thymoma (-0061 and -0071)</FONT></P></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">140</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; text-align: center; font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CDKO-125a-010
    Phase 2 </FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center; font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Milciclib</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center; font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">HCC
    monotherapy</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center; font: 10pt Times New Roman, Times, Serif; padding-right: 0; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="5" STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total
    Patients Exposed</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; padding-right: 0; border-bottom: Black 4pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>296</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Source: Development Safety Update Report No. 7, February 27,
2018, Tiziana Life Sciences PLC; Investigator Brochure, Version 11, 2015.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Since our inception in
March 2014, we have devoted substantially all our resources to conducting preclinical studies and clinical trials, organizing
and staffing our company, business planning, raising capital and establishing our intellectual property portfolio. We do not have
any products approved for sale and have not generated any revenue from product sales. We have funded our operations to date primarily
with proceeds from the sale of ordinary shares. Through December 31, 2017, we had received net cash proceeds of $18.3 million
from sales of our ordinary shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> Since our inception,
we have incurred operating losses. Our net loss was $8.7 million and $9.8 million for the years ended December 31, 2017 and 2016,
respectively. As of December 31, 2017, we had an accumulated loss of $42.6 million. As of December 31, 2017, we had cash and cash
equivalents of $0.1 million. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We expect to continue
to incur significant expenses for the foreseeable future as we advance our product candidates through preclinical and clinical
development and seek regulatory approval and pursue commercialization of any approved product candidates. In addition, if we obtain
marketing approval for any of our product candidates, we expect to incur significant commercialization expenses related to product
manufacturing, marketing, sales and distribution.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 59 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Legal proceedings</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">From time to time,
we may be a party to litigation or subject to claims incident to the ordinary course of business. Although the results of litigation
and claims cannot be predicted with certainty, we currently believe that the final outcome of these ordinary course matters will
not have a material adverse effect on our business. Regardless of the outcome, litigation can have an adverse impact on us because
of defense and settlement costs, diversion of management resources and other factors. We are not currently a party to any material
legal proceedings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Foreign currency translations</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Items included in
the financial statements are measured using the currency of the primary economic environment in which the entity operates (the
functional currency). The consolidated financial statements are presented in U.S. dollars, which is our presentation currency.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Foreign currency transactions
are translated into the functional currency using exchange rates prevailing at the dates of the transactions. Foreign exchange
gains and losses resulting from the settlement of foreign currency transactions and from the translation at year-end exchange rates
of monetary assets and liabilities denominated in foreign currencies are recognized in the income statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The financial statements
of overseas subsidiary undertakings are translated into U.S. dollars on the following basis:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets and liabilities at the rate of exchange ruling at the year-end date.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Profit and loss account items at the average rate of exchange for the year.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Exchange differences arising from the translation of the net investment in foreign entities, borrowings
and other currency instruments designated as hedges of such investments, are taken to equity (and recognized in the statement
of comprehensive income) on consolidation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 60 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Components of Our Results of Operations</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Revenues</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">To date, we have not
generated any revenue from product sales and do not expect to generate any revenue from the sale of products in the near future.
If our development efforts for our product candidates are successful and result in regulatory approval, we may generate revenue
in the future from product sales.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Operating Expenses</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Research and Development Expenses</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> R&amp;D expenses
consist primarily of costs incurred in connection with the R&amp;D of our product candidates and are expensed as incurred. These
expenses consist of: </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-right: 0; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">expenses incurred under agreements with CROs, CMOs, as well as investigative sites and consultants that conduct our clinical trials, preclinical studies and other scientific development services;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-right: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">manufacturing scale-up expenses and the cost of acquiring and manufacturing materials for preclinical studies and clinical trial materials;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-right: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">employee-related expenses, including salaries, related benefits, travel and share-based compensation expense for employees engaged in R&amp;D functions;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">costs related to compliance with regulatory requirements;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">facilities costs, depreciation and other expenses, which include rent and utilities; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">fees for maintaining our third-party licensing agreements.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We recognize external
development costs based on an evaluation of the progress to completion of specific tasks using information provided to us by our
service providers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our direct R&amp;D
expenses are tracked on a program-by-program basis for our product candidates and consist primarily of external costs, such as
fees paid to outside consultants, CROs and CMOs in connection with our preclinical development, manufacturing and clinical development
activities. Our direct R&amp;D expenses by program also include fees incurred under our license agreements. We do not allocate
employee costs or facility expenses, including depreciation or other indirect costs, to specific programs because these costs are
deployed across multiple programs and, as such, are not separately classified. We use internal resources primarily to oversee the
R&amp;D as well as for managing our preclinical development, process development, manufacturing and clinical development activities.
These employees work across multiple programs and, therefore, we do not track their costs by program.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The table below summarizes
our R&amp;D expenses incurred by program:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0">Year ended December 31,</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0">2017</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0">2016</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">Direct research and development expense by program:</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; font-family: Times New Roman, Times, Serif; padding-right: 0">(in thousands)</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 76%; font-family: Times New Roman, Times, Serif; padding-right: 0">Foralumab</TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">$</TD><TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0">1,202</TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">$</TD><TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0">714</TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">Milciclib</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0">2,625</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0">1,542</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">BCL-3</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0">347</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0">637</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">TZLS-0501</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0">-</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"><P STYLE="margin: 0pt 0">-</P>


</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0">Stemprinter</TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0">1,201</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0">371</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">Total direct research and development expense</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">$</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0">5,375</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">$</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0">3,500</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0">Indirect research and development expense</TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0">640</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0">507</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-bottom: 4pt; font-family: Times New Roman, Times, Serif; padding-right: 0">Total research and development expense</TD><TD STYLE="padding-bottom: 4pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0">6,015</TD><TD STYLE="padding-bottom: 4pt; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="padding-bottom: 4pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0">4,007</TD><TD STYLE="padding-bottom: 4pt; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">R&amp;D activities
are central to our business model. Product candidates in later stages of clinical development generally have higher development
costs than those in earlier stages of clinical development, primarily due to the increased size and duration of later-stage clinical
trials and related product manufacturing expenses. As a result, we expect that our R&amp;D expenses will increase substantially
over the next several years as we increase personnel costs and prepare for regulatory filings related to our product candidates.
We also expect to incur additional expenses related to milestone, royalty payments and maintenance fees payable to third parties
with whom we have entered into license agreements to acquire the rights related to our product candidates.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 61 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
successful development and commercialization of our product candidates is highly uncertain. At this time, we cannot reasonably
estimate or know the nature, timing and costs of the efforts that will be necessary to complete the preclinical and clinical development
of any of our product candidates or when, if ever, material net cash inflows may commence from any of our product candidates.
This uncertainty is due to the numerous risks and uncertainties associated with development and commercialization, including the
uncertainty of:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         scope, progress, outcome and costs of our preclinical development activities, clinical
                                         trials and other R&amp;D activities;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">establishing
                                         an appropriate safety profile with IND- and CTA-enabling studies;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">successful
                                         patient enrollment in, and the initiation and completion of, clinical trials;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         timing, receipt and terms of any marketing approvals from applicable regulatory authorities;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">establishing
                                         commercial manufacturing capabilities or making arrangements with third-party manufacturers;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">development
                                         and timely delivery of commercial-grade drug formulations that can be used in our clinical
                                         trials and for &#9;commercial launch;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">obtaining,
                                         maintaining, defending and enforcing patent claims and other intellectual property rights;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">significant
                                         and changing government regulation;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">launching
                                         commercial sales of our product candidates, if and when approved, whether alone or in
                                         collaboration with &#9;others; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">maintaining
                                         a continued acceptable safety profile of the product candidates following approval.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may never succeed in achieving regulatory approval for any of our product candidates. We may obtain unexpected results from our
clinical trials. We may elect to discontinue, delay or modify clinical trials.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>General
and Administrative Expenses</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
and administrative expenses consist primarily of salaries, related benefits, travel and share-based compensation expense for personnel
in executive, finance and administrative functions. General and administrative expenses also include professional fees for legal,
consulting, accounting and audit services.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
anticipate that our general and administrative expenses will increase in the future as we increase our headcount to support our
continued research activities and development of our product candidates. We also anticipate that we will incur increased accounting,
audit, legal, regulatory, compliance, director and officer insurance costs, as well as investor and public relations expenses
associated with being a public company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Other
Income (Expense)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
expense consists of interest on a convertible loan note.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Results of Operations</B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -10.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
results of operations that follow reflect the historic periods under review and should not be taken as indicative of future performance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets out information relating to the consolidated interim and annual income statements during the periods under
review.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes our results of operations for the years ended December 31, 2017 and 2016:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD COLSPAN="10" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0"> Year
    Ended December 31, </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0"> 2017 </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0"> 2016 </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0"> Change </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> Operating Expenses: </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-family: Times New Roman, Times, Serif; padding-right: 0"> (in thousands) </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 64%; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> Research and development </TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> $ </TD><TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> (6,015 </TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> ) </TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> $ </TD><TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> (4,007 </TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> ) </TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> $ </TD><TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> (2,008 </TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0"> General
    and administrative </TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> $ </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> (4,602 </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> ) </TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> $ </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> (5,872 </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> ) </TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> $ </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> 1,271 </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0"> Total
    Operating expenses </TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> $ </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> (10,617 </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> ) </TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> $ </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> (9,879 </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> ) </TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> $ </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> (738 </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 8pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> Other Income/ (Expense) </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> (12 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> ) </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> (12 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> ) </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> - </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 8pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> Tax credit </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> 1,912 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> 121 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> 1.791 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 8pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0"> Net Loss </TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> $ </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> (8,716 </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> ) </TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> $ </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> (9,770 </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> ) </TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> $ </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> 1,054 </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 8pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> Other comprehensive loss: </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0"> Foreign
    currency translation adjustment </TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> 70 </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> 650 </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> (617 </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 8pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-bottom: 4pt; font-family: Times New Roman, Times, Serif; padding-right: 0"> Total Comprehensive
    Loss </TD><TD STYLE="padding-bottom: 4pt; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> $ </TD><TD STYLE="border-bottom: Black 4pt double; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> (8,646 </TD><TD STYLE="padding-bottom: 4pt; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> ) </TD><TD STYLE="padding-bottom: 4pt; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> $ </TD><TD STYLE="border-bottom: Black 4pt double; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> (9,120 </TD><TD STYLE="padding-bottom: 4pt; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> ) </TD><TD STYLE="padding-bottom: 4pt; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> $ </TD><TD STYLE="border-bottom: Black 4pt double; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> 437 </TD><TD STYLE="padding-bottom: 4pt; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 62 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Research and Development Expenses</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Research and development
activities were $6 million for the year ended December 31, 2017 compared to $4 million for the year ended December 31, 2016. The
increase of $2 million was primarily due to the continuation of Phase 2 clinical trials for Milciclib and Foralumab, and engaging
a CRO for Stemprinter. The research and development costs increased due to the introduction of a per patient cost.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>General and Administrative Expenses</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">General and administrative
expenses were $4.6 million and $5.8 million for the years ended December 31, 2017 and 2016. Within general and administrative expenses,
there were decreases in legal and professional fees of $0.5 million driven by a reduction in ad hoc activity, travel of $0.4 million,
and exchange rate charges of $0.2 million. As the company finalized its restructuring the general and administrative costs decreased.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Taxation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The tax expense for
a period represents the total of current taxation and deferred taxation. The charges in respect of current taxation are based on
the estimated taxable profit for the relevant year. Taxable profit for the year is based on the profit as shown in the income statement,
as adjusted for items of income or expenditure which are not deductible or chargeable for tax purposes. The current tax liability
for the year is calculated using tax rates which have either been enacted or substantively enacted at the relevant balance sheet
date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> Under UK tax legislation,
small and medium entity R&amp;D relief allows us to claim back up to 14.5% of our surrenderable losses as a tax cash credit. We
therefore recognized a tax credit of $1.9 million and $0.1 million for the years ended December 31, 2017 and 2016. The tax credit
in 2017 represents a provision for the credit due for the year ended December 31, 2017 and the amount claimed for the years ended
December 31, 2016. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Liquidity and Capital Resources</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: -10.25pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Since our inception, we have not generated any revenue and have incurred operating losses and negative
cash flows from our operations. We have funded our operations to date primarily with proceeds from the sale of ordinary shares
and convertible loan notes. Through December 31, 2017, we had received net cash proceeds of $18.6 million from sales of our ordinary
shares and conversion of warrants. From January 15, 2018 to April 19, 2018 we raised $2,250,233 from the sale of ordinary shares
at prices ranging from $1.06 to $1.98. Cash received from these financings are invested in a money market fund with a view of liquidity
and capital preservation.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Cash
Flows</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes our cash flows for each of the periods presented:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0"> Year
    Ended December 31, </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0"> in
    thousands </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0"> 2017 </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0"> 2016 </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 76%; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> Net cash used in
    operating activities. </TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> $ </TD><TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> (7,533 </TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> ) </TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> $ </TD><TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> (6,926 </TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> Net cash used in investing activities </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> (1 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> ) </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> (342 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> Net cash provided by financing
    activities. </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> 1,542 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> 1,575 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0"> Effect
    of exchange rate changes on cash and cash equivalents </TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> 254 </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> (1,633 </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-bottom: 4pt; font-family: Times New Roman, Times, Serif; padding-right: 0"> Net increase
    (decrease) in cash and cash equivalents </TD><TD STYLE="padding-bottom: 4pt; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> $ </TD><TD STYLE="border-bottom: Black 4pt double; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> (5,738 </TD><TD STYLE="padding-bottom: 4pt; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> ) </TD><TD STYLE="padding-bottom: 4pt; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> $ </TD><TD STYLE="border-bottom: Black 4pt double; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> (7,326 </TD><TD STYLE="padding-bottom: 4pt; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> ) </TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Net
Cash Used in Operating Activities</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Our use of cash in
each of the years ended December 31, 2017 and 2016 resulted primarily from our net losses, adjusted for non-cash charges and
changes in components of working capital. Net cash used in operating activities of $7.5 million during the year ended
December 31, 2017 increased by $0.6 million compared to the year ended December 31, 2016. The increase in net cash used in
operating activities was primarily due to an increase of $0.6 million in operating expenses.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 63 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Net
Cash Used in Investing Activities</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"> During the year ended
December 31, 2017, we used $0.001 million of cash in investing activities for the purchases of property and equipment. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Net
Cash Provided by Financing Activities</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the years ended December 31, 2017 and 2016, net cash provided by financing activities was $1.5 million and $1.6 million, respectively,
consisting of net cash proceeds from our sale and issuance of ordinary shares and warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Funding
Requirements</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect our expenses to increase substantially in connection with our ongoing activities, particularly as we advance the preclinical
activities, manufacturing and clinical trials of our product candidates. In addition, following our Nasdaq listing, we expect
to incur additional costs associated with operating as a public company. Our expenses will also increase as we:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">seek
                                         regulatory approvals for any product candidates that successfully complete clinical trials;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="padding-right: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">establish
                                         a sales, marketing and distribution infrastructure in anticipation of commercializing
                                         any product candidates for which we may obtain marketing approval and intend to commercialize
                                         on our own or jointly;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">hire
                                         additional clinical, medical and development personnel;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">expand
                                         our infrastructure and facilities to accommodate our growing employee base; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">maintain,
                                         expand and protect our intellectual property portfolio.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that our existing cash, will enable us to fund our operating expenses and capital expenditure requirements for the foreseeable
future. We have based these estimates on assumptions that may prove to be wrong, and we could utilize our available capital resources
sooner than we expect. If we receive regulatory approval for our other product candidates, we expect to incur significant commercialization
expenses related to product manufacturing, sales, marketing and distribution.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
of the numerous risks and uncertainties associated with research, development and commercialization of pharmaceutical product
candidates, we are unable to estimate the exact amount of our working capital requirements. Our future funding requirements will
depend on and could increase significantly as a result of many factors, including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="padding-right: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         scope, progress, outcome and costs of our preclinical development activities, clinical
                                         trials and other R&amp;D activities;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         costs, timing, receipt and terms of any marketing approvals from applicable regulatory
                                         authorities;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="padding-right: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         costs of future activities, including product sales, marketing, manufacturing and distribution,
                                         for any of our product candidates for which we receive marketing approval;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="padding-right: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         revenue, if any, received from commercial sale of our products, should any of our product
                                         candidates receive marketing approval;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         costs and timing of hiring new employees to support our continued growth;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="padding-right: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         costs of preparing, filing and prosecuting patent applications, maintaining and enforcing
                                         our intellectual property rights and defending intellectual property-related claims;
                                         and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         extent to which we acquire technologies.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Until
such time, if ever, that we can generate product revenue sufficient to achieve profitability, we expect to finance our cash needs
through equity offerings. To the extent that we raise additional capital through the sale of equity, your ownership interest will
be diluted. If we raise additional funds through other third-party funding, collaboration agreements, strategic alliances, licensing
arrangements or marketing and distribution arrangements, we may have to relinquish valuable rights to our technologies, future
revenue streams, research programs or product candidates or grant licenses on terms that may not be favorable to us. If we are
unable to raise additional funds through equity financings when needed, we may be required to delay, limit, reduce or terminate
our product development or future commercialization efforts or grant rights to develop and market products or product candidates
that we would otherwise prefer to develop and market ourselves.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Borrowings</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On August 16th 2017,
we completed a conversion of all of our outstanding convertible loan notes through the issuance of 28,455,214 ordinary shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 64 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Off-Balance Sheet Arrangements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: -9.8pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We did not have during
the periods presented, and we do not currently have, any off-balance sheet arrangements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Contractual Obligations</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: -9.35pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The following table
summarizes our contractual commitments and obligations as of December 31, 2017.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD COLSPAN="18" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0">Payments Due by Period</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0">(in thousands)</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0">Total</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0">Less than <BR>
1 Year</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0">Between 1 and 3 Years</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0">Between <BR>
3&nbsp;and <BR>
5 Years</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0">More than<BR>
 5 Years</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">Borrowings</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0">-</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0">-</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0">-</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0">-</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0">-</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 40%; text-align: left; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0">Operating lease obligations</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">$</TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0">854</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">$</TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0">278</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">$</TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0">575</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0">-</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0">-</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="padding-bottom: 4pt; font-family: Times New Roman, Times, Serif; padding-right: 0">Total</TD><TD STYLE="padding-bottom: 4pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0">854</TD><TD STYLE="padding-bottom: 4pt; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="padding-bottom: 4pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0">278</TD><TD STYLE="padding-bottom: 4pt; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="padding-bottom: 4pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0">575</TD><TD STYLE="padding-bottom: 4pt; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="padding-bottom: 4pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0">-</TD><TD STYLE="padding-bottom: 4pt; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="padding-bottom: 4pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0">-</TD><TD STYLE="padding-bottom: 4pt; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Critical Accounting Policies and Significant Judgments and Estimates</B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -10.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
consolidated financial statements are prepared in accordance with IFRS. The preparation of our consolidated financial statements
and related disclosures requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, costs
and expenses, and the disclosure of contingent assets and liabilities in our consolidated financial statements. We base our estimates
on historical experience, known trends and events and various other factors that we believe are reasonable under the circumstances,
the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily
apparent from other sources. We evaluate our estimates and assumptions on an ongoing basis. Our actual results may differ from
these estimates under different assumptions or conditions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
our significant accounting policies are described in more detail in our consolidated financial statements, we believe that the
following accounting policies are those most critical to the judgments and estimates used in the preparation of our consolidated
financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Accrued
Research and Development Expenses</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
part of the process of preparing our consolidated financial statements, we are required to estimate our accrued R&amp;D expenses.
This process involves reviewing open contracts and purchase orders, communicating with our personnel to identify services that
have been performed on our behalf and estimating the level of service performed and the associated cost incurred for the service
when we have not yet been invoiced or otherwise notified of actual costs. We make estimates of our accrued expenses as of each
balance sheet date in the consolidated financial statements based on facts and circumstances known to us at that time. We periodically
confirm the accuracy of these estimates with the service providers and make adjustments if necessary. Examples of estimated accrued
R&amp;D expenses include fees paid to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vendors
                                         in connection with preclinical development activities;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CROs
                                         and investigative sites in connection with preclinical studies and clinical trials; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CMOs
                                         in connection with drug substance and drug product formulation of preclinical study and
                                         clinical trial materials.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: left; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 65 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
base our expenses related to preclinical studies and clinical trials on our estimates of the services received and efforts expended
pursuant to quotes and contracts with multiple research institutions and CROs that conduct and manage preclinical studies and
clinical trials on our behalf. The financial terms of these agreements are subject to negotiation, vary from contract to contract
and may result in uneven payment flows. There may be instances in which payments made to our vendors will exceed the level of
services provided and result in a prepayment of the expense. Payments under some of these contracts depend on factors such as
the successful enrollment of patients and the completion of clinical trial milestones. In accruing service fees, we estimate the
time period over which services will be performed and the level of effort to be expended in each period. If the actual timing
of the performance of services or the level of effort varies from the estimate, we adjust the accrual or the amount of prepaid
expenses accordingly. Although we do not expect our estimates to be materially different from amounts actually incurred, our understanding
of the status and timing of services performed relative to the actual status and timing of services performed may vary and may
result in reporting amounts that are too high or too low in any particular period. To date, there have not been any material adjustments
to our prior estimates of accrued R&amp;D expenses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Valuation
of Share-Based Compensation and Tranche Obligations</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share-Based
Compensation</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
recognize compensation expense for equity awards based on the grant date fair value of the award. For equity awards that vest
based on a service condition, the share-based compensation expense is recognized on a straight-line basis over the requisite service
period. For equity awards that contain both performance and service conditions, we recognize share-based compensation expense
ratably over the requisite service period when the achievement of a performance-based milestone is probable based on the relative
satisfaction of the performance condition as of the reporting date. We use the fair value of our ordinary shares to determine
the fair value of restricted share awards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
date, the share-based awards granted to our employees and directors have been in the form of time and/or performance vesting share
options and have been reported in our consolidated statements of operations as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0">Years Ended December 31,</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0">In thousands</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0">2017</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0">2016</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 76%; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">Employee costs</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">$</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0">539</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">$</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0">1,015</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The calculation of
the fair value of equity-settled share based awards and the resulting charge to the statement of comprehensive income requires
assumptions to be made regarding future events and market conditions. These assumptions include the future volatility of the company&rsquo;s
ordinary share price. These assumptions are then applied to a recognized valuation model in order to calculate the fair value of
the awards.</P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where
employees, directors or advisers are rewarded using share based payments, the fair value of the employees&rsquo;, directors&rsquo; or advisers&rsquo;
services are determined by reference to the fair value of the share options / warrants awarded. Their value is appraised at the
date of grant and excludes the impact of any nonmarket vesting conditions (for example, profitability and sales growth targets).
Warrants issued in association with the issue of convertible loan notes are also considered as share based payments and a share
based payment charge is calculated for these too.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with IFRS 2, a charge is made to the statement of comprehensive income for all share-based payments including share
options based upon the fair value of the instrument used. A corresponding credit is made to a reserve, or Share Based Payment
Reserve, in the case of options/warrants awarded to employees, directors or advisers, and ordinary shares to be issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reserve
in the case of warrants issued in association with the issue of convertible loan notes, net of deferred tax where applicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
vesting periods or other vesting conditions apply, the expense is allocated over the vesting period, based on the best available
estimate of the number of share options / warrants expected to vest. Non-market vesting conditions are included in assumptions
about the number of options / warrants that are expected to become exercisable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimates
are subsequently revised, if there is any indication that the number of share options / warrants expected to vest differs from
previous estimates. No adjustment is made to the expense or share issue cost recognized in prior periods if fewer share options
ultimately are exercised than originally estimated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
exercise of share options / warrants, the proceeds received are allocated to share capital with any excess being recorded as share
premium.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where
share options are cancelled, this is treated as an acceleration of the vesting period of the options. The amount that otherwise
would have been recognized for services received over the vesting period is recognized immediately within the statement of comprehensive
income.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Share-based compensation
expense totaled $0.5 million and $1.0 million for the years ended December 31, 2017 and 2016, respectively. The decrease in expense
is due to a significant number of option forfeitures that occurred in the year ended December 31, 2017.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect the impact of our share-based compensation expense for share option awards granted to employees, directors and other service
providers to grow in future periods due to the potential increases in the value of our ordinary shares and headcount.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 66 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
conducting the valuations, we considered all objective and subjective factors that we believed to be relevant for each valuation
conducted, including our best estimate of our business condition, prospects and operating performance at each valuation date.
Within the valuations performed, a range of factors, assumptions and methodologies were used. The significant factors included:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         lack of an active public market for our ordinary shares;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                         results of operations, financial position and the status of our research and preclinical
                                         development efforts;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         material risks related to our business;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                         business strategy;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         market performance of publicly traded companies in the life sciences and biotechnology
                                         sectors;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         prices paid in recent transactions involving our ordinary shares;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         likelihood of achieving a liquidity event for the holders of our ordinary shares, such
                                         as an IPO, given prevailing market conditions; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         recent contemporaneous valuations of our ordinary shares prepared in accordance with
                                         methodologies outlined in the practice aid.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
dates of our valuations have not always coincided with the dates of our share grants. In determining the value of our ordinary
shares set forth in the table above, our board of directors considered, among other things, the most recent sale and issuance
of our ordinary shares, our stage of R&amp;D, our operating and financial performance and current business conditions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
estimates of fair value of our ordinary shares are highly complex and subjective. There are significant judgments and estimates
inherent in the determination of the fair value of our ordinary shares. These judgments and estimates include assumptions regarding
our future operating performance, and the determinations of the appropriate valuation methods. The assumptions underlying these
valuations represent management&rsquo;s best estimates, which involve inherent uncertainties and the application of management
judgment. If we had made different assumptions, our stock-based compensation expense, net loss and net loss per share could have
been materially different. If we had made different assumptions, our net loss and net loss per ordinary share could have been
materially different.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Taxation</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
tax expense for a period represents the total of current taxation and deferred taxation. The charges in respect of current taxation
are based on the estimated taxable profit for the relevant year. Taxable profit for the year is based on the profit as shown in
the income statement, as adjusted for items of income or expenditure which are not deductible or chargeable for tax purposes.
The current tax liability for the year is calculated using tax rates which have either been enacted or substantively enacted at
the relevant balance sheet date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
tax is provided in full, using the liability method on temporary differences arising between the tax base of assets and liabilities
and their carrying values in the financial statements. The deferred tax is not accounted for if it arises from initial recognition
of an asset or liability in a transaction other than a business combination that at the time of the transaction affects neither
accounting nor taxable profit or loss. Deferred tax is determined using tax rates which have been enacted or substantively enacted
at the balance sheet date and are expected to apply when the related deferred tax asset is realized or the deferred income tax
liability is settled.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
tax assets are recognized to the extent that it is probable that future taxable profits will be available against which the temporary
differences can be utilized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
tax is provided on temporary differences arising on investments in subsidiaries and associates, except where the timing of the
reversal of the temporary difference is controlled by the group and it is probable that the temporary difference will not reverse
in the foreseeable future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Emerging
Growth Company Status</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
April 2012, the JOBS Act was enacted. Section 107 of the JOBS Act provides that an EGC may take advantage of the extended transition
period provided in Section 7(a)(2)(B) of the Securities Act of 1933, or Securities Act, for complying with new or revised accounting
standards. Therefore, an EGC can delay the adoption of certain accounting standards until those standards would otherwise apply
to private companies. We have irrevocably elected not to avail ourselves of this extended transition period and, as a result,
we will adopt new or revised accounting standards on the relevant dates on which adoption of such standards is required for other
public companies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 67 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="a_016"></A>Business</FONT></P>




<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Overview</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We are a biotechnology
company that is focused on the discovery and development of novel molecules and related diagnostics to treat high unmet medical
needs in oncology and immunology. Our lead product candidate in immunology is Foralumab (TZLS-401), which we believe is the only
fully human anti-CD3 monoclonal antibody, or mAb, in clinical development. MAbs represent a single pure antibody produced by single
clones and are an important class of human therapeutics for treating cancers and autoimmune diseases. Generation of antibodies
for use in humans developed in animals, leads to strong, immune responses limiting their effectiveness and potentially leading
to severe side effects. A process known as &ldquo;humanization&rdquo; removes most of the animal components of the antibody thereby
lowering the immune response from the human immune system. The entire omission of other animal material, as in fully human antibodies,
is the optimal goal to avoid incompatibility with the human immune system. Our lead product candidate in oncology is Milciclib
(TZLS-201), which is an orally bioavailable, small molecule broad spectrum inhibitor of cyclin-dependent kinases, or CDKs, and
Src family kinases. CDKs are a highly conserved family of enzymes that phosphorylate a specific group of proteins that are involved
in regulating the cell cycle. The cell cycle is a series of events that takes place in cells leading to division and duplication
of its DNA to produce two daughter cells. Src family kinases are non-receptor tyrosine kinase proteins encoded by the Src gene
also involved in regulating cell growth and potential transformation of normal cells to cancer cells. We also have a drug discovery
pipeline of small molecule new chemical entities, or NCEs, and biologics. We employ a lean and virtual research and development,
or R&amp;D, model using highly experienced teams of experts for each business function to maximize value accretion by focusing
resources on the drug discovery and development processes. Our mission is to design and deliver next generation therapeutics and
diagnostics for oncology and immune diseases of high unmet medical need by combining deep understanding of disease biology with
clinical development expertise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> We are developing
Foralumab, for which we in-licensed the intellectual property from Novimmune SA, or Novimmune, in December 2014, as a potential
treatment for non-alcoholic steatohepatitis, or NASH, and Crohn&rsquo;s disease as well as neurodegenerative diseases such as
multiple sclerosis, or MS. We believe that oral or nasal administration of Foralumab has the potential to reduce inflammation
while minimizing the toxicity and related side effects. To date, Foralumab has been studied in one Phase 1 and two Phase 2a clinical
trials conducted by Novimmune in 68 patients dosed by the intravenous route of administration. In these trials, Foralumab was
observed to be well-tolerated and produced immunologic effects consistent with potential clinical benefit while demonstrating
mild to moderate infusion related reactions, or IRR. We plan to initially investigate Foralumab for safety and its immunomodulatory
activity in healthy volunteers in two Phase 1 trials. In one of the Phase 1 trials, subjects will be dosed Foralumab in a newly
developed oral formulation (enteric capsule) with an intention to treat patients with NASH and/or Crohn&rsquo;s disease and in
the other Phase 1 trial, Foralumab will be dosed via intranasal administration using a hand held nasal device with an intention
to treat patients with MS. An IND for the first-in-human evaluation of Foralumab in healthy human volunteers was filed on June
1, 2018 and we expect to commence a dose ranging trial to evaluate biomarkers of immunomodulation of clinical responses in the
third quarter of 2018. In addition, we expect to initiate a Phase 1 trial in the first quarter of 2019 and a Phase 2 trial for
oral Foralumab by the end of 2019, in patients with NASH and/or Crohn&rsquo;s disease. On April 16, 2018 we entered into an exclusive
license agreement with The Brigham and Women&rsquo;s Hospital, Inc., or BWH, relating to a novel formulation of Foralumab in a
medical device for nasal administration. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> We are developing
Milciclib, for which we in-licensed the intellectual property from Nerviano Medical Sciences S.r.l., or Nerviano, in January 2015,
as a potential treatment for hepatocellular carcinoma, or HCC. A novel feature of Milciclib is its ability to reduce levels of
microRNAs, miR-221 and miR-222. MicroRNAs are small RNA molecules that play a significant role in the regulation of gene expression.
miR-221 and miR-222 are believed to be linked to the development of blood supply in cancer tumors. Levels of these microRNAs are
consistently elevated in HCC patients and may contribute towards resistance to treatment with Sorafenib, a multikinase inhibitor
(a drug which may inhibit the cellular division and proliferation associated with certain cancers) often prescribed to HCC patients.
To date, Milciclib has been studied in a total of seven completed and ongoing Phase 1 and Phase 2 clinical trials in a total of
296 patients conducted by Nerviano. In these trials, Milciclib was well-tolerated with minimal adverse events. We initiated a
Phase 2a trial for Milciclib as a monotherapy in patients with HCC in the fourth quarter of 2017 and expect to initiate a Phase
2b trial for Milciclib in combination with Sorafenib (a multikinase inhibitor drug, also known under its brand name Nexavar&reg;,
used to treat some types of kidney, liver and thyroid cancers) in patients with HCC in the first quarter of 2019. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In addition, we are
developing a fully human mAb targeting the IL-6R (TZLS-501). We licensed the intellectual property from Novimmune in January 2017.
This fully human mAb has a novel mechanism of action, binding to both the membrane-bound and soluble forms of the IL-6R and depleting
circulating levels of the IL-6 in the blood. Excessive production of IL-6 is regarded as a key driver of chronic inflammation,
associated with autoimmune diseases such as multiple myeloma, oncology indications and rheumatoid arthritis, and we believe that
TZLS-501 may have potential therapeutic value for these indications.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In preclinical studies,
TZLS-501 demonstrated the potential for overcoming the limitations of other IL-6 pathway drugs. Compared to tocilizumab and sarilumab,
TZLS-501 has been observed to have a higher affinity for the soluble IL-6 receptor from antibody binding studies conducted in cell
culture. TZLS-501 also demonstrated the potential to block or reduce IL-6 signaling in mouse models of inflammation. The soluble
form of IL-6 has been implicated to have a larger role in disease progression compared to the receptor bound form (Kallen, K.J.
(2002). &ldquo;The role of transsignalling via the agonistic soluble IL-6 receptor in human diseases.&rdquo; Biochimica et Biophysica
Acta. 1592 (3): 323&ndash;343.).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Our Competitive Strengths</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our mission is to
design and deliver next generation therapeutics and diagnostics for oncology and immune diseases of high unmet medical need by
combining deep understanding of disease biology with clinical development expertise. We believe the following strengths will allow
us to continue to pursue this mission:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 68 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our mission is to
design and deliver next generation therapeutics and diagnostics for oncology and immune diseases of high unmet medical need by
combining deep understanding of disease biology with clinical development expertise. We believe the following strengths will allow
us to continue to pursue this mission:</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Advanced,
                                         novel pipeline</I></B><FONT STYLE="font-size: 10pt">. We have an advanced pipeline of
                                         novel and proprietary drug candidates, including antibodies and small molecules, to address
                                         high unmet medical needs in the inflammation, autoimmune and oncology markets with significant
                                         commercial potential.</FONT></FONT></P></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Proprietary
                                         technology</I></B>. Our proprietary technology enables the development of alternative
                                         routes of administration of antibodies, including oral delivery. We believe oral delivery
                                         will alleviate the significant time and cost burden associated with other routes of administration,
                                         including intravenous delivery.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"><P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
                                                                       <P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Broad
                                         and engaged network of experts. </I></B>Our strong relationships with key opinion leaders
                                         contribute to our clinical development efforts and position us well to support our products,
                                         if approved. Dr. Napoleone Ferrara, Dr. Arun Sanyal, Dr. Kevan Herold, and Dr. Howard
                                         Weiner are among the thought leaders on our scientific advisory committee.</FONT></TD></TR>
</TABLE></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Specialized expertise and focus on oncology and inflammation</I></B>. Our management team, including Dr. Kunwar Shailubhai, Dr. Fayez Hamzeh, Jules Jacob, Dr. Priya Eddy and Dr. Vaseem Palejwala, has considerable experience translating technologies from bench to market, and managing the global administration of clinical trials.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Strong
                                         intellectual property and know-how</I></B>. We believe our proprietary intellectual property
                                         portfolio, in-licensed from Nerviano and Novimmune, provides us with a substantial competitive
                                         advantage for the commercial development of small molecule NCEs, and biologics, as well
                                         as expanded possibilities for new development programs in the future. We have retained
                                         the worldwide development and commercialization rights to all of our product candidates.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Lean
                                         research and development model, designed to maximize value</I></B>. We employ a lean
                                         and virtual R&amp;D model using highly experienced teams of experts for each business
                                         function to maximize value accretion by focusing resources on the drug discovery and
                                         development processes.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Our
Strategy</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> Our goal is to
become a leading biotechnology company focused on developing and delivering therapies and related diagnostics in both oncology
and immunology. The key elements of our strategy to achieve this goal are to:&nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advance
the clinical development of orally administered Foralumab for the treatment of NASH and Crohn&rsquo;s disease using a novel and
proprietary oral formulation by initiating a Phase 1 trial in the first quarter of 2019 and a Phase 2 trial in 2019.&nbsp;&nbsp;In
addition, a Phase 1 trial for the first-in-human evaluation of the nasal administration of Foralumab in healthy volunteers, for
neurodegenerative disease indications such as MS, is expected to be initiated in the second half of 2018.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34.65pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Continue
    to advance the clinical development and obtain regulatory approval for our lead oncology product candidate, Milciclib, as
    a monotherapy in HCC and as a combination therapy for the treatment of refractory solid tumors (being cancers which are non-responsive
    or become resistant to treatment) and HCC by continuing to enroll the ongoing Phase 2a trial as a monotherapy and initiating
    a planned Phase 2b trial in combination with Sorafenib.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34.65pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Continue to leverage relationships with key opinion leaders to promote clinical trial success and enhance future commercialization.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Continue preclinical studies and non-clinical development of our product candidate, TZLS-501, a fully human mAb targeting the IL-6R (a biological mAb which may control the proteins involved in cell signaling relevant to many inflammatory diseases and cancers), for treatment of inflammatory and oncology indications.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Opportunistically identify and acquire or in-license complimentary product and technology candidates.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seek
orphan drug, fast track or breakthrough designation for our product candidates where warranted.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: -0.25in">&nbsp;&nbsp;</P>


<!-- Field: Page; Sequence: 69 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Our
Product Candidates</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
product candidate pipeline is set forth below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 7.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 7.1pt"><IMG SRC="img_7n.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 7.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Foralumab
(TZLS-401 formerly known as NI-0401)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> We believe Foralumab
is the only fully human anti-CD3 mAb in clinical development, in contrast to the previous non-human or humanized anti-CD3 mAbs.
Foralumab targets the CD3 epsilon (CD3&epsilon;) receptor, which is a recognized approach for modulating T-Cell response and achieving
immunosuppression. We believe Foralumab could have broad application to autoimmune and inflammatory diseases, such as NASH, Crohn&rsquo;s
disease, MS, type-1 diabetes, or T1D, inflammatory bowel disease, psoriasis and rheumatoid arthritis, where modulation of a T-cell
response is desirable. In July 2017, we announced publication of a research article in, Clinical Immunology, entitled: &ldquo;Oral
treatment with Foralumab, a fully human anti-CD3 mAb, prevents skin xenograft rejection in humanized mice.&rdquo; We believe this
is the first-ever published report demonstrating the potential of oral therapy with Foralumab for inflammatory diseases such as
NASH and is based on the landmark discovery by Prof. Howard Weiner of Harvard University, one of our Scientific Advisory Committee
members. We plan to initially investigate Foralumab for safety and its immunomodulatory activity in healthy volunteers in two
Phase 1 trials. In one of the Phase 1 trials, subjects will be dosed Foralumab in a newly developed oral formulation (enteric
capsule) with an intention to treat patients with NASH and/or Crohn&rsquo;s disease and in the other Phase 1 trial, Foralumab
will be dosed via intranasal administration using a hand held nasal device with an intention to treat patients with MS. An IND
for the first-in-human evaluation of Foralumab in healthy human volunteers was filed on June 1, 2018 and we expect to commence
a dose ranging trial to evaluate biomarkers of immunomodulation of clinical responses in the third quarter of 2018. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Non-alcoholic
steatohepatitis</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Non-alcoholic fatty liver
disease, or NAFLD, comprises a spectrum of progressive liver diseases, which currently affects approximately one-third of the
western world. It is associated with liver-related morbidity and mortality and with increased risk of cardiovascular disease,
type 2 diabetes mellitus, or T2DM, hyperlipidemia (acquired or genetic disorders resulting in elevated levels of lipids circulating
in the blood) and abdominal obesity. NASH, one of the manifestations of NAFLD, leads to inflammation and fat and fibrous tissue
buildup in the liver, and elevated liver enzymes levels, and can lead to liver cirrhosis, end-stage liver disease and primary
liver cancer, or HCC (as shown in the graphic on page 72 under &ldquo;&mdash;Milciclib&mdash;Hepatocellular Cancer.&rdquo; NASH
is predicted to become the leading cause of liver transplantation in the US by 2020. Both genetic predisposition and environmental
factors have been implicated in its onset, and inflammation and associated fibrogenesis contribute to its perpetuation.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 70 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Chronic
inflammatory processes involve an imbalance in pro-versus anti-inflammatory cytokines (small proteins which are secreted by certain
cells of the immune system and have an effect on other cells), altered insulin responses due to inflammation and fat and fibrous
tissue buildup. Therapeutic avenues must provide for multifactorial effects, with focus on reduced insulin resistance and inflammatory
processes. Mild inflammation imparts a hepatoprotective effect (preventing damage to the liver), while excessive inflammation
triggers hepatocyte damage (damage to cell membranes and tissue death) and irreversible liver damage, fibrosis and carcinogenesis.
Such detrimental effects are associated with overexpression of inflammatory genes and increased activity of Kupffer cells, natural
killer T-cells, hepatic stellate cells, sinusoidal endothelial cells, dendritic cells, monocytes and lymphocytes, which secrete
a range of proinflammatory factors, including cytokines, chemokines, lipid messengers and reactive oxygen species.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
several drugs, such as pioglitazone (Actos&reg;), have proven effective in improving NASH-related features, side effects, including
weight gain, adipose tissue insulin resistance, increased risk of bone fracture in women, congestive heart failure, heightened
risk of bladder cancer, increased mortality, risk of hemorrhage stroke, prostate cancer in men over 50 years of age, pruritus
and increased low-density lipoprotein cholesterol have been measured following their chronic use.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Crohn&rsquo;s
Disease</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"> Crohn&rsquo;s disease
is a relapsing, transmural inflammatory disease of the gastrointestinal mucosa that can affect all parts of the intestinal tract
as well as extra intestinal organs. Crohn&rsquo;s disease affects between 400,000 and 600,000 people in North America. Prevalence
estimates for Northern Europe have ranged from 27&ndash;48 per 100,000. Although the incidence and prevalence of Crohn&rsquo;s
disease are beginning to stabilize in high-incidence areas such as northern Europe and North America, they continue to rise in
low-incidence areas such as southern Europe, Asia, and much of the developing world. Differences in incidence across age, time,
and geographic region suggest that environmental factors significantly modify the expression of Crohn&rsquo;s disease. The strongest
environmental factors identified are cigarette smoking and appendectomy. The disease affects slightly more females than males
and is most commonly diagnosed in young adults, e.g. late adolescence to the third decade of life (Kim, S.C. and G.D. Ferry. Gastroenterology
(June 2004) 126 (6): 1550-1560). Although the exact etiology remains unknown, the occurrence of Crohn&rsquo;s disease is strongly
associated with mutations of a receptor for microbial pathogens (NOD2) that lead to increased activation of antigen presenting
cells and a defect in the release of antimicrobial defensins. It is now widely accepted that as a result of this altered balance
of immune homeostasis, exposure to commensal bacterial antigens causes increased stimulation and proliferation of mucosal T-lymphocytes,
leading to immune inflammation. Additional pathogenic mechanisms may include a defect in T-cell programmed death, or apoptosis,
and possibly a defect in regulatory T-cell function. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Crohn&rsquo;s
disease usually presents as acute or chronic bowel inflammation then the inflammatory process evolves toward one of two patterns
of the disease: a fibrostenotic-obstructing pattern or a penetrating-fistulous pattern, each with different treatments and prognoses.
The site of disease influences the clinical manifestations and can include diarrhea, abdominal pain, fever, clinical signs of
bowel obstruction, as well as passage of blood or mucus or both.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Up to 25% patients with
Crohn&rsquo;s disease will develop extraintestinal disease manifestations which usually respond to treatment of the underlying
disease (e.g. arthritis, uveitis, primary sclerosing cholangitis) (Harrison&rsquo;s principles of internal Medicine 2008).</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Crohn&rsquo;s
disease is histologically characterized by a discontinuous transmural granulomatous inflammation of the intestinal wall, but typical
granulomas are found on mucosal biopsies in a minority of subjects. Surgical resection reveals granulomas in about half of cases
(Harrison&rsquo;s 17th edition).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
pharmacological management of Crohn&rsquo;s disease is based on the control of the inflammatory process. Current treatment regimens
include:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 20.25pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 15.75pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">anti-inflammatory
                                         drugs (e.g. corticosteroids, aminosalicylates), which are the first-line treatment to
                                         induce remission in acute active disease;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -15.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 20.25pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 15.75pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">immunosuppressants
                                         such as azathioprine, 6-mercaptopurine and methotrexate (Feagan, 2000) which are used
                                         to maintain remission or treating chronic active disease; biologic immunotherapies (e.g.
                                         anti-TNF mAbs including infliximab and adalimumab) which are used to induce and maintain
                                         remission.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -15.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 71 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">All
of these treatments have limited long-term efficacy and potential for serious adverse effects (Targan, 1997; Present, 1999).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"> Previously reported
studies using anti-cluster definition 4, or anti-CD4, and tumor necrosis factor, or TNF, binding mAbs provide a strong rationale
for targeting T-cells in Crohn&rsquo;s disease (van Deventer et. al. Intl. J. Clin. Pharm. (1997) 19(2): 55-9). It is now known
that TNF targeting mAbs in Crohn&rsquo;s disease and IBD are effective because of the bringing about of programmed cell death
(apoptosis) of activated T-lymphocytes rather than neutralization of soluble TNF (Chowers et.al., Current Drug Targets (2010)
11: 138-142; Atreya et. al. Gastroenterology (2011) 141 (6): 2026-2038. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, there are few published clinical data on the use of anti-CD3 mAbs in subjects with Crohn&rsquo;s disease. One product
in development, visilizumab (Nuvion&reg;, PDL Biopharma) has been tested in the clinical setting. Two studies with visilizumab
in patients with severe Crohn&rsquo;s disease have been performed: An open-label study (ClinicalTrials.gov Identifier: NCT00267709)
in patients with Crohn&rsquo;s disease having peri-anal fistulas and an open-label study (ClinicalTrials.gov Identifier: NCT00267722)
in patients with moderate-to-severe inflammatory, non-structuring, non-penetrating Crohn&rsquo;s disease. Eighteen patients were
expected to be enrolled in each study.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preliminary
results from the second study suggested that two 10 &mu;g/kg doses of visilizumab administered by IV bolus injection on consecutive
days appeared to have clinical activity. Ten of the 14 patients reported a clinical response by day 59, as determined by a drop
in the Crohn&rsquo;s disease Activity Index, or CDAI score, of 100 points. Five patients achieved a complete remission, as defined
by a CDAI score of &lt;150 during the 59 days. Of note, two patients who never responded to infliximab, as well as seven patients
who lost their response to infliximab, responded to visilizumab.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Multiple
Sclerosis</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MS
is an inflammatory-mediated demyelinating disease of the human central nervous system. The disease develops in young adults with
a complex predisposing genetic trait and most likely involves an environmental insult such as a viral infection to trigger the
disease. The activation of CD4+ autoreactive T cells and their differentiation are crucial initial steps in the progression of
this disease. The therapeutic use of monoclonal antibodies was initially viewed with great skepticism owing to the high rates
of sensitization against mouse proteins, their pharmacokinetic properties, and the difficulties in their production. However,
most of these problems have been overcome, and monoclonal antibodies are now among the most promising therapies for MS.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Autoimmune
and Inflammatory Diseases</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Autoimmune
diseases are primarily due to a malfunction when the immune system attacks certain cells in the body as foreign invaders. This
can result in irreparable damage to critical organs and tissues eventually resulting in autoimmune diseases.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
humans, CD3-epsilon is encoded by the CD3&epsilon; gene on Chromosome 11. The CD3&epsilon; molecule, along with four other membrane-bound
polypeptides (CD3-gamma, -delta, -zeta, and -eta) form the CD3 complex, which is associated with the T-cell receptor. Upon antigen
bindings, the CD3 complex sends signals through the cell membrane to the cytoplasm inside the T-cell. This leads to activation
of the T-cell that rapidly divides to produce new T-cells sensitized to fight the particular antigen to which the TCR was exposed.
While T-cell activation is critical for the human immune system to properly fight bacterial, viral or parasitic infections, abnormal
T-cell induction can cause and worsen numerous human diseases, including T-cell lymphoma and leukemia, human malignancies, autoimmune
disorders, cardiovascular disease and transplant rejection.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Our
Solution</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I></I></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> We believe Foralumab
is the only fully human anti-CD3 mAb in clinical development. Since the discovery of the hybridoma technology, a method to generate
large quantities of a single (monoclonal) antibody, the production and manufacture of mAbs has become widely available showing
promise in several autoimmune and inflammatory disease clinical trials and therapeutic utility in animal models. The first murine
anti-CD3 mAb (IgG2a) was developed and approved by the FDA in 1985 under the name of muromonab, OKT3, (Ortho Kung T3; Orthoclone&reg;)
to treat allograft rejection in kidney, liver and heart transplantation by exerting its potent immunosuppressive effects, mainly
due to depletion of T-cells in tissues and thereby preventing rejection of the allografts. Subsequently, OKT3 was administered
in clinical trials to patients with MS, T1D, inflammatory bowel disease, rheumatoid arthritis and NASH. Although showing promise
to alleviate the disease process, the mAb being of murine origin and extremely immunogenic in humans, was associated with a wide
range of side effects that included the typical CRS or flu-like syndrome, limiting its clinical development. The side effect profile
of OKT3 is a consequence of T-cell activation resulting in the release of numerous cytokines into the systemic circulation. These
shortcomings of the murine OKT3 led to the development of a new generation of anti-CD3 mAbs using genetic engineering of the mAb
structure, as depicted below. </P>







<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 72 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><IMG SRC="image_004.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foralumab
dosed intravenously has been observed to alter T-cell function via antigenic modulation, that is, removal of the CD3/TCR complex
from the T-cell surface. Modulation has two therapeutic benefits:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="padding-right: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
                                         transiently renders the T-cells incapable of recognizing an antigen and thus unable to
                                         orchestrate an immune response such as an allograft rejection; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="padding-right: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
                                         has a favorable long-term effect on generation and maintenance of regulatory T-cells,
                                         a specialized subset of T-cells that promote immunological tolerance.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In comparison with
the two other anti-CD3 mAbs evaluated in patients with T1D (otelixizumab and teplizumab), Foralumab was less mitogenic (capable
of causing cell division), therefore allowing re-treatment, and to have a better risk/benefit profile. As such, Foralumab was previously
developed by Novimmune as an intravenous formulation for the treatment of autoimmune indications: Crohn&rsquo;s disease and in
renal allograft recipients.</P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
recent data from studies conducted in the laboratories of our Scientific Advisory Committee members, Prof. Howard Weiner of
Harvard University and Prof. Kevan Herold of Yale University, suggest that oral administration of Foralumab has the potential
for therapeutic utility while minimizing toxicity associated with intravenous administration, such as CRS. Importantly, recent
clinical studies conducted by Prof. Yaron Ilan with oral administration of anti-CD3 (OKT3; murine mAb) in HCV infected patients
(non-respondents) and in NASH patients suggested that the treatment was well-tolerated and produced immunologic effects consistent
with potential clinical benefits.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"> In addition, increasing
appreciation for the gut-liver cross-talk and of its role in the initiation of NASH-associated inflammation and fibrogenesis has
led to the understanding that systemic inflammatory processes can be alleviated by modulating the gut immune system, without inducing
generalized immunosuppression. This has been achieved in multiple approaches, including oral administration of fatty liver-derived
proteins, anti-CD3 antibodies, TNF, fusion protein, anti-lipopolysaccharide antibodies, glucosylceramide, delayed-release mercaptopurine
and soy-derived extracts. Several of these compounds were shown to be effective in patients with NASH. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"> Orally administered
OKT3 was evaluated in a Phase 2 trial in 36 patients with NASH and type 2 diabetes and was found to be well tolerated. Increases
in regulatory T-cell markers consistent with induction of regulatory T-cells was observed as well as increases in other anti-inflammatory
markers. Although not powered sufficiently to evaluate efficacy endpoints, positive trends were observed including lowering of
liver enzymes and lowering of glucose levels (Lalazar et.al, J. Clin. Immunol. (2015) 34 (4):399-407). </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">More recent animal
studies conducted separately by Prof. Howard Weiner and Prof. Kevan Herold demonstrated therapeutic utility of orally administered
Foralumab for immune-inflammatory diseases. Our strategy is to build on these findings to develop orally administered Foralumab
for the treatment of NASH, Crohn&rsquo;s disease and other autoimmune diseases. We believe Foralumab may also be combined with
our other product candidate, TZLS-501, a fully human anti-IL-6R mAb, for the treatment of rheumatoid arthritis and other diseases.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On May 29, 2018 we entered into an exclusive license agreement with BWH relating to a novel formulation
of Foralumab in a medical device for nasal administration. <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
IND for what we believe to be the first-in-human evaluation of the nasal administration of Foralumab in healthy volunteers was
filed on June 1, 2018 and we expect to commence a trial to evaluate biomarkers of immunomodulation of clinical responses in in
the third quarter of 2018.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 13.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Clinical
Development Plan</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B><I>Proposed Phase 1 Clinical Trial for
Foralumab in Healthy Volunteers</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The proposed Phase 1 clinical trial for Foralumab in healthy volunteers is a single center single arm
ascending study in which low doses (1.0, 2.5 and 5.0 mg/dose) of Foralumab will be orally administered for 5 consecutive days followed
by monitoring for tolerance and adverse events for 10 days. At each dose level, starting with the low dose if the resultant data
indicates that the drug is well tolerated and free from significant adverse events, the next higher dose will be administered orally
further for 5 consecutive days followed by 10 days of monitoring for tolerance and adverse events. If data from the Phase 1 trials
indicate that the drug is well tolerated and free from adverse events, a Phase 2a trial is expected to be initiated in 2019 with
the intent to treat patients with NASH and/or Crohn&rsquo;s disease. The primary endpoint of the Phase 1 study is safety and tolerability
of Foralumab in humans.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 73 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B><I>Proposed Phase 2 Clinical Trial
for Foralumab for the Treatment of NASH </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The proposed Phase 2 clinical trial for Foralumab is a randomized, placebo-controlled, four-arm, double-blind
study. Subjects (48) will be randomized (1:1:1:1) to receive either a once daily oral placebo or Foralumab dose of 0.5 mg, 2.5
mg or 5.0 mg for 30 consecutive days. Subjects will record adverse events and daily administration of study medication in a subject
diary. This will serve as a measure of compliance and record of adverse events and tolerability. Subjects will be followed up for
30 days following completion of treatment. Study visits performed on Days 14, 30 and 60 of the study, will monitor metabolic parameters
(body mass index and waist circumference), serum lipid profiles, immunological markers (C-reactive protein and an array of cytokines),
hepatic enzymes and functions (13C-methacetin breath test and liver steatosis/fibrosis), which will be compared to baseline levels
(Day 1).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The safety and tolerability
of the treatment regimen is the primary endpoint and will be determined by monitoring vital signs, laboratory values, adverse events
and physical findings throughout the study. In addition, efficacy/immunomodulatory activity will be established using the following
criteria: (1) reduced Day 30 serum alanine aminotransferase (ALT) levels; (2) reduced hemoglobin A1c; (3) improved homeostasis
model assessment (HOMA); (4) HOMA of insulin resistance (HOMA-IR) scores; as well as (5) levels of T cells and cytokines as compared
to baseline (Day 1).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B><I>Proposed Phase 1 Clinical Trial for
Foralumab for the Treatment of Multiple Sclerosis</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The proposed Phase
1 clinical trial of nasally administered Foralumab in healthy volunteers is a single center single arm ascending study in which
low doses (10, 50 and 250 &micro;g/dose) of Foralumab will be nasally administered for 5 consecutive days followed by monitoring
for tolerance and adverse events for 10 days. At each dose level, starting with the low dose, if the resultant data indicates that
the drug is well tolerated and free from significant adverse events, the next higher dose will be administered nasally for 5 consecutive
days followed by 10 days of monitoring each time for tolerance and adverse events. If data from the Phase 1 trials indicate that
the drug is well tolerated and free from adverse events, Phase 2a trials will be initiated at a later date for the treatment of
MS. The primary endpoint of the Phase 1 study is safety and tolerability of Foralumab in humans dosed intra-nasally using a hand-held
nasal spray device.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;<I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intravenous
Foralumab has been studied in a total of three Phase 1 and Phase 2 clinical trials conducted by Novimmune. A total of 68 patients
were exposed to Foralumab in the Novimmune trials:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Study
NI-0401-01:</B> a Phase 1/2a randomized, double-blind, placebo-controlled and dose escalation study NI-0401-01 in subjects with
moderate to severe active CD. The study was completed and 33 subjects were exposed to Foralumab. The study NI-0401-01 was designed
to assess tolerability of Foralumab and was not powered to evaluate efficacy parameters included the proportion of patients achieving,
clinical response and change from baseline of Crohn&rsquo;s Disease Endoscopy Index of Severity. A trend, although not statistically
significant, was seen when analyzing the clinical response and endoscopic response. Single and repeat intravenous doses of 1.0,
2.0 and 10.0 mg Foralumab were administered to subjects and serum pharmacokinetics evaluated for up to five days. Limited pharmacokinetic
data was collected, however it was observed that at doses over 1.0 mg, Foralumab accumulated over the five day dosing period.
CD3 modulation on CD4 positive and CD8 positive T cells was related to Foralumab dose. There was a dose response for the reduction
of peripheral T-cell (CD2 positive) count. The main adverse events were infusion related reactions related to limited release
of cytokines at doses exceeding 1 mg.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Study
NI-0401-02:</B> an open-label, dose titration, multicenter Phase 1 study of Foralumab for the treatment of subjects with biopsy-proven
acute cellular renal allograft rejection (BpACR). The study was completed and 11 subjects were exposed to Foralumab. Patients
were dosed with 1.0 mg, 1.5 mg, 2.0 mg and 2.5 mg of Foralumab daily for five days and most were pre-treated with methylprednisolone.
The data from study NI-0401-02 has confirmed the dose response in terms of CD3 modulation and reduction of peripheral T-cell count.
A CD3 modulation of up to 90% was achieved at study NI-0401-02 day five with a daily dose of 2.5 mg during the 5 days of treatment
period. Conclusions about effectiveness of Foralumab in reversing acute renal rejection could not be drawn. The main adverse events
were infusion related reactions in patients that were not premedication with prednisolone.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Study
NI-0401-03:</B> a Phase 2a study with an open label dose escalation phase followed by a double-blind phase to assess safety and
efficacy of Foralumab in subjects with moderate to severe active CD. The study NI-0401-03 was completed and 24 subjects were exposed
to Foralumab. 74% of patients had achieved a clinical response at week 2 and 87% of patients at week 4. At weeks 6, 8 and 12 the
proportion of patients with a clinical response decreased to 75%, 70% and 67%, respectively. 30% of patients had achieved clinical
remission at week 2, 42% by weeks 4, 38% by week 6, 43% at week 8 and 46% at week 12. Treatment failures were 12.5%. Pharmacokinetic
evaluations were performed and no dose-response relationship was established due to variability between patients. The observed
half-life of Foralumab was approximately 180 hours. A rapid and almost complete disappearance of CD45 positive lymphocytes, CD3
positive T-cells, CD3 positive and CD4 positive helper T-cells and CD3 positive and CD8 positive cytotoxic T-cells from the circulation
was observed was observed within 24 hours of infusion for all dose cohorts. The lowest unit dose in the study NI-0401-03 was equivalent
to the 1 mg daily unit dose that was the maximum tolerated dose in study NI-0401-01. Pre-medication with prednisolone reduced
the severity and frequency of infusion related reactions.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>


<!-- Field: Page; Sequence: 74 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
a Phase 2a trial conducted by Novimmune, patients with Crohn&rsquo;s disease and renal allograft rejection in kidney transplants
demonstrated Foralumab&rsquo;s immunomodulatory activity in humans. We have decided not to pursue evaluation of intravenous Foralumab
in Crohn&rsquo;s Disease because we believe the market for this disease is saturated by other FDA approved drugs. Further, while
intravenous administration of antibodies has been widely used, side effects from the intravenous administration still are prevalent
as well as patient compliant issues come into play. We intend to move forward with an oral formulation of Foralumab for treatment
of Crohn&rsquo;s disease.</FONT> </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Two
of Novimmune&rsquo;s clinical trials were in patients with Crohn&rsquo;s disease and the third clinical trial was conducted in
patients undergoing kidney transplantation and suffering with renal allograft rejection. Sixty-eight subjects with active Crohn&rsquo;s
disease and 11 subjects with acute cellular renal allograft rejection were treated with Foralumab. The route of administration
of Foralumab in these studies was via intravenous administration.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
these trials, it was observed that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         short-term tolerability profile of Foralumab was very similar to those reported with
                                         other anti CD3 antibodies and no new emerging concerns have been identified.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
                                         daily doses of up to 1mg (~ 500 &micro;g/m2) per patient were generally well tolerated
                                         without corticosteroid premedication. The most common adverse events following exposure
                                         to Foralumab were IRRs, which occurred in all patients treated with the compound. In
                                         the majority of cases, these symptoms were mild (66%) in intensity and were reported
                                         following the first two infusions of the 5-infusion treatment course. The number of affected
                                         patients and the severity of symptoms tended to increase with increasing dose level,
                                         or DL.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                         clear reduction of CRS and its associated IRRs were observed with steroid pre-medication.
                                         All patients who received pre-medication with steroids had mild or no IRRs, and CRS was
                                         reduced. Only one patient who did not receive steroid pre-medication had significant
                                         levels of CRS, in particularly IL-6.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Usage
                                         of steroid pre-medication allows the administration of higher doses.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Both
                                         the magnitude and duration of CD3 modulation increased in a dose related manner.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
                                         anti-drug antibodies were detected.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Prior
Clinical Experience</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Oral
anti-CD3 antibodies, as opposed to the narrow therapeutic window of its intravenous counterpart, have been shown to impact the
gut immune system and mesenteric lymph nodes, thereby promoting regulatory T-cells activity, without inducing immunosuppression.
The treatment alleviated experimental autoimmune encephalitis and T1D mellitus, which was associated with regulatory T-cells induction.
Orally and nasally administered anti-CD3 suppressed autoantibody production in a mouse lupus model. Oral anti-CD3 yielded reduced
pancreatic hyperplasia, hepatic fat accumulation and muscle inflammation in a leptin-deficient model of NASH and diabetes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 75 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Pharmacology
Summary (In Vitro Studies)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
key conclusions arising from the non-clinical studies of Foralumab by Novimmune are:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foralumab
                                         is a specific anti-CD3 epsilon mAb, as it binds to human T-cells and the recombinant
                                         human CD3 epsilon chain, and can be displaced by another specific anti-CD3 epsilon mAb,
                                         muromonab CD3.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
                                         bound to its target, Foralumab triggers calcium flux into the cell and modulates the
                                         CD3/TCR complex causing its&rsquo; transient removal from the cell surface.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         combination of the two-point mutations introduced into the Fc portion (the constant region
                                         of the antibody that has limited structural variability and is responsible for adverse
                                         side effects) of Foralumab, resulting in the abrogation of the binding to Fc gamma receptors,
                                         and C1q, consequently eliminates T-cell proliferation and the release of numerous cytokines
                                         including TNF, and interferon gamma, or IFN&gamma; <I>in vitro</I>.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foralumab
                                         does not cross react with CD3 molecules expressed by T-cells of other species including
                                         baboon, <I>Rhesus </I>monkey, <I>Cynomolgus </I>monkey, rabbit, dog, rat and mouse. As
                                         a consequence, options for the most relevant species selection for pharmacology and toxicology
                                         assessment of Foralumab are limited. Novimmune addressed this limitation by studying
                                         LCD3 transgenic mice. This transgenic mouse line expresses the human as well as the mouse
                                         CD3 epsilon chain on the surface of their T-cells.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Using
                                         a transgenic line of mice expressing both human and mouse CD3 molecules (1:1 ratio) at
                                         the surface of T-cell (LCD3<I>), </I>following a single intravenous injection, Foralumab
                                         dose dependently:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Modifies
                                         human CD3 epsilon expression; that is, more than 80% of the cell surface protein was
                                         removed within 24 hours when given at a saturating dose. This modulation was transient
                                         as receptor expression levels returned to baseline values within 7 days of dosing.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Caused
                                         a reduction of 70-80% in the number of circulating T-cells when given at a saturating
                                         dose. The maximal effect was observed at hour 6 post dose. Cell counts returned to baseline
                                         levels within 3.5 days.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Demonstrated
                                         a half-life of 1.4 and 1.7 days for doses of 5 and 200 &micro;g per mouse, respectively.
                                         This seemingly short half-life is similar to that observed in vivo for other anti-CD3
                                         mAbs and reflects internalization of Foralumab by the human CD3 molecule on the T-cells
                                         of these transgenic mice. It was therefore expected that Foralumab will be internalized
                                         by human T-cells in patients and consequently have a half-life comparable to other therapeutic
                                         anti-CD3 mAbs.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Milciclib
(TZLS-201)</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> Milciclib is an
orally bioavailable, small molecule broad spectrum inhibitor of CDKs (CDKs): 1, 2, 4, 5 and 7 and Src family kinases. CDKs are
a family of highly conserved enzymes that are involved in regulating the cell cycle, which is a series of events that takes place
in cells leading to division and duplication of its DNA to produce two daughter cells. Src family kinases regulate cell growth
and potential transformation of normal cells to cancer cells. A novel feature of Milciclib is its ability to reduce microRNAs,
miR-221 and miR-222, that silence gene expression. miR-221 and miR-222 promote the formation of blood vessels (angiogenesis) that
are important for spread of cancer cells (metastasis). Levels of these microRNAs are consistently increased in HCC patients and
may contribute towards resistance to treatment with Sorafenib. As a result we are investigating Milciclib both as a monotherapy
and plan a combination treatment with Sorafenib. To date, Milciclib has been studied in a total of seven completed and ongoing
Phase 1 and Phase 2 clinical trials in 296 patients. In these trials, Milciclib was observed to be well-tolerated and showed initial
signals of anti-tumor action. We initiated a Phase 2a trial (CDK-125a-010) for Milciclib as a single therapy in patients with
HCC in the first half of 2017 and expect to initiate a Phase 2b trial (TZLS (201)-125a-011) for Milciclib in combination with
Sorafenib (the standard of care for treatment of HCC) in patients with HCC in the fourth quarter of 2019. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Hepatocellular
Cancer</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We are initially developing
Milciclib for the treatment of HCC. HCC, or liver cancer, is the sixth most common worldwide and second most leading cause of death
in the United States. Liver cancer incidence and death rates are steadily rising. As of 2012, rates of new liver cancer cases went
up 38% from 2003 to 2012 according to the Centers for Disease Control and Prevention.</P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"> Most HCC patients
present with advanced disease and do not benefit from transplantation, surgical resection, or locoregional therapies, and there
is only one chemotherapeutic agent, Sorafenib approved in the United States and EU for advanced HCC patients. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 76 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"> The primary risk factor
for HCC is hepatic cirrhosis, with an estimated 78% of HCC cases and 57% of cases of liver cirrhosis caused by chronic infection
with hepatitis B virus or HCV. Recently, the combination of insulin resistance, hypertension, dyslipidemia and obesity, termed
&ldquo;metabolic syndrome,&rdquo; has also been recognized as a cause of NAFLD, which is the most common liver disease, cirrhosis
and HCC. The following graphic represents the progression from a healthy liver to NAFLD, NASH and HCC. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><IMG SRC="image_005.jpg" ALT=""><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally,
cancer is primarily due to deficiencies in cell cycle control, eventually resulting in transformation of normal cells to rapidly
growing cancer cells. Therapeutic intervention to control cell cycle has long been anticipated as effective cancer therapies.
CDKs are a family of enzymes first discovered as regulators of the cell cycle. CDKs have been found to be overexpressed in a variety
of human diseases with abnormal cell growth such as cancers, viral infections, neurodegenerative disorders and other proliferative
diseases. We believe that modulating CDK activity with targeted therapies is an attractive strategy to reinforce cell cycle control
and decrease the rate of abnormal proliferation of cancer cells. The first FDA approval in March 2015 of a CDK inhibitor for palbociclib,
and more recently in 2017, ribociclib, for a type of breast cancer, has led to great interest in the development of this class
of drugs as oncology therapeutics.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Our
Solution</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 17.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Milciclib
is an oral, broad-spectrum inhibitor of CDKs, as well as several other protein kinases responsible for controlling cell growth
and replication. Milciclib has an unusual kinase inhibitory profile making it active against other receptors such as, tyrosine
kinase, Src family and splicing kinases, which play a role in cell growth and transformation from normal to cancerous cell types.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 17.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
tumor cells exposed to Milciclib, a block in G1 phase (first phase of the growth cycle where the cell synthesizes messenger RNA
and proteins before cell division) of the cell cycle was observed, supporting the postulated mechanism of action of the compound
as determined in biochemical assays. Additionally, Milciclib was able to modulate the phosphorylation of the Retinoblastoma protein,
a substrate of the CDK/cyclin complex as well as to reduce phosphorylation status of proteins of the TRKa signaling pathway in
cells expressing the tyrosine kinase receptor. These results supported that Milciclib was active against several families of protein
kinases that actively controlled cell growth and transformation from normal to cancerous cell types. This is important because
many chemotherapeutic agents are effective at only a single point in the cell cycle, allowing cells to &ldquo;escape&rdquo; the
biochemical blockage through alternative biochemical pathways.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Significant anti-tumor
activity was observed in all tested preclinical animal models with different oral treatment schedules of Milciclib. Cancerous cell
types were transplanted into immunosuppressed animals and the number and volume of cancerous lesions were evaluated by magnetic
resonance imaging after oral administration of Milciclib at different dose levels (DLs) and dose schedules compared to untreated,
control animals. In various human xenograft and transgenic models (prostate cancer, lung adenocarcinoma and hepatocarcinoma), consistent
tumor growth inhibition, up to 91%, (evaluated by measuring the number and volume of tumors for treated animals versus control
animals) was observed -with repeat daily treatment at tolerated doses. Similar results were obtained in a mammary carcinoma model
(stasis and partial remission in 58% and 25% of the primary tumors, respectively) with repeat daily dosing.</P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Clinical
Development Plan</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Phase
2a Clinical Trial (CDKO-125a-010) for Milciclib as a Monotherapy for the Treatment of HCC</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In January 2017, we
initiated a single-arm, multicenter, Phase 2a clinical trial (CDK-125a-010) for Milciclib in adult patients with unresectable or
metastatic HCC and good liver function. The trial is studying the tolerability and safety of Milciclib in these adult patients.
As of , 2018, we have enrolled approximately 10 patients at sites in Italy, Greece and Israel. Eligible patients are receiving
Milciclib orally, 100 mg/day for four consecutive days a week (four days on followed by three days off) for a total of 12 weeks.
The dose will be reduced to 80 mg/day on subsequent cycles if more than two of the first six treated patients exhibit poor tolerability.</P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 77 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.4in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.4in">The primary endpoint
for the study is the overall tolerability profile, evaluated based on laboratory findings and adverse events emerging during the
trial. The occurrence of adverse events and laboratory tests will be performed weekly during treatment. All the enrolled patients
who receive at least one drug administration will be evaluated for safety. An interim evaluation of tolerability and adverse events
was undertaken as soon as the 10th patient had completed the first cycle of treatment a second interim evaluation will be conducted
when 10 patients have completed their first cycle of treatment. Enrollment of additional patients was allowed after a positive
safety evaluation of the first 10 patients by an IDMC. On December 8, 2017 we announced the results of the first interim review
by the IDMC that treatment with Milciclib was well-tolerated with no drug-related serious adverse events. The IDMC recommended
continuing with the trial. The second IDMC meeting held on January 25, 2018 recommended that all patients (first cohort) who received
at least one dose of Milciclib should be assessed for safety and tolerability at the end of protocol mandated follow up before
enrolling the second cohort. The IDMC reconvened on its scheduled date on May 9, 2018 to evaluate the complete safety data for
all 11 patients who completed the study mandated visits. The IDMC concluded that safety and tolerability profile of Milciclib in
the first cohort, is acceptable and that there are no safety signals that preclude continuation of enrollment of the remaining
cohorts as planned. The IDMC has also been informed of the patients who opted to continue Milciclib on &ldquo;compassionate use
basis.&rdquo; Four patients have completed protocol mandated treatment (six cycles, six months). Three of these patients and their
health care-provider/investigator opted to continue treatment with Milciclib (compassionate use) with approval of their local Ethics
Committee. Based on this IDMC assessment, the study is actively enrolling 20 more patients. Secondary endpoints include Objective
Tumor Response Rate, based on the modified Response Evaluation Criteria in Solid Tumors, or mRECIST, a set of criteria developed
to assess tumor response in HCC. In this study, objective response by RECIST will also be evaluated as supportive analysis, along
with several secondary parameters. The decrease in alpha-fetoprotein, or AFP, as compared to baseline in patients with high AFP
at baseline will also be considered, based on reports suggesting a better outcome for patients who achieve an AFP response. As
an exploratory endpoint, the expression of micro-RNAs and their possible association with Milciclib treatment will be investigated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.4in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <B><I>Phase 2b Clinical Trial (TZLS
(201)-125a-011) for Milciclib as a Combination Therapy with sorafenib for the Treatment of HCC</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> By the first quarter
of 2019, we intend to initiate a randomized, multicenter study to explore tolerability and antitumor activity, of Milciclib in
combination with Sorafenib, administered as first-line systemic therapy in adult patients with recurrent, unresectable or metastatic
HCC and good liver function. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> Sorafenib (Nexavar&reg;)
is the standard of care for treatment of HCC, yet treatment extends survival probability from 7.9 months (placebo control) to
10.7 months (Llovet et al. N Engl J Med (2008) 359:378-390). There is a need for improvement which may be realized by combination
of Milciclib with Sorafenib. Milciclib modulates cell cycle, DNA replication and growth factor receptor cell signaling (Albanese
et.al, Mol. Cancer Therap. (2010) 9(8):2243-54). Sorafenib is a multikinase inhibitor which has demonstrated both anti-proliferative
and anti-angiogenic properties in vitro and in vivo. The combination of Sorafenib with Milciclib should exert a combined anti-proliferative
effect on tumor cells, involving targets different from the ones modulated by Milciclib, together with antiangiogenesis properties. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="img_8n.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Clinical Data</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Milciclib has been
studied in a total of seven completed and ongoing Phase 1 and Phase 2 clinical trials conducted by Nerviano in approximately 296
patients. Milciclib was observed to be well tolerated by patients with thymoma in Phase 1 and Phase 2 clinical trials.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 78 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Phase 1 Development</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Milciclib has been
investigated in each of the below, open-label, multi-center, non-randomized, dose-escalation Phase 1 clinical trials.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 19%; border: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 2pt; padding-left: 4"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Trial</B></FONT></TD>
    <TD STYLE="width: 22%; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 2pt; padding-left: 4"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Patient
    Population</B></FONT></TD>
    <TD STYLE="width: 22%; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 2pt; padding-left: 4"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Treatment&nbsp;Schedule&nbsp;/&nbsp;Dosing</B></FONT></TD>
    <TD STYLE="width: 37%; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 2pt; padding-left: 4"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Key
    Findings</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 2pt; padding-left: 4"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CDKO-125a-001</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2pt; padding-left: 4"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advanced/metastatic
        solid tumors</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">37
        patients</FONT></P></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2pt; padding-left: 4"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1st
        Schedule: Orally, once daily</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">for
        7 consecutive days every 14 days in a 2-week cycle at escalating doses of 50, 100,</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">150,
        200 and 300 mg</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2nd
        Schedule: Orally, once daily for 4 consecutive</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">days
        a week for 3 weeks in a 4-week cycle at escalating doses of 150, 180 and 200 mg</FONT></P></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2pt; padding-left: 4"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Pharmacokinetics:</I></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Comparable
        plasma pharmacokinetic parameters between the two schedules were observed.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
        exposure to Milciclib increased with the dose and there was a 3-fold accumulation in the daily systemic exposure after
        repeated dosing, in good agreement with expectations on the basis of the half-life of the compound (24-43 h).</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Clinical
        observations:</I></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
        objective responses were achieved on 1st schedule; Disease stabilizations, defined as cancer disease that is neither increasing
        nor decreasing in extent or severity, was observed in 6 of 14 evaluable patients (42.9%).</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
        partial response, or PR, was achieved in 2 out of 14 evaluable patients (14.3%) on 2nd schedule; Disease stabilization
        (no change in extent or severity of disease state) was reported in 3 patients (21.4%), all treated at 180 mg/day DL, including
        a stabilization lasting 31 weeks in a patient with pancreatic cancer and stable disease, or SD, lasting 29 weeks in a
        patient with carcinoid.</FONT></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 79 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-top: Black 1pt solid; border-right: Black 1pt solid; border-left: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 2pt; padding-left: 4; width: 19%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Trial</B></FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 2pt; padding-left: 4; width: 22%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Patient
    Population</B></FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 2pt; padding-left: 4; width: 22%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Treatment&nbsp;Schedule&nbsp;/&nbsp;Dosing</B></FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 2pt; padding-left: 4; width: 37%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Key
    Findings</B></FONT></TD></TR>

<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 19%; border-top: black 1pt solid; border-right: Black 1pt solid; border-left: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 2pt; padding-left: 4"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CDKO-125a-002</FONT></TD>
    <TD STYLE="width: 22%; border-top: black 1pt solid; border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 2pt; padding-left: 4"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recurrent
    malignant glioma 28 patients (Phase 1)</FONT></TD>
    <TD STYLE="width: 22%; border-top: black 1pt solid; border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 2pt; padding-left: 4"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Escalating
    oral doses of 18, 36, 54 and 72 mg/m2 once a day for 14 consecutive days followed by 7 days of rest in a 3-week cycle</FONT></TD>
    <TD STYLE="width: 37%; border-top: black 1pt solid; border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2pt; padding-left: 4"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Pharmacokinetics:</I></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Results
        indicated that the pharmacokinetics of Milciclib was dose-independent in the dose range 18</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ndash;
        72 mg/m2.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-right: Black 1pt solid; border-left: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 2pt; padding-left: 4"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2pt; padding-left: 4"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">34
        patients (Phase 2)</FONT></P></TD>
    <TD STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2pt; padding-left: 4"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">54
        mg/m2 (RP2D)</FONT></P></TD>
    <TD STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 2pt; padding-left: 4"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Systemic
    exposure values of Milciclib maleate accumulated by a factor of 3</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 2pt; padding-left: 4"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 2pt; padding-left: 4"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 2pt; padding-left: 4"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2pt; padding-left: 4"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Clinical
        observations:</I></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phase
        1: No evidence of clinical effect was observed in all the 28 treated patients. However 5 patients seemed to have benefitted
        from therapy with SD observed (no change in extent or severity of cancer).</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phase
        2: One out of 34 patients achieved the primary endpoint. PFS at 6 months or PFS-6 rate was 2.9%. No complete response,
        or CR (disappearance of all signs of cancer in response to treatment) or PR (decrease in tumor size or extent of cancer
        in the body) were reported. 4 patients showed SD as best overall response (11.8%). Prolonged SD (&ge; 6 months) was observed
        in one patient whose SD lasted for 24.9 months.</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 2pt; padding-left: 4"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 2pt; padding-left: 4"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 2pt; padding-left: 4"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2pt; padding-left: 4"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Safety:</I></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">34
        patients were enrolled and treated: 29 patients of non-Enzyme Inducing Anti-Epileptic Drugs, or non-EIAED, population
        and 5 of EIAEDs population. The primary clinical endpoint was not met. Only one patient (non-EIAEDs) achieved the study
        primary endpoint out of 34 treated patients. PFS-6 rate evaluated in the treated patients was 2.9% (95% CI, 0.07-15.33).
        No CR or PR was reported; 4 patients in the treated patients showed SD as best overall response on treatment (11.8%).
        Prolonged SDs (&ge;6 months) was observed in one patient whose SD lasted for 24.9 months. Median OS in treated patients
        was 7.03 months (95% CI, 5.72-10.58). The exploration of the role play by potential prognostic factors, such as Karnofsky&nbsp;Performance Scale&nbsp;(&ge;90 vs. &lt;90), age (&lt;40 vs. &ge;40) and interval between initial diagnosis and current recurrence
        (&ge;52 weeks vs. &lt;52 weeks) indicated a better survival outcome for patients whose interval between initial diagnosis
        and current recurrence was (&ge;52 weeks). Given the non-comparative nature of the study, it cannot be said whether the
        treatment played any role in this result.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
        influence of other factors cannot be excluded but was not apparent in the current sample.</FONT></P></TD></TR>
</TABLE>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 80 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-top: Black 1pt solid; border-right: Black 1pt solid; border-left: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 2pt; padding-left: 4; width: 19%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Trial</B></FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 2pt; padding-left: 4; width: 22%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Patient
    Population</B></FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 2pt; padding-left: 4; width: 22%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Treatment&nbsp;Schedule&nbsp;/&nbsp;Dosing</B></FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 2pt; padding-left: 4; width: 37%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Key
    Findings</B></FONT></TD></TR>

<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 19%; border-top: black 1pt solid; border-right: Black 1pt solid; border-left: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 2pt; padding-left: 4"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CDKO-125a-003</FONT></TD>
    <TD STYLE="width: 22%; border-top: black 1pt solid; border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2pt; padding-left: 4"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advanced/metastatic
        solid tumors</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30
        patients</FONT></P></TD>
    <TD STYLE="width: 22%; border-top: black 1pt solid; border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2pt; padding-left: 4"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1st
        Schedule: Orally, once daily</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">for
        21 consecutive days followed by 7 days of rest in a 4-week cycle at escalating doses of 16 and 24 mg/m2</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2nd
        Schedule: Orally, once daily for 14 consecutive days followed by 7 days of rest in a</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3-week
        cycle at escalating doses of 24, 48, 54 and 72 mg/m2</FONT></P></TD>
    <TD STYLE="width: 37%; border-top: black 1pt solid; border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2pt; padding-left: 4"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Pharmacokinetics:</I></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
        differences in the pharmacokinetics were observed between the two schedules after both single and repeated dosing.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
        systemic exposure to Milciclib (amount of Milciclib available systemically in the patient) increased with dose in terms
        of both Cmax (maximum concentration of Milciclib in plasma) and daily Area Under the Plasma Drug Concentration, or AUC,
        vs Time Curve, a measure of drug bioavailability without deviations from dose-proportionality (plasma concentration changes
        in a linear relationship to amount of drug dosed).</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-right: Black 1pt solid; border-left: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 2pt; padding-left: 4"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 2pt; padding-left: 4"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 2pt; padding-left: 4"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 2pt; padding-left: 4"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">After repeated administrations, Milciclib Cmax and AUC accumulated by a factor of 2-4, independent of the dose-level.</FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 2pt; padding-left: 4"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 2pt; padding-left: 4"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 2pt; padding-left: 4"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2pt; padding-left: 4"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Clinical
                                         observations:</I></FONT> </P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT> </P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
        objective (measurable) responses were achieved. SDs were reported in 5 out of 16 evaluable patients (31.3%), starting
        from the dose of 48 mg/m2/day. One disease stabilization maintained for 12 cycles (10.5 months) at 48 mg/m2/day, was achieved
        in a parotid gland patient.</FONT> </P></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 2pt; padding-left: 4"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CDKO-125a-004</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2pt; padding-left: 4"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advanced/metastatic
        solid tumors</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16
        patients</FONT></P></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2pt; padding-left: 4"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Orally
        administered at 45, 60 and 80 mg/m2 once daily for 7 days on / 7 days off (Days 1 to 7 and 15 to 21) in a 4-week cycle
        in combination with fixed dose of IV gemcitabine (1000 mg/m2/day) on Days 1, 8, 15</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">over
        30 minutes every 4 weeks</FONT></P></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2pt; padding-left: 4"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Pharmacokinetics:</I></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pharmacokinetic
        parameters (Cmax, AUC) of Milciclib after Milciclib maleate/ gemcitabine combination were consistent with those previously
        observed after Milciclib maleate administration as single agent, suggesting no influence of gemcitabine on the pharmacokinetics
        of the compound.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Clinical
        observations:</I></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">One
        PR in 14 evaluable patients (7.1%) and one SD in 10 patients (71.4%).</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disease
        stabilizations lasting z 6 months were recorded in 4 cases (28.6%) in thyroid, prostatic, pancreatic carcinoma and peritoneal
        mesothelioma, in 2 of them lasting 13.4 months (peritoneal mesothelioma) and 14.3 months (prostate cancer).</FONT> </P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
        PR and 3 of the 4 long lasting disease stabilizations were obtained at the recommended Phase 2 dose (RP2D) of 80 mg/m2/day
        plus 1000 mg/m2/day gemcitabine, supporting development of combination therapies with Milciclib in advanced cancer patients.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Results
        of trial CDKO-125a-004 were published: S. Aspeslagh et.al. Cancer Chemother. Pharmacol (2017) 79: 1257-1265</FONT> </P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 81 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Phase
2 Development</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 19%; border: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 2pt; padding-left: 4"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Trial</B></FONT></TD>
    <TD STYLE="width: 22%; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 2pt; padding-left: 4"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Patient
    Population</B></FONT></TD>
    <TD STYLE="width: 22%; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2pt; padding-left: 4"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Treatment&nbsp;Schedule&nbsp;/&nbsp;Dosing</B></FONT></P></TD>
    <TD STYLE="width: 37%; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 2pt; padding-left: 4"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Key
    Findings</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 2pt; padding-left: 4"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CDKO-125a-005</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2pt; padding-left: 4"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Malignant
        pleural mesothelioma</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">38
        patients</FONT></P></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2pt; padding-left: 4"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">150
        mg/day orally</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">administered
        for 7 consecutive days every 14 days in 2-week cycles</FONT></P></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2pt; padding-left: 4"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Pharmacokinetics:</I></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Plasma
        levels of Milciclib were comparable to those previously obtained in the Phase 1 study CDK0-125a-001 at the same dosage
        and with the same schedule, confirming the reliability of the pharmacokinetic profile of the compound.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Clinical
        observations:</I></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
        objective responses were reported; prolonged SDs were observed in 2 patients, lasting 8.9 months and 8.7 months, respectively.</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2pt; padding-left: 4"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CDKO-125a-006</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trial
        cutoff: 1/9/2017</FONT></P></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2pt; padding-left: 4"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Malignant
        B3 thymoma / thymic carcinoma</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">72
        patients</FONT></P></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 2pt; padding-left: 4"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2pt; padding-left: 4"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Clinical
        Observations:</I></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Treatment
        with Milciclib met the primary endpoint of PFS at 3 months (PFS-3). 56 of 72 treated patients had median PFS of 5.78 months
        with upper and lower 95% confidence limits of 3.48 months and 7.89 months, respectively. The secondary endpoint, OS, was
        also met in this trial. 36 of 72 patients (50%) had median OS of 24.44 months with upper and lower 95% confidence limits
        of 22.05 and 54.55 months, respectively. Five patients from this study are continuing treatment with Milciclib.</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2pt; padding-left: 4"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CDKO-125a-007</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trial
        cutoff: 1/9/2017</FONT></P></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2pt; padding-left: 4"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Malignant
        B3 thymoma / thymic carcinoma</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30
        patients</FONT></P></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 2pt; padding-left: 4"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2pt; padding-left: 4"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Clinical
        Observations:</I></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Treatment
        with Milciclib met the primary endpoint of PFS-3. 18 of 30 patients had median PFS of 5.65 months with upper and lower
        95% confidence limits of 3.94 months and 17.45 months, respectively. The secondary endpoint, OS, was met in this trial.
        18 of 30 treated patients (54.5%) had OS of 48 months. Upper and lower 95% confidence limits could not be calculated because
        the median survival probability was not reached.</FONT></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Source:
Milciclib Investigators Brochure version 13</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 82 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Safety</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Overall,
Milciclib has indicated a similar pattern of toxicity across studies. Consistent with preclinical findings, the safety
profile of the compound in humans is characterized by a dose-limiting neurological toxicity and, to a lesser extent, by GI
toxicity. Asthenia (weakness) and fatigue have also been observed, as well as effects on liver, especially with prolonged
schedules of administration. Mild/moderate tremors are a common finding, reported also at recommended Phase 2 doses (RP2Ds)
(only one case of grade 3), whereas ataxia (loss of muscle control and balance) was observed primarily during the first
dose-escalation study (one case of grade 3 ataxia occurred also at the RP2D in the combination study CDKO-125a-004 and one in
CDKO-125a-006 trial). Both tremor and ataxia were generally reversible in all cases in up to 7-9 days, upon drug
discontinuation or dose reduction in some cases. Grade 1-2 dizziness was also reported, with only one grade 3 occurrence,
overall. Mild dysgeusia (disorder of sense of taste) is another event that was reported across studies, as well as headache
and anorexia (loss of appetite). Grade 3 myasthenia (muscle weakness) was also reported in two patients. Nausea and/or
vomiting and/or diarrhea were mostly of grade 1-2 in severity and were manageable with appropriate therapy. Diarrhea was
occasionally severe, leading to dehydration in several instances. Skin disorders were also reported across studies; the
events were mainly of grade 1-2 in severity except for one case of grade 3 rash maculopapular and one case grade 3 of
erythema multiforme. Hematological toxicity was mainly represented by lymphocytes (white blood cells) decrease and, to a
lesser extent by all the other hematological parameters. Severe thrombocytopenia (decrease in number of platelets in blood)
was sporadically observed, especially at the highest doses tested and in combination with gemcitabine. Effects on liver were
dose-dependent and mainly represented by transient transaminase elevation (with bilirubin slightly less affected).
ALT/AST (liver enzymes measured to monitor liver damage) elevations were usually mild using the 7 days on / 7 days off
schedule (even if prolonged transaminases (liver enzymes) were occasionally observed). The more prolonged administrations
were associated with a more frequent and pronounced effect on liver function tests. Asymptomatic grade 3-4 lipase (a
pancreatic enzyme that breaks down fats, measured to monitor pancreatic function) elevations were sometimes reported, without
clinical manifestation. No important effects on renal function were noted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Monitoring
of visual function was performed through visual acuity, funduscopy (ophthalmic examination of the back of the eye) and, in a subset
of studies, electroretinography examinations, or ERG. Overall, no clinically relevant abnormalities for these parameters emerged
during treatment across studies, except for ERG worsening, compared to baseline, observed in three patients, who for this reason
discontinued study treatment as per protocol, and one case of retinal detachment reported as a serious event in one patient (CDKO-125a-006
trial) and assessed as probably related to Milciclib maleate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
interim review in trial CDKD-125A-010, as noted above, found Milciclib to be well-tolerated with no drug-related serious adverse
events in 6 patients with unresectable or metastatic HCC who had concluded a first cycle of treatment with Milciclib.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Phase
2 Data in Thymoma and Thymic Carcinoma</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thymomas
and thymic carcinomas are tumors that originate in epithelial cells of the thymus gland. Generally, thymoma does not spread beyond
the thymus, while thymic carcinoma, represents an aggressive cancer that metastasizes rapidly and poses treatment challenges.
Both cancers are rare, and it is estimated that together they account for ~400 cases per year in the US, or about 1.5 persons
per million diagnosed with thymoma/thymic carcinoma. Patients more often present with advanced disease, with a 5-year survival
of 30% to 50%. Standard primary treatment for patients with these types of tumors is surgical resection. Depending on tumor stage,
treatment options include the use of radiation therapy and chemotherapy with or without surgery. First line of chemotherapy treatment
is the combination of cisplatin, doxorubicin and cyclophosphamide for thymoma. For thymic carcinoma the first line of treatment
is the combination of paclitaxel and carboplatin.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Milciclib met its primary endpoints in two Phase 2 clinical trials in patients with thymic carcinoma and
thymoma. Clinical trials, CDKO-125A-006 (72 patients) and CDKO-125A-007 (30 patients) in patients with thymic carcinoma and thymoma,
respectively, were conducted in the US, France and Italy. Monotherapy treatment regimen with Milciclib (150mg/day; 7 days on /
7 days off) was well-tolerated. Seven patients (5 patients in the CDKO-125A-006 study and 2 patients in the CDKO-125A-007) have
been continuing treatment with Milciclib for more than 2 years with excellent tolerance profile. Among these, 2 patients have been
treated with Milciclib for approximately 5 years, demonstrating tolerability of the drug for long term treatment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
trial CDKO-125A-006, 56 of 72 treated patients had median PFS of 5.78 months with upper and lower 95% confidence limits of 3.48
and months, respectively. In trial CDKO-125A-007, 18 of 30 treated patients had median PFS of 5.65 months with upper and lower
95% confidence limits of 3.94 and 17.45 months, respectively. These results materially exceeded the median PFS&gt; 10.2 weeks
established for monotherapy with pemetrexed. The OS secondary endpoint was also met in both trials. In trial CDKO-125A-006, 36
of 72 (50%) treated patients had median OS of 24.44 months with upper and lower 95% confidence limits of 22.05 and 53.55 months,
respectively. In trial CDKO-125A-007, 18 of 30 patients had an OS (54.5%) of 48 months. As a median was not reached, the 95% confidence
limits could not be calculated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Both clinical studies
demonstrated that treatment with Milciclib met PFS as the primary endpoint and OS as a secondary endpoint.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 83 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Preclinical
Data</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
pharmacokinetics of Milciclib were investigated in mouse, rat, dog and monkey models after single intravenous and oral administration
of the compound. Since the compound is intended for the oral administration route, the pharmacokinetics were further characterized
after single and repeated oral administrations. These preclinical studies were performed with Milciclib formulated as maleate
or mono/di/tri-hydrochloride salt. Following intravenous administration, Milciclib was characterized by a moderate clearance
in mice, rats and monkeys and a high clearance in dogs. The volume of distribution was higher than the total body water in all
tested species, suggesting an extensive tissue distribution. Following oral administration to rats and monkeys, Milciclib crossed
the blood-brain barrier and distributed in the brain. In all species, Milciclib plasma levels increased largely in direct proportion
with the dose.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preclinical
toxicology studies conducted with Milciclib have shown that the hemolymphopoietic system, the GI tract and the male reproductive
organs are the major target organs considered related to the pharmacological activity of the compound in all species. The effects
on the hemolymphopoietic system and GI tract were reversible after drug withdrawal. Reversibility could not be demonstrated in
the male reproductive organs at the end of the 2-3-week recovery period because of the longtime of maturation of the seminiferous
epithelium. Additional toxicities, that are considered not related to the mechanism of action of the compound, were Central Nervous
System, or CNS, ocular and renal toxicities. In addition, hemorrhages in different organs were observed in dogs and monkeys. Clinical
signs of CNS toxicity were observed at high doses given as single or repeated administrations in all species.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Our
Preclinical Programs</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Anti-IL6R
Fully Human mAb TZLS-501 (formerly known as NI-1201)</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">TZLS-501 is a fully human
mAb targeting the IL-6R. We licensed the intellectual property from Novimmune in January 2017. This fully human mAb has a novel
mechanism of action, binding to both the membrane-bound and soluble forms of the IL-6R and depleting circulating levels of the
IL-6 in the blood. An excessive production of IL-6 is regarded as a key driver of chronic inflammation, associated with autoimmune
diseases such as multiple myeloma, oncology indications and rheumatoid arthritis, and we believe that TZLS-501 may have potential
therapeutic value for these indications.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
preclinical studies, TZLS-501 demonstrated the potential for overcoming the limitations of other IL-6 pathway drugs. Compared
to tocilizumab and sarilumab, TZLS-501 has been observed to have a higher affinity for the soluble IL-6 receptor from antibody
binding studies conducted in cell culture. TZLS-501 also demonstrated the potential to block or reduce IL-6 signaling in mouse
models of inflammation. The soluble form of IL-6 has been implicated to have a larger role in disease progression compared to
the receptor bound form (Kallen, K.J. (2002). &ldquo;The role of transsignalling via the agonistic soluble IL-6 receptor in human
diseases.&rdquo; Biochimica et Biophysica Acta. 1592 (3): 323&ndash;343.).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>StemPrintER&trade;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">StemPrintER
is a multi-gene signature assay intended for use in patients diagnosed with estrogen-receptor positive ER+/HER2 negative breast
cancers. We believe this in-vitro prognostic test will be used in conjunction with clinical evaluation to identify those patients
at increased risk for early and/or late metastasis. StemPrintER is designed to help physicians distinguish ER+/HER2 negative patients:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">with
                                         an elevated risk of early recurrence (&lt;5 years) who could benefit from chemotherapy
                                         in addition to hormonal therapy;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">with
                                         a high risk of late recurrence who could benefit from prolonged endocrine treatment up
                                         to 10 years; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">with
                                         a low risk of early recurrence who might be spared chemotherapy or be eligible for less
                                         aggressive treatments.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Our diagnostic has a
novel biological basis, being based on the detection of cancer stem cell markers, uses a reliable platform (qRT-PCR, FFPE), and
has been evaluated in an initial retrospective validation study using a consecutive cohort of approximately 2400 patients with
breast cancer. Our development team is preparing for a retrospective validation study using an independent cohort and has conducted
a pre-submission meeting with the FDA.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Manufacturing</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">We believe our current
CMOs will be able to fully meet our current clinical trial needs and anticipated future commercial demand for Foralumab and Milciclib
in a cost-effective manner.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">A large-scale cGMP
manufacturing of Foralumab drug substance has been accomplished and we have produced sufficient purified material for completing
all clinical studies up to Phase 3. This material was produced by Lonza Group AG using a proprietary cell culture technology. The
Foralumab material is highly stable when stored at -80oC for several years. A novel and proprietary formulation suitable for oral
administration of Foralumab has been developed. We are currently producing formulated drug product for clinical studies under cGMP
conditions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 84 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->80<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have also achieved cGMP manufacturing of Milciclib at pilot scale. The chemical scheme for manufacturing is simple with reproducible
yields. This method has been used for producing drug substance to supply the ongoing clinical studies. The chemical process is
very cost-effective and can be scaled-up for much larger scale needed for commercialization.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Competition</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
biotechnology and pharmaceutical industries are characterized by rapidly changing technologies, significant competition and a
strong emphasis on intellectual property. We face substantial competition from many different sources, including large and specialty
pharmaceutical and biotechnology companies, academic research institutions, government agencies and public and private research
institutions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are aware of a number of companies focused on developing therapies in various indications. Any advances made by a competitor may
be used to develop therapies that could compete against any of our product candidates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
our specific product candidates, the main competitors include:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sorafenib
                                         is currently the standard of use therapy for HCC but the drug exhibits severe toxicities
                                         and patients often develop resistance to the treatment with Sorafenib. As a result, there
                                         is an immediate need for improvement in treatment for HCC.</FONT> </TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We believe that Foralumab is currently the only fully human anti-CD3 mAb in clinical development for treatment of NASH and Crohn&rsquo;s disease.</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Many
of our potential competitors, alone or with their strategic partners, have substantially greater financial, technical and other
resources than we do, such as larger R&amp;D, clinical, marketing and manufacturing organizations. Mergers and acquisitions in
the biotechnology and pharmaceutical industries may result in even more resources being concentrated among a smaller number of
competitors. Our commercial opportunity could be reduced or eliminated if competitors develop and commercialize products that
are safer, more effective, have fewer or less severe side effects, are more convenient or are less expensive than any products
that we may develop. Competitors also may obtain FDA or other regulatory approval for their products more rapidly than we may
obtain approval for ours, which could result in our competitors establishing a strong market position before we are able to enter
the market. Additionally, technologies developed by our competitors may render our potential product candidates uneconomical or
obsolete, and we may not be successful in marketing our product candidates against competitors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Intellectual
Property</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
strive to protect and enhance the proprietary technologies, inventions and improvements that we believe are important to our business,
including seeking, maintaining and defending patent rights, whether developed internally or licensed from third parties. Our policy
is to seek to protect our proprietary position by, among other methods, pursuing and obtaining patent protection in the United
States and in jurisdictions outside of the United States related to our proprietary technology, inventions, improvements, platforms
and our product candidates that are important to the development and implementation of our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<!-- Field: Page; Sequence: 85 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->81<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">As of May, 31 2018, our intellectual property portfolio was made up as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><IMG SRC="img_3n.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 6pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">We have rights to a patent
family that discloses the Milciclib compound, methods of using the compound, and processes for making the compound under license
from Nerviano (which is further described below). This patent family includes five granted U.S. patents, one granted European
patent, and one granted Eurasian patent. This patent family also includes granted patents in Africa (African Intellectual Property
Organization, African Regional Intellectual Property Organization), Algeria, Argentina, Australia, Barbados, Bosnia &amp; Herzegovina,
Canada, Colombia, Costa Rica, Croatia, Cuba, Ecuador, Georgia, Iceland, India, Indonesia, Israel, Japan, Korea, Kosovo, Malaysia,
Mexico, Mongolia, Montenegro, New Zealand, Nicaragua, Norway, Pakistan, Philippines, Serbia, Singapore, South Africa, Sri Lanka,
Taiwan, Tunisia, Ukraine, Uzbekistan, and Vietnam. Several applications are pending in the U.S. and other countries in this family.
The patents in this family will expire in April, 2024, excluding any patent term adjustment and patent term extension in the U.S.
and similar regulatory extensions available in several other jurisdictions, such as Europe.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We also have rights to a second patent family which covers related entities, such as salts and crystal
forms, of Milciclib, and methods of using the salts and crystal forms. This patent family comprises one granted U.S. patent and
one granted patent in each of Europe, China, Japan, and Hong Kong. One application is pending in this family in Europe. The patents
in this family will expire in April, 2030, excluding any patent term adjustment and patent term extension in the U.S. and several
other jurisdictions, such as Europe.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In addition, we have
rights to five patent families which cover methods of using Milciclib in the treatment of multiple indications. These patent families
comprise five granted U.S. patents, and granted patents in Europe, China, Hong Kong, and Japan, and one pending patent application
in Europe. The patents in these families will expire between February, 2027 and March, 2030, excluding any patent term adjustment
and patent term extension in the U.S. and similar regulatory extensions available in several other jurisdictions, such as Europe.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Among the above five
patent families, two families also cover combination therapies of Milciclib with cytotoxic agents. These families comprise two
granted U.S. patents, and granted patents in Europe, China, Hong Kong, and Japan. The patents in these families will expire between
November, 2029 and March, 2030, excluding any patent term adjustment and patent term extension in the U.S. and similar regulatory
extensions available in several other jurisdictions, such as Europe.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">One family of the
above five patent families also covers combination therapies of Milciclib with therapeutic antibodies. This patent family includes
one granted U.S. patent, and granted patents in Europe, China, and Japan. The patents in this family will expire in February, 2027,
excluding any patent term adjustment and patent term extension in the U.S. and similar regulatory extensions available in several
other jurisdictions, such as Europe.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In addition, we have
rights to a patent family which covers methods of using Milciclib together with a second anti-cancer agent in the treatment of
cancer. This patent family includes one pending application in the U.S. The patent applications in this family, if issued as patents,
will expire in December, 2038, excluding any patent term adjustment and patent term extension in the U.S. and similar regulatory
extensions available in several other jurisdictions, such as Europe.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 86 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->82<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We have rights to
a first patent family that disclose methods of using Foralumab, licensed from Novimmune (which is further described below). This
patent family includes, one granted European patent, and one granted Eurasian patent. This patent family also includes granted
patents in Australia, Canada, China, Hong Kong, Israel, Japan, Mexico, Norway, Singapore, South Africa, Ukraine, and Portugal.
One application is pending in Norway. The patents in this family will expire in April, 2025, excluding any patent term extensions
available in several jurisdictions, such as Europe.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We also have rights
to a second patent family that discloses the Foramulab compound and methods of using the compound also licensed from Novimmune.
This patent family comprises three granted U.S. patent one granted European patent, and one granted Eurasian patent. This patent
family also includes granted patents in Australia, Canada, China, Hong Kong, India, Israel, Japan, Mexico, Norway, Republic of
Korea, Singapore, South Africa, and Ukraine. Applications are pending in Brazil, Japan, Singapore and U.S. The patents in these
families will expire in June, 2025, excluding any patent term adjustment in the U.S. and patent term extensions available in the
U.S. and several other jurisdictions, such as Europe.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">In addition, we have
rights to a third patent family that discloses combination therapies of Foramulab with Il-6 or IL-6R antibodies licensed from
Novimmune. This patent family has one pending U.S. application. The patents in these families will expire in January, 2032, excluding
any patent term adjustment and patent term extensions available in the U.S.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"> We own and have right
to a forth patent family that discloses formulations of Foramulab and dosing regimens for treating various disorders. This patent
family has one pending U.S. application and one pending PCT application. National application filings are due February, 2017.
The patents in these families will expire in August, 2037, excluding any patent term adjustment and patent term extensions available
in the U.S and several other jurisdictions </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We have rights to
a patent family that discloses methods of using TZLS-501 to treat various disorders, licensed from Novimmune. This patent family
includes, four granted U.S. patents and one granted European patent. This patent family also includes granted patents in Australia,
Canada, China, Japan and Mexico. Applications are pending in U.S. and India. The patents in this family will expire in May, 2029,
excluding any patent term extensions available in several jurisdictions, such as Europe.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Individual
patents extend for varying periods depending on the date of filing of the patent application or the date of patent issuance and
the legal term of patents in the countries in which they are obtained. Generally, patents issued for regularly filed applications
in the United States are granted a term of 20 years from the earliest effective non-provisional filing date. In addition, in certain
instances, a patent term can be extended to recapture a portion of the USPTO delay in issuing the patent as well as a portion
of the term effectively lost as a result of the FDA regulatory review period. However, as to the FDA component, the restoration
period cannot be longer than five years and the total patent term including the restoration period must not exceed 14 years following
FDA approval. The duration of foreign patents varies in accordance with provisions of applicable local law, but typically is also
20 years from the earliest effective filing date. However, the actual protection afforded by a patent varies on a product by product
basis, from country to country and depends upon many factors, including the type of patent, the scope of its coverage, the availability
of regulatory-related extensions, the availability of legal remedies in a particular country and the validity and enforceability
of the patent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
we rely upon trade secrets and know-how and continuing technological innovation to develop and maintain our competitive position.
We seek to protect our proprietary information, in part, using confidentiality agreements with our collaborators, employees and
consultants and invention assignment agreements with our employees. We also have confidentiality agreements or invention assignment
agreements with our collaborators and selected consultants. These agreements are designed to protect our proprietary information
and, in the case of the invention assignment agreements, to grant us ownership of technologies that are developed through a relationship
with a third party. These agreements may be breached, and we may not have adequate remedies for any breach. In addition, our trade
secrets may otherwise become known or be independently discovered by competitors. To the extent that our collaborators, employees
and consultants use intellectual property owned by others in their work for us, disputes may arise as to the rights in related
or resulting know-how and inventions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
commercial success will also depend in part on not infringing upon the proprietary rights of third parties. It is uncertain whether
the issuance of any third-party patent would require us to alter our development or commercial strategies, or our product candidates
or processes, obtain licenses or cease certain activities. Our breach of any license agreements or failure to obtain a license
to proprietary rights that we may require to develop or commercialize our future product candidates may have an adverse impact
on us. If third parties have prepared and filed patent applications prior to March 16, 2013 in the United States that also claim
technology to which we have rights, we may have to participate in interference proceedings in the USPTO, to determine priority
of invention. For more information, see &ldquo;Risk Factors&mdash;Risks Related to Our Intellectual Property.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Material
Agreements</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Nerviano
Agreement</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
January 2015, we entered into an agreement with Nerviano, or the Nerviano Agreement, pursuant to which we obtained a worldwide,
exclusive license to patents owned or controlled by Nerviano, or the Nerviano License to develop and commercialize products and
services incorporating Milciclib as an active ingredient, and any product or service controlled or owned by Nerviano that is used
to diagnose or assess responsiveness to Milciclib therapy or dosage. The Nerviano License confers the right on us grant sub-licenses,
and otherwise to employ third party manufacturers and distributors to produce and sell licensed products and services.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
party to the Nerviano Agreement agreed to a development plan, or the Nerviano Development Plan, approved by a joint development
committee, or the JDC. The JDC is comprised of at least two members of each party, meets at least twice a year and endeavors to
make decisions by consensus, save that where there is a disagreement with respect to any aspect of the licensed products or services
we shall have a deciding vote.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Under the Nerviano Development
Plan, we (or, as the case may be, our sub-licensee(s)) are obliged to use commercially reasonable efforts to develop and commercialize
a licensed product or service in at least one therapeutic indication that arises out of the Nerviano Development Plan, and Nerviano
is obliged to use commercially reasonable efforts to manufacture such product(s) or service(s). Pursuant to the Nerviano Development
Plan, we have sole responsibility for costs for further clinical development and Nerviano is obliged to perform Phase 2 studies
of licensed products and services, save that the amounts to be invoiced by Nerviano to us for Phase 2 studies shall be commercially
reasonable and not be greater than a low-double-digit percentage in excess than amounts estimated to be invoiced by another reputable
clinical research organization.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 87 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->83<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the term of the Nerviano Development Plan, or the Nerviano Exclusivity Period, we and our affiliates may not, directly or indirectly,
develop, make, use, sell, offer for sale or import any small molecule compound or other biological or chemical molecule other
than Milciclib that directly binds to, with an affinity indicated by an IC50 of 100nM or less, and modulates the following specified
pharmacological targets hit by Milciclib: Cdk-2, Cdc-4 and Cdc6.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Upon entry into the
Nerviano Agreement, we paid an upfront, non-refundable initial license fee of $3,500,000 to Nerviano. We issued 4,233,616 of ordinary
shares, fully paid with a nominal value of three pence each, or the Consideration Shares, to Nerviano at an issue price of 50.5
pence (equivalent to an aggregate value of &pound;2,137,976.08).</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Nerviano
granted us an option, or the Nerviano Option, to buy-back all the Consideration Shares for a de minimis aggregate consideration
exercisable on written notice at any time after the earlier of:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">(i)</TD><TD STYLE="text-align: justify">an unsuccessful Phase 2 trial for HCC or breast cancer
with a licensed product or service and the concomitant decision of the company, our affiliates or sub-licensees to discontinue
development of a licensed product or service;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">(ii)</TD><TD STYLE="text-align: justify">the fifth anniversary of the Nerviano Agreement, (provided
that if on such date a Phase 2 trial has commenced but has not been completed our ability to exercise the Nerviano Option shall
be delayed until the outcome of the Phase 2 trial has become clear); or</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">(iii)</TD><TD>our abandonment of any licensed product or service
for bona fide scientific reasons.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: -26.25pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">The Nerviano Option cannot be exercised if any of the following
events (each, a Release Event), occurs:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">(i)</TD><TD STYLE="text-align: justify">a successful completion of a Phase 2 trial for HCC or breast cancer with a licensed product or service,
where such successful conclusion renders the licensed product or service eligible for entry into a Phase 3 trial with no further
clinical study; or</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
abandonment of the development of, or failure to exercise commercially reasonable efforts develop any, licensed product or service,
save for where we have bona fide scientific reasons.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 16.6pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Nerviano Option effectively allows us to recover the Consideration Shares if it transpires that Milciclib proves to be unsuccessful
in the indications for which we licensed it or we fail to see satisfactory results in a period of 5 years from the date of the
license agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 16.6pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to a Release Event, Nerviano has agreed to not transfer, dispose of, or grant options or other rights over directly or indirectly
any interests in the Consideration Shares nor to derive any financial benefit from the Shares, but is entitled to exercise all
voting rights arising from the Consideration Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
a Release Event, Nerviano has agreed to a 12 month lock-up, or the Nerviano Lock-Up, in respect of the Consideration Shares, subject
to customary exceptions, including the prior written consent of the company and our nominated adviser from time to time (which
consent may be approved, provided or provided subject to conditions as each may determine in its absolute discretion), acceptance
of takeover bids, share buy-backs by the company, or where required by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the lapse of the term of the Nerviano Lock-Up, Nerviano has agreed to not directly or indirectly, transfer, sell, mortgage, charge
or otherwise dispose of more than 10% of the Consideration Shares (i.e. 423,362 ordinary shares) per calendar month, and to utilize
the company&rsquo;s broker from time to time to execute those transactions in respect of the legal and or beneficial ownership
or any other interest in the Consideration Shares so as to ensure an orderly market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are obligated to pay Nerviano the following additional amounts in respect of the first licensed product or service which achieves
the stated development milestones:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$100,000 upon initiation, first patient dosed, or FPD, of the first
Phase 3 registration trial in thymic carcinoma.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(b) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$4,000,000
upon FPD of the first Phase 3 registration trial in HCC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: -25.3pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(c) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$6,000,000
upon FPD of the first Phase 3 registration trial in breast cancer.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -24.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Upon
the first NDA equivalent in: thymic carcinoma, $900,000; HCC, $9,000,000; breast cancer, $15,000,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are obliged to pay Nerviano a low-single-digit percentage royalty fee of the annual net sales of licensed products or services,
subject to certain royalty off-sets on a country-by-country basis and, subject to certain exclusions, a low-double-digit percentage
of sub-licensing revenues from the sale of licensed products or services for the life of the licensed patents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the Nerviano Exclusivity Period, we have the right to terminate activities and funding to Nerviano after 24 months from the beginning
of the Nerviano Exclusivity Period but not prior thereto. If we exercise our termination right, we are obliged to transfer to
Nerviano all relevant data, licensed products and services and an exclusive license pertaining to the licensed product or services,
and Nerviano shall pay us a low-single-digit percentage royalty on annual net sales of licensed products and services, subject
to certain exceptions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the expiry of the Nerviano Exclusivity Period, we may terminate the Nerviano Agreement at any time on 90 days&rsquo; written notice,
and either party may terminate the Nerviano Agreement for material breach by the other party of any material obligation or condition
of the Nerviano Agreement by written notice, subject to a 45 day cure period for a payment breach, and a 120 day cure period for
any other breach.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Absent
early termination, the Nerviano Agreement shall remain in force until the later of, in all countries in which licensed products
and services are marketed pursuant to the Nerviano Agreement, (a) the expiration of the last claim in an issued, unexpired patent
within the licensed patents, subject to certain exceptions, which covers the sale of such licensed products or services, or (b)
five years from the date of first commercial sale of such licensed product or service in such country.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 88 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->84<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Novimmune
CD3 Agreement</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In December 2014,
we entered into a license and sublicense agreement with Novimmune, or the Novimmune CD3 Agreement, pursuant to which we obtained
a worldwide, exclusive license to certain patents owned or controlled by Novimmune, or the Novimmune CD3 License, together with
a sublicense to certain patent licenses from Bristol-Myers Squibb Company, or BMS, or the BMS CD3 Sublicense, and any associated
know-how, biologic materials, clinical data or other technology relating to CD3 receptor mAbs and their use in order to research,
develop and commercialize products and services. The Novimmune CD3 License and BMS CD3 Sublicense both confer the right to us to
grant sublicenses, and otherwise to employ third party manufacturers and distributors to produce and sell licensed products and
services, respectively.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Novimmune CD3 Agreement, Novimmune granted the BMS CD3 Sub-License to us. Novimmune effected such grant pursuant to a research
and commercialization agreement between Novimmune and BMS dated September 2004, or the BMS R&amp;C Agreement, and the agreement
for the exclusive commercial license for the CD3 licensed product (NI-0401) between Novimmune and BMS dated February 2005.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Novimmune CD3 Agreement, we have full control and authority over the research, development and commercialization of licensed
products and services, and are required to exercise commercially reasonable efforts to commercialize such licensed products and
services at all times.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
our entry into the Novimmune CD3 Agreement we paid an upfront fee of $750,000 to Novimmune (to be on paid by Novimmune to BMS
pursuant to the terms of the BMS R&amp;C Agreement), and a further upfront fee of $500,000 to Novimmune. We are required to pay
Novimmune installments of $250,000 on each of the 14 month, 26 month and 38 month anniversaries of the date of the Novimmune CD3
Agreement. For the term of the Novimmune Agreement, we are obligated to pay to Novimmune a royalty of a low-single-digit percentage
on net sales of licensed products and services, together with any amounts owed to BMS incurred pursuant to the BMS CD3 Sub-License.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may terminate the Novimmune CD3 Agreement at any time on 90 days&rsquo; written notice, and either party may terminate the Novimmune
CD3 Agreement by written notice for a payment breach or any other breach, subject to 45 day and 120 day cure periods, respectively.
Absent early termination, the Novimmune CD3 Agreement will continue until the later of, in all countries in which licensed products
are marketed pursuant to the Novimmune CD3 Agreement, (a) the expiration of the last claim in an issued, unexpired patent within
the licensed patents or a claim that has not been pending more than five years, subject to certain exceptions, which covers the
sale of such licensed product or service, or (b) the end of any market exclusivity period granted by the relevant governmental
authority in a country that prevents another party from marketing the same licensed product or service.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Novimmune
IL-6r Agreement</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2016, we entered into a license and sublicense agreement with Novimmune, or the Novimmune IL-6r Agreement, pursuant to
which we obtained a worldwide, exclusive license to certain patents owned or controlled by Novimmune, or the Novimmune IL-6r License,
together with a sub-license to certain patent licenses from BMS, or the BMS IL-6r Sub-License, and any associated know-how, biologic
materials, clinical data or other technology relating to IL-6r mAbs and their use in order to research, develop, commercialize
products and services. The Novimmune IL-6r License and BMS IL-6r Sub-License both confer the right to us to grant sub-licenses,
and otherwise to employ third party manufacturers and distributors to produce and sell licensed products and services, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Novimmune IL-6r Agreement, Novimmune granted the BMS IL-6r Sub-License. Novimmune effected such grant pursuant to the BMS
R&amp;C Agreement and the agreement for the IL-6r exclusive commercial license for the IL-6r antibody licensed product (NI-1201)
between Novimmune and BMS dated September 2009, or the IL-6r Commercial License Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Novimmune IL-6r Agreement, we have full control and authority over the research, development and commercialization of licensed
products and services, and are required to exercise commercially reasonable efforts to commercialize such licensed products and
services at all times.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
our entry into the Novimmune IL-6r Agreement we paid an upfront fee of $100,000 to Novimmune. For the term of the Novimmune IL-6r
Agreement, we are obligated to pay to Novimmune a royalty of a low-single-digit percentage on net sales of licensed products and
services, or low-double-digit percentage of any sub-license royalty revenue which we receive that arises from sales of licensed
products and services, together with any amounts owed to BMS incurred pursuant to the BMS IL-6r Sub-License.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
BMS R&amp;C Agreement and the IL-6r Commercial License Agreement were amended pursuant to an agreement between Novimmune and BMS
dated December 2016, or the Novimmune Amendment Agreement. Pursuant to the Novimmune Amendment Agreement, in the event that Novimmune
(or, as the case may be, a sublicensee) commercializes a combination product comprising NI-1201 and NI-0401, then such product
shall be subject to a single royalty.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may terminate the Novimmune IL-6r Agreement at any time on 90 days&rsquo; written notice, and either party may terminate the Novimmune
IL-6r Agreement by written notice for a payment breach or any other breach, subject to 45 day and 120 day cure periods, respectively.
Absent early termination, the Novimmune IL-6r Agreement will continue until the later of, in all countries in which licensed products
are marketed pursuant to the Novimmune IL-6r Agreement, (a) the expiration of the last claim in an issued, unexpired patent within
the licensed patents or a claim that has not been pending more than five years, subject to certain exceptions, which covers the
sale of such licensed product or service, or (b) the end of any market exclusivity period granted by the relevant governmental
authority in a country that prevents another party from marketing the same licensed product or service.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 89 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->85<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Brigham
and Women&rsquo;s Hospital License</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 29, 2018, we entered into a license agreement, or the BWH License, with BWH pursuant to which we obtained a worldwide exclusive
license to a patent owned by BWH for a novel technology discovered by Dr. Howard Weiner. The patent relates to a formulation of
Foralumab in a medical device developed for nasal administration of Foralumab. The BWH License extends to any associated know-how,
clinical data and use in order to research, develop and commercialize products and services. The BWH License confers on us the
right to grant sub-licenses, and otherwise to employ third party manufacturers and distributors to sell licensed products and
services.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the BWH License we have full control and amnesty over the research, development and commercialization of licensed products and
services and are required to exercise commercially reasonable efforts to commercialize such licensed products and services at
all times.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Upon our entry into
the BWH License we paid an upfront fee of $10,000 to BWH. We are required to pay annual maintenance fees, all ongoing patent maintenance
and prosecution costs and a low single-digit royalty on annual net sales (and a 12% royalty of non-royalty sub-license revenues
for the life of the intellectual property). We are also obliged to make certain milestone payments of: (a) US$300,000 within 60
days of first patient enrolled in a Phase 1 human clinical trial; (b) US$600,000 within 60 days of first patient enrolled in a
Phase 2 human clinical trial; (c) US$1,500,000 within 60 days of first patient enrolled in a Phase 3 clinical trial; and (d) US$3,000,000
within 60 days of first commercial sale of a licensed product.</P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may terminate the BWH License at any time on 90 days&rsquo; written notice, and either party may terminate the BWH License by
written notice for payment or other breach, subject to a 60 day cure period. Absent early termination the BWH License will remain
in effect until the date on which all patents and filed patent applications have expired or been abandoned.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 9pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 9pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Research and development</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 7pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In January 2017, we
finalized the acquisition of an exclusive world-wide license for NI-1201 (TZLS-501), a fully human anti-IL-6R mAb, from Novimmune.
In exchange for the exclusive license from Novimmune we agreed to an upfront cash payment, milestone payments, and a royalty on
future sales.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">MAbs against IL-6R
have been explored as potential drugs to treat inflammation in the past. NI-1201&rsquo;s novel mechanism, however, has the potential
to considerably increase anti-inflammatory activity as well as complementing our Foralumab program, a fully human oral anti-CD3
mAb.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The acquisition of
NI-1201 strengthens our business strategy of developing novel fully human mAbs to treat life-threatening inflammatory diseases
and rheumatoid arthritis. In addition, it represents an opportunity to expand the current research with Foralumab, the oral anti-CD3
mAb, to treat autoimmune and inflammatory diseases.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> In April, 2017,
we announced the approval in Israel of a Phase 2 clinical trial protocol for testing Milciclib, a novel inhibitor of CDKs, in
patients with refractory HCC. A similar clinical trial protocol has been submitted for approval in Italy, Turkey and Greece. The
primary objective of these multi-centered, multi-country Phase 2a clinical studies is to evaluate the safety of Milciclib in HCC
patients who fail to respond or are intolerant to the existing standard of care treatment. In July 2017, we announced the enrolment
of the first patient. Top line data from this trial was announced on December 8, 2017 as a result of the IDMC completing an interim
analysis of the safety and pharmacokinetic data from the first 6 patients who had received and completed an initial cycle of treatment
with Milciclib and found that Milciclib was well tolerated with no drug-related series adverse effects in patients with unresectable
or metastatic HCC. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In June 2017, we resolved
to discontinue funding of our preclinical program Bcl-3 inhibitors as potential cancer therapeutics, which includes the potential
candidate CB1 (TZLS-101), to refocus efforts on other promising candidates in the company&rsquo;s pipeline, which we believe have greater
near-term potential to deliver value for shareholders. We retain all of the intellectual property relating to the Bcl-3 program
and will work with scientists at Cardiff University in examining the potential to develop the program further with grant funding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In July 2017, we announced
publication of a research article in a prestigious journal, Clinical Immunology, entitled: &ldquo;Oral treatment with Foralumab,
a fully human anti-CD3 mAb, prevents skin xenograft rejection in humanized mice.&rdquo; We believe this is the first-ever published
report demonstrating the potential of oral therapy with Foralumab for inflammatory diseases such as NASH. We believe Foralumab
is the only fully human engineered anti-CD3 mAb in clinical development to date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> On November 23,
2017 we announced that Milciclib met its primary endpoints in two Phase 2 clinical trials in patients with thymic carcinoma and
thymoma. The treatment regimen with Milciclib (150 mg/day; 7 days On/7 days Off) was well tolerated in these patients with continuing
expose of up to 5 years. In both clinical trials it was demonstrated that treatment with Milciclib met progress free survival,
or PFS, as the primary endpoint and overall survival, or OS, as a secondary endpoint.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Organizational
Structure</B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -10.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets out details of our significant subsidiaries:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0"> Name </TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Principal</B></FONT> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>activity</B></FONT> </P></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0"> Registered
    address </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; border-bottom: Black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif; padding-right: 0"> Percentage
    shareholding </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif; padding-right: 0"> Country
    of incorporation </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 22%; text-align: left; vertical-align: top; font-family: Times New Roman, Times, Serif; padding-right: 0"> Tiziana
    Pharma Limited </TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="width: 22%; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> Clinical stage biotechnology
    company </TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="width: 22%; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> 3rd Floor, 11-12
    St James&rsquo;s Square, London, SW1Y </TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> 100 </TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> % </TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="width: 19%; text-align: center; font-family: Times New Roman, Times, Serif; padding-right: 0"> England &amp;
    Wales </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 7pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 7pt">&nbsp;</FONT> </TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 7pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 7pt">&nbsp;</FONT> </TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 7pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 7pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 7pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 7pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 7pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 7pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 7pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; vertical-align: top; font-family: Times New Roman, Times, Serif; padding-right: 0"> Tiziana
    Therapeutics, Inc. </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; vertical-align: top; font-family: Times New Roman, Times, Serif; padding-right: 0"> Clinical
    stage biotechnology company </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> 4LB 420 Lexington Avenue <BR>Suite
    2525 <BR>New York, NY 10170 </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> 100 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> % </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif; padding-right: 0"> USA </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 7pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 7pt">&nbsp;</FONT> </TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 7pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 7pt">&nbsp;</FONT> </TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 7pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 7pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 7pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 7pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 7pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 7pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-size: 7pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; vertical-align: top; font-family: Times New Roman, Times, Serif; padding-right: 0"> Longevia
    Genomics S.r.l. </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; vertical-align: top; font-family: Times New Roman, Times, Serif; padding-right: 0"> Biotechnology
    discovery company </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> Via Constantinopli 42 <BR>&nbsp;09100-Cagliria
    (CA) <BR> </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"> 100 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"> % </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif; padding-right: 0"> Italy </TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: left; margin-bottom: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 90 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->86<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Government
Regulation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Overview</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Government
authorities in most jurisdictions extensively regulate the research, development, clinical testing, manufacture, distribution
and marketing of pharmaceutical products such as those that the company is developing. Obtaining regulatory approvals and ensuring
subsequent compliance with applicable laws and regulations requires the expenditure of substantial time and financial and managerial
resources. Regulatory requirements in different jurisdictions vary, and the timing and success of efforts to obtain regulatory
approvals can be highly uncertain. Development of a successful drug candidate, from identification of a candidate drug compound,
through preclinical and clinical testing, to registration, typically takes more than ten years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Drug
development is a highly structured process divided into two major stages, preclinical and clinical. In the preclinical stage,
the toxicology and mode of action of an active compound is evaluated. The clinical stage is designed to prove the safety of any
new pharmaceutical, determine dosage requirements and, predominantly in the later phases, prove its therapeutic utility. This
stage is carried out in three phases, which, as a developer moves through the phases, require increasingly large, complex, expensive
and time-consuming clinical studies. During Phase 1, the product candidate is initially given to a small number of healthy human
subjects or patients and tested for safety, tolerance, absorption, metabolism, distribution and excretion. During Phase 2, additional
trials are conducted in a larger, but still relatively limited, patient population to verify that the product candidate has the
desired effect and to identify optimal dosage levels. Furthermore, possible adverse effects and safety risks are identified. The
therapeutic utility of the product candidate for specific targeted diseases is also studied in more depth. During Phase 3, trials
are undertaken to further evaluate dosage, to provide statistically significant evidence of clinical effectiveness and to further
study the safety in an expanded patient population at multiple clinical trial sites. Phase 3 trials may require several hundreds
or thousands of patients and are therefore the most expensive and time-consuming to conduct. At any time during one of the phases,
a trial may produce a negative result, in which case the developer may choose to end the development project.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
completion of the Phase 3 trials, the developer submits all the preclinical and clinical trial documentation as well as extensive
data characterizing the manufacturing process to the regulator to seek regulatory approval to market the formulation as a pharmaceutical
product. The regulator reviews all the information related to the safety of the active compound, and whether the pharmacological
effect claimed by the developer on the proposed label can be substantiated by the results of the clinical trials. The regulator
has the option to decide to approve the application as requested, ask for changes to the claims made by the developer, ask for
more information, require that further clinical trials are undertaken, or refuse to approve the formulation for sale.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Even
after initial regulatory approval has been obtained, further studies, including Phase 4 post-approval safety studies, may be required
to provide additional data on safety and will be required to gain approval for the use of a product as a treatment for clinical
indications other than those for which the product was initially tested. There are also continuing, annual user fee requirements
for any marketed products and the establishments at which such products are manufactured, as well as new application fees for
supplemental applications with clinical data. In addition, regulatory authorities require post-marketing reporting to monitor
the adverse effects of the product. Results of post-approval programs may limit or expand the further marketing of the products.
Further, if there are any modifications to the product, including changes in indication, manufacturing process or labeling, or
a change in the manufacturing facility, an application seeking approval of such changes or, as the case may be, notification,
must be submitted to the relevant regulatory authorities before the modified product can be commercialized. Moreover, an approved
drug product may be subject to a REMS, which could impose a number of post-approval obligations, including (among other things)
a communication plan for physicians regarding safe use of the drug, distribution and use restrictions, and/or periodic assessments
of the effectiveness of the REMS. Finally, studies may be required as a contingency of regulatory approval (post-approval commitments),
and completion of these studies within a regulator mandated time frame may be required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>European
Union</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
development, marketing and sale of medicinal products in the EU is subject to extensive pre and post marketing regulation by regulatory
authorities at both the EU and national levels. The requirements, regulatory approvals and processes governing the conduct of
clinical trials, product licensing, pricing and reimbursement vary from country to country, although there is some degree of EU
wide harmonization.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Clinical
Trials</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clinical
trials of medicinal products in the EU must be conducted in accordance with EU and national regulations, focusing in particular
on traceability, apply to clinical trials of advanced therapy medicinal products. If the sponsor of the clinical trial is not
established within the EU, it must appoint an entity within the EU to act as its legal representative. The sponsor must take out
a clinical trial insurance policy and, in most EU countries, the sponsor is liable to provide &lsquo;no fault&rsquo; compensation
to any study subject injured in the clinical trial.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to commencing a clinical trial, the sponsor must obtain a clinical trial authorization from the relevant regulatory authority,
and a positive opinion from an independent ethics committee. The application for a clinical trial authorization must include,
among other things, a copy of the trial protocol and an investigational medicinal product dossier containing information about
the manufacture and quality of the medicinal product under investigation. Currently, clinical trial authorization applications
must be submitted to the regulatory authority in each Member State in which the trial will be conducted. Under the new Regulation
on Clinical Trials, which is currently expected to take effect in October 2018, there will be a centralized application procedure
where one national authority takes the lead in reviewing the application and the other national authorities have only a limited
involvement. Any substantial changes to the trial protocol or other information submitted with the clinical trial applications
must be notified to or approved by the relevant competent authorities and ethics committees. Medicines used in clinical trials
must be manufactured in accordance with cGMP.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 11.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 91 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->87<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Marketing
Approval</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In the EU medicinal
products can only be commercialized after obtaining an MA. There are three procedures for obtaining marketing approvals: the centralized
procedure, the decentralized procedure and the mutual recognition procedure/national procedure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Community marketing
authorization, which is issued by the European Commission through the centralized procedure, based on the opinion of the CHMP of
the EMA, is valid throughout the entire territory of the EU. The centralized procedure is mandatory for certain types of products,
such as biotechnology medicinal products, orphan medicinal products, and medicinal products containing a new active substance indicated
for the treatment of AIDS, cancer, neurodegenerative disorders, diabetes, autoimmune and viral diseases. The centralized procedure
is optional for products containing a new active substance not yet authorized in the EU, or for products that constitute a significant
therapeutic, scientific or technical innovation or which are in the interest of public health in the EU.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Marketing approvals obtained using the decentralized procedure are available for products not falling
within the mandatory scope of the Centralized Procedure. An identical dossier is submitted to the regulatory authorities of each
of the Member States in which the marketing approval is sought, one of which is selected by the applicant as the Reference Member
State, or RMS. The competent authority of the RMS prepares a draft assessment report, a draft summary of the product characteristics
and a draft of the labeling and package leaflet, which are sent to the other the concerned Member States, or CMSs, for their approval.
A CMS can raise an objection, based on the assessment report, the summary of product characteristics, the labelling and the package
leaflet on the grounds of potential serious risk to public health. If no such objections are raised the product will be granted
a national marketing authorization in the RMS and all of the selected CMSs. Where a product has already been authorized for marketing
in a Member State, this decentralized procedure approval can be recognized in other Member States through the mutual recognition
procedure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Marketing approvals
obtained using the national procedure are issued by a single regulatory authority of one of the Member States and only apply to
the territory covered by the relevant regulatory authority. They are available for products not falling within the mandatory scope
of the centralized procedure. Once a product has been authorized for marketing in a Member State through the national procedure,
any application in another Member State must be by the mutual recognition procedure whereby the marketing approval can also be
recognized in other Member States through the mutual recognition procedure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Under the procedures
described above, before granting the MA, the EMA or the relevant regulatory authority of the Member States of the EU makes an assessment
of the risk-benefit balance of the product on the basis of scientific criteria concerning its quality, safety and therapeutic utility.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The holder of a marketing
authorization in any Member State of the EU is subject to various obligations under applicable EU regulations, such as pharmacovigilance
obligations, requiring it to, among other things, report and maintain detailed records of adverse reactions, and to submit periodic
safety update reports to the regulatory authorities. The holder must also ensure that the manufacturing and batch release of its
product is in compliance with the applicable requirements. The marketing approval holder is further obligated to ensure that the
advertising and promotion of its products complies with applicable laws, which can differ from Member State to Member State of
the EU.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Data
Exclusivity</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 17pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MAAs
for generic medicinal products in the EU do not need to include the results of preclinical and clinical trials, but instead can
refer to the data included in the marketing approval of a reference product for which regulatory data exclusivity has expired.
If a marketing approval is granted for a medicinal product containing a new active substance, that product benefits from eight
years of data exclusivity, during which generic MAAs referring to the data of that product may not be accepted by the regulatory
authorities, and a further two years of market exclusivity, during which such generic products may not be placed on the market.
The two-year period may be extended to three years if during the first eight years a new therapeutic indication with significant
clinical benefit over existing therapies is approved.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 17pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 17pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is a special regime for biosimilars, or biological medicinal products that are similar to a reference medicinal product but that
do not meet the definition of a generic medicinal product, for example, because of differences in raw materials or manufacturing
processes. For such products, the results of appropriate preclinical or clinical trials must be provided, and guidelines from
the EMA detail the type of quantity of supplementary data to be provided for different types of biological product. There are
no such guidelines for complex biological products, such as gene or cell therapy medicinal products, and so it is unlikely that
biosimilars of those products will currently be approved in the EU. However, guidance from the EMA states that they will be considered
in the future in light of the scientific knowledge and regulatory experience gained at the time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 17pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 17pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 92 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->88<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 17pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Orphan
Medicinal Products</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 17pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
EMA&rsquo;s Committee for Orphan Medicinal Products, or COMP, may recommend orphan medicinal product designation to promote the
development of products that are intended for the diagnosis, prevention or treatment of life-threatening or chronically debilitating
conditions affecting not more than five in 10,000 persons in the EU. Additionally, designation is granted for products intended
for the diagnosis, prevention or treatment of a life-threatening, seriously debilitating or serious and chronic condition and
when, without incentives, it is unlikely that sales of the product in the EU would be sufficient to justify the necessary investment
in developing the medicinal product. The COMP may only recommend orphan medicinal product designation when the product in question
offers a significant clinical benefit over existing approved products for the relevant indication. Following a positive opinion
by the COMP, the European Commission adopts a decision granting orphan status. The COMP will reassess orphan status in parallel
with EMA review of a marketing authorization application and orphan status may be withdrawn at that stage if it no longer fulfills
the orphan criteria (for instance because in the meantime a new product was approved for the indication and no convincing data
are available to demonstrate a significant benefit over that product). Orphan medicinal product designation entitles a party to
financial incentives such as reduction of fees or fee waivers and ten years of market exclusivity is granted following marketing
authorization. During this period, the competent authorities may not accept or approve any similar medicinal product, unless it
offers a significant clinical benefit. This period may be redacted to six years if the orphan medicinal product designation criteria
are no longer met, including where it is shown that the product is sufficiently profitable not to justify maintenance of market
exclusivity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 17pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>United
States</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Standard
Procedure</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the United States, the FDA regulates drugs under the Federal Food, Drug, and Cosmetic Act of 1938 and its implementing regulations.
The process of obtaining regulatory approvals and the subsequent compliance with applicable federal, state, local and foreign
statutes and regulations requires the expenditure of substantial time and financial resources. Failure to comply with the applicable
U.S. requirements at any time during the product development process, approval process or after approval, may subject an applicant
to a variety of administrative or judicial sanctions, such as the FDA&rsquo;s refusal to approve pending NDAs, withdrawal of an
approval, imposition of a clinical hold, issuance of warning letters, product recalls, product seizures, total or partial suspension
of production or distribution, injunctions, fines, refusals of government contracts, restitution, disgorgement or civil or criminal
penalties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
process required by the FDA before a drug may be marketed in the United States generally involves the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="padding-right: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">completion
                                         of preclinical laboratory studies, animal studies and formulation studies in compliance
                                         with the FDA&rsquo;s good laboratory practice regulations;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">submission
                                         to the FDA of an IND, which must become effective before human clinical trials may begin;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">approval
by the institutional review board, or IRB, at each clinical site before each trial may be initiated;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="padding-right: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">performance
                                         of adequate and well-controlled human clinical trials in accordance with applicable IND
                                         and other clinical trial-related regulations, sometimes referred to as GCPs to establish
                                         the safety and clinical utility of the proposed product candidate for its proposed indication;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">submission
                                         to the FDA of a BLA or NDA;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">satisfactory
                                         completion of an FDA pre-approval inspection of the production facility or facilities
                                         where the product is produced to assess compliance with the FDA&rsquo;s cGMP requirements
                                         to assure that the facilities, methods and controls are adequate to preserve the product&rsquo;s
                                         identity, strength, quality, purity and potency;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">potential
                                         FDA audit of the preclinical and/or clinical trial sites that generated the data in support
                                         of the NDA; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FDA
                                         review and approval of the BLA or NDA prior to any commercial marketing or sale of the
                                         product in the United States.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Once
an approval is granted, the FDA may withdraw the approval if compliance with regulatory requirements and standards is not maintained
or if problems occur after the product reaches the market. Other potential consequences include, among other things:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="padding-right: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">restrictions
                                         on the marketing or manufacturing of the product, complete withdrawal of the product
                                         from the market or product recalls;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">fines,
                                         warning letters or holds on post-approval clinical trials;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="padding-right: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">refusal
                                         of the FDA to approve pending NDAs or supplements to approved NDAs, or suspension or
                                         revocation of product approvals;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">product
                                         seizure or detention, or refusal to permit the import or export of products; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">injunctions
                                         or the imposition of civil or criminal penalties.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: left; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: left; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 93 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->89<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: left; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Clinical
Trials</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clinical
trials involve the administration of the IND to human patients under the supervision of qualified investigators in accordance
with GCP requirements, which include the requirement that all research patients provide their informed consent in writing for
their participation in any clinical trial. Clinical trials are conducted under protocols detailing, among other things, the objectives
of the trial, the parameters to be used in monitoring safety and the effectiveness criteria to be evaluated. A protocol for each
clinical trial and any subsequent protocol amendments must be submitted to the FDA as part of the IND. In addition, an IRB at
each institution participating in the clinical trial must review and approve the plan for any clinical trial before it commences
at that institution. Information about certain clinical trials must be submitted within specific timeframes to the National Institutes
of Health for public dissemination on their website. Regulatory authorities, IRBs or the sponsor may suspend or terminate a clinical
trial at any time on various grounds, including a finding that the research patients are being exposed to an unacceptable health
risk.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Marketing
Approval</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Assuming successful
completion of the required clinical testing, the results of the preclinical studies and clinical trials, together with detailed
information relating to the product&rsquo;s chemistry, manufacture, controls, or CMC, and proposed labeling, among other things,
are submitted to the FDA as part of an NDA requesting approval to market the product for one or more indications. In most cases,
the submission of an NDA is subject to a substantial application user fee. Under the Prescription Drug User Fee Act guidelines
that are currently in effect, the FDA has a goal of ten months from the date of filing of a standard NDA for a new molecular entity
to review and act on the submission. This review typically takes twelve months from the date the NDA is submitted to the FDA because
the FDA has approximately two months to make a filing decision.</P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, under the Pediatric Research Equity Act of 2003<B><I>, </I></B>certain NDAs or supplements to an NDA must contain data
that are adequate to assess the safety and effectiveness of the drug for the claimed indications in all relevant pediatric subpopulations,
and to support dosing and administration for each pediatric subpopulation for which the product is safe and effective. The FDA
may, on its own initiative or at the request of the applicant, grant deferrals for submission of some or all pediatric data until
after approval of the product for use in adults, or full or partial waivers from the pediatric data requirements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
FDA conducts a preliminary review of all NDAs within the first 60 days after submission, before accepting them for filing, to
determine whether they are sufficiently complete to permit substantive review. The FDA may request additional information rather
than accept an NDA for filing. In this event, the application must be resubmitted with the additional information. The resubmitted
application is also subject to review before the FDA accepts it for filing. Once the submission is accepted for filing, the FDA
begins an in-depth substantive review. The FDA reviews an NDA to determine, among other things, whether the drug is safe and effective
and whether the facility in which it is manufactured, processed, packaged or held meets standards designed to assure the product&rsquo;s
continued safety, quality and purity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
FDA may refer an application for a novel drug to an advisory committee. An advisory committee is a panel of independent experts,
including clinicians and other scientific experts, that reviews, evaluates and provides a recommendation as to whether the application
should be approved and under what conditions. The FDA is not bound by the recommendations of an advisory committee, but it considers
such recommendations carefully when making decisions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
approving a BLA or NDA, the FDA typically will inspect the facility or facilities where the product is manufactured. The FDA will
not approve an application unless it determines that the manufacturing processes and facilities are in compliance with cGMP requirements
and adequate to assure consistent production of the product within required specifications. Additionally, before approving an
NDA, the FDA may inspect one or more clinical trial sites to assure compliance with GCP requirements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">After evaluating the
NDA and all related information, including the advisory committee recommendation, if any, and inspection reports regarding the
manufacturing facilities and clinical trial sites, the FDA may issue an approval letter, or, in some cases, a CR letter. A CR letter
generally contains a statement of specific conditions that must be met in order to secure final approval of the NDA and may require
additional clinical or preclinical testing in order for the FDA to reconsider the application. Even with submission of this additional
information, the FDA ultimately may decide that the application does not satisfy the regulatory criteria for approval. If and when
those conditions have been met to the FDA&rsquo;s satisfaction, the FDA will typically issue an approval letter. An approval letter
authorizes commercial marketing of the drug with specific prescribing information for specific indications.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Even if the FDA approves
a product, it may limit the approved indications for use of the product, require that contraindications, warnings or precautions
be included in the product labeling, require that post-approval studies, including Phase 4 clinical trials, be conducted to further
assess a drug&rsquo;s safety after approval, require testing and surveillance programs to monitor the product after commercialization,
or impose other conditions, including distribution and use restrictions or other risk management mechanisms under a REMS, which
can materially affect the potential market and profitability of the product. The FDA may prevent or limit further marketing of
a product based on the results of post-marketing studies or surveillance programs. After approval, some types of changes to the
approved product, such as adding new indications, manufacturing changes, and additional labeling claims, are subject to further
testing requirements and FDA review and approval.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 94 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->90<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Orphan
Drug Designation</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Orphan Drug Act of 1983, the FDA may designate a biologic product as an &ldquo;orphan drug&rdquo; if it is intended to treat
a rare disease or condition (generally meaning that it affects fewer than 200,000 individuals in the United States, or more in
cases in which there is no reasonable expectation that the cost of developing and making a biologic product available in the United
States for treatment of the disease or condition will be recovered from sales of the product).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a product with orphan status receives the first FDA approval for the disease or condition for which it has such designation, the
product is entitled to orphan product exclusivity, meaning that the FDA may not approve any other applications to market the same
drug or biologic product for the same indication for seven years, except in limited circumstances, such as a showing of clinical
superiority to the product with orphan exclusivity or if the party holding the exclusivity fails to assure the availability of
sufficient quantities of the drug to meet the needs of patients with the disease or condition for which the drug was designated.
Competitors, however, may receive approval of different products for the same indication for which the orphan product has exclusivity
or obtain approval for the same product but for a different indication for which the orphan product has exclusivity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Post-Approval
Requirements for the EU and United States</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
FDA and the relevant regulatory authorities in the EU strictly regulate marketing, labeling, advertising and promotion of products
that are placed on the market in their respective territories. Drugs may be promoted only for the approved indications and in
accordance with the provisions of the approved label. The regulatory authorities actively enforce the laws and regulations prohibiting
the promotion of off-label uses, and a company that is found to have improperly promoted off-label uses may be subject to significant
liability.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, drug manufacturers and other entities involved in the manufacture and distribution of approved drugs are required to
register their establishments with the relevant regulatory authorities, and are subject to periodic unannounced inspections by
them to confirm compliance with cGMP requirements. Changes to the manufacturing process are strictly regulated and often require
prior approval of the relevant regulatory authorities before being implemented. Regulations laid down by the FDA and the regulatory
authorities in the EU also require investigation and correction of any deviations from the requirements of cGMP and impose reporting
and documentation requirements upon the marketing approval holder and any third party manufacturers that the marketing approval
holder may decide to use.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Other
Healthcare Laws in the EU and United States</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The company will also
be subject to healthcare regulation and enforcement by the U.S. federal government and the states and governments in the EU and
any other countries in which the company conducts its business, including its research, and the marketing and distribution of its
product candidates and products once they have obtained an MA. Failure to comply with these laws, where applicable, can result
in the imposition of significant civil penalties, criminal penalties, exclusion from participating in health care programs, additional
reporting requirements and oversight if the company becomes subject to a corporate integrity agreement or similar agreement to
resolve allegations of non-compliance with these laws and other sanctions. The healthcare laws and regulations that may affect
the company&rsquo;s ability to operate in the United States include: the federal fraud and abuse laws, including the federal anti-kickback
and false claims laws; federal data privacy and security laws; and federal transparency laws related to payments and/or other transfers
of value made to physicians and other healthcare professionals and teaching hospitals. Many US states have similar laws and regulations
that may differ from each other and federal law in significant ways. Moreover, several US states have enacted legislation requiring
pharmaceutical manufacturers to, among other things, establish marketing compliance programs, file periodic reports with the state,
and make periodic public disclosures on sales and marketing activities, and prohibiting certain other sales and marketing practices.
Rules and legislation covering more or less the same subject matter as those in the United States apply to in countries in the
EU and to other countries. These can differ between jurisdictions and can sometimes result in lower or higher exposure in those
countries than in the United States. Where a product is sold in a number of countries compliance efforts can therefore be complicated.</P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Coverage
and Reimbursement in the EU and United States</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Sales of products
developed from the company&rsquo;s product candidates, if approved, will depend, in part, on the extent to which such products will be
covered by third party payors, such as government health care authorities, government health care programs, commercial insurance
and managed healthcare organizations. These third party payors are increasingly limiting coverage or reducing reimbursements for
medical products and services. In the United States, no uniform policy of coverage and reimbursement for products exists among
third party payors. Therefore, coverage and reimbursement for products can differ significantly from payor to payor. In addition,
the U.S. government, state legislatures and foreign governments have continued implementing cost-containment programs, including
price controls, restrictions on reimbursement and requirements for substitution of generic products.</P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Governments
influence the price of medicinal products in the EU through their pricing and reimbursement rules and control of national healthcare
systems that fund a large part of the cost of those products to consumers. Some jurisdictions operate positive and negative list
systems under which products may only be marketed once a reimbursement price has been agreed. To obtain reimbursement or pricing
approval, some of these countries may require the completion of clinical trials that compare the cost-effectiveness of a particular
product candidate to currently available therapies. Other Member States allow companies to fix their own prices for medicines,
but monitor and control company profits. The downward pressure on healthcare costs in general in the EU governments influence
the price of medicinal products through their pricing and reimbursement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 95 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->91<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The adoption of price
controls and cost-containment measures, and the adoption of more restrictive policies in jurisdictions with existing controls and
measures, could further limit the company&rsquo;s net revenue and results. Decreases in third party reimbursement for the company&rsquo;s product
candidates or a decision by a third party payor to not cover the company&rsquo;s product candidates could reduce physician usage of the
company&rsquo;s product candidates, once approved, and have a material adverse effect on the company&rsquo;s sales, results of operations and
financial condition.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Property,
Plant and Equipment</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The below table contains
information regarding existing or planned material tangible fixed assets owned or leased by us and our subsidiaries. We believe
that suitable additional or substitute space will be available as needed to accommodate any future expansion of our operations.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 25%; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0"><B>Location</B></TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0"><B>&nbsp;</B></TD>
    <TD STYLE="width: 22%; border-bottom: Black 1.5pt solid; text-align: left; vertical-align: top; font-family: Times New Roman, Times, Serif; padding-right: 0"><B>Tenure</B></TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0"><B>&nbsp;</B></TD>
    <TD STYLE="width: 26%; text-align: left; border-bottom: Black 1.5pt solid; vertical-align: top; font-family: Times New Roman, Times, Serif; padding-right: 0"><B>Principal use</B></TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0"><B>&nbsp;</B></TD>
    <TD STYLE="width: 24%; border-bottom: Black 1.5pt solid; text-align: left; vertical-align: top; font-family: Times New Roman, Times, Serif; padding-right: 0"><B>Size</B></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">55 Park Lane, Suite 14a,<BR>
 London W1K 1NA, <BR>
United Kingdom</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top; font-family: Times New Roman, Times, Serif; padding-right: 0">Annual Lease</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top; font-family: Times New Roman, Times, Serif; padding-right: 0">Principal Office</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top; font-family: Times New Roman, Times, Serif; padding-right: 0">652 square feet</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">420 Lexington Avenue <BR>Suite 2525 <BR>New York, United States</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top; font-family: Times New Roman, Times, Serif; padding-right: 0">Five-year Lease</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top; font-family: Times New Roman, Times, Serif; padding-right: 0">Principal Office</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top; font-family: Times New Roman, Times, Serif; padding-right: 0">3,011 square feet <BR></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">3805 Old Easton Road,<BR>
 Doylestown, PA, <BR>
United States</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top; font-family: Times New Roman, Times, Serif; padding-right: 0">Annual Lease</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top; font-family: Times New Roman, Times, Serif; padding-right: 0">Research &amp; Development Centre</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top; font-family: Times New Roman, Times, Serif; padding-right: 0">451 square feet</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 96 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->92<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="a_017"></A>MANAGEMENT</FONT></P>




<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DIRECTORS,
SENIOR MANAGEMENT AND EMPLOYEES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> The following table sets forth information
regarding our directors as of&nbsp;August 23, 2018. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0">Name</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0">Age</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0">Position</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 35%; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">Gabriele Marco Antonio Cerrone MBA&nbsp;(2)</TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 10%; text-align: center; font-family: Times New Roman, Times, Serif; padding-right: 0">45</TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 53%; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">Executive Chairman</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">Dr. Riccardo Dalla-Favera (1),(3)</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif; padding-right: 0">65</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">Non-Executive Director</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">Willy Simon&nbsp;(3)</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif; padding-right: 0">66</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">Non-Executive Director</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; vertical-align: top; font-family: Times New Roman, Times, Serif; padding-right: 0">Dr. Kunwar
    Shailubhai MBA (1),(2)</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top; font-family: Times New Roman, Times, Serif; padding-right: 0">60</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">Chief Executive Officer, Chief Scientific Officer and Executive Director</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">Leopoldo Zambeletti (1)(2)(3)</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif; padding-right: 0">49</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">Non-Executive Director</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0; font-family: Times New Roman, Times, Serif"><DIV STYLE="font: 1pt Times New Roman, Times, Serif; border-top: Black 1.5pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.3in; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remuneration Committee member</FONT></TD></TR>
</TABLE>


<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.3in; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nominating Committee member</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">(3)</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">
Audit Committee member</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> The following table sets forth information
regarding our senior managers as of&nbsp;August 23, 2018: </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 50%; font-weight: bold; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0">Name</TD><TD STYLE="width: 1%; font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 49%; font-weight: bold; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0">Position</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">Tiziano Lazzaretti</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">Chief Financial Officer</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">Fayez Hamzeh, MD, PhD</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">Senior Vice President, Clinical Development</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">Jules S. Jacob</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">Senior Director, CMC &amp; Non-Clinical Development</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">Dr. Evangeline Priya Eddy DABT</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">Senior Director, Safety and Toxicology</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">Dr. Vaseem A. Palejwala</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">Director, Non-Clinical Studies</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Gabriele
Marco Antonio Cerrone &ndash; <I>Executive Chairman</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Mr.
Gabriele Marco Antonio Cerrone, is the Founder of the company and has been its Executive Chairman since April 2017. Mr. Cerrone
has founded nine biotechnology companies in oncology, infectious diseases and molecular diagnostics, and has listed six of these
companies on Nasdaq and one on AIM. Mr. Cerrone co-founded Trovagene, Inc. a molecular diagnostic company and served as its co-chairman.
Mr. Cerrone was a co-founder and served as chairman of both Synergy Pharmaceuticals, Inc. and Callisto Pharmaceuticals, Inc.),
and was a director of and led the restructuring of Siga Technologies, Inc.). Mr. Cerrone co-founded FermaVir Pharmaceuticals,
Inc. and served as chairman until its merger in September 2007 with Inhibitex, Inc. Mr. Cerrone served as a director of Inhibitex,
Inc. until its US$2.5bn sale to Bristol Myer Squibb in 2012. Mr. Cerrone graduated from New York University&rsquo;s Stern School
of Business with a master in business administration (MBA).</FONT> </P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 97 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->93<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Dr.
Riccardo Dalla-Favera &ndash;  <I>Non-Executive Director</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Dr. Riccardo Dalla-Favera
currently serves as a Non-Executive Director of the company and is a leader in the field of molecular oncology and has made fundamental
contributions to the field of cancer, especially in the study of the molecular genetics of B cell malignancies. A faculty member
for more than 15 years, Dr. Dalla-Favera helped found and has led the Institute for Cancer Genetics at Columbia University since
1999. Dr. Dalla-Favera is the Percy and Joanne Uris Professor of Pathology and Professor of Genetics &amp; Development at the Columbia
University College of Physicians and Surgeons. Dr. Dalla-Favera is also a director of the Specialized Center for research on Lymphoma
at Columbia University funded by the Leukemia Lymphoma Society. Dr. Dalla-Favera joined Columbia University&rsquo;s College of
Physicians and Surgeons in the Department of Pathology in 1989. Dr. Dalla-Favera completed a fellowship at the National Cancer
Institute and was previously a faculty member at New York University School of Medicine. Dr. Dalla-Favera co-founded Therasis,
Inc. in 2007 and has since served as a director of that company. Dr. Dalla-Favera is currently serving as a member of the scientific
advisory board of Xigen SA. Dr. Dalla-Favera was a director of the Herbert Irving Comprehensive Cancer Centre from 2005 2011. Dr.
Dalla-Favera has served as the chair of the Scientific Advisory Board of the Yale Cancer Centre. Dr. Dalla-Favera served as the
co-chair of the National Centre Institute Program Review Group for Leukemia, Lymphoma and Myeloma and as a member of the boards
of the Scientific Counsellors of the National Institute of Environmental Health and the National Cancer Institute.</P>







<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Willy
Simon &ndash;  <I>Non-Executive Director</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Willy Jules Simon
has served as a Non-Executive Director of the company since November 2015. Mr. Simon has served as non-executive chairman of Bever
Holding B.V. a Dutch listed public company focused on real estate development since August 2007. Mr. Simon served as the Chief
Executive Officer of Fortis Investment Management from January 2000 to July 2002. Mr. Simon worked in banking at Kredietbank N.V.
from August 1975 to December 1983 and at Citibank London from January 1984 to December 1996 before serving as an executive member
of the board of Generale Bank NL from January 1997 to December 1999. From July 2004 until April 2012, he served as a non-executive
director of Redi &amp; Partners Ltd., a fund of funds. Mr. Simon was previously chairman of AIM-traded Velox3 plc (formerly 24/7
Gaming Group Holdings plc), a company focused on publishing and developing gaming software for the mobile gaming industry, from
April 2012 until April 2014. Mr. Simon was a director of Playlogic Entertainment Inc., a Nasdaq listed company focused on developing,
publishing, and selling interactive software games, from December 2003 to September 2011. Mr. Simon acted as chairman of Bank Oyens
&amp; van Eeghen from September 2002 to December 2004. Mr. Simon holds a law degree from the University of Louvain and a post-graduate
degree in European law and economics from Institut des Hautes Etudes Europ&eacute;ennes, Strasbourg.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></P>







<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Leopoldo
Zambeletti &ndash; <I>Non-Executive Director</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Mr. Zambeletti joined our board of directors on April 19, 2018. During a 19 year career as an investment
banker, Mr. Zambeletti led the European Healthcare Investment Banking team at JPMorgan for eight years from April 1999 to April
2007 before taking up the same position at Credit Suisse for a further five years from September 2012 to November 2012. Since 2013
he has been an independent strategic advisor to life science companies on merger and acquisitions, out-licensing deals and financing
strategy. He is a non-executive director of, Qardio Inc., Summit Therapeutics plc, Nogra Pharma Limited, Faron Pharmaceuticals
OY and DS Biopharma Limited. Mr. Zambeletti started his career at KPMG as an auditor. Mr. Zambeletti received a B.A. in Business
from Bocconi University in Milan, Italy. He serves as a trustee to Barts and the London Charity, which helps to fund the hospitals
of the Barts NHS Trust including St Bartholomew, the Royal London and the London Chest Hospitals. He is the founder of the cultural
initiative 5x5 Italy.</P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Dr.
Kunwar Shailubhai &ndash;  <I>Chief Executive Officer, Chief Scientific Officer and Executive Director</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Dr. Kunwar Shalilubhai
has served as Chief Executive Officer, Chief Scientific Officer and Executive Director of the company since <FONT STYLE="background-color: white">2008.
Since April, 2017, Dr.</FONT> Shailubhai has served as Chief Executive Officer of Rasna Therapeutics, Inc. Dr. Shailubhai was a
co-founder of Synergy Pharmaceuticals Inc. and served as Chief Scientific Officer from July 2008 to May 2017. From March 2004 until
July 2008, Dr. Shailubhai served as Senior Vice President, Drug Discovery of Synergy, which at that time was a subsidiary of Callisto
Pharmaceuticals, Inc. (&ldquo;Synergy DE&rdquo;). From May 2003 until March 2004, Dr. Shailubhai served as executive vice president,
R&amp;D of Synergy DE. From 2001 to April 2003, Dr. Shailubhai held the position of Vice President, Drug Discovery at Synergy DE
where he was chiefly responsible for the preclinical development of its GC-C agonist program for drugs to treat colon cancer and
GI inflammation. Between 1993 and 2000, he was with Monsanto Company, serving as group leader of the cancer chemoprevention group.
Dr. Shailubhai previously served as a senior staff fellow at the National Institutes of Health, and as an assistant professor at
the University of Maryland. Dr. Shailubhai received his Ph.D. in microbiology in 1984 from the University of Baroda, India, and
his MBA in 2001 from the University of Missouri, St. Louis.</P>







<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 98 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->94<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Tiziano
Lazzaretti &ndash;  <I>Chief Financial Officer</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Mr. Lazzaretti has
served as Chief Financial Officer of the company and Rasna Therapeutics, Inc., respectively, since March 2016. Mr. Lazzaretti has
extensive experience in the healthcare and pharmaceutical industries and joined the company from Pharmentis Srl, a spin-off from
Teva Ratiopharm, where he served as group finance director from 2011 to 2016. Mr. Lazzaretti was executive director at Alliance
Boots Healthcare, an international pharmacy-led health and beauty group. Mr. Lazzaretti held senior positions at SNIA Spa, Accenture,
and Fiat Group. Mr. Lazzaretti received his bachelor of science (BSc Hons) in accounting and finance from the University of Turin,
Italy, was awarded a master in business administration from Bocconi University, Milan and studied corporate finance at the London
Business School.</P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fayez
Hamzeh, MD, Ph.D. &ndash; <I>Senior Vice President, Clinical Development</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Dr. Fayez Hamzeh has
served as Sr. Vice President for Clinical Development since February 2018. Before joining us, Dr. Hamzeh served as Head of Clinical
Trials Planning and Implementation Strategy of Immunology and Infectious Diseases at Roche Innovation Center, New York from 2015
to 2017. During this period Dr. Hamzeh focus was Phase 1 and Phase 2 clinical trials in immunology, hepatology and infectious
diseases. Dr. Hamzeh served as a Group Medical Director and Head of Infectious Disease, Transplantation and Hepatology at Genentech
Inc, South San Francisco from 2009 through 2011 and 2013 through 2015 where he was responsible for glioblastoma and avastin pan
tumor indications. Dr. Hamzeh served as Sr. Medical Director of Hepatology, Transplantation and Infectious Diseases at Roche Pharmaceutical,
Nutley NJ from 2003 through 2009. During this period, Dr. Hamzeh was responsible for clinical trials in virology focusing on anti-HIV,
anti-influenza, anti-cytomegalovirus, anti-HCV and anti-HBV drugs. Prior to joining the industry in 2003, Dr. Hamzeh served as
an Assistant Professor of Medicine and Pharmacology and Molecular Therapeutics at Johns Hopkins School of Medicine, Baltimore MD.
During his academic and industry career, Dr. Hamzeh served on many National Institute of Health scientific steering committees
including, AIDS Clinical Trials Group, AIDS Malignancy Consortium, Hepatitis-C (HALT-C) Scientific Steering Committee. Dr. Hamzeh
received his MD degree in 1981 from the University of Jordan Medical School and his PhD from Johns Hopkins School of Medicine in
1990.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Jules
S. Jacob &ndash;  <I>Senior Director, CMC &amp; Non-Clinical Development</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Mr. Jules Jacob has
served as Senior Director of CMC and Non-Clinical Development of the company and Rasna Therapeutics, Inc., respectively, since
July 2017 and has over 25 years of drug development experience. Previously, Mr. Jacob was senior director of product development
at Aprecia Pharmaceuticals Company, a drug delivery technology platform company, from March 2009 to July 2017, where he led the
development of Spritam&reg;, the first FDA-approved dosage form manufactured using 3-dimensional printing, and other 505(b)(2)
pipeline products. Mr. Jacob was director of formulation development at Panacos Pharmaceuticals Inc., a drug company focused on
human immunodeficiency virus, or HIV, and other major human viral diseases, from March 2007 to December 2008, where he worked on
the development of first-in-class maturation inhibitors for the treatment of HIV. Mr. Jacob was a founding scientist, director
of R&amp;D and director of technology development at Spherics, Inc., a pharmaceutical company that engaged in developing and manufacturing
oral pharmaceutical products for CNS conditions, GI disorders, and cancer, from February 2000 to February 2007. Mr. Jacob worked
on the development of bioadhesive dosage forms for treatment of CNS disorders, through the 505(b)(2) regulatory pathway at Spherics
Inc. Mr. Jacob completed his undergraduate degree and graduate education in biological and medical sciences at Brown University
and has an active visiting faculty appointment in the Department of Molecular Pharmacology, Physiology and Biotechnology at Brown
University.</P>







<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Dr.
Evangeline Priya Eddy &ndash;  <I>Senior Director, Safety &amp; Toxicology</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Dr. Eddy has served
as Senior Director, Safety &amp; Toxicology of the company and of Rasna Therapeutics, Inc., respectively, since January 2017 and
has over 20 years of experience in drug discovery and development. Dr. Eddy served as senior director, toxicology and safety pharmacology
at Synergy Pharmaceuticals Inc. from September 2013 to January 2017, where she was responsible for toxicology, ADME/PK and safety
pharmacology studies. Dr. Eddy contributed to the NDA for Trulance&reg; and her work at Synergy also included the development of
a delayed release formulation for dolcanatide, as well as involvement in the supply of API for GLP and feasibility studies. Dr.
Eddy worked at Endo Pharmaceuticals as an associate director, toxicology and safety pharmacology from February 2011 to October
2012 and as senior director, preclinical development at Zelos Therapeutics from April 2008 to February 2011. Dr. Eddy worked at
Millennium Pharmaceuticals (now a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited) 2000 to 2003 and at SmithKline
Beecham Pharmaceuticals (now GlaxoSmithKline) from August 1992 to February 1999 in the areas of drug discovery and development
including early clinical development. Dr. Eddy received her Ph.D. degree in biochemistry from Osmania University, Hyderabad India
and is a board-certified toxicologist of the American Board of Toxicology. Before joining the pharmaceutical industry, Dr. Eddy
worked at Case Western Reserve University in Cleveland, OH in the area of chemical carcinogenesis and environmental health sciences.</P>







<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 99 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->95<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Dr.
Vaseem A. Palejwala &ndash;  <I>Director, Non-Clinical Studies</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Dr. Palejwala has
served as Director, Non-Clinical Studies of the company since January 2017 and has 18 years of experience in drug discovery and
development. Dr. Palejwala also currently serves as director of discovery and preclinical research at Rasna Therapeutics, Inc.
From January 2015 to January 2017, Dr. Palejwala served as director of discovery and preclinical research, and from December 2012
to December 2014 served as associate director of discovery and preclinical research, at Synergy Pharmaceuticals Inc. where he actively
contributed to establishing GI tract-related preclinical animal models for testing the efficacy and validating the mechanism of
action for both plecanatide and dolcanatide. Dr. Palejwala also actively participated in preparation of the nonclinical pharmacology
section of the NDA for Trulance&reg;. From 2001 to 2012, Dr. Palejwala served as discovery scientist/manager at Sanofi S.A., <I>a
</I>multinational pharmaceutical company, where he advanced both small molecule and biologic programs in immunology, inflammation,
oncology, CNS and metabolic disorders and also contributed to establishing and managing high-throughput gene expression profiling
platform capabilities. Dr. Palejwala holds a degree in microbiology and chemistry from Bombay University, as well as a master of
science degree in microbiology and a Ph.D. in microbiology from the Maharaja Sayajirao University of Baroda.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign
Private Issuer Exemption</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Corporate
Governance Practices</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are an FPI as defined by the SEC. As a result, in accordance with Nasdaq listing requirements, we may rely on home country governance
requirements and certain exemptions thereunder rather than complying with Nasdaq corporate governance standards. While we voluntarily
follow most Nasdaq corporate governance rules, we may choose to take advantage of the following limited exemptions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 20.25pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exemption
                                         from filing quarterly reports on Form 10-Q containing unaudited financial and other specified
                                         information or current reports on Form 8-K upon the occurrence of specified significant
                                         events.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 20.25pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exemption
                                         from Section 16 rules requiring insiders to file public reports of their stock ownership
                                         and trading activities and liability for insiders who profit from trades in a short period
                                         of time, which will provide less data in this regard than shareholders of U.S. companies
                                         that are subject to the Exchange Act.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 20.25pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exemption
                                         from the Nasdaq requirement requiring disclosure of any waivers of the code of business
                                         conduct and ethics for directors and officers.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 20.25pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exemption
from the requirement that our board of directors have a remuneration committee that is composed entirely of independent directors
with a written charter addressing the committee&rsquo;s purpose and responsibilities.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 20.25pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exemption
                                         from the requirement to have independent director oversight of director nominations.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 100 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->96<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
intend to follow U.K. corporate governance practices in lieu of Nasdaq corporate governance requirements as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 20.25pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                         do not intend to follow Nasdaq Rule 5620(c) regarding quorum requirements applicable
                                         to meetings of shareholders. Such quorum requirements are not required under English
                                         law. In accordance with generally accepted business practice, our Articles will provide
                                         alternative quorum requirements that are generally applicable to meetings of shareholders.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 20.25pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                         do not intend to follow Nasdaq Rule 5605(b)(2), which requires that independent directors
                                         regularly meet in executive sessions where only independent directors are present. Our
                                         independent directors may choose to meet in executive sessions at their discretion.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
we may rely on certain home country corporate governance practices, we must comply with Nasdaq&rsquo;s Notification of Noncompliance
requirement (Nasdaq Rule 5625) and the Voting Rights requirement (Nasdaq Rule 5640). Further, we must have an audit committee
that satisfies Nasdaq Rule 5605(c)(3), which addresses audit committee responsibilities and authority and requires that the audit
committee consist of members who meet the independence requirements of Nasdaq Rule 5605(c)(2)(A)(ii).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
intend to take all actions necessary for us to maintain compliance as an FPI under the applicable corporate governance requirements
of the Sarbanes-Oxley Act, the rules adopted by the SEC and Nasdaq listing rules. Accordingly, our shareholders will not have
the same protections afforded to shareholders of companies that are subject to all of the corporate governance requirements of
Nasdaq. For an overview of our corporate governance principles, see the section titled &ldquo;Description of Share Capital and
Articles of Association&mdash;Differences in Corporate Law.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Composition
of Our Board of Directors</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors is currently composed of four members. Our board of directors has determined that, of our four directors, none
have a relationship that would interfere with the exercise of independent judgment in carrying out the responsibilities of two
of the directors, Mr. Dalla-Favera and Mr. Simon, and that each of these directors is &ldquo;independent&rdquo; as that term is
defined under Nasdaq rules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> In accordance
with our Articles, each of our directors for whom it is the third annual general meeting following the annual general meeting
at which they were elected or last re-elected, or who was appointed by the board since the previous annual general meeting, shall
retire from office but shall be eligible to stand for re-election. See &ldquo;Description of Share Capital and Articles of Association&mdash;Articles
of Association&mdash;Board of Directors.&rdquo; </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Committees
of Our Board of Directors</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors has three standing committees: an audit committee, a remuneration committee and a nominating committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit
Committee</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
audit committee, which consists of Dr. Dalla-Favera, Mr. Zambeletti and Mr. Simon, assists the board of directors in overseeing
our accounting and financial reporting processes. Mr. Simon serves as chairman of the audit committee. The audit committee consists
exclusively of members of our board who are financially literate, and Mr. Simon is considered an &ldquo;audit committee financial
expert&rdquo; as defined by applicable SEC rules and has the requisite financial sophistication as defined under the applicable
Nasdaq rules and regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board has determined that all of the members of the audit committee satisfy the &ldquo;independence&rdquo; requirements set forth
in Rule 10A-3 under the Exchange Act. The audit committee will be governed by a charter that complies with Nasdaq rules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
audit committee&rsquo;s responsibilities include:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 20.4pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">recommending
                                         the appointment of the independent auditor to the general meeting of shareholders;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 20.4pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         appointment, compensation, retention and oversight of any accounting firm engaged for
                                         the purpose of preparing or issuing an audit report or performing other audit services;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 20.4pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">pre-approving
                                         the audit services and non-audit services to be provided by our independent auditor before
                                         the auditor is engaged to render such services;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 101 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->97<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 20.4pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">evaluating
                                         the independent auditor&rsquo;s qualifications, performance and independence, and presenting
                                         its conclusions to the full board of directors on at least an annual basis;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 20.4pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
                                         and discussing with management and our independent registered public accounting firm
                                         our financial statements and our financial reporting process; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 20.4pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing,
                                         approving or ratifying any related party transactions.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remuneration
Committee</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
remuneration committee consists of Dr. Dalla-Favera, Mr. Zambeletti and Mr. Simon. Dr. Dalla-Favera serves as chairman of the
remuneration committee. Under SEC and Nasdaq rules, there are heightened independence standards for members of the remuneration
committee, including a prohibition against the receipt of any compensation from us other than standard board member fees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
remuneration committee&rsquo;s responsibilities include:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 20.4pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">identifying,
                                         reviewing and proposing policies relevant to the compensation and benefits of our directors
                                         and executive officers;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 20.4pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">evaluating
                                         each executive officer&rsquo;s performance in light of such policies and reporting to
                                         the board; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 20.4pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">overseeing
                                         and administering our employee share option scheme or equity incentive plans in operation
                                         from time to time.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nominating
Committee</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The nominating committee
consists of Mr. Cerrone, Mr. Simon and Mr. Zambeletti. Mr. Zambeletti serves as chairman of the nominating committee. The nominating
committee&rsquo;s responsibilities include:</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 20.4pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">drawing
                                         up selection criteria and appointment procedures for directors;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 20.4pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">recommending
                                         nominees for election to our board of directors and its corresponding committees;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 20.4pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">assessing
                                         the functioning of individual members of our board of directors and executive officers
                                         and reporting the results of such assessment to the board of directors; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 20.4pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">developing
                                         corporate governance guidelines.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Code
of Business Conduct and Ethics</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Prior to effectiveness
of this registration statement, we plan to adopt a Code of Business Conduct and Ethics applicable to our employees, executive officers
and directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Compensation of Executive Officers and
Directors</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">For the year ended
December 31, 2017, the aggregate compensation accrued or paid to the members of our board of directors and our executive officers
for services in all capacities was $0.2 million.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Executive Director Employment Agreement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Dr. Kunwar Shailubhai</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We entered into an
employment agreement with Dr. Kunwar Shailubhai in May 2017. This agreement entitles Dr. Shailubhai to receive an initial annual
base salary of $300,000 per year. Dr. Shailubhai is eligible to receive an annual bonus of up to 35% of his base salary, such bonus
amount to be determined in our sole discretion. Dr. Shailubhai is also entitled to the same fringe benefits as we provide to our
other executives from time to time and is eligible to receive employee share incentives. The vesting of any unvested employee share
incentives held by Dr. Shailubhai will accelerate in the event his employment is terminated without cause (as such term is defined
in his employment agreement), or if he resigns for good reason (as such term is defined in his employment agreement) and, in each
case, such termination is upon the consummation of or within 12 months following a change of control of the company. If Dr. Shailubhai&rsquo;s
employment with the company is terminated without cause, or if he resigns for good reason, Dr. Shailubhai will also be entitled
to receive severance equal to continuation of his base salary as then currently in effect for 12 months following his date of termination
and will be eligible for reimbursement for medical coverage premiums for up to the same period. Dr. Shailubhai, his spouse and
eligible dependents are entitled to stay on our health insurance plans for a period of 12 months following his termination for
any reason. Dr. Shailubhai&rsquo;s severance benefits are conditioned on, among other things, his execution of our standard separation
agreement and a general release of claims in our favor.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 102 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->98<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
agreement provides that Dr. Shailubhai&rsquo;s employment with us is at-will. If required by the company, the agreement further
provides that Dr. Shailubhai will resign from his position on our board of directors effective as of the date of his termination
for any reason. The agreement further contains a six-month non-competition covenant and a 12-month non-solicitation covenant by
Dr. Shailubhai.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Executive
Director Service Contracts</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
remuneration of our non-executive directors is determined by our board as a whole, based on a review of current practices in other
companies. We intend to enter into service contracts with our directors for their services or amend and restate any prior service
contracts in place prior to, or as soon as practicable, following the filing of this registration statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Employees</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As of December 31,
2017 and 2016, we had 5&nbsp;and 9 employees, respectively. All of our employees were based in the United Kingdom, except that,
as of December 31, 2017, we had 3 employees based outside of the United Kingdom in the US. All of our employees were engaged in
either administrative or R&amp;D functions. None of our employees are covered by a collective bargaining agreement.</P>









<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Insurance
and Indemnification</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the extent permitted by the Companies Act, we are empowered to indemnify our directors against any liability they incur by reason
of their directorship. We maintain directors&rsquo; and officers&rsquo; insurance to insure such persons against certain liabilities.
We expect to enter into a deed of indemnity with each of our directors and executive officers prior to, or as soon as practicable,
following the filing of this registration statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to such indemnification, we provide our directors and executive officers with directors&rsquo; and officers&rsquo; liability
insurance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insofar
as indemnification of liabilities arising under the Securities Act may be permitted to our board of directors, executive officers,
or persons controlling us pursuant to the foregoing provisions, we have been informed that, in the opinion of the SEC, such indemnification
is against public policy as expressed in the Securities Act and is therefore unenforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Compensation<SUP></SUP></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Total
Compensation for the Chairman and Non-Executive Directors:</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below sets out the total remuneration received by the Chairman and the Non-Executive Directors for the year ended December
31, 2017.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid; padding-right: 0"> Name </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid; padding-right: 0"> Position </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-right: 0"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid; padding-right: 0"> Fees
    earned or paid in cash <BR> ($) </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-right: 0"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid; padding-right: 0"> Options
    awarded <BR> ($) </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-right: 0"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid; padding-right: 0"> Total
    <BR> ($) </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 32%; font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 0"> Gabriele Marco Antonio
    Cerrone </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="width: 31%; font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 0"> Chairman </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 0"><P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif"> 86,262 </P>


</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 0"> - </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 0"> 86,262 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 0"> Riccardo Dalla-Favera </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 0"> Non &ndash; Executive Director </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 0"> 25,750 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 0"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 0"> 25,750 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 0"> Willy Simon </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 0"> Non &ndash; Executive Director </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 0"> 48,925 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 0"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 0"> 48,925 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0"></TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0; font-family: Times New Roman, Times, Serif"><DIV STYLE="font: 1pt Times New Roman, Times, Serif; border-top: Black 1.5pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.3in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         amounts have been translated into U.S. dollars from Pounds Sterling based upon the exchange
                                         rate as certified by the Federal Reserve Bank of New York for customs purposes as of
                                         December 31, 2017. These translations are merely for the convenience of the reader and
                                         should not be construed as representations that the Pounds Sterling amounts actually
                                         represent such U.S. dollar amounts or could be converted into U.S. dollars at the rate
                                         indicated.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.3in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
                                         the fair value of incentive stock options granted during the year to December 31, 2017
                                         using the Black-Scholes model for computing stock-based compensation expense as of the
                                         date of grant.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 103 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->99<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Compensation
of Executive Directors and Senior Managers</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below sets the remuneration of each of the Executive Directors and Senior Managers for the financial year ended December
31, 2017.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid; padding-right: 0">Name</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-right: 0">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid; padding-right: 0">Position</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-right: 0">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid; padding-right: 0">Fees earned or paid in cash <BR> ($)</TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-right: 0">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid; padding-right: 0">Options awarded <BR> ($)</TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-right: 0">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid; padding-right: 0">Total <BR> ($)</TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 32%; font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 0">Kunwar Shailubhai</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 31%; font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 0">Executive Director</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0">&nbsp;</TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 0">310,847</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0">&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0">&nbsp;</TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 0">309,078</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0">&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0">&nbsp;</TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 0">619,915</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 0">Tiziano Lazzaretti</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 0">Chief Financial Officer</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 0">135,151</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 0">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 0">135,151</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <B>The Tiziana Life Sciences plc Employee Share Option Plan
with Non-Employee Sub-Plan and US Sub-Plan </B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <B>&nbsp;</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> The Tiziana Life
Sciences plc Employee Share Option Plan with Non-Employee Sub-Plan and US Sub-Plan , or the 2016 Plan, was adopted by the Board
on March 23, 2016 and approved by shareholders on June 30, 2016 and allows for the grant of options to eligible service providers.
The material terms of the 2016 Plan are summarized below. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Eligibility
and Administration</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> Our employees,
consultants and directors, and employees and consultants of our subsidiaries are eligible to receive options under the 2016 Plan.
The 2016 Plan is administered by our board of directors, which may delegate its duties and responsibilities to one or more committees
of our directors and/or officers (referred to collectively as the plan administrator below), subject to the limitations imposed
under the 2016 Plan, stock exchange rules and other applicable laws. The plan administrator has the authority to take all actions
and make all determinations under the 2016 Plan, to interpret the 2016 Plan and option agreements and to adopt, amend and repeal
rules for the administration of the 2016 Plan as it deems advisable. The plan administrator also has the authority to determine
which eligible service providers receive options, to grant options and to set the terms and conditions of all options granted
under the 2016 Plan, including any vesting and vesting acceleration provisions, subject to the conditions and limitations in the
2016 Plan. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <I>Shares Available for Options</I> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <I>&nbsp;</I> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> An aggregate of
10% of the company&rsquo;s ordinary share capital from time to time may be placed under options granted under the 2016 Plan. Shares
issued to satisfy the exercise of options granted under the 2016 Plan may be newly issued shares or shares purchased on the open
market </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> If an option granted
under the 2016 Plan, expires, lapses or is terminated, exchanged for cash, surrendered, canceled without having been fully exercised
or forfeited, any unused shares subject to the option will, as applicable, become or again be available for new grants under the
2016 Plan. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> <I>Options </I> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <I>&nbsp;</I> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> The 2016 Plan
provides for the grant of options. All options granted under the 2016 Plan will be set forth in option agreements, which will
detail the terms and conditions of the options. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 104 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->100<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> Options provide
for the purchase of our ordinary shares in the future at an exercise price set on the grant date. The plan administrator will
determine the number of shares covered by each option, the exercise price of each option and the conditions and limitations applicable
to the exercise of each option </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> If a holder of
options dies, options may be exercised by the personal representative with 12 months following death in respect of all or such
proportion of the option as the plan administrator may specify to take account of the extent to which any exercise conditions
have been achieved at the relevant date. If a holder of options leaves as a good leaver or the plan administrator allows, options
may be exercised within 90 days in respect of all or such proportion of the option as the plan administrator may specify to take
account of the extent to which any exercise conditions have been achieved at the relevant date </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <I>Exercise Conditions</I> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <I>&nbsp;</I> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> The plan administrator
may specify one or more appropriate exercise conditions that must be satisfied before options may be exercised. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <I>Change of Control and Variation of Share Capital</I> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <I>&nbsp;</I> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> In the event of
a change of control, the plan administrator may specify whether all or a proportion of options will be exercisable to take account
of the extent to which any exercise conditions have been achieved at the relevant date. Alternatively, holders of options may
agree to accept an offer to exchange options for options to acquire shares in an acquiring company. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> If there is a
variation of our ordinary shares the plan administrator may adjust the number of shares under options and/or the exercise price. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Plan
Amendment and Termination</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 7pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> Our board of directors
may amend the 2016 Plan at any time; however, the provisions governing eligibility requirements, equity dilution, the basis for
determining the rights of holders of options and the adjustment of options cannot be altered to the advantage of existing or new
holders of options without the prior approval of our shareholders in general meeting. No options may be granted under the 2016
Plan after the tenth anniversary of the date of adoption by our board of directors. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> <I>&nbsp;</I> </P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 105 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->101<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <I>Transferability </I> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <I>&nbsp;</I> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> Options granted
under the 2016 Plan are generally non-transferrable, except on death. With regard to tax withholding and exercise price obligations
arising in connection with the exercise of options under the 2016 Plan, the plan administrator may, in its discretion, accept
cash, wire transfer or cheque,<I>&nbsp;</I> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <I>Non-Employee Sub-Plan </I> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <I>&nbsp;</I> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 14.2pt"> Under the Non-Employee
Sub-Plan, options may be granted to advisers, consultants and non-executive directors on terms comparable to those described above. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 14.2pt"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <I>US Sub-Plan</I> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 14.2pt"> The US Sub-Plan
permits the grant of options to employees, directors and consultants who are US residents and US taxpayers, including potentially
tax efficient Incentive Stock Options (as defined in Section 422 of the Internal Revenue Code of 1986, as amended). A maximum
of 9,233,392 ordinary shares may be issued under the US Sub-Plan (which number shall be the maximum number that may be granted
as Incentive Stock Options). <I>&nbsp;</I> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> <I>&nbsp;</I> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> The following
table summarizes: (i) the outstanding number of options and awards under the equity incentive plans; and (ii) the number of ordinary
shares granted to directors, executive officers, and non-executive directors, as of August 23, 2018: </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 6pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 7pt Times New Roman, Times, Serif"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif">Name</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif">Ordinary Shares</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif">Ordinary Shares Underlying Options</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif">Exercise Price Per Ordinary Share (&pound;)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif">Grant Date</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif">Expiration Date</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 40%; text-align: left; font-family: Times New Roman, Times, Serif">Gabriele Cerrone</TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif">1,200,000</TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif">0.15</TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 11%; text-align: center; font-family: Times New Roman, Times, Serif">25/06/2014</TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 11%; text-align: center; font-family: Times New Roman, Times, Serif">25/06/2024</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">2,000,000</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">0.35</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">25/06/2014</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">25/06/2024</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">3,259,403</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">1.50</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">09/06/2016</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">09/06/2026</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">550,000</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">0.8175</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">30/04/2018</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">30/04/2028</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">Riccardo Dalla-Favera</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">320,000</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">0.15</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">25/06/2014</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">25/06/2024</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">50,000</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">0.35</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">25/06/2014</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">25/06/2024</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">50,000</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">0.50</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">25/06/2014</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">25/06/2024</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">Willy Simon</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">Kunwar Shailubhai</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">300,000</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">0.50</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">25/06/2014</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">25/06/2024</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">400,000</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">1.595</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">30/08/2017</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">30/08/2027</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">2,500,000</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">0.8175</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">30/04/2018</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">30/04/2028</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">4,000,000</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">0.8175</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">30/04/2018</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">30/04/2028</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">Leopoldo Zambeletti</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">550,000</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">0.8175</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">30/04/2018</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">30/04/2028</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">Tiziano Lazzaretti</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">200,000</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">1.26</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">23/03/2016</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">23/03/2026</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">100,000</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">1.86</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">05/11/2016</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">05/11/2026</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">Fayez Hamzeh</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">600,000</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">0.8175</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">30/04/2018</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">30/04/2028</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">Jules Jacob</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">50,000</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">1.595</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">30/08/2017</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">30/08/2027</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">Evangeline Priya-Eddy</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">50,000</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">1.595</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">30/08/2017</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">30/08/2027</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">Vasteem Palejwala</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">40,000</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">1.595</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">30/08/2017</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">30/08/2027</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 6pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Non-Employee
Directors Remuneration</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 6pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The following table
sets forth the remuneration paid during the year ended December 31, 2017 to the current non-employee directors, all of which was
in the form of annual fees:</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 6pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif">Name</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif">Annual Fees ($)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 88%; text-align: left; text-indent: -12pt; padding-left: 12pt; font-family: Times New Roman, Times, Serif">Willy Simon</TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif">48,925</TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -12pt; padding-left: 12pt; font-family: Times New Roman, Times, Serif">Riccardo Dalla-Favera</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">25,750</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -12pt; padding-left: 12pt; font-family: Times New Roman, Times, Serif">Leopoldo Zambeletti</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">-</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -12pt; padding-left: 12pt; font-family: Times New Roman, Times, Serif">Gabriele Marco Antonio Cerrone</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">86,262</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 6pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Non-Employee
Director Service Contracts</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
remuneration of the non-executive directors is determined by our board as a whole, based on a review of current practices in other
companies. We have entered into service contracts with our directors for their services, which are subject to a three-month termination
period. There are no arrangements under which any non-executive director is entitled to receive compensation upon the early termination
of his appointment.</FONT></P>


<!-- Field: Page; Sequence: 106 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->102<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;&nbsp;</P>

<P STYLE="margin: 0; font-family: Times New Roman, Times, Serif"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_018"></A>RELATED
PARTY TRANSACTIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The following is a
description of related party transactions we have entered into with the beneficial owners of 3% or more of our ordinary shares,
which are our only voting securities, and senior management and members of our board of directors, for the three year period ended
December 31, 2017.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Indemnity Agreements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We have entered into
deeds of indemnity with each of our directors and we expect to enter into a new deed of indemnity with each of our directors and
executive officers in connection with this offering. See &ldquo;Management&mdash;Insurance and Indemnification.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Related Person Transaction Policy</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our board of directors
has adopted a written related person transaction policy, to be effective immediately upon the effectiveness of the registration
statement of which this prospectus forms a part, setting forth the policies and procedures for the review and approval or ratification
of related person transactions. This policy will cover, any transaction or proposed transactions between us and a related person
that are material to us or the related person, including without limitation, purchases of goods or services by or from the related
person or entities in which the related person has a material interest, indebtedness, guarantees of indebtedness and employment
by us of a related person. In reviewing and approving any such transactions, our audit and risk committee is tasked to consider
all relevant facts and circumstances, including, but not limited to, whether the transaction is on terms comparable to those that
could be obtained in an arm&rsquo;s length transaction and the extent of the related person&rsquo;s interest in the transaction.
All of the transactions described in this section occurred prior to the adoption of this policy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="margin: 0; font-family: Times New Roman, Times, Serif"></P>

<!-- Field: Page; Sequence: 107 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->103<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; font-family: Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B><A NAME="a_019"></A>PRINCIPAL
SHAREHOLDERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth information relating to the beneficial ownership of our ordinary shares as of December 31, 2017 by:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 30px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
    person, or group of affiliated persons, known by us to own beneficially 5% or more of our outstanding ordinary shares; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -22.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 30px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
    member of our board of directors and each of our executive officers.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> The number of
ordinary shares beneficially owned by each entity, person, board member, or executive officer is determined in accordance with
the rules of the SEC, and the information is not necessarily indicative of beneficial ownership for any other purpose. Under such
rules, beneficial ownership includes any ordinary shares over which the individual has sole or shared voting power or investment
power as well as any ordinary shares that the individual has the right to acquire within 60 days of August 23, 2018 through the
exercise of any option, warrant or other right. Except as otherwise indicated, and subject to applicable community property laws,
the persons named in the table have sole voting and investment power with respect to all ordinary shares held by that person. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> The percentage
of ordinary shares beneficially owned before this offering is computed on the basis of 126,904,285 ordinary shares outstanding
as of August 23, 2018. Ordinary shares that a person has the right to acquire within 60 days of August 23, 2018 are deemed outstanding
for purposes of computing the percentage ownership of the person holding such rights, but are not deemed outstanding for purposes
of computing the percentage ownership of any other person, except with respect to the percentage ownership of all board members
and executive officers as a group. Unless otherwise indicated below, the address for each beneficial owner listed is Tiziana Life
Sciences plc, 3<SUP>rd</SUP> Floor, 11-12 St James&rsquo;s Square, London SW1 4LB. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"> &nbsp; </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> Number of Ordinary Shares
    Beneficially Owned </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> &nbsp; </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> Percentage of <BR> Ordinary
    Shares <BR> Beneficially Owned </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid"> Name and address of beneficial owner </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> Before <BR> Offering </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> &nbsp; </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> After <BR> Offering </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> &nbsp; </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> Before Offering </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> &nbsp; </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> After <BR> Offering </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD> &nbsp; </TD><TD> &nbsp; </TD>
    <TD COLSPAN="2"> &nbsp; </TD><TD> &nbsp; </TD><TD> &nbsp; </TD>
    <TD COLSPAN="2"> &nbsp; </TD><TD> &nbsp; </TD><TD> &nbsp; </TD>
    <TD COLSPAN="2"> &nbsp; </TD><TD> &nbsp; </TD><TD> &nbsp; </TD>
    <TD COLSPAN="2"> &nbsp; </TD><TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold"> 5% or Greater Shareholders: </TD><TD> &nbsp; </TD>
    <TD COLSPAN="2"> &nbsp; </TD><TD> &nbsp; </TD><TD> &nbsp; </TD>
    <TD COLSPAN="2"> &nbsp; </TD><TD> &nbsp; </TD><TD> &nbsp; </TD>
    <TD COLSPAN="2"> &nbsp; </TD><TD> &nbsp; </TD><TD> &nbsp; </TD>
    <TD COLSPAN="2"> &nbsp; </TD><TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gabriele Cerrone<SUP>(1)</SUP></FONT> </TD><TD STYLE="width: 1%"> &nbsp; </TD>
    <TD STYLE="width: 1%; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; text-align: right"> 64,160,170 </TD><TD STYLE="width: 1%; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%"> &nbsp; </TD>
    <TD STYLE="width: 1%; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; text-align: right"> 64,160,170 </TD><TD STYLE="width: 1%; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%"> &nbsp; </TD>
    <TD STYLE="width: 1%; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; text-align: right"> 50.56 </TD><TD STYLE="width: 1%; text-align: left"> % </TD><TD STYLE="width: 1%"> &nbsp; </TD>
    <TD STYLE="width: 1%; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; text-align: right"> 50.56 </TD><TD STYLE="width: 1%; text-align: left"> % </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &nbsp; </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &nbsp; </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &nbsp; </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &nbsp; </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left"> Executive Officers and Directors: </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &nbsp; </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &nbsp; </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &nbsp; </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &nbsp; </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gabriele Cerrone<SUP>(1)</SUP></FONT> </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 64,160,170 </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 64,160,170 </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 50.56 </TD><TD STYLE="text-align: left"> % </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 50.56 </TD><TD STYLE="text-align: left"> % </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"> Riccardo Dalla-Favera </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> - </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> - </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> - </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> - </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"> Willy Simon </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> - </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> - </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> - </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> - </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"> Leopoldo Zambeletti </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> - </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> - </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> - </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> - </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"> Kunwar Shailubhai </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 5,000 </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 5,000 </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;*&nbsp;</FONT> </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;*</FONT> </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"> Tiziano Lazzaretti </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 2,000 </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 2,000 </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;*&nbsp;</FONT> </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;*</FONT> </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicates
beneficial ownership of less than 1% of the total outstanding ordinary shares.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>(1)</SUP></FONT> </TD><TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Mr.
                                         Gabriele Cerrone is the ultimate beneficial owner of ordinary shares through Planwise
                                         Group Limited and Panetta Partners Limited.</FONT> </TD>
</TR></TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 108 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->104<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B><A NAME="a_020"></A>DESCRIPTION
OF SHARE CAPITAL AND ARTICLES OF ASSOCIATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> We were originally
incorporated under the laws of England and Wales on February 11, 1998 under the name of Bigboom plc, with the goal of leveraging
the expertise of our management team as well as Dr. Napoleone Ferrara, Dr. Arun Sanyal, Dr. Howard Weiner and Dr. Kevan Herold,
and to acquire and exploit certain intellectual property in biotechnology. We subsequently changed our name to Tiziana Life Sciences
plc in April 2014 as a result of the acquisition of Tiziana Pharma Limited in April 2014. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
registered office is located at 3rd Floor, 11-12 St James&rsquo;s Square, London SW1Y 4LB and our telephone number is +44 20 7495
2379. Our website address is www.tizianalifesciences.com. The reference to our website is an inactive textual reference only and
the information contained in, or that can be accessed through, our website is not a part of this registration statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Current
authorized share capital</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Current
issued share capital</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> As of August 23,
2018, our issued share capital was 123,827,938 ordinary shares with a nominal value of &pound;0.03 per share. Each issued ordinary
share is fully paid. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Options</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> As of August 23,
2018, there were options to purchase 10,717,403 ordinary shares outstanding with a weighted average exercise price of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;p per ordinary
share. The options generally lapse after 10 years from date of grant. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Warrants</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> As of August 23, 2018, there were warrants
to purchase 5,009,246 ordinary shares outstanding as follows: </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No.
    outstanding</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    Price</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    Price</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Final
    Exercise Date</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-weight: bold; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-weight: bold; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-weight: bold; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-weight: bold; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-weight: bold; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-weight: bold; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-weight: bold; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-weight: bold; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-weight: bold; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 19%; text-align: center; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;API&rdquo;</FONT> </TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="width: 17%; text-align: right; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">329,926</FONT> </TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD><TD STYLE="width: 17%; text-align: right; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.65</FONT> </TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&pound;</FONT> </TD><TD STYLE="width: 17%; text-align: right; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.50</FONT> </TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: center; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="width: 17%; text-align: center; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/31/2021</FONT> </TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Special&rdquo;</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">600,000</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.65</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&pound;</FONT> </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.50</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/31/2021</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;C&rdquo;</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,048,685</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.87</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&pound;</FONT> </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.66</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/31/2021</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;D&rdquo;</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.38</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&pound;</FONT> </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.05</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/31/2021</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;E&rdquo;</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,021,792</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.29</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&pound;</FONT> </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.50</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/31/2021</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;F&rdquo;</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">189,176</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.29</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&pound;</FONT> </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.50</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/31/2021</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;G&rdquo;</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100,000</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.21</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&pound;</FONT> </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.60</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/31/2023</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;H&rdquo;</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">183,333</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.21</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&pound;</FONT> </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.60</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/31/2023</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;I&rdquo;</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">196,667</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.21</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&pound;</FONT> </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.60</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/31/2023</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;J&rdquo;</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">131,667</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.21</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&pound;</FONT> </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.60</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1/15/2024</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;K&rdquo;</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">80,000</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.21</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&pound;</FONT> </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.60</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1/22/2024</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;L&rdquo;</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">78,000</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.33</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&pound;</FONT> </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.00</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3/5/2023</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;M&rdquo;</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">51.563</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.06</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&pound;</FONT> </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.80</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/19/2023</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;N&rdquo;</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">66,667</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.22</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&pound;</FONT> </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.60</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">01/22/2023</FONT> </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>History
of share capital</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following changes have occurred in our issued share capital in the last three years:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</FONT></TD>
    <TD STYLE="padding-right: 0; text-align: justify; font-family: Times New Roman, Times, Serif; padding-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    January 20, 2015, we issued 4,233,616 ordinary shares to Nerviano in connection with entry into the Nerviano Agreement, at
    a price of &pound;0.505 per ordinary share, for an aggregate consideration of &pound;2,137,976, following which we had 88,905,928
    ordinary shares in issue.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"></P>

<!-- Field: Page; Sequence: 109 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->105<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</FONT></TD>
    <TD STYLE="padding-right: 0; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    March 20, 2015, we issued 28,000 ordinary shares to option holders following the exercise of options, at an exercise price
    of &pound;0.03 per ordinary share, for an aggregate consideration of &pound;840, following which we had 88,933,928 ordinary
    shares in issue.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(C)</FONT></TD>
    <TD STYLE="padding-right: 0; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    March 31, 2015, we completed a placing and issued 3,400,000 ordinary shares to new investors, at a price of &pound;0.75 per
    ordinary share, for a net consideration of &pound;2,550,000, following which we had 92,333,928 ordinary shares in issue.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(D)</FONT></TD>
    <TD STYLE="padding-right: 0; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    October 30, 2015, we issued 58,222 ordinary shares to Warrant Holders following the exercise by such Warrant Holders of existing
    warrants, at an exercise price of &pound;1.50 per ordinary share, for an aggregate consideration of &pound;87,333, following
    which we had 92,392,150 ordinary shares in issue.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(E)</FONT></TD>
    <TD STYLE="padding-right: 0; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    April 28, 2016, we issued 1,095,000 ordinary shares to Warrant Holders following the exercise by such Warrant Holders of existing
    warrants, at an exercise price of &pound;0.20 per ordinary share, for an aggregate consideration of &pound;219,000, following
    which we had 93,487,150 ordinary shares in issue.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(F)</FONT></TD>
    <TD STYLE="padding-right: 0; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    June, 29, 2016, we issued 206,250 ordinary shares to Warrant Holders following the exercise by such Warrant Holders of existing
    warrants, at an exercise price of &pound;0.32 per ordinary share, for an aggregate consideration of &pound;66,000 and a further
    700,000 ordinary shares following the conversion of CLN Holders, at a conversion price of &pound;0.24, for an aggregate consideration
    of &pound;168,000, following which we had 94,393,400 ordinary shares in issue.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(G)</FONT></TD>
    <TD STYLE="padding-right: 0; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    June 30, 2016, we issued one ordinary share pursuant to the terms of a deferred share buyback, at a price of &pound;1.50 per
    ordinary share, for an aggregate consideration of &pound;1.50, following which we had 94,393,401 ordinary shares in issue.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(H)</FONT></TD>
    <TD STYLE="padding-right: 0; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    March 24, 2017, we issued 1,789,524 ordinary shares to Warrant Holders following the exercise by such Warrant Holders of existing
    warrants, at an exercise price of &pound;0.32 per ordinary share, for an aggregate consideration of &pound;572,648, following
    which we had 96,182,925 ordinary shares in issue.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I)</FONT></TD>
    <TD STYLE="padding-right: 0; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    August 16, 2017, we issued 27,645,013 ordinary shares to CLN Holders on conversion of all outstanding convertible loan notes,
    following which we had 123,827,938 ordinary shares in issue.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(J)</FONT> </TD>
    <TD STYLE="padding-right: 0; text-align: justify; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    November 20, 2017, the company issued 100,000 new ordinary shares at &pound;1.50 per share to raise &pound;150,000, each new
    ordinary share was issued with a warrant to subscribe for one additional share at a price of &pound;1.60, for a 5 year period.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(K)</FONT> </TD>
    <TD STYLE="padding-right: 0; text-align: justify; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    November 27, 2017, the company issued 183,333 new ordinary shares at &pound;1.50 per share to raise &pound;275,000, each new
    ordinary share was issued with a warrant to subscribe for one additional share at a price of &pound;1.60 for a five year period.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(L)</FONT> </TD>
    <TD STYLE="padding-right: 0; text-align: justify; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    December 15, 2017, the company issued 133,333 new ordinary shares at &pound;1.50 per share to raise &pound;200,000, each new
    ordinary share was issued with a warrant to subscribe for one additional share at a price of &pound;1.60 for a five year period.
    In addition the company granted a further 31,667 warrants on identical terms in lieu of fees and commissions on the funds
    raised.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(M)</FONT> </TD>
    <TD STYLE="padding-right: 0; text-align: justify; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    January 6, 2018, the company issued 100,000 new ordinary shares at &pound;1.50 per share to raise &pound;150,000, each new
    ordinary share was issued with a warrant to subscribe for one additional share at a price of &pound;1.60 for a five year period.
    In addition the company granted a further 63,334 warrants on identical terms in lieu of fees and commissions on the funds
    raised. The company also issued a further 801,201 ordinary shares, credited as fully paid, to former holders of convertible
    loan notes (including in the face value capitalized at (I) above).</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(N)</FONT> </TD>
    <TD STYLE="padding-right: 0; text-align: justify; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    January 22, 2018, the company issued 66,667 new ordinary shares at a price of &pound;1.50 per share to raise &pound;100,000,
    each new ordinary share was issued with a warrant attached to subscribe for one additional share at a price of &pound;1.60
    for a five year period. In addition the company granted a further 66,667 warrants on identical terms in lieu of fees and commissions
    on the funds raised.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"></P>

<!-- Field: Page; Sequence: 110 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->106<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(O)</FONT> </TD>
    <TD STYLE="padding-right: 0; text-align: justify; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    March 5, 2018, the company issued 600,000 new ordinary shares at a price of &pound;1.00 per share to raise &pound;600,000.
    In addition the company granted 78,000 warrants, each entitling the holder to subscribe for one new ordinary share at a price
    of &pound;1.00 per share for a 5 year period.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(P)</FONT> </TD>
    <TD STYLE="padding-right: 0; text-align: justify; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    April 19, 2018, the company issued 1,031,250 new ordinary shares at a price of 80p per share to raise &pound;825,000. In addition
    the company issued 51,563 new ordinary shares credited as fully paid and 51.563 warrants, each entitling the holder to subscribe
    for one new ordinary share at a price of 80p, in lieu of fees and commissions.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -14.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Q)</FONT> </TD>
    <TD STYLE="padding-right: 0; text-align: justify; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    April 27, 2018, the company issued 23,014 new ordinary shares credited as fully paid at a price of 70p per share to a former
    holder of convertible loan notes (as described at (I) above) in relation to a calculation error with respect to capitalized
    interest.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -14.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Information
about the Ordinary Shares</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with our Articles to be in effect upon the filing of this registration statement, the following summarizes the rights
of holders of our ordinary shares:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">each holder of our
    ordinary shares is entitled to one vote per ordinary share on all matters to be voted on by shareholders generally;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the holders of the
    ordinary shares shall be entitled to receive notice of, attend, speak and vote at our general meetings; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-right: 0; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">holders
    of our ordinary shares are entitled to receive such dividends as are recommended by our directors and declared by our shareholders.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Registered
Shares</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> We are required
by the Companies Act to keep a register of our shareholders. Under English law, the ordinary shares are deemed to be issued when
the name of the shareholder is entered in our share register. The share register therefore is prima facie evidence of the identity
of our shareholders, and the shares that they hold. The share register generally provides limited, or no, information regarding
the ultimate beneficial owners of our ordinary shares. Our share register is maintained by our registrar, Link Asset Services. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Potential future holders
of our ADSs will not be treated as one of our shareholders and their names will therefore not be entered in our share register.
The depositary, the custodian or their nominees will be the holder of the shares underlying our ADSs. Potential future holders
of our ADSs have a right to receive the ordinary shares underlying their ADSs. For discussion on our ADSs and ADS holder rights,
see &ldquo;Description of the American Depositary Shares&rdquo; in this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Companies Act, we must enter an allotment of shares in our share register as soon as practicable and in any event within two
months of the allotment. We will perform all procedures necessary to update the share register to reflect any ordinary shares
being sold in any potential offering, including updating the share register with the number of ordinary shares to be issued to
the depositary upon the closing of any such offering in the future. We also are required by the Companies Act to register a transfer
of shares (or give the transferee notice of and reasons for refusal as the transferee may reasonably request) as soon as practicable
and in any event within two months of receiving notice of the transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We,
any of our shareholders, or any other affected person may apply to the court for rectification of the share register if:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; font-size: 10pt"> &nbsp; </TD>
    <TD STYLE="width: 24px; font-size: 10pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font-size: 10pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    name of any person, without sufficient cause, is entered in or omitted from our register of members; or</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"> &nbsp; </TD>
    <TD STYLE="width: 24px"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">default is made
    or unnecessary delay takes place in entering on the register the fact of any person having ceased to be a member or on which
    we have a lien, provided that such delay does not prevent dealings in the shares taking place on an open and proper basis.</FONT> </TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 111 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->107<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <I>Pre-emptive Rights</I> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <I>&nbsp;</I> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> English law generally
provides shareholders with pre-emptive rights when new shares are issued for cash; however, it is possible for the Articles, or
shareholders by special resolution, to exclude pre-emptive rights. Such an exclusion of pre-emptive rights may be for a maximum
period of up to five years from the date of adoption of the Articles, if the exclusion is contained in the Articles, or from the
date of the shareholder resolution, if the exclusion is by shareholder resolution. In either case, this exclusion would need to
be renewed by our shareholders upon its expiration (i.e., at least every five years). Typically U.K. public companies renew the
disapplication of pre-emption rights on an annual basis or their annual general meeting. On June 25, 2018, our shareholders approved
the exclusion of pre-emptive rights for a period of 15 months or the date of the next annual general meeting, which exclusion
is for a number of shares equal to 20% of the issued share capital at the time of passing of the resolution and which will need
to be renewed upon expiration (i.e., the earlier of 15 months from the date of passing the resolution on the date of the next
annual general meeting) to remain effective. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Articles
of Association</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Articles were adopted by a special resolution of the founder shareholder passed at a general meeting on June 30, 2016. A summary
of the terms of the Articles is set out below. The summary below is not a complete copy of the terms of the Articles.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Articles contain no specific restrictions on our purpose and therefore, by virtue of section 31(1) of the Companies Act, our purpose
is unrestricted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Articles contain, among other things, provisions to the following effect:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Share
Capital</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> Our share capital
currently consists of ordinary shares. Subject to the Companies Act and to any rights attached to existing shares, we may issue
shares with such rights or restrictions as may be determined by ordinary resolution or if no ordinary resolution has been passed
or so far as such ordinary resolution does not make specific provision, as the board may determine. In addition, shares which
are to be redeemed, or are liable to be redeemed at our option or the holder of such shares may be issued with the board determining
the terms and conditions of such redemption. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Voting</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
shareholders have the right to receive notice of, and to vote at, our general meetings. Each shareholder who is present in person
(or, being a corporation, by representative) at a general meeting on a show of hands has one vote and, on a poll, every such holder
who is present in person (or, being a corporation, by representative) or by proxy has one vote in respect of every share held
by him.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Variation
of Rights</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> Subject to the
Companies Act, whenever our share capital is divided into different classes of shares, the special rights attached to any class
may be varied or abrogated either with the consent in writing of the holders of three-fourths in nominal value of the issued shares
of that class (excluding any shares held as treasury shares) or with the sanction of a special resolution passed at a separate
general meeting of the holders of the shares of that class, held in accordance with the Articles. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Dividends</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may, subject to the provisions of the Companies Act and the Articles, by ordinary resolution from time to time declare dividends
to be paid to shareholders not exceeding the amount recommended by our board of directors. Subject to the provisions of the Companies
Act, in so far as, in the board of directors&rsquo; opinions, our profits justify such payments, the board of directors may pay
interim dividends on any class of our shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> Any dividend unclaimed
after a period of 12 years from the date such dividend was declared or became payable shall, if the board of directors resolve,
be forfeited and shall cease to remain owing by us. No dividend or other moneys payable on or in respect of a share shall bear
interest as against us. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Transfer
of Ordinary Shares</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
member may transfer all or any of his shares which are in certificated form by means of an instrument of transfer in any usual
form or in any other form which the board of directors may approve. Each member may transfer all or any of his shares which are
in uncertificated form by means of a &ldquo;relevant system&rdquo; (i.e., the CREST System) in such manner provided for, and subject
as provided in, the CREST Regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 112 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->108<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board may, in its absolute discretion, refuse to register a transfer of certificated shares unless:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 27px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">it is for a share
    which is fully paid up;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 27px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">it is for a share
    upon which the company has no lien;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 27px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">it is only for one
    class of share;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 27px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">it is in favor of
    a single transferee or no more than four joint transferees;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 27px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD>
    <TD STYLE="padding-right: 0; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">it
    is duly stamped or is duly certificated or otherwise shown to the satisfaction of the board of directors to be exempt from
    stamp duty; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 27px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</FONT></TD>
    <TD STYLE="padding-right: 0; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">it
    is delivered for registration to the registered office of the company (or such other place as the board of directors may determine),
    accompanied (except in the case of a transfer by a person to whom the company is not required by law to issue a certificate
    and to whom a certificate has not been issued or in the case of a renunciation) by the certificate for the shares to which
    it relates and such other evidence as the board of directors may reasonably require to prove the title of the transferor (or
    person renouncing) and the due execution of the transfer or renunciation by him or, if the transfer or renunciation is executed
    by some other person on his behalf, the authority of that person to do so.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
board of directors may refuse to register a transfer of uncertificated shares in any circumstances that are allowed or required
by the CREST Regulations and the CREST System.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> <B><I>Allotment
of Shares and Pre-emption Rights</I></B> </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the Companies Act and to any rights attached to existing shares, any share may be issued with or have attached to it such rights
and restrictions as the company may by ordinary resolution determine, or if no ordinary resolution has been passed or so far as
the resolution does not make specific provision, as the board of directors may determine (including shares which are to be redeemed,
or are liable to be redeemed at the option of the company or the holder of such shares).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with section 551 of the Companies Act, the board of directors may be generally and unconditionally authorized to exercise
all the powers of the company to allot shares up to an aggregate nominal amount equal to the amount stated in the relevant ordinary
resolution authorizing such allotment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> The provisions
of section 561 of the Companies Act (which confer on shareholders rights of pre-emption in respect of the allotment of equity
securities which are paid up in cash) apply to the company except to the extent disapplied by special resolution of the company.
Such pre-emption rights have been disapplied, in part, pursuant to the special resolution passed on June 25, 2018. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Alteration
of Share Capital</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
company may by ordinary resolution consolidate or divide all of its share capital into shares of larger nominal value than its
existing shares, or cancel any shares which, at the date of the ordinary resolution, have not been taken or agreed to be taken
by any person and diminish the amount of its share capital by the nominal amount of shares so cancelled or sub-divide its shares,
or any of them, into shares of smaller nominal value.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
company may, in accordance with the Companies Act, reduce or cancel its share capital or any capital redemption reserve or share
premium account in any manner and with and subject to any conditions, authorities and consents required by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Board
of Directors</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise determined by the company by ordinary resolution, the number of directors (other than any alternate directors) shall
not be less than two, but there shall be no maximum number of directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the Articles and the Companies Act, the company may by ordinary resolution appoint a person who is willing to act as a director
and the board of directors shall have power at any time to appoint any person who is willing to act as a director, in both cases
either to fill a vacancy or as an addition to the existing board of directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> At every annual
general meeting any director who either (i) has been appointed by the board of directors since the last annual general meeting
or (ii) was not elected or re-elected at one of the preceding two annual general meetings, must retire from office and may offer
themselves for re-election by the shareholders by ordinary resolution. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 113 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->109<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the provisions of the Articles, the board of directors may regulate their proceedings as they deem appropriate. A director
may, and the secretary at the request of a director shall, call a meeting of the directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
quorum for a meeting of the board of directors shall be fixed from time to time by a decision of the board of directors, but it
must never be less than two and unless otherwise fixed, it is two.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> Questions and
matters requiring resolution arising at a meeting shall be decided by a majority of votes of the participating directors, with
each director having one vote. In the case of an equality of votes, the chairman will only have a casting vote or second vote
(unless he is not entitled to vote on the resolution in question). </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> Directors shall
be entitled to receive such remuneration as the board shall determine for their services to the company as directors, and for
any other service which they undertake for the company provided that the aggregate fees payable to the directors must not exceed
&pound;250,000 per annum or such higher amount as decided by ordinary resolution. The directors shall also be entitled to be paid
all reasonable expenses properly incurred by them in connection with their attendance at meetings of shareholders or class meetings,
board of director or committee meetings or otherwise in connection with the exercise of their powers and the discharge of their
responsibilities in relation to the company. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
board of directors may, in accordance with the requirements in the Articles, authorize any matter proposed to them by any director
which would, if not authorized, involve a director breaching his duty under the Companies Act, to avoid conflicts of interests.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
director seeking authorization in respect of such conflict shall declare to the board of directors the nature and extent of his
interest in a conflict as soon as is reasonably practicable. The director shall provide the board with such details of the matter
as are necessary for the board to decide how to address the conflict together with such additional information as may be requested
by the board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
authorization by the board of directors will be effective only if:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="padding-right: 0; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
    the extent permitted by the Companies Act, the matter in question shall have been proposed by any director for consideration
    in the same way that any other matter may be proposed to the directors under the provisions of the Articles;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD>
    <TD STYLE="padding-right: 0; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    requirement as to the quorum for consideration of the relevant matter is met without counting the conflicted director and
    any other conflicted director; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD>
    <TD STYLE="padding-right: 0; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    matter is agreed to without the conflicted director voting or would be agreed to if the conflicted director&rsquo;s and any
    other interested director&rsquo;s vote is not counted.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the provisions of the Companies Act, every director, secretary or other officer of the company (other than an auditor) is entitled
to be indemnified against all costs, charges, losses, damages and liabilities incurred by him in the actual purported exercise
or discharge of his duties or exercise of his powers or otherwise in relation to them.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>General
Meetings</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
company must convene and hold annual general meetings in accordance with the Companies Act. Under the Companies Act, an annual
general meeting must be called by notice of at least 21 days.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
business shall be transacted at any general meeting unless a quorum is present when the meeting proceeds to business, but the
absence of a quorum shall not preclude the choice or appointment of a chairman of the meeting which shall not be treated as part
of the business of the meeting. Save as otherwise provided by the Articles, two shareholders present in person or by proxy and
entitled to vote shall be a quorum for all purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Borrowing
Powers</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the Articles and the Companies Act, the board of directors may exercise all of the powers of the company to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">borrow money;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">indemnify and guarantee;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">mortgage or charge;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">create and issue
    debentures and other securities; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">give security either
    outright or as collateral security for any debt, liability or obligation of the company or of any third party.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> The borrowing
powers are restricted to the sum of &pound;25,000,000 but this limit may be increased by ordinary resolution of shareholders. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 114 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->110<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Capitalization
of profits</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
directors may, if they are so authorized by an ordinary resolution of the shareholders, decide to capitalize any undivided profits
of the company (whether or not they are available for distribution), or any sum standing to the credit of the company&rsquo;s
share premium account or capital redemption reserve. The directors may also, subject to the aforementioned ordinary resolution,
appropriate any sum which they so decide to capitalize to the persons who would have been entitled to it if it were distributed
by way of dividend and in the same proportions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Uncertificated
Shares</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the Companies Act, the board of directors may permit title to shares of any class to be issued or held otherwise than by a
certificate and to be transferred by means of a &ldquo;relevant system&rdquo; (i.e., the CREST System) without a certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
board of directors may take such steps as it sees fit in relation to the evidencing of and transfer of title to uncertificated
shares, any records relating to the holding of uncertificated shares and the conversion of uncertificated shares to certificated
shares, or vice-versa.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> The board of directors
may by notice to the holder of an uncertificated share, require that share to be converted into certificated form. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
board of directors may take such other action that the board considers appropriate to achieve the sale, transfer, disposal, forfeiture,
re-allotment or surrender of an uncertified share or otherwise to enforce a lien in respect of it.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Other
Relevant Laws and Regulations</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Mandatory
Bid</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
U.K. City Code on Takeovers and Mergers, or Takeover Code, applies to the company. Under the Takeover Code, where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="padding-right: 0; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    person, together with persons acting in concert with him, acquires, whether by a series of transactions over a period of time
    or not, an interest in shares which (taken together with shares in which he is already interested, and in which persons acting
    in concert with him are interested) carry 30% or more of the voting rights of a company; or</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="padding-right: 0; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    person who, together with persons acting in concert with him, is interested in shares which in the aggregate carry not less
    than 30% of the voting rights of a company but does not hold shares carrying more than 50% of such voting rights and such
    person, or any person acting in concert with him, acquires an interest in any other shares which increases the percentage
    of shares carrying voting rights in which he is interested, such person shall, except in limited circumstances, be obliged
    to extend offers, on the basis set out in Rules 9.3, 9.4 and 9.5 of the Takeover Code, to the holders of any class of equity
    share capital, whether voting or non-voting, and also to the holders of any other class of transferable securities carrying
    voting rights. Offers for different classes of equity share capital must be comparable; the U.K. Panel on Takeovers and Mergers,
    or Takeover Panel, should be consulted in advance in such cases.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
offer under Rule 9 of the Takeover Code must be in cash and at the highest price paid for any interest in the shares by the person
required to make an offer or any person acting in concert with him during the 12 months prior to the announcement of the offer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> Under the Takeover
Code, a &ldquo;concert party&rdquo; arises where persons acting together pursuant to an agreement or understanding (whether formal
or informal and whether or not in writing) cooperate, through the acquisition by them of an interest in shares in a company, to
obtain or consolidate control of the company. &ldquo;Control&rdquo; means holding, or aggregate holdings, of an interest in shares
carrying 30% or more of the voting rights of the company, irrespective of whether the holding or holdings give <I>de facto</I>
control. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 115 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->111<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Squeeze-out</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Companies Act, if a takeover offer (as defined in Section 974 of the Companies Act) is made for the shares of a company and
the offeror were to acquire, or unconditionally contract to acquire:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">not less than 90%
    in value of the shares to which the takeover offer relates, or the Takeover Offer Shares&#894; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">where those shares
    are voting shares, not less than 90% of the voting rights attached to the Takeover Offer Shares,</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> the offeror could acquire compulsorily
the remaining 10%. It would do so by sending a notice to outstanding shareholders within three months of the last day on which
its offer can be accepted telling them that it will acquire compulsorily their shares, or Takeover Offer Shares, and then, six
weeks later, it would send a copy of the notice to the company with an executed instrument of transfer of the outstanding Takeover
Offer Shares in its favor and pay the consideration to the company, which would hold the consideration on trust for outstanding
shareholders. The consideration offered to the shareholders whose Takeover Offer Shares are acquired compulsorily under the Companies
Act must, in general, be the same as the consideration that was available under the takeover offer. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Sell-out</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Companies Act also gives minority shareholders a right to be bought out in certain circumstances by an offeror who has made a
takeover offer (as defined in Section 974 of the Companies Act). If a takeover offer related to all the shares of a company and,
at any time before the end of the period within which the offer could be accepted, the offeror held or had agreed to acquire not
less than 90% of the shares to which the offer relates, any holder of the shares to which the offer related who had not accepted
the offer could by a written communication to the offeror require it to acquire those shares. The offeror is required to give
any shareholder notice of his or her right to be bought out within one month of that right arising. The offeror may impose a time
limit on the rights of the minority shareholders to be bought out, but that period cannot end less than three months after the
end of the acceptance period. If a shareholder exercises his or her rights, the offeror is bound to acquire those shares on the
terms of the offer or on such other terms as may be agreed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Shareholder
Notification and Disclosure Requirements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholders
are obliged to comply with the shareholding notification and disclosure requirements set out in Chapter 5 of the Disclosure Guidance
and Transparency Rules, or DTRs. A shareholder is required pursuant to Rule 5 of the DTRs to notify the company if, as a result
of an acquisition or disposal of shares or financial instruments, the shareholder&rsquo;s percentage of voting rights of the company
reaches, exceeds or falls below 3% of the nominal value of the company&rsquo;s share capital or any 1% threshold above that.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
DTRs can be accessed and downloaded from the Financial Conduct Authority&rsquo;s website at www.fshandbook.info/FS/html/FCA/DTR.
Shareholders are urged to consider their notification and disclosure obligations carefully as a failure to make a required disclosure
to the company may result in disenfranchisement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>U.K.
City Code on Takeovers and Mergers</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a U.K. public company with its place of central management and control inside the United Kingdom, we are subject to the Takeover
Code, which is issued and administered by the Takeover Panel. The Takeover Code provides a framework within which takeovers are
regulated and conducted. Under the Takeover Code, where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any person, together
    with persons acting in concert with him, acquires, whether by a series of transactions over a period of time or not, an interest
    in shares which (taken together with shares in which he is already interested, and in which persons acting in concert with
    him are interested) carry 30% or more of the voting rights of a company; or</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any person who,
    together with persons acting in concert with him, is interested in shares which in the aggregate carry not less than 30% of
    the voting rights of a company but does not hold shares carrying more than 50% of such voting rights and such person, or any
    person acting in concert with him, acquires an interest in any other shares which increases the percentage of shares carrying
    voting rights in which he is interested;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">such
person shall, except in limited circumstances, be obliged to extend offers, on the basis set out in Rules 9.3, 9.4 and 9.5 of
the Takeover Code, to the holders of any class of equity share capital, whether voting or non-voting, and also to the holders
of any other class of transferable securities carrying voting rights. Offers for different classes of equity share capital must
be comparable; the Takeover Panel should be consulted in advance in such cases.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 116 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->112<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
offer under Rule 9 of the Takeover Code must be in cash and at the highest price paid for any interest in the shares by the person
required to make an offer or any person acting in concert with him during the 12 months prior to the announcement of the offer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Under the Takeover
Code, a &ldquo;concert party&rdquo; arises where persons acting together pursuant to an agreement or understanding (whether formal
or informal and whether or not in writing) cooperate, through the acquisition by them of an interest in shares in a company, to
obtain or consolidate control of the company. &ldquo;Control&rdquo; means holding, or aggregate holdings, of an interest in shares
carrying 30% or more of the voting rights of the company, irrespective of whether the holding or holdings give de facto control.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Differences
in Corporate Law</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
applicable provisions of the Companies Act differ from laws applicable to U.S. corporations and their shareholders. Set forth
below is a summary of certain differences between the provisions of the Companies Act applicable to us and the Delaware General
Corporation Law relating to shareholders&rsquo; rights and protections. This summary is not intended to be a complete discussion
of the respective rights and it is qualified in its entirety by reference to Delaware law and English law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 26%; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 36%; border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>England
    and Wales</B></FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 36%; border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Delaware</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number of Directors</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under the Companies
    Act, a public limited company must have at least two directors and the number of directors may be fixed by or in the manner
    provided in a company&rsquo;s Articles.</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under Delaware law,
    a corporation must have at least one director and the number of directors shall be fixed by or in the manner provided in the
    bylaws.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Removal of Directors</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under the Companies
    Act, shareholders may remove a director without cause by an ordinary resolution (which is passed by a simple majority of those
    voting in person or by proxy at a general meeting) irrespective of any provisions of any service contract the director has
    with the company, provided 28 clear days&rsquo; notice of the resolution has been given to the company and its shareholders.
    On receipt of notice of an intended resolution to remove a director, the company must forthwith send a copy of the notice
    to the director concerned. Certain other procedural requirements under the Companies Act must also be followed, such as allowing
    the director to make representations against his or her removal either at the meeting or in writing.</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under Delaware law,
    any director or the entire board of directors may be removed, with or without cause, by the holders of a majority of the shares
    then entitled to vote at an election of directors, except (i) unless the certificate of incorporation provides otherwise,
    in the case of a corporation whose board of directors is classified, stockholders may effect such removal only for cause,
    or (ii) in the case of a corporation having cumulative voting, if less than the entire board of directors is to be removed,
    no director may be removed without cause if the votes cast against his removal would be sufficient to elect him if then cumulatively
    voted at an election of the entire board of directors, or, if there are classes of directors, at an election of the class
    of directors of which he is a part.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 117 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->113<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 26%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 36%; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>England
    and Wales</B></FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 36%; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Delaware</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Vacancies on the Board of Directors</B></FONT> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under English
    law, the procedure by which directors, other than a company&rsquo;s initial directors, are appointed is generally set out
    in a company&rsquo;s Articles, provided that where two or more persons are appointed as directors of a public limited company
    by a single resolution of the shareholders, such resolution must not be put to shareholders unless a resolution that it should
    so be made has first been agreed to by the shareholders without any vote being given against it.</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under Delaware
    law, vacancies and newly created directorships may be filled by a majority of the directors then in office (even though less
    than a quorum) or by a sole remaining director unless (i) otherwise provided in the certificate of incorporation or bylaws
    of the corporation or (ii) the certificate of incorporation directs that a particular class of stock is to elect such director,
    in which case a majority of the other directors elected by such class, or a sole remaining director elected by such class,
    will fill such vacancy.</FONT> </TD></TR>
<TR STYLE="vertical-align: top">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Annual General Meeting</B></FONT> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under the Companies
    Act, a public limited company must hold an annual general meeting in each six-month period beginning with the day following
    the company&rsquo;s annual accounting reference date.</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under Delaware
    law, the annual meeting of stockholders shall be held at such place, on such date and at such time as may be designated from
    time to time by the board of directors or as provided in the certificate of incorporation or by the bylaws.</FONT> </TD></TR>
<TR STYLE="vertical-align: top">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>General Meeting</B></FONT> </TD>
    <TD> &nbsp; </TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> Under the Companies Act, a
        general meeting of the shareholders of a public limited company may be called by the directors. </P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> &nbsp; </P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> Shareholders holding at least
        5% of the paid-up capital of the company carrying voting rights at general meetings (excluding any paid up capital held
        as treasury shares) can require the directors to call a general meeting and, if the directors fail to do so within a certain
        period, may themselves or any of them representing more than one half of the total voting rights of all of them convene
        a general meeting. </P></TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under Delaware
    law, special meetings of the stockholders may be called by the board of directors or by such person or persons as may be authorized
    by the certificate of incorporation or by the bylaws.</FONT> </TD></TR>
<TR STYLE="vertical-align: top">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notice of General Meetings</B></FONT> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under the Companies
    Act, at least 21 days&rsquo; notice must be given for an annual general meeting and any resolutions to be proposed at the
    meeting, subject to a company&rsquo;s Articles providing for a longer period. Subject to a company&rsquo;s Articles providing
    for a longer period, at least 14 days&rsquo; notice is required for other general meetings of a public limited company which
    fulfill certain conditions. In addition, certain matters, such as the removal of directors or auditors, require special notice,
    which is 28 days&rsquo; notice. The shareholders of a company may in all cases consent to a shorter notice period, the proportion
    of shareholders&rsquo; consent required being 100% of those entitled to attend and vote in the case of an annual general meeting
    and, in the case of any other general meeting, a majority in number of the members having a right to attend and vote at the
    meeting, being a majority who together hold not less than 95% in nominal value of the shares giving a right to attend and
    vote at the meeting.</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under Delaware
    law, unless otherwise provided in the certificate of incorporation or bylaws, written notice of any meeting of the stockholders
    must be given to each stockholder entitled to vote at the meeting not less than ten nor more than 60 days before the date
    of the meeting and shall specify the place, date, hour and purpose or purposes of the meeting.</FONT> </TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 118 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->114<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 26%; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 36%; border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>England
    and Wales</B></FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 36%; border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Delaware</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Quorum</B></FONT> </TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
    to the provisions of a company&rsquo;s Articles, the Companies Act provides that two shareholders present at a meeting (in
    person, by proxy or authorised under the Companies Act) shall constitute a quorum for companies with more than one shareholder.</FONT> </TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    certificate of incorporation or bylaws may specify the number of shares, the holders of which shall be present or represented
    by proxy at any meeting in order to constitute a quorum, but in no event shall a quorum consist of less than one third of
    the shares entitled to vote at the meeting. In the absence of such specification in the certificate of incorporation or bylaws,
    a majority of the shares entitled to vote, present in person or represented by proxy, shall constitute a quorum at a meeting
    of stockholders.</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proxy</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under the Companies
    Act, at any meeting of shareholders, a shareholder may designate another person to attend, speak and vote at the meeting on
    their behalf by proxy.</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under Delaware law,
    at any meeting of stockholders, a stockholder may designate another person to act for such stockholder by proxy, but no such
    proxy shall be voted or acted upon after three years from its date, unless the proxy provides for a longer period. A director
    of a Delaware corporation may not issue a proxy representing the director&rsquo;s voting rights as a director.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Issue of New Shares</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under the Companies
    Act, the directors of a company must not exercise any power to allot shares or grant rights to subscribe for, or to convert
    any security into, shares unless they are authorized to do so by the company&rsquo;s Articles or by an ordinary resolution
    of the shareholders. Any authorization given must state the maximum amount of shares that may be allotted under it and specify
    the date on which it will expire, which must be not more than five years from the date the authorization was given. The authority
    can be renewed by a further resolution of the shareholders.</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under Delaware law,
    if the company&rsquo;s certificate of incorporation so provides, the directors have the power to authorize additional stock.
    The directors may authorize capital stock to be issued for consideration consisting of cash, any tangible or intangible property
    or any benefit to the company or any combination thereof.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 119 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->115<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 26%; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 36%; border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>England
    and Wales</B></FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 36%; border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Delaware</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pre-emptive
    Rights</B></FONT> </TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"> Under the Companies Act,
    &ldquo;equity securities,&rdquo; being (i) shares in the company other than shares that, with respect to dividends and capital,
    carry a right to participate only up to a specified amount in a distribution, referred to as &ldquo;ordinary shares,&rdquo;
    or (ii) rights to subscribe for, or to convert securities into, ordinary shares, proposed to be allotted for cash must be
    offered first to the existing equity shareholders in the company in proportion to the respective nominal value of their holdings,
    unless the period during which any such offer may be accepted has expired or the company has received notice of acceptance
    or refusal, or an exception applies or a special resolution to the contrary has been passed by shareholders in a general meeting
    or the Articles provide otherwise in each case in accordance with the provisions of the Companies Act. </TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"> Under Delaware law, shareholders
    have no pre-emptive rights to subscribe to additional issues of stock or to any security convertible into such stock unless,
    and except to the extent that, such rights are expressly provided for in the certificate of incorporation. </TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Authority
    to Allot</B></FONT> </TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"> Under the Companies Act,
    the directors of a company must not allot shares or grant rights to subscribe for or convert any security into shares unless
    an ordinary resolution to the contrary has been passed by shareholders in a general meeting or the Articles provide otherwise,
    in each case in accordance with the provisions of the Companies Act. </TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
    Delaware law, if the corporation&rsquo;s charter or certificate of incorporation so provides, the board of directors has the
    power to authorize the issuance of stock. The board of directors may authorize capital stock to be issued for consideration
    consisting of cash, any tangible or intangible property or any benefit to the corporation or any combination thereof. It may
    determine the amount of such consideration by approving a formula. In the absence of actual fraud in the transaction, the
    judgment of the directors as to the value of such consideration is conclusive.</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Liability
    of Directors and Officers</B></FONT> </TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"> Under the Companies Act,
    any provision, whether contained in a company&rsquo;s Articles or any contract or otherwise, that purports to exempt a director
    of a company, to any extent, from any liability that would otherwise attach to him in connection with any negligence, default,
    breach of duty or breach of trust in relation to the company, is void. Any provision by which a company directly or indirectly
    provides an indemnity, to any extent, for a director of the company or of an associated company against any liability attaching
    to him in connection with any negligence, default, breach of duty or breach of trust in relation to the company of which he
    is a director is also void except as permitted by the Companies Act, which provides exceptions for the company to: (i) purchase
    and maintain insurance against such liability; (ii) provide a &ldquo;qualifying third party indemnity,&rdquo; or an indemnity
    against liability incurred by the director to a person other than the company or an associated company; and (iii) provide
    a &ldquo;qualifying pension scheme indemnity,&rdquo; or an indemnity against liability incurred in connection with the company&rsquo;s
    activities as trustee of an occupational pension plan. </TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
                                         Delaware law, a corporation&rsquo;s certificate of incorporation may include a provision
                                         eliminating or limiting the personal liability of a director to the corporation and its
                                         stockholders for damages arising from a breach of fiduciary duty as a director. However,
                                         no provision can limit the liability of a director for:</FONT> </P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 10pt; text-align: justify; text-indent: -10pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
        any breach of the director&rsquo;s duty of loyalty to the corporation or its stockholders;</FONT> </P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 10pt; text-align: justify; text-indent: -10pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
        acts or omissions not in good faith or that involve intentional misconduct or a knowing violation of law;</FONT> </P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 10pt; text-align: justify; text-indent: -10pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
        intentional or negligent payment of unlawful dividends or stock purchases or redemptions; or</FONT> </P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 10pt; text-align: justify; text-indent: -10pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
        any transaction from which the director derives an improper personal benefit.</FONT> </P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 120 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->116<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 26%; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 36%; border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>England
    and Wales</B></FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 36%; border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Delaware</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Voting
    Rights</B></FONT> </TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
                                         the model articles for public companies, unless a poll is demanded by the shareholders
                                         of a company or is required by the chairman of the meeting or the company&rsquo;s Articles,
                                         shareholders shall vote on all resolutions on a show of hands. Under the Companies Act,
                                         a poll may be demanded by: (i) not fewer than five shareholders having the right to vote
                                         on the resolution; (ii) any shareholder(s) representing not less than 10% of the total
                                         voting rights of all the shareholders having the right to vote on the resolution (excluding
                                         any voting rights attaching to treasury shares); or (iii) any shareholder(s) holding
                                         shares in the company conferring a right to vote on the resolution (excluding any voting
                                         rights attaching to treasury shares) being shares on which an aggregate sum has been
                                         paid up equal to not less than 10% of the total sum paid up on all the shares conferring
                                         that right. A company&rsquo;s Articles may provide more extensive rights for shareholders
                                         to call a poll.</FONT> </P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
        English law, an ordinary resolution is passed on a show of hands if it is approved by a simple majority (more than 50%)
        of the votes cast by shareholders present (in person or by proxy) and entitled to vote. If a poll is demanded, an ordinary
        resolution is passed if it is approved by holders representing a simple majority of the total voting rights of shareholders
        present, in person or by proxy, who, being entitled to vote, vote on the resolution. Special resolutions require the affirmative
        vote of not less than 75% of the votes cast by shareholders present, in person or by proxy, at the meeting.</FONT></P></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Delaware
    law provides that, unless otherwise provided in the certificate of incorporation, each stockholder is entitled to one vote
    for each share of capital stock held by such stockholder.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 121 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->117<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 26%; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 36%; border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>England
    and Wales</B></FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 36%; border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Delaware</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Shareholder
    Vote on Certain Transactions</B></FONT> </TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Companies Act provides for schemes of arrangement, which are arrangements or compromises
                                         between a company and any class of shareholders or creditors and used in certain types
                                         of reconstructions, amalgamations, capital reorganizations or takeovers. These arrangements
                                         require:</FONT> </P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 10pt; text-align: justify; text-indent: -10pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;the
        approval at a shareholders&rsquo; or creditors&rsquo; meeting convened by order of the court, of a majority in number
        of shareholders or creditors or class thereof representing 75% in value, the class of shareholders or creditors, or class
        thereof present and voting, either in person or by proxy; and</FONT> </P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -18.75pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 10pt; text-align: justify; text-indent: -10pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;the approval of the court.</FONT> </P></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally,
                                         under Delaware law, unless the certificate of incorporation provides for the vote of
                                         a larger portion of the stock, completion of a merger, consolidation, sale, lease or
                                         exchange of all or substantially all of a corporation&rsquo;s assets or dissolution requires:</FONT> </P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 10pt; text-align: justify; text-indent: -10pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;the approval of the board of directors; and</FONT> </P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -18.75pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 10pt; text-align: justify; text-indent: -10pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;the approval by the vote of the holders of a majority of the outstanding stock or, if the certificate of incorporation
        provides for more or less than one vote per share, a majority of the votes of the outstanding stock of the corporation
        entitled to vote on the matter.</FONT> </P></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Standard of Conduct for Directors</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
        English law, a director owes various statutory and fiduciary duties to the company, including:</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 10pt; text-align: justify; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;to act in the way he considers, in good faith, would be most likely to promote the success of the company for the benefit
        of its members as a whole;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -18.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 10pt; text-align: justify; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;to avoid a situation in which he has, or can have, a direct or indirect interest that conflicts, or possibly conflicts,
        with the interests of the company;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -18.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 10pt; text-align: justify; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;to act in accordance with the company&rsquo;s constitution and only exercise his powers for the purposes for which they
        are conferred;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -18.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 10pt; text-align: justify; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;to exercise independent judgment;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -18.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 10pt; text-align: justify; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;to exercise reasonable care, skill and diligence;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -18.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 10pt; text-align: justify; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;not to accept benefits from a third party conferred by reason of his being a director or doing, or not doing, anything
        as a director; and</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -18.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 10pt; text-align: justify; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;to declare any interest that he has, whether directly or indirectly, in a proposed or existing transaction or arrangement
        with the company.</FONT></P></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Delaware
        law does not contain specific provisions setting forth the standard of conduct of a director. The scope of the fiduciary
        duties of directors is generally determined by the courts of the State of Delaware. In general, directors have a duty
        to act without self-interest, on a well-informed basis and in a manner they reasonably believe to be in the best interest
        of the stockholders.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Directors
        of a Delaware corporation owe fiduciary duties of care and loyalty to the corporation and to its shareholders. The duty
        of care generally requires that a director act in good faith, with the care that an ordinarily prudent person would exercise
        under similar circumstances. Under this duty, a director must inform himself of all material information reasonably available
        regarding a significant transaction. The duty of loyalty requires that a director act in a manner he reasonably believes
        to be in the best interests of the corporation. He must not use his corporate position for personal gain or advantage.
        In general, but subject to certain exceptions, actions of a director are presumed to have been made on an informed basis,
        in good faith and in the honest belief that the action taken was in the best interests of the corporation. However, this
        presumption may be rebutted by evidence of a breach of one of the fiduciary duties. Delaware courts have also imposed
        a heightened standard of conduct upon directors of a Delaware corporation who take any action designed to defeat a threatened
        change in control of the corporation.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
        addition, under Delaware law, when the board of directors of a Delaware corporation approves the sale or break-up of a
        corporation, the board of directors may, in certain circumstances, have a duty to obtain the highest value reasonably
        available to the shareholders.</FONT></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 122 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->118<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 26%; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 36%; border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>England
    and Wales</B></FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 36%; border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Delaware</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Shareholder Suits</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under English law,
    generally, the company, rather than its shareholders, is the proper claimant in an action in respect of a wrong done to the
    company or where there is an irregularity in the company&rsquo;s internal management. Notwithstanding this general position,
    the Companies Act provides that (i) a court may allow a shareholder to bring a derivative claim (that is, an action in respect
    of and on behalf of the company) in respect of a cause of action arising from a director&rsquo;s negligence, default, breach
    of duty or breach of trust and (ii) a shareholder may bring a claim for a court order where the company&rsquo;s affairs have
    been or are being conducted in a manner that is unfairly prejudicial to some of its shareholders.</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
        Delaware law, a stockholder may initiate a derivative action to enforce a right of a corporation if the corporation fails
        to enforce the right itself. The complaint must:</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 10pt; text-align: justify; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;state that the plaintiff was a stockholder at the time of the transaction of which the plaintiff complains or that the
        plaintiffs shares thereafter devolved on the plaintiff by operation of law; and</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -18.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 10pt; text-align: justify; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;allege with particularity the efforts made by the plaintiff to obtain the action the plaintiff desires from the directors
        and the reasons for the plaintiff&rsquo;s failure to obtain the action; or</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -18.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 10pt; text-align: justify; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;state the reasons for not making the effort.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -18.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
        the plaintiff must remain a stockholder through the duration of the derivative suit. The action will not be dismissed
        or compromised without the approval of the Delaware Court of Chancery.</FONT></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Other
U.K. Law Considerations</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Registered
Shares</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are required by the Companies Act to keep a register of our shareholders. Under English law, shares are deemed to be issued when
the name of the shareholder is entered in our register of members. The register of members therefore is prima facie evidence of
the identity of our shareholders, and the shares that they hold. The register of members generally provides limited, or no, information
regarding the ultimate beneficial owners of our shares. Our register of members is maintained by our registrar, LINK Asset Services
Limited.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Companies Act, we must enter an allotment of shares in our register of members as soon as practicable and in any event within
two months of the allotment. We will perform all procedures necessary to update the register of members to reflect the ordinary
shares and the ADSs being allotted and issued in this offering. We also are required by the Companies Act to register a transfer
of shares (or give the transferee notice of and reasons for refusal as the transferee may reasonably request) as soon as practicable
and in any event within two months of receiving notice of the transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We,
any of our shareholders or any other affected person may apply to the court for rectification of the register of members if:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    name of any person, without sufficient cause, is entered in or omitted from our register of members; or</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">default
    is made or unnecessary delay takes place in entering on the register the fact of any person having ceased to be a member.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Distributions
and Dividends</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Companies Act, before a company can lawfully make a distribution or dividend, it must ensure that it has sufficient distributable
reserves, as determined on a non-consolidated basis. The basic rule is that a company&rsquo;s profits available for the purpose
of making a distribution are its accumulated, realized profits, so far as not previously utilized by distribution or capitalization,
less its accumulated, realized losses, so far as not previously written off in a reduction or reorganization of capital duly made.
The requirement to have sufficient distributable reserves before a distribution or dividend can be paid applies to us and to each
of our subsidiaries that has been incorporated under English law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"> As a public company,
it is also not sufficient that we have made a distributable profit for the purpose of making a distribution. An additional capital
maintenance requirement is imposed on us to ensure that the net worth of the company is at least equal to the amount of its capital.
A public company can only make a distribution: </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if, at the time
    that the distribution is made, the amount of its net assets (that is, the total excess of assets over liabilities) is not
    less than the total of its called up share capital and undistributable reserves; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if, and to the extent
    that, the distribution itself, at the time that it is made, does not reduce the amount of its net assets to less than that
    total.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"></P>

<!-- Field: Page; Sequence: 123 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->119<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Limitation
on Owning Securities</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Articles do not restrict in any way the ownership or voting of our shares by non-residents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Purchase
of Own Shares</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">English
law permits a public limited company to purchase its own shares out of the distributable profits of the company or the proceeds
of a fresh issue of shares made for the purpose of financing the purchase, subject to complying with procedural requirements under
the Companies Act and provided that its Articles do not prohibit it from doing so. Our Articles, a summary of which is provided
above, do not prohibit us from purchasing our own shares. A public limited company must not purchase its own shares if, as a result
of the purchase, there would no longer be any issued shares of the company other than redeemable shares or shares held as treasury
shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"> Any such purchase
will be either a &ldquo;market purchase&rdquo; or &ldquo;off market purchase,&rdquo; each as defined in the Companies Act. A &ldquo;market
purchase&rdquo; is a purchase made on a &ldquo;recognized investment exchange&rdquo; (other than an overseas exchange) as defined
in the U.K. Financial Services and Markets Act 2000, or FSMA and is not an &ldquo;off-market purchase.&rdquo; An &ldquo;off market
purchase&rdquo; is a purchase that is not made on a &ldquo;recognized investment exchange&rdquo; or purchased on a &ldquo;recognized
investment exchange&rdquo; but not subject to a marketing arrangement on such &ldquo;recognized investment exchange.&rdquo; Both
&ldquo;market purchases&rdquo; and &ldquo;off market purchases&rdquo; require prior shareholder approval by way of an ordinary
resolution. In the case of an &ldquo;off market purchase,&rdquo; a company&rsquo;s shareholders, other than the shareholders from
whom the company is purchasing shares, must approve the terms of the contract to purchase shares and in the case of a &ldquo;market
purchase,&rdquo; the shareholders must approve the maximum number of shares that can be purchased and the maximum and minimum
prices to be paid by the company. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nasdaq
Capital Market is an &ldquo;overseas exchange&rdquo; for the purposes of the Companies Act and does not fall within the definition
of a &ldquo;recognized investment exchange&rdquo; for the purposes of FSMA and any purchase made by us would need to comply with
the procedural requirements under the Companies Act that regulate &ldquo;off market purchases.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
share buyback by a company of its shares will give rise to U.K. stamp duty at the rate of 0.5% of the amount or value of the consideration
payable by the company, and such stamp duty will be paid by the company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Articles do not have conditions governing changes to our capital which are more stringent that those required by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Shareholder
Rights</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
rights granted under the Companies Act, including the right to requisition a general meeting or require a resolution to be put
to shareholders at the annual general meeting, are only available to our members. For English law purposes, our members are the
persons who are registered as the owners of the legal title to the shares and whose names are recorded in our register of members.
In the case of shares held in a settlement system operated by the Depository Trust Company, or DTC, the registered member will
be DTC&rsquo;s nominee, Cede &amp; Co. If a person who holds their ADSs in DTC wishes to exercise certain of the rights granted
under the Companies Act, they may be required to first take steps to withdraw their ADSs from the settlement system operated by
DTC and become the registered holder of the shares in our register of members. A withdrawal of shares from DTC may have tax implications,
for additional information on the potential tax implications of withdrawing your shares from the settlement system operated by
DTC, see &ldquo;Material Tax Considerations&mdash;United Kingdom Taxation.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 124 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->120<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>DESCRIPTION
OF THE AMERICAN DEPOSITARY SHARES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">JPMorgan
Chase Bank, N.A., as depositary will issue the ADSs which you will be entitled to receive in this offering. Each ADS will represent
an ownership interest a designated number of ordinary shares which we will deposit with the custodian, as agent of the depositary,
under the deposit agreement among ourselves, the depositary and yourself as an ADR holder. In the future, each ADS will also represent
any securities, cash or other property deposited with the depositary but which they have not distributed directly to you. Unless
certificated ADRs are specifically requested by you, all ADSs will be issued on the books of our depositary in book-entry form
and periodic statements will be mailed to you which reflect your ownership interest in such ADSs. In our description, references
to American depositary receipts, or ADRs, shall include the statements you will receive which reflect your ownership of ADSs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
depositary&rsquo;s office is located at 4 New York Plaza, Floor 12, New York, NY, 10004.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
may hold ADSs either directly or indirectly through your broker or other financial institution. If you hold ADSs directly, by
having an ADS registered in your name on the books of the depositary, you are an ADR holder. This description assumes you hold
your ADSs directly. If you hold the ADSs through your broker or financial institution nominee, you must rely on the procedures
of such broker or financial institution to assert the rights of an ADR holder described in this section. You should consult with
your broker or financial institution to find out what those procedures are.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
an ADR holder, we will not treat you as a shareholder of ours and you will not have any shareholder rights. The law of England
and Wales governs shareholder rights. Because the depositary or its nominee will be the shareholder of record for the ordinary
shares represented by all outstanding ADSs, shareholder rights rest with such record holder. Your rights are those of an ADR holder.
Such rights derive from the terms of the deposit agreement to be entered into among us, the depositary and all registered holders
from time to time of ADRs issued under the deposit agreement. The obligations of our company, the depositary and its agents are
also set out in the deposit agreement. Because the depositary or its nominee will actually be the registered owner of the ordinary
shares, you must rely on it to exercise the rights of a shareholder on your behalf. The deposit agreement and the ADSs are governed
by New York law. Under the deposit agreement, as an ADR holder, you agree that any legal suit, action or proceeding against or
involving us or the depositary, arising out of or based upon the deposit agreement, the ADSs or the transactions contemplated
thereby, may only be instituted in a state or federal court in New York, New York, and you irrevocably waive any objection which
you may have to the laying of venue of any such proceeding and irrevocably submit to the exclusive jurisdiction of such courts
in any such suit, action or proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a summary of what we believe to be the material terms of the deposit agreement. Notwithstanding this, because it
is a summary, it may not contain all the information that you may otherwise deem important. For more complete information, you
should read the entire deposit agreement and the form of ADR which contains the terms of your ADSs. You can read a copy of the
deposit agreement which is filed as an exhibit to the registration statement of which this prospectus forms a part. You may also
obtain a copy of the deposit agreement at the SEC&rsquo;s Public Reference Room which is located at 100 F Street, NE, Washington,
DC 20549. You may obtain information on the operation of the Public Reference Room by calling the SEC at 1-800-732-0330. You may
also find the registration statement and the attached deposit agreement on the SEC&rsquo;s website at www.sec.gov.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 4.3pt; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Share
Dividends and Other Distributions</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>How
will I receive dividends and other distributions on the ordinary shares underlying my ADSs?</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may make various types of distributions with respect to our securities. The depositary has agreed that, to the extent practicable,
it will pay to you the cash dividends or other distributions it or the custodian receives on ordinary shares or other deposited
securities, after converting any cash received into U.S. dollars (if it determines such conversion may be made on a reasonable
basis) and, in all cases, making any necessary deductions provided for in the deposit agreement. The depositary may utilize a
division, branch or affiliate of JPMorgan Chase Bank, N.A. to direct, manage and/or execute any public and/or private sale of
securities under the deposit agreement. Such division, branch and/or affiliate may charge the depositary a fee in connection with
such sales, which fee is considered an expense of the depositary. You will receive these distributions in proportion to the number
of underlying securities that your ADSs represent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></P>

<!-- Field: Page; Sequence: 125 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->121<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as stated below, the depositary will deliver such distributions to ADR holders in proportion to their interests in the following
manner:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 16.1pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Cash.</I>&nbsp;The
    depositary will distribute any U.S. dollars available to it resulting from a cash dividend or other cash distribution or the
    net proceeds of sales of any other distribution or portion thereof (to the extent applicable), on an averaged or other practicable
    basis, subject to (i)&nbsp;appropriate adjustments for taxes withheld, (ii)&nbsp;such distribution being impermissible or
    impracticable with respect to certain registered ADR holders, and (iii)&nbsp;deduction of the depositary&rsquo;s and/or its
    agents&rsquo; expenses in (1)&nbsp;converting any foreign currency to U.S. dollars to the extent that it determines that such
    conversion may be made on a reasonable basis, (2)&nbsp;transferring foreign currency or U.S. dollars to the United States
    by such means as the depositary may determine to the extent that it determines that such transfer may be made on a reasonable
    basis, (3)&nbsp;obtaining any approval or license of any governmental authority required for such conversion or transfer,
    which is obtainable at a reasonable cost and within a reasonable time and (4)&nbsp;making any sale by public or private means
    in any commercially reasonable manner.&nbsp;<I>If exchange rates fluctuate during a time when the depositary cannot convert
    a foreign currency, you may lose some or all of the value of the distribution.</I></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 16.1pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary Shares.&nbsp;In
    the case of a distribution in ordinary shares, the depositary will issue additional ADRs to evidence the number of ADSs representing
    such ordinary shares. Only whole ADSs will be issued. Any ordinary shares which would result in fractional ADSs will be sold
    and the net proceeds will be distributed in the same manner as cash to the ADR holders entitled thereto.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Rights to receive
    additional ordinary shares.</I>&nbsp;In the case of a distribution of rights to subscribe for additional ordinary shares or
    other rights, if we timely provide evidence satisfactory to the depositary that it may lawfully distribute such rights, the
    depositary will distribute warrants or other instruments in the discretion of the depositary representing rights to acquire
    additional ADRs. However, if we do not timely furnish such evidence, the depositary may:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
sell such rights if practicable and distribute the net proceeds in the same manner as cash to the ADR holders entitled thereto;
or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
if it is not practicable to sell such rights by reason of the non-transferability of the rights, limited markets therefor, their
short duration or otherwise, do nothing and allow such rights to lapse, in which case ADR holders will receive nothing and the
rights may lapse.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Other Distributions.</I>&nbsp;In
    the case of a distribution of securities or property other than those described above, the depositary may either (i)&nbsp;distribute
    such securities or property in any manner it deems equitable and practicable or (ii)&nbsp;to the extent the depositary deems
    distribution of such securities or property not to be equitable and practicable, sell such securities or property and distribute
    any net proceeds in the same way it distributes cash.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Elective Distributions.&nbsp;</I>In
    the case of a dividend payable at the election of our shareholders in cash or in additional ordinary shares, we will notify
    the depositary at least 30 days prior to the proposed distribution stating whether or not we wish such elective distribution
    to be made available to ADR holders. The depositary shall make such elective distribution available to ADR holders only if
    (i)&nbsp;we shall have timely requested that the elective distribution is available to ADR holders, (ii)&nbsp;the depositary
    shall have determined that such distribution is reasonably practicable and (iii)&nbsp;the depositary shall have received satisfactory
    documentation within the terms of the deposit agreement including any legal opinions of counsel that the depositary in its
    reasonable discretion may request. If the above conditions are not satisfied, the depositary shall, to the extent permitted
    by law, distribute to the ADR holders, on the basis of the same determination as is made in the local market in respect of
    the ordinary shares for which no election is made, either (x)&nbsp;cash or (y)&nbsp;additional ADSs representing such additional
    ordinary shares. If the above conditions are satisfied, the depositary shall establish procedures to enable ADR holders to
    elect the receipt of the proposed dividend in cash or in additional ADSs. There can be no assurance that ADR holders generally,
    or any ADR holder in particular, will be given the opportunity to receive elective distributions on the same terms and conditions
    as the holders of ordinary shares.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 16.1pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 16.1pt; text-align: justify; background-color: white"></P>

<!-- Field: Page; Sequence: 126 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->122<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 16.1pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the depositary determines in its discretion that any distribution described above is not practicable with respect to any specific
registered ADR holder, the depositary may choose any method of distribution that it deems practicable for such ADR holder, including
the distribution of foreign currency, securities or property, or it may retain such items, without paying interest on or investing
them, on behalf of the ADR holder as deposited securities, in which case the ADSs will also represent the retained items.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
U.S. dollars will be distributed by checks drawn on a bank in the United States for whole dollars and cents. Fractional cents
will be withheld without liability and dealt with by the depositary in accordance with its then current practices.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>The
depositary is not responsible if it fails to determine that any distribution or action is lawful or reasonably practicable.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>There
can be no assurance that the depositary will be able to convert any currency at a specified exchange rate or sell any property,
rights, shares or other securities at a specified price, nor that any of such transactions can be completed within a specified
time period. All purchases and sales of securities will be handled by the Depositary in accordance with its then current policies,
which are currently set forth in the &ldquo;Depositary Receipt Sale and Purchase of Security&rdquo; section of www.adr.com/Investors/FindOutAboutDRs,
the location and contents of which the Depositary shall be solely responsible for.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 4.5pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Deposit,
withdrawal and Cancellation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>How
does the depositary issue ADSs?</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
depositary will issue ADSs if you or your broker deposit ordinary shares or evidence of rights to receive ordinary shares with
the custodian and pay the fees and expenses owing to the depositary in connection with such issuance. In the case of the ADSs
to be issued under this prospectus, we will arrange with the underwriters named herein to deposit such ordinary shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary
shares deposited in the future with the custodian must be accompanied by certain delivery documentation and shall, at the time
of such deposit, be registered in the name of the depositary, the custodian or a nominee of either.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
custodian will hold all deposited ordinary shares (including those being deposited by or on our behalf in connection with this
offering to which this prospectus relates) for the account and to the order of the depositary for the benefit of registered holders
of ADRs, to the extent not prohibited by law. ADR holders thus have no direct ownership interest in the ordinary shares and only
have such rights as are contained in the deposit agreement. The custodian will also hold any additional securities, property and
cash received on or in substitution for the deposited ordinary shares. The deposited ordinary shares and any such additional items
are referred to as &ldquo;deposited securities.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
each deposit of ordinary shares, receipt of related delivery documentation and compliance with the other provisions of the deposit
agreement, including the payment of the fees and charges of the depositary and any taxes or other fees or charges owing, the depositary
will issue an ADR or ADRs in the name or upon the order of the person entitled thereto evidencing the number of ADSs to which
such person is entitled. All of the ADSs issued will, unless specifically requested to the contrary, be part of the depositary&rsquo;s
direct registration system, and a registered holder will receive periodic statements from the depositary which will show the number
of ADSs registered in such holder&rsquo;s name. An ADR holder can request that the ADSs not be held through the depositary&rsquo;s
direct registration system and that a certificated ADR be issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"></P>

<!-- Field: Page; Sequence: 127 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->123<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>How
do ADR holders cancel an ADS and obtain deposited securities?</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
you turn in your ADR certificate at the depositary&rsquo;s office, or when you provide proper instructions and documentation in
the case of direct registration ADSs, the depositary will, upon payment of certain applicable fees, charges and taxes, deliver
the underlying ordinary shares to you or upon your written order. Delivery of deposited securities in certificated form will be
made at the custodian&rsquo;s office. At your risk, expense and request, the depositary may deliver deposited securities at such
other place as you may request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
depositary may only restrict the withdrawal of deposited securities in connection with:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 16.1pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">temporary delays
    caused by closing our transfer books or those of the depositary or the deposit of ordinary shares in connection with voting
    at a shareholders meeting, or the payment of dividends;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the payment of fees,
    taxes and similar charges; or</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">compliance with
    any U.S. or foreign laws or governmental regulations relating to the ADRs or to the withdrawal of deposited securities.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
right of withdrawal may not be limited by any other provision of the deposit agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Record
Dates</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
depositary may, after consultation with us if practicable, fix record dates (which, to the extent applicable, shall be as near
as practicable to any corresponding record dates set by us) for the determination of the registered ADR holders who will be entitled
(or obligated, as the case may be):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 16.1pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to receive any distribution
    on or in respect of deposited securities;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.5pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to give instructions
    for the exercise of voting rights;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.5pt; text-align: justify; text-indent: -0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to pay the fee assessed
    by the depositary for administration of the ADR program and for any expenses as provided for in the ADR;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.5pt; text-align: justify; text-indent: -0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to receive any notice
    or to act in respect of other matters; or</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.5pt; text-align: justify; text-indent: -0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all subject to the
    provisions of the deposit agreement.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 4.5pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Voting
Rights</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>How
do I vote?</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you are an ADR holder and the depositary asks you to provide it with voting instructions, you may instruct the depositary how
to exercise the voting rights for the ordinary shares which underlie your ADSs. Subject to the next sentence, as soon as practicable
after receipt from us of notice of any meeting at which the holders of ordinary shares are entitled to vote, or of our solicitation
of consents or proxies from holders of ordinary shares, the depositary shall fix the ADS record date in accordance with the provisions
of the deposit agreement in respect of such meeting or solicitation of consent or proxy. The depositary shall, if we request in
writing in a timely manner (the depositary having no obligation to take any further action if our request shall not have been
received by the depositary at least 30 days prior to the date of such vote or meeting) and at our expense and provided no legal
prohibitions exist, distribute to the registered ADR holders a notice stating such information as is contained in the voting materials
received by the depositary, stating that that each registered holder of ADRs on the ADS record date will, subject to any applicable
provisions of the law of England and Wales, be entitled to instruct the depositary as to the exercise of any voting rights pertaining
to ordinary shares underlying such holder&rsquo;s ADSs, and describing how you may instruct the depositary to exercise the voting
rights for the ordinary shares which underlie your ADSs, including instructions for giving a discretionary proxy to a person designated
by us. For instructions to be valid, the depositary must receive them in the manner and on or before the date specified. The depositary
will try, as far as is practical, subject to the provisions of or governing the underlying ordinary shares or other deposited
securities, to vote or cause to be voted the ordinary shares or other deposited securities as you instruct. The depositary will
only vote or attempt to vote as you instruct. Holders are strongly encouraged to forward their voting instructions to the depositary
as soon as possible. Voting instructions will not be deemed to be received until such time as the ADR department responsible for
proxies and voting has received such instructions notwithstanding that such instructions may have been physically received by
the depositary prior to such time. The depositary will not itself exercise any voting discretion. Furthermore, neither the depositary
nor its agents are responsible for any failure to carry out any voting instructions, for the manner in which any vote is cast
or for the effect of any vote. Notwithstanding anything contained in the deposit agreement or any ADR, the depositary may, to
the extent not prohibited by law or regulations, or by the requirements of the stock exchange on which the ADSs are listed, in
lieu of distribution of the materials provided to the depositary in connection with any meeting of, or solicitation of consents
or proxies from, holders of deposited securities, distribute to the registered holders of ADRs a notice that provides such holders
with, or otherwise publicizes to such holders, instructions on how to retrieve such materials or receive such materials upon request
(<I>i.e.</I>, by reference to a website containing the materials for retrieval or a contact for requesting copies of the materials).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"></P>

<!-- Field: Page; Sequence: 128 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->124<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is no guarantee that you will receive voting materials in time to instruct the depositary to vote and it is possible that you,
or persons who hold their ADSs through brokers, dealers or other third parties, will not have the opportunity to exercise a right
to vote.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 5.8pt; text-align: justify; text-indent: 16.7pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Reports
and Other Communications</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 5.8pt; text-align: justify; text-indent: 16.7pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Will
ADR holders be able to view our reports?</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
depositary will make available for inspection by ADR holders at the offices of the depositary and the custodian the deposit agreement,
the provisions of or governing deposited securities, and any written communications from us which are both received by the custodian
or its nominee as a holder of deposited securities and made generally available to the holders of deposited securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
if we make any written communications generally available to holders of our ordinary shares, and we furnish copies thereof (or
English translations or summaries) to the depositary, it will distribute the same to registered ADR holders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 5.8pt; text-align: justify; text-indent: 16.7pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fees
and Expenses</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 5.8pt; text-align: justify; text-indent: 16.7pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>What
fees and expenses will I be responsible for paying?</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
depositary may charge each person to whom ADSs are issued, including, without limitation, issuances against deposits of ordinary
shares, issuances in respect of share distributions, rights and other distributions, issuances pursuant to a stock dividend or
stock split declared by us or issuances pursuant to a merger, exchange of securities or any other transaction or event affecting
the ADSs or deposited securities, and each person surrendering ADSs for withdrawal of deposited securities or whose ADSs are cancelled
or reduced for any other reason, $5.00 for each 100 ADSs (or any portion thereof) issued, delivered, reduced, cancelled or surrendered,
as the case may be. The depositary may sell (by public or private sale) sufficient securities and property received in respect
of a share distribution, rights and/or other distribution prior to such deposit to pay such charge.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following additional charges shall be incurred by the ADR holders, by any party depositing or withdrawing ordinary shares or by
any party surrendering ADSs and/or to whom ADSs are issued (including, without limitation, issuance pursuant to a stock dividend
or stock split declared by us or an exchange of stock regarding the ADSs or the deposited securities or a distribution of ADSs),
whichever is applicable:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 16.1pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a fee of U.S.$1.50 per ADR or ADRs for transfers
    of certificated or direct registration ADRs;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a fee of up to U.S.$0.05 per ADS for any cash
    distribution made pursuant to the deposit agreement;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an aggregate fee
    of up to U.S.$0.05 per ADS per calendar year (or portion thereof) for services performed by the depositary in administering
    the ADRs (which fee may be charged on a periodic basis during each calendar year and shall be assessed against holders of
    ADRs as of the record date or record dates set by the depositary during each calendar year and shall be payable in the manner
    described in the next succeeding provision);</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a fee for the reimbursement
    of such fees, charges and expenses as are incurred by the depositary and/or any of its agents (including, without limitation,
    the custodian and expenses incurred on behalf of holders in connection with compliance with foreign exchange control regulations
    or any law or regulation relating to foreign investment) in connection with the servicing of the ordinary shares or other
    deposited securities, the sale of securities (including, without limitation, deposited securities), the delivery of deposited
    securities or otherwise in connection with the depositary&rsquo;s or its custodian&rsquo;s compliance with applicable law,
    rule or regulation (which fees and charges shall be assessed on a proportionate basis against holders as of the record date
    or dates set by the depositary and shall be payable at the sole discretion of the depositary by billing such holders or by
    deducting such charge from one or more cash dividends or other cash distributions);</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36.2pt; text-align: justify; text-indent: -36.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36.2pt; text-align: justify; text-indent: -36.2pt"></P>

<!-- Field: Page; Sequence: 129 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->125<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36.2pt; text-align: justify; text-indent: -36.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a fee for the distribution
    of securities (or the sale of securities in connection with a distribution), such fee being in an amount equal to the $0.05
    per ADS issuance fee for the execution and delivery of ADSs which would have been charged as a result of the deposit of such
    securities (treating all such securities as if they were ordinary shares) but which securities or the net cash proceeds from
    the sale thereof are instead distributed by the depositary to those holders entitled thereto;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">stock transfer or
    other taxes and other governmental charges;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SWIFT, cable, telex
    and facsimile transmission and delivery charges incurred at your request in connection with the deposit or delivery of ordinary
    shares, ADRs or deposited securities;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">transfer or registration
    fees for the registration or transfer of deposited securities on any applicable register in connection with the deposit or
    withdrawal of deposited securities;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in connection with
    the conversion of foreign currency into U.S. dollars, JPMorgan Chase Bank, N.A. shall deduct out of such foreign currency
    the fees, expenses and other charges charged by it and/or its agent (which may be a division, branch or affiliate) so appointed
    in connection with such conversion; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">fees of any division,
    branch or affiliate of the depositary utilized by the depositary to direct, manage and/or execute any public and/or private
    sale of securities under the deposit agreement.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36.2pt; text-align: justify; text-indent: -36.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">JPMorgan
Chase Bank, N.A. and/or its agent may act as principal for such conversion of foreign currency. For further details see <U>www.adr.com</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will pay all other charges and expenses of the depositary and any agent of the depositary (except the custodian) pursuant to agreements
from time to time between us and the depositary. The charges described above may be amended from time to time by agreement between
us and the depositary. The right of the depositary to receive payment of fees, charges and expenses as provided above shall survive
the termination of the deposit agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
depositary may make available to us a set amount or a portion of the depositary fees charged in respect of the ADR program or
otherwise upon such terms and conditions as we and the depositary may agree from time to time. The depositary collects its fees
for issuance and cancellation of ADSs directly from investors depositing ordinary shares or surrendering ADSs for the purpose
of withdrawal or from intermediaries acting for them. The depositary collects fees for making distributions to investors by deducting
those fees from the amounts distributed or by selling a portion of distributable property to pay the fees. The depositary may
collect its annual fee for depositary services by deduction from cash distributions, or by directly billing investors, or by charging
the book-entry system accounts of participants acting for them. The depositary will generally set off the amounts owing from distributions
made to holders of ADSs. If, however, no distribution exists and payment owing is not timely received by the depositary, the depositary
may refuse to provide any further services to holders that have not paid those fees and expenses owing until such fees and expenses
have been paid. At the discretion of the depositary, all fees and charges owing under the deposit agreement are due in advance
and/or when declared owing by the depositary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 130 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->126<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Payment
of Taxes</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any taxes or other governmental charges (including any penalties and/or interest) shall become payable by or on behalf of the
custodian or the depositary with respect to any ADR, any deposited securities represented by the ADSs evidenced thereby or any
distribution thereon, such tax or other governmental charge shall be paid by the holder thereof to the depositary and by holding
or having held an ADR the holder and all prior holders thereof, jointly and severally, agree to indemnify, defend and save harmless
each of the depositary and its agents in respect thereof. If an ADR holder owes any tax or other governmental charge, the depositary
may (i)&nbsp;deduct the amount thereof from any cash distributions, or (ii)&nbsp;sell deposited securities by public or private
sale (after attempting by reasonable means to notify the ADR holder hereof prior to such sale) and deduct the amount owing from
the net proceeds of such sale. In either case the ADR holder remains liable for any shortfall. If any tax or governmental charge
is unpaid, the depositary may also refuse to effect any registration, registration of transfer,&nbsp;split-up&nbsp;or combination
of deposited securities or withdrawal of deposited securities until such payment is made. If any tax or governmental charge is
required to be withheld on any cash distribution, the depositary may deduct the amount required to be withheld from any cash distribution
or, in the case of a non-cash distribution, sell the distributed property or securities (by public or private sale) in such amounts
and in such manner as the depositary deems necessary and practicable to pay such taxes and distribute any remaining net proceeds
or the balance of any such property after deduction of such taxes to the ADR holders entitled thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
holding an ADR or an interest therein, you will be agreeing to indemnify us, the depositary, its custodian and any of our or their
respective officers, directors, employees, agents and affiliates against, and hold each of them harmless from, any claims by any
governmental authority with respect to taxes, additions to tax, penalties or interest arising out of any refund of taxes, reduced
rate of withholding at source or other tax benefit obtained.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Reclassifications,
Recapitalizations and Mergers</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we take certain actions that affect the deposited securities, including (i)&nbsp;any change in nominal value,&nbsp;split-up,&nbsp;consolidation,
cancellation or other reclassification of deposited securities or (ii)&nbsp;any distributions of ordinary shares or other property
not made to holders of ADRs or (iii)&nbsp;any recapitalization, reorganization, merger, consolidation, liquidation, receivership,
bankruptcy or sale of all or substantially all of our assets, then the depositary may choose to, and shall if reasonably requested
by us:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">amend
the form of ADR;</FONT></TD>
</TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
<TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
<TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">distribute
additional or amended ADRs;</FONT></TD>
</TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
<TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
<TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">distribute
cash, securities or other property it has received in connection with such actions;</FONT></TD>
</TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
<TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
<TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">sell
any securities or property received and distribute the proceeds as cash; or</FONT></TD>
</TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
<TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
<TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">none
of the above.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the depositary does not choose any of the above options, any of the cash, securities or other property it receives will constitute
part of the deposited securities and each ADS will then represent a proportionate interest in such property.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Amendment
and Termination</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>How
may the deposit agreement be amended?</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may agree with the depositary to amend the deposit agreement and the ADSs without your consent for any reason. ADR holders must
be given at least 30 days&rsquo; notice of any amendment that imposes or increases any fees or charges (other than stock transfer
or other taxes and other governmental charges, transfer or registration fees, SWIFT, cable, telex or facsimile transmission costs,
delivery costs or other such expenses), or otherwise prejudices any substantial existing right of ADR holders. Such notice need
not describe in detail the specific amendments effectuated thereby, but must identify to ADR holders a means to access the text
of such amendment. If an ADR holder continues to hold an ADR or ADRs after being so notified, such ADR holder is deemed to agree
to such amendment and to be bound by the deposit agreement as so amended. Any amendments or supplements which (i)&nbsp;are reasonably
necessary (as agreed by us and the depositary) in order for (a)&nbsp;the ADSs to be registered on Form F-6 under the Securities
Act or (b)&nbsp;the ADSs or ordinary shares to be traded solely in electronic book-entry form and (ii)&nbsp;do not in either such
case impose or increase any fees or charges to be borne by ADR holders, shall be deemed not to prejudice any substantial rights
of ADR holders. Notwithstanding the foregoing, if any governmental body or regulatory body should adopt new laws, rules or regulations
which would require amendment or supplement of the deposit agreement or the form of ADR to ensure compliance therewith, we and
the depositary may amend or supplement the deposit agreement and the ADR at any time in accordance with such changed laws, rules
or regulations, which amendment or supplement may take effect before a notice is given or within any other period of time as required
for compliance. No amendment, however, will impair your right to surrender your ADSs and receive the underlying securities, except
in order to comply with mandatory provisions of applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 131 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->127<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>How
may the deposit agreement be terminated?</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
depositary may, and shall at our written direction, terminate the deposit agreement and the ADRs by mailing notice of such termination
to the registered holders of ADRs at least 30 days prior to the date fixed in such notice for such termination; provided, however,
if the depositary shall have (i)&nbsp;resigned as depositary under the deposit agreement, notice of such termination by the depositary
shall not be provided to registered holders unless a successor depositary shall not be operating under the deposit agreement within
60 days of the date of such resignation, and (ii)&nbsp;been removed as depositary under the deposit agreement, notice of such
termination by the depositary shall not be provided to registered holders of ADRs unless a successor depositary shall not be operating
under the deposit agreement on the 120<SUP>th</SUP>&nbsp;day after our notice of removal was first provided to the depositary.
After termination, the depositary&rsquo;s only responsibility will be (i)&nbsp;to deliver deposited securities to ADR holders
who surrender their ADRs, and (ii)&nbsp;to hold or sell distributions received on deposited securities. As soon as practicable
after the expiration of six months from the termination date, the depositary will sell the deposited securities which remain and
hold the net proceeds of such sales (as long as it may lawfully do so), without liability for interest, in trust for the ADR holders
who have not yet surrendered their ADRs. After making such sale, the depositary shall have no obligations except to account for
such proceeds and other cash.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Limitations
on Obligations and Liability to ADR holders</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Limits
on our obligations and the obligations of the depositary; limits on liability to ADR holders and holders of ADSs</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to the issue, registration, registration of transfer, split-up, combination, or cancellation of any ADRs, or the delivery of any
distribution in respect thereof, and from time to time in the case of the production of proofs as described below, we or the depositary
or its custodian may require:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">payment with respect
    thereto of (i)&nbsp;any stock transfer or other tax or other governmental charge, (ii)&nbsp;any stock transfer or registration
    fees in effect for the registration of transfers of ordinary shares or other deposited securities upon any applicable register
    and (iii)&nbsp;any applicable fees and expenses described in the deposit agreement;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the production of
    proof satisfactory to it of (i)&nbsp;the identity of any signatory and genuineness of any signature and (ii)&nbsp;such other
    information, including without limitation, information as to citizenship, residence, exchange control approval, beneficial
    ownership of any securities, compliance with applicable law, regulations, provisions of or governing deposited securities
    and terms of the deposit agreement and the ADRs, as it may deem necessary or proper; and</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">compliance with
    such regulations as the depositary may establish consistent with the deposit agreement.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
issuance of ADRs, the acceptance of deposits of ordinary shares, the registration, registration of transfer, split-up or combination
of ADRs or the withdrawal of ordinary shares, may be suspended, generally or in particular instances, when the ADR register or
any register for deposited securities is closed or when any such action is deemed advisable by the depositary; provided that the
ability to withdraw ordinary shares may only be limited under the following circumstances: (i)&nbsp;temporary delays caused by
closing transfer books of the depositary or our transfer books or the deposit of ordinary shares in connection with voting at
a shareholders meeting, or the payment of dividends, (ii)&nbsp;the payment of fees, taxes, and similar charges, and (iii)&nbsp;compliance
with any laws or governmental regulations relating to ADRs or to the withdrawal of deposited securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 132 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->128<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
deposit agreement expressly limits the obligations and liability of the depositary, ourselves and each of our and the depositary&rsquo;s
respective agents, provided, however, that no disclaimer of liability under the Securities Act is intended by any of the limitations
of liabilities provisions of the deposit agreement. In the deposit agreement it provides that neither we nor the depositary nor
any such agent will be liable to registered holders or beneficial owners of ADSs if:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any present or future
    law, rule, regulation, fiat, order or decree of the United States, England and Wales or any other country or jurisdiction,
    or of any governmental or regulatory authority or securities exchange or market or automated quotation system, the provisions
    of or governing any deposited securities, any present or future provision of our charter, any act of God, war, terrorism,
    nationalization, expropriation, currency restrictions, work stoppage, strike, civil unrest, revolutions, rebellions, explosions,
    computer failure or circumstance beyond our, the depositary&rsquo;s or our respective agents&rsquo; direct and immediate control
    shall prevent or delay, or shall cause any of them to be subject to any civil or criminal penalty in connection with, any
    act which the deposit agreement or the ADRs provide shall be done or performed by us, the depositary or our respective agents
    (including, without limitation, voting);</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">it exercises or
    fails to exercise discretion under the deposit agreement or the ADRs including, without limitation, any failure to determine
    that any distribution or action may be lawful or reasonably practicable;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">it performs its
    obligations under the deposit agreement and ADRs without gross negligence or willful misconduct; or</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">it takes any action
    or refrains from taking any action in reliance upon the advice of or information from legal counsel, accountants, any person
    presenting ordinary shares for deposit, any registered holder of ADRs, or any other person believed by it to be competent
    to give such advice or information.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36.2pt; text-align: justify; text-indent: -36.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We,
the depositary and its agents may rely and shall be protected in acting upon any written notice, request, direction, instruction
or document believed by them to be genuine and to have been signed, presented or given by the proper party or parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
the depositary nor its agents have any obligation to appear in, prosecute or defend any action, suit or other proceeding in respect
of any deposited securities or the ADRs. We and our agents shall only be obligated to appear in, prosecute or defend any action,
suit or other proceeding in respect of any deposited securities or the ADRs, which in our opinion may involve us in expense or
liability, if indemnity satisfactory to us against all expense (including fees and disbursements of counsel) and liability is
furnished as often as may be required. The depositary and its agents may fully respond to any and all demands or requests for
information maintained by or on its behalf in connection with the deposit agreement, any registered holder or holders of ADRs,
any ADRs or otherwise related to the deposit agreement or ADRs to the extent such information is requested or required by or pursuant
to any lawful authority, including without limitation laws, rules, regulations, administrative or judicial process, banking, securities
or other regulators. The depositary shall not be liable for the acts or omissions made by, or the insolvency of, any securities
depository, clearing agency or settlement system. Furthermore, the depositary shall not be responsible for, and shall incur no
liability in connection with or arising from, the insolvency of any custodian that is not a branch or affiliate of JPMorgan Chase
Bank, N.A. Notwithstanding anything to the contrary contained in the deposit agreement or any ADRs, the depositary shall not be
responsible for, and shall incur no liability in connection with or arising from, any act or omission to act on the part of the
custodian except to the extent that any registered holder of ADRs has incurred liability directly as a result of the custodian
having (i)&nbsp;committed fraud or willful misconduct in the provision of custodial services to the depositary or (ii)&nbsp;failed
to use reasonable care in the provision of custodial services to the depositary as determined in accordance with the standards
prevailing in the jurisdiction in which the custodian is located. The depositary shall not have any liability for the price received
in connection with any sale of securities, the timing thereof or any delay in action or omission to act nor shall it be responsible
for any error or delay in action, omission to act, default or negligence on the part of the party so retained in connection with
any such sale or proposed sale.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
depositary has no obligation to inform ADR holders or other holders of an interest in any ADSs about the requirements of the law
of England and Wales, rules or regulations or any changes therein or thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 133 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->129<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
the depositary nor its agents will be responsible for any failure to carry out any instructions to vote any of the deposited securities,
for the manner in which any such vote is cast or for the effect of any such vote. The depositary may rely upon instructions from
us or our counsel in respect of any approval or license required for any currency conversion, transfer or distribution. The depositary
shall not incur any liability for the content of any information submitted to it by us or on our behalf for distribution to ADR
holders or for any inaccuracy of any translation thereof, for any investment risk associated with acquiring an interest in the
deposited securities, for the validity or worth of the deposited securities, for the credit-worthiness of any third party, for
allowing any rights to lapse upon the terms of the deposit agreement or for the failure or timeliness of any notice from us. The
depositary shall not be liable for any acts or omissions made by a successor depositary whether in connection with a previous
act or omission of the depositary or in connection with any matter arising wholly after the removal or resignation of the depositary.
Neither the depositary nor any of its agents shall be liable to registered holders or beneficial owners of interests in ADSs for
any indirect, special, punitive or consequential damages (including, without limitation, legal fees and expenses) or lost profits,
in each case of any form incurred by any person or entity, whether or not foreseeable and regardless of the type of action in
which such a claim may be brought.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the deposit agreement each party thereto (including, for avoidance of doubt, each holder and beneficial owner and/or holder of
interests in ADRs) irrevocably waives, to the fullest extent permitted by applicable law, any right it may have to a trial by
jury in any suit, action or proceeding against the depositary and/or us directly or indirectly arising out of or relating to the
ordinary shares or other deposited securities, the ADSs or the ADRs, the deposit agreement or any transaction contemplated therein,
or the breach thereof (whether based on contract, tort, common law or any other theory).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
depositary and its agents may own and deal in any class of securities of our company and our affiliates and in ADSs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Disclosure
of Interest in ADSs</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the extent that the provisions of or governing any deposited securities may require disclosure of or impose limits on beneficial
or other ownership of deposited securities, other ordinary shares and other securities and may provide for blocking transfer,
voting or other rights to enforce such disclosure or limits, you agree to comply with all such disclosure requirements and ownership
limitations and to comply with any reasonable instructions we may provide in respect thereof. We reserve the right to instruct
you to deliver your ADSs for cancellation and withdrawal of the deposited securities so as to permit us to deal with you directly
as a holder of ordinary shares and, by holding an ADS or an interest therein, you will be agreeing to comply with such instructions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Books
of Depositary</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
depositary or its agent will maintain a register for the registration, registration of transfer, combination and split-up of ADRs,
which register shall include the depositary&rsquo;s direct registration system. Registered holders of ADRs may inspect such records
at the depositary&rsquo;s office at all reasonable times, but solely for the purpose of communicating with other holders in the
interest of the business of our company or a matter relating to the deposit agreement. Such register may be closed at any time
or from time to time, when deemed expedient by the depositary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
depositary will maintain facilities for the delivery and receipt of ADRs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 134 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->130<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pre-release
of ADSs</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
its capacity as depositary, the depositary shall not lend ordinary shares or ADSs; provided, however, that the depositary may
(i)&nbsp;issue ADSs prior to the receipt of ordinary shares and (ii)&nbsp;deliver ordinary shares prior to the receipt of ADSs
for withdrawal of deposited securities, including ADSs which were issued under (i)&nbsp;above but for which ordinary shares may
not have been received, each such transaction a &ldquo;pre-release.&rdquo; The depositary may receive ADSs in lieu of ordinary
shares under (i)&nbsp;above (which ADSs will promptly be canceled by the depositary upon receipt by the depositary) and receive
ordinary shares in lieu of ADSs under (ii)&nbsp;above. Each such pre-release will be subject to a written agreement whereby the
person/entity, or applicant to whom ADSs or ordinary shares are to be delivered (a)&nbsp;represents that at the time of the pre-release
the applicant or its customer owns the ordinary shares or ADSs that are to be delivered by the applicant under such pre-release,
(b)&nbsp;agrees to indicate the depositary as owner of such ordinary shares or ADSs in its records and to hold such ordinary shares
or ADSs in trust for the depositary until such ordinary shares or ADSs are delivered to the depositary or the custodian, (c)&nbsp;unconditionally
guarantees to deliver to the depositary or the custodian, as applicable, such ordinary shares or ADSs, and (d)&nbsp;agrees to
any additional restrictions or requirements that the depositary deems appropriate. Each such pre-release will be at all times
fully collateralized with cash, U.S. government securities or such other collateral as the depositary deems appropriate, terminable
by the depositary on not more than five (5)&nbsp;business days&rsquo; notice and subject to such further indemnities and credit
regulations as the depositary deems appropriate. The depositary will normally limit the number of ADSs and ordinary shares involved
in such pre-release at any one time to thirty per cent. (30%)&nbsp;of the ADSs outstanding (without giving effect to ADSs outstanding
under (i)&nbsp;above), provided, however, that the depositary reserves the right to change or disregard such limit from time to
time as it deems appropriate. The depositary may also set limits with respect to the number of ADSs and ordinary shares involved
in pre-release with any one person on a case-by-case basis as it deems appropriate. The depositary may retain for its own account
any compensation received by it in conjunction with the foregoing. Collateral provided in connection with pre-release transactions,
but not the earnings thereon, shall be held for the benefit of the ADR holders (other than the applicant).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Appointment</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the deposit agreement, each registered holder of ADRs and each person holding an interest in ADSs, upon acceptance of any ADSs
(or any interest therein) issued in accordance with the terms and conditions of the deposit agreement will be deemed for all purposes
to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">be a party to and
    bound by the terms of the deposit agreement and the applicable ADR or ADRs; and</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">appoint the depositary
    its attorney-in-fact, with full power to delegate, to act on its behalf and to take any and all actions contemplated in the
    deposit agreement and the applicable ADR or ADRs, to adopt any and all procedures necessary to comply with applicable laws
    and to take such action as the depositary in its sole discretion may deem necessary or appropriate to carry out the purposes
    of the deposit agreement and the applicable ADR and ADRs, the taking of such actions to be the conclusive determinant of the
    necessity and appropriateness thereof.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36.2pt; text-indent: -36.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Governing
Law</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
deposit agreement and the ADRs shall be governed by and construed in accordance with the laws of the State of New York. In the
deposit agreement, we have submitted to the jurisdiction of the courts of the State of New York and appointed an agent for service
of process on our behalf. Notwithstanding the foregoing, any action based on the deposit agreement or the transactions contemplated
thereby may be instituted by the depositary in any competent court in England and Wales.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
holding an ADS or an interest therein, registered holders of ADRs and owners of ADSs each irrevocably agree that any legal suit,
action or proceeding against or involving us or the depositary, arising out of or based upon the deposit agreement, the ADSs or
the transactions contemplated thereby, may only be instituted in a state or federal court in New York, New York, and each irrevocably
waives any objection which it may have to the laying of venue of any such proceeding, and irrevocably submits to the exclusive
jurisdiction of such courts in any such suit, action or proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 135 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->131<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="a_022"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>ORDINARY
SHARES AND ads</B></FONT><B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">s <FONT STYLE="text-transform: uppercase">ELIGIBLE
FOR FUTURE SALE</FONT></FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to this offering, no public market existed for our ADSs. Future sales of substantial amounts of ADSs in the public market, the
availability of ADSs for future sale or the perception that such sales may occur, however, could adversely affect the market price
of our ADSs and/or ordinary shares and also could adversely affect our future ability to raise capital through the sale of our
ADSs and/or ordinary shares or other equity-related securities at times and prices we believe appropriate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Based on the number of
our ordinary shares outstanding as of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; , 2018, upon the closing of the offering, we will have &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
ADSs outstanding, representing &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ordinary shares, and&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ordinary
shares outstanding (including ordinary shares in the form of ADSs), or, if the underwriters exercise in full their over-allotment
option to purchase an additional &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ADSs, &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
ordinary shares (including ordinary shares in the form of ADSs).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
of the ADSs sold in this offering will be freely tradable without restrictions or further registration under the Securities Act,
except for any shares sold to our &ldquo;affiliates,&rdquo; as that term is defined under Rule 144 under the Securities Act. The
outstanding ordinary shares held by existing shareholders are &ldquo;restricted securities,&rdquo; as that term is defined in
Rule 144 under the Securities Act. Restricted securities may be sold in the public market only if the offer and sale is registered
under the Securities Act or if the offer and sale of those securities qualifies for exemption from registration, including exemptions
provided by Rules 144 or 701 promulgated under the Securities Act. Restricted securities may also be sold outside of the United
States to non-U.S. persons in accordance with Rule 904 of Regulation S under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the lock-up agreements described below and the provisions of Rule 144 or Regulation S under the Securities Act, as well as
our insider trading policy, these restricted securities will be available for sale in the public market at various times beginning
at least 135 days after the date of this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Rule
144</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
general, under Rule 144 as currently in effect, once we have been subject to public company reporting requirements for at least
90 days, a person who is not deemed to have been one of our affiliates for purposes of the Securities Act at any time during the
90 days preceding a sale and who has beneficially owned the shares proposed to be sold for at least six months, including the
holding period of any prior owner other than our affiliates, is entitled to sell such shares without complying with the manner
of sale, volume limitation, or notice provisions of Rule 144, subject to compliance with the public information requirements of
Rule 144. If such a person has beneficially owned the shares proposed to be sold for at least one year, including the holding
period of any prior owner other than our affiliates, then such person is entitled to sell such shares without complying with any
of the requirements of Rule 144.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
general, under Rule 144, as currently in effect, our affiliates or persons selling shares on behalf of our affiliates are entitled
to sell upon expiration of the lock-up agreements described below, within any three-month period beginning 90 days after the date
of this prospectus, a number of shares that does not exceed the greater of:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1% of the number
    of ADSs then outstanding, which will equal approximately shares immediately after this offering&#894; or</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the average weekly
    trading volume of our ADSs during the four calendar weeks preceding the filing of a notice on Form 144 with respect to such
    sale.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales
under Rule 144 by our affiliates or persons selling shares on behalf of our affiliates are also subject to certain manner of sale
provisions and notice requirements and to the availability of current public information about us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Rule
701</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rule
701 generally allows a shareholder who was issued shares pursuant to a written compensatory plan or contract and who is not deemed
to have been an affiliate of our company during the immediately preceding 90 days to sell these shares in reliance upon Rule 144,
but without being required to comply with the public information, holding period, volume limitation or notice provisions of Rule
144. Rule 701 also permits affiliates of our company to sell their Rule 701 shares under Rule 144 without complying with the holding
period requirements of Rule 144. All holders of Rule 701 shares, however, are required by that rule to wait until 90 days after
the date of this prospectus before selling those shares pursuant to Rule 701.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Regulation
S</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Regulation
S provides generally that sales made in offshore transactions are not subject to the registration or prospectus-delivery requirements
of the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Lock-up
Arrangements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We,
our executive officers, directors and certain holders of our shares have agreed that, subject to certain exceptions, for a period
of up to 180 days from the date of this prospectus, we and they will not, without the prior written consent of Laidlaw &amp; Company
(UK) Ltd., dispose of or hedge any shares or any securities convertible into or exchangeable for shares of our company. Laidlaw
&amp; Company (UK) Ltd. may, at their discretion, release or waive any of the securities subject to these lock-up agreements at
any time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 136 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->132<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="a_023"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>MATERIAL
TAX CONSIDERATIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>U.S.
Federal Income Tax Considerations for U.S. Holders</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following discussion describes the material U.S. federal income tax consequences relating to the ownership and disposition of
our ADSs by U.S. Holders. This discussion applies to U.S. Holders that purchase our ADSs pursuant to this offering and hold such
ADSs as capital assets for tax purposes. This discussion is based on the Internal Revenue Code, U.S. Treasury regulations promulgated
thereunder and administrative and judicial interpretations thereof, and the income tax treaty between the United Kingdom and the
United States, or the Treaty, all as in effect on the date hereof and all of which are subject to change, possibly with retroactive
effect. This discussion does not address all of the U.S. federal income tax consequences that may be relevant to specific U.S.
Holders in light of their particular circumstances or to U.S. Holders subject to special treatment under U.S. federal income tax
law (such as certain financial institutions, insurance companies, dealers or traders in securities or other persons that generally
mark their securities to market for U.S. federal income tax purposes, tax-exempt entities or governmental organizations, retirement
plans, regulated investment companies, real estate investment trusts, grantor trusts, brokers, dealers or traders in securities,
commodities, currencies or notional principal contracts, certain former citizens or long-term residents of the United States,
persons who hold our ADSs as part of a &ldquo;straddle,&rdquo; &ldquo;hedge,&rdquo; &ldquo;conversion transaction,&rdquo; &ldquo;synthetic
security&rdquo; or integrated investment, persons that have a &ldquo;functional currency&rdquo; other than the U.S. dollar, persons
who are subject to the tax accounting rules of Section 451(b) of the Internal Revenue Code, persons that own directly, indirectly
or through attribution 10% or more (by vote or value) of our equity, corporations that accumulate earnings to avoid U.S. federal
income tax, partnerships and other pass-through entities, and investors in such pass-through entities). This discussion does not
address any U.S. state or local or non-U.S. tax consequences or any U.S. federal estate, gift or alternative minimum tax consequences.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
used in this discussion, the term &ldquo;U.S. Holder&rdquo; means a beneficial owner of our ADSs that is, for U.S. federal income
tax purposes, (1) an individual who is a citizen or resident of the United States, (2) a corporation (or entity treated as a corporation
for U.S. federal income tax purposes) created or organized in or under the laws of the United States, any state thereof, or the
District of Columbia, (3) an estate the income of which is subject to U.S. federal income tax regardless of its source or (4)
a trust (x) with respect to which a court within the United States is able to exercise primary supervision over its administration
and one or more United States persons have the authority to control all of its substantial decisions or (y) that has elected under
applicable U.S. Treasury regulations to be treated as a domestic trust for U.S. federal income tax purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an entity treated as a partnership for U.S. federal income tax purposes holds our ADSs, the U.S. federal income tax consequences
relating to an investment in such ADSs will depend upon the status and activities of such entity and the particular partner. Any
such entity and a partner in any such entity should consult its own tax advisor regarding the U.S. federal income tax consequences
applicable to it (and, as applicable, its partners) of the purchase, ownership and disposition of our ADSs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have not sought, nor will we seek, a ruling from the IRS with respect to the matters discussed below. There can be no assurance
that the IRS will not take a different position concerning the tax consequences of the purchase, ownership or disposition of the
ADSs or that any such position would not be sustained. Persons considering an investment in our ADSs should consult their own
tax advisors as to the particular tax consequences applicable to them relating to the purchase, ownership and disposition of our
ADSs, including the applicability of U.S. federal, state and local tax laws and non-U.S. tax laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Passive
Foreign Investment Company Rules</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
general, a corporation organized outside the United States will be treated as a PFIC for any taxable year in which either (1)
at least 75% of its gross income is &ldquo;passive income,&rdquo; or the PFIC income test, or (2) on average at least 50% of its
assets, determined on a quarterly basis, are assets that produce passive income or are held for the production of passive income,
or the PFIC asset test. Passive income for this purpose generally includes, among other things, dividends, interest, royalties,
rents, and gains from the sale or exchange of property that give rise to passive income. Assets that produce or are held for the
production of passive income generally include cash, even if held as working capital or raised in a public offering, marketable
securities, and other assets that may produce passive income. Generally, in determining whether a non-U.S. corporation is a PFIC,
a proportionate share of the income and assets of each corporation in which it owns, directly or indirectly, at least a 25% interest
(by value) is taken into account.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 137 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->133<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
PFIC status is determined on an annual basis and generally cannot be determined until the end of the taxable year, based on the
nature of our current and expected income and the current and expected value and composition of our assets, we believe we were
a PFIC for our 2017 tax year and we expect to be a PFIC for our current taxable year. There can be no assurance that we will not
be a PFIC in future taxable years. Even if we determine that we are not a PFIC for a taxable year, there can be no assurance that
the IRS will agree with our conclusion and that the IRS would not successfully challenge our position. Because of the uncertainties
involved in establishing our PFIC status, our U.S. counsel expresses no opinion regarding our PFIC status, and also expresses
no opinion with respect to our predictions or past determinations regarding our PFIC status.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we are a PFIC in any taxable year during which a U.S. Holder owns our ADSs, the U.S. Holder could be liable for additional taxes
and interest charges under the &ldquo;PFIC excess distribution regime&rdquo; upon (1) a distribution paid during a taxable year
that is greater than 125% of the average annual distributions paid in the three preceding taxable years, or, if shorter, the U.S.
Holder&rsquo;s holding period for our ADSs, and (2) any gain recognized on a sale, exchange or other disposition, including, under
certain circumstances, a pledge, of our ADSs, whether or not we continue to be a PFIC. Under the PFIC excess distribution regime,
the tax on such distribution or gain would be determined by allocating the distribution or gain ratably over the U.S. Holder&rsquo;s
holding period for our ADSs. The amount allocated to the current taxable year (<I>i.e</I>., the year in which the distribution
occurs or the gain is recognized) and any year prior to the first taxable year in which we are a PFIC will be taxed as ordinary
income earned in the current taxable year. The amount allocated to other taxable years will be taxed at the highest marginal rates
in effect for individuals or corporations, as applicable, to ordinary income for each such taxable year, and an interest charge,
generally applicable to underpayments of tax, will be added to the tax.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we are a PFIC for any year during which a U.S. Holder holds our ADSs, we must generally continue to be treated as a PFIC by that
U.S. Holder for all succeeding years during which the U.S. Holder holds such ADSs, unless we cease to meet the requirements for
PFIC status and the U.S. Holder makes a &ldquo;deemed sale&rdquo; election with respect to our ADSs. If the election is made,
the U.S. Holder will be deemed to sell our ADSs it holds at their fair market value on the last day of the last taxable year in
which we qualified as a PFIC, and any gain recognized from such deemed sale would be taxed under the PFIC excess distribution
regime. After the deemed sale election, the U.S. Holder&rsquo;s ADSs would not be treated as shares of a PFIC unless we subsequently
become a PFIC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we are a PFIC for any taxable year during which a U.S. Holder holds our ADSs and one of our non-United States subsidiaries is
also a PFIC (<I>i.e</I>., a lower-tier PFIC), such U.S. Holder would be treated as owning a proportionate amount (by value) of
the shares of the lower-tier PFIC and would be taxed under the PFIC excess distribution regime on distributions by the lower-tier
PFIC and on gain from the disposition of shares of the lower-tier PFIC even though such U.S. Holder would not receive the proceeds
of those distributions or dispositions. Any of our non-United States subsidiaries that have elected to be disregarded as entities
separate from us or as partnerships for U.S. federal income tax purposes would not be corporations under U.S. federal income tax
law and accordingly, cannot be classified as lower-tier PFICs. However, a non-United States subsidiary that has not made the election
may be classified as a lower-tier PFIC if we are a PFIC during your holding period and the subsidiary meets the PFIC income test
or PFIC asset test.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we are a PFIC, a U.S. Holder will not be subject to tax under the PFIC excess distribution regime on distributions or gain recognized
on our ADSs if a valid &ldquo;mark-to-market&rdquo; election is made by the U.S. Holder for our ADSs. An electing U.S. Holder
generally would take into account as ordinary income each year, the excess of the fair market value of our ADSs held at the end
of such taxable year over the adjusted tax basis of such ADSs. The U.S. Holder would also take into account, as an ordinary loss
each year, the excess of the adjusted tax basis of such ADSs over their fair market value at the end of the taxable year, but
only to the extent of the excess of amounts previously included in income over ordinary losses deducted as a result of the mark-to-market
election. The U.S. Holder&rsquo;s tax basis in our ADSs would be adjusted annually to reflect any income or loss recognized as
a result of the mark-to-market election. Any gain from a sale, exchange or other disposition of our ADSs in any taxable year in
which we are a PFIC would be treated as ordinary income and any loss from such sale, exchange or other disposition would be treated
first as ordinary loss (to the extent of any net mark-to-market gains previously included in income) and thereafter as capital
loss. If, after having been a PFIC for a taxable year, we cease to be classified as a PFIC because we no longer meet the PFIC
income or PFIC asset test, the U.S. Holder would not be required to take into account any latent gain or loss in the manner described
above and any gain or loss recognized on the sale or exchange of the ADSs would be classified as a capital gain or loss.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 138 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->134<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
mark-to-market election is available to a U.S. Holder only for &ldquo;marketable stock.&rdquo; Generally, stock will be considered
marketable stock if it is &ldquo;regularly traded&rdquo; on a &ldquo;qualified exchange&rdquo; within the meaning of applicable
U.S. Treasury regulations. A class of stock is regularly traded during any calendar year during which such class of stock is traded,
other than in de minimis quantities, on at least 15 days during each calendar quarter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
ADSs will be marketable stock as long as they remain listed on Nasdaq and are regularly traded. A mark-to-market election will
not apply to the ADSs for any taxable year during which we are not a PFIC, but will remain in effect with respect to any subsequent
taxable year in which we become a PFIC. Such election will not apply to any of our non-U.S. subsidiaries. Accordingly, a U.S.
Holder may continue to be subject to tax under the PFIC excess distribution regime with respect to any lower-tier PFICs notwithstanding
the U.S. Holder&rsquo;s mark-to-market election for our ADSs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
tax consequences that would apply if we are a PFIC would also be different from those described above if a U.S. Holder were able
to make a valid QEF election. As we do not expect to provide U.S. Holders with the information necessary for a U.S. Holder to
make a QEF election, prospective investors should assume that a QEF election will not be available.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
U.S. federal income tax rules relating to PFICs are very complex. Prospective U.S. investors are strongly urged to consult their
own tax advisors with respect to the impact of PFIC status on the purchase, ownership and disposition of our ADSs, the consequences
to them of an investment in a PFIC, any elections available with respect to the ADSs and the IRS information reporting obligations
with respect to the purchase, ownership and disposition of ADSs of a PFIC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Distributions</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the discussion above under &ldquo;&mdash; Passive Foreign Investment Company Rules,&rdquo; a U.S. Holder that receives a distribution
with respect to our ADSs generally will be required to include the gross amount of such distribution in gross income as a dividend
when actually or constructively received by the U.S. Holder to the extent of the U.S. Holder&rsquo;s pro rata share of our current
and/or accumulated earnings and profits (as determined under U.S. federal income tax principles). To the extent a distribution
received by a U.S. Holder is not a dividend because it exceeds the U.S. Holder&rsquo;s pro rata share of our current and accumulated
earnings and profits, it will be treated first as a tax-free return of capital and reduce (but not below zero) the adjusted tax
basis of the U.S. Holder&rsquo;s ADSs. To the extent the distribution exceeds the adjusted tax basis of the U.S. Holder&rsquo;s
ADSs, the remainder will be taxed as capital gain. Because we may not account for our earnings and profits in accordance with
U.S. federal income tax principles, U.S. Holders should expect all distributions to be reported to them as dividends. The amount
of a dividend will include any amounts withheld by the company in respect of United Kingdom taxes.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Distributions
on our ADSs that are treated as dividends generally will constitute income from sources outside the United States for foreign
tax credit purposes and generally will constitute passive category income. Subject to applicable limitations, some of which vary
depending upon the U.S. Holder&rsquo;s particular circumstances, any United Kingdom income taxes withheld from dividends on ADSs
at a rate not exceeding the rate provided by the Treaty will be creditable against the U.S. Holder&rsquo;s U.S. federal income
tax liability. The rules governing foreign tax credits are complex and U.S. Holders should consult their tax advisers regarding
the creditability of foreign taxes in their particular circumstances. In lieu of claiming a foreign tax credit, U.S. Holders may,
at their election, deduct foreign taxes, including any United Kingdom income tax, in computing their taxable income, subject to
generally applicable limitations under U.S. law. An election to deduct foreign taxes instead of claiming foreign tax credits applies
to all foreign taxes paid or accrued in the taxable year. The amount of any dividend income paid in a currency other than the
U.S. dollar will be the U.S. dollar amount calculated by reference to the exchange rate in effect on the date of actual or constructive
receipt, regardless of whether the payment is in fact converted into U.S. dollars at that time. If the dividend is converted into
U.S. dollars on the date of receipt, a U.S. holder should not be required to recognize foreign currency gain or loss in respect
of the dividend amount. A U.S. Holder may have foreign currency gain or loss if the dividend is converted into U.S. dollars after
the date of receipt.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Distributions
paid on our ADSs will not be eligible for the &ldquo;dividends received&rdquo; deduction generally allowed to corporate shareholders
with respect to dividends received from U.S. corporations under the Internal Revenue Code. Dividends paid by a &ldquo;qualified
foreign corporation&rsquo;&rsquo; to non-corporate U.S. Holders are eligible for taxation at a reduced capital gains rate rather
than the marginal tax rates generally applicable to ordinary income provided that a holding period requirement (more than 60 days
of ownership, without protection from the risk of loss, during the 121-day period beginning 60 days before the ex-dividend date)
and certain other requirements are met. Each U.S. Holder is advised to consult its tax advisors regarding the availability of
the reduced tax rate on dividends to its particular circumstances. However, if we are a PFIC for the taxable year in which the
dividend is paid or the preceding taxable year (see discussion above under &ldquo;&mdash; Passive Foreign Investment Company Rules&rsquo;&rsquo;),
we will not be treated as a qualified foreign corporation, and therefore the reduced capital gains tax rate described above will
not apply.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 139 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->135<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
non-United States corporation (other than a corporation that is classified as a PFIC for the taxable year in which the dividend
is paid or the preceding taxable year) generally will be considered to be a qualified foreign corporation with respect to any
dividend it pays on ADSs that are readily tradable on an established securities market in the United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
amount of any dividend income that is paid in Pounds Sterling will be the U.S. dollar amount calculated by reference to the exchange
rate in effect on the date of receipt, regardless of whether the payment is in fact converted into U.S. dollars. If the dividend
is converted into U.S. dollars on the date of receipt (actual or constructive), a U.S. Holder should not be required to recognize
foreign currency gain or loss in respect of the dividend income. A U.S. Holder may have foreign currency gain or loss if the dividend
is converted into U.S. dollars after the date of receipt (actual or constructive).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Sale,
Exchange or Other Taxable Disposition of Our ADSs</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the discussion above under &ldquo;&mdash; Passive Foreign Investment Company Rules,&rdquo; a U.S. Holder generally will recognize
capital gain or loss for U.S. federal income tax purposes upon the sale, exchange or other disposition of our ADSs in an amount
equal to the difference, if any, between the amount realized (<I>i.e</I>., the amount of cash plus the fair market value of any
property received) on the sale, exchange or other disposition and such U.S. Holder&rsquo;s adjusted tax basis in the ADSs. Such
capital gain or loss generally will be long-term capital gain taxable at a reduced rate for non-corporate U.S. Holders or long-term
capital loss if, on the date of sale, exchange or other disposition, the ADSs were held by the U.S. Holder for more than one year.
Any capital gain of a non-corporate U.S. Holder that is not long-term capital gain is taxed at ordinary income rates. The deductibility
of capital losses is subject to limitations. Any gain or loss recognized from the sale or other disposition of our ADSs will generally
be gain or loss from sources within the United States for U.S. foreign tax credit purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Medicare
Tax</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
U.S. Holders that are individuals, estates or trusts and whose income exceeds certain thresholds generally are subject to a 3.8%
tax on all or a portion of their net investment income, which may include their gross dividend income and net gains from the disposition
of our ADSs. If you are a U.S. Holder that is an individual, estate or trust, you are encouraged to consult your tax advisors
regarding the applicability of this Medicare tax to your income and gains in respect of your investment in our ADSs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Information
Reporting and Backup Withholding</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.
Holders may be required to file certain U.S. information reporting returns with the IRS with respect to an investment in our ADSs,
including, among others, IRS Form 8938 (Statement of Specified Foreign Financial Assets). In addition, each U.S. Holder who is
a shareholder of a PFIC must file an annual report containing certain information. U.S. Holders paying more than $100,000 for
our ADSs may be required to file IRS Form 926 (Return by a U.S. Transferor of Property to a Foreign Corporation) reporting this
payment. Substantial penalties and other adverse circumstances may be imposed upon a U.S. Holder that fails to comply with the
required information reporting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividends
on and proceeds from the sale or other disposition of our ADSs generally have to be reported to the IRS unless the U.S. Holder
establishes a basis for exemption. Backup withholding may apply to amounts subject to reporting if the holder (1) fails to provide
an accurate U.S. taxpayer identification number or otherwise establish a basis for exemption, or (2) is described in certain other
categories of persons. However, U.S. Holders that are corporations generally are excluded from these information reporting and
backup withholding tax rules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Backup
withholding is not an additional tax. Any amounts withheld under the backup withholding rules generally will be allowed as a refund
or a credit against a U.S. Holder&rsquo;s U.S. federal income tax liability if the required information is furnished by the U.S.
Holder on a timely basis to the IRS.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.
Holders should consult their own tax advisors regarding the backup withholding tax and information reporting rules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EACH
PROSPECTIVE INVESTOR IS URGED TO CONSULT ITS OWN TAX ADVISOR ABOUT THE TAX CONSEQUENCES TO IT OF AN INVESTMENT IN OUR ADSS IN
LIGHT OF THE INVESTOR&rsquo;S OWN CIRCUMSTANCES. IN ADDITION, SIGNIFICANT CHANGES IN U.S. FEDERAL INCOME TAX LAWS WERE RECENTLY
ENACTED. PROSPECTIVE INVESTORS SHOULD ALSO CONSULT WITH THEIR TAX ADVISORS WITH RESPECT TO SUCH CHANGES IN U.S. TAX LAW AS WELL
AS POTENTIAL CONFORMING CHANGES IN STATE TAX LAWS.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 140 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->136<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>U.K.
Taxation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is intended as a general guide to current U.K. tax law and HMRC, or published practice applying as at the date of this
prospectus (both of which are subject to change at any time, possibly with retrospective effect) relating to the holding of ADSs
.. It does not constitute legal or tax advice and does not purport to be a complete analysis of all U.K. tax considerations relating
to the holding of ADSs, or all of the circumstances in which holders of ADSs may benefit from an exemption or relief from U.K.
taxation. It is written on the basis that the company is and remains solely resident in the U.K. for tax purposes and will therefore
be subject to the U.K. tax regime and not the U.S. tax regime save as set out above under &ldquo;U.S. Federal Income Taxation.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
to the extent that the position of non-U.K. resident persons is expressly referred to, this guide relates only to persons who
are resident (and, in the case of individuals, domiciled or deemed domiciled) for tax purposes solely in the U.K. and do not have
a permanent establishment or fixed base in any other jurisdiction with which the holding of the ADSs is connected, or U.K. Holders,
who are absolute beneficial owners of the ADSs (where the ADSs are not held through an Individual Savings Account or a Self-Invested
Personal Pension) and who hold the ADSs as investments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
guide may not relate to certain classes of U.K. Holders, such as (but not limited to):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons who are connected with the company;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">financial institutions;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">insurance companies;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">charities or tax-exempt organizations;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">collective investment schemes;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">pension schemes;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">market makers, intermediaries, brokers or dealers
    in securities;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons who have (or are deemed to have) acquired
    their ADSs by virtue of an office or employment or who are or have been officers or employees of the company or any of its
    affiliates; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">individuals who are subject to U.K. taxation
    on a remittance basis.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
decision of the First-tier Tribunal (Tax Chamber) in <I>HSBC Holdings PLC and The Bank of New York Mellon Corporation v HMRC</I>
(2012) cast some doubt on whether a holder of a depositary receipt is the beneficial owner of the underlying shares. However,
based on published HMRC guidance we would expect that HMRC will regard a holder of ADSs as holding the beneficial interest in
the underlying shares and therefore these paragraphs assume that a holder of ADSs is the beneficial owner of the underlying ordinary
shares and any dividends paid in respect of the underlying ordinary shares (where the dividends are regarded for U.K. purposes
as that person&rsquo;s own income) for U.K. direct tax purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THESE
PARAGRAPHS ARE A SUMMARY OF CERTAIN U.K. TAX CONSIDERATIONS AND ARE INTENDED AS A GENERAL GUIDE ONLY. IT IS RECOMMENDED THAT ALL
HOLDERS OF ADSs OBTAIN ADVICE AS TO THE CONSEQUENCES OF THE ACQUISITION, OWNERSHIP AND DISPOSAL OF THE ADSs IN THEIR OWN SPECIFIC
CIRCUMSTANCES FROM THEIR OWN TAX ADVISORS. IN PARTICULAR, NON-U.K. RESIDENT OR DOMICILED PERSONS ARE ADVISED TO CONSIDER THE POTENTIAL
IMPACT OF ANY RELEVANT DOUBLE TAXATION AGREEMENTS.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 141 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->137<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Dividends</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Withholding
Tax</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividends
paid by the company will not be subject to any withholding or deduction for or on account of U.K. tax, irrespective of the residence
or particular circumstances of the holders of ADSs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Income
Tax</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
individual U.K. Holder may, depending on his or her particular circumstances, be subject to U.K. tax on dividends received from
the company. An individual holder of ADSs who is not resident for tax purposes in the United Kingdom should not be chargeable
to U.K. income tax on dividends received from the company unless he or she carries on (whether solely or in partnership) a trade,
profession or vocation in the U.K. through a branch or agency to which the ADSs are attributable. There are certain exceptions
for trading in the U.K. through independent agents, such as some brokers and investment managers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 19.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
dividends received by an individual U.K. Holder from us or from other sources will form part of that U.K. Holder&rsquo;s total
income for income tax purposes and will constitute the top slice of that income. A nil rate of income tax will apply to the first
&pound;2,000 of taxable dividend income received by the individual U.K. Holder in a tax year. Income within the nil-rate band
will be taken into account in determining whether income in excess of the &pound;2,000 tax-free allowance falls within the basic
rate, higher rate or additional rate tax bands. Dividend income in excess of the tax-free allowance will (subject to the availability
of any income tax personal allowance) be taxed at 7.5 per cent. to the extent that the excess amount falls within the basic rate
tax band, 32.5 per cent. to the extent that the excess amount falls within the higher rate tax band and 38.1 per cent. to the
extent that the excess amount falls within the additional rate tax band.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 19.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Corporation
Tax</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
corporate holder of ADSs who is not resident for tax purposes in the United Kingdom should not be chargeable to U.K. corporation
tax on dividends received from the company unless it carries on (whether solely or in partnership) a trade in the United Kingdom
through a permanent establishment to which the ADSs are attributable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corporate
U.K. Holders should not be subject to U.K. corporation tax on any dividend received from the company so long as the dividends
qualify for exemption, which should be the case, provided the dividends fall within an exempt class and certain conditions are
met. If the conditions for the exemption are not satisfied, or such U.K. Holder elects for an otherwise exempt dividend to be
taxable, U.K. corporation tax will be chargeable on the amount of any dividends (at the current rate of 19%).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Chargeable
Gains</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
disposal or deemed disposal of ADSs by a U.K. Holder may, depending on the U.K. Holder&rsquo;s circumstances and subject to any
available exemptions or reliefs (such as the annual exemption), give rise to a chargeable gain or an allowable loss for the purposes
of U.K. capital gains tax and corporation tax on chargeable gains.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an individual U.K. Holder who is subject to U.K. income tax at either the higher or the additional rate is liable to U.K. capital
gains tax on the disposal of ADSs, the current applicable rate will be 20%. For an individual U.K. Holder who is subject to U.K.
income tax at the basic rate and liable to capital gains tax on such disposal, the current applicable rate would be 10%, save
to the extent that any capital gains when aggregated with the U.K. Holder&rsquo;s other taxable income and gains in the relevant
tax year exceed the unused basic rate tax band. In that case, the rate currently applicable to the excess would be 20%.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a corporate U.K. Holder becomes liable to U.K. corporation tax on the disposal (or deemed disposal) of ADSs, the main rate of
U.K. corporation tax (currently 19%) would apply. Indexation allowance is not available in respect of disposals of ADSs acquired
on or after January 1, 2018 (and only covers the movement in the retail prices index up until 31 December 2017, in respect of
assets acquired prior to that date). A holder of ADSs which is not resident for tax purposes in the United Kingdom should not
normally be liable to U.K. capital gains tax or corporation tax on chargeable gains on a disposal (or deemed disposal) of ADSs
unless the person is carrying on (whether solely or in partnership) a trade, profession or vocation in the United Kingdom through
a branch or agency (or, in the case of a corporate holder of ADSs, through a permanent establishment) to which the ADSs are attributable.
However, an individual holder of ADSs who is treated as resident outside the United Kingdom for the purposes of a double tax treaty,
or who has ceased to be resident for tax purposes in the United Kingdom for a period of less than five years and who disposes
of ADSs during that period may be liable on his or her return to the United Kingdom to U.K. tax on any capital gain realized (subject
to any available exemption or relief).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 142 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->138<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Stamp
Duty and Stamp Duty Reserve Tax</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>The
discussion below relates to the holders of our ordinary shares or ADSs wherever resident, however it should be noted that special
rules may apply to certain persons such as market makers, brokers, dealers or intermediaries.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Issue
of Shares</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
U.K. stamp duty or stamp duty reserve tax, or SDRT, is payable on the issue of the underlying ordinary shares in the company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Transfers
of Shares</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
U.K. stamp duty nor SDRT should arise on transfers of the underlying ordinary shares (including instruments transferring ordinary
shares and agreements to transfer ordinary shares) on the basis that the ordinary shares are admitted to trading on AIM, provided
the following requirements are (and continue to be) met:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the ordinary shares
    are admitted to trading on AIM, but are not listed on any market (with the term &ldquo;listed&rdquo; being construed in accordance
    with section 99A of the Finance Act 1986), and this has been certified to Euroclear; and</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AIM continues to
    be accepted as a &ldquo;recognized growth market&rdquo; as construed in accordance with section 99A of the Finance Act 1986).</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event that either of the above requirements is not met, stamp duty or SDRT will generally apply to transfers of, or agreements
to transfer, ordinary shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Issue
and Transfers of ADSs</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
U.K. stamp duty or SDRT is payable on the issue or transfer of (including an agreement to transfer) ADSs in the company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 143 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->139<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><A NAME="a_024"></A><B>UNDERWRITERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Laidlaw
&amp; Company (UK) Ltd., is acting as the Representative of the underwriters of this offering. We have entered into an underwriting
agreement dated&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
2018 with the Representative. Subject to the terms and conditions of the underwriting agreement, we have agreed to sell to each
underwriter named below and each underwriter named below has severally and not jointly agreed to purchase from us, at the IPO
price per share less the underwriting discounts set forth on the cover page of this prospectus, the number of ADSs listed next
to its name in the following table:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; text-align: justify; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underwriters</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ADSs</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 88%; text-align: justify; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Laidlaw
    &amp; Company (UK) Ltd.</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; text-align: justify; padding-bottom: 4pt; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</FONT></TD><TD STYLE="padding-bottom: 4pt; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 4pt double; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
underwriters are offering the ADSs subject to their acceptance of the ADSs from us and subject to prior sale. The underwriting
agreement provides that the obligations of the several underwriters to pay for and accept delivery of the ADSs offered by this
prospectus are subject to the approval of certain legal matters by their counsel and to certain other conditions. The underwriters
are obligated, severally and not jointly, to take and pay for all of the ADSs offered by this prospectus if any such ADSs are
taken, other than the ADSs covered by the underwriters&rsquo; over-allotment option to purchase additional ADSs described below.
The underwriting agreement also provides that if an underwriter defaults, the purchase commitments of non-defaulting underwriters
may be increased or this offering may be terminated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
underwriters initially propose to offer part of the ADSs directly to the public at the IPO price listed on the cover page of this
prospectus and part of the ADSs to certain dealers at a price that represents a concession not in excess of US$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per
ADS from the IPO price. After the initial offering of the ADSs, the IPO price and other selling terms may from time to time be
varied by the underwriters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Option
to Purchase Additional ADSs</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have granted to the underwriters an over-allotment option, exercisable for 30 days from the date of this prospectus, to purchase
up to&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;additional ADSs at the IPO price listed on the cover page of this prospectus,
less underwriting discounts and commissions. The underwriters may exercise this over-allotment option solely for the purpose of
covering over-allotments, if any, made in connection with this offering of the ADSs, as offered by this prospectus. To the extent
the over-allotment option is exercised, each underwriter will become obligated, subject to certain conditions, to purchase about
the same percentage of the additional ADSs as the number listed next to the underwriter&rsquo;s name in the preceding table bears
to the total number of ADSs listed next to the names of all underwriters in the preceding table.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Commissions
and Expenses</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table shows the per ADS and total IPO price, underwriting discounts and commissions, and proceeds before expenses to
us. These amounts are shown assuming both no exercise and full exercise of the underwriters&rsquo; over-allotment option to purchase
up to an additional&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ADSs:&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Per
    ADS</B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Without &nbsp;Over-allotment Option</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    With &nbsp;Over-allotment &nbsp;Option</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 64%; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IPO price</FONT></TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underwriting discounts
    and commissions (7%)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-accountable expense
    allowance (1%)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
                                       &nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proceeds, before expenses,
    to us</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
                                       &nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 144 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->140<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We have agreed to pay
a non-accountable expense allowance to the underwriters equal to 1.0% of the gross proceeds received in this offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We have paid an expense
deposit of $25,000 to the Representative for out-of-pocket-accountable expenses and have agreed to pay an additional $25,000 to
the Representative upon closing of this offering, which will be returned to us to the extent such out-of-pocket accountable expenses
are not actually incurred in accordance with FINRA Rule 5110(f)(2)(C).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In addition, we have
agreed to reimburse the Representative for fees and expenses of legal counsel to the underwriters in an amount not to exceed $125,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Representatives&rsquo; Warrants</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> Upon closing of
this offering, we have agreed to issue to the Representative as compensation the Representative&rsquo;s Warrants, which are warrants
to purchase a number of shares of common stock equal to 2% of the aggregate number of ordinary shares underlying the ADSs sold
in this offering. These Representative&rsquo;s Warrants will be exercisable at a per share exercise price equal to 120% of the
per share price of the ordinary shares underlying ADS sold in this offering. The Representative&rsquo;s Warrants are exercisable
at any time and from time to time, in whole or in part, during the four and a half-year period commencing six months from the
effective date of the registration statement related to this offering. We have registered the ordinary shares issuable upon the
exercise of the Representative&rsquo;s Warrants in the registration statement of which this prospectus is a part. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Representative&rsquo;s
Warrants have been deemed compensation by FINRA and are therefore subject to a 180-day lock-up pursuant to Rule 5110(g)(1) of
FINRA. The Representative (or permitted assignees under Rule 5110(g)(1)) will not sell, transfer, assign, pledge, or hypothecate
these warrants or the securities underlying these warrants, nor will they engage in any hedging, short sale, derivative, put,
or call transaction that would result in the effective economic disposition of the warrants or the underlying securities for a
period of 180 days from the effective date of the registration statement of which this prospectus forms a part. In addition, the
warrants provide for registration rights upon request, in certain cases. The demand registration right provided will not be greater
than five years from the effective date of this offering in compliance with FINRA Rule 5110(f)(2)(G)(iv). The piggyback registration
right provided will not be greater than seven years from the effective date of this offering in compliance with FINRA Rule 5110(f)(2)(G)(v).
We will bear all fees and expenses attendant to registering the securities issuable on exercise of the Representative&rsquo;s
Warrants other than underwriting commissions incurred and payable by the holders. The exercise price and number of ordinary shares
issuable upon exercise of the Representative&rsquo;s Warrants may be adjusted in certain circumstances including in the event
of a stock dividend or our recapitalization, reorganization, merger or consolidation. However, the warrant exercise price or underlying
ordinary shares will not be adjusted for issuances of ordinary shares at a price below the warrant exercise price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Right of First Refusal</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Until 7 months from
the execution of the underwriting agreement, the Representative will have, subject to certain exceptions, an irrevocable right
of first refusal to act as investment banker, book-runner, financial advisor and/or lead placement agent, at the Representative&rsquo;s
discretion, for each and every future U.S. public and private equity and debt offerings for us, or any successor to or any subsidiary
of us, including all equity linked financings, on terms customary for the Representative. The Representative will have the sole
right to determine whether or not any other broker-dealer shall have the right to participate in any such offering and the economic
terms of any such participation. The Representative will not have more than one opportunity to waive or terminate the right of
first refusal in consideration of any payment or fee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Pricing of this Offering</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Prior to this offering,
there has been no public market for our ADSs. The IPO price was determined by negotiations between us and the Representatives
and based on the prevailing price of our ordinary shares which are traded on AIM. Among the factors considered in determining
the IPO price were our future prospects and those of our industry in general, our sales, earnings and certain other financial
and operating information in recent periods, and the price-earnings ratios, price-sales ratios, market prices of securities, and
certain financial and operating information of companies engaged in activities similar to ours.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Lock-Up Agreements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Pursuant to certain
&ldquo;lock-up&rdquo; agreements, we and our executive officers, directors and certain of our other shareholders, have agreed,
subject to certain exceptions, not to offer, sell, assign, transfer, pledge, contract to sell, or otherwise dispose of or announce
the intention to otherwise dispose of, or enter into any swap, hedge or similar agreement or arrangement that transfers, in whole
or in part, the economic risk of ownership of, directly or indirectly, or engage in any short selling of, or make any demand or
request for or exercise any right with respect to the registration of, or file with the SEC a registration statement under the
Securities Act relating to, our ADSs or ordinary shares or securities convertible into or exchangeable or exercisable for our
ADSs or ordinary shares without the prior written consent of the Representative for a period of 180 days after the date of the
pricing of this offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 145 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->141<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">This lock-up provision
applies to ADSs, ordinary shares and securities convertible into or exchangeable or exercisable for ADSs or ordinary shares. It
also applies to ADSs or ordinary shares owned now or acquired later by the person executing the lock-up agreement or for which
the person executing the lock-up agreement later acquires the power of disposition. The exceptions permit us, among other things
and subject to restrictions, to: (a) issue ADSs, ordinary shares or options pursuant to employee benefit incentive or share option
plans, and file a registration statement to register the offer and sale of such securities or (b) issue ADSs or ordinary shares
upon the conversion of outstanding securities or the exercise of outstanding options, or warrants or convertible debt securities.
The exceptions permit parties to the lock-up agreements, among other things and subject to restrictions, to: (a) make certain
gifts; (b) if the party is a corporation, partnership, limited liability company or other business entity, make transfers to any
shareholders, partners, members of, or owners of similar equity interests in, the party, or to an affiliate of the party, if such
transfer is not for value; (c) make transfers of our ADSs or ordinary shares acquired in the open market after the this offering;
(d) if the party is a corporation, partnership, limited liability company or other business entity, make transfers in connection
with the sale or transfer of all of the party&rsquo;s capital stock, partnership interests, membership interests or other similar
equity interests, as the case may be, or all or substantially all of the party&rsquo;s assets, in any such case not undertaken
for the purpose of avoiding the restrictions imposed by the lock-up agreement; (d) make certain transfers by operation of law;
(e) make transfers of ADSs or ordinary shares acquired in the open market following this offering; and (f) participate in tenders
involving the acquisition of all of our outstanding ordinary shares. In addition, the lock-up provision will not restrict broker-dealers
from engaging in market making and similar activities conducted in the ordinary course of their business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The underwriters
in their sole discretion, may release our ADS or ordinary shares and other securities subject to the lock-up agreements described
above in whole or in part at any time. When determining whether or not to release our ADSs or ordinary shares and other securities
from lock-up agreements, the underwriters will consider, among other factors, the holder&rsquo;s reasons for requesting the release,
the number of ADSs or ordinary shares for which the release is being requested, and market conditions at the time of the request.
In the event of such a release or waiver for one of our directors or officers, the underwriters shall provide us with notice of
the impending release or waiver at least three business days before the effective date of such release or waiver and we will announce
the impending release or waiver by issuing a press release at least two business days before the effective date of the release
or waiver.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Price Stabilization, Short Positions
and Penalty Bids</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">In connection with
this offering, the underwriters may purchase and sell ADSs in the open market. These transactions may include short sales in accordance
with Regulation M under the Exchange Act, stabilizing transactions and purchases to cover positions created by short sales. Short
sales involve the sale by the underwriters of a greater number of ADSs than they are required to purchase in this offering. &ldquo;Covered&rdquo;
short sales are sales made in an amount not greater than the underwriters&rsquo; over-allotment option to purchase additional
ADSs in this offering. The underwriters may close out any covered short position by either exercising their over-allotment option
to purchase additional ADSs or purchasing ADSs in the open market. In determining the source of ADSs to close out the covered
short position, the underwriters will consider, among other things, the price of ADSs available for purchase in the open market
as compared to the price at which they may purchase additional ADSs pursuant to the over-allotment option granted to them. &ldquo;Naked&rdquo;
short sales are any sales in excess of such option. The underwriters must close out any naked short position by purchasing ADSs
in the open market. A naked short position is more likely to be created if the underwriters are concerned that there may be downward
pressure on the price of the ADSs in the open market after pricing that could adversely affect investors who purchase in this
offering. Stabilizing transactions consist of various bids for, or purchases of, ADSs made by the underwriters in the open market
prior to the completion of this offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">The underwriters
may also impose a penalty bid. This occurs when a particular underwriter repays to the underwriters a portion of the underwriting
discount received by it because the representatives have repurchased ADSs sold by, or for the account of, such underwriter in
stabilizing or short covering transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>


<!-- Field: Page; Sequence: 146 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->142<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">Purchases to cover
a short position and stabilizing transactions, as well as other purchases by the underwriters for their own accounts, may have
the effect of preventing or retarding a decline in the market price of the ADSs, and together with the imposition of the penalty
bid, may stabilize, maintain or otherwise affect the market price of the ADSs. As a result, the price of the ADSs may be higher
than the price that otherwise might exist in the open market. If these activities are commenced, they are required to be conducted
in accordance with applicable laws and regulations, and they may be discontinued at any time. These transactions may be effected
on the Nasdaq, the over-the-counter market or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Indemnification</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We have agreed to
indemnify the underwriters against liabilities relating to this offering arising under the Securities Act and the Exchange Act,
liabilities arising from breaches of some or all of the representations and warranties contained in the underwriting agreement,
and to contribute to payments that the underwriters may be required to make for these liabilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Discretionary Sales</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The underwriters
have informed us that they do not intend sales to discretionary accounts to exceed 5% of the total number of ADSs offered by them.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Nasdaq Listing</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We plan to submit
an application to list our ADSs on the Nasdaq Capital Market under the trading symbol&nbsp;&ldquo;TLSA.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Electronic Distribution</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">A prospectus in electronic
format will be made available on the websites maintained by one or more of the underwriters or one or more securities dealers.
One or more of the underwriters may distribute prospectuses electronically. The underwriters may agree to allocate a number of
ADSs for sale to their online brokerage account holders. ADSs to be sold pursuant to an internet distribution will be allocated
on the same basis as other allocations. In addition, ADSs may be sold by the underwriters to securities dealers who resell ADSs
to online brokerage account holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Selling Restrictions</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">No action has been
taken in any jurisdiction (except in the United States) that would permit a public offering of our ADSs, or the possession, circulation
or distribution of this prospectus supplement, the accompanying prospectus or any other material relating to us or our ADSs in
any jurisdiction where action for that purpose is required. Accordingly, our ADSs may not be offered or sold, directly or indirectly,
and none of this prospectus or any other offering material or advertisements in connection with our ADSs may be distributed or
published, in or from any country or jurisdiction, except in compliance with any applicable rules and regulations of any such
country or jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">For the avoidance
of doubt, such prospectus will not constitute a &ldquo;prospectus&rdquo; for the purposes of Directive 2003/71/EC (and amendments
thereto, including Directive 2010/73/EU, to the extent implemented in each relevant Member State) and will not have been reviewed
by any competent authority in any Member State.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>European Economic Area</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In relation to each
member state of the European Economic Area which has implemented the Prospectus Directive, or a Relevant Member State, an offer
to the public of any ADSs which are the subject of this offering contemplated by this prospectus may not be made in that Relevant
Member State except that an offer to the public in that Relevant Member State of any ADSs may be made at any time under the following
exemptions under the Prospectus Directive, if they have been implemented in that Relevant Member State:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
    any legal entity which is a &ldquo;qualified investor&rdquo; as defined in the Prospectus Directive;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 147 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->143<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
    fewer than 150 natural or legal persons (other than qualified investors as defined in the Prospectus Directive), as permitted
    under the Prospectus Directive, subject to obtaining the prior consent of the underwriters or the underwriters nominated by
    us for any such offer; or</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
    any other circumstances falling within Article 3(2) of the Prospectus Directive, provided that no such offer of ADSs or ordinary
    shares shall require us or any of the underwriters to publish a prospectus pursuant to Article 3 of the Prospectus Directive
    or supplement a prospectus pursuant to Article 16 of the Prospectus Directive.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Each person located
in a Relevant Member State to whom any offer of ADSs is made or who receives any communication in respect of an offer of ADSs,
or who initially acquires any ADSs will be deemed to have represented, warranted, acknowledged and agreed to and with each of
the underwriters and us that (1) it is a &ldquo;qualified investor&rdquo; within the meaning of the law in that Relevant Member
State implementing Article 2(1)(e) of the Prospectus Directive; and (2) in the case of any ADSs acquired by it as a financial
intermediary as that term is used in Article 3(2) of the Prospectus Directive, the ADSs acquired by it in the offer have not been
acquired on behalf of, nor have they been acquired with a view to their offer or resale to, persons in any Relevant Member State
other than qualified investors, as that term is defined in the Prospectus Directive, or in circumstances in which the prior consent
of the underwriters or the underwriters nominated by us has been given to the offer or resale; or where ADSs have been acquired
by it on behalf of persons in any Relevant Member State other than qualified investors, the offer of those ADSs to it is not treated
under the Prospectus Directive as having been made to such persons.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The company, the
underwriters and their respective affiliates will rely upon the truth and accuracy of the foregoing representations, warranties,
acknowledgments and agreements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">This prospectus has
been prepared on the basis that any offer of ADSs in any Relevant Member State will be made pursuant to an exemption under the
Prospectus Directive from the requirement to publish a prospectus for offers of securities. Accordingly any person making or intending
to make an offer in that Relevant Member State of ADSs which are the subject of this offering may only do so in circumstances
in which no obligation arises for us or any of the underwriters to publish a prospectus pursuant to Article 3 of the Prospectus
Directive in relation to such offer. Neither us nor the underwriters have authorized, nor do they authorize, the making of any
offer of ADSs in circumstances in which an obligation arises for the company or the underwriters to publish a prospectus for such
offer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The expressions &ldquo;offer
ADSs to the public&rdquo; in relation to our ADSs in any Relevant Member State means the communication in any form and by any
means of sufficient information on the terms of the offer and our ADSs to be offered so as to enable an investor to decide to
purchase or subscribe to our ADSs, as the same may be varied in that Relevant Member State by any measure implementing the Prospectus
Directive in that Relevant Member State, and the expression &ldquo;Prospectus Directive&rdquo; means Directive 2003/71/EC (and
amendments thereto, including the 2010 PD Amending Directive, to the extent implemented in the Relevant Member State), and includes
any relevant implementing measure in the Relevant Member State and the expression &ldquo;2010 PD Amending Directive&rdquo; means
Directive 2010/73/EU.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Solely for the purposes
of the product governance requirements contained within: (a) EU Directive 2014/65/EU on markets in financial instruments, as amended,
or MiFID II; (b) Articles 9 and 10 of Commission Delegated Directive (EU) 2017/593 supplementing MiFID II; and (c) local implementing
measures, together, the MiFID II Product Governance Requirements, and disclaiming all and any liability, whether arising in tort,
contract or otherwise, which any &ldquo;manufacturer&rdquo; (for the purposes of the MiFID II Product Governance Requirements)
may otherwise have with respect thereto, the ADSs have been subject to a product approval process, which has determined that such
securities are: (i) compatible with an end target market of retail investors and investors who meet the criteria of professional
clients and eligible counterparties, each as defined in MiFID II; and (ii) eligible for distribution through all distribution
channels as are permitted by MiFID II, or the Target Market Assessment. Notwithstanding the Target Market Assessment, &ldquo;distributors&rdquo;
(for the purposes of the MiFID II Product Governance Requirements) should note that: the price of ADSs may decline and investors
could lose all or part of their investment; the ADSs offer no guaranteed income and no capital protection; and an investment in
ADSs is compatible only with investors who do not need a guaranteed income or capital protection, who (either alone or in conjunction
with an appropriate financial or other adviser) are capable of evaluating the merits and risks of such an investment and who have
sufficient resources to be able to bear any losses that may result therefrom. The Target Market Assessment is without prejudice
to the requirements of any contractual, legal or regulatory selling restrictions in relation to this offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 148 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->144<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">For the avoidance
of doubt, the Target Market Assessment does not constitute: (a) an assessment of suitability or appropriateness for the purposes
of MiFID II; or (b) a recommendation to any investor or group of investors to invest in, or purchase, or take any other action
whatsoever with respect to ADSs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Each distributor
is responsible for undertaking its own target market assessment in respect of the ADSs and determining appropriate distribution
channels.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 18.35pt"><B>Information to
Distributors</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 18.35pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 18.35pt">Solely for the purposes
of the product governance requirements contained within: (a) EU Directive 2014/65/EU on markets in financial instruments, as amended,
or MiFID II; (b) Articles 9 and 10 of Commission Delegated Directive (EU) 2017/593 supplementing MiFID II; and (c) local implementing
measures, (together, the &ldquo;MiFID II Product Governance Requirements&rdquo;), and disclaiming all and any liability, whether
arising in tort, contract or otherwise, which any &ldquo;manufacturer&rdquo; (for the purposes of the MiFID II Product Governance
Requirements) may otherwise have with respect thereto, the ADSs have been subject to a product approval process, which has determined
that such securities are: (i) compatible with an end target market of retail investors and investors who meet the criteria of
professional clients and eligible counterparties, each as defined in MiFID II; and (ii) eligible for distribution through all
distribution channels as are permitted by MiFID II, or the Target Market Assessment. Notwithstanding the Target Market Assessment,
distributors should note that: the price of the ADSs may decline and investors could lose all or part of their investment; the
ADSs offer no guaranteed income and no capital protection; and an investment in the ADSs is compatible only with investors who
do not need a guaranteed income or capital protection, who (either alone or in conjunction with an appropriate financial or other
adviser) are capable of evaluating the merits and risks of such an investment and who have sufficient resources to be able to
bear any losses that may result therefrom. The Target Market Assessment is without prejudice to the requirements of any contractual,
legal or regulatory selling restrictions in relation to this offering.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 18.35pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 18.35pt">For the avoidance
of doubt, the Target Market Assessment does not constitute: (a) an assessment of suitability or appropriateness for the purposes
of MiFID II; or (b) a recommendation to any investor or group of investors to invest in, or purchase, or take any other action
whatsoever with respect to the ADSs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 18.35pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Each distributor
is responsible for undertaking its own target market assessment in respect of the ADSs and determining appropriate distribution
channels.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>United Kingdom</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Each of the underwriters
has represented and agreed that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">it
    has not made or will not make an offer of the ADSs to the public in the United Kingdom within the meaning of section 102B
    of FSMA, except to legal entities which are authorized or regulated to operate in the financial markets or, if not so authorized
    or regulated, whose corporate purpose is solely to invest in securities or otherwise in circumstances which do not require
    the publication by us of a prospectus pursuant to the Prospectus Rules of the U.K. Financial Conduct Authority;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">it
has only communicated or caused to be communicated and will only communicate or cause to be communicated an invitation;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">or
    inducement to engage in investment activity (within the meaning of section 21 of FSMA) to persons in the United Kingdom that
    are qualified investors within the meaning of Article 2(1)(e) of the Prospectus Directive that also are (i) investment professionals
    falling within Article 19(5) of the FSMA (Financial Promotion) Order 2005, as amended, or the Order, and/or (ii) high net
    worth entities falling within Article 49(2)(a) to (d) of the Order and other persons to whom it may lawfully be communicated
    (each such person being referred to as a &ldquo;relevant person&rdquo;); and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 149 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->145<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">it
    has complied with and will comply with all applicable provisions of FSMA with respect to anything done by it in relation to
    the securities in, from or otherwise involving the United Kingdom.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In the United Kingdom,
this document is being distributed only to, and is directed only at, and any offer subsequently made may only be directed at,
relevant persons. This prospectus and its contents are confidential and should not be distributed, published or reproduced (in
whole or in part) or disclosed by recipients to any other persons in the United Kingdom. Any person in the United Kingdom that
is not a relevant person should not act or rely on this document or any of its contents. Any investment or investment activity
to which this prospectus relates is available only to relevant persons and will be engaged in only with relevant persons.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Canada </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The offering of our
ADSs in Canada is being made on a private placement basis in reliance on exemptions from the prospectus requirements under the
securities laws of each applicable Canadian province and territory where our ADSs may be offered and sold, and therein may only
be made with investors that are purchasing, or deemed to be purchasing, as principal and that qualify as both an &ldquo;accredited
investor&rdquo; as such term is defined in National Instrument 45-106 <I>Prospectus Exemptions</I> or subsection 73.3(1) of the
<I>Securities Act</I> (Ontario) and as a &ldquo;permitted client&rdquo; as such term is defined in National Instrument 31-103
<I>Registration Requirements, Exemptions and Ongoing Registrant Obligations.</I> Any offer and sale of our ADSs in any province
or territory of Canada may only be made through a dealer that is properly registered under the securities legislation of the applicable
province or territory wherein our ADSs are offered and/or sold or, alternatively, where such registration is not required.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Any resale of our
ADSs by an investor resident in Canada must be made in accordance with applicable Canadian securities laws, which require resales
to be made in accordance with an exemption from, or in a transaction not subject to, prospectus requirements under applicable
Canadian securities laws. These resale restrictions may under certain circumstances apply to resales of the ADSs outside of Canada.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Securities legislation
in certain provinces or territories of Canada may provide a purchaser with remedies for rescission or damages if this prospectus
(including any amendment thereto) contains a misrepresentation, provided that the remedies for rescission or damages are exercised
by the purchaser within the time limit prescribed by the securities legislation of the purchaser&rsquo;s province or territory.
The purchaser should refer to any applicable provisions of the securities legislation of the purchaser&rsquo;s province or territory
for particulars of these rights or consult with a legal advisor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Pursuant to section
3A.3 (or, in the case of securities issued or guaranteed by the government of a non-Canadian jurisdiction, section 3A.4) of National
Instrument 33-105 <I>Underwriting Conflicts</I> (&ldquo;NI 33-105&rdquo;), the underwriters are not required to comply with the
disclosure requirements of NI 33-105 regarding underwriter conflicts of interest in connection with this offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Upon receipt of this
prospectus, each Qu&eacute;bec investor hereby confirms that it has expressly requested that all documents evidencing or relating
in any way to the sale of the ADSs described herein (including for greater certainty any purchase confirmation or any notice)
be drawn up in the English language only. <I>Par la r&eacute;ception de ce document, chaque investisseur qu&eacute;becois confirme
par les pr&eacute;sentes qu&rsquo;il a express&eacute;ment exig&eacute; que tous les documents faisant foi ou se rapportant de
quelque mani&egrave;re que ce soit &agrave; la vente des valeurs mobili&egrave;res d&eacute;crites aux pr&eacute;sentes (incluant,
pour plus de certitude, toute confirmation d&rsquo;achat ou tout avis) soient r&eacute;dig&eacute;s en anglais seulement</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 150 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->146<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_025"></A><FONT STYLE="text-transform: uppercase"><B>Expenses
of This Offering</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We estimate that our expenses in connection
with this offering, other than underwriting discounts and commissions, will be as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; padding-right: 0">Amount</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 88%; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">SEC registration fee</TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">$</TD><TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0">1,468</TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">FINRA filing fee</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0">2,268</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">Nasdaq Capital Market listing fee</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">Printing and engraving expenses</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">Legal fees and expenses</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">Transfer agent and registrar fees and expenses</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">Accounting fees and expenses</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0; padding-bottom: 1.5pt">Miscellaneous costs</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0; padding-bottom: 4pt">Total</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0; border-bottom: Black 4pt double">$</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; padding-right: 0; border-bottom: Black 4pt double"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0; padding-bottom: 4pt">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify; font-family: Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif; padding-right: 0"></TD><TD STYLE="width: 0.25in; text-align: left; font-family: Times New Roman, Times, Serif; padding-right: 0">*</TD><TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0">To be filed by amendment</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">All amounts in the
table are estimates except the SEC registration fee, the listing fee, and the FINRA filing fee. We will pay all of the expenses
of this offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 151 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->147<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><A NAME="a_026"></A><B>LEGAL
MATTERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> The validity of
our ordinary shares registered hereby and certain other matters of English law will be passed upon for us by Cooley (UK) LLP and
certain matters of U.S. federal law will be passed upon for us by Cooley LLP. Certain legal matters respect will be passed upon
for the underwriters by Sheppard, Mullin, Richter &amp; Hampton LLP, New York, New York. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_027"></A>EXPERTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The consolidated
financial statements of Tiziana Pharma Limited as of December 31, 2016 and 2017, and for each of the years then ended, have been
included herein and in the registration statement in reliance on the report of Mazars LLP, an independent registered public accounting
firm, appearing elsewhere herein, and upon the authority of said firm as experts in accounting and auditing. The registered business
address of Mazars LLP is Tower Bridge House, St Katherine&rsquo;s Way, London E1W 1DD.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_028"></A><B>SERVICE OF PROCESS AND ENFORCEMENT OF
LIABILITIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We are incorporated
and currently existing under the laws of England and Wales. In addition, certain of our directors and officers reside outside
the United States, and most of the assets of our non-U.S. subsidiaries are located outside the United States. As a result, it
may be difficult for investors to effect service of process on us or those persons in the United States or to enforce in the United
States judgments obtained in United States courts against us or those persons based on the civil liability or other provisions
of the United States securities laws or other laws. In addition, uncertainty exists as to whether the courts of England and Wales
would:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recognize or enforce
    judgments of United States courts obtained against us or our directors or officers predicated upon the civil liabilities provisions
    of the securities laws of the United States or any state in the United States; or</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">entertain original
    actions brought in England and Wales against us or our directors or officers predicated upon the securities laws of the United
    States or any state in the United States.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We have been advised
by Cooley&nbsp;(UK) LLP that there is currently no treaty between (i)&nbsp;the United States and (ii)&nbsp;England and Wales providing
for reciprocal recognition and enforcement of judgments of United States courts in civil and commercial matters (although the
United States and the United Kingdom are both parties to the New York Convention on the Recognition and Enforcement of Foreign
Arbitral Awards) and that a final judgment for the payment of money rendered by any general or state court in the United States
based on civil liability, whether predicated solely upon the United States securities laws, would not be automatically enforceable
in England and Wales. We have also been advised by Cooley (UK) LLP that any final and conclusive monetary judgment for a definite
sum obtained against us in United States courts would be treated by the courts of England and Wales as a cause of action in itself
and sued upon as a debt at common law so that no retrial of the issues would be necessary, provided that:&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the relevant U.S.
    court had jurisdiction over the original proceedings according to English conflicts of laws principles at the time when proceedings
    were initiated;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">England and Wales
    courts had jurisdiction over the matter on enforcement and we either submitted to such jurisdiction or were resident or carrying
    on business within such jurisdiction and were duly served with process;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the U.S. judgment
    was final and conclusive on the merits in the sense of being final and unalterable in the court that pronounced it and being
    for a definite sum of money;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the judgment given
    by the courts was not in respect of penalties, taxes, fines or similar fiscal or revenue obligations (or otherwise based on
    a U.S. law that an English court considers to relate to a penal, revenue or other public law);</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 152 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->148<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the judgment was
    not procured by fraud;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">recognition or enforcement
    of the judgment in England and Wales would not be contrary to public policy or the Human Rights Act 1998;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the proceedings
    pursuant to which judgment was obtained were not contrary to natural justice;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the U.S. judgment
    was not arrived at by doubling, trebling or otherwise multiplying a sum assessed as compensation for the loss or damages sustained
    and not being otherwise in breach of Section&nbsp;5 of the U.K. Protection of Trading Interests Act 1980, or is a judgment
    based on measures designated by the Secretary of State under Section&nbsp;1 of that Act;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">there is not a prior
    decision of an English court or the court of another jurisdiction on the issues in question between the same parties; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the English enforcement
    proceedings were commenced within the limitation period.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Whether these requirements
are met in respect of a judgment based upon the civil liability provisions of the United States securities laws, including whether
the award of monetary damages under such laws would constitute a penalty, is an issue for the court making such decision.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Subject to the foregoing,
investors may be able to enforce in England and Wales judgments in civil and commercial matters that have been obtained from U.S.
federal or state courts. Nevertheless, we cannot assure you that those judgments will be recognized or enforceable in England
and Wales.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">If an English court
gives judgment for the sum payable under a U.S. judgment, the English judgment will be enforceable by methods generally available
for this purpose. These methods generally permit the English court discretion to prescribe the manner of enforcement. In addition,
it may not be possible to obtain an English judgment or to enforce that judgment if the judgment debtor is or becomes subject
to any insolvency or similar proceedings, or if the judgment debtor has any set-off or counterclaim against the judgment creditor.
Also note that, in any enforcement proceedings, the judgment debtor may raise any counterclaim that could have been brought if
the action had been originally brought in England unless the subject of the counterclaim was in issue and denied in the U.S. proceedings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 153 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->149<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_029"></A>WHERE YOU CAN FIND ADDITIONAL INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We have filed with
the SEC a registration statement (including amendments and exhibits to the registration statement) on Form F-1 under the Securities
Act. This prospectus, which is part of the registration statement, does not contain all of the information in the registration
statement and its exhibits. For further information with respect to us and the ADSs offered by this prospectus, we refer you to
the registration statement and the exhibits and schedules to the registration statement. Statements contained in this prospectus
as to the contents of any contract or any other document referred to are not necessarily complete, and in each instance, we refer
you to the copy of the contract or other document filed as an exhibit to the registration statement. Each of these statements
is qualified in all respects by the filed exhibits.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">You may review a
copy of the registration statement, including exhibits and any schedule filed therewith, and obtain copies of such materials at
the SEC&rsquo;s Public Reference Room at 100 F Street, N.E., Washington, D.C. 20549. You may obtain information on the operation
of the Public Reference Room by calling the SEC at&nbsp;1-800-SEC-0330.&nbsp;The SEC maintains an Internet website (www.sec.gov)
that contains reports, proxy and information statements and other information regarding issuers, like us, that file electronically
with the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Upon completion of
this offering, we will be subject to the information reporting requirements of the Exchange Act applicable to FPIs. Accordingly,
we will be required to file reports and other information with the SEC, including annual reports on Form&nbsp;20-F&nbsp;and reports
on Form&nbsp;6-K.&nbsp;Those reports may be inspected without charge at the locations described above. As an FPI, we will be exempt
from the rules under the Exchange Act related to the furnishing and content of proxy statements, and our officers, directors and
principal shareholders will be exempt from the reporting and short-swing profit recovery provisions contained in Section&nbsp;16
of the Exchange Act. In addition, we will not be required under the Exchange Act to file periodic reports and financial statements
with the SEC as frequently or as promptly as U.S. companies whose securities are registered under the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We also maintain
a website at www.tizianalifesciences.com contained in, or accessible through, our website is not a part of this prospectus, and
the inclusion of our website address in this prospectus is an inactive textual reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 154 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; padding-right: 0">&nbsp;</TD><TD STYLE="width: 34%; text-align: center; padding-right: 0"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->150<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right; padding-right: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_030"></A>INDEX TO CONSOLIDATED FINANCIAL STATEMENTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TIZIANA LIFE SCIENCES PLC</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 90%; font-family: Times New Roman, Times, Serif; padding-right: 0"><A HREF="#f_001"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Report of Independent Registered Public Accounting Firm</FONT></A></TD>
    <TD STYLE="width: 10%; text-align: center; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-2</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><A HREF="#f_002"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated Balance Sheets</FONT></A></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-3</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><A HREF="#f_003"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated Statements of Comprehensive Income</FONT></A></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-4</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><A HREF="#f_004"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated Statements of Changes in Shareholders&rsquo; Equity</FONT></A></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-5</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><A HREF="#f_005"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated Statement of Cash Flows</FONT></A></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-6</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-right: 0"><A HREF="#f_006"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes to Consolidated Financial Statements</FONT></A></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-7</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>Financial Statements and Notes to Financial
Statements to be provided under separate cover</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 155; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="f_001"></A><I>REPORT OF INDEPENDENT REGISTERED PUBLIC
ACCOUNTING FIRM</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Board of Directors and Shareholders of Tiziana Life Sciences
plc</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Opinion on the Consolidated Financial
Statements</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> We have audited the accompanying consolidated
balance sheet of Tiziana Life Sciences plc and its subsidiaries (the Group) as of December 31, 2017 and 2016, the related consolidated
statements of operations and comprehensive loss, changes in shareholders&rsquo; equity, and cash flows for the years then ended
and the related notes (collectively, the consolidated financial statements). In our opinion, the consolidated financial statements
present fairly, in all material respects, the financial position of the Group as of December 31, 2017 and 2016, and the results
of its operations and its cash flows for the years then ended, in conformity with International Auditing Standards as issued by
the International Accounting Standards Board. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Material uncertainty related to going
concern</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We draw attention to note 2 in the financial
statements concerning the applicability of the going concern basis of preparation. The Group is pre revenue and its business model
requires significant ongoing expenditure on research and development. At December 31, 2017 the Group had net liabilities of $2,278,000
and cash and cash equivalent reserves of $64,000. In note 2 the directors explain that to date they have successfully raised funds
to finance clinical trials and they are in the process of securing additional funding sufficient to finance clinical trials and
other liabilities as they fall due. As the directors are confident that the Group will raise the additional funding they have
prepared the consolidated financial statements on the going concern basis. However, until the Group secures sufficient investment
to fund their clinical trials, there is a material uncertainty that casts a significant doubt about the Group&rsquo;s ability
to continue as a going concern.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our opinion is not modified in respect
of this matter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Basis for Opinion</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These consolidated financial statements
are the responsibility of the company&rsquo;s management. Our responsibility is to express an opinion on these consolidated financial
statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board
(United States) (PCAOB) and are required to be independent with respect to the company in accordance with the U.S. federal securities
laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We conducted our audits in accordance
with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about
whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. Our audits included
performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error
or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence
regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting
principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated
financial statements. We believe that our audits provide a reasonable basis for our opinion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Basis for Opinion</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These consolidated financial statements
are the responsibility of the company&rsquo;s management. Our responsibility is to express an opinion on these consolidated financial
statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board
(United States) (PCAOB) and are required to be independent with respect to the company in accordance with the U.S. federal securities
laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We conducted our audits in accordance
with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about
whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. Our audits included
performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error
or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence
regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting
principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated
financial statements. We believe that our audits provide a reasonable basis for our opinion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mazars LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">London, England</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> August 23,&nbsp;2018 </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt">&nbsp;</P>


<!-- Field: Page; Sequence: 156; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I><A NAME="f_002"></A>TIZIANA LIFE SCIENCES PLC</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Consolidated Balance Sheets</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(In thousands)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"> Year
    ended<BR> December&nbsp;31, </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"> 2017 </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"> 2016 </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-family: Times New Roman, Times, Serif"> $ </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-family: Times New Roman, Times, Serif"> $ </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; text-align: center; font-family: Times New Roman, Times, Serif"> ASSETS </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"> Current assets: </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 76%; text-align: left; padding-left: 9pt; font-family: Times New Roman, Times, Serif"> Cash and cash equivalents </TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif"> 64 </TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif"> 5,802 </TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt; font-family: Times New Roman, Times, Serif"> Prepayments
    and other receivables </TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"> 2,383 </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"> 395 </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-left: 27pt; font-family: Times New Roman, Times, Serif"> Total current assets </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> 2,447 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> 6,197 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-left: 9pt; font-family: Times New Roman, Times, Serif"> Property and Equipment, net </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> 23 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> 35 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-left: 27pt; font-family: Times New Roman, Times, Serif; padding-bottom: 4pt"> Total
    non-current assets </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; border-bottom: Black 4pt double"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; border-bottom: Black 4pt double"> 23 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; border-bottom: Black 4pt double"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; border-bottom: Black 4pt double"> 35 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 4pt; padding-left: 27pt; font-family: Times New Roman, Times, Serif"> Total
    assets </TD><TD STYLE="padding-bottom: 4pt; font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; text-align: right; font-family: Times New Roman, Times, Serif"> 2,471 </TD><TD STYLE="padding-bottom: 4pt; text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="padding-bottom: 4pt; font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; text-align: right; font-family: Times New Roman, Times, Serif"> 6,231 </TD><TD STYLE="padding-bottom: 4pt; text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; text-align: center; font-family: Times New Roman, Times, Serif"> LIABILITIES AND SHAREHOLDERS&rsquo;
    EQUITY </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"> Liabilities: </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-left: 9pt; font-family: Times New Roman, Times, Serif"> Current liabilities: </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-left: 0.25in; font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> Accounts
    payable and accrued expenses </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"> 4,749 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"> 2,143 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 27pt; font-family: Times New Roman, Times, Serif"> Total
    current liabilities </TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"> 4,749 </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"> 2,143 </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 27pt; font-family: Times New Roman, Times, Serif"> Total
    liabilities </TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"> 4,749 </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"> 2,143 </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> Shareholders&rsquo; Equity: </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> Called up share capital </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> 8,141 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> 6,903 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"> Share premium </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> 31,284 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> 8,943 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> Share based payment reserve </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> 3,213 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> 2,647 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> Shares to be issued reserve (warrants) </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> 579 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> 271 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> Convertible loan note reserve </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> - </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> 17,158 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> Merger relief reserve </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> - </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> - </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> Other reserve </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> (46,171 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> ) </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> (46,171 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> Translation reserve </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> 1,997 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"></TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> 2,771 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> Capital reduction reserve </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> 41,292 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> 41,292 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"> Retained earnings </TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"> (42,613 </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif"> ) </TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"> (29,726 </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 27pt; font-family: Times New Roman, Times, Serif"> Total
    shareholders&rsquo; equity </TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"> (2,278 </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif"> ) </TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"> 4,088 </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 4pt; padding-left: 27pt; font-family: Times New Roman, Times, Serif"> Total
    liabilities and shareholders&rsquo; equity </TD><TD STYLE="padding-bottom: 4pt; font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; text-align: right; font-family: Times New Roman, Times, Serif"> 2,471 </TD><TD STYLE="padding-bottom: 4pt; text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="padding-bottom: 4pt; font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; text-align: right; font-family: Times New Roman, Times, Serif"> 6,231 </TD><TD STYLE="padding-bottom: 4pt; text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The accompanying notes are an integral
part of these condensed consolidated interim financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 157; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I><A NAME="f_003"></A>TIZIANA LIFE SCIENCES PLC</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Consolidated Statements of Operations
and Comprehensive Loss</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(In thousands, except loss per share))</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"> Year
    ended December 31, </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"> 2017 </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"> 2016 </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-family: Times New Roman, Times, Serif"> $ </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-family: Times New Roman, Times, Serif"> $ </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"> Revenue </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"> Cost of revenue </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> - </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> - </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-left: 9pt; font-family: Times New Roman, Times, Serif"> Gross Profit </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> - </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> - </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> Operating expenses: </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 76%; text-align: left; font-family: Times New Roman, Times, Serif"> Research and Development </TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif"> (6,015 </TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"> ) </TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif"> (4,007 </TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> Operating Expenses </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> (4,602 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> ) </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> (5,872 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-left: 9pt; font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> Total
    operating expenses </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"> (10,617 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> ) </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"> (9,879 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-bottom: 4pt; font-family: Times New Roman, Times, Serif"> Loss from operations </TD><TD STYLE="padding-bottom: 4pt; font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; text-align: right; font-family: Times New Roman, Times, Serif"> (10,617 </TD><TD STYLE="padding-bottom: 4pt; text-align: left; font-family: Times New Roman, Times, Serif"> ) </TD><TD STYLE="padding-bottom: 4pt; font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; text-align: right; font-family: Times New Roman, Times, Serif"> (9,879 </TD><TD STYLE="padding-bottom: 4pt; text-align: left; font-family: Times New Roman, Times, Serif"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> Other income/(expense): </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> Finance Income/(expense) </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> (12 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> ) </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> (12 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> Other income </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"> (12 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> ) </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"> (12 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-bottom: 4pt; font-family: Times New Roman, Times, Serif"> Loss from operations before
    income taxes </TD><TD STYLE="padding-bottom: 4pt; font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; text-align: right; font-family: Times New Roman, Times, Serif"> (10,628 </TD><TD STYLE="padding-bottom: 4pt; text-align: left; font-family: Times New Roman, Times, Serif"> ) </TD><TD STYLE="padding-bottom: 4pt; font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; text-align: right; font-family: Times New Roman, Times, Serif"> (9,891 </TD><TD STYLE="padding-bottom: 4pt; text-align: left; font-family: Times New Roman, Times, Serif"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> Income tax provision </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"> 1,912 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"> 121 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-bottom: 4pt; font-family: Times New Roman, Times, Serif"> Loss for the year </TD><TD STYLE="padding-bottom: 4pt; font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; text-align: right; font-family: Times New Roman, Times, Serif"> (8,716 </TD><TD STYLE="padding-bottom: 4pt; text-align: left; font-family: Times New Roman, Times, Serif"> ) </TD><TD STYLE="padding-bottom: 4pt; font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; text-align: right; font-family: Times New Roman, Times, Serif"> (9,770 </TD><TD STYLE="padding-bottom: 4pt; text-align: left; font-family: Times New Roman, Times, Serif"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> Other Comprehensive loss: </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"> Currency translation </TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"> 70 </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"> 650 </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-bottom: 4pt; font-family: Times New Roman, Times, Serif"> Comprehensive loss </TD><TD STYLE="padding-bottom: 4pt; font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; text-align: right; font-family: Times New Roman, Times, Serif"> (8,646 </TD><TD STYLE="padding-bottom: 4pt; text-align: left; font-family: Times New Roman, Times, Serif"> ) </TD><TD STYLE="padding-bottom: 4pt; font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; text-align: right; font-family: Times New Roman, Times, Serif"> (9,120 </TD><TD STYLE="padding-bottom: 4pt; text-align: left; font-family: Times New Roman, Times, Serif"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><P STYLE="margin: 0pt 0"> Restated </P>


</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> Basic and diluted loss per share attributable
    to common shareholders </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> $ </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> (0.09 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> ) </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> $ </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"> (0.11 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"> ) </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 158; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="f_004"></A><I>TIZIANA LIFE SCIENCES PLC</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Consolidated Statements of Shareholders&rsquo;
Equity</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(In thousands)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 5pt; text-indent: -5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>&nbsp;</B></FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>&nbsp;</B></FONT> </TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>Share
    Capital</B></FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>&nbsp;</B></FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>&nbsp;</B></FONT> </TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>Share
    Premium</B></FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>&nbsp;</B></FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>&nbsp;</B></FONT> </TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>Share
    Based Payment Reserve</B></FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>&nbsp;</B></FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>&nbsp;</B></FONT> </TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>Shares
    to Be Issued Reserve (warrants)</B></FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>&nbsp;</B></FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>&nbsp;</B></FONT> </TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>Convertible
    Loan Note Reserve</B></FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>&nbsp;</B></FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>&nbsp;</B></FONT> </TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>Merger
    Reserve</B></FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>&nbsp;</B></FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>&nbsp;</B></FONT> </TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>Other
    Reserve</B></FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>&nbsp;</B></FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>&nbsp;</B></FONT> </TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>Retained
    Earnings</B></FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>&nbsp;</B></FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>&nbsp;</B></FONT> </TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>Capital
    Redemption Reserve</B></FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>&nbsp;</B></FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>&nbsp;</B></FONT> </TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>Translation
    Reserve</B></FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>&nbsp;</B></FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>&nbsp;</B></FONT> </TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>Capital
    Reduction Reserve</B></FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>&nbsp;</B></FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>&nbsp;</B></FONT> </TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>Total
    Equity</B></FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>&nbsp;</B></FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 5pt; text-indent: -5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="text-align: center; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="text-align: center; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="text-align: center; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="text-align: center; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="text-align: center; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="text-align: center; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="text-align: center; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="text-align: center; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="text-align: center; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="text-align: center; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="text-align: center; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="text-align: center; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 8pt Times New Roman, Times, Serif">
    <TD STYLE="width: 10%; font: bold 8pt Times New Roman, Times, Serif; text-indent: -5pt; padding-left: 5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Balance
    at 1 January 2015</FONT> </TD><TD STYLE="width: 0.5%; font: bold 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 0.5%; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="width: 6%; font: bold 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">15,217</FONT> </TD><TD STYLE="width: 0.5%; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="width: 0.5%; font: bold 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 0.5%; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="width: 6%; font: bold 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">27,069</FONT> </TD><TD STYLE="width: 0.5%; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="width: 0.5%; font: bold 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 0.5%; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="width: 6%; font: bold 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">232</FONT> </TD><TD STYLE="width: 0.5%; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="width: 0.5%; font: bold 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 0.5%; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="width: 6%; font: bold 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="width: 0.5%; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="width: 0.5%; font: bold 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 0.5%; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="width: 6%; font: bold 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">3,519</FONT> </TD><TD STYLE="width: 0.5%; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="width: 0.5%; font: bold 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 0.5%; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="width: 6%; font: bold 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">9,448</FONT> </TD><TD STYLE="width: 0.5%; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="width: 0.5%; font: bold 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 0.5%; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="width: 6%; font: bold 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(46,171</FONT> </TD><TD STYLE="width: 0.5%; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT> </TD><TD STYLE="width: 0.5%; font: bold 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 0.5%; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="width: 6%; font: bold 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(5,604</FONT> </TD><TD STYLE="width: 0.5%; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT> </TD><TD STYLE="width: 0.5%; font: bold 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 0.5%; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="width: 6%; font: bold 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="width: 0.5%; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="width: 0.5%; font: bold 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 0.5%; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="width: 6%; font: bold 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(942</FONT> </TD><TD STYLE="width: 0.5%; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT> </TD><TD STYLE="width: 0.5%; font: bold 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 0.5%; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="width: 6%; font: bold 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="width: 0.5%; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="width: 0.5%; font: bold 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 0.5%; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="width: 6%; font: bold 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,768</FONT> </TD><TD STYLE="width: 0.5%; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif">
    <TD STYLE="text-decoration: underline; text-align: left; text-indent: -5pt; padding-left: 5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Transactions
    with owners</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 8pt Times New Roman, Times, Serif">
    <TD STYLE="text-indent: -5pt; padding-left: 5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Issue
    of share capital</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">346</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">6,427</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">6,773</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -5pt; padding-left: 5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Share
    based payments (options)</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,433</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,433</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 8pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -5pt; padding-left: 5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Share
    based payments (warrants)</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">162</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">162</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -5pt; padding-left: 5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Convertible
    loan note &ndash; equity component</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">11,991</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(456</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">11,535</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 8pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; text-indent: -5pt; padding-left: 5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Options
    cancelled</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(162</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">162</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -5pt; padding-left: 5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Total
    transactions with owners</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">346</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">6,427</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,271</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">162</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">11,991</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(294</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">19,903</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 8pt Times New Roman, Times, Serif">
    <TD STYLE="text-decoration: underline; text-align: left; text-indent: -5pt; padding-left: 5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Comprehensive
    income</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -5pt; padding-left: 5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Loss
    for the period&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(13,193</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(13,193</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 8pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; text-indent: -5pt; padding-left: 5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Translation
    income</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">3,063</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">3,063</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -5pt; padding-left: 5pt; padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Total
    comprehensive income</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(13,193</FONT> </TD><TD STYLE="text-align: left; padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">3,063</FONT> </TD><TD STYLE="text-align: left; padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(10,130</FONT> </TD><TD STYLE="text-align: left; padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 8pt Times New Roman, Times, Serif">
    <TD STYLE="text-indent: -5pt; padding-left: 5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-indent: -5pt; padding-left: 5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Balance
    at 31 December 2015</FONT> </TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">15,563</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">33,496</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,503</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">162</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">15,510</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">9,448</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(46,171</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT> </TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(19,091</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT> </TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,121</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">12,540</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 8pt Times New Roman, Times, Serif">
    <TD STYLE="text-indent: -5pt; padding-left: 5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif">
    <TD STYLE="text-decoration: underline; text-align: left; text-indent: -5pt; padding-left: 5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Transactions
    with owners</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 8pt Times New Roman, Times, Serif">
    <TD STYLE="text-indent: -5pt; padding-left: 5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Issue
    of share capital</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">84</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">546</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"><P STYLE="margin: 0pt 0; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">630</FONT> </P>


</TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -5pt; padding-left: 5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Share
    based payment (options)</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,144</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,144</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 8pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -5pt; padding-left: 5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Share
    based payment (warrants)</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">109</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">109</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -5pt; padding-left: 5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Convertible
    loan note &ndash; equity component</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,649</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(851</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">798</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 8pt Times New Roman, Times, Serif">
    <TD STYLE="text-indent: -5pt; padding-left: 5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Cancellation
    of deferred shares</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(8,744</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">8,744</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -5pt; padding-left: 5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Capital
    Reduction</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(25,099</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(9,448</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(8,744</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">41,292</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,999</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 8pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; text-indent: -5pt; padding-left: 5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Prior
    Year Adjustment</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(14</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(14</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -5pt; padding-left: 5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Total
    transactions with owners</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(8,660</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(24,553</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,144</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">109</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,649</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(9,448</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(865</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">41,292</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(669</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 8pt Times New Roman, Times, Serif">
    <TD STYLE="text-decoration: underline; text-align: left; text-indent: -5pt; padding-left: 5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Comprehensive
    income</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -5pt; padding-left: 5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Loss
    for the period</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(9,770</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(9,770</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 8pt Times New Roman, Times, Serif">
    <TD STYLE="padding-bottom: 1.5pt; text-indent: -5pt; padding-left: 5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Translation</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">650</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">650</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -5pt; padding-left: 5pt; padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Total
    comprehensive income</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(9,770</FONT> </TD><TD STYLE="text-align: left; padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">650</FONT> </TD><TD STYLE="text-align: left; padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(9,120</FONT> </TD><TD STYLE="text-align: left; padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 8pt Times New Roman, Times, Serif">
    <TD STYLE="text-indent: -5pt; padding-left: 5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-indent: -5pt; padding-left: 5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Balance
    at 31 December 2016</FONT> </TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">6,903</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">8,943</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,647</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">271</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">17,158</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(46,171</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT> </TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(29,726</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)&nbsp;</FONT> </TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,771</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">41,292</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">4,088</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 8pt Times New Roman, Times, Serif">
    <TD STYLE="text-indent: -5pt; padding-left: 5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif">
    <TD STYLE="text-indent: -5pt; padding-left: 5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Issue
    of share capital</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">84</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,464</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,548</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 8pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -5pt; padding-left: 5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Share
    based payment (options)</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,324</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,324</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -5pt; padding-left: 5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Share
    based payment (warrants)</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">308</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">308</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 8pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -5pt; padding-left: 5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Option
    forfeited in the year</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(758</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(758</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -5pt; padding-left: 5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Options
    cancelled in the year</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"><P STYLE="margin: 0pt 0; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(142</FONT> </P>


<FONT STYLE="font-size: 8pt"></FONT></TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(142</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 8pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -5pt; padding-left: 5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Convertible
    loan note &ndash; equity component</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">419&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(419)</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -5pt; padding-left: 5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Convertible
    loan note interest</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">3,610</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(3,610</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 8pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; text-indent: -5pt; padding-left: 5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Convertible
    Loan Note Conversion</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,154</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">20,877</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(21,188</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(844</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -5pt; padding-left: 5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Total
    transactions with owners</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,237</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">22,341</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">566</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">308</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(17,158</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(4,171</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(844</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,280</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 8pt Times New Roman, Times, Serif">
    <TD STYLE="text-decoration: underline; text-align: left; text-indent: -5pt; padding-left: 5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Comprehensive
    income</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -5pt; padding-left: 5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Loss
    for the period</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(8,716</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="text-align: right; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(8,716</FONT> </TD><TD STYLE="text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 8pt Times New Roman, Times, Serif">
    <TD STYLE="padding-bottom: 1.5pt; text-indent: -5pt; padding-left: 5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Translation</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">70</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">70</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 8pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; text-indent: -5pt; padding-left: 5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Total
    comprehensive income</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(8,716</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">70</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(8,646</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font: 8pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 8pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-indent: -5pt; padding-left: 5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Balance
    at 31 December 2017</FONT> </TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">8,141</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">31,284</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">3,213</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">579</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(46,171</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT> </TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(42,613</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT> </TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,997</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 8pt Times New Roman, Times, Serif; text-align: left"></TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">41,292</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(2,278</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The capital reduction reserve
includes reserves designated as realized profits available for distribution under section 830(2) of the Companies Act 2006
arising from the court approved capital reduction detailed in notes 16 and 21.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 159; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="f_005"></A><I>TIZIANA LIFE SCIENCES PLC</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Consolidated Statements of Cash Flows</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(In thousands)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif">Year ended December 31,</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif">2017</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif">2016</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; text-align: left; font-family: Times New Roman, Times, Serif">CASH FLOWS FROM OPERATING ACTIVITIES:</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 76%; text-align: left; font-family: Times New Roman, Times, Serif"><P STYLE="margin: 0pt 0">Loss from operations before income taxes</P>


</TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif">$</TD><TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif">(10,628</TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif">)</TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif">$</TD><TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif">(9,891</TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">Adjustments to reconcile net loss to net cash used in operating activities:</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">Convertible loan interest accrued</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">12</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">12</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">Share based payment &ndash; options</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">539</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">1,257</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">Cancellation of options</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">(135</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">)</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">-</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">Share based payment &ndash; warrants</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">294</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">121</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">Net (increase)/decrease in operating assets/other receivables</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">54</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">121</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">Net increase/(decrease) in operating liabilities /other liabilities</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">2,305</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">1,174</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">Depreciation</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">13</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">11</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">Loss on foreign exchange</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">45</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">214</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">Lease adjustment</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">(31</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">)</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">55</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-left: 9pt; font-family: Times New Roman, Times, Serif">Net cash used in operating activities</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">(7,533</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">)</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">(6,926</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; text-align: left; font-family: Times New Roman, Times, Serif">CASH FLOWS FROM INVESTING ACTIVITIES</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">PPE</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">(1</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">)</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">(48</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">Acquisition of other investments</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">(294</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-left: 9pt; font-family: Times New Roman, Times, Serif">Net cash used in investing activities</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">(1</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">)</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">(342</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; text-align: left; font-family: Times New Roman, Times, Serif">CASH FLOWS FROM FINANCING ACTIVITIES:</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">Proceeds from issuance of ordinary shares</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">1,542</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">614</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">Proceeds from issuance of convertible loan notes</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">961</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-left: 9pt; font-family: Times New Roman, Times, Serif">Net cash provided by financing activities</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">1,542</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">1,575</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">Net decrease in cash and cash equivalents</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">(5,992</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">)</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">(5,693</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">Cash and cash equivalent, beginning of period</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">5,802</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">13,128</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">Exchange difference</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">254</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">(1,633</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">Cash and cash equivalent, end of period</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">64</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">5,802</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 160; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="f_006"></A><B>TIZIANA LIFE SCIENCES PLC</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Notes to Consolidated Financial Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>GENERAL INFORMATION</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Tiziana Life Sciences PLC is
a public limited company incorporated in the United Kingdom under the Companies Act and quoted on AIM, a market of the London
Stock Exchange (AIM: TILS). The principal activities of the company and its subsidiaries (the Group) are that of a clinical stage
biotechnology company focused on targeted drugs to treat diseases in oncology and immunology.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">These financial statements
are presented in thousands of dollars ($&rsquo;000) which is the presentational currency of the company. The functional currency
is Pounds sterling (&pound;) indicative of the primary economic environment in which the company operates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The ultimate parent of the
group is Planwise Group Limited, incorporated in the British Virgin Islands. Gabriele Cerrone is the ultimate beneficial owner
of the entire issued share capital of Planwise Group Limited.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ACCOUNTING POLICIES</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The principal accounting policies
applied in the preparation of these consolidated financial statements are set out below. These policies have been applied consistently
to all the years presented unless otherwise stated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><B>Basis of preparation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The consolidated financial
statements of the Group have been prepared in accordance with International Financial Reporting Standards (IFRS) as issued by
the International Accounting Standards Board, IFRIC interpretations and the Companies Act 2006 as applicable to companies reporting
under IFRS. These accounts have been prepared under the historical cost convention.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><B>Going Concern</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Group incurred losses during
the year and has net liabilities at the year end.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Group is in the early stages
of developing its business focusing on the discovery and development of novel molecules that treat human disease in oncology and
immunology. The directors expect the company to incur further losses and to require significant capital expenditure in continuing
to develop clinical stage development therapeutic candidates in both oncology and immunology. The Group has successfully funded
clinical trials to date and is in the process of securing additional investment for purposes of continuing to fund their clinical
trials moving forward.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The directors have prepared
cash flow projections that include the costs associated with the continued clinical trials and additional investment to fund that
operation.&nbsp; On the basis of those projections, the directors conclude that the company will be able to meet its liabilities
as they fall due for the foreseeable future, and therefore that it is appropriate to prepare the financial statements under the
going concern basis of preparation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">However, until and unless the
company secures sufficient investment to fund their clinical trials, there is a material uncertainty about the company&rsquo;s
ability to continue as a going concern, and therefore about the applicability of the going concern basis of preparation.&nbsp;
The financial statements do not include the adjustments that would be required if the going concern basis of preparation was considered
inappropriate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><B>Basis of consolidation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Subsidiary undertakings are
all entities over which the Group exercises control. The Group has control when it can demonstrate all of the following: (a) power
over the investee; (b) exposure, or rights, to variable returns from its involvement with the investee; and (c) the ability to
use its power over the investee to affect the amount of the investor&rsquo;s return.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The existence and effect of
both current voting rights and potential voting rights that are currently exercisable or convertible are considered when assessing
whether control of an entity is exercised. Subsidiaries are consolidated from the date at which the Group obtains control and
are de-consolidated from the date at which control ceases.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><B>Business combination</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> The consolidated position of the Group
is as a result of the reverse acquisition of Alexander David Investments plc by Tiziana Pharma Limited and the subsequent listing
on AIM of the company as Tiziana Life Sciences plc on 24 April 2014. The reverse acquisition for the business combination is detailed
below: </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">On April 24, 2014, the company
(Alexander David Investments plc, (ADI)) acquired via a share for share exchange the entire issued share capital of Tiziana Pharma
Limited, whose principal activity is that of a clinical stage biotechnology company focused on targeted drugs to treat diseases
in oncology and immunology.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 161; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="background-color: white"><B>Prior
period adjustment</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="background-color: white">The Company identified
and recorded an out-of-period adjustment relating to the net loss figures used to calculate the loss per share. The adjustment
was made to include the interest accrued on the Convertible Loan note equity instrument in the numerator of the calculation. The
adjustment is reflected as an increase in the net loss and a corresponding increase in the loss per share. A tabular summary of
the revisions is presented below:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: blue"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; padding-bottom: 1.5pt"> &nbsp; </TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="22" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> Consolidated Statement
    of Operations </TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; padding-bottom: 1.5pt"> &nbsp; </TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="10" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> Year ended December&nbsp;31,
    2017 </TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"> &nbsp; </TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="10" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> Year ended December&nbsp;31,
    2016 </TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; padding-bottom: 1.5pt"> &nbsp; </TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> Revisions </TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"> &nbsp; </TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> Previously Reported </TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"> &nbsp; </TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> Revised Reported </TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"> &nbsp; </TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> Revisions </TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"> &nbsp; </TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> Previously Reported </TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"> &nbsp; </TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> Revised Reported </TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 28%; font-style: italic; text-align: left; padding-bottom: 1.5pt"> Net Loss $&rsquo;000 </TD><TD STYLE="width: 1%; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="width: 1%; text-align: left; border-bottom: Black 1.5pt solid"> $ </TD><TD STYLE="width: 9%; text-align: right; border-bottom: Black 1.5pt solid"> 419 </TD><TD STYLE="width: 1%; text-align: left; padding-bottom: 1.5pt"> &nbsp; </TD><TD STYLE="width: 1%; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="width: 1%; text-align: left; border-bottom: Black 1.5pt solid"> $ </TD><TD STYLE="width: 9%; text-align: right; border-bottom: Black 1.5pt solid"> 8,716 </TD><TD STYLE="width: 1%; text-align: left; padding-bottom: 1.5pt"> &nbsp; </TD><TD STYLE="width: 1%; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="width: 1%; text-align: left; border-bottom: Black 1.5pt solid"> $ </TD><TD STYLE="width: 9%; text-align: right; border-bottom: Black 1.5pt solid"> 9,135 </TD><TD STYLE="width: 1%; text-align: left; padding-bottom: 1.5pt"> &nbsp; </TD><TD STYLE="width: 1%; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="width: 1%; text-align: left; border-bottom: Black 1.5pt solid"> $ </TD><TD STYLE="width: 9%; text-align: right; border-bottom: Black 1.5pt solid"> 851 </TD><TD STYLE="width: 1%; text-align: left; padding-bottom: 1.5pt"> &nbsp; </TD><TD STYLE="width: 1%; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="width: 1%; text-align: left; border-bottom: Black 1.5pt solid"> $ </TD><TD STYLE="width: 9%; text-align: right; border-bottom: Black 1.5pt solid"> 9,770 </TD><TD STYLE="width: 1%; text-align: left; padding-bottom: 1.5pt"> &nbsp; </TD><TD STYLE="width: 1%; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="width: 1%; text-align: left; border-bottom: Black 1.5pt solid"> $ </TD><TD STYLE="width: 9%; text-align: right; border-bottom: Black 1.5pt solid"> 10,621 </TD><TD STYLE="width: 1%; text-align: left; padding-bottom: 1.5pt"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &nbsp; </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &nbsp; </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &nbsp; </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &nbsp; </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &nbsp; </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &nbsp; </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-style: italic; padding-bottom: 1.5pt"> Net loss per share $ </TD><TD STYLE="padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"> &nbsp; </TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"> (0.01 </TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"> ) </TD><TD STYLE="padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"> &nbsp; </TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"> (0.08 </TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"> ) </TD><TD STYLE="padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"> &nbsp; </TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"> (0.09 </TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"> ) </TD><TD STYLE="padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"> &nbsp; </TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"> (0.01 </TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"> ) </TD><TD STYLE="padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"> &nbsp; </TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"> (0.10 </TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"> ) </TD><TD STYLE="padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"> &nbsp; </TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"> (0.11 </TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"> ) </TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Due to the relative values
of the companies, the former Tiziana Pharma Limited shareholders became majority shareholders with 96.1% of the enlarged share
capital in ADI which was renamed Tiziana Life Sciences plc, and hence hold the majority of the voting rights. Furthermore, the
executive management of Tiziana Pharma Limited became the executive management of Tiziana Life Sciences plc. A qualitative and
quantitative analysis of these factors led the Directors to conclude that in this transaction Tiziana Pharma Limited has the controlling
interest and should be treated as the accounting acquirer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">In determining the appropriate
accounting treatment for the reverse acquisition, the Directors considered the Application Supplement to IFRS 3, Business combinations.
However, they concluded that this transaction fell outside the scope of IFRS 3 since Tiziana Life Sciences plc, whose activity
prior to the acquisition was purely the maintenance of the AIM listing, did not constitute a business. It was therefore determined
that the transaction should be accounted for in a manner that was similar to the reverse acquisition accounting as described in
IFRS 3, but without recognizing goodwill.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The following accounting treatment
has been applied in respect of the reverse acquisition;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify; font-family: Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
assets and liabilities of the legal subsidiary, Tiziana Pharma Limited are recognized and measured in the consolidated financial
statements at their pre-combination carrying amounts, without restatement to their fair value.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify; font-family: Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
retained reserves recognized in the consolidated financial statements reflect the retained reserves of Tiziana Pharma Limited
to the date of acquisition.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify; font-family: Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
applying IFRS 3 by analogy, the equity structure appearing in the consolidated financial statements reflects the equity structure
of the legal parent Tiziana Life Sciences plc, including the equity instruments issued under the share exchange to effect the
business combination.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify; font-family: Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
reverse acquisition reserve has been created to enable the presentation of a consolidated balance sheet which combines the equity
structure of the legal parent with the non-statutory reserves of the legal subsidiary.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Tiziana Pharma Limited was
incorporated on 4th November 2013 and prepared its first set of financial statements to 31 December 2014. Therefore, the parent
and subsidiary had the same reporting date but Tiziana Pharma Limited had a long period of account. No adjustment was made in
the consolidated financial statements for the difference in length of reporting period because the only transaction in Tiziana
Pharma Limited at 31 December 2013 was the issue of ordinary share capital of $1.65.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Inter-company transactions,
balances and unrealized gains on transactions between group companies are eliminated upon consolidation. Unrealized losses are
also eliminated. Accounting policies of subsidiaries have been changed where necessary to ensure consistency with the policies
adopted by the group.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><B>Segment reporting</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Operating segments are reported
in a manner consistent with the internal reporting provided to the Board. The Board allocates resources to and assess the performance
of the segments. The Board considers there to be only one operating segment being the research and development of biotechnological
and pharmaceutical products.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 162; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><B>Taxation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The tax expense for a period
represents the total of current taxation and deferred taxation. The charges in respect of current taxation are based on the estimated
taxable profit for the relevant year. Taxable profit for the year is based on the profit as shown in the income statement, as
adjusted for items of income or expenditure which are not deductible or chargeable for tax purposes. The current tax liability
for the year is calculated using tax rates which have either been enacted or substantively enacted at the relevant balance sheet
date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><B>Foreign currency translation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Items included in the financial
statements of each of the Group&rsquo;s entities are measured using the currency of the primary economic environment in which
the entity operates (the functional currency). The consolidated financial statements are presented in US dollars, which is the
Group&rsquo;s presentation currency.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Foreign currency transactions
are translated into the functional currency using exchange rates prevailing at the dates of the transactions. Foreign exchange
gains and losses resulting from the settlement of foreign currency transactions and from the translation at year-end exchange
rates of monetary assets and liabilities denominated in foreign currencies are recognized in the income statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The financial statements of
overseas subsidiary undertakings are translated into US dollars on the following basis:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify; font-family: Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets
and liabilities at the rate of exchange ruling at the year-end date.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify; font-family: Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Profit
and loss account items at the average rate of exchange for the year.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Exchange differences arising
from the translation of the net investment in foreign entities, borrowings and other currency instruments designated as hedges
of such investments, are taken to equity (and recognized in the statement of comprehensive income) on consolidation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><B>License fees</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Payments related to the acquisition
of rights to a product or technology are capitalized as intangible assets if it is probable that future economic benefits from
the asset will flow to the entity and the cost of the asset can be reliably measured.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Payments made which provide
the right to perform research are carefully evaluated to determine whether such payments are to fund research or acquire an asset.
Where fees related to research and development projects are recognized as an expense in the income statement, due to the uncertainty
in the length of time that the Group will hold them the expense is recognized fully at the point of recognition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><B>Research and development</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">All on-going research and development
expenditure is currently expensed in the period in which it is incurred. Due to the regulatory environment inherent in the development
of the Group&rsquo;s products, the criteria for development costs to be recognized as an asset, as set out in IAS 38 &lsquo;Intangible
Assets&rsquo;, are not met until a product has been granted regulatory approval and it is probable that future economic benefit
will flow to the Group. The Group currently has no qualifying expenditure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><B>Financial instruments</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><I>Financial assets</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Group classifies its financial
assets into one of the categories discussed below, depending on the purpose for which the asset was acquired.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><B><I>Loans and receivables</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Loans and receivables are recognized
initially at fair value and are subsequently measured at amortized cost.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><B><I>Cash and cash equivalents</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Cash and cash equivalents comprise
cash at bank and in hand and other short term highly liquid deposits with original maturities of three months or less. Bank overdrafts
are shown within borrowings in current liabilities on the balance sheet.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><I>Financial liabilities</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Group classifies its financial
liabilities into one of the categories discussed below, depending on the purpose for which the liability was committed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 163; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><B><I>Trade and other payables</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Trade and other payables are
recognized initially at fair value and are subsequently measured at amortized cost using the effective interest method.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><B><I>Share capital</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Ordinary shares of the company
are classified as equity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><B><I>Property, IT and equipment</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"><B><I>&nbsp;</I></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify; font-family: Times New Roman, Times, Serif">
<TD STYLE="width: 0; font-family: Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(i)</I></FONT></TD><TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Recognition
and measurement</I></FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Items of property, IT and equipment
are measured at cost less accumulated depreciation and accumulated impairment losses. Costs include expenditures that are directly
attributable to the acquisition of the asset. Purchased software that is integral to the functionality of the related equipment
is capitalized as part of that equipment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt">When parts of an item of property, IT and equipment
have different useful lives, they are accounted for as separate items (major components) of property, IT and equipment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Gains and losses on disposal
of an item of property, IT and equipment are determined by comparing the proceeds from disposal with the carrying amount of property,
IT and equipment, and are recognized in profit or loss. When revalued assets are sold, the amounts included in the revaluation
reserve are transferred to retained earnings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify; font-family: Times New Roman, Times, Serif">
<TD STYLE="width: 0; font-family: Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(ii)</I></FONT></TD><TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt">Depreciation is calculated on the depreciable amount,
which is the cost of an asset, or other amount substituted for cost, less its residual value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt">Depreciation is recognized in profit or loss on
a straight-line basis over the estimated useful life of each part of an item of property, IT and equipment. Leased assets are
depreciated over the shorter of the lease term and their useful lives unless it is reasonably certain that the company will obtain
ownership by the end of the lease term.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt">The estimated useful lives for the current period
and the comparative period are as follows.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 30%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IT and equipment</FONT></TD>
    <TD STYLE="width: 70%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3 years</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fixtures and fittings</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5 years</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Depreciation methods, useful
lives and residual values are reviewed at each reporting date. Depreciation is allocated to the operating expenses line of the
income statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><B><I>Impairment</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">A financial asset not carried
at fair value is assessed at each reporting date to determine whether there is objective evidence that it should be impaired.
A financial asset is impaired if objective evidence indicates that a loss event has occurred after the initial recognition of
the asset, and that the loss event had a negative effect on the estimated future cash flows of that asset that can be estimated
reliably.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Objective evidence that financial
assets are impaired can include default or delinquency of a debtor, restructuring of an amount due to the company on terms that
the company would not consider otherwise and indications that a debtor will enter bankruptcy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Non-financial assets are tested
for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Non-financial assets are impaired
when its carrying amount exceed its recoverable amount. The recoverable amount is measured as the higher of fair value less cost
of disposal and value in use. The value in use is calculated as being net projected cash flows based on financial forecasts discounted
back to present value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 164; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><B>Operating leases</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Payments made under operating
leases are recognized in profit and loss on a straight-line basis over the term of the lease. Lease incentives received are recognized
as an integral part of the total lease expense, over the term of the lease.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><B>Fair Value Measurement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Management have assessed the
categorization of the fair value measurements using the IFRS 13 fair value hierarchy. Categorization within the hierarchy has
been determined on the basis of the lowest level of input that is significant to the fair value measurement of the relevant asset
as follows;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify; font-family: Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
1 -valued using quoted prices in active markets for identical assets</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify; font-family: Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
2 -valued by reference to valuation techniques using observable inputs other than quoted prices included within Level 1;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify; font-family: Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
3 -valued by reference to valuation techniques using inputs that are not based on observable market data.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><B>Share based payments</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The calculation of the fair
value of equity-settled share based awards and the resulting charge to the statement of comprehensive income requires assumptions
to be made regarding future events and market conditions. These assumptions include the future volatility of the company&rsquo;s share
price. These assumptions are then applied to a recognized valuation model in order to calculate the fair value of the awards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Where employees, directors
or advisers are rewarded using share based payments, the fair value of the employees&rsquo;, directors&rsquo; or advisers&rsquo; services are determined
by reference to the fair value of the share options / warrants awarded. Their value is appraised at the date of grant and excludes
the impact of any nonmarket vesting conditions (for example, profitability and sales growth targets). Warrants issued in association
with the issue of Convertible Loan Notes are also considered as share based payments and a share based payment charge is calculated
for these too.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">In accordance with IFRS 2,
a charge is made to the Statement of Comprehensive Income for all share-based payments including share options based upon the
fair value of the instrument used. A corresponding credit is made to a Share Based Payment Reserve, in the case of options / warrants
awarded to employees, directors or advisers, and Shares To Be Issued Reserve in the case of warrants issued in association with
the issue of Convertible Loan Notes, net of deferred tax where applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">If vesting periods or other
vesting conditions apply, the expense is allocated over the vesting period, based on the best available estimate of the number
of share options / warrants expected to vest. Non market vesting conditions are included in assumptions about the number of options
/ warrants that are expected to become exercisable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Estimates are subsequently
revised, if there is any indication that the number of share options / warrants expected to vest differs from previous estimates.
No adjustment is made to the expense or share issue cost recognized in prior periods if fewer share options ultimately are exercised
than originally estimated. Exercise of share options / warrants, the proceeds received are allocated to share capital with any
excess being recorded as share premium.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Where share options are cancelled,
this is treated as an acceleration of the vesting period of the options. The amount that otherwise would have been recognized
for services received over the remainder of the vesting period is recognized immediately within the Statement of Comprehensive
Income.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">All goods and services received
in exchange for the grant of any share based payment are measured at their fair value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><B>Convertible loan notes</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Under IAS 32 the liability
and equity components of convertible loan notes must be presented separately on the Statement of Financial Position. The Group
has examined the terms of each issue of convertible loan notes and determined their accounting treatment accordingly. Convertible
loan notes are treated differently depending upon a number of factors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><I>Where there is no option
to repay as cash and the interest rate is fixed</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Group considers these to
be Convertible Equity Instruments and records the principal of the loan note as an equity in a Convertible loan note reserve.
The accrued interest on the principal amount, for which there is no obligation to settle in cash, is also recorded in the Convertible
loan note reserve. Upon redemption of the instrument and the issue of share capital, the amount is reclassified from the convertible
loan note reserve to share capital and share premium.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><I>Where there is no option
to repay as cash and the interest rate is variable</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Group considers these to
be Convertible Debt Instruments and records the principal of the loan note as a debt liability in the liabilities section of the
balance sheet. The accrued interest on the principal amount is recorded in the income statement and as an increase in the debt
liability. Upon redemption of the instrument and the issue of share capital, the amount is reclassified from the debt liability
to share capital and share premium.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 165; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.</B></FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CRITICAL ACCOUNTING
    ESTIMATES AND JUDGEMENTS</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The preparation of financial
information in accordance with generally accepted accounting practice, in the case of the Group being International Financial
Reporting Standards as adopted by the European Union, requires the directors to make estimates and judgements that affect the
reported amount of assets, liabilities, income and expenditure and the disclosures made in the financial statements. Such estimates
and judgements must be continually evaluated based on historical experience and other factors, including expectations of future
events.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">When entering into agreements
with third parties which provide the rights to conduct research into specific biological processes the group account for these
agreements as an expense if the agreements are &lsquo;milestone&rsquo; in nature and relate to the Group&rsquo;s own research and development costs.
Such agreements involve periodic payments and are evaluated as representing payments made to fund research.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The only other critical accounting
estimates and judgements in the preparation of the financial statements were fair value estimates used in the calculation of share
based payments and warrants which have been detailed above in note 2, accounting policies, and note 16, share based payments,
to the accounts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OPERATING LOSS</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Group and Company&rsquo;s
operating loss are stated after charging the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif">Year Ended December 31,</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif">2017<BR> $&rsquo;000</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif">2016<BR> $&rsquo;000</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 76%; text-align: left; font-family: Times New Roman, Times, Serif">License fee</TD><TD STYLE="width: 1%; font-weight: bold; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="width: 9%; font-weight: bold; text-align: right; font-family: Times New Roman, Times, Serif">662</TD><TD STYLE="width: 1%; font-weight: bold; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="width: 1%; font-weight: bold; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="width: 9%; font-weight: bold; text-align: right; font-family: Times New Roman, Times, Serif">561</TD><TD STYLE="width: 1%; font-weight: bold; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">Depreciation</TD><TD STYLE="font-weight: bold; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right; font-family: Times New Roman, Times, Serif">13</TD><TD STYLE="font-weight: bold; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-weight: bold; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right; font-family: Times New Roman, Times, Serif">11</TD><TD STYLE="font-weight: bold; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">Foreign exchange losses/(gain)</TD><TD STYLE="font-weight: bold; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right; font-family: Times New Roman, Times, Serif">45</TD><TD STYLE="font-weight: bold; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-weight: bold; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right; font-family: Times New Roman, Times, Serif">215</TD><TD STYLE="font-weight: bold; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="padding-bottom: 4pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right; font-family: Times New Roman, Times, Serif">720</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right; font-family: Times New Roman, Times, Serif">788</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SEGMENTAL REPORTING</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">During the year under review
Management identified the Group&rsquo;s only operating segment as the research and development of biotechnological and pharmaceutical
products. This one segment is monitored and strategic decisions are made based upon it and other non-financial data collated from
industry intelligence. The form of financial reporting reported to the Board is consistent with those presented in the annual
financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AUDITOR&rsquo;S REMUNERATION</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif">Year Ended December 31,</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif">2017<BR> $&rsquo;000</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif">2016<BR> $&rsquo;000</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 76%; text-align: left; text-indent: -10pt; padding-left: 10pt; font-family: Times New Roman, Times, Serif">Remuneration receivable by the company&rsquo;s auditor for the audit of the consolidated and Company financial statements</TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif">54</TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif">49</TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">Remuneration receivable by the company&rsquo;s auditor for other assurance services</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">24</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify; font-family: Times New Roman, Times, Serif">
<TD STYLE="width: 0; font-family: Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; text-align: left; font-family: Times New Roman, Times, Serif"><B>7.</B></TD><TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>EMPLOYEES</B></FONT></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif">Year Ended December 31,</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif">2017<BR> $&rsquo;000</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif">2016<BR> $&rsquo;000</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><U>Group</U></TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">Staff costs comprised:</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 76%; text-align: left; font-family: Times New Roman, Times, Serif">Directors&rsquo; salaries</TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif">211</TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif">214</TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">Wages and salaries</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">1,107</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">786</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">Social security costs</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">491</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">38</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">Share based payment charge</TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif">539</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif">1,015</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="padding-bottom: 4pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="padding-bottom: 4pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right; font-family: Times New Roman, Times, Serif">2,348</TD><TD STYLE="padding-bottom: 4pt; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="padding-bottom: 4pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right; font-family: Times New Roman, Times, Serif">2,053</TD><TD STYLE="padding-bottom: 4pt; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 10pt; font-family: Times New Roman, Times, Serif">The average monthly number of employees, including directors, employed by the group during the year was:</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">Corporate and administration</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">11</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">6</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>



<!-- Field: Page; Sequence: 166; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REMUNERATION OF KEY MANAGEMENT PERSONNEL</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 8pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="14" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif">Year ended December 31,</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">$&rsquo;000</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif">2017</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif">2016</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif">Directors fees</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif">Salary</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif">Directors fees</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif">Salary</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 52%; text-align: left; font-family: Times New Roman, Times, Serif">W Simon</TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif">49</TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif">52</TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="width: 1%; font-weight: bold; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="width: 9%; font-weight: bold; text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;-</TD><TD STYLE="width: 1%; font-weight: bold; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">G. Cerrone (1)</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">86</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">108</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-weight: bold; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right; font-family: Times New Roman, Times, Serif">-</TD><TD STYLE="font-weight: bold; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">R. Dalla-Favera</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">26</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">27</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-weight: bold; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right; font-family: Times New Roman, Times, Serif">-</TD><TD STYLE="font-weight: bold; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">K. Shailubhai (2)</TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif">10</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif">286</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif">27</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right; font-family: Times New Roman, Times, Serif">-</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="padding-bottom: 4pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right; font-family: Times New Roman, Times, Serif">171</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right; font-family: Times New Roman, Times, Serif">286</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right; font-family: Times New Roman, Times, Serif">214</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right; font-family: Times New Roman, Times, Serif">-</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 8pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify; font-family: Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD><TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
November 1, 2017, Gabriele Cerrone has waived his right to receive director&rsquo;s fees for the foreseeable future.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 8pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify; font-family: Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD><TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kunwar
Shailubhai became an employee of the company on May 24, 2017, at which point he ceased to be a non-executive director.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 8pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following share options were granted to directors in the
year:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 8pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-weight: bold; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; font-family: Times New Roman, Times, Serif">2017</TD><TD STYLE="font-weight: bold; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-weight: bold; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; font-family: Times New Roman, Times, Serif">2016</TD><TD STYLE="font-weight: bold; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif">Number of options</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif">Number of options</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 76%; text-align: left; font-family: Times New Roman, Times, Serif">G. Cerrone</TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif">-</TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif">3,259,403</TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">K. Shailubhai</TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif">400,000</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right; font-family: Times New Roman, Times, Serif">-</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="padding-bottom: 4pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right; font-family: Times New Roman, Times, Serif">400,000</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right; font-family: Times New Roman, Times, Serif">3,259,403</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 8pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The key management personnel of the Group
are considered to be represented by the directors and officers of the company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 8pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">No director has yet benefitted from any
increase in the value of share capital since issuance of the options.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 8pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">No director exercised share options in
the year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 8pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The company made $6k (2016: $0k) of payments
to a defined contribution pension schemes on behalf of directors or employees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 8pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9.</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FINANCE COSTS</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 8pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif">Year Ended December 31,</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif">2017<BR> $&rsquo;000</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif">2016<BR> $&rsquo;000</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><U>Group</U></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 76%; text-align: left; font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt">Finance charge accrued on convertible loan notes (recognized as debt)</TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid">12</TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid">12</TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="padding-bottom: 4pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="padding-bottom: 4pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right; font-family: Times New Roman, Times, Serif">12</TD><TD STYLE="padding-bottom: 4pt; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="padding-bottom: 4pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right; font-family: Times New Roman, Times, Serif">12</TD><TD STYLE="padding-bottom: 4pt; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 8pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TAXATION</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 8pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif">Year Ended December 31,</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif">2017<BR> $&rsquo;000</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif">2016<BR> $&rsquo;000</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><U>Group</U></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 76%; text-align: left; font-family: Times New Roman, Times, Serif">Current tax (credit)</TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif">(1,912</TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif">)</TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif">(121</TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">Deferred tax</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt">Origination and reversal of timing differences</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nil</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nil</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">Total tax (credit) for the period</TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif">(1,912</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif">)</TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif">(121</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 10pt; font-family: Times New Roman, Times, Serif">The tax charge for the year is different from the standard rate of corporation tax in the United Kingdom of 21.49%. The difference can be reconciled as follows:</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">Loss before taxation</TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif">(10,628</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif">)</TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif">(9,770</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif">Loss charged at standard rate of corporation tax 19.25% (2016: 20%)</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">(2,046</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">)</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">(1,953</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">Other timing differences</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">2,889</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">1,656</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">Expenses not deductible for taxation</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">31</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">297</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">Adjustments due to prior periods</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">(1,423</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">)</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">(121</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">Research and development claim</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">(1,366</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">)</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">-</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">Other timing differences</TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif">3</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif">(1,912</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif">)</TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif">(121</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif">)</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 8pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 167; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="background-color: white">The
Research and Development claim has been calculated in accordance with the R&amp;D tax relief available to small and medium sized
entities, whereby the entity is able to claim a cash tax credit (if loss making), worth up to 14.5% of the surrenderable losses.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="background-color: white">The
adjustments due to prior periods relates to R&amp;D tax relief claims or the years ended December 31, 2016 and 2015. In prior
periods there was not enough certainty to recognize an asset for these claims. Under UK tax legislation, a 2 year window is available
under which R&amp;D tax relief can be claimed.</FONT> </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">No deferred tax asset has been recognized
in respect of trading losses carried forward because of uncertainty as to when these losses will be recoverable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The amount of tax losses for which no deferred tax assets has
been recognized is $4,738 (2016: &pound;3,535).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>11.</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>LOSS PER SHARE</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Basic loss per share is calculated by
dividing the profit attributable to equity holders of the company by the weighted average number of ordinary shares in issue during
the year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"> Year
    Ended December 31, </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"> 2017 </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"> 2016 </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 76%; text-align: left; font-family: Times New Roman, Times, Serif"> (Loss) attributable to equity holders
    of the company ($000) </TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif"> (9,135 </TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"> ) </TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif"> (10,622 </TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> Weighted average number of ordinary shares
    in issue </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"> 106,403,903 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"> &nbsp; </TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"> 93,592,195 </TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"> Basic loss per share (cents
    per share) </TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"> (8.59 </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif"> ) </TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"> (11.35 </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif"> ) </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As the Group is reporting a loss from
continuing operations for the year then, in accordance with IAS 33, the share options are not considered dilutive because the
exercise of the share options would have an anti-dilutive effect. The basic and diluted earnings per share as presented on the
face of the income statement are therefore identical. All earnings per share figures presented above arise from continuing and
total operations and therefore no earnings per share for discontinued operations are presented.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="background-color: white">The
earnings have been amended to include the interest accrued on Convertible Loan Notes.</FONT> </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>12.</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROPERTY, IT AND EQUIPMENT</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Details of the Groups property, IT and equipment are as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>$000</B></FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif">Furniture<BR>
 and fixtures</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif">IT<BR>
 equipment</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif">Total</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; font-family: Times New Roman, Times, Serif">Cost</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">At 1 January 2016</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">-</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">-</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">-</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 64%; font-family: Times New Roman, Times, Serif">Additions</TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif">15</TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif">30</TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif">45</TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">Disposals</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">-</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">-</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">-</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; font-family: Times New Roman, Times, Serif">At 31 December 2016</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">15</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">30</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">45</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; font-family: Times New Roman, Times, Serif">Depreciation</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">At 1 January 2016</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">-</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">-</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">-</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">Charge in year</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">1</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">9</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">10</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; font-family: Times New Roman, Times, Serif">At 31 December 2016</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">1</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">9</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">10</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; font-family: Times New Roman, Times, Serif">Net Book Value as at 31 December 2016</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">14</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">21</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">35</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 168; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>$000</B></FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif">Furniture<BR>
 and fixtures</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif">IT <BR>
equipment</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif">Total</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; font-family: Times New Roman, Times, Serif">Cost</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 64%; font-family: Times New Roman, Times, Serif">At 1 January 2017</TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif">15</TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif">30</TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif">45</TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">Additions</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">-</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">1</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">1</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">Disposals</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">-</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">-</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">-</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; font-family: Times New Roman, Times, Serif">At 31 December 2017</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">15</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">31</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">46</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; font-family: Times New Roman, Times, Serif">Depreciation</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">At 1 January 2017</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">1</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">9</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">10</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">Charge in year</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">2</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">11</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">13</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; font-family: Times New Roman, Times, Serif">At 31 December 2017</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">3</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">20</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">23</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; font-family: Times New Roman, Times, Serif">Net Book Value as at 31 December 2017</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">12</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">11</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">23</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify; font-family: Times New Roman, Times, Serif">
<TD STYLE="width: 0; font-family: Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>13.</B></FONT></TD><TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OTHER
RECEIVABLES</B></FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>$000</B></FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Year Ended December 31,</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2017</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2016</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold">Group</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left">Other receivables</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">109</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">115</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Taxation receivable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,851</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt">Prepayments</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">36</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">12</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,997</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">127</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There are no differences between the carrying
amount and fair value of any of the trade and other receivables above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>13.</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OTHER ASSETS</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In June 2016, the Board approved the purchase
of the Data repository of DNA from SharDNA (an Italian entity in liquidation) for EUR 258,000, approximately $268,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management recognizes that the transaction
is not the purchase of a business but the purchase of key assets owned by SharDNA. These assets are to be owned by Tiziana Life
Sciences PLC and will be loaned to its subsidiary Longevia SRL for no extra cost.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">No research and development work has been
carried out to this date, but Management anticipates that this will commence within the next 12 months.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As there is current legal action pending
against the liquidators as to the validity to the sale of the assets, the company is unable to utilize these assets until the
legal action is resolved. For this reason, the investment has been recognized as a current asset until such a time that the company
is able to use this asset. . In the event the company is unable to use the asset as a result of the legal action denoted above,
the company will receive their money back.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>14.</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INVESTMENTS IN SUBSIDIARIES</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The company&rsquo;s interest in subsidiary undertakings is
as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name</B></FONT> </TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Principal
    activity</B></FONT> </TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Registered
    Address</B></FONT> </TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Percentage
    shareholding</B></FONT> </TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Country
    of incorporation</B></FONT> </TD></TR>
<TR STYLE="background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; width: 20%; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tiziana
    Pharma Limited</FONT> </TD>
    <TD STYLE="vertical-align: bottom; width: 1%; font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="vertical-align: top; width: 19%; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clinical
    stage biotechnology company</FONT> </TD>
    <TD STYLE="vertical-align: bottom; width: 1%; font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom; width: 19%; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3<SUP>rd
    </SUP>Floor, 11-12</FONT><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">St James&rsquo;s Square,</FONT><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">London, SW1Y 4LB</FONT> </TD>
    <TD STYLE="vertical-align: bottom; width: 1%; font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom; width: 1%; font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom; width: 17%; text-align: right; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</FONT> </TD>
    <TD STYLE="vertical-align: bottom; width: 1%; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT> </TD>
    <TD STYLE="vertical-align: bottom; width: 1%; font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom; width: 19%; text-align: center; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">England
    &amp; Wales</FONT> </TD></TR>
<TR STYLE="background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tiziana
    Therapeutics, Inc.</FONT> </TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clinical
    stage biotechnology company</FONT> </TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">420
    Lexington Avenue </FONT><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Suite 2525 </FONT><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New York, NY 10170 </FONT> </TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom; text-align: right; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</FONT> </TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT> </TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom; text-align: center; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">USA</FONT> </TD></TR>
<TR STYLE="background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Longevia
    Genomics SRL</FONT> </TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Biotech
    Discovery Company</FONT> </TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Via
    Constantinpoli 42 </FONT><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">09100-Cagliari (CA)</FONT> </TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom; text-align: right; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</FONT> </TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT> </TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom; text-align: center; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Italy</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> Tiziana Therapeutics, Inc. was incorporated
on 28 October 2015. This entity was set up to house the company&rsquo;s US operations. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Longevia Genomics SRL was incorporated
on 4 July 2016. This entity was established to enable the company to carry out R&amp;D activities in Sardinia.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 169; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>15.</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SHARE CAPITAL</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><U>Company
    and Group</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2017</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2016</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2017</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2016</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2017</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2016</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ordinary
    Shares</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Deferred
    Shares</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&pound;000</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&pound;000</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 28%; padding-left: 10pt; text-indent: -10pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    issue at 1 January</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">94,393,401</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">92,392,150</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">121,189,912</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,832</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,375</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued
    for cash</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,206,190</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,301,250</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">66</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">40</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conversion
    of Convertible Loan notes</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28,455,214</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">700,000</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">854</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sale
    of deferred shares</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
    shares transferred to capital redemption reserve</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(121,189,911</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6,604</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    issue at 31 December</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">125,054,805</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">94,393,401</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,752</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,832</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Ordinary Shares</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ordinary shares have a par value of &pound;0.03.
They entitle the holder to participate in dividends, and to share in the proceeds of winding up the company in proportion to the
number of and amounts paid on the shares held. On a show of hands every holder of ordinary shares present at a meeting in person
or by proxy, is entitled to one vote, and upon a poll each share is entitled to one vote. The company does not have a limited
amount of authorized capital.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Issuance of ordinary shares</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In March 2017, a notification was received
from warrant holders to exercise warrants over 1,789,524 ordinary shares in the company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In August 2017, the Board passed a resolution
to convert all outstanding Convertible Loan Notes effective from 26<SUP>th</SUP> July 2017. It also resolved that the Convertible
loan note holders be offered an additional bonus coupon of three years of interest at the relevant applicable rate of return for
agreeing to the immediate conversion of the Convertible loan note&rsquo;s into ordinary shares. The company has issued 28,455,214
new ordinary shares in respect of this conversion. All of the new shares are subject to a restriction on disposal for a period
of 12 months.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In November 2017, 283,333 new ordinary
shares were issued by way of a further placing of ordinary shares to raise finance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">An additional 133,333 new ordinary shares
were issued in December 17 by way of a further placing of ordinary shares to raise finance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>16.</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SHARE BASED PAYMENTS</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Group and Company Options</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The company operates share-based payment
arrangements to remunerate directors and key employees in the form of a share option scheme. The exercise price of the option
is normally equal to the market price of an ordinary share in the company at the date of grant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2017</B></FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2016</B></FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Weighted</B></FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Options</B></FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Weighted</B></FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Options</B></FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Average
    exercise price (cents)</B></FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(&lsquo;000)</B></FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Average
    exercise price (cents)</B></FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(&lsquo;000)</B></FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 52%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at 1 January</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">90</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,449</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">35</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,985</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">216</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">668</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">190</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,464</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeited</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(20</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,400</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at 31 December</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">125</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,717</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">90</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,449</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable at 31 December</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">57</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,011</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,152</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: -0.05pt">No options were exercised during the
period to 31st December 2017 and 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 170; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Share options outstanding at the end of
the year have the following expiry date and exercise prices:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date
    of issue</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number
    at 31 December 2017</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exercise
    price</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date
    from which exercisable</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Expiry
    Date</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 17%; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24 April
    2014</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 17%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">400,500</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 17%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.15</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 22%; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24 April
    2015</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 19%; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24 April
    2025</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24 April 2014</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">400,500</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.15</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24 April 2016</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24 April 2026</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24 April 2014</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">400,500</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.15</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24 April 2017</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24 April 2027</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24 April 2014</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">400,500</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.15</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24 April 2018</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24 April 2028</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25 June 2014</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">90,000</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.28</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17 May 2015</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17 May 2025</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25 June 2014</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">90,000</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.28</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17 May 2016</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17 May 2026</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25 June 2014</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">90,000</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.28</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17 May 2017</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17 May 2027</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25 June 2014</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">90,000</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.28</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17 May 2018</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17 May 2028</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25 June 2014</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,250</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.33</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24 April 2015</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24 April 2025</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25 June 2014</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,250</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.33</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24 April 2016</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24 April 2026</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25 June 2014</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,250</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.33</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24 April 2017</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24 April 2027</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25 June 2014</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,250</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.33</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24 April 2018</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24 April 2028</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">07 July 2014</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,500</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.35</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18 June 2015</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18 June 2025</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">07 July 2014</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,500</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.35</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18 June 2016</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18 June 2026</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">07 July 2014</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,500</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.35</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18 June 2017</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18 June 2027</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">07 July 2014</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,500</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.35</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18 June 2018</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18 June 2028</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23 January 2015</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,050,000</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.35</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23 January 2015</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23 January 2025</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23 January 2015</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">150,000</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.5</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1 October 2015</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1 October 2025</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23 January 2015</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">150,000</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.5</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1 October 2016</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1 October 2026</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23 January 2015</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">150,000</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.5</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1 October 2017</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1 October 2027</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23 January 2015</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">150,000</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.5</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1 October 2018</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1 October 2028</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23 January 2015</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">75,000</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.57</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12 September 2015</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12 September 2025</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23 January 2015</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">75,000</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.57</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12 September 2016</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12 September 2026</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23 January 2015</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">75,000</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.57</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12 September 2017</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12 September 2027</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23 January 2015</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">75,000</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.57</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12 September 2018</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12 September 2028</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">02 March 2015</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">150,000</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.55</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2 March 2015</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2 March 2025</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">02 March 2015</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">150,000</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.55</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2 March 2016</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2 March 2026</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">02 March 2015</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">150,000</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.55</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2 March 2017</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2 March 2027</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">02 March 2015</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">150,000</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.55</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2 March 2018</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2 March 2028</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23 March 2016</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.26</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23 March 2017</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22 March 2026</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23 March 2016</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.26</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23 March 2018</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22 March 2026</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23 March 2016</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.26</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23 March 2019</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22 March 2026</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23 March 2016</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.26</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23 March 2020</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22 March 2026</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">09 June 2016</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26,250</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.50</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">09 June 2017</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">09 June 2027</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">09 June 2016</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26,250</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.50</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">09 June 2018</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">09 June 2028</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">09 June 2016</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26,250</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.50</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">09 June 2019</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">09 June 2029</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">09 June 2016</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26,250</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.50</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">09 June 2020</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">09 June 2030</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">09 June 2016</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,259,403</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.50</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If weighted average
    of an ordinary share is greater than &pound;3 for 120 consecutive
    dealing days</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15 years from vesting
    date</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">05 November 2016</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100,000</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.86</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">05 November 2017</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">05 November 2027</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">01 December 2016</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">600,000</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.925</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Successful
    completion of     clinical trials within 24 months of 1<SUP>st</SUP> September
    2016</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5 years from vesting
    conditions being met</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10 March 2017</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100,000</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.725</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30 August 2018</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30 August 2028</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10 March 2017</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100,000</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.725</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30 August 2019</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30 August 2029</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10 March 2017</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100,000</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.725</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30 August 2020</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30 August 2030</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10 March 2017</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100,000</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.725</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30 August 2021</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30 August 2031</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30 August 2017</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">284,000</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.595</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30 August 2018</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30 August 2028</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30 August 2017</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">284,000</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.595</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30 August 2019</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30 August 2029</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30 August 2017</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">284,000</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.595</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30 August 2020</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30 August 2030</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30 August 2017</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">284,000</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.595</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30 August 2021</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30 August 2031</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 171; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The total outstanding fair value of the
share option instruments is deemed to be approximately $6,217k as at December 31, 2017 (2016: $2,305k).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Directors have used the Black-Scholes
option pricing model to estimate the fair value of most of the options applying the assumptions below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Historical volatility relies in part on
the historical volatility of a group of peer companies that management believes is generally comparable to the company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The company has not paid any dividends
on common stock since its inception and does not anticipate paying dividends on its common stock in the foreseeable future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The company has estimated a forfeiture
rate of zero.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>24
    April</B></FONT><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2014</B></FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>25&nbsp;June</B></FONT><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2014</B></FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7
    July</B></FONT><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2014</B></FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 64%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Grant date share price</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&pound;</FONT></TD>
    <TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.12</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&pound;</FONT></TD>
    <TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.39</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&pound;</FONT></TD>
    <TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.44</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise share price</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&pound;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.15</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&pound;0.28 to &pound;0.33</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&pound;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.35</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vesting periods</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25% each</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25% each</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25% each</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yr
    1, Yr 2, Yr 3, Yr 4</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yr
    1, Yr 2, Yr 3, Yr 4</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yr
    1, Yr 2, Yr 3, Yr 4</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk free rate</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.55%&nbsp;to&nbsp;1.54%</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.55%
    to 1.54%</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.55% to 1.54%</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected volatility</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99% to 197%</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99% to 197%</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99% to 197%</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Option life</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10 years</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10 years</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10 years</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 64%; text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 9%; border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>23&nbsp;January</B></FONT><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2015</B></FONT></TD>
    <TD STYLE="width: 1%; text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 9%; border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2
    March</B></FONT><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2015</B></FONT></TD>
    <TD STYLE="width: 1%; text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 9%; border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7
    May</B></FONT><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2015</B></FONT></TD>
    <TD STYLE="width: 1%; text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Grant date share price</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&pound;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.575</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&pound;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.615</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&pound;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.465</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise share price</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&pound;0.35 to &pound;0.57</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&pound;0.28 to &pound;0.33</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&pound;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.15</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vesting periods</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">900,000
    25% each</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25% each</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Immediate</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yr
    1, Yr 2, Yr 3, Yr 4</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yr
    1, Yr 2, Yr 3, Yr 4</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.05m immediate</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk free rate</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.55% to 1.54%</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.55% to 1.54%</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.55%
    to 1.54%</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected volatility</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99% to 197%</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99% to 197%</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99% to 197%</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Option life</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10 years</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10 years</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2
    years 9 months</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>23
    March</B></FONT><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2016</B></FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9
    June</B></FONT><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2016</B></FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5
    November</B></FONT><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2016</B></FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 64%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Grant date share price</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&pound;</FONT></TD>
    <TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.26</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&pound;</FONT></TD>
    <TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.38</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&pound;</FONT></TD>
    <TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.86</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise share price</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&pound;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.26</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&pound;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.5</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&pound;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.86</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vesting periods</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25% each</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Immediate,
    25% each</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">33.3% each</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yr
    1, Yr 2, Yr 3, Yr 4</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yr
    1, Yr 2, Yr 3, Yr 4</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yr
    1, Yr 2, Yr 3</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk free rate</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.55% to 1.54%</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.55% to 1.54%</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.55%
    to 1.54%</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected volatility</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99% to 197%</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99% to 197%</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99% to 197%</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Option life</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10 years</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-15 years</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10 years</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1
    December</B></FONT><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2016</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10
    March</B></FONT><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2017</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 64%; font-family: Times New Roman, Times, Serif">Grant date share price</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&pound;</FONT></TD>
    <TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.86</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&pound;</FONT></TD>
    <TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.725</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&pound;</FONT></TD>
    <TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.595</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise share price</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&pound;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.925</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&pound;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.725</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&pound;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.595</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vesting periods</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: right; font-family: Times New Roman, Times, Serif">within 24 months of <BR>
1&nbsp;September 2016</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yr1,
    Yr 2, Yr 3, Yr4</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yr
    1, Yr 2, Yr 3, Yr4</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk free rate</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.55% to 1.54%</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.38% to 1.09%</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.69% to 1.09%</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected volatility</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99% to 197%</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">80% to 167%</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">58% to 60%</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Option life</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2 years</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10 years</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10 years</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 172; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the options issued with a market condition
attached, the Directors have used the Monte Carlo simulation to estimate the fair value of these options, the company uses the
following methods to determine its underlying assumptions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">expected volatilities
    are based on the historical volatilities of the market</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the expected term
    of the awards is based on managements&rsquo; assessment of when the market condition is likely to be achieved of 15 years</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a range of fair
    values per share were produced and management have determined the most appropriate value based on their knowledge of the market
    and vesting conditions being fulfilled.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Warrants</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Directors have estimated the fair
value of the warrants in services provided using an appropriate valuation model. The total fair value of the warrant instruments
is deemed to be approximately $340,501. For each set of warrants, the charge has been expensed over the vesting period. A share
based payment charge for the year of $120,441 (year to December 2015: $156,424) has been expensed in the statement of comprehensive
income.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>17.</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONVERTIBLE LOAN NOTES</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Group and Company</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Planwise Convertible Loan Notes 2016</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">From the date of the reverse acquisition
a convertible loan note of $247k was in existence as detailed in the Admission Document dated 31 March 2014. Proceeds of the subscriptions
for the notes are to be used exclusively to finance the company&rsquo;s on-going working capital requirements. The terms of the loan
note are that the loan notes, plus accrued interest at a rate of 4 per cent above Bank of England base rate per annum, will convert
into ordinary shares in the company at a price of &pound;0.10 per share at the election of Planwise any time after the second
anniversary of the readmission to AIM on 24 April 2014. The company considers this to be a Convertible Debt Instrument as detailed
in the policy described at note 2.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Accounting for the convertible debt instrument</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The net proceeds received from the issue
of the Planwise Convertible Loan Note has been recorded as a debt liability in the balance sheet and the accrued interest charged
to the income statement and the debt liability. The liability for the convertible debt instrument is;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Planwise Convertible Loan Note</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-weight: bold; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; font-family: Times New Roman, Times, Serif">2017</TD><TD STYLE="font-weight: bold; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-weight: bold; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; font-family: Times New Roman, Times, Serif">2016</TD><TD STYLE="font-weight: bold; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif">$000</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif">$000</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 76%; text-align: left; font-family: Times New Roman, Times, Serif">Convertible loan notes issued</TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif">278</TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif">247</TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">Accrued interest</TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif">12</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif">31</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: right; padding-bottom: 4pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="padding-bottom: 4pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right; font-family: Times New Roman, Times, Serif">290</TD><TD STYLE="padding-bottom: 4pt; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="padding-bottom: 4pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right; font-family: Times New Roman, Times, Serif">278</TD><TD STYLE="padding-bottom: 4pt; text-align: left; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>18.</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONVERTIBLE EQUITY INSTRUMENTS</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On 16th August 2017, the company passed
a resolution that as of 26 July 2017, Convertible Loan Note Holders be offered an additional bonus coupon of 3 years of interest
at the relevant applicable rate of return for agreeing to the immediate conversion of the convertible loan note&rsquo;s into ordinary
shares. The convertible loan note holders are also subject to a restriction not to dispose of the relevant shares for a period
of 12 months following conversion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The principal amount of the Convertible
Equity Instrument for Tranches A to F are recorded as shares to be issued reserve and the accrued interest also charged to the
same reserve.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>$000</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>A</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>B</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>C</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>D</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>E</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>F</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 16%; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance
    as at January 2017</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,142</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.893</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,646</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">336</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,153</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">988</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,267</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="white-space: nowrap; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Addition
    to Equity (Interest)</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(39</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">55</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">838</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">166</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,063</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bonus 3 years interest</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">171</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">305</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">963</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">901</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">167</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,547</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance as at 26
    July 2017</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,276</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,263</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,465</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">385</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,228</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,149</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,876</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif; padding-left: 0.25in; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No of shares</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,276,430</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,407,099</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,608,099</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">303,287</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,259,086</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">601,213</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28,455,214</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 173; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>19.</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RESERVES</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The shares to be issued reserve represent
the value of equity shares which could be issued in future accounting periods if the warrants in issue are exercised.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The share based payment reserve represents
the value of equity shares which could be issued in future accounting periods if the share based payment options in issue are
exercised.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The merger relief reserve was created
as a result of the reverse merger reverse acquisition of Alexander David Investments plc. The reserve represents the difference
between the fair value of the consideration transferred and the nominal value of the shares. This reserve has been written off
as part of the balance sheet capital reduction exercise described below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The other reserve was created as a result
of the reverse acquisition of Alexander David Investments plc in the year and the accounting treatment required, which is described
in Note 2. The reserve is required due to the fact that the reverse acquisition accounting requires the legal parent&rsquo;s equity
structure to be shown.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Retained earnings represent the cumulative
profits / (losses) of the entity which have not been distributed to shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The capital reduction reserve is credited
with $41.3m of reserves arising from the court approved capital reduction detailed below. These reserves are designated as realized
profits available for distribution under section 830 (2) of the Companies Act 2006.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.05pt">On the 14th of September
2016, the High court granted the company permission to cancel its share premium account and its capital redemption reserve. The
order had previously been ratified at the AGM held on 30th June 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The company also decided to cancel its
merger relief reserve as part of the capital reduction exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>20.</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FINANCIAL INSTRUMENTS</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.05pt">The main risks arising
from the Group&rsquo;s financial instruments are liquidity risk, foreign currency risk and credit risk. The directors regularly
review and agree policies for managing each of these risks which are summarized below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Market risk</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Market risk encompasses three types of
risk, being foreign currency exchange risk, price risk and fair value interest rate risk. The Group policies for managing fair
value interest rate risk are considered along with those for managing cash flow interest rate risk and are set out in the subsection
entitled &ldquo;interest rate risk&rdquo; below. The directors do not consider the Group&rsquo;s exposure to price
risk to be significant. The Group&rsquo;s risk management is coordinated by the directors, and focuses on actively securing the
Group&rsquo;s short to medium term cash flows by minimizing the exposure to financial markets. The Group does not engage in the
trading of financial assets for speculative purposes nor does it write options.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Credit risk</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Credit risk is managed on a group basis.
Credit risk arises principally from cash and cash equivalents and deposits with banks and financial institutions as well as credit
exposure to customers including committed transactions and outstanding receivables. The group reviews its banking arrangements
carefully to minimize such risks and currently has no customers and therefore this risk is viewed as minimal. Management monitor
loans between members of the group as part of their internal reporting and assess outstanding receivables for ability to be repaid.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Liquidity risk</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The group&rsquo;s policy is to regularly
monitor current and expected liquidity requirements to ensure that it maintains sufficient reserves of cash to meet its liquidity
requirements in the short and long term. The Group ordinarily finances its activities through cash generated from operating activities
and private and public offerings of equity and debt securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The table below summarizes the maturity
profile of the Group&rsquo;s financial liabilities based on contractual undiscounted payments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></TD>
    <TD COLSPAN="10" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2017</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></TD>
    <TD COLSPAN="10" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2016</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>$000</B></FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Less
    than </B></FONT><B><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3 months</FONT></B></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3
    to 12 months</B></FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total</B></FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Less
    than</B></FONT><B><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3 months</FONT></B></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3
    to 12 months</B></FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total</B></FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 28%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade and other payables</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,719</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,192</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,911</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,231</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,247</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,478</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible loan notes (debt)</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">218</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">656</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">874</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; padding-bottom: 4pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</FONT></TD>
    <TD STYLE="padding-bottom: 4pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,722</FONT></TD>
    <TD STYLE="padding-bottom: 4pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="padding-bottom: 4pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,301</FONT></TD>
    <TD STYLE="padding-bottom: 4pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="padding-bottom: 4pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,923</FONT></TD>
    <TD STYLE="padding-bottom: 4pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="padding-bottom: 4pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,249</FONT></TD>
    <TD STYLE="padding-bottom: 4pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="padding-bottom: 4pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,903</FONT></TD>
    <TD STYLE="padding-bottom: 4pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="padding-bottom: 4pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,922</FONT></TD>
    <TD STYLE="padding-bottom: 4pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 174; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Foreign currency risks</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The group operates internationally although
the majority of its operations are based in the United Kingdom and the majority of assets and liabilities denominated in British
Pounds. It therefore is exposed to foreign exchange risk arising from exposure to various currencies primarily the Euro and US
Dollar.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Due to the majority of assets being denominated
in British Pounds the group has no formal policies for managing foreign currency risks.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Interest rate risk</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.05pt">The Group has limited
exposure to interest-rate risk arising from its bank deposits. These deposit accounts are held at variable interest rates based
on Allied Irish Bank base rate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The directors do not consider the impact
of possible interest rate changes based on current market conditions to be material to the net result for the year or the equity
position at the year-end for either the year ended 31 December 2017 or 31 December 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>21.</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CAPITAL RISK MANAGEMENT</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the purpose of the Group&rsquo;s capital
management, capital includes called up share capital, share premium, shares to be issued reserve, convertible loan note reserve,
shares to be issued reserve (warrants), capital reduction reserve and all other equity reserves attributable to the equity holders
of the parent as reflected in the statement of financial position.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group adjusts its capital structure
in light of changes in economic conditions and expected business demands on capital. In order to maintain or adjust its capital
structure, the Group considers whether or not to pay dividends and adjusts the amount of any dividend payments to shareholders.
The Group may also return capital to shareholders or issue additional shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>22.</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TRADE AND OTHER PAYABLES</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Year
    Ending December&nbsp;31,</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Group</U></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2017</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2016</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 76%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">000</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">000</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade payables</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,573</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,496</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accruals</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">650</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">369</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible loan note liability</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">290</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">278</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,513</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,143</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>23.</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RELATED PARTY TRANSACTIONS</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Tiziana Pharma Limited is a wholly owned
subsidiary of Tiziana Life Sciences plc. At year end, Tiziana Life Sciences plc had transferred $5,164k (2016: $3,604k) in total
to Tiziana Pharma Limited.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> Tiziana Therapeutics, Inc. is a wholly
owned subsidiary of Tiziana Life Sciences plc. During the year, Tiziana Life Sciences plc transferred $1,181,525 (2016:$1,182k)
to Tiziana Therapeutics, Inc. This balance is included within other debtors. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>24.</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OPERATING LEASES</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.05pt">The Group leases
number of office premises under operating lease. The future minimum rentals payable under non-cancellable operating leases as
at 31 December are as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: -0.05pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2017</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2016</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">000</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">000</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 76%; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less
    than one year</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">278</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">266</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Between one and
    five years</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">575</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">612</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; padding-bottom: 4pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="padding-bottom: 4pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">853</FONT></TD>
    <TD STYLE="padding-bottom: 4pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="padding-bottom: 4pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">878</FONT></TD>
    <TD STYLE="padding-bottom: 4pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: -0.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Lease expenses during the year to December 30, 2016 amount
to $142k (2016: $146k).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 175; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>25.</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>POST BALANCE SHEET EVENTS</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 16, 2018, the company raised
$207k by the issue of 100,000 new ordinary shares at a price of 150p per share. Each issued share has a warrant attached entitling
the holder to subscribe for one new ordinary share at an exercise price of 160p per share, exercisable until 15 January 2024.
Fees in connection with the placing are to be satisfied through the issue of an additional 63,334 warrants on the same terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 22, 2018, the company raised
$139k by the issue of 66,667 new ordinary shares at a price of 150p per share. Each issued share has a warrant attached entitling
the holder to subscribe for one new ordinary share at an exercise price of 160p per share, exercisable until 15 January 2024.
Fees in connection with the placing are to be satisfied through the issue of an additional 13,333 warrants on the same terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 5, 2018, the company raised $828k
by the issue of 600,000 new ordinary shares at a price of 100p per share. Fees in connection with the placing are to be satisfied
through the issue of an additional 78,000 warrants at an exercise price of 100p per share, exercisable until 5 March 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 4, 2018, the company appointed
Mr Leopoldo Zambeletti to the Board as a non-executive director with responsibility for strategic development. Mr Zambeletti will
also chair the Nomination Committee and serve as a member on the Audit committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 16, 2018, the company entered
into an exclusive license agreement for novel technology discovered by Dr Howard Weiner at BWH, Harvard&nbsp;Medical School. Tiziana
has agreed to pay certain milestone payments up until 31 December 2033, dependent on the outcome of clinical trials, in addition
to a low single digit percentage of net sales to BWH in royalties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 19, 2018, the company raised
$1,175k by the issue of 1,031,250 new ordinary shares at a price of 80p per share</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, on April 24, 2018, the company
issued 51,563 new ordinary shares credited as fully paid and 51,563 warrants exercisable at a price of 80p per share to intermediaries
in lieu of commissions on the funds raised. The company also announced that it had allotted 23,014 ordinary shares in the company
at a price of&nbsp;70p per share in relation to a shortfall in capitalized interest due to a former holder of the company&rsquo;s Class
C Convertible Loan Notes which was discovered during the annual audit process.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 1, 2018, the company announced
that the Board had awarded 2,500,000 options to Kunwar Shailubhai in exchange for his agreement to waive his rights under his
realisation bonus. The options are exercisable at a price of 81.75 pence per share. These options will vest immediately but are
only exercisable on a change of control event. In addition Dr Shailubhai was awarded options to acquire 4,000,000 ordinary shares
in the capital of the company. The options are exercisable at a price of 81.75 pence per share. The options will vest in equal
tranches over four years beginning on the date of grant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Additional awards were made to Leopoldo
Zambeletti and Gabriele Cerrone. Leopoldo Zambeletti was awarded options to acquire 550,000 ordinary shares in the capital of
the company. &nbsp;The options are exercisable at a price of 81.75 pence per share. The options will vest in equal tranches over
four years beginning on the date of grant.&nbsp;Gabriele Cerrone was also awarded options to acquire 550,000 ordinary shares in
the capital of the company. &nbsp;The options vest and are exercisable at a price of 81.75 pence per share contingent on the volume
weighted average share price exceeding 163.50 pence for five trading days.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A further 600,000 options to acquire ordinary
shares in the capital of the company at 81.75 pence per were awarded to new staff members. The options are exercisable at a price
of 81.75 pence per share. &nbsp;The options will vest in equal tranches over four years beginning on the date of grant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A further 200,000 options to acquire ordinary
shares in the capital of the company at 81.75 pence per share were awarded to Arun Sanyal, our most recent member of our scientific
advisory board. The company also granted Dr Howard Weiner options to acquire 1,000,000 ordinary shares exercisable at a price
of 81.75 pence per share.&nbsp; These options are subject to clinical milestones reflective of the development objectives of the
company&rsquo;s anti-CD3 program.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A further 100,000 options to acquire ordinary
shares in the capital of the company at a price of 81.75 pence per share were granted to another consultant, the exercise of which
are conditional upon a change of control of the company in consideration for the surrender of a realisation bonus (which could
otherwise have crystallised a significant cash cost to the company).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 16, 2018, the company announced
that the independent data monitor committee (IDMC) completed a second, interim analysis of tolerability data from the first eleven
treated patients and recommended expansion of the initial cohort to continue enrolment of an additional 20 patients to complete
the trial.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> On August 16, 2018, the company announced
the submission of an IND application to the FDA in collaboration with BWH to initiate Phase 1 clinical trials with Foralumab,
to be administered nasally to healthy volunteers, with the objective of demonstrating proof of concept for the treatment of neurodegenerative
diseases, such as progressive MS. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>26.</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FINANCIAL COMMITMENTS</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group&rsquo;s main financial commitments relate to the contractual payments in respect of its licensing
agreements. Due to the uncertain nature of scientific research and development and the length of time required to reach commercialization
of the products of this research and development, preclinical, clinical and commercial milestone obligations are not detailed until
there is a reasonable certainty that the obligation will become payable. Contractual commitments are detailed where amounts are
known and certain.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif">Milciclib project research funding of approximately
$1.2m has been committed to for 2018 and beyond. Other payments relate to the achievement of clinical milestones or the payment
of royalties.</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foralumab project
    &ndash;  license fees payable for the continued development of Foralumab of $250k in 2018 for a total fee payment of
    $750,000. Diligence obligations are payable to BMS / Medarex should the project continue. Other payments relate to the achievement
    of clinical milestones or the payment of royalties.</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 176; Options: NewSection; Value: 22 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 14pt">American
Depositary Shares<BR>
&nbsp;</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 14pt"><B>Representing&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Ordinary
Shares</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="image_007.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 0; margin-bottom: 0; font-family: Times New Roman, Times, Serif"><DIV STYLE="font: 1pt Times New Roman, Times, Serif; border-top: Black 1.5pt solid; width: 65%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 14pt"><B>PROSPECTUS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 0; margin-bottom: 0; font-family: Times New Roman, Times, Serif"><DIV STYLE="font: 1pt Times New Roman, Times, Serif; border-top: Black 1.5pt solid; width: 65%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;, 2018</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 18pt"><B>Laidlaw
&amp; Company (UK) Ltd.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Through and including &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
2018 (25 days after commencement of this offering), all dealers that effect transactions in these securities, whether or not participating
in this offering, may be required to deliver a prospectus. This is in addition to the dealers&rsquo; obligation to deliver a prospectus
when acting as underwriters and with respect to their unsold allotments or subscriptions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 177 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PART II</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INFORMATION NOT REQUIRED IN PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Unless otherwise
indicated, all references to &ldquo;Tiziana&rdquo; or the &ldquo;company,&rdquo; &ldquo;we,&rdquo; &ldquo;our,&rdquo; &ldquo;us&rdquo;
or similar terms refer to Tiziana Life Sciences plc and its subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item 6. Indemnification of Directors
and Officers.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Subject to the U.K.
Companies Act 2006, members of the registrant&rsquo;s board of directors and its officers (excluding auditors) have the benefit
of the following indemnification provisions in the registrant&rsquo;s Articles:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Current and former
members of the registrant&rsquo;s board of directors or officers shall be reimbursed for:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all costs, charges,
    losses, expenses and liabilities sustained or incurred in relation to his or her actual or purported execution of his or her
    duties in relation to the registrant, including any liability incurred in defending any criminal or civil proceedings; and</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">expenses incurred
    or to be incurred in defending any criminal or civil proceedings, in an investigation by a regulatory authority or against
    a proposed action to be taken by a regulatory authority, or in connection with any application for relief under the statutes
    of the United Kingdom and any other statutes that concern and affect the registrant as a company, or collectively the Statutes,
    arising in relation to the registrant or an associated company, by virtue of the actual or purposed execution of the duties
    of his or her office or the exercise of his or her powers.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In the case of current
or former members of the registrant&rsquo;s board of directors, there shall be no entitlement to reimbursement as referred to
above for (i)&nbsp;any liability incurred to the registrant or any associated company,(ii) the payment of a fine imposed in any
criminal proceeding or a penalty imposed by a regulatory authority for non-compliance with any requirement of a regulatory nature,
(iii)&nbsp;the defense of any criminal proceeding if the member of the registrant&rsquo;s board of directors is convicted, (iv)&nbsp;the
defense of any civil proceeding brought by the registrant or an associated company in which judgment is given against the director,
and (v)&nbsp;any application for relief under the statutes of the United Kingdom and any other statutes that concern and affect
the registrant as a company in which the court refuses to grant relief to the director.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In addition, members
of the registrant&rsquo;s board of directors and its officers who have received payment from the registrant under these indemnification
provisions must repay the amount they received in accordance with the Statutes or in any other circumstances that the registrant
may prescribe or where the registrant has reserved the right to require repayment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The underwriting
agreement the registrant will enter into in connection with this offering of ADSs being registered hereby provides that the underwriters
will indemnify, under certain conditions, the registrant&rsquo;s board of directors and its officers against certain liabilities
arising in connection with this offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item 7. Recent Sales of Unregistered
Securities.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The following list
sets forth information regarding all unregistered securities issued by us since January&nbsp;1, 2014 through the date of the prospectus
that is a part of this registration statement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">There has been no
material change in our capitalization and indebtedness as of December 31, 2016 (being the last date in respect of which we have
published audited financial information) save that (1) on August 16, 2017 the company issued 27,645,013 new ordinary shares to
convert, with noteholder consent, $16,733,146 (&pound;12,969,219) of convertible loan notes, rendering the company debt free and
adding $16,733,146 (&pound;12,969,219) to our share capital; (2) on November 20, 2017 the company issued 100,000 new ordinary
shares for cash adding $197,715 (&pound;150,000) to our share capital; (3) on November 27, 2017 the company issued 183,333 new
ordinary shares for cash adding $362,477 (&pound;275,000) to our share capital; (4) on December 16, 2017 the company issued 133,333
new ordinary shares for cash adding $263,620 (&pound;200,000) to our share capital; on January 16, 2018 the company issued 100,000
new ordinary shares for cash adding $199,500 (&pound;150,000) to our share capital, and 810,201 new ordinary shares to our former
noteholders in respect of accrued interest (included in the figure given in respect of (1), above); on January 22, 2018 the company
issued 66,667 new ordinary shares for cash adding $133,000 (&pound;100,000) to our share capital; and on March 5, 2018 the company
issued 600,000 new ordinary shares for cash adding $798,000 (&pound;600,000) to our share capital; on April 19, 2018 the company
issued 1,031,250 new ordinary shares adding $1,100,000 (&pound;825,000) to our share capital and simultaneously issued 51,563
new ordinary shares, credited as fully paid to intermediaries in lieu of commissions on the fundraise; and on April 27, 2018 the
company issued 23,014 new ordinary shares to our former noteholders in respect of final accrued interest (in respect of the conversion
described in (1), above). Our cash balance as of September 30, 2017 was $1,020,414 and as of that date we had no borrowings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">None of the foregoing
transactions involved any underwriters, underwriting discounts or commissions, or any public offering. Unless otherwise specified
above, we believe these transactions were exempt from registration under the Securities Act in reliance upon Section 4(a)(2) of
the Securities Act (and Regulation S promulgated thereunder), or Rule 701 promulgated under Section 3(b) of the Securities Act
as transactions by an issuer not involving any public offering or pursuant to benefit plans and contracts relating to compensation
as provided under Rule 701. The recipients of the securities in each of these transactions represented their intentions to acquire
the securities for investment only and not with a view to or for sale in connection with any distribution thereof, and appropriate
legends were placed upon the share certificates issued in these transactions. All recipients had adequate access, through their
relationships with us, to information about us. The sales of these securities were made without any general solicitation or advertising.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 178; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 8. Exhibits and Financial Statement Schedules.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>ITEM 19: EXHIBITS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; width: 9%; border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
    No.</B></FONT> </TD>
    <TD STYLE="vertical-align: top; width: 1%; font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom; width: 90%; border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description</B></FONT> </TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</FONT> </TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"> <A HREF="ff12018a1ex1-1_tiziana.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
    of Underwriting Agreement.</FONT></A> </TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT> </TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"> <A HREF="ff12018a1ex3-1_tiziana.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Memorandum
    and Articles of Association of Tiziana Life Sciences plc.</FONT></A> </TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT> </TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"> <A HREF="ff12018a1ex4-1_tiziana.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
    of Deposit Agreement.</FONT></A> </TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</FONT> </TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"> <A HREF="ff12018a1ex4-1_tiziana.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
    of American Depositary Receipt (included in Exhibit 4.1).</FONT></A> </TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"> 4.3 </TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"> <A HREF="ff12018a1ex4-3_tiziana.htm">Form of
    Representative&rsquo;s Warrant.</A> </TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1</FONT> </TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"> <A HREF="ff12018a1ex5-1_tiziana.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Opinion
    of Cooley (UK) LLP.</FONT></A> </TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT> </TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><P STYLE="margin: 0pt 0"> <A HREF="ff12018a1ex10-1_tiziana.htm">License
                                         Agreement relating to Milciclib between Nerviano Medical Services S.r.l. and Tiziana
                                         Life Sciences plc, dated January 2015.</A> </P>


</TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT> </TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><P STYLE="margin: 0pt 0"> <A HREF="ff12018a1ex10-2_tiziana.htm">License
                                         and Sublicense Agreement relating to CD3 (NI-0401) between Novimmune SA and Tiziana Life
                                         Sciences plc, dated December 2014.</A> </P>


</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</FONT> </TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><P STYLE="margin: 0pt 0"> <A HREF="ff12018a1ex10-3_tiziana.htm">License
                                         and Sublicense Agreement relating to IL-6r (NI-1201) between Novimmune SA and Tiziana
                                         Life Sciences plc, dated December 2016.</A> </P>


</TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</FONT> </TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><P STYLE="margin: 0pt 0"> <A HREF="ff12018a1ex10-4_tiziana.htm">License
                                         Agreement relating to a novel formulation of Foralumab in a medical device for nasal
                                         administration between The Brigham and Women&rsquo;s Hospital, Inc. and Tiziana Life
                                         Sciences plc, dated April 2018.</A> </P>


</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5</FONT> </TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><P STYLE="margin: 0pt 0"> <A HREF="ff12018a1ex10-5_tiziana.htm">Annual
                                         Lease for 55 Park Lane, Suite 14a, London W1K 1NA, United Kingdom, dated&nbsp;June 29,
                                         2018.</A> </P>


</TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6</FONT> </TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><P STYLE="margin: 0pt 0"> <A HREF="ff12018a1ex10-6_tiziana.htm">Five-Year
                                         Lease for 420 Lexington Avenue, Suite 2525, New York, United States, dated&nbsp;August
                                         2, 2016.</A> </P>


</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.7</FONT> </TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"> <A HREF="ff12018a1ex10-7_tiziana.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Annual
    Lease for 3085 Old Easton Road, Doylestown, Pennsylvania, United States, dated&nbsp;December 6, 2017.</FONT></A> </TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.8</FONT> </TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><P STYLE="margin: 0pt 0"> <A HREF="ff12018a1ex10-8_tiziana.htm">Tiziana
                                         Life Sciences plc Employee Share Option Plan, with Non-Employee Sub-Plan and US Sub-Plan,
                                         adopted by the Board on 23 March 2016 and approved by shareholders on June&nbsp;30, 2016.</A> </P>


</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.9</FONT> </TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"> <A HREF="ff12018a1ex10-9_tiziana.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contract
    of Employment, dated May 2017, between the registrant and Dr. Kunwar Shailubhai.</FONT></A> </TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.10</FONT> </TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"> <A HREF="ff12018a1ex10-10_tiziana.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
    of Deed of Indemnity for board members.</FONT></A> </TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.1</FONT> </TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"> <A HREF="ff12018a1ex21-1_tiziana.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">List
    of subsidiaries.</FONT></A> </TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1</FONT> </TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"> <A HREF="ff12018a1ex23-1_tiziana.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent
    of Mazars LLP, independent registered public accounting firm, regarding the financial statements of Tiziana Life Sciences
    plc as of December 31, 2016 and 2015 and for each of the two years in the period ended December 31, 2016.</FONT></A> </TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.2</FONT> </TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"> <A HREF="ff12018a1ex5-1_tiziana.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent
    of Cooley (UK) LLP (included in Exhibit 5.1).</FONT></A> </TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.1*</FONT> </TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/1723069/000121390018009705/ff12018_tizianalife.htm#sig">Power of Attorney (included on signature page).</A></FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"> * </TD><TD STYLE="text-align: justify"> Previously filed </TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 179; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Financial Statement
    Schedules.</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">All financial statement
schedules are omitted because the information required to be set forth therein is not applicable or is shown in the consolidated
financial statements or the notes thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item 9. Undertakings.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The undersigned
    registrant hereby undertakes to provide to the underwriters at the closing specified in the underwriting agreement, certificates
    in such denominations and registered in such names as required by the underwriter to permit prompt delivery to each purchaser</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insofar as indemnification
    for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the registrant
    pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the U.S. Securities
    and Exchange Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore,
    unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant
    of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any
    action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities
    being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent,
    submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as
    expressed in the Securities Act and will be governed by the final adjudication of such issue.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The undersigned
    registrant hereby undertakes that:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify; font-family: Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font-family: Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD><TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of determining any liability under the Securities Act, the information omitted from the form of prospectus filed as part
of this registration statement in reliance upon Rule&nbsp;430A and contained in a form of prospectus filed by the registrant pursuant
to Rule&nbsp;424(b)(1) or (4)&nbsp;or 497(h) under the Securities Act shall be deemed to be part of this registration statement
as of the time it was declared effective.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 1in; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the purpose
    of determining any liability under the Securities Act, each post-effective amendment that contains a form of prospectus shall
    be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities
    at that time shall be deemed to be the initial bona fide offering thereof.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 180; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="sig"></A><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 18pt"> Pursuant to the
requirements of the Securities Act of 1933, as amended, the Registrant has duly caused this Registration Statement to be signed
on its behalf by the undersigned, thereunto duly authorized, in the City of London, United Kingdom, on the 23<SUP>rd</SUP> day
of August, 2018. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TIZIANA LIFE SCIENCES PLC</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 60%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 4%; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 36%; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;/s/ Kunwar Shailubhai</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kunwar Shailubhai</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Chief Executive Officer</I></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Pursuant to the requirements
of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities
and on the dates indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 38%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Signature</B></FONT></TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 40%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title</B></FONT></TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 20%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Kunwar Shailubhai</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">August 23, 2018</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kunwar Shailubhai</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Principal Executive Officer)</I></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ *</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">August 23, 2018</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tiziano Lazzaretti</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Principal Financial Officer and</I></FONT><BR>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Principal Accounting Officer)</I></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ *</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive Chairman</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">August 23, 2018</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gabriele Cerrone</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ *</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">August 23, 2018</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Riccardo Dalla-Favera</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ *</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">August 23, 2018</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Willy Simon</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ *</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">August 23, 2018</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leopoldo Zambeletti</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; font-size: 10pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*By:</FONT> </TD>
    <TD STYLE="width: 34%; border-bottom: Black 1.5pt solid; text-align: left; font-size: 10pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Kunwar     Shailubhai</FONT> </TD>
    <TD STYLE="width: 62%"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"> &nbsp; </TD>
    <TD STYLE="text-align: left; font-size: 10pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kunwar
    Shailubhai,&nbsp;<I>Attorney-In-Fact</I></FONT> </TD>
    <TD> &nbsp; </TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<!-- Field: Page; Sequence: 181; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>ff12018a1ex1-1_tiziana.htm
<DESCRIPTION>FORM OF UNDERWRITING AGREEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: right"><B>Exhibit 1.1</B></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin-top: 0; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>TIZIANA
LIFE SCIENCES plc</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]
American Depositary Shares</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Representing
[&#9679;] Ordinary Shares</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Nominal
Value &pound;0.03 Each)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>UNDERWRITING
AGREEMENT</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;],
2018</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Laidlaw
&amp; Company (UK) Ltd.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">546
5th Avenue, 5</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">th</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Floor</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, NY 10036</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
Representative of the several Underwriters named in <U>Schedule A</U> hereto</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dear
Sirs and Madams:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1. <FONT STYLE="font-variant: small-caps"><I>Introductory</I></FONT>.
Tiziana Life Sciences plc, a public limited company incorporated under the laws of England and Wales with registered number 03508592
(the &ldquo;<B><I>Company</I></B>&rdquo;), proposes to issue and sell, pursuant to the terms of this Underwriting Agreement (the
&ldquo;<B><I>Agreement</I></B>&rdquo;), to the several underwriters named in <U>Schedule A</U> hereto (the &ldquo;<B><I>Underwriters</I></B>,&rdquo;
or, each, an &ldquo;<B><I>Underwriter</I></B>&rdquo;), an aggregate [&#9679;] American Depositary Shares (&ldquo;<B><I>ADSs</I></B>&rdquo;),
each representing five (5) ordinary shares, nominal value &pound;0.03 each (the &ldquo;<B><I>Ordinary Shares</I></B>&rdquo;) (the
&ldquo;<B><I>Firm ADSs</I></B>&rdquo;). The Company also proposes to issue and sell to the Underwriters, upon the terms and conditions
set forth in Section 3 hereof, up to an additional [&#9679;] ADSs (the &ldquo;<B><I>Optional ADSs</I></B><I>&rdquo;</I>). The
ADSs and, if and to the extent such option is exercised, the Optional ADSs are referred to herein as the &ldquo;<B><I>Offered
Securities</I></B>.&rdquo; Unless context otherwise requires, each reference to the Firm ADSs, the Optional ADSs and the Offered
Securities herein also includes the Ordinary Shares represented by the ADSs. Laidlaw &amp; Company (UK) Ltd. is acting as representative
of the several Underwriters and in such capacity is hereinafter referred to as the &ldquo;<B><I>Representative</I></B>.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
ADSs will be evidenced by American Depositary Receipts (the &ldquo;<B><I>ADRs</I></B>&rdquo;) to be issued pursuant to a deposit
agreement, dated on or about the Closing Date (as defined in Section 3 hereof) (the &ldquo;<B><I>Deposit Agreement</I></B>&rdquo;),
among the Company, JPMorgan Chase Bank, N.A., as depositary (the &ldquo;<B><I>Depositary</I></B>&rdquo;), and the holders from
time to time of the ADRs evidencing the ADSs issued thereunder. The Company shall, following subscription by the Underwriters
of the Firm ADSs and, if applicable, the Optional ADSs, deposit, on behalf of the Underwriters, the Ordinary Shares represented
by such ADSs with JPMorgan Chase Bank, N.A., as custodian (the &ldquo;<B><I>Custodian</I></B>&rdquo;) for the Depositary, which
shall deliver such ADSs to the Representative for the account of the several Underwriters for subsequent delivery to the other
several Underwriters or the investors, as the case may be.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2. <FONT STYLE="font-variant: small-caps"><I>Representations
and Warranties of the Company. </I></FONT>The Company represents and warrants to the several Underwriters, as of the date hereof
and as of each Closing Date (as defined in Section 3 hereof ), and agrees with the several Underwriters, that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(a) <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
registration statement of the Company on Form F-1 (File No. 333-) (including all pre-effective amendments thereto, and all
post-effective amendments thereto filed before execution of this Agreement, the &ldquo;<B><I>Initial Registration
Statement</I></B>&rdquo;) in respect of the Offered Securities has been filed with the Securities and Exchange Commission
(the &ldquo;<B><I>Commission</I></B>&rdquo;). The Initial Registration Statement in the form heretofore delivered to the
Representative, and, excluding exhibits thereto, to the Representative for each of the other Underwriters, has been declared
effective by the Commission in such form and complies in all material respects with the requirements of the Securities Act of
1933, as amended (the &ldquo;<B><I>Securities Act</I></B>&rdquo;), and the rules and regulations of the Commission thereunder
(the &ldquo;<B><I>Rules and Regulations</I></B>&rdquo;). Other than (i) the Initial Registration Statement, (ii) a
registration statement, if any, increasing the size of the offering filed pursuant to Rule 462(b) under the Securities Act
and the Rules and Regulations (a &ldquo;<B><I>Rule 462(b) Registration Statement</I></B>&rdquo;), (iii) a registration
statement on Form F-6 (File No. 333-226368) covering the registration of the ADSs to be issued and sold by the Company to the
Underwriters hereunder under the Securities Act and the Rules and Regulations (the &ldquo;<B><I>ADS
Registration Statement</I></B>&rdquo;), (iv) any Preliminary Prospectus (as defined below), (v) the Prospectus (as defined
below) contemplated by this Agreement to be filed pursuant to Rule 424(b) of the Rules and Regulations in accordance with
Section 4(a) hereof and (vi) any Issuer Free Writing Prospectus (as defined below), no other document with respect to the
offer and sale of the Offered Securities has heretofore been filed with the Commission. No stop order suspending the
effectiveness of the Initial Registration Statement, any post-effective amendment thereto, the Rule 462(b) Registration
Statement, if any, or the ADS Registration Statement has been issued, and no proceeding for that purpose or pursuant to
Section 8A of the Securities Act has been initiated or threatened by the Commission (any preliminary prospectus included in
the Initial Registration Statement or filed with the Commission pursuant to Rule 424(a) of the Rules and Regulations is
hereinafter called a &ldquo;<B><I>Preliminary Prospectus</I></B>&rdquo;). The Initial Registration Statement and the Rule
462(b) Registration Statement, if any, in each case including all exhibits thereto and including (y) the information
contained in the Prospectus filed with the Commission pursuant to Rule 424(b) of the Rules and Regulations and deemed by
virtue of Rule 430A under the Securities Act to be part of the Initial Registration Statement at the time it became effective
and (z) the documents incorporated by reference in the Rule 462(b) Registration Statement at the time the Rule
462(b) Registration Statement became effective, are hereinafter collectively called the &ldquo;<B><I>Registration
Statement</I></B>.&rdquo; The final prospectus, in the form filed pursuant to and within the time limits described in Rule
424(b) under the Rules and Regulations, is hereinafter called the &ldquo;<B><I>Prospectus</I></B>.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps; text-transform: uppercase"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) As
of the Applicable Time (as defined below) and as of the Closing Date (as defined in Section 3 hereof) or the Option Closing Date
(as defined below), as the case may be, neither (i) the General Use Free Writing Prospectus(es) (as defined below) issued at or
prior to the Applicable Time, the Pricing Prospectus (as defined below) and the information included in <U>Schedule C</U> hereto,
all considered together (collectively, the &ldquo;<B><I>General Disclosure Package</I></B>&rdquo;), (ii) any individual Limited
Use Free Writing Prospectus (as defined below), (iii) the bona fide electronic road show (as defined in Rule 433(h)(5) of the
Rules and Regulations), nor (iv) any individual Written Testing-the-Waters Communication, when considered together with the General
Disclosure Package, included or will include any untrue statement of a material fact or omitted or will omit to state a material
fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading;
<I>provided</I>, <I>however</I>, that the Company makes no representations or warranties as to information contained in or omitted
from the Pricing Prospectus in reliance upon, and in conformity with, written information furnished to the Company through the
Representative by or on behalf of any Underwriter specifically for inclusion therein, which information the parties hereto agree
is limited to the Underwriters&rsquo; Information (as defined in Section 17 hereof). As used in this paragraph (b) and elsewhere
in this Agreement:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Applicable
Time</I></B>&rdquo; means [&#9679;] [A/P].M., New York time, on the date of this Agreement or such other time as agreed to by the
Company and the Representative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>General
Use Free Writing Prospectus</I></B>&rdquo; means any Issuer Free Writing Prospectus that is identified in <U>Schedule B</U> to
this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Issuer
Free Writing Prospectus</I></B>&rdquo; means any &ldquo;issuer free writing prospectus,&rdquo; as defined in Rule 433 of the Rules
and Regulations relating to the Offered Securities in the form filed or required to be filed with the Commission or, if not required
to be filed, in the form retained in the Company&rsquo;s records pursuant to Rule 433(g) of the Rules and Regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Limited
Use Free Writing Prospectuses</I></B>&rdquo; means any Issuer Free Writing Prospectus that is not a General Use Free Writing Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Pricing
Prospectus</I></B>&rdquo; means the Preliminary Prospectus relating to the Offered Securities that is included in the Registration
Statement immediately prior to the Applicable Time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Written
Testing-the-Waters Communication</I></B>&rdquo; means any Testing-the-Waters Communication (as defined below) that is a written
communication within the meaning of Rule 405 of the Rules and Regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) No
order preventing or suspending the use of any Preliminary Prospectus, any Issuer Free Writing Prospectus or the Prospectus relating
to the proposed offering of the Offered Securities has been issued by the Commission, and no proceeding for that purpose or pursuant
to Section 8A of the Securities Act has been instituted or threatened by the Commission, and each Preliminary Prospectus, at the
time of filing thereof, conformed in all material respects to the requirements of the Securities Act and the Rules and Regulations,
and did not contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary
to make the statements therein, in the light of the circumstances under which they were made, not misleading; <I>provided</I>,
<I>however</I>, that the Company makes no representations or warranties as to information contained in or omitted from any Preliminary
Prospectus, in reliance upon, and in conformity with, written information furnished to the Company through the Representative
by or on behalf of any Underwriter specifically for inclusion therein, which information the parties hereto agree is limited to
the Underwriters&rsquo; Information (as defined in Section 17 hereof).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) At
the respective times the Registration Statement and any amendments thereto and the ADS Registration Statement and any amendments
thereto became or become effective and at each Closing Date (as defined in Section 3 hereof), the Registration Statement and any
amendments thereto and the ADS Registration Statement and any amendments thereto conformed and will conform in all material respects
to the requirements of the Securities Act and the Rules and Regulations, and did not and will not contain any untrue statement
of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein
not misleading; and the Prospectus and any amendments or supplements thereto, at the time the Prospectus or any amendment or supplement
thereto was issued and at each Closing Date (as defined in Section 3 hereof), conformed and will conform in all material respects
to the requirements of the Securities Act and the Rules and Regulations, and did not and will not contain an untrue statement
of a material fact or omit to state a material fact necessary in order to make the statements therein, in light of the circumstances
under which they were made, not misleading; <I>provided</I>, <I>however</I>, that the foregoing representations and warranties
in this paragraph (d) shall not apply to information contained in or omitted from the Registration Statement, the ADS Registration
Statement or the Prospectus or any amendment or supplement thereto, in reliance upon, and in conformity with, written information
furnished to the Company through the Representative by or on behalf of any Underwriter specifically for inclusion therein, which
information the parties hereto agree is limited to the Underwriters&rsquo; Information (as defined in Section 17 hereof). The
Prospectus contains or will contain all required information under Rule 430A.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) Each
Issuer Free Writing Prospectus, as of its issue date and at all subsequent times through the completion of the public offer and
sale of the Offered Securities or until any earlier date that the Company notified or notifies the Representative as described
in Section 4(h) hereof, did not, does not and will not include any information that conflicted, conflicts or will conflict with
the information contained in the Registration Statement, the ADS Registration Statement, the Pricing Prospectus or the Prospectus,
or included or would include an untrue statement of a material fact or, omitted or would omit to state a material fact required
to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they
were made, not misleading; <I>provided</I>, <I>however</I>, that the foregoing representations and warranties in this paragraph
(e) shall not apply to information contained in or omitted from the Registration Statement, the ADS Registration Statement or
the Prospectus, or any amendment or supplement thereto, in reliance upon, and in conformity with, written information furnished
to the Company through the Representative by or on behalf of any Underwriter specifically for inclusion therein, which information
the parties hereto agree is limited to the Underwriters&rsquo; Information (as defined in Section 17 hereof).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) The
Company is a &ldquo;foreign private issuer&rdquo; within the meaning of Rule 405 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g) The
Company has not, directly or indirectly, distributed and will not distribute any offering material in connection with the offering
and sale of the Offered Securities other than any Preliminary Prospectus, the Prospectus and other materials, if any, permitted
under the Securities Act and consistent with Section 4(e) below. The Company will file with the Commission all Issuer Free Writing
Prospectuses (other than a &ldquo;road show&rdquo; as described in Rule 433(d)(8) of the Rules and Regulations) in the time and
manner required under Rules 163(b)(2) and 433(d) of the Rules and Regulations. From and after twelve (12) months prior to the
date of this Agreement, the Company has not taken any action which would constitute an offer of the Offered Securities to the
public in any Member State of the European Economic Area which has implemented Directive 2003/71/EC as amended (including by Directive
2010/73/EU and any relevant implementing measures in the relevant Member State (the &ldquo;<B><I>EU Prospectus Directive</I></B>&rdquo;))
for which a prospectus would need to be approved and published, in accordance with the EU Prospectus Directive, as implemented
in such relevant jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h) Intentionally
omitted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) At
the time of filing the Initial Registration Statement, the ADS Registration Statement, any Rule 462(b) Registration Statement
and any post-effective amendments thereto, and at the date hereof, the Company was not, and the Company currently is not, an &ldquo;ineligible
issuer,&rdquo; as defined in Rule 405 of the Rules and Regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j) Intentionally
omitted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k) The
Company has been duly incorporated and is validly existing as a public limited company under the laws of England and Wales. Each
subsidiary of the Company has been duly incorporated and is validly existing as a private limited company under the laws of England
and Wales, Italy or the United States. The Company and each of its subsidiaries are duly qualified to do business and is in good
standing, to the extent such concept applies, in each jurisdiction in which their respective ownership or lease of property or
the conduct of their respective businesses requires such qualification and have all power and authority (corporate or other) necessary
to own or hold their respective properties and to conduct the businesses in which they are engaged, except where the failure to
so qualify or be in good standing, if applicable, or have such power or authority (corporate or other) would not (i) have, individually
or in the aggregate, a material adverse effect on the business, properties, assets, management, financial position, shareholders&rsquo;
equity, results of operations or prospects of the Company and its subsidiaries, taken as a whole, or (ii) impair in any material
respect the ability of the Company to perform its obligations under this Agreement or to consummate any transactions contemplated
by this Agreement, the General Disclosure Package or the Prospectus (any such effect as described in clauses (i) or (ii), a &ldquo;<B><I>Material
Adverse Effect</I></B>&rdquo;). The Company does not own or control, directly or indirectly, any interest in any corporation,
partnership, limited liability company, association or other entity, other than as listed in <U>Schedule E</U> hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l) This
Agreement has been duly authorized, executed and delivered by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m) The
Deposit Agreement has been duly authorized, executed and delivered by the Company and, assuming due authorization, execution and
delivery by the Depositary, constitutes a valid and legally binding obligation of the Company, enforceable in accordance with
its terms, except as the enforceability thereof may be limited by bankruptcy, insolvency, reorganization or similar laws relating
to or affecting creditors&rsquo; rights generally or by general equitable principles. Upon due issuance by the Depositary of the
ADRs evidencing the Offered Securities in the form of ADSs against the deposit of the Ordinary Shares in respect thereof in accordance
with the provisions of the Deposit Agreement, such ADRs will be duly and validly issued and the persons in whose names the ADRs
are registered will be entitled to the rights specified therein and in the Deposit Agreement. The issuance and sale of the Offered
Securities in the form of ADSs by the Company and the deposit of the Ordinary Shares with the Depositary and the issuance of the
ADRs evidencing such Offered Securities as contemplated by this Agreement and the Deposit Agreement will not trigger any anti-dilution
rights of any holder of any Ordinary Shares or ADSs, securities convertible into or exchangeable or exercisable for Ordinary Shares
or ADSs or options, warrants or other rights to purchase Ordinary Shares or ADSs or any other securities of the Company with respect
to such Ordinary Shares, ADSs, securities, options, warrants or rights, save for any rights of pre-emption under the United Kingdom
Companies Act 2006 (&ldquo;<B><I>CA 2006</I></B>&rdquo;) that have been duly waived or disapplied. The Deposit Agreement and the
ADRs conform in all material respects to each description thereof in the Registration Statement, General Disclosure Package and
Prospectus. Each holder of ADRs issued pursuant to the Deposit Agreement shall be entitled, subject to the Deposit Agreement,
to seek enforcement of its rights through the Depositary or its nominee registered as a representative of the holders of the ADRs
in a direct suit, action or proceeding against the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n) The
Offered Securities in the form of Ordinary Shares to be issued and sold by the Company to the Underwriters hereunder have been
duly and validly authorized (including pursuant to section 551 of the CA 2006) and, when allotted, issued and delivered against
payment therefor as provided herein, will be duly and validly allotted and issued, fully paid, not subject to any call for the
payment of further capital and free of any liens, encumbrances, rights of first refusal, preemptive or other similar rights, save
for any rights of pre-emption under the CA 2006 that have been duly waived or disapplied and will conform to the descriptions
thereof in the Registration Statement, the General Disclosure Package and the Prospectus. The Ordinary Shares represented by ADSs
may be freely deposited by the Company with the Custodian for the Depositary against issuance of ADRs evidencing such Offered
Securities in the form of ADSs, as contemplated by the Deposit Agreement. The Offered Securities in the form of ADSs have been
duly authorized for issuance and sale pursuant to this Agreement (including, in respect of Ordinary Shares represented by the
ADSs, pursuant to section 551 of the CA 2006) and, when issued and delivered against payment therefor as provided herein, will
be duly and validly issued, fully paid and nonassessable, and free of any liens, encumbrances, rights of first refusal, preemptive
or other similar rights, and will conform to the descriptions thereof in the Registration Statement, the General Disclosure Package
and the Prospectus. The issuance of the Offered Securities is not subject to any liens, encumbrances, rights of first refusal,
preemptive or similar rights (including those provided by section 561 (1) of the CA 2006 in respect of the Ordinary Shares represented
by ADSs). Upon the issuance, sale and delivery to the Underwriters of the Offered Securities, and payment therefor, the Underwriters
will acquire good, marketable and valid title to such Offered Securities, free and clear of all pledges, liens, security interests,
charges, claims or encumbrances.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o) The
Company has an issued and outstanding share capital as set forth under the heading &ldquo;Capitalization&rdquo; in the Pricing
Prospectus, and all of the issued shares of the Company have been duly and validly authorized and issued, are fully paid, and
are not subject to any call for the payment of further capital and are free of any preemptive or other similar rights, and have
been issued in compliance with the Company&rsquo;s articles of association and applicable company and securities laws, and conform
to the description thereof contained in the General Disclosure Package and the Prospectus under the heading &ldquo;Description
of Share Capital and Articles of Association.&rdquo; All of the Company&rsquo;s options and other rights to purchase or exchange
any securities for shares of the Company&rsquo;s capital stock have been duly authorized and validly granted or issued and were
granted or issued in compliance with applicable company and securities laws. None of the outstanding Ordinary Shares were issued
in violation of any preemptive rights, rights of first refusal or other similar rights to subscribe for or purchase securities
of the Company. As of the date set forth in the General Disclosure Package, there were no authorized or outstanding shares, options,
warrants, preemptive rights, rights of first refusal or other rights to purchase, or equity or debt securities convertible into
or exchangeable or exercisable for, any shares of the Company or any of its subsidiaries, other than those described above or
described in the General Disclosure Package. Since such date, the Company has not issued any securities other than Ordinary Shares
issued upon the exercise of share options or other awards outstanding under the Company&rsquo;s share option plans, options or
other securities granted or issued pursuant to the Company&rsquo;s existing equity compensation plans or other plans, the issuance
of Ordinary Shares pursuant to employee stock purchase plans or upon the exercise of warrants described in the General Disclosure
Package. The description of the Company&rsquo;s share option, share bonus and other share plans or arrangements, and the options
or other rights granted thereunder, as described in the General Disclosure Package and the Prospectus, accurately and fairly present
the information required to be shown with respect to such plans, arrangements, options and rights. All of the outstanding issued
share capital of each subsidiary of the Company has been duly and validly authorized and issued, is fully paid, nonassessable
and free of any preemptive or other similar rights, and has been issued in compliance with applicable company and securities laws
and is owned directly by the Company free and clear of any claim, lien, encumbrance, security interest, restriction on voting
or transfer or other claim of any third party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p) The
issuance and sale of the Offered Securities as contemplated hereby will not cause any holder of any share capital, securities
convertible into or exchangeable or exercisable for share capital or options, warrants or other rights to purchase share capital
or any other securities of the Company to have any right to acquire any preferred shares of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q) The
execution, delivery and performance of this Agreement by the Company, the issue and sale of the Offered Securities by the Company,
the deposit of the Ordinary Shares represented by ADSs with the Custodian for the Depositary, and the consummation of the transactions
contemplated hereby will not (with or without notice or lapse of time or both) (i) conflict with or result in a breach or violation
of any of the terms or provisions of, constitute a default or a Debt Repayment Triggering Event (as defined below) under, or result
in the creation or imposition of any lien, encumbrance, security interest, claim or charge upon any property or assets of the
Company or any of its subsidiaries pursuant to, any indenture, mortgage, deed of trust, loan agreement or other agreement or instrument
to which the Company is a party or by which the Company or any of its subsidiaries is bound or to which any of the property or
assets of the Company or any of its subsidiaries is subject, (ii) result in any violation of the provisions of the articles of
association or certificate of incorporation of the Company or any of its subsidiaries or (iii) result in the violation of any
U.S. or non-U.S. law, statute, rule, regulation, judgment, order or decree of any court or governmental or regulatory agency or
authority, having jurisdiction over the Company or any of its subsidiaries or any of their respective properties or assets except,
in the case of clauses (i) to (iii) above, to the extent that any such conflict, breach, violation or default that would not,
individually or in the aggregate, have a Material Adverse Effect. A &ldquo;<B><I>Debt Repayment Triggering Event</I></B>&rdquo;
means any event or condition that gives, or with the giving of notice or lapse of time would give the holder of any note, debenture
or other evidence of indebtedness (or any person acting on such holder&rsquo;s behalf) the right to require the repurchase, redemption
or repayment of all or a portion of such indebtedness by the Company or any of its subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r) Except
for the registration of the Offered Securities under the Securities Act and Exchange Act (as defined below) and applicable U.S.
state securities laws and such consents, approvals, authorizations, orders and registrations or qualifications as may be required
by the Financial Industry Regulatory Authority, Inc. (&ldquo;<B><I>FINRA</I></B>&rdquo;), The Nasdaq Capital Market (the &ldquo;<B><I>Exchange</I></B>&rdquo;),
the UK Financial Conduct Authority (the &ldquo;<I>FCA</I>&rdquo;) and the London Stock Exchange plc (the &ldquo;<B><I>London Stock
Exchange</I></B>&rdquo;), or pursuant to the AIM Rules for Companies published by the London Stock Exchange from time to time
(the &ldquo;<B><I>AIM Rules for Companies</I></B>&rdquo;), or pursuant to the CA 2006, the United Kingdom Financial Services and
Markets Act 2000, as amended, and/or EU Regulation (EU 596/2014) on market abuse (the &ldquo;<B><I>Market Abuse Regulation</I></B>&rdquo;),
in connection with the purchase and distribution of the Offered Securities by the Underwriters, the listing of the Offered Securities
on the Exchange and the admission of the Ordinary Shares to be sold by the Company hereunder to trading on the AIM market operated
by the London Stock Exchange (&ldquo;AIM&rdquo;), as applicable, no consent, approval, authorization or order of, or filing, qualification
or registration (each, an &ldquo;<B><I>Authorization</I></B>&rdquo;) with, any U.S. or non-U.S. court, governmental or regulatory
agency or authority, which has not been made, obtained or taken and is not in full force and effect, is required for the execution,
delivery and performance of this Agreement or the Deposit Agreement by the Company, the issuance and sale of the Offered Securities,
the deposit of the Ordinary Shares represented by ADSs with the Custodian for the Depositary or the consummation of the transactions
contemplated hereby; and no event has occurred that allows or results in, or after notice or lapse of time or both would allow
or result in, revocation, suspension, termination or invalidation of any such Authorization or any other impairment of the rights
of the holder or maker of any such Authorization. All corporate approvals (including those of shareholders) necessary for the
Company to consummate the transactions contemplated by this Agreement have been obtained and are in effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s) Mazars
LLP, who have certified certain financial statements of the Company and its subsidiaries included in the Registration Statement,
the General Disclosure Package and the Prospectus, is an independent registered public accounting firm with respect to the Company
within the meaning of Article 2-01 of Regulation S-X and the Public Company Accounting Oversight Board (United States) (the &ldquo;<B><I>PCAOB</I></B>&rdquo;)
and applicable laws of England and Wales.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t) The
financial statements, together with the related notes, included in the General Disclosure Package, the Prospectus and in the Registration
Statement present fairly, in all material respects, the financial position and the results of operations and changes in financial
position of the Company and its subsidiaries at the respective dates or for the respective periods therein specified. Such statements
and related notes have been prepared in accordance with International Financial Reporting Standards (&ldquo;<B><I>IFRS</I></B>&rdquo;)
as issued by the European Union and the International Accounting Standards Board (&ldquo;<B><I>IASB</I></B>&rdquo;) applied on
a consistent basis throughout the periods involved except as may be set forth in the related notes included in the General Disclosure
Package. The financial statements, together with the related notes, included in the General Disclosure Package and the Prospectus
comply in all material respects with Regulation S-X. No other financial statements or supporting schedules or exhibits are required
by Regulation S-X to be described or included in the Registration Statement, the General Disclosure Package or the Prospectus.
The pro forma and pro forma as adjusted financial information included in the Registration Statement, the General Disclosure Package
and the Prospectus have been properly compiled and prepared in accordance with the applicable requirements of Rule 11-02 of Regulation
S-X and present fairly, in all material respects, the information shown therein, and the assumptions used in the preparation thereof
are reasonable and the adjustments used therein are appropriate to give effect to the transactions and circumstances referred
to therein. The summary and selected financial data included in the General Disclosure Package, the Prospectus and the Registration
Statement present fairly, in all material respects, the information shown therein as at the respective dates and for the respective
periods specified and are derived from the consolidated financial statements set forth in the Registration Statement, the Pricing
Prospectus and the Prospectus and other financial information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u) Neither
the Company nor any of its subsidiaries has sustained, since the date of the latest audited financial statements included in the
General Disclosure Package, (i) any material loss or interference with its business from fire, explosion, flood or other calamity,
whether or not covered by insurance, or from any labor dispute or action, order or decree of any court or governmental or regulatory
authority, otherwise than as set forth or contemplated in the General Disclosure Package, or (ii) any change in the capital stock
(other than the issuance of Ordinary Shares or other securities of the Company upon exercise, exchange, vesting, or conversion
of awards granted pursuant to, and the grant of awards under, existing equity incentive plans described in the Registration Statement,
the General Disclosure Package and the Prospectus or the issuance of Ordinary Shares pursuant to the terms of warrants, each as
described in the Registration Statement, the General Disclosure Package and the Prospectus) or long-term debt of the Company or
any of its subsidiaries, or any dividend or distribution of any kind declared, set aside for payment, paid or made by the Company
on any class of capital stock, or any material adverse changes, or, to the Company&rsquo;s knowledge, any development involving
a prospective material adverse change, in or affecting the business, properties, assets, management, financial position, shareholders&rsquo;
equity, results of operations or prospects of the Company and its subsidiaries, taken as a whole, otherwise than as set forth
or contemplated in the General Disclosure Package.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v) Neither
the Company nor any of its subsidiaries is a party to any corporate integrity agreements, monitoring agreements, consent decrees,
settlement orders, or similar agreements with or imposed by any governmental or regulatory authority. The Company and each of
its subsidiaries is in compliance with all applicable U.S. or non-U.S. laws, rules, regulations, orders and decrees governing
its business and the regulation of pharmaceuticals or biohazardous substances or materials, including without limitation the U.S.
federal Food, Drug and Cosmetic Act, U.S. data privacy and securities laws and U.S. health care fraud and abuse laws, except where
noncompliance would not, individually or in the aggregate, have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w) Neither
the Company nor any of its subsidiaries is in (i) violation of its articles of association or certificate of incorporation, as
applicable, (ii) violation of the AIM Rules for Companies and/or, assuming compliance by the Underwriters with the requirements
and restrictions described under the captions &ldquo;Underwriters&mdash;Selling Restrictions&mdash;European Economic Area&rdquo;
and &ldquo;&mdash;United Kingdom&rdquo; in the Registration Statement, the General Disclosure Package and the Prospectus, the
FCA&rsquo;s Prospectus Rules, (iii) default in any respect, and no event has occurred which, with notice or lapse of time or both,
would constitute such a default, in the due performance or observance of any term, covenant or condition contained in any indenture,
mortgage, deed of trust, loan agreement, lease or other agreement or instrument to which it is a party or by which it is bound
or to which any of its property or assets is subject (including, without limitation, those administered by the U.S. Food and Drug
Administration of the U.S. Department of Health and Human Services (the &ldquo;<B><I>FDA</I></B>&rdquo;), the European Medicines
Agency (the &ldquo;<B><I>EMA</I></B>&rdquo;) or comparable U.S. or non-U.S. governmental authorities of competent jurisdiction)
or (iv) violation in any respect of any other law, ordinance, governmental rule, regulation or court order, decree or judgment
to which it or its property or assets may be subject except, in the case of clauses (ii) through (iv) above, for any such violation
or default that would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x) The
Company and each of its subsidiaries possess all licenses, certificates, authorizations and permits issued by, and has made all
declarations and filings with, the appropriate U.S. or non-U.S. governmental or regulatory authorities of competent jurisdiction
(including, without limitation, the FDA, the EMA or comparable U.S. or non-U.S. governmental authorities of competent jurisdiction)
that are necessary for the ownership or lease of their respective properties or the conduct of their respective businesses as
described in the Registration Statement, General Disclosure Package and the Prospectus (collectively, the &ldquo;<B><I>Governmental
Permits</I></B>&rdquo;), except where any failures to possess or make the same would not, individually or in the aggregate, reasonably
be expected to have a Material Adverse Effect. The Company and its subsidiaries are in compliance with all such Governmental Permits,
and all such Governmental Permits are valid and in full force and effect, except where such non-compliance, invalidity or failure
to be in full force and effect would not reasonably be expected, individually or in the aggregate, to have a Material Adverse
Effect. Neither the Company nor any subsidiary has received written notification of any revocation, modification, suspension,
termination or invalidation (or proceedings related thereto) of any such Governmental Permit and the Company has no knowledge
that any such Governmental Permit requiring renewal will not be renewed. The Company and each of its subsidiaries have filed,
obtained, maintained or submitted all material reports, documents, forms, notices, applications, records, claims, submissions
and supplements or amendments as required by any applicable laws or Governmental Permits, and all such reports, documents, forms,
notices, applications, records, claims, submissions and supplements or amendments were complete and accurate on the date filed
in all material respects (or were corrected or supplemented by a subsequent submission), except where the failure to so file,
obtain, maintain or submit, or such incompleteness or inaccuracy, would not reasonably be expected to have a Material Adverse
Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(y) The
studies, tests and preclinical studies or clinical trials conducted by or on behalf of the Company and its subsidiaries that are
described in the General Disclosure Package and the Prospectus (the &ldquo;<B><I>Company Studies and Trials</I></B>&rdquo;) were
and, if still pending, are being, conducted in all material respects in accordance with applicable laws and regulations; the descriptions
of the results of the Company Studies and Trials contained in the Registration Statement, General Disclosure Package and the Prospectus
are accurate in all material respects; the Company has no knowledge of any other studies or trials not described in the General
Disclosure Package and the Prospectus, the results of which materially call into question the results described or referred to
in the General Disclosure Package and the Prospectus; and the Company has not received any written notices or correspondence from
the FDA, the EMA or comparable U.S. or non-U.S. governmental authorities of competent jurisdiction requiring the termination,
suspension or material modification of any Company Studies and Trials where such termination, suspension or material modification
would reasonably be expected to have a Material Adverse Effect. Neither the Company, nor its subsidiaries nor to the Company&rsquo;s
knowledge, any of their respective directors, officers, employees or agents is debarred, suspended or excluded, or has been convicted
of any crime that would result in a debarment, suspension or exclusion from any U.S. federal or state government health care program
or human clinical research.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(z) The
Company is not and, after giving effect to the offering of the Offered Securities and the application of the proceeds thereof
as described in the General Disclosure Package and the Prospectus, will not be required to register as an &ldquo;investment company&rdquo;
or an entity &ldquo;controlled&rdquo; by an &ldquo;investment company&rdquo; within the meaning of the U.S. Investment Company
Act of 1940, as amended, and the rules and regulations of the Commission thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(aa)&#9;There
are no business relationships or related person transactions involving the Company or any of its subsidiaries or any other person
required to be described in the General Disclosure Package and the Prospectus that have not been described as required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(bb)&#9;Neither
the Company nor, to the Company&rsquo;s knowledge, any of its officers, directors or affiliates has taken or will take, directly
or indirectly, any action designed or intended to stabilize or manipulate the price of any security of the Company, or which caused
or resulted in, or which might in the future reasonably be expected to cause or result in, stabilization or manipulation of the
price of any security of the Company, save where such action was carried out in conformity with Article 5 of the Market Abuse
Regulation and the delegated regulation(s) thereunder (or, prior to the Market Abuse Regulation coming into effect on July 3,
2016, the price stabilizing rules of the FCA).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(cc)&#9;The
Company and each of its subsidiaries owns or possesses the valid right to use all (i) patents, patent applications, trademarks,
trademark registrations, service marks, service mark registrations, Internet domain name registrations, copyrights, copyright
registrations, licenses and trade secret rights (collectively, &ldquo;<B><I>Intellectual Property Rights</I></B>&rdquo;) and (ii)
inventions, software, works of authorships, trademarks, service marks, trade names, databases, formulae, know how, Internet domain
names and other intellectual property (including trade secrets and other unpatented and/or unpatentable proprietary confidential
information, systems, or procedures) (collectively, &ldquo;<B><I>Intellectual Property Assets</I></B>&rdquo;) that, to the Company&rsquo;s
knowledge, are necessary to conduct their respective businesses as currently conducted, and as proposed to be conducted and described
in the Registration Statement, General Disclosure Package and the Prospectus. Neither the Company nor any of its subsidiaries
has received any opinion from its legal counsel concluding that any activities of its business infringes, misappropriates, or
otherwise violates, valid and enforceable Intellectual Property Rights of any other person. Neither the Company nor any of its
subsidiaries has received written notice of any challenge, which is to their knowledge still pending, by any other person to the
rights of the Company and its subsidiaries with respect to any Intellectual Property Rights or Intellectual Property Assets owned
or exclusively licensed by the Company or its subsidiaries. To the Company&rsquo;s knowledge, the Company&rsquo;s and its respective
subsidiaries&rsquo; businesses as now conducted and as proposed to be conducted as described in the Registration Statement, General
Disclosure Package and the Prospectus do not and will not give rise to any infringement of, any misappropriation of, or other
violation of, any valid and enforceable Intellectual Property Rights of any other person. Except as disclosed in the Registration
Statement, General Disclosure Package, and Prospectus, to the Company&rsquo;s knowledge, there are no third parties who have rights
to any Intellectual Property Rights described in the Registration Statement, General Disclosure Package and the Prospectus as
being owned by or exclusively licensed to the Company (collectively, &ldquo;<B><I>Company Intellectual Property Rights</I></B>&rdquo;),
including no liens, security interests, or other encumbrances, except for customary reversionary rights of third-party licensors
with respect to Intellectual Property Rights that are disclosed as licensed to the Company or one or more of its subsidiaries.
To the Company&rsquo;s knowledge, there is no infringement by third parties of any Company Intellectual Property Rights. To the
Company&rsquo;s knowledge, there are no material defects in any of the patents or patent applications included in the Company
Intellectual Property Rights disclosed in the Registration Statement, General Disclosure Package and the Prospectus as being owned
by or exclusively licensed to the Company. To the Company&rsquo;s knowledge, all licenses for the use of the Company Intellectual
Property Rights described in the Registration Statement, the General Disclosure Package and the Prospectus as exclusively licensed
to the Company or its subsidiaries (collectively, <I>&ldquo;<B>Company In-Licenses</B>&rdquo;</I>) are valid, binding upon and
enforceable by or against the Company or its subsidiaries and by or against the other parties thereto in accordance with their
terms. The Company and each of its subsidiaries has complied in all material respects with all Company In-Licenses, and is not
in breach of any Company In-License. Neither the Company nor any of its subsidiaries has received written notice of any asserted
or threatened claim of breach of any Company In-License, and the Company has no knowledge of any breach by any other person of
any Company In-License. Except as described in the General Disclosure Package, there is no pending, and the Company has not received
written notice of any threatened, action, suit, proceeding, or claim against the Company or any of its subsidiaries (i) alleging
the infringement by the Company or any of its subsidiaries of any patent, trademark, service mark, trade name, copyright, trade
secret, license or other intellectual property right or franchise right of any person; or (ii) challenging the validity, enforceability,
or scope of any Company Intellectual Property Rights owned by, and to the Company&rsquo;s knowledge, exclusively licensed to the
Company, including no interferences, oppositions, reexaminations, or government proceedings, and the Company is unaware of any
facts which would form a reasonable basis for any such action, suit, proceeding, or claim. The Company and its subsidiaries have
taken all reasonable steps to protect, maintain and safeguard the Company Intellectual Property Rights, including the execution
of appropriate nondisclosure, confidentiality agreements and invention assignments with their employees, and to the Company&rsquo;s
knowledge, no employee of the Company is in or has been in violation of any term of any employment contract, patent disclosure
agreement, invention assignment agreement, non-competition agreement, non-solicitation agreement, nondisclosure agreement, or
any restrictive covenant to or with a former employer where the basis of such violation relates to such employee&rsquo;s employment
with the Company. To the Company&rsquo;s knowledge, the duty of candor and good faith as required by the United States Patent
and Trademark Office during the prosecution of the United States patents and patent applications included in the Company Intellectual
Property Rights owned by the Company have been complied with; and in all foreign offices having similar requirements, all such
requirements have been complied with. The consummation of the transactions contemplated by this Agreement will not result in the
loss or impairment of or payment of any additional amounts with respect to, nor require the consent of any other person in respect
of, the Company's or any of its subsidiaries&rsquo; right to own, use, or hold for use any of the Company Intellectual Property
Rights described in the Registration Statement, the General Disclosure Package and the Prospectus as owned by or licensed to the
Company for use in the conduct of the business of the Company or its subsidiaries as currently conducted. The Company has at all
times complied with all applicable U.S. or non-U.S. laws relating to privacy, data protection, and the collection and use of personal
information collected, used, or held for use by the Company in the conduct of the Company&rsquo;s business, except where the failure
to so comply would not reasonably be expected to have a Material Adverse Effect. Except where such claim would not reasonably
be expected to have a Material Adverse Effect, no claims have been asserted or threatened in writing against the Company alleging
a violation of any person&rsquo;s privacy or personal information or data rights and the consummation of the transactions contemplated
hereby will not breach or otherwise cause any violation of any law related to privacy, data protection, or the collection and
use of personal information collected, used, or held for use by the Company in the conduct of the Company&rsquo;s business. The
Company and each of its subsidiaries has taken all necessary actions to obtain ownership of all works of authorship and inventions
made by its employees, consultants and contractors during the time they were employed by or under contract with the Company or
any of its subsidiaries and which relate to the Company&rsquo;s business. All key employees have signed confidentiality and invention
assignment agreements with the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(dd)&#9;The
Company and its subsidiaries own no real property. The Company and its subsidiaries have valid and marketable rights to lease
or otherwise use, all items of real or personal property which are material to the business of the Company and its subsidiaries
taken as a whole, in each case free and clear of all liens, encumbrances, security interests, claims and defects that, individually
or in the aggregate, could reasonably be expected to materially affect the value of such property or interfere with the use made
and proposed to be made of such property by the Company; and all of the leases and subleases material to the business of the Company,
and under which the Company holds properties described in the General Disclosure Package and the Prospectus, are in full force
and effect and the Company has not received any notice of any material claim of any sort that has been asserted by anyone adverse
to the rights of the Company under any of the leases or subleases mentioned above, or affecting or questioning the rights of the
Company to the continued possession of the leased or subleased premises under any such lease or sublease.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ee)&#9;There
is (A) no unfair labor practice complaint pending against the Company, nor, to the Company&rsquo;s knowledge, threatened against
it, before any U.S. or non-U.S. governmental authorities of competent jurisdiction (including the U.S. National Labor Relations
Board and any U.S. state or local labor relations board or any foreign labor relations board), and no significant grievance or
significant arbitration proceeding arising out of or under any collective bargaining agreement is so pending against the Company,
or, to the Company&rsquo;s knowledge, threatened against it and (B) no labor disturbance by or dispute with, employees of the
Company exists or, to the Company&rsquo;s knowledge, is contemplated or threatened, and the Company is not aware of any existing
or imminent labor disturbance by the employees of any of the Company&rsquo;s principal suppliers, manufacturers, customers or
contractors, that would reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect. The Company
is not aware that any key employee or significant group of employees of the Company or any subsidiary plans to terminate employment
with the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ff)&#9;The
Company is in compliance with all U.S. and non-U.S. rules, laws and regulations issued by governmental authorities of competent
jurisdiction relating to the use, treatment, storage and disposal of hazardous or toxic substances or waste and protection of
health and safety or the environment which are applicable to its business (the &ldquo;<B><I>Environmental Laws</I></B>&rdquo;).
Except as would not be reasonably expected, individually or in the aggregate, to have a Material Adverse Effect, (i) there has
been no storage, generation, transportation, handling, treatment, disposal, discharge, emission, or other release of any kind
of toxic or other wastes or other hazardous substances by, due to, or caused by the Company (or, to the Company&rsquo;s knowledge,
any other entity for whose acts or omissions the Company is or may otherwise be liable) upon any of the property now or previously
owned or leased by the Company, or upon any other property, in violation of any law, statute, ordinance, rule, regulation, order,
judgment, decree or permit or which would, under any law, statute, ordinance, rule (including rule of common law), regulation,
order, judgment, decree or permit, give rise to any liability; and (ii) there has been no disposal, discharge, emission or other
release of any kind on to such property or into the environment surrounding such property of any toxic or other wastes or other
hazardous substances. In the ordinary course of business, the Company conducts periodic reviews of the effect of Environmental
Laws on the business and assets of the Company and its subsidiaries, in the course of which the Company identifies and evaluates
associated costs and liabilities (including, without limitation, any capital or operating expenditures required for clean-up,
closure of properties or compliance with Environmental Laws or Governmental Permits issued thereunder, any related constraints
on operating activities and any potential liabilities to third parties). The Company has not identified any such associated costs
and liabilities that would reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(gg)&#9;The
Company and its subsidiaries (i) have filed all necessary U.S. and non-U.S. (federal, state, local and foreign) tax returns (or
properly requested extensions with respect to such returns), and such returns were when filed, and remain, complete and correct
(ii) have paid all federal, state, local and foreign taxes required to be paid and any related assessments, fines, penalties or
governmental charges due and payable for which it is liable, except as may be being contested in good faith by appropriate proceedings,
and (iii) do not have any tax deficiency or claims outstanding or assessed or, to its knowledge, proposed against it, except,
in each of (i), (ii) and (iii) above, as would not, individually or in the aggregate, reasonably be expected to have a Material
Adverse Effect. The accruals and reserves on the books and records of the Company and its subsidiaries in respect of tax liabilities
for any taxable period not yet finally determined are adequate to meet any assessments and related liabilities for any such period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(hh)&#9;Except
as described in the Registration Statement or the Prospectus, no stamp duty, stamp duty reserve, registration, transfer or other
similar taxes or duties (&ldquo;<B><I>Transfer Taxes</I></B>&rdquo;) are payable in the United Kingdom by or on behalf of the
Underwriters in connection with (i) the creation and issuance and delivery of the Ordinary Shares by the Company in the manner
contemplated by this Agreement and the Deposit Agreement; (ii) the delivery of the Ordinary Shares by the Company to or for the
account of the Underwriters in the manner contemplated by this Agreement (and for the avoidance of doubt, the &ldquo;manner contemplated
by this Agreement&rdquo; is that such delivery of Ordinary Shares shall form part of the issuance of such Ordinary Shares to or
for the account of the Underwriters); (iii) the delivery of the Ordinary Shares by the Company to the Depositary in the manner
contemplated by the Deposit Agreement; (iv) the issuance of the Firm ADSs to or for the account of the Underwriters, in each case
in the manner contemplated by this Agreement and the Deposit Agreement; (v) the initial sale and delivery by the Underwriters
of the Firm ADSs and the Optional ADSs (or the ADRs evidencing the Firm ADSs and the Optional ADSs) to purchasers thereof in the
manner contemplated by this Agreement; or (vi) the execution and delivery of this Agreement or the Deposit Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) The
Company carries or is covered by insurance in such amounts and covering such risks as is adequate for the conduct of its business
and the value of their respective properties and as is generally deemed customary for companies engaged in similar businesses
in similar industries. The Company has no reason to believe that it will not be able to renew its existing insurance coverage
as and when such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business
at a cost that would not have a Material Adverse Effect. All policies of insurance owned by the Company are, to the Company&rsquo;s
knowledge, in full force and effect and the Company is in compliance in all material respects with the terms of such policies.
The Company has not received written notice from any insurer, agent of such insurer or the broker of the Company that any material
capital improvements or any other material expenditures (other than premium payments) are required or necessary to be made in
order to continue such insurance. Except for customary deductibles, the Company does not insure risk of loss through any captive
insurance, risk retention group, reciprocal group or by means of any fund or pool of assets specifically set aside for contingent
liabilities other than as described in the General Disclosure Package.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(jj)&#9;The
Company and each of its subsidiaries has established and maintains a system of &ldquo;<I>internal control over financial reporting</I>&rdquo;
(as such term is defined in Rule 13a-15(f) of the General Rules and Regulations under the Securities Exchange Act of 1934, as
amended (such act, the &ldquo;<B><I>Exchange Act</I></B>,&rdquo; and such rules and regulations, the &ldquo;<B><I>Exchange Act
Rules</I></B>&rdquo;)) that enables the Company to comply with the AIM Rules for Companies and that will enable the Company to
comply with the Exchange Act and has been designed by its principal executive and principal financial officers, or under their
supervision, to provide reasonable assurances that: (i) transactions are executed in accordance with management&rsquo;s general
or specific authorizations; (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity
with IFRS as issued by IASB and to maintain accountability for assets; (iii) access to assets is permitted only in accordance
with management&rsquo;s general or specific authorization; and (iv) the recorded accountability for assets is compared with existing
assets at reasonable intervals and appropriate action is taken with respect to any differences. The internal control over financial
reporting of the Company and its subsidiaries are effective. Except as described in the General Disclosure Package, since the
end of the Company&rsquo;s most recently audited fiscal year, there has been (A) no material weakness in the Company&rsquo;s internal
control over financial reporting (whether or not remediated) and (B) no change in the Company&rsquo;s internal control over financial
reporting that has materially affected, or is reasonably likely to materially affect, the Company&rsquo;s internal control over
financial reporting. The Company&rsquo;s internal control over financial reporting is overseen or will be overseen, when required
in accordance with the Exchange Act Rules, by the audit committee (the &ldquo;<B><I>Audit Committee</I></B>&rdquo;) of the board
of directors of the Company (the &ldquo;<B><I>Board</I></B>&rdquo;). Except as described in the General Disclosure Package and
the Prospectus, the Company has not publicly disclosed or reported to the Audit Committee or to the Board, and within the next
ninety (90) days the Company does not reasonably expect to publicly disclose or report to the Audit Committee or the Board, a
significant deficiency, material weakness, change in internal control over financial reporting or fraud involving management or
other employees who have a significant role in the internal control over financial reporting (each, an &ldquo;<B><I>Internal Control
Event</I></B>&rdquo;) or any material violation of, or failure to comply in all material respects with, U.S. federal securities
laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(kk)&#9;The
Company has not received any notice, oral or written, from the Board stating that it is reviewing or investigating, and neither
the Company&rsquo;s independent auditors nor the Audit Committee have recommended that the Board review or investigate, (i) adding
to, deleting, changing the application of or changing the Company&rsquo;s disclosure with respect to, any of the Company&rsquo;s
material accounting policies, (ii) any matter which could result in a restatement of the Company&rsquo;s financial statements
for any annual or interim period during the current or prior three (3) fiscal years, or (iii) any Internal Control Event.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ll)&#9;The
Company has established and maintains disclosure controls and procedures (as such is defined in Rule 13a-15(e) of the Exchange
Act Rules) that enable the Company to comply with the requirements of the AIM Rules for Companies and that will enable the Company
to comply with the Exchange Act; such disclosure controls and procedures have been designed to ensure that material information
relating to the Company and its consolidated subsidiaries which is required to be disclosed by the Company in reports that they
file or submit is recorded, processed, summarized and reported within the time periods specified by the London Stock Exchange
and the Commission, including controls and procedures designed to ensure that such information is accumulated and communicated
to the Company&rsquo;s management to allow timely decisions regarding disclosures. The Company has conducted, or will conduct
when required, evaluations of the effectiveness of its disclosure controls as required by Rule 13a-15 of the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(mm)&#9;The
minute books of the Company and its subsidiaries have been made available to the Underwriters and counsel to the Underwriters,
and such books (i) contain a complete summary of all meetings and actions of the Board (including each Board committee) and shareholders
of the Company and its subsidiaries (or analogous governing bodies and interest holders, as applicable) since the time of its
incorporation through the date of the latest meeting and action, and (ii) accurately in all material respects reflect all transactions
referred to in such minutes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(nn)&#9;There
is no license, lease, contract, or other agreement or document required by the Securities Act or by the Rules and Regulations
to be described in the General Disclosure Package or to be filed as an exhibit to the Registration Statement which is not so described
therein or filed therewith as required; and all descriptions of any such licenses, leases, contracts, or other agreements or documents
contained in the General Disclosure Package are accurate and complete descriptions of such documents in all material respects.
Other than as described in the General Disclosure Package, no such license, lease, contract or other agreement has been suspended
or terminated for convenience or default by the Company or any of the other parties thereto, and the Company and its subsidiaries
have not received notice of and the Company does not have knowledge of any such pending or threatened suspension or termination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(oo) No
relationship, direct or indirect, exists between or among the Company or any of its subsidiaries, on the one hand, and the directors,
officers, shareholders (or analogous interest holders), customers or suppliers of the Company or any of its affiliates, on the
other hand, which is required by the Securities Act or by the Rules and Regulations to be described in the General Disclosure
Package and the Prospectus and which is not so described.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(pp)&#9;No
person or entity has the right to require registration of shares of Ordinary Shares, ADSs or other securities of the Company or
any of its subsidiaries because of the filing or effectiveness of the Registration Statement, the ADS Registration Statement or
otherwise, except for persons and entities who have expressly waived such right in writing or who have been given timely and proper
written notice and have failed to exercise such right within the time or times required under the terms and conditions of such
right. Except as described in the General Disclosure Package, there are no persons with registration rights or similar rights
to have any securities registered by the Company or any of its subsidiaries under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(qq)&#9;The
Company does not own any &ldquo;margin securities&rdquo; as that term is defined in Regulation U of the Board of Governors of
the Federal Reserve System (the &ldquo;<B><I>Federal Reserve Board</I></B>&rdquo;), and none of the proceeds of the sale of the
Offered Securities will be used, directly or indirectly, for the purpose of purchasing or carrying any margin security, for the
purpose of reducing or retiring any indebtedness which was originally incurred to purchase or carry any margin security or for
any other purpose which might cause any of the Offered Securities to be considered a &ldquo;purpose credit&rdquo; within the meanings
of Regulation T, U or X of the Federal Reserve Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(rr)&#9;Other
than this Agreement, neither the Company nor any of its subsidiaries is a party to any contract, agreement or understanding with
any person that would give rise to a valid claim against the Company or any of its subsidiaries, or the Underwriters for a brokerage
commission, finder&rsquo;s fee or like payment in connection with the offering and sale of the Offered Securities or any transaction
contemplated by this Agreement, the Registration Statement, the General Disclosure Package or the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ss)&#9;Since
the date as of which information is given in the General Disclosure Package through the date hereof, and except for the obligations
created by this Agreement and as set forth in the General Disclosure Package, the Company has not (i) issued or granted any securities
other than options to purchase Ordinary Shares pursuant to the Company&rsquo;s share option plan, (ii) incurred any material liability
or obligation, direct or contingent, other than liabilities and obligations which were incurred in the ordinary course of business,
(iii) entered into any material transaction other than in the ordinary course of business or (iv) declared or paid any dividend
on its shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(tt)&#9;If
applicable, all of the information provided to the Underwriters or to counsel for the Underwriters by the Company, and to the
Company&rsquo;s knowledge, by its officers and directors and the holders of any securities (debt or equity) or options to acquire
any securities of the Company in connection with letters, filings or other supplemental information provided to FINRA pursuant
to FINRA Rule 5110 or 5121 is true, correct and complete in all material respects as of the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(uu)&#9;Except
as described in the General Disclosure Package, no subsidiary of the Company is currently prohibited, directly or indirectly,
under any agreement or other instrument to which it is a party or is subject, from paying any dividends to the Company, from making
any other distribution on such subsidiary&rsquo;s shares, from repaying to the Company any loans or advances to such subsidiary
from the Company or from transferring any of such subsidiary&rsquo;s properties or assets to the Company or any other subsidiary
of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vv)&#9;No
forward-looking statement (within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act) contained
in either the General Disclosure Package, or the Prospectus has been made or reaffirmed without a reasonable basis or has been
disclosed other than in good faith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ww)&#9;The
Offered Securities in the form of ADSs have been approved for listing subject to notice of issuance on the Exchange. A registration
statement has been filed on Form 8-A pursuant to Section 12 of the Exchange Act, which registration statement complies in all
material respects with the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xx) The
Company is in compliance with all listing and admission requirements and continuing obligations pursuant to the AIM Rules for
Companies, the Market Abuse Regulation and the UK Disclosure Guidance and Transparency Rules made by the FCA as amended from time
to time (as applicable to the Company).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(yy)&#9;The
Company has taken all actions reasonably necessary to ensure that, upon and at all times after the effectiveness of the Registration
Statement, it will be in compliance in all material respects with all applicable provisions of the Sarbanes-Oxley Act of 2002
and the rules and regulations promulgated in connection therewith (the &ldquo;<B><I>Sarbanes-Oxley Act</I></B>&rdquo;) that are
then in effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(zz)&#9;Neither
the Company nor any of its subsidiaries nor, to the Company&rsquo;s knowledge, any director, officer, employee, agent, affiliate,
or other person acting on behalf of the Company or any of its subsidiaries, has (i) used any corporate funds for unlawful contributions,
gifts, entertainment or other unlawful expenses relating to political activity, (ii) made any direct or indirect unlawful payment
to U.S. or non-U.S. government officials or employees, political parties or campaigns, political party officials, or candidates
for political office from corporate funds, (iii) violated or is in violation of any applicable provision of the U.S. Foreign Corrupt
Practices Act of 1977, as amended, or any applicable anti-corruption laws, rules, or regulations of England and Wales or any other
jurisdiction in which the Company conducts business; or (iv) made any other unlawful bribe, rebate, payoff, influence payment,
kickback, or other unlawful payment to any U.S. or non-U.S. government official or employee, political party or campaign, political
party official, or candidate for political office.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(aaa)&#9;There
are no transactions, arrangements or other relationships between and/or among the Company, any of its affiliates (as such term
is defined in Rule 405 of the Rules and Regulations) and any unconsolidated entity, including, but not limited to, any structured
finance, special purpose or limited purpose entity that could reasonably be expected to materially affect the Company&rsquo;s
liquidity or the availability of or requirements for its capital resources required to be described in the General Disclosure
Package and the Prospectus which have not been described as required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(bbb)&#9;There
are no outstanding loans, advances (except normal advances for business expenses in the ordinary course of business) or guarantees
of indebtedness by the Company to or for the benefit of any of the officers or directors of the Company or any of their respective
family members, except as disclosed in the Registration Statement, the General Disclosure Package and the Prospectus. All transactions
by the Company with office holders or control persons of the Company have been duly approved by the Board, or duly appointed committees
or officers thereof, if and to the extent required under the laws of England and Wales.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ccc)&#9;The
statistical and market-related data included in the Registration Statement, the General Disclosure Package and the Prospectus
are based on or derived from sources that the Company believes to be reliable and accurate, and such data agree with the sources
from which they are derived. All consents of third parties required for the inclusion and use of such data in the Registration
Statement, the General Disclosure Package and the Prospectus have been obtained.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ddd)&#9;The
operations of the Company and its subsidiaries are and have been conducted at all times in compliance with applicable financial
recordkeeping and reporting requirements, including those of the U.S. Bank Secrecy Act, as amended by Title III of the Uniting
and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism Act of 2001 (USA PATRIOT
Act), and the applicable money laundering statutes of jurisdictions where the Company and its subsidiaries conduct business, the
rules&nbsp;and regulations thereunder and any related or similar rules, regulations or guidelines, issued, administered or enforced
by any governmental agency&nbsp; (collectively, the &ldquo;<B><I>Money Laundering Laws</I></B>&rdquo;), and no action, suit or
proceeding by or before any court or governmental or regulatory authority or any arbitrator involving the Company or any of its
subsidiaries with respect to the Money Laundering Laws is pending, or to the Company&rsquo;s knowledge, threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(eee)&#9;Neither
the Company nor any of its subsidiaries nor, to the Company&rsquo;s knowledge, any director, officer, agent, employee, affiliate,
or other person acting on behalf of the Company or any of its subsidiaries is (i) a person, or is owned or controlled by a person
that is, designated on the Specially Designated Nationals and Blocked Persons List or Foreign Sanctions Evaders List, which are
both maintained by the Office of Foreign Assets Control of the U.S. Department of Treasury (<B><I>&ldquo;OFAC&rdquo;</I></B>),
or any applicable prohibited party list maintained by the United Nations Security Council, the European Union, Her Majesty&rsquo;s
Treasury or other relevant sanctions authority, nor (ii) currently subject to any sanctions administered by OFAC, the United Nations
Security Council, the European Union, Her Majesty&rsquo;s Treasury or any other relevant sanctions authority (collectively, <B><I>&ldquo;Relevant
Sanctions Authorities&rdquo;</I></B>). The Company is not located, organized or resident in a country or territory that is the
subject of an embargo by the U.S. government (the &ldquo;<B><I>Embargoed Countries&rdquo;</I></B>), including Cuba, Iran, North
Korea, Sudan, Syria, and the Crimea. Unless authorized by the Relevant Sanctions Authorities, the Company will not directly or
indirectly use the proceeds of the offering, or lend, contribute or otherwise make available such proceeds to any subsidiary,
joint venture partner or other person or entity, for the purpose of financing the activities of or business with any Embargoed
Country or any person currently subject to any sanctions administered by the Relevant Sanctions Authorities, or in any manner
that will result in a violation by any person (including any person participating in the transactions, whether as an underwriter,
advisor, investor or otherwise) of sanctions administered by the Relevant Sanctions Authorities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(fff)&#9;Neither
the Company nor, to the Company&rsquo;s knowledge, any of its affiliates (within the meaning of FINRA Rule 5121(f)(1)) directly
or indirectly controls, is controlled by, or is under common control with, or is an associated person (within the meaning of Article
I, Section 1(rr) of the By-laws of FINRA) of, any of the Underwriters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ggg)&#9;The
directors of the Company have considered the compliance by the Company with the provisions of the UK Corporate Governance Code
(2016) as published by the UK Financial Reporting Council (the &ldquo;<B><I>UK Corporate Governance Code</I></B>&rdquo;), and
the Company strives, where practicable for a company of its size and nature, to comply with the standards of good practice prescribed
by the UK Corporate Governance Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(hhh)&#9;The
choice of the laws of the State of New York as the governing law of this Agreement is a valid&nbsp;choice of law&nbsp;under the
laws of England and Wales and will be recognized by courts in England and Wales except as may be limited by general principles
of equity and except where to do so would be inconsistent with or overridden by the Regulation (EC) No 593/2008 on the Law Applicable
to Contractual Obligations (Rome I). The Company has the corporate power to submit, and pursuant to Section 16 of this Agreement,
has legally, validly, effectively and irrevocably submitted, to the personal jurisdiction of each New York State and United States
federal court sitting in The City of New York, New York (each, a &ldquo;<B><I>New York Court</I></B>&rdquo;) and has validly and
irrevocably waived any objection to the laying of venue of any suit, action or proceeding brought in any such court; and the Company
has the power to designate, appoint and empower an authorized agent for service of process in any action arising out of or relating
to this Agreement, the Registration Statement, the General Disclosure Package, the Prospectus or the offering of the Offered Securities
in any New York Court and service of process effected on such authorized agent will be effective to notify the Company of any
action under this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii) Neither
the Company nor any of its subsidiaries nor any of their respective properties, assets or revenues enjoy any rights of immunity
from legal proceedings or the execution of judgement or other attachment in England and Wales, pursuant to the State Immunity
Act 1978, or the United States, pursuant to the Foreign Sovereign Immunities Act 1976, with respect to this Agreement, the Deposit
Agreement or the Offered Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(jjj)&#9;This
Agreement and the Deposit Agreement are each in proper form to be enforceable in England and Wales in accordance with its terms;
to ensure the legality, validity, enforceability or admissibility into evidence in England and Wales of this Agreement or the
Deposit Agreement it is not necessary that this Agreement or the Deposit Agreement, respectively, be filed or recorded with any
court or other authority in England and Wales (other than court filings in the ordinary course of proceedings).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(kkk)&#9;Any
final judgment for a fixed or readily calculable sum of money rendered by a New York Court having jurisdiction under its own domestic
laws and recognized by the English courts as having jurisdiction (according to English conflicts of laws principles and rules
of English private international law at the time when proceedings were initiated) to give such final judgment in respect of any
suit, action or proceeding against the Company based upon this Agreement or the Deposit Agreement and any instruments or agreements
entered into for the consummation of the transactions contemplated herein and therein would be declared enforceable against the
Company, without re-examination or review of the merits of the cause of action in respect of which the original judgment was given
or re-litigation of the matters adjudicated upon, by the courts of England and Wales; provided, however, that the Company may
have defenses open to it and enforcement may not be permitted if, among other things, (a) the judgment was obtained by fraud,
or in proceedings contrary to natural or substantial justice, or contravenes public policy in England or the Human Rights Act
1998 (or any subordinate legislation made thereunder, to the extent applicable); (b) the judgment is for a sum payable in respect
of taxes, or other charges of a like nature or is in respect of a fine or other penalty or otherwise based on a foreign law that
an English court considers to relate to a penal, revenue or other public law; (c) the judgment amounts to judgment on a matter
previously determined by an English court or conflicts with a judgment on the same matter given by a court other than a New York
Court or was obtained in breach of a jurisdiction or arbitration clause except with the agreement of the defendant or the defendant&rsquo;s
subsequent submission to the jurisdiction of the court; (d) the judgment is given in proceedings brought in breach of an agreement
for the settlement of disputes; (e) the judgment has been arrived at by doubling, trebling or otherwise multiplying a sum assessed
as compensation for the loss or damage sustained, or is a judgment that is otherwise specified in Section 5 of the Protection
of Trading Interests Act 1980, or is a judgment based on measures designated by the Secretary of State under Section 1 of that
Act; and (f) enforcement proceedings are not commenced within six (6) years of the date of such judgment. The Company is not aware
of any reason why the enforcement in England and Wales of such a New York Court judgment would be, as of the date hereof, contrary
to public policy of England and Wales or the Human Rights Act 1998 (or any subordinate legislation made thereunder, to the extent
applicable).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(lll)&#9;Except
as provided by laws or statutes generally applicable to transactions of the type described in this Agreement, neither the Company
nor any of its respective properties, assets or revenues has any right of immunity under United Kingdom, New York or United States
law, from any legal action, suit or proceeding, from the giving of any relief in any such legal action, suit or proceeding, from
set-off or counterclaim, from the jurisdiction of any law of the United Kingdom, New York or United States federal court, from
service of process, attachment upon or prior judgment, or attachment in aid of execution of judgment, or from execution of a judgment,
or other legal process or proceeding for the giving of any relief or for the enforcement of a judgment, in any such court, with
respect to its obligations, liabilities or any other matter under or arising out of or in connection with this Agreement or the
Deposit Agreement. To the extent that the Company or any of its respective properties, assets or revenues may have or may hereafter
become entitled to any such right of immunity in any such court in which proceedings may at any time be commenced, the Company
waives or will waive such right to the extent permitted by law and has consented to such relief and enforcement as provided in
Section 16 of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(mmm)&#9;There
are no debt securities or preferred stock issued, or guaranteed, by the Company that are rated by a &ldquo;nationally recognized
statistical rating organization,&rdquo; as that term is defined by the Commission for purposes of Section 3(a)(62) of the Exchange
Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
certificate signed by or on behalf of the Company and delivered to the Representative or to counsel to the Underwriters pursuant
to the terms of this Agreement shall be deemed to be a representation and warranty by the Company to each Underwriter as to the
matters covered thereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3. <FONT STYLE="font-variant: small-caps"><I>Purchase,
Sale and Delivery of Offered Securities</I></FONT>. On the basis of the representations, warranties and agreements herein contained,
but subject to the terms and conditions herein set forth, the Company agrees to issue and sell to the Underwriters, and the Underwriters
agree, severally and not jointly, to purchase from the Company the respective numbers of Firm ADSs set forth opposite the names
of the Underwriters in <U>Schedule A</U> hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purchase price to be paid by the Underwriters to the Company for the ADSs will be $[&#9679;] per ADS (the &ldquo;<B><I>ADS Purchase
Price</I></B>&rdquo;). The ADS Purchase Price are collectively hereinafter referred to as the &ldquo;<B><I>Purchase Price</I></B>.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will deliver, or cause to be delivered, the Firm ADSs to the Representative for the respective accounts of the several
Underwriters, through the facilities of The Depository Trust Company (&ldquo;<B><I>DTC</I></B>&rdquo;) and CREST, as applicable,
issued in such names and in such denominations as the Representative may direct by notice in writing to the Company given at or
prior to 9:00 A.M., New York time, on the Closing Date against payment of the ADS Purchase Price therefor by wire transfer in
federal (same day) funds to an account at a bank specified by the Company and reasonably acceptable to the Representative payable
to the order of the Company for the Firm ADSs sold by them all at the offices of Sheppard Mullin Richter &amp; Hampton LLP, 30
Rockefeller Plaza, 39<SUP>th</SUP> Floor, New York, New York 10112. Time shall be of the essence, and delivery at the time and
place specified pursuant to this Agreement is a further condition of the obligations of each Underwriter hereunder. The time and
date of the delivery and payment shall be at [&#9679;]:00 [A/P].M., New York time, on [&#9679;], 2018, in accordance with Rule
15c6-1 of the Exchange Act. The time and date of such payment and delivery are herein referred to as the &ldquo;<B><I>Closing
Date</I></B>&rdquo;. The Closing Date and the location of delivery of, and the form of payment for, the Firm ADSs may be varied
by agreement between the Company and the Representative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the purpose of covering any over-allotments in connection with the distribution and sale of the Firm ADSs as contemplated by the
Prospectus, the Underwriters may purchase all or less than all of the Optional ADSs. The purchase price per ADS to be paid for
the Optional ADSs shall be the ADS Purchase Price. The Company agrees to sell to the Underwriters the number of Optional ADSs
specified in the written notice delivered by the Representative to the Company described below and the Underwriters agree, severally
and not jointly, to purchase such Optional ADSs. Such Optional ADSs shall be purchased from the Company for the account of each
Underwriter in the same proportion as the number of Firm ADSs set forth opposite such Underwriter&rsquo;s name in <U>Schedule
A</U> bears to the total number of Firm ADSs (subject to adjustment by the Representative to eliminate fractions). The option
granted hereby may be exercised as to all or any part of the Optional ADSs at any time, and from time to time, not more than thirty
(30) days subsequent to the date of this Agreement. No Optional ADSs shall be sold and delivered unless the Firm ADSs previously
has been, or simultaneously is being, sold and delivered. The right to purchase the Optional ADSs or any portion thereof may be
surrendered and terminated at any time upon notice by the Representative to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
option granted hereby may be exercised by written notice being given to the Company by Representative setting forth the number
of Optional ADSs to be purchased by the Underwriters and the date and time for delivery of and payment for the Optional ADSs.
Each date and time for delivery of and payment for the Optional ADSs (which may be the Closing Date, but not earlier) is herein
called the &ldquo;<B><I>Option Closing Date</I></B>&rdquo; and shall in no event be earlier than two (2) business days nor later
than five (5) business days after written notice is given. The Option Closing Date and the Closing Date are herein called the
&ldquo;<B><I>Closing Dates</I></B>.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will deliver, or cause to be delivered, the Optional ADSs to the Representative for the respective accounts of the several
Underwriters through the facilities of DTC issued in such names and in such denominations as the Representative may direct by
notice in writing to the Company given at or prior to 9:00 A.M., New York time, on the Option Closing Date against payment of
the aggregate Purchase Price therefor by wire transfer in federal (same day) funds to an account at a bank specified by the Company
and reasonably acceptable to the Representative payable to the order of the Company, at the offices of Sheppard Mullin Richter
&amp; Hampton LLP, 30 Rockefeller Plaza, 39<SUP>th</SUP> Floor, New York, New York 10112. Time shall be of the essence, and delivery
at the time and place specified pursuant to this Agreement is a further condition of the obligations of each Underwriter hereunder.
The Option Closing Date and the location of delivery of, and the form of payment for, the Optional ADSs may be varied by agreement
between the Company and the Representative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
several Underwriters propose to offer the Offered Securities for sale upon the terms and conditions set forth in the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps">4. <I>Further
Agreements Of The Company. </I></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company agrees
with the several Underwriters:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) To
prepare the Rule 462(b) Registration Statement, if necessary, in a form approved by the Representative and file such Rule 462(b)
Registration Statement with the Commission by 10:00 P.M., New York time, on the date hereof, and the Company shall at the time
of filing either pay to the Commission the filing fee for the Rule 462(b) Registration Statement or give irrevocable instructions
for the payment of such fee pursuant to Rule 111(b) under the Rules and Regulations; to prepare the Prospectus in a form approved
by the Representative containing information previously omitted at the time of effectiveness of the Registration Statement in
reliance on Rule 430A of the Rules and Regulations and to file such Prospectus pursuant to Rule 424(b) of the Rules and Regulations
not later than the second (2<SUP>nd</SUP>) business day following the execution and delivery of this Agreement or, if applicable,
such earlier time as may be required by Rule 430A of the Rules and Regulations; to notify the Representative immediately of the
Company&rsquo;s intention to file or prepare any supplement or amendment to the Registration Statement, the ADS Registration Statement
or to the Prospectus and to make no amendment or supplement to the Registration Statement, the ADS Registration Statement, the
General Disclosure Package or to the Prospectus to which the Representative shall reasonably object by notice to the Company after
a reasonable period to review; to advise the Representative, promptly after it receives notice thereof, of the time when any amendment
to the Registration Statement or the ADS Registration Statement has been filed or becomes effective or any supplement to the General
Disclosure Package, or the Prospectus or any amended Prospectus or any Issuer Free Writing Prospectus or any Written Testing-the-Waters
Communication has been filed and to furnish the Underwriters with copies thereof; to file promptly all material required to be
filed by the Company with the Commission pursuant to Rules 433(d) or 163(b)(2) of the Rules and Regulations, as the case may be;
to advise the Representative, promptly after it receives notice thereof, of the issuance by the Commission of any stop order or
of any order preventing or suspending the use of any Preliminary Prospectus, any Issuer Free Writing Prospectus, the Prospectus
or any Written Testing-the-Waters Communication, of the suspension of the qualification of the Offered Securities for offering
or sale in any jurisdiction, of the initiation or threatening of any proceeding for any such purpose, or of any request by the
Commission for the amending or supplementing of the Registration Statement, the General Disclosure Package or the Prospectus or
for additional information; and, in the event of the issuance of any stop order or of any order preventing or suspending the use
of any Preliminary Prospectus, any Issuer Free Writing Prospectus or the Prospectus or suspending any such qualification, and
promptly to use its best efforts to obtain the withdrawal of such order.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) The
Company will promptly notify the Representative if the Company ceases to be an Emerging Growth Company at any time prior to the
later of (i) the completion of the distribution of the Firm ADSs within the meaning of the Securities Act and (ii) completion
of the Lock-Up Period (as defined below).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) If
at any time following the distribution of any Written Testing-the-Waters Communication there occurred or occurs an event or development
as a result of which such Written Testing-the-Waters Communication included or would include an untrue statement of a material
fact or omitted or would omit to state a material fact required to be stated therein or necessary in order to make the statements
therein, in the light of the circumstances under which they were made, not misleading, the Company will promptly notify the Representative
and will promptly amend or supplement, at its own expense, such Written Testing-the-Waters Communication to eliminate or correct
such untrue statement or omission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) The
Company represents and agrees that, unless it obtains the prior written consent of the Representative, and each Underwriter represents
and agrees that, unless it obtains the prior written consent of the Company and the Representative, it has not made and will not,
make any offer relating to the Offered Securities that would constitute a &ldquo;free writing prospectus&rdquo; as defined in
Rule 405 of the Rules and Regulations (each, a &ldquo;<B><I>Permitted Free Writing Prospectus</I></B>&rdquo;); <I>provided</I>,
<I>however</I>, that the prior written consent of the Company and the Representative hereto shall be deemed to have been given
in respect of the Issuer Free Writing Prospectuses included in <U>Schedule B</U> hereto. The Company represents that it has treated
and agrees that it will treat each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, comply with the requirements
of Rules 164 and 433 of the Rules and Regulations applicable to any Issuer Free Writing Prospectus, including the requirements
relating to timely filing with the Commission, legending and record keeping, and will not take any action that would result in
an Underwriter or the Company being required to file with the Commission pursuant to Rule 433(d) of the Rules and Regulations
a free writing prospectus prepared by or on behalf of such Underwriter that such Underwriter otherwise would not have been required
to file thereunder. The Company will satisfy the condition in Rule 433 of the Rules and Regulations to avoid a requirement to
file with the Commission any electronic road show.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) The
Company agrees, prior to each Closing Date, to deposit Ordinary Shares underlying the ADSs with the Custodian on behalf of the
Depositary in accordance with the provisions of the Deposit Agreement and otherwise to comply with the Deposit Agreement so that
ADRs evidencing the applicable Offered Securities will be issued by the Depositary against receipt of such Ordinary Shares and
delivered to the Underwriters at such Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) If
at any time when a prospectus relating to the Offered Securities is (or, but for the exception afforded by Rule 172 promulgated
under the Securities Act, would be) required by the Securities Act to be delivered in connection with sales of the Offered Securities,
any event occurs or condition exists as a result of which the Prospectus as then amended or supplemented would include any untrue
statement of a material fact, or omit to state any material fact necessary to make the statements therein, in light of the circumstances
under which they were made when the Prospectus is delivered (or in lieu thereof, the notice referred to in Rule 173(a) of the
Rules and Regulations), not misleading, or if it is necessary at any time to amend or supplement the Registration Statement, the
ADS Registration Statement or the Prospectus to comply with the Securities Act, then the Company will promptly notify the Representative
thereof and upon their request will prepare an appropriate amendment or supplement in form and substance satisfactory to the Representative
which will correct such statement or omission or effect such compliance and will use its reasonable best efforts to have any amendment
to any Registration Statement or the ADS Registration Statement declared effective as soon as possible. The Company will furnish
without charge to each Underwriter and to any dealer in securities as many copies as the Representative may from time to time
reasonably request of such amendment or supplement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g) If
the General Disclosure Package is being used to solicit offers to buy the Offered Securities at a time when the Prospectus is
not yet available to prospective purchasers and any event shall occur as a result of which, in the judgment of the Company or
in the reasonable opinion of the Underwriters, it becomes necessary to amend or supplement the General Disclosure Package in order
to make the statements therein, in the light of the circumstances then prevailing, not misleading, or to make the statements therein
not conflict with the information contained in the Registration Statement then on file and not superseded or modified, or if it
is necessary at any time to amend or supplement the General Disclosure Package to comply with any law, the Company promptly will
prepare, file with the Commission (if required) and furnish to the Underwriters and any dealers an appropriate amendment or supplement
to the General Disclosure Package.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h) If
at any time following issuance of an Issuer Free Writing Prospectus there occurred or occurs an event or development as a result
of which such Issuer Free Writing Prospectus conflicted or will conflict with the information contained in the Registration Statement,
Pricing Prospectus or Prospectus and not superseded or modified or included or would include an untrue statement of a material
fact or omitted or would omit to state a material fact required to be stated therein or necessary in order to make the statements
therein, in the light of the circumstances prevailing at the subsequent time, not misleading, the Company has promptly notified
or will promptly notify the Representative so that any use of the Issuer Free Writing Prospectus may cease until it is amended
or supplemented and has promptly amended or will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus
to eliminate or correct such conflict, untrue statement or omission. The foregoing sentence does not apply to statements in or
omissions from any Issuer Free Writing Prospectus in reliance upon, and in conformity with, written information furnished to the
Company through the Representative by or on behalf of any Underwriter specifically for inclusion therein, which information the
parties hereto agree is limited to the Underwriters&rsquo; Information (as defined in Section 17 hereof).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) To
the extent not available on the Commission&rsquo;s Electronic Data Gathering, Analysis and Retrieval system or any successor system
(&ldquo;<B><I>EDGAR</I></B>&rdquo;), upon the request of the Representative, to furnish promptly to the Representative and to
counsel for the Underwriters a signed copy of each of the Registration Statement or the ADS Registration Statement as originally
filed with the Commission, and of each amendment thereto filed with the Commission, including all consents and exhibits filed
therewith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j) To
deliver promptly to the Representative in New York such number of the following documents as the Representative shall reasonably
request: (i) conformed copies of the Registration Statement and the ADS Registration Statement as originally filed with the Commission
(in each case excluding exhibits); (ii) each Preliminary Prospectus; (iii) any Issuer Free Writing Prospectus; (the delivery of
the documents referred to in clauses (i), (ii) and (iii) of this paragraph (i) to be made not later than 10:00 A.M., New York
time, on the business day following the execution and delivery of this Agreement); (iv) the Prospectus; (v) conformed copies of
any amendment to the Registration Statement or the ADS Registration Statement (in each case excluding exhibits); and (vi) any
amendment or supplement to the General Disclosure Package or the Prospectus (the delivery of the documents referred to in clauses
(iv), (v) and (vi) of this paragraph (j) to be made not later than 10:00 A.M., New York time, on the business day following the
date of such amendment or supplement).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k) To
make generally available to its shareholders as soon as practicable, but in any event not later than sixteen (16) months after
the effective date of the Registration Statement (as defined in Rule 158(c) of the Rules and Regulations), an earnings statement
of the Company and its subsidiaries (which need not be audited) complying with Section 11(a) of the Securities Act (including,
at the option of the Company, Rule 158); and to furnish to its shareholders as soon as practicable after the end of each fiscal
year an annual report (including a balance sheet and statements of income, shareholders&rsquo; equity and cash flows of the Company
certified by independent public accountants) and as soon as possible after the second (2<SUP>nd</SUP>) fiscal quarter of each
fiscal year (beginning with the first (1<SUP>st</SUP>) second (2<SUP>nd</SUP>) fiscal quarter after the effective date of such
Registration Statement), consolidated summary financial information of the Company for the first (1<SUP>st</SUP>) half of the
fiscal year in reasonable detail.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l) To
take promptly from time to time such actions as the Representative may reasonably request to qualify the Offered Securities for
offering and sale under the securities or Blue Sky laws of such U.S. or non-U.S. jurisdictions as the Representative may designate
and to continue such qualifications in effect, and to comply with such laws, for so long as required to permit the offer and sale
of the Offered Securities in such jurisdictions; <I>provided</I>, <I>however</I>, that the Company shall not be obligated to (i)
qualify as a foreign corporation in any jurisdiction in which it is not so qualified, (ii) file a general consent to service of
process in any jurisdiction or (iii) subject itself to taxation in any such jurisdiction if it is not otherwise so subject.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m) Upon
request, during the period of five (5) years from the date hereof, to deliver to each of the Underwriters, (i) as soon as they
are available, copies of all reports or other communications (financial or other) furnished to shareholders of the Company, and
(ii) as soon as they are available, copies of any reports and financial statements furnished or filed with the Commission or any
national securities exchange on which the Offered Securities are listed. However, so long as the Company is subject to the reporting
requirements of either Section 13 or Section 15(d) of the Exchange Act and is timely filing reports with the Commission on its
EDGAR system, it is not required to furnish such reports or statements to the Underwriters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n) During
the period commencing on and including the date hereof and ending on and including the one hundred eightieth (180<SUP>th</SUP>)
day following the date of this Agreement (as the same may be extended as described below, the &ldquo;<B><I>Lock-Up Period</I></B>&rdquo;),
the Company will not, without the prior written consent of the Representative (which consent may be withheld at the sole discretion
of the Representative), directly or indirectly offer, sell (including, without limitation, any short sale), assign, transfer,
pledge, contract to sell, establish an open &ldquo;put equivalent position&rdquo; within the meaning of Rule 16a-1(h) under the
Exchange Act, or otherwise dispose of, or announce the offering of, or file any registration statement under the Securities Act
in respect of, any ADSs, Ordinary Shares, options, rights or warrants to acquire ADSs, securities exchangeable or exercisable
for or convertible into ADSs or Ordinary Shares (other than as contemplated by this Agreement with respect to the Offered Securities)
or publicly announce any intention to do any of the foregoing; <I>provided</I>, <I>however</I>, that the Company may: (i) issue
and sell the Offered Securities pursuant to this Agreement; (ii) issue Ordinary Shares, ADSs, options to purchase Ordinary Shares
or ADSs, or other awards pursuant to any director or employee incentive plan, stock ownership plan or dividend reinvestment plan
of the Company in effect on the date hereof and described in the General Disclosure Package and issue Ordinary Shares or ADSs
upon the exercise, exchange, vesting, or conversion of options or other awards issued in accordance with this clause (ii); (iii)
issue Ordinary Shares pursuant to the conversion of securities or the exercise of warrants, which securities or warrants are outstanding
on the date hereof and described in the General Disclosure Package; (iv) adopt a new equity incentive plan, file a registration
statement on Form S-8 under the Securities Act to register the offer and sale of securities on such new equity incentive plan
or on equity incentive plans described in the General Disclosure Package, and issue securities pursuant to such equity incentive
plans (including, without limitation, the issuance of Ordinary Shares upon the exercise of options or other securities issued
pursuant to such equity incentive plans); <I>provided</I> that (1) such equity incentive plans satisfy the transaction requirements
of General Instruction A.1 of Form S-8 under the Securities Act and (2) this clause (iv) shall not be available unless each recipient
of Ordinary Shares, or securities exchangeable or exercisable for or convertible into Ordinary Shares, pursuant to such equity
incentive plans shall be contractually prohibited from selling, offering, disposing of or otherwise transferring any such shares
or securities during the remainder of the Lock-Up Period; and (v) issue ADSs or Ordinary Shares in connection with any joint venture,
commercial or collaborative relationship or the acquisition or license by the Company of the securities, business, property or
other assets of another person or entity or pursuant to any employee benefit plan as assumed by the Company in connection with
any such acquisition; <I>provided</I> that ADSs and Ordinary Shares issued under this clause (v) shall not in the aggregate exceed
ten percent (10%) of the Company&rsquo;s outstanding share capital immediately following the consummation of the offering of the
Offered Securities contemplated by this Agreement. In addition, the Company will cause each person and entity listed in <U>Schedule
D</U> to furnish to the Representative, prior to the Closing Date, an agreement in the form of <U>Exhibit I</U> hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o) If
the Representative, in its sole discretion, agrees to release or waive the restrictions set forth in a lock-up letter described
in Section 4(n) hereof for an officer or director of the Company, the Representative will provide the Company with notice of the
impending release or waiver at least three (3) business days before the effective date of the release or waiver, the Company agrees
to announce the impending release or waiver by a press release substantially in the form of <U>Exhibit II</U> hereto through a
major news service at least two (2) business days before the effective date of the release or waiver.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p) To
supply the Representative with copies of all written correspondence and to advise the Representative of all oral correspondence
to and from, and all documents issued to and by, the Commission in connection with the registration of the Offered Securities
under the Securities Act or any of the Registration Statement, the ADS Registration Statement, any Preliminary Prospectus or the
Prospectus, or any amendment or supplement thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q) Prior
to the latest of the Closing Dates, not to issue any press release or other communication directly or indirectly or hold any press
conference with respect to the Company, its condition, financial or otherwise, or earnings, business affairs or business prospects
(except for routine marketing communications in the ordinary course of business and consistent with the past practices of the
Company and of which the Representative is notified), without the prior written consent of the Representative, unless in the judgment
of the Company and its counsel, and after notification to the Representative, such press release or communication is required
by law or regulation, including any applicable stock exchange rules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r) Until
the Representative shall have notified the Company of the completion of the resale of the Offered Securities, that the Company
will not, and will use its reasonable best efforts to cause its affiliated purchasers (as defined in Regulation M under the Exchange
Act Rules) not to, either alone or with one or more other persons, bid for or purchase, for any account in which it or any of
its affiliated purchasers has a beneficial interest, any Offered Securities, or attempt to induce any person to purchase any Offered
Securities; and not to, and to use its reasonable best efforts to cause its affiliated purchasers not to, make bids or purchases
for the purpose of creating actual, or apparent, active trading in or of raising the price of the Offered Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s) Not
to take any action prior to the latest of the Closing Dates which would require the Prospectus to be amended or supplemented pursuant
to Section 4(f).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t) To
at all times comply in all material respects with all applicable provisions of the Sarbanes-Oxley Act in effect from time to time
and to file with the Commission such information on Form 20-F as may be required by Rule 463 of the Rules and Regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u) To
maintain, at its expense, a registrar and transfer agent and a depositary for the Offered Securities, as applicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v) To
apply the net proceeds from the issuance and sale of the Offered Securities as set forth in the Registration Statement, the General
Disclosure Package and the Prospectus under the heading &ldquo;Use of Proceeds,&rdquo; and except as disclosed in the General
Disclosure Package, the Company does not intend to use any of the proceeds from the sale of the Offered Securities hereunder to
repay any outstanding debt owed to any affiliate of any Underwriter. The Company shall manage its affairs and investments in such
a manner as not to be or become an &ldquo;investment company&rdquo; within the meaning of the Investment Company Act and the rules
and regulations thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w) To
use its reasonable best efforts to list, subject to notice of issuance, the Offered Securities on the Exchange.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x) To
use its reasonable best efforts to do and perform all things required to be done or performed under this Agreement by the Company
prior to each Closing Date and to satisfy all conditions precedent to the delivery of the Firm ADSs and the Optional ADSs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(y) Upon
request of any Underwriter, to furnish, or cause to be furnished, to such Underwriter an electronic version of the Company&rsquo;s
trademarks, service marks and corporate logo for use on the website, if any, operated by such Underwriter for the purpose of facilitating
the on-line offering of the Offered Securities (the &ldquo;<B><I>License</I></B>&rdquo;); <I>provided</I>, <I>however</I>, that
the License shall be used solely for the purpose described above, is granted without any fee and may not be assigned or transferred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(z) Provided
that the Firm ADSs are sold in accordance with the terms of this Agreement, the Representative shall have an irrevocable right
of first refusal (the &ldquo;Right of First Refusal&rdquo;), for a period of seven (7) months after the date the Offering is completed,
to act as investment banker, book-runner, financial advisor, and/or lead placement agent, at the Representative&rsquo;s discretion,
for each and every future U.S. public and private equity and debt offering, including all equity linked financings (each, a &ldquo;Subject
Transaction&rdquo;), during such seven (7) month period, of the Company, or any successor to or subsidiary of the Company, on
terms and conditions customary to the Representative for such Subject Transactions. For the avoidance of any doubt, the Company
shall not retain, engage or solicit any additional investment banker, book-runner, financial advisor, underwriter and/or placement
agent in a Subject Transaction without the express written consent of the Representative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company shall notify the Representative of its intention to pursue a Subject Transaction, including the material terms thereof,
by providing written notice thereof by registered mail, overnight courier service or other electronic transmission addressed to
the Representative.&nbsp; If the Representative fails to exercise its Right of First Refusal with respect to any Subject Transaction
within thirty (30) Business Days after the mailing of such written notice, then the Representative shall have no further claim
or right with respect to the Subject Transaction. The Representative may elect, in its sole and absolute discretion, not to exercise
its Right of First Refusal with respect to any Subject Transaction; provided that any such election by the Representative shall
not adversely affect the Representative&rsquo;s Right of First Refusal with respect to any other Subject Transaction during the
seven (7) month period agreed to above.&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5. <FONT STYLE="font-variant: small-caps"><I>Payment
of Expenses</I></FONT>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) The
Company agrees to pay, or reimburse if paid by any Underwriter, whether or not the transactions contemplated hereby are consummated
or this Agreement is terminated: (a) the costs incident to the authorization, issuance, sale, preparation and delivery of the
Offered Securities and any taxes payable in that connection (other than any Transfer Taxes and VAT (as defined below), which for
the avoidance of doubt, are provided for under sections 5(b) and 5(c), and furthermore for the avoidance of doubt, not including
any taxes computed on or by reference to net income, profits or gains of the Underwriters or any entity connected with the Underwriters
for tax purposes); (b) the costs incident to the registration of the Offered Securities under the Securities Act and the Exchange
Act; (c) the costs incident to the preparation, printing and distribution of the Registration Statement, the ADS Registration
Statement, any Preliminary Prospectus, any Issuer Free Writing Prospectus, the General Disclosure Package, the Prospectus, any
amendments, supplements and exhibits thereto and the costs of printing, reproducing and distributing this Agreement, the Deposit
Agreement and any closing documents by mail, telex or other means of communications; (d) the fees and expenses (including related
fees and expenses of counsel for the Underwriters) incurred in connection with securing any required review by FINRA of the terms
of the sale of the Offered Securities and any filings made with FINRA relating to the offering of the Offered Securities, plus
VAT and disbursements; (e) any applicable listing or other fees for the ADSs; (f) the fees and expenses (including related fees
and expenses of counsel to the Underwriters) of qualifying the Offered Securities under the securities laws of the several jurisdictions
as provided in Section 4(l) and of preparing, printing and distributing wrappers, Blue Sky memoranda and legal investment surveys;
(g) the cost of preparing and printing stock certificates; (h) all fees and expenses of the registrar and transfer agent, agent
for service of process and/or depositary of the Offered Securities; (i) the costs and expenses (including, without limitation,
any damages or other amounts payable in connection with the legal or contractual liability) associated with the reforming of any
contracts for sale of the Offered Securities made by the Underwriters caused by a breach of the representation contained in Section
2(b); (j) the costs and expenses of the Company relating to investor presentations on any &ldquo;road show&rdquo; undertaken in
connection with the marketing of the offering of the Offered Securities, including, without limitation, expenses associated with
the preparation or dissemination of any electronic road show, expenses associated with the production of road show slides and
graphics, fees and expenses of any consultants engaged in connection with the road show presentations with the prior approval
of the Company, travel and lodging expenses of the officers of the Company and such consultants, and 100% of the cost of the Representative
in the event that the Offering does not price; (k) all fees and expenses of the Representative, including, without limitation,
its legal fees and expenses, all such fees not to exceed $125,000 in the aggregate; (l) all other costs and expenses of the Company
incident to the offering of the Offered Securities or the performance of the obligations of the Company under this Agreement and
the Deposit Agreement (including, without limitation, the fees and expenses of the Company&rsquo;s counsel and the Company&rsquo;s
independent accountants); <I>provided</I>, <I>however</I>, that, except to the extent otherwise provided in this Section 5 and
in Sections 9 and 10, the Underwriters shall pay their own costs and expenses, including the fees and expenses of their counsel
not contemplated herein, any Transfer Taxes on the resale of any Offered Securities by them and the expenses of advertising any
offering of the Offered Securities made by the Underwriters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the Company agrees to pay the Representative (a) a retainer of fifty thousand dollars ($50,000) of which twenty five
thousand dollars ($25,000) was payable upon execution of the engagement letter between the Company and the Representative and
the balance, or twenty five thousand dollars ($25,000) is payable upon the completion of the Offering; (b) a cash fee equal to
seven percent (7%) of the value of the aggregate amount raised in the Offering payable at the Closing Date; and (c) a non-accountable
allowance of one percent (1%) of the aggregate amount raised in the Offering payable at the Closing Date. The Company also agrees
to issue the Representative and/or its designees warrants in an amount equal to two percent (2%) of the aggregate number of ADSs
issued in the Offering which warrants shall be exercisable for a period of five (5) years at an exercise price equal to one hundred
twenty percent (120%) of the offering price of the ADSs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) The
Company will indemnify and hold harmless the Underwriters against any Transfer Taxes, including any interest and penalties, which
are required to be paid or are incurred in connection with (i) the issuance and delivery of the Offered Securities by the Company
or the Depositary (as applicable) in the manner contemplated by this Agreement, the Deposit Agreement and the Prospectus, (ii)
the initial sale and delivery by the Underwriters of the Firm ADSs and the Optional ADSs to purchasers thereof in the manner contemplated
by this Agreement, the Deposit Agreement and the Prospectus; and (iii) the execution and delivery by the Company or the Underwriters
of this Agreement and the Deposit Agreement . All payments to be made by the Company under this Agreement shall be made without
withholding or deduction for or on account of any present or future taxes, levies, imposts, duties, fees, assessments or governmental
charges whatsoever, imposed or levied by or on behalf of the United Kingdom or any political subdivision or taxing authority thereof
or therein unless the Company is or becomes required by law to deduct or withhold such taxes, levies, imposts, fees, duties, assessments
or other governmental charges. In that event, and except for any net income, capital gains or franchise taxes imposed on the Underwriters
by England and Wales or other applicable jurisdiction or by any political subdivision or taxing authority thereof or therein as
a result of any present or former connection (other than any connection resulting from the transactions contemplated by this Agreement)
between the Underwriters and such jurisdiction, the Company shall pay such additional amounts as may be necessary in order to
ensure that the net amounts received by each Underwriter after such withholding or deduction shall equal the amounts that would
have been received if no withholding or deduction had been made.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) If
the performance by the Underwriters of any of their obligations under this Agreement shall represent for VAT purposes under any
applicable law the making by the Underwriters of any supply of goods or services to the Company (to the extent applicable), the
Company shall pay to the Underwriters, in addition to the amounts otherwise payable by the Company pursuant to this Agreement,
an amount equal to the VAT chargeable on any such supply of goods and services provided that the Underwriters have issued the
Company with an appropriate VAT invoice in respect of the supply to which the payment relates. Where a sum (a &ldquo;<B><I>Relevant
Sum</I></B>&rdquo;) is paid or reimbursed to the Underwriters pursuant to this Agreement in respect of any cost, expense or other
amount and that cost, expense or other amount includes an amount in respect of irrecoverable VAT (the &ldquo;<B><I>VAT Element</I></B>&rdquo;)
which has been certified as such by the Underwriters (acting reasonably), then the Company, to the extent applicable, shall, in
addition, pay an amount equal to the VAT Element to the Underwriters. For the purposes of this Agreement, &ldquo;<B><I>VAT</I></B>&rdquo;
means value added tax as provided for in the Value Added Tax Act 1994 (&ldquo;<B><I>VATA</I></B>&rdquo;) and subordinate legislation
made under VATA as amended, modified or re-enacted (whether before or after the date of this Agreement) and any similar sales,
consumption, use or turnover tax whether within the United Kingdom or elsewhere in the world.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6. <FONT STYLE="font-variant: small-caps"><I>Conditions
of Underwriters&rsquo; Obligations.</I></FONT> The respective obligations of the several Underwriters hereunder are subject to
the accuracy, when made and as of the Applicable Time and on each Closing Date, of the representations and warranties of the Company
contained herein, to the accuracy of the statements of the Company made in any certificates pursuant to the provisions hereof,
to the performance by the Company of its obligations hereunder, and to each of the following additional terms and conditions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) The
Registration Statement has become effective under the Securities Act, and no stop order suspending the effectiveness of the Registration
Statement or any part thereof, preventing or suspending the use of any Preliminary Prospectus, the Prospectus or any Permitted
Free Writing Prospectus or any part thereof shall have been issued and no proceedings for that purpose or pursuant to Section
8A under the Securities Act shall have been initiated or threatened by the Commission, and all requests for additional information
on the part of the Commission (to be included in the Registration Statement or the Prospectus or otherwise) shall have been complied
with to the reasonable satisfaction of the Representative; the Rule 462(b) Registration Statement, if any, each Issuer Free Writing
Prospectus and the Prospectus shall have been filed with, the Commission within the applicable time period prescribed for such
filing by, and in compliance with, the Rules and Regulations and in accordance with Section 4(a) of this Agreement, and the Rule
462(b) Registration Statement, if any, shall have become effective immediately upon its filing with the Commission and FINRA shall
have raised no unresolved objection to the fairness and reasonableness of the terms of this Agreement or the transactions contemplated
hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) The
Underwriters shall have received on the Closing Date a certified copy of (i) the minutes or resolutions of the Board (or a duly
constituted committee thereof) resolving, inter alia, to approve the execution by the Company of this Agreement, the Deposit Agreement,
the Registration Statement, the ADS Registration Statement, the General Disclosure Package, each Issuer Free Writing Prospectus
and the Prospectus and the listing of the ADSs on the Exchange, and (ii) the minutes of a general meeting of the Company at which
resolutions were passed to, <I>inter alia</I>, give the Board authority to allot the Ordinary Shares represented by ADSs and the
Offered Securities in the form of Ordinary Shares and to disapply statutory pre-emption rights in respect of such allotment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) None
of the Underwriters shall have discovered and disclosed to the Company on or prior to such Closing Date that the Registration
Statement or any amendment or supplement thereto contains an untrue statement of a fact which, in the opinion of counsel for the
Underwriters, is material or omits to state any fact which, in the opinion of such counsel, is material and is required to be
stated therein or is necessary to make the statements therein not misleading, or that the General Disclosure Package, any Issuer
Free Writing Prospectus or the Prospectus or any amendment or supplement thereto contains an untrue statement of fact which, in
the opinion of such counsel, is material or omits to state any fact which, in the opinion of such counsel, is material and is
necessary in order to make the statements, in the light of the circumstances in which they were made, not misleading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) All
corporate proceedings and other legal matters incident to the authorization, form and validity of each of this Agreement, the
Deposit Agreement, the Offered Securities, the Registration Statement, the ADS Registration Statement, the General Disclosure
Package, each Issuer Free Writing Prospectus and the Prospectus and all other legal matters relating to this Agreement and the
transactions contemplated hereby shall be reasonably satisfactory in all material respects to counsel to the Underwriters, and
the Company shall have furnished to such counsel all documents and information that they may reasonably request to enable them
to pass upon such matters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) <FONT STYLE="background-color: white">Cooley
LLP, U.S. counsel to the Company,</FONT> shall have furnished to the Representative such counsel&rsquo;s written opinion and negative
assurance letter, addressed to the Underwriters and dated as of such Closing Date, in form and substance reasonably satisfactory
to the Representative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) <FONT STYLE="background-color: white">Cooley
(UK) LLP, UK counsel to the Company,</FONT> shall have furnished to the Representative such counsel&rsquo;s written opinion, addressed
to the Underwriters and dated as of such Closing Date, in form and substance reasonably satisfactory to the Representative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g) <FONT STYLE="background-color: white">Intentionally
omitted</FONT>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h) <FONT STYLE="background-color: white">Intentionally
omitted</FONT>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) <FONT STYLE="background-color: white">Ziegler,
Ziegler &amp; Associates, LLP, counsel for the Depositary,</FONT> shall have furnished to the Representative such counsel&rsquo;s
written opinion, addressed to the Underwriters and dated as of such Closing Date, in form and substance reasonably satisfactory
to the Representative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j) Intentionally
omitted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k) Intentionally
omitted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l) At
the time of the execution of this Agreement, the Representative shall have received from Mazars LLP, a letter, addressed to the
Underwriters, executed and dated such date, in form and substance satisfactory to the Representative (i) confirming that they
are an independent registered accounting firm with respect to the Company and its subsidiaries within the meaning of the Securities
Act and the Rules and Regulations and PCAOB and (ii) stating the conclusions and findings of such firm, of the type ordinarily
included in accountants&rsquo; &ldquo;comfort letters&rdquo; to underwriters, with respect to the financial statements and certain
financial information contained in the Registration Statements, the General Disclosure Package and the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m) On
the effective date of any post-effective amendment to the Registration Statement and on such Closing Date, the Representative
shall have received a letter (the &ldquo;<B><I>bring-down letter</I></B>&rdquo;) from Mazars LLP addressed to the Underwriters
and dated such Closing Date confirming, as of the date of the bring-down letter (or, with respect to matters involving changes
or developments since the respective dates as of which specified financial information is given in the General Disclosure Package
and the Prospectus, as the case may be, as of a date not more than three (3) business days prior to the date of the bring-down
letter), the conclusions and findings of such firm, of the type ordinarily included in accountants&rsquo; &ldquo;comfort letters&rdquo;
to underwriters, with respect to the financial information and other matters covered by its letter delivered to the Representative
concurrently with the execution of this Agreement pursuant to paragraph (l) of this Section 6.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n) The
Company shall have furnished to the Representative a certificate, dated as of such Closing Date, of its Chief Executive Officer
and its Chief Financial Officer stating in their respective capacities as officers of the Company on behalf of the Company and
not in their individual capacities that (i) no stop order suspending the effectiveness of the Registration Statement (including,
for avoidance of doubt, any Rule 462(b) Registration Statement), the ADS Registration Statement or any post-effective amendment
thereto, shall be in effect and no proceedings for such purpose shall have been instituted or, to their knowledge, threatened
by the Commission, (ii) for the period from and including the date of this Agreement through and including such Closing Date,
there has not occurred a Material Adverse Effect, (iii) to their knowledge, after reasonable investigation, as of such Closing
Date, the representations and warranties of the Company in this Agreement are true and correct and the Company has complied with
all agreements and satisfied all conditions on its part to be performed or satisfied hereunder at or prior to such Closing Date,
and (iii) there has not been, subsequent to the date of the most recent audited financial statements included in the General Disclosure
Package, any material adverse change in the financial position or results of operations of the Company, or any change or development
that, individually or in the aggregate, would reasonably be expected to involve a material adverse change in the financial position
or results of operations of the Company, except as set forth in the General Disclosure Package and the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o) Since
the date of the latest audited financial statements included in the General Disclosure Package, (i) neither the Company nor any
of its subsidiaries shall have sustained any loss or interference with its business from fire, explosion, flood or other calamity,
whether or not covered by insurance, or from any labor dispute or court or governmental action, order or decree, otherwise than
as set forth in the General Disclosure Package, and (ii) there shall not have been any change in the capital stock (other than
the issuance of Ordinary Shares or other securities of the Company upon exercise, exchange, vesting, or conversion of awards granted
pursuant to, and the grant of awards under, equity incentive plans described in the Registration Statement, the General Disclosure
Package and the Prospectus, or the issuance of Ordinary Shares pursuant to the terms of the warrants, each as described in the
Registration Statement, the General Disclosure Package and the Prospectus) or long-term debt of the Company or any of its subsidiaries,
or any change, or any development involving a prospective change, in or affecting the business, properties, assets, general affairs,
management, financial position, shareholders&rsquo; equity or results of operations of the Company and its subsidiaries, taken
as a whole, otherwise than as set forth in the General Disclosure Package or the Prospectus, the effect of which, in any such
case described in clause (i) or (ii) of this paragraph 6(l), is, in the judgment of the Representative, so material and adverse
as to make it impracticable or inadvisable to proceed with the sale or delivery of the Offered Securities on the terms and in
the manner contemplated in the General Disclosure Package.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p) No
action shall have been taken and no law, statute, rule, regulation or order shall have been enacted, adopted or issued by any
governmental or regulatory authority that would prevent the issuance or sale of the Offered Securities or materially and adversely
affect or potentially materially and adversely affect the business or operations of the Company; and no injunction, restraining
order or order of any other nature by any foreign, federal or state court of competent jurisdiction shall have been issued which
would prevent the issuance or sale of the Offered Securities or materially and adversely affect or potentially materially and
adversely affect the business or operations of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q) Subsequent
to the execution and delivery of this Agreement there shall not have occurred any of the following: (i) trading in any of the
Company&rsquo;s securities shall have been suspended or materially limited by the Commission, the Exchange, or trading in securities
generally on the New York Stock Exchange, Nasdaq Global Select Market, Nasdaq Global Market, Nasdaq Capital Market, the NYSE MKT
LLC or in the over-the-counter market, or trading in any securities of the Company on any exchange or in the over-the-counter
market, shall have been suspended or materially limited, or minimum or maximum prices or maximum range for prices shall have been
established on any such exchange or such market by the Commission, by such exchange or market or by any other regulatory body
or governmental authority having jurisdiction, (ii) a banking moratorium shall have been declared by federal or state authorities
in the United States or authorities in England and Wales or a material disruption has occurred in commercial banking or securities
settlement or clearance services in the United States or England and Wales, (iii) the United States or England and Wales shall
have become engaged in hostilities, or the subject of a major act of terrorism, or there shall have been an outbreak of or escalation
in hostilities involving the United States or England and Wales, or there shall have been a declaration of a national emergency
or war by the United States or England and Wales or (iv) there shall have occurred such a material adverse change in general economic,
political or financial conditions (or the effect of international conditions on the financial markets in the United States or
England and Wales shall be such) as to make it, in the judgment of the Representative, impracticable or inadvisable to proceed
with the sale or delivery of the Offered Securities on the terms and in the manner contemplated in the General Disclosure Package
and the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r) The
Exchange shall have approved the ADSs for listing therein, subject only to official notice of issuance and evidence of satisfactory
distribution; the ADSs shall have been determined to be eligible for clearance and settlement through the facilities of the DTC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s) The
Company shall have applied to the London Stock Exchange for the Ordinary Shares represented by the ADSs to be admitted to trading
on AIM at 8:00 a.m. (UK time) on the business day immediately following the Closing Date or Option Closing Date, as applicable,
which application has not been rejected, and such Ordinary Shares have been allotted conditional only on receipt by the Company
of funds for the Ordinary Shares represented by the ADSs and admission to AIM.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 34; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t) The
Representative shall have received on such Closing Date satisfactory evidence of the good standing of the Company and its subsidiaries
in their respective jurisdictions of organization and their good standing as foreign corporations in such other jurisdictions
as the Representative may reasonably request, in each case in writing or any standard form of telecommunication from the appropriate
governmental authorities of such jurisdictions, dated no more than one (1) business day prior to such Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u) The
Representative shall have received the written agreements, substantially in the form of <U>Exhibit&nbsp;I</U> hereto, of the officers,
directors, and all shareholders of the Company listed in <U>Schedule D</U> to this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v) The
Company shall have furnished to the Representative a Secretary&rsquo;s Certificate of the Company, in form and substance reasonably
satisfactory to counsel to the Underwriters and customary for the type of offering contemplated by this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w) The
Company shall have furnished to the Representative a certificate, dated such Closing Date, of its Chief Financial Officer, in
form and substance reasonably satisfactory to the Representative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x) The
Custodian shall have furnished to the Representative a certificate satisfactory to the Representative of one of its authorized
officers with respect to the deposit with it of the Ordinary Shares represented by the Offered Securities in the form of ADSs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(y) The
Depositary shall have furnished or caused to be furnished to the Representative a certificate satisfactory to the Representative
of one of its authorized officers with respect to the issuance of the Offered Securities in the form of ADSs, the execution, issuance,
countersignature and delivery of the ADRs evidencing the Offered Securities in the form of ADSs pursuant to the Deposit Agreement,
and such other customary matters related thereto as the Representative may reasonably request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(z) On
or prior to such Closing Date, the Company shall have furnished to the Representative such further certificates and documents
as the Representative may reasonably request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
opinions, letters, evidence and certificates mentioned above or elsewhere in this Agreement shall be deemed to be in compliance
with the provisions hereof only if they are in form and substance reasonably satisfactory to counsel for the Underwriters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 35; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps">7. <I>Indemnification
and Contribution.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) The
Company shall indemnify and hold harmless each Underwriter and its affiliates, directors, officers, managers, members, employees,
representatives and agents and each person, if any, who controls any Underwriter within the meaning of Section 15 of the Securities
Act or Section 20 of the Exchange Act (collectively the &ldquo;<B><I>Underwriter Indemnified Parties</I></B>,&rdquo; and each,
an &ldquo;<B><I>Underwriter Indemnified Party</I></B>&rdquo;) against any loss, claim, damage, expense or liability whatsoever
(or any action, investigation or proceeding in respect thereof), joint or several, to which such Underwriter Indemnified Party
may become subject, under the Securities Act or otherwise, insofar as such loss, claim, damage, expense, liability, action, investigation
or proceeding arises out of or is based upon (i) any untrue statement or alleged untrue statement of a material fact contained
in any Written Testing-the-Waters Communication, any Preliminary Prospectus, any Issuer Free Writing Prospectus, the Registration
Statement, the ADS Registration Statement, the Prospectus or in any amendment or supplement thereto or in any materials or information
provided to investors by, or with the approval of, the Company in connection with the marketing of the offering of the Offered
Securities, including any road show or investor presentations made to investors by the Company (whether in person or electronically)
(&ldquo;<B><I>Marketing Materials</I></B>&rdquo;) or (ii) the omission or alleged omission to state in any Written Testing-the-Waters
Communication, any Preliminary Prospectus, any Issuer Free Writing Prospectus, the Registration Statement, the ADS Registration
Statement, the Prospectus or in any amendment or supplement thereto or in any Marketing Materials, a material fact required to
be stated therein or necessary to make the statements therein not misleading, and shall reimburse each Underwriter Indemnified
Party promptly upon demand for any legal fees or other expenses reasonably incurred by that Underwriter Indemnified Party in connection
with investigating, or preparing to defend, or defending against, or appearing as a third party witness in respect of, or otherwise
incurred in connection with, any such loss, claim, damage, expense, liability, action, investigation or proceeding, as such fees
and expenses are incurred; <I>provided</I>, <I>however</I>, that the Company shall not be liable in any such case to the extent
that any such loss, claim, damage, expense or liability arises out of or is based upon an untrue statement or alleged untrue statement
in, or omission or alleged omission from any Written Testing-the-Waters Communication, Preliminary Prospectus, the Registration
Statement, the ADS Registration Statement, the Prospectus or any such amendment or supplement thereto, any Issuer Free Writing
Prospectus or any Marketing Materials made in reliance upon and in conformity with written information furnished to the Company
through the Representative by or on behalf of any Underwriter specifically for use therein, which information the parties hereto
agree is limited to the Underwriter&rsquo;s Information. Each indemnity agreement in this Section 7(a) is not exclusive and is
in addition to each other indemnity agreement in this Section 7(a) and each other liability which the Company might have under
this Agreement or otherwise, and shall not limit any rights or remedies which may otherwise be available under this Agreement,
at law or in equity to any Underwriter Indemnified Party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) Each
Underwriter, severally and not jointly, shall indemnify and hold harmless the Company and its directors, its officers who signed
the Registration Statement or the ADS Registration Statement and each person, if any, who controls the Company within the meaning
of Section 15 of the Securities Act or Section 20 of the Exchange Act (collectively, the &ldquo;<B><I>Company Indemnified Parties</I></B>,&rdquo;
and each, a &ldquo;<B><I>Company Indemnified Party</I></B>&rdquo;) against any loss, claim, damage, expense or liability whatsoever
(or any action, investigation or proceeding in respect thereof), joint or several, to which such Company Indemnified Party may
become subject, under the Securities Act or otherwise, insofar as such loss, claim, damage, expense, liability, action, investigation
or proceeding arises out of or is based upon (i) any untrue statement or alleged untrue statement of a material fact contained
in any Written Testing-the-Waters Communication, any Preliminary Prospectus, any Issuer Free Writing Prospectus, the Registration
Statement, the ADS Registration Statement, the Prospectus or in any amendment or supplement thereto or in any Marketing Materials,
or (ii) the omission or alleged omission to state in any Written Testing-the-Waters Communication, any Preliminary Prospectus,
any Issuer Free Writing Prospectus, the Registration Statement, the ADS Registration Statement, the Prospectus or in any amendment
or supplement thereto or in any Marketing Materials, a material fact required to be stated therein or necessary to make the statements
therein not misleading, but in each case only to the extent that the untrue statement or alleged untrue statement or omission
or alleged omission was made in reliance upon and in conformity with written information furnished to the Company through the
Representative by or on behalf of that Underwriter specifically for use therein, which information the parties hereto agree is
limited to the Underwriters&rsquo; Information (as defined in Section 17 hereof), and shall reimburse any Company Indemnified
Party promptly upon demand for any legal fees or other expenses reasonably incurred by such Company Indemnified Party in connection
with investigating, or preparing to defend, or defending against, or appearing as a third-party witness in respect of, or otherwise
incurred in connection with any such loss, claim, damage, expense, liability, action, investigation or proceeding, as such fees
and expenses are incurred. Each indemnity agreement in this Section 7(b) is not exclusive and is in addition to each other indemnity
agreement in this Section 7(b) and each other liability which the Underwriters or any single Underwriter might have under this
Agreement or otherwise, and shall not limit any rights or remedies which may otherwise be available under this Agreement, at law
or in equity to any Company Indemnified Party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 36; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) Promptly
after receipt by an indemnified party under this Section 7 of notice of the commencement of any action, the indemnified party
shall, if a claim in respect thereof is to be made against an indemnifying party under this Section 7, notify such indemnifying
party in writing of the commencement of that action; <I>provided</I>, <I>however</I>, that the failure to notify the indemnifying
party shall not relieve it from any liability which it may have under this Section 7 except to the extent it has been materially
prejudiced by such failure; <I>provided</I>, <I>further</I>, that the failure to notify an indemnifying party shall not relieve
it from any liability which it may have to an indemnified party otherwise than under this Section 7. If any such action shall
be brought against an indemnified party, and it shall notify the indemnifying party thereof, the indemnifying party shall be entitled
to participate therein and, to the extent that it wishes, jointly with any other similarly notified indemnifying party, to assume
the defense of such action with counsel reasonably satisfactory to the indemnified party (which counsel shall not, except with
the written consent of the indemnified party, be counsel to the indemnifying party). After notice from the indemnifying party
to the indemnified party of its election to assume the defense of such action, except as provided herein, the indemnifying party
shall not be liable to the indemnified party under Section 7 for any legal or other expenses subsequently incurred by the indemnified
party in connection with the defense of such action other than reasonable costs of investigation; <I>provided</I>, <I>however</I>,
that any indemnified party shall have the right to employ separate counsel in any such action and to participate in the defense
of such action but the fees and expenses of such counsel (other than reasonable costs of investigation) shall be at the expense
of such indemnified party unless (i) the employment thereof has been specifically authorized in writing by the Company in the
case of a claim for indemnification under Section 7(a) or the Representative in the case of a claim for indemnification under
Section 7(b), (ii) such indemnified party shall have been advised by its counsel that there may be one or more legal defenses
available to it which are different from or additional to those available to the indemnifying party, or (iii) the indemnifying
party has failed to assume the defense of such action and employ counsel reasonably satisfactory to the indemnified party within
a reasonable period of time after notice of the commencement of the action or the indemnifying party does not diligently defend
the action after assumption of the defense, in which case, if such indemnified party notifies the indemnifying party in writing
that it elects to employ separate counsel at the expense of the indemnifying party, the indemnifying party shall not have the
right to assume the defense of (or, in the case of a failure to diligently defend the action after assumption of the defense,
to continue to defend) such action on behalf of such indemnified party and the indemnifying party shall be responsible for legal
or other expenses subsequently incurred by such indemnified party in connection with the defense of such action; <I>provided</I>,
<I>however</I>, that the indemnifying party shall not, in connection with any one such action or separate but substantially similar
or related actions in the same jurisdiction arising out of the same general allegations or circumstances, be liable for the reasonable
fees and expenses of more than one separate firm of attorneys at any time for all such indemnified parties (in addition to any
local counsel), which firm shall be designated in writing by the Representative if the indemnified parties under this Section
7 consist of any Underwriter Indemnified Party or by the Company if the indemnified parties under this Section&nbsp;7 consist
of any Company Indemnified Parties. Subject to this Section 7(c), the amount payable by an indemnifying party under Section 7
shall include, but not be limited to, (x) reasonable documented legal fees and expenses of counsel to the indemnified party and
any other expenses in investigating, or preparing to defend or defending against, or appearing as a third-party witness in respect
of, or otherwise incurred in connection with, any action, investigation, proceeding or claim, and (y) all amounts paid in settlement
of any of the foregoing. No indemnifying party shall, without the prior written consent of the indemnified parties (which consent
shall not be unreasonably withheld or delayed), settle or compromise or consent to the entry of judgment with respect to any pending
or threatened action or any claim whatsoever, in respect of which indemnification or contribution could be sought under this Section
7 (whether or not the indemnified parties are actual or potential parties thereto), unless such settlement, compromise or consent
(A) includes an unconditional release of each indemnified party in form and substance reasonably satisfactory to such indemnified
party from all liability arising out of such action or claim and (B) does not include a statement as to or an admission of fault,
culpability or a failure to act by or on behalf of any indemnified party. Subject to the provisions of the following sentence,
no indemnifying party shall be liable for settlement of any pending or threatened action or any claim whatsoever that is effected
without its written consent (which consent shall not be unreasonably withheld or delayed), but if settled with its written consent,
if its consent has been unreasonably withheld or delayed or if there be a judgment for the plaintiff in any such matter, the indemnifying
party agrees to indemnify and hold harmless any indemnified party from and against any loss or liability by reason of such settlement
or judgment. In addition, if at any time an indemnified party shall have requested that an indemnifying party reimburse the indemnified
party for fees and expenses of counsel, such indemnifying party agrees that it shall be liable for any settlement of the nature
contemplated by Section 7(a) effected without its written consent if (i) such settlement is entered into more than forty-five
(45) days after receipt by such indemnifying party of the request for reimbursement, (ii) such indemnifying party shall have received
notice of the terms of such settlement at least thirty (30) days prior to such settlement being entered into and (iii)&nbsp;such
indemnifying party shall not have reimbursed such indemnified party in accordance with such request prior to the date of such
settlement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 37; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) If
the indemnification provided for in this Section 7 is unavailable or insufficient to hold harmless an indemnified party under
Section 7(a) or 7(b), then each indemnifying party shall, in lieu of indemnifying such indemnified party, contribute to the amount
paid, payable or otherwise incurred by such indemnified party as a result of such loss, claim, damage, expense or liability (or
any action, investigation or proceeding in respect thereof), as incurred, (i) in such proportion as shall be appropriate to reflect
the relative benefits received by the Company on the one hand and the Underwriters on the other from the offering of the Offered
Securities, or (ii) if the allocation provided by clause (i) of this Section 7(d) is not permitted by applicable law, in such
proportion as is appropriate to reflect not only the relative benefits referred to in clause (i) of this Section 7(d), but also
the relative fault of the Company on the one hand and the Underwriters on the other with respect to the statements, omissions,
acts or failures to act which resulted in such loss, claim, damage, expense or liability (or any action, investigation or proceeding
in respect thereof) as well as any other relevant equitable considerations. The relative benefits received by the Company on the
one hand and the Underwriters on the other with respect to such offering shall be deemed to be in the same proportion as the total
net proceeds from the offering of the Offered Securities purchased under this Agreement (before deducting expenses) received by
the Company bear to the total underwriting discounts and commissions received by the Underwriters with respect to the Offered
Securities purchased under this Agreement, in each case as set forth in the table on the cover page of the Prospectus. The relative
fault of the Company on the one hand and the Underwriters on the other shall be determined by reference to, among other things,
whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact
relates to information supplied by the Company on the one hand or the Underwriters on the other, the intent of the parties and
their relative knowledge, access to information and opportunity to correct or prevent such untrue statement, omission, act or
failure to act; <I>provided</I>, <I>however</I>, that the parties hereto agree that the written information furnished to the Company
through the Representative by or on behalf of the Underwriters for use in the Preliminary Prospectus, the Registration Statement,
the ADS Registration Statement, the Prospectus or in any amendment or supplement thereto, consists solely of the Underwriters&rsquo;
Information (as defined in Section 17 hereof).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) The
Company and the Underwriters agree that it would not be just and equitable if contributions pursuant to Section 7(d) above were
to be determined by pro rata allocation or by any other method of allocation which does not take into account the equitable considerations
referred to Section 7(d) above. The amount paid or payable by an indemnified party as a result of the loss, claim, damage, expense,
liability, action, investigation or proceeding referred to in Section 7(d) above shall be deemed to include, subject to the limitations
set forth above, any legal or other expenses reasonably incurred by such indemnified party in connection with investigating, preparing
to defend or defending against or appearing as a third party witness in respect of, or otherwise incurred in connection with,
any such loss, claim, damage, expense, liability, action, investigation or proceeding. Notwithstanding the provisions of this
Section 7, no Underwriter shall be required to contribute any amount in excess of the amount by which the total underwriting discounts
and commissions received by such Underwriter with respect to the offering of the Offered Securities exceeds the amount of any
damages which the Underwriter has otherwise paid or become liable to pay by reason of any untrue or alleged untrue statement,
omission or alleged omission, act or alleged act or failure to act or alleged failure to act. No person guilty of fraudulent misrepresentation
(within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty
of such fraudulent misrepresentation. The Underwriters&rsquo; obligations to contribute as provided in this Section 7 are several
in proportion to their respective underwriting obligations and not joint.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8. <FONT STYLE="font-variant: small-caps"><I>Termination</I>.
</FONT>The obligations of the Underwriters hereunder may be terminated by the Representative, in their absolute discretion, by
notice given to the Company prior to delivery of and payment for the Firm ADSs if, prior to that time, any of the events described
in Sections 6(o) or 6(q) have occurred or if the Underwriters shall decline to purchase the Offered Securities for any reason
permitted under this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 38; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9. <FONT STYLE="font-variant: small-caps"><I>Reimbursement
of Underwriters&rsquo; Expenses</I></FONT>. Notwithstanding anything to the contrary in this Agreement, if (a) this Agreement
shall have been terminated pursuant to Section 8, (b) the Company shall fail to tender the Offered Securities for delivery to
the Underwriters for any reason not permitted under this Agreement, (c) the Underwriters shall decline to purchase the Offered
Securities for any reason permitted under this Agreement or (d) the sale of the Offered Securities is not consummated because
any condition to the obligations of the Underwriters set forth herein is not satisfied or because of the refusal, inability or
failure on the part of the Company to perform any agreement herein or to satisfy any condition or to comply with the provisions
hereof, then, in addition to the payment of amounts in accordance with Section 5, the Company shall reimburse the Underwriters
in accordance with this Section 9 for the fees and expenses of Underwriters&rsquo; counsel and for such other documented out-of-pocket
expenses as shall have been reasonably incurred by them in connection with this Agreement and the proposed purchase of the Offered
Securities, including, without limitation, travel and lodging expenses of the Underwriters, and upon demand the Company shall
pay the full amount thereof to the Representative; <I>provided</I>, <I>however</I>, that if this Agreement is terminated pursuant
to Section 10 by reason of the default of one or more Underwriters, the Company shall not be obligated to reimburse any defaulting
Underwriter on account of expenses to the extent incurred by such defaulting Underwriter; <I>provided</I>, <I>further</I>, that
the foregoing shall not limit any reimbursement obligation of the Company to any non-defaulting Underwriter under this Section
9.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10. <FONT STYLE="font-variant: small-caps"><I>Substitution
of Underwriters</I></FONT>. If any Underwriter or Underwriters shall default in its or their obligations to purchase the shares
of Offered Securities hereunder on any Closing Date, and the aggregate number of shares which such defaulting Underwriter or Underwriters
agreed but failed to purchase does not exceed ten percent (10%) of the total number of shares to be purchased by all Underwriters
on such Closing Date, the other Underwriters shall be obligated severally, in proportion to their respective commitments hereunder,
to purchase the shares which such defaulting Underwriter or Underwriters agreed but failed to purchase on such Closing Date. If
any Underwriter or Underwriters shall so default and the aggregate number of shares with respect to which such default or defaults
occur is more than ten percent (10%) of the total number of shares to be purchased by all Underwriters on such Closing Date, and
arrangements satisfactory to the Representative and the Company for the purchase of such shares by other persons are not made
within forty-eight (48) hours after such default, this Agreement shall terminate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the remaining Underwriters or substituted Underwriters are required hereby or agree to take up all or part of the shares of Offered
Securities of a defaulting Underwriter or Underwriters on such Closing Date as provided in this Section&nbsp;10, (i) the Company
shall have the right to postpone such Closing Dates for a period of not more than five (5) full business days in order that the
Company may effect whatever changes may thereby be made necessary in the Registration Statement, the Prospectus, or in any other
documents or arrangements, and the Company agrees promptly to file any amendments to the Registration Statement or supplements
to the Prospectus which may thereby be made necessary, and (ii) the respective numbers of shares to be purchased by the remaining
Underwriters or substituted Underwriters shall be taken as the basis of their underwriting obligation for all purposes of this
Agreement. Nothing herein contained shall relieve any defaulting Underwriter of its liability to the Company or the other Underwriters
for damages occasioned by its default hereunder. Any termination of this Agreement pursuant to this Section 10 shall be without
liability on the part of any non-defaulting Underwriter or the Company, except that the representations, warranties, covenants,
indemnities, agreements and other statements set forth in Section 2, the obligations with respect to expenses to be paid or reimbursed
pursuant to Sections 5 and 9 and the provisions of Section 7 and Sections 11 through 21, inclusive, shall not terminate and shall
remain in full force and effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 39; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11. <FONT STYLE="font-variant: small-caps"><I>Absence
of Fiduciary Relationship. </I></FONT> The Company acknowledges and agrees that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) each
Underwriter&rsquo;s responsibility to the Company is solely contractual in nature, the Representative has been retained solely
to act as underwriter in connection with the sale of the Offered Securities and no fiduciary, advisory or agency relationship
between the Company and the Representative has been created in respect of any of the transactions contemplated by this Agreement,
irrespective of whether any of the Representative has advised or is advising the Company on other matters;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) the
price of the Offered Securities set forth in this Agreement was established by the Company following discussions and arm&rsquo;s-length
negotiations with the Representative, and the Company is capable of evaluating and understanding, and understands and accepts,
the terms, risks and conditions of the transactions contemplated by this Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) it
has been advised that the Representative and its affiliates are engaged in a broad range of transactions which may involve interests
that differ from those of the Company and that the Representative has no obligation to disclose such interests and transactions
to the Company by virtue of any fiduciary, advisory or agency relationship; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) it
waives, to the fullest extent permitted by law, any claims it may have against the Representative for breach of fiduciary duty
or alleged breach of fiduciary duty and agrees that the Representative shall have no liability (whether direct or indirect) to
the Company in respect of such a fiduciary duty claim or to any person asserting a fiduciary duty claim on behalf of or in right
of the Company, including shareholders, employees or creditors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12. <FONT STYLE="font-variant: small-caps"><I>Successors;
Persons Entitled to Benefit of Agreement</I></FONT>. This Agreement shall inure to the benefit of and be binding upon the several
Underwriters, the Company and their respective successors and assigns. Nothing expressed or mentioned in this Agreement is intended
or shall be construed to give any person, other than the persons mentioned in the preceding sentence, any legal or equitable right,
remedy or claim under or in respect of this Agreement, or any provisions herein contained, this Agreement and all conditions and
provisions hereof being intended to be and being for the sole and exclusive benefit of such persons and for the benefit of no
other person; except that the representations, warranties, covenants, agreements and indemnities of the Company contained in this
Agreement shall also be for the benefit of the Underwriter Indemnified Parties, and the indemnities of the several Underwriters
shall be for the benefit of the Company Indemnified Parties. It is understood that each Underwriter&rsquo;s responsibility to
the Company is solely contractual in nature and the Underwriters do not owe the Company, or any other party, any fiduciary duty
as a result of this Agreement. No purchaser of any of the Offered Securities from any Underwriter shall be deemed to be a successor
or assign by reason merely of such purchase.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 40; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13. <FONT STYLE="font-variant: small-caps"><I>Survival
of Indemnities, Representations, Warranties, etc</I></FONT><I>. </I> The respective indemnities, covenants, agreements, representations,
warranties and other statements of the Company and the several Underwriters, as set forth in this Agreement or made by them respectively,
pursuant to this Agreement, shall remain in full force and effect, regardless of any investigation made by or on behalf of any
Underwriter, the Company or any person controlling any of them and shall survive delivery of and payment for the Offered Securities.
Notwithstanding any termination of this Agreement, including without limitation any termination pursuant to Section 8 or Section
10, the indemnities, covenants, agreements, representations, warranties and other statements forth in Sections 2, 5, 7 and 9 and
Sections 11 through 21, inclusive, of this Agreement shall not terminate and shall remain in full force and effect at all times.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14. <FONT STYLE="font-variant: small-caps"><I>Notices</I></FONT>.
All statements, requests, notices and agreements hereunder shall be in writing, and:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&#9;if
to the Underwriters, shall be delivered or sent by mail, telex, facsimile transmission or email to (i) [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]; (ii) [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]; (iii)
[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] and (iv) [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) if
to the Company shall be delivered or sent by mail, telex, facsimile transmission or email to Tiziana Life Sciences plc, Attention:
Kunwar Shailubhai, with a copy to Cooley LLP, 114 Avenue of the Americas, New York, New York 10036, Attention: Divikar Guptar,
Esq.;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>provided</I>,
<I>however</I>, that any notice to an Underwriter pursuant to Section 7 shall be delivered or sent by mail, or facsimile transmission
to such Underwriter at its address set forth in its acceptance telex to the Representative, which address will be supplied to
any other party hereto by the Representative upon request. Any such statements, requests, notices or agreements shall take effect
at the time of receipt thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15. <FONT STYLE="font-variant: small-caps"><I>Definition
of Certain Terms</I></FONT>. For purposes of this Agreement, (i) &ldquo;<B><I>affiliate</I></B>&rdquo; has the meaning set forth
in Rule 405 under the Rules and Regulations, (ii) &ldquo;<B><I>business day</I></B>&rdquo; means any day on which The Nasdaq Stock
Market is open for trading and (iii) &ldquo;<B><I>subsidiary&rdquo;</I></B> has the meaning set forth in Rule 405 of the Rules
and Regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16. <FONT STYLE="font-variant: small-caps"><I>Governing
Law.</I></FONT> <B>This Agreement shall be governed by and construed in accordance with the laws of the State of New York, including
without limitation Section 5-1401 of the New York General Obligations.</B> The Company irrevocably (i) submits to the non-exclusive
jurisdiction of the Federal and state courts in the Borough of Manhattan in The City of New York for the purpose of any suit,
action or other proceeding arising out of this Agreement or the transactions contemplated by this Agreement, the Registration
Statement, the ADS Registration Statement and any Preliminary Prospectus or the Prospectus, (ii) agrees that all claims in respect
of any such suit, action or proceeding may be heard and determined by any such court, (iii) waives to the fullest extent permitted
by applicable law, any immunity from the jurisdiction of any such court or from any legal process, (iv) agrees not to commence
any such suit, action or proceeding other than in such courts, (v) waives, to the fullest extent permitted by applicable law,
any claim that any such suit, action or proceeding is brought in an inconvenient forum and (vi) appoints Tiziana Therapeutics,
Inc. as its agent to receive service of process or other legal summons for purposes of any such suit, action or proceeding that
may be instituted in any state or federal court in the City and County of New York.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 41; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17. <FONT STYLE="font-variant: small-caps"><I>Underwriters&rsquo;
Information</I></FONT><I>.</I> The parties hereto acknowledge and agree that, for all purposes of this Agreement, the &ldquo;<B><I>Underwriters&rsquo;
Information</I></B>&rdquo; consists solely of the following information in the Prospectus: the statements concerning the Underwriters
contained in the first sentence of the third paragraph and the twentieth paragraph under the heading &ldquo;Underwriting.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18. <FONT STYLE="font-variant: small-caps"><I>Authority
of the Representative</I></FONT>. In connection with this Agreement, the Representative will act for and on behalf of the several
Underwriters, and any action taken under this Agreement by the Representative, will be binding on all of the Underwriters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19. <FONT STYLE="font-variant: small-caps"><I>Partial
Unenforceability</I>. </FONT>The invalidity or unenforceability of any section, paragraph, clause or provision of this Agreement
shall not affect the validity or enforceability of any other section, paragraph, clause or provision hereof. If any section, paragraph,
clause or provision of this Agreement is for any reason determined to be invalid or unenforceable, there shall be deemed to be
made such minor changes (and only such minor changes) as are necessary to make it valid and enforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20. <FONT STYLE="font-variant: small-caps"><I>General</I></FONT>.
This Agreement constitutes the entire agreement of the parties to this Agreement and supersedes all prior written or oral and
all contemporaneous oral agreements, understandings and negotiations with respect to the subject matter hereof. In this Agreement,
the masculine, feminine and neuter genders and the singular and the plural include one another. The section headings in this Agreement
are for the convenience of the parties only and will not affect the construction or interpretation of this Agreement. This Agreement
may be amended or modified, and the observance of any term of this Agreement may be waived, only by a writing signed by the Company
and the Representative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21. <FONT STYLE="font-variant: small-caps"><I>Counterparts</I></FONT>.
This Agreement may be signed in any number of counterparts, including by facsimile or other electronic transmission, each of which
shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22. <FONT STYLE="font-variant: small-caps"><I>Judgment
Currency</I></FONT>.&nbsp; The obligations of the Company pursuant to this Agreement in respect of any sum due to any Underwriter
shall, notwithstanding any judgment in a currency other than United States dollars, not be discharged until the first (1<SUP>st</SUP>)
business day, following receipt by such Underwriter of any sum adjudged to be so due in such other currency, on which (and only
to the extent that) such Underwriter may in accordance with normal banking procedures purchase United States dollars with such
other currency; if the United States dollars so purchased are less than the sum originally due to such Underwriter hereunder,
the Company agrees, as a separate obligation and notwithstanding any such judgment, to indemnify such Underwriter against such
loss.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(<I>Signature
page follows</I>)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B></B></FONT></P>

<!-- Field: Page; Sequence: 42; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the foregoing is in accordance with your understanding of the agreement between the Company and the several Underwriters, kindly
indicate your acceptance in the space provided for that purpose below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very
                                         truly yours,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 4%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; width: 36%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TIZIANA
    LIFE SCIENCES PLC</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; border-bottom: Black 1.5pt solid"></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    Kunwar Shailubhai</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    Chief Executive Officer</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 43; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>




<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 50%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accepted
as of the date first above written:</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps">laidlaw
        &amp; company (uk) ltd.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><BR>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acting on their own behalf</FONT><BR>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">and as Representative of several</FONT><BR>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underwriters listed in <U>Schedule A</U> to this Agreement.&nbsp;</FONT></P></TD>
    <TD STYLE="width: 50%; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 4%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="width: 36%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LAIDLAW
    &amp; COMPANY (UK) LTD.</FONT></TD>
    <TD STYLE="width: 60%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 44; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>




<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE
A</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 68%; text-align: left; border-bottom: Black 1.5pt solid">Name</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 15%; text-align: center; border-bottom: Black 1.5pt solid">Number of Firm ADSs</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 15%; text-align: center; border-bottom: Black 1.5pt solid">Number of Optional ADSs</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-variant: small-caps; text-align: left">laidlaw &amp; company (uk) ltd.</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; border-bottom: Black 1.5pt solid"></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; border-bottom: Black 1.5pt solid"></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 4pt">Total</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="text-align: center; border-bottom: Black 4pt double">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="text-align: center; border-bottom: Black 4pt double">&nbsp;</TD></TR>
</TABLE>




<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 45; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">Sch. A</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE
B</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
Use Free Writing Prospectuses</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 46; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">Sch. B</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>




<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE
C</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">Pricing
Information</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 50%; text-align: left">Firm ADSs:</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 49%; text-align: left">&nbsp;&nbsp;[&#9679;] ADSs, representing [&#9679;] Ordinary Shares<BR></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Offering Price:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$[&#9679;] per ADS </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Optional ADSs:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;&nbsp;[&#9679;] ADSs, representing [&#9679;] Ordinary Shares</TD></TR>
</TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 47; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">Sch. C</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>




<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE
D</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">Lock-Up
Parties</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kunwar
                                         Shailubhai</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tiziano
                                         Lazzaretti</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gabriele
                                         Cerrone</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Riccardo
                                         Dalla-Favera</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Willy
                                         Simon</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leopoldo
                                         Zambeletti</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Planwise
                                         Group Limited</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.25in"></P>

<!-- Field: Page; Sequence: 48; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">Sch. D</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE
E</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">Subsidiaries</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tiziana
Pharma Limited</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tiziana
Therapeutics Inc</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Longevia
Genomics SRL</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 49; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">Sch. E</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>




<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit
I</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
of Lock-Up Agreement</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Laidlaw
&amp; Company (UK) Ltd.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">546
5th Avenue, 5</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">th</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Floor</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, NY 10036</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
Representative of the several Underwriters named on Schedule 1 to the Underwriting Agreement referenced below</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladies
and Gentlemen:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned understands that you and certain other firms (the &ldquo;<B><I>Underwriters</I></B>&rdquo;) propose to enter into
an Underwriting Agreement (the &ldquo;<B><I>Underwriting Agreement</I></B>&rdquo;) providing for the purchase by the Underwriters
of American Depository Shares (the &ldquo;<B><I>Securities</I></B>&rdquo;), of Tiziana Life Sciences PLC, a company incorporated
in England and Wales (the &ldquo;<B><I>Company</I></B>&rdquo;), and that the Underwriters propose to reoffer the Securities to
the public (the &ldquo;<B><I>Offering</I></B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
consideration of the execution of the Underwriting Agreement by the Underwriters, and for other good and valuable consideration,
the undersigned hereby irrevocably agrees that, without the prior written consent of the Representative, on behalf of the Underwriters,
the undersigned will not, directly or indirectly, (1) offer for sale, sell, pledge, or otherwise transfer or dispose of (or enter
into any transaction or device that is designed to, or could be expected to, result in the transfer or disposition by any person
at any time in the future of) any of the Securities (including, without limitation, Securities that may be deemed to be beneficially
owned by the undersigned in accordance with the rules and regulations of the Securities and Exchange Commission and Ordinary Shares
that may be issued upon exercise of any options or warrants) or any Ordinary Shares owned or securities owned which are convertible
into or exercisable or exchangeable for Ordinary Shares, (2) enter into any swap or other derivatives transaction that transfers
to another, in whole or in part, any of the economic benefits or risks of ownership of such securities, whether any such transaction
described in clause (1) or (2) above is to be settled by delivery of the Securities or other securities, in cash or otherwise,
(3) except as provided for below, make any demand for or exercise any right or cause to be filed a registration statement, including
any amendments thereto, with respect to the registration of Ordinary Shares or securities convertible into or exercisable or exchangeable
for Ordinary Shares or any other securities of the Company, or (4) publicly disclose the intention to do any of the foregoing
for a period commencing on the date hereof and ending on the 180th day after the date of the Prospectus relating to the Offering
(such 180-day period, the &ldquo;<B><I>Lock-Up Period</I></B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 50; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing paragraph shall not apply to (a) transactions relating to the Securities or other securities acquired in the open market
after the completion of the Offering, <I>provided </I>that no filing under Section 16(a) of the Securities Exchange Act of 1934,
as amended (the <B><I>&ldquo;Exchange Act&rdquo;</I></B>), shall be required or shall be voluntarily made in connection with subsequent
sales of Ordinary Shares or other securities acquired in such open market transactions; (b) bona fide gifts, sales or other dispositions
of shares of any class of the Company&rsquo;s capital stock or any security convertible into Ordinary Shares, in each case that
are made exclusively between and among the undersigned or members of the undersigned&rsquo;s family, or affiliates of the undersigned,
including its partners (if a partnership) or members (if a limited liability company); (c) any transfer of Ordinary Shares or
any security convertible into Ordinary Shares by will or intestate succession upon the death of the undersigned; (d) transfer
of Ordinary Shares or any security convertible into Ordinary Shares to an immediate family member (for purposes of this Lock-Up
Letter Agreement, &ldquo;immediate family&rdquo; shall mean any relationship by blood, marriage or adoption, not more remote than
first cousin) or any trust, limited partnership, limited liability company or other entity for the direct or indirect benefit
of the undersigned or any immediate family member of the undersigned; <I>provided </I>that, in the case of clauses (b)- (d) above,
it shall be a condition to any such transfer that (i) the transferee/donee agrees to be bound by the terms of this Lock-Up Letter
Agreement (including, without limitation, the restrictions set forth in the preceding sentence) to the same extent as if the transferee/donee
were a party hereto, (ii) each party (donor, donee, transferor or transferee) shall not be required by law (including without
limitation the disclosure requirements of the Securities Act of 1933, as amended, (the &ldquo;<B><I>Securities Act</I></B>&rdquo;)
and the Exchange Act) to make, and shall agree to not voluntarily make, any filing or public announcement of the transfer or disposition
prior to the expiration of the 180-day period referred to above, and (iii) the undersigned notifies the Representative at least
two business days prior to the proposed transfer or disposition; (e) the transfer of shares to the Company to satisfy withholding
obligations for any equity award granted pursuant to the terms of the Company&rsquo;s stock option/incentive plans, such as upon
exercise, vesting, lapse of substantial risk of forfeiture, or other similar taxable event, in each case on a &ldquo;cashless&rdquo;
or &ldquo;net exercise&rdquo; basis (which, for the avoidance of doubt shall not include &ldquo;cashless&rdquo; exercise programs
involving a broker or other third party), <I>provided </I>that as a condition of any transfer pursuant to this clause (e), that
if the undersigned is required to file a report under Section 16(a) of the Exchange Act, reporting a reduction in beneficial ownership
of Ordinary Shares or any securities convertible into or exercisable or exchangeable for Ordinary Shares during the Lock-Up Period,
the undersigned shall include a statement in such report, and if applicable an appropriate disposition transaction code, to the
effect that such transfer is being made as a share delivery or forfeiture in connection with a net value exercise, or as a forfeiture
or sale of shares solely to cover required tax withholding, as the case may be; (f) transfers of Ordinary Shares or any security
convertible into or exercisable or exchangeable for Ordinary Shares pursuant to a bona fide third party tender offer made to all
holders of the Ordinary Shares, merger, consolidation or other similar transaction involving a change of control (as defined below)
of the Company, including voting in favor of any such transaction or taking any other action in connection with such transaction,
<I>provided </I>that in the event that such merger, tender offer or other transaction is not completed, the Ordinary Shares and
any security convertible into or exercisable or exchangeable for Ordinary Shares shall remain subject to the restrictions set
forth herein; (g) the exercise of warrants or the exercise of stock options granted pursuant to the Company&rsquo;s stock option/incentive
plans or otherwise outstanding on the date hereof; <I>provided</I>, that the restrictions shall apply to Ordinary Shares issued
upon such exercise or conversion; (h) the establishment of any contract, instruction or plan that satisfies all of the requirements
of Rule 10b5-1 (a &ldquo;<B><I>Rule 10b5-1 Plan</I></B>&rdquo;) under the Exchange Act; <I>provided</I>, <I>however</I>, that
no sales of Ordinary Shares or securities convertible into, or exchangeable or exercisable for, Ordinary Shares, shall be made
pursuant to a Rule 10b5-1 Plan prior to the expiration of the Lock-Up Period; <I>provided further</I>, that the Company is not
required to report the establishment of such Rule 10b5-1 Plan in any public report or filing with the Commission under the Exchange
Act during the Lock-Up Period and does not otherwise voluntarily effect any such public filing or report regarding such Rule 10b5-1
Plan; and (i) any demands or requests for, exercise any right with respect to, or take any action in preparation of, the registration
by the Company under the Securities Act of the undersigned&rsquo;s Ordinary Shares, provided that no transfer of the undersigned&rsquo;s
Ordinary Shares registered pursuant to the exercise of any such right and no registration statement shall be filed under the Securities
Act with respect to any of the undersigned&rsquo;s Ordinary Shares during the Lock-Up Period. For purposes of clause (f) above,
&ldquo;change of control&rdquo; shall mean the consummation of any bona fide third party tender offer, merger, purchase, consolidation
or other similar transaction the result of which is that any &ldquo;person&rdquo; (as defined in Section 13(d)(3) of the Exchange
Act), or group of persons, becomes the beneficial owner (as defined in Rules 13d-3 and 13d-5 of the Exchange Act) of a majority
of total voting power of the voting stock of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 51; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned also agrees and consents to the entry of stop transfer instructions with the Company&rsquo;s transfer agent and registrar
against the transfer of the undersigned&rsquo;s securities subject to this Lock-Up Letter Agreement except in compliance with
this Lock-Up Letter Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is understood that, if the Company notifies the Underwriters that it does not intend to proceed with the Offering, if the Underwriting
Agreement does not become effective, or if the Underwriting Agreement (other than the provisions thereof which survive termination)
shall terminate or be terminated prior to payment for and delivery of the Stock, the undersigned will be released from its obligations
under this Lock-Up Letter Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned understands that the Company and the Underwriters will proceed with the Offering in reliance on this Lock-Up Letter
Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Whether
or not the Offering actually occurs depends on a number of factors, including market conditions. Any Offering will only be made
pursuant to an Underwriting Agreement, the terms of which are subject to negotiation between the Company and the Underwriters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Lock-Up Letter Agreement shall automatically terminate upon the earliest to occur, if any, of (1) the termination of the Underwriting
Agreement before the sale of any securities to the Underwriters or (2) October 31, 2018 in the event that the Underwriting Agreement
has not been executed by that date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[Signature
page follows]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 52; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned represents and warrants that the undersigned beneficially owns the Company securities subject to this Lock-Up Agreement
and that the undersigned now has and, except as contemplated by clauses (b)-(d) in the second paragraph of the Lock-Up Agreement,
will have good and marketable title to the undersigned&rsquo;s Ordinary Shares, free and clear of all liens, encumbrances, and
claims whatsoever, except with respect to any liens, encumbrances and claims that were in existence on the date hereof and disclosed
to the Representative. The undersigned hereby represents and warrants that the undersigned has full power and authority to enter
into this Lock-Up Letter Agreement and that, upon request, the undersigned will execute any additional documents necessary in
connection with the enforcement hereof. Any obligations of the undersigned shall be binding upon the heirs, personal Representative,
successors and assigns of the undersigned.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very
                    truly yours,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 4%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; width: 36%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; border-bottom: Black 1.5pt solid"></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 53; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
II </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
of Press Release</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Tiziana
Life Sciences plc</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>[Date]</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tiziana
Life Sciences plc announced today that Laidlaw &amp; Company (UK) Ltd., the lead book-running manager in the Company&rsquo;s recent
public sale of [<B>&#9679;</B>] American Depositary Shares, each representing five (5) ordinary shares, is [waiving][releasing]
a lock-up restriction with respect to [<B>&#9679;</B>] shares of the Company&rsquo;s ordinary shares [and [<B>&#9679;</B>] shares
of the Company&rsquo;s American Depositary Shares] held by [certain officers or directors][an officer or director] of the Company.
The [waiver][release] will take effect on &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 20&nbsp;&nbsp; , and the shares may be sold on or after such date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>This
press release is not an offer for sale of the securities in the United States or in any other jurisdiction where such offer is
prohibited, and such securities may not be offered or sold in the United States absent registration or exemption from registration
under the United States Securities Act of 1933, as amended.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B></B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>3
<FILENAME>ff12018a1ex3-1_tiziana.htm
<DESCRIPTION>MEMORANDUM AND ARTICLES OF ASSOCIATION OF TIZIANA LIFE SCIENCES PLC
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
3.1</B></FONT></P>

<P STYLE="margin: 0; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TIZIANA
LIFE SCIENCES PLC</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex3-1_001.jpg" ALT="">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLES
OF ASSOCIATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Adopted
by Special Resolution on</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>30
June 2016</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><IMG SRC="ex3-1_002.jpg" ALT="" STYLE="width: 137px; height: 45px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cooley
(UK) LLP, Dashwood, 69 Old Broad Street, London EC2M 1QS, UK<BR>
T: +44 (0) 20 7583 4055 F: +44 (0) 20 7785 9355 www.cooley.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contents</FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clause</FONT></P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="width: 82%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exclusion
    of model articles (and any other prescribed regulations)</FONT></TD>
    <TD STYLE="width: 9%; text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interpretation</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
    of resolution</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Limited
    liability</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change
    of name</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">3</TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power
    to attach rights to shares</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Allotment
    of shares and pre-emption</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redeemable
    shares</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pari
    passu issues</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Variation
    of rights</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment
    of commission</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trusts
    not recognised</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Uncertificated
    shares</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share
    certificates</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Replacement
    certificates</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lien
    on shares not fully paid</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Enforcement
    of lien by sale</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Application
    of proceeds of sale</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Calls</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liability
    of joint holders</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
    on calls</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power
    to differentiate</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment
    of calls in advance</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notice
    if call or instalment not paid</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeiture
    for non-compliance</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notice
    after forfeiture</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">27.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeiture
    may be annulled</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Surrender</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sale
    of forfeited shares</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effect
    of forfeiture</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Evidence
    of forfeiture</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
    of transfer</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">33.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right
    to refuse registration of transfer</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">34.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notice
    of refusal to register a transfer</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">35.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    fees on registration</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">36.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    powers in relation to transfers</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">37.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transmission
    of shares on death</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">38.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Election
    of person entitled by transmission</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">39.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rights
    on transmission</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">40.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Destruction
    of documents</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">41.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sub-division</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 9%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">42.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 82%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fractions</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 9%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">43.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Annual
    general meetings</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">44.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convening
    of general meetings</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">45.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notice
    of general meetings</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">46.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contents
    of notice of meetings</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">47.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Omission
    to give notice and non-receipt of notice</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">48.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Postponement
    of general meeting</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">49.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quorum
    at general meeting</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Procedure
    if quorum not present</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">19</TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">51.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman
    of general meeting</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">52.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Entitlement
    to attend and speak</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">53.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adjournments</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">54.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notice
    of adjournment</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">55.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Business
    of adjourned meeting</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">56.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security
    arrangements and orderly conduct</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">57.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Overflow
    meeting rooms</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">58.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Satellite
    meeting places</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">59.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendment
    to resolutions</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">22</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">60.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Members&rsquo;
    resolutions</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">61.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Method
    of voting</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">62.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Objection
    to error in voting</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">63.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Procedure
    on a poll</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">64.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Votes
    of members</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">65.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    right to vote where sums overdue on shares</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">66.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Voting
    by Proxy</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">67.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Receipt
    of proxy</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">27</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">68.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revocation
    of proxy</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">69.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corporate
    representatives</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">70.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Failure
    to disclose interests in shares</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">71.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power
    of sale of shares of untraced members</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">72.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Application
    of proceeds of sale of shares of untraced members</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">73.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of directors</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">74.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power
    of company to appoint directors</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">75.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power
    of board to appoint directors</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">76.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Eligibility
    of new directors</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">77.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Retirement
    of directors</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">78.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deemed
    re-appointment</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">79.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Procedure
    if insufficient directors appointed</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">35</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">80.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Removal
    of directors</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">35</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">81.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vacation
    of office by director</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">35</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">82.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Resolution
    as to vacancy conclusive</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">36</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">83.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Appointment
    of alternate directors</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">36</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">84.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alternate
    directors&rsquo; participation in board meetings</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">37</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">85.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alternate
    director responsible for own acts</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">37</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">86.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interests
    of alternate director</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">37</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">87.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revocation
    of alternate director</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">37</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 9%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">88.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 82%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Directors&rsquo;
    fees</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 9%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">38</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">89.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expenses</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">38</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">90.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional
    remuneration</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">38</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">91.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remuneration
    of executive directors</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">38</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">92.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pensions
    and other benefits</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">93.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Powers
    of the board</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">94.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Powers
    of directors if less than minimum number</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">95.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Powers
    of executive directors</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">40</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">96.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Delegation
    to committees</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">40</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">97.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Local
    management</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">40</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">98.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power
    of attorney</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    of voting power</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provision
    for employees on cessation of business</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Overseas
    registers</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">102.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Borrowing
    powers</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">42</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">103.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Board
    meetings</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">43</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">104.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notice
    of board meetings</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">44</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">105.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quorum</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">44</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">106.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">44</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">107.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Voting</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">45</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">108.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Participation
    by telephone or other form of communication</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">45</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">109.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Resolution
    in writing</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">45</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">110.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proceedings
    of committees</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">46</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">111.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Minutes
    of proceedings</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">46</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">112.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Validity
    of proceedings</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">46</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">113.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transactions
    or other arrangements with the company</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">46</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">114.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorisation
    of Directors&rsquo; conflicts of interest</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">47</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">115.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Directors&rsquo;
    permitted interests</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">49</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">116.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">General</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">117.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power
    to authenticate documents</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">118.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Use
    of seals</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">51</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">119.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Declaration
    of dividends</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">51</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">120.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interim
    dividends</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">51</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">121.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Calculation
    and currency of dividends</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">52</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">122.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts
    due on shares can be deducted from dividends</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">52</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">123.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividends
    not in cash</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">52</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">124.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    interest on dividends</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">53</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">125.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Method
    of payment</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">53</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">126.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Uncashed
    dividends</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">54</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">127.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unclaimed
    dividends</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">54</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">128.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Scrip
    dividends</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">54</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">129.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalisation
    of reserves</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">56</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">130.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Record
    dates</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">58</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">131.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inspection
    of records</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">58</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">132.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Account
    to be sent to members</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">58</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">133.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Service
    of Notices</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">59</FONT></TD></TR>

<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 9%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">134.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 82%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notice
    on person entitled by transmission</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 9%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">61</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">135.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Record
    date for service</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">61</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">136.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Evidence
    of service</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">61</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">137.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notice
    when post not available</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">62</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">138.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indemnity
    and insurance</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">62</FONT></TD></TR>
</TABLE>


<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>THE COMPANIES ACT 2006</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>PUBLIC COMPANY LIMITED BY SHARES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>ARTICLES OF ASSOCIATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>OF</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>TIZIANA LIFE SCIENCES PLC</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>(Adopted by special resolution on 30
June 2016)</B></P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">1.</FONT></TD><TD STYLE="text-align: justify">Exclusion of model articles (and any other prescribed regulations)</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">No regulations or articles set
out in any statute, or in any statutory instrument or other subordinate legislation made under any statute, concerning companies
(including the regulations in the Companies (Model Articles) Regulations 2008 (SI 2008/3229)) shall apply as the articles of the
Company. The following shall be the articles of association of the Company.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">2.</FONT></TD><TD STYLE="text-align: justify">Interpretation</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">2.1</TD><TD STYLE="text-align: justify">In these articles, unless the context otherwise requires:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><B>Act:</B> Companies Act 2006.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><B>address:</B> includes any number
or address used for the purposes of sending or receiving documents or information by electronic means.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><B>Articles:</B> these articles
of association as altered from time to time and &ldquo;Article&rdquo; shall be construed accordingly.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><B>Board:</B> the board of Directors
for the time being of the Company or the Directors present or deemed to be present at a duly convened quorate meeting of the Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><B>certificated shares:</B> a
share which is not an uncertificated share and references in these Articles to a share being held in certificated form shall be
construed accordingly.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><B>clear days:</B> in relation
to a period of notice means that period excluding the day when the notice is served or deemed to be served and the day for which
it is given or on which it is to take effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><B>Companies Acts:</B> the Act,
the Companies Act 1985 and, where the context requires, every other statute from time to time in force concerning companies and
affecting the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><B>Company:</B> Tiziana Life Sciences
plc, company number 3508592.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><B>Director:</B> a director for
the time being of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><B></B></P>

<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><B>&nbsp;</B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><B>FSMA:</B> Financial Services
and Markets Act 2000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><B>electronic form:</B> has the
meaning given to it in section 1168 of the Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><B>electronic means:</B> has the
meaning given to it in section 1168 of the Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><B>member:</B> a member of the
Company, or where the context requires, a member of the Board or of any committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><B>Office:</B> the registered
office from time to time of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><B>Official List:</B> the list
of securities that have been admitted to listing which is maintained by the Financial Conduct Authority (FCA) in accordance with
section 74(1) of FSMA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><B>Operator:</B> Euroclear UK
and Ireland Limited or such other person as may for the time being be approved by HM Treasury as Operator under the uncertificated
securities rules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><B>paid up:</B> paid up or credited
as paid up.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><B>participating class:</B> a
class of shares title to which is permitted by the Operator to be transferred by means of a relevant system.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><B>Register:</B> the register
of members of the Company to be maintained under the Act or as the case may be any overseas branch register maintained under Article
101.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><B>relevant system:</B> a computer-based
system which allows units of securities without written instruments to be transferred and endorsed pursuant to the uncertificated
securities rules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><B>Share Warrant:</B> a warrant
to bearer issued by the Company in respect of its shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><B>Seal:</B> the common seal of
the Company or, where the context allows, any official seal kept by the Company under section 50 of the Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><B>uncertificated securities rules:</B>
any provision of the Companies Acts relating to the holding, evidencing of title to, or transfer of uncertificated shares and any
legislation, rules or other arrangements made under or by virtue of such provision.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><B>uncertificated share:</B> a
share of a class which is at the relevant time a participating class, title to which is recorded on the Register as being held
in uncertificated form and references in these Articles to a share being held in uncertificated form shall be construed accordingly.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><B>UKLA:</B> the United Kingdom
listing authority which is the Financial Conduct Authority (FCA) when performing its functions under Part VI of FSMA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">2.2</TD><TD STYLE="text-align: justify">Headings are used for convenience only and shall not affect the construction or interpretation
of these Articles.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">2.3</TD><TD STYLE="text-align: justify">A <B>person</B> includes a corporate and an unincorporated body (whether or not having separate
legal personality).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">2.4</TD><TD STYLE="text-align: justify">Words in the singular shall include the plural and vice versa.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">2.5</TD><TD STYLE="text-align: justify">A reference to one gender shall include a reference to the other gender.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">2.6</TD><TD STYLE="text-align: justify">A reference to a statute or statutory provision is a reference to it as it is in force for the
time being, taking account of any amendment, extension, or re-enactment and includes any subordinate legislation for the time being
in force made under it.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">2.7</TD><TD STYLE="text-align: justify">Any words or expressions defined in the Companies Acts in force when these Articles or any part
of these Articles are adopted shall (if not inconsistent with the subject or context in which they appear) have the same meaning
in these Articles or that part, save that the word &ldquo;company&rdquo; shall include any body corporate.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">2.8</TD><TD STYLE="text-align: justify">A reference to a document <B>being signed </B>or to <B>signature</B> includes references to its
being executed under hand or under seal or by any other method and, in the case of a communication in electronic form, such references
are to its being authenticated as specified by the Companies Acts.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">2.9</TD><TD STYLE="text-align: justify">A reference to <B>writing</B> or <B>written</B> includes references to any method of representing
or reproducing words in a legible and non-transitory form whether sent or supplied in electronic form or otherwise.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">2.10</TD><TD STYLE="text-align: justify">A reference to documents or information <B>being sent or supplied by or to</B> a company (including
the Company) shall be construed in accordance with section 1148(3) of the Act.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">2.11</TD><TD STYLE="text-align: justify">A reference to a <B>meeting</B> shall not be taken as requiring more than one person to be present
if any quorum requirement can be satisfied by one person.</TD></TR></TABLE>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">3.</FONT></TD><TD STYLE="text-align: justify">Form of resolution</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">Subject to the Companies Acts,
where anything can be done by passing an ordinary resolution, this can also be done by passing a special resolution.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">4.</FONT></TD><TD STYLE="text-align: justify">Limited liability</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">The liability of the members of
the Company is limited to the amount, if any, unpaid on the shares in the Company held by them.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">5.</FONT></TD><TD STYLE="text-align: justify">Change of name</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">The Company may change its name
by resolution of the Board.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase"></FONT></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">6.</FONT></TD><TD STYLE="text-align: justify">Power to attach rights to shares</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">Subject to the Companies Acts
and to any rights attached to existing shares, any share may be issued with or have attached to it such rights and restrictions
as the Company may by ordinary resolution determine, or if no ordinary resolution has been passed or so far as the resolution does
not make specific provision, as the Board may determine.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">7.</FONT></TD><TD STYLE="text-align: justify">Allotment of shares and pre-emption</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">7.1</TD><TD STYLE="text-align: justify">Subject to the Companies Acts, these Articles and to any relevant authority of the Company in general
meeting required by the Act, the Board may offer, allot (with or without conferring rights of renunciation), grant options over
or otherwise deal with or dispose of shares or grant rights to subscribe for or convert any security into shares to such persons,
at such times and upon such terms as the Board may decide. No share may be issued at a discount.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">7.2</TD><TD STYLE="text-align: justify">The Board may, at any time after the allotment of any share but before any person has been entered
in the Register, recognise a renunciation by the allottee in favour of some other person and accord to the allottee of a share
a right to effect such renunciation and/or allow the rights to be represented to be one or more participating securities, in each
case upon the subject to such terms and conditions as the Board may think fit to impose.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">7.3</TD><TD STYLE="text-align: justify">Under and in accordance with section 551 of the Act, the Directors shall be generally and unconditionally
authorised to exercise for each prescribed period all the powers of the Company to allot shares up to an aggregate nominal amount
equal to the Section 551 Amount.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">7.4</TD><TD STYLE="text-align: justify">Under and within the terms of the said authority or otherwise in accordance with section 570 of
the Act, the Directors shall be empowered during each prescribed period to allot equity securities (as defined by the Act) wholly
for cash:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(a)</TD><TD STYLE="text-align: justify">in connection with a rights issue; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(b)</TD><TD STYLE="text-align: justify">otherwise than in connection with a rights issue up to an aggregate nominal amount equal to the
Section 561 Amount.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">7.5</TD><TD STYLE="text-align: justify">During each prescribed period the Company and its Directors by such authority and power may make
offers or agreements which would or might require equity securities or other securities to be allotted after the expiry of such
period.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">7.6</TD><TD STYLE="text-align: justify">For the purposes of this Article 7:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(a)</TD><TD STYLE="text-align: justify"><B>rights issue </B>means an offer of equity securities (as defined by the Act) open for acceptance
for a period fixed by the Board to holders of equity securities on the Register on a fixed record date in proportion to their respective
holdings of such securities or in accordance with the rights attached to them but subject to such exclusions or other arrangements
as the Board may deem necessary or expedient with regard to treasury shares, fractional entitlements or legal or practical problems
under the laws of any territory or under the requirements of any recognised regulatory body or stock exchange in any territory;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(b)</TD><TD STYLE="text-align: justify"><B>prescribed period</B> means any period (not exceeding five years on any occasion) for which
the authority, in the case of Article 7.3, is conferred or renewed by ordinary or special resolution stating the Section 551 Amount
and in the case of Article 7.4 is conferred or renewed by special resolution stating the Section 561 Amount;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(c)</TD><TD STYLE="text-align: justify"><B>Section 551 Amount</B> means for any prescribed period, the amount stated in the relevant ordinary
or special resolution;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(d)</TD><TD STYLE="text-align: justify"><B>Section 561 Amount</B> means for any prescribed period, the amount stated in the relevant special
resolution; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(e)</TD><TD STYLE="text-align: justify">the nominal amount of any securities shall be taken to be, in the case of rights to subscribe for
or to convert any securities into shares of the Company, the nominal amount of such shares which may be allotted pursuant to such
rights.</TD></TR></TABLE>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">8.</FONT></TD><TD STYLE="text-align: justify">Redeemable shares</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">Subject to the Companies Acts
and to any rights attaching to existing shares, any share may be issued which can be redeemed or is liable to be redeemed at the
option of the Company or the holder. The Board may determine the terms, conditions and manner of redemption of any redeemable shares
which are issued. Such terms and conditions shall apply to the relevant shares as if the same were set out in these Articles.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">9.</FONT></TD><TD STYLE="text-align: justify">Pari passu issues</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">If new shares are created or issued
which rank equally with any other existing shares, the rights of the existing shares will not be regarded as changed or abrogated
unless the terms of the existing shares expressly say otherwise.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">10.</FONT></TD><TD STYLE="text-align: justify">Variation of rights</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">10.1</TD><TD STYLE="text-align: justify">Subject to the Companies Acts, the rights attached to any class of shares can be varied or abrogated
either with the consent in writing of the holders of not less than three-quarters in nominal value of the issued share of that
class (excluding any shares of that class held as treasury shares) or with the authority of a special resolution passed at a separate
meeting of the holders of the relevant class of shares known as a <B>class meeting</B>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">10.2</TD><TD STYLE="text-align: justify">The provisions of this Article will apply to any variation or abrogation of rights of shares forming
part of a class. Each part of the class which is being treated differently is treated as a separate class in applying this Article.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">10.3</TD><TD STYLE="text-align: justify">All the provisions in these Articles as to general meetings shall apply, with any necessary modifications,
to every class meeting except that:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(a)</TD><TD STYLE="text-align: justify">the quorum at every such meeting shall not be less than two persons holding or representing by
proxy at least one-third of the nominal amount paid up on the issued shared of the class ) (excluding any shares of that class
held as treasury shares); and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(b)</TD><TD STYLE="text-align: justify">if at any adjourned meeting of such holders such quorum as set out above is not present, at least
one person holding shares of the class who is present in person or by proxy shall be a quorum.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">10.4</TD><TD STYLE="text-align: justify">The Board may convene a class meeting whenever it thinks fit and whether or not the business to
be transacted involves a variation or abrogation of class rights.</TD></TR></TABLE>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">11.</FONT></TD><TD STYLE="text-align: justify">Payment of commission</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">The Company may in connection
with the issue of any shares or the sale for cash of treasury shares exercise all powers of paying commission and brokerage conferred
or permitted by the Companies Acts. Any such commission or brokerage may be satisfied by the payment of cash or by the allotment
of fully or partly paid shares or other securities or the grant of an option to call for an allotment of shares or any combination
of such methods.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">12.</FONT></TD><TD STYLE="text-align: justify">Trusts not recognised</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">Except as otherwise expressly
provided by these Articles, required by law or as ordered by a court of competent jurisdiction, the Company shall not recognise
any person as holding any share on any trust, and the Company shall not be bound by or required in any way to recognise (even when
having notice of it) any equitable, contingent, future, partial or other claim to or interest in any share other than an absolute
right of the holder of the whole of the share.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">13.</FONT></TD><TD STYLE="text-align: justify">Uncertificated shares</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">13.1</TD><TD STYLE="text-align: justify">Under and subject to the uncertificated securities rules, the Board may permit title to shares
of any class to be evidenced otherwise than by certificate and title to shares of such a class to be transferred by means of a
relevant system and may make arrangements for a class of shares (if all shares of that class are in all respects identical) to
become a participating class. Title to shares of a particular class may only be evidenced otherwise than by a certificate where
that class of shares is at the relevant time a participating class. The Board may also, subject to compliance with the uncertificated
securities rules, determine at any time that title to any class of shares may from a date specified by the Board no longer be evidenced
otherwise than by a certificate or that title to such a class shall cease to be transferred by means of any particular relevant
system.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">13.2</TD><TD STYLE="text-align: justify">In relation to a class of shares which is a participating class and for so long as it remains a
participating class, no provision of these Articles shall apply or have effect to the extent that it is inconsistent in any respect
with:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(a)</TD><TD STYLE="text-align: justify">the holding of shares of that class in uncertificated form;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(b)</TD><TD STYLE="text-align: justify">the transfer of title to shares of that class by means of a relevant system; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(c)</TD><TD STYLE="text-align: justify">any provision of the uncertificated securities rules;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">and, without prejudice to the
generality of this Article, no provision of these Articles shall apply or have effect to the extent that it is in any respect inconsistent
with the maintenance, keeping or entering up by the Operator, so long as that is permitted or required by the uncertificated securities
rules, of an Operator register of securities in respect of that class of shares in uncertificated form.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">13.3</TD><TD STYLE="text-align: justify">Shares of a class which is at the relevant time a participating class may be changed from uncertificated
to certificated form, and from certificated to uncertificated form, in accordance with and subject as provided in the uncertificated
securities rules.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">13.4</TD><TD STYLE="text-align: justify">If, under these Articles or the Companies Acts, the Company is entitled to sell, transfer or otherwise
dispose of, forfeit, re-allot, accept the surrender of or otherwise enforce a lien over an uncertificated share, then, subject
to these Articles and the Companies Acts, such entitlement shall include the right of the Board to:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(a)</TD><TD STYLE="text-align: justify">require the holder of the uncertificated share by notice in writing to change that share from uncertificated
to certificated form within such period as may be specified in the notice and keep it as a certificated share for as long as the
Board requires;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(b)</TD><TD STYLE="text-align: justify">appoint any person to take such other steps, by instruction given by means of a relevant system
or otherwise, in the name of the holder of such share as may be required to effect the transfer of such share and such steps shall
be as effective as if they had been taken by the registered holder of that share; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(c)</TD><TD STYLE="text-align: justify">take such other action that the Board considers appropriate to achieve the sale, transfer, disposal,
forfeiture, re-allotment or surrender of that share or otherwise to enforce a lien in respect of that share.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">13.5</TD><TD STYLE="text-align: justify">Unless the Board determines otherwise, shares which a member holds in uncertificated form shall
be treated as separate holdings from any shares which that member holds in certificated form but a class of shares shall not be
treated as two classes simply because some shares of that class are held in certificated form and others in uncertificated form.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">13.6</TD><TD STYLE="text-align: justify">Unless the Board determines otherwise or the uncertificated securities rules require otherwise,
any shares issued or created out of or in respect of any uncertificated shares shall be uncertificated shares and any shares issued
or created out of or in respect of any certificated shares shall be certificated shares.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">13.7</TD><TD STYLE="text-align: justify">The Company shall be entitled to assume that the entries on any record of securities maintained
by it in accordance with the uncertificated securities rules and regularly reconciled with the relevant Operator register of securities
are a complete and accurate reproduction of the particulars entered in the Operator register of securities and shall accordingly
not be liable in respect of any act or thing done or omitted to be done by or on behalf of the Company in reliance on such assumption.
Any provision of these Articles which requires or envisages that action will be taken in reliance on information contained in the
Register shall be construed to permit that action to be taken in reliance on information contained in any relevant record of securities
(as so maintained and reconciled).</TD></TR></TABLE>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">14.</FONT></TD><TD STYLE="text-align: justify">Share certificates</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">14.1</TD><TD STYLE="text-align: justify">Every person (except a person to whom the Company is not by law required to issue a certificate)
whose name is entered in the Register as a holder of any certificated shares shall be entitled, without charge, to receive within
the time limits prescribed by the Companies Acts (unless the terms of issue prescribe otherwise) one certificate for all of the
shares of that class registered in his name.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">14.2</TD><TD STYLE="text-align: justify">The Company shall not be bound to issue more than one certificate in respect of shares held jointly
by two or more persons. Delivery of a certificate to the person first named in the Register shall be sufficient delivery to all
joint holders.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">14.3</TD><TD STYLE="text-align: justify">Where a member has transferred part only of the shares comprised in a certificate, he shall be
entitled without charge to a certificate for the balance of such shares to the extent that the balance is to be held in certificated
form. Where a member receives more shares of any class, he shall be entitled without charge to a certificate for the extra shares
of that class to the extent that the balance is to be held in certificated form.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">14.4</TD><TD STYLE="text-align: justify">A share certificate may be issued under Seal (by affixing the Seal to or printing the Seal or a
representation of it on the certificate) or signed by at least two Directors or by at least one Director and the Secretary. Such
certificate shall specify the number and class of the shares in respect of which it is issued and the amount or respective amounts
paid up on it. The Board may be resolution decide, either generally or in any particular case or cases, that any signatures on
any share certificates need not be autographic but may be applied to the certificates by some mechanical or other means or may
be printed on them or that the certificates need not be signed by any person.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">14.5</TD><TD STYLE="text-align: justify">Every share certificate sent in accordance with these Articles will be sent at the risk of the
member or other person entitled to the certificate. The Company will not be responsible for any share certificate lost or delayed
in the course of delivery.</TD></TR></TABLE>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">15.</FONT></TD><TD STYLE="text-align: justify">Replacement certificates</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">15.1</TD><TD STYLE="text-align: justify">Any two or more certificates representing shares of any one class held by any member may at his
request be cancelled and a single new certificate for such shares issued in lieu without charge on surrender of the original certificates
for cancellation.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">15.2</TD><TD STYLE="text-align: justify">Any certificate representing shares of any one class held by any member may at his request be cancelled
and two or more certificates for such shares may be issued instead.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">15.3</TD><TD STYLE="text-align: justify">If a share certificate is defaced, worn out or said to be stolen, lost or destroyed, it may be
replaced on such terms as to evidence and indemnity as the Board may decide and, where it is defaced or worn out, after delivery
of the old certificate to the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">15.4</TD><TD STYLE="text-align: justify">The Board may require the payment of any exceptional out-of-pocket expenses of the Company incurred
in connection with the issue of any certificates under this Article. In the case of shares held jointly by several persons, any
such request as is mentioned in this Article may be made by any one of the joint holders.</TD></TR></TABLE>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">16.</FONT></TD><TD STYLE="text-align: justify">Lien on shares not fully paid</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">The Company shall have a first
and paramount lien on every share, not being a fully paid share, for all amounts payable to the Company (whether presently or not)
in respect of that share. The Company&rsquo;s lien over a share takes priority over any third party&rsquo;s interest in that share, and extends
to any dividend or other money payable by the Company in respect of that share (and, if the lien is enforced and the share is sold
by the Company, the proceeds of sale of that share). The Board may at any time, either generally or in any particular case, waive
any lien that has arisen or declare any share to be wholly or in part exempt from the provisions of this Article.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase"></FONT></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">17.</FONT></TD><TD STYLE="text-align: justify">Enforcement of lien by sale</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">The Company may sell, in such
manner as the Board may decide, any share over which the Company has a lien if a sum in respect of which the lien exists is presently
payable and is not paid within 14 clear days after a notice has been served on the holder of the share or the person who is entitled
by transmission to the share, demanding payment and stating that if the notice is not complied with the share may be sold. For
giving effect to the sale, in the case of a certificated share, the Board may authorise some person to sign an instrument of transfer
of the share sold to, or in accordance with the directions, of the buyer. In the case of an uncertificated share, the Board may
require the Operator to convert the share into certificated form and after such conversion, authorise any person to sign the instrument
of transfer of the share to effect the sale of the share. The buyer shall not be bound to see to the application of the purchase
money, nor shall his title to the share be affected by any irregularity or invalidity in the proceedings in reference to the sale.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">18.</FONT></TD><TD STYLE="text-align: justify">Application of proceeds of sale</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">The net proceeds of any sale of
shares subject to any lien, after payment of the costs, shall be applied:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(a)</TD><TD STYLE="text-align: justify">first, in or towards satisfaction of so much of the amount due to the Company or of the liability
or engagement (as the case may be) as is presently payable or is liable to be presently fulfilled or discharged; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(b)</TD><TD STYLE="text-align: justify">second, any residue shall be paid to the person who was entitled to the share at the time of the
sale but only after the certificate for the shares sold has been surrendered to the company for cancellation, or an indemnity in
a form reasonably satisfactory to the directors has been given for any lost certificates, and subject to a like lien for debts
or liabilities not presently payable as existed on the share prior to the sale.</TD></TR></TABLE>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">19.</FONT></TD><TD STYLE="text-align: justify">Calls</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">19.1</TD><TD STYLE="text-align: justify">Subject to these Articles and the terms on which the shares are allotted, the Board may from time
to time make calls on the members in respect of any monies unpaid on their shares (whether in respect of nominal value or premium)
and not payable on a date fixed by or in accordance with the terms of issue.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">19.2</TD><TD STYLE="text-align: justify">Each member shall (subject to the Company serving upon him at least 14 clear days&rsquo; notice specifying
when and where payment is to be made and whether or not by instalments) pay to the Company as required by the notice the amount
called on for his shares.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">19.3</TD><TD STYLE="text-align: justify">A call shall be deemed to have been made at the time when the resolution of the Board authorising
the call was passed.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">19.4</TD><TD STYLE="text-align: justify">A call may be revoked or postponed, in whole or in part, as the Board may decide.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">19.5</TD><TD STYLE="text-align: justify">Liability to pay a call is not extinguished or transferred by transferring the shares in respect
of which the call is required to be paid.</TD></TR></TABLE>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">20.</FONT></TD><TD STYLE="text-align: justify">Liability of joint holders</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">The joint holders of a share shall
be jointly and severally liable to pay all calls in respect of the share.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">21.</FONT></TD><TD STYLE="text-align: justify">Interest on calls</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">If a call remains unpaid after
it has become due and payable, the person from whom it is due and payable shall pay all expenses that have been incurred by the
Company by reason of such non-payment together with interest on the amount unpaid from the day it is due and payable to the time
of actual payment at such rate (not exceeding the Bank of England base rate by more than five percentage points) as the Board may
decide. The Board may waive payment of the interest or the expenses in whole or in part.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">22.</FONT></TD><TD STYLE="text-align: justify">Power to differentiate</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">On or before the issue of shares,
the Board may decide that allottees or holders of shares can be called on to pay different amounts or that they can be called on
at different times.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">23.</FONT></TD><TD STYLE="text-align: justify">Payment of calls in advance</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">The Board may, if it thinks fit,
receive from any member willing to advance the same, all or any part of the monies uncalled and unpaid on the shares held by him.
Such payment in advance of calls shall, to the extent of the payment, extinguish the liability on the shares on which it is made.
The Company may pay interest on the money paid in advance, or so much of it as exceeds the amount for the time being called upon
the shares in respect of which such advance has been made, at such rate as the Board may decide. The Board may at any time repay
the amount so advanced by giving at least three months&rsquo; notice in writing to such member of its intention to do so, unless before
the expiration of such notice the amount so advanced shall have been called up on the shares in respect of which it was advanced.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">24.</FONT></TD><TD STYLE="text-align: justify">Notice if call or instalment not paid</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">If any member fails to pay the
whole of any call (or any instalment of any call) by the date when payment is due, the Board may at any time give notice in writing
to such member (or to any person entitled to the shares by transmission), requiring payment of the amount unpaid (and any accrued
interest and any expenses incurred by the Company by reason of such non-payment) by a date not less than 14 clear days from the
date of the notice. The notice shall name the place where the payment is to be made and state that, if the notice is not complied
with, the shares in respect of which such call was made will be liable to be forfeited.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase"></FONT></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">25.</FONT></TD><TD STYLE="text-align: justify">Forfeiture for non-compliance</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">If the notice referred to in Article
24 is not complied with, any share for which it was given may be forfeited, by resolution of the Board to that effect, at any time
before the payment required by the notice has been made. Such forfeiture shall include all dividends declared or other monies payable
in respect of the forfeited shares and not paid before the forfeiture.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">26.</FONT></TD><TD STYLE="text-align: justify">Notice after forfeiture</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">When any share has been forfeited,
notice of the forfeiture shall be served on the holder of the share or the person entitled to such share by transmission (as the
case may be) before forfeiture. An entry of such notice having been given and of the forfeiture and the date of forfeiture shall
immediately be made in the Register in respect of such share. However, no forfeiture shall be invalidated by any omission to give
such notice or to make such entry in the Register.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">27.</FONT></TD><TD STYLE="text-align: justify">Forfeiture may be annulled</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">The Board may annul the forfeiture
of a share, at any time before any forfeited share has been cancelled or sold, re-allotted or otherwise disposed of, on the terms
that payment shall be made of all calls and interest due on it and all expenses incurred in respect of the share and on such further
terms (if any) as the Board shall see fit.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">28.</FONT></TD><TD STYLE="text-align: justify">Surrender</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">The Board may accept the surrender
of any share liable to be forfeited and, in any event, references in these Articles to forfeiture shall include surrender.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">29.</FONT></TD><TD STYLE="text-align: justify">Sale of forfeited shares</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">29.1</TD><TD STYLE="text-align: justify">A forfeited share shall become the property of the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">29.2</TD><TD STYLE="text-align: justify">Subject to the Companies Acts, any such share may be sold, re-allotted or otherwise disposed of,
on such terms and in such manner as the Board thinks fit.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">29.3</TD><TD STYLE="text-align: justify">The Board may, for the purposes of the disposal, authorise some person to transfer the share in
question and may enter the name of the transferee in respect of the transferred share in the Register even if no share certificate
is lodged and may issue a new certificate to the transferee. An instrument of transfer executed by that person shall be as effective
as if it had been executed by the holder of, or the person entitled by transmission to, the share. The Company may receive the
consideration (if any) given for the share on its disposal.</TD></TR></TABLE>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase"></FONT></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">30.</FONT></TD><TD STYLE="text-align: justify">Effect of forfeiture</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">A shareholder whose shares have
been forfeited shall cease to be a member in respect of such forfeited shares and shall surrender the certificate for such shares
to the Company for cancellation. Such shareholder shall remain liable to pay to the Company all sums which at the date of forfeiture
were presently payable by him to the Company in respect of such shares with interest (not exceeding the Bank of England base rate
by 2 percentage points) from the date of the forfeiture to the date of payment. The Directors may waive payment of interest wholly
or in part and may enforce payment, without any reduction or allowance for the value of the shares at the time of forfeiture or
for any consideration received on their disposal.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">31.</FONT></TD><TD STYLE="text-align: justify">Evidence of forfeiture</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">A statutory declaration by a Director
or the Secretary that a share has been forfeited on a specified date shall be conclusive evidence of the facts stated in it as
against all persons claiming to be entitled to the share. The declaration shall (subject to the execution of an instrument of transfer
if necessary) constitute a good title to the share. The person to whom the share is transferred or sold shall not be bound to see
to the application of the purchase money or other consideration (if any), nor shall his title to the share be affected by any act,
omission or irregularity relating to or connected with the proceedings in reference to the forfeiture or disposal of the share.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">32.</FONT></TD><TD STYLE="text-align: justify">Form of transfer</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">32.1</TD><TD STYLE="text-align: justify">Subject to these Articles:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(a)</TD><TD STYLE="text-align: justify">each member may transfer all or any of his shares which are in certificated form by instrument
of transfer in writing in any usual form or in any form approved by the Board. Such instrument shall be executed by or on behalf
of the transferor and (in the case of a transfer of a share which is not fully paid up) by or on behalf of the transferee. All
instruments of transfer, when registered, may be retained by the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(b)</TD><TD STYLE="text-align: justify">each member may transfer all or any of his shares which are in uncertificated form by means of
a relevant system in such manner provided for, and subject as provided in, the uncertificated securities rules. No provision of
these Articles shall apply in respect of an uncertificated share to the extent that it requires or contemplates the effecting of
a transfer by an instrument in writing or the production of a certificate for the share to be transferred.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">32.2</TD><TD STYLE="text-align: justify">The transferor of a share shall be deemed to remain the holder of the share concerned until the
name of the transferee is entered in the Register in respect of it.</TD></TR></TABLE>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase"></FONT></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">33.</FONT></TD><TD STYLE="text-align: justify">Right to refuse registration of transfer</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">33.1</TD><TD STYLE="text-align: justify">The Board may, in its absolute discretion, refuse to register any transfer of a share in certificated
form (or renunciation of a renounceable letter of allotment) unless:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(a)</TD><TD STYLE="text-align: justify">it is for a share which is fully paid up;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(b)</TD><TD STYLE="text-align: justify">it is for a share upon which the Company has no lien;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(c)</TD><TD STYLE="text-align: justify">it is only for one class of share;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(d)</TD><TD STYLE="text-align: justify">it is in favour of a single transferee or no more than four joint transferees;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(e)</TD><TD STYLE="text-align: justify">it is duly stamped or is duly certificated or otherwise shown to the satisfaction of the Board
to be exempt from stamp duty (if this is required); and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(f)</TD><TD STYLE="text-align: justify">it is delivered for registration to the Office (or such other place as the Board may determine),
accompanied (except in the case of a transfer by a person to whom the Company is not required by law to issue a certificate and
to whom a certificate has not been issued or in the case of a renunciation) by the certificate for the shares to which it relates
and such other evidence as the Board may reasonably require to prove the title of the transferor (or person renouncing) and the
due execution of the transfer or renunciation by him or, if the transfer or renunciation is executed by some other person on his
behalf, the authority of that person to do so.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">33.2</TD><TD STYLE="text-align: justify">The Board shall not refuse to register any transfer or renunciation of partly paid shares which
are admitted to the Official List on the grounds that they are partly paid shares in circumstances where such refusal would prevent
dealings in such shares from taking place on an open and proper basis.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">33.3</TD><TD STYLE="text-align: justify">Transfers of shares will not be registered in the circumstances referred to in Article 70.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">33.4</TD><TD STYLE="text-align: justify">The Board may refuse to register a transfer of uncertificated shares in any circumstances that
are allowed or required by the uncertificated securities rules and the relevant system.</TD></TR></TABLE>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">34.</FONT></TD><TD STYLE="text-align: justify">Notice of refusal to register a transfer</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">If the Board refuses to register
a transfer of a share it shall notify the transferee of the refusal and the reasons for it within two months after the date on
which the transfer was lodged with the Company or the instructions to the relevant system received. Any instrument of transfer
which the Board refuses to register shall be returned to the person depositing it (except if there is suspected or actual fraud).
All instruments of transfer which are registered may be retained by the Company.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase"></FONT></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">35.</FONT></TD><TD STYLE="text-align: justify">No fees on registration</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">No fee shall be charged for registration
of a transfer or other document or instruction relating to or affecting the title to any share or for making any other entry in
the Register.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">36.</FONT></TD><TD STYLE="text-align: justify">Other powers in relation to transfers</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">Nothing in these Articles shall
prevent the Board:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(a)</TD><TD STYLE="text-align: justify">from recognising a renunciation of the allotment of any share by the allottee in favour of another
person; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(b)</TD><TD STYLE="text-align: justify">(if empowered to do so by these Articles) from authorising any person to execute an instrument
of transfer of a share and from authorising any person to transfer that share in accordance with any procedures implemented under
Article 17.</TD></TR></TABLE>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">37.</FONT></TD><TD STYLE="text-align: justify">Transmission of shares on death</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">If a member dies, the survivors
or survivor (where he was a joint holder), and his executors or administrators (where he was a sole or the only survivor of joint
holders), shall be the only persons recognised by the Company as having any title to his shares. Nothing in these Articles shall
release the estate of a deceased member from any liability for any share which has been solely or jointly held by him.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">38.</FONT></TD><TD STYLE="text-align: justify">Election of person entitled by transmission</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">38.1</TD><TD STYLE="text-align: justify">Any person becoming entitled to a share because of the death or bankruptcy of a member, or otherwise
by operation of law, may (on such evidence as to his title being produced as the Board may require) elect either to become registered
as a member or to have some person nominated by him registered as a member. If he elects to become registered himself, he shall
notify the Company to that effect. If he elects to have some other person registered, he shall execute an instrument of transfer
of such share to that person. All the provisions of these Articles relating to the transfer of shares shall apply to the notice
or instrument of transfer (as the case may be) as if it were an instrument of transfer executed by the member and his death, bankruptcy
or other event had not occurred. Where the entitlement of a person to a share because of the death or bankruptcy of a member or
otherwise by operation of law is proved to the satisfaction of the Board, the Board shall within 30 days after proof cause the
entitlement of that person to be noted in the Register.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">38.2</TD><TD STYLE="text-align: justify">A person entitled by transmission to a share in uncertificated form who elects to have some other
person registered shall either:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(a)</TD><TD STYLE="text-align: justify">procure that instructions are given by means of the relevant system to effect transfer of such
uncertificated share to that person; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(b)</TD><TD STYLE="text-align: justify">change the uncertificated share to certificated form and execute an instrument of transfer of that
certificated share to that person.</TD></TR></TABLE>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">39.</FONT></TD><TD STYLE="text-align: justify">Rights on transmission</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">Where a person becomes entitled
to a share because of the death or bankruptcy of any member, or otherwise by operation of law, the rights of the holder in relation
to such share shall cease. However, the person so entitled may give a good discharge for any dividends and other monies payable
in respect of it and shall have the same rights to which he would be entitled if he were the holder of the share, except that he
shall not be entitled to receive notice of, or to attend or vote at, any meeting of the Company or an separate meeting of the holders
of any class of shares of the Company before he is registered as the holder of the share. The Board may at any time give notice
requiring any such person to elect either to be registered himself or to transfer the share. If the notice is not complied with
within 30 days, the Board may withhold payment of all dividends and the other monies payable in respect of such share until the
requirements of the notice have been complied with.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">40.</FONT></TD><TD STYLE="text-align: justify">Destruction of documents</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">40.1</TD><TD STYLE="text-align: justify">The Company may destroy any:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(a)</TD><TD STYLE="text-align: justify">instrument of transfer, after six years from the date on which it is registered;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(b)</TD><TD STYLE="text-align: justify">dividend mandate or any variation or cancellation of a dividend mandate or any notification of
change of name or address, after two years from the date on which it is recorded;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(c)</TD><TD STYLE="text-align: justify">share certificate, after one year from the date on which it is cancelled;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(d)</TD><TD STYLE="text-align: justify">instrument of proxy which has been used for the purpose of a poll at any time after one year has
elapsed from the date of use;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(e)</TD><TD STYLE="text-align: justify">instrument of proxy which has not been used for the purpose of a poll at any time after a period
of one month has elapsed from the end of the meeting to which the instrument of proxy relates;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(f)</TD><TD STYLE="text-align: justify">Share Warrant (including coupons or tokens detailed from it) which has been cancelled at any time
after seven years from the date on which it was cancelled; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(g)</TD><TD STYLE="text-align: justify">other document for which any entry in the Register is made, after six years from the date on which
an entry was first made in the Register in respect of it,</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">provided that the Company may
destroy any such type of document at a date earlier than that authorised by this Article if a copy of such document is made and
retained (whether electronically, by microfilm, by digital imaging or by other similar means) until the expiration of the period
applicable to the destruction of the original of such document.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">40.2</TD><TD STYLE="text-align: justify">It shall be conclusively presumed in favour of the Company that every:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(a)</TD><TD STYLE="text-align: justify">entry in the Register purporting to have been made on the basis of a document so destroyed was
duly and properly made;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(b)</TD><TD STYLE="text-align: justify">instrument of transfer so destroyed was duly registered;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(c)</TD><TD STYLE="text-align: justify">share certificate so destroyed was duly cancelled; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(d)</TD><TD STYLE="text-align: justify">other document so destroyed had been properly dealt with under its terms and was valid and effective
according to the particulars in the records of the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">40.3</TD><TD STYLE="text-align: justify">This Article shall only apply to the destruction of a document in good faith and without notice
of any claim (regardless of the parties to it) to which the document might be relevant. Nothing in this Article shall be construed
as imposing any liability on the Company in respect of the destruction of any such document other than as provided for in this
Article which would not attach to the Company in the absence of this Article. References in this Article to the destruction of
any document include references to the disposal of it in any manner.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">40.4</TD><TD STYLE="text-align: justify">References in this Article to instruments of transfer shall include, in relation to uncertificated
shares, instructions and/or notifications made in accordance with the relevant system relating to the transfer of such shares.</TD></TR></TABLE>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">41.</FONT></TD><TD STYLE="text-align: justify">Sub-division</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">Any resolution authorising the
Company to sub-divide its shares or any of them may determine that, as between the shares resulting from the sub-division, any
of them may have any preference or advantage or be subject to any restriction as compared with the others.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">42.</FONT></TD><TD STYLE="text-align: justify">Fractions</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">If any shares are consolidated
or consolidated and then divided, the Board has power to deal with any fractions of shares which result. If the Board decides to
sell any shares representing fractions, it can do so for the best price reasonably obtainable and distribute the net proceeds of
sale among members in proportion to their fractional entitlements. The Board can arrange for any shares representing fractions
to be entered in the Register as certificated shares if they consider that this makes it easier to sell them. The Board can sell
those shares to anyone, including the Company if the legislation allows, and may authorise any person to transfer or deliver the
shares to the buyer or in accordance with the buyer&rsquo;s instructions. The buyer shall not be bound to see to the application of the
purchase money, nor shall his title to the share be affected by any irregularity or invalidity in the proceedings in reference
to the sale.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase"></FONT></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">43.</FONT></TD><TD STYLE="text-align: justify">Annual general meetings</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">An annual general meeting shall
be held once a year, at such time (consistent with the terms of the Companies Acts) and place as may be determined by the Board.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">44.</FONT></TD><TD STYLE="text-align: justify">Convening of general meetings</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">All meetings other than annual
general meetings shall be called general meetings. The Board may, whenever it thinks fit, and shall on requisition in accordance
with the Companies Acts, proceed to convene a general meeting.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">45.</FONT></TD><TD STYLE="text-align: justify">Notice of general meetings</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">A general meeting shall be called
by at least such minimum notice as is required or permitted by the Companies Acts. The period of notice shall in either case be
exclusive of the day on which it is served or deemed to be served and of the day on which the meeting is to be held and shall be
given to all members other than those who are not entitled to receive such notices from the Company. The Company may give such
notice by any means or combination of means permitted by the Companies Acts.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">46.</FONT></TD><TD STYLE="text-align: justify">Contents of notice of meetings</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">46.1</TD><TD STYLE="text-align: justify">Every notice calling a meeting shall specify the place, date and time of the meeting, and there
shall appear with reasonable prominence in every such notice a statement that a member entitled to attend and vote is entitled
to a proxy or (if he has more than one share) proxies to exercise all or any of his rights to attend, speak and vote and that a
proxy need not be a member of the Company. Such notice shall also include the address of the website on which the information required
by the Act is published, state the procedures with which members must comply in order to be able to attend and vote at the meeting
(including the date by which they must comply), provide details of any forms to be used for the appointment of a proxy and state
that a member has the right to ask questions at the meeting in accordance with the Act.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">46.2</TD><TD STYLE="text-align: justify">The notice shall specify the general nature of the business to be transacted at the meeting and
shall set out the text of all resolutions to be considered by the meeting and shall state in each case whether it is proposed as
an ordinary resolution or as a special resolution.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">46.3</TD><TD STYLE="text-align: justify">In the case of an annual general meeting, the notice shall also specify the meeting as such</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"></P>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">46.4</TD><TD STYLE="text-align: justify">For the purposes of determining which persons are entitled to attend or vote at a meeting and how
many votes a person may cast, the Company may specify in the notice of meeting a time, not more than 48 hours before the time fixed
for the meeting (not taking into account non-working days) by which a person must be entered in the Register in order to have the
right to attend or vote at the meeting or appoint a proxy to do so.</TD></TR></TABLE>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">47.</FONT></TD><TD STYLE="text-align: justify">Omission to give notice and non-receipt of notice</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">The accidental omission to give
notice of any meeting or to send an instrument of proxy (where this is intended to be sent out with the notice) to, or the non-receipt
of either by, any person entitled to receive the same shall not invalidate the proceedings of that meeting.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">48.</FONT></TD><TD STYLE="text-align: justify">Postponement of general meeting</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">If the Board considers that it
is impracticable or unreasonable to hold a general meeting on the date or at the time or place stated in the notice calling the
meeting, it may postpone or move the meeting (or do both). The Board shall take reasonable steps to ensure that notice of the date,
time and place of the rearranged meeting is given to any member trying to attend the meeting at the original time and place. Notice
of the date, time and place of the rearranged meeting shall, if practicable, also be placed in at least two national newspapers
published in the United Kingdom. Notice of the business to be transacted at such rearranged meeting shall not be required. If a
meeting is rearranged in this way, appointments of proxy are valid if they are received as required by these Articles not less
than 48 hours before the time appointed for holding the rearranged meeting and for the purpose of calculating this period, the
Board can decide in their absolute discretion, not to take account of any part of a day that is not a working day. The Board may
also postpone or move the rearranged meeting (or do both) under this Article.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">49.</FONT></TD><TD STYLE="text-align: justify">Quorum at general meeting</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">No business shall be transacted
at any general meeting unless a quorum is present. If a quorum is not present a chairman of the meeting can still be chosen and
this will not be treated as part of the business of the meeting. Two members present in person or by proxy and entitled to attend
and to vote on the business to be transacted shall be a quorum.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">50.</FONT></TD><TD STYLE="text-align: justify">Procedure if quorum not present</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">If a quorum is not present within
fifteen minutes (or such longer interval as the chairman in his absolute discretion thinks fit) from the time appointed for holding
a general meeting, or if a quorum ceases to be present during a meeting, the meeting shall be dissolved if convened on the requisition
of members. In any other case, the meeting shall stand adjourned to another day, (not being less than ten clear days after the
date of the original meeting), and at such time and place as the chairman (or, in default, the Board) may determine. If at such
adjourned meeting a quorum is not present within fifteen minutes from the time appointed for holding the meeting, one person entitled
to vote on the business to be transacted, being a member or a proxy for a member or a duly authorised representative of a corporation
which is a member, shall be a quorum and any notice of an adjourned meeting shall state this.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase"></FONT></P>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">51.</FONT></TD><TD STYLE="text-align: justify">Chairman of general meeting</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">The chairman of the Board shall
preside at every general meeting of the Company. If there is no such chairman or if at any meeting he shall not be present within
five minutes after the time appointed for holding the meeting, or shall be unwilling to act as chairman, the deputy chairman (if
any) of the Board shall, if present and willing to act, preside at such meeting. If more than one deputy chairman is present they
shall agree amongst themselves who is to take the chair or, if they cannot agree, the deputy chairman who has been in office as
a director the longest shall take the chair. If no chairman or deputy chairman shall be so present and willing to act, the Directors
present shall choose one of their number to act or, if there be only one Director present, he shall be chairman if willing to act.
If there be no Director present and willing to act, the members present and entitled to vote shall choose one of their number to
be chairman of the meeting. Nothing in these Articles shall restrict or exclude any of the powers or rights of a chairman of a
meeting which are given by law.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"></P>



<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">52.</FONT></TD><TD STYLE="text-align: justify">Entitlement to attend and speak</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">A Director (and any other person
invited by the chairman to do so) may attend and speak at any general meeting and at any separate meeting of the holders of any
class of shares of the Company, whether or not he is a member.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">53.</FONT></TD><TD STYLE="text-align: justify">Adjournments</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">The chairman may, with the consent
of a meeting at which a quorum is present, and shall, if so directed by the meeting, adjourn any meeting from time to time (or
indefinitely) and from place to place as the meeting shall determine. However, without prejudice to any other power which he may
have under these Articles or at common law, the chairman may, without the need for the consent of the meeting, interrupt or adjourn
any meeting from time to time and from place to place or for an indefinite period if he is of the opinion that it has become necessary
to do so in order to secure the proper and orderly conduct of the meeting or to give all persons entitled to do so a reasonable
opportunity of attending, speaking and voting at the meeting or to ensure that the business of the meeting is properly disposed
of.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase"></FONT></P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">54.</FONT></TD><TD STYLE="text-align: justify">Notice of adjournment</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">If the meeting is adjourned indefinitely
or for more than three months, notice of the adjourned meeting shall be given in the same manner as in the case of the original
meeting. Except as provided in these Articles, there is no need to give notice of the adjourned meeting or of the business to be
considered there.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">55.</FONT></TD><TD STYLE="text-align: justify">Business of adjourned meeting</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">No business shall be transacted
at any adjourned meeting other than the business which might properly have been transacted at the meeting from which the adjournment
took place.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">56.</FONT></TD><TD STYLE="text-align: justify">Security arrangements and orderly conduct</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">56.1</TD><TD STYLE="text-align: justify">The Board may direct that any person wishing to attend any meeting should provide such evidence
of identity and submit to such searches or other security arrangements or restrictions as the Board shall consider appropriate
in the circumstances and shall be entitled in its absolute discretion to refuse entry to any meeting to any person who fails to
provide such evidence of identity or to submit to such searches or to otherwise comply with such security arrangements or restrictions.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">56.2</TD><TD STYLE="text-align: justify">The chairman shall take such action or give directions as he thinks fit to promote the orderly
conduct of the business of the meeting as laid down in the notice of the meeting and to ensure the security of the meeting and
the safety of the people attending the meeting. The chairman&rsquo;s decision on matters of procedure or arising incidentally from the
business of the meeting shall be final as shall be his determination as to whether any matter is of such a nature.</TD></TR></TABLE>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">57.</FONT></TD><TD STYLE="text-align: justify">Overflow meeting rooms</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">57.1</TD><TD STYLE="text-align: justify">The Board may, in accordance with this Article, make arrangements for members and proxies who are
entitled to attend and participate in a general meeting, but who cannot be seated in the main meeting room where the chairman will
be, to attend and take part in a general meeting in an overflow room or rooms. Any overflow room will have appropriate links to
the main room and will enable audio-visual communication between the meeting rooms throughout the meeting. The Board will decide
how to divide members and proxies between the main room and the overflow room. If an overflow room is used, the meeting will be
treated as being held and taking place in the main meeting room and the meeting will consist of all the members and proxies who
are attending both in the main meeting room and the overflow room.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">57.2</TD><TD STYLE="text-align: justify">Details of any arrangements for overflow rooms will be set out in the notice of the meeting but
failure to do so will not invalidate the meeting.</TD></TR></TABLE>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">58.</FONT></TD><TD STYLE="text-align: justify">Satellite meeting places</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">58.1</TD><TD STYLE="text-align: justify">To facilitate the organisation and administration of any general meeting, the Board may decide
that the meeting shall be held at two or more locations.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"></P>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">58.2</TD><TD STYLE="text-align: justify">For the purposes of these Articles, any general meeting of the Company taking place at two or more
locations shall be treated as taking place where the chairman of the meeting presides ( the <B>principal meeting place</B>) and
any other location where that meeting takes place is referred in these Articles as a <B>satellite meeting</B>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">58.3</TD><TD STYLE="text-align: justify">A member present in person or by proxy at a satellite meeting may be counted in the quorum and
may exercise all rights that they would have been able to exercise if they were present at the principal meeting place.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">58.4</TD><TD STYLE="text-align: justify">The Board may make and change from time to time such arrangements as they shall in their absolute
discretion consider appropriate to:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(a)</TD><TD STYLE="text-align: justify">ensure that all members and proxies for members wishing to attend the meeting can do so;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(b)</TD><TD STYLE="text-align: justify">ensure that all persons attending the meeting are able to participate in the business of the meeting
and to see and hear anyone else addressing the meeting;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(c)</TD><TD STYLE="text-align: justify">ensure the safety of persons attending the meeting and the orderly conduct of the meeting; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(d)</TD><TD STYLE="text-align: justify">restrict the numbers of members and proxies at any one location to such number as can safely and
conveniently be accommodated there.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">58.5</TD><TD STYLE="text-align: justify">The entitlement of any member or proxy to attend a satellite meeting shall be subject to any such
arrangements then in force and stated by the notice of the meeting or adjourned meeting to apply to the meeting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">58.6</TD><TD STYLE="text-align: justify">If there is a failure of communication equipment or any other failure in the arrangements for participation
in the meeting at more than one place, the chairman may adjourn the meeting in accordance with Article 53. Such adjournment will
not affect the validity of such meeting, or any business conducted at such meeting up to the point of adjournment, or any action
taken pursuant to such meeting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">58.7</TD><TD STYLE="text-align: justify">A person (<B>satellite chairman</B>) appointed by the Board shall preside at each satellite meeting.
Every satellite chairman shall carry out all requests made of him by the chairman of the meeting, may take such action as he thinks
necessary to maintain the proper and orderly conduct of the satellite meeting and shall have all powers necessary or desirable
for such purposes.</TD></TR></TABLE>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">59.</FONT></TD><TD STYLE="text-align: justify">Amendment to resolutions</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">59.1</TD><TD STYLE="text-align: justify">If an amendment to any resolution under consideration is proposed but is ruled out of order by
the chairman of the meeting in good faith, any error in such ruling shall not invalidate the proceedings on the original resolution.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"></P>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">59.2</TD><TD STYLE="text-align: justify">In the case of a resolution duly proposed as a special resolution, no amendment to it (other than
an amendment to correct a patent error) may in any event be considered or voted on. In the case of a resolution duly proposed as
an ordinary resolution no amendment to it (other than an amendment to correct a patent error) may be considered or voted on unless
either at least 48 hours prior to the time appointed for holding the meeting or adjourned meeting at which such ordinary resolution
is to be proposed, notice in writing of the terms of the amendment and intention to move the same has been lodged at the Office
or received in electronic form at the electronic address at which the Company has or is deemed to have agreed to receive it or
the chairman of the meeting in his absolute discretion decides that it may be considered or voted on.</TD></TR></TABLE>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">60.</FONT></TD><TD STYLE="text-align: justify">Members&rsquo; resolutions</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">60.1</TD><TD STYLE="text-align: justify">Members of the Company shall have the rights provided by the Companies Acts to have the Company
circulate and give notice of a resolution which may be properly moved, and is intended to be moved, at the Company&rsquo;s nest annual
general meeting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">60.2</TD><TD STYLE="text-align: justify">Expenses of complying with these rights shall be borne in accordance with the Companies Acts.</TD></TR></TABLE>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">61.</FONT></TD><TD STYLE="text-align: justify">Method of voting</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">61.1</TD><TD STYLE="text-align: justify">At any general meeting a resolution put to a vote of the meeting shall be decided on a show of
hands, unless (before or on the declaration of the result of the show of hands) a poll is duly demanded. Subject to the Companies
Acts, a poll may be demanded by:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(a)</TD><TD STYLE="text-align: justify">the chairman of the meeting; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(b)</TD><TD STYLE="text-align: justify">at least two members present in person (or by proxy) and entitled to vote at the meeting; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(c)</TD><TD STYLE="text-align: justify">a member or members present in person (or by proxy) representing at least one-tenth of the total
voting rights of all the members having the right to vote at the meeting; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(d)</TD><TD STYLE="text-align: justify">a member or members present in person (or by proxy) holding shares conferring a right to vote at
the meeting, being shares on which an aggregate sum has been paid up equal to at least one-tenth of the total sum paid up on all
the shares conferring that right.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">61.2</TD><TD STYLE="text-align: justify">The chairman of the meeting may also demand a poll before a resolution is put to the vote on a
show of hands.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"></P>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">61.3</TD><TD STYLE="text-align: justify">At general meetings, resolutions shall be put to the vote by the chairman of the meeting and there
shall be no requirement for the resolution to be proposed or seconded by any person.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">61.4</TD><TD STYLE="text-align: justify">Unless a poll is duly demanded and the demand is not withdrawn, a declaration by the chairman of
the meeting that a resolution has on a show of hands been carried, or carried unanimously or by a particular majority, or lost,
or not carried by a particular majority, and an entry to that effect in the book containing the minutes of proceedings of the Company,
shall be conclusive evidence of the fact, without proof of the number or proportion of the votes recorded in favour of or against
such resolution.</TD></TR></TABLE>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">62.</FONT></TD><TD STYLE="text-align: justify">Objection to error in voting</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">No objection shall be raised to
the qualification of any voter or to the counting of, or failure to count, any vote, except at the meeting or adjourned meeting
at which the vote objected to is given or tendered or at which the error occurs. Any objection or error shall be referred to the
chairman of the meeting and shall only vitiate the decision of the meeting on any resolution if the chairman decides that the same
is of sufficient magnitude to vitiate the resolution or may otherwise have affected the decision of the meeting. The decision of
the chairman of the meeting on such matters shall be final and conclusive.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">63.</FONT></TD><TD STYLE="text-align: justify">Procedure on a poll</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">63.1</TD><TD STYLE="text-align: justify">Any poll duly demanded on the election of a chairman or on any question of adjournment shall be
taken immediately. A poll duly demanded on any other matter shall be taken in such manner (including the use of ballot or voting
papers or tickets) and at such time and place, not more than 30 days from the date of the meeting or adjourned meeting at which
the poll was demanded, as the chairman shall direct. The chairman may appoint scrutineers who need not be members. It is not necessary
to give notice of a poll not taken immediately if the time and place at which it is to be taken are announced at the meeting at
which it is demanded. In any other case, at least seven clear days&rsquo; notice shall be given specifying the time, date and place
at the which the poll shall be taken. The result of the poll shall be deemed to be the resolution of the meeting at which the poll
was demanded.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">63.2</TD><TD STYLE="text-align: justify">The demand for a poll (other than on the election of a chairman or any question of adjournment)
shall not prevent the continuance of the meeting for the transaction of any business other than the question on which a poll has
been demanded.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">63.3</TD><TD STYLE="text-align: justify">The demand for a poll may, before the poll is taken, be withdrawn, but only with the consent of
the chairman of the meeting. A demand so withdrawn validates the result of a show of hands declared before the demand was made.
If a poll is demanded before the declaration of the result of a show of hands and the demand is duly withdrawn, the meeting shall
continue as if the demand had not been made.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">63.4</TD><TD STYLE="text-align: justify">On a poll votes may be given in person or by proxy. A member entitled to more than one vote need
not, if he votes, use all his votes or cast all the votes he uses in the same way.</TD></TR></TABLE>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"></P>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">64.</FONT></TD><TD STYLE="text-align: justify">Votes of members</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">64.1</TD><TD STYLE="text-align: justify">Subject to Article 64.2, the Companies Acts, to any special terms as to voting on which any shares
may have been issued or may for the time being be held and to any suspension or abrogation of voting rights under these Articles,
at any general meeting every member who is present in person (or by proxy) shall on a show of hands have one vote and every member
present in person (or by proxy) shall on a poll have one vote for each share of which he is the holder.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">64.2</TD><TD STYLE="text-align: justify">On a show of hands, a duly appointed proxy has one vote for and one vote against a resolution if
the proxy has been appointed by more than one member entitled to vote on the resolution and the proxy has been instructed:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(a)</TD><TD STYLE="text-align: justify">by one or more of those members to vote for the resolution and by one or more other of those members
to vote against it; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(b)</TD><TD STYLE="text-align: justify">by one or more of those members to vote either for or against the resolution and by one or more
other of those members to use his/her discretion as to how to vote.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">64.3</TD><TD STYLE="text-align: justify">If two or more persons are joint holders of a share, then in voting on any question the vote of
the senior who tenders a vote, whether in person or by proxy, shall be accepted to the exclusion of the votes of the other joint
holders. For this purpose seniority shall be determined by the order in which the names of the holders stand in the Register.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">64.4</TD><TD STYLE="text-align: justify">Where in England or elsewhere a receiver or other person (by whatever name called) has been appointed
by any court claiming jurisdiction in that behalf to exercise powers with respect to the property or affairs of any member on the
ground (however formulated) of mental disorder, the Board may in its absolute discretion, upon or subject to production of such
evidence of the appointment as the Board may require, permit such receiver or other person on behalf of such member to vote in
person, on a show of hands or on a poll, by proxy on behalf of such member at any general meeting or to exercise any other right
conferred by membership in relation to meetings of the Company. Evidence to the satisfaction of the Board of the authority of the
person claiming to exercise the right to vote shall be deposited at the Office, or at such other place as is specified in accordance
with these Articles for the deposit of instruments of proxy, at least 48 hours before the time appointed for holding the meeting
or adjourned meeting at which the right to vote is to be exercised and, in default, the right to vote shall not be exercisable.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">64.5</TD><TD STYLE="text-align: justify">In the case of equality of votes whether on a show of hands or on a poll, the chairman of the meeting
at which the show of hands takes place or at which the poll is demanded shall not be entitled to a casting vote.</TD></TR></TABLE>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"></P>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">65.</FONT></TD><TD STYLE="text-align: justify">No right to vote where sums overdue on shares</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">No member may vote at a general
meeting (or any separate meeting of the holders of any class of shares), either in person or by proxy, or to exercise any other
right or privilege as a member in respect of a share held by him unless:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(a)</TD><TD STYLE="text-align: justify">all calls or other sums presently due and payable by him in respect of that share whether alone
or jointly with any other person together with interest and expenses (if any) have been paid to the Company; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(b)</TD><TD STYLE="text-align: justify">the Board determines otherwise.</TD></TR></TABLE>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">66.</FONT></TD><TD STYLE="text-align: justify">Voting by Proxy</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">66.1</TD><TD STYLE="text-align: justify">Subject to Article 66.2, an instrument appointing a proxy shall be in writing in any usual form
(or in another form approved by the Board) executed under the hand of the appointor or his duly constituted attorney or, if the
appointor is a corporation, under its seal or signed by a duly authorised officer or attorney or other person authorised to sign.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">66.2</TD><TD STYLE="text-align: justify">Subject to the Companies Acts, the Board may accept the appointment of a proxy received by electronic
means on such terms and subject to such conditions as it considers fit. The appointment of a proxy received by electronic means
shall not be subject to the requirements of Article 66.1.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">66.3</TD><TD STYLE="text-align: justify">For the purposes of Articles 66.1 and 66.2, the Board may require such reasonable evidence it considers
necessary to determine:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(a)</TD><TD STYLE="text-align: justify">the identity of the member and the proxy; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(b)</TD><TD STYLE="text-align: justify">where the proxy is appointed by a person acting on behalf of the member, the authority of that
person to make the appointment.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">66.4</TD><TD STYLE="text-align: justify">A member may appoint another person as his proxy to exercise all or any of his rights to attend
and to speak and to vote (both on a show of hands and on a poll) on a resolution or amendment of a resolution, or on other business
arising, at a meeting or meetings of the Company. Unless the contrary is stated in it, the appointment of a proxy shall be deemed
to confer authority to exercise all such rights, as the proxy thinks fit.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">66.5</TD><TD STYLE="text-align: justify">A proxy need not be a member.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">66.6</TD><TD STYLE="text-align: justify">A member may appoint more than one proxy in relation to a meeting, provided that each proxy is
appointed to exercise the rights attached to different shares held by the member. When two or more valid but differing appointments
of proxy are delivered or received for the same share for use at the same meeting, the one which is last validly delivered or received
(regardless of its date or the date of its execution) shall be treated as replacing and revoking the other or others as regards
that share. If the Company is unable to determine which appointment was last validly delivered or received, none of them shall
be treated as valid in respect of that share.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"></P>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">66.7</TD><TD STYLE="text-align: justify">Delivery or receipt of an appointment of proxy does not prevent a member attending and voting in
person at the meeting or an adjournment of the meeting or on a poll.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">66.8</TD><TD STYLE="text-align: justify">The appointment of a proxy shall (unless the contrary is stated in it) be valid for an adjournment
of the meeting as well as for the meeting or meetings to which it relates. The appointment of a proxy shall be valid for 12 months
from the date of execution or, in the case of an appointment of proxy delivered by electronic means, for 12 months from the date
of delivery unless otherwise specified by the Board.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">66.9</TD><TD STYLE="text-align: justify">Subject to the Companies Acts, the Company may send a form of appointment of proxy to all or none
of the persons entitled to receive notice of and to vote at a meeting. If sent, the form shall provide for three-way voting on
all resolutions (other than procedural resolutions) set out in the notice of meeting.</TD></TR></TABLE>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">67.</FONT></TD><TD STYLE="text-align: justify">Receipt of proxy</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">67.1</TD><TD STYLE="text-align: justify">An instrument appointing a proxy and any reasonable evidence required by the Board in accordance
with Article 66.3 shall:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(a)</TD><TD STYLE="text-align: justify">subject to Articles 67.1(c) and (d), in the case of an instrument of proxy in hard copy form, delivered
to the office, or another place in the United Kingdom specified in the notice convening the meeting or in the form of appointment
of proxy or other accompanying document sent by the Company in relation to the meeting (a &ldquo;<B>proxy notification address</B>&rdquo;)
not less than 48 hours before the time for holding the meeting or adjourned meeting at which the person named in the form of appointment
of proxy proposes to vote;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(b)</TD><TD STYLE="text-align: justify">subject to Articles 67.1(c) and (d), in the case of an appointment of a proxy sent by electronic
means, where the Company has given an electronic address (a &ldquo;<B>proxy notification electronic address</B>&rdquo;):</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 92.7pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 64.35pt"></TD><TD STYLE="width: 28.35pt">(i)</TD><TD STYLE="text-align: justify">in the notice calling the meeting;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99.25pt; text-align: justify; text-indent: -34.9pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 64.35pt"></TD><TD STYLE="width: 28.35pt">(ii)</TD><TD STYLE="text-align: justify">in an instrument of proxy sent out by the Company in relation to the meeting;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99.25pt; text-align: justify; text-indent: -34.9pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 64.35pt"></TD><TD STYLE="width: 28.35pt">(iii)</TD><TD STYLE="text-align: justify">in an invitation to appoint a proxy issued by the Company in relation to the meeting; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 98.7pt; text-align: justify; text-indent: -34.35pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 98.7pt; text-align: justify; text-indent: -34.35pt"></P>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 98.7pt; text-align: justify; text-indent: -34.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 65.45pt"></TD><TD STYLE="width: 33.8pt">(iv)</TD><TD STYLE="text-align: justify">on a website maintained by or on behalf of the Company on which any information relating to the
meeting is required by the Act to be kept,</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify">it shall be received at such proxy
notification electronic address not less than 48 hours before the time for holding the meeting or adjourned meeting at which the
person named in the form of appointment of proxy proposes to vote;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(c)</TD><TD STYLE="text-align: justify">in the case of a poll taken more than 48 hours after it is demanded, delivered or received at a
proxy notification address or a proxy notification electronic address and not less than 24 hours before the time appointed for
the holding of the adjourned meeting or the taking of the poll; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(d)</TD><TD STYLE="text-align: justify">in the case of a poll which is not taken at the meeting at which it is demanded but is taken 48
hours or less after it is demanded, or in the case of an adjourned meeting to be held 48 hours or less after the time fixed for
holding the original meeting, received:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 92.7pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 66.55pt"></TD><TD STYLE="width: 27.25pt">(i)</TD><TD STYLE="text-align: justify">at a proxy notification address or a proxy notification electronic address in accordance with Articles
67.1(a) or (b);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99.25pt; text-align: justify; text-indent: -34.9pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 66.55pt"></TD><TD STYLE="width: 33.8pt">(ii)</TD><TD STYLE="text-align: justify">by the chairman of the meeting or the secretary or any director at the meeting at which the poll
is demanded or, as the case may be, at the original meeting; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99.25pt; text-align: justify; text-indent: -34.9pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 66.55pt"></TD><TD STYLE="width: 33.8pt">(iii)</TD><TD STYLE="text-align: justify">at a proxy notification address or a proxy notification electronic address by such time as the
chairman of the meeting may direct at the meeting at which the poll is demanded.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify">In calculating the periods
in this Article, no account shall be taken of any part of a day that is not a working day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">67.2</TD><TD STYLE="text-align: justify">The Board may decide, either generally or in any particular case, to treat a proxy appointment
as valid notwithstanding that the appointment or any of the information required under Article 66.3 has not been received in accordance
with the requirements of this Article.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">67.3</TD><TD STYLE="text-align: justify">Subject to Article 67.2, if the proxy appointment and any of the information required under Article
66.3 is not received in the manner set out in Article 67.1, the appointee shall not be entitled to vote in respect of the shares
in question.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">67.4</TD><TD STYLE="text-align: justify">Without limiting the foregoing, in relation to any uncertificated shares, the Board may from time
to time:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(a)</TD><TD STYLE="text-align: justify">permit appointments of a proxy by means of a communication sent in electronic form in the form
of an uncertificated proxy instruction; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt"></P>

<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(b)</TD><TD STYLE="text-align: justify">permit supplements to, or amendments or revocations of, any such uncertificated proxy instruction
by the same means.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">The Board may in addition prescribe
the method of determining the time at which any such uncertificated proxy instruction is to be treated as received by the Company
or a participant acting on its behalf. The Board may treat any such uncertificated proxy instruction which purports to be or is
expressed to be sent on behalf of a holder of a share as sufficient evidence of the authority of the person sending that instruction
to send it on behalf of that holder.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">68.</FONT></TD><TD STYLE="text-align: justify">Revocation of proxy</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">A vote given or poll demanded
by a proxy shall be valid in the event of the death or mental disorder of the principal or the revocation of the instrument of
proxy, or of the authority under which the instrument of proxy was executed, or the transfer of the share for which the instrument
of proxy is given, unless notice in writing of such death, mental disorder, revocation or transfer shall have been received by
the Company at the Office, or at such other place as has been appointed for the deposit of instruments of proxy, no later than
the last time at which an appointment of a proxy should have been received in order for it to be valid for use at the meeting or
on the holding of the poll at which the vote was given or the poll taken.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">69.</FONT></TD><TD STYLE="text-align: justify">Corporate representatives</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">69.1</TD><TD STYLE="text-align: justify">A corporation (whether or not a company within the meaning of the Act) which is a member may, by
resolution of its directors or other governing body, authorise such person as it thinks fit to act as its representative (or, as
the case may be, representatives) at any meeting of the Company or at any separate meeting of the holders of any class of shares.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">69.2</TD><TD STYLE="text-align: justify">Any person so authorised shall be entitled to exercise the same powers on behalf of the corporation
(in respect of that part of the corporation&rsquo;s holdings to which the authority relates) as the corporation could exercise if it
were an individual member.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">69.3</TD><TD STYLE="text-align: justify">The corporation shall for the purposes of these Articles be deemed to be present in person and
at any such meeting if a person so authorised is present at it, and all references to attendance and voting in person shall be
construed accordingly.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">69.4</TD><TD STYLE="text-align: justify">A Director, the Secretary or some person authorised for the purpose by the Secretary may require
the representative to produce a certified copy of the resolution so authorising him or such other evidence of his authority reasonably
satisfactory to them before permitting him to exercise his powers.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">69.5</TD><TD STYLE="text-align: justify">A vote given or a poll demanded by a corporate representative shall be valid notwithstanding that
he is no longer authorised to represent the member unless notice of the revocation of appointment was delivered in writing to the
Company at such place or address and by such time as is specified in Article 68 for the revocation of the appointment of a proxy.</TD></TR></TABLE>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase"></FONT></P>

<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">70.</FONT></TD><TD STYLE="text-align: justify">Failure to disclose interests in shares</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">70.1</TD><TD STYLE="text-align: justify">If a member, or any other person appearing to be interested in shares held by that member, has
been issued with a notice under section 793 of the Act (<B>section 793 notice</B>) and has failed in relation to any shares (<B>default
shares</B>, which expression includes any shares issued after the date of such notice in right of those shares) to give the Company
the information required by the section 793 notice within the prescribed period from the service of the notice, the following sanctions
shall apply unless the Board determines otherwise:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(a)</TD><TD STYLE="text-align: justify">the member shall not be entitled in respect of the default shares to be present or to vote (either
in person or by representative or proxy) at any general meeting or at any separate meeting of the holders of any class of shares
or on any poll or to exercise any other right conferred by membership in relation to any such meeting or poll; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(b)</TD><TD STYLE="text-align: justify">where the default shares represent at least 0.25% in nominal value of the issued shares of their
class (calculated exclusive of any shares held as treasury shares):</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99.25pt; text-align: justify; text-indent: -34.9pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 66.55pt"></TD><TD STYLE="width: 33.8pt">(i)</TD><TD STYLE="text-align: justify">any dividend or other money payable for such shares shall be withheld by the Company, which shall
not have any obligation to pay interest on it, and the member shall not be entitled to elect, pursuant to Article 127, to receive
shares instead of that dividend; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99.25pt; text-align: justify; text-indent: -34.9pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 66.55pt"></TD><TD STYLE="width: 33.8pt">(ii)</TD><TD STYLE="text-align: justify">no transfer, other than an excepted transfer, of any shares held by the member shall be registered
unless the member himself is not in default of supplying the required information and the member proves to the satisfaction of
the Board that no person in default of supplying such information is interested in any of the shares that are the subject of the
transfer.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(c)</TD><TD STYLE="text-align: justify">For the purposes of ensuring Article 70.1(b)(ii) can apply to all shares held by the member, the
Company may in accordance with the uncertificated securities rules, issue a written notification to the Operator requiring conversion
into certificated form of any share held by the member in uncertificated form.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">70.2</TD><TD STYLE="text-align: justify">Where the sanctions under Article 70.1 apply in relation to any shares, they shall cease to have
effect (and any dividends withheld under Article 70.1(b) shall become payable):</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(a)</TD><TD STYLE="text-align: justify">if the shares are transferred by means of an excepted transfer but only in respect of the shares
transferred; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt"></P>

<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(b)</TD><TD STYLE="text-align: justify">at the end of the period of seven days (or such shorter period as the Board may determine) following
receipt by the Company of the information required by the section 793 notice and the Board being fully satisfied that such information
is full and complete.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">70.3</TD><TD STYLE="text-align: justify">Where, on the basis of information obtained from a member in respect of any share held by him,
the Company issues a section 793 notice to any other person, it shall at the same time send a copy of the notice to the member,
but the accidental omission to do so, or the non-receipt by the member of the copy, shall not invalidate or otherwise affect the
application of Article 70.1.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">70.4</TD><TD STYLE="text-align: justify">For the purposes of this Article:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(a)</TD><TD STYLE="text-align: justify">a person, other than the member holding a share, shall be treated as appearing to be interested
in that share if the member has informed the Company that the person is, or may be, so interested, or if the Company (after taking
account of any information obtained from the member or, pursuant to a section 793 notice, from anyone else) knows or has reasonable
cause to believe that the person is, or may be, so interested;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(b)</TD><TD STYLE="text-align: justify"><B>interested</B> shall be construed as it is for the purpose of section 793 of the Act;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(c)</TD><TD STYLE="text-align: justify">reference to a person having failed to give the Company the information required by a notice, or
being in default as regards supplying such information, includes reference:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 92.7pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 64.35pt"></TD><TD STYLE="width: 28.35pt">(i)</TD><TD STYLE="text-align: justify">to his having failed or refused to give all of any part of it; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99.25pt; text-align: justify; text-indent: -34.9pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 66.55pt"></TD><TD STYLE="width: 33.8pt">(ii)</TD><TD STYLE="text-align: justify">to his having given information which he knows to be false in a material particular or having recklessly
given information which is false in a material particular;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(d)</TD><TD STYLE="text-align: justify"><B>prescribed period</B> means 14 days;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(e)</TD><TD STYLE="text-align: justify"><B>excepted transfer</B> means, in relation to any shares held by a member:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99.25pt; text-align: justify; text-indent: -34.9pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 66.55pt"></TD><TD STYLE="width: 33.8pt">(i)</TD><TD STYLE="text-align: justify">a transfer by way of or pursuant to acceptance of a takeover offer for the Company (within the
meaning of section 974 of the Act); or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99.25pt; text-align: justify; text-indent: -34.9pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 66.55pt"></TD><TD STYLE="width: 33.8pt">(ii)</TD><TD STYLE="text-align: justify">a transfer in consequence of a sale made through a recognised investment exchange (as defined in
section 285 of the FSMA) or any other stock exchange outside the United Kingdom on which the Company&rsquo;s shares are normally traded;
or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99.25pt; text-align: justify; text-indent: -34.9pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 66.55pt"></TD><TD STYLE="width: 33.8pt">(iii)</TD><TD STYLE="text-align: justify">a transfer which is shown to the satisfaction of the Board to be made in consequence of a sale
of the whole of the beneficial interest in the shares to a person who is unconnected with the member and with any other person
appearing to be interested in the shares.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">70.5</TD><TD STYLE="text-align: justify">Nothing contained in this Article shall be taken to limit the powers of the Company under section
794 of the Act.</TD></TR></TABLE>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"></P>

<!-- Field: Page; Sequence: 35; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;<FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">71.</FONT></TD><TD STYLE="text-align: justify">Power of sale of shares of untraced members</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">71.1</TD><TD STYLE="text-align: justify">The Company shall be entitled to sell at the best price reasonably obtainable any share of a member,
or any share to which a person is entitled by transmission, if and provided that:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(a)</TD><TD STYLE="text-align: justify">during the period of 12 years before the date of sending of the notice referred to in Article 71.1(b)
no cheque, order or warrant in respect of such share sent by the Company through the post in a pre-paid envelope addressed to the
member or to the person entitled by transmission to the share, at his address on the Register or other last known address given
by the member or person to which cheques, orders or warrants in respect of such share are to be sent has been cashed and the Company
has received no communications in respect of such share from such member or person entitled, provided that during such period of
12 years the Company has paid at least three cash dividends (whether interim or final) and no such dividend has been claimed by
the person entitled to it;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(b)</TD><TD STYLE="text-align: justify">on or after expiry of the said period of 12 years, the Company has given notice of its intention
to sell such share by sending a notice to the member or person entitled by transmission to the share at his address on the Register
or other last known address given by the member or person entitled by transmission to the share and before sending such a notice
to the member or other person entitled by transmission, the Company must have used reasonable efforts to trace the member or other
person entitled, engaging, if considered appropriate, a professional asset reunification company or other tracing agent and/or
giving notice of its intention to sell the share by advertisement in a national newspaper and in a newspaper circulating in the
area of the address of the member or person entitled by transmission to the share shown in the Register;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(c)</TD><TD STYLE="text-align: justify">during the further period of three months following the date of such notice and prior to the exercise
of the power of sale the Company has not received any communication in respect of such share from the member or person entitled
by transmission; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(d)</TD><TD STYLE="text-align: justify">the Company has given notice to the UKLA of its intention to make such sale, if shares of the class
concerned are listed on the Official List or dealt in on the London Stock Exchange.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">71.2</TD><TD STYLE="text-align: justify">To give effect to any sale of shares under this Article, the Board may authorise some person to
transfer the shares in question and may enter the name of the transferee in respect of the transferred shares in the Register even
if no share certificate has been lodged for such shares and may issue a new certificate to the transferee. An instrument of transfer
executed by that person shall be as effective as if it had been executed by the holder of, or the person entitled by transmission
to, the shares. The buyer shall not be bound to see to the application of the purchase monies, nor shall his title to the shares
be affected by any irregularity or invalidity in the proceedings in reference to the sale. If the shares are in uncertificated
form, in accordance with the uncertificated securities rules, the Board may issue a written notification to the Operator requiring
the conversion of the share to certificated form.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"></P>

<!-- Field: Page; Sequence: 36; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">71.3</TD><TD STYLE="text-align: justify">If during the period of 12 years referred to in Article 71.1, or during any period ending on the
date when all the requirements of Articles 71.1(a) to 71.1(d) have been satisfied, any additional shares have been issued in respect
of those held at the beginning of, or previously so issued during, any such period and all the requirements of Articles 71.1(b)
to 71.1(d) have been satisfied in regard to such additional shares, the Company shall also be entitled to sell the additional shares.</TD></TR></TABLE>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">72.</FONT></TD><TD STYLE="text-align: justify">Application of proceeds of sale of shares of untraced members</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">The Company shall account to the
member or other person entitled to the share for the net proceeds of a sale under Article 71 by carrying all monies relating to
such sale to a separate account. The Company shall be deemed to be a debtor to, and not a trustee for, such member or other person
in respect of such monies. Monies carried to such separate account may either be employed in the business of the Company or invested
in such investments as the Board may think fit. No interest shall be payable to such member or other person in respect of such
monies and the Company does not have to account for any money earned on them.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">73.</FONT></TD><TD STYLE="text-align: justify">Number of directors</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">Unless otherwise determined by
the Company by ordinary resolution, the number of Directors (other than any alternate Directors) shall be at least two but shall
not be subject to any maximum number].</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">74.</FONT></TD><TD STYLE="text-align: justify">Power of company to appoint directors</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">Subject to these Articles and
the Companies Acts, the Company may by ordinary resolution appoint a person who is willing to act to be a Director, either to fill
a vacancy or as an addition to the existing Board but the total number of Directors shall not exceed any maximum number fixed in
accordance with these Articles.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">75.</FONT></TD><TD STYLE="text-align: justify">Power of board to appoint directors</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">Subject to these Articles, the
Board shall have power at any time to appoint any person who is willing to act as a Director, either to fill a vacancy or as an
addition to the existing Board but the total number of Directors shall not exceed any maximum number fixed in accordance with these
Articles.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase"></FONT></P>

<!-- Field: Page; Sequence: 37; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">76.</FONT></TD><TD STYLE="text-align: justify">Eligibility of new directors</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">76.1</TD><TD STYLE="text-align: justify">No person, other than a retiring Director (by rotation or otherwise), shall be appointed or re-appointed
a Director at any general meeting unless:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(a)</TD><TD STYLE="text-align: justify">he is recommended by the Board; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(b)</TD><TD STYLE="text-align: justify">at least seven but not more than 42 clear days before the date appointed for the meeting the Company
has received notice from a member (other than the person proposed) entitled to vote at the meeting of his intention to propose
a resolution for the appointment or re-appointment of that person, stating the particulars which would, if he were so appointed
or re-appointed, be required to be included in the Company&rsquo;s register of directors and a notice executed by that person of his
willingness to be appointed or re-appointed, is lodged at the Office.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">76.2</TD><TD STYLE="text-align: justify">A Director need not be a member of the Company.</TD></TR></TABLE>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">77.</FONT></TD><TD STYLE="text-align: justify">Retirement of directors</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: 0pt">At each annual
general meeting of the Company any Director then in office:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(a)</TD><TD STYLE="text-align: justify">Who has been appointed by the Board since the previous annual general meeting in accordance with
Article 75; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(b)</TD><TD STYLE="text-align: justify">For whom it is the third annual general meeting following the annual general meeting at which he
was elected or last re-elected;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">shall retire from office but shall
be eligible for re-appointment.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">78.</FONT></TD><TD STYLE="text-align: justify">Deemed re-appointment</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">78.1</TD><TD STYLE="text-align: justify">A Director who retires at an annual general meeting shall (unless he is removed from office or
his office is vacated in accordance with these Articles) retain office until the close of the meeting at which he retires or (if
earlier) when a resolution is passed at that meeting not to fill the vacancy or to elect another person in his place or the resolution
to re-appoint him is put to the meeting and lost.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">78.2</TD><TD STYLE="text-align: justify">If the Company, at any meeting at which a Director retires in accordance with these Articles does
not fill the office vacated by such Director, the retiring Director, if willing to act, shall be deemed to be re-appointed unless
at that meeting a resolution is passed not to fill the vacancy or elect another person in his place or unless the resolution to
re-appoint him is put to the meeting and lost.</TD></TR></TABLE>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase"></FONT></P>

<!-- Field: Page; Sequence: 38; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">79.</FONT></TD><TD STYLE="text-align: justify">Procedure if insufficient directors appointed</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">79.1</TD><TD STYLE="text-align: justify">If:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(a)</TD><TD STYLE="text-align: justify">at the annual general meeting in any year any resolution or resolutions for the appointment or
re-appointment of the persons eligible for appointment or re-appointment as Directors are put to the meeting and lost; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(b)</TD><TD STYLE="text-align: justify">at the end of that meeting the number of Directors is fewer than any minimum number of Directors
required under Article 73.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">All retiring Directors who stood
for re-appointment at that meeting (<B>Retiring Directors</B>) shall be deemed to have been re-appointed as Directors and shall
remain in office but the Retiring Directors may only act for the purpose of filling vacancies, convening general meetings of the
Company and performing such duties as are essential to maintain the Company as a going concern, and not for any other purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">79.2</TD><TD STYLE="text-align: justify">The Retiring Directors shall convene a general meeting as soon as reasonably practicable following
the meeting referred to in Article 79.1 and they shall retire from office at that meeting. If at the end of any meeting convened
under this Article the number of Directors is fewer than any minimum number of Directors required under Article 73, the provisions
of this Article shall also apply to that meeting.</TD></TR></TABLE>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">80.</FONT></TD><TD STYLE="text-align: justify">Removal of directors</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">In addition to any power of removal
conferred by the Companies Acts, the Company may by special resolution, or by ordinary resolution of which special notice has been
given in accordance with section 312 of the Act, remove a director before the expiry of his period of office (without prejudice
to a claim for damages for breach of contract or otherwise) and may (subject to these Articles) by ordinary resolution appoint
another person who is willing to act to be a director in his place.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">81.</FONT></TD><TD STYLE="text-align: justify">Vacation of office by director</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">81.1</TD><TD STYLE="text-align: justify">Without prejudice to the provisions for retirement (by rotation or otherwise) contained in these
Articles, the office of a Director shall be vacated if:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(a)</TD><TD STYLE="text-align: justify">he resigns by notice in writing delivered to the Secretary at the Office or at an address specified
by the Company for the purposes of communication by electronic means or tendered at a Board meeting;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(b)</TD><TD STYLE="text-align: justify">he offers to resign by notice in writing delivered to the Secretary at the Office or at an address
specified by the Company for the purposes of communication by electronic means or tendered at a Board meeting and the Board resolves
to accept such offer;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt"></P>

<!-- Field: Page; Sequence: 39; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(c)</TD><TD STYLE="text-align: justify">he is requested to resign by all of the other Directors by notice in writing addressed to him at
his address as shown in the register of Directors (without prejudice to any claim for damages which he may have for breach of any
contract between him and the Company);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(d)</TD><TD STYLE="text-align: justify">he ceases to be a Director by virtue of any provision of the Companies Acts, is removed from office
pursuant to these Articles or the Act or becomes prohibited by law from being a Director;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(e)</TD><TD STYLE="text-align: justify">he becomes bankrupt or makes an arrangement or composition with his creditors generally;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(f)</TD><TD STYLE="text-align: justify">a registered medical practitioner who is treating that person gives a written opinion to the Company
stating that person has become physically or mentally incapable of acting as a director and may remain so for more than three months,
or he is or has been suffering from mental or physical ill health and the Board resolves that his office be vacated; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(g)</TD><TD STYLE="text-align: justify">he is absent (whether or not his alternate Director appointed by him attends), without the permission
of the Board, from Board meetings for six consecutive months and a notice is served on him personally, or at his residential address
provided to the Company under section 165 of the Act signed by all the other Directors stating that he shall cease to be a Director
with immediate effect (and such notice may consist of several copies each signed by one or more Directors).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">81.2</TD><TD STYLE="text-align: justify">If the office of a Director is vacated for any reason, he shall cease to be a member of any committee
or sub-committee of the Board.</TD></TR></TABLE>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">82.</FONT></TD><TD STYLE="text-align: justify">Resolution as to vacancy conclusive</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">A resolution of the Board declaring
a Director to have vacated office under the terms of Article 81 shall be conclusive as to the fact and ground of vacation stated
in the resolution.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">83.</FONT></TD><TD STYLE="text-align: justify">Appointment of alternate directors</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">83.1</TD><TD STYLE="text-align: justify">Each Director may appoint any person (including another Director) to be his alternate and may at
his discretion remove an alternate Director so appointed. Any appointment or removal of an alternate Director must be by written
notice delivered to the Office or at an address specified by the Company for the purposes of communication by electronic means
or tendered at a Board meeting or in any other manner approved by the Board. The appointment requires the approval of the Board
unless it has been previously approved or the appointee is another Director.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">83.2</TD><TD STYLE="text-align: justify">An alternate Director must provide the particulars, and sign any form for public filing required
by the Companies Acts relating to his appointment.</TD></TR></TABLE>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"></P>

<!-- Field: Page; Sequence: 40; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">84.</FONT></TD><TD STYLE="text-align: justify">Alternate directors&rsquo; participation in board meetings</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">84.1</TD><TD STYLE="text-align: justify">Every alternate Director is (subject to his giving to the Company an address within the United
Kingdom at which notices may be served on him (and, if applicable, an address in relation to which electronic communications may
be received by him)) entitled to receive notice of all meetings of the Board and all committees of the Board of which his appointor
is a member and, in his appointor&rsquo;s absence, to attend and vote at such meetings and to exercise all the powers, rights, duties
and authorities of his appointor. Each person acting as an alternate Director shall have a separate vote at Board meetings for
each Director for whom he acts as alternate Director in addition to his own vote if he is also a Director, but he shall count as
only one for the purpose of determining whether a quorum is present.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">84.2</TD><TD STYLE="text-align: justify">Signature by an alternate Director of any resolution in writing of the Board or a committee of
the Board will, unless the notice of his appointment provides otherwise, be as effective as signature by his appointor.</TD></TR></TABLE>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">85.</FONT></TD><TD STYLE="text-align: justify">Alternate director responsible for own acts</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">Each person acting as an alternate
Director will be an officer of the Company, will alone be responsible to the Company for his own acts and defaults and will not
be deemed to be the agent of the Director appointing him.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">86.</FONT></TD><TD STYLE="text-align: justify">Interests of alternate director</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">An alternate Director is entitled
to contract and be interested in and benefit from contracts or arrangements with the Company, to be repaid expenses and to be indemnified
to the same extent as if he were a Director. However, he is not entitled to receive from the Company any fees for his services
as alternate, except such part (if any) of the fee payable to his appointor as such appointor may by written notice to the Company
direct.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">87.</FONT></TD><TD STYLE="text-align: justify">Revocation of alternate director</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">An alternate Director will cease
to be an alternate Director:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(a)</TD><TD STYLE="text-align: justify">if his appointor revokes his appointment; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(b)</TD><TD STYLE="text-align: justify">if he resigns his office by notice in writing to the Company; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(c)</TD><TD STYLE="text-align: justify">if his appointor ceases for any reason to be a Director, provided that if any Director retires
but is re-appointed or deemed to be re-appointed at the same meeting, any valid appointment of an alternate Director which was
in force immediately before his retirement shall remain in force; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(d)</TD><TD STYLE="text-align: justify">if any event happens in relation to him which, if he were a Director otherwise appointed, would
cause him to vacate his office.</TD></TR></TABLE>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt"></P>

<!-- Field: Page; Sequence: 41; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;<FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">88.</FONT></TD><TD STYLE="text-align: justify">Directors&rsquo; fees</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">Each of the Directors may be paid
a fee at such rate as may from time to time be determined by the Board. However, the aggregate of all fees payable to the Directors
(other than amounts payable under any other provision of these Articles) must not exceed &pound;250,000 a year or such higher amount
as may from time to time be decided by ordinary resolution of the Company. Any fees payable under this Article shall be distinct
from any salary, remuneration or other amounts payable to a Director under any other provisions of these Articles and shall accrue
from day to day.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">89.</FONT></TD><TD STYLE="text-align: justify">Expenses</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">Each Director may be paid his
reasonable travelling, hotel and other expenses properly incurred by him in or about the performance of his duties as Director,
including any expenses incurred in attending meetings of the Board or any committee of the Board or general meetings or separate
meetings of the holders of any class of shares or debentures of the Company. Subject to the Act, the Directors shall have the power
to make arrangements to provide a Director with funds to meet expenditure incurred or to be incurred by him for the purposes of
the Company or for the purpose of enabling him to perform his duties as an officer of the Company or to enable him to avoid incurring
any such expenditure.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">90.</FONT></TD><TD STYLE="text-align: justify">Additional remuneration</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">If by arrangement with the Board
any Director shall perform or render any special duties or services outside his ordinary duties as a Director and not in his capacity
as a holder of employment or executive office, he may be paid such reasonable additional remuneration (whether by way of salary,
commission, participation in profits or otherwise) as the Board may determine.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">91.</FONT></TD><TD STYLE="text-align: justify">Remuneration of executive directors</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">The salary or remuneration of
any Director appointed to hold any employment or executive office in accordance with these Articles may be either a fixed sum of
money, or may altogether or in part be governed by business done or profits made or otherwise determined by the Board, and may
be in addition to or instead of any fee payable to him for his services as Director under these Articles.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase"></FONT></P>

<!-- Field: Page; Sequence: 42; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">92.</FONT></TD><TD STYLE="text-align: justify">Pensions and other benefits</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">92.1</TD><TD STYLE="text-align: justify">The Board may exercise all the powers of the Company to provide pensions or other retirement or
superannuation benefits and to provide death or disability benefits or other allowances or gratuities (whether by insurance or
otherwise) for any person who is or has at any time been a Director or employee of:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(a)</TD><TD STYLE="text-align: justify">the Company;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(b)</TD><TD STYLE="text-align: justify">any company which is or was a holding company or a subsidiary undertaking of the Company;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(c)</TD><TD STYLE="text-align: justify">any company which is or was allied to or associated with the Company or a subsidiary undertaking
or holding company of the Company; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(d)</TD><TD STYLE="text-align: justify">a predecessor in business of the Company or of any holding company or subsidiary undertaking of
the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">and, in each case, for any member
of his family (including a spouse or former spouse) and any person who is or was dependent on him.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">92.2</TD><TD STYLE="text-align: justify">The Board may establish, maintain, subscribe and contribute to any scheme, institution, association,
club, trust or fund and pay premiums and, subject to the Companies Acts, lend money or make payments to, guarantee or give an indemnity
in respect of, or give any financial or other assistance in connection with any of the matters set out in Article 92.1 above. The
Board may procure any of such matters to be done by the Company either alone or in conjunction with any other person. Any Director
or former Director shall be entitled to receive and retain for his own benefit any pension or other benefit provided under this
Article and shall not have to account for it to the Company. The receipt of any such benefit will not disqualify any person from
being or becoming a Director of the Company.</TD></TR></TABLE>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">93.</FONT></TD><TD STYLE="text-align: justify">Powers of the board</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">93.1</TD><TD STYLE="text-align: justify">Subject to the Companies Acts, these Articles and to any directions given by special resolution
of the Company, the business of the Company will be managed by the Board, which may exercise all the powers of the Company, whether
relating to the management of the business or not.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">93.2</TD><TD STYLE="text-align: justify">No alteration of these Articles and no such direction given by the Company shall invalidate any
prior act of the Board which would have been valid if such alteration had not been made or such direction had not been given. Provisions
contained elsewhere in these Articles as to any specific power of the Board shall not be deemed to limit the general powers given
by this Article.</TD></TR></TABLE>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">94.</FONT></TD><TD STYLE="text-align: justify">Powers of directors if less than minimum number</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">If the number of Directors is
less than the minimum prescribed in Article 73 or decided by the Company by ordinary resolution, the remaining Director or Directors
may act only for the purposes of appointing an additional Director or Directors to make up that minimum or convening a general
meeting of the Company for the purpose of making such appointment. If no Director or Directors is or are able or willing to act,
two members may convene a general meeting for the purpose of appointing Directors. An additional Director appointed in this way
holds office (subject to these Articles) only until the dissolution of the next annual general meeting after his appointment unless
he is reappointed during the annual general meeting.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase"></FONT></P>

<!-- Field: Page; Sequence: 43; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">95.</FONT></TD><TD STYLE="text-align: justify">Powers of executive directors</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">The Board or any committee authorised
by the Board may:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(a)</TD><TD STYLE="text-align: justify">delegate or entrust to and confer on any Director holding executive office (including a Chief Executive
or Managing Director) such of its powers, authorities and discretions (with power to sub-delegate) for such time, on such terms
and subject to such conditions as it thinks fit; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(b)</TD><TD STYLE="text-align: justify">revoke, withdraw, alter or vary all or any of such powers.</TD></TR></TABLE>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">96.</FONT></TD><TD STYLE="text-align: justify">Delegation to committees</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">96.1</TD><TD STYLE="text-align: justify">The Board may delegate any of its powers, authorities and discretions (with power to sub-delegate)
for such time on such terms and subject to such conditions as it thinks fit to any committee consisting of one or more Directors
and (if thought fit) one or more other persons provided that:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(a)</TD><TD STYLE="text-align: justify">a majority of the members of a committee shall be Directors; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(b)</TD><TD STYLE="text-align: justify">no resolution of a committee shall be effective unless a majority of those present when it is passed
are Directors or alternate Directors.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">96.2</TD><TD STYLE="text-align: justify">The Board may confer such powers either collaterally with, or to the exclusion of and in substitution
for, all or any of the powers of the Board in that respect and may revoke, withdraw, alter or vary any such powers and discharge
any such committee in whole or in part. Insofar as any power, authority or discretion is so delegated, any reference in these Articles
to the exercise by the Board of such power, authority or discretion shall be construed as if it were a reference to the exercise
of such power, authority or discretion by such committee.</TD></TR></TABLE>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">97.</FONT></TD><TD STYLE="text-align: justify">Local management</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">97.1</TD><TD STYLE="text-align: justify">The Board may establish any local or divisional boards or agencies for managing any of the affairs
of the Company in any specified locality, either in the United Kingdom or elsewhere, and appoint any persons to be members of such
local or divisional board, or any managers or agents, and may fix their remuneration.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">97.2</TD><TD STYLE="text-align: justify">The Board may delegate to any local or divisional board, manager or agent so appointed any of its
powers, authorities and discretions (with power to sub-delegate) and may authorise the members of any such local or divisional
board, or any of them, to fill any vacancies and to act notwithstanding vacancies. Any such appointment or delegation under this
Article may be made, on such terms conditions as the Board may think fit. The Board may confer such powers either collaterally
with, or to the exclusion of and in substitution for, all or any of the powers of the Board in that respect and may revoke, withdraw,
alter or vary all or any of such powers.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">97.3</TD><TD STYLE="text-align: justify">Subject to any terms and conditions expressly imposed by the Board, the proceedings of any local
or divisional board or agency with two or more members shall be governed by such of these Articles as regulate the proceedings
of the Board, so far as they are capable of applying.</TD></TR></TABLE>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"></P>

<!-- Field: Page; Sequence: 44; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">98.</FONT></TD><TD STYLE="text-align: justify">Power of attorney</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">The Board may, by power of attorney
or otherwise, appoint any person or persons to be the agent or attorney of the Company and may delegate to any such person or persons
any of its powers, authorities and discretions (with power to sub-delegate), in each case for such purposes and for such time,
on such terms (including as to remuneration) and conditions as it thinks fit. The Board may confer such powers either collaterally
with, or to the exclusion of and in substitution for, all or any of the powers of the Board in that respect and may revoke, withdraw,
alter or vary any of such powers.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">99.</FONT></TD><TD STYLE="text-align: justify">Exercise of voting power</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">The Board may exercise or cause
to be exercised the voting power conferred by the shares in any other company held or owned by the Company, or any power of appointment
to be exercised by the Company, in such manner as it thinks fit (including the exercise of the voting power or power of appointment
in favour of the appointment of any Director as a director or other officer or employee of such company or in favour of the payment
of remuneration to the directors, officers or employees of such company).</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">100.</FONT></TD><TD STYLE="text-align: justify">Provision for employees on cessation of business</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">The Board may, by resolution,
sanction the exercise of the power to make provision for the benefit of persons employed or formerly employed by the Company or
any of its subsidiary undertakings, in connection with the cessation or the transfer to any person of the whole or part of the
undertaking of the Company or that subsidiary undertaking, but any such resolution shall not be sufficient for payments to or for
the benefit of directors, former directors or shadow directors.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">101.</FONT></TD><TD STYLE="text-align: justify">Overseas registers</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">Subject to the Companies Acts,
the Company may keep an overseas, local or other register and the Board may make and vary such regulations as it thinks fit respecting
the keeping of any such register.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase"></FONT></P>

<!-- Field: Page; Sequence: 45; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">102.</FONT></TD><TD STYLE="text-align: justify">Borrowing powers</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">102.1</TD><TD STYLE="text-align: justify">Subject to these Articles and the Companies Acts, the Board may exercise all the powers of the
Company to:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(a)</TD><TD STYLE="text-align: justify">borrow money;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(b)</TD><TD STYLE="text-align: justify">indemnify and guarantee;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(c)</TD><TD STYLE="text-align: justify">mortgage or charge all or any part of the undertaking, property and assets (present and future)
and uncalled capital of the Company;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(d)</TD><TD STYLE="text-align: justify">create and issue debentures and other securities; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(e)</TD><TD STYLE="text-align: justify">give security either outright or as collateral security for any debt, liability or obligation of
the Company or of any third party.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">102.2</TD><TD STYLE="text-align: justify">The Board shall restrict the borrowings of the Company and exercise all voting and other rights
or powers of control exercisable by the Company in relation to its subsidiary undertakings (if any) so as to secure (as regards
the subsidiary undertakings, so far as by such exercise they can secure) that the aggregate of the amounts borrowed by the Group
and remaining outstanding at any time (excluding intra-Group borrowings) shall not without the previous sanction of an ordinary
resolution of the Company exceed &pound;25,000,000.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">102.3</TD><TD STYLE="text-align: justify">For the purpose of this Article <B>Group</B> means the Company and its subsidiary undertakings
for the time being.;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">102.4</TD><TD STYLE="text-align: justify">Borrowings shall be deemed to include the following except in so far as otherwise taken into account:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(a)</TD><TD STYLE="text-align: justify">the nominal amount of any issued and paid up share capital (other than equity share capital) of
any subsidiary undertaking of the Company owned otherwise than by a member of the Group;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(b)</TD><TD STYLE="text-align: justify">the nominal amount of any other issued and paid up share capital and the principal amount of any
debentures or borrowed moneys which is not at the relevant time beneficially owned by a member of the Group, the redemption or
repayment of which is the subject of a guarantee or indemnity by a member of the Group or which any member of the Group may be
required to buy;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(c)</TD><TD STYLE="text-align: justify">the principal amount of any debenture (whether secured or unsecured) of a member of the Group beneficially
owned otherwise than by a member of the Group;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(d)</TD><TD STYLE="text-align: justify">the outstanding amount raised by acceptances by any bank or accepting house under any acceptance
credit opened by or on behalf of any member of the Group;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(e)</TD><TD STYLE="text-align: justify">the minority proportion of moneys borrowed by a member of the Group and owing to a partly-owned
subsidiary undertaking.</TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt"></P>

<!-- Field: Page; Sequence: 46; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">102.5</TD><TD STYLE="text-align: justify">Borrowings shall not include and shall be deemed not to include:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(a)</TD><TD STYLE="text-align: justify">borrowings incurred by any member of the Group for the purpose of repaying within six months of
the borrowing the whole or any part (with or without premium) of any borrowings of that or other member of the Group then outstanding,
pending their application for such purpose within such period;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(b)</TD><TD STYLE="text-align: justify">the minority proportion of moneys borrowed by a partly owned subsidiary undertaking and not owing
to another member of the Group.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">102.6</TD><TD STYLE="text-align: justify">When the aggregate principal amount of borrowings required to be taken into account on any particular
date is being ascertained, any particular borrowing then outstanding which is denominated or repayable in a currency other than
sterling shall be notionally converted into sterling at the rate of exchange prevailing in London on the last business day before
that date or, if it would result in a lower figure, at the rate of exchange prevailing in London on the last business day six months
before that date. For these purposes the rate of exchange shall be taken to be the spot rate in London recommended by a London
clearing bank, selected by the Board, as being the most appropriate rate for the purchase by the company of the currency in question
for sterling on the day in question.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">102.7</TD><TD STYLE="text-align: justify">A certificate or report by the auditors of the Company as to the amount of any borrowings or to
the effect that the limit imposed by this Article has not been or will not be exceeded at any particular time or times, shall be
conclusive evidence of such amount or fact for the purposes of this Article. Nevertheless the Board may at any time rely on a bona
fide estimate of the aggregate of the borrowings. If, in consequence, the limit on borrowings set out in this Article is inadvertently
exceeded, the amount of borrowings equal to the excess may be disregarded for 90 days after the date on which by reason of a determination
of the auditors of the Company or otherwise the Board becomes aware that such a situation has or may have arisen.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">102.8</TD><TD STYLE="text-align: justify">No person dealing with the Company or any of its subsidiary undertakings shall be concerned to
see or enquire whether the said limit is observed and no debt incurred or security given in excess of such limit shall be invalid
or ineffectual unless the lender or recipient of the security had, at the time the debt was incurred or security given, express
notice that the said limit had been or would be exceeded.</TD></TR></TABLE>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">103.</FONT></TD><TD STYLE="text-align: justify">Board meetings</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">103.1</TD><TD STYLE="text-align: justify">The Board can decide when and where to have meetings and how they will be conducted. They may also
adjourn meetings.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">103.2</TD><TD STYLE="text-align: justify">A Board meeting can be called by any Director. The company secretary must call a Board meeting
if asked to do so by a Director.</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"></P>

<!-- Field: Page; Sequence: 47; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;<FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">104.</FONT></TD><TD STYLE="text-align: justify">Notice of board meetings</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">104.1</TD><TD STYLE="text-align: justify">Notice of a Board meeting shall be deemed to be duly given to a Director if it is given to him
personally or by word of mouth or given in writing or by electronic means to him at his last known address or any other address
given by him to the Company for that purpose.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">104.2</TD><TD STYLE="text-align: justify">A Director may waive the requirement that notice be given to him of any Board meeting, either prospectively
or retrospectively and any retrospective waiver shall not affect the validity of the meeting or of any business conducted at the
meeting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">104.3</TD><TD STYLE="text-align: justify">It shall not be necessary to give notice of a Board meeting to a Director who is absent from the
United Kingdom unless he has asked the Board in writing that notices of Board meetings shall during his absence be given to him
at any address in the United Kingdom notified to the Company for this purpose, but he shall not, in such event, be entitled to
a longer period of notice than if he had been present in the United Kingdom at that address.</TD></TR></TABLE>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">105.</FONT></TD><TD STYLE="text-align: justify">Quorum</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">105.1</TD><TD STYLE="text-align: justify">The quorum necessary for the transaction of business may be determined by the Board and until otherwise
determined shall be two persons, each being a Director or an alternate Director. A duly convened meeting of the Board at which
a quorum is present shall be competent to exercise all or any of the authorities, powers, and discretions for the time being vested
in or exercisable by the Board.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">105.2</TD><TD STYLE="text-align: justify">If a Director ceases to be a director at a Board meeting, he can continue to be present and to
act as a director and be counted in the quorum until the end of the meeting if no other Director objects and if otherwise a quorum
of Directors would not be present.</TD></TR></TABLE>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">106.</FONT></TD><TD STYLE="text-align: justify">Chairman</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">106.1</TD><TD STYLE="text-align: justify">The Board may appoint one or more of its body as chairman or joint chairman and one or more of
its body as deputy chairman of its meetings and may determine the period for which he is or they are to hold office and may at
any time remove him or them from office.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">106.2</TD><TD STYLE="text-align: justify">If no such chairman or deputy chairman is elected, or if at any meeting neither a chairman nor
a deputy chairman is present within ten minutes of the time appointed for holding the same, the Directors present shall choose
one of their number to be chairman of such meeting. In the event two or more joint Chairmen or, in the absence of a chairman, two
or more deputy chairman being present, the joint chairman or deputy chairman to act as chairman of the meeting shall be decided
by those Directors present.</TD></TR></TABLE>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase"></FONT></P>

<!-- Field: Page; Sequence: 48; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">107.</FONT></TD><TD STYLE="text-align: justify">Voting</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">Questions arising at any Board
meeting shall be determined by a majority of votes. In the case of an equality of votes the chairman of that meeting shall have
a second or casting vote (unless he is not entitled to vote on the resolution in question).</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">108.</FONT></TD><TD STYLE="text-align: justify">Participation by telephone or other form of communication</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">108.1</TD><TD STYLE="text-align: justify">Any Director or his alternate may validly participate in a meeting of the Board or a committee
of the Board through the medium of conference telephone or any other form of communications equipment (whether in use when these
Articles are adopted or developed subsequently), provided that all persons participating in the meeting are able to hear and speak
to each other throughout such meeting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">108.2</TD><TD STYLE="text-align: justify">A person so participating by telephone or other communication shall be deemed to be present in
person at the meeting and shall be counted in a quorum and entitled to vote. Such a meeting shall be deemed to take place where
the largest group of those participating is assembled or, if there is no group which is larger than any other group, where the
chairman of the meeting then is.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">108.3</TD><TD STYLE="text-align: justify">A resolution passed at any meeting held in the above manner, and signed by the chairman of the
meeting, shall be as valid and effectual as if it had been passed at a meeting of the Board (or committee, as the case may be)
duly convened and held.</TD></TR></TABLE>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">109.</FONT></TD><TD STYLE="text-align: justify">Resolution in writing</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">109.1</TD><TD STYLE="text-align: justify">A resolution in writing signed or confirmed electronically by all the Directors for the time being
entitled to receive notice of a Board meeting and to vote on the resolution and not being less than a quorum (or by all the members
of a committee of the Board for the time being entitled to receive notice of such committee meeting and to vote on the resolution
and not being less than a quorum of that committee), shall be as valid and effective for all purposes as a resolution duly passed
at a meeting of the Board (or committee, as the case may be).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">109.2</TD><TD STYLE="text-align: justify">Such a resolution may consist of several documents or electronic communications in the same form
each signed or authenticated by one or more of the Directors or members of the relevant committee.</TD></TR></TABLE>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"></P>

<!-- Field: Page; Sequence: 49; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">110.</FONT></TD><TD STYLE="text-align: justify">Proceedings of committees</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">All committees of the Board shall,
in the exercise of the powers delegated to them and in the transaction of business, conform with any mode of proceedings and regulations
which the Board may prescribe and subject to this shall be governed by such of these Articles as regulate the proceedings of the
Board as are capable of applying.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">111.</FONT></TD><TD STYLE="text-align: justify">Minutes of proceedings</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">111.1</TD><TD STYLE="text-align: justify">The Board shall keep minutes of all shareholder meetings, all Board meetings and meetings of committees
of the Board. The minutes must include the names of the Directors present.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">111.2</TD><TD STYLE="text-align: justify">Any such minutes, if purporting to be signed by the chairman of the meeting at which the proceedings
were held or by the chairman of the next meeting or the Secretary, shall be evidence of the matters stated in such minutes without
any further proof.</TD></TR></TABLE>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">112.</FONT></TD><TD STYLE="text-align: justify">Validity of proceedings</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">All acts done by a meeting of
the Board, or of a committee of the Board, or by any person acting as a Director, alternate Director or member of a committee shall
be valid even if it is discovered afterwards that there was some defect in the appointment of any person or persons acting, or
that they or any of them were or was disqualified from holding office or not entitled to vote, or had in any way vacated their
or his office.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">113.</FONT></TD><TD STYLE="text-align: justify">Transactions or other arrangements with the company</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">113.1</TD><TD STYLE="text-align: justify">Subject to the Companies Acts and provided he has declared the nature and extent of his interest
in accordance with the requirements of the Companies Acts, a Director who is in any way, whether directly or indirectly, interested
in an existing or proposed transaction or arrangement with the Company may:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(a)</TD><TD STYLE="text-align: justify">be a party to, or otherwise interested in, any transaction or arrangement with the Company or in
which the Company is otherwise (directly or indirectly) interested;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(b)</TD><TD STYLE="text-align: justify">act by himself or through his firm in a professional capacity for the Company (otherwise than as
auditor) and he or his firm shall be entitled to remuneration for professional services as if he were not a Director;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(c)</TD><TD STYLE="text-align: justify">be or become a director or other officer of, or employed by, or a party to a transaction or arrangement
with, or otherwise interested in, any body corporate in which the Company is otherwise (directly or indirectly) interested; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(d)</TD><TD STYLE="text-align: justify">hold any office or place of profit with the Company (except as auditor) in conjunction with his
office of Director for such period and upon such terms, including as to remuneration as the Board may decide.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">113.2</TD><TD STYLE="text-align: justify">A Director shall not, save as he may otherwise agree, be accountable to the Company for any benefit
which he derives from any such contract, transaction or arrangement or from any such office or employment or from any interest
in any such body corporate and no such contract, transaction or arrangement shall be liable to be avoided on the grounds of any
such interest or benefit nor shall the receipt of any such remuneration or other benefit constitute a breach of his duty under
section 176 of the Act.</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"></P>

<!-- Field: Page; Sequence: 50; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;<FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">114.</FONT></TD><TD STYLE="text-align: justify">Authorisation of Directors&rsquo; conflicts of interest</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">114.1</TD><TD STYLE="text-align: justify">The Board may, in accordance with the requirements set out in this Article, authorise any matter
or situation proposed to them by any Director which would, if not authorised, involve a Director (an <B>Interested Director</B>)
breaching his duty under the Act to avoid conflicts of interest.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">114.2</TD><TD STYLE="text-align: justify">A Director seeking authorisation in respect of a conflict of interest shall declare to the Board
the nature and extent of his interest in a conflict of interest as soon as is reasonably practicable. The Director shall provide
the Board with such details of the matter as are necessary for the Board to decide how to address the conflict of interest together
with such additional information as may be requested by the Board.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">114.3</TD><TD STYLE="text-align: justify">Any authorisation under this Article will be effective only if:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(a)</TD><TD STYLE="text-align: justify">to the extent permitted by the Act, the matter in question shall have been proposed by any Director
for consideration in the same way that any other matter may be proposed to the Directors under the provisions of these Articles;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(b)</TD><TD STYLE="text-align: justify">any requirement as to the quorum for consideration of the relevant matter is met without counting
the Interested Director and any other interested Director; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(c)</TD><TD STYLE="text-align: justify">the matter is agreed to without the Interested Director voting or would be agreed to if the Interested
Director&rsquo;s and any other interested Director&rsquo;s vote is not counted.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">114.4</TD><TD STYLE="text-align: justify">Any authorisation of a conflict of interest under this Article must be recorded in writing (but
the authority shall be effective whether or not the terms are so recorded) and may (whether at the time of giving the authorisation
or subsequently):</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(a)</TD><TD STYLE="text-align: justify">extend to any actual or potential conflict of interest which may reasonably be expected to arise
out of the matter or situation so authorised;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(b)</TD><TD STYLE="text-align: justify">provide that the Interested Director be excluded from the receipt of documents and information
and the participation in discussions (whether at meetings of the Directors or otherwise) related to the conflict of interest;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt"></P>

<!-- Field: Page; Sequence: 51; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(c)</TD><TD STYLE="text-align: justify">impose upon the Interested Director such other terms for the purposes of dealing with the conflict
of interest as the Directors think fit;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(d)</TD><TD STYLE="text-align: justify">provide that, where the Interested Director obtains, or has obtained (through his involvement in
the conflict of interest and otherwise than through his position as a Director) information that is confidential to a third party,
he will not be obliged to disclose that information to the Company, or to use it in relation to the Company&rsquo;s affairs where
to do so would amount to a breach of that confidence; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(e)</TD><TD STYLE="text-align: justify">permit the Interested Director to absent himself from the discussion of matters relating to the
conflict of interest at any meeting of the Directors and be excused from reviewing papers prepared by, or for, the Directors to
the extent they relate to such matters.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">114.5</TD><TD STYLE="text-align: justify">Where the Directors authorise a conflict of interest, the Interested Director will be obliged to
conduct himself in accordance with any terms and conditions imposed by the Directors in relation to the conflict of interest.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">114.6</TD><TD STYLE="text-align: justify">The Directors may revoke or vary such authorisation at any time, but this will not affect anything
done by the Interested Director, prior to such revocation or variation, in accordance with the terms of such authorisation.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">114.7</TD><TD STYLE="text-align: justify">A Director is not required, by reason of being a Director (or because of the fiduciary relationship
established by reason of being a director), to account to the Company for any remuneration, profit or other benefit which he derives
from or in connection with a relationship involving a conflict of interest which has been authorised by the directors or by the
Company in general meeting (subject in each case to any terms, limits or conditions attaching to that authorisation) and no contract
shall be liable to be avoided on such grounds.</TD></TR></TABLE>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">115.</FONT></TD><TD STYLE="text-align: justify">Directors&rsquo; permitted interests</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">115.1</TD><TD STYLE="text-align: justify">A Director cannot vote or be counted in the quorum on any resolution relating to any transaction
or arrangement with the Company in which he has an interest and which may reasonably be regarded as likely to give rise to a conflict
of interest but can vote (and be counted in the quorum) on the following:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(a)</TD><TD STYLE="text-align: justify">giving him any security, guarantee or indemnity for any money or any liability which he, or any
other person, has lent or obligations he or any other person has undertaken at the request, or for the benefit, of the Company
or any of its subsidiary undertakings;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(b)</TD><TD STYLE="text-align: justify">giving any security, guarantee or indemnity to any other person for a debt or obligation which
is owed by the Company or any of its subsidiary undertakings, to that other person if the Director has taken responsibility for
some or all of that debt or obligation. The Director can take this responsibility by giving a guarantee, indemnity or security;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt"></P>

<!-- Field: Page; Sequence: 52; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(c)</TD><TD STYLE="text-align: justify">a proposal or contract relating to an offer of any shares or debentures or other securities for
subscription or purchase by the Company or any of its subsidiary undertakings, if the Director takes part because he is a holder
of shares, debentures or other securities, or if he takes part in the underwriting or sub-underwriting of the offer;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(d)</TD><TD STYLE="text-align: justify">any arrangement for the benefit of employees of the Company or any of its subsidiary undertakings
which only gives him benefits which are also generally given to employees to whom the arrangement relates;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(e)</TD><TD STYLE="text-align: justify">any arrangement involving any other company if the Director (together with any person connected
with the Director) has an interest of any kind in that company (including an interest by holding any position in that company or
by being a shareholder of that company). This does not apply if he knows that he has a Relevant Interest.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(f)</TD><TD STYLE="text-align: justify">a contract relating to insurance which the Company can buy or renew for the benefit of the Directors
or a group of people which includes Directors; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(g)</TD><TD STYLE="text-align: justify">a contract relating to a pension, superannuation or similar scheme or a retirement, death, disability
benefits scheme or employees&rsquo; share scheme which gives the Director benefits which are also generally given to the employees to
whom the scheme relates.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">115.2</TD><TD STYLE="text-align: justify">A Director cannot vote or be counted in the quorum on a resolution relating to his own appointment
or the settlement or variation of the terms of his appointment to an office or place of profit with the Company or any other company
in which the Company has an interest.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">115.3</TD><TD STYLE="text-align: justify">Where the Directors are considering proposals about the appointment, or the settlement or variation
of the terms or the termination of the appointment of two or more Directors to other offices or places of profit with the Company
or any company in which the Company has an interest, a separate resolution may be put in relation to each Director and in that
case each of the Directors concerned shall be entitled to vote and be counted in the quorum in respect of each resolution unless
it concerns his own appointment or the settlement or variation of the terms or the termination of his own appointment or the appointment
of another director to an office or place of profit with a company in which the Company has an interest and the Director seeking
to vote or be counted in the quorum has a Relevant Interest in it.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"></P>

<!-- Field: Page; Sequence: 53; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">115.4</TD><TD STYLE="text-align: justify">A company shall be deemed to be one in which the Director has a <B>Relevant Interest</B> if and
so long as (but only if and so long as) he is to his knowledge (either directly or indirectly) the holder of or beneficially interested
in one per cent or more of any class of the equity share capital of that company (calculated exclusive of any shares of that class
in that company held as treasury shares) or of the voting rights available to members of that company. In relation to an alternate
Director, an interest of his appointor shall be treated as an interest of the alternate Director without prejudice to any interest
which the alternate Director has otherwise. Where a company in which a Director has Relevant Interest is interested in a contract,
he also shall be deemed interested in that contract.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">115.5</TD><TD STYLE="text-align: justify">If a question arises at a Board meeting about whether a Director (other than the chairman of the
meeting) has an interest which is likely to give rise to a conflict of interest, or whether he can vote or be counted in the quorum,
and the Director does not agree to abstain from voting on the issue or not to be counted in the quorum, the question must be referred
to the chairman of the meeting. The chairman&rsquo;s ruling about the relevant Director is final and conclusive, unless the nature and
extent of the Director&rsquo;s interests have not been fairly disclosed to the Directors. If the question arises about the chairman of
the meeting, the question must be directed to the Directors. The chairman cannot vote on the question but can be counted in the
quorum. The Directors&rsquo; resolution about the chairman is final and conclusive, unless the nature and extent of the chairman&rsquo;s interests
have not been fairly disclosed to the Directors.</TD></TR></TABLE>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">116.</FONT></TD><TD STYLE="text-align: justify">General</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">For the purposes of Articles 112
to 114 inclusive (which shall apply equally to alternate Directors):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">116.1</TD><TD STYLE="text-align: justify">An interest of a person who is connected (which word shall have the meaning given to it by section
252 of the Act) with a Director shall be treated as an interest of the Director.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">116.2</TD><TD STYLE="text-align: justify">A contract includes references to any proposed contract and to any transaction or arrangement or
proposed transaction or arrangement whether or not consulting a contract.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">116.3</TD><TD STYLE="text-align: justify">A conflict of interest includes a conflict of interest and duty and a conflict of duties.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">116.4</TD><TD STYLE="text-align: justify">Subject to the Companies Acts, the Company may by ordinary resolution suspend or relax the provisions
of Articles 112 to 114 to any extent or ratify any contract not properly authorised by reason of a contravention of any of the
provisions of Articles 112 to 114.</TD></TR></TABLE>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">117.</FONT></TD><TD STYLE="text-align: justify">Power to authenticate documents</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">Any Director, the Secretary or
any person appointed by the Board for the purpose shall have power to authenticate any documents affecting the constitution of
the Company and any resolution passed by the Company or the Board or any committee, and any books, records, documents and accounts
relating to the business of the Company, and to certify copies or extracts as true copies or extracts. Where any books, records,
documents or accounts are not at the Office, the local manager or other officer of the Company who has their custody shall be deemed
to be a person appointed by the Board for this purpose. A document purporting to be a copy of a resolution, or an extract from
the minutes of a meeting, of the Company or the Board or any committee which is so certified shall be conclusive evidence in favour
of all persons dealing with the Company that such resolution has been duly passed or, as the case may be, that any minute so extracted
is a true and accurate record of proceedings at a duly constituted meeting.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase"></FONT></P>

<!-- Field: Page; Sequence: 54; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">118.</FONT></TD><TD STYLE="text-align: justify">Use of seals</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">118.1</TD><TD STYLE="text-align: justify">The Board shall provide for the safe custody of the Seal. A Seal shall not be used without the
authority of the Board or of a committee of the Board so authorised.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">118.2</TD><TD STYLE="text-align: justify">Subject as otherwise provided in these Articles, every document which is sealed using the Seal
must be signed by at least one authorised person in the presence of a witness who attests the signature. An authorised person for
this purpose is any Director, the Secretary or any other person authorised by the Directors for the purpose of signing documents
to which the Seal is applied.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">118.3</TD><TD STYLE="text-align: justify">The Seal shall be used only for sealing securities issued by the Company and documents creating
or evidencing securities so issued. Any such securities or documents sealed with the Seal shall not require to be signed unless
the Board decides otherwise or the law otherwise requires.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">118.4</TD><TD STYLE="text-align: justify">The Board may decide who will sign an instrument to which a Seal is affixed (or in the case of
a share certificate, on which the Seal may be printed) either generally or in relation to a particular instrument or type of instrument
and may also determine either generally or in a particular case that a signature may be dispensed with or affixed by mechanical
means.</TD></TR></TABLE>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">119.</FONT></TD><TD STYLE="text-align: justify">Declaration of dividends</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">Subject to the Act and these Articles,
the Company may by ordinary resolution declare dividends to be paid to members according to their respective rights and interests
in the profits of the Company. However, no dividend shall exceed the amount recommended by the Board.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">120.</FONT></TD><TD STYLE="text-align: justify">Interim dividends</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">Subject to the Act, the Board
may declare and pay such interim dividends (including any dividend at a fixed rate) as appears to the Board to be justified by
the profits of the Company available for distribution. If the Board acts in good faith, it shall not incur any liability to the
holders of shares for any loss that they may suffer by the lawful payment of any interim dividend on any other class of shares
ranking with or after those shares.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"></P>

<!-- Field: Page; Sequence: 55; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">121.</FONT></TD><TD STYLE="text-align: justify">Calculation and currency of dividends</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">Except as provided otherwise by
the rights attached to shares, all dividends:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(a)</TD><TD STYLE="text-align: justify">shall be declared and paid accordingly to the amounts paid up (otherwise than in advance of calls)
on the shares on which the dividend is paid;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(b)</TD><TD STYLE="text-align: justify">shall be apportioned and paid proportionately to the amounts paid up on the shares during any portion
or portions of the period in respect of which the dividend is paid, but if any share is issued on terms that it shall rank for
dividend as from a particular date, it shall rank for dividend accordingly; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(c)</TD><TD STYLE="text-align: justify">may be declared or paid in any currency. The Board may decide the rate of exchange for any currency
conversions that may be required and how any costs involved are to be met.</TD></TR></TABLE>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">122.</FONT></TD><TD STYLE="text-align: justify">Amounts due on shares can be deducted from dividends</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">The Board may deduct from any
dividend or other money payable to any person on or in respect of a share all such sums as may be due from him to the Company on
account of calls or otherwise in relation to the shares of the Company. Sums so deducted can be used to pay amounts owing to the
Company in respect of the shares.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">123.</FONT></TD><TD STYLE="text-align: justify">Dividends not in cash</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">The Board may, by ordinary resolution
of the Company direct, or in the case of an interim dividend may without the authority of an ordinary resolution direct, that payment
of any dividend declared may be satisfied wholly or partly by the distribution of assets, and in particular of paid up shares or
debentures of any other company, or in any one or more of such ways. Where any difficulty arises regarding such distribution, the
Board may settle it as it thinks fit. In particular, the Board may:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(a)</TD><TD STYLE="text-align: justify">issue fractional certificates (or ignore fractions);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(b)</TD><TD STYLE="text-align: justify">fix the value for distribution of such assets or any part of them and determine that cash payments
may be made to any members on the footing of the values so fixed, in order to adjust the rights of members; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(c)</TD><TD STYLE="text-align: justify">vest any such assets in trustees on trust for the person entitled to the dividend.</TD></TR></TABLE>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase"></FONT></P>

<!-- Field: Page; Sequence: 56; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">124.</FONT></TD><TD STYLE="text-align: justify">No interest on dividends</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">Unless otherwise provided by the
rights attached to the share, no dividend or other monies payable by the Company or in respect of a share shall bear interest as
against the Company.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">125.</FONT></TD><TD STYLE="text-align: justify">Method of payment</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">125.1</TD><TD STYLE="text-align: justify">The Company may pay any dividend, interest or other sum payable in respect of a share in cash or
by direct debit, bank transfer, cheque, dividend warrant, or money order or by any other method, including by electronic means,
as the Board may consider appropriate. For uncertificated shares, any payment may be made by means of the relevant system (subject
always to the facilities and requirements of the relevant system) and such payment may be made by the Company or any person on
its behalf by sending an instruction to the operator of the relevant system to credit the cash memorandum account of the holder
or joint holders of such shares or, if permitted by the Company, of such person as the holder or joint holders may in writing direct.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">125.2</TD><TD STYLE="text-align: justify">The Company may send such payment by post or other delivery service (or by such means offered by
the Company as the member or person entitled to it may agree in writing) to the registered address of the member or person entitled
to it (or, if two or more persons are holders of the share or are jointly entitled to it because of the death or bankruptcy of
the member or otherwise by operation of law, to the registered address of such of those persons as is first named in the Register)
or to such person and such address as such member or person may direct in writing.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">125.3</TD><TD STYLE="text-align: justify">Every cheque, warrant, order or other form of payment is sent at the risk of the person entitled
to the money represented by it, shall be made payable to the person or persons entitled, or to such other person as the person
or persons entitled may direct in writing. Payment of the cheque, warrant, order or other form of payment (including transmission
of funds through a bank transfer or other funds transfer system or by such other electronic means as permitted by these Articles
or in accordance with the facilities and requirements of the relevant system concerned) shall be good discharge to the Company.
If any such cheque, warrant, order or other form of payment has or shall be alleged to have been lost, stolen or destroyed the
Company shall not be responsible.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">125.4</TD><TD STYLE="text-align: justify">Any joint holder or other person jointly entitled to a share may give an effective receipt for
any dividend or other monies payable in respect of such share.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">125.5</TD><TD STYLE="text-align: justify">The Board may, at its discretion, make provisions to enable any member as the Board shall determine
to receive duly declared dividends in a currency or currencies other than sterling. For the purposes of the calculation of the
amount receivable in respect of any dividend, the rate of exchange to be used to determine the foreign currency equivalent of any
sum payable as a dividend shall be such rate or rates and the payment shall be on such terms and conditions as the Board may in
its absolute discretion determine.</TD></TR></TABLE>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase"></FONT></P>

<!-- Field: Page; Sequence: 57; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">126.</FONT></TD><TD STYLE="text-align: justify">Uncashed dividends</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">If cheques, warrants or orders
for dividends or other sums payable in respect of a share sent by the Company to the person entitled to them are returned to the
Company or left uncashed on two consecutive occasions or, following one occasion, reasonable enquires have failed to establish
any new address to be used for the purpose, the Company does not have to send any dividends or other monies payable in respect
of that share due to that person until he notifies the Company of an address to be used for the purpose.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">127.</FONT></TD><TD STYLE="text-align: justify">Unclaimed dividends</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">All dividends, interest or other
sums payable and unclaimed for 12 months after having become payable may be invested or otherwise made use of by the Board for
the benefit of the Company until claimed. The Company shall not be a trustee in respect of such unclaimed dividends and will not
be liable to pay interest on it. All dividends that remain unclaimed for 12 years after they were first declared or became due
for payment shall (if the Board so resolves) be forfeited and shall cease to remain owing by the Company.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">128.</FONT></TD><TD STYLE="text-align: justify">Scrip dividends</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">Subject to the Act, the Board
may, by ordinary resolution of the Company and subject to such terms and conditions as the Board may determine, offer to any holders
of ordinary shares (excluding any member holding shares as treasury shares) the right to elect to receive ordinary shares, credited
as fully paid, instead of cash in respect of the whole (or some part, to be determined by the Board) of any dividend specified
by the ordinary resolution. The following provisions shall apply:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(a)</TD><TD STYLE="text-align: justify">the said resolution may specify a particular dividend, or may specify all or any dividends declared
within a specified period or periods but such period may not end later than the fifth anniversary of the date of the meeting at
which the ordinary resolution is passed;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(b)</TD><TD STYLE="text-align: justify">the entitlement of each holder of ordinary shares to new ordinary shares shall be such that the
relevant value of the entitlement shall be as nearly as possible equal to (but not greater than) the cash amount (disregarding
any tax credit) of the dividend that such holder would have received by way of dividend. For this purpose <B>relevant value</B>
shall be calculated by reference to the average of the middle market quotations for the ordinary shares on the London Stock Exchange
as derived from the Daily Official List (or any other publication of a recognised investment exchange showing quotations for the
Company&rsquo;s ordinary shares), for the day on which the ordinary shares are first quoted &ldquo;ex&rdquo; the relevant dividend and
the four subsequent dealing days, or in such other manner as the Board may determine on such basis as it considers to be fair and
reasonable. A certificate or report by the Company&rsquo;s auditors as to the amount of the relevant value in respect of any dividend
shall be conclusive evidence of that amount;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt"></P>

<!-- Field: Page; Sequence: 58; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(c)</TD><TD STYLE="text-align: justify">no fractions of a share shall be allotted. The Board may make such provisions as it thinks fit
for any fractional entitlements including provisions where, in whole or in part, the benefit accrues to the Company and/or under
which fractional entitlements are accrued and/or retained and in each case accumulated on behalf of any member and such accruals
or retentions are applied to the allotment by way of bonus to or cash subscription on behalf of any member of fully paid ordinary
shares and/or provisions where cash payments may be made to members in respect of their fractional entitlements;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(d)</TD><TD STYLE="text-align: justify">the Board shall, after determining the basis of allotment, notify the holders of ordinary shares
in writing of the right of election offered to them, and specify the procedure to be followed and place at which, and the latest
time by which, elections must be lodged in order to be effective. No such notice need to be given to holders of ordinary shares
who have previously given election mandates in accordance with this Article and whose mandates have not been revoked. The accidental
omission to give notice of any right of election to, or the non-receipt (even if the Company becomes aware of such non-receipt)
of any such notice by, any holder of ordinary shares entitled to the same shall neither invalidate any offer of an election nor
give rise to any claim, suit or action;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(e)</TD><TD STYLE="text-align: justify">the Board shall not proceed with any election unless the company has sufficient reserves or funds
that may be capitalised, and the Board has authority to allot sufficient shares, to give effect to it after the basis of the allotment
is determined;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(f)</TD><TD STYLE="text-align: justify">the Board may exclude from any offer or make other arrangements in relation to any holders of ordinary
shares where the Board considers that the making of the offer to them or in respect of such shares would or might involve the contravention
of the laws of any territory or that for any other reason the offer should not be made to them or in respect of such shares;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(g)</TD><TD STYLE="text-align: justify">the Board may establish or vary a procedure for election mandates in respect of future rights of
election and may determine that every duly effected election in respect of any ordinary shares shall be binding on every successor
in title to the holder;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt"></P>

<!-- Field: Page; Sequence: 59; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(h)</TD><TD STYLE="text-align: justify">the dividend (or that part of the dividend in respect of which a right of election has been offered)
shall not be payable on ordinary shares in respect of which an election has been duly made (<B>elected ordinary shares</B>) and
instead additional ordinary shares shall be allotted to the holders of the elected ordinary shares on the basis of allotment determined
as stated above. For such purpose the Board may capitalise, out of any amount for the time being standing to the credit of any
reserve or fund (including any share premium account or capital redemption reserve) or of any of the profits which could otherwise
have been applied in paying dividends in cash as the Board may determine, a sum equal to the aggregate nominal amount of the additional
ordinary shares to be allotted on such basis and apply it in paying up in full the appropriate number of unissued ordinary shares
for allotment and distribution to the holders of the elected ordinary shares on such basis. The Board may do all acts and things
considered necessary or expedient to give effect to any such capitalisation;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(i)</TD><TD STYLE="text-align: justify">the Board may decide how any costs relating to the new shares available in place of a cash dividend
will be met, including to deduct an amount from the entitlement of a holder of ordinary shares under this Article;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(j)</TD><TD STYLE="text-align: justify">the additional ordinary shares so allotted shall rank <I>pari passu</I> in all respects with each
other and with the fully paid ordinary shares in issue on the record date for the dividend in respect of which the right of election
has been offered, except that they will not rank for any dividend or other distribution or other entitlement which has been declared,
paid or made by reference to such record date; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(k)</TD><TD STYLE="text-align: justify">the Board may terminate, suspend, or amend any offer of the right to elect to receive ordinary
shares in lieu of any cash dividend at any time and generally may implement any scrip dividend scheme on such terms and conditions
as the Board may determine and take such other action as the Board may deem necessary or desirable in respect of any such scheme.</TD></TR></TABLE>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">129.</FONT></TD><TD STYLE="text-align: justify">Capitalisation of reserves</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">The Board may, with the authority
of an ordinary resolution of the Company:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(a)</TD><TD STYLE="text-align: justify">subject as provided in this Article, resolve to capitalise any undivided profits of the Company
not required for paying any preferential dividend (whether or not they are available for distribution) or any sum standing to the
credit of any reserve or fund of the Company which is available for distribution or standing to the credit of the share premium
account of capital redemption reserve or other undistributable reserve;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(b)</TD><TD STYLE="text-align: justify">appropriate the sum resolved to be capitalised to the members in proportion to the nominal amounts
of the shares (whether or not fully paid) held by them respectively which would entitle them to participate in a distribution of
that sum if the shares were fully paid and the sum were then distributable and were distributed by way of dividend and apply such
sum on their behalf either in or towards paying up the amounts, if any, for the time being unpaid on any shares held by them respectively,
or in paying up in full unissued shares or debentures of the Company of a nominal amount equal to that sum, and allot the shares
or debentures credited as fully paid to those members or as they may direct, in those proportions, or partly in one way and partly
in the other, provided that:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99.25pt; text-align: justify; text-indent: -34.9pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99.25pt; text-align: justify; text-indent: -34.9pt"></P>

<!-- Field: Page; Sequence: 60; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99.25pt; text-align: justify; text-indent: -34.9pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 66.55pt"></TD><TD STYLE="width: 33.8pt">(i)</TD><TD STYLE="text-align: justify">the share premium account, the capital redemption reserve, any other undistributable reserve and
any profits which are not available for distribution may, for the purposes of this Article, only be applied in paying up in full
shares to be allotted to members credited as fully paid;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99.25pt; text-align: justify; text-indent: -34.9pt">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 66.55pt"></TD><TD STYLE="width: 33.8pt">(ii)</TD><TD STYLE="text-align: justify">the Company will also be entitled to participate in the relevant distribution in relation to any
shares of the relevant class held by it as treasury shares and the proportionate entitlement of the relevant class of members to
the distribution will be calculated accordingly; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 98.7pt; text-align: justify; text-indent: -34.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 67.65pt"></TD><TD STYLE="width: 32.7pt">(iii)</TD><TD STYLE="text-align: justify">in a case where any sum is applied in paying amounts for the time being unpaid on any shares of
the Company or in paying up in full debentures of the Company, the amount of the net assets of the Company at that time in not
less than the aggregate of the called up share capital of the Company and its undistributable reserves as shown in the latest audited
accounts of the Company or such other accounts as may be relevant and would not be reduced below that aggregate by the payment
of it;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(c)</TD><TD STYLE="text-align: justify">resolve that any shares so allotted to any member in respect of a holding by him of any partly
paid shares shall, so long as such shares remain partly paid, rank for dividends only to the extent that such partly paid shares
rank for dividends;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(d)</TD><TD STYLE="text-align: justify">make such provision by the issue of fractional certificates (or by ignoring fractions or by accruing
the benefit of it to the Company rather than to the members concerned) or by payment in cash or otherwise as it thinks fit in the
case of shares or debentures becoming distributable in fractions;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(e)</TD><TD STYLE="text-align: justify">authorise any person to enter on behalf of such members concerned into an agreement with the Company
providing for either:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99.25pt; text-align: justify; text-indent: -34.9pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 66.55pt"></TD><TD STYLE="width: 33.8pt">(i)</TD><TD STYLE="text-align: justify">the allotment to them respectively, credited as fully paid up, of any shares or debentures to which
they may be entitled on such capitalisation; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99.25pt; text-align: justify; text-indent: -34.9pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 66.55pt"></TD><TD STYLE="width: 33.8pt">(ii)</TD><TD STYLE="text-align: justify">the payment up by the Company on behalf of such members by the application of their respective
proportions of the reserves or profits resolved to be capitalised, of the amounts or any part of the amounts remaining unpaid on
their existing shares,</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify">(any agreement made under such
authority being effective and binding on all such members); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(f)</TD><TD STYLE="text-align: justify">generally do all acts and things required to give effect to such resolution.</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt"></P>

<!-- Field: Page; Sequence: 61; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;<FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">130.</FONT></TD><TD STYLE="text-align: justify">Record dates</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">130.1</TD><TD STYLE="text-align: justify">Notwithstanding any other provision of these Articles but without prejudice to the rights attached
to any shares and subject always to the Act, the Company or the Board may by resolution specify any date (<B>record date</B>) as
the date at the close of business (or such other time as the Board may determine) on which persons registered as the holders of
shares or other securities shall be entitled to receipt of any dividend, distribution, interest, allotment, issue, notice, information,
document or circular. Such record date may be before, on or after the date on which the dividend, distribution, interest, allotment,
issue, notice, information, document or circular is declared, made, paid, given, or served.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">130.2</TD><TD STYLE="text-align: justify">In the absence of a record date being fixed, entitlement to any dividend, distribution, interest,
allotment, issue, notice, information, document or circular shall be determined by reference to the date on which the dividend
is declared, the distribution allotment or issue is made or the notice, information, document or circular made, given or served.</TD></TR></TABLE>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">131.</FONT></TD><TD STYLE="text-align: justify">Inspection of records</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">No member (other than a Director)
shall have any right to inspect any accounting record or other document of the Company unless he is authorised to do so by law,
by order of a court of competent jurisdiction, by the Board or by ordinary resolution of the Company.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">132.</FONT></TD><TD STYLE="text-align: justify">Account to be sent to members</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">132.1</TD><TD STYLE="text-align: justify">In respect of each financial year, a copy of the Company&rsquo;s annual accounts, the strategic report,
the Directors&rsquo; report, the Directors&rsquo; remuneration report, the auditor&rsquo;s report on those accounts and on the auditable part of
the Directors&rsquo; remuneration report shall be sent or supplied to:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(a)</TD><TD STYLE="text-align: justify">Every member (whether or not entitled to receive notices of general meetings);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(b)</TD><TD STYLE="text-align: justify">Every holder of debentures (whether or not entitled to receive notice of general meetings);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(c)</TD><TD STYLE="text-align: justify">Every other person who is entitle to receive notice of general meetings;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">not less than 21 clear days before
the date of the meeting at which copies of those documents are to be laid in accordance with the Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"></P>

<!-- Field: Page; Sequence: 62; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">132.2</TD><TD STYLE="text-align: justify">This Article does not require copies of the documents to which it applies to be sent or supplied
to:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(a)</TD><TD STYLE="text-align: justify">A member or holder of debentures of whose address the Company is unaware; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(b)</TD><TD STYLE="text-align: justify">More than one of the joint holders of shares or debentures.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">132.3</TD><TD STYLE="text-align: justify">The Board may determine that persons entitled to receive a copy of the Company&rsquo;s annual accounts,
the strategic report, the Directors&rsquo; report, the Directors&rsquo; remuneration report, the auditor&rsquo;s report on those accounts and on
the auditable part of the Directors&rsquo; remuneration report are those persons entered on the Register at the close of business on
a day determined by the Board, provided that the day determined by the Board may not be more than 21 days before the day that the
relevant copies are being sent.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">132.4</TD><TD STYLE="text-align: justify">Where permitted by the Act, a strategic report with supplementary material in the form and containing
the information prescribed by the Act may be sent or supplied to a person so electing in place of the documents required to be
sent or supplied by Article 132.1.</TD></TR></TABLE>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">133.</FONT></TD><TD STYLE="text-align: justify">Service of Notices</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">133.1</TD><TD STYLE="text-align: justify">The Company can send, deliver or serve any notice or other document, including a share certificate,
to or on a member:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(a)</TD><TD STYLE="text-align: justify">personally;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(b)</TD><TD STYLE="text-align: justify">by sending it through the postal system addressed to the member at his registered address or by
leaving it at that address addressed to the member;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(c)</TD><TD STYLE="text-align: justify">through a relevant system, where the notice or document relates to uncertificated shares;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(d)</TD><TD STYLE="text-align: justify">where appropriate, by sending or supplying it in electronic form to an address notified by the
member to the Company for that purpose;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(e)</TD><TD STYLE="text-align: justify">where appropriate, by making it available on a website and notifying the member of its availability
in accordance with this Article; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(f)</TD><TD STYLE="text-align: justify">by any other means authorised in writing by the member.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt"></P>

<!-- Field: Page; Sequence: 63; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">133.2</TD><TD STYLE="text-align: justify">In the case of joint holders of a share:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(a)</TD><TD STYLE="text-align: justify">service, sending or supply of any notice, document or other information on or to one of the joint
holders shall for all purposes be deemed a sufficient service on, sending or supplying to all the joint holders; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(b)</TD><TD STYLE="text-align: justify">anything to be agreed or specified in relation to any notice, document or other information to
be served on, sent or supplied to them may be agreed or specified by any one of the joint holders and the agreement or specification
of the first named in the Register shall be accepted to the exclusion of that of the other joint holders.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">133.3</TD><TD STYLE="text-align: justify">Where a member (or, in the case of a joint holders, the person first named in the Register) has
a registered address outside the United Kingdom but has notified the Company of an address within the United Kingdom at which notices,
documents or other information may be given to him or has given to the Company an address for the purposes of communications by
electronic means at which notices, documents or other information may be served, sent or supplied to him, he shall be entitled
to have notices served, sent or supplied to him at such address or, where applicable, the Company may make them available on a
website and notify the holder of that address. Otherwise no such member shall be entitled to receive any notice, document or other
information from the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">133.4</TD><TD STYLE="text-align: justify">If on three consecutive occasions any notice, document or other information has been sent to any
member at his registered address or his address for the service of notices (by electronic means or otherwise) but has been returned
undelivered, such member shall not be entitled to receive notices, documents or other information from the Company until he shall
have communicated with the Company and supplied in writing a new registered address or address within the United Kingdom for the
service of notices or has informed the Company of an address for the service of notices and the sending or supply of documents
and other information in electronic form. For these purposes, any notice, document or other information served, sent or supplied
by post shall be treated as returned undelivered if the notice, document or other information is served, sent or supplied back
to the Company (or its agents) and a notice, document or other information served, sent or supplied in electronic form shall be
treated as returned undelivered if the Company (or its agents) receives notification that the notice, document or other information
was not delivered to the address to which it was served, sent or supplied.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">133.5</TD><TD STYLE="text-align: justify">The Company may at any time and in its sole discretion choose to serve, send or supply notices,
documents or other information in hard copy form alone to some or all of the members.</TD></TR></TABLE>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase"></FONT></P>

<!-- Field: Page; Sequence: 64; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">134.</FONT></TD><TD STYLE="text-align: justify">Notice on person entitled by transmission</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">The Company may give notice to
the person entitled to a share because of the death or bankruptcy of a member or otherwise by operation of law, by sending or delivering
it in any manner authorised by these Articles for the giving of notice to a member, addressed to that person by name, or by the
title of representative of the deceased or trustee of the bankrupt or representative by operation of law or by any like description,
at the address (if any) within the United Kingdom supplied for the purpose by the person claimed to be so entitled or to which
notices may be sent in electronic form. Until such an address has been so supplied, a notice may be given in any manner in which
it might have been given if the death or bankruptcy or operation of law had not occurred.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">135.</FONT></TD><TD STYLE="text-align: justify">Record date for service</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">Any notice, document or other
information may be served, sent or supplied by the Company by reference to the register as it stands at any time not more than
15 days before the date of service, sending or supplying. No change in the register after that time shall invalidate that service,
sending or supply. Where any notice, document or other information is served on, sent or supplied to any person in respect of a
share in accordance with these Articles, no person deriving any title or interest in that share shall be entitled to any further
service, sending or supplying of that notice, document or other information.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">136.</FONT></TD><TD STYLE="text-align: justify">Evidence of service</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">136.1</TD><TD STYLE="text-align: justify">Any notice, document or other information, addressed to a member at his registered address or address
for service in the United Kingdom shall, if served, sent or supplied by first class post, be deemed to have been served or delivered
on the day after the day when it was put in the post (or, where second class post is employed, on the second day after the day
when it was put in the post). Proof that an envelope containing the notice, document or other information was properly addressed
and put into the post as a prepaid letter shall be conclusive evidence that the notice was given.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">136.2</TD><TD STYLE="text-align: justify">Any notice, document or other information not served, sent or supplied by post but delivered or
left at a registered address or address for service in the United Kingdom (other than an address for the purposes of communications
by electronic means) shall be deemed to have been served or delivered on the day on which it was so delivered or left.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">136.3</TD><TD STYLE="text-align: justify">Any notice, document or other information, if served, sent or supplied by electronic means shall
be deemed to have been received on the day on which the electronic communication was sent by or on behalf of the Company notwithstanding
that the Company subsequently sends a hard copy of such notice, document or other information by post. Any notice, document or
other information made available on a website shall be deemed to have been received on the day on which the notice, document or
other information was first made available on the website or, if later, when a notice of availability is received or deemed to
have been received pursuant to this Article. Proof that the notice, document or other information was properly addressed shall
be conclusive evidence that the notice by electronic means was given.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">136.4</TD><TD STYLE="text-align: justify">Any notice, document or other information served, sent or supplied by the Company by means of a
relevant system shall be deemed to have been received when the Company or any sponsoring system-participant acting on its behalf
sends the issuer-instruction relating to the notice, document or other information.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"></P>

<!-- Field: Page; Sequence: 65; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">136.5</TD><TD STYLE="text-align: justify">Any notice, document or other information served, sent or supplied by the Company by any other
means authorised in writing by the member concerned shall be deemed to have been received when the Company has carried out the
action it has been authorised to take for that purpose.</TD></TR></TABLE>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">137.</FONT></TD><TD STYLE="text-align: justify">Notice when post not available</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">If at any time by reason of the
suspension, interruption or curtailment of postal services within the United Kingdom the Company is unable effectively to convene
a general meeting by notices sent through the post, the Company need only give notice of a general meeting to those members with
whom the Company can communicate by electronic means and who have provided the Company with an address for this purpose. The Company
shall also advertise the notice in at least one national newspaper published in the United Kingdom and make it available on its
website from the date of such advertisement until the conclusion of the meeting or any adjournment of it. In any such case the
Company shall send confirmatory copies of the notice by post to those members to whom notice cannot be given by electronic means
if, at least seven days prior to the meeting, the posting of notices to addresses throughout the United Kingdom again becomes practicable.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="text-transform: uppercase">138.</FONT></TD><TD STYLE="text-align: justify">Indemnity and insurance</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">138.1</TD><TD STYLE="text-align: justify">In this Article:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(a)</TD><TD STYLE="text-align: justify">companies are <B>associated</B> if one is a subsidiary of the other or both are subsidiaries of
the same body corporate;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(b)</TD><TD STYLE="text-align: justify">a <B>relevant officer</B> means any Director or other officer or former director or other officer
of the Company or an associated company (including any company which is a trustee of an occupational pension scheme (as defined
by section 235(6) of the Act), but excluding in each case any person engaged by the Company (or associated company) as auditor
(whether or not he is also a director or other officer), to the extent he acts in his capacity as auditor); and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(c)</TD><TD STYLE="text-align: justify"><B>relevant loss</B> means any loss or liability which has been or may be incurred by a relevant
officer in connection with that relevant officer&rsquo;s duties or powers in relation to the company, any associated company or any pension
fund or employees&rsquo; share scheme of the company or associated company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"></P>

<!-- Field: Page; Sequence: 66; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">138.2</TD><TD STYLE="text-align: justify">Subject to Article 138.4, but without prejudice to any indemnity to which a relevant officer is
otherwise entitled:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(a)</TD><TD STYLE="text-align: justify">each relevant officer shall be indemnified out of the Company&rsquo;s assets against all relevant loss
and in relation to the Company&rsquo;s (or any associated company&rsquo;s) activities as trustee of an occupational pension scheme (as defined
in section 235(6) of the Act), including any liability incurred by him in defending any civil or criminal proceedings, in which
judgment is given in his favour or in which he is acquitted or the proceedings are otherwise disposed of without any finding or
admission of any material breach of duty on his part or in connection with any application in which the court grants him, in his
capacity as a relevant officer, relief from liability for negligence, default, breach of duty or breach of trust in relation to
the Company&rsquo;s (or any associated company&rsquo;s) affairs; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 28.35pt">(b)</TD><TD STYLE="text-align: justify">the Company may provide any relevant officer with funds to meet expenditure incurred or to be incurred
by him in connection with any proceedings or application referred to in Article 138.2(a) and otherwise may take any action to enable
any such relevant officer to avoid incurring such expenditure.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">138.3</TD><TD STYLE="text-align: justify">This Article does not authorise any indemnity which would be prohibited or rendered void by any
provision of the Companies Acts or by any other provision of law.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt">138.4</TD><TD STYLE="text-align: justify">The Directors may decide to purchase and maintain insurance, at the expense of the Company, for
the benefit of any relevant officer in respect of any relevant loss.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"></P>

<!-- Field: Page; Sequence: 67; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>4
<FILENAME>ff12018a1ex4-1_tiziana.htm
<DESCRIPTION>FORM OF DEPOSIT AGREEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 4.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"><IMG SRC="ex4-1_001.jpg" ALT=""></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="margin: 0; text-align: right">&nbsp;<IMG SRC="ex4-1_002.jpg" ALT=""></P>

<P STYLE="margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><IMG SRC="ex4-1_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TABLE OF CONTENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 0 1.5pt; text-indent: 0; width: 8%">&nbsp;</TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="padding: 0 0 1.5pt; text-indent: 0; width: 82%">&nbsp;</TD>
    <TD STYLE="padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; text-align: center; width: 8%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PARTIES</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RECITALS</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section 1.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain Definitions</FONT></TD>
    <TD STYLE="padding: 0; text-align: center">1</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ADR Register</FONT></TD>
    <TD STYLE="padding: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ADRs; Direct Registration ADRs</FONT></TD>
    <TD STYLE="padding: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ADS</FONT></TD>
    <TD STYLE="padding: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Custodian</FONT></TD>
    <TD STYLE="padding: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD></TR>

<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deliver, execute, issue et al.</FONT></TD>
    <TD STYLE="padding: 0; text-align: center">2</TD></TR>

<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Delivery Order</FONT></TD>
    <TD STYLE="padding: 0; text-align: center">2</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deposited Securities</FONT></TD>
    <TD STYLE="padding: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Direct Registration System</FONT></TD>
    <TD STYLE="padding: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder</FONT></TD>
    <TD STYLE="padding: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities Act of 1933</FONT></TD>
    <TD STYLE="padding: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities Exchange Act of 1934</FONT></TD>
    <TD STYLE="padding: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</FONT></TD>
    <TD STYLE="padding: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transfer Office</FONT></TD>
    <TD STYLE="padding: 0; text-align: center">3</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Withdrawal Order</FONT></TD>
    <TD STYLE="padding: 0; text-align: center">3</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section 2.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of ADRs</FONT></TD>
    <TD STYLE="padding: 0; text-align: center">3</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section 3.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deposit of Shares</FONT></TD>
    <TD STYLE="padding: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section 4.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue of ADRs</FONT></TD>
    <TD STYLE="padding: 0; text-align: center">4</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section 5.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Distributions on Deposited Securities</FONT></TD>
    <TD STYLE="padding: 0; text-align: center">5</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section 6.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Withdrawal of Deposited Securities</FONT></TD>
    <TD STYLE="padding: 0; text-align: center">5</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section 7.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Substitution of ADRs</FONT></TD>
    <TD STYLE="padding: 0; text-align: center">5</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section 8.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cancellation and Destruction of ADRs</FONT></TD>
    <TD STYLE="padding: 0; text-align: center">5</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section 9.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Custodian</FONT></TD>
    <TD STYLE="padding: 0; text-align: center">6</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section 10.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lists of Holders </FONT></TD>
    <TD STYLE="padding: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section 11.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depositary&rsquo;s Agents</FONT></TD>
    <TD STYLE="padding: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section 12. </FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Resignation and Removal of the Depositary; Appointment of Successor Depositary</FONT></TD>
    <TD STYLE="padding: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section 13. </FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reports</FONT></TD>
    <TD STYLE="padding: 0; text-align: center">8</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section 14.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional Shares</FONT></TD>
    <TD STYLE="padding: 0; text-align: center">8</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section 15.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indemnification</FONT></TD>
    <TD STYLE="padding: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section 16.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notices</FONT></TD>
    <TD STYLE="padding: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section 17.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Counterparts</FONT></TD>
    <TD STYLE="padding: 0; text-align: center">10</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section 18.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No Third Party Beneficiaries; Holders and Beneficial Owners as Parties; Binding Effect</FONT></TD>
    <TD STYLE="padding: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section 19.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Severability</FONT></TD>
    <TD STYLE="padding: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section 20.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent to Jurisdiction; Appointment of Agent for Service of Process</FONT></TD>
    <TD STYLE="padding: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section 21.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Appointment</FONT></TD>
    <TD STYLE="padding: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section 22.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Waiver of Immunity </FONT></TD>
    <TD STYLE="padding: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section 23.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Waiver of Jury Trial</FONT></TD>
    <TD STYLE="padding: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TESTIMONIUM</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SIGNATURES</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&ndash; <!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --> &ndash;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><IMG SRC="ex4-1_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 0 1.5pt; font-family: Courier New, Courier, Monospace; width: 12%; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0 0 1.5pt; font-family: Courier New, Courier, Monospace; width: 79%; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0 0 1.5pt; font-family: Courier New, Courier, Monospace; width: 1%; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; font-family: Courier New, Courier, Monospace; width: 8%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Page</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>EXHIBIT A</B></FONT></TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2" STYLE="padding: 0 0 0 0in; font-family: Courier New, Courier, Monospace; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>FORM OF FACE OF ADR</B></FONT></TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">A-1</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2" STYLE="padding: 0 0 0 0.375in; font-family: Courier New, Courier, Monospace; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Introductory Paragraph</FONT></TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">A-1</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0 0 0 0.375in; font-family: Courier New, Courier, Monospace; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1)</FONT></TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Issuance of ADSs</FONT></TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">A-2</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0 0 0 0.375in; font-family: Courier New, Courier, Monospace; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">(2)</FONT></TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Withdrawal of Deposited Securities</FONT></TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">A-3</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0 0 0 0.375in; font-family: Courier New, Courier, Monospace; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">(3)</FONT></TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Transfers of ADRs</FONT></TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">A-3</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0 0 0 0.375in; font-family: Courier New, Courier, Monospace; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">(4)
</FONT></TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Certain Limitations</FONT></TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">A-3</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0 0 0 0.375in; font-family: Courier New, Courier, Monospace; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">(5)
</FONT></TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Liability of Holder for Taxes, Duties and Other Charges</FONT></TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">A-4</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0 0 0 0.375in; font-family: Courier New, Courier, Monospace; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">(6)</FONT></TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Disclosure of Interests</FONT></TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">A-5</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0 0 0 0.375in; font-family: Courier New, Courier, Monospace; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">(7)</FONT></TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Charges of Depositary</FONT></TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">A-6</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0 0 0 0.375in; font-family: Courier New, Courier, Monospace; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">(8)</FONT></TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Available Information</FONT></TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">A-8</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0 0 0 0.375in; font-family: Courier New, Courier, Monospace; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">(9)</FONT></TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Execution</FONT></TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">A-8</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2" STYLE="padding: 0 0 0 0.375in; font-family: Courier New, Courier, Monospace; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Signature of Depositary</FONT></TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">A-8</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2" STYLE="padding: 0 0 0 0.375in; font-family: Courier New, Courier, Monospace; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Address of Depositary&rsquo;s Office </FONT></TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">A-8</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2" STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>FORM OF REVERSE OF ADR</B></FONT></TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">A-9</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0 0 0 0.375in; font-family: Courier New, Courier, Monospace; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">(10)</FONT></TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Distributions on Deposited Securities</FONT></TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">A-9</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0 0 0 0.375in; font-family: Courier New, Courier, Monospace; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">(11)</FONT></TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Record Dates</FONT></TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">A-10</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0 0 0 0.375in; font-family: Courier New, Courier, Monospace; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">(12) </FONT></TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Voting of Deposited Securities</FONT></TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">A-10</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0 0 0 0.375in; font-family: Courier New, Courier, Monospace; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">(13) </FONT></TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Changes Affecting Deposited Securities</FONT></TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">A-11</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0 0 0 0.375in; font-family: Courier New, Courier, Monospace; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">(14)</FONT></TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Exoneration</FONT></TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">A-12</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0 0 0 0.375in; font-family: Courier New, Courier, Monospace; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">(15)</FONT></TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Resignation and Removal of Depositary; the Custodian</FONT></TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">A-14</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0 0 0 0.375in; font-family: Courier New, Courier, Monospace; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">(16)</FONT></TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Amendment</FONT></TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">A-15</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0 0 0 0.375in; font-family: Courier New, Courier, Monospace; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">(17)</FONT></TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Termination</FONT></TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">A-15</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0 0 0 0.375in; font-family: Courier New, Courier, Monospace; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">(18)</FONT></TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Appointment</FONT></TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">A-16</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0 0 0 0.375in; font-family: Courier New, Courier, Monospace; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">(19)</FONT></TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Waiver</FONT></TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">A-16</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0 0 0 0.375in; font-family: Courier New, Courier, Monospace; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">(20)</FONT></TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Elective Distributions in Cash or Shares</FONT></TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; font-family: Courier New, Courier, Monospace; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">A-16</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Courier; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&ndash; <!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --> &ndash;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: right"><IMG SRC="ex4-1_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DEPOSIT
AGREEMENT dated as of [DATE] , 2018 (the &ldquo;<B>Deposit Agreement</B>&rdquo;) among TIZIANA LIFE SCIENCES PLC and its successors
(the &ldquo;<B>Company</B>&rdquo;), JPMORGAN CHASE BANK, N.A., as depositary hereunder (the &ldquo;Depositary&rdquo;), and all holders
from time to time of American Depositary Receipts issued hereunder (&ldquo;<B>ADRs</B>&rdquo;) evidencing American Depositary Shares
(&ldquo;<B>ADSs</B>&rdquo;) representing deposited Shares (defined below). The Company hereby appoints the Depositary as depositary
for the Deposited Securities and hereby authorizes and directs the Depositary to act in accordance with the terms set forth in
this Deposit Agreement. All capitalized terms used herein have the meanings ascribed to them in Section 1 or elsewhere in this
Deposit Agreement. The parties hereto agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<B>Certain Definitions</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;&ldquo;<B>ADR
Register</B>&rdquo; is defined in paragraph (3) of the form of ADR (<I>Transfers, Split-Ups and Combinations of ADRs</I>).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;&ldquo;<B>ADRs</B>&rdquo;
mean the American Depositary Receipts executed and delivered hereunder. ADRs may be either in physical certificated form or Direct
Registration ADRs (as hereinafter defined). ADRs in physical certificated form, and the terms and conditions governing the Direct
Registration ADRs, shall be substantially in the form of Exhibit A annexed hereto (the &ldquo;<B>form of ADR</B>&rdquo;). The term
&ldquo;<B>Direct Registration ADR</B>&rdquo; means an ADR, the ownership of which is recorded on the Direct Registration System.
References to &ldquo;ADRs&rdquo; shall include certificated ADRs and Direct Registration ADRs, unless the context otherwise requires.
The form of ADR is hereby incorporated herein and made a part hereof; the provisions of the form of ADR shall be binding upon
the parties hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&nbsp;Subject
to paragraph (13) of the form of ADR, (<I>Changes Affecting Deposited Securities</I>) each &ldquo;<B>ADS</B>&rdquo; evidenced by
an ADR represents the right to receive, and to exercise the beneficial ownership interests in, the number of Shares specified
in the form of ADR attached hereto as Exhibit A (as amended from time to time) that are on deposit with the Depositary and/or
the Custodian and a pro rata share in any other Deposited Securities, subject, in each case, to the terms of this Deposit Agreement
and the ADSs. The ADS(s)-to-Share(s) ratio is subject to amendment as provided in the form of ADR (which may give rise to fees
contemplated in paragraph (7) thereof).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&nbsp;&ldquo;<B>Custodian</B>&rdquo;
means the agent or agents of the Depositary (singly or collectively, as the context requires) and any additional or substitute
Custodian appointed pursuant to Section 9.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 4; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: right"><IMG SRC="ex4-1_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)&nbsp;The
terms &ldquo;<B>deliver</B>&rdquo;, &ldquo;<B>execute</B>&rdquo;, &ldquo;<B>issue</B>&rdquo;, &ldquo;<B>register</B>&rdquo;, &ldquo;<B>surrender</B>&rdquo;,
&ldquo;<B>transfer</B>&rdquo; or &ldquo;<B>cancel</B>&rdquo;, when used with respect to Direct Registration ADRs, shall refer to an
entry or entries or an electronic transfer or transfers in the Direct Registration System, and, when used with respect to ADRs
in physical certificated form, shall refer to the physical delivery, execution, issuance, registration, surrender, transfer or
cancellation of certificates representing the ADRs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)&nbsp;&ldquo;<B>Delivery
Order</B>&rdquo; is defined in Section 3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)&nbsp;&ldquo;<B>Deposited
Securities</B>&rdquo; as of any time means all Shares at such time deposited under this Deposit Agreement and any and all other
Shares, securities, property and cash at such time held by the Depositary or the Custodian in respect or in lieu of such deposited
Shares and other Shares, securities, property and cash. Deposited Securities are not intended to, and shall not, constitute proprietary
assets of the Depositary, the Custodian or their nominees. Beneficial ownership in Deposited Securities is intended to be, and
shall at all times during the term of the Deposit Agreement continue to be, vested in the holders of the beneficial interests
in the ADSs representing such Deposited Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)&nbsp;&ldquo;<B>Direct
Registration System</B>&rdquo; means the system for the uncertificated registration of ownership of securities established by The
Depository Trust Company (&ldquo;<B>DTC</B>&rdquo;) and utilized by the Depositary pursuant to which the Depositary may record the
ownership of ADRs without the issuance of a certificate, which ownership shall be evidenced by periodic statements issued by the
Depositary to the Holders entitled thereto. For purposes hereof, the Direct Registration System shall include access to the Profile
Modification System maintained by DTC which provides for automated transfer of ownership between DTC and the Depositary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)&nbsp;&ldquo;<B>Holder</B>&rdquo;
means the person or persons in whose name an ADR is registered on the ADR Register.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)&nbsp;&ldquo;<B>Securities
Act of 1933</B>&rdquo; means the United States Securities Act of 1933, as from time to time amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)&nbsp;&ldquo;<B>Securities
Exchange Act of 1934</B>&rdquo; means the United States Securities Exchange Act of 1934, as from time to time amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)&nbsp;&ldquo;<B>Shares</B>&rdquo;
mean the ordinary shares of the Company, and shall include the rights to receive Shares specified in paragraph (1) of the form
of ADR (<I>Issuance of ADSs</I>).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: right"><IMG SRC="ex4-1_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)&nbsp;&ldquo;<B>Transfer
Office</B>&rdquo; is defined in paragraph (3) of the form of ADR (<I>Transfers, Split-Ups and Combinations of ADRs</I>).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)&nbsp;&ldquo;<B>Withdrawal
Order</B>&rdquo; is defined in Section 6.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<B>Form of ADRs</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<I>Direct Registration ADRs</I>. Notwithstanding anything in this Deposit Agreement or in the form of ADR to the contrary, ADSs
shall be evidenced by Direct Registration ADRs, unless certificated ADRs are specifically requested by the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<I>Certificated ADRs</I>. ADRs in certificated form shall be printed or otherwise reproduced at the discretion of the Depositary
in accordance with its customary practices in its American depositary receipt business, or at the request of the Company typewritten
and photocopied on plain or safety paper, and shall be substantially in the form set forth in the form of ADR, with such changes
as may be required by the Depositary or the Company to comply with their obligations hereunder, any applicable law, regulation
or usage or to indicate any special limitations or restrictions to which any particular ADRs are subject. ADRs may be issued in
denominations of any number of ADSs. ADRs in certificated form shall be executed by the Depositary by the manual or facsimile
signature of a duly authorized officer of the Depositary. ADRs in certificated form bearing the facsimile signature of anyone
who was at the time of execution a duly authorized officer of the Depositary shall bind the Depositary, notwithstanding that such
officer has ceased to hold such office prior to the delivery of such ADRs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<I>Binding Effect. </I>Holders shall be bound by the terms and conditions of this Deposit Agreement and of the form of ADR, regardless
of whether their ADRs are Direct Registration ADRs or certificated ADRs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<B>Deposit of Shares</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;<I>Requirements.
</I>In connection with the deposit of Shares hereunder, the Depositary or the Custodian may require the following in a form satisfactory
to it:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)<I>&nbsp;</I>a
written order directing the Depositary to issue to, or upon the written order of, the person or persons designated in such order
a Direct Registration ADR or ADRs evidencing the number of ADSs representing such deposited Shares (a &ldquo;<B>Delivery Order</B>&rdquo;);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)&nbsp;proper
endorsements or duly executed instruments of transfer in respect of such deposited Shares;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: right"><IMG SRC="ex4-1_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
&nbsp;instruments assigning to the Depositary, the Custodian or a nominee of either any distribution
on or in respect of such deposited Shares or indemnity therefor; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)&nbsp;proxies
entitling the Custodian to vote such deposited Shares</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)<I>&nbsp;Registration
of Deposited Securities. </I>As soon as practicable after the Custodian receives Deposited Securities pursuant to any such deposit
or pursuant to paragraph (10) (<I>Distributions on Deposited Securities</I>) or (13) (<I>Changes Affecting Deposited Securities</I>)
of the form of ADR, the Custodian shall present such Deposited Securities for registration of transfer into the name of the Depositary,
the Custodian or a nominee of either, in each case for the benefit of Holders, to the extent such registration is practicable,
at the cost and expense of the person making such deposit (or for whose benefit such deposit is made) and shall obtain evidence
satisfactory to it of such registration. Deposited Securities shall be held by the Custodian for the account and to the order
of the Depositary for the benefit of Holders of ADRs (to the extent not prohibited by law) at such place or places and in such
manner as the Depositary shall determine. Notwithstanding anything else contained herein, in the form of ADR and/or any outstanding
ADSs, the Depositary, the Custodian and their respective nominees are intended to be, and shall at all times during the term of
the Deposit Agreement be, the record holder(s) only of the Deposited Securities represented by the ADSs for the benefit of the
Holders. The Depositary, on its own behalf and on behalf of the Custodian and their respective nominees, disclaims any beneficial
ownership interest in the Deposited Securities held on behalf of the Holders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&nbsp;<I>Delivery
of Deposited Securities. </I>Deposited Securities may be delivered by the Custodian to any person only under the circumstances
expressly contemplated in this Deposit Agreement. To the extent that the provisions of or governing the Shares make delivery of
certificates therefor impracticable, Shares may be deposited hereunder by such delivery thereof as the Depositary or the Custodian
may reasonably accept, including, without limitation, by causing them to be credited to an account maintained by the Custodian
for such purpose with the Company or an accredited intermediary, such as a bank, acting as a registrar for the Shares, together
with delivery of the documents, payments and Delivery Order referred to herein to the Custodian or the Depositary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
<B>Issue of ADRs</B>. After any such deposit of Shares, the Custodian shall notify the Depositary of such deposit and of the information
contained in any related Delivery Order by letter, first class airmail postage prepaid, or, at the request, risk and expense of
the person making the deposit, by SWIFT, cable, telex or facsimile transmission. After receiving such notice from the Custodian,
the Depositary, subject to this Deposit Agreement, shall properly issue at the Transfer Office, to or upon the order of any person
named in such notice, an ADR or ADRs registered as requested and evidencing the aggregate ADSs to which such person is entitled.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: right"><IMG SRC="ex4-1_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
<B>Distributions on Deposited Securities</B>. To the extent that the Depositary determines in its discretion that any distribution
pursuant to paragraph (10) of the form of ADR (<I>Distributions on Deposited Securities</I>) is not practicable with respect to
any Holder, the Depositary may make such distribution as it so deems practicable, including the distribution of foreign currency,
securities or property (or appropriate documents evidencing the right to receive foreign currency, securities or property) or
the retention thereof as Deposited Securities with respect to such Holder&rsquo;s ADRs (without liability for interest thereon or the
investment thereof).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.
<B>Withdrawal of Deposited Securities.</B> In connection with any surrender of an ADR for withdrawal of the Deposited Securities
represented by the ADSs evidenced thereby, the Depositary may require proper endorsement in blank of such ADR (or duly executed
instruments of transfer thereof in blank) and the Holder&rsquo;s written order directing the Depositary to cause the Deposited Securities
represented by the ADSs evidenced by such ADR to be withdrawn and delivered to, or upon the written order of, any person designated
in such order (a &ldquo;<B>Withdrawal Order</B>&rdquo;). Directions from the Depositary to the Custodian to deliver Deposited Securities
shall be given by letter, first class airmail postage prepaid, or, at the request, risk and expense of the Holder, by SWIFT, cable,
telex or facsimile transmission. Delivery of Deposited Securities may be made by the delivery of certificates (which, if required
by law shall be properly endorsed or accompanied by properly executed instruments of transfer or, if such certificates may be
registered, registered in the name of such Holder or as ordered by such Holder in any Withdrawal Order) or by such other means
as the Depositary may deem practicable, including, without limitation, by transfer of record ownership thereof to an account designated
in the Withdrawal Order maintained either by the Company or an accredited intermediary, such as a bank, acting as a registrar
for the Deposited Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.
<B>Substitution of ADRs</B>. The Depositary shall execute and deliver a new Direct Registration ADR in exchange and substitution
for any mutilated certificated ADR upon cancellation thereof or in lieu of and in substitution for such destroyed, lost or stolen
certificated ADR, unless the Depositary has notice that such ADR has been acquired by a bona fide purchaser, upon the Holder thereof
filing with the Depositary a request for such execution and delivery and a sufficient indemnity bond and satisfying any other
reasonable requirements imposed by the Depositary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.
<B>Cancellation and Destruction of ADRs</B>. All ADRs surrendered to the Depositary shall be cancelled by the Depositary. The
Depositary is authorized to destroy ADRs in certificated form so cancelled in accordance with its customary practices.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: right"><IMG SRC="ex4-1_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.
<B>The Custodian</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;<I>Rights
of the Depositary</I>. Any Custodian in acting hereunder shall be subject to the directions of the Depositary and shall be responsible
solely to it. The Depositary reserves the right to add, replace or remove a Custodian. The Depositary will give prompt notice
of any such action, which will be advance notice if practicable. The Depositary may discharge any Custodian at any time upon notice
to the Custodian being discharged.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;<I>Rights
of the Custodian.</I> Any Custodian may resign from its duties hereunder by providing at least 30 days&rsquo; prior written notice to
the Depositary. The Depositary may discharge any Custodian at any time upon notice to the Custodian being discharged. Any Custodian
ceasing to act hereunder as Custodian shall deliver, upon the instruction of the Depositary, all Deposited Securities held by
it to a Custodian continuing to act. Notwithstanding anything to the contrary contained in this Deposit Agreement (including the
ADRs) and subject to the penultimate sentence of paragraph (14) of the form of ADR (<I>Exoneration</I>), the Depositary shall
not be responsible for, and shall incur no liability in connection with or arising from, any act or omission to act on the part
of the Custodian except to the extent that any Holder has incurred liability directly as a result of the Custodian having (i)
committed fraud or willful misconduct in the provision of custodial services to the Depositary or (ii) failed to use reasonable
care in the provision of custodial services to the Depositary as determined in accordance with the standards prevailing in the
jurisdiction in which the Custodian is located.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.
<B>Lists of Holders</B>. The Company shall have the right to inspect transfer records of the Depositary and its agents and the
ADR Register, take copies thereof and require the Depositary and its agents to supply copies of such portions of such records
as the Company may request. The Depositary or its agent shall furnish to the Company promptly upon the written request of the
Company, a list of the names, addresses and holdings of ADSs by all Holders as of a date within seven days of the Depositary&rsquo;s
receipt of such request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.
<B>Depositary&rsquo;s Agents</B>. The Depositary may perform its obligations under this Deposit Agreement through any agent appointed
by it, provided that the Depositary shall notify the Company of such appointment and shall remain responsible for the performance
of such obligations as if no agent were appointed, subject to paragraph (14) of the form of ADR (<I>Exoneration</I>).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 2in"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: right"><IMG SRC="ex4-1_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.
<B>Resignation and Removal of the Depositary; Appointment of Successor Depositary</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;<I>Resignation
of the Depositary</I>. The Depositary may at any time resign as Depositary hereunder by written notice of its election to do so
delivered to the Company, such resignation to take effect upon the appointment of a successor depositary and its acceptance of
such appointment as hereinafter provided.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;<I>Removal
of the Depositary</I>. The Depositary may at any time be removed by the Company by providing no less than 60 days&rsquo; prior written
notice of such removal to the Depositary, such removal to take effect the later of (i) the 60<SUP>th</SUP> day after such notice
of removal is first provided and (ii) the appointment of a successor depositary and its acceptance of such appointment as hereinafter
provided. Notwithstanding the foregoing, if upon the resignation or removal of the Depositary a successor depositary is not appointed
within the applicable 45-day period (in the case of resignation) or 60-day period (in the case of removal) as specified in paragraph
(17) of the form of ADR (<I>Termination</I>), then the Depositary may elect to terminate this Deposit Agreement and the ADR and
the provisions of said paragraph (17) shall thereafter govern the Depositary&rsquo;s obligations hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)<I>&nbsp;Appointment
of Successor Depositary</I>. In case at any time the Depositary acting hereunder shall resign or be removed, the Company shall
use its reasonable best efforts to appoint a successor depositary, which shall be a bank or trust company having an office in
the Borough of Manhattan, The City of New York. Every successor depositary shall execute and deliver to its predecessor and to
the Company an instrument in writing accepting its appointment hereunder, and thereupon such successor depositary, without any
further act or deed, shall become fully vested with all the rights, powers, duties and obligations of its predecessor. The predecessor
depositary, only upon payment of all sums due to it and on the written request of the Company, shall (i) execute and deliver an
instrument transferring to such successor all rights and powers of such predecessor hereunder (other than its rights to indemnification
and fees owing, each of which shall survive any such removal and/or resignation), (ii)&nbsp;duly assign, transfer and deliver
all right, title and interest to the Deposited Securities to such successor, and (iii) deliver to such successor a list of the
Holders of all outstanding ADRs(including the name, address and number of ADSs registered in the ADR Register in the name of each
such Holder). Any such successor depositary shall promptly mail notice of its appointment to such Holders. Any bank or trust company
into or with which the Depositary may be merged or consolidated, or to which the Depositary shall transfer substantially all its
American depositary receipt business, shall be the successor of the Depositary without the execution or filing of any document
or any further act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: right"><IMG SRC="ex4-1_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.
<B>Reports.</B> On or before the first date on which the Company makes any communication available to holders of Deposited Securities
or any securities regulatory authority or stock exchange, by publication or otherwise, the Company shall transmit to the Depositary
a copy thereof in English or with an English translation or summary. The Company has delivered to the Depositary, the Custodian
and any Transfer Office, a copy of all provisions of or governing the Shares and any other Deposited Securities issued by the
Company or any affiliate of the Company and, promptly upon any change thereto, the Company shall deliver to the Depositary, the
Custodian and any Transfer Office, a copy (in English or with an English translation) of such provisions as so changed. The Depositary
and its agents may rely upon the Company&rsquo;s delivery of all such communications, information and provisions for all purposes of
this Deposit Agreement and the Depositary shall have no liability for the accuracy or completeness of any thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.
<B>Additional Shares</B>. The Company agrees with the Depositary that neither the Company nor any company controlling, controlled
by or under common control with the Company shall (i) issue additional Shares, (ii) rights to subscribe for Shares, (iii) securities
convertible into or exchangeable for Shares or (iv) rights to subscribe for any such securities or shall deposit any Shares under
this Deposit Agreement, except under circumstances complying in all respects with the Securities Act of 1933. At the reasonable
request of the Depositary where it deems necessary, the Company will furnish the Depositary with legal opinions, in forms and
from counsels reasonably acceptable to the Depositary, dealing with such issues requested by the Depositary as are customary and
reasonable in the circumstances. The Depositary will use reasonable efforts to comply with written instructions of the Company
not to accept for deposit hereunder any Shares identified in such instructions at such times and under such circumstances as may
reasonably be specified in such instructions in order to facilitate the Company&rsquo;s compliance with the requirements of the securities
laws, rules and regulations in the United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.
<B>Indemnification.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)<I>&#9;Indemnification
by the Company</I>. The Company shall indemnify, defend and save harmless each of the Depositary, the Custodian and their respective
directors, officers, employees, agents and affiliates against any loss, liability or expense (including reasonable fees and expenses
of counsel) which may arise out of acts performed or omitted, in connection with the provisions of this Deposit Agreement and
of the ADRs, as the same may be amended, modified or supplemented from time to time in accordance herewith (i) by either the Depositary
or a Custodian or their respective directors, officers, employees, agents and affiliates, except for any liability or expense
directly arising out of the negligence, or willful misconduct of the Depositary or its directors, officers or affiliates acting
in their capacities as such hereunder; provided however that, with respect to the acts and omissions to act of a Custodian, the
Custodian shall not be entitled to be indemnified hereunder for any liability or expense directly arising out of (a) the Custodian
having committed fraud or willful misconduct in the provision of custodial services to the Depositary or (b) the Custodian having
failed to use reasonable care in the provision of custodial services to the Depositary as determined in accordance with the standards
prevailing in the jurisdiction in which the Custodian is located, or (ii) by the Company or any of its directors, officers, employees,
agents and affiliates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
indemnities set forth in the preceding paragraph shall also apply to any liability or expense which may arise out of any misstatement
or alleged misstatement or omission or alleged omission in any registration statement, proxy statement, prospectus (or placement
memorandum), or preliminary prospectus (or preliminary placement memorandum) relating to the offer, issuance, withdrawal or sale
of ADSs or the deposit of Shares in connection therewith, except to the extent any such liability or expense arises out of (i)
information relating to the Depositary or its agents (other than the Company), as applicable, furnished in writing by the Depositary
expressly for use in any of the foregoing documents and not changed or altered by the Company or (ii) if such information is provided,
the failure to state a material fact necessary to make the information provided not misleading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<I>Indemnification by the Depositary.</I> Subject to the limitations provided for in Section 15(c) below, the Depositary shall
indemnify, defend and save harmless the Company against any direct loss, liability or expense (including reasonable fees and expenses
of counsel) incurred by the Company in respect of this Deposit Agreement to the extent such loss, liability or expense is due
to the negligence or willful misconduct of the Depositary.]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<I>&nbsp;Damages or Lost Profits</I>. Notwithstanding any other provision of this Deposit Agreement or the ADRs to the contrary,
neither the Depositary nor any of its agents shall be liable for any indirect, special, punitive or consequential damages (including,
without limitation, legal fees and expenses) or lost profits, in each case of any form incurred by any person or entity, whether
or not foreseeable and regardless of the type of action in which such a claim may be brought.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
person seeking indemnification hereunder (an &ldquo;indemnified person&rdquo;) shall notify the person from whom it is seeking indemnification
(the &ldquo;indemnifying person&rdquo;) of the commencement of any indemnifiable action or claim promptly after such indemnified
person becomes aware of such commencement (provided that the failure to make such notification shall not affect such indemnified
person&rsquo;s rights to indemnification except and only to the limited extent the indemnifying person is materially prejudiced by such
failure) and shall consult in good faith with the indemnifying person as to the conduct of the defense of such action or claim
that may give rise to an indemnity hereunder, which defense shall be reasonable under the circumstances. No indemnified person
shall compromise or settle any indemnifiable action without the prior written consent of the indemnifying person ((which consent
shall not unreasonably (from the point of view of the person seeking indemnification)) be withheld or delayed) unless (i) there
is no finding or admission of any violation of law and no effect on any other claims that may be made against such indemnifying
person and (ii) the sole relief provided is monetary damages that are paid in full by the indemnified person (without indemnification
hereunder by the indemnifying person) seeking such compromise or settlement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: right"><IMG SRC="ex4-1_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)<I>&#9;Survival.</I>&#9;The
obligations set forth in this Section 15 shall survive the termination of this Deposit Agreement and the succession or substitution
of any indemnified person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.
<B>Notices</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)<I>&nbsp;Notice
to Holders</I>. Notice to any Holder shall be deemed given when first mailed, first class postage prepaid, to the address of such
Holder on the ADR Register or received by such Holder. Failure to notify a Holder or any defect in the notification to a Holder
shall not affect the sufficiency of notification to other Holders or to the beneficial owners of ADSs held by such other Holders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<I>&nbsp;Notice to the Depositary or the Company</I>. Notice to the Depositary or the Company
shall be deemed given when first received by it at the address or facsimile transmission number set forth in (a) or (b), respectively,
or at such other address or facsimile transmission number as either may specify to the other by written notice:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1.5in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">JPMorgan
                                         Chase Bank, N.A.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">383
Madison Avenue, Floor 11</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, New York, 10179</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Depositary Receipts Group</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fax:
(302) 220-4591</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1.5in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tiziana
                                         Life Sciences plc</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">55
Park Lane</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">London
W1K 1NA</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">England</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
[CONTACT PERSON] </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fax:
[FACSIMILE]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: right"><IMG SRC="ex4-1_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.
<B>Counterparts. </B>This Deposit Agreement may be executed in any number of counterparts, each of which shall be deemed an original
and all of which shall constitute one instrument. Delivery of an executed signature page of this Deposit Agreement by facsimile
or other electronic transmission (including &ldquo;.pdf&rdquo;, &ldquo;.tif&rdquo; or similar format) shall be effective as delivery
of a manually executed counterpart hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.
<B>No Third-Party Beneficiaries; Holders and Beneficial Owners as Parties; Binding Effect</B>. This Deposit Agreement is for the
exclusive benefit of the Company, the Depositary, the Holders, and their respective successors hereunder, and, except to the extent
specifically set forth in Section 15 of this Deposit Agreement, shall not give any legal or equitable right, remedy or claim whatsoever
to any other person. The Holders and owners of interests in ADRs from time to time shall be parties to this Deposit Agreement
and shall be bound by all of the provisions hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19.
<B>Severability</B>. If any such provision is invalid, illegal or unenforceable in any respect, the remaining provisions shall
in no way be affected thereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.
<B>Governing Law; Consent to Jurisdiction</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;The
Deposit Agreement, the ADSs and the ADRs shall be governed by and construed in accordance with the internal laws of the State
of New York without giving effect to the application of the conflict of law principles thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&#9;<I>By
the Company.</I>&#9;The Company irrevocably agrees that any legal suit, action or proceeding against the Company brought by the
Depositary or any Holder, arising out of or based upon this Deposit Agreement, the ADSs or the ADRs or the transactions contemplated
hereby or thereby, may be instituted in any state or federal court in New York, New York, and irrevocably waives any objection
which it may now or hereafter have to the laying of venue of any such proceeding, and irrevocably submits to the non-exclusive
jurisdiction of such courts in any such suit, action or proceeding. The Company also irrevocably agrees that any legal suit, action
or proceeding against the Depositary brought by the Company, arising out of or based upon this Deposit Agreement or the transactions
contemplated hereby, may only be instituted in a state or federal court in New York, New York.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&nbsp;<I>By
Holders and Owners etc.</I> By holding an ADS or an interest therein, Holders and owners of interests in ADSs each irrevocably
agree that any legal suit, action or proceeding against or involving the Company or the Depositary, arising out of or based upon
this Deposit Agreement, the ADSs, the ADRs or the transactions contemplated herein, therein or hereby, may only be instituted
in a state or federal court in New York, New York, and by holding an ADS or an interest therein each irrevocably waives any objection
which it may now or hereafter have to the laying of venue of any such proceeding, and irrevocably submits to the exclusive jurisdiction
of such courts in any such suit, action or proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: right"><IMG SRC="ex4-1_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&nbsp;Notwithstanding
the foregoing, any action against the Company based on this Deposit Agreement, the ADSs or the ADRs or the transactions contemplated
hereby or thereby, may be instituted by the Depositary in any competent court in the United Kingdom and/or the United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.
<B>Agent for Service.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)<I>&nbsp;Appointment</I>.
The Company has appointed _________________________, New York, New York, as its authorized agent (the &ldquo;<B>Authorized Agent</B>&rdquo;)
upon which process may be served in any such action arising out of or based on this Deposit Agreement or the transactions contemplated
hereby which may be instituted in any state or federal court in New York, New York by the Depositary or any Holder, and waives
any other requirements of or objections to personal jurisdiction with respect thereto. Subject to the Company&rsquo;s rights to
replace the Authorized Agent with another entity in the manner required were the Authorized Agent to have resigned, such appointment
shall be irrevocable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)<I>&nbsp;Agent
for Service of Process</I>. The Company represents and warrants that the Authorized Agent has agreed to act as said agent for
service of process, and the Company agrees to take any and all action, including the filing of any and all documents and instruments,
that may be necessary to continue such appointment in full force and effect as aforesaid. The Company further hereby irrevocably
consents and agrees to the service of any and all legal process, summons, notices and documents in any suit, action or proceeding
against the Company, by service by mail of a copy thereof upon the Authorized Agent (whether or not the appointment of such Authorized
Agent shall for any reason prove to be ineffective or such Authorized Agent shall fail to accept or acknowledge such service),
with a copy mailed to the Company by registered or certified air mail, postage prepaid, to its address provided in Section 16(b)
hereof. The Company agrees that the failure of the Authorized Agent to give any notice of such service to it shall not impair
or affect in any way the validity of such service or any judgment rendered in any suit, action or proceeding based thereon. If,
for any reason, the Authorized Agent named above or its successor shall no longer serve as agent of the Company to receive service
of process in New York, the Company shall promptly appoint a successor that is a legal entity with offices in New York, New York,
so as to serve and will promptly advise the Depositary thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: right"><IMG SRC="ex4-1_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)<I>&nbsp;Waiver
of Personal Service of Process</I>. In the event the Company fails to continue such designation and appointment in full force
and effect, the Company hereby waives personal service of process upon it and consents that any such service of process may be
made by certified or registered mail, return receipt requested, directed to the Company at its address last specified for notices
hereunder, and service so made shall be deemed completed five (5) days after the same shall have been so mailed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22.
<B>Waiver of Immunities. </B>To the extent that the Company or any of its properties, assets or revenues may have or may hereafter
be entitled to, or have attributed to it, any right of immunity, on the grounds of sovereignty or otherwise, from any legal action,
suit or proceeding, from the giving of any relief in any respect thereof, from setoff or counterclaim, from the jurisdiction of
any court, from service of process, from attachment upon or prior to judgment, from attachment in aid of execution or judgment,
or from execution of judgment, or other legal process or proceeding for the giving of any relief or for the enforcement of any
judgment, in any jurisdiction in which proceedings may at any time be commenced, with respect to its obligations, liabilities
or other matters under or arising out of or in connection with the Shares or Deposited Securities, the ADSs, the ADRs or this
Deposit Agreement, the Company, to the fullest extent permitted by law, hereby irrevocably and unconditionally waives, and agrees
not to plead or claim, any such immunity and consents to such relief and enforcement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.
<B>Waiver of Jury Trial</B>. EACH PARTY TO THIS DEPOSIT AGREEMENT (INCLUDING, FOR AVOIDANCE OF DOUBT, EACH HOLDER AND BENEFICIAL
OWNER OF, AND/OR HOLDER OF INTERESTS IN, ADSS OR ADRS) HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE
LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN ANY SUIT, ACTION OR PROCEEDING AGAINST THE DEPOSITARY AND/OR THE COMPANY DIRECTLY
OR INDIRECTLY ARISING OUT OF OR RELATING TO THE SHARES OR OTHER DEPOSITED SECURITIES, THE ADSs OR THE ADRs, THE DEPOSIT AGREEMENT
OR ANY TRANSACTION CONTEMPLATED HEREIN OR THEREIN, OR THE BREACH HEREOF OR THEREOF (WHETHER BASED ON CONTRACT, TORT, COMMON LAW
OR ANY OTHER THEORY).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: right"><IMG SRC="ex4-1_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, TIZIANA LIFE SCIENCES PLC and JPMORGAN CHASE BANK, N.A. have duly executed this Deposit Agreement as of the day
and year first above set forth and all holders of ADRs shall become parties hereto upon acceptance by them of ADRs issued in accordance
with the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TIZIANA
    LIFE SCIENCES PLC</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; width: 35%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 0 1.5pt; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0 0 1.5pt; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">JPMORGAN
    CHASE BANK, N.A.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 0 1.5pt; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0 0 1.5pt; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Executive Director</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: right"><IMG SRC="ex4-1_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXHIBIT
A</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ANNEXED
TO AND INCORPORATED IN</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>DEPOSIT
AGREEMENT </U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[FORM
OF FACE OF ADR]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; width: 60%; text-indent: 0">____</TD>
    <TD STYLE="padding: 0; width: 40%; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No. of ADSs:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each ADS represents</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Five Shares</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CUSIP:</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AMERICAN
DEPOSITARY RECEIPT</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">evidencing</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AMERICAN
DEPOSITARY SHARES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">representing</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ORDINARY
SHARES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">of</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TIZIANA
LIFE SCIENCES PLC</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Incorporated
under the laws of England and Wales)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">JPMORGAN
CHASE BANK, N.A., a national banking association organized under the laws of the United States of America, as depositary
hereunder (the &ldquo;<B>Depositary</B>&rdquo;), hereby certifies that ______ is the registered owner (a
&ldquo;<B>Holder</B>&rdquo;) of American Depositary Shares (&ldquo;<B>ADSs</B>&rdquo;), each (subject to paragraph (13)
(<I>Changes Affecting Deposited Securities</I>)) representing five ordinary shares (including the rights to receive Shares
described in paragraph (1) (<I>Issuance of ADSs</I>), &ldquo;<B>Shares</B>&rdquo; and, together with any other securities,
cash or property from time to time held by the Depositary in respect or in lieu of deposited Shares, the &ldquo;<B>Deposited
Securities</B>&rdquo;), of Tiziana Life Sciences plc, a corporation organized under the laws of England and Wales (the
&ldquo;Company&rdquo;), deposited under the Deposit Agreement dated as of [DATE], 2018 (as amended from time to time, the
&ldquo;<B>Deposit Agreement</B>&rdquo;) among the Company, the Depositary and all Holders from time to time of
American Depositary Receipts issued thereunder (&ldquo;<B>ADRs</B>&rdquo;), each of whom by accepting an ADR becomes a party
thereto. The Deposit Agreement and this ADR (which includes the provisions set forth on the reverse hereof) shall be governed
by and construed in accordance with the internal laws of the State of New York without giving effect to the application of
the conflict of law principles thereof. All capitalized terms used herein, and not defined herein, shall have the meanings
ascribed to such terms in the Deposit Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 17; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: right"><IMG SRC="ex4-1_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
<B>Issuance of ADSs</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<I>Issuance</I>. This ADR is one of the ADRs issued under the Deposit Agreement. Subject to the other provisions hereof, the Depositary
may so issue ADRs for delivery at the Transfer Office (as hereinafter defined) only against deposit of: (i) Shares in a form satisfactory
to the Custodian; or (ii) rights to receive Shares from the Company or any registrar, transfer agent, clearing agent or other
entity recording Share ownership or transactions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<I>Lending</I>. In its capacity as Depositary, the Depositary shall not lend Shares or ADSs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<I>Representations and Warranties of Depositors</I>. Every person depositing Shares under the Deposit Agreement represents and
warrants that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">such
                                         Shares and the certificates therefor are duly authorized, validly issued and outstanding,
                                         fully paid, nonassessable and legally obtained by such person,</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
                                         pre-emptive and comparable rights, if any, with respect to such Shares have been validly
                                         waived or exercised,</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         person making such deposit is duly authorized so to do,</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Shares presented for deposit are free and clear of any lien, encumbrance, security interest,
                                         charge, mortgage or adverse claim and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">such
                                         Shares (A) are not &ldquo;restricted securities&rdquo; as such term is defined in Rule
                                         144 under the Securities Act of 1933 (&ldquo;<B>Restricted Securities</B>&rdquo;) unless
                                         at the time of deposit the requirements of paragraphs (c), (e), (f) and (h) of Rule 144
                                         shall not apply and such Shares may be freely transferred and may otherwise be offered
                                         and sold freely in the United States or (B) have been registered under the Securities
                                         Act of 1933. To the extent the person depositing Shares is an &ldquo;affiliate&rdquo; of
                                         the Company as such term is defined in Rule 144, the person also represents and warrants
                                         that upon the sale of the ADSs, all of the provisions of Rule 144 which enable the Shares
                                         to be freely sold (in the form of ADSs) will be fully complied with and, as a result
                                         thereof, all of the ADSs issued in respect of such Shares will not be on the sale thereof,
                                         Restricted Securities</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: right"><IMG SRC="ex4-1_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Such
representations and warranties shall survive the deposit and withdrawal of Shares and the issuance and cancellation of ADSs in
respect thereof and the transfer of such ADSs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1.1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&nbsp;The
Depositary may refuse to accept for such deposit any Shares identified by the Company in order to facilitate compliance with the
requirements of the Securities Act of 1933 or the Rules made thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
<B>Withdrawal of Deposited Securities</B>. Subject to paragraphs (4) (<I>Certain Limitations to Registration, Transfer etc.) </I>and
(5) (<I>Liability of Holder for Taxes, Duties and Other Charges</I>), upon surrender of (a) a certificated ADR in a form satisfactory
to the Depositary at the Transfer Office or (b) proper instructions and documentation in the case of a Direct Registration ADR,
the Holder hereof is entitled to delivery at, or to the extent in dematerialized form from, the Custodian&rsquo;s office of the Deposited
Securities at the time represented by the ADSs evidenced by this ADR. At the request, risk and expense of the Holder hereof, the
Depositary may deliver such Deposited Securities at such other place as may have been requested by the Holder. Notwithstanding
any other provision of the Deposit Agreement or this ADR, the withdrawal of Deposited Securities may be restricted only for the
reasons set forth in General Instruction I.A.(1) of Form F-6 (as such instructions may be amended from time to time) under the
Securities Act of 1933.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
<B>Transfers, Split-Ups and Combinations of ADRs</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1.1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<I>Transfer Office</I>. The Depositary or its agent will keep, at a designated transfer office (the &ldquo;Transfer Office&rdquo;),
(i) a register (the &ldquo;<B>ADR Register</B>&rdquo;) for the registration, registration of transfer, combination and split-up
of ADRs, and, in the case of Direct Registration ADRs, shall include the Direct Registration System, which at all reasonable times
will be open for inspection by Holders and the Company for the purpose of communicating with Holders in the interest of the business
of the Company or a matter relating to the Deposit Agreement and (ii) facilities for the delivery and receipt of ADRs. The term
ADR Register includes the Direct Registration System. Title to this ADR (and to the Deposited Securities represented by the ADSs
evidenced hereby), when properly endorsed (in the case of ADRs in certificated form) or upon delivery to the Depositary of proper
instruments of transfer, is transferable by delivery with the same effect as in the case of negotiable instruments under the laws
of the State of New York; <U>provided</U> that the Depositary, notwithstanding any notice to the contrary, may treat the person
in whose name this ADR is registered on the ADR Register as the absolute owner hereof for all purposes and neither the Depositary
nor the Company will have any obligation or be subject to any liability under the Deposit Agreement to any holder of an ADR, unless
such holder is the Holder thereof. Subject to paragraphs (4) and (5), this ADR is transferable on the ADR Register and may be
split into other ADRs or combined with other ADRs into one ADR, evidencing the aggregate number of ADSs surrendered for split-up
or combination, by the Holder hereof or by duly authorized attorney upon surrender of this ADR at the Transfer Office properly
endorsed (in the case of ADRs in certificated form) or upon delivery to the Depositary of proper instruments of transfer and duly
stamped as may be required by applicable law; <U>provided</U> that the Depositary may close the ADR Register or any portion thereof
at any time or from time to time when deemed expedient by it, and it may also close the issuance book portion of the ADR Register
when reasonably requested by the Company solely in order to enable the Company to comply with applicable law. At the request of
a Holder, the Depositary shall, for the purpose of substituting a certificated ADR with a Direct Registration ADR, or vice versa,
execute and deliver a certificated ADR or a Direct Registration ADR, as the case may be, for any authorized number of ADSs requested,
evidencing the same aggregate number of ADSs as those evidenced by the certificated ADR or Direct Registration ADR, as the case
may be, substituted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)
<B>Certain Limitations to Registration, Transfer etc</B>. Prior to the issue, registration, registration of transfer, split-up
or combination of any ADR, the delivery of any distribution in respect thereof, or, subject to the last sentence of paragraph
(2) (<I>Withdrawal of Deposited Securities</I>), the withdrawal of any Deposited Securities, and from time to time in the case
of clause (b)(ii) of this paragraph (4), the Company, the Depositary or the Custodian may require:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
payment with respect thereto of (i) any stock transfer or other tax or other governmental charge, (ii) any stock transfer or registration
fees in effect for the registration of transfers of Shares or other Deposited Securities upon any applicable register and (iii)
any applicable charges as provided in paragraph (7) (<I>Charges of Depositary</I>) of this ADR;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
the production of proof satisfactory to it of (i) the identity of any signatory and genuineness of any signature and (ii) such
other information, including without limitation, information as to citizenship, residence, exchange control approval, beneficial
ownership of any securities, compliance with applicable law, regulations, provisions of or governing Deposited Securities and
terms of the Deposit Agreement and this ADR, as it may deem necessary or proper; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: right"><IMG SRC="ex4-1_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
compliance with such regulations as the Depositary may establish consistent with the Deposit Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
issuance of ADRs, the acceptance of deposits of Shares, the registration, registration of transfer, split-up or combination of
ADRs or, subject to the last sentence of paragraph (2) (<I>Withdrawal of Deposited Securities</I>), the withdrawal of Deposited
Securities may be suspended, generally or in particular instances, when the ADR Register or any register for Deposited Securities
is closed or when any such action is deemed advisable by the Depositary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)
<B>Liability of Holder for Taxes, Duties and Other Charges</B>. If any tax or other governmental charges (including any penalties
and/or interest) shall become payable by or on behalf of the Custodian or the Depositary with respect to this ADR, any Deposited
Securities represented by the ADSs evidenced hereby or any distribution thereon, such tax or other governmental charge shall be
paid by the Holder hereof to the Depositary and by holding or having held an ADR the Holder and all prior Holders hereof, jointly
and severally, agree to indemnify, defend and save harmless each of the Depositary and its agents in respect thereof. The Depositary
may refuse to effect any registration, registration of transfer, split-up or combination hereof or, subject to the last sentence
of paragraph (2) (<I>Withdrawal of Deposited Securities</I>), any withdrawal of such Deposited Securities until such payment is
made. The Depositary may also deduct from any distributions on or in respect of Deposited Securities, or may sell by public or
private sale for the account of the Holder hereof any part or all of such Deposited Securities (after attempting by reasonable
means to notify the Holder hereof prior to such sale), and may apply such deduction or the proceeds of any such sale in payment
of such tax or other governmental charge, the Holder hereof remaining liable for any deficiency, and shall reduce the number of
ADSs evidenced hereby to reflect any such sales of Shares. In connection with any distribution to Holders, the Company will remit
to the appropriate governmental authority or agency all amounts (if any) required to be withheld and owing to such authority or
agency by the Company; and the Depositary and the Custodian will remit to the appropriate governmental authority or agency all
amounts (if any) required to be withheld and owing to such authority or agency by the Depositary or the Custodian. If the Depositary
determines that any distribution in property other than cash (including Shares or rights) on Deposited Securities is subject to
any tax that the Depositary or the Custodian is obligated to withhold, the Depositary may dispose of all or a portion of such
property in such amounts and in such manner as the Depositary deems necessary and practicable to pay such taxes, by public or
private sale, and the Depositary shall distribute the net proceeds of any such sale or the balance of any such property after
deduction of such taxes to the Holders entitled thereto. Each Holder of an ADR or an interest therein agrees to indemnify the
Depositary, the Company, the Custodian and any of their respective officers, directors, employees, agents and affiliates against,
and hold each of them harmless from, any claims by any governmental authority with respect to taxes, additions to tax, penalties
or interest arising out of any refund of taxes, reduced rate of withholding at source or other tax benefit obtained which obligations
shall survive any transfer or surrender of ADSs or the termination of the Deposit Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: right"><IMG SRC="ex4-1_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)
<B>Disclosure of Interests</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <I>General</I>.
To the extent that the provisions of or governing any Deposited Securities may require disclosure of or impose limits on
beneficial or other ownership of, or interests in, Deposited Securities, other Shares and other securities and may
provide for blocking transfer, voting or other rights to enforce such disclosure or limits, Holders and all persons holding
ADRs agree to comply with all such disclosure requirements and ownership limitations and to comply with any reasonable
Company instructions in respect thereof. The Company reserves the right to instruct Holders to deliver their ADSs for
cancellation and withdrawal of the Deposited Securities so as to permit the Company to deal directly with the Holder thereof
as a holder of Shares and Holders agree to comply with such instructions. The Depositary agrees to cooperate with the Company
in its efforts to inform Holders of the Company&rsquo;s exercise of its rights under this paragraph and agrees to consult with, and
provide reasonable assistance without risk, liability or expense on the part of the Depositary, to the Company on the manner
or manners in which it may enforce such rights with respect to any Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
any provision of the Deposit Agreement or of the ADRs and without limiting the foregoing, by being a Holder, each such Holder
agrees to provide such information as the Company may request in a disclosure notice (a &ldquo;Disclosure Notice&rdquo;) given pursuant
to the United Kingdom Companies Act 2006 (as amended from time to time and including any statutory modification or re-enactment
thereof, the &ldquo;Companies Act&rdquo;) or the Articles of Association of the Company. By accepting or holding an ADR, each Holder
acknowledges that it understands that failure to comply with a Disclosure Notice may result in the imposition of sanctions against
the holder of the Shares in respect of which the non-complying person is or was, or appears to be or has been, interested as provided
in the Companies Act and the Articles of Association which currently include, the withdrawal of the voting rights of such Shares
and the imposition of restrictions on the rights to receive dividends on and to transfer such Shares. In addition, by accepting
or holding an ADR each Holder agrees to comply with the provisions of the United Kingdom Disclosure Guidance and Transparency
Rules (as amended from time to time, the &ldquo;DTRs&rdquo;) with regard to the notification to the Company of interests in Shares
and certain financial instruments, which currently provide, <U>inter alia</U>, that a Holder must notify the Company of the percentage
of its voting rights he holds as shareholder or holds or is deemed to hold through his direct or indirect holding of certain financial
instruments (or a combination of such holdings) if the percentage of those voting rights (i) reaches, exceeds or falls below 3%,
4%, 5%, 6%, 7%, 8%, 9%, 10% and each 1% threshold thereafter up to 100% as a result of an acquisition or disposal of Shares or
certain financial instruments, or (ii) reaches, exceeds or falls below such applicable thresholds as a result of events changing
the breakdown of voting rights and on the basis of information disclosed by the Company in accordance with the DTRs. The notification
must be effected as soon as possible, but not later than two trading days after the Holder (a) learns of the acquisition or disposal
or of the possibility of exercising voting rights, or on which, having regard to the circumstances, should have learned of it,
regardless of the date on which the acquisition, disposal or possibility of exercising voting rights takes effect, or (b) is informed
of the event mentioned in (ii) above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: right"><IMG SRC="ex4-1_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)
<B>Charges of Depositary</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<I>Rights of the Depositary</I>. The Depositary may charge, and collect from, (i) each person to whom ADSs are issued,&nbsp;including,
without limitation, issuances&nbsp;against deposits of Shares,&nbsp;issuances in respect of Share Distributions, Rights and Other
Distributions (as such terms are defined in paragraph (10) (<I>Distributions on Deposited Securities</I>)),&nbsp;issuances pursuant
to a stock dividend or stock split declared by the Company, or issuances pursuant to a merger,&nbsp;exchange of securities or
any other transaction or event affecting the ADSs or the Deposited Securities, and&nbsp;(ii) each person surrendering ADSs for
withdrawal of Deposited Securities or whose ADSs are cancelled or reduced for any other reason U.S.$5.00 for each 100 ADSs (or
portion thereof) issued, delivered, reduced, cancelled&nbsp;or surrendered, or upon which a Share Distribution or elective distribution
is made or offered (as the case may be). The Depositary may sell (by public or private sale) sufficient securities and property
received in respect of Share Distributions, Rights and Other Distributions prior to such deposit to pay such charge.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<I>Additional charges by the Depositary</I>. The following additional charges shall also be incurred by the Holders, by any party
depositing or withdrawing Shares or by any party surrendering ADSs and/or to whom ADSs are issued (including, without limitation,
issuances pursuant to a stock dividend or stock split declared by the Company or an exchange of stock regarding the ADSs or the
Deposited Securities or a distribution of ADSs pursuant to paragraph (10) (<I>Distributions on Deposited Securities</I>), whichever
is applicable:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                         fee of U.S.$0.05 or less per ADS held for any Cash distribution made, or for any elective
                                         cash/stock dividend offered, pursuant to the Deposit Agreement,</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-indent: -0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                         fee of U.S.$1.50 per ADR or ADRs for transfers made pursuant to paragraph (3) hereof,</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-indent: -0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                         fee for the distribution or sale of securities pursuant to paragraph (10) hereof, such
                                         fee being in an amount equal to the fee for the execution and delivery of ADSs referred
                                         to above which would have been charged as a result of the deposit of such securities
                                         (for purposes of this paragraph (7) treating all such securities as if they were Shares)
                                         but which securities or the net cash proceeds from the sale thereof are instead distributed
                                         by the Depositary to Holders entitled thereto,</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-indent: -0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
                                         aggregate fee of U.S.$0.05 or less per ADS per calendar year (or portion thereof) for
                                         services performed by the Depositary in administering the ADRs (which fee may be charged
                                         on a periodic basis during each calendar year and shall be assessed against Holders as
                                         of the record date or record dates set by the Depositary during each calendar year and
                                         shall be payable at the sole discretion of the Depositary by billing such Holders or
                                         by deducting such charge from one or more cash dividends or other cash distributions),
                                         and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-indent: -0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                         fee for the reimbursement of such fees, charges and expenses as are incurred by the Depositary
                                         and/or any of its agents (including, without limitation, the Custodian and expenses incurred
                                         on behalf of Holders in connection with compliance with foreign exchange control regulations
                                         or any law or regulation relating to foreign investment) in connection with the servicing
                                         of the Shares or other Deposited Securities, the sale of securities (including, without
                                         limitation, Deposited Securities), the delivery of Deposited Securities or otherwise
                                         in connection with the Depositary&rsquo;s or its Custodian&rsquo;s compliance with applicable law,
                                         rule or regulation (which fees and charges shall be assessed on a proportionate basis
                                         against Holders as of the record date or dates set by the Depositary and shall be payable
                                         at the sole discretion of the Depositary by billing such Holders or by deducting such
                                         charge from one or more cash dividends or other cash distributions).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: right"><IMG SRC="ex4-1_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<I>Obligations of the Company</I>. The Company will pay all other charges and expenses of the Depositary and any agent of the
Depositary (except the Custodian) pursuant to agreements from time to time between the Company and the Depositary, except:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">stock
                                         transfer or other taxes and other governmental charges (which are payable by Holders
                                         or persons depositing Shares);</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-indent: -0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SWIFT,
                                         cable, telex and facsimile transmission and delivery charges incurred at the request
                                         of persons depositing, or Holders delivering Shares, ADRs or Deposited Securities (which
                                         are payable by such persons or Holders);</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-indent: -0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">transfer
                                         or registration fees for the registration or transfer of Deposited Securities on any
                                         applicable register in connection with the deposit or withdrawal of Deposited Securities
                                         (which are payable by persons depositing Shares or Holders withdrawing Deposited Securities;
                                         there are no such fees in respect of the Shares as of the date of the Deposit Agreement),
                                         and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-indent: -0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                         connection with the conversion of foreign currency into U.S. dollars, JPMorgan Chase
                                         Bank, N.A. (&ldquo;JPMorgan&rdquo;) shall deduct out of such foreign currency the fees,
                                         expenses and other charges charged by it and/or its agent (which may be a division, branch
                                         or affiliate) so appointed in connection with such conversion. JPMorgan and/or its agent
                                         may act as principal for such conversion of foreign currency. Such charges may at any
                                         time and from time to time be changed by agreement between the Company and the Depositary.
                                         For further details see https://www.adr.com.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<I>Disclosure of Potential Depositary Payments</I>. The Depositary anticipates reimbursing the Company for certain expenses incurred
by the Company that are related to the establishment and maintenance of the ADR program upon such terms and conditions as the
Company and the Depositary may agree from time to time.&nbsp; The Depositary may make available to the Company a set amount or
a portion of the Depositary fees charged in respect of the ADR program or otherwise upon such terms and conditions as the Company
and the Depositary may agree from time to time.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
The right of the Depositary to receive payment of fees, charges and expenses as provided above shall survive the termination of
the Deposit Agreement. As to any Depositary, upon the resignation or removal of such Depositary, such right shall extend for those
fees, charges and expenses incurred prior to the effectiveness of such resignation or removal.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: right"><IMG SRC="ex4-1_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)
<B>Available Information</B>. The Deposit Agreement, the provisions of or governing Deposited Securities and any written communications
from the Company, which are both received by the Custodian or its nominee as a holder of Deposited Securities and made generally
available to the holders of Deposited Securities, are available for inspection by Holders at the offices of the Depositary and
the Custodian, at the Transfer Office or on the U.S. Securities and Exchange Commission&rsquo;s website. The Depositary will distribute
copies of such communications (or English translations or summaries thereof) to Holders when furnished by the Company. The Company
is subject to the periodic reporting requirements of the Securities Exchange Act of 1934 and accordingly files certain reports
with the United States Securities and Exchange Commission (the &ldquo;Commission&rdquo;). Such reports and other information may
be inspected and copied through the Commission&rsquo;s EDGAR system or at public reference facilities maintained by the Commission
located at the date hereof at 100 F Street, NE, Washington, DC 20549.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)
<B>Execution</B>. This ADR shall not be valid for any purpose unless executed by the Depositary by the manual or facsimile signature
of a duly authorized officer of the Depositary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">JPMORGAN CHASE BANK, N.A., as Depositary</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 0 1.5pt; width: 60%; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0 0 1.5pt; width: 4%; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By </FONT></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; width: 36%; text-indent: 0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorized Officer</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Depositary&rsquo;s office is located at 383 Madison Avenue, Floor 11, New York, New York 10179.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: right"><IMG SRC="ex4-1_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[FORM
OF REVERSE OF ADR]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10)
<B>Distributions on Deposited Securities</B>. Subject to paragraphs (4) (<I>Certain Limitations to Registration, Transfer etc.</I>)
and (5) (<I>Liability of Holder for Taxes, Duties and other Charges</I>), to the extent practicable, the Depositary will distribute
as soon as reasonably practicable to each Holder entitled thereto on the record date set by the Depositary therefor at such Holder&rsquo;s
address shown on the ADR Register, in proportion to the number of Deposited Securities (on which the following distributions on
Deposited Securities are received by the Custodian) represented by ADSs evidenced by such Holder&rsquo;s ADRs:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<I>Cash</I>. Any U.S. dollars available to the Depositary resulting from a cash dividend or other cash distribution or the net
proceeds of sales of any other distribution or portion thereof authorized in this paragraph (10) (&ldquo;<B>Cash</B>&rdquo;), on
an averaged or other practicable basis, subject to (i) appropriate adjustments for taxes withheld, (ii) such distribution being
impermissible or impracticable with respect to certain Holders, and (iii) deduction of the Depositary&rsquo;s and/or its agents&rsquo; fees
and expenses in (1) converting any foreign currency to U.S. dollars by sale or in such other manner as the Depositary may determine
to the extent that it determines that such conversion may be made on a reasonable basis, (2) transferring foreign currency or
U.S. dollars to the United States by such means as the Depositary may determine to the extent that it determines that such transfer
may be made on a reasonable basis, (3) obtaining any approval or license of any governmental authority required for such conversion
or transfer, which is obtainable at a reasonable cost and within a reasonable time and (4) making any sale by public or private
means in any commercially reasonable manner.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<I>Shares</I>. (i) Additional ADRs evidencing whole ADSs representing any Shares available to the Depositary resulting from a
dividend or free distribution on Deposited Securities consisting of Shares (a &ldquo;<B>Share Distribution</B>&rdquo;) and (ii)
U.S. dollars available to it resulting from the net proceeds of sales of Shares received in a Share Distribution, which Shares
would give rise to fractional ADSs if additional ADRs were issued therefor, as in the case of Cash.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<I>Rights</I>. (i) Warrants or other instruments in the discretion of the Depositary representing rights to acquire additional
ADRs in respect of any rights to subscribe for additional Shares or rights of any nature available to the Depositary as a result
of a distribution on Deposited Securities (&ldquo;<B>Rights</B>&rdquo;), to the extent that the Company timely furnishes to the
Depositary evidence satisfactory to the Depositary that the Depositary may lawfully distribute the same (the Company has no obligation
to so furnish such evidence), or (ii) to the extent the Company does not so furnish such evidence and sales of Rights are practicable,
any U.S. dollars available to the Depositary from the net proceeds of sales of Rights as in the case of Cash, or (iii) to the
extent the Company does not so furnish such evidence and such sales cannot practicably be accomplished by reason of the nontransferability
of the Rights, limited markets therefor, their short duration or otherwise, nothing (and any Rights may lapse).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: right"><IMG SRC="ex4-1_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<I>Other Distributions</I>. (i) Securities or property available to the Depositary resulting from any distribution on Deposited
Securities other than Cash, Share Distributions and Rights (&ldquo;<B>Other Distributions</B>&rdquo;), by any means that the Depositary
may deem equitable and practicable, or (ii) to the extent the Depositary deems distribution of such securities or property not
to be equitable and practicable, any U.S. dollars available to the Depositary from the net proceeds of sales of Other Distributions
as in the case of Cash. The Depositary reserves the right to utilize a division, branch or affiliate of JPMorgan Chase Bank, N.A.
to direct, manage and/or execute any public and/or private sale of securities hereunder. Such division, branch and/or affiliate
may charge the Depositary a fee in connection with such sales, which fee is considered an expense of the Depositary contemplated
above and/or under paragraph (7) (<I>Charges of Depositary</I>). Any U.S. dollars available will be distributed by checks drawn
on a bank in the United States for whole dollars and cents. Fractional cents will be withheld without liability and dealt with
by the Depositary in accordance with its then current practices. All purchases and sales of securities will be handled by the
Depositary in accordance with its then current policies, which are currently set forth in the &ldquo;Depositary Receipt Sale and
Purchase of Security&rdquo; section of https://www.adr.com/Investors/FindOutAboutDRs, the location and contents of which the Depositary
shall be solely responsible for.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11)
<B>Record Dates</B>. The Depositary may, after consultation with the Company if practicable, fix a record date (which, to the
extent applicable, shall be as near as practicable to any corresponding record date set by the Company) for the determination
of the Holders who shall be responsible for the fee assessed by the Depositary for administration of the ADR program and for any
expenses provided for in paragraph (7) hereof as well as for the determination of the Holders who shall be entitled to receive
any distribution on or in respect of Deposited Securities, to give instructions for the exercise of any voting rights, to receive
any notice or to act in respect of other matters and only such Holders shall be so entitled or obligated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(12)
<B>Voting of Deposited Securities</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<I>Notice of any Meeting or Solicitation</I>. Subject to the next sentence, as soon as practicable after receipt of notice of
any meeting at which the holders of Shares are entitled to vote, or of solicitation of consents or proxies from holders of Shares
or other Deposited Securities, the Depositary shall fix the ADS record date in accordance with paragraph (11) above in respect
of such meeting or solicitation of consent or proxy. The Depositary shall, if requested by the Company in writing in a timely
manner (the Depositary having no obligation to take any further action if the request shall not have been received by the Depositary
at least 30 days prior to the date of such vote or meeting) and at the Company&rsquo;s expense and provided no legal prohibitions exist,
distribute to Holders a notice stating (i) such information as is contained in such notice and any solicitation materials, (ii)
that each Holder on the record date set by the Depositary therefor will, subject to any applicable provisions of English law,
be entitled to instruct the Depositary as to the exercise of the voting rights, if any, pertaining to the Deposited Securities
represented by the ADSs evidenced by such Holder&rsquo;s ADRs and (iii) the manner in which such instructions may be given, including
instructions to give a discretionary proxy to a person designated by the Company. There is no guarantee that Holders generally
or any Holder in particular will receive the notice described above with sufficient time to enable such Holder to return any voting
instructions to the Depositary in a timely manner.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: right"><IMG SRC="ex4-1_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<I>Voting of Deposited Securities</I>. Upon actual receipt by the ADR department of the Depositary of instructions of a Holder
on such record date in the manner and on or before the time established by the Depositary for such purpose, the Depositary shall
endeavor insofar as practicable and permitted under the provisions of or governing Deposited Securities to vote or cause to be
voted the Deposited Securities represented by the ADSs evidenced by such Holder&rsquo;s ADRs in accordance with such instructions. The
Depositary will not itself exercise any voting discretion in respect of any Deposited Securities. Notwithstanding anything contained
in the Deposit Agreement or any ADR, the Depositary may, to the extent not prohibited by law or regulations, or by the requirements
of the stock exchange on which the ADSs are listed, in lieu of distribution of the materials provided to the Depositary in connection
with any meeting of, or solicitation of consents or proxies from, holders of Deposited Securities, distribute to the Holders a
notice that provides Holders with, or otherwise publicizes to Holders, instructions on how to retrieve such materials or receive
such materials upon request (<I>i.e.</I>, by reference to a website containing the materials for retrieval or a contact for requesting
copies of the materials). Holders are strongly encouraged to forward their voting instructions as soon as possible. Voting instructions
will not be deemed received until such time as the ADR department responsible for proxies and voting has received such instructions
notwithstanding that such instructions may have been physically received by JPMorgan Chase Bank, N.A., as Depositary, prior to
such time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(13)
<B>Changes Affecting Deposited Securities</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Subject to paragraphs (4) (<I>Certain Limitations to Registration, Transfer etc.</I>) and (5) (<I>Liability of Holder to Taxes,
Duties and Other Charges</I>), the Depositary may, in its discretion, and shall if reasonably requested by the Company, amend
this ADR or distribute additional or amended ADRs (with or without calling this ADR for exchange) or cash, securities or property
on the record date set by the Depositary therefor to reflect any change in par value, split-up, consolidation, cancellation or
other reclassification of Deposited Securities, any Share Distribution or Other Distribution not distributed to Holders or any
cash, securities or property available to the Depositary in respect of Deposited Securities from (and the Depositary is hereby
authorized to surrender any Deposited Securities to any person and, irrespective of whether such Deposited Securities are surrendered
or otherwise cancelled by operation of law, rule, regulation or otherwise, to sell by public or private sale any property received
in connection with) any recapitalization, reorganization, merger, consolidation, liquidation, receivership, bankruptcy or sale
of all or substantially all the assets of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: right"><IMG SRC="ex4-1_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
To the extent the Depositary does not so amend this ADR or make a distribution to Holders to reflect any of the foregoing, or
the net proceeds thereof, whatever cash, securities or property results from any of the foregoing shall constitute Deposited Securities
and each ADS evidenced by this ADR shall automatically represent its pro rata interest in the Deposited Securities as then constituted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Promptly upon the occurrence of any of the aforementioned changes affecting Deposited Securities, the Company shall notify the
Depositary in writing of such occurrence and as soon as practicable after receipt of such notice from the Company, may instruct
the Depositary to give notice thereof, at the Company&rsquo;s expense, to Holders in accordance with the provisions hereof. Upon receipt
of such instruction, the Depositary shall give notice to the Holders in accordance with the terms thereof, as soon as reasonably
practicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(14)
<B>Exoneration</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The Depositary, the Company, and each of their respective directors, officers, employees, agents and affiliates and each of them
shall: (i) incur no liability to Holders or beneficial owners of ADSs (A) if any present or future law, rule, regulation, fiat,
order or decree of the United States, England, Wales or any other country or jurisdiction, or of any governmental or regulatory
authority or any securities exchange or market or automated quotation system, the provisions of or governing any Deposited Securities,
any present or future provision of the Company&rsquo;s articles of association, any act of God, war, terrorism, nationalization, expropriation,
currency restrictions, work stoppage, strike, civil unrest, revolutions, rebellions, explosions, computer failure or circumstance
beyond its direct and immediate control shall prevent or delay, or shall cause any of them to be subject to any civil or criminal
penalty in connection with, any act which the Deposit Agreement or this ADR provides shall be done or performed by it or them
(including, without limitation, voting pursuant to paragraph (12) hereof), or (B) by reason of any exercise or failure to exercise
any discretion given it in the Deposit Agreement or this ADR (including, without limitation, any failure to determine that any
distribution or action may be lawful or reasonably practicable); (ii) assume no liability to Holders or beneficial owners of ADSs
except to perform its obligations to the extent they are specifically set forth in this ADR and the Deposit Agreement without
gross negligence or willful misconduct; (iii) in the case of the Depositary and its agents, be under no obligation to appear in,
prosecute or defend any action, suit or other proceeding in respect of any Deposited Securities or this ADR; (iv) in the case
of the Company and its agents hereunder be under no obligation to appear in, prosecute or defend any action, suit or other proceeding
in respect of any Deposited Securities or this ADR, which in its opinion may involve it in expense or liability, unless indemnity
satisfactory to it against all expense (including fees and disbursements of counsel) and liability be furnished as often as may
be required; and (v) not be liable to Holders or beneficial owners of ADSs for any action or inaction by it in reliance upon the
advice of or information from legal counsel, accountants, any person presenting Shares for deposit, any Holder, or any other person
believed by it to be competent to give such advice or information. The Depositary shall not be liable for the acts or omissions
made by, or the insolvency of, any securities depository, clearing agency or settlement system.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<I>The Depositary</I>. The Depositary shall not be responsible for, and shall incur no liability in connection with or arising
from, the insolvency of any Custodian that is not a branch or affiliate of JPMorgan Chase Bank, N.A. The Depositary shall not
have any liability for the price received in connection with any sale of securities, the timing thereof or any delay in action
or omission to act nor shall it be responsible for any error or delay in action, omission to act, default or negligence on the
part of the party so retained in connection with any such sale or proposed sale. Notwithstanding anything to the contrary contained
in the Deposit Agreement (including the ADRs), subject to the penultimate sentence of this paragraph (14), the Depositary shall
not be responsible for, and shall incur no liability in connection with or arising from, any act or omission to act on the part
of the Custodian except to the extent that any Holder has incurred liability directly as a result of the Custodian having (i)
committed fraud or willful misconduct in the provision of custodial services to the Depositary or (ii) failed to use reasonable
care in the provision of custodial services to the Depositary as determined in accordance with the standards prevailing in the
jurisdiction in which the Custodian is located.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
The Depositary, its agents and the Company may rely and shall be protected in acting upon any written notice, request, direction,
instruction or document believed by them to be genuine and to have been signed, presented or given by the proper party or parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: right"><IMG SRC="ex4-1_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
The Depositary shall be under no obligation to inform Holders or any other holders of an interest in any ADSs about the requirements
of the laws, rules or regulations or any changes therein or thereto of any country or jurisdiction or of any governmental or regulatory
authority or any securities exchange or market or automated quotation system.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
The Depositary and its agents will not be responsible for any failure to carry out any instructions to vote any of the Deposited
Securities, for the manner in which any such vote is cast or for the effect of any such vote.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
The Depositary may rely upon instructions from the Company or its counsel in respect of any approval or license required for any
currency conversion, transfer or distribution.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
The Depositary and its agents may own and deal in any class of securities of the Company and its affiliates and in ADRs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
Notwithstanding anything to the contrary set forth in the Deposit Agreement or an ADR, the Depositary and its agents may fully
respond to any and all demands or requests for information maintained by or on its behalf in connection with the Deposit Agreement,
any Holder or Holders, any ADR or ADRs or otherwise related hereto or thereto to the extent such information is requested or required
by or pursuant to any lawful authority, including without limitation laws, rules, regulations, administrative or judicial process,
banking, securities or other regulators</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
None of the Depositary, the Custodian or the Company shall be liable for the failure by any Holder or beneficial owner to obtain
the benefits of credits or refunds of non-U.S. tax paid against such Holder&rsquo;s or beneficial owner&rsquo;s income tax liability.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
The Depositary and the Company shall not incur any liability for any tax or tax consequences that may be incurred by Holders and
beneficial owners, or any of them, on account of their ownership or disposition of the ADRs or ADSs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
The Depositary shall not incur any liability for the content of any information submitted to it by or on behalf of the Company
for distribution to the Holders or for any inaccuracy of any translation thereof, for any investment risk associated with acquiring
an interest in the Deposited Securities, for the validity or worth of the Deposited Securities, for the credit-worthiness of any
third party, for allowing any rights to lapse upon the terms of the Deposit Agreement or for the failure or timeliness of any
notice from the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: right"><IMG SRC="ex4-1_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
The Depositary shall not be liable for any acts or omissions made by a successor depositary whether in connection with a previous
act or omission of the Depositary or in connection with any matter arising wholly after the removal or resignation of the Depositary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)&nbsp;By
holding an ADS or an interest therein, Holders and owners of ADSs each irrevocably agree that any legal suit, action or proceeding
against or involving the Company or the Depositary, arising out of or based upon the Deposit Agreement, the ADSs or the transactions
contemplated herein, therein or hereby, may only be instituted in a state or federal court in New York, New York, and by holding
an ADS or an interest therein each irrevocably waives any objection which it may now or hereafter have to the laying of venue
of any such proceeding, and irrevocably submits to the exclusive jurisdiction of such courts in any such suit, action or proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)
&nbsp;The Company has agreed to indemnify the Depositary and its agents under certain circumstances
and the Depositary has agreed to indemnify the Company under certain circumstances.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)&nbsp;Neither
the Depositary nor any of its agents shall be liable to Holders or beneficial owners of interests in ADSs for any indirect, special,
punitive or consequential damages (including, without limitation, legal fees and expenses) or lost profits, in each case of any
form incurred by any person or entity, whether or not foreseeable and regardless of the type of action in which such a claim may
be brought.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)
No disclaimer of liability under the Securities Act of 1933 is intended by any provision hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(15)
<B>Resignation and Removal of Depositary; the Custodian</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<I>Resignation</I>. The Depositary may resign as Depositary by written notice of its election so to do delivered to the Company,
such resignation to take effect&nbsp;upon the appointment of a successor depositary and its acceptance of such appointment as
provided in the Deposit Agreement. &nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<I>Removal</I>. The Depositary may at any time be removed by the Company by no less than 60 days&rsquo; prior written notice of such
removal, to become effective upon the later of (i) the 60th day after delivery of the notice to the Depositary and (ii) the appointment
of a successor depositary and its acceptance of such appointment as provided in the Deposit Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: right"><IMG SRC="ex4-1_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<I>The Custodian</I>. The Depositary may appoint substitute or additional Custodians and the term &ldquo;<B>Custodian</B>&rdquo;
refers to each Custodian or all Custodians as the context requires.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(16)
<B>Amendment</B>. Subject to the last sentence of paragraph (2) (<I>Withdrawal of Deposited Securities</I>), the ADRs and the
Deposit Agreement may be amended by the Company and the Depositary, <U>provided</U> that any amendment that imposes or increases
any fees or charges (other than stock transfer or other taxes and other governmental charges, transfer or registration fees, SWIFT,
cable, telex or facsimile transmission costs, delivery costs or other such expenses), or that shall otherwise prejudice any substantial
existing right of Holders, shall become effective 30 days&rsquo; after notice of such amendment shall have been given to the Holders.
Every Holder of an ADR at the time any amendment to the Deposit Agreement so becomes effective shall be deemed, by continuing
to hold such ADR, to consent and agree to such amendment and to be bound by the Deposit Agreement as amended thereby. In no event
shall any amendment impair the right of the Holder of any ADR to surrender such ADR and receive the Deposited Securities represented
thereby, except in order to comply with mandatory provisions of applicable law. Any amendments or supplements which (i) are reasonably
necessary (as agreed by the Company and the Depositary) in order for (a) the ADSs to be registered on Form F-6 under the Securities
Act of 1933 or (b) the ADSs or Shares to be traded solely in electronic book-entry form and (ii) do not in either such case impose
or increase any fees or charges to be borne by Holders, shall be deemed not to prejudice any substantial rights of Holders. Notwithstanding
the foregoing, if any governmental body or regulatory body should adopt new laws, rules or regulations which would require amendment
or supplement of the Deposit Agreement or the form of ADR to ensure compliance therewith, the Company and the Depositary may amend
or supplement the Deposit Agreement and the ADR at any time in accordance with such changed laws, rules or regulations. Such amendment
or supplement to the Deposit Agreement in such circumstances may become effective before a notice of such amendment or supplement
is given to Holders or within any other period of time as required for compliance. Notice of any amendment to the Deposit Agreement
or form of ADRs shall not need to describe in detail the specific amendments effectuated thereby, and failure to describe the
specific amendments in any such notice shall not render such notice invalid, provided, however, that, in each such case, the notice
given to the Holders identifies a means for Holders to retrieve or receive the text of such amendment (i.e., upon retrieval from
the Commission&rsquo;s, the Depositary&rsquo;s or the Company&rsquo;s website or upon request from the Depositary).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(17)
<B>Termination</B>. The Depositary may, and shall at the written direction of the Company, terminate the Deposit Agreement and
this ADR by mailing notice of such termination to the Holders at least 30 days prior to the date fixed in such notice for such
termination; provided, however, if the Depositary shall have (i) resigned as Depositary hereunder, notice of such termination
by the Depositary shall not be provided to Holders unless a successor depositary shall not be operating hereunder within 45 days
of the date of such resignation, or (ii) been removed as Depositary hereunder, notice of such termination by the Depositary shall
not be provided to Holders unless a successor depositary shall not be operating hereunder on the 60<SUP>th</SUP> day after the
Company&rsquo;s notice of removal was first provided to the Depositary. Notwithstanding anything to the contrary herein, the Depositary
may terminate the Deposit Agreement without notice to the Company, but subject to giving 30 days&rsquo; notice to the Holders,
under the following circumstances: (i) in the event of the Company&rsquo;s bankruptcy or insolvency, (ii) if the Shares cease
to be listed on an internationally recognized stock exchange, (iii) if the Company effects (or will effect) a redemption of all
or substantially all of the Deposited Securities, or a cash or share distribution representing a return of all or substantially
all of the value of the Deposited Securities, or (iv) there occurs a merger, consolidation, sale of assets or other transaction
as a result of which securities or other property are delivered in exchange for or in lieu of Deposited Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
the date so fixed for termination, the Depositary and its agents will perform no further acts under the Deposit Agreement and
this ADR, except to receive and hold (or sell) distributions on Deposited Securities and deliver Deposited Securities being withdrawn.
As soon as practicable after the expiration of six months from the date so fixed for termination, the Depositary shall use its
reasonable efforts to sell the Deposited Securities and shall thereafter (as long as it may lawfully do so) hold in an account
(which may be a segregated or unsegregated account) the net proceeds of such sales, together with any other cash then held by
it under the Deposit Agreement, without liability for interest, in trust for the <U>pro rata</U> benefit of the Holders of ADRs
not theretofore surrendered. After making such sale, the Depositary shall be discharged from all obligations in respect of the
Deposit Agreement and this ADR, except to account for such net proceeds and other cash and for any indemnification obligations
it may have to the Company with respect to acts or omissions prior to such termination. After the date so fixed for termination,
the Company shall be discharged from all obligations under the Deposit Agreement except for its obligations to the Depositary
and its agents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: right"><IMG SRC="ex4-1_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(18)
<B>Appointment; Acknowledgements and Agreements</B>. Each Holder and each owner or person holding an interest in ADSs or ADRs,
upon acceptance of any ADSs or ADRs (or any interest in any of them) issued in accordance with the terms and conditions of the
Deposit Agreement shall be deemed for all purposes to (a) be a party to and bound by the terms of the Deposit Agreement and the
applicable ADR(s), (b) appoint the Depositary its attorney-in-fact, with full power to delegate, to act on its behalf and to take
any and all actions contemplated in the Deposit Agreement and the applicable ADR(s), to adopt any and all procedures necessary
to comply with applicable law and to take such action as the Depositary in its sole discretion may deem necessary or appropriate
to carry out the purposes of the Deposit Agreement and the applicable ADR(s), the taking of such actions to be the conclusive
determinant of the necessity and appropriateness thereof, and (c) acknowledge and agree that (i) nothing in the Deposit Agreement
or any ADR shall give rise to a partnership or joint venture among the parties thereto nor establish a fiduciary or similar relationship
among such parties, (ii) the Depositary, its divisions, branches and affiliates, and their respective agents, may from time to
time be in the possession of non-public information about the Company, Holders, owners of ADSs and/or their respective affiliates,
(iii) the Depositary and its divisions, branches and affiliates may at any time have multiple banking relationships with the Company,
Holders, owners of ADSs and/or the affiliates of any of them, (iv) the Depositary and its divisions, branches and affiliates may,
from time to time, be engaged in transactions in which parties adverse to the Company or the Holders or owners of ADSs may have
interests, (v) nothing contained in the Deposit Agreement or any ADR(s) shall (A) preclude the Depositary or any of its divisions,
branches or affiliates from engaging in such transactions or establishing or maintaining such relationships, or (B) obligate the
Depositary or any of its divisions, branches or affiliates to disclose such transactions or relationships or to account for any
profit made or payment received in such transactions or relationships, and (vi) the Depositary shall not be deemed to have knowledge
of any information held by any branch, division or affiliate of the Depositary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(19)
<B>Waiver</B>. EACH PARTY TO THE DEPOSIT AGREEMENT (INCLUDING, FOR AVOIDANCE OF DOUBT, EACH HOLDER AND BENEFICIAL OWNER OF, AND/OR
HOLDER OF INTERESTS IN, ADSS OR ADRS) HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT
IT MAY HAVE TO A TRIAL BY JURY IN ANY SUIT, ACTION OR PROCEEDING AGAINST THE DEPOSITARY AND/OR THE COMPANY DIRECTLY OR INDIRECTLY
ARISING OUT OF OR RELATING TO THE SHARES OR OTHER DEPOSITED SECURITIES, THE ADSs OR THE ADRs, THE DEPOSIT AGREEMENT OR ANY TRANSACTION
CONTEMPLATED HEREIN OR THEREIN, OR THE BREACH HEREOF OR THEREOF (WHETHER BASED ON CONTRACT, TORT, COMMON LAW OR ANY OTHER THEORY).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(20)
<B>Elective Distributions in Cash or Shares</B>. Whenever the Company intends to distribute a dividend payable at the election
of the holders of Shares in cash or in additional Shares, the Company shall give notice thereof to the Depositary at least 30
days prior to the proposed distribution stating whether or not it wishes such elective distribution to be made available to Holders.
Upon receipt of notice indicating that the Company wishes such elective distribution to be made available to Holders, the Depositary
shall consult with the Company to determine, and the Company shall assist the Depositary in its determination, whether it is lawful
and reasonably practicable to make such elective distribution available to the Holders. The Depositary shall make such elective
distribution available to Holders only if (i) the Company shall have timely requested that the elective distribution is available
to Holders, (ii) the Depositary shall have determined that such distribution is reasonably practicable and (iii) the Depositary
shall have received satisfactory documentation within the terms of Section 14 of the Deposit Agreement including, without limitation,
any legal opinions of counsel in any applicable jurisdiction that the Depositary in its reasonable discretion may request, at
the expense of the Company. If the above conditions are not satisfied, the Depositary shall, to the extent permitted by law, distribute
to the Holders, on the basis of the same determination as is made in the local market in respect of the Shares for which no election
is made, either (x) cash or (y) additional ADSs representing such additional Shares. If the above conditions are satisfied, the
Depositary shall establish a record date and establish procedures to enable Holders to elect the receipt of the proposed dividend
in cash or in additional ADSs. The Company shall assist the Depositary in establishing such procedures to the extent necessary.
Nothing herein shall obligate the Depositary to make available to Holders a method to receive the elective dividend in Shares
(rather than ADSs). There can be no assurance that Holders generally, or any Holder in particular, will be given the opportunity
to receive elective distributions on the same terms and conditions as the holders of Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">A-16</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>



<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.3
<SEQUENCE>5
<FILENAME>ff12018a1ex4-3_tiziana.htm
<DESCRIPTION>FORM OF REPRESENTATIVE'S WARRANT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: right"><B>Exhibit 4.3</B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form
of Representative&rsquo;s Warrant</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.2pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THE
REGISTERED HOLDER OF THIS PURCHASE WARRANT BY ITS ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER OR ASSIGN THIS PURCHASE
WARRANT EXCEPT AS HEREIN PROVIDED AND THE REGISTERED HOLDER OF THIS PURCHASE WARRANT AGREES THAT IT WILL NOT SELL, TRANSFER, ASSIGN,
PLEDGE OR HYPOTHECATE THIS PURCHASE WARRANT FOR A PERIOD OF ONE HUNDRED EIGHTY DAYS FOLLOWING THE EFFECTIVE DATE (DEFINED BELOW)
TO ANYONE OTHER THAN (I) <FONT STYLE="text-transform: uppercase">Laidlaw &amp; COMPANY (UK) LTD</FONT>. <FONT STYLE="text-transform: uppercase">Or
</FONT>AN UNDERWRITER OR A SELECTED DEALER IN CONNECTION WITH THE OFFERING, OR (II) A BONA FIDE OFFICER OR PARTNER OF LAIDLAW
&amp; COMPANY (UK) LTD. OR OF ANY SUCH UNDERWRITER OR SELECTED DEALER.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
PURCHASE WARRANT IS NOT EXERCISABLE PRIOR TO [________________] [<B>DATE THAT IS SIX MONTHS FROM THE EFFECTIVE DATE</B>]. VOID
AFTER 5:00 P.M., EASTERN TIME, [___________________] [<B>DATE THAT IS FIVE YEARS FROM THE EFFECTIVE DATE</B>].</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ORDINARY
SHARES PURCHASE WARRANT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the Purchase of [_____] Ordinary Shares</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">of</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tiziana
Life Sciences plc</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1. <U>Purchase
Warrant</U>. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of Laidlaw &amp; Company (UK) Ltd. (&ldquo;<B>Holder</B>&rdquo;),
as registered owner of this Purchase Warrant, to Tiziana Life Sciences plc, a public limited company incorporated in England and
Wales (the &ldquo;<B>Company</B>&rdquo;), Holder is entitled, at any time or from time to time from [________________] [<B>DATE
THAT IS SIX MONTHS FROM THE EFFECTIVE DATE</B>] (the &ldquo;<B>Commencement Date</B>&rdquo;), and at or before 5:00 p.m., Eastern
time, [____________] [<B>DATE THAT IS FIVE YEARS FROM THE EFFECTIVE DATE</B>] (the&nbsp;&ldquo;<B>Expiration&nbsp;Date</B>&rdquo;),
but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [____] [<B>2% of the number of Ordinary
Shares underlying American Depositary Shares sold in the Offering</B>] Ordinary Shares of nominal value 3 pence each in the capital
of the Company (the &ldquo;<B>Shares</B>&rdquo;), subject to adjustment as provided in Section 6 hereof. If the Expiration Date
is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next
succeeding day which is not such a day in accordance with the terms herein. This Purchase Warrant is initially exercisable at
$[___] per Share [<B>120% of the per share price of the Ordinary Shares underlying American Depositary Shares sold in the Offering</B>],
subject to adjustment as provided herein. The term &ldquo;<B>Exercise Price</B>&rdquo; shall mean the initial exercise price or
the adjusted exercise price, depending on the context. The term &ldquo;<B>Effective Date</B>&rdquo; shall mean [____], the date
on which the Registration Statement on Form F-1 (File No. 333-226368) of the Company was declared effective by the Securities
and Exchange Commission (the &ldquo;<B>Registration Statement</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2. <U>Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1 <U>Exercise
Form</U>. In order to exercise this Purchase Warrant, the exercise form attached hereto must be duly executed and completed and
delivered to the Company, together with this Purchase Warrant and payment of the Exercise Price for the Shares being purchased,
payable in cash by wire transfer of immediately available funds to an account designated by the Company or by certified check
or official bank check. If the subscription rights represented hereby shall not be exercised at or before 5:00 p.m., Eastern time,
on the Expiration Date, this Purchase Warrant shall become and be void without further force or effect, and all rights represented
hereby shall cease and expire.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2 <U>Cashless
Exercise</U>.&nbsp; If at any time after the Commencement Date there is no effective registration statement registering, or no
current prospectus available for, the resale of the Shares by the Holder, then in lieu of exercising this Purchase Warrant by
payment of cash or check payable to the order of the Company pursuant to Section 2.1 above, Holder may elect to receive the number
of Shares equal to the value of this Purchase Warrant (or the portion thereof being exercised), by surrender of this Purchase
Warrant to the Company, together with the exercise form attached hereto, in which event the Company shall issue to Holder Shares
in accordance with the following formula:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD ROWSPAN="2" STYLE="vertical-align: middle; padding: 0; text-align: center; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</FONT></TD>
    <TD ROWSPAN="2" STYLE="vertical-align: middle; padding: 0; text-align: center; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">=</FONT></TD>
    <TD COLSPAN="4" STYLE="vertical-align: top; padding: 0; text-align: center; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Y(A-B)</U></FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="4" STYLE="vertical-align: top; padding: 0; text-align: center; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="3" STYLE="padding: 0; text-align: justify; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where,</FONT></TD>
    <TD STYLE="padding: 0; text-align: justify; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: center; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="padding: 0; text-align: justify; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="3" STYLE="padding: 0; text-align: center; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: justify; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</FONT></TD>
    <TD STYLE="padding: 0; text-align: center; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">=</FONT></TD>
    <TD COLSPAN="2" STYLE="padding: 0; text-align: justify; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    number of Shares to be issued to Holder;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="3" STYLE="padding: 0; text-align: center; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: justify; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Y</FONT></TD>
    <TD STYLE="padding: 0; text-align: center; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">=</FONT></TD>
    <TD COLSPAN="2" STYLE="padding: 0; text-align: justify; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    number of Shares for which this Purchase Warrant is being exercised;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="3" STYLE="padding: 0; text-align: center; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: justify; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A</FONT></TD>
    <TD STYLE="padding: 0; text-align: center; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">=</FONT></TD>
    <TD COLSPAN="2" STYLE="padding: 0; text-align: justify; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    fair market value of one Share; and</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="3" STYLE="padding: 0; text-align: center; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: justify; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B</FONT></TD>
    <TD STYLE="padding: 0; text-align: center; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">=</FONT></TD>
    <TD COLSPAN="2" STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
        Exercise Price.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 5%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 5%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 4%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 4%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 2%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 79%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of this Section 2.2, the fair market value of a Share is defined as follows:</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 50.7pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 23.4pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                         the Company&rsquo;s American Depositary Shares are traded on a national securities exchange,
                                         the value shall be deemed to be the closing price on such exchange prior to the exercise
                                         form being submitted in connection with the exercise of this Purchase Warrant; or</FONT></TD></TR>                                                                                                                                           <TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">&nbsp;</TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
</TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 50.7pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 23.4pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                         the Company&rsquo;s American Depositary Shares are actively traded on the over-the-counter
                                         market, the value shall be deemed to be the closing bid prior to the exercise form being
                                         submitted in connection with the exercise of this Purchase Warrant; if there is no active
                                         public market, the value shall be the fair market value thereof, as determined in good
                                         faith by the Company&rsquo;s Board of Directors.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3
 <U>Legend</U>. Each certificate for the securities purchased under this Purchase Warrant
shall bear a legend as follows, unless such securities have been registered under the Securities Act of 1933, as amended (the
&ldquo;<B>Securities Act</B>&rdquo;):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;The
securities represented by this certificate have not been registered under the Securities Act of 1933, as amended (the &ldquo;<B>Securities
Act</B>&rdquo;), or applicable state law. Neither the securities nor any interest therein may be offered for sale, sold or otherwise
transferred except pursuant to an effective registration statement under the Securities Act, or pursuant to an exemption from
registration under the Securities Act and applicable state law which, in the opinion of counsel to the Company, is available.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3. <U>Transfer</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1 <U>General
Restrictions</U>. The registered Holder of this Purchase Warrant agrees by his, her or its acceptance hereof, that such Holder
will not: (a) sell, transfer, assign, pledge or hypothecate this Purchase Warrant for a period of one hundred eighty (180) days
following the Effective Date to anyone other than: (i) Laidlaw &amp; Company (UK) Ltd. (&ldquo;<B>Laidlaw</B>&rdquo;) or an Underwriter
or a selected dealer in connection with the sale of securities of the Company pursuant to the terms of that certain Underwriting
Agreement, by and between Laidlaw and the other underwriters named on <U>Schedule I</U> thereto (collectively, the &ldquo;<B>Underwriters</B>&rdquo;)
and the Company, dated as of [___________], 2018 (the &ldquo;<B>Underwriting Agreement</B>&rdquo;), or (ii) a bona fide officer
or partner of Laidlaw or of any such Underwriter or selected dealer, in each case in accordance with FINRA Conduct Rule 5110(g)(1),
or (b) cause this Purchase Warrant or the securities issuable hereunder to be the subject of any hedging, short sale, derivative,
put or call transaction that would result in the effective economic disposition of this Purchase Warrant or the securities hereunder,
except as provided for in FINRA Rule 5110(g)(2). On and after 180 days after the Effective Date, transfers to others may be made
subject to compliance with or exemptions from applicable securities laws. In order to make any permitted assignment, the Holder
must deliver to the Company the assignment form attached hereto duly executed and completed, together with this Purchase Warrant
and payment of all transfer taxes, if any, payable in connection therewith. Subject to the other provisions of this Section 3.1,
the Company shall within five (5) Business Days transfer this Purchase Warrant on the books of the Company and shall execute and
deliver a new Purchase Warrant or Purchase Warrants of like tenor to the appropriate assignee(s) expressly evidencing the right
to purchase the aggregate number of Shares purchasable hereunder or such portion of such number as shall be contemplated by any
such assignment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2
 <U>Restrictions Imposed by the Securities Act</U>. The securities evidenced by this
Purchase Warrant shall not be transferred unless and until: (a) the Company has received the opinion of counsel for the Holder
that the securities may be transferred pursuant to an exemption from registration under the Securities Act and applicable state
securities laws, the availability of which is established to the reasonable satisfaction of the Company (the Company hereby agreeing
that the opinion of Sheppard, Mullin, Richter &amp; Hampton LLP shall be deemed satisfactory evidence of the availability of an
exemption), or (b) a registration statement or a post-effective amendment to a registration statement relating to the offer and
sale of such securities has been filed by the Company and declared effective by the U.S. Securities and Exchange Commission (the&nbsp;&ldquo;<B>Commission</B>&rdquo;)
and compliance with applicable state securities law has been established.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4. <U>Registration
Rights</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1 <U>Demand
Registration</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1.1 <U>Grant
of Right</U>. The Company, upon written demand (a &ldquo;<B>Demand Notice</B>&rdquo;) of the Holder(s) of at least 51% of the
Purchase Warrants and/or the underlying Shares, agrees to register, on one occasion, all or any portion of the Shares underlying
this Purchase Warrant (collectively, the &ldquo;<B>Registrable Securities</B>&rdquo;). On such occasion, the Company will file
a registration statement with the Commission covering the Registrable Securities within sixty (60) days after receipt of a Demand
Notice and use its reasonable best efforts to have the registration statement declared effective promptly thereafter, subject
to compliance with any review by the Commission; <U>provided</U>, <U>however</U>, that the Company shall not be required to comply
with a Demand Notice if the Company has filed a registration statement with respect to which the Holder is entitled to piggy-back
registration rights pursuant to Section 4.2 hereof and either: (a) the Holder has elected to participate in the offering covered
by such registration statement or (b) if such registration statement relates to an underwritten primary offering of securities
of the Company, until the offering covered by such registration statement has been withdrawn or until thirty (30) days after such
offering is consummated. The demand for registration may be made at any time during a period of four and one-half (4.5) years
beginning on the Commencement Date. The Company covenants and agrees to give written notice of its receipt of any Demand Notice
by any Holder(s) to all other registered Holders of the Registrable Securities (as listed on the Company&rsquo;s warrant ledger)
within ten (10) days after the date of the receipt of any such Demand Notice. Notwithstanding the foregoing, the Company shall
not be required to register any Registrable Securities pursuant to this Section 4.1.1 that are the subject of a then-effective
registration statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1.2
 <U>Terms</U>. The Company shall bear all fees and expenses attendant to the registration
of the Registrable Securities pursuant to Section 4.1.1, but the Holders shall pay any and all underwriting commissions and the
expenses of any legal counsel selected by the Holders to represent them in connection with the sale of the Registrable Securities.
The Company agrees to use its commercially reasonable efforts to cause the filing required herein to become effective promptly
and to qualify or register the Registrable Securities in such states as are reasonably requested by the Holder(s); <U>provided</U>,
<U>however</U>, that in no event shall the Company be required to register the Registrable Securities in a state in which such
registration would cause the Company to be obligated to register or license to do business in such state or submit to general
service of process in such state. The Company shall cause any registration statement filed pursuant to the demand right granted
under Section 4.1.1 to remain effective until the earlier of: (i) the one (1) year anniversary of the effective date of such registration
statement or (ii) the date when all Registrable Securities covered by such registration statement have been sold. The Holders
shall only use the prospectuses provided by the Company to sell the shares covered by such registration statement, and will immediately
cease to use any prospectus furnished by the Company if the Company advises the Holder that such prospectus may no longer be used
due to a material misstatement or omission. Notwithstanding the provisions of this Section 4.1.2, the Holder shall be entitled
to a demand registration under this Section 4.1.2 on only one (1) occasion and such demand registration right shall terminate
on the fifth anniversary of the Effective Date, in accordance with FINRA Rule 5110(f)(2)(G)(iv).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2
&ldquo;<U>Piggy-Back&rdquo; Registration</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2.1 <U>Grant
of Right</U>. The Holder shall have the right, for a period of no more than seven (7) years from the Effective Date, in accordance
with FINRA Rule 5110(f)(2)(G)(v), to include all or any portion of the Registrable Securities as part of any other registration
of securities filed by the Company (other than in connection with a transaction contemplated by Rule 145(a) promulgated under
the Securities Act or pursuant to Form S-4 or Form S-8 or any equivalent form); <U>provided</U>, <U>however</U>, that if, solely
in connection with any primary underwritten public offering for the account of the Company, the managing underwriter(s) thereof
shall, in its reasonable discretion, impose a limitation on the number of shares of Ordinary Shares which may be included in the
registration statement because, in such underwriter&rsquo;s judgment, marketing or other factors dictate such limitation is necessary
to facilitate public distribution, then the Company shall be obligated to include in such registration statement only such limited
portion of the Registrable Securities with respect to which the Holder requested inclusion hereunder as the underwriter shall
reasonably permit. To the extent there are multiple holders of Registrable Securities, any exclusion of Registrable Securities
shall be made pro-rata among the holders seeking to include Registrable Securities in proportion to the number of Registrable
Securities sought to be included by such holders; <U>provided</U>, <U>however</U>, that the Company shall not exclude any Registrable
Securities unless the Company has first excluded all outstanding securities, the holders of which are not entitled to inclusion
of such securities in such registration statement or are not entitled to pro-rata inclusion with the Registrable Securities. Notwithstanding
the foregoing, the Company shall not be required to register any Registrable Securities pursuant to this Section 4.2.1 that are
the subject of a then-effective registration statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2.2
 <U>Terms</U>. The Company shall bear all fees and expenses attendant to registering
the Registrable Securities pursuant to Section 4.2.1 hereof, but the Holder shall pay any and all underwriting commissions and
the expenses of any legal counsel selected by the Holder to represent it in connection with the sale of the Registrable Securities.
If there is not an effective registration statement covering all of the Registrable Securities held by the Holder at the time
of such a proposed registration, the Company shall furnish the Holder with not less than fifteen (15) days written notice prior
to the proposed date of filing of such registration statement. Notice of such a proposed registration shall continue to be given
to the Holder for each registration statement filed by the Company until such time as all of the Registrable Securities held by
the Holder have been sold. The Holder shall exercise the &ldquo;piggy-back&rdquo; rights provided for herein by giving written
notice within five (5) days of the receipt of the Company&rsquo;s notice of its intention to file a registration statement. Except
as otherwise provided in this Purchase Warrant, there shall be no limit on the number of times the Holder may request registration
under this Section 4.2.2; <U>provided</U>, <U>however</U>, that such registration rights shall terminate on the seventh anniversary
of the Effective Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3 <U>General
Terms</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3.1 <U>Indemnification</U>.
The Company shall indemnify the Holder of the Registrable Securities to be sold pursuant to any registration statement hereunder
and each person, if any, who controls the Holder within the meaning of Section 15 of the Securities Act or Section 20(a) of the
Securities Exchange Act of 1934, as amended (&ldquo;<B>Exchange Act</B>&rdquo;), against all loss, claim, damage, expense or liability
(including all reasonable attorneys&rsquo; fees and other expenses reasonably incurred in investigating, preparing or defending
against any claim whatsoever) to which any of them may become subject under the Securities Act, the Exchange Act or otherwise,
arising from a registration statement registering for resale the Registrable Securities, but only to the same extent and with
the same effect as the provisions pursuant to which the Company has agreed to indemnify the Underwriters contained in Section
7(a) of the Underwriting Agreement. Holder and its successors and assigns, shall severally, and not jointly, indemnify the Company
and each person, if any, who controls the Company within the meaning of Section 15 of the Securities Act or Section 20 of the
Exchange Act, each director of the Company, and each officer of the Company who signs the registration statement registering for
resale Registrable Securities, against all loss, claim, damage, expense or liability (including all reasonable attorneys&rsquo;
fees and other expenses reasonably incurred in investigating, preparing or defending against any claim whatsoever) to which the
Company may become subject under the Securities Act, the Exchange Act or otherwise, arising from information furnished by or on
behalf of Holder, or its successors or assigns, in writing, for specific inclusion in a registration statement registering for
resale Registrable Securities, to the same extent and with the same effect as the provisions contained in Section 7(b) of the
Underwriting Agreement pursuant to which the Underwriters have agreed to indemnify the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3.2
 <U>Exercise of Purchase Warrant</U>. Nothing contained in this Purchase Warrant shall
be construed as requiring the Holder to exercise its Purchase Warrant prior to or after the initial filing of any registration
statement or the effectiveness thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3.3
 <U>Documents to be Delivered by Holder</U>. At least 10 Trading Days prior to the first
anticipated filing date of a registration statement registering for resale the Registrable Securities under this Section 4, the
Company will notify the Holder of the information the Company requires from the Holder, if any, which such information shall be
delivered to the Company promptly upon request and, in any event, within five Trading Days prior to the applicable anticipated
filing date. If the Holder returns a request for information after its deadline, the Company shall use its commercially reasonable
efforts to take such actions as are required to name such Holder as a selling security holder in the registration statement or
any pre-effective or post-effective amendment thereto and to include (to the extent not theretofore included) in the registration
statement the Registrable Securities identified in such late request for information. The Holder acknowledges and agrees that
the information in any request for information as described in this Section 4.3.3 will be used by the Company in the preparation
of the registration statement registering for resale the Registrable Securities and hereby consents to the inclusion of such information
in such registration statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5. <U>New
Purchase Warrants to be Issued</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1 <U>Partial
Exercise or Transfer</U>. Subject to the restrictions in Section 3 hereof, this Purchase Warrant may be exercised or assigned
in whole or in part. In the event of the exercise or assignment hereof in part only, upon surrender of this Purchase Warrant for
cancellation, together with the duly executed exercise or assignment form and funds sufficient to pay any Exercise Price and/or
transfer tax if exercised pursuant to Section 2.1 hereto, the Company shall cause to be delivered to the Holder without charge
a new Purchase Warrant of like tenor to this Purchase Warrant in the name of the Holder evidencing the right of the Holder to
purchase the number of Shares purchasable hereunder as to which this Purchase Warrant has not been exercised or assigned.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2
 <U>Lost Certificate</U>. Upon receipt by the Company of evidence satisfactory to it
of the loss, theft, destruction or mutilation of this Purchase Warrant and of reasonably satisfactory indemnification or the posting
of a bond, the Company shall execute and deliver a new Purchase Warrant of like tenor and date. Any such new Purchase Warrant
executed and delivered as a result of such loss, theft, mutilation or destruction shall constitute a substitute contractual obligation
on the part of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6. <U>Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1 <U>Adjustments
to Exercise Price and Number of Securities</U>. The Exercise Price and the number of Shares underlying this Purchase Warrant shall
be subject to adjustment from time to time as hereinafter set forth:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1.1 <U>Share
Dividends; Split Ups</U>. If, after the date hereof, and subject to the provisions of Section 6.3 below, the number of outstanding
Ordinary Shares of the Company is increased by a stock dividend payable in shares of Ordinary Shares of the Company or by a split
up of Ordinary Shares of the Company or other similar event, then, on the effective date thereof, the number of Shares purchasable
hereunder shall be increased in proportion to such increase in outstanding Ordinary Shares of the Company, and the Exercise Price
shall be proportionately decreased.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1.2
 <U>Aggregation of Shares</U>. If, after the date hereof, and subject to the provisions
of Section 6.3 below, the number of outstanding Ordinary Shares of the Company is decreased by a consolidation, combination or
reclassification of Ordinary Shares of the Company or other similar event, then, on the effective date thereof, the number of
Shares purchasable hereunder shall be decreased in proportion to such decrease in outstanding Ordinary Shares of the Company,
and the Exercise Price shall be proportionately increased.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1.3
 <U>Replacement of Securities upon Reorganization, etc.</U> In case of any reclassification
or reorganization of the outstanding Ordinary Shares of the Company other than a change covered by Section 6.1.1 or 6.1.2 hereof,
or in the case of any share reconstruction or merger, amalgamation or consolidation of the Company with or into another corporation
(other than a consolidation or share reconstruction or amalgamation in which the Company is the continuing corporation and which
does not result in any reclassification or reorganization of the outstanding Ordinary Shares of the Company), or in the case of
any sale or conveyance to another corporation or entity of the property of the Company as an entirety or substantially as an entirety
in connection with which the Company is dissolved, the Holder of this Purchase Warrant shall have the right thereafter (until
the expiration of the right of exercise of this Purchase Warrant) to receive upon the exercise hereof, for the same aggregate
Exercise Price payable hereunder immediately prior to such event, the kind and amount of shares of stock or other securities or
property (including cash) receivable upon such reclassification, reorganization, share reconstruction or merger, amalgamation,
or consolidation, or upon a dissolution following any such sale or transfer, by a holder of the number of Ordinary Shares of the
Company obtainable upon exercise of this Purchase Warrant immediately prior to such event; and if any reclassification also results
in a change in the outstanding Ordinary Shares of the Company covered by Section 6.1.1 or 6.1.2, then such adjustment shall be
made pursuant to Section 6.1.1, Section 6.1.2 and this Section 6.1.3. The provisions of this Section 6.1.3 shall similarly apply
to successive reclassifications, reorganizations, share reconstructions or amalgamations, or consolidations, sales or other transfers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1.4
 <U>Changes in Form of Purchase Warrant</U>. This form of Purchase Warrant need not be
changed because of any change pursuant to this Section 6.1, and Purchase Warrants issued after such change may state the same
Exercise Price and the same number of Shares as are stated in this Purchase Warrant. The acceptance by Holder of the issuance
of new Purchase Warrants reflecting a required or permissive change shall not be deemed to waive any rights to an adjustment occurring
after the Commencement Date or the computation thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.2
 <U>Substitute Purchase Warrant</U>. In case of any merger or consolidation of the Company
with, or share reconstruction or amalgamation of the Company with or into, another corporation (other than a consolidation or
share reconstruction or merger or amalgamation which does not result in any reclassification or change of the outstanding Ordinary
Shares of the Company), the corporation formed by such merger or consolidation or share reconstruction or amalgamation shall execute
and deliver to the Holder a supplemental Purchase Warrant providing that the Holder shall have the right thereafter (until the
stated expiration of this Purchase Warrant) to receive, upon exercise of this Purchase Warrant, the kind and amount of shares
of stock and other securities and property receivable upon such merger or consolidation or share reconstruction or amalgamation,
by a holder of the number of Ordinary Shares of the Company for which this Purchase Warrant might have been exercised immediately
prior to such merger or consolidation, share reconstruction or amalgamation, sale or transfer. Such supplemental Purchase Warrant
shall provide for adjustments which shall be identical to the adjustments provided for in this Section 6. The above provision
of this Section 6 shall similarly apply to successive consolidations or share reconstructions or amalgamations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.3
 <U>Elimination of Fractional Interests</U>. The Company shall not be required to issue
certificates representing fractions of Shares upon the exercise of this Purchase Warrant, nor shall it be required to issue scrip
or pay cash in lieu of any fractional interests, it being the intent of the parties that all fractional interests shall be eliminated
by rounding any fraction up or down, as the case may be, to the nearest whole number of Shares or other securities, properties
or rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.4 <U>Notice
of Change in Exercise Price</U>. Upon the occurrence of each adjustment to the Exercise Price pursuant to this Section 6, the
Company at its expense will promptly compute such adjustment, in good faith, in accordance with the terms of this Purchase Warrant,
and prepare a certificate setting forth such adjustment, including a statement of the adjusted Exercise Price and adjusted number
or type of Shares or other securities issuable upon exercise of this Purchase Warrant (as applicable), describing the transactions
giving rise to such adjustments and showing in reasonable detail the facts upon which such adjustments are based. The Company
will promptly deliver a copy of each such certificate to the Holder and to the Company&rsquo;s transfer agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.
 <U>Reservation and Listing</U>. The Company shall at all times reserve and keep available
out of its authorized Ordinary Shares, solely for the purpose of issuance upon exercise of this Purchase Warrant, such number
of Ordinary Shares or other securities, properties or rights as shall be issuable upon the exercise hereof. The Company covenants
and agrees that, upon exercise of this Purchase Warrant and payment of the Exercise Price, in accordance with the terms hereby,
all Shares and other securities issuable upon such exercise shall be duly and validly issued, fully paid and non-assessable and
not subject to preemptive rights of any shareholder. The Company further covenants and agrees that upon exercise of the Purchase
Warrants and payment of the exercise price therefor, all Shares and other securities issuable upon such exercise shall be duly
and validly issued, fully paid and non-assessable and not subject to preemptive rights of any shareholder. As long as this Purchase
Warrant shall be outstanding, the Company shall use its commercially reasonable efforts to cause all Shares issuable upon exercise
of this Purchase Warrant to be listed (subject to official notice of issuance) on all national securities exchanges (or, if applicable,
on the OTCQB or higher platform of the OTC Markets, Inc. or any successor trading market) on which the Shares issued to the public
in the Offering may then be listed and/or quoted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8. <U>Certain
Notice Requirements</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1 <U>Holder&rsquo;s
Right to Receive Notice</U>. Nothing herein shall be construed as conferring upon the Holder the right to vote or consent or to
receive notice as a shareholder for the election of directors or any other matter, or as having any rights whatsoever as a shareholder
of the Company. If, however, at any time prior to the expiration of this Purchase Warrant and its exercise, any of the events
described in Section 8.2 shall occur, then, in the case of the occurrence of one or more of said events, the Company shall give
written notice of such event at least ten days prior to the date fixed as a record date or the date of closing the transfer books
for the determination of the shareholders entitled to such dividend, distribution, conversion or exchange of securities or subscription
rights, or entitled to vote on such proposed dissolution, liquidation, winding up or sale; <U>provided that</U>, the Company shall
not be required to provide such notice if such notice and the contents thereof shall be deemed to constitute material non-public
information. Such notice shall specify such record date or the date of the closing of the transfer books, as the case may be.
Notwithstanding the foregoing, the failure to deliver such notice or any defect therein shall not affect the validity of the corporate
action required to be described in such notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2
 <U>Events Requiring Notice</U>. The Company shall be required to give the notice described
in this Section 8 upon the occurrence of one or more of the following events: (a) if the Company shall take a record of the holders
of its outstanding Ordinary Shares for the purpose of entitling them to receive a dividend or distribution payable otherwise than
in cash, or a cash dividend or distribution payable otherwise than out of retained earnings, as indicated by the accounting treatment
of such dividend or distribution on the books of the Company, (b) the Company shall offer to all the holders of its outstanding
Ordinary Shares any additional shares of capital stock of the Company or securities convertible into or exchangeable for shares
of capital stock of the Company, or any option, right or warrant to subscribe therefor, or (c) a dissolution, liquidation or winding
up of the Company (other than in connection with a consolidation or share reconstruction or amalgamation) or a sale of all or
substantially all of its property, assets and business shall be proposed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.3
 <U>Transmittal of Notices</U>. All notices, requests, consents and other communications
under this Purchase Warrant shall be in writing and shall be deemed to have been duly made when hand delivered, or mailed by express
mail or private courier service: (a) if to the registered Holder of this Purchase Warrant, to the address of the Holder as shown
on the books of the Company, or (b) if to the Company, to the following address or to such other address as the Company may designate
by notice to the Holder:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
to the Holder:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Laidlaw
&amp; Company (UK) Ltd.<BR>
546 Fifth Avenue, 5<SUP>th</SUP> Floor<BR>
New York, New York 10036<BR>
Attn: Attention: Hugh Regan, Executive Director</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fax
No.: (212) 297-0670</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">with
a copy (which shall not constitute notice) to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sheppard, Mullin, Richter &amp; Hampton LLP</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30
Rockefeller Plaza, 38<SUP>th</SUP> Floor</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, NY 10112</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
Jeffrey Fessler</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fax
No.: 212-634-3067</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
to the Company:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tiziana
Life Sciences plc</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3rd
Floor,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11-12
St James&rsquo;s Square</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">London
SW1 4LB</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">United
Kingdom</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Tiziano Lazzaretti</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">with
a copy (which shall not constitute notice) to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cooley
(UK) LLP</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dashwood,
69 Old Broad Street<BR>
London EC2M 1QS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fax
No: +44(0)20 7760 6478</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9. <U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.1 <U>Amendments</U>.
The Company and Laidlaw may from time to time supplement or amend this Purchase Warrant without the approval of the Holder in
order to cure any ambiguity, to correct or supplement any provision contained herein that may be defective or inconsistent with
any other provisions herein, or to make any other provisions in regard to matters or questions arising hereunder that the Company
and Laidlaw may deem necessary or desirable and that the Company and Laidlaw deem shall not adversely affect the interest of the
Holder. All other modifications or amendments shall require the written consent of and be signed by the party against whom enforcement
of the modification or amendment is sought.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.2
 <U>Headings</U>. The headings contained herein are for the sole purpose of convenience
of reference, and shall not in any way limit or affect the meaning or interpretation of any of the terms or provisions of this
Purchase Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.3.
 <U>Entire Agreement</U>. This Purchase Warrant (together with the other agreements and
documents being delivered pursuant to or in connection with this Purchase Warrant) constitutes the entire agreement of the parties
hereto with respect to the subject matter hereof, and supersedes all prior agreements and understandings of the parties, oral
and written, with respect to the subject matter hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.4
 <U>Binding Effect</U>. This Purchase Warrant shall inure solely to the benefit of and
shall be binding upon, the Holder and the Company and their permitted assignees, respective successors, legal representative and
assigns, and no other person shall have or be construed to have any legal or equitable right, remedy or claim under or in respect
of or by virtue of this Purchase Warrant or any provisions herein contained.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.5
 <U>Governing Law; Submission to Jurisdiction; Trial by Jury</U>. This Purchase Warrant
shall be governed by and construed and enforced in accordance with the laws of the State of New York, without giving effect to
conflict of laws principles thereof. The Company hereby agrees that any action, proceeding or claim against it arising out of,
or relating in any way to, this Purchase Warrant shall be brought and enforced in the New York Supreme Court, County of New York,
or in the United States District Court for the Southern District of New York, and irrevocably submits to such jurisdiction, which
jurisdiction shall be exclusive. The Company hereby waives any objection to such exclusive jurisdiction and that such courts represent
an inconvenient forum. Any process or summons to be served upon the Company may be served by transmitting a copy thereof by registered
or certified mail, return receipt requested, postage prepaid, addressed to it at the address set forth in Section 8.3 hereof.
Such mailing shall be deemed personal service and shall be legal and binding upon the Company in any action, proceeding or claim.
The Company and the Holder agree that the prevailing party(ies) in any such action shall be entitled to recover from the other
party(ies) all of its reasonable attorneys&rsquo; fees and expenses relating to such action or proceeding and/or incurred in connection
with the preparation therefor. The Company (on its behalf and, to the extent permitted by applicable law, on behalf of its shareholders
and affiliates) and the Holder hereby irrevocably waive, to the fullest extent permitted by applicable law, any and all right
to trial by jury in any legal proceeding arising out of or relating to this Purchase Warrant or the transactions contemplated
hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.6
 <U>Waiver, etc</U>. The failure of the Company or the Holder to at any time enforce
any of the provisions of this Purchase Warrant shall not be deemed or construed to be a waiver of any such provision, nor to in
any way affect the validity of this Purchase Warrant or any provision hereof or the right of the Company or the Holder to thereafter
enforce each and every provision of this Purchase Warrant. No waiver of any breach, non-compliance or non-fulfillment of any of
the provisions of this Purchase Warrant shall be effective unless set forth in a written instrument executed by the party or parties
against whom or which enforcement of such waiver is sought; and no waiver of any such breach, non-compliance or non-fulfillment
shall be construed or deemed to be a waiver of any other or subsequent breach, non-compliance or non-fulfillment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.7
 <U>Execution in Counterparts</U>. This Purchase Warrant may be executed in one or more
counterparts, and by the different parties hereto in separate counterparts, each of which shall be deemed to be an original, but
all of which taken together shall constitute one and the same agreement, and shall become effective when one or more counterparts
has been signed by each of the parties hereto and delivered to each of the other parties hereto. Such counterparts may be delivered
by facsimile transmission or other electronic transmission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.8
 <U>Exchange Agreement</U>. As a condition of the Holder&rsquo;s receipt and acceptance
of this Purchase Warrant, Holder agrees that, at any time prior to the complete exercise of this Purchase Warrant by Holder, if
the Company and Laidlaw enter into an agreement (the &ldquo;<B>Exchange Agreement</B>&rdquo;) pursuant to which they agree that
this Purchase Warrant will be exchanged for securities or cash or a combination of both, then Holder shall agree to such exchange
and become a party to the Exchange Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>[<I>Signature
Page Follows</I>]</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Purchase Warrant to be signed by its duly authorized officer as of the ___ day of
_____________, 2018.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding: 0; text-indent: 0">Tiziana Life Sciences plc</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0; width: 4%">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; width: 36%">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; width: 60%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">By:</TD>
    <TD STYLE="padding: 0; text-indent: 0; border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">Name:</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">Title:</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<I>Form
to be used to exercise Purchase Warrant</I>]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
__________________, 20______</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-right: 0; margin-bottom: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned hereby elects irrevocably to exercise the Purchase Warrant for ______ Ordinary Shares of nominal value 3 pence each
(the &ldquo;<B>Shares</B>&rdquo;) in the capital of Tiziana Life Sciences plc, a public limited company incorporated in England
and Wales (the &ldquo;<B>Company</B>&rdquo;), and hereby makes payment of $____ (at the rate of $____ per Share) in payment of
the Exercise Price pursuant thereto. Please issue the Shares as to which the Purchase Warrant is exercised in accordance with
the instructions given below and, if applicable, a new Purchase Warrant representing the number of Shares for which the Purchase
Warrant has not been exercised.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-right: 0; margin-bottom: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-right: 0; margin-bottom: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned hereby elects irrevocably to convert its right to purchase ___ Ordinary Shares of the Company under the Purchase Warrant
for ______ Shares, as determined in accordance with the following formula:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD ROWSPAN="2" STYLE="vertical-align: middle; padding: 0; text-align: center; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</FONT></TD>
    <TD ROWSPAN="2" STYLE="vertical-align: middle; padding: 0; text-align: center; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">=</FONT></TD>
    <TD COLSPAN="4" STYLE="vertical-align: top; padding: 0; text-align: center; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Y(A-B)</U></FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="4" STYLE="vertical-align: top; padding: 0; text-align: center; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="3" STYLE="padding: 0; text-align: justify; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where,</FONT></TD>
    <TD STYLE="padding: 0; text-align: justify; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: center; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="padding: 0; text-align: justify; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="3" STYLE="padding: 0; text-align: center; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: justify; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</FONT></TD>
    <TD STYLE="padding: 0; text-align: center; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">=</FONT></TD>
    <TD COLSPAN="2" STYLE="padding: 0; text-align: justify; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
number of Shares to be issued to Holder;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="3" STYLE="padding: 0; text-align: center; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: justify; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Y</FONT></TD>
    <TD STYLE="padding: 0; text-align: center; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">=</FONT></TD>
    <TD COLSPAN="2" STYLE="padding: 0; text-align: justify; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    number of Shares for which the Purchase Warrant is being exercised;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="3" STYLE="padding: 0; text-align: center; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: justify; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A</FONT></TD>
    <TD STYLE="padding: 0; text-align: center; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">=</FONT></TD>
    <TD COLSPAN="2" STYLE="padding: 0; text-align: justify; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    fair market value of one Share is equal to $_____; and</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="3" STYLE="padding: 0; text-align: center; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: justify; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B</FONT></TD>
    <TD STYLE="padding: 0; text-align: center; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">=</FONT></TD>
    <TD COLSPAN="2" STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    Exercise Price which is equal to $______ per Share.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 5%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 5%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 4%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 4%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 2%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 79%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-right: 0; margin-bottom: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned agrees and acknowledges that the calculation set forth above is subject to confirmation by the Company and any disagreement
with respect to the calculation shall be resolved by the Company in its sole discretion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-right: 0; margin-bottom: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
issue the Shares as to which the Purchase Warrant is exercised in accordance with the instructions given below and, if applicable,
a new Purchase Warrant representing the number of Shares for which the Purchase Warrant has not been converted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; width: 7%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signature</FONT></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; width: 33%; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"></TD>
    <TD STYLE="width: 60%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font-family: Times New Roman, Times, Serif; width: 14%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signature&nbsp;Guaranteed</FONT></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; width: 26%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">INSTRUCTIONS
FOR REGISTRATION OF SECURITIES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; width: 7%">Name:</TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; width: 33%; border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-align: center">(Print in Block Letters)</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0">Address:</TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTICE:
The signature to this form must correspond with the name as written upon the face of the Purchase Warrant without alteration or
enlargement or any change whatsoever, and must be guaranteed by a bank, other than a savings bank, or by a trust company or by
a firm having membership on a registered national securities exchange.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>[<I>Form
to be used to assign Purchase Warrant</I>]</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASSIGNMENT</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(To
be executed by the registered Holder to effect a transfer of the within Purchase Warrant):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, _________________ does hereby sell, assign and transfer unto ______________ the right to purchase the Ordinary
Shares of nominal value 3 pence each in the capital of Tiziana Life Sciences plc, a public limited company incorporated in England
and Wales (the &ldquo;<B>Company</B>&rdquo;), evidenced by the Purchase Warrant and does hereby authorize the Company to transfer
such right on the books of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
__________, 20_____</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; width: 7%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signature</FONT></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; width: 33%; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 60%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font-family: Times New Roman, Times, Serif; width: 14%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signature&nbsp;Guaranteed</FONT></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; width: 26%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTICE:
The signature to this form must correspond with the name as written upon the face of the within Purchase Warrant without alteration
or enlargement or any change whatsoever, and must be guaranteed by a bank, other than a savings bank, or by a trust company or
by a firm having membership on a registered national securities exchange.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif">-15-</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>6
<FILENAME>ff12018a1ex5-1_tiziana.htm
<DESCRIPTION>OPINION OF COOLEY (UK) LLP
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 5.1</B></P>



<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"><IMG SRC="ex5-1_001.jpg" ALT="">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">23 August 2018</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Tiziana Life Sciences plc</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">3rd Floor,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">11-12 St James&rsquo;s Square</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">London SW1 4LB</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">United Kingdom</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><B>Re:</B></TD><TD STYLE="text-align: justify"><B>Tiziana Life Sciences plc &ndash; Registration Statement
on Form&nbsp;F-1 &ndash; Exhibit&nbsp;5.1</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have acted as English legal advisers
to Tiziana Life Sciences plc, a public limited company incorporated in England and Wales (the &ldquo;<B>Company</B>&rdquo;) in
connection with the proposed offering of American Depositary Shares (&ldquo;<B>ADSs</B>&rdquo;), each representing ordinary shares
of nominal value &pound;0.03 each in the issued share capital of the Company (&ldquo;<B>Ordinary Shares</B>&rdquo;) (the &ldquo;<B>Offering</B>&rdquo;
and the Ordinary Shares allotted and issued in connection therewith, including those being issued to JPMorgan Chase Bank, N.A.)
as the custodian and represented by ADSs, being the &ldquo;<B>Shares</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">1.</TD><TD STYLE="text-align: justify"><B>INTRODUCTION</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.1</TD><TD STYLE="text-align: justify"><B>Purpose</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In connection with the preparation
and filing of a registration statement on Form&nbsp;F-1 (File No. 333-226368) (such registration statement, as amended through
the date hereof, the &ldquo;<B>Registration Statement</B>&rdquo;), to which this letter is attached as an exhibit, with the U.S.
Securities and Exchange Commission (the &ldquo;<B>SEC</B>&rdquo;) pursuant to the U.S. Securities Act of 1933, as amended (the
&ldquo;<B>Securities Act</B>&rdquo;), we have been asked to provide opinions on certain matters, as set out below. We have taken
instruction in this regard solely from the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">1.2</TD><TD STYLE="text-align: justify"><B>Defined terms and headings</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In this letter:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD STYLE="text-align: justify">capitalised terms used without definition in this letter or the schedules hereto have the meanings
assigned to them in the Registration Statement unless a contrary indication appears;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 2.25pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(b)</TD><TD STYLE="text-align: justify">headings are for ease of reference only and shall not affect interpretation; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(c)</TD><TD STYLE="text-align: justify">the term &ldquo;<B>Shares</B>&rdquo; shall include any additional Ordinary Shares registered by
the Company pursuant to Rule 462(b) under the Securities Act in connection with the offering contemplated by the Registration Statement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">1.3</TD><TD STYLE="text-align: justify"><B>Legal review</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0">For the
purpose of issuing this letter, we have examined such matters of fact and questions of law as we have considered appropriate. We
have reviewed only the following documents and conducted only the following enquiries and searches:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 18pt">(a)</TD><TD STYLE="text-align: justify">an online search at Companies House in respect of information available for inspection on the Company&rsquo;s
file conducted on 23 August 2018 at 09:00 a.m.&nbsp;(London time);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2.25pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Cooley (UK) LLP Dashwood 69 Old Broad Street
London EC2M 1QS, UK<BR>
t: +44 (0) 20 7583 4055 f: +44 (0) 20 7785 9355 cooley.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Cooley (UK) LLP is a limited liability partnership
and is registered in England and Wales with registered number OC395270. Our registered office is at the address above. Cooley (UK)
LLP is authorised and regulated by the Solicitors Regulation Authority (SRA number 617791). A list of the members of Cooley (UK)
LLP and their professional qualifications is open to inspection at its registered office. The word &lsquo;partner,&rsquo; used in relation
to Cooley (UK) LLP, refers to a member of Cooley (UK) LLP or an employee or consultant of Cooley (UK) LLP (or any affiliated firm)
of equivalent standing.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2.25pt"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2.25pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 18pt">(b)</TD><TD STYLE="text-align: justify">an enquiry by telephone at the Central Index of Winding Up Petitions, London on 23 August 2018
at 10:00 a.m.&nbsp;(London time) ((a)&nbsp;and (b)&nbsp;together, the &ldquo;<B>Searches</B>&rdquo;);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 18pt">(c)</TD><TD STYLE="text-align: justify">a certified PDF executed copy of the minutes of the annual general meeting of the Company (the
&ldquo;<B>AGM Minutes</B>&rdquo;), which was held on 25 June 2018 (the &ldquo;<B>AGM</B>&rdquo;);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 53.45pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 18pt">(d)</TD><TD STYLE="text-align: justify">a certified PDF copy of the resolutions passed at the AGM (the &ldquo;<B>AGM Resolutions</B>&rdquo;);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 53.45pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 18pt">(e)</TD><TD STYLE="text-align: justify">a PDF copy of the executed written resolutions of the board of directors of the Company (the &ldquo;<B>Board</B>&rdquo;)
dated 25 July 2018 regarding, <I>inter alia</I>, the appointment of a pricing committee of the Board (the &ldquo;<B>Pricing Committee</B>&rdquo;)
and the Registration Statement (together, the &ldquo;<B>Written Resolutions</B>&rdquo;);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 53.45pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 18pt">(f)</TD><TD STYLE="text-align: justify">a draft copy of minutes of a meeting of the Pricing Committee to be held resolving,&nbsp;<I>inter
alia</I>, to allot the Shares (the &ldquo;<B>Allotment Resolutions</B>&rdquo; and together with the Written Resolutions, the AGM
Minutes and the AGM Resolutions, the &ldquo;<B>Corporate Approvals</B>&rdquo;);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 53.45pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 18pt">(g)</TD><TD STYLE="text-align: justify">a PDF copy of the certificate of incorporation of the Company dated 11 February 1998, and PDF copies
of the certificates of incorporation on change of name of the Company dated 6 August 1998, 18 February 2011 and 23 April 2014,
respectively;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 53.45pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 18pt">(h)</TD><TD STYLE="text-align: justify">a PDF copy of the current articles of association of the Company dated 30 June 2016 (the &ldquo;<B>Articles</B>&rdquo;);
and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 53.45pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 18pt">(i)</TD><TD STYLE="text-align: justify">a draft copy of the Registration Statement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">1.4</TD><TD STYLE="text-align: justify"><B>Applicable law</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.55pt">This letter,
the opinions given in it, and any non-contractual obligations arising out of or in connection with this letter and/or the opinions
given in it, are governed by, and to be construed in accordance with, English law and relate only to English law as applied by
the English courts, including the laws of the European Union to the extent having the force of law in England, as at today&rsquo;s
date. In particular:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2.25pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 18pt">(a)</TD><TD STYLE="text-align: justify">we have not investigated the laws of any country other than England and we assume that no foreign
law affects any of the opinions stated below;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 53.45pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 18pt">(b)</TD><TD STYLE="text-align: justify">we do not undertake or accept any obligation to update this letter and/or the opinions given in
it to reflect subsequent changes in English law or factual matters; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2.25pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 18pt">(c)</TD><TD STYLE="text-align: justify">we express no opinion in this letter on the laws of any jurisdiction other than England. It is
assumed that no foreign law which may apply to the matters contemplated by the Registration Statement, the Company, any document
or any other matter contemplated by any document would or might affect this letter and/or the opinions given in it.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Cooley (UK) LLP Dashwood 69 Old Broad Street
London EC2M 1QS, UK<BR>
t: +44 (0) 20 7583 4055 f: +44 (0) 20 7785 9355 cooley.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Cooley (UK) LLP is a limited liability partnership
and is registered in England and Wales with registered number OC395270. Our registered office is at the address above. Cooley (UK)
LLP is authorised and regulated by the Solicitors Regulation Authority (SRA number 617791). A list of the members of Cooley (UK)
LLP and their professional qualifications is open to inspection at its registered office. The word &lsquo;partner,&rsquo; used in relation
to Cooley (UK) LLP, refers to a member of Cooley (UK) LLP or an employee or consultant of Cooley (UK) LLP (or any affiliated firm)
of equivalent standing.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">1.5</TD><TD STYLE="text-align: justify"><B>Assumptions and reservations</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The opinions given in this letter
are given on the basis of each of the assumptions set out in schedule&nbsp;1 (<I>Assumptions</I>) and are subject to each of the
reservations set out in schedule 2 (<I>Reservations</I>) to this letter. The opinions given in this letter are strictly limited
to the matters stated in paragraph 2 (<I>Opinions</I>) below and do not extend, and should not be read as extending, by implication
or otherwise, to any other matters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">2.</TD><TD STYLE="text-align: justify"><B>OPINION</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Subject to paragraph 1 (<I>Introduction</I>)
and the other matters set out in this letter and its schedules, and subject further to the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD STYLE="text-align: justify">the Registration Statement, as finally amended, becoming effective under the Securities Act;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 2.25pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(b)</TD><TD STYLE="text-align: justify">the number of Shares to be allotted and issued in connection with the Offering not being greater
than the aggregate nominal value specified in the Written Resolutions;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 2.25pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(c)</TD><TD STYLE="text-align: justify">that the Corporate Approvals were or will be (as appropriate) each passed at a meeting which was
or will be duly convened and held in accordance with all applicable laws and regulations; that in particular, but without limitation,
a duly qualified quorum of directors or, as the case may be, shareholders was or will be present in each case throughout the meeting
and voted in favour of the resolutions; and that in relation to each meeting of the Board and of the Pricing Committee, each provision
contained in the Companies Act 2006, as amended (the &ldquo;<B>Act</B>&rdquo;) or the Articles relating to the declaration of the
directors&rsquo; interests or the power of the interested directors to vote and to count in the quorum was or will be duly observed;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 2.25pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(d)</TD><TD STYLE="text-align: justify">the receipt in full of payment for the Shares in an amount of &ldquo;cash consideration&rdquo;
(as defined in section 583(3)&nbsp;of the Act) of not less than the aggregate nominal value for such Shares; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 2.25pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(e)</TD><TD STYLE="text-align: justify">valid entries having been made in relation to the allotment and issue of the Shares in the books
and registers of the Company,</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="background-color: white">it
is our opinion that, as at today&rsquo;s date, the Shares, if and when allotted and issued, registered in the name of the recipient
in the register of members of the Company and delivered as described in the Registration Statement, will be duly and validly authorised
and issued, fully paid or credited as fully paid (subject to the receipt of valid consideration by the Company for the issue thereof
in connection with the Offering) and will not be subject to any call for payment of further capital.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">3.</TD><TD STYLE="text-align: justify"><B>EXTENT OF OPINIONS</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">We express no opinion as to any
agreement, instrument or other document other than as specified in this letter or as to any liability to tax or duty which may
arise or be suffered as a result of or in connection with the Offering or the transactions contemplated thereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">This letter only applies to those
facts and circumstances which exist as at today&rsquo;s date and we assume no obligation or responsibility to update or supplement
this letter to reflect any facts or circumstances which may subsequently come to our attention, any changes in laws which may occur
after today, or to inform the addressee of any change in circumstances happening after the date of this letter which would alter
our opinion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Cooley (UK) LLP Dashwood 69 Old Broad Street
London EC2M 1QS, UK<BR>
t: +44 (0) 20 7583 4055 f: +44 (0) 20 7785 9355 cooley.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Cooley (UK) LLP is a limited liability partnership
and is registered in England and Wales with registered number OC395270. Our registered office is at the address above. Cooley (UK)
LLP is authorised and regulated by the Solicitors Regulation Authority (SRA number 617791). A list of the members of Cooley (UK)
LLP and their professional qualifications is open to inspection at its registered office. The word &lsquo;partner,&rsquo; used in relation
to Cooley (UK) LLP, refers to a member of Cooley (UK) LLP or an employee or consultant of Cooley (UK) LLP (or any affiliated firm)
of equivalent standing.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">4.</TD><TD STYLE="text-align: justify"><B>DISCLOSURE AND RELIANCE</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.55pt">This letter
is addressed to you in connection with the Registration Statement. We consent to the filing of this letter as an exhibit to the
Registration Statement. We further consent to the incorporation by reference of this letter and consent into any registration statement
filed pursuant to Rule&nbsp;462(b)&nbsp;under the Securities Act with respect to the Shares. In giving such consent, we do not
thereby admit that we are in the category of persons whose consent is required under Section&nbsp;7 of the Securities Act or the
rules&nbsp;and regulations thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.55pt">Other than
for the purpose set out in the prior paragraph, this letter may not be relied upon, or assigned, for any purpose, without our prior
written consent, which may be granted or withheld in our discretion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Yours faithfully</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ Edward J. Lukins</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Cooley (UK) LLP</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Cooley (UK) LLP Dashwood 69 Old Broad Street
London EC2M 1QS, UK<BR>
t: +44 (0) 20 7583 4055 f: +44 (0) 20 7785 9355 cooley.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Cooley (UK) LLP is a limited liability partnership
and is registered in England and Wales with registered number OC395270. Our registered office is at the address above. Cooley (UK)
LLP is authorised and regulated by the Solicitors Regulation Authority (SRA number 617791). A list of the members of Cooley (UK)
LLP and their professional qualifications is open to inspection at its registered office. The word &lsquo;partner,&rsquo; used in relation
to Cooley (UK) LLP, refers to a member of Cooley (UK) LLP or an employee or consultant of Cooley (UK) LLP (or any affiliated firm)
of equivalent standing.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SCHEDULE 1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ASSUMPTIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The opinions in this letter have been given
on the basis of the following assumptions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD STYLE="text-align: justify">the genuineness of all signatures, stamps and seals on all documents, the authenticity and completeness
of all documents submitted to us as originals, and the conformity to original documents of all documents submitted to us as copies;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 3pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(b)</TD><TD STYLE="text-align: justify">that, where a document has been examined by us in draft or specimen form, it will be or has been
duly executed in the form of that draft or specimen, and that each of the signed documents examined by us has been duly executed
and, where applicable, delivered on behalf of the Company;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 3pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(c)</TD><TD STYLE="text-align: justify">that the Articles remain in full force and effect, and no alteration has been made or will be made
to such articles of association, in each case prior to the date of allotment and issue of the Shares (the &ldquo;<B>Allotment Date</B>&rdquo;);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(d)</TD><TD STYLE="text-align: justify">on the Allotment Date the Company will comply with all applicable laws to allot and issue the Shares
and the Company will receive such amounts as are necessary to fully pay the nominal value of the Shares and any applicable share
premium;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 3pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(e)</TD><TD STYLE="text-align: justify">that all documents, forms and notices which should have been delivered to the Registrar of Companies
in respect of the Company have been so delivered, that information revealed by the Searches was complete and accurate in all respects
and has not, since the time of the Searches, been altered and that the results of the Searches will remain complete and accurate
as at the Allotment Date;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(f)</TD><TD STYLE="text-align: justify">that the Company has not taken any corporate or other action nor have any steps been taken or legal
proceedings been started against the Company for the liquidation, winding up, dissolution, reorganisation or bankruptcy of, or
for the appointment of a liquidator, receiver, trustee, administrator, administrative receiver or similar officer of, the Company
or all or any of its assets (or any analogous proceedings in any jurisdiction) and the Company is not unable to pay its debts as
they fall due within the meaning of section 123 of the Insolvency Act 1986, as amended (the &ldquo;<B>Insolvency Act</B>&rdquo;),
and will not become unable to pay its debts within the meaning of that section as a result of any of the transactions contemplated
herein, is not insolvent and has not been dissolved or declared bankrupt (although the Searches gave no indication that any winding-up,
dissolution or administration order or appointment of a receiver, administrator, administrative receiver or similar officer has
been made with respect to the Company);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(g)</TD><TD STYLE="text-align: justify">that the minutes of the meeting of the Pricing Committee provided to us in connection with the
giving of the opinions in this letter reflect a true record of the proceedings described in them in duly convened, constituted
and quorate meetings in which all constitutional, statutory and other formalities were duly observed, and the resolutions set out
in the minutes were validly passed and have not been and will not be revoked or varied and remain in full force and effect and
will remain so as at the Allotment Date;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(h)</TD><TD STYLE="text-align: justify">that the resolutions set out in the Corporate Approvals were validly passed and have not been and
will not be revoked or varied and remain in full force and effect and will remain so as at the Allotment Date;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 3pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(i)</TD><TD STYLE="text-align: justify">that in relation to the allotment and issue of the Shares, the directors of the Company have acted
and will act in the manner required by section 172 of the Act (<I>Duty to promote the success of the Company</I>), and there has
not been and will not be any bad faith, breach of trust, fraud, coercion, duress or undue influence on the part of any of the directors
of the Company;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(j)</TD><TD STYLE="text-align: justify">following the date of this letter and prior to the issue of the Ordinary Shares, the Company will
validly enter into an underwriting agreement on substantially the terms and conditions described in Exhibit 1.1 of the Registration
Statement; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(k)</TD><TD STYLE="text-align: justify">that no Shares or rights to subscribe for Shares have been or shall be offered to the public in
the United Kingdom in breach of the Financial Services and Markets Act 2000, as amended (&ldquo;<B>FSMA</B>&rdquo;) or of any other
United Kingdom laws or regulations concerning offers of securities to the public, and no communication has been or shall be made
in relation to the Shares in breach of section 21 of FSMA or any other United Kingdom laws or regulations relating to offers or
invitations to subscribe for, or to acquire rights to subscribe for or otherwise acquire, shares or other securities.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Cooley (UK) LLP Dashwood 69 Old Broad Street
London EC2M 1QS, UK<BR>
t: +44 (0) 20 7583 4055 f: +44 (0) 20 7785 9355 cooley.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Cooley (UK) LLP is a limited liability partnership
and is registered in England and Wales with registered number OC395270. Our registered office is at the address above. Cooley (UK)
LLP is authorised and regulated by the Solicitors Regulation Authority (SRA number 617791). A list of the members of Cooley (UK)
LLP and their professional qualifications is open to inspection at its registered office. The word &lsquo;partner,&rsquo; used in relation
to Cooley (UK) LLP, refers to a member of Cooley (UK) LLP or an employee or consultant of Cooley (UK) LLP (or any affiliated firm)
of equivalent standing.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SCHEDULE 2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>RESERVATIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The opinions in this letter are subject to the following reservations:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD STYLE="text-align: justify">the Searches are not capable of revealing conclusively whether or not a winding-up or administration
petition or order has been presented or made, a receiver appointed, a company voluntary arrangement proposed or approved or any
other insolvency proceeding commenced, and the available records may not be complete or up-to-date. In particular, the Central
Registry of Winding-Up Petitions in England may not contain details of administration applications filed, or appointments recorded
in or orders made by, district registries and county courts outside London. Searches at Companies House and at the Central Registry
of Winding Up Petitions in England are not capable of revealing whether or not a winding up petition or a petition for the making
of an administration order has been presented and, further, notice of a winding up order or resolution, notice of an administration
order and notice of the appointment of a receiver may not be filed at Companies House immediately and there may be a delay in the
relevant notice appearing on the file of the company concerned. Further, not all security interests are registrable, such security
interests have not in fact been registered or such security interests have been created by an individual or an entity which is
not registered in England. We have not made enquiries of any District Registry or County Court in England;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 3pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(b)</TD><TD STYLE="text-align: justify">the opinions set out in this letter are subject to: (i)&nbsp;any limitations arising from applicable
laws relating to insolvency, bankruptcy, administration, reorganisation, liquidation, moratoria, schemes or analogous circumstances;
and (ii)&nbsp;an English court exercising its discretion under section 426 of the Insolvency Act (<I>co-operation between courts
exercising jurisdiction in relation to insolvency</I>) to assist the courts having the corresponding jurisdiction in any part of
the United Kingdom or any relevant country or territory;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 3pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(c)</TD><TD STYLE="text-align: justify">we express no opinion as to matters of fact;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(d)</TD><TD STYLE="text-align: justify">we have only reviewed the documents listed in paragraph 2 above;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(e)</TD><TD STYLE="text-align: justify">we have made no enquiries of any individual connected with the Company;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(f)</TD><TD STYLE="text-align: justify">a certificate, documentation, notification, opinion or the like might be held by the English courts
not to be conclusive if it can be shown to have an unreasonable or arbitrary basis or in the event of a manifest error; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 3pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(g)</TD><TD STYLE="text-align: justify">it should be understood that we have not been responsible for investigating or verifying the accuracy
of the facts, including statements of foreign law, or the reasonableness of any statements of opinion, contained in the Registration
Statement, or that no material facts have been omitted from it.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Cooley (UK) LLP Dashwood 69 Old Broad Street
London EC2M 1QS, UK<BR>
t: +44 (0) 20 7583 4055 f: +44 (0) 20 7785 9355 cooley.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Cooley (UK) LLP is a limited liability partnership
and is registered in England and Wales with registered number OC395270. Our registered office is at the address above. Cooley (UK)
LLP is authorised and regulated by the Solicitors Regulation Authority (SRA number 617791). A list of the members of Cooley (UK)
LLP and their professional qualifications is open to inspection at its registered office. The word &lsquo;partner,&rsquo; used in relation
to Cooley (UK) LLP, refers to a member of Cooley (UK) LLP or an employee or consultant of Cooley (UK) LLP (or any affiliated firm)
of equivalent standing.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 6; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>7
<FILENAME>ff12018a1ex10-1_tiziana.htm
<DESCRIPTION>LICENSE AGREEMENT RELATING TO MILCICLIB BETWEEN NERVIANO MEDICAL SERVICES S.R.L. AND TIZIANA LIFE SCIENCES PLCPLC, DATED JANUARY 2015
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 10.1</B></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; margin-right: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; margin-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>LICENSE
AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; margin-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
License Agreement (&ldquo;<U>Agreement</U>&rdquo;) by and between Nerviano Medical Sciences, Viale Pasteur 10, Nerviano, Milano,
Italy ( &ldquo;Licensor&rdquo; or &ldquo;NMS&rdquo;), and Tiziana Life Sciences Plc, 18 South Street, Mayfair, London W1K 1DG, United
Kingdom (&ldquo;<U>Licensee</U>&rdquo; or &ldquo;TIZIANA&rdquo;) is made effective as of the date that the Agreement is signed by
the last Party to sign below (&ldquo;<U>Effective Date</U>&rdquo;). Licensor and Licensee are each hereafter referred to individually
as a &ldquo;<U>Party</U>&rdquo; and together as the &ldquo;<U>Parties</U>.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
TIZIANA and NMS are herewith entering into a license Agreement whereby TIZIANA will have the exclusive right to develop and commercialize
the Licensed Product(s) worldwide and NMS will receive from TIZIANA up-front payments and Equity Stock as well as success milestone
payments and royalties in consideration for the rights granted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOW,
THEREFORE, in consideration of the mutual covenants contained herein, and for other good and valuable consideration, the receipt
and adequacy of which are hereby acknowledged, the Parties hereby agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.&nbsp;<B>DEFINITIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalized
terms used in this Agreement shall have the meanings specified below or elsewhere herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1.&nbsp;&ldquo;<U>Affiliate</U>&rdquo; means
any Person who directly or indirectly controls or is controlled by or is under common control with another Person. A Person
shall only be considered an Affiliate during the duration of such control. For purposes of this definition,
&ldquo;<U>control</U>&rdquo; or &ldquo;<U>controlled</U>&rdquo; means ownership, directly or through one or more Affiliates, of
fifty percent (50%) or more of the shares of stock entitled to vote for the election of directors, in the case of a
corporation, or fifty percent (50%) or more of the equity interest, in the case of any other type of legal entity, or status
as a general partner in any partnership, or the contractual right to control the election of directors or direct the affairs
of any Person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2.&nbsp;&ldquo;<U>Confidential
Information</U>&rdquo; means with respect to a Party (the &ldquo;<U>Receiving Party</U>&rdquo;), all information that is (i)
disclosed by the other Party (the &ldquo;<U>Disclosing Party</U>&rdquo;) to the Receiving Party; and (ii) would be reasonably
understood from notices or legends, the nature of such information itself or the circumstances of such information&rsquo;s
disclosure to be confidential by a reasonable person familiar with the applicable industry; provided, however, that
Confidential Information shall not include information that the Receiving Party can demonstrate by its records or other
suitable documentary evidence, (a) as of the date of disclosure is demonstrably known to the Receiving Party or its
Affiliates other than by virtue of a prior confidential disclosure to such Party or its Affiliates; (b) as of the date of
disclosure is in, or subsequently enters, the public domain, through no fault or omission of the Receiving Party; (c) is
obtained from a Third Party having a lawful right to make such disclosure free from any obligation of confidentiality to the
Disclosing Party; or (d) is independently developed by or for the Receiving Party without reference to or reliance upon any
Confidential Information of the Disclosing Party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3.
&ldquo;<U>Cover</U>&rdquo; (in all its verb and adjectival forms, such as &ldquo;Covered&rdquo; and &ldquo;Covers&rdquo;) means
with respect to Valid Claims in an issued patent, that, in the absence of a license, the use, sale, or manufacture of the
product in question would infringe such Valid Claim.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.4.
&ldquo;<U>Diligent Efforts</U>&rdquo; The term &lsquo;Diligent Efforts&rsquo; will mean those commercially reasonable efforts
and resources comparable with a Party&rsquo;s internal program of similar market potential and market size, risk, and at a
similar stage of development.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.5.
&ldquo;<U>Field</U>&rdquo; means any and all uses, including all diagnostic and therapeutic uses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.6.
&ldquo;<U>Improvement</U>&rdquo; means any improvement, enhancement or modification of or to any technology claimed or
described in the Licensed Patents, and any invention or discovery concerning any development, manufacture, use or testing of
any technology claimed or described in the Licensed Patents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.7.
&ldquo;<U>Indemnitee</U>&rdquo; means a Licensor Indemnitee or a Licensee Indemnitee, as applicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.8.
&ldquo;<U>Licensor Indemnitees</U>&rdquo; means Licensor, its Affiliates and the directors, officers, employees and agents of
Licensor and its Affiliates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.9. <U>Licensed
Patents</U>&rdquo; means any and all NMS Patents, patent applications and NMS Know-How owned or controlled by NMS or its
Affiliates (solely or jointly with TIZIANA), now or during the term of the Agreement, that are necessary or useful to
develop, make, use, sell, offer for sale or import Licensed Products in the Field in the Territory, including all
provisionals, substitutions, continuations, continuations-in-part, divisionals, supplementary protection certificates,
renewals, all letters patent granted thereon, and all reissues, reexaminations, extensions, confirmations, revalidations,
registrations, patents of addition thereof, and foreign equivalents to any of the foregoing, including without limitations,
the patents and patent applications listed on Schedule A hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.10.
&ldquo;<U>Licensed Product</U>&rdquo; means any product or service incorporating Milciclib as active ingredient and any product
controlled or owned by NMS as of the Effective Date, used to diagnose or assess responsiveness to Milciclib therapy or dosage
in patients, the manufacture, use, sale, importation or performance of which would, absent the license granted herein, infringe
a Valid Claim of the Licensed Patents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.11.
&ldquo;<U>Licensee Indemnitees</U>&rdquo; means Licensee, its Affiliates, Sublicensees, and the directors, officers, employees and
agents of Licensee and its Affiliates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.12.
&ldquo;<U>Manufacturing Technology</U>&rdquo; means all information, know-how and patents necessary for the manufacture of a
Licensed Product including without limitation, all tangible and intangible information, techniques, practices, trade secrets
methods, knowledge data and results, reports and batch records, analytical and quality control data, analytical methods,
packaging records, release, stability, storage, shelf-life data, manufacturing process information, results and descriptions
related to the production, manufacture, filling, finishing, packaging, labeling, inspection, receiving, holding and shipping
of Licensed Products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.13.
&ldquo;<U>Net Sales</U>&rdquo; means, in the case of sales by or for the benefit of TIZIANA and its Affiliates (the &ldquo;Seller&rdquo;)
to independent, unrelated persons (&ldquo;Buyers&rdquo;) in bona fide arm&rsquo;s length transactions (except as provided below with respect
to clinical trial samples), the gross amount billed or invoiced by Seller with respect to the Licensed Product, less the following
deductions, in each case to the extent actually allowed and taken by such Buyers and not otherwise recovered by or reimbursed
to Seller in connection with such Licensed Product (&ldquo;Permitted Deductions&rdquo;):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">trade,
cash, promotional and quantity discounts to the extent that such amounts are set forth separately as such in the total amount
billed or invoiced;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">taxes
on sales (such as excise, sales or use taxes or value added tax) to the extent imposed upon and paid directly with respect to
the sales price and set forth separately as such in the total amount billed or invoiced (and excluding national, state or local
taxes based on income);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">taxes
on sales of pharmaceutical specialties reimbursed pursuant to a government health service, health insurance, social insurance
or similar social services program;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">freight,
insurance, packing costs and other transportation charges to the extent added to the sales price and set forth separately as such
in the total amount billed or invoiced;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">amounts
repaid or credits taken by reason of rejections, defects or returns or because of retroactive price reductions, or due to recalls
or laws or regulations requiring rebates;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">free
goods, rebates taken by or fees paid to distributors, and charge-backs to the extent that such amounts are documented;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">documented
customs duties actually paid by Seller on import into the country of sale; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.05in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">rebates
and/or discounts on sales of Licensed Product given to health insurance and other types of payers in any given country of the
Territory due to specific agreement (&ldquo;claw-back&rdquo; type of agreements) involving the Licensed Product.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Net
Sales&rdquo; shall not include any consideration received with respect to a sale, use or other disposition of any Licensed
Product in a country as part of a clinical trial necessary to obtain regulatory approval in such country. All of the
foregoing elements of Net Sales calculations shall be determined in accordance with IFRS or successor standards and
guidelines thereto. In the case of transfers of Licensed Product between any of TIZIANA, its sublicensees, and Affiliates of
any of the foregoing, for subsequent sale, rental, lease or other transfer of such Licensed Products to Third Parties, Net
Sales shall be the gross invoice or contract price charged to the Third Party customer for that Licensed Product, less the
deductions set forth in this clause.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.14.
&ldquo;<U>Person</U>&rdquo; means any individual, corporation, limited or general partnership, limited liability company, joint
venture, trust, unincorporated association, governmental body, authority, bureau or agency, or any other entity or body.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.15.
&ldquo;<U>Release Event</U>&rdquo; means:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.15.1.
a successful conclusion of a Phase II Trial for Hepatocellular Carcinoma or for Breast Cancer with a Licensed Product, where such
successful conclusion that renders the Licensed Product eligible for entry into a Phase III trial with no further clinical trial
study;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.15.2.
the abandonment by Tiziana of development of any Licensed Product, or if Tiziana fails to be diligent in development of a Licensed
Product, except where such abandonment or failure to progress development occurs for bona fide scientific reasons; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.15.3.
the valid exercise of the Option.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.95in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.16.
&ldquo;<U>Royalty Term</U>&rdquo; means, with respect to each Licensed Product, the period of time beginning on the first commercial
sale of such Licensed Product and will extend, on a Licensed Product by Licensed Product basis and on a country-by-country basis
until the later of (a) the expiration of the last to expire Valid Claim under the Licensed Patents or (b) five (5) years from
the date of first commercial sale.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.17.
&ldquo;<U>Sublicensee</U>&rdquo; means any Third Party to whom Licensee grants a sublicense of some or all of the rights granted
to Licensee under this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.18.
&ldquo;<U>Substitute Interest</U>&rdquo; means any shares or stock or instruments convertible into shares, stock or cash proceeds
that are issued to NMS in exchange for, or in connection with, the sale or redemption of the Shares (as defined in clause 5.1
below).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.19.
&ldquo;<U>Territory</U>&rdquo; means worldwide.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.20.
&ldquo;<U>Third Party</U>&rdquo; means any person or entity other than Licensee, Licensor and their respective Affiliates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.21.
&ldquo;<U>Valid Claim</U>&rdquo; means a claim of an issued and unexpired patent that has not been: (i) disclaimed, (ii) dedicated
to the public, (iii) abandoned, or (iv) declared invalid, unenforceable, or revoked by a court or government agency of competent
jurisdiction from which no appeal can be or has been taken.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.&nbsp;<B>LICENSE
GRANT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.&nbsp;<B>License. </B>Licensor
hereby grants to Licensee a worldwide, exclusive license (even as to Licensor), including the right to grant sublicenses to
Affiliates and Third Parties, under the Licensed Patents and under Licensor&rsquo;s right, title and interest in and to
Improvements, for Licensee and its Affiliates to research, develop, make, have made, use, offer for sale, sell, have sold and
import Licensed Products for any and all uses in the Field in the Territory, subject to the terms and conditions of this
Agreement. The foregoing includes the right to employ Third Party distributors to sell Licensed Products and Third Party
contract manufacturers to make Licensed Products, neither of which shall be construed as a sub-license.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2. <B>Manufacturing
License. </B>Licensor shall further grant to Licensee an exclusive license (with a right to grant sublicenses to Affiliates
and Third Parties) under any and all the Manufacturing Technology to make or have made Licensed Product in the Territory upon
conditions and subject to terms set forth in a Supply Agreement. The terms of the Supply Agreement shall be negotiated
in good faith and the consideration paid by TIZIANA for the manufacture of Licensed Product shall not include additional
milestones or royalties and shall be based on a cost plus basis (not to exceed cost plus 10%).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3. <B>Necessary
Rights. </B>Each Party shall use Diligent Efforts to conduct its respective tasks set forth in the JDC-approved
Development Plan (as defined in Section 3.2).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<B>DEVELOPMENT AND COMMERCIALIZATION OF LICENSED PRODUCTS.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1. <B>Governance. </B>The
Parties will establish a Joint Development Committee (JDC), composed of at least two members of each Party, in charge of the
supervision, review and coordination of the Development Plan, including any changes to and following up of the implementation
of the Development Plan and the IP strategy. The JDC shall meet at least twice a year, at alternating sites (Milan, New York
and London) if not otherwise agreed, or by means of videoconference or telephone conferences. The JDC shall endeavor to make
decisions by consensus; <I>provided </I>that, in the event of disagreement, TIZIANA shall have the deciding vote on
any aspect of the Licensed Product(s). TIZIANA will keep NMS regularly informed about its development and commercialization
activities, including annual progress updates to NMS and prompt notices of any material events in the development of the
Licensed Product.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2. <B>Clinical
Research Program. </B>The Parties will, within ninety (90) days of the Effective Date negotiate in good faith an
initial JDC-approved development plan <B>(&ldquo;Development Plan&rdquo;) </B>that will detail the roles and responsibilities
of each Party. The Development Plan shall provide that TIZIANA shall be solely responsible and bear all costs for further
clinical development, however, TIZIANA will entrust at least the performance of the planned Phase II studies to NMS, provided
that the Parties shall negotiate in good faith the amounts to be invoiced by NMS for such Phase II studies, such amounts to
be commercially reasonable and not to exceed by more than 10% the amounts estimated to be invoiced by a reputable clinical
research organization.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3. <B>Responsibility
for Phase II Trial. </B>The Parties may agree on a phase II development plan to be performed by NMS and financed by TIZIANA
based on a budget proposal acceptable to TIZIANA in accordance with section 3.2 above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4.&nbsp;<B>Manufacturing,
Clinical and Commercial Supply. </B>NMS shall have sole responsibility for and use Diligent Efforts for the manufacturing of all
Licensed Products for clinical studies up to and including Phase II studies on commercially reasonable terms and conditions defined
in a Supply Agreement as set forth in section 2.2 above (which shall not include any additional milestones or royalties and shall
be based on a cost plus basis (not to exceed cost plus 10%).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5.
<B>Manufacturing Technology Transfer. </B>If requested by TIZIANA, NMS shall perform a technology transfer, at no additional cost
for up to 20 man days, after the end of the phase II, to allow TIZIANA and/or its designee to manufacture the Licensed Product.
Such transfer shall include all necessary NMS manufacturing know how and shall disclose and provide copies, as applicable, to
Tiziana, Affiliates and Sublicensees or a third party manufacturer to manufacture Licensed Product based on a manufacturing process
determined by the Parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6.&nbsp;<B>Regulatory
Matters. </B>Unless otherwise agreed to with NMS, TIZIANA (or its sublicensee(s)) shall be responsible for and shall use
Diligent Efforts for the compilation, preparation and filing of all regulatory documents for the development and the
commercialization of Licensed Product(s).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.7.&nbsp;<B>Diligence.
</B>Each Party shall use Diligent Efforts to conduct its respective tasks set forth in the JDC-approved Development Plan. NMS
shall use Diligent Efforts on the manufacture of Licensed Product(s). TIZIANA (or its sublicensee(s)) shall have sole responsibility
for, bear all costs and use Diligent Efforts to develop and commercialize Licensed Product in at least one therapeutic indication
that arises out of the Development Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.8.&nbsp;<B>Exclusivity
Term. </B>During the term of the Development Plan <B>(&ldquo;Exclusivity Term&rdquo;), </B>TIZIANA and its Affiliates shall
not, directly or indirectly, develop, make, use, sell, offer for sale or import any small molecule compound or other
biological or chemical molecule other than Milciclib that directly binds to, with an affinity indicated by an IC<SUB>50</SUB>
of 100nM or less, and modulates the following specified pharmacological targets hit by Milciclib: Cdk-2, Cdc-4 and Cdc6. The
Exclusivity Term shall terminate upon early termination of the Development Plan by TIZIANA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.<B>&nbsp;PAYMENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1.<B>&nbsp;Upfront
Fee. </B>In consideration of the transfer of rights and the grant of the Exclusive License, TIZIANA shall pay to NMS a non-refundable
initial license fee of USD 3,500,000 to be paid in two installments as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;First
installment USD 1,500,000 within seven business days of signing of this Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;Second
installment USD 2,000,000 no later than June 22, 2015, with the restriction that if the USD 2.0 M is not timely paid, then TIZIANA
will forfeit the USD 1.5 M payment previously made and the Agreement shall be deemed terminated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2.
<B>Milestone Payments. Subject to the </B>terms and conditions of this Agreement,</FONT> and in consideration for the rights granted
to TIZIANA under the Agreement, TIZIANA will make the following further payments to NMS for the first Licensed Product that achieves
such development milestone within 30 days of such event:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;USD
100,000 upon initiation (First Patient Dosed; &ldquo;FPD&rdquo;) of the first Phase III Registration Trial in Thymic Carcinoma.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;USD
4,000,000 upon initiation (FPD) of the first Phase III Registration Trial in Hepatocellular Carcinoma.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&nbsp;USD
6,000,000 upon initiation (FPD) of the first Phase III Registration Trial in Breast Cancer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&nbsp;Upon
the first NDA or equivalent in:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thymic
Carcinoma USD 900,000</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hepatocellular
Carcinoma USD 9,000,000</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Breast
Cancer USD 15,000,000</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
all milestones are achieved, then TIZIANA will pay a total of USD 35,000,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3.
<B>Royalty Payments.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3.1.
<B>Royalty Rates. Subject </B>to the other terms of this Agreement, </FONT>Licensee shall pay to Licensor a royalty of three and
one-half percent (3.5%) of annual Net Sales by Licensee and by Licensee Affiliates for each country as to which the Royalty Term
remains in effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3.2.
<B>Royalty Offsets. </B>On a country-by-country basis, TIZIANA will have the right to reduce any royalties owed to NMS by an amount
equal to 50% of any third party royalties required by TIZIANA or its Sublicensees to make, use, sell, offer for sale, or import
any Licensed Product. In the event of competition consisting of a competing product having a market share equal to or more than
20% of the aggregate of Licensed Product and generic product measured on a unit basis for any quarter, TIZIANA will have the right
to reduce any royalties owed to NMS by an amount equal to 50% for that period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3.3.
<B>One Royalty. </B>Only one royalty shall be payable to Licensor hereunder for each sale of a Licensed Product.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3.4.
<B>Sublicense Revenue. </B>TIZIANA will owe NMS 15% of Sublicense Revenues for the life of the Licensed Patents. Sublicense Revenues
consist of all consideration received by TIZIANA or its Affiliates from Sublicensees on account of the sale of Licensed Products.
Sublicense Revenues will not include: (a) amounts paid by such sublicensee as reimbursement for research and development costs
incurred under such Sublicense with respect to Licensed Products if Licensee collaborates on research and/or development with
such a Sublicensee; (b) bona fide loans; (c) reimbursement for clinical trial costs and expenses with respect to Licensed Products
incurred after the execution of such Sublicense; (d) equity investment in Licensee to the extent such investments reflect the
fair market value of such equity (any amounts paid in excess of fair market value shall be deemed Sublicense Revenues); (e) amounts
paid for supplies of Licensed Products or other tangible materials, or that are otherwise paid in reimbursement of costs or expenditures,
whether incurred before or after the date of the relevant sublicense agreement; (f) withholding taxes, taxes on sales (such as
excise, sales or use taxes or value added tax) or other amounts actually withheld from the amounts received. Sublicense Revenues
shall not include amounts received in connection with a merger, consolidation or sale of all or substantially all of the business
or assets of Licensee to which this Agreement relates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4.&nbsp;<B>Payment
Terms.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4.1.
<B>Payment of Royalties. </B>Licensee shall make any royalty payments owed to Licensor hereunder in arrears, within thirty (30)
days from the end of each half of the calendar year in which such payment accrues. Each royalty payment shall be accompanied by
a report for each country in which sales of Licensed Products occurred in the calendar half year covered by such statement, specifying:
the gross sales (if available) and Net Sales in each country&rsquo;s currency; the applicable royalty rate under this Agreement; the
royalties payable in each country&rsquo;s currency, including an accounting of deductions taken in the calculation of Net Sales in accordance
with Licensee&rsquo;s accounting practices; the applicable exchange rate to convert from each country&rsquo;s currency to United States Dollars;
and the royalties payable in United States Dollars.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4.2.
<B>Accounting. </B>All payments hereunder shall be made in United States dollars. Conversion of foreign currency to United States
dollars shall be made in the same manner as Licensee converts all of its other revenues, provided that (a) such manner is consistent
with United States generally accepted accounting principles, and (b) the exchange rates employed are those quoted by a reputable
source, such as a recognized money center bank such as JP Morgan, Bank of America or an equivalent, OANDA.com, or the Wall Street
Journal.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4.3. <B>Tax
Withholding; Restrictions on Payment. </B>All payments hereunder shall be made free and clear of any taxes, duties,
levies, fees or charges, except for withholding taxes and interest and penalties thereon (to the extent applicable). Licensee
shall make any applicable withholding payments due on behalf of Licensor and shall provide Licensor upon request with such
written documentation regarding any such payment as available to Licensee relating to an application by Licensor for a
foreign tax credit for such payment with the United States Internal Revenue Service. Licensor shall provide all information
necessary to determine if withholding taxes are applicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5.
<B>Records Retention by Licensee; Review.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5.1.
<B>Royalty Records. </B>Commencing as of the date of First Commercial Sale of the first Licensed Product hereunder, Licensee and
its Affiliates and Sublicensees shall keep for at least three (3) years from the end of the calendar year to which they pertain
complete and accurate records of sales by Licensee or its Affiliates and Sublicensees, as the case may be, of each Licensed Product,
in sufficient detail to allow the accuracy of the payments hereunder to be confirmed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5.2.
<B>Review. </B>Subject to the other terms of this Section 4.5, at the request of Licensor, which shall not be made more frequently
than once per calendar year during the Term, and upon at least thirty (30) days&rsquo; prior written notice from Licensor, and
at the expense of Licensor (except as otherwise provided herein), Licensee shall permit an independent certified public accountant
selected by Licensor and reasonably acceptable to Licensee to inspect (during Licensee&rsquo;s regular business hours) the relevant
records required to be maintained by Licensee under Section 4.5. In every case the accountant must have previously entered into
a confidentiality agreement with both Parties substantially similar to the provisions of Article 6 and limiting the disclosure
and use of such information by such accountant to authorized representatives of the Parties and the purpose of verifying royalties
payable to Licensor hereunder. Results of any such review shall be binding on both Parties absent manifest error. Licensor shall
treat the results of any such accountant&rsquo;s review of Licensee&rsquo;s records as Confidential Information of Licensee subject
to the terms of Article 6. If any review reveals a deficiency in the calculation and/or payment of royalties by Licensee, then
(a) Licensee shall pay Licensor the amount remaining to be paid, and (b) if such underpayment is by ten percent (10%) or more
for any twelve (12) month consecutive period, then Licensee shall reimburse Licensor for its reasonable out-of-pocket costs and
expenses incurred in performing the review.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.<B>&nbsp;CONSIDERATION
SHARES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1.
<B>Issue of Shares. </B>In consideration for granting of the license pursuant to clause 2 above, upon signing of the Agreement,
TIZIANA will pay to NMS the additional amount of &pound;2,137,976.08 which shall only be payable by TIZIANA allotting and NMS
subscribing for 4,233,616 ordinary shares with nominal value of three pence each in the share capital of TIZIANA <B>(&ldquo;Shares&rdquo;)
(being equivalent </B>to five percent (5%) of the entire issued share capital). The Shares shall be issued fully paid and free
of liens and encumbrances (other than the restrictions as set out in this Agreement) and shall rank <I>pari passu </I>with all
other ordinary shares in the share capital of TIZIANA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 5.2. <B>Restrictions
on Transfer. </B>Prior to a Release Event:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2.1.
NMS agrees that it shall not transfer, dispose of, or grant options or other rights (including any grant or right of security)
over directly or indirectly any interest in the Shares (or, as the case may be, Substitute Interests);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2.2.
NMS acknowledges that it shall derive no financial benefit from the Shares (or, as the case may be, Substitute Interests) prior
to a Release Event and to the extent it receives any dividend or capital from the Shares it shall hold such interest in trust
for the benefit of itself (following a Release Event other than the exercise of the Option) or TIZIANA (following the exercise
of the Option);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2.3.
NMS shall be entitled to exercise all voting rights arising from the Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.05in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3. <B>Restrictions
following a Release Event. </B>Following a Release Event the restrictions in clause 5.2 shall cease to apply to the Shares
and NMS undertakes that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.05in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3.1.
for a period of 12 months following a Release Event it shall not directly or indirectly, transfer, sell, mortgage, charge, assign,
issue options in respect of, or otherwise dispose of or announce an offering or transfer of the legal and/or beneficial ownership
of or any other interest in the Shares (or, as the case may be, Substitute Interests) other than:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)&nbsp;with
the prior written consent of TIZIANA and TIZIANA&rsquo;s nominated adviser from time to time (which consent may be refused, provided
or provided subject to such conditions as each may determine in its absolute discretion);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)&nbsp;in
the acceptance of any takeover bids;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)&nbsp;pursuant
to an offer by TIZIANA to purchase its own shares; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)&nbsp;where
required by law; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3.2.
it will not directly or indirectly, transfer, sell, mortgage, charge, or otherwise dispose of:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)&nbsp;more
than 10% of the Shares (i.e. 423,362 ordinary shares) per calendar month; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)&nbsp;the
legal and/or beneficial ownership of or any other interest in any of the Shares (or, as the case may be, Substitute Interests)
owned by NMS (or in which NMS is otherwise interested), other than through TIZIANA&rsquo;s broker from time to time <B>(&ldquo;Broker&rdquo;)
</B>and in accordance with the reasonable requirements of the Broker so as to ensure an orderly market for the issued share capital
of TIZIANA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4.
<B>Trade sale.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4.1.
In the event there is an acquisition of the entire issued share capital of TIZIANA prior to a Release Event, then the consideration
which would otherwise be due to NMS if the Shares were unrestricted will be held in escrow (the <B>&ldquo;Escrowed Amount&rdquo;)
</B>by a 3rd party acceptable to both Parties and will be payable to NMS (following a Release Event other than the exercise of
the Option) or to the shareholders of TIZIANA (other than NMS) at the time of the Trade Sale pro rata to their shareholding (if
the Option would have become exercisable).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.6in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4.2.
In the event of a takeover which results in the Shares held by NMS being exchanged for Substitute Interests (which shall include
any shares in a proposed purchaser <B>(&ldquo;Proposed Purchaser&rdquo;) </B>that may be issued to NMS in connection with the acquisition
of TIZIANA), such Substitute Interests shall for the purposes of this Agreement be deemed to form part of the Shares held by NMS,
and this Agreement shall apply in respect of the Substitute Interests in the same manner as they would otherwise apply to the
Shares (with any necessary modifications). Thereafter, references in this clause 5 to TIZIANA shall, <I>mutatis mutandis, </I>be
deemed to be references to the Proposed Purchaser to the extent the context allows.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 5.5. <B>Option.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.5.1.
NMS grants to TIZIANA an option <B>(&ldquo;Option&rdquo;) </B>to purchase all of the Shares and any Substitute Interests (together
<B>&ldquo;Option Shares&rdquo;) </B>on the terms and conditions as set out in this clause 5.5 and subject to the authorization of
the terms of this agreement by a resolution of TIZIANA&rsquo;s shareholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.5.2.
The Option shall be exercisable by written notice to be given by TIZIANA <B>(&ldquo;Option Notice&rdquo;) </B>at any time after
the earlier of:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
unsuccessful Phase II Trial for Hepatocellular Carcinoma or an unsuccessful Phase II Trial for Breast Cancer with a Licensed Product
and the concomitant decision of TIZIANA, its Affiliates and sublicensees, as the case may be, to discontinue any development of
a Licensed Product; or</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.45in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         fifth anniversary of the date of this Agreement, provided that if on such date a Phase
                                         II Trial has commenced but not been completed, the ability of TIZIANA to exercise the
                                         Option shall be delayed until the outcome of the Phase II Trial has become clear; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.45in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         abandonment by Tiziana of development of any Licensed Product, where such abandonment
                                         or failure to progress development occurs for bona fide scientific reasons.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.45in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.5.3.
The Option shall not be exercisable following a Release Event.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2.9in; text-indent: -1.95in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2.9in; text-indent: -1.95in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2.9in; text-indent: -1.95in">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.5.4.
The price payable by TIZIANA to NMS upon exercise of the Option shall be &pound;1 <B>(&ldquo;Purchase Price&rdquo;)</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.5.5.
Upon the exercise of the Option, TIZIANA shall be bound to buy and NMS shall be bound to sell the Option Shares for the Purchase
Price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.5.6.
Completion of the sale and purchase of the Option Shares <B>(&ldquo;Option Completion&rdquo;) </B>shall take place at the registered
office of TIZIANA (or at such other place as may be agreed between the Parties) on the fifth business day after the receipt (or
deemed receipt) by NMS of the Option Notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.5.7.
On Option Completion:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)&nbsp;NMS
shall:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1.5in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">transfer
                                         or procure the transfer of the Option Shares to TIZIANA;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2.05in; text-indent: -0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1.5in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">deliver
                                         all relevant share certificates and other documents of title in respect of the Option
                                         Shares to TIZIANA;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2.05in; text-indent: -0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1.5in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">use
                                         its reasonable endeavors to procure registration of the transfers of the Option Shares
                                         forthwith (subject to the transfer being stamped with any necessary stamp duty at the
                                         expense of TIZIANA); and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2.05in; text-align: justify; text-indent: -0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1.5in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">do
                                         such things and execute such documents as shall be necessary or as TIZIANA may request
                                         to give effect to the sale of the Option Shares; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2.05in; text-align: justify; text-indent: -0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)&nbsp;TIZIANA
shall, subject to applicable law:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1.5in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">pay
                                         the Purchase Price to NMS; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2.05in; text-indent: -0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1.5in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">return
                                         all rights in and to the Licensed Product to NMS.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2.05in; text-indent: -0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.6in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.6.&nbsp;<B>Return
of the Licensed Product</B>. In the event of TIZIANA&rsquo;s abandonment of development of a Licensed Product for any reason,
then all rights in and to the Licensed Product shall be returned to NMS and consequences of termination as per section 10 of the
Agreement shall apply.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.&nbsp;<B>TREATMENT
OF CONFIDENTIAL INFORMATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1.&nbsp;<B>Confidential
Obligations. </B>Licensor and Licensee each recognize that the other Party&rsquo;s Confidential Information constitutes highly
valuable and proprietary confidential information. Licensor and Licensee each agree that during the Term and for five (5)
years thereafter, it will keep confidential, and will cause its employees, consultants (including academic collaborators,
CROs and manufacturers), professional advisors, Affiliates and, in the case of Licensee, Sublicensees to keep confidential,
all Confidential Information of the other Party. Neither Licensor nor Licensee nor any of their respective employees,
consultants, Affiliates or, in the case of Licensee, Sublicensees, shall use any Confidential Information of the other Party
for any purpose whatsoever other than exercising any rights granted to it or reserved by it hereunder or as expressly
permitted in this Article 6. Licensee may disclose Licensor&rsquo;s Confidential Information to the extent such disclosure is
reasonably necessary to file and prosecute patent applications and/or maintain patents which are filed or prosecuted in
accordance with the provisions of this Agreement, or to obtain any authorization to conduct clinical studies or any
regulatory approval for Licensed Products. Each Party may disclose the other Party&rsquo;s Confidential Information as reasonably
necessary to file, conduct or defend litigation in accordance with the provisions of this Agreement or comply with applicable
laws, regulations or court orders; provided, however, that if a Party is required to make any such disclosure of the other
Party&rsquo;s Confidential Information in connection with any of the foregoing, it will give reasonable advance notice to the other
Party of such disclosure requirement and will use reasonable efforts to assist such other Party in efforts to
secure confidential treatment of such information required to be disclosed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.2.&nbsp;<B>Limited
Disclosure and Use. </B>Each Party may disclose the other Party&rsquo;s Confidential Information to any of its officers, employees,
consultants, agents or Affiliates, or in the case of Licensee, Sublicensees, if and only to the extent necessary to carry out
its rights and responsibilities under this Agreement. Such disclosures shall be limited to the maximum extent possible
consistent with such rights and responsibilities and shall only be made to the extent any such persons receiving the other
Party&rsquo;s Confidential Information are bound by written confidentiality obligations to maintain the confidentiality thereof and
not to use such Confidential Information except as expressly permitted by this Agreement. Licensor and Licensee each agree
not to disclose or transfer the other Party&rsquo;s Confidential Information to any Third Parties under any circumstance without
the prior written approval from the other Party, except as otherwise required by law, and except as otherwise expressly
permitted under this Article 6 or elsewhere in this Agreement. Each Party shall take such action, and shall cause its
Affiliates, and in the case of Licensee, Sublicensees, to take such action, to preserve the confidentiality of each other&rsquo;s
Confidential Information as it would customarily take to preserve the confidentiality of its own Confidential Information,
using, in all such circumstances, not less than reasonable care. Each Party, upon the request of the other Party, will return
all the Confidential Information disclosed or transferred to it by the other Party pursuant to this Agreement, including all
copies and extracts of documents and all manifestations in whatever form, in such Party&rsquo;s possession within sixty (60) days
of such request or, if earlier, the termination or expiration of this Agreement; provided however, that a Party may retain
(a) any Confidential Information of the other Party relating to any license that is still in force hereunder or which
expressly survives such termination, and (b) one (1) copy of all other Confidential Information in inactive archives solely
for the purpose of establishing the contents thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.3.&nbsp;<B>Terms
of Agreement. </B>The terms of this Agreement constitute each Party&rsquo;s Confidential Information; provided, however, that
either Party may disclose the terms of this Agreement (a) to the extent required by law or by the requirements of any
nationally recognized securities exchange, quotation system or over-the-counter market on which such Party has its securities
listed or traded, or (b) in confidence to its attorneys, accountants and other fiduciaries, and (c) to any acquirers,
potential acquirers, investors, prospective investors, lenders and other potential financing sources who are obligated by
contract to keep such information confidential.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.4.&nbsp;<B>Press
Release. </B>The Parties shall diligently work together to draft a mutually agreeable press release announcing the execution of
this Agreement, and shall publish such press release in a mutually agreeable manner no later than 07:00 UK time on the day after
the Effective Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.&nbsp;<B>FILING,
PROSECUTION AND MAINTENANCE OF PATENT RIGHTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.1.<B>&nbsp;Patent
Prosecution Control. </B>For purposes of this Article, the right to control prosecution of a Patent Right shall include the right
to control preparing, filing, and prosecuting patent applications therefor, and obtaining and maintaining any resulting patents,
including the conduct of interferences, the defense of oppositions and other similar proceedings with respect to a patent. After
the successful payment of the first and second installment of the Upfront Payment as per Section 16 above, TIZIANA shall have
the diligent obligation and primary responsibility, for the preparation, filing, prosecution, maintenance and enforcement of the
Licensed Technology, at its own expense and using attorneys of its choice. For the avoidance of doubt, the diligent obligation
and primary responsibility remains with NMS prior to the payment of the second installment. NMS will have the opportunity to review
and provide comment on any such prosecution in advance of filing any paper in a patent office.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.2.&nbsp;<B>Patent
Enforcement. </B>If, during the Term, either Party learns of any actual, alleged or threatened infringement by a Third Party of
any Licensed Patents, such Party shall promptly notify the other Party and shall provide the other Party with available evidence
of such infringement. TIZIANA shall have the first right (but not the obligation), at its own expense and with legal counsel of
its own choice, to bring suit (or take other appropriate legal action) against any actual, alleged or threatened infringement
of the Licensed Technology by any product or service that competes with a Licensed Product, as reasonably determined by TIZIANA.
NMS shall take all actions necessary to assist Licensee in any suit, including joining in such suit as a party if legally required.
NMS shall have the right, at its own expense, to be represented in any such action by counsel of NMS&rsquo;s own choice; provided, however,
that the foregoing shall not affect the right of TIZIANA to control the suit. If TIZIANA exercises its right to sue, out of any
sums recovered in such suit or in settlement thereof for all costs and expenses of every kind and character, including reasonable
attorneys&rsquo; fees, necessarily incurred in the prosecution of any such suit it shall first reimburse each Party&rsquo;s costs incurred.
If, after such reimbursement, any funds shall remain from said recovery, then NMS shall receive an amount equal to ten percent
(10%) of such funds and the remaining ninety percent (90%) of such funds shall be retained by TIZIANA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.&nbsp;<B>REPRESENTATIONS
AND WARRANTIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1.<B>&nbsp;Licensor
Representations. </B>Licensor represents, warrants and covenants to Licensee that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;the
execution and delivery of this Agreement and the performance of the transactions contemplated hereby have been duly authorized
by all appropriate Licensor corporate action;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;this
Agreement is a legal and valid obligation binding upon Licensor and enforceable in accordance with its terms, and the execution,
delivery and performance of this Agreement by the Parties does not conflict with any agreement, instrument or understanding to
which Licensor is a party or by which it is bound;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&nbsp;Licensor
has the full right and legal capacity to grant the rights granted to Licensee hereunder;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&nbsp;the
Licensed Patents have been properly filed and prosecuted as of the Effective Date;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)&nbsp;Licensor
and its Affiliates is the sole owner of the entire right, title and interest in and to the Licensed Patents and no other party
has any right, title or interest in and to the Licensed Patents;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)&nbsp;as
of the Effective Date, Licensor has not licensed to any Third Party any rights under the Licensed Patents;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)&nbsp;Licensor
is not aware of any Third Party patent, patent application or other intellectual property right that would be infringed (i) by
practicing any process or method or by making, using or selling any composition which is claimed or disclosed in, or which constitutes,
Licensed Patents, or (ii) by making, using, offering for sale, selling or importing Licensed Products; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)&nbsp;Licensor
is not aware of any infringement or misappropriation by a Third Party of the Licensed Patents as of the Effective Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.6in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2.&nbsp;<B>Licensee
Representations. </B>Licensee represents and warrants to Licensor that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2.1.
the execution and delivery of this Agreement and the performance of the transactions contemplated hereby have been duly authorized
by all appropriate Licensee corporate action; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2.2.
this Agreement is a legal and valid obligation binding upon Licensee and enforceable in accordance with its terms, and the execution,
delivery and performance of this Agreement by the Parties does not conflict with any agreement, instrument or understanding to
which Licensee is a party or by which it is bound.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.3.&nbsp;<B>No
Warranties. </B>Except as expressly set forth in this Agreement, NEITHER PARTY MAKES ANY REPRESENTATION OR EXTENDS ANY
WARRANTIES OF ANY KIND, EITHER EXPRESS OR IMPLIED. THERE ARE NO EXPRESS OR IMPLIED WARRANTIES OF MERCHANTABILITY OR FITNESS
FOR A PARTICULAR PURPOSE, OR OF NON-INFRINGEMENT OF ANY PATENT, COPYRIGHT, TRADEMARK, OR OTHER RIGHTS OF THIRD PARTIES, OR AS
TO THE SUCCESS OR LIKELIHOOD OF SUCCESS OF THE RESEARCH, DEVELOPMENT OR COMMERCIALIZATION OF LICENSED PRODUCTS UNDER THIS
AGREEMENT, OR ANY OTHER EXPRESS OR IMPLIED WARRANTIES.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.&nbsp;<B>INDEMNIFICATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.1.&nbsp;<B>Indemnification
by Licensee. </B>Licensee shall indemnify, defend and hold harmless the Licensor Indemnitees from and against any and all
losses, damages, fees, expenses, settlement amounts and costs (including reasonable attorneys&rsquo; fees and witness fees)
(collectively, &ldquo;<U>Losses</U>&rdquo;) relating to or in connection with a Third Party claim arising after the Effective
Date out of (a) any breach by Licensee of its representations, warranties or covenants made under this Agreement, or (b) any
actual or alleged death, personal bodily injury or damage to real or tangible personal property claimed to result, directly
or indirectly, from the possession, use or consumption of, or treatment with, the Licensed Product made or sold by or on
behalf of Licensee or its Affiliates or Sublicensees, including any product liability claims; provided, however, that the
foregoing indemnity shall not apply to the extent that any such Losses (i) are attributable to the negligence or willful
misconduct of the Licensor Indemnitees, or (ii) are subject to an obligation by Licensor to indemnify the Licensee
Indemnitees under Section 9.2. For the avoidance of doubt, Licensee shall not indemnify Licensor for any activities,
including clinical trial activities, carried out by Licensor or Licensor&rsquo;s agents prior to the Effective Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.2.&nbsp;<B>Indemnification
by Licensor. </B>Licensor shall indemnify, defend and hold harmless the Licensee Indemnitees from and against any and all Losses
relating to or in connection with a Third Party claim arising after the Effective Date out of (a) any breach by Licensor of its
representations, warranties or covenants made under this Agreement, or (b) any negligent act or omission or willful misconduct
of Licensor or its Affiliates or its or their sublicensees, or any of their employees, contractors or agents, in performing Licensor&rsquo;s
obligations or exercising Licensor&rsquo;s rights under this Agreement; provided, however, that the foregoing indemnity shall not apply
to the extent that any such Losses are attributable to (i) the negligence or willful misconduct of the Licensee Indemnitees, or
(ii) are otherwise subject to an obligation by Licensee to indemnify the Licensor Indemnitees under Section 9.1. For the avoidance
of doubt, Licensor shall not indemnify Licensee for any activities, including clinical trial activities, carried out by Licensee
or Licensee&rsquo;s agents after the Effective Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.&nbsp;<B>TERM
AND TERMINATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1.
<B>Term; Expiration. </B>Unless earlier terminated in accordance with this Article, the term of this Agreement (the &ldquo;<U>Term</U>&rdquo;)
shall commence as of the Effective Date and remain in force until the Royalty Term has expired with respect to all Licensed Products
in all countries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2.
<B>Termination During Exclusivity Term. </B>During the Exclusivity Term, TIZIANA will have the right to terminate activities and
funding after 24 months from the beginning of the Exclusivity Term but not prior thereto. In the event of termination under these
circumstances, TIZIANA will agree to transfer to NMS relevant data and Licensed Products and grant NMS an exclusive license, with
the right to sublicense, under the TIZIANA Patents and other patents controlled by TIZIANA that cover the Licensed Product (&ldquo;TIZIANA
Project Patents&rdquo;) that are necessary to develop, make, use, sell, offer for sale, or import Licensed Products. In such a
case, NMS shall pay TIZIANA a 1.5% royalty on annual net sales of Licensed Products where the sale of such Licensed Product would
infringe a valid, issued claim within TIZIANA Project Patents in the country of sale. The royalty term will begin upon the first
commercial sale of such Licensed Product and will extend on a Licensed Product-by-Licensed Product basis and on a country-by-country
basis until the expiration of the last to expire Valid Claim under the TIZIANA Project Patents covering such Licensed Product
in the country of sale.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3.
<B>Voluntary Termination. </B>After the Exclusivity Term has expired, Licensee may terminate this Agreement at any time upon ninety
(90) days&rsquo; notice to Licensor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4.
<B>Termination for Breach. </B>Subject to the other terms of this Agreement, this Agreement and the rights granted herein may
be terminated by either Party for the material breach by the other Party of any material obligation or condition hereof, provided
that the breaching Party has not cured such breach within forty-five (45) days after the date of written notice to the breaching
Party in the case of a payment breach and one hundred twenty (120) days after the date of written notice to the breaching Party
in the case of any other breach, which notice shall describe such breach in reasonable detail and shall state the non-breaching
Party&rsquo;s intention to terminate this Agreement pursuant to this Section. In the case of the uncured material breach by Licensee,
Licensor shall in its notice of termination, indicate its intention to elect its remedy under Section 10.6 below. In the case
of uncured material breach by Licensor, Licensee shall in its notice of termination, indicate its intention to either terminate
this Agreement or elect its alternative remedy pursuant to Section 10.10.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5.
<B>Termination for Bankruptcy of Licensee or Licensor. </B>In the event Licensee declares bankruptcy or otherwise becomes insolvent,
then the Agreement shall terminate, subject to the provisions of section 10.6 and all rights shall revert to Licensor. In the
event Licensor declares bankruptcy or otherwise becomes insolvent, then the Licensed Patents shall be assigned to Licensee and
Licensee shall continue to make any payments under this Agreement to the Trustee in bankruptcy for the benefit of NMS.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6.
<B>Effects of Expiration or Termination for Breach and Termination by Tiziana after the Development Term. </B>If (a) NMS terminates
for an uncured material breach by TIZIANA, or (b) after the Exclusivity Term ends TIZIANA voluntarily terminates activities and
funding on a Licensed Product, TIZIANA will agree to transfer to NMS relevant data (including all preclinical and clinical data
generated by or for TIZIANA), regulatory filings and Licensed Product and grant NMS an exclusive license, with right to sublicense,
under Licensed Patents, TIZIANA Project Patents and, to the extent invented as a direct result of performing activities under
the Agreement or actually used or embodied in the Reversion Products at the time of termination, other intellectual property controlled
by TIZIANA that covers the Reversion Product (as defined below) (and a non-exclusive license under any patents controlled by TIZIANA
that cover the applicable Licensed Product) that is necessary to develop, make, use, sell, offer for sale or import only Reversion
Products. In addition, at the time of transfer of the Reversion Product to NMS, TIZIANA will agree to negotiate in good faith
a license to other intellectual property owned or controlled by TIZIANA necessary to make, use, sell, offer for sale, or import
such Reversion Product in its then current form. TIZIANA shall also wind down all pending clinical trials, transfer, if applicable,
the manufacturing processes for the Reversion Product and, subject to commercially reasonable compensation, supply Reversion Products
for a transition period to be negotiated in good faith by the Parties. &ldquo;Reversion Product&rdquo; means all Licensed Products
that were being developed or commercialized by TIZIANA at the time of termination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 0.55in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NMS
shall pay TIZIANA a royalty on its net sales of Reversion Products as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: right; border-bottom: Black 1.5pt solid; padding: 0; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Development
Status at Termination</B></FONT></P></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Royalty Rate</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0">Prior to commencement of a Phase II clinical trial</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">none</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 88%; text-align: left; padding: 0; text-indent: 0">Prior to commencement of a Phase III or other pivotal clinical trial</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">1.5</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0">After commencement of a Phase III or other pivotal clinical trial</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.0</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
NMS reasonably believes in good faith, as evidence primarily by documents from regulatory agencies, or by documents from
independent experts chosen by both parties, that the results of TIZIANA&rsquo;s development reasonably require that portions of
such development efforts must be redone to bring such Licensed Product to the development stage it achieved when applying
industry standards, the parties shall negotiate in good faith an equitable adjustment of the applicable royalty rate to take
into account the value that must be recreated by NMS by redoing such development efforts. One example of the foregoing is a
product that completed Phase II, but adverse events require reformulating the product or using a different dosing regimen and
NMS must develop such formulation and redo the Phase II trials. The royalty term will begin upon the first commercial sale of
such Reversion Product and will extend on a Licensed Product-by-Licensed Product basis and on a country-by-country basis
until the expiration of the last to expire Valid Claim under the Licensed Intellectual Property or TIZIANA Project Patents
covering such Licensed Product in the country of sale.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.7.
<B>Survival of Sublicenses. </B>Notwithstanding anything to the contrary, no termination of this Agreement shall be construed
as a termination of any sublicense of any Sublicensee, and thereafter each such Sublicensee shall be considered a direct licensee
of Licensor, provided that (i) Licensee represents and warrants to Licensor that, to Licensee&rsquo;s actual knowledge, as of the effective
date of such termination, such Sublicensee is then in full compliance with all terms and conditions of its sublicense, (ii) such
Sublicensee agrees in writing to assume all applicable obligations of Licensee under this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.8.
<B>Remedies</B>. Except as otherwise expressly set forth in this Agreement, the termination provisions of this Article are in
addition to any other relief and remedies available to either Party at law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.9.
<B>Surviving Provisions</B>. Notwithstanding any provision herein to the contrary, the rights and obligations of the Parties set
forth in Articles and Sections 1 (Definitions), 4.5 (Records Retention by Licensee; Review), 6 (Treatment of Confidential Information),
8 (Representations and Warranties), 9 (Indemnification), 10.6 (Effects of Expiration or Termination), 10.7 (Survival of Sublicensees),
10.8 (Remedies), 10.9 (Surviving Provisions), and <U>0</U><STRIKE>11</STRIKE> (Miscellaneous) as well as any rights or obligations
otherwise accrued hereunder (including any accrued payment obligations), shall survive the expiration or termination of the Term.
Without limiting the generality of the foregoing, Licensee shall have no obligation to make any milestone or royalty payment to
Licensor that has not accrued prior to the effective date of any termination of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.10.
<B>Remedy in Lieu of Termination. </B>If Licensor materially breaches or defaults with respect to any material obligation or condition
of this Agreement and fails to cure such breach or default within one hundred twenty (120) days after receipt of written notice
from Licensee that describes such breach in reasonable detail, Licensee may reduce each of its payment obligations under this
Agreement by fifty percent (50%), which reduction shall be effective with respect to any payment obligations that come due on
or after the first day following such one hundred twenty (120) day cure period. The foregoing shall be in lieu of any right of
termination of this Agreement, if any, for such material breach or default, but in any event will be without prejudice to any
other right or remedy that may be available to Licensee under this Agreement or at law or in equity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.
<B>MISCELLANEOUS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.1.
<B>Notices</B>. All notices, requests and other communications hereunder shall be in writing, shall be addressed to the receiving
Party&rsquo;s address set forth below or to such other address as a Party may designate by notice hereunder, and shall be either (i)
delivered by hand, (ii) made by email transmission (to be followed with written postal confirmation), (iii) sent by private courier
service providing evidence of receipt, or (iv) sent by registered or certified mail, return receipt requested, postage prepaid.
The addresses and other contact information for the Parties are as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
to Licensor: Nerviano Medical Sciences S.r.L.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Viale
Pasteur, 10</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20014
Nerviano (MI) Italy</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone
+ 390331581111</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fax +
390331581753</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.8in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 1in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If to
Licensee:</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Tiziana Life Sciences</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone:
+44 (0)20 7493 2853</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Fax: +44 (0) 20 7495 2379</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
notices, requests and other communications hereunder shall be deemed to have been given either (i) if by hand, at the time of
the delivery thereof to the receiving Party at the address of such Party set forth above, (ii) if made by telecopy or email transmission,
at the time that receipt thereof has been acknowledged by the recipient, (iii) if sent by private courier, on the day such notice
is delivered to the recipient, or (iv) if sent by registered or certified mail, on the seventh (7th) business day following the
day such mailing is made.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.2.
<B>Language. </B>The Parties hereto have requested that this Agreement and any related documents be drafted in English, which
shall be controlling for all purposes. Any translation of this Agreement or any part hereof into a language other than English
is for convenience only, and only the original English language version of this Agreement, as it may be amended from time to time
as permitted herein, shall have legal effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.3.
<B>Governing Law. </B>This Agreement will be construed, interpreted and applied in accordance with the laws of England and Wales
(excluding any body of law controlling conflicts of law). The UN Convention for the International Sale of Goods shall not apply
to this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.4. <B>Venue. </B>Any
dispute, controversy or claim initiated by either Party arising out of, resulting from or relating to this Agreement, or the
performance by either Party of its obligations under this Agreement, whether before or after termination of this
Agreement, shall be subject to the sole jurisdiction of, and venue in, the courts of competent jurisdiction located within
England and Wales. Licensee and Licensor each irrevocably consent to the jurisdiction of such courts, irrevocably waive any
objection based on inconvenience of forum, and agree that process may be served in the manner provided herein for giving
notices or otherwise as allowed by applicable English law. Notwithstanding the foregoing, either Party shall have the right,
without waiving any right or remedy available to such Party under this Agreement or otherwise, to seek and obtain from any
court of competent jurisdiction any Interim or provisional relief that is necessary or desirable to protect the rights or
property of such Party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.05in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.05in"></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.05in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.5.
<B>Entire Agreement; Amendment. </B>This Agreement comprises the entire Agreement between the Parties with respect to the subject
matter hereof and thereof and supersede all prior representations, understandings and agreements between the Parties with respect
to the subject matter hereof. No modification shall be effective unless in writing with specific reference to this Agreement and
signed by the Parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.6.
<B>Assignment. </B>This Agreement may not be assigned by either Party without the prior written consent of the other Party, which
shall not be unreasonably withheld. Notwithstanding the foregoing, Licensee may, without the written consent of Licensor, assign
this Agreement (i) in whole or in part to an Affiliate for any reason and (ii) in whole or in part, and its rights and delegate
its obligations hereunder to its Affiliates, in connection with a transfer of substantially all the assets to which this Agreement
pertains, for in the event of its merger, consolidation, change in control or similar transaction. Any permitted assignee shall
assume all obligations of its assignor under this Agreement. The terms and conditions of this Agreement shall be binding upon
and inure to the benefit of the permitted successors and assigns of the Parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.7.
<B>Force Majeure. </B>Neither Party shall be liable for failure of or delay in performing obligations set forth in this Agreement,
and neither shall be deemed in breach of its obligations, if such failure or delay is due to natural disasters or any causes beyond
the reasonable control of such Party. In event of such force majeure, the Party affected thereby shall use reasonable efforts
to cure or overcome the same and resume performance of its obligations hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.8.
<B>Construction. </B>The Parties hereto acknowledge and agree that: (i) each Party and its counsel reviewed and negotiated the
terms and provisions of this Agreement and have contributed to its revision; (ii) the rule of construction to the effect that
any ambiguities are resolved against the drafting Party shall not be employed in the interpretation of this Agreement; and (iii)
the terms and provisions of this Agreement shall be construed fairly as to all Parties hereto and not in favor of or against any
Party, regardless of which Party was generally responsible for the preparation of this Agreement. In this Agreement: (a) the word
&ldquo;including&rdquo; shall be deemed to be followed by the phrase &ldquo;without limitation&rdquo; or like expression; (b)
the singular shall include the plural and vice versa; (c) masculine, feminine and neuter pronouns and expressions shall be interchangeable,
(d) all references to &ldquo;days&rdquo; means &ldquo;calendar days&rdquo; unless expressly stated to be &ldquo;business days,&rdquo;
and (e) all references to dollars or $ are to United States dollars, whether or not so expressly stated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.9. <B>Severability. </B>If
any provision(s) of this Agreement are or become invalid, are ruled illegal by any court of competent jurisdiction or are
deemed unenforceable under then-current applicable law from time to time in effect during the Term hereof, it is the
intention of the Parties that such provision(s) be deemed to be severed from this Agreement and the remainder of
this Agreement shall not be affected thereby. The Parties hereto agree to renegotiate any such severed provision in good
faith in order to provide a reasonably acceptable, valid alternative to the severed provision, it being the intent of the
Parties that the basic purposes of this Agreement are to be effectuated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.10.
<B>Status. Further Assurances. </B>Each Party agrees to execute, acknowledge and deliver such further instructions, and to do
all such other acts, as may be necessary or appropriate in order to carry out the purposes and intent of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.11.
<B>Counterparts. </B>This Agreement may be executed simultaneously in one or more counterparts, each of which shall be deemed
an original, but all of which together shall constitute one and the same instrument.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">[Remainder of page intentionally left blank]</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Parties have executed this Agreement effective as of the Effective Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.15in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.15in; text-indent: 0.5in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding: 0; text-indent: 0">NERVIANO MEDICAL SCIENCES</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 0; text-indent: 0">TIZIANA LIFE SCIENCES</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0; width: 5%">By:</TD>
    <TD STYLE="padding: 0; border-bottom: Black 1.5pt solid; text-indent: 0; width: 35%">/s/ Marco A. Pierotti</TD>
    <TD STYLE="padding: 0; text-indent: 0; width: 20%">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; width: 5%">By:</TD>
    <TD STYLE="padding: 0; border-bottom: Black 1.5pt solid; text-indent: 0; width: 35%">/s/ Gabriele Cerrone</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">Name:&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">Dr. MARCO A. PIEROTTI</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">Name&nbsp;:</TD>
    <TD STYLE="padding: 0; text-indent: 0">Gabriele Cerrone</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">Title:</TD>
    <TD STYLE="padding: 0; text-indent: 0">President and Chief Executive Officer</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">Title:</TD>
    <TD STYLE="padding: 0; text-indent: 0">Chairman</TD></TR>

<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">Date:</TD>
    <TD STYLE="padding: 0; text-indent: 0">22 December 2014</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">Date:</TD>
    <TD STYLE="padding: 0; text-indent: 0">January 19<SUP>th</SUP> 2015</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.15in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.15in; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Schedule
A &mdash; Licensed Patents</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I><U>Case
Number: 1079 NMS</U></I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Owner:
</I></B>NERVIANO MEDICAL SCIENCES S.r.l.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Title:
</I></B>PYRAZOLO-QUINAZOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS KINASE INHIBITORS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Priority:</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 32%; padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Country </I></B></FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 32%; padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Application Number </I></B></FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 32%; padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Filing Date</I></B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">United States of America </FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">60/472661</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22-May-2003</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;<BR>
<B><I>Foreseen Expiry: </I></B>2024</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.6in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Abstract:</I></B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pyrazolo-quinazoline
derivatives of formula (Ia) or (Ib) as defined in the specification, and pharmaceutically acceptable salts thereof, process for
their preparation and pharmaceutical compositions comprising them are disclosed; the compounds of the invention may be useful,
in therapy, in the treatment of diseases associated with a disregulated protein kinase activity, like cancer.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.85in; text-align: justify; text-indent: -0.85in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Inventors:</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TRAQUANDI,
GABRIELLA</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BRASCA,
MARIA GABRIELLA</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">D&rsquo;ALESSIO,
ROBERTO</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">POLUCCI, PAOLO</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">ROLETTO, FULVIA</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">VULPETTI, ANNA</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PEVARELLO,
PAOLO</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PANZERI,
ACHILLE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">QUARTIERI, FRANCESCA</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">FERGUSON, RONALD DALE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">VIANELLO, PAOLA</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">FANCELLI, DANIELE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><B>Country Exp.date</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; vertical-align: bottom"><B>Status</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><B>AppNumber</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><B>FilDate</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><B>PatNumber</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><B>IssDate</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>African Regional Industrial</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: bottom">Granted</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">AP/P/2005/003452</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">4/27/2004</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; vertical-align: bottom">AP 2064</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">10/30/2009</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">4/27/2024</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Property Organization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 33%; text-align: left">African Union Territories (OAPI)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: center; vertical-align: bottom">&nbsp;</TD><TD STYLE="width: 9%; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD><TD STYLE="width: 9%; text-align: center">1200500329</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD><TD STYLE="width: 9%; text-align: center">4/27<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/2004</FONT></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD><TD STYLE="width: 9%; text-align: center">13170</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD><TD STYLE="width: 9%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6/30/2006</FONT></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD><TD STYLE="width: 9%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2024</FONT></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Algeria</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">050451</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">5017</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10/25/2009</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2024</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Antigua and Barbuda</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pending</FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">3/2005</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11/21/2005</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Argentina</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Published</FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">P040101748</FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5/20/2004</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Armenia</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">200501849</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">010904</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8/29/2008</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2024</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Australia</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">2004240772</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">2004240772</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8/11/2011</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2024</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Austria</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">04741483.4</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">1636236</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10/9/2013</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">4/27<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/2024</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Azerbaijan</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">200501849</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">010904</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8/29/2008</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2024</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Barbados</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pending</FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">2001/1177</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">4/27<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/2004</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>

<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 33%">Belarus</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD><TD STYLE="width: 9%; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD><TD STYLE="width: 9%; text-align: center">200501849</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD><TD STYLE="width: 9%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD><TD STYLE="width: 9%; text-align: center">010904</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD><TD STYLE="width: 9%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8/29/2008</FONT></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD><TD STYLE="width: 9%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2024</FONT></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Belgium</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">04741483.4</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">1636236</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10/9/2013</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2024</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Bosnia and Herzegovina</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BAP052273A</FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BAP052273</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9/30/2009</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2024</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Brazil</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Published</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PI0410563-0</FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Bulgaria</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">04741483.4</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">1636236</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10/9/2013</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2024</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Canada</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">2526578</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">2,526,578</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1/24/2012</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2024</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Chile</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Abandoned</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1173-2004</FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5/20/2004</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">China (People&rsquo;s Republic)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Abandoned</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">200480021075.2</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">China (People&rsquo;s Republic)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Abandoned</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">201010586319.9</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Colombia</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">05.118.410</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">1212</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5/16/2011</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2024</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Costa Rica</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">8102</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">2799</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11/30/2011</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5/22/2023</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Costa Rica</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pending</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2011-81</FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/11/2011</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Croatia</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">P20050967A</FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">P20050967</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3/13/2014</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2024</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Cuba</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">2005/0228</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">23596</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10/8/2010</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2024</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Cyprus, Republic of</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">04741483.4</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">1636236</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10/9/2013</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2024</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Czech Republic</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">04741483.4</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">1636236</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10/9/2013</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2024</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Denmark</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">04741483.4</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">1636236</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10/9/2013</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2024</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>


<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Ecuador</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: bottom">Granted</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: bottom">SP-05-6194</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">11/30/2005</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: bottom">PI 13-2117</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">9/30/2013</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">4/27/2024</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 33%">Egypt</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 1%">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom; width: 9%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pending</FONT></TD><TD STYLE="text-align: left; width: 1%">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 1%">&nbsp;</TD><TD STYLE="text-align: center; width: 9%">749/2005</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 1%">&nbsp;</TD><TD STYLE="text-align: center; width: 9%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11/22/2005</FONT></TD><TD STYLE="text-align: left; width: 1%">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 1%">&nbsp;</TD><TD STYLE="text-align: center; width: 9%">&nbsp;</TD><TD STYLE="text-align: left; width: 1%">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 1%">&nbsp;</TD><TD STYLE="text-align: center; width: 9%">&nbsp;</TD><TD STYLE="text-align: left; width: 1%">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 1%">&nbsp;</TD><TD STYLE="text-align: center; width: 9%">&nbsp;</TD><TD STYLE="text-align: left; width: 1%">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 23; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Sch A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="border-bottom: Black 1.5pt solid; background-color: White; font-family: Times New Roman, Times, Serif; width: 32%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Country
    Exp.date</B></FONT></TD><TD STYLE="background-color: White; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="text-align: left; background-color: White; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD><TD STYLE="text-align: center; vertical-align: bottom; border-bottom: Black 1.5pt solid; background-color: White; font-family: Times New Roman, Times, Serif; width: 9%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Status</B></FONT></TD><TD STYLE="text-align: left; background-color: White; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="text-align: left; background-color: White; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD><TD STYLE="text-align: center; border-bottom: Black 1.5pt solid; background-color: White; font-family: Times New Roman, Times, Serif; width: 9%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AppNumber</B></FONT></TD><TD STYLE="background-color: White; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="text-align: center; background-color: White; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD><TD STYLE="text-align: center; border-bottom: Black 1.5pt solid; background-color: White; font-family: Times New Roman, Times, Serif; width: 9%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FilDate</B></FONT></TD><TD STYLE="text-align: left; background-color: White; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="text-align: left; background-color: White; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD><TD STYLE="text-align: center; border-bottom: Black 1.5pt solid; background-color: White; font-family: Times New Roman, Times, Serif; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PatNumber</B></FONT></TD><TD STYLE="text-align: left; background-color: White; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="text-align: center; background-color: White; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD><TD STYLE="text-align: center; border-bottom: Black 1.5pt solid; background-color: White; font-family: Times New Roman, Times, Serif; width: 9%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IssDate</B></FONT></TD><TD STYLE="text-align: left; background-color: White; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="text-align: center; background-color: White; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD><TD STYLE="text-align: center; background-color: White; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; width: 9%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD><TD STYLE="text-align: left; background-color: White; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>

<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Estonia</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: center">04741483.4</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: center">1636236</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10/9/2013</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2024</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Eurasian Patent Organization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: center">200501849</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: center">010904</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8/29/2008</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2024</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">European Patent Convention</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inactive</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: center">04741483.4</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: center">1636236</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10/9/2013</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2024</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Finland</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: center">04741483.4</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: center">1636236</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10/9/2013</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2024</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>

<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">France</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">04741483.4</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">1636236</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10/9/2013</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2024</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Georgia</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AP2004009128</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">P4664</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/10/2009</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2024</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Germany</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">04741483.4</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">60
                                         2004 043</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10/9/2013</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2024</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Greece</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">04741483.4</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">1636236</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10/9/2013</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2024</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Hong Kong</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Published</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">06110800.3</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Hungary</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">04741483.4</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">1636236</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10/9/2013</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2024</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Iceland</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pending</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">8132</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">India</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">5352/DELNP/2005</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">247222</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3/30/2011</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2024</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>

<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Indonesia</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Pending</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">W-00200503092</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif">4/27/2004</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Ireland</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">04741483.4</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">1636236</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10/9/2013</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2024</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Israel</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pending</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">172046</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Italy</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">04741483.4</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">1636236</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10/9/2013</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2024</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Japan</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2006-530168</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">5043432</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7/20/2012</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2024</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Kazakhstan</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">200501849</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">010904</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8/29/2008</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2024</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Korea, Republic of</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-2005-7022355</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-1084871</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11/11/2011</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2024</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Kosovo</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">119/1A&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">506</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3/7/2012</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">4/27/2024</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Kyrgyz Republic</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">200501849</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">010904</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8/29/2008</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2024</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Liechtenstein</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">04741483.4</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">1636236</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10/9/2013</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2024</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Luxembourg</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">04741483.4</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">1636236</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10/9/2013</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2024</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Malaysia</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PI20041795</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5/13/2004</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MY-142019-A</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8/16/2010</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5/13/2024</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Mexico</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PA/A/2005/012573</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">273468</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1/18/2010</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2024</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Moldova</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">200501849</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">010904</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8/29/2008</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2024</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Monaco</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">04741483.4</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">1636236</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10/9/2013</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2024</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Mongolia</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">3677</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">2745</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6/26/2006</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6/26/2026</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Montenegro</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">P-259/08</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">00142</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8/24/2010</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2024</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>

<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Netherlands</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">04741483.4</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">1636236</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10/9/2013</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2024</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">New Zealand</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">543661</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">543661</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9/10/2009</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2024</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Nicaragua</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2005/0202-I</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2263
                                         RPI</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10/25/2013</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2024</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Norway</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">20055496</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">334992</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8/18/2014</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2024</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Pakistan</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">367/2004</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5/22/2003</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">138943</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9/20/2006</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5/22/2023</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Patent Cooperation Treaty</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inactive</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PCT/EP2004/050612</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Philippines</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1-2005-502088</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1-2005-502088</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7/19/2012</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2024</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Poland</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">04741483.4</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">1636236</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10/9/2013</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2024</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Portugal</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">04741483.4</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">1636236</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10/9/2013</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2024
                                         </FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Romania</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">04741483.4</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">1636236</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10/9/2013</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2024</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Sch A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; width: 33%; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Country
    Exp.date</FONT></TD><TD STYLE="font-weight: bold; width: 1%; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: left; width: 1%; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: center; vertical-align: bottom; width: 9%; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Status</B></FONT></TD><TD STYLE="font-weight: bold; text-align: left; width: 1%; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: left; width: 1%; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: center; width: 9%; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AppNumber</B></FONT></TD><TD STYLE="font-weight: bold; width: 1%; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: center; width: 1%; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: center; width: 9%; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FilDate</B></FONT></TD><TD STYLE="font-weight: bold; text-align: left; width: 1%; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: left; width: 1%; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: center; width: 9%; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PatNumber</B></FONT></TD><TD STYLE="font-weight: bold; text-align: left; width: 1%; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: center; width: 1%; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: center; width: 9%; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IssDate</B></FONT></TD><TD STYLE="font-weight: bold; text-align: left; width: 1%; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; width: 1%; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; width: 9%; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; width: 1%; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; background-color: White; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="background-color: White; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; background-color: White; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; background-color: White; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; background-color: White; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; background-color: White; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="background-color: White; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; background-color: White; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; background-color: White; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; background-color: White; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; background-color: White; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; background-color: White; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; background-color: White; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; background-color: White; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; background-color: White; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; background-color: White; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; background-color: White; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; background-color: White; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; background-color: White; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Russian Federation</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">200501849</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">010904</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8/29/2008</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2024</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Serbia</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">P-944/05</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">52899</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10/24/2013</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2024</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Singapore</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">200507117-0</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">117008</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/31/2007</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2024</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Slovakia</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">04741483.4</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">1636236</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10/9/2013</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2024</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>

<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Slovenia</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">04741483.4</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">1636236</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10/9/2013</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2024</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">South Africa</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">2005/09486</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">2005/09486</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9/25/2008</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2024</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Spain</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">04741483.4</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">1636236</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10/9/2013</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2024</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Sri Lanka</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">13892</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">13892</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5/25/2011</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2024</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Sweden</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">04741483.4</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">1636236</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10/9/2013</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2024</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Switzerland</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">04741483.4</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">1636236</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10/9/2013</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2024</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Taiwan</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">93112449</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5/4/2004</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1-349672</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10/1/2011</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5/4/2024</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Tajikistan</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">200501849</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">010904</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8/29/2008</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2024</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Thailand</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pending</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">090552</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/30/2004</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Trinidad and Tobago</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pending</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TT/A/2005/00188</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Tunisia</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pending</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SN05298</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Turkey</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">04741483.4</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">1636236</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10/9/2013</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2024</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Turkmenistan</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">200501849</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">010904</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8/29/2008</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2024</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Ukraine</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">200512347</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">80763</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10/25/2007</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2024</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">United Kingdom</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">04741483.4</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">1636236</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10/9/2013</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2024</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">United States of America</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Abandoned</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">60/472661</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5/22/2003</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">United States of America</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">10/557565&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11/21/2005</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">7,482,354</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">1/27/2009</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">5/16/2024</FONT></TD></TR>

<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">United States of America</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">12/262,933</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10/31/2008</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">8,541,429</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9/24/2013</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2024</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">United States of America</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Published</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">13/972,659</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8/22/2013</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Uzbekistan</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IAP20050435</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IAP
                                         03934</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5/29/2009</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2024</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Venezuela</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pending</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2004-000815</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5/21/2004</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Viet Nam</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1-2005-01901</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2004</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">11081</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1/28/2013</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2024</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Sch A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I><U>Case
Number: NMS 005</U></I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Owner:
</I></B>NERVIANO MEDICAL SCIENCES S.r.1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Title:
</I></B>COMBINATIONS COMPRISING A CDK INHIBITOR AND A GROWTH FACTOR ANTIBODY OR ANTI-MITOTIC</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Priority:</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 32%; padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Country </I></B></FONT></TD>
    <TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 32%; padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Application Number </I></B></FONT></TD>
    <TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 32%; padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Filing Date</I></B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">European Patent Convention</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">06101523.6</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-Feb-2006</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"> <FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>Foreseen Expiry: </I></B>2027</FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.6in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Abstract:</I></B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
present invention provides a combination comprising a compound A of formula (I) as set forth in the specification, and an antibody
inhibiting a growth factor or its receptor and/or an anti-mitotic agent or a derivative or prodrug thereof, useful in the treatment
of tumors. The combination resulted to be highly effective without increased toxicity</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Inventors:</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I></I></B></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MERCURIO,
CIRO</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PESENTI,
ENRICO</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PORRO,
MARIA GRAZIA</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PEVARELLO,
PAOLO</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid"><B>Country Exp.date</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center"><B>Status</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><B>AppNumber</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><B>FilDate</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><B>PatNumber</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><B>IssDate</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Argentina</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Abandoned</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: bottom">P-070100470</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">2/5/2007</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 34%">Australia</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: center">Abandoned</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD><TD STYLE="width: 9%; text-align: center">2007213791</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD><TD STYLE="width: 9%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/2/2007</FONT></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD><TD STYLE="width: 9%; text-align: center">&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD><TD STYLE="width: 9%; text-align: center">&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD><TD STYLE="width: 9%; text-align: center">&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Austria</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Granted</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">07726297.0</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/2/2007</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">1986632</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8/15/2012</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/2/2027</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Belgium</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Granted</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">07726297.0</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/2/2007</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">1986632</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8/15/2012</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/2/2027</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Brazil</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Abandoned</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PI
                                         0707580-4</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/2/2007</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Canada</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Abandoned</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">2623729</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/2/2007</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Chile</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Abandoned</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2007-355</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/9/2007</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">China (People&rsquo;s Republic)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Granted</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">200780001301.4</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/2/2007</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ZL20078000</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1/10/2013</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/2/2027</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Eurasian Patent Organization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Abandoned</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">200801308</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/2/2007</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">014231</FONT></P></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10/29/2010</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/2/2027</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">European Patent Convention</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Abandoned</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">06101523.6</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/10/2006</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">European Patent Convention</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Inactive</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">07726297.0</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/2/2007</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">1986632</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8/15/2012</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/2/2027</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>France</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Granted</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">07726297.0</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/2/2007</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">1986632</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8/15/2012</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/2/2027</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Germany</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Granted</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">07726297.0</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/2/2007</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">60
                                         2007 024</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8/15/2012</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/2/2027</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Hong Kong</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Abandoned</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">09103726.6</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/22/2009</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>India</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Abandoned</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">4772/CHENP/2008</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/2/2007</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Ireland</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Granted</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">07726297.0</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/2/2007</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">1986632</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8/15/2012</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/2/2027</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Italy</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Granted</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">07726297.0</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/2/2007</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">1986632</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8/15/2012</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/2/2027</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Japan</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Granted</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2008-553730</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/2/2007</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">5537035</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5/9/2014</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/2/2027</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Liechtenstein</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Granted</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">07726297.0</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/2/2007</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">1986632</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8/15/2012</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/2/2027</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Mexico</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Abandoned</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MX/a/2008/010096</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/2/2007</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Netherlands</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Granted</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">07726297.0</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/2/2007</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">1986632</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8/15/2012</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/2/2027</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Patent Cooperation Treaty</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Inactive</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PCT/EP2007/051020</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/2/2007</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Spain</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Granted</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">07726297.0</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/2/2007</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">1986632</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8/15/2012</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/2/2027</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Sweden</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Granted</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">07726297.0</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/2/2007</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">1986632</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8/15/2012</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/2/2027</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Switzerland</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Granted</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">07726297.0</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/2/2007</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">1986632</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8/15/2012</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/2/2027</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Taiwan</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Abandoned</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">96104553</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/8/2007</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Thailand</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Abandoned</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">0701000465</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/2/2007</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">United Kingdom</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Granted</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">07726297.0</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/2/2007</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">1986632</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8/15/2012</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/2/2027</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">United States of America</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Granted</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">12/278,530</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/2/2007</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">8,084,027</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/27/2011</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8/26/2027</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Sch A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I><U>Case
Number: NMS 044</U></I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Owner:
</I></B>NERVIANO MEDICAL SCIENCES S.r.l.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Title:
</I></B>THERAPEUTIC COMBINATION COMPRISING A CDKs INHIBITOR AND AN ANTINEOPLASTIC AGENT</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>Priority:</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I></I></B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 32%; padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Country </I></B></FONT></TD>
    <TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 32%; padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Application Number </I></B></FONT></TD>
    <TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 32%; padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Filing Date</I></B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">European Patent Convention</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">08161320.0</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29-Jul-2008</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>Foreseen
Expiry: 2029</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.6in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Abstract:</I></B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
present invention provides a therapeutic combination comprising (a) a compound of formula (I) as set forth in the specification
and (b) one or more antineoplastic agents selected from the group consisting of alkylating or alkylating-like agents, antimetabolite agents and topoisomerase I inhibitors, wherein the active ingredients are present in each case in (free
form or in the form of a pharmaceutically acceptable salt or any hydrate thereof.</FONT> </TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>Inventors:</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CIOMEI,
MARINA</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MARSIGLIO,
AURELIO</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CROCI,
VALTER DOMENICO</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PESENTI,
ENRICO</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT>&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid"><B>Country Exp.date</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center; vertical-align: bottom"><B>Status</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><B>AppNu mber</B></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><B>FilDate</B></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><B>PatNumber</B></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><B>IssDate</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1.5pt; text-align: center"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 32%; text-align: left">China (People&rsquo;s Republic)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: center; vertical-align: bottom">&nbsp;</TD><TD STYLE="width: 9%; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD><TD STYLE="width: 9%; text-align: center">200980129267.8</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD><TD STYLE="width: 9%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7/29/2009</FONT></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD><TD STYLE="width: 9%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ZL20098012</FONT></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD><TD STYLE="width: 9%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10/17/2012</FONT></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD><TD STYLE="width: 9%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7/29/2029</FONT></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">European Patent Convention</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Published</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">09781243.2</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7/29/2009</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">European Patent Convention</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Abandoned</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EP08161320.0</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7/29/2008</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Hong Kong</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Published</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">11108482.5</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7/29/2009</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Japan</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2011-520505</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7/29/2009</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">5579715</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7/18/2014</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7/29/2029</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Patent Cooperation Treaty</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inactive</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PCT/EP2009/059815</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7/29/2009</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">United States of America</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">13/055,541</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7/29/2009</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">8,518,930</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8/27/2013</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/5/2030</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>


<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Sch A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I><U>Case
Number: NMS 050</U></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Owner:
</I></B>NERVIANO MEDICAL SCIENCES S.r.1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Title:
</I></B>USE OF A CDK INHIBITOR FOR THE TREATMENT OF GLIOMA</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Priority:</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 32%; padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Country </I></B></FONT></TD>
    <TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 32%; padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Application Number </I></B></FONT></TD>
    <TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 32%; padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Filing Date</I></B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">European Patent Convention</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">08161323.4</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29-Jul-2008</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Foreseen
Expiry: </I></B>2029</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.6in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Abstract:</I></B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
invention provides a low molecular weight ATP-competitive CDK inhibitor able to cross the blood brain barrier for use in the treatment
of malignant glioma and, in particular, of glioblastoma. The compound can be administered together with one or more agents selected
from the group consisting of cytotoxic or cytostatic agents and ionizing radiation.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.9in; text-indent: -0.9in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Inventors:</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CIOMEI,
MARINA</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FIORENTINI,
FRANCESCO</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PESENTI,
ENRICO</FONT></P>



<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left; vertical-align: bottom; border-bottom: Black 1.5pt solid"><B>Country Exp.date</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; vertical-align: bottom"><B>Status</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><B>AppNumber</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><B>FilDate</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: center; border-bottom: Black 1.5pt solid"><B>PatNumber</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><B>IssDate</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 33%; text-align: left">China (People&rsquo;s Republic)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: center; vertical-align: bottom">&nbsp;</TD><TD STYLE="width: 9%; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD><TD STYLE="width: 9%; text-align: center">200980129259.3</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD><TD STYLE="width: 9%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7/28/2009</FONT></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: center">CN1021051</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD><TD STYLE="width: 9%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/18/2013</FONT></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD><TD STYLE="width: 9%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7/28/2029</FONT></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">European Patent Convention</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Published*</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">09781195.4</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7/28/2009</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">European Patent Convention</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Abandoned</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">08161323.4</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7/29/2008</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Hong Kong</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">11108251.4</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7/28/2009</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">HK1153938</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8/29/2014</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7/28/2029</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Japan</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Published</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2011-520488</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7/28/2009</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Patent Cooperation Treaty</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inactive</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PCT/EP2009/059747</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7/28/2009</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">United States of America</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Published</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">13/055,533</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7/28/2009</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*Notice
of allowability issued on 9 May 2014</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"></P>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Sch A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I><U>Case
Number: NMS 058</U></I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Owner:
</I></B>NERVIANO MEDICAL SCIENCES S.r.l.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Title:
</I></B>CDK INHIBITOR FOR THE TREATMENT OF MESOTHELIOMA</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Priority:</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I></I></B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 32%; padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Country </I></B></FONT></TD>
    <TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 32%; padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Application Number </I></B></FONT></TD>
    <TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 32%; padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Filing Date</I></B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">European Patent Convention</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">08169790.6</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24-Nov-2008</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Foreseen
Expiry: </I></B>2029</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.6in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Abstract:</I></B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
invention provides a low molecular weight ATP-competitive CDK inhibitor for use in the treatment of mesothelioma. The compound
can be administered together with one or more cytotoxic or cytostatic agents.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Inventors:</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.9in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CIOMEI,
MARINA</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SCABURRI,
ANGELA</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT>&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left; vertical-align: bottom; border-bottom: Black 1.5pt solid"><B>Country Exp.date</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><B>Status</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><B>AppNumber</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><B>FilDate</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><B>PatNumber</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><B>IssDate</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 33%; text-align: left">China (People&rsquo;s Republic)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD><TD STYLE="width: 9%; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD><TD STYLE="width: 9%; text-align: center">200980146449.6</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD><TD STYLE="width: 9%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11/23/2009</FONT></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD><TD STYLE="width: 9%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ZL20098014</FONT></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD><TD STYLE="width: 9%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/3/2013</FONT></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD><TD STYLE="width: 9%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11/23/2029</FONT></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">European Patent Convention</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inactive</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">09760831.9</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11/23/2009</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">2376084</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7/17/2013</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11/23/2029</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">European Patent Convention</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Abandoned</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">08169790.6</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11/24/2008</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>France</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">09760831.9</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11/23/2009</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">2376084</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7/17/2013</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11/23/2029</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Germany</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">09760831.9</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11/23/2009</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">60 2009 017</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7/17/2013</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11/23/2029</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Hong Kong</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">12101219.9</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11/23/2009</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">HK1160779</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11/8/2013</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11/23/2029</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Italy</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">09760831.9</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11/23/2009</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">2376084</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7/17/2013</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11/23/2029</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Japan</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Abandoned</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2011-536889</FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11/23/2009</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Patent Cooperation Treaty</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inactive</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PCT/EP2009065643</FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11/23/2009</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">United Kingdom</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">09760831.9</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11/23/2009</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">2376084</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7/17/2013</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11/23/2029</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">United States of America</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Published</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">13/130,903</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11/23/2009</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.15in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.15in"></P>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Sch A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I><U>Case
Number: NMS 061</U></I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Owner:
</I></B>NERVIANO MEDICAL SCIENCES S.r.l.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Title:
</I></B>USE OF A KINASE INHIBITOR FOR THE TREATMENT OF THYMOMA</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I></I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>Priority:</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I></I></B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 32%; padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>Country </I></B></FONT></TD>
    <TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 32%; padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>Application Number </I></B></FONT></TD>
    <TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 32%; padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>Filing Date</I></B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">European Patent Convention</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: center">09155745.4</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">20-Mar-2009</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>Foreseen Expiry: </I></B>2030</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.6in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Abstract:</I></B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
invention provides a low molecular weight ATP-competitive CDK inhibitor and TRKA inhibitor for use in the treatment of thymoma.
The compound can be administered together with one or more cytotoxic or cytostatic agents.</FONT></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Inventors:</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SCABURRI,
ANGELA</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PACCIARINI,
MARIA ADELE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CIOMEI,
MARINA</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LAFFRANCHI,
BERNARD</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">COMIS,
SILVIA</FONT></P>



<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><B>Country Exp.date</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; vertical-align: bottom; border-bottom: Black 1.5pt solid"><B>Status</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><B>AppNumber</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><B>FilDate</B></TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD>&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom; border-bottom: Black 1.5pt solid"><B>PatNumber</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><B>IssDate</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 33%">Austria</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: center; vertical-align: bottom">&nbsp;</TD><TD STYLE="width: 9%; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD><TD STYLE="width: 9%; text-align: center">10708552.4</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD><TD STYLE="width: 9%; text-align: center">3/15/2010</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD><TD STYLE="width: 9%; text-align: center; vertical-align: bottom">2408776</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD><TD STYLE="width: 9%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1/8/2014</FONT></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD><TD STYLE="width: 9%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3/15/2030</FONT></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Belgium</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">10708552.4</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">3/15/2010</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom">2408776</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1/8/2014</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3/15/2030</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">China (People&rsquo;s Republic)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Published</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">201080012093.X</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: center">3/15/2010</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">European Patent Convention</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Abandoned</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">09155745.4</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3/20/2009</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">European Patent Convention</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inactive</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">10708552.4</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">3/15/2010</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom">2408776</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1/8/2014</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3/15/2030</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>France</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">10708552.4</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">3/15/2010</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom">2408776</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1/8/2014</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3/15/2030</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Germany</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">10708552.4</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3/15/2010</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">60 2010 012</FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1/8/2014</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3/15/2030</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Hong Kong</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Published</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">12107532.6</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3/15/2010</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Ireland</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom">Granted</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">10708552.4</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">3/15/2010</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom">2408776</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">1/8/2014</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">3/15/2030</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>

<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 33%">Italy</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 1%">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom; width: 9%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left; width: 1%">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 1%">&nbsp;</TD><TD STYLE="text-align: center; width: 9%">10708552.4</TD><TD STYLE="text-align: left; width: 1%">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 1%">&nbsp;</TD><TD STYLE="text-align: center; width: 9%">3/15/2010</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom; width: 9%">2408776</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 1%">&nbsp;</TD><TD STYLE="text-align: center; width: 9%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1/8/2014</FONT></TD><TD STYLE="text-align: left; width: 1%">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 1%">&nbsp;</TD><TD STYLE="text-align: center; width: 9%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3/15/2030</FONT></TD><TD STYLE="text-align: left; width: 1%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Japan</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Published</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2012-500209</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3/15/2010</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Liechtenstein</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">10708552.4</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">3/15/2010</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom">2408776</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1/8/2014</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3/15/2030</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Netherlands</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">10708552.4</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">3/15/2010</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom">2408776</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1/8/2014</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3/15/2030</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Patent Cooperation Treaty</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inactive</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PCT/EP2010/053311</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3/15/2010</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Spain</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">10708552.4</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">3/15/2010</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom">2408776</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1/8/2014</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3/15/2030</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Sweden</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">10708552.4</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">3/15/2010</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom">2408776</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1/8/2014</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3/15/2030</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Switzerland</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">10708552.4</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">3/15/2010</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom">2408776</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1/8/2014</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3/15/2030</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">United Kingdom</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">10708552.4</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">3/15/2010</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom">2408776</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1/8/2014</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3/15/2030</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">United States of America</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">13/256,467</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">3/15/2010</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom">8,580,793</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11/12/2013</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3/15/2030</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Sch A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I><U>Case
Number: NMS 012</U></I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Owner:
</I></B>NERVIANO MEDICAL SCIENCES S.r.l.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>Title: </I></B>CDK INHIBITOR SALTS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Priority:</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 32%; padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>Country </I></B></FONT></TD>
    <TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 32%; padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>Application Number </I></B></FONT></TD>
    <TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 32%; padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>Filing Date</I></B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">European Patent Convention</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: center">09159030.7</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29-Apr-2009</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Foreseen
Expiry: </I></B>2030</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.6in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Abstract:</I></B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
present invention relates to novel crystalline form(s) of water-soluble salts and of free base of a cdk inhibitor. Such crystal
salts are for example fumarate, L-malate, maleate, succinate, adipate, malonate, glycolate, phosphate, mesylate, L-lactate, hydrochloride,
di-hydrochloride, tri-hydrochloride. Hydrates and polymorphs of such new salt forms, a process for their preparation, their utility
in therapy and to the pharmaceutical compositions containing them are also claimed and described in the present application.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.85in; text-align: justify; text-indent: -0.85in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Inventors:</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ZAMPIERI,
MASSIMO</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AIROLDI,
ANNALISA</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FORNARETTO,
MARIA GIOIA</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BRASCA,
MARIA GABRIELLA</FONT></P>



<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify; border-bottom: Black 1.5pt solid"><B>Country</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; vertical-align: bottom"><B>Status</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><B>AppNumber</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><B>FilDate</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><B>PatNumber</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><B>IssDate</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><B>Exp.date</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Argentina</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Abandoned</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">P 10 01 01427</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/28/2010</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 33%; text-align: left">China (People&rsquo;s Republic)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: center; vertical-align: bottom">&nbsp;</TD><TD STYLE="width: 9%; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Published</FONT></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD><TD STYLE="width: 9%; text-align: center">201080018865.0</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD><TD STYLE="width: 9%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/23/2010</FONT></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD><TD STYLE="width: 9%; text-align: center">&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD><TD STYLE="width: 9%; text-align: center">&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD><TD STYLE="width: 9%; text-align: center">&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">European Patent Convention</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Published</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">10715240.7</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/23/2010</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">European Patent Convention</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Abandoned</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">09159030.7</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/29/2009</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Hong Kong</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Published</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">12110192.1</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/23/2010</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Japan</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pending</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2012-507696</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/23/2010</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Patent Cooperation Treaty</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inactive</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PCT/EP2010/055463</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/23/2010</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Taiwan</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Abandoned</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">099113232</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/27/2010</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">United States of America</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">13/265,918</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/23/2010</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">8,586,598</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11/19/2013</FONT></TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/23/2030</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sch
A-9</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>8
<FILENAME>ff12018a1ex10-2_tiziana.htm
<DESCRIPTION>LICENSE AND SUBLICENSE AGREEMENT RELATING TO CD3 (NI-0401) BETWEEN NOVIMMUNE SA AND TIZIANA LIFE SCIENCES PLC, DATED DECEMBER 2014
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3.6pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3.6pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>LICENSE
AND SUBLICENSE AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3.6pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
License and Sublicense Agreement (&ldquo;<U>Agreement</U>&rdquo;) is made effective as of December <U>19<SUP>th</SUP></U>, 2014
(&ldquo;<U>Effective Date</U>&rdquo;) by and between on the one hand NovImmune S.A., 14 Chemin des Aulx, 1228 Plan les Ouates,
Geneva, Switzerland (&ldquo;Licensor&rdquo;), and Tiziana Life Sciences Plc, 18 South Street, Mayfair, London, W1K 1DG, UK (&ldquo;<U>Licensee</U>&rdquo;).
Licensor and Licensee are each hereafter referred to individually as a &ldquo;<U>Party</U>&rdquo; arid together as the &ldquo;<U>Parties</U>.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
Licensee desires to obtain an exclusive license to patents owned or controlled by Licensor, a sublicense to certain patents licensed
from Bristol-Myers Squibb Company (&ldquo;BMS&rdquo;), along with any associated know-how, biologic materials, clinical data or
other technology relating to CD3 receptor monoclonal antibodies and their use in order to research, develop and commercialize
products and services;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOW,
THEREFORE, in consideration of the mutual covenants contained herein, and for other good and valuable consideration, the receipt
and adequacy of which are hereby acknowledged, the Parties hereby agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3.6pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.
DEFINITIONS</B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3.6pt 0pt 0; text-align: justify; text-indent: 32.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalized
terms used in this Agreement shall have the meanings specified below or elsewhere herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3.6pt 0pt 0; text-align: justify; text-indent: 32.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1.
&ldquo;<U>Affiliate</U>&rdquo; means any Person who directly or indirectly controls or is controlled by or is under common control
with another Person. A Person shall only be considered an Affiliate during the duration of such control. For purposes of this
definition, &ldquo;<U>control</U>&rdquo; or &ldquo;<U>controlled</U>&rdquo; means ownership, directly or through one or more Affiliates,
of fifty percent (50%) or more of the shares of stock entitled to vote for the election of directors, in the case of a corporation,
or fifty percent (50%) or more of the equity interest, in the case of any other type of legal entity, or status as a general partner
in any partnership, or the contractual right to control the election of directors or direct the affairs of any Person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2.
&ldquo;<U>Confidential Information</U>&rdquo; means with respect to a Party (the &ldquo;<U>Receiving Party</U>&rdquo;), all information
that is (i) disclosed by the other Party (the &ldquo;<U>Disclosing Party</U>&rdquo;) to the Receiving Party; and (ii) would be
reasonably understood from notices or legends, the nature of such information itself or the circumstances of such information&rsquo;s
disclosure to be confidential by a reasonable person familiar with the applicable industry; provided, however, that Confidential
Information shall not include information that the Receiving Party can demonstrate by its records or other suitable documentary
evidence, (a) as of the date of disclosure is demonstrably known to the Receiving Party or its Affiliates other than by virtue
of a prior confidential disclosure to such Party or its Affiliates; (b) as of the date of disclosure is in, or subsequently enters,
the public domain, through no fault or omission of the Receiving Party; (c) is obtained from a Third Party having a lawful right
to make such disclosure free from any obligation of confidentiality to the Disclosing Party; or (d) is independently developed
by or for the Receiving Party without reference to or reliance upon any Confidential Information of the Disclosing Party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3.6pt 0pt 0; text-align: justify; text-indent: 32.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3.6pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3.
&ldquo;<U>Cover</U>&rdquo; means with respect to Valid Claims in an issued patent, that, in the absence of a license, the use,
sale, or manufacture of the product in question would infringe such Valid Claim.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.4.
&ldquo;<U>Field</U>&rdquo; means any and all uses including all therapeutic uses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.5.
&ldquo;<U>First Commercial Sale</U>&rdquo; means, on a country-by-country basis, the date of the first arm&rsquo;s length transaction,
transfer or disposition for value by or on behalf of Licensee or any Affiliate or Sublicensee of Licensee to a Third Party of
a Licensed Product after the granting of all regulatory approvals and marketing authorizations. First Commercial Sale excludes
any sale or other distribution in connection with seeking regulatory approval.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.6,&#9;&ldquo;<U>Licensor
Indemnitees</U>&rdquo; means Licensor, its Affiliates arid the directors, officers, employees and agents of LICENSOR and its Affiliates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.7.
&ldquo;<U>Licensed Patents</U>&rdquo; means the patents and patent applications listed on Exhibit 1 hereto, and including all
provisionals, substitutions, continuations, continuations-in-part, divisionals, supplementary protection certificates, renewals,
all letters patent granted thereon, and all reissues, reexaminations, extensions, confirmations, revalidations, registrations,
patents of addition thereof, and foreign equivalents to any of the foregoing,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9;1.8.&#9;&ldquo;<U>Licensed
Product</U>&rdquo; means any product or service, the manufacture, use, sale, importation or performance of which would, absent
the license granted herein, infringe a Valid Claim of the Licensed Patents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.9.
&ldquo;<U>Licensee Indemnitees</U>&rdquo; means Licensee, its Affiliates, Sublicensees, and the directors, officers, employees
and agents of Licensee and its Affiliates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.10.
&ldquo;<U>Net Sales</U>&rdquo; means, for any period, the gross amount invoiced by Licensee and its Affiliates for the sale of
Licensed Products to third parties, less deduction for:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
normal and customary trade, quantity and cash discounts and sales returns and allowances including (i) those granted on account
of price adjustments, billing errors, rejected goods, damaged goods, returns and rebates, (ii) administrative and other fees and
reimbursements and similar payments directly related to the sale or delivery of Licensed Products paid to wholesalers and other
distributors, buying groups, pharmacy benefit management organizations, health care insurance carriers and other institutions,
(iii) allowances, rebates, and fees directly related to the sale of delivery of License Products paid to distributors and (iv)
chargebacks;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
freight, postage, shipping and insurance costs to the extent that such items are included in the gross amount invoiced;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
customs and excise duties and other duties related to the sales to the extent that such items are included in the gross amount
invoiced;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
rebates and similar payments made with respect to sales paid for or reimbursed by any governmental or regulatory authority such
as, by way of illustration, federal or state Medicaid, Medicare or similar state program or equivalent foreign governmental program;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
sales and other taxes and duties directly related to the sale or delivery of Licensed Products (but not including taxes assessed
against the income derived from such sale) to the extent that such items are included in the gross amount invoiced;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
distribution costs and expenses to the extent that such items are included in the gross amount invoiced;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
any such invoiced amounts that are not collected by the parties or their Affiliates;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">provided
that with respect to the deductions specified in subsections (a) through (g) above, an amount shall be deducted only once regardless
how many categories may apply to it.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
of the deductions listed above that involves a payment by Licensee or its Affiliates shall be taken as a deduction in the calendar
quarter in which the payment is accrued. Deductions pursuant to section (g) above shall be taken in the calendar quarter in which
such sales are no longer recorded as a receivable. For purposes of determining Net Sales, the Licensed Products shall be deemed
to be sold when invoiced and a &ldquo;sale&rdquo; shall not include transfers or dispositions for charitable, promotional, pre-clinical,
clinical, regulatory or governmental purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the purposes of calculating Net Sales of Licensed Products, sales between or among Licensee or its Affiliates shall be excluded
from the computation of Net Sales, but sales by Licensee or its Affiliates to third parties shall be included in the computation
of Net Sales.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event that a Licensed Product is sold in any country in the form of a combination product containing one or more therapeutically
active ingredients in addition to the Licensed Product, with respect thereto, the parties shall negotiate in good faith to determine
what portion of the net sales of such combination product shall be treated as Net Sales under the Agreement, which determination
shall be based on the value added by the Licensed Product compared to the value added by such other therapeutically effective
ingredients, to the invoice price of such combination product.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.11.
&ldquo;<U>NI-0401</U>&rdquo; means the CD3 receptor monoclonal antibody Licensed Product</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.12.
&ldquo;<U>Person</U>&rdquo; means any individual, corporation, limited or general partnership, limited liability company, joint
venture, trust, unincorporated association, governmental body, authority, bureau or agency, or any other entity or body.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.13.
&ldquo;<U>Royalty Term</U>&rdquo; means, with respect to each Licensed Product, the period of time beginning on the First Commercial
Sale of such Licensed Product in a country following the receipt of applicable regulatory approval with respect to such sale of
such Licensed Product in such country and continuing on a country-by-country and product-by-product basis until the later of
(a) the expiration of the last Valid Claim of the Licensed Patents which Covers the sale of such Licensed Product in such country
or (b) the end of any market exclusivity period granted by the relevant governmental authority in a country that prevents another
party from marketing the same Licensed Product.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.14.
&ldquo;<U>Sublicensee</U>&rdquo; means any Third Party to whom Licensee grams a sublicense of some or all of the rights granted
to Licensee under this Agreement</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.15.
&ldquo;<U>Sublicense Revenue</U>&rdquo; means all cash payments received by Licensee or its Affiliates from Sublicensees in consideration
for and directly attributable to the grant by Licensee of a sublicense under the Licensed Patents, including any upfront payments,
license maintenance fees, milestone payments and the like. Sublicense Revenue will not include: (a) in the case where Licensee
collaborates on research and/or development with a Sublicensee, amounts paid by such Sublicensee as reimbursement for research
and development costs; (b) bona fide loans; (c) reimbursement for clinical trial costs and expenses; (d) equity investment in
Licensee to the extent such investments reflect the fair market value of such equity (any amounts paid in excess of fair market
value shall be deemed Sublicense Revenues); (e) amounts paid for supplies of Licensed Products or other tangible materials, or
that are otherwise paid in reimbursement of costs or expenditures, whether incurred before or after the date of the relevant sublicense
agreement; and (g) withholding taxes or other amounts actually withheld from the amounts received.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.16.
<U>Territory</U>. Worldwide.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.17.
&ldquo;<U>Third Party</U>&rdquo; means any person or entity other than Licensee, Licensor and their respective Affiliates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.18.
&ldquo;<U>Valid Claim</U>&rdquo; means a claim in an issued, unexpired patent within the Licensed Patents or a claim that has
not been pending more than five (5) years, in either case that (a) has not been finally cancelled, withdrawn, abandoned or rejected
by any administrative agency or other body of competent jurisdiction, (b) has not been revoked, held invalid, or declared unpatentable
or unenforceable in a decision of a court or other body of competent jurisdiction that is unappealable or unappealed within the
lime allowed for appeal, (c) has not been rendered unenforceable through disclaimer or otherwise, and (d) is not lost through
an interference proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.
LICENSE GRANT</B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.
<B>License</B>. Licensor hereby grants to Licensee a worldwide, exclusive license (even as to Licensor), including the right to
grant sublicenses, under the Licensed Patents, for Licensee and its Affiliates to research, develop, make, have made, use, offer
for sale, sell, have sold and import Licensed Products for any and all uses in the Field in the Territory, subject to the terms
and conditions of this Agreement. The foregoing includes the right to employ Third Party distributors to sell Licensed Products
and Third Party contract manufacturers to make Licensed Products, neither of which shall be construed as a sublicense.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2.
<B>Sublicense to BMS Rights</B>. Licensor hereby grants <I>an </I>exclusive sublicense to Licensee, including the right to grant
further sublicenses, under the Research and Commercialization Agreement between NovImmune and BMS dated September 30, 2004 and
any amendments thereto, and the Exclusive Commercial License between NovImmune and BMS dated February 17, 2005, for the CD3 Antibody
Licensed Product, copies of which are attached hereto as Schedule A, to make, have made, use, offer for sale, sell, have sold
and/or import Licensed Products in the Field in the Territory. Licensee acknowledges and agrees that the terms of the sublicense
pursuant to this Agreement shall be subordinate to and consistent with all the terms and conditions of the Research and Commercialization
Agreement and any amendments thereto, and the Exclusive Commercial License between  and BMS.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.
DEVELOPMENT AND COMMERCIALIZATION OF LICENSED PRODUCTS.</B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.
<B>Authority</B>. Licensee shall have full control and authority over the research, development (including regulatory matters)
and commercialization of Licensed Products in the Field worldwide.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2.
<B>Diligence</B>. Licensee will, itself or through its Affiliates or Sublicensees, at all times exercise commercially reasonable
efforts to commercialize Licensed Products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3.
<B>Drug Substance, Storage Testing and Transfer</B>. Licensor has a quantity of NI-0401 drug substance manufactured and stored
by Licensor which Licensee will require for development purposes. Within 30 days of signing the agreement Licensee may elect to
instruct Licensor on its requirements for drug substance which may include:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3.1.
Transfer of drug substance to another location in a timeframe to be agreed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3.2.
Continued storage by Licensor and any required testing schedule, followed by later requests for transfer to another location.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3.3.
Licensee agrees to pay the costs of transfer of drug substance, and the costs of any storage and testing schedule, such costs
to include consumables, third party services, and documented Licensor personnel time charged at fully loaded cost (CHF375,000/FTE).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3.4.
Licensor will not charge Licensee for the existing drug substance itself, only the costs required to store, test and transfer
the drug substance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4.
<B>Drug Manufacturing</B>. Licensor has an established manufacturing process for NI-0401, and relationships with a contract manufacturing
organisation for the manufacturing of drug substance and drug product Licensee may elect to request assistance from Licensor to
manufacture additional quantities of NI-0401 drug substance and/or drug product. Upon such request, Licensor will provide a proposal
for providing such assistance which will include the pass through of costs from the contract manufacturer, plus the cost of Licensor&rsquo;s
personnel time charged at fully loaded cost (CHF375,000/FTE).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5.
<B>Transfer of Data and Know How</B>. Licensor will transfer all data and documentation relevant to NI-0401 to Licensee at no
cost. For a period of 90 days from signature, Licensor will make key personnel available to Licensee for briefings, to answer
questions, and offer advice on pro-clinical data, science, and manufacturing. As Licensee contemplates pursuing an alternative
clinical indication Licensor will not be able to assist in advising on clinical development. Should the tune requirement for Licensor
personnel supporting Licensee to take over the NI-0401 program become burdensome to Licensor, the parties will discuss and agree
to an alternative mutually satisfactory arrangement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.
PAYMENTS</B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1.
<B>Upfront Fee for BMS Obligation</B>. Within five (5) days of the Effective Date, Licensee shall pay to Licensor the amount of
$750,000 USD owed to BMS under the diligence obligations in Section 8.3.4 of the Research and Commercialization Agreement and
Licensor shall forward that payment to BMS forthwith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2.
<B>Upfront Fee to Novlmmune</B>. Within sixty (60) days of the Effective Date, Licensee shall pay to Licensor the amount of $500,000
USD.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3.
<B>Anniversary Fee</B>. On each of the 14 month, 26 month and 38 month anniversary of the Effective Date of the Agreement, Licensee
shall pay Licensor the sum of $250,000 USD (for a total of $750,000 USD).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4.
<B>Milestone and Diligence obligations Payments</B>. Subject to the terms and conditions of this Agreement, Licensee shall pay
all milestone and Diligence obligations payments owed to BMS, except the December 2014 Diligence obligation payment owed to BMS
which will be forwarded to Licensor for payment to BMS.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5.
<B>Royalty and Sublicense Revenue</B>. Licensee will pay to Licensor a royalty or Sublicense Revenue based on sales of the Licensed
Product as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5.1.
In the event that Licensee or its Affiliates sell Licensed Product to third parties, Licensee shall pay to Licensor a running
royalty of 3.5% on Net Sales for the Royalty Term.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5.2.
In the event that Licensee sublicenses its rights under this agreement to a sublicensee, then Licensee shall first be reimbursed
front whatever revenues it receives from sales of Licensed Product by such sublicensee for (a) all payments made to BMS and (b)
for all documented clinical trial and development costs and expenses incurred in the development and commercialization of a Licensed
Product. Thereafter Licensee shall pay to Licensor 17.5% of all Sublicense Revenue it receives from such sublicensee as consideration
for Licensed Product.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.6.
Payment Terms.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6.1.
<B>Payment of Received Revenue</B>. Licensee shall make any payments owed to Licensor hereunder in arrears, within ninety (90)
days from the end of each quarter in which such payment accrues. Each payment shall be accompanied by a report for each country
in which sales of Licensed Products occurred in the calendar quarter covered by such statement, specifying: the gross sales (if
available) and sales in each country&rsquo;s currency; the applicable revenue sharing amount under this Agreement; the amount
payable in each country&rsquo;s currency, including an accounting of deductions taken in accordance with Licensee&rsquo;s accounting
practices; the applicable exchange rate to convert from each country&rsquo;s currency to United States Dollars; and the amounts
payable in United States Dollars.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6.2.
<B>Accounting. </B>All payments hereunder shall be made in in United States dollars. Conversion of foreign currency to United
States dollars shall be made in the same manner as Licensee converts all of its other revenues, provided that (a) such manner
is consistent with United States generally accepted accounting principles, and (b) the exchange rates employed are those quoted
by a reputable source, such as a recognized money center bank such as JP Morgan, Bank of America or an equivalent,.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6.3.
<B>Tax Withholding; Restrictions on Payment. </B>All payments hereunder shall be made free and clear of any taxes, duties, levies,
fees or charges, except for withholding taxes and interest and penalties thereon (to the extent applicable). Licensee shall make
any applicable withholding payments due on behalf of Licensor and shall provide Licensor upon request with such written documentation
regarding any such payment as available to Licensee relating to an application by Licensor for a foreign tax credit for such payment
with the United States Internal Revenue Service. Licensor shall provide all information necessary to determine if withholding
taxes are applicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.7.
Records Retention by Licensee; Review.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7.1.
<B>Royalty Records</B>. Commencing as of the date of First Commercial Sale of the first Licensed Product hereunder, Licensee and
its Affiliates and Sublicensees shall keep for at least three (3) years from the end of the calendar year to which they pertain
complete and accurate records of sales by Licensee or its Affiliates and Sublicensees, as the case may be, of each Licensed Product,
in sufficient detail to allow the accuracy of the payments hereunder to be confirmed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7.2.
<B>Review. </B>Subject to the other terms of this Section 4.7, at the request of Licensor, which shall not be made more frequently
than once per calendar year during the Term, and upon at least thirty (30) days&rsquo; prior written notice from Licensor, and
at the expense of Licensor (except as otherwise provided herein), Licensee shall permit an independent certified public accountant
selected by Licensor and reasonably acceptable to Licensee to inspect (during Licensee&rsquo;s regular business hours) the relevant
records required to be maintained by Licensee under Section 4.7. In every case the accountant must have previously entered into
a confidentiality agreement with both Parties substantially similar to the provisions of Article 5 and limiting the disclosure
and use of such information by such accountant to authorized representatives of the Parties and the purpose of verifying amounts
payable to Licensor hereunder. Results of any such review shall be binding on both Parties absent manifest error. If any review
reveals a deficiency in the calculation and/or payment of amounts owed by Licensee, then (a) Licensee shall pay Licensor the amount
remaining to be paid, and (b) if such underpayment is by ten percent (10%) or more for any twelve (12) month consecutive period,
then Licensee shall reimburse Licensor for its reasonable out-of-pocket costs and expenses incurred in performing the review.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
<B>TREATMENT OF CONFIDENTIAL INFORMATION</B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1.
<B>Confidential Obligations. </B>Licensor and Licensee each recognize that the other Party&rsquo;s Confidential Information constitutes
highly valuable and proprietary confidential information, Licensor and Licensee each agree that during the Term and for five (5)
years thereafter, it will keep confidential, and will cause its employees, consultants (including academic collaborators, CROs
and manufacturers), professional advisors, Affiliates and, in the case of Licensee, Sublicensees to keep confidential, all Confidential
Information of the other Party, Neither Licensor nor Licensee nor any of their respective employees, consultants, Affiliates or,
in the case of Licensee, Sublicensees, shall use any Confidential Information of the other Party for any purpose whatsoever other
than exercising any rights granted to it hereunder or as expressly permitted in this Article 5. Licensee may disclose Licensor&rsquo;s
Confidential Information to the extent such disclosure is reasonably necessary to file and prosecute patent applications and/or
maintain patents which are filed or prosecuted in accordance with the provisions of this Agreement, or to obtain any authorization
to conduct clinical studies or any regulatory approval for Licensed Products. Each Party may disclose the other Party&rsquo;s
Confidential Information as reasonably necessary to file, conduct or defend litigation in accordance with the provisions of this
Agreement or comply with applicable laws, regulations or court orders; provided, however, that if a Party is required to make
any such disclosure of the other Party&rsquo;s Confidential Information in connection with any of the foregoing, it will give
reasonable advance notice to the other Party of such disclosure requirement and will use reasonable efforts to assist such other
Party in efforts to secure confidential treatment of such information required to be disclosed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2.
<B>Limited Disclosure and Use</B>. Each Party may disclose the other Party&rsquo;s Confidential Information to any of its officers,
employees, consultants, agents or Affiliates, or in the case of Licensee, Sublicensees, if and only to the extent necessary to
carry out its rights and responsibilities under this Agreement. Such disclosures shall be limited to the maximum extent possible
consistent with such rights and responsibilities and shall only be made to the extent any such persons receiving the other Party&rsquo;s
Confidential Information are bound by written confidentiality obligations to maintain the confidentiality thereof and not to use
such Confidential Information except as expressly permitted by this Agreement. LICENSOR and Licensee each agree not to disclose
or transfer the other Party&rsquo;s Confidential Information to any Third Parties under any circumstance without the prior written
approval from the other Party, except as otherwise required by law, and except as otherwise expressly permitted under this Article
5 or elsewhere in this Agreement. Each Party shall take such action, and shall cause its Affiliates, and in the case of Licensee,
Sublicensees, to take such action, to preserve the confidentiality of each other&rsquo;s Confidential Information as it would
customarily take to preserve the confidentiality of its own Confidential Information, using, in all such circumstances, not less
than reasonable care. Each Party, upon the request of the other Party, will return all the Confidential Information disclosed
or transferred to it by the other Party pursuant to this Agreement, including all copies and extracts of documents and all manifestations
in whatever form, in such Party&rsquo;s possession within sixty (60) days of such request or, if earlier, the termination or expiration
of this Agreement; provided however, that a Party may retain (a) any Confidential Information of the other Party relating to any
license that is still in force hereunder or which expressly survives such termination, and (b) one (1) copy of all other Confidential
Information in inactive archives solely for the purpose of establishing the contents thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3.
<B>Terms of Agreement</B>. The terms of this Agreement constitute each Party&rsquo;s Confidential Information; provided, however,
that either Party may disclose the terms of this Agreement (a) to the extent required by law or by the requirements of any nationally
recognized securities exchange, quotation system or over-the-counter market on which such Party has its securities listed or traded,
or (b) in confidence to its attorneys, accountants and other fiduciaries, and (c) to any acquirers, potential acquirers, investors,
prospective investors, lenders and other potential financing sources who are obligated to keep such information confidential.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4.
<B>Press Release. </B>The Parties shall diligently work together to draft a mutually agreeable press release announcing the execution
of this Agreement such announcement to be made no later than 07:00 on the day following the Effective Date, and shall publish
such press release in a mutually agreeable manner.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.
<B>FILING, PROSECUTION AND MAINTENANCE OF PATENT RIGHTS</B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1.
<B>Prosecution Control. </B>For purposes of this Article 6, the right to control prosecution of a Patent Right shall include the
right to control preparing, filing, and prosecuting patent applications therefor, and obtaining and maintaining any resulting
patents, including the conduct of interferences, the defense of oppositions and other similar proceedings with respect to a patent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.2.
<B>Patent Prosecution.</B> Licensee shall, at its expense, assume control of the prosecution of the Licensed Patents, subject
to the provisions of this Article 6. If Licensee decides not to prosecute or maintain any Patent Right within the Licensed Patents,
then Licensee shall provide Licensor with written notice of such decision prior to the deadline for taking any action for such
Patent Right or the date on which the abandonment of&rsquo; any such Patent Right would become effective, whichever is earlier.
If Licensee does not wish to continue prosecution of a case or decides not to file in a particular country, then Licensor may
do so at Licensor&rsquo;s own cost. Licensee shall pay the December 2014 costs of National Phase entry for Licensed Patents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.3.
<B>Right of Review and Comment. </B>Licensee shall consult with Licensor regarding the prosecution of the Licensed Patents by
using commercially reasonable efforts to provide Licensor a Reasonable Opportunity to review and comment on all proposed submissions
to any patent office before submission, where &ldquo;<U>Reasonable Opportunity</U>&rdquo; means that Licensee shall provide Licensor
or patent counsel true copies of all documents relating to filing, registration, prosecution, and maintenance of patent applications
and patents within the Licensed Patents as soon as reasonably practical after Licensee has received such documents and materials.
Licensee shall consider in good faith Licensor&rsquo;s comments concerning such documents and materials that it timely receives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.
PATENT ENFORCEMENT</B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.1.
<B>Notice of Infringement</B>. If, during the Term, either Party learns of any actual, alleged or threatened infringement by a
Third Party of any Licensed Patents, such Party shall promptly notify the other Party and shall provide the other Party with available
evidence of such infringement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.2.
<B>Infringement of Patent Rights</B>. Licensee shall have the first right (but not the obligation), at its own expense and with
legal counsel of its own choice, to bring suit (or take other appropriate legal action) against any actual, alleged or threatened
infringement of the Licensed Patents in the Field by any product or service that competes with a Licensed Product, as reasonably
determined by Licensee. Licensor shall take all actions necessary to assist Licensee in any suit, including joining in such suit
as a party if legally required, at Licensee&rsquo;s expense. Licensor shall have the right, at its own expense, to be represented
in any such action by counsel of Licensor&rsquo;s own choice; provided, however, that the foregoing shall not affect the right
of Licensee to control the suit as described in this Section. In the event that the Licensee does not bring suit, Licensor shall
have the right to bring suit, provided that there is no commercially reasonable reason that Licensee did not bring suit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.
REPRESENTATIONS AND WARRANTIES</B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1.
<B>Licensor Representations</B>. Licensor represents, warrants and covenants to Licensee that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1.1.
the execution and delivery of this Agreement and the performance of the transactions contemplated hereby have been duly authorized
by all appropriate Licensor corporate action;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1.2.
this Agreement is a legal and valid obligation binding upon Licensor and enforceable in accordance with its terms, and the execution,
delivery and performance of this Agreement by the Parties does not conflict with any agreement, instrument or understanding to
which Licensor is a party or by which it is bound;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1.3.
Licensor has the full right and legal capacity to grant the rights granted to Licensee hereunder;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1.4.
the Licensed Patents have been properly filed and prosecuted as of the Effective Date;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1.5.
Licensor is the sole owner of the Licensed Patents;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1.6.
as of the Effective Date, Licensor has not licensed or transferred to any Person, including Licensor Affiliates, any rights under
the Licensed Patents; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1.7.
Licensor is not aware of any Third Party patent, patent application or other intellectual property right that would be infringed
(i) by practicing any process or method or by making, using or selling any composition which is claimed or disclosed in, or which
constitutes, Licensed Patents, or (ii) by making, using, offering for sale, selling or importing Licensed Products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2.
<B>Licensee Representations</B>. Licensee represents and warrants to Licensor that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2.1.
the execution and delivery of this Agreement and the performance of the transactions contemplated hereby have been duly authorized
by all appropriate Licensee corporate action; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2.2.
this Agreement is a legal and valid obligation binding upon Licensee and enforceable in accordance with its terms, and the execution,
delivery and performance of this Agreement by the Parties does not conflict with any agreement, instrument or understanding to
which Licensee is a party or by which it is bound.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.3.
<B>No Warranties</B>. Except as expressly set forth in this Agreement, NEITHER PARTY MAKES ANY REPRESENTATION OR EXTENDS ANY WARRANTIES
OF ANY KIND, EITHER EXPRESS OR IMPLIED. THERE ARE NO EXPRESS OR IMPLIED WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR
PURPOSE, OR OF NON-INFRINGEMENT OF ANY PATENT, COPYRIGHT, TRADEMARK, OR OTHER RIGHTS OF THIRD PARTIES, OR AS TO THE SUCCESS OR
LIKELIHOOD OF SUCCESS OF THE RESEARCH, DEVELOPMENT OR COMMERCIALIZATION OF LICENSED PRODUCTS UNDER THIS AGREEMENT, OR ANY OTHER
EXPRESS OR IMPLIED WARRANTIES.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.
<B>INDEMNIFICATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.1.
<B>Indemnification by Licensee</B>. Licensee shall indemnify, defend and hold harmless the Licensor Indemnitees from and against
any and all losses, damages, fees, expenses, settlement amounts and costs (including reasonable attorneys&rsquo; fees and witness fees)
(collectively, &ldquo;<U>Losses</U>&rdquo;) relating to or in connection with a Third Party claim arising after the Effective
Date out of (a) any breach by Licensee of its representations, warranties or covenants made under this Agreement, or (b) any actual
or alleged death, personal bodily injury or damage to real or tangible personal property claimed to result, directly or indirectly,
from the possession, use or consumption of, or treatment with, the Licensed Product made or sold by or on behalf of Licensee or
its Affiliates or Sublicensees, including any product liability claims; provided, however, that the foregoing indemnity shall
not apply to the extent that any such Losses (i) are attributable to the negligence or willful misconduct of the Licensor Indemnitees,
or (ii) are subject to an obligation by Licensor to indemnify the Licensee Indemnitees under Section 9.2. For the avoidance of
doubt, Licensee shall not indemnify Licensor for any activities, including clinical trial activities, carried out by Licensor
or Licensor&rsquo;s agents prior to the Effective Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.2.
<B>Indemnification by Licensor</B>. Licensor shall indemnify, defend and hold harmless the Licensee Indemnitees from and against
any and all Losses relating to or in connection with a Third Party claim arising after the Effective Date out of (a) any breach
by Licensor of its representations, warranties or covenants made under this Agreement, or (b) any negligent act or omission or
willful misconduct of Licensor or its Affiliates or its or their sublicensees, or any of their employees, contractors or agents,
in performing Licensor&rsquo;s obligations or exercising Licensor&rsquo;s rights under this Agreement; provided, however, that the foregoing
indemnity shall not apply to the extent that any such Losses are attributable to (i) the negligence or willful misconduct of the
Licensee Indemnitees, or (ii) are otherwise subject to an obligation by Licensee to indemnify the Licensor Indemnitees under Section
9.1. For the avoidance of doubt, Licensor shall not indemnify Licensee for any activities, including clinical trial activities,
carried out by Licensee or Licensee&rsquo;s agents after to the Effective Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.
<B>TERM AND TERMINATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1.
<B>Term; Expiration</B>. Unless earlier terminated in accordance with this Article, the term if this Agreement (the &ldquo;<U>Term</U>&rdquo;)
shall commence as of the Effective Date and remain in force until the Royalty Term has expired with respect to all Licensed Products
in all countries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2.
<B>Termination for Breach</B>. Subject to the other terms of this Agreement, this Agreement and the rights granted herein may
be terminated by either Party for the material breach by the other Party of any material obligation or condition hereof, provided
that the breaching Party has not cured such breach within forty-five (45) days after the date of written notice to the breaching
Party in the case of a payment breach and one hundred twenty (120) days after the date of written notice to the breaching Party
in the case of any other breach, which notice shall describe such breach in reasonable detail and shall state the non-breaching
Party&rsquo;s intention to terminate this Agreement pursuant to this Section or in the case of Licensee, its intention to either terminate
this Agreement or elect its alternative remedy pursuant to Section 10.8.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3.
<B>Voluntary Termination</B>. Licensee may terminate this Agreement at any time upon ninety (90) days&rsquo; notice to Licensor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4.
<B>Effects of Expiration or Termination</B>. Upon any termination of this Agreement (i) as of the effective date of such termination
all licenses granted by Licensor to Licensee under this Agreement hereunder shall terminate automatically; provided, however,
that Licensee and its Affiliates and Sublicensees may sell Licensed Products in their inventory as of the effective date of such
termination, subject to the payment of royalties under Section 4, and (ii) each Party shall return all Confidential Information
of the other Party. For the avoidance of doubt, in the event of a voluntary termination or termination due to uncured breach by
Licensee, then all Licensed Patents and any improvements thereto necessary to make use and sell a Licensed Product, as well as
all clinical trial data, biologic materials and other information necessary and desirable to make, use and sell Licensed Product
shall revert to Licensor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5.
<B>Survival of Sublicenses</B>. Notwithstanding anything to the contrary, no termination of this Agreement shall be construed
as a termination of any sublicense of any Sublicensee, and thereafter each such Sublicensee shall be considered a direct licensee
of Licensor, provided that (i) Licensee represents and warrants to Licensor that, to Licensee&rsquo;s actual knowledge, as of the effective
date of such termination, such Sublicensee is then in full compliance with all terms and conditions of its sublicense, (ii) such
Sublicensee agrees in writing to assume all applicable obligations of Licensee under this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6.
<B>Remedies</B>. Except as otherwise expressly set forth in this Agreement, the termination provisions of this Article 11 are
in addition to any other relief and remedies available to either Party at law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.7.
<B>Surviving Provisions</B>. Notwithstanding any provision herein to the contrary, the rights and obligations of the Parties set
forth in Articles and Sections 1 (Definitions), 4.7 (Records Retention by Licensee; Review), 5 (Treatment of Confidential Information),
8 (Representations and Warranties), 9 (Indemnification), 10,4 (Effects of Expiration or Termination), 10,5 (Survival of Sublicensees),
10.6 (Remedies), 7 (Surviving Provisions), and 11 (Miscellaneous) as well as any rights or obligations otherwise accrued hereunder
(including any accrued payment obligations), shall survive the expiration or termination of the Term. Without limiting the generality
of the foregoing, Licensee shall have no obligation to make any milestone or payment to Licensor that has not accrued prior to
the effective date of any termination of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.8.
<B>Remedy in Lieu of Termination</B>. If Licensor materially breaches or defaults with respect to any material obligation or condition
of this Agreement and fails to cure such breach or default within one hundred twenty (120) days after receipt of written notice
from Licensee that describes such breach in reasonable detail, Licensee may reduce each of its payment obligations under this
Agreement by fifty percent (50%), which reduction shall be effective with respect to any payment obligations that come due on
or after the first day following such one hundred twenty (120) day cure period. The foregoing shall be in lieu of any right of
termination of this Agreement, if any, for such material breach or default, but in any event will be without prejudice to any
other right or remedy that may be available to Licensee under this Agreement or at law or in equity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.
<B>MISCELLANEOUS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.1.
<B>Notices</B>. All notices, requests and other communications hereunder shall be in writing, shall be addressed to the receiving
Party&rsquo;s address set forth below or to such other address as a Party may designate by notice hereunder, and shall be either (i)
delivered by hand, (ii) made by email (to be followed with postal confirmation), (iii) sent by private courier service providing
evidence of receipt, or (iv) sent by registered or certified mail, return receipt requested, postage prepaid. The addresses and
other contact information for the Parties are as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 25%; padding-left: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    to LICENSOR:</FONT></TD>
    <TD STYLE="width: 75%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Novlmmune
    S.A.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14
    Chemin des Aulx</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1228
    Plan les Ouates, Geneva, Switzerland</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone:
    +41 22 839 71 41 </FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fax:
    +41 22 839 71 43</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 25%; padding-left: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    to Licensee:</FONT></TD>
    <TD STYLE="width: 75%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tiziana
    Life Sciences Plc</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18
    South Street, Mayfair, London W1K 1DG, UK</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone:
    +44 (0) 20 7493 2853</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fax:
    +44 (0) 20 7495 2379</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
notices, requests and other communications hereunder shall be deemed to have been given either (i) if by hand, at the time of
the delivery thereof to the receiving Party at the address of such Party set forth above, (ii) if made by telecopy or facsimile
transmission, at the time that receipt thereof has been acknowledged by the recipient, (iii) if sent by private courier, on the
day such notice is delivered to the recipient, or (iv) if sent by registered or certified mail, on the seventh (7th) business
day following the day such mailing is made.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.2.
<B>Language</B>. The Parties hereto have requested that this Agreement and any related documents be drafted in English, which
shall be controlling for all purposes. Any translation of this Agreement or any part hereof into a language other than English
is for convenience only, and only the original English language version of this Agreement, as it may be amended from time to time
as permitted herein, shall have legal effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.3.
<B>Governing Law</B>. This Agreement will be construed, interpreted and applied in accordance with the laws of England and Wales
(excluding any law controlling conflicts of law). The UN Convention for the International Sale of Goods shall not apply to this
Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.4.
<B>Venue</B>. Any dispute. controversy or claim initiated by either Party arising out of, resulting from or relating to this Agreement,
or the performance by either Party of its obligations under this Agreement, whether before or after termination of this Agreement,
shall be subject to the sole jurisdiction of; and venue in, the courts of competent jurisdiction located within England and Wales.
Licensee and Licensor each irrevocably consent to the jurisdiction of such courts, irrevocably waive any objection based on inconvenience
of forum, and agree that process may be served in the manner provided herein for giving notices or otherwise as allowed by the
law of England and Wales. Notwithstanding the foregoing, either Party shall have the right, without waiving any right or remedy
available to such Party under this Agreement or otherwise, to seek and obtain from any court of competent jurisdiction any Interim
or provisional relief that is necessary or desirable to protect the rights or property of such Party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.5.
<B>Entire Agreement; Amendment</B>. This Agreement comprises the entire Agreement between the Parties with respect to the subject
matter hereof and thereof and supersede all prior representations, understandings and agreements between the Parties with respect
to the subject matter hereof. No modification shall be effective unless in writing with specific reference to this Agreement and
signed by the Parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.6.
<B>Assignment</B>. Licensee may, without the written consent of Licensor, assign this Agreement, in whole or in part, and its
rights and delegate its obligations hereunder to its Affiliates, for any reason, including without limitation in the event of
its merger, consolidation, change in control or similar transaction. Any permitted assignee shall assume all obligations of its
assignor under this Agreement The terms and conditions of this Agreement shall be binding upon and inure to the benefit of the
permitted successors and assigns of the Parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.7.
<B>Force Majeure</B>. Neither Party shall be liable for failure of or delay in performing obligations set forth in this Agreement,
and neither shall be deemed in breach of its obligations, if such failure or delay is due to natural disasters or any causes beyond
the reasonable control of such Party. In event of such force majeure, the Party affected thereby shall use reasonable efforts
to <I>cure </I>or overcome the same and resume performance of its obligations hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.8.
<B>Construction</B>. The Parties hereto acknowledge and agree that: (i) each Party and its counsel reviewed and negotiated the
terms and provisions of this Agreement and have contributed to its revision; (ii) the rule of construction to the effect that
any ambiguities are resolved against the drafting Party shall not be employed in the interpretation of this Agreement; and (iii)
the terms and provisions of this Agreement shall be construed fairly as to all Parties hereto and not in favor of or against any
Party, regardless of which Party was generally responsible for the preparation of this Agreement, In this Agreement: (a) the word
&ldquo;including&rdquo; shall be deemed to be followed by the phrase &ldquo;without limitation&rdquo; or like expression; (b) the
singular shall include the plural and vice versa; (c) masculine, feminine and neuter pronouns and expressions shall be interchangeable,
(d) all references to &ldquo;days&rdquo; means &ldquo;calendar days&rdquo; unless expressly stated to be &ldquo;business days,&rdquo;
and (e) all references to dollars or $ are to United States dollars, whether or not so expressly stated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.9.
<B>Severability</B>. If any provision(s) of this Agreement are or become invalid, are ruled illegal by any court of competent
jurisdiction or are deemed unenforceable under then-current applicable law from time to time in effect during the Term hereof,
it is the intention of the Parties that such provision(s) be deemed to be severed from this Agreement and the remainder of this
Agreement shall not be affected thereby, The Parties hereto agree to renegotiate any such severed provision in good faith in order
to provide a reasonably acceptable, valid alternative to the severed provision, it being the intent of the Parties that the basic
purposes of this Agreement are to be effectuated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.10.
<B>Status Further Assurances</B>. Each Party agrees to execute, acknowledge and deliver such further instructions, and to do
all such other acts, as may be necessary or appropriate in order to carry out the purposes and intent of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.11.
<B>Counterparts</B>. This Agreement may be executed simultaneously in one or more counterparts, each of which shall be deemed
an original, but all of which together shall constitute one and the same instrument.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Remainder
of page intentionally left blank]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Parties have executed this Agreement effective as of the Effective Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 40%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOVIMMUNE</FONT></TD>
    <TD STYLE="width: 20%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 40%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TIZIANA
    LIFE SCIENCES</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Eduard E. Holdener</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Gabriele Cerrone</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Eduard
    E. Holdener, MD</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gabriele
    Cerrone</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive
    Chairman</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive
    Chairman</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 40%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Jack Barbut</FONT></TD>
    <TD STYLE="width: 60%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jack
    Barbut, ScD</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CEO</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex10-2_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex10-2_002.jpg" ALT=""></FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex10-2_003.jpg" ALT=""></FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex10-2_004.jpg" ALT=""></FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Page; Sequence: 20; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>9
<FILENAME>ff12018a1ex10-3_tiziana.htm
<DESCRIPTION>LICENSE AND SUBLICENSE AGREEMENT RELATING TO IL-6R (NI-1201) BETWEEN NOVIMMUNE SA AND TIZIANA LIFE SCIENCES PLC, DATED DECEMBER 2016
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: right"><B>Exhibit 10.3</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>LICENSE AND SUBLICENSE
AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">This License and Sublicense Agreement (&ldquo;<U>Agreement</U>&rdquo;)
is made effective as of December 22, 2016 (&ldquo;<U>Effective Date</U>&rdquo;) by and between on the one hand NovImmune S.A., 14
Chemin des Aulx, Plan les Ouates, Geneva, Switzerland (&ldquo;Licensor&rdquo;), and Tiziana Life Sciences, 18 South Street, Mayfair,
London, W1K 1DG, UK (&ldquo;<U>Licensee</U>&rdquo;). Licensor and Licensee are each hereafter referred to individually as a &ldquo;<U>Party</U>&rdquo;
and together as the &ldquo;<U>Parties</U>.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">WHEREAS, Licensee desires to obtain an
exclusive license to patents owned or controlled by Licensor, a sublicense to certain patents licensed from Bristol-Myers Squibb
Company (&ldquo;BMS&rdquo;), along with any associated know-how, biologic materials, clinical data or other technology relating to
IL-6 receptor monoclonal antibodies (identified as NI-1201), and their use in order to research, develop and commercialize products
and services;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">NOW, THEREFORE, in consideration of the
mutual covenants contained herein, and for other good and valuable consideration, the receipt and adequacy of which are hereby
acknowledged, the Parties hereby agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">1. <B>DEFINITIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">Capitalized terms used in this Agreement
shall have the meanings specified below or elsewhere herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">1.1. &ldquo;<U>Affiliate</U>&rdquo; means
any Person who directly or indirectly controls or is controlled by or is under common control with another Person. A Person shall
only be considered an Affiliate during the duration of such control. For purposes of this definition, &ldquo;<U>control</U>&rdquo;
or &ldquo;<U>controlled</U>&rdquo; means ownership, directly or through one or more Affiliates, of fifty percent (50%) or more of
the shares of stock entitled to vote for the election of directors, in the case of a corporation, or fifty percent (50%) or more
of the equity interest, in the case of any other type of legal entity, or status as a general partner in any partnership, or the
contractual right to control the election of directors or direct the affairs of any Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">1.2. &ldquo;<U>Confidential Information</U>
means with respect to a Party (the &ldquo;<U>Receiving Party</U>&rdquo;), all information that is (i) disclosed by the other Party
(the &ldquo;<U>Disclosing Party</U>&rdquo;) to the Receiving Party; and (ii) would be reasonably understood from notices or legends,
the nature of such information itself or the circumstances of such information&rsquo;s disclosure to be confidential by a reasonable
person familiar with the applicable industry; provided, however, that Confidential Information shall not include information that
the Receiving Party can demonstrate by its records or other suitable documentary evidence, (a) as of the date of disclosure is
demonstrably known to the Receiving Party or its Affiliates other than by virtue of a prior confidential disclosure to such Party
or its Affiliates; (b) as of the date of disclosure is in, or subsequently enters, the public domain, through no fault or omission
of the Receiving Party; (c) is obtained from a Third Party having a lawful right to make such disclosure free from any obligation
of confidentiality to the Disclosing Party; or (d) is independently developed by or for the Receiving Party without reference to
or reliance upon any Confidential Information of the Disclosing Party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">1.3. <U>Cover</U>&rdquo; means
with respect to Valid Claims in an issued patent, that, in the absence of a license, the use, sale, or manufacture of the product
in question would infringe such Valid Claim.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">1.4. &ldquo;<U>Field</U>&rdquo;
means any and all uses including all therapeutic uses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">1.5. &ldquo;<U>First Commercial Sale</U>&rdquo;
means, on a country-by-country basis, the date of the first arm&rsquo;s length transaction, transfer or disposition for value by or on
behalf of Licensee or any Affiliate or Sublicensee of Licensee to a Third Party of a Licensed Product after the granting of all
regulatory approvals and marketing authorizations. First Commercial Sale excludes any sale or other distribution in connection
with seeking regulatory approval.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">1.6. &ldquo;<U>Licensor Indemnitees</U>&rdquo;
means Licensor, its Affiliates and the directors, officers, employees and agents of LICENSOR and its Affiliates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">1.7.
&ldquo;<U>Licensed Patents</U>&rdquo; means the patents and patent applications listed on Exhibit 1 hereto, and including all
provisionals, substitutions, continuations, continuations-in-part, divisionals, supplementary protection certificates, renewals,
all letters patent granted thereon, and all reissues, reexaminations, extensions, confirmations, revalidations, registrations,
patents of addition thereof, and foreign equivalents to any of the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">1.8. &ldquo;<U>Licensed Product</U>&rdquo;
means any product or service, the manufacture, use, sale, importation or performance of which would, absent the license granted
herein, infringe a Valid Claim of the Licensed Patents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">1.9. &ldquo;<U>Licensee Indemnitees</U>&rdquo;
means Licensee, its Affiliates, Sublicensees, and the directors, officers, employees and agents of Licensee and its Affiliates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">1.10. &ldquo;<U>Net Sales</U>&rdquo; means,
for any period, the gross amount invoiced by Licensee and its Affiliates for the sale of Licensed Products to third parties, less
deduction for:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left">(a)</TD><TD STYLE="text-align: justify">Normal and customary trade, quantity and cash discounts
and sales returns and allowances including (i) those granted on account of price adjustments, billing errors, rejected goods,
damaged goods, returns and rebates, (ii) administrative and other fees and reimbursements and similar payments directly related
to the sale or delivery of Licensed Products paid to wholesalers and other distributors, buying groups, pharmacy benefit management
organizations, health care insurance carriers and other institutions, (iii) allowances, rebates, and fees directly related to
the sale of delivery of License Products paid to distributors and (iv) chargebacks;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left">(b)</TD><TD STYLE="text-align: justify">Freight, postage, shipping and insurance costs to the
extent that such items are included in the gross amount invoiced;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left">(c)</TD><TD STYLE="text-align: justify">Customs and excise duties and other duties related
to the sales to the extent that such items are included in the gross amount invoiced;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left">(d)</TD><TD STYLE="text-align: justify">rebates and similar payments made with respect to sales
paid for or reimbursed by any governmental or regulatory authority such as, by way of illustration, federal or state Medicaid,
Medicare or similar state program or equivalent foreign governmental program;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left">(e)</TD><TD STYLE="text-align: justify">sales and other taxes and duties directly related to
the sale or delivery of Licensed Products (but not including taxes assed against the income derived from such sale) to the extent
that such items are included in the gross amount invoiced;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left">(f)</TD><TD STYLE="text-align: justify">distribution costs and expenses to the extent that
such items are included in the gross amount invoiced;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left">(g)</TD><TD STYLE="text-align: justify">any such invoiced amounts that are not collected by
the parties or their Affiliates;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.75in; text-align: justify">provided that with respect to the deductions
specified in subsections (as) through (g) above, an amount shall be deducted only once regardless how many categories may apply
to it.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: -0.25in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.75in; text-align: justify">Any of the deductions listed above that
involves a payment by Licensee or its Affiliates shall be taken as a deduction in the calendar quarter in which the payment is
accrued. Deductions pursuant to section (g) above shall be taken in the calendar quarter in which such sales are no longer recorded
as a receivable. For purposes of determining Net Sales, the Licensed Products shall be deemed to be sold when invoiced and a &ldquo;sale&rdquo;
shall not include transfers or dispositions for charitable, promotional, pre-clinical, regulatory or governmental purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: -0.25in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.75in; text-align: justify">For the purposed of calculating Net Sales
of Licensed Products, sales between or among Licensee or its Affiliates shall be excluded from the computation of Net Sales, but
sales by Licensee or its Affiliates to third parties shall be included in the computation of Net Sales.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: -0.25in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.75in; text-align: justify">In the event that a Licensed Product is
sold in any country in the form of a combination product containing one or more therapeutically active ingredients in addition
to the Licensed Product, with respect thereto, the parties shall negotiate in good faith to determine what portion of the net sales
of such combination product shall be treated as Net Sales under the Agreement, which determination shall be based on the value
added by the Licensed Product compared to the value added by such other therapeutically effective ingredients, to the invoice price
of such combination product.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">1.11. &ldquo;<U>Person</U>&rdquo; means any
individual, corporation, limited or general partnership, limited liability company, joint venture, trust, unincorporated association,
governmental body, authority, bureau or agency, or any other entity or body.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; color: #1C1B1B; text-indent: 0.5in">1.12. &ldquo;<U>Revenue
Term</U>&rdquo; means, with respect to each Licensed Product, the period of time beginning on the First Commercial Sale of such
Licensed Product in a country following the receipt of applicable regulatory approval with respect to such sale of such Licensed
Product in such country and continuing on a country-by-country and product-by-product basis until the later of (a) the expiration
of the last Valid Claim of the Licensed Patents which Covers the sale of such Licensed Product in such country or (b) the end of
any market exclusivity period granted by the relevant governmental authority in a country that prevents another party from marketing
the same Licensed Product.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; color: #1C1B1B">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; color: #1C1B1B; text-indent: 0.5in">1.13. &ldquo;<U>Sublicensee</U>&rdquo;
means any Third Party to whom Licensee grants a sublicense of some or all of the rights granted to Licensee under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; color: #1C1B1B">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; color: #1C1B1B; text-indent: 0.5in">1.14. <U>Territory</U>.
Worldwide.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; color: #1C1B1B">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; color: #1C1B1B; text-indent: 0.5in">1.15.
&ldquo;<U>Third Party</U>&rdquo; means any person or entity other than Licensee, Licensor and their respective Affiliates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; color: #1C1B1B">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; color: #1C1B1B; text-indent: 0.5in">1.16. &ldquo;<U>Valid Claim</U>&rdquo;
means a claim in an issued, unexpired patent within the Licensed Patents or a claim that has not been pending more than five (5)
years, in either case that (a) has not been finally cancelled, withdrawn, abandoned or rejected by any administrative agency or
other body of competent jurisdiction, (b) has not been revoked, held invalid, or declared unpatentable or unenforceable in a decision
of a court or other body of competent jurisdiction that is unappealable or unappealed within the time allowed for appeal, (c) has
not been rendered unenforceable through disclaimer or otherwise, and (d) is not lost through an interference proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; color: #1C1B1B">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; color: #1C1B1B">2. <B>LICENSE GRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; color: #1C1B1B"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; color: #1C1B1B; text-indent: 0.5in">2.1. <B>License</B>.
Licensor hereby grants to Licensee a worldwide, exclusive license (even as to Licensor), including the right to grant
sublicenses, under the Licensed Patents, for Licensee and its Affiliates to research, develop, make, have made, use, offer
for sale, sell, have sold and import Licensed Products for any and all uses in the Field in the Territory, subject to the
terms and conditions of this Agreement. The foregoing includes the right to employ Third Party distributors to sell Licensed
Products and Third Party contract manufacturers to make Licensed Products, neither of which shall be construed as a
sublicense.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; color: #1C1B1B">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; color: #1C1B1B; text-indent: 0.5in">2.2. <B>Sublicense
to BMS Rights</B>. Licensor hereby grants an exclusive sublicense to Licensee, including the right to grant
further sublicenses, under the Research and Commercialization Agreement between NovImmune and BMS dated September 30, 2004
and any amendments thereto, and the Exclusive Commercial License between NovImmune and BMS dated September 25, 2009, for the
IL-6 Antibody Licensed Product, copies of which are attached hereto as Schedule A, to make, have made, use, offer for sale,
sell, have sold and/or import Licensed Products in the Field in the Territory. Licensee acknowledges and agrees that the
terms of the sublicense pursuant to this Agreement shall be subordinate to and consistent with all the terms and conditions
of the Research and Commercialization Agreement and any amendments thereto, and the Exclusive Commercial License between
NovImmune and BMS.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">3. <B>DEVELOPMENT AND COMMERCIALIZATION
OF LICENSED PRODUCTS</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">3.1. <B>Authority</B>.
Licensee shall have full control and authority over the research, development (including regulatory matters) and commercialization
of Licensed Products in the Field worldwide.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">3.2. <B>Diligence</B>.
Licensee will, itself or through its Affiliates or Sublicensees, at all times exercise commercially reasonable efforts to commercialize
Licensed Products.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">3.3. <B>Transfer of Data and Know How.
</B>Licensor will transfer all data and documentation relevant to Licensed Product to Licensee at no cost. For a period of 90 days
from signature, Licensor will make key personnel available to Licensee for briefings, to answer questions, and offer advice on
pre-clinical data, science, and manufacturing. As Licensee contemplates pursuing an alternative clinical indication Licensor will
not be able to assist in advising on clinical development. Should the time requirement for Licensor personnel supporting Licensee
to take over the NI-1201 program become burdensome to Licensor, the parties will discuss and agree to an alternative mutually satisfactory
arrangement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">4. <B>PAYMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">4.1. <B>BMS Obligation</B>.
Licensee shall pay directly to BMS any amounts owed to BMS pursuant to the Research and Commercialization Agreement, such amounts
to be negotiated with BMS.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">4.2. <B>Upfront Fee
to NovImmune</B>. Within sixty (60) days of the Effective Date, Licensee shall pay to Licensor the amount of $100,000 USD.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">4.3. <B>Royalties.
</B>Licensee will pay a royalty of 2% on Net Sales, or 12.5% of any sublicense royalty revenue it receives arising from sales
of a Licensed Product, either by itself or through a sublicensee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">4.4. <B>Payment Terms</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">4.4.1. <B>Payment
of Received Revenue</B>. Licensee shall make any payments owed to Licensor hereunder in arrears, within ninety (90) days from the
end of each quarter in which such payment accrues. Each payment shall be accompanied by a report for each country in which sales
of Licensed Products occurred in the calendar quarter covered by such statement, specifying: the gross sales (if available) and
sales in each country&rsquo;s currency; the applicable revenue sharing amount under this Agreement; the amount payable in each </FONT>country&rsquo;s
currency, including an accounting of deductions taken in accordance with Licensee&rsquo;s accounting practices; the applicable exchange
rate to convert from each country&rsquo;s currency to United States Dollars; and the amounts payable in United States Dollars.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in">4.4.2. <B>Accounting</B>. All payments
hereunder shall be made in in United States dollars. Conversion of foreign currency to United States dollars shall be made in the
same manner as Licensee converts all of its other revenues, provided that (a) such manner is consistent with United States generally
accepted accounting principles, and (b) the exchange rates employed are those quoted by a reputable source, such as a recognized
money center bank such as JP Morgan, Bank of America or an equivalent,.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in">4.4.3. <B>Tax Withholding; Restrictions
on Payment</B>. All payments hereunder shall be made free and clear of any taxes, duties, levies, fees or charges, except for withholding
taxes and interest and penalties thereon (to the extent applicable). Licensee shall make any applicable withholding payments due
on behalf of Licensor and shall provide Licensor upon request with such written documentation regarding any such payment as available
to Licensee relating to an application by Licensor for a foreign tax credit for such payment with the United States Internal Revenue
Service. Licensor shall provide all information necessary to determine if withholding taxes are applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">4.5. <B>Records Retention by Licensee;
Review</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in">4.5.1. <B>Royalty Records</B>. Commencing
as of the date of First Commercial Sale of the first Licensed Product hereunder, Licensee and its Affiliates and Sublicensees shall
keep for at least three (3) years from the end of the calendar year to which they pertain complete and accurate records of sales
by Licensee or its Affiliates and Sublicensees, as the case may be, of each Licensed Product, in sufficient detail to allow the
accuracy of the payments hereunder to be confirmed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in">4.5.2. <B>Review</B>. Subject to the other
terms of this Section 4.5, at the request of Licensor, which shall not be made more frequently than once per calendar year during
the Term, and upon at least thirty (30) days&rsquo; prior written notice from Licensor, and at the expense of Licensor (except as otherwise
provided herein), Licensee shall permit an independent certified public accountant selected by Licensor and reasonably acceptable
to Licensee to inspect (during Licensee&rsquo;s regular business hours) the relevant records required to be maintained by Licensee under
Section 4.5. In every case the accountant must have previously entered into a confidentiality agreement with both Parties substantially
similar to the provisions of Article 5 and limiting the disclosure and use of such information by such accountant to authorized
representatives of the Parties and the purpose of verifying amounts payable to Licensor hereunder. Results of any such review shall
be binding on both Parties absent manifest error. If any review reveals a deficiency in the calculation and/or payment of amounts
owed by Licensee, then (a) Licensee shall pay Licensor the amount remaining to be paid, and (b) if such underpayment is by ten
percent (10%) or more for any twelve (12) month consecutive period, then Licensee shall reimburse Licensor for its reasonable out-of-pocket
costs and expenses incurred in performing the review.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; color: #1C1B1B">5. <B>TREATMENT OF CONFIDENTIAL
INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; color: #1C1B1B">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">5.1. <B>Confidential Obligations.
</B>Licensor and Licensee each recognize that the other Party&rsquo;s Confidential Information constitutes highly valuable and proprietary
confidential information. Licensor and Licensee each agree that during the Term and for five (5) years thereafter, it will keep
confidential, and will cause its employees, consultants (including academic collaborators and CROs), professional advisors, Affiliates
and, in the case of Licensee, Sublicensees to keep confidential, all Confidential Information of the other Party. Neither Licensor
nor Licensee nor any of their respective employees, consultants, Affiliates or, in the case of Licensee, Sublicensees, shall use
any Confidential Information of the other Party for any purpose whatsoever other than exercising any rights granted to it hereunder
or as expressly permitted in this Article 5. Licensee may disclose Licensor&rsquo;s Confidential Information to the extent such disclosure
is reasonably necessary to file and prosecute patent applications and/or maintain patents which are filed or prosecuted in accordance
with the provisions of this Agreement, or to obtain any authorization to conduct clinical studies or any regulatory approval for
Licensed Products. Each Party may disclose the other Party&rsquo;s Confidential Information as reasonably necessary to file, conduct
or defend litigation in accordance with the provisions of this Agreement or comply with applicable laws, regulations or court orders;
provided, however, that if a Party is required to make any such disclosure of the other Party&rsquo;s Confidential Information in connection
with any of the foregoing, it will give reasonable advance notice to the other Party of such disclosure requirement and will use
reasonable efforts to assist such other Party in efforts to secure confidential treatment of such information required to be disclosed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; color: #1C1B1B">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #1C1B1B">5.2.
<B>Limited Disclosure and Use</B>. Each Party may disclose the other Party&rsquo;s Confidential Information to any of its officers,
employees, consultants, agents or Affiliates, or in the case of Licensee, Sublicensees, if and only to the extent necessary to
carry out its rights and responsibilities under this Agreement. Such disclosures shall be limited to the maximum extent possible
consistent with such rights and responsibilities and shall only be made to the extent any such persons receiving the other Party&rsquo;s
Confidential Information are bound by written confidentiality obligations to maintain the confidentiality thereof and not to use
such Confidential Information except as expressly permitted by this Agreement. Licensor and Licensee each agree not to disclose
or transfer the other Party&rsquo;s Confidential Information to any Third Parties under any circumstance without the prior written
approval from the other Party, except as otherwise required by law, and except as otherwise expressly permitted under this Article
5 or elsewhere in this Agreement. Each Party shall take such action, and shall cause its Affiliates, and in the case of Licensee,
Sublicensees, to take such action, to preserve the confidentiality of each other&rsquo;s Confidential Information as it would
customarily take to preserve the confidentiality of its own Confidential Information, using, in all such circumstances, not less
than reasonable care. Each Party, upon the request of the other Party, will return all the Confidential Information disclosed
or transferred to it by the other Party pursuant to this Agreement, including all copies and extracts of documents and all manifestations
in whatever form, in such Party&rsquo;s possession within sixty (60) days of such request or, if earlier, the termination or expiration
of this Agreement; provided however, that a Party may retain (a) any Confidential Information of the other Party relating to any
license that is still in force hereunder or which expressly survives such termination, and (b) one (1) </FONT>copy of all other
Confidential Information in inactive archives solely for the purpose of establishing the contents thereof,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">5.3. <B>Terms of Agreement</B>. The terms
of this Agreement constitute each Party&rsquo;s Confidential Information; provided, however, that either Party may disclose the terms
of this Agreement (a) to the extent required by law or by the requirements of any nationally recognized securities exchange, quotation
system or over-the-counter market on which such Party has its securities listed or traded, or (b) in confidence to its attorneys,
accountants and other fiduciaries, and (c) to any acquirers, potential acquirers, investors, prospective investors, lenders and
other potential financing sources who are obligated to keep such information confidential.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">5.4. <B>Press Release</B>. The Parties
shall diligently work together to draft a mutually agreeable press release announcing the execution of this Agreement such announcement
to be made no later than 07:00 on the day following the Effective Date, and shall publish such press release in a mutually agreeable
manner.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">6.
<B>FILING, PROSECUTION AND MAINTENANCE OF PATENT RIGHTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">6.1. <B>Prosecution
Control</B>. For purposes of this Article 6, the right to control prosecution of a Patent Right shall include the right to
control preparing, filing, and prosecuting patent applications therefor, and obtaining and maintaining any resulting patents,
including the conduct of interferences, the defense of oppositions and other similar proceedings with respect to a
patent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">6.2. <B>Patent
Prosecution</B>. Licensee shall, at its expense, to assume control of the prosecution of the Licensed Patents, subject to the
provisions of this Article 6. If Licensee decides not to prosecute or maintain any Patent Right within the Licensed
Patents, then Licensee shall provide Licensor with written notice of such decision prior to the deadline for taking any
action for such Patent Right or the date on which the abandonment of any such Patent Right would become effective, whichever
is earlier. If Licensee does not wish to continue prosecution of a case or decides not to file in a particular country, the
Licensor may do so at Licensor&rsquo;s own cost.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">6.3. <B>Right of Review and Comment</B>. Licensee
shall consult with Licensor regarding the prosecution of the Licensed Patents by using commercially reasonable efforts to provide
Licensor a Reasonable Opportunity to review and comment on all proposed submissions to any patent office before submission, where
&ldquo;<U>Reasonable Opportunity</U>&rdquo; means that Licensee shall provide Licensor or patent counsel true copies of all documents
relating to filing, registration, prosecution, and maintenance of patent applications and patents within the Licensed Patents as
soon as reasonably practical after Licensee has received such documents and materials. Licensee shall consider in good faith Licensor&rsquo;s
comments concerning such documents and materials that it timely receives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">7.
<B>PATENT ENFORCEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">7.1. <B>Notice
of Infringement</B>. If, during the Term, either Party learns of any actual, alleged or threatened infringement by a Third
Party of any Licensed Patents, such Party shall promptly notify the other Party and shall provide the other Party with
available evidence of such infringement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; color: #1E1D1D">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; color: #1E1D1D"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; color: #1E1D1D">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; color: #1E1D1D; text-indent: 0.5in">7.2. <B>Infringement
of Patent Rights</B>. Licensee shall have the first right (but not the obligation), at its own expense and with legal counsel
of its own choice, to bring suit (or take other appropriate legal action) against any actual, alleged or threatened
infringement of the Licensed Patents in the Field by any product or service that competes with a Licensed Product, as
reasonably determined by Licensee. Licensor shall take all actions necessary to assist Licensee in any suit, including
joining in such suit as a party if legally required, at Licensee&rsquo;s expense. Licensor shall have the right, at its own
expense, to be represented in any such action by counsel of Licensor&rsquo;s own choice; provided, however, that the foregoing
shall not affect the right of Licensee to control the suit as described in this Section. In the event that the Licensee does
not bring suit, Licensor shall have the right to bring suit, provided that there is no commercially reasonable reason that
Licensee did not bring suit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; color: #1E1D1D">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; color: #1E1D1D">8. <B>REPRESENTATIONS AND
WARRANTIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; color: #1E1D1D">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; color: #1E1D1D; text-indent: 0.5in">8.1. <B>Licensor Representations.
</B>Licensor represents, warrants and covenants to Licensee that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; color: #1E1D1D">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; color: #1E1D1D; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left">(a)</TD><TD STYLE="text-align: justify">the execution and delivery of this Agreement and the
performance of the transactions contemplated hereby have been duly authorized by all appropriate Licensor corporate action;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; color: #1E1D1D">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; color: #1E1D1D; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left">(b)</TD><TD STYLE="text-align: justify">this Agreement is a legal and valid obligation binding
upon Licensor and enforceable in accordance with its terms, and the execution, delivery and performance of this Agreement by the
Parties does not conflict with any agreement, instrument or understanding to which Licensor is a party or by which it is bound;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; color: #1E1D1D">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; color: #1E1D1D; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left">(c)</TD><TD STYLE="text-align: justify">Licensor has the full right and legal capacity to grant
the rights granted to Licensee hereunder;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; color: #1E1D1D">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; color: #1E1D1D; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left">(d)</TD><TD STYLE="text-align: justify">the Licensed Patents have been properly filed and prosecuted
as of the Effective Date;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; color: #1E1D1D">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; color: #1E1D1D; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left">(e)</TD><TD STYLE="text-align: justify">Licensor is the sole owner of the Licensed Patents;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; color: #1E1D1D">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; color: #1E1D1D; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left">(f)</TD><TD STYLE="text-align: justify">as of the Effective Date, Licensor has not licensed or
transferred to any Person, including Licensor Affiliates, any rights under the Licensed Patents; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; color: #1E1D1D">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; color: #1E1D1D; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left">(g)</TD><TD STYLE="text-align: justify">Licensor is not aware of any Third Party patent, patent
application or other intellectual property right that would be infringed (i) by practicing any process or method or by making,
using or selling any composition which is claimed or disclosed in, or which constitutes, Licensed Patents, or (ii) by making,
using, offering for sale, selling or importing Licensed Products.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; color: #1E1D1D">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; color: #1E1D1D"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; color: #1E1D1D">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">8.2.
<B>Licensee Representations</B>. Licensee represents and warrants to Licensor that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-align: justify; text-indent: 1in">8.2.1. the execution and delivery of this
Agreement and the performance of the transactions contemplated hereby have been duly authorized by all appropriate Licensee corporate
action; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in">8.2.2. this Agreement is a legal and valid
obligation binding upon Licensee and enforceable in accordance with its terms, and the execution, delivery and performance of this
Agreement by the Parties does not conflict with any agreement, instrument or understanding to which Licensee is a party or by which
it is bound.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">8.3.
<B>No Warranties</B>. Except as expressly set forth in this Agreement, NEITHER PARTY MAKES ANY REPRESENTATION OR EXTENDS ANY WARRANTIES
OF ANY KIND, EITHER EXPRESS OR IMPLIED. THERE ARE NO EXPRESS OR IMPLIED WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR
PURPOSE, OR OF NON-INFRINGEMENT OF ANY PATENT, COPYRIGHT, TRADEMARK, OR OTHER RIGHTS OF THIRD PARTIES, OR AS TO THE SUCCESS OR
LIKELIHOOD OF SUCCESS OF THE RESEARCH, DEVELOPMENT OR COMMERCIALIZATION OF LICENSED PRODUCTS UNDER THIS AGREEMENT, OR ANY OTHER
EXPRESS OR IMPLIED WARRANTIES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">9.
<B>INDEMNIFICATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">9.1.
<B>Indemnification by Licensee</B>. Licensee shall indemnify, defend and hold harmless the Licensor Indemnitees from and against
any and all losses, damages, fees, expenses, settlement amounts and costs (including reasonable attorneys&rsquo; fees and witness
fees) (collectively, &ldquo;<U>Losses</U>&rdquo;) relating to or in connection with a Third Party claim arising after the Effective
Date out of (a) any breach by Licensee of its representations, warranties or covenants made under this Agreement, or (b) any actual
or alleged death, personal bodily injury or damage to real or tangible personal property claimed to result, directly or indirectly,
from the possession, use or consumption of, or treatment with, the Licensed Product made or sold by or on behalf of Licensee or
its Affiliates or Sublicensees, including any product liability claims; provided, however, that the foregoing indemnity shall
not apply to the extent that any such Losses (i) are attributable to the negligence or willful misconduct of the Licensor Indemnitees,
or (ii) are subject to an obligation by Licensor to indemnify the Licensee Indemnitees under Section 9.2. For the avoidance of
doubt, Licensee shall not indemnify Licensor for any activities, including clinical trial activities, carried out by Licensor
or Licensor&rsquo;s agents prior to the Effective Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">9.2. <B>Indemnification by Licensor</B>. Licensor
shall indemnify, defend and hold harmless the Licensee Indemnitees from and against any and all Losses relating to or in connection
with a Third Party claim arising after the Effective Date out of (a) any breach by Licensor of its representations, warranties
or covenants made under this Agreement, or (b) any negligent act or omission or willful misconduct of Licensor or its Affiliates
or its or their sublicensees, or any of their employees, contractors or agents, in performing Licensor&rsquo;s obligations or exercising
Licensor&rsquo;s rights under this Agreement; provided, however, that the foregoing indemnity shall not apply to the extent that any
such Losses are attributable to (i) the negligence or willful misconduct of the Licensee Indemnitees, or (ii) are otherwise subject
to an obligation by Licensee to indemnify the Licensor Indemnitees under Section 9.1. For the avoidance of doubt, Licensor shall
not indemnify Licensee for any activities, including clinical trial activities, carried out by Licensee or Licensee&rsquo;s agents after
to the Effective Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">10. <B>TERM AND TERMINATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">10.1.
<B>Term; Expiration</B>. Unless earlier terminated in accordance with this Article, the term of this Agreement (the &ldquo;<U>Term</U>&rdquo;)
shall commence as of the Effective Date and remain in force until the Revenue Term has expired with respect to all Licensed Products
in all countries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">10.2. <B>Termination for Breach</B>. Subject
to the other terms of this Agreement, this Agreement and the rights granted herein may be terminated by either Party for the material
breach by the other Party of any material obligation or condition hereof, provided that the breaching Party has not cured such
breach within forty-five (45) days after the date of written notice to the breaching Party in the case of a payment breach and
one hundred twenty (120) days after the date of written notice to the breaching Party in the case of any other breach, which notice
shall describe such breach in reasonable detail and shall state the non-breaching Party&rsquo;s intention to terminate this Agreement
pursuant to this Section or in the case of Licensee, its intention to either terminate this Agreement or elect its alternative
remedy pursuant to Section 10.8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">10.3. <B>Voluntary Termination</B>. Licensee
may terminate this Agreement at any time upon ninety (90) days&rsquo; notice to Licensor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">10.4. <B>Effects of Expiration or Termination.
</B>Upon any termination of this Agreement, (i) as of the effective date of such termination all licenses granted by Licensor to
Licensee under this Agreement hereunder shall terminate automatically; provided, however, that Licensee and its Affiliates and
Sublicensees may sell Licensed Products in their inventory as of the effective date of such termination, subject to the payment
of royalties under Section 4, and (ii) each Party shall return all Confidential Information of the other Party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">10.5. <B>Survival of Sublicenses</B>. Notwithstanding
anything to the contrary, no termination of this Agreement shall be construed as a termination of any sublicense of any Sublicensee,
and thereafter each such Sublicensee shall be considered a direct licensee of Licensor, provided that (i) Licensee represents and
warrants to Licensor that, to Licensee&rsquo;s actual knowledge, as of the effective date of such termination, such Sublicensee is then
in full compliance with all terms and conditions of its sublicense, (ii) such Sublicensee agrees in writing to assume all applicable
obligations of Licensee under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">10.6. <B>Remedies</B>. Except as otherwise
expressly set forth in this Agreement, the termination provisions of this Article 11 are in addition to any other relief and remedies
available to either Party at law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">10.7.
<B>Surviving Provisions</B>. Notwithstanding any provision herein to the contrary, the rights and obligations of the Parties set
forth in Articles and Sections 1 (Definitions), 4.5 (Records Retention by Licensee; Review), 5 (Treatment of Confidential Information),
8 (Representations and Warranties), 9 (Indemnification), 10.4 (Effects of Expiration or Termination), 10.5 (Survival of Sublicensees),
10.6 (Remedies), 7 (Surviving Provisions), and 11 (Miscellaneous) as well as any rights or obligations otherwise accrued hereunder
(including any accrued payment obligations), shall survive the expiration or termination of the Term. Without limiting the generality
of the foregoing, Licensee shall have no obligation to make any milestone or payment to Licensor that has not accrued prior to
the effective date of any termination of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">10.8. <B>Remedy in Lieu of Termination.
</B>if Licensor materially breaches or defaults with respect to any material obligation or condition of this Agreement and fails
to cure such breach or default within one hundred twenty (120) days after receipt of written notice from Licensee that describes
such breach in reasonable detail, Licensee may reduce each of its payment obligations under this Agreement by fifty percent (50%),
which reduction shall be effective with respect to any payment obligations that come due on or after the first day following such
one hundred twenty (120) day cure period. The foregoing shall be in lieu of any right of termination of this Agreement, if any,
for such material breach or default, but in any event will be without prejudice to any other right or remedy that may be available
to Licensee under this Agreement or at law or in equity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">11.
<B>MISCELLANEOUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">11.1. <B>Notices</B>. All notices,
requests and other communications hereunder shall be in writing, shall be addressed to the receiving Party&rsquo;s address set forth
below or to such other address as a Party may designate by notice hereunder, and shall be either (i) delivered by hand, (ii) made
by email (to be followed with postal confirmation), (iii) sent by private courier service providing evidence of receipt, or (iv)
sent by registered or certified mail, return receipt requested, postage prepaid. The addresses and other contact information for
the Parties are as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 1.12in">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">If to LICENSOR:</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">NovImmune S.A.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">14 Chemin des Aulx</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">1228
Plan les Ouates, Geneva, Switzerland</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">Phone: +41 22 839 71 41</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">Fax: +41 22 839 71 42</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">If to Licensee:</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">Tiziana Life Sciences</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">18
South Street, Mayfair, London, UK</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">Phone: +44 (0) 20 7 493 2853</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">All
notices, requests and other communications hereunder shall be deemed to have been given either (i) if by hand, at the time
of the delivery thereof to the receiving Party at the address of such Party set forth above, (ii) if made by telecopy or
facsimile transmission, at the time that receipt thereof has been acknowledged by the recipient, (iii) if sent by private
courier, on the day such notice is delivered to the recipient, or (iv) if sent by registered or certified mail, on the
seventh (7th) business day following the day such mailing is made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">11.2. <B>Language</B>. The Parties
hereto have requested that this Agreement and any related documents be drafted in English, which shall be controlling for all purposes.
Any translation of this Agreement or any part hereof into a language other than English is for convenience only, and only the original
English language version of this Agreement, as it may be amended from time to time as permitted herein, shall have legal effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">11.3. <B>Governing Law</B>. This
Agreement will be construed, interpreted and applied in accordance with the laws of England and Wales (excluding any law controlling
conflicts of law). The UN Convention for the International Sale of Goods shall not apply to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">11.4. <B>Venue</B>. Any dispute,
controversy or claim initiated by either Party arising out of, resulting from or relating to this Agreement, or the performance
by either Party of its obligations under this Agreement, whether before or after termination of this Agreement, shall be subject
to the sole jurisdiction of, and venue in, the courts of competent jurisdiction located within England and Wales. Licensee and
Licensor each irrevocably consent to the jurisdiction of such courts, irrevocably waive any objection based on inconvenience of
forum, and agree that process may be served in the manner provided herein for giving notices or otherwise as allowed by the law
of England and Wales. Notwithstanding the foregoing, either Party shall have the right, without waiving any right or remedy available
to such Party under this Agreement or otherwise, to seek and obtain from any court of competent jurisdiction any Interim or provisional
relief that is necessary or desirable to protect the rights or property of such Party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">11.5.
<B>Entire Agreement; Amendment</B>. This Agreement comprises the entire Agreement between the Parties with respect to the subject
matter hereof and thereof and supersede all prior representations, understandings and agreements between the Parties with respect
to the subject matter hereof. No modification shall be effective unless in writing with specific reference to this Agreement and
signed by the Parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">11.6. <B>Assignment</B>. Licensee
may, without the written consent of Licensor, assign this Agreement, in whole or in part, and its rights and delegate its obligations
hereunder to its Affiliates, for any reason, including without limitation in the event of its merger, consolidation, change in
control or similar transaction. Any permitted assignee shall assume all obligations of its assignor under this Agreement. The terms
and conditions of this Agreement shall be binding upon and inure to the benefit of the permitted successors and assigns of the
Parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">11.7. <B>Force Majeure</B>. Neither
Party shall be liable for failure of or delay in performing obligations set forth in this Agreement, and neither shall be deemed
in breach of its obligations, if such failure or delay is due to natural disasters or any causes beyond the reasonable control
of such Party. In event of such force majeure, the Party affected thereby shall use reasonable efforts to cure or overcome the
same and resume performance of its obligations hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-align: justify; text-indent: 0.5in">11.8. <B>Construction</B>. The
Parties hereto acknowledge and agree that: (i) each Party and its counsel reviewed and negotiated the terms and provisions of this
Agreement and have contributed to its revision; (ii) the rule of construction to the effect that any ambiguities are resolved against
the drafting Party shall not be employed in the interpretation of this Agreement; and (iii) the terms and provisions of this Agreement
shall be construed fairly as to all Parties hereto and not in favor of or against any Party, regardless of which Party was generally
responsible for the preparation of this Agreement. In this Agreement: (a) the word &ldquo;including&rdquo; shall be deemed to be
followed by the phrase &ldquo;without limitation&rdquo; or like expression; (b) the singular shall include the plural and vice versa:
(c) masculine, feminine and neuter pronouns and expressions shall be interchangeable, (d) all references to &ldquo;days&rdquo; means
&ldquo;calendar days&rdquo; unless expressly stated to be &ldquo;business days,&rdquo; and (e) all references to dollars or $ are to
United States dollars, whether or not so expressly stated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">11.9. <B>Severability</B>. If
any provision(s) of this Agreement are or become invalid, are ruled illegal by any court of competent jurisdiction or are deemed
unenforceable under then<FONT STYLE="color: #747372">-</FONT>current applicable law from time to time in effect during the Term
hereof, it is the intention of the Parties that such provision(s) be deemed to be severed from this Agreement and the remainder
of this Agreement shall not be affected thereby. The Parties hereto agree to renegotiate any such severed provision in good faith
in order to provide a reasonably acceptable, valid alternative to the severed provision, it being the intent of the Parties that
the basic purposes of this Agreement are to be effectuated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-align: justify; text-indent: 0.5in">11.10. <B>Status. Further Assurances</B>. Each Party agrees to execute, acknowledge and deliver such further instructions, and to do all such other acts, as may be necessary
or appropriate in order to carry out the purposes and intent of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">11.11. <B>Counterparts</B>. This
Agreement may be executed simultaneously in one or more counterparts, each of which shall be deemed an original, but all of which
together shall constitute one and the same instrument.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">[Remainder of page intentionally
left blank]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0; text-align: justify; color: #1B1B1B; text-indent: 0.5in">IN WITNESS WHEREOF,
the Parties have executed this Agreement effective as of the Effective Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 35%; padding-right: 55.8pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: #1B1B1B">NOVIMMUNE SA</FONT></TD>
    <TD STYLE="width: 30%; padding-right: 0.25pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 35%; padding-right: 0.25pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: #1B1B1B">TIZIANA LIFE SCIENCES</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 55.8pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 0.25pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 0.25pt; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 55.8pt; text-align: justify; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: #1B1B1B">/s/ Eduard E. Holdener</FONT></TD>
    <TD STYLE="padding-right: 0.25pt; text-align: justify; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.25pt; text-align: justify; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: #1B1B1B">/s/ Gabriele Cerrone</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 55.8pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: #1B1B1B">Eduard E. Holdener, MD</FONT></TD>
    <TD STYLE="padding-right: 0.25pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 0.25pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: #1B1B1B">Gabriele Cerrone, Chairman</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 2.6pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: #1B1B1B">Chairman and CEO</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 1.35in; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 1.35in; text-align: justify; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: #1B1B1B">/s/ Nathalie Muller</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 1.35in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: #1B1B1B">Nathalie Muller</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 1.35in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: #1B1B1B">Legal Director</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;<IMG SRC="ex10-3_001.jpg" ALT=""></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center"><IMG SRC="ex10-3_002.jpg" ALT="">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>AMENDMENT TO THE RESEARCH AND COMMERCIALIZATION
AGREEMENT</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This amendment to
the Research and Commercialization Agreement (the &ldquo;<B>IL-6r Amendment</B>&rdquo;) is entered into as of the 22nd day of
December, 2016 (the &ldquo;<B>IL-6r Amendment Effective Date</B>&rdquo;) by and between:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Bristol-Myers Squibb
Company</B>, a Delaware corporation with a principal place of business at 345 Park Avenue, New York, NY 10154 (&ldquo;<B>BMS</B>&rdquo;),
<B>Medarex, Inc.,</B> a wholly owned subsidiary of BMS (&ldquo;<B>Medarex</B>&rdquo;), <B>GenPharm International, Inc.,</B> a
wholly owned subsidiary of Medarex, Inc. (together with BMS and Medarex, &ldquo;<B>Medarex</B>&rdquo;) and Novimmune S.A. (&ldquo;<B>Novimmune</B>&rdquo;),
with a principal place of business at 18 chemin des Aulx, Plan les Ouates, Geneva, Switzerland. <B>Medarex</B> and <B>Novimmune
</B>may sometimes individually be referred to hereafter as a &ldquo;<B>Party</B>&rdquo; or collectively as the &ldquo;<B>Parties</B>&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><U>BACKGROUND</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, the
Parties have executed that certain Research and Commercialization Agreement dated September 30, 2004 (the &ldquo;Agreement&rdquo;)
and the IL-6r Antibody Exclusive Commercial License (&ldquo;<B>EC License</B>&rdquo;) between <B>Novimmune</B> and <B>BMS</B>
dated September 25, 2009, and the Parties would like to further Amend said <B>Agreement and EC License</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>NOW, THEREFORE</B>,
in consideration of the mutual covenants and obligations set forth herein, and for other good and valuable consideration, the
Parties hereby agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1. All terms and conditions of the <B>Agreement
</B>and the <B>EC License</B> not modified by the Amendment shall continue in full force and effect in accordance with their terms.
All capitalized terms not otherwise defined herein shall have the same definition as in the <B>Agreement</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2. The Parties acknowledge that the Exclusive
Commercial License fee has been paid. The Parties agree that the development deadline set forth in section 8.3 for the filing of
an IND shall be reset until November 30, 2019, with all subsequent development milestones or non-diligence payments delayed and
reset based on the filing date of the IND. All amounts of such development milestones and non-diligence payments shall otherwise
be unchanged.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3. The Parties further agree that in the
event that Novimmune or a sublicensee commercializes a combination product comprising an anti IL-6r antibody (NI-1201) and an
anti CD3 antibody (NI-0401) then such product shall be subject to a single royalty at the rate set forth is section 5.5.1 of the
<B>Agreement</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4. The Parties agree that pursuant the
terms of this Amendment, the <B>Agreement</B> and <B>EC License</B>, shall be considered in full force and effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>IN WITNESS WHEREOF</B>, the Parties
hereto have caused this Amendment to be executed by their duly authorized representatives as set forth below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>BRISTOL-MYERS SQUIBB COMPANY</B></FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOVIMMUNE S.A.</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="width: 35%; text-align: justify; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Arthur H. Bertelsen&nbsp;</FONT></TD>
    <TD STYLE="width: 20%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 5%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify; width: 35%">/s/ Eduard E. Holdener</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Arthur H.
    Bertelsen, Ph.D.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Eduard E. Holdener</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vice President, Research Collaborations</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman and CEO</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify">/s/ Nathalie Muller</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nathalie Muller</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legal Director</FONT></TD></TR>
</TABLE>


<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 18; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0"></P>




</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>10
<FILENAME>ff12018a1ex10-4_tiziana.htm
<DESCRIPTION>LICENSE AGREEMENT RELATING TO A NOVEL FORMULATION OF FORALUMAB IN A MEDICAL DEVICE FOR NASAL ADMINISTRATION BETWEEN THE BRIGHAM AND WOMEN'S HOSPITAL, INC. AND TIZIANA LIFE SCIENCES PLC, DATED APRIL 2018
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: right"><B>Exhibit 10.4</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B><FONT STYLE="font-size: 10pt">EXCLUSIVE PATENT LICENSE AGREEMENT</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>BWH Agreement No: A225080<BR>
BWH Case No: BWH 24334</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">This Exclusive Patent License
Agreement (&ldquo;Agreement&rdquo;) is made as of the last signature date of this Agreement, (&ldquo;Effective Date&rdquo;), by
and between Tiziana Pharma Ltd., a company incorporated in England and Wales, having a principal place of business at 3<SUP>rd
</SUP>Floor, 11-12 St. James Square, London, United Kingdom SW1Y 4LB (&ldquo;Company&rdquo;) and The Brigham and Women&rsquo;s
Hospital, Inc., a not-for-profit Massachusetts corporation, with a principal place of business at 75 Francis Street, Boston, Massachusetts
02115 (&ldquo;Hospital&rdquo;), each referred to herein individually as a &ldquo;Party&rdquo; and collectively as the &ldquo;Parties&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>RECITALS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">Hospital,
as a center for patient care, research and education, is the owner of certain Patent Rights (defined below) and desires to grant
a license of those Patent Rights to Company in order to benefit the public by disseminating the results of its research via the
commercial development, manufacture, distribution and use of Products and Processes (defined below).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">Company
has the capability to commercially develop, manufacture, distribute and use Products and Processes for public use and benefit and
desires to license such Patent Rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">For good
and valuable consideration, the sufficiency of which is hereby acknowledged, the Parties hereby agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>1. CERTAIN DEFINITIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">As used
in this Agreement, the following terms shall have the following meanings, unless the context requires otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">1.1 &ldquo;<U>Affiliate</U>&rdquo; with respect to either
Party shall mean any corporation or other legal entity other than that Party in whatever country organized, controlling,
controlled by or under common control with that Party. The term &ldquo;control&rdquo; shall mean (i) in the case of Company,
direct or indirect ownership of fifty percent (50%) or more of the voting securities having the right to elect directors, and
(ii) in the case of Hospital, the power, direct or indirect, to elect or appoint fifty percent (50%) or more of the directors
or trustees, or to cause direction of management and policies, whether through the ownership of voting securities, by
contract or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">1.2 &ldquo;<U>Claim</U>&rdquo; shall
mean any pending or issued claim of any Patent Right that has not been permanently revoked, nor held unenforceable or invalid
by a decision of a court or other governmental agency of competent jurisdiction that is unappealable or unappealed in the
time allowed for appeal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid; text-align: justify"><P STYLE="margin: 0pt; text-align: justify">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt; text-align: justify"><P STYLE="margin: 0pt; text-align: justify">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify"><FONT STYLE="font-size: 10pt">1.3
&ldquo;<U>Distributor</U>&rdquo; shall mean any third party entity to whom Company, a Company Affiliate </FONT>or a Sublicensee
has granted, express or implied, the right to distribute any Product or Process pursuant to Section 2.1(b)(ii).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">1.4 &ldquo;<U>First Commercial
Sale</U>&rdquo; shall mean the initial Sale anywhere in the applicable License Territory of a Product or Process.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">1.5 &ldquo;<U>License Field</U>&rdquo; shall mean all uses
of the Patent Rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">1.6 &ldquo;<U>License Territory</U>&rdquo; shall mean worldwide.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">1.7 &ldquo;<U>Net Sales</U>&rdquo; shall be calculated
as set forth in this Section 1.7.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(a)</TD><TD STYLE="text-align: justify">Subject to the conditions set forth below, &ldquo;Net
Sales&rdquo; shall mean:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left">(i)</TD><TD STYLE="text-align: justify">the gross amount billed or invoiced, or if no such
bill or invoice is issued the amount received, whichever is greatest, by Company and its Affiliates and Sublicensees for or on
account of Sales of Products and Processes;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left">(ii)</TD><TD STYLE="text-align: justify"><U>less</U> the following amounts:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(A)</TD><TD STYLE="text-align: justify">to the extent separately stated on the bill or invoice,
actually paid by Company and its Affiliates in effecting such Sale:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 2in"></TD><TD STYLE="width: 0.5in; text-align: left">1.</TD><TD STYLE="text-align: justify">amounts repaid or credited by reason of rejection or
return of applicable Products or Processes;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 2in"></TD><TD STYLE="width: 0.5in; text-align: left">2.</TD><TD STYLE="text-align: justify">reasonable and customary trade, quantity or cash rebates
or discounts to the extent allowed and taken;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 2in"></TD><TD STYLE="width: 0.5in; text-align: left">3.</TD><TD STYLE="text-align: justify">amounts for outbound transportation, insurance, handling
and shipping, but only to the extent separately invoiced in a manner that clearly specifies the charges applicable to the applicable
Products; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 2in"></TD><TD STYLE="width: 0.5in; text-align: left">4.</TD><TD STYLE="text-align: justify">taxes, customs duties and other governmental charges
levied on or measured by Sales of Products or Processes, to the extent separately invoiced, whether paid by or on behalf of Company
so long as Company&rsquo;s price is reduced thereby, but not franchise or income taxes of any kind whatsoever.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(B)</TD><TD STYLE="text-align: justify">the gross amount billed or invoiced, or if no such
bill or invoice is issued the amount received, whichever is greatest, by Company and its Affiliates and Sublicensees for or on
account of Sales of Products and Processes to Hospital and Hospital&rsquo;s Affiliates.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">&nbsp;</P>




<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Specifically excluded
from the definition of &ldquo;Net Sales&rdquo; are amounts attributable to any Sale of any Product or Process between or among
Company and any Company Affiliate and/or Sublicensee, unless the transferee is the end purchaser, user or consumer of such Product
or Process.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(c)</TD><TD STYLE="text-align: justify">No deductions shall be made for any commissions paid
to any individuals or for any costs or expenses of collections.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(d)</TD><TD STYLE="text-align: justify">Net Sales shall be deemed to have occurred and the
applicable Product or Process &ldquo;Sold&rdquo; on the earliest of the date of billing, invoicing, delivery or payment or the
due date for payment.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(e)</TD><TD STYLE="text-align: justify">If any Product or Process is Sold at a discounted
price that is lower than the customary price charged, or for non-cash consideration (whether or not at a discount), Net Sales
shall be calculated based on the non-discounted cash amount charged to an independent third party for the Product or Process during
the same Reporting Period or, in the absence of such transaction, on the fair market value of the Product or Process. Non-cash
consideration that could affect any payment due to Hospital hereunder shall not be accepted without the prior written consent
of Hospital.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">1.8 &ldquo;<U>Patent Rights</U>&rdquo;
shall mean, inclusively, the U.S. Patent Application number 62/515,711, filed on June 6<SUP>th</SUP> 2017, and/or the equivalent
of such application including any division, continuation (but not including continuation-in-part), foreign patent application,
Letters Patent, and/or the equivalent thereof issuing thereon, and/or reissue, reexamination or extension thereof, as may be further
described in Appendix A.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">1.9 &ldquo;<U>Process</U>&rdquo;
shall mean any process, method or service the use or performance of which, in whole or in part, absent the license granted
hereunder would infringe, or is covered by, one or more Claims of Patent Rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">1.10 &ldquo;<U>Product</U>&rdquo; shall mean
any article, device or composition, the manufacture, use, or sale of which, in whole or in part, absent the license granted hereunder
would infringe, or is covered by, one or more Claims of Patent Rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">1.11 &ldquo;<U>Reporting Period</U>&rdquo;
shall mean each three month period ending March 31, June 30, September 30 and December 31.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">1.12 &ldquo;<U>Sell</U>&rdquo; (and &ldquo;Sale&rdquo;
and &ldquo;Sold&rdquo; as the case may be) shall mean to sell or have sold, to lease or have leased, to import or have imported or
otherwise to transfer or have transferred a Product or Process for valuable consideration (in the form of cash or otherwise), and
further in the case of a Process to use or perform such Process for the benefit of a third party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">1.13 &ldquo;<U>Sublicense
Income</U>&rdquo; shall mean consideration in any form received by Company and/or Company&rsquo;s Affiliate(s) in connection with
a grant of a sublicense or any other right, license, privilege or immunity (regardless of whether such grantee is a &ldquo;Sublicensee&rdquo;
as defined <FONT STYLE="font-size: 10pt">in this Agreement) to make, have made, use, have used, Sell or have Sold Products or
Processes, but excluding consideration included within Net Sales. Sublicense Income shall include without limitation any license
signing fee, license maintenance fee, unearned portion of any minimum royalty payment, distribution or joint marketing fee, research
and development funding in excess of the cost of performing such research and development, and any consideration received for
an equity interest in, extension of credit to or other investment in Company or Company&rsquo;s Affiliates to the extent such
consideration exceeds the fair market value of the equity or other interest received as determined by agreement of the Parties
or by an independent appraiser mutually agreeable to the Parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">1.14 &ldquo;<U>Sublicensee</U>&rdquo;
shall mean any sublicensee of rights granted in accordance with Section 2.1(a)(ii). For purpose of this Agreement, a Distributor
of a Product or Process shall not be included in the definition of Sublicensee unless such Distributor (i) is granted any right
to make, have made, use or have used Products or Processes in accordance with Section 2.1(a)(ii), or (ii) has agreed to pay to
Company or its Affiliate(s) royalties on such Distributor&rsquo;s sales of Products or Processes, in which case such Distributor shall
be a Sublicensee for all purposes of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>2. LICENSE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">2.1 <U>Grant of License</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Subject to the terms
of this Agreement and Hospital&rsquo;s rights in Patent Rights, </FONT>Hospital hereby grants to Company in the License Field
in the License Territory:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left">(i)</TD><TD STYLE="text-align: justify">an exclusive, royalty-bearing license under its rights
in Patent Rights to make, have made, use, have used, Sell and have Sold Products and Processes; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left">(ii)</TD><TD STYLE="text-align: justify">the right to grant sublicenses under the rights granted
in Section 2.1(a)(i) to Sublicensees, provided that in each case Company shall be responsible for the performance of any obligations
of Sublicensees relevant to this Agreement as if such performance were carried out by Company itself, including, without limitation,
the payment of any royalties or other payments provided for hereunder, regardless of whether the terms of any sublicense provide
for such amounts to be paid by the Sublicensee directly to Hospital.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(b)</TD><TD STYLE="text-align: justify">The license granted in Section 2.1(a) above includes:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left">(i)</TD><TD STYLE="text-align: justify">the right to grant to the final purchaser, user or
consumer of Products the right to use such purchased Products in a method coming within the scope of Patent Rights within the
License Field and License Territory; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left">(ii)</TD><TD STYLE="text-align: justify">the right to grant a Distributor the right to Sell
(but not to make, have made, use or have used) such Products and/or Processes for or on behalf of Company, its Affiliates and
Sublicensees in a manner consistent with this Agreement.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify"><FONT STYLE="font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(c)</TD><TD STYLE="text-align: justify">The foregoing license grant shall include the grant
of such license to any Affiliate of Company, provided that such Affiliate shall assume the same obligations as those of Company
and be subject to the same terms and conditions hereunder; and further provided that Company shall be responsible for the performance
of all of such obligations and for compliance with all of such terms and conditions by Affiliate. Company shall provide to Hospital
a fully signed, non-redacted copy of each agreement with each Affiliate that assumes the aforesaid obligations, including all
exhibits, attachments and related documents and any amendments, within thirty (30) days of request by Hospital.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">2.2 <U>Sublicenses</U>. Each sublicense granted hereunder
shall be consistent with and comply with all terms of this Agreement, shall incorporate terms and conditions sufficient to
enable Company to comply with this Agreement, shall prohibit any further sublicense or assignment by a Sublicensee without
Hospital consent and shall provide that Hospital is a third party beneficiary thereof. Any sublicense granted by Company
shall be subject to the prior written approval of Hospital, which approval shall not be unreasonably withheld. Company shall
provide to Hospital a fully signed non-redacted copy of all sublicense agreements and amendments thereto, including all
exhibits, attachments and related documents, within thirty (30) days of executing the same. Upon termination of this
Agreement or any license granted hereunder for any reason, any sublicenses shall be addressed in accordance with Section
10.7. Any sublicense which is not in accordance with the forgoing provisions shall be null and void.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">2.3 <U>Retained Rights; Requirements</U>. Any and all
licenses granted hereunder are subject to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(a)</TD><TD STYLE="text-align: justify">the right of Hospital and Hospital&rsquo;s Affiliates
and academic, government and not-for-profit institutions to make and to use the subject matter described and/or claimed in the
Patent Rights; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(b)</TD><TD STYLE="text-align: justify">for Patent
                                         Rights supported by federal funding, the rights, conditions and limitations imposed by
                                         U.S. law <I>(see </I>35 U.S.C. &sect; 202 <U>et</U>&nbsp;<U>seq</U>. and regulations
                                         pertaining thereto), including without limitation:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left">(i)</TD><TD STYLE="text-align: justify">the royalty-free non-exclusive license granted to the
U.S. government; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left">(ii)</TD><TD STYLE="text-align: justify">the requirement that any Products used or sold in the
United States shall be manufactured substantially in the United States.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">2.4 <U>No Additional Rights</U>. It is understood that
nothing in this Agreement shall be construed to grant Company or any of its Affiliates a license, express or implied, under
any patent owned solely or jointly by Hospital other than the Patent Rights expressly licensed hereunder. Hospital shall have
the right to license any Patent Rights to any other party for any purpose outside of the License Field or the License
Territory.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>3. DUE
DILIGENCE OBLIGATIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">3.1 <U>Diligence Requirements</U>. Company shall use, and
shall cause its Affiliates and Sublicensees, as applicable, to use, best efforts to develop and make available to the public
Products and Processes throughout the License Territory in the License Field. Such efforts shall include achieving the
following objectives within the time periods designated below following the Effective Date:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(a)</TD><TD STYLE="text-align: justify">First patient
                                         enrolled in a Phase I human clinical trial to be completed by December 31<SUP>st</SUP>
                                         2025.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(b)</TD><TD STYLE="text-align: justify">First patient
                                         enrolled in a Phase II human clinical trial to be completed by December 31<SUP>st</SUP>
                                         2027.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(c)</TD><TD STYLE="text-align: justify">First patient
                                         enrolled in a Phase III human clinical trial to be completed by December 31<SUP>st</SUP>
                                         2031.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(d)</TD><TD STYLE="text-align: justify">First Commercial
                                         Sale of a Product to be completed by December 31<SUP>st</SUP> 2033.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Achievement of the
foregoing objectives shall be deemed to satisfy Company&rsquo;s obligations to use best efforts under this Section 3.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">3.2 <U>Diligence Failures</U>. If Hospital determines
that Company has failed to fulfill any of its obligations under Section 3.1, then Hospital may treat such failure as a
default and may terminate this Agreement and/or any license granted hereunder in accordance with Section 10.4.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">3.3 <U>Diligence Reports</U>. Company
shall provide all reports with respect to its obligations under Section 3.1 as set forth in Section 5.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>4. PAYMENTS AND ROYALTIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">4.1 <U>License Issue Fee</U>. Company shall pay Hospital a
non-refundable license issue fee in the amount of ten Thousand Dollars ($10,000) upon execution of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">4.2 <U>Patent Cost Reimbursement</U>. Company shall
reimburse Hospital for all costs associated with the preparation, filing, prosecution and maintenance of all Patent Rights
(&ldquo;Patent Costs&rdquo;). Company shall pay to Hospital, or at Hospital&rsquo;s request directly to patent counsel, all
other Patent Costs within thirty (30) days of Company&rsquo;s receipt of an invoice for such Patent Costs either from
Hospital or Hospital&rsquo;s patent counsel. Company agrees to indemnify, defend and hold Hospital harmless from and against
any and all liabilities, damages, costs and expenses arising from the failure of Company to timely pay such invoices and
Patent Costs. Hospital shall instruct patent counsel to provide copies to Hospital for Hospital&rsquo;s administrative files
of all invoices detailing Patent Costs which are sent directly to Company. If Company pays any Patent Costs directly, Company
shall advise patent counsel that Hospital is and shall remain patent counsel&rsquo;s client.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify"><FONT STYLE="font-size: 10pt">4.3 <U>Annual License Fee; Annual Minimum Royalty</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(a)</TD><TD STYLE="text-align: justify"><U>Before First Commercial Sale</U>. Prior to the First
Commercial Sale, Company shall pay to Hospital the following non-refundable amounts as an annual license fee within sixty (60)
days after each of the following anniversaries of the Effective Date:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left">(i)</TD><TD STYLE="text-align: justify">the first anniversary of the Effective Date: Five Thousand
Dollars ($5,000);</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in; text-align: justify"></TD><TD STYLE="width: 0.5in; text-align: justify">(ii)</TD><TD STYLE="text-align: justify; padding-right: 0.05in">the second anniversary of the Effective Date: Five Thousand Dollars ($5,000);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in; text-align: justify"></TD><TD STYLE="width: 0.5in; text-align: justify">(iii)</TD><TD STYLE="text-align: justify; padding-right: 0.05in">the third anniversary and on each subsequent anniversary of the Effective
Date thereafter: Five Thousand Dollars ($5,000).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(b)</TD><TD STYLE="text-align: justify"><U>After First Commercial Sale</U>. Following the First
Commercial Sale, Company shall pay Hospital a non-refundable minimum annual royalty in the amount of Five Thousand Dollars ($5,000)
per year within sixty (60) days after each annual anniversary of the Effective Date. The annual minimum royalty shall be credited
against royalties subsequently due on Net Sales made during the same calendar year, if any, but shall not be credited against
royalties due on Net Sales made in any other year.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">4.4 <U>Milestone Payments</U>. In addition to the
payments set forth in Sections 4.1 through 4.3 above, Company shall pay Hospital milestone payments, as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(a)</TD><TD STYLE="text-align: justify">Three Hundred Thousand dollars ($300,000) within sixty
(60) days of first patient enrolled in a Phase I human clinical trial.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in; text-align: justify"></TD><TD STYLE="width: 0.5in; text-align: justify">(b)</TD><TD STYLE="text-align: justify; padding-right: 0.05in">Six Hundred Thousand dollars ($600,000) within sixty (60) days of first
patient enrolled in a Phase II human clinical trial.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in; text-align: justify"></TD><TD STYLE="width: 0.5in; text-align: justify">(c)</TD><TD STYLE="text-align: justify; padding-right: 0.05in">One Million and Five Hundred Thousand dollars ($1,500,000) within sixty
(60) days of first patient enrolled in a Phase III human clinical trial.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in; text-align: justify"></TD><TD STYLE="width: 0.5in; text-align: justify">(d)</TD><TD STYLE="text-align: justify; padding-right: 0.05in">Three Million Dollars ($3,000,000) within sixty (60) days of First Commercial
Sale of a Product.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify"><FONT STYLE="font-size: 10pt">4.5 <U>Royalties and Sublicense Income</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in; text-align: justify"></TD><TD STYLE="width: 0.5in; text-align: justify">(a)</TD><TD STYLE="text-align: justify; padding-right: 0.05in">Beginning with the First Commercial Sale in any country in the License Territory,
Company shall pay Hospital during the term of any license granted under Section 2.1(a)(i), a royalty of One and One Half Percent
(1.5%) of the Net Sales of all Products and Processes.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in; text-align: justify"></TD><TD STYLE="width: 0.5in; text-align: justify">(b)</TD><TD STYLE="text-align: justify; padding-right: 0.05in">Company shall pay Hospital Twelve Percent (12%) of any and all Sublicense
Income.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in; text-align: justify"></TD><TD STYLE="width: 0.5in; text-align: justify">(c)</TD><TD STYLE="text-align: justify; padding-right: 0.05in">All payments due to Hospital under this Section 4.5 shall be due and payable
by Company within thirty (30) days after the end of each Reporting Period, and shall be accompanied by a report as set forth in
Sections 5.3 and 5.4.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">4.6 <U>Form of Payment</U>. All payments due under this
Agreement shall be drawn on a United States bank and shall be payable in United States dollars. Each payment shall reference
this Agreement and its Agreement Number and identify the obligation under this Agreement that the payment satisfies.
Conversion of foreign currency to U.S. dollars shall be made at the conversion rate existing in the United States, as
reported in The Wall Street Journal, on the last working day of the applicable Reporting Period. Such payments shall be
without deduction of exchange, collection or other charges, and, specifically, without deduction of withholding or similar
taxes or other government imposed fees or taxes, except as permitted in the definition of Net Sales.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">Checks for all payments due
to the Hospital under this Agreement shall be made payable to the Hospital and addressed as set forth below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0; text-align: justify">Brigham and Women&rsquo;s Hospital</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0; text-align: justify">BOA-Lockbox Services</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0; text-align: justify">PCSR Lockbox #415007</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0; text-align: justify">MA5-527-02-07</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0; text-align: justify">2 Morrissey Blvd</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0; text-align: justify">Dorchester, MA 02125</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0; text-align: justify"><FONT STYLE="font-size: 10pt">Reference Agreement <I>#: </I>A225080</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">Payments via wire transfer should be made as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0; text-align: justify">ACH Credit: ABA # 011-000-138</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0; text-align: justify">Federal Reserve Wire: ABA#026-009-593</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0; text-align: justify">SWIFT Code: BOFAUS3N</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0; text-align: justify">Account #0050169434</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0; text-align: justify">Brigham and Women&rsquo;s Hospital</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0; text-align: justify">Bank of America</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0; text-align: justify">100 Federal Street</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0; text-align: justify">Boston, MA 02110</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0; text-align: justify">Reference Agreement #: A225080</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">4.7 <U>Overdue Payments</U>. The payments due under this
Agreement shall, if overdue, bear interest beginning on the first day following the Reporting Period to which such payment
was incurred and until payment thereof at a per annum rate equal to two percent (2%) above the prime rate in effect on the
due date as reported by The Wall Street Journal, such interest rate being compounded on the last day of each Reporting
Period, not to exceed the maximum permitted by law. Any such overdue payments when made shall be accompanied by all interest
so accrued. Said interest and the payment and acceptance thereof shall not preclude Hospital from exercising any other rights
it may have as a consequence of the lateness of any payment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>5. REPORTS AND RECORDS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">5.1 <U>Diligence Reports</U>. Within sixty (60) days
after the end of each calendar year, Company shall report in writing to Hospital on progress made toward the objectives set
forth in Section 3.1 during such preceding 12 month period, including, without limitation, progress on research and
development, status of applications for regulatory approvals, manufacturing, sublicensing and the number of sublicenses
entered into and marketing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">5.2 <U>Milestone Achievement
Notification, </U>Company shall report to Hospital the dates on which it achieves the milestones set forth in Section 4.4
within sixty (60) days of each such occurrence.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">5.3 <U>Sales Reports</U>. Company
shall report to Hospital the date on which it achieves the First Commercial Sale in each country of the License Territory
within thirty (30) days of each such occurrence. Following the First Commercial Sale, Company shall deliver reports to
Hospital within thirty (30) days after the end of each Reporting Period. Each report under this Section 5.3 shall have
substantially the format outlined in Appendix B, shall be certified as correct by an officer of Company and shall contain at
least the following information as may be pertinent to a royalty accounting hereunder for the immediately preceding Reporting
Period:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(a)</TD><TD STYLE="text-align: justify">the number of Products and Processes Sold by Company,
its Affiliates and Sublicensees in each country;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the amounts billed, invoiced
and received by Company, its Affiliates and </FONT>Sublicensees for each Product and Process, in each country, and total billings
or payments due or made for all Products and Processes;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(c)</TD><TD STYLE="text-align: justify">calculation of Net Sales for the applicable Reporting
Period in each country, including an itemized listing of permitted offsets and deductions;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(d)</TD><TD STYLE="text-align: justify">total royalties payable on Net Sales in U.S. dollars,
together with the exchange rates used for conversion; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(e)</TD><TD STYLE="text-align: justify">any other payments due to Hospital under this Agreement. </TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">If no amounts are due to Hospital for any Reporting Period, the report shall so state.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">5.4 <U>Sublicense Income Reports</U>. Company shall,
along with delivering payment as set forth in Section 4.6, report to Hospital within thirty (30) days of receipt the amount
of all Sublicense Income received by Company, and Company&rsquo;s calculation of the amount due and paid to Hospital from
such income, including an itemized listing of the source of income comprising such consideration, and the name and address of
each entity making such payments in substantially the format outlined in Appendix C.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">5.5 <U>Audit Rights</U>. Company
shall maintain, and shall cause each of its Affiliates and Sublicensees to maintain, complete and accurate records relating
to the rights and obligations under this Agreement and any amounts payable to Hospital in relation to this Agreement, which
records shall contain sufficient information to permit Hospital and its representatives to confirm the accuracy of any
payments and reports delivered to Hospital and compliance in all other respects with this Agreement. Company shall retain and
make available, and shall cause each of its Affiliates and Sublicensees to retain and make available, such records for at
least five (5) years following the end of the calendar year to which they pertain, to Hospital and/or its representatives and
upon at least fifteen (15) days&rsquo; advance written notice, for inspection during normal business hours, to verify any
reports and payments made and/or compliance in other respects under this Agreement. If any examination conducted by Hospital
or its representatives pursuant to the provisions of this Section show an underreporting or underpayment of five percent (5%)
or more in any payment due to Hospital hereunder, Company shall bear the full cost of such audit and shall remit any amounts
due to Hospital (including interest due in accordance with Section 4.7) within thirty (30) days of receiving notice thereof
from Hospital.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>6. PATENT PROSECUTION AND MAINTENANCE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">6.1 <U>Prosecution</U>. Hospital shall be responsible for
the preparation, filing, prosecution and maintenance of all patent applications and patents included in Patent Rights.
Company shall reimburse Hospital for Patent Costs incurred by Hospital relating thereto in accordance with Section 4.2.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">6.2 <U>Copies of Documents</U>. With
respect to any Patent Right licensed hereunder, Hospital shall instruct the patent counsel prosecuting such Patent Right to
(i) copy Company on patent <FONT STYLE="font-size: 10pt">prosecution documents that are received from or filed with the
United States Patent and Trademark Office and foreign equivalent, as applicable; (ii) if requested by Company, provide
Company with copies of draft submissions to the USPTO prior to filing; and (iii) give consideration to the comments and
requests of Company or its patent counsel.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">6.3 <U>Company&rsquo;s Election Not
to Proceed</U>. Company may elect to surrender any patent or patent application in Patent Rights in any country upon sixty
(60) days advance written notice to Hospital. Such notice shall relieve Company from the obligation to pay for future Patent
Costs but shall not relieve Company from responsibility to pay Patent Costs incurred prior to the expiration of the sixty
(60) day notice period. Such U.S. or foreign patent application or patent shall thereupon cease to be a Patent Right
hereunder, Company shall have no further rights therein and Hospital shall be free to license its rights to that particular
U.S. or foreign patent application or patent to any other party on any terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">6.4 <U>Confidentiality of
Prosecution and Maintenance Information</U>. Company agrees to treat all information related to prosecution and maintenance
of Patent Rights as Confidential Information in accordance with the provisions of Appendix D.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>7. THIRD PARTY INFRINGEMENT AND LEGAL
ACTIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">7.1 <U>Hospital Right to Prosecute</U>. Hospital will
protect its Patent Rights from infringement and prosecute infringers when, in its sole judgment, such action may be
reasonably necessary, proper and justified. If Company shall have supplied Hospital with written evidence demonstrating to
Hospital&rsquo;s reasonable satisfaction prima facie infringement of a claim of a Patent Right in the License Field in the
License Territory by a third party which poses a material threat to Company&rsquo;s rights under this Agreement, Company may
by notice request Hospital to take steps to protect such Patent Right. Hospital shall notify Company within three (3) months
of the receipt of such notice whether Hospital intends to prosecute the alleged infringement. If Hospital notifies Company
that it intends to so prosecute, Hospital shall, within three (3) months of its notice to Company either (i) cause such
infringement to terminate, or (ii) initiate legal proceedings against the infringer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">7.2 <U>Company Right to
Prosecute</U>. In the event Hospital notifies Company that Hospital does not intend to prosecute infringement identified
under Section 7.1, Company may, upon notice to Hospital, initiate legal proceedings against the infringer at Company&rsquo;s
expense with respect to a claim of a Patent Right in the License Field in the License Territory. Before commencing such
action, Company and, as applicable, any Affiliate, shall consult with Hospital, concerning, among other things,
Company&rsquo;s standing to bring suit, the advisability of bringing suit, the selection of counsel and the jurisdiction for
such action (provided Company must have Hospital&rsquo;s prior written consent with respect to selection of jurisdiction for
any action in which Hospital may be joined as a party-plaintiff) and shall use reasonable efforts to accommodate the views of
Hospital regarding the proposed action, including without limitation with respect to potential effects on the public
interest. Company shall be responsible for all costs, expenses and liabilities in connection with any such action and shall
indemnify and hold Hospital harmless therefrom, regardless of whether Hospital is a party-plaintiff, except for the expense
of any independent counsel retained by Hospital in accordance with Section 7.5 below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">7.3 <U>Hospital Joined as
Party-Plaintiff</U>. If Company elects to commence an action as described in Section 7.2 above, Hospital shall have, in its
sole discretion, the option to join such action as a party-plaintiff. If Hospital is required by law to join such action as a
party-plaintiff, Hospital may either, in its sole discretion, permit itself to be joined as a party-plaintiff at the sole
expense of Company, or assign to Company all of Hospital&rsquo;s right, title and interest in and to the Patent Right which
is the subject of such action (subject to all of Hospital&rsquo;s obligations to the government under law and any other
rights that others may have in such Patent Right). If Hospital makes such an assignment, such action by Company shall
thereafter be brought or continued without Hospital as a party; provided, however, that Hospital shall continue to have all
rights of prosecution and maintenance with respect to Patent Rights and Company shall continue to meet all of its obligations
under this Agreement as if the assigned Patent Right were still licensed to Company hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">7.4 <U>Notice of
Actions<SUP>.</SUP>, Settlement</U>. Company shall promptly inform Hospital of any action or suit relating to Patent Rights
and shall not enter into any settlement, consent judgment or other voluntary final disposition of any action relating to
Patent Rights, including but not limited to appeals, without the prior written consent of Hospital.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">7.5 <U>Cooperation</U>.
Each Party agrees to cooperate reasonably in any action under Section 7 which is controlled by the other Party, provided that
the controlling party reimburses the cooperating party for any costs and expenses incurred by the cooperating party in
connection with providing such assistance, except for the expense of any independent counsel retained by the cooperating
party in accordance with this Section 7.5. Such controlling party shall keep the cooperating party informed of the progress
of such proceedings and shall make its counsel available to the cooperating party. The cooperating party shall also be
entitled to independent counsel in such proceedings but at its own expense, said expense to be offset against any damages
received by the Party bringing suit in accordance with Section 7.6.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">7.6 <U>Recovery</U>. Any
award paid by third parties as the result of such proceedings (whether by way of settlement or otherwise) shall first be
applied to reimbursement of any legal fees and expenses incurred by either Party and then the remainder shall be divided
between the Parties as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(a)</TD>
    <TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">Company shall receive an amount equal to
its lost profits or a reasonable royalty on the infringing sales, or whichever measure of damages the court shall have applied;
and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left">(ii)</TD><TD STYLE="text-align: justify">Hospital shall receive an amount equal to the royalties
and other amounts that Company would have paid to Hospital if Company had Sold the infringing Products and Services rather than
the infringer; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(b)</TD><TD STYLE="text-align: justify">the balance, if any, remaining after Company and Hospital
have been compensated under Section 7.6(a) shall be shall be shared equally by the Parties.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>8. INDEMNIFICATION
AND INSURANCE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> 8.1 <U>Indemnification</U>.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in; text-align: justify"></TD><TD STYLE="width: 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0.05in"><FONT STYLE="font-size: 10pt">Company shall indemnify, defend and hold harmless Hospital and its Affiliates and
their respective trustees, directors, officers, medical and professional staff, employees, and agents and their respective successors,
heirs and assigns (the &ldquo;Indemnitees&rdquo;), against any liability, damage, loss or expense (including reasonable attorney&rsquo;s
fees and expenses of litigation) incurred by or imposed upon the Indemnitees or any one of them in connection with any claims,
suits, actions, demands or judgments arising out of any theory of product liability (including, but not limited to, actions in
the form of contract, tort, warranty, or strict liability) concerning any product, process or service made, used, or sold or performed
pursuant to any right or license granted under this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in; text-align: justify"></TD><TD STYLE="width: 0.5in; text-align: justify">(b)</TD><TD STYLE="text-align: justify; padding-right: 0.05in">Company agrees, at its own expense, to provide attorneys reasonably acceptable
to the Hospital to defend against any actions brought or filed against any party indemnified hereunder with respect to the subject
of indemnity contained herein, whether or not such actions are rightfully brought; provided, however, that any Indemnitee shall
have the right to retain its own counsel, at the expense of Company, if representation of such Indemnitee by counsel retained by
Company would be inappropriate because of conflict of interests of such Indemnitee and any other party represented by such counsel.
Company agrees to keep Hospital informed of the progress in the defense and disposition of such claim and to consult with Hospital
prior to any proposed settlement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in; text-align: justify"></TD><TD STYLE="width: 0.5in; text-align: justify">(c)</TD><TD STYLE="text-align: justify">This section 8.1 shall survive expiration or termination of this Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">8.2 <U>Insurance</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Beginning at such time
as any such product, process or service is being </FONT>commercially distributed, sold, leased or otherwise transferred, or performed
or used (other than for the purpose of obtaining regulatory approvals), by Company, an Affiliate or Sublicensee, Company shall,
at its sole cost and expense, procure and maintain commercial general liability insurance in amounts not less than $2,000,000
per incident and $2,000,000 annual aggregate and naming the Indemnitees as additional insureds. Such commercial general liability
insurance shall provide (i) product liability coverage and (ii) broad form contractual liability coverage for Company&rsquo;s
indemnification under Section 8.1 of this Agreement. If Company elects to self-insure all or part of the limits described above
(including deductibles or retentions which are in excess of $250,000 annual aggregate) such self-insurance program must be acceptable
to the Hospital and the Risk Management Foundation. The minimum amounts of insurance coverage required <FONT STYLE="font-size: 10pt">under
this Section 8.2 shall not be construed to create a limit of Company&rsquo;s liability with respect to its indemnification under
Section 8.1 of this Agreement.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(b)</TD><TD STYLE="text-align: justify">Company shall provide Hospital with written evidence
of such insurance upon request of Hospital. Company shall provide Hospital with written notice at least fifteen (15) days prior
to the cancellation, non-renewal or material change in such insurance; if Company does not obtain replacement insurance providing
comparable coverage prior to the expiration of such fifteen (15) day period, Hospital shall have the right to terminate this Agreement
effective at the end of such fifteen (15) day period without notice or any additional waiting periods.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(c)</TD><TD STYLE="text-align: justify">Company shall maintain such commercial general liability
insurance beyond the expiration or termination of this Agreement during (i) the period that any such product, process, or service
is being commercially distributed, sold, leased or otherwise transferred, or performed or used (other than for the purpose of
obtaining regulatory approvals), by Company or by a licensee, affiliate or agent of Company and (ii) a reasonable period after
the period referred to in (c) (i) above which in no event shall be less than fifteen (15) years.</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(d)</TD><TD STYLE="text-align: justify">This section 8.2 shall survive expiration or termination
of this Agreement.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>9. DISCLAIMER
OF WARRANTIES; LIMITATION OF LIABILITY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">9.1 <U>Title to Patent Rights</U>. To the best knowledge
of Hospital&rsquo;s Innovation office, Hospital is the owner by assignment from Dr. Howard Weiner and Dr. Oleg Butovsky of
the Patent Rights and has the authority to enter into this Agreement and license the Patent Rights to Company hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">9.2 <U>No Warranties</U>. HOSPITAL
MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND, EXPRESS OR IMPLIED, CONCERNING THE PATENT RIGHTS AND THE RIGHTS GRANTED
HEREUNDER, INCLUDING, WITHOUT LIMITATION, WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NONINFRINGEMENT,
VALIDITY OF PATENT RIGHTS CLAIMS, WHETHER ISSUED OR PENDING, AND THE ABSENCE OF LATENT OR OTHER DEFECTS, WHETHER OR NOT
DISCOVERABLE, AND HEREBY DISCLAIMS THE SAME. SPECIFICALLY, AND NOT TO LIMIT THE FOREGOING, HOSPITAL MAKES NO WARRANTY OR
REPRESENTATION (i) REGARDING THE VALIDITY OR SCOPE OF ANY OF THE CLAIM(S), WHETHER ISSUED OR PENDING, OF ANY OF THE PATENT
RIGHTS, AND (ii) THAT THE EXPLOITATION OF THE PATENT RIGHTS OR ANY PRODUCT WILL NOT INFRINGE ANY PATENTS OR OTHER
INTELLECTUAL PROPERTY RIGHTS OF HOSPITAL OR OF ANY THIRD PARTY.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">9.3 <U>Limitation of
Liability</U>. IN NO EVENT SHALL HOSPITAL OR ANY OF ITS AFFILIATES OR ANY OF THEIR RESPECTIVE TRUSTEES, DIRECTORS, OFFICERS,
MEDICAL OR PROFESSIONAL STAFF, EMPLOYEES AND AGENTS BE LIABLE TO LICENSEE OR ANY OF ITS AFFILIATES, SUBLICENSEES OR
DISTRIBUTORS FOR INDIRECT, SPECIAL, INCIDENTAL OR CONSEQUENTIAL DAMAGES OF ANY KIND ARISING IN ANY WAY OUT OF THIS AGREEMENT
OR THE LICENSE OR RIGHTS GRANTED HEREUNDER, HOWEVER CAUSED AND ON ANY THEORY OF LIABILITY, INCLUDING WITHOUT LIMITATION
ECONOMIC DAMAGES OR INJURY TO PROPERTY OR LOST PROFITS, REGARDLESS OF WHETHER HOSPITAL SHALL BE ADVISED, SHALL HAVE OTHER
REASON TO KNOW, OR IN FACT SHALL KNOW OF THE POSSIBILITY OF THE FOREGOING.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>10. TERM AND TERMINATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">10.1 <U>Term</U>. The term of this Agreement
shall commence on the Effective Date and shall remain in effect until the date on which all issued patents and filed patent applications
within the Patent Rights have expired or been abandoned, unless this Agreement is terminated earlier in accordance with any of
the other provisions of Section 10.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">10.2 <U>Termination for Failure to Pay</U>.
If Company fails to make any payment due hereunder, Hospital shall have the right to terminate this Agreement upon ten (10) business
days written notice, unless Company makes such payments plus any interest due, as set forth in Section 4.7, within said ten (10)
day notice period. If payments are not made, Hospital may immediately terminate this Agreement at the end of said ten (10) day
period. Company shall be entitled to only one such cure period in a calendar year; for a second failure to make payment on time,
Hospital shall have the right to terminate this Agreement immediately upon written notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">10.3 <U>Termination for Insurance and Insolvency</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.55in; text-align: justify"></TD><TD STYLE="width: 0.5in; text-align: justify">(a)</TD><TD STYLE="text-align: justify"><U>Insurance</U>. Hospital shall have the right to terminate this Agreement in accordance with
Section 8.2(b) if Company fails to maintain the insurance required by Section 8.2.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.55in; text-align: justify"></TD><TD STYLE="width: 0.5in; text-align: justify">(b)</TD><TD STYLE="text-align: justify"><U>Insolvency and other Bankruptcy Related Events</U>. Hospital shall have the right to terminate
this Agreement immediately upon written notice to Company with no further notice obligation or opportunity to cure if Company:
(i) shall become insolvent; (ii) shall make an assignment for the benefit of creditors; or (iii) or shall have a petition in bankruptcy
filed for or against it.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">10.4 <U>Termination for Non-Financial Default</U>.
If Company, any of its Affiliates or any Sublicensee shall default in the performance of any of its other obligations under this
Agreement not otherwise covered by the provisions of Section 10.2 and 10.3, and if such default has not been cured within sixty
(60) days after notice by Hospital in writing of such default, Hospital may immediately terminate this Agreement, and/or any license
granted hereunder with respect to the country or countries in which such default has occurred, at the end of said sixty (60) day
cure period. Hospital shall also have the right to terminate this Agreement and/or any such license immediately, upon written notice,
in the event of repeated defaults even if cured within such sixty (60) day periods.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">10.5 <U>Challenging Validity</U>.
During the term of this Agreement, Company shall not challenge, and shall restrict Company Affiliates and Sublicensees from challenging,
the validity of the Patent Rights and in the event of any breach of this provision Hospital shall have the right to terminate this
Agreement and any license granted hereunder immediately. In addition, if the Patent Rights are upheld Company shall reimburse Hospital
for its legal costs and expenses incurred in defending any such challenge.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">10.6 <U>Termination by Company</U>.
Company shall have the right to terminate this Agreement by giving ninety (90) days advance written notice to Hospital and upon
such termination shall immediately cease all use and Sales of Products and Processes, subject to Section 10.9.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">10.7 <U>Effect of Termination
on Sublicenses</U>. Any sublicenses granted by Company under this Agreement shall provide for termination or assignment to Hospital
of Company&rsquo;s interest therein, at the option of Hospital, upon termination of this Agreement or upon termination of any license
hereunder under which such sublicense has been granted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">10.8 <U>Effects of Termination
of Agreement</U>. Upon termination of this Agreement or any of the licenses hereunder for any reason, final reports in accordance
with Section 5 shall be submitted to Hospital and all royalties and other payments, including without limitation any unreimbursed
Patent Costs, accrued or due to Hospital as of the termination date shall become immediately payable. Company shall cease, and
shall cause its Affiliates and Sublicensees to cease under any sublicense granted by Company, all Sales and uses of Products and
Processes upon such termination, subject to Section 10,9. The termination or expiration of this Agreement or any license granted
hereunder shall not relieve Company, its Affiliates or Sublicensees of obligations arising before such termination or expiration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">10.9 <U>Inventory</U>. Upon
early termination of this Agreement other than for Company default, Company, Company Affiliates and Sublicensees may complete and
sell any work-in-progress and inventory of Products that exist as of the effective date of termination provided that (i) Company
pays Hospital the applicable running royalty or other amounts due on such Net Sales in accordance with the terms and conditions
of this Agreement, and (ii) Company, Company Affiliates and Sublicensees shall complete and sell all work-in-progress and inventory
of Products within six (6) months after the effective date of termination. Upon expiration of this Agreement, Company shall pay
to Hospital the royalties set forth in Section 4.5(a) for Sales of any Product that was in inventory or was a work-in-progress
on the date of expiration of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>11. COMPLIANCE WITH LAW</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">11.1 <U>Compliance</U>.
Company shall have the sole obligation for compliance with, and shall ensure that any Affiliates and Sublicensees comply
with, all government statutes and regulations that relate to Products and Processes, including, but not limited to, those of
the Food and Drug Administration and the Export Administration, as amended, and any applicable laws and regulations of any
other country in the License Territory. Company agrees that it shall be solely responsible for obtaining any necessary
licenses to export, re-export, or import Products or <FONT STYLE="font-size: 10pt">Processes covered by Patent Rights and/or
Confidential Information. Company shall indemnify and hold harmless Hospital for any breach of Company&rsquo;s obligations
under this Section 11.1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">11.2 <U>Patent Numbers</U>.
Company shall cause all Products sold in the United States to be marked with all applicable U.S. Patent Numbers, to the full extent
required by United States law. Company shall similarly cause all Products shipped to or sold in any other country to be marked
in such a manner as to conform with the patent laws and practices of such country.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>12. MISCELLANEOUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">12.1 <U>Entire Agreement</U>.
This Agreement constitutes the entire understanding between the Parties with respect to the subject matter hereof. For the avoidance
of doubt, this Agreement supersedes the Exclusive Option Agreement with an effective date of November 7<SUP>th</SUP> 2017, by
and between the Parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">12.2 <U>Notices</U>. Any notices,
reports, waivers, correspondences or other communications required under or pertaining to this Agreement shall be in writing and
shall be delivered by hand, or sent by a reputable overnight mail service (e.g., Federal Express), or by first class mail (certified
or registered), or by facsimile confirmed by one of the foregoing methods, to the other party. Notices will be deemed effective
(a) three (3) working days after deposit, postage prepaid, if mailed, (b) the next day if sent by overnight mail, or (c) the same
day if sent by facsimile and confirmed as set forth above or delivered by hand. Unless changed in writing in accordance with this
Section, the notice address for Hospital shall be as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0; text-align: justify">Chief Innovation Officer, Innovation,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0; text-align: justify">Partners
Health Care,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0; text-align: justify">The Brigham and Women&rsquo;s Hospital,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0; text-align: justify">215 First Street,
Suite 500</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0; text-align: justify">Cambridge, MA 02142</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">12.3 <U>Amendment; Waiver</U>. This Agreement
may be amended and any of its terms or conditions may be waived only by a written instrument executed by an authorized signatory
of the Parties or, in the case of a waiver, by the Party waiving compliance. The failure of either Party at any time or times to
require performance of any provision hereof shall in no manner affect its rights at a later time to enforce the same. No waiver
by either Party of any condition or term shall be deemed as a further or continuing waiver of such condition or term or of any
other condition or term.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">12.4 <U>Binding Effect</U>.
This Agreement shall be binding upon and inure to the benefit of and be enforceable by the Parties hereto and their respective
permitted successors and assigns.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">12.5 <U>Assignment</U>. Company shall
not assign this Agreement or any of its rights or obligations under this Agreement without the prior written consent of Hospital;
provided, however, that if Company has fulfilled its diligence obligations as set forth in Section 3, no such consent will be
required to assign this Agreement to a successor of the Company&rsquo;s business to which this Agreement pertains or to a purchaser
of substantially all of the Company&rsquo;s assets related to this <FONT STYLE="font-size: 10pt">Agreement, so long as such successor
or purchaser shall agree in writing to be bound by all of the terms and conditions hereof prior to such assignment. Company shall
notify Hospital in writing of any such assignment and provide a copy of all assignment documents and related agreements to Hospital
within thirty (30) days of such assignment. Failure of an assignee to agree to be bound by the terms hereof or failure of Company
to notify hospital and provide copies of assignment documentation shall be grounds for termination of this Agreement for default.
Further, neither any rights granted under this Agreement nor any sublicense may be assigned by any Sublicensee without the prior
written consent of Hospital.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">12.6 <U>Force Majeure</U>. Neither
Party shall be responsible for delays resulting from causes beyond the reasonable control of such Party, including without limitation
fire, explosion, flood, war, sabotage, strike or riot, provided that the nonperforming Party uses commercially reasonable efforts
to avoid or remove such causes of nonperformance and continues performance under this Agreement with reasonable dispatch whenever
such causes are removed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">12.7 <U>Use of Name</U>. Neither
Party shall use the name of the other Party or of any trustee, director, officer, staff member, employee, student or agent of the
other Party or any adaptation thereof in any advertising, promotional or sales literature, publicity or in any document employed
to obtain funds or financing without the prior written approval of the Party or individual whose name is to be used. For Hospital,
such approval shall be obtained from Hospital&rsquo;s VP of Public Affairs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">12.8 <U>Governing
Law</U>. This Agreement shall be governed by and construed and interpreted in accordance with the laws of the Commonwealth of
Massachusetts, excluding with respect to conflict of laws, except that questions affecting the construction and effect of any
patent shall be determined by the law of the country in which the patent shall have been granted. Each
Party agrees to submit to the exclusive jurisdiction of the Superior Court for Suffolk County, Massachusetts, and the
United States District Court for the District of Massachusetts with respect to any claim, suit or action in law or equity
arising in any way out of this Agreement or the subject matter hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">12.9 <U>Hospital Policies</U>.
Company acknowledges that Hospital&rsquo;s employees and medical and professional staff members and the employees and staff members of
Hospital&rsquo;s Affiliates are subject to the applicable policies of Hospital and such Affiliates, including, without limitation, policies
regarding conflicts of interest, intellectual property and other matters. Company shall provide Hospital with any agreement it
proposes to enter into with any employee or staff member of Hospital or any of Hospital&rsquo;s Affiliates for Hospital&rsquo;s prior review
and shall not enter into any oral or written agreement with such employee or staff member which conflicts with any such policy.
Hospital shall provide Company, at Company&rsquo;s request, with copies of any such policies applicable to any such employee or staff
member.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">12.10 <U>Severability</U>.
If any provision(s) of this Agreement are or become invalid, are ruled illegal by any court of competent jurisdiction or are
deemed unenforceable under then current applicable law from time to time in effect during the term hereof, it is the
intention of the parties that the remainder of this Agreement shall not be effected thereby. It is further the intention of
the parties that in lieu of each such provision which is invalid, illegal or unenforceable, there be substituted or added as
part of this Agreement a provision which shall be as similar as possible in economic and business objectives as intended by
the parties to such invalid, illegal or enforceable provision, but shall be valid, legal and enforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">12.11 <U>Survival</U>. In addition to any
specific survival references in this Agreement, Sections 1, 2.4, 4.2, 4.6, 4.7, 5.3, 5.4, 5.5, 6.4, 8.1, 8.2, 9.2, 9.3, 10.7, 10.8,
10.9, 12.1, 12.2, 12.3, 12.4, 12.7, 12.8, 12.9, 12.10, 12.11, 12.12 and 12.13 shall survive termination or expiration of this Agreement.
Any other rights, responsibilities, obligations, covenants and warranties which by their nature should survive this Agreement shall
similarly survive and remain in effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">12.12 <U>Interpretation</U>. The parties
hereto are sophisticated, have had the opportunity to consult legal counsel with respect to this transaction and hereby waive any
presumptions of any statutory or common law rule relating to the interpretation of contracts against the drafter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">12.13 <U>Headings</U>. All headings are
for convenience only and shall not affect the meaning of any provision of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><I>[Remainder of page intentionally left
blank]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">IN WITNESS
WHEREOF, the Parties have caused this Agreement to be executed by their duly authorized representatives as of the Effective Date
first written above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: left; font-variant: small-caps"><FONT STYLE="font-size: 10pt; font-variant: small-caps"><B>Tiziana Pharma Ltd.</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: left; font-variant: small-caps"><FONT STYLE="font-size: 10pt; font-variant: small-caps"><B>The Brigham And Women&rsquo;s Hospital, Inc.</B></FONT></TD></TR>

<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: left; font-variant: small-caps">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: left; font-variant: small-caps">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; text-align: justify"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="width: 40%; text-align: justify; border-bottom: Black 1.5pt solid">/s/ Gabriele Cerrone</TD>
    <TD STYLE="width: 10%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 5%; text-align: justify"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="width: 40%; text-align: justify; border-bottom: Black 1.5pt solid">/s/ Emy Chen</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="text-align: justify">Gabriele Cerrone</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="text-align: justify">Emy Chen &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="text-align: justify">Chairman</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="text-align: justify">Director, Licensing Partners Healthcare Innovation</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="text-align: justify">5/29/2018</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="text-align: justify">5/29/2018</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify"></P>


<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>Appendix A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>DESCRIPTION OF PATENT
RIGHTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">US Provisional Patent
Application 62/515,711. Filed June 6<SUP>th</SUP> 2017.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"></P>


<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; color: Red; text-indent: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Appendix B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>SALES REPORTS</B></P>



<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 50%"><B>AGREEMENT INCOME REPORT</B></TD>
    <TD STYLE="width: 50%"><P STYLE="margin: 0pt 0; text-align: right"><B>Royalty Income</B></P>


</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.15in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 30%">[MGH][BWH] <FONT STYLE="font: 10pt Times New Roman, Times, Serif">Agreement # -</FONT></TD>
    <TD STYLE="width: 70%; border-bottom: Black 1.5pt solid">&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>Licensee -</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>Sub-Licensee -</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD>
    </TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.15in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-indent: 0"><I>Separate reports must be filed for:</I></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><B><I>1.</I></B></TD><TD STYLE="text-align: justify"><B><I>Each Product sold.</I></B></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><B><I>2.</I></B></TD><TD STYLE="text-align: justify"><B><I>Each country of sale, if different deductions
or royalty rates apply.</I></B></TD>
</TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-indent: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 20%"><P STYLE="margin: 0pt 0"><B>Product Name:</B></P>


</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 80%">&nbsp;</TD>
    </TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><B>Report Time Period:</B></P>

<P STYLE="margin: 0 0 0 0.5in; text-indent: 0">&nbsp;</P>

<P STYLE="margin: 0 0 0 0.5in; text-indent: 0">From&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <I>mm&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;/dd/yyyy</I>_________________________________________________________________</P>

<P STYLE="margin: 0 0 0 0.5in; text-indent: 0">From&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <I>mm&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;/dd/yyyy</I>_________________________________________________________________</P>

<P STYLE="margin: 0 0 0 0.5in; text-indent: 0">&nbsp;</P>

<P STYLE="margin: 0 0 0 0.5in; text-indent: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 100%; border: Black 1.5pt solid">&nbsp;</TD>
    </TR>
</TABLE>

<P STYLE="margin: 0 0 0 0.5in; text-indent: 0">&nbsp;</P>

<P STYLE="margin: 0 0 0 0.5in; text-indent: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 22%; padding: 0; text-indent: 0"><B><I>Country of Sale</I></B></TD>
    <TD STYLE="width: 2%; padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="width: 24%; border-bottom: Black 1.5pt solid; padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="width: 2%; padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="width: 24%; border-bottom: Black 1.5pt solid; padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="width: 2%; padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="width: 24%; border-bottom: Black 1.5pt solid; padding: 0; text-indent: 0">&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="padding: 0; text-indent: 0"><B><I>Quantity Sold</I></B></TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; padding: 0; text-indent: 0">&nbsp;</TD>
    </TR>

<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="padding: 0; text-indent: 0"><B><I>Gross Sales (USD)</I></B></TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; border-bottom: Black 1.5pt solid">$<U></U></TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; border-bottom: Black 1.5pt solid">$<U></U></TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; border-bottom: Black 1.5pt solid">$<U></U></TD>
    </TR>

<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="padding: 0; text-indent: 0"><B><I>Exchange Rate</I></B></TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; padding: 0; text-indent: 0">&nbsp;</TD>
    </TR>
</TABLE>

<P STYLE="margin: 0; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><B><I>Deductions (Itemize)</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify"><I>Please list each deduction separately. Use
same definition as appears in Agreement and include the contract paragraph as a reference (Std Section 1.17(a)(ii) line item deductions
listed below).</I></P>



<P STYLE="margin: 0; text-indent: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 22%; padding-left: 0.75in"><B><I>A1.</I></B></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 24%; border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 24%; border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 24%; border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="padding-left: 0.75in"><B><I>A2.</I></B></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="padding-left: 0.75in"><B><I>A3.</I></B></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="padding-left: 0.75in"><B><I>A4.</I></B></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="padding-left: 0.75in"><B><I>B.</I></B></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0; text-indent: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 22%; padding: 0; text-indent: 0"><B><I>Total Deductions</I></B></TD>
    <TD STYLE="width: 2%; padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="width: 24%; padding: 0; text-indent: 0">(<U>__________________________</U>)</TD>
    <TD STYLE="width: 2%; padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="width: 24%; padding: 0; text-indent: 0">(<U>__________________________</U>)</TD>
    <TD STYLE="width: 2%; padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="width: 24%; padding: 0; text-indent: 0">(<U>__________________________</U>)</TD>
    </TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="padding: 0; text-indent: 0"><B><I>Net Sales</I></B></TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; padding: 0; text-indent: 0">&nbsp;</TD>
    </TR>

<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="padding: 0; text-indent: 0"><B><I>Royalty Percentage</I></B></TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; padding: 0; text-indent: 0">&nbsp;</TD>
    </TR>

<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="padding: 0; text-indent: 0"><B><I>Credits (Itemize)</I></B></TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">(<U>__________________________</U>)</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">(<U>__________________________</U>)</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">(<U>__________________________</U>)</TD>
    </TR>

<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="padding: 0; text-indent: 0"><B><I>Royalties Due</I></B></TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">$<U>__________________________</U></TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">$<U>__________________________</U></TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">$<U>__________________________</U></TD>
    </TR>
</TABLE>
<P STYLE="margin: 0; text-indent: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border: Black 1.5pt solid; width: 100%">&nbsp;</TD>
    </TR>
</TABLE>

<P STYLE="margin: 0; text-indent: 0">&nbsp;</P>

<P STYLE="margin: 0; text-indent: 0"><FONT STYLE="font-size: 10pt"><B>PLEASE ATTACH DETAIL SALES REPORTS AS REQUIRED</B></FONT></P>

<P STYLE="margin: 0; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>Appendix C</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 50%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>AGREEMENT
    INCOME REPORT</B></FONT></TD>
    <TD STYLE="width: 50%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Sublicense
    Income</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; width: 24%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">[MGH][BWH]
Agreement # -</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; width: 76%; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Licensee -</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Sub-Licensee -</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>Separate
reports must be filed for Payments associated with each Product:</I></B></FONT></P>



<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; width: 15%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Product
                                         Name:</B></FONT></P>


<FONT></FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; width: 83%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; width: 40%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Report
    Time Period:</B></FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; width: 58%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 8%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; width: 15%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">From
    <I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;mm</I></FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; width: 7%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;<I>/dd/yyyy</I></FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; width: 70%; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">To
    <I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;mm</I></FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;<I>/dd/yyyy</I></FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; border: Black 1.5pt solid; width: 100%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Detailed
Explanation of Payment</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Required
for &ldquo;Other Payment&rdquo;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 70%; font-weight: bold; font-style: italic; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Annual
    Fees/Minimum Royalties</FONT></TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 9%; text-align: right; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"></TD><TD STYLE="width: 15%; text-align: right; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"></TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; font-style: italic; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Milestone
    Payments</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; font-style: italic; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Sublicense
    Fees and Royalties</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; font-style: italic; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Other
    Payment</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; font-style: italic; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Other
    Payment</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; font-style: italic; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Other
    Payment</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; font-style: italic; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">TOTAL</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; border: Black 1.5pt solid; width: 100%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>PLEASE
ATTACH DETAIL AS REQUIRED</B></FONT></P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify"></P>


<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>Appendix D</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>CONFIDENTIALITY TERMS
AND CONDITIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify">1. <U>Definition of
Confidential Information</U>. &ldquo;Confidential Information&rdquo; shall mean any information, including but not limited to
data, techniques, protocols or results, or business, financial, commercial or technical information, disclosed by one Party
(each a &ldquo;Discloser&rdquo; as applicable) to the other Party (each a &ldquo;Recipient&rdquo; as applicable) in
connection with the terms of that certain Agreement and identified as confidential at the time of disclosure (the
&ldquo;Purpose&rdquo;). Hospital&rsquo;s Confidential Information shall also include all information disclosed by Hospital to
Company in connection with the Patent Rights. Capitalized terms used in this Appendix that are not otherwise defined herein
have the meanings ascribed in the License Agreement to which this Appendix is attached and made a part thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">2. <U>Exclusions</U>.
&ldquo;Confidential Information&rdquo; under this Agreement shall not include any information that (i) is or becomes publicly
available through no wrongful act of Recipient; (ii) was known by Recipient prior to disclosure by Discloser, as evidenced by
tangible records; (iii) becomes known to Recipient after disclosure from a third
party having an apparent bona fide right to disclose it; (iv) is independently developed or discovered by Recipient without
use of Discloser&rsquo;s Confidential Information, as evidenced by tangible records; or (v) is disclosed to another party by
Discloser without restriction on further disclosure. The obligations of confidentiality and non-use set forth in this
Agreement shall not apply with respect to any information that Recipient is required to disclose or produce pursuant to
applicable law, court order or other valid legal process provided that Recipient promptly notifies Discloser prior to such
required disclosure, discloses such information only to the extent so required and cooperates reasonably with
Discloser&rsquo;s efforts to contest or limit the scope of such disclosure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">3. <U>Permitted
Purpose</U>. Recipient shall have the right to, and agrees that it will, use Discloser&rsquo;s Confidential Information
solely for the Purpose as described in the License Agreement, except as may be otherwise specified in a separate definitive
written agreement negotiated and executed between the parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">4. <U>Restrictions</U>. For
the term of the Agreement and a period of three {3) years thereafter (and indefinitely with respect to any individually identifiable
health information disclosed by Hospital to Company, if any), each Recipient agrees that: (i) it will not use such Confidential
Information for any purpose other than as specified herein, including without limitation for its own benefit or the benefit of
any other person or entity; and (ii) it will use reasonable efforts (but no less than the efforts used to protect its own confidential
and/or proprietary information of a similar nature) not to disclose such Confidential Information to any other person or entity
except as expressly permitted hereunder. Recipient may, however, disclose Discloser&rsquo;s Confidential Information only on a
need-to-know basis to its and its Affiliates employees, staff members and agents (&ldquo;Receiving Individuals&rdquo;) who are
directly participating in the Purpose and who are informed of the confidential nature of such information, provided Recipient
shall be responsible for compliance by Receiving Individuals with the terms of this Agreement and any breach thereof. Each party
further agrees not to use the name of the other party or any of its Affiliates or any of their respective trustees, directors,
officers, staff members, employees, students or agents in any advertising, promotional or sales literature, publicity or in any
document employed to obtain funds or financing without the prior written approval of the party or individual whose name is to
be used, in the case of Hospital such approval to be given by the Public Affairs Department. This Section 4 shall survive termination
or expiration of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"></P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">5. <U>Right
to Disclose</U>. Discloser represents that to the best of its knowledge it has the right to disclose to each Recipient all of
Discloser&rsquo;s Confidential Information that will be disclosed hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">6. <U>Ownership</U>.
All Confidential Information disclosed pursuant to this Agreement, including without limitation all written and tangible forms
thereof, shall be and remain the property of the Discloser. Upon termination of this Agreement, if requested by Discloser, Recipient
shall return or destroy at Discloser&rsquo;s discretion all of Discloser&rsquo;s Confidential Information, provided that Recipient
shall be entitled to keep one copy of such Confidential Information in a secure location solely for the purpose of determining
Recipient&rsquo;s legal obligations hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">7. <U>No
License</U>. Nothing in this Agreement shall be construed as granting or conferring, expressly or impliedly, any rights by license
or otherwise, under any patent, copyright, or other intellectual property rights owned or controlled by Discloser relating to
Confidential Information, except as specifically set forth in the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">8. <U>Remedies</U>.
Each party acknowledges that any breach of this Agreement by it may cause irreparable harm to the other party and that each party
is entitled to seek injunctive relief and any other remedy available at law or in equity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">9. <U>General</U>.
These Confidentiality Terms and Conditions, along with the License, contain the entire understanding of the parties with respect
to the subject matter hereof, and supersede any prior oral or written understandings between the parties relating to confidential
treatment of information. Sections 1, 2, 4, 6, 8 and 9 of these Confidentiality Terms and Conditions shall survive any expiration
or termination of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"></P>

<!-- Field: Page; Sequence: 25; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.5
<SEQUENCE>11
<FILENAME>ff12018a1ex10-5_tiziana.htm
<DESCRIPTION>ANNUAL LEASE FOR 55 PARK LANE, SUITE 14A, LONDON W1K 1NA, UNITED KINGDOM, DATED JUNE 29, 2018
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: right"><B>Exhibit 10.5</B></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DATED
29 June, 2018</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>HYDE
PARK RESIDENCE LIMITED (1)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AND</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TIZIANA
PHARMA LIMITED (2)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 50%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>LEASE
RELATING TO SUITE 14A, 55 PARK LANE, LONDON,</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>W1K
1NA</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 50%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Lewis
Silkin LLP<BR>
5 Chancery Lane<BR>
Clifford&rsquo;s Inn</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>London
EC4A 1BL</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Ref: PB8093/403.139</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We hereby certify this to be a true</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">and accurate copy of the original</FONT></P>

</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 7%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 33%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signed</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Lewis Silkin LLP</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lewis
    Silkin LLP</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2
    July 2018</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B></B></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PARTICULARS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 25%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Break
    Date</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 75%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31
    December 2018</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Building</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    building known as 55 Park Lane, London WIK 1NA of which the Premises form part and described in more detail in Part 1 of the
    First Schedule</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Contractual
    Term</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    term of one year from and including the Term Commencement Date ending on and including 30 June 2019</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Landlord</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>HYDE
    PARK RESIDENCE LIMITED </B>(company number 2061713) whose registered office is at 55 Park Lane, London W1K 1NA</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Permitted
    Use</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    use of the Premises as B1 offices</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Principal
    Rent</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    rent of FORTY TWO THOUSAND NINE HUNDRED AND SEVENTY THREE POUNDS AND TWENTY THREE PENCE (&pound;42,973.23) per annum exclusive of
    Value Added Tax and business rates.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Premises</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    part of the Building known as Office Suite 14A, 55 Park Lane, London W1K 1NA shown on the Plan and described in more detail
    in Part 2 of the First Schedule</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Rent
    Commencement Date</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Term Commencement Date</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Tenant</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TIZIANA
    PHARMA LIMITED </B>(company registration number <B>08760354) </B>whose registered office is at 3<SUP>rd</SUP> Floor, 11-12
    St James&rsquo;s Square, London SW1Y 4LB</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Term
    Commencement Date</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1
    July 2018</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B></B></FONT></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THIS
LEASE </B>is dated 29 June 2018</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>BETWEEN:-</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(1)</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Landlord; and</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(2)</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Tenant.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; width: 0.5in"><B>1</B></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Definitions</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
this Lease, unless the contrary intention appears, and where appropriate:-</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;1954
Act&rdquo; </B>means the Landlord and Tenant Act 1954;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;1995
Act&rdquo; </B>means the Landlord and Tenant (Covenants) Act 1995;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Alterations&rdquo;
</B>means any alterations, additions or other works to the Premises;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Common
Parts&rdquo; </B>means all those parts of the Building from time to time intended for the common use of the Landlord, the Tenant
and any other occupiers of the Building;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Conduits&rdquo;
</B>means all conducting media and ancillary apparatus used for the passage or transmission of Utilities;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;EPC&rdquo;
</B>means energy performance certificate and recommendation report, as such terms are defined in the Energy Performance of Buildings
(England and Wales) Regulations 2012;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Insolvency
Event&rdquo; </B>means any of the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
Tenant Is unable to pay its debts or is deemed to be unable to pay its debts under s123 Insolvency Act 1986 (if a company) or
s268 Insolvency Act 1986 (if an individual);</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
Tenant makes any agreement, arrangement, scheme, composition or moratorium with Its creditors, including a voluntary arrangement
under Part I (if a company) or Part VIII (if an individual) of the insolvency Act 1986;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">where
the Tenant is a company, it has an administration application made in relation to it or voluntarily makes an administration application,
notice of intention to appoint an administrator to the company is given by any of the persons entitled to give such notice under
the insolvency Act 1986, as amended by the Enterprise Act 2002, an administrator is appointed or it has an administration order
or interim order made against it under the Enterprise Act 2002;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">where
                                         the Tenant is an individual, he is the subject of a bankruptcy petition or his circumstances
                                         are such that a bankruptcy petition could be presented under Part IX of the Insolvency
                                         Act 1986, he has a bankruptcy order made against him or he is otherwise adjudged to be
                                         bankrupt;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.55in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         step is taken to enforce security over or to obtain possession of the Premises or any
                                         other assets or income of the Tenant, including the appointment of an interim receiver,
                                         receiver or administrative receiver;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.55in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                         the Tenant is a company, any step is taken by any person with a view to the winding up,
                                         whether solvent or insolvent, of the Tenant, or the Tenant ceases to carry on all or
                                         a material part of its business, except in relation to a voluntary winding up for the
                                         purpose of a reconstruction, amalgamation, reorganisation, merger or consolidation of
                                         the Tenant while solvent in respect of which a statutory declaration of solvency has
                                         been filed with the Registrar of Companies; or</FONT></TD></TR></TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><IMG SRC="ex10-5_003.jpg" ALT=""><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 51%; font: 10pt Times New Roman, Times, Serif; border-top: Black 1.5pt solid; padding-top: 5"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FLOOR
                                         : GROUND</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AREA
        : Gross internal 60.6 m2 / 652 ft2</FONT></P></TD>
    <TD STYLE="width: 49%; font: 10pt Times New Roman, Times, Serif; border-top: Black 1.5pt solid; border-left: Black 1.5pt solid; padding-left: 5; padding-top: 5"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">OFFICE
                                         SUITE 14A</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">55
        PARK LANE LONDON W1</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; border-left: Black 1.5pt solid; padding-left: 5"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DATE
    : SEPT 2006 DRAWING NUMBER : 14A / G</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
respect of a Tenant incorporated or resident in a jurisdiction outside England and Wales, any event or circumstance occurs which,
under the laws of that jurisdiction, has an analogous or equivalent effect to any of the Insolvency Events contained in this definition.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Insurance
Event&rdquo; </B>means any damage to or destruction of the Building by any of the Insured Risks or the Supplemental Risks which
at the date of such destruction or damage is covered by any insurance policy maintained by Landlord or any Superior Landlord;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Insured
Risks&rdquo; </B>means the insured risks defined in the Superior Lease;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Interest&rdquo;
</B>means interest charged at the Interest Rate, both before and after any judgment, and calculated on a daily basis from the
date due for payment to the date on which payment is received and compounded with rests on the Quarter Days;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Interest
Rate&rdquo; </B>means 4% per annum above the base rate for the time being of Barclays Bank plc (or such other bank as the Landlord
may from time to time nominate);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Lease&rdquo;
</B>means this underlease and any document supplemental to it;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Previous
Lease&rdquo; </B>means the Lease of the Premises dated 19 August 2015 and made between (1) Hyde Park Residence Limited and (2)
Vistra (UK) Limited;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Plan&rdquo;
</B>means the plan annexed to this Lease;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Quarter
Days&rdquo; </B>means 25 March, 24 June, 29 September and 25 December; <B>&ldquo;Rents&rdquo; </B>means the rents payable by the
Tenant under clause 4.1;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Retained
Parts&rdquo; </B>means all parts of the Building, excluding any parts of the Building, including the Premises, designed to be let
to occupational tenants;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Service
Charge&rdquo; </B>means EIGHT THOUSAND TWO HUNDRED AND SIXTY FOUR POUNDS AND TEN PENCE (&pound;8,264.10) per annum exclusive of VAT;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Services&rdquo;
</B>means (subject to clause 12.1(d)) the services listed in The Second Schedule; <B>&ldquo;Superior Landlord&rdquo; </B>means the
landlord for the time being under the Superior Lease;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Superior
Lease&rdquo; </B>means a lease of the Building dated 11 May 2001 and made between (1) Park Lane Residences BVI Limited and (2)
the Landlord and includes any documents supplemental to it at the date of this Lease;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Supplemental
Risks&rdquo; </B>means such of the following risks as shall not from time to time be Insured Risks: fire; lightning; explosion;
aircraft or other aerial devices and articles dropped from them; earthquake; riot; civil commotion; malicious damage; flood; storm;
or tempest; bursting or overflowing of water tanks, apparatus or pipes; impact and such other risks (including terrorism) as the
Landlord may from time to time consider appropriate;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Tenant&rsquo;s
Covenants&rdquo; </B>means the obligations in this Lease to be complied with by the Tenant;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Term&rdquo;
</B>means the Contractual Term granted by this Lease;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&ldquo;Utilities&rdquo;
</B>means the drainage of surface water and sewerage and the supply or transmission of gas, electricity, telecommunications, water
and any other supplies or services made to or consumed in the Building; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Value
Added Tax&rdquo; </B>includes any future tax of a similar nature.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
 <TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Interpretation</B></FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp; <FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>



<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In</FONT> <FONT STYLE="font: 10pt Times New Roman, Times, Serif">this Lease, unless the contrary intention appears, and where appropriate:-</FONT></P>



<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp; <FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
 <TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
definitions on the preceding pages headed &ldquo;Land Registry Particulars&rdquo; and &ldquo;Additional Particulars&rdquo; apply to
this Lease;</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
 <TD STYLE="width: 0.5in; text-align: left">&nbsp;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
 <TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">obligations
                                         which are entered into by more than one person shall be deemed to be joint and several;</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
 <TD STYLE="width: 0.5in; text-align: left">&nbsp;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
 <TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">references
to one gender include all other genders and vice versa;</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
 <TD STYLE="width: 0.5in; text-align: left">&nbsp;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
 <TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">references
to the singular include the plural and vice versa;</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
 <TD STYLE="width: 0.5in; text-align: left">&nbsp;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
 <TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.5</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">references
to the parties include their successors in title;</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
 <TD STYLE="width: 0.5in; text-align: left">&nbsp;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
 <TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.6</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">references
to persons include individuals, companies, corporations, firms, partnerships, government bodies and agencies;</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
 <TD STYLE="width: 0.5in; text-align: left">&nbsp;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
 <TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.7</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">titles
and headings are for reference only and shall not affect the interpretation of this Lease;</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
 <TD STYLE="width: 0.5in; text-align: left">&nbsp;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
 <TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.8</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">references
to a statute mean that statute as amended, consolidated or re-enacted at the relevant time and any statutory instrument, regulation
or order made under it which is then in force and references to statutes in general include statutes in existence or enacted at
any time in the future;</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
 <TD STYLE="width: 0.5in; text-align: left">&nbsp;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
 <TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.9</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">references
to an indemnity mean an indemnity against all actions, claims, demands and proceedings made against the Landlord and all costs,
expenses, liabilities and losses incurred directly or indirectly by the Landlord and &ldquo;indemnify&rdquo; and &ldquo;indemnified&rdquo;
shall be construed accordingly;</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
 <TD STYLE="width: 0.5in; text-align: left">&nbsp;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
 <TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.10</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
any provision in this Lease is held to be illegal, void, invalid or unenforceable for any reason, the legality, validity and enforceability
of the remainder of this Lease shall not be affected;</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
 <TD STYLE="width: 0.5in; text-align: left">&nbsp;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
 <TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.11</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">references
to the Premises or the Building include any part of them;</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
 <TD STYLE="width: 0.5in; text-align: left">&nbsp;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
 <TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.12</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">references
to the end of the Term include the determination of the Term before the end of the Contractual Term, whether by re-entry, surrender
or otherwise;</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
 <TD STYLE="width: 0.5in; text-align: left">&nbsp;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
 <TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.13</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">where
the Tenant requires the consent of the Landlord to any alterations, any change to the Permitted Use, or any assignment or underletting,
such consent shall not be effective unless given by way of a formal licence signed as a deed and any other consent or approval
shall be in writing;</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
 <TD STYLE="width: 0.5in; text-align: left">&nbsp;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
 <TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.14</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
document entered into pursuant to this Lease shall be in such form and contain such restrictions and conditions as the Landlord
shall reasonably require;</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
 <TD STYLE="width: 0.5in; text-align: left">&nbsp;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
 <TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.15</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
obligation on the Tenant to obtain the consent or approval of the Landlord shall include, where required under any document, an
obligation to obtain such consent or approval from the holder of any superior interest and any mortgagee, and nothing contained
in this Lease shall impose any obligation on any such person to act reasonably;</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
 <TD STYLE="width: 0.5in; text-align: left">&nbsp;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
 <TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.16</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
reference to the date of assignment shall mean the date of the deed of assignment or transfer of this Lease and any covenants
given to the Landlord on any assignment of this Lease shall take effect from such date;</FONT></TD>
</TR></TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
 <TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.17</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
obligation on the Tenant includes an obligation on the Tenant to ensure that any person deriving title under the Tenant and its
and their agents, employees, licensees and any other person under its or their control comply with that obligation and any reference
to an act or default of the Tenant includes an act or default of those persons;</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
 <TD STYLE="width: 0.5in; text-align: left">&nbsp;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
 <TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.18</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">references
to a &ldquo;proper proportion&rdquo; mean such proportion as is reasonably determined by the Landlord (or its surveyor) whose decision
shall be binding, except in the case of manifest error;</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
 <TD STYLE="width: 0.5in; text-align: left">&nbsp;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
 <TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.19</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
words &ldquo;including&rdquo; and &lsquo;include&rdquo; shall be deemed to be followed by the words &lsquo;without limitation&rdquo;;</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
 <TD STYLE="width: 0.5in; text-align: left">&nbsp;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
 <TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.20</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
obligation on the Tenant not to do an act includes an obligation not to permit that act to be done;</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
 <TD STYLE="width: 0.5in; text-align: left">&nbsp;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
 <TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.21</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
there is any conflict between the Plan and the description of the Premises in Part 2 of Schedule 1, then the latter shall prevail;
and</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
 <TD STYLE="width: 0.5in; text-align: left">&nbsp;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
 <TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.22</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">references
to &ldquo;working days&rdquo; mean any day from Monday to Friday (inclusive) and shall exclude any Bank or other public holiday,
Saturday or Sunday.</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
 <TD STYLE="width: 0.5in; text-align: left">&nbsp;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
 <TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Creation
                                         of letting</B></FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
 <TD STYLE="width: 0.5in; text-align: left">&nbsp;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
 <TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Grant
of lease</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Landlord lets the Premises to the Tenant for the Contractual Term.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Rights
and reservations</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Premises are let:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">together
                                         with the rights set out in Part 3 of The First Schedule, in favour of the Tenant and
                                         any person deriving title under the Tenant, to be enjoyed in common with the Landlord,
                                         any Superior Landlord and every person authorised by them (including those to whom the
                                         Landlord or the Superior Landlord shall grant or have granted such rights) and all others
                                         having like or similar rights, unless otherwise stated in The First Schedule;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">subject
                                         to the rights set out in The Third Schedule to the Superior Lease, in favour of the Superior
                                         Landlord, every person authorised by the Superior Landlord and all others who are or
                                         may become entitled to exercise them;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">subject
                                         to the rights set out in Part 4 of The First Schedule, in favour of the Landlord, every
                                         person authorised by the Landlord and all others who are or may become entitled to exercise
                                         them; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">subject
                                         to the title matters set out in The Fifth Schedule to the Superior Lease and all other
                                         rights, easements, covenants and privileges enjoyed over or against the Premises or the
                                         Building, so far as any of them are still subsisting and capable of taking effect.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>No
implied rights</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Tenant shall not be entitled to the benefit of or to enforce any right, easement, covenant or agreement in respect of the Premises
or the Building, except those expressly granted in clause 3.2(a), and s62 Law of Property Act 1925 shall not apply to this Lease.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left">3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Modification
of rights</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Landlord shall be entitled to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">exercise
                                         the rights set out in Part 3 of The First Schedule, without any liability to the Tenant
                                         except as set out in The First Schedule; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">modify
                                         or end the rights granted in part 2 of The First Schedule without any liability to the
                                         Tenant if it grants such alternative rights as may be necessary for the proper and reasonable
                                         enjoyment of the Premises.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Payments</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Rents</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Tenant shall pay to the Landlord by way of rent without any abatement, counterclaim, deduction, reduction or set off whatsoever
(except as required by law):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">from
                                         and including the Rent Commencement Date, the Principal Rent by equal quarterly payments
                                         in advance on the Quarter Days and, if the Landlord so requires, by banker&rsquo;s standing
                                         order, the first payment (being a proportionate sum) being due on the date of this Lease;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">from
                                         and including the Rent Commencement Date, the Service Charge by equal quarterly payments
                                         in advance on the Quarter Days, and, if the Landlord so requires, by banker&rsquo;s standing
                                         order, the first payment (being a proportionate sum) being due on the date of this Lease;
                                         and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         other sums payable under this Lease,</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Interest
on late payments</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Tenant shall pay to the Landlord on demand Interest on any sums due to the Landlord which are not paid within fifteen working
days of the due date for payment or, for the Principal Rent, on the due date for payment,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Value
Added Tax</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
sums payable by the Tenant under this Lease for taxable supplies of goods or services shall be treated as being exclusive of
the Value Added Tax chargeable on such sums. The Tenant shall pay on demand all Value Added Tax properly demanded by the
Landlord.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Outgoings
and rates</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Tenant shall pay and indemnify the Landlord against all rates, taxes, charges and outgoings assessed or charged on the Premises
or payable by the owner <B>or </B>occupier of them (except any tax, other than Value Added Tax, payable by the Landlord on the
Rents, or any tax payable on the grant of this Lease or on any other dealing by the Landlord with its interest in the Building).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Valuations</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Tenant shall not agree or propose to alter the rating valuation of the Premises without the Landlord&rsquo;s consent, such consent not
to be unreasonably withheld or delayed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Loss
of rating relief</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Tenant shall pay to the Landlord on demand an amount equal to any rating relief which the Landlord is unable to claim after the
Term has ended as a result of the Tenant having made such a claim.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Utilities</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Tenant shall pay for all Utilities used by the Tenant and any related meter rents, installation charges and connection charges.
In the absence of direct assessment of any of the Utilities, the Tenant shall pay to the Landlord on demand a proper proportion
of the cost of the Tenant&rsquo;s use of the Utilities and any related rents and charges.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Landlord&rsquo;s
costs</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Tenant shall pay on a full indemnity basis and on demand all proper charges and expenses incurred by or on behalf of the Landlord
(including legal and surveying fees and the Landlord&rsquo;s own administration and management expenses) for and in connection with:-</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         preparation and service of any notice and/or any proceedings under ss146 and/or 147 Law
                                         of Property Act 1925 and/or the Leasehold Property (Repairs) Act 1938, whether or not
                                         forfeiture is avoided other than by relief granted by the Court;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         preparation and service of any notice and/or schedule relating to dilapidations served
                                         during or within 12 months after the end of the Term;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         recovery of any arrears of Rent or other sums due to the Landlord under this Lease;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0.05in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         preparation and service of any notice pursuant to s81 Tribunals, Courts and Enforcement
                                         Act 2007;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0.05in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         preparation and service of any notice under s17 of the 1995 Act;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         steps taken by the Landlord to ensure that the Tenant makes good or has made good any
                                         breach of the Tenant&rsquo;s Covenants, including any survey carried out to ascertain the nature
                                         and extent of any such breach; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         application for consent to any matter for which the consent of the Landlord is required
                                         under this Lease, whether such consent is granted or not, unless the Landlord acts unreasonably
                                         in refusing consent. Any costs payable under this clause 4.8(g) shalt include the costs
                                         and expenses of the Superior Landlord where the consent of the Superior Landlord is required
                                         under the Superior Lease.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.9</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Indemnity</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Tenant shall keep the Landlord indemnified against any breach of the Tenant&rsquo;s Covenants or any act or default of the Tenant in
relation to the Premises or the Building.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Repairing
                                         Obligations</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Repair</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Tenant shall:</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0.05in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">keep
                                         the Premises arid the tenant&rsquo;s fixtures in good and substantial repair and condition;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">replace
                                         any damaged or destroyed external glazing serving the Premises with glazing of the same
                                         specification, appearance and quality as previously;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">replace
                                         any landlord&rsquo;s fixtures (including plant and machinery) in the Premises with new articles
                                         of a similar kind and quality if they become incapable of repair, as a result of any
                                         act or default of the Tenant.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clause
5.1(a) shall not apply to the extent that any disrepair has been caused by an Insurance Event, except to the extent that payment
of the insurance monies is withheld as a result of some act or default of the Tenant.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Decoration</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the three months before the end of the Term, the Tenant shall decorate the interior of the Premises in a good arid workmanlike
manner and with appropriate materials of good quality to the reasonable satisfaction of the Landlord, using colours and materials
which shall be first approved by the Landlord (which shall not be unreasonably withheld or delayed).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Clean</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Tenant shall keep the Premises clean and tidy, with all of the interior surfaces of the windows and other glazing in the
Premises being cleaned at least once every month.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Conduits</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Tenant shall:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">keep
                                         the Conduits which form part of the Premises clear and unobstructed and not do anything
                                         that causes any obstruction or damage to any of the Conduits serving the Premises or
                                         the Building; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">take
                                         all necessary precautions against the bursting or overflowing of any Conduit, tank or
                                         water apparatus that forms part of the Premises (whether by frost damage or otherwise),
                                         provided that the Conduits, tank or water apparatus were adequately insulated at the
                                         date of this Lease.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.5</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Remedy
breaches on notice</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Within
                                         three months of receiving notice from the Landlord of any breach of the Tenant&rsquo;s Covenants
                                         relating to the repair and condition of the Premises, or immediately in case of emergency,
                                         the Tenant shall complete all works required to remedy such breach,</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                         the Tenant fails to remedy the breach specified within the requisite time, the Tenant
                                         shall permit the Landlord and any person authorised by the Landlord to enter the Premises
                                         and remedy the breach and all costs incurred by the Landlord shall be a debt payable
                                         by the Tenant as additional rent on demand to the Landlord on a full indemnity basis.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Use</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title
matters</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Tenant shall comply with the conditions, covenants, restrictions and other matters contained or referred to in the deeds and documents
specified in The Fifth Schedule to the Superior Lease.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.2</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Permitted
Use</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Tenant shall use the Premises only for the Permitted Use.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.3</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Prohibited
uses</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Tenant shall not use the Premises:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">for
                                         any religious, public or political meeting;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">for
                                         the sale or production of alcohol;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">for
                                         residential purposes or allow any person to sleep in the Premises;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0.05in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
                                         a club, sex shop, amusement arcade, betting office, staff agency or employment agency;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">for
                                         the preparation or cooking of food, other than in those areas reasonably designated by
                                         the Landlord for those purposes;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">for
                                         any illegal or immoral purposes;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0.05in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">for
                                         any noxious, noisy or offensive trade or business; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0.05in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">for
                                         a sale by auction; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">for
any use which is prohibited by the Superior Lease.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.4</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Restrictions
on use</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Tenant shall not:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0.05in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">allow
                                         any fish, bird, reptile or animal, other than guide dogs, anywhere in the Premises or
                                         the Building;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">do
                                         anything that may, in the reasonable opinion of the Landlord, be or grow to be a nuisance,
                                         annoyance, disturbance, inconvenience or damage to the Landlord, the Superior Landlord
                                         or the other tenants and occupiers in the Building or in any adjoining or nearby property;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">overload
                                         the electrical systems of the Premises or the Building or connect any equipment to such
                                         electrical systems except in accordance with the design and specification of such electrical
                                         systems;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">overload
                                         the floors, or suspend any excessive weight from the ceilings or walls of the Premises
                                         or overload the lifts serving the Premises and not be unduly noisy or cause vibration
                                         or electrical or other interference;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">bring
                                         upon, store or use on the Premises any materials, substances or liquids of a specially
                                         hazardous, combustible, inflammable, explosive, dangerous or offensive nature;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">obstruct
                                         the Common Parts or any means of escape or other facilities serving the Premises or the
                                         Building;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">discharge
                                         anything into the Conduits which is or may become corrosive or harmful or cause any blockage
                                         or damage to them;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">install
                                         or operate any machinery or mechanical equipment in or on the Premises, except for office
                                         machinery and equipment used by the Tenant in the normal operation of its business, and
                                         that does not breach clause 6.4(b);</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">erect,
                                         exhibit or hang any signs, advertisements, placards, flags, posters, aerials, poles,
                                         masts or satellite dishes or any other thing whatsoever on the exterior of the Premises
                                         or any other parts of the Building unless permitted to do so under clause 3.2(a);</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">store
any refuse in the Premises except in suitable containers for that purpose, with all food waste and other pungent or perishable
refuse being removed from the Premises daily and all other refuse being removed from the Premises weekly; or</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">change
the name or postal address of the Premises without the Landlord&rsquo;s consent, such consent not to be unreasonably withheld
or delayed.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.5</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Regulations</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Tenant shall:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">comply
with the provisions of all statutes and the requirements of any competent authority in relation to the Premises and the Common
Parts and shall carry out and maintain at its own cost all works and arrangements required under any statute, whether imposed
on the Tenant or any other person, so far as they relate to the Premises;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">give
                                         to the Landlord a copy of every notice, direction, order, proposal, licence, consent
                                         or permission relating to the Premises made or given under any statute within ten working
                                         days of receipt (or sooner in cases of emergency) and, if required by the Landlord, the
                                         Tenant shall at its own cost make or join the Landlord in making such objections, applications
                                         or representations relating to them as the Landlord may reasonably require;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">comply
                                         with all requirements and recommendations of the local fire officer in respect of the
                                         Premises and the Building or their use; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">comply
                                         with all reasonable regulations made by the Landlord or the Superior Landlord at any
                                         time for the management of the Building and the exercise of the rights granted to the
                                         Tenant under clause 3.2(a) and communicated to the Tenant in writing.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.6</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Defective
Premises</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Tenant shall do everything necessary to comply with the Defective Premises Act 1972. In particular, the Tenant shall:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">immediately
                                         notify the Landlord of any defect in the Premises or the Building which may give rise
                                         to a duty of care on the Landlord or the Superior Landlord under that Act;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">not
                                         do anything which might breach any duty of care; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">display
                                         or maintain on the Premises any notices which the Landlord or the Superior Landlord may
                                         reasonably require.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.7</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>No
new covenants</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Tenant shall not enter into any covenant relating to the Premises with any person other than the Landlord or require any assignee
or undertenant to give covenants that would restrict the use of the Premises to a greater extent than the restrictions on use
contained in this Lease.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.8</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Covenants
in other leases</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nothing
in this Lease shall give the Tenant any right to enforce or to receive the benefit of or to prevent the release or modification
of any covenant or condition in any lease (other than this Lease), deed or document relating to the Premises, the remainder of
the Building or any adjoining or nearby property.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Encroachments</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.1</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Loss
of existing rights</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Tenant shall not stop-up, darken or obstruct any window or other opening belonging to the Premises or the Building or do anything
which may lead to any rights benefiting the Premises or the Building being lost.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.2</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Creation
of new rights</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Tenant shall not permit any encroachment to be made which may lead to rights being acquired by any person over the Premises or
the Building and shall at its own cost take such action as the Landlord may reasonably require to prevent any rights being acquired
over the Premises or the Building or any rights benefiting the Premises or the Building being lost.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.3</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notification</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Tenant shall give to the Landlord notification as soon as practicable of any interference with or any encroachment of any right
enjoyed by the Premises or the Building or of any attempt to acquire any right over the Premises or the Building.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>8</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Alterations</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Prohibited
alterations</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Tenant shall not carry out any Alterations except as permitted in this clause 8.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Non-structural
alterations</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Tenant may carry out Alterations that are internal and non-structural with the prior consent of the Landlord, such consent not
to be unreasonably withheld or delayed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.3</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>General
provisions</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
respect of all Alterations, the Tenant shall at its own cost:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">provide
                                         the Landlord in triplicate with plans, drawings and specifications showing the Premises
                                         before and after the proposed Alterations;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">obtain
                                         all necessary consents to the Alterations;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">give
                                         the insurers of the Building full details of the Alterations and obtain their approval
                                         to them;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">carry
                                         out the Alterations with good quality materials, in a good, substantial and workmanlike
                                         manner, in accordance with the terms of consents obtained for the Alterations and with
                                         the requirements of the local planning and other authorities;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">comply
                                         with the requirements of any statute which affects the Alterations or the manner in which
                                         they are carried out;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">carry
                                         out the Alterations to the reasonable satisfaction in all respects of the Landlord and,
                                         where the consent of the Superior Landlord is required, the Superior Landlord;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">give
to the Landlord and the Superior Landlord full details of the reinstatement value of the Alterations, excluding any tenant&rsquo;s
fixtures forming part of the Alterations, for insurance purposes; and</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">remove
the Alterations (whether made during the Term of this Lease or during the term of the Previous Lease) and reinstate the Premises
to the satisfaction of the Landlord and the Superior Landlord at the end of the Term, unless and to the extent that the Landlord
notifies the Tenant in writing otherwise.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.4</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Indemnity</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Tenant shall indemnify the Landlord in respect of any matter arising out of the execution, retention and use of any Alterations,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Planning</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.1</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Tenant&rsquo;s
obligations</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Tenant shall comply with the provisions of all town and country planning legislation insofar as they relate to the Premises and
the use of the Common Parts and shall not:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">make
                                         any application for planning permission or any application for a determination that planning
                                         permission is not required for any Alterations or any change of use of the Premises without
                                         the prior consent of the Landlord. Consent shall not be unreasonably withheld or delayed
                                         if the application relates to a matter for which the Landlord cannot unreasonably withhold
                                         or delay its consent under this Lease; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">carry
                                         out any Alterations or change the use of the Premises until all necessary planning permissions
                                         have been obtained and approved in writing by the Landlord. Subject to clause 9.2, the
                                         Landlord shall not unreasonably withhold or delay its approval where it has given consent
                                         to the application for planning permission being made.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.2</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Approval
of permissions</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Landlord shall be entitled to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">impose
                                         reasonable conditions to the giving of its approval; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">withhold
                                         its approval to any planning permission if any conditions contained in or omitted from
                                         it or its duration would, in the reasonable opinion of the Landlord, have or be likely
                                         to have an adverse effect on the value of the Landlord&rsquo;s interest in the Building at
                                         any time during or after the end of the Term.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Alienation</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Assignment</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Assignment
                                         of part</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Tenant shall not assign part only of the Premises.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Assignment
                                         of whole</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Tenant shall not assign the whole of the Premises.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Underlettings</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Underletting
                                         of part</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Tenant shall not underlet part only of the Premises.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Underletting
                                         of whole</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Tenant shall not underlet the whole of the Premises.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Charging</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Charging
                                         of part</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Tenant shall not charge part only of the Premises.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Charging
                                         of whole</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Tenant shall not charge the whole of the Premises.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Sharing
occupation</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Tenant shall not share the occupation of or part with or share the possession of the Premises or hold this Lease on trust for
any other person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Release
of Landlord</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Tenant shall not unreasonably withhold or delay its consent to a request made by any person under s6 or s7 of the 1995 Act for
a release from all or any of the covenants in this Lease to be complied with by the Landlord.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Disclosure
of information</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Tenant shall provide to the Landlord immediately on request full details of all occupants of the Premises and the terms of their
occupation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>11</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Insurance</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.1</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Insurance
of the Building</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Landlord shall insure the Building, or shall take all necessary steps to procure that the Superior Landlord insures the Building.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.2</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Supplemental
insurance</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Landlord shall insure, with a reputable insurance office or through reputable underwriters and through such agency as the Landlord
may from time to time determine:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Building (other than glazing) against damage or destruction by any of the Insured Risks
                                         which the Superior Landlord fails to insure in breach of the terms of the Superior Lease
                                         and the Supplemental Risks, in each case in their full reinstatement cost, including
                                         the cost of demolition, site clearance, hoarding, shoring up, obtaining all planning
                                         permissions, building regulation and all other consents required, complying with the
                                         requirements of any statute or public or any other authority, all professional fees,
                                         and all other incidental expenses, together in each case with Value Added Tax;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">three
                                         years&rsquo; loss of the Principal Rent, to the extent that the Principal Rent exceeds the
                                         annual amount in respect of which the Superior Landlord insures the Head Rent, taking
                                         into account the Landlord&rsquo;s reasonable estimate of any increases in the Principal Rent;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">its
                                         property owner&rsquo;s and public liability in respect of the Building; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">such
                                         other risks as the Landlord may consider appropriate in connection with the Building.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.3</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Insurance
details</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Landlord shall at the written request and cost of the Tenant, but not more than once
                                         a year, give to the Tenant reasonable evidence of the terms of the insurance policy relating
                                         to the Building and of payment of the last premium.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Tenant shall at the request of the Landlord but at its own cast, give to the Landlord
                                         reasonable evidence of valid employers&rsquo; and occupiers&rsquo; liability insurance.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.4</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Insurance
provisos</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Landlord&rsquo;s obligations under clause 11.2 shall be subject always to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">insurance
                                         cover for properties similar to the Building being ordinarily available with reputable
                                         insurance offices in the United Kingdom or underwriters against the Insured Risks and
                                         Supplement Risks on reasonable commercial terms;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">such
                                         excesses, exclusions, limitations and conditions as the insurers mu apply;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         policy of insurance not being made void or voidable by any act or default of the Tenant;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                         respect of the Landlord&rsquo;s obligations under clause 11.2, the Tenant notifying the Landlord
                                         of the reinstatement value of any Alterations in accordance with clause 8.3(g).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<SUP>&nbsp;</SUP></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.5</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Insurance
costs</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Tenant shall pay to the Landlord as additional rent on demand:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
costs incurred by the Landlord in complying with its obligations under clause 11.2</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         amount of any excess which may be deducted or disallowed by the insurers upon the settlement
                                         of any insurance claim;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">where
                                         the Landlord insures the Building under clause 11.2, the reasonable and proper costs
                                         incurred by the Landlord in valuing the Building at reasonable intervals for insurance
                                         purposes; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         reasonable and proper costs incurred by the Landlord in preparing and making any insurance
                                         claim under any insurance policy maintained by the Landlord in relation to the Building.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.6</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Tenant&rsquo;s
obligations</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Tenant shall:-</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">comply
                                         with the reasonable requirements and recommendations of the insurers of the Building,
                                         so far as they relate to the Premises or the use of the Common Parts and provided they
                                         are notified to the Tenant in writing;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">not
                                         do or bring anything upon the Premises or any other part of the Building which may cause
                                         any policy of insurance effected by the Landlord under this Lease or by the Superior
                                         Landlord under the Superior Lease to become void or voidable or any sums payable under
                                         such policy to be irrecoverable;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">not
                                         do or bring anything upon the Premises or any other part of the Building which may increase
                                         the premium payable for any policy of insurance effected by the Landlord under this Lease
                                         or by the Superior Landlord under the Superior Lease;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">give
                                         notice to the Landlord as soon as practicable upon any event occurring which might lead
                                         to a claim under or invalidate the insurance policy relating to the Building or might
                                         increase the insurance premium payable for the Building or might constitute an Insured
                                         Risk;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">except
                                         as specifically required under this Lease and except as to tenant&rsquo;s fixtures and contents,
                                         not to effect any insurance policy in relation to the Premises or the Building. If the
                                         Tenant breaches this clause 11.6(e), it shall hold the benefit of any insurance monies
                                         which it receives in respect of such insurance on trust for the Landlord and shall pay
                                         such sums to the Landlord immediately on receipt; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">pay
                                         on demand to the Landlord any irrecoverable insurance monies and increases in insurance
                                         premiums and indemnify the Landlord against all sums payable by the Landlord to the Superior
                                         Landlord under the Superior Lease arising from any breach of the covenants contained
                                         in this clause 11.6.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.7</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Tenant
to Insure</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Tenant shall:-</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">keep
insured with an insurance office which is, in the Landlord&rsquo;s reasonable opinion, reputable:-</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
internal parts of the Premises;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
                                         glazing forming part of the Premises in its full reinstatement cost; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">such
                                         third party and other risks as the Landlord shall reasonably require, including, but
                                         not limited to, employer&rsquo;s and occupier&rsquo;s liability insurance;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">produce
to the Landlord on demand any policy relating to the insurance referred to in clause 11.7(a) and reasonable evidence that such
policy is in force (but shall not be required to do so more than once per year); and</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">following
damage or destruction of any glazing, promptly reinstate it with glazing of the same specification, appearance and quality as
previously.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.8</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Suspension
of Principal Rent</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If,
                                         following an Insurance Event, the Premises are rendered unfit for occupation and use
                                         or inaccessible, the Principal Rent, or a proper proportion of it according to the nature
                                         and extent of the damage or destruction, shall be suspended (except to the extent that
                                         any insurance monies are withheld due to any act or default of the Tenant) until the
                                         date on which the Premises have been reinstated so as to be fit for occupation and use
                                         and made accessible or, if earlier, the date on which the period covered by the Landlord&rsquo;s
                                         or Superior Landlord&rsquo;s loss of rent insurance expires.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                         dispute about the operation of clause 11.8(a)(a) may be submitted at the request of the
                                         Landlord or the Tenant to arbitration.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.9</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Reinstatement
of the Premises</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the provisions of clauses 11.10 and 11.11, following an Insurance Event, unless any insurance monies are withheld due to any
act or default of the Tenant and are not made good by the Tenant under clause 11.6(f), the Landlord shall:</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">use
its reasonable endeavours to procure that the Superior Landlord complies with its obligations to rebuild or reinstate the Building
in accordance with the terms of the Superior Lease; and</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">where
any insurance monies are payable to the Landlord in respect of reinstatement of the Building:</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">use
                                         its reasonable endeavours to obtain any planning permissions and other consents required
                                         to rebuild or reinstate the Building, but without any obligation to appeal against a
                                         refusal or failure to grant planning permission or any other consent; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">subject
                                         to all necessary planning permissions and consents being obtained and the Tenant paying
                                         to the Landlord any sums due under clause 11.6(f), the Landlord shall apply such of the
                                         insurance monies as are received from the insurers in respect of the Building by virtue
                                         of clause 11.2 towards the rebuilding or reinstatement of the Building with all reasonable
                                         speed.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
rebuilding or reinstating, the Landlord shall be entitled to use materials of a different quality, type or specification and may
make reasonable changes in the original design, layout or specification of the Building, so long as the extent of the Premises
is not materially altered.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Landlord shall not be liable to rebuild or reinstate if prevented by one or more of the following reasons:-</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
Landlord failing (despite using reasonable endeavours) to obtain the necessary planning permissions and consents;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         planning permissions or consents being granted subject to a condition which the Landlord
                                         reasonably considers to be unreasonable; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         other reason beyond the Landlord&rsquo;s reasonable control.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
such circumstances, all insurance monies received or receivable shall belong to the Landlord.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.10</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Termination
where reinstatement impossible within loss of rent period</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an Insurance Event occurs which damages or destroys the Premises and the Landlord is responsible for rebuilding and reinstating
them pursuant to clause 11.9(a)(ii)(1), but it is likely, in the reasonable opinion <B>of </B>the Landlord, that it will be impossible
to rebuild and reinstate the Premises within the period specified in clause 11.2(a), the Landlord may serve on the Tenant not
less than six months&rsquo; prior written notice and this Lease shall end on the date when such notice expires and all insurance monies
received or receivable by the Landlord shall belong to the Landlord.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.11</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Termination
where no reinstatement within one year</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an Insurance Event occurs which renders the Premises unfit for occupation and use or inaccessible, and they have not been reinstated
and made accessible within one year of its occurrence, then if the Superior Landlord serves notice on the Landlord or Tenant under
the terms of the Superior Lease:-</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
Landlord shall provide the Tenant with a copy of any such notice;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">this
Lease shall end on the date when the notice expires; and</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
insurance monies received or receivable by each of the Superior Landlord and the Landlord under any insurance policies maintained
by them, respectively, shall belong to them.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
dispute about the operation of this clause 11.11 may be submitted at the request of the Landlord or the Tenant to arbitration.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>12</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Services</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.1</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Landlord&rsquo;s
obligations</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; font-style: normal">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; font-style: normal">Subject
                                         to the Tenant having paid the Rents and all other sums due to the Landlord under this
                                         Lease, the Landlord shall use reasonable endeavours to provide the Services in accordance
                                         with the principles of good estate management.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
providing the Services, the Landlord shall not be liable to the Tenant for any failure, interruption <B>or </B>delay in the supply
of the Services which results from:</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         Insured Risk, any mechanical or other breakdown, inclement weather, labour disputes,
                                         any shortage of fuel, water or materials or any other reason beyond the Landlord&rsquo;s reasonable
                                         control; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         inspection, repair, maintenance, servicing or replacement of the Building, the Conduits
                                         or any other plant or machinery used in the provision of the Services.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Landlord shall not be liable to the Tenant for any disrepair to the Retained Parts unless and until the Landlord fails to comply
with its obligation to repair within a reasonable time of receiving actual notice of any such disrepair.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Landlord shall be entitled at its discretion to withhold, add to or alter the Services, or alter the manner in which they are
provided, if the Landlord considers that it is desirable to do so, provided that it does not conflict with the principles of good
estate management and further provided that the Landlord shall act reasonably in so doing.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.2</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Service
Charge disputes</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Tenant shall not be entitled to dispute the Service Charge on the grounds that any of the Services could have been provided or
incurred at a cost lower than that incurred by the Landlord, save in the case that the Landlord has acted unreasonably.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>13</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>End
                                         of the Term</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the end of the Term, the Tenant shall:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.1</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">return
the Premises to the Landlord with vacant possession, repaired, cleaned and maintained in accordance with the Tenant&rsquo;s Covenants,
and in accordance with the tenant&rsquo;s covenants contained in the Previous Lease;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.2</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">unless
and to the extent that the Landlord notifies the Tenant in writing otherwise, reinstate all Alterations (whether carried out during
the Term of this Lease or during the term of the Previous Lease) and restore the Premises to the state and condition in which
the Tenant first took possession of them under the Previous Lease;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.3</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">return
all keys and security passes to the Premises and the Building to the Landlord;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.4</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">deliver
to the Landlord the original Lease and all other title deeds and documents relating to the Premises; and</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.5</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">execute
such deed or document as the Landlord shall require in order to cancel any entry or title relating to this Lease at the Land Registry.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>14</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Superior
                                         lease</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.1</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Tenant&rsquo;s
obligations</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Tenant shall comply with the obligations on the part of the tenant contained in the Superior Lease, except for the obligation
to pay the rents reserved by it.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.2</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Landlord&rsquo;s
obligations</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Landlord shall:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">pay
                                         to the Superior Landlord the rents reserved by the Superior Lease and perform the covenants
                                         of the tenant and the conditions contained in, the Superior Lease, except insofar as
                                         the covenants fall to be observed and performed by the Tenant by reason of the obligations
                                         of the Tenant in this Lease; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
                                         the request and cost of the Tenant, use its reasonable endeavours to procure that the
                                         Superior Landlord complies with the obligations on the part of the Landlord contained
                                         in the Superior Lease; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; padding-right: 1.05in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">acknowledge
                                         the right of the Tenant to production and to take copies of the Superior Lease.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.3</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Consents</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where
the consent or approval of the Landlord is required under this Lease:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">it
                                         shall be a condition precedent to the grant of that consent or approval that, if required
                                         under the Superior Lease, the consent or approval of the Superior Landlord is obtained;
                                         and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">where
                                         the Landlord may not unreasonably withhold its consent or approval, the Landlord shall,
                                         at the cost of the Tenant on a full indemnity basis, use its reasonable endeavours to
                                         obtain the consent or approval of the Superior Landlord, where this is required under
                                         the Superior Lease.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>15</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Quiet
                                         enjoyment</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Tenant shall be entitled quietly to enjoy the Premises throughout the Term, without any interruption by the Landlord or any person
lawfully claiming under or in trust for the Landlord.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>16</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Agreements
                                         and provisos</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.1</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Re-entry</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Landlord shall be entitled to re-enter the Premises and terminate this Lease if:-</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Rents, or any part of them, remain unpaid twenty-one days after becoming due (whether formally demanded or not);</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Tenant, or any guarantor of the Tenant, is in breach of any of its obligations under
                                         this Lease;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">there
is an Insolvency Event.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.2</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exclusion
of compensation</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Tenant shall not be entitled to any compensation under any statute or otherwise at the end of the Term, so far as the law allows.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.3</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Tenant&rsquo;s
property</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If,
at the end of the Term, the Tenant leaves any property belonging to the Tenant on the Premises, the Landlord shall be entitled
at the cost of the Tenant to remove such property from the Premises. If the Tenant fails to collect such property within ten working
days of being requested to do so in writing by the Landlord or if the Landlord is unable to make such request, within twenty working
days of the Landlord&rsquo;s first attempt to do so:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; font-style: normal">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; font-style: normal">the
                                         Landlord shall be entitled, as the agent for the Tenant, to sell such property;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Tenant shall indemnify the Landlord against any liability incurred by the Landlord to
                                         any third party whose property shall have been sold by the Landlord in the bona fide
                                         mistaken belief (which shall be presumed unless the contrary be proved) that such property
                                         belonged to the Tenant;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Tenant shall indemnify the Landlord against any damage caused to the Premises and any
                                         liability of the Landlord caused by or related to the presence of the Tenant&rsquo;s property
                                         in the Premises;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Landlord shall be entitled to use any proceeds of sale to defray any costs properly incurred
                                         in connection with the removal, storage and sale of such property and to discharge any
                                         other sums which may still be due to the Landlord under the terms of this Lease; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                         the Landlord, having made reasonable efforts, is unable to locate the Tenant, the Landlord
                                         shall be entitled to retain such proceeds of sale absolutely, unless the Tenant claims
                                         them within three months of the date on which the Tenant vacated the Premises.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.4</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Disputes
with adjoining occupiers</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any dispute arises between the Tenant and the occupiers of other parts of the Building or any adjoining or nearby property in
connection with the use of the Premises and any other part of the Building or any adjoining or nearby property or as to the boundary
structures separating the Premises from any other property it shall be decided by the Landlord or in such manner as the Landlord
shall direct.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.5</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Entire
understanding</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Lease embodies the entire understanding of the parties relating to the Premises and to all matters dealt with by any of the provisions
of this Lease.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.6</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Representations</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Tenant acknowledges that in entering into this Lease no reliance has been placed upon any representation, warranty or statement
(whether oral, written or implied) made by or on behalf of the Landlord.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.7</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notices</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.45in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                         notice to be given under this Lease shall be in writing.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.45in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                         notice may be served on the recipient at its address set out in the Particulars (or such
                                         other address as that party may specify in writing to the other from time to time).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.45in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                         notice served by DX shall be deemed to be received on the first working day after being
                                         sent.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.45in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                         notice served by first class post, special delivery or recorded post shall be deemed
                                         to be received on the second working day after being sent.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.45in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                         notice served by second class post shall be deemed to be received on the third working
                                         day after being sent.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.45in; text-align: left">(f)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
notice shall be valid if given by the solicitors acting on behalf of the party serving the notice.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.45in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notice
may not be served by electronic mail or by fax.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.8</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>New
tenancy</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Lease creates a &ldquo;new tenancy&rsquo; for the purposes of sl of the 1995 Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.9</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Landlord
and Tenant Act 1954</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.45in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         parties agree that the provisions of ss24 to 28 (inclusive) of the 1954 Act shall not
                                         apply to the tenancy created by this Lease.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.45in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         parties confirm that the Landlord has served on the Tenant a notice in relation to the
                                         tenancy created by this Lease in the form, or substantially the form, set out in Schedule
                                         1 to the Regulatory Reform (Business Tenancies) (England and Wales) Order 2003 (&ldquo;the
                                         Order&rdquo;).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.45in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         parties further confirm that the Tenant or a person duly authorised by the Tenant has
                                         made a statutory declaration in relation to the notice referred to in clause (b), in
                                         a form complying with the requirements of Schedule 2 to the Order.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.45in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is no agreement for lease to which this Lease gives effect. </FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.10</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Contracts
(Rights of Third Parties) Act 1999</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
this Lease states otherwise, the parties do not intend to confer any right or benefit which is enforceable by virtue of the Contracts
(Rights of Third Parties) Act 1999 upon any party who is not a party to this Lease.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.11</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Arbitration</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where
any matter may be referred to arbitration under this Lease, the matter is to be submitted to a single arbitrator under the Arbitration
Act 1996, and the arbitrator shall be appointed by agreement between the Landlord and the Tenant or, in the absence of agreement,
by the President of the Royal Institution of Chartered Surveyors, or the next available officer, on the application of either
the Landlord or the Tenant. The arbitrator shall not have the power to order the rectification, setting aside or cancellation
of the Lease.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.12</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Break
Clause</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Either
the Landlord or the Tenant may end this Lease on the Break Date by serving not less than one month&rsquo;s prior written notice on the
other party. This Lease shall then end on the Break Date provided that in the case of a notice served by the Tenant the Tenant
has paid all of the Rents due under this Lease up to and including the Break Date unless and to the extent that the Landlord in
its absolute discretion elects in writing to waive these conditions. Any overpayment of Rents shall be refunded to the Tenant
within 14 days of the date of determination of the Lease.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.13</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Outstanding
liabilities on termination</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
this Lease ends, whether by effluxion of time, or otherwise, it shall be without prejudice to outstanding liabilities of any party
to any other party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.14</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Jurisdiction</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Lease shall be governed and construed in accordance with English law and the English courts shall have exclusive jurisdiction
in relation to any disputes between the Landlord and the Tenant arising out of or related to this Lease.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.15</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Execution</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
parties have signed this Lease as a deed and it is intended to be and shall be delivered on the date of this Lease.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>The
First Schedule</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Part
1</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Building</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Building:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="text-align: justify; padding-right: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">includes
                                         all Conduits from time to time within or leading to the Building that serve it, but excludes
                                         those that form part of the public mains;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">includes
                                         all landlord&rsquo;s fixtures forming part of the Building from time to time;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">includes
                                         all additions, alterations and improvements made to the Building; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">excludes
                                         any tenant&rsquo;s fixtures forming part of the Building from time to time.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Part
2</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Premises</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left">1</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>The
Premises Include:</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.45in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
non-structural or non-loadbearing walls and columns within the Premises;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.45in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
inner half, severed vertically, of any non-structural or non-load bearing walls and columns that divide the Premises from other
parts of the Building;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.45in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
internal plaster surfaces and finishes of the wails of the Premises, including those on any structural or loadbearing walls and
columns within or enclosing the Premises;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.45in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.4</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
ceiling finishes;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.45in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.5</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
internal windows (including the frames and fitments and all glazing);</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.45in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.6</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
curtains and blinds provided or paid for by the Landlord and their replacements;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.45in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.7</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
doors and door frames in all walls within or enclosing the Premises and all door furniture and glazing within the doors;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.45in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.8</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
other glazing (whether in partitions or otherwise);</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.45in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.9</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
floor finishes, floor screeds and raised floor systems;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.45in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.10</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
carpets or other floor coverings provided or paid for by the Landlord;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.45in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.11</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
sanitary and hot and cold water apparatus and equipment within and exclusively serving the Premises;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.45in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.12</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
Conduits within or leading to the Premises that exclusively serve the Premises, but excludes those that form part of the public
mains;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.45in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.13</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
other landlord&rsquo;s fixtures that exclusively serve the Premises;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.45in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.14</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
Alterations, except to the extent that they comprise tenant&rsquo;s fixtures; and</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.45in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.15</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
air conditioning apparatus and equipment within and exclusively serving the Premises.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>The
                                         Premises Exclude:</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.45in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
structural or loadbearing walls and columns and the structural slabs of any roofs and floors;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.45in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,2</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
external windows (including the frames and fitments and all glazing);</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.45in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
Conduits and landlord&rsquo;s fixtures within the Premises which do not exclusively serve the Premises;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.45in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
air space above the suspended ceiling systems and the suspended ceiling systems and light fittings; and</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.45in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.5</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ail
tenant&rsquo;s fixtures and chattels.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Part
3</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rights
granted to the Tenant</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Access</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
right:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.45in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">on
foot only to use the Common Parts for the purpose of access to and from the Premises;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.45in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
emergency only, to use the fire escape routes within the Building.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Conduits</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
right to the passage of Utilities through any Conduits that serve the Premises and that do not form part of the public mains.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Support</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
right of support, shelter and protection for the Premises from the remainder of the Building.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Signs</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
right to display at the entrance to the Premises a sign stating the Tenant&rsquo;s name and business, of such type and size and in such
position as the Landlord may determine.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Part
4</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rights
reserved to the Landlord and others</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Entry
                                         On The Premises</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.45in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
right at any time to enter and remain on the Premises with or without plant, machinery and equipment to:-</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">exercise
                                         the rights reserved in clause 3,2 of this Lease;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.55in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">inspect,
                                         clean, maintain, repair, connect, remove, lay, renew, replace, alter and carry out any
                                         other works to or in connection with the Conduits and the provision of the Services and
                                         any easements or services benefiting the Premises, the remainder of the Building and
                                         any adjoining or nearby property;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.55in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">view
                                         the state and condition of the Premises, the remainder of the Building and any adjoining
                                         or nearby property including, where necessary, opening up any part or parts of the floors,
                                         ceilings and walls of the Premises;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.55in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">remedy
                                         any breach of the Tenant&rsquo;s Covenants;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.55in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">carry
                                         out any repairs, decoration, alterations, works of refurbishment, cleaning and any other
                                         works to the remainder of the Building or to any adjoining or nearby property, or to
                                         do anything which the Landlord may, or is obliged to do under this Lease or otherwise;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.55in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                         connection with any requirements of the insurers of the Premises or the Building;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.55in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">value
                                         the Premises or the Building, whether for insurance purposes or otherwise;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.55in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">prepare
                                         for the disposal of the Landlord&rsquo;s or any superior interest in the Premises or the Building
                                         or, in the last six months of the Term, the reletting of the Premises;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.55in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">affix
                                         on the exterior of the Premises notices for the sale of the Premises or the Building
                                         or, in the last six months of the Term, the reletting of the Premises;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.55in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">comply
                                         with its obligations to any superior landlord or mortgagee;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.55in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                         emergency only, to use the fire escape routes within the Premises designated by the Landlord
                                         for use as a means of escape in case of fire;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.55in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
measure and assess the Premises and carry out works pursuant to and in connection with any EPC; and</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
other reasonable purpose.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.45in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
the exercise of any rights of entry on the Premises (except where the Tenant is in breach of the Tenant&rsquo;s Covenants), the
person entering shall give reasonable prior notice to the Tenant (except in cases of emergency), cause as little damage and inconvenience
as reasonably practicable in the exercise of the rights and make good any damage caused to the Premises in the exercise of those
rights.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Conduits</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
right to the passage of Utilities through any Conduits which are now or may at any time be in, under or over the Premises and
the right to create new services or easements in, under or over the Premises and to connect into and use any existing Conduits
or lay new Conduits in, under or over the Premises.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Support</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
right of support, shelter and protection from the Premises for the remainder of the Building and any adjoining or nearby property.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>The
                                         Building</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.45in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
right at any time to raise the height of, build on, rebuild, alter, demolish, develop, repair, clean, decorate or carry out any
other works to any part of the Building and any adjoining or nearby property and the right to erect new buildings of any height
on any part of the Building and any adjoining or nearby property, in each case in such manner as the Landlord thinks fit.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.45in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
exercising the rights in paragraph 4.1 of Part 3 of this First Schedule, the Landlord shall be entitled to build on or into any
external wall of the Premises and to oversell cranes and their loads over the Premises and erect scaffolding against any external
wall of the Premises for the duration of the works being carried out.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.45in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Tenant shall not be entitled to claim against the Landlord for any interference in the right and passage of light and air to the
Premises arising from the exercise of the rights in this paragraph 4.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>The
Second Schedule</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Services</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Maintaining
Retained Parts</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inspecting,
repairing, maintaining, treating, cleaning, decorating, servicing, and, when in the reasonable opinion of the Landlord necessary,
altering, replacing and rebuilding the Retained Parts, (excluding the external glazing serving the Premises) and all plant, machinery,
equipment and Conduits,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Toilets</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maintaining
a supply of hot and cold water to the lavatories in the Common Parts at such times as the Landlord reasonably considers necessary
or desirable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Heating
and air. Conditioning</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Providing
central heating and air-conditioning to the Common Parts at such temperatures as the Landlord reasonably considers to be adequate
for such hours and at such times of the year as the Landlord reasonably considers necessary or desirable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>lighting</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Providing
lighting to the Common Parts, where appropriate, at such times as the Landlord reasonably considers necessary or desirable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Maintenance
of Fire Equipment</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Providing,
inspecting, operating, maintaining and, when in the reasonable opinion of the Landlord necessary, and replacing fire prevention
and fire fighting equipment including fire alarms, extinguishers, detectors and sprinkler systems in the Common Parts,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Cleaning</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cleaning
the external glazing of the Building and all glazing and window-frames in the Retained Parts on a quarterly basis, except where
the individual responsibility of any tenant or occupier of the Building, and cleaning other external Retained Parts and providing
and maintaining facilities and equipment for these purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executed
    as a deed by <B>HYDE PARK </B></FONT></TD>
    <TD STYLE="width: 11%; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD STYLE="width: 40%; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RESIDENCE
    LIMITED </B>acting by a</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director
    and its secretary/two directors</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1.5pt solid">/s/ Astrid Bray</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1.5pt solid">/s/ <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Andrew Morgan</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Secretary/Director</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executed
    as a deed by </FONT></TD>
    <TD STYLE="width: 11%; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD STYLE="width: 40%; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TIZIANA
    PHARMA LIMITED</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">acting
    by Director and its </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">secretary/two
    directors</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1.5pt solid">/s/ Gabriele Cerrone<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1.5pt solid">/s/ Kunwar Shailubhai<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Secretary/Director</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Page; Sequence: 27; Options: Last -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.6
<SEQUENCE>12
<FILENAME>ff12018a1ex10-6_tiziana.htm
<DESCRIPTION>FIVE-YEAR LEASE FOR 420 LEXINGTON AVENUE, SUITE 2525, NEW YORK, UNITED STATES, DATED AUGUST 2, 2016
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: right"><B>Exhibit 10.6</B></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>EXECUTION
ORIGINAL</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>AGREEMENT OF LEASE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>between</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SLG
Graybar Mesne Lease LLC</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Landlord</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>and</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Tiziana
Life Sciences PLC</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Tenant</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Dated
as of August 2, 2016</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Suite
2525-28</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>420 Lexington Avenue
</B><BR>
<B>New York, New York</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>TABLE
OF CONTENTS</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left; width: 12%"><B>ARTICLE
    1</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left; width: 80%"><B>DEMISE;
    PREMISES AND PURPOSE</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 8%"><B>1</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>ARTICLE
    2</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>TERM</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>2</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>ARTICLE
    3</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>RENT
    AND ADDITIONAL RENT</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>2</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>ARTICLE
    4</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>ASSIGNMENT/SUBLETTING</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>3</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>ARTICLE
    5</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>DEFAULT</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>9</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>ARTICLE
    6</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>RELETTING,
    ETC.</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>10</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>ARTICLE
    7</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>LANDLORD
    MAY CURE DEFAULTS</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>10</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>ARTICLE
    8</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>ALTERATIONS</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>11</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>ARTICLE
    9</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>LIENS</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>14</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>ARTICLE
    10</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>REPAIRS</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>14</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>ARTICLE
    11</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>FIRE
    OR OTHER CASUALTY</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>15</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>ARTICLE
    12</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>END
    OF TERM</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>16</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>ARTICLE
    13</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>SUBORDINATION
    AND ESTOPPEL, ETC.</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>17</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>ARTICLE
    14</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>CONDEMNATION</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>20</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>ARTICLE
    15</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>REQUIREMENTS
    OF LAW</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>20</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>ARTICLE
    16</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>CERTIFICATE
    OF OCCUPANCY</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>21</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>ARTICLE
    17</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>POSSESSION</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>21</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>ARTICLE
    18</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>QUIET
    ENJOYMENT</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>21</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>ARTICLE
    19</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>RIGHT
    OF ENTRY</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>22</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>ARTICLE
    20</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>INDEMNITY</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>22</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>ARTICLE
    21</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>LANDLORD&rsquo;S
    LIABILITY, ETC.</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>22</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>ARTICLE
    22</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>CONDITION
    OF PREMISES</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>23</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>ARTICLE
    23</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>CLEANING</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>23</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>ARTICLE
    24</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>JURY
    WAIVER</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>24</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>ARTICLE
    25</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>NO
    WAIVER, ETC.</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>24</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>ARTICLE
    26</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>OCCUPANCY
    AND USE BY TENANT</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>25</B></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left; width: 12%"><B>ARTICLE
    27</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left; width: 80%"><B>NOTICES&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 8%"><B>25</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>ARTICLE
    28</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>WATER</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>26</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>ARTICLE
    29</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>SPRINKLER
    SYSTEM</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>26</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>ARTICLE
    30</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>HEAT,
    ELEVATOR, ETC.</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>26</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>ARTICLE
    31</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>SECURITY
    DEPOSIT</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>27</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>ARTICLE
    32</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>TAX
    ESCALATION</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>27</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>ARTICLE
    33</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>RENT
    CONTROL</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>30</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>ARTICLE
    34</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>SUPPLIES</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>30</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>ARTICLE
    35</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>AIR
    CONDITIONING</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>31</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>ARTICLE
    36</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>SHORING</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>32</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>ARTICLE
    37</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>EFFECT
    OF CONVEYANCE, ETC.</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>32</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>ARTICLE
    38</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>RIGHTS
    OF SUCCESSORS AND ASSIGNS</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>33</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>ARTICLE
    39</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>CAPTIONS</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>33</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>ARTICLE
    40</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>BROKERS</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>33</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>ARTICLE
    41</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>ELECTRICITY</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>33</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>ARTICLE
    42</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>LEASE
    SUBMISSION</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>38</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>ARTICLE
    43</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>INSURANCE</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>38</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>ARTICLE
    44</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>SIGNAGE</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>40</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>ARTICLE
    45</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>RIGHT
    TO RELOCATE</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>41</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>ARTICLE
    46</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>FUTURE
    CONDOMINIUM CONVERSION</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>42</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>ARTICLE
    47</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>MISCELLANEOUS</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>42</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>ARTICLE
    48</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>COMPLIANCE
    WITH LAW</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>43</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>&nbsp;</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>ARTICLE
    49</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><B>RULES
    AND REGULATIONS</B></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>45</B></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B></B></FONT></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INDEX
OF DEFINED TERMS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 0; padding-right: 0; padding-left: 0; text-indent: 0; width: 90%; border-bottom: Black 1.5pt solid"><B>TERM</B></TD>
    <TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; text-align: center; width: 8%"><B>PAGE</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0">Additional Rent</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: center">2</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0">Alterations</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: center">10</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0">Base Tax Year</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: center">28</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0">Brokers</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: center">33</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0">Building</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: center">1</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0">Building Cleaning Contractor</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: center">23</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0">Building Project</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: center">28</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0">Commencement Date</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: center">2</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0">Comparative Year</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: center">28</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0">Cooling Season</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: center">31</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0">Declaration</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: center">42</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0">Delivery Personnel</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: center">1</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0">Designated Agent</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: center">3</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0">ERIF</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: center">34</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0">excess electricity</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: center">35</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0">Existing HVAC Equipment</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: center">31</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0">Expiration Date</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: center">2</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0">Fixed Annual Rent</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: center">2</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0">HVAC System</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: center">31</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0">Landlord</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: center">1</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0">Landlord&rsquo;s Electrical Consultant</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: center">35</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0">Landlord&rsquo;s Relocation Work</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: center">41</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0">Landlord&rsquo;s Restoration Work</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: center">15</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0">Landlord&rsquo;s Work</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: center"><B>22</B></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0">Lease</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: center">1</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0">Leaseback Area</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: center">4</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0">Ordinary Business Hours</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: center">34</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0">Ordinary Equipment</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: center">35</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0">Premises</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: center">1</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0">Real Estate Taxes</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: center">28</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0">Recapture Date</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: center">4</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0">Relocation Effective Date</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: center">41</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0">Relocation Notice</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: center">41</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0">Relocation Space</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: center">41</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0">Rent</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: center">2</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0">Security</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: center">27</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0">Supplemental Systems</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: center">31</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0">Tenant</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: center">1</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0">Tenant Cleaning Services</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: center">23</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0">Tenant&rsquo;s Recapture Offer</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: center">4</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0">Tenant&rsquo;s Share</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: center">27</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0">Term</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: center">2</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>LEASE
</B>(this &ldquo;<U>Lease</U>&rdquo;) made as of the 2<SUP>nd</SUP> day of August 2016 between SLG Graybar Mesne Lease LLC having
an office c/o SL Green Realty Corp., at 420 Lexington Avenue, New York, New York, 10170, hereinafter referred to as &ldquo;<U>Landlord</U>&rdquo;,
and Tiziana Life Sciences PLC, a United Kingdom public limited company having an office at 18 South Street, Mayfair, London W1K
1DG, United Kingdom, hereinafter referred to as &ldquo;<U>Tenant</U>&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>W</U>&nbsp;<U>I</U>&nbsp;<U>T</U>&nbsp;<U>N</U>&nbsp;<U>E</U>&nbsp;<U>S</U>&nbsp;<U>S</U>&nbsp;<U>E</U>&nbsp;<U>T</U>&nbsp;<U>H</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">Landlord and Tenant, in
consideration of the mutual agreements herein contained and other good and valuable consideration, the receipt and sufficiency
of which is hereby acknowledged, hereby covenant and agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>DEMISE;
PREMISES AND PURPOSE</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.01
Landlord hereby leases and demises to Tenant, and Tenant hereby hires and takes from Landlord, those certain premises located
on and comprising a rentable portion of the twenty-fifth (25<SUP>th</SUP>) floor designated as Suite 2525-28, approximately as
indicated by hatch marks on the plan annexed hereto and made a part hereof as &ldquo;Exhibit A&rdquo; (the &ldquo;<U>Premises</U>&rdquo;)
in the building known as and located at 420 Lexington Avenue, New York, New York (the &ldquo;<U>Building</U>&rdquo;) subject to
the provisions of this Lease.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.02
The Premises shall be used and occupied for executive and general office use consistent with that found in Class &ldquo;A&rdquo;
high-rise office buildings located in midtown Manhattan only and for no other purpose.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.03
Neither the Premises, nor the halls, corridors, stairways, elevators or any other portion of the Building shall be used by
Tenant or Tenant&rsquo;s servants, employees, licensees, invitees or visitors in connection with the aforesaid permitted use
or otherwise so as to cause any congestion of the public portions of the Building or the entrance ways, sidewalks or roadways
adjoining the Building whether by trucking or by the congregating or loitering thereon of Tenant and/or the servants,
employees, licensees, invitees or visitors of Tenant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.04
Tenant shall not permit messengers, delivery personnel or other individuals providing such services to Tenant (&ldquo;<U>Delivery
Personnel</U>&rdquo;) to: (i) assemble, congregate or to form a line outside of the Premises or the Building or otherwise impede
the flow of pedestrian traffic outside of the Premises or Building or (ii) park or otherwise leave bicycles, wagons or other delivery
carts outside of the Premises or the Building except in locations outside of the Building designated by Landlord from time-to-time.
Tenant shall require all Delivery Personnel to comply with rules promulgated by Landlord from time-to-time regarding the use of
outside messenger services.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><U>TERM</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.01
The Premises are leased for a term of five (5) years and two (2) months (the &ldquo;<U>Term</U>&rdquo;) which shall commence on
September 1, 2016 (the &ldquo;<U>Commencement Date</U>&rdquo;) and shall end on the 31<SUP>st</SUP> day of October, 2021 (the
&ldquo;<U>Expiration Date</U>&rdquo;) or on such earlier date upon which the Term shall expire, be canceled or terminated pursuant
to any of the conditions or covenants of this Lease or pursuant to law. For purposes of this Lease, the term &ldquo;Rent Commencement
Date&rdquo; shall mean the date occurring two (2) months following the Commencement Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
3</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>RENT
AND ADDITIONAL RENT</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.01
Tenant shall pay fixed annual rent without electricity (the &ldquo;<U>Fixed Annual Rent</U>&rdquo;) at the rates provided for
in the schedule annexed hereto and made a part hereof as &ldquo;Exhibit B&rdquo; in equal monthly installments in advance on the
first (1<SUP>st</SUP>) day of each calendar month during the Term, except that the first (1<SUP>st</SUP>) monthly installment
of Fixed Annual Rent shall be paid by Tenant upon its execution of this Lease. All sums other than Fixed Annual Rent payable hereunder
shall be deemed to be &ldquo;<U>Additional Rent</U>&rdquo; and shall be payable on demand, unless other payment dates are hereinafter
provided. Tenant shall pay all Fixed Annual Rent and Additional Rent due hereunder at the office of Landlord or such other place
as Landlord may designate, payable in United States legal tender, by cash, or by good and sufficient check drawn on a New York
City bank which is a member of the New York Clearing House or a successor thereto, and without any set off or deduction whatsoever.
The term &ldquo;<U>Rent</U>&rdquo; as used in this Lease shall mean Fixed Annual Rent and Additional Rent. Landlord may apply
payments made by Tenant towards the payment of any item of Fixed Annual Rent and/or Additional Rent payable hereunder notwithstanding
any designation by Tenant as to the items against which any such payment should be credited.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.02
Subject to the provisions hereof, if and so long as Tenant is not in default under this Lease, after notice and the expiration
of the grace period applicable to such default hereunder, if any, the first two (2) monthly installments of Fixed Annual Rent
(without electricity) accruing under the Lease shall be abated by the sum of $15,556.84 per month (for a total abatement in the
aggregate amount of $31,113.68). Anything contained hereinabove to the contrary notwithstanding, if Tenant at any time during
the term of the Lease, breaches any material covenant, condition or provision of the Lease and fails to cure such breach within
any applicable grace period, and provided that the Lease is terminated by Landlord because of such material default, then, in
addition to all other damages and remedies herein provided and to which Landlord may be otherwise entitled, Landlord shall also
be entitled to the repayment in full of all Rent which has theretofore been abated under the provisions of this Lease, which repayment
Tenant shall make upon demand therefor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
4</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>ASSIGNMENT/SUBLETTING</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.01
Neither Tenant nor Tenant&rsquo;s legal representatives or successors in interest by operation of law or otherwise, shall assign,
mortgage or otherwise encumber this Lease, or sublet or permit all or part of the Premises to be used by (i) others, without the
prior written consent of Landlord in each instance or (ii) a Prohibited Person (as such term is hereinafter defined). The transfer
of a majority of the issued and outstanding capital stock of any corporate tenant or sublessee of this Lease or a majority of
the total interest in any partnership tenant or sublessee or company, however accomplished, and whether in a single transaction
or in a series of related or unrelated transactions, the conversion of a tenant or sublessee entity to either a limited liability
company or a limited liability partnership or the merger or consolidation of a corporate tenant or sublessee, shall be deemed
an assignment of this Lease or of such sublease. If this Lease is assigned, or if the Premises or any part thereof is underlet
or occupied by anybody other than Tenant, Landlord may, after default by Tenant, collect rent from the assignee, undertenant or
occupant, and apply the net amount collected to the rent herein reserved, but no assignment, underletting, occupancy or collection
shall be deemed a waiver of the provisions hereof, the acceptance of the assignee, undertenant or occupant as tenant, or a release
of Tenant from the further performance by Tenant of covenants on the part of Tenant herein contained. The consent by Landlord
to an assignment or underletting shall not in any way be construed to relieve Tenant from obtaining the express consent in writing
of Landlord to any further assignment or underletting. In no event shall any permitted sublessee assign or encumber its sublease
or further sublet all or any portion of its sublet space, or otherwise suffer or permit the sublet space or any part thereof to
be used or occupied by others, without Landlord&rsquo;s prior written consent in each instance. A modification, amendment or extension
of a sublease shall be deemed a sublease. The listing of the name of a party or entity other than that of Tenant on the Building
or floor directory or on or adjacent to the entrance door to the Premises shall neither grant such party or entity any right or
interest in this Lease or in the Premises nor constitute Landlord&rsquo;s consent to any assignment or sublease to, or occupancy
of the Premises by, such party or entity. If any lien is filed against the Premises or the Building of which the same form a part
for brokerage services claimed to have been performed for Tenant in connection with any such assignment or sublease, whether or
not actually performed, the same shall be discharged within ten (10) days thereafter, at Tenant&rsquo;s expense, by filing the
bond required by law, or otherwise, and paying any other necessary sums, and Tenant agrees to indemnify Landlord and its agents
and hold them harmless from and against any and all claims, losses or liability resulting from such lien for brokerage services
rendered. Tenant hereby grants Landlord&rsquo;s rental agent for the Building, or such other licensed real estate broker as shall
be designated by Landlord from time-to-time (the &ldquo;<U>Designated Agent</U>&rdquo;), the sole and exclusive right to effect
any sublet, assignment, release and other disposition of the Premises and any other space Tenant has under lease elsewhere in
the Building for a period of ninety (90) days from the receipt of notice from Tenant with respect to each such sublet, assignment,
release and disposition (provided, however, that Tenant acknowledges and agrees that such Designated Agent from time to time may
be obligated to endeavor to rent competitive space available in the Building on behalf of and pursuant to the instructions of
Landlord or another tenant of the Building) and Tenant shall pay to such Designated Agent upon execution of each such sublease,
assignment, release or other disposition a commission computed in accordance with such Designated Agent&rsquo;s standard rates
and rules then in effect for the locality in which the Building is located.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.02
In no event shall Tenant have the right to sublease less than the entire Premises. If Tenant desires to assign this Lease or to
sublet the entire Premises, it shall first submit in writing to Landlord the documents described in Section 4.06 hereof, and shall
offer in writing (&ldquo;<U>Tenant&rsquo;s Recapture Offer</U>&rdquo;), (i) with respect to a prospective assignment, to assign
this Lease to Landlord without any payment of moneys or other consideration therefor, or, (ii) with respect to a prospective subletting,
to sublet to Landlord the entire Premises (&ldquo;<U>Leaseback Area</U>&rdquo;) for the term specified by Tenant in its proposed
sublease or, at Landlord&rsquo;s option for the balance of the term of the Lease less one (1) day, and at the lower of (a) Tenant&rsquo;s
proposed subrental or (b) the rate of Fixed Annual Rent and Additional Rent, and otherwise on the same terms, covenants and conditions
(including provisions relating to escalation rents), as are contained herein. Tenant&rsquo;s Recapture Offer shall specify the
date when the Leaseback Area will be made available to Landlord, which date shall be in no event earlier than forty-five (45)
days nor later than ninety (90) days following the acceptance of Tenant&rsquo;s Recapture Offer (the &ldquo;<U>Recapture Date</U>&rdquo;).
If an offer of sublease is made, and if the proposed sublease will result in the entire Premises being sublet, then Landlord shall
have the option to extend the term of its proposed sublease for the balance of the term of this Lease less one (1) day. Landlord
shall have a period of forty-five (45) days from the receipt of such Tenant&rsquo;s Recapture Offer to either accept or reject
Tenant&rsquo;s Recapture Offer or to terminate this Lease.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.03.
If Landlord exercises its option to terminate this Lease, then (i) the term of this Lease shall end at the election of Landlord
either (x) on the date that such assignment or sublet was to become effective or commence, as the case may be, or (y) on the Recapture
Date and (ii) Tenant shall surrender to Landlord and vacate the Premises on or before such date in the same condition as is otherwise
required upon the expiration of this Lease by its terms, (iii) the Rent and Additional Rent due hereunder shall be paid and apportioned
to such date, and (iv) Landlord shall be free to lease the Premises (or any portion thereof) to any individual or entity including,
without limitation, Tenant&rsquo;s proposed assignee or subtenant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.04.
If Landlord shall accept Tenant&rsquo;s Recapture Offer (i) Tenant shall then execute and deliver to Landlord, or to anyone designated
or named by Landlord, an assignment or sublease, as the case may be, in either case in a form reasonably satisfactory to Landlord&rsquo;s
counsel; and (ii) Tenant, on demand, shall pay to Landlord or its managing agent (as Landlord shall elect) an amount equal to
the brokerage commissions which would have been incurred by Tenant but for Landlord&rsquo;s accepting Tenant&rsquo;s Recapture
Offer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a sublease is so made it shall expressly:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) permit
Landlord to make further subleases of all or any part of the Leaseback Area and (at no cost or expense to Tenant) to make and
authorize any and all changes, alterations, installations and improvements in such space as necessary;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) provide
that Tenant will at all times permit reasonably appropriate means of ingress to and egress from the Leaseback Area;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
negate any intention that the estate created under such sublease be merged with any other estate held by either of the
parties;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
provide that at the expiration of the term of such sublease Tenant will accept the Leaseback Area in its then existing condition,
subject to the obligations of Landlord to make such repairs thereto as may be necessary to preserve the Leaseback Area in good
order and condition, ordinary wear and tear excepted (provided, however, that Tenant shall not be obligated to remove any alterations,
installations and improvements made by or on behalf of Landlord or its designee in the Leaseback Area or to restore the Leaseback
Area to the condition existing prior to the performance thereof).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.05
Landlord shall indemnify and save Tenant harmless from all obligations under this Lease as to the Leaseback Area during the period
of time it is so sublet, except for Fixed Annual Rent and Additional Rent, if any, due under the within Lease, which are in excess
of the rents and additional sums due under such sublease. Subject to the foregoing, performance by Landlord, or its designee,
under a sublease of the Leaseback Area shall be deemed performance by Tenant of any similar obligation under this Lease and any
default under any such sublease shall not give rise to a default under a similar obligation contained in this Lease, nor shall
Tenant be liable for any default under this Lease or deemed to be in default hereunder if such default is occasioned by or arises
from any act or omission of the tenant under such sublease or is occasioned by or arises from any act or omission of any occupant
holding under or pursuant to any such sublease.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.06
If Tenant requests Landlord&rsquo;s consent to a specific assignment or subletting, it shall submit in writing to Landlord (i)
the name and address of the proposed assignee or sublessee, (ii) a duly executed counterpart of the proposed agreement of assignment
or sublease, (iii) reasonably satisfactory information as to the nature and character of the business of the proposed assignee
or sublessee and as to the nature of its proposed use of the space, and (iv) banking, financial or other credit information relating
to the proposed assignee or sublessee reasonably sufficient to enable Landlord to determine the financial responsibility and character
of the proposed assignee or sublessee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.07.
If Landlord shall not have accepted Tenant&rsquo;s Recapture Offer and Landlord shall not have terminated this Lease, as provided
for in Section 4.02 hereof, then Landlord will consent or deny its consent to such assignment or subletting in accordance with
the terms set forth herein within forty-five (45) days after Tenant notifies Landlord of its desire to assign this Lease or to
sublet all or any portion of the Premises (which notice may be given simultaneously with Tenant&rsquo;s Recapture Offer). Landlord
will not unreasonably withhold or delay its consent to Tenant&rsquo;s request for consent to such specific assignment or subletting
for the use permitted under this Lease, provided that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
The Premises shall not, without Landlord&rsquo;s prior consent, have been listed or otherwise publicly advertised for
assignment or subletting at a rental rate lower than the higher of (a) the Fixed Annual Rent and all Additional Rent then
payable, or (b) the then prevailing rental rate for other space in the Building; provided, however that this Section 4.07(i)
shall not be deemed to prevent Tenant from effectuating an assignment or sublease at a rental rate lower than the then
prevailing rental rate for other space in the Building;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) The
proposed assignee or subtenant shall have a financial standing, be of a character, be engaged in a business, and propose to use
the Premises, in a manner consistent with the permitted use and in keeping with the standards of the Building;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii) The
proposed assignee or subtenant shall not then be a tenant, subtenant, assignee or occupant of any space in the Building, nor shall
the proposed assignee or subtenant be a person or entity who has dealt with Landlord or Landlord&rsquo;s agent (directly or through
a broker) with respect to space in the Building during the six (6) months immediately preceding Tenant&rsquo;s request for Landlord&rsquo;s
consent;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv) The
character of the business to be conducted in the Premises by the proposed assignee or subtenant shall not be likely to increase
operating expenses or the burden on existing cleaning services, elevators or other services and/or systems of the Building;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v) In
case of a subletting, the subtenant shall be expressly subject to all of the obligations of Tenant under this Lease and the further
condition and restriction that such sublease shall not be assigned, encumbered or otherwise transferred or the Premises further
sublet by the subtenant in whole or in part, or any part thereof suffered or permitted by the subtenant to be used or occupied
by others, without the prior written consent of Landlord in each instance;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi) No
subletting shall end later than one (1) day before the Expiration Date nor shall any subletting be for a term of less than two
(2) years unless it commences less than two (2) years before the Expiration Date;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii) At
no time shall there be more than one (1) occupant (including Tenant, if Tenant is in occupancy, but excluding Related Entities
and other entities occupying desk-top space in accordance with the provisions of this Article 4), in the Premises;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii) Tenant
shall reimburse Landlord on demand for any reasonable costs, including attorneys&rsquo; fees and disbursements, that may be incurred
by Landlord in connection with said assignment or sublease;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ix) The
character of the business to be conducted in the Premises by the proposed assignee or subtenant shall not require any alterations,
installations, improvements, additions or other physical changes to be performed, or made to, any portion of the Building or the
Real Property other than the Premises; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)
The proposed assignee or subtenant shall not be (i) any Person on, or, under the relevant statute and/or regulations
governing any such list, deemed to be on, the list of Specially Designated Nationals and Blocked Persons maintained by the
Office of Foreign Assets Control of the United States Department of the Treasury or on any comparable list hereafter
maintained by said Office or successor thereto, or by any other office or agency of the government of the United States or
any similarly designated Persons under any federal statute which is a successor to or similar to or of similar import as the
statutes currently providing for such designations or maintenance of lists of such designated Persons, or (ii) a Person
entitled to diplomatic or sovereign immunity or which is not subject to service of process in the State of New York or to the
jurisdiction of the courts of the State of New York and the United States located in New York County (any Person described in
(i) and/or (ii) hereinafter referred to as a &ldquo;Prohibited Person&rdquo;). A &ldquo;Person&rdquo; means any individual,
corporation, partnership, joint venture, limited liability company, estate, trust, unincorporated association, any federal
state, county or municipal government or any bureau, department or agency thereof and any fiduciary acting in such capacity
on behalf of any of the foregoing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.08
Any consent of Landlord under this Article shall be subject to the terms of this Article and conditioned upon there being no default
by Tenant, beyond any grace period, under any of the terms, covenants and conditions of this Lease at the time that Landlord&rsquo;s
consent to any such subletting or assignment is requested and on the date of the commencement of the term of any proposed sublease
or the effective date of any proposed assignment. Tenant acknowledges and agrees that no assignment or subletting shall be effective
unless and until Tenant, upon receiving any necessary Landlord&rsquo;s written consent (and unless it was theretofore delivered
to Landlord) causes a duly executed copy of the sublease or assignment to be delivered to Landlord within ten (10) days after
execution thereof. Any such sublease shall provide that the sublessee shall comply with all applicable terms and conditions of
this Lease to be performed by Tenant hereunder. Any such assignment of this Lease shall contain an assumption by the assignee
of all of the terms, covenants and conditions of this Lease to be performed by Tenant. In addition to the foregoing, as a condition
to such consent, Landlord may require Tenant to deposit additional security in an amount equal to fifty (50%) percent of the security
then on deposit with Landlord hereunder in order to secure performance of the obligations of Tenant accruing from and after the
commencement date of any proposed sublease or the effective date of any proposed assignment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.09
Anything hereinabove contained to the contrary notwithstanding, Landlord&rsquo;s consent shall not be required for an assignment of
this Lease, or sublease of all or part of the Premises for the uses permitted hereunder, to a Related Entity, provided that (i)
Landlord is given prior notice thereof and reasonably satisfactory proof that the requirements of this Lease have been met and
Tenant agrees to remain primarily liable, jointly and severally, with any transferee or assignee, for the obligations of Tenant
under this Lease, (ii) any such transaction complies with the other provisions of this Article, and (iii) in Landlord&rsquo;s reasonable
judgment the proposed assignee or subtenant is engaged in a business and the Premises, or the relevant part thereof, will be used
in a manner which (x) is in keeping with the standards of the Building and (y) would not adversely affect or increase Landlord&rsquo;s
cost in the operation of the Building.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.10
For purposes of this Article:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
a &ldquo;<U>Related Entity</U>&rdquo; shall mean (x) a wholly-owned subsidiary of Tenant or any corporation or entity which controls
or is controlled by Tenant or is under common control with Tenant or (y) any entity (i) to which substantially all the assets
of Tenant are transferred or (ii) into which Tenant may be merged or consolidated, provided that in either such case both the
net worth and ratio of current assets to current liabilities (exclusive of good will) of such transferee or of the resulting or
surviving corporation or other business entity, as the case may be, as certified by the certified public accountants of such transferee
or the resulting or surviving business entity in accordance with generally accepted accounting principles, consistently applied,
is not less than Tenant&rsquo;s net worth and ratio of current assets to current liabilities (exclusive of good will), as so certified,
as of (a) the Commencement Date or (b) the day immediately prior to such transaction, whichever is greater, provided also that
any such transaction complies with the other provisions of this Article; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
the term &ldquo;<U>control</U>&rdquo; shall mean, in the case of a corporation or other entity, ownership or voting control, directly
or indirectly, of at least fifty (50%) percent of all of the general or other partnership (or similar) interests therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.11
If Landlord shall not have accepted Tenant&rsquo;s Recapture Offer hereunder and Landlord has not elected to terminate this Lease,
and Tenant effects any assignment or subletting (other than pursuant to Section 4.09 above), then Tenant thereafter shall pay
to Landlord a sum equal to fifty (50%) percent of (a) any rent or other consideration payable to Tenant by any subtenant (after
deducting the cost to Tenant, if any, in effecting the subletting or assignment, for reasonable alteration costs, advertising
expenses, brokerage commissions, reasonable rent concessions and legal fees) which is in excess of the rent allocable to the subleased
space which is then being paid by Tenant to Landlord pursuant to the terms hereof, and (b) any other profit or gain realized by
Tenant (after deducting the cost to Tenant, if any, in effecting the subletting or assignment, for reasonable alteration costs,
advertising expenses, brokerage commissions, reasonable rent concessions and legal fees not previously deducted in subsection
a above) from any such subletting or assignment. In computing such excess amount and/or profit or gain, any advertising, legal
expenses and brokerage commissions reasonably incurred by Tenant in connection with such assignment or subleasing shall be deducted
on an amortized basis (i.e., in equal monthly installments) over the balance of the term of the sublease, in the event of a subletting,
or this Lease, in the event of an assignment. The foregoing amounts shall be payable to Landlord only if, as and when, the same
are received by Tenant from said assignee or sublessee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.12
In no event shall Tenant be entitled to make, nor shall Tenant make, any claim, and Tenant hereby waives any claim, for money
damages (nor shall Tenant claim any money damages by way of set-off, counterclaim or defense) based upon any claim or assertion
by Tenant that Landlord has unreasonably withheld or unreasonably delayed its consent or approval to a proposed assignment or
subletting as provided for in this Article. Tenant&rsquo;s sole remedy shall be an action or proceeding to enforce any such provision,
or for specific performance, injunction or declaratory judgment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.13
Notwithstanding anything to the contrary herein contained, Tenant shall be permitted to license up to one (1) office or workstation
within the Premises (the &ldquo;<U>Licensed Space</U>&rdquo;) for uses permitted under this Lease only, provided that (i) any
such offices or workstations do not have separate entrances to the public corridor, (ii) Landlord is delivered advance notice
of each such licensing including, without limitation, the name, address and bank references of each such licensee and the material
terms and conditions of each such license, and (iii) each such license otherwise complies with the provisions of this Lease. Landlord
and Tenant hereby acknowledge and agree that Rasna Therapeutics Limited will be occupying the Licensed Space in accordance with
the provisions hereunder and for uses permitted under this Lease.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
5</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>DEFAULT</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.01
Landlord may terminate this Lease on three (3) days&rsquo; notice: (a) if Fixed Annual Rent or Additional Rent is not paid within
seven (7) days after written notice from Landlord; or (b) if Tenant shall have failed to cure a default in the performance of
any covenant of this Lease (except the payment of Rent), or any rule or regulation hereinafter set forth, within fifteen (15)
days after written notice thereof from Landlord, or if default cannot be completely cured in such time, if Tenant shall not promptly
proceed to cure such default within said fifteen (15) days, or shall not complete the curing of such default with due diligence;
or (c) when and to the extent permitted by law, if a petition in bankruptcy shall be filed by or against Tenant or if Tenant shall
make a general assignment for the benefit of creditors, or receive the benefit of any insolvency or reorganization act; or (d)
if a receiver or trustee is appointed for any portion of Tenant&rsquo;s property and such appointment is not vacated within twenty-five
(25) days; or (e) if an execution or attachment shall be issued under which the Premises shall be taken or occupied or attempted
to be taken or occupied by anyone other than Tenant; or (f) if the Premises become and remain deserted for a period of ten (10)
days; or (g) if Tenant shall default beyond any grace period under any other lease between Tenant and Landlord. At the expiration
of the three (3) day notice period, this Lease and any rights of renewal or extension thereof shall terminate as completely as
if that were the date originally fixed for the expiration of the Term of this Lease, but Tenant shall remain liable as hereinafter
provided.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.02
In the event that Tenant is in arrears for Fixed Annual Rent or any item of Additional Rent, Tenant waives its right, if any,
to designate the items against which payments made by Tenant are to be credited and Landlord may apply any payments made by Tenant
to any items which Landlord in its sole discretion may elect irrespective of any designation by Tenant as to the items against
which any such payment should be credited.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.03
Tenant shall not seek to remove and/or consolidate any summary proceeding brought by Landlord with any action commenced by Tenant
in connection with this Lease or Tenant&rsquo;s use and/or occupancy of the Premises.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.04
In the event of a default by Landlord hereunder, no property or assets of Landlord, or any principals, shareholders, officers,
directors, partners or members of Landlord, whether disclosed or undisclosed, other than the Building in which the Premises are
located and the land upon which the Building is situated, shall be subject to levy, execution or other enforcement procedure for
the satisfaction of Tenant&rsquo;s remedies under or with respect to this Lease, the relationship of Landlord and Tenant hereunder
or Tenant&rsquo;s use and occupancy of the Premises.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
6</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>RELETTING,
ETC.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.01
If Landlord shall re-enter the Premises on the default of Tenant, by summary proceedings or otherwise: (a) Landlord may
re-let the Premises or any part thereof, as Tenant&rsquo;s agent, in the name of Landlord, or otherwise, for a term shorter
or longer than the balance of the term of this Lease, and may grant concessions or free rent; (b) Tenant shall pay Landlord
any deficiency between the rent hereby reserved and the net amount of any rents collected by Landlord for the remaining term
of this Lease, through such re-letting. Such deficiency shall become due and payable monthly, as it is determined. Landlord
shall have no obligation to re-let the Premises, and its failure or refusal to do so, or failure to collect rent on
re-letting, shall not affect Tenant&rsquo;s liability hereunder. In computing the net amount of rents collected through such
re-letting, Landlord may deduct all expenses incurred in obtaining possession or re-letting the Premises, including legal
expenses and fees, brokerage fees, the cost of restoring the Premises to good order, and the cost of all alterations and
decorations deemed necessary by Landlord to effect re-letting. In no event shall Tenant be entitled to a credit or repayment
for rerental income which exceeds the sums payable by Tenant hereunder or which covers a period after the original term of
this Lease; (c) Tenant hereby expressly waives any right of redemption granted by any present or future law.
&ldquo;Re-enter&rdquo; and &ldquo;reentry&rdquo; as used in this Lease are not restricted to their technical legal meaning.
In the event of a breach or threatened breach of any of the covenants or provisions hereof, Landlord shall have the right of
injunctive relief. Mention herein of any particular remedy shall not preclude Landlord from any other available remedy; (d)
Landlord shall recover as liquidated damages, in addition to accrued rent and other charges, if Landlord&rsquo;s re-entry is
the result of Tenant&rsquo;s bankruptcy, insolvency, or reorganization, the full rental for the maximum period allowed by any
act relating to bankruptcy, insolvency or reorganization.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.02
If Landlord re-enters the Premises for any cause, or if Tenant abandons the Premises, or after the expiration of the term of this
Lease, any property left in the Premises by Tenant shall be deemed to have been abandoned by Tenant, and Landlord shall have the
right to retain or dispose of such property in any manner without any obligation to account therefor to Tenant. If Tenant shall
at any time default hereunder, and if Landlord shall institute an action or summary proceeding against Tenant based upon such
default, then Tenant will reimburse Landlord for the legal expenses and fees thereby incurred by Landlord.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
7</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>LANDLORD
MAY CURE DEFAULTS</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.01
If Tenant shall default in performing any covenant or condition of this Lease, after any required notice is given to Tenant and
expiration of the grace period applicable to such default hereunder, if any, (provided, however, that notice under this Article
shall not be required in the event of an imminent danger to health or safety or in the event that the failure to promptly remedy
such default may result in potential criminal or other liability or a default by Landlord under a mortgage, ground lease or other
agreement), Landlord may perform the same for the account of Tenant, and if Landlord, in connection therewith, or in connection
with any default by Tenant, makes any expenditures or incurs any obligations for the payment of money, including but not limited
to reasonable attorney&rsquo;s fees, such sums so paid or obligations incurred shall be deemed to be Additional Rent hereunder,
and shall be paid by Tenant to Landlord within fifteen (15) days of rendition of any bill or statement therefor, and if Tenant&rsquo;s
lease term shall have expired at the time of the making of such expenditures or incurring of such obligations, such sums shall
be recoverable by Landlord as damages.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
8</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>ALTERATIONS</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.01
Tenant shall make no alteration, addition or improvement in the Premises, without the prior written consent of Landlord which
consent shall be granted or withheld in accordance with the provisions of this Article 8, and then only by contractors or mechanics
and in such manner and time, and with such materials, as approved by Landlord. Subject to all of the other provisions of this
Article 8, Landlord shall not unreasonably withhold its consent to the performance of work and improvements in the Premises by
contractors employing union labor with the proper jurisdictional qualifications provided, however, that (i) all work affecting
the Building&rsquo;s &ldquo;Class E&rdquo; system shall be performed by Landlord&rsquo;s designated contractor and all plan filings
with the Department of Buildings shall be performed by Landlord&rsquo;s designated expeditor and Landlord&rsquo;s designated consulting
engineer, and (ii) Landlord&rsquo;s previous experience with a contractor, and concerns regarding the financial stability of, and any
criminal proceedings currently or previously pending against, a contractor or mechanic may form a basis upon which Landlord may
withhold its consent. All alterations, additions or improvements to the Premises, including air-conditioning equipment and duct
work, except movable office furniture (including movable partitions) and trade equipment installed at the expense of Tenant, shall,
unless Landlord elects otherwise in writing, become the property of Landlord, and shall be surrendered with the Premises, at the
expiration or sooner termination of the term of this Lease. Any such alterations, additions and improvements which Landlord shall
designate shall be removed by Tenant and any damage repaired, at Tenant&rsquo;s expense, prior to the expiration of this Lease.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.02
Anything hereinabove to the contrary notwithstanding, Landlord will not unreasonably withhold, condition or delay approval of
written requests of Tenant to make nonstructural interior alterations, decorations, additions and improvements (herein referred
to as &ldquo;<U>Alterations</U>&rdquo;) in the Premises, provided that such Alterations do not affect utility services or plumbing
and electrical lines or other systems of the Building and do not affect and are not visible from any portion of the Building outside
of the Premises (and purely decorative changes such as painting, wallpapering and carpeting shall not require the consent of Landlord,
subject, however, to all other applicable provisions of this Lease). Notwithstanding anything to the contrary set forth herein,
Tenant shall have the right, without the prior consent of Landlord, to make Alterations in the Premises provided that such Alterations:
(a) cost no more than Fifteen Thousand and 00/100 ($15,000.00) Dollars in the aggregate, (b) are non-structural, (c) do not require
a building permit or change in the certificate of occupancy for the Building, (d) do not directly or indirectly affect building
systems, (e) do not directly or indirectly affect any portion of the Building outside of the Premises, and (f) are not visible
from any portion of the Building outside of the Premises. All Alterations shall be performed in accordance with the following
conditions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
Prior to the commencement of any Alterations costing more than $15,000.00 or requiring a building permit, Tenant shall first
submit to Landlord for its approval detailed dimensioned coordinated plans and specifications, including layout,
architectural, mechanical, </FONT>electrical, plumbing and structural drawings for each proposed Alteration. Landlord shall
be given, in writing, a good description of all other Alterations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) All
Alterations in and to the Premises shall be performed in a good and workmanlike manner and in accordance with the Building&rsquo;s
rules and regulations governing Tenant Alterations. Prior to the commencement of any such Alterations, Tenant shall, at its sole
cost and expense, obtain and exhibit to Landlord any governmental permit required in connection with such Alterations. In order
to compensate Landlord for its general conditions and the costs incurred by Landlord in connection with Tenant&rsquo;s performance
of Alterations in and/or to the Premises (including, without limitation, the costs incurred by Landlord in connection with the
coordination of Alterations which may affect systems or services of the Building or portions of the Building outside of the Premises),
Tenant shall pay to Landlord a fee equal to five (5%) percent of the cost of such Alterations excluding, however, Alterations
performed by Tenant in the Premises within the first one hundred fifty (150) days of the Term in order to prepare the Premises
for Tenant&rsquo;s initial occupancy thereof. Such fee shall be paid by Tenant as Additional Rent hereunder within ten (10) days
following receipt of an invoice therefor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
All Alterations shall be done in compliance with all other applicable provisions of this Lease and with all applicable laws, ordinances,
directions, rules and regulations of governmental authorities having jurisdiction, including, without limitation, the Americans
with Disabilities Act of 1990 and New York City Local Law No. 58/87 and similar present or future laws, and regulations issued
pursuant thereto, and also New York City Local Law No. 76 and similar present or future laws, and regulations issued pursuant
thereto, on abatement, storage, transportation and disposal of asbestos and other hazardous materials, which work, if required,
shall be effected at Tenant&rsquo;s sole cost and expense, by contractors and consultants approved by Landlord and in strict compliance
with the aforesaid rules and regulations and with Landlord&rsquo;s rules and regulations thereon. Notwithstanding anything contained
herein to the contrary, Landlord shall (a) cure any violations of record as of the date hereof which would interfere with Tenant&rsquo;s
occupancy of the Premises and (b) remove, enclose, encapsulate or otherwise manage to the extent required by Applicable Laws (as
hereinafter defined) any deteriorated asbestos or asbestos-containing material (collectively, &ldquo;<U>ACM</U>&rdquo;) located
within the Premises; provided, however, that notwithstanding anything contained in this Lease to the contrary, Tenant shall remove,
enclose, encapsulate or otherwise manage such ACM as required by applicable law to the extent that (i) Tenant (x) disturbed such
ACM or caused such ACM to become friable or (y) installed the same, or (ii) such ACM consists of vinyl asbestos tiles.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv) All
work shall be performed with union labor having the proper jurisdictional qualifications.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v) Tenant
shall keep the Building and the Premises free and clear of all liens for any work or material claimed to have been furnished to
Tenant or to the Premises.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi) Prior
to the commencement of any work by or for Tenant, Tenant shall furnish to Landlord certificates evidencing the existence of the
following insurance:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) Workmen&rsquo;s
compensation insurance covering all persons employed for such work and with respect to whom death or bodily injury claims could
be asserted against Landlord, Tenant or the Premises.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) Broad
form general liability insurance written on an occurrence basis naming Tenant as an insured and naming Landlord and its designees
as additional insureds, with limits of not less than $3,000,000 combined single limit for personal injury in any one occurrence,
and with limits of not less than $500,000 for property damage (the foregoing limits may be revised from time to time by Landlord
to such higher limits as Landlord from time to time reasonably requires). Tenant, at its sole cost and expense, shall cause all
such insurance to be maintained at all time when the work to be performed for or by Tenant is in progress. All such insurance
shall be obtained from a company authorized to do business in New York and shall provide that it cannot be canceled without thirty
(30) days prior written notice to Landlord. All policies, or certificates therefor, issued by the insurer and bearing notations
evidencing the payment of premiums, shall be delivered to Landlord. Blanket coverage shall be acceptable, provided that coverage
meeting the requirements of this paragraph is assigned to Tenant&rsquo;s location at the Premises.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii) In
granting its consent to any Alterations, Landlord may impose such conditions as to guarantee completion (including, without limitation,
requiring Tenant to post additional security or a bond to insure the completion of such Alterations, payment, restoration or otherwise),
as Landlord may reasonably require.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii) All
work to be performed by Tenant shall be done in a manner which will not interfere with or disturb other tenants and occupants
of the Building.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ix) The
review and/or approval by Landlord, its agents, consultants and/or contractors, of any Alteration or of plans and specifications
therefor and the coordination of such Alteration work with the Building, as described in part above, are solely for the benefit
of Landlord, and neither Landlord nor any of its agents, consultants or contractors shall have any duty toward Tenant; nor shall
Landlord or any of its agents, consultants and/or contractors be deemed to have made any representation or warranty to Tenant,
or have any liability, with respect to the safety, adequacy, correctness, efficiency or compliance with laws of any plans and
specifications, Alterations or any other matter relating thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x) Promptly
following the substantial completion of any Alterations, Tenant shall submit to Landlord: (a) one (1) sepia and one (1) copy on
floppy disk (using a current version of Autocad or such other similar software as is then commonly in use) of final, &ldquo;as-built&rdquo;
plans for the Premises showing all such Alterations and demonstrating that such Alterations were performed substantially in accordance
with plans and specifications first approved by Landlord and (b) an itemization of Tenant&rsquo;s total construction costs, detailed
by contractor, subcontractors, vendors and materialmen; bills, receipts, lien waivers and releases from all contractors, subcontractors,
vendors and materialmen; architects&rsquo; and Tenant&rsquo;s certification of completion, payment and acceptance, and all governmental
approvals and confirmations of completion for such Alterations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
9</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><U>LIENS </U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.01
Prior to commencement of its work in the Premises, Tenant shall obtain and deliver to Landlord a written letter of authorization,
in form satisfactory to Landlord&rsquo;s counsel, signed by all architects, engineers and designers to become involved in such
work, which shall confirm that any of their drawings or plans are to be removed from any filing with governmental authorities
on request of Landlord, in the event that said architect, engineer or designer thereafter no longer is providing services with
respect to the Premises. With respect to contractors, subcontractors, materialmen and laborers, and architects, engineers and
designers, for all work or materials to be furnished to Tenant at the Premises, Tenant agrees to obtain and deliver to Landlord
written and unconditional waiver of mechanics liens upon the Premises or the Building after payments to the contractors, etc.,
subject to any then applicable provisions of the Lien Law. Notwithstanding the foregoing, Tenant at its expense shall cause any
lien filed against the Premises or the Building, for work or materials claimed to have been furnished to Tenant, to be discharged
of record within ten (10) days after notice thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
10</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><U>REPAIRS </U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.01
Tenant shall take good care of the Premises and the fixtures and appurtenances therein, and shall make all non-structural repairs
necessary to keep them in good working order and condition, and all structural repairs when those are necessitated by the act,
omission or negligence of Tenant or its agents, employees, invitees or contractors, subject to the provisions of Article 11 hereof.
During the term of this Lease, Tenant may have the use of any air-conditioning equipment servicing the Premises, subject to the
provisions of Article 35 of this Lease, and shall reimburse Landlord, in accordance with Article 41 of this Lease, for electricity
consumed by the equipment. The exterior walls and roofs of the Building, the mechanical rooms, service closets, shafts, areas
above any hung ceiling and the windows and the portions of all window sills outside same are not part of the Premises demised
by this Lease, and Landlord hereby reserves all rights to such parts of the Building. Tenant shall not paint, alter, drill into
or otherwise change the appearance of the windows including, without limitation, the sills, jambs, frames, sashes, and meeting
rails.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.02
Landlord shall maintain and repair the structural elements and the common facilities, equipment and systems of the Building (other
than the distribution portions of the Building&rsquo;s systems located in the Premises) and the perimeter heating system. Notwithstanding
anything to the contrary contained herein, Landlord&rsquo;s aforesaid obligation shall be performed at the expense of Tenant to
the extent that the need for same arises out of the negligence or willful misconduct of Tenant, its employees, agents or invitees,
or Tenant&rsquo;s breach of the terms, covenants or conditions of this Lease.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
11</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>FIRE
OR OTHER CASUALTY</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.01
Damage by fire or other casualty to the Building and to the core and shell of the Premises (excluding the tenant improvements
and betterments and Tenant&rsquo;s personal property) shall be repaired at the expense of Landlord (&ldquo;<U>Landlord&rsquo;s
Restoration Work</U>&rdquo;), but without prejudice to the rights of subrogation, if any, of Landlord&rsquo;s insurer to the extent
not waived herein. Landlord shall not be required to repair or restore any of Tenant&rsquo;s property or any alteration, installation
or leasehold improvement made in and/or to the Premises. If, as a result of such damage to the Building or to the core and shell
of the Premises, the Premises are rendered untenantable, the Rent shall abate in proportion to the portion of the Premises not
usable by Tenant from the date of such fire or other casualty until Landlord&rsquo;s Restoration Work is substantially completed.
Landlord shall not be liable to Tenant for any delay in performing Landlord&rsquo;s Restoration Work (so long as Landlord uses
commercially reasonably efforts to expeditiously complete such work), Tenant&rsquo;s sole remedy being the right to an abatement
of Rent, as provided above. Tenant shall cooperate with Landlord in connection with the performance by Landlord of Landlord&rsquo;s
Restoration Work. If the Premises are rendered wholly untenantable by fire or other casualty and if Landlord shall decide not
to restore the Premises, or if the Building shall be so damaged that Landlord shall decide to demolish it or not to rebuild it
(whether or not the Premises have been damaged), Landlord may within ninety (90) days after such fire or other cause give written
notice to Tenant of its election that the term of this Lease shall automatically expire no less than ten (10) days after such
notice is given. Notwithstanding the foregoing, each party shall look first to any insurance in its favor before making any claim
against the other party for recovery for loss or damage resulting from fire or other casualty, and to the extent that such insurance
is in force and collectible and to the extent permitted by law, Landlord and Tenant each hereby releases and waives all right
of recovery against the other or any one claiming through or under each of them by way of subrogation or otherwise. The foregoing
release and waiver shall be in force only if both releasors&rsquo; insurance policies contain a clause providing that such a release
or waiver shall not invalidate the insurance and also, provided that such a policy can be obtained without additional premiums.
Tenant hereby expressly waives the provisions of Section 227 of the Real Property Law and agrees that the foregoing provisions
of this Article shall govern and control in lieu thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.02
In the event that the Premises has been damaged or destroyed and this Lease has not been terminated in accordance with the provisions
of this Article, Tenant shall (i) cooperate with Landlord in the restoration of the Premises and shall remove from the Premises
as promptly as reasonably possible all of Tenant&rsquo;s salvageable inventory, movable equipment, furniture and other property
and (ii) repair the damage to the tenant improvements and betterments and Tenant&rsquo;s personal property and restore the Premises
within one hundred eighty (180) days following the date upon which the core and shell of the Premises shall have been substantially
repaired by Landlord.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.03
For purposes of this Section 11.03, a &ldquo;Major Casualty&rdquo; shall mean damage or destruction (i) to the core and
shell of the Premises or (ii) the Building to the extent that Tenant&rsquo;s access to the Premises has been substantially
impaired. Provided that Landlord does not elect to terminate this Lease in accordance with the provisions of this Article, in
the event of a Major Casualty, if: (i) there has been substantial damage or destruction to any portion or portions of the
Building and Landlord shall not have substantially restored Tenant&rsquo;s access to the Premises within twelve (12) months
from the date of such Major Casualty, or within such period after such date (not exceeding three (3) months) as shall equal
the aggregate period Landlord may have been delayed in doing so by reasons of Force Majeure (defined below); or (ii) if
damage is confined substantially to the Premises and Landlord shall not have substantially completed the making of the
required repairs to the core and shell of the Premises within nine (9) months from the date of such Major Casualty, or within
such period after such date (not exceeding three (3) months) as shall equal the aggregate period Landlord may have been
delayed in doing so by reasons of Force Majeure, then, and in such event, Tenant may elect to terminate this Lease upon
giving written notice to Landlord within thirty (30) days after the end of such twelve (12) or nine (9) month period, as the
case may be, and as the same may be extended in accordance with the provisions hereof, and the term of this Lease shall
expire on the date set forth therein which shall be not less than thirty (30) days after the date such notice is given (the
&ldquo;Cancellation Date&rdquo;) provided that Landlord does not substantially complete the required repairs to the Building
or to the core and shell of the Premises, as the case may be, prior to the Cancellation Date. For purposes of this Article,
&ldquo;Force Majeure&rdquo; shall mean the inability of Landlord to perform an obligation accruing under this Article by
reason of accidents, strikes, the inability to secure a proper supply of fuel, gas, steam, water, electricity, labor or
supplies, governmental restrictions, regulations or controls or by reason of any other similar cause beyond the
reasonable control of Landlord.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
12</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><U>END OF TERM</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.01
Tenant shall surrender the Premises to Landlord at the expiration or sooner termination of this Lease in good order and condition,
except for reasonable wear and tear and damage by fire or other casualty, and Tenant shall remove all of its property. Tenant
agrees it shall indemnify and save Landlord harmless against all costs, claims, loss or liability resulting from delay by Tenant
in so surrendering the Premises, including, without limitation, any claims made by any succeeding tenant founded on such delay.
The parties recognize and agree that the damage to Landlord resulting from any failure by Tenant timely to surrender the Premises
will be substantial, will exceed the amount of monthly Rent theretofore payable hereunder, and will be impossible of accurate
measurement. Tenant therefore agrees that if possession of the Premises is not surrendered to Landlord within one (1) day after
the date of the expiration or sooner termination of the Term of this Lease, then Tenant will pay Landlord as liquidated damages
for each month and for each portion of any month during which Tenant holds over in the Premises after expiration or termination
of the Term of this Lease, a sum equal to two (2) times the average Rent and Additional Rent which was payable per month under
this Lease during the last six months of the Term thereof. The aforesaid obligations shall survive the expiration or sooner termination
of the Term of this Lease. At any time during the Term of this Lease, Landlord may exhibit the Premises to prospective purchasers
and/or superior lessors and mortgagees (as such terms are hereinafter defined). During the last year of the term of this Lease,
Landlord may exhibit the Premises to prospective tenants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
13</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>SUBORDINATION
AND ESTOPPEL, ETC.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.01
This Lease, and all rights of Tenant hereunder, are, and shall continue to be, subject and subordinate in all respects to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.05in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1) all
ground leases, overriding leases and underlying leases of the land and/or the building now or hereafter existing and to all matters
to which such leases are or shall be subordinate including, without limitation, all present and future ground leases, underlying
leases and all subleases of the entire premises demised by that certain ground lease dated December 30, 1957 and recorded in the
office of the Register of the City of New York in the County of New York on December 31, 1957, in Liber 5024 of Conveyances, Page
430 of which the premises hereby demised form a part;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2) all
mortgages that may now or hereafter affect the land, the Building and/or any of such leases, whether or not such mortgages shall
also cover other lands and/or buildings;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3) each
and every advance made or hereafter to be made under such mortgages;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4) all
renewals, modifications, replacements and extensions of such leases and such mortgages; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5) all
spreaders and consolidations of such mortgages.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.02
The provisions of Section 13.01 of this Article shall be self-operative, and no further instrument of subordination shall be required.
In confirmation of such subordination, Tenant shall execute and deliver any instrument that Landlord, the lessor of any such lease,
the holder of any mortgage or any of its successors in interest shall reasonably request to evidence such subordination and, in
the event that Tenant shall fail to execute and deliver any such instrument within ten (10) days after request therefor, Tenant
shall irrevocably constitute and appoint Landlord as Tenant&rsquo;s attorney-in-fact, coupled with an interest, to execute and
deliver any such instrument for and on behalf of Tenant. The leases to which this Lease is, at the time referred to, subject and
subordinate pursuant to this Article 13 are herein sometimes called &ldquo;superior leases&rdquo;, the mortgages to which this
Lease is, at the time referred to, subject and subordinate are herein sometimes called &ldquo;superior mortgages&rdquo;, the lessor
of a superior lease or its successor in interest at the time referred to is sometimes herein called a &ldquo;lessor&rdquo; and
the mortgagee under a superior mortgage or its successor in interest at the time referred to is sometimes herein called a &ldquo;mortgagee&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.05in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.05in"></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.05in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.03
In the event of any act or omission of Landlord that would give Tenant the right, immediately or after lapse of a period of time,
to cancel or terminate this Lease, or to claim a partial or total eviction, Tenant shall not exercise such right until:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.05in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) it
has given written notice of such act or omission to the mortgagee of each superior mortgage and the lessor of such superior lease
whose name and address shall previously have been furnished to Tenant; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) a
reasonable period for remedying such act or omission shall have elapsed following the giving of such notice and following the
time when such mortgagee or lessor shall have obtained possession of the Premises and become entitled under such superior mortgage
or superior lease, as the case may be, to remedy the same (which reasonable period shall in no event be less than the period to
which Landlord would be entitled under this Lease or otherwise, after similar notice, to effect such remedy). Nothing contained
herein shall obligate such lessor or mortgagee to remedy such act or omission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.04
In the event of termination, re-entry or dispossession by a lessor under a superior lease or the mortgagee of a superior
mortgage (hereinafter sometimes called a &ldquo;successor landlord&rdquo;), such successor landlord may at its option: (1)
take over all of the right, title and interest of Landlord under this Lease, and such Tenant shall, at such successor
landlord&rsquo;s option, attorn to successor landlord pursuant to the then executory provisions of this Lease, (2) require
Tenant to enter into a new lease pursuant to the then executory provisions of this Lease with such successor landlord or such
successor landlord&rsquo;s designee, or (3) terminate this Lease or allow this Lease to remain terminated to the extent it
has terminated by operation of law or otherwise; except that in the case of such successor landlord proceeding under clauses
(1) or (2), such successor landlord shall not (A) be liable for any previous act or omission of Landlord, it being understood
that the foregoing is not intended to relieve such successor landlord of any liability arising by reason of its acts or
omissions from and after the date it succeeds to the interest of the Landlord, including a continuation of the failure of the
prior landlord to perform obligations under this Lease in which case such successor landlord upon receipt of notice of such
continuation from Tenant shall have a reasonable period of time to remedy same, (B) be subject to any offset or defenses that
Tenant might have against Landlord, other than abatements expressly provided for in this Lease which are customary in
comparable leases in comparable buildings in the applicable submarket in midtown Manhattan, which theretofore accrued to
Tenant against Landlord, (C) be bound by any previous amendment, modification of or supplement to this Lease (other than
those previously consented to or approved by such successor landlord in writing or an amendment, modification, or supplement,
the provisions of which could have been entered into and included in the original Lease in the first instance without such
successor landlord&rsquo;s consent), (D) be bound by any previous prepayment of more than one month&rsquo;s rent, (other than
semi-annual prepayments of taxes or customary prepayments in respect of estimated operating expenses), unless actually
received by successor landlord, or, in the case of any prepayments on account of insurance premiums or taxes, unless shall
actually have been applied toward the payment of insurance premiums or taxes, (E) be obligated to return or otherwise account
for any security theretofore deposited, except to the extent that such security shall actually have been turned over to such
successor landlord (or such designee), (F) be bound by any covenant of Landlord (i) to undertake, complete and/or pay for any
alterations of the Premises to make same ready for such Tenant&rsquo;s occupancy (as opposed to the ongoing obligations of
the Landlord with respect to maintenance, repairs and compliance with law) or (ii) to undertake, complete and/or pay for any
restoration, replacement or rebuilding of the space demised to Tenant or any other portion of the Premises that may be
required, due to any damage or destruction that shall have occurred prior to or after such termination, except to the extent
that insurance proceeds and/or any condemnation award received by such successor landlord (or such designee) shall be
sufficient to pay the cost of such restoration, replacement or rebuilding, provided that in such event Tenant shall retain
any termination rights it may have hereunder in the event of successor landlord&rsquo;s failure to restore, replace or
rebuild such space or any other portion of the Premises.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.05
If, in connection with obtaining financing or refinancing for the Building, a banking, insurance, or other lender shall request
reasonable modifications to this Lease as a condition to such financing or refinancing, Tenant shall not unreasonably withhold,
delay, or defer its consent thereto, provided that such modifications do not materially increase the obligation, or materially
decrease the rights, of Tenant hereunder. In no event shall a requested modification of this Lease requiring Tenant to do the
following be deemed to materially adversely affect the leasehold interest hereby created:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) give
notice of any default by Landlord under this Lease to such lender and/or permit the curing of such defaults by such lender; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) obtain
such lender&rsquo;s consent for any modification of this Lease.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.06
Tenant agrees that if this Lease terminates, expires or is canceled for any reason or by any means whatsoever by reason of a default
under a ground lease or mortgage, and the ground lessor or mortgagee so elects by written notice to Tenant, this Lease shall automatically
be reinstated for the balance of the term which would have remained but for such termination, expiration or cancellation, at the
same rental, and upon the same agreements, covenants, conditions, restrictions and provisions herein contained, with the same
rental, and upon the same agreements, covenants, conditions, restrictions and provisions herein contained, with the same force
and effect as if no such termination, expiration or cancellation had taken place. Tenant covenants to execute and deliver any
instrument required to confirm the validity of the foregoing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.07
From time to time, Tenant, on at least ten (10) days&rsquo; prior written request by Landlord, shall deliver to Landlord a statement
in writing certifying as of the date of the certificate that (1) this Lease is unmodified and in full force and effect (or if
there shall have been modifications, that the same is in full force and effect as modified and stating the modifications), (2)
the dates to which the Rent and other charges have been paid in advance, (3) whether or not, to the actual knowledge of Tenant
as of such date, Landlord is in default in the performance of any covenant, agreement or condition contained in this Lease, and
to Tenant&rsquo;s actual knowledge, that no facts or circumstance exist that, with the passage of time or the giving of notice
or both, would constitute a default hereunder (and, if so, specifying each such default of which Tenant has actual knowledge),
(4) the Commencement Date, Expiration Date and Rent Commencement Date (if applicable), and (5) that, as of such date, Tenant is
not, to Tenant&rsquo;s actual knowledge, entitled to any defenses, offsets, claims, counterclaims or rights or recoupment against
its obligations hereunder. Tenant hereby irrevocably constitutes and appoints Landlord the attorney-in-fact of Tenant to execute,
acknowledge and deliver any such statements or certificates for and on behalf of Tenant in the event that Tenant fails to so execute
any such statement or certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
14</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>CONDEMNATION</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.01
If the whole or any substantial part of the Premises shall be condemned by eminent domain or acquired by private purchase in lieu
thereof, for any public or quasi-public purpose, this Lease shall terminate on the date of the vesting of title through such proceeding
or purchase, and Tenant shall have no claim against Landlord for the value of any unexpired portion of the Term of this Lease,
nor shall Tenant be entitled to any part of the condemnation award or private purchase price. If less than a substantial part
of the Premises is condemned, this Lease shall not terminate, but Rent shall abate in proportion to the portion of the Premises
condemned.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
15</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>REQUIREMENTS
OF LAW</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.01
Tenant at its expense shall comply with all laws, orders and regulations of any governmental authority having or asserting jurisdiction
over the Premises, which shall impose any violation, order or duty upon Landlord or Tenant with respect to the Premises or the
use or occupancy thereof, including, without limitation, compliance in the Premises with all City, State and Federal laws, rules
and regulations on the disabled or handicapped, on fire safety and on hazardous materials. The foregoing shall not require Tenant
to do structural work to the Building (collectively, &ldquo;<U>Applicable Laws</U>&rdquo;). The foregoing shall not require Tenant
to do structural work to the Building. Notwithstanding anything contained in this Article to the contrary, Tenant&rsquo;s obligations
to perform repairs or alterations in order to comply with Applicable Laws shall be limited to the performance of such work necessitated
by (i) alterations and tenant improvements in the Premises made by or on behalf of Tenant, and (ii) a breach by Tenant of its
obligations under this Lease or (iii) the negligence or willful misconduct of Tenant, its agents, servants, contractors, invitees,
subtenants and/or any person or entity entering or occupying the Premises or any portion thereof with the consent of Tenant or
any such parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.02
Tenant shall require every person engaged by him to clean any window in the Premises from the outside, to use the equipment
and safety devices required by Section 202 of the Labor Law and the rules of any governmental authority having or asserting
jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.03
Tenant at its expense shall comply with all requirements of the New York Board of Fire Underwriters, or any other similar body
affecting the Premises, and shall not use the Premises in a manner which shall increase the rate of fire insurance of Landlord
or of any other tenant, over that in effect prior to this Lease. If Tenant&rsquo;s use of the Premises increases the fire insurance
rate, Tenant shall reimburse Landlord for all such increased costs. That the Premises are being used for the purpose set forth
in Article 1 hereof shall not relieve Tenant from the foregoing duties, obligations and expenses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
16</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>CERTIFICATE
OF OCCUPANCY</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.01
Tenant will at no time use or occupy the Premises in violation of the certificate of occupancy issued for the Building. The statement
in this Lease of the nature of the business to be conducted by Tenant shall not be deemed to constitute a representation or guaranty
by Landlord that such use is lawful or permissible in the Premises under the certificate of occupancy for the Building.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
17</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><U>POSSESSION</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.01
If Landlord shall be unable to give possession of the Premises on the Commencement Date because of the retention of possession
of any occupant thereof, alteration or construction work, or for any other reason, Landlord shall not be subject to any liability
for such failure. In such event, this Lease shall stay in full force and effect, without extension of its Term. However, the Rent
hereunder shall not commence until the Premises are available for occupancy by Tenant in the condition required by this Lease,
as expressly provided in Article 22 of this Lease. If delay in possession is due to work, changes or decorations being made by
or for Tenant, or is otherwise caused by Tenant, there shall be no rent abatement and the Rent shall commence on the date specified
in this Lease. If permission is given to Tenant to occupy the Premises or other Premises prior to the date specified as the commencement
of the Term, such occupancy shall be deemed to be pursuant to the terms of this Lease, except that the parties shall separately
agree as to the obligation of Tenant to pay Rent for such occupancy. The provisions of this Article are intended to constitute
an &ldquo;express provision to the contrary&rdquo; within the meaning of Section 223(a), New York Real Property Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
18</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>QUIET
ENJOYMENT</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.01
Landlord covenants that if Tenant pays the Rent and performs all of Tenant&rsquo;s other obligations under this Lease, Tenant
may peaceably and quietly enjoy the Premises, subject to the terms, covenants and conditions of this Lease and to the ground leases,
underlying leases and mortgages herein before mentioned.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
19</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>RIGHT
OF ENTRY</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19.01
Tenant shall permit Landlord to erect, construct and maintain pipes, conduits </FONT>and shafts in and through the Premises,
provided that they are concealed, erected along perimeter walls wherever possible and are installed in a manner which does
not interfere with Tenant&rsquo;s use of the Premises. Landlord or its agents shall have the right to enter or pass through
the Premises at all times, upon reasonable advance notice to Tenant (which may be given in person or by telephone) and, in
the event of an emergency, by master key, reasonable force or otherwise, to examine the same, and to make such repairs,
alterations or additions as it may deem necessary or desirable to the Premises or the Building, and to take all material into
and upon the Premises that may be required therefor. Landlord shall use reasonable efforts to minimize interference with
Tenant&rsquo;s normal business activities within the Premises provided, however, that Tenant acknowledges and agrees that at,
Landlord&rsquo;s election, all such work shall be performed on normal business days during normal business hours, unless
Tenant requests and pays Landlord incremental difference in cost for overtime or premium labor. Such entry and work shall not
constitute an eviction of Tenant in whole or in part, shall not be grounds for any abatement of Rent, and shall impose no
liability on Landlord by reason of inconvenience or injury to Tenant&rsquo;s business. Landlord shall have the right at any
time, without the same constituting an actual or constructive eviction, and without incurring any liability to Tenant, to
change the arrangement and/or location of entrances or passageways, windows, corridors, elevators, stairs, toilets, or other
public parts of the Building, and to change the designation of rooms and suites and the name or number by which the Building
is known.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
20</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><U>INDEMNITY</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.01
Tenant shall indemnify, defend and save Landlord harmless from and against any liability or expense arising from the use or occupation
of the Premises by Tenant, or anyone on the Premises with Tenant&rsquo;s permission, or from any breach of this Lease.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
21</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>LANDLORD&rsquo;S
LIABILITY, ETC.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.01
This Lease and the obligations of Tenant hereunder shall not in any way be affected because Landlord is unable to fulfill
any of its obligations or to supply any service, by reason of strike or other cause not within Landlord&rsquo;s control.
Landlord shall have the right, without incurring any liability to Tenant, to stop any service because of accident or
emergency, or for repairs, alterations or improvements, necessary or desirable in the judgment of Landlord, until such
repairs, alterations or improvements shall have been completed. Landlord shall not be liable to Tenant or anyone else, for
any loss or damage to person, property or business; nor shall Landlord be liable for any latent defect in the Premises or the
Building. Neither the partners, entities or individuals comprising Landlord, nor the agents, directors, or officers or
employees of any of the foregoing shall be liable for the performance of Landlord&rsquo;s obligations hereunder. Tenant
agrees to look solely to Landlord&rsquo;s estate and interest in the land and Building, or the lease of the Building or of
the land and Building, and the Premises, for the satisfaction of any right or remedy of Tenant for the collection of a
judgment (or other judicial process) requiring the payment of money by Landlord, and in the event </FONT>of any liability by
Landlord, no other property or assets of Landlord or of any of the aforementioned parties shall be subject to levy, execution
or other enforcement procedure for the satisfaction of Tenant&rsquo;s remedies under or with respect to this Lease, the
relationship of Landlord and Tenant hereunder, or Tenant&rsquo;s use and occupancy of the Premises or any other liability of
Landlord to Tenant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
22</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>CONDITION
OF PREMISES</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22.01
The parties acknowledge that Tenant has inspected the Premises and the Building and is fully familiar with the physical condition
thereof and Tenant agrees to accept the Premises at the commencement of the Term in its then &ldquo;as is&rdquo; condition. Tenant
acknowledges and agrees that Landlord shall have no obligation to do any work in or to the Premises in order to make it suitable
and ready for occupancy and use by Tenant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
23</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><U>CLEANING</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.01
Landlord shall cause the Premises to be kept clean in accordance with Landlord&rsquo;s customary standards for the Building, provided
they are kept in order by Tenant. Landlord, its cleaning contractor and their employees shall have after-hours access to the Premises
and the use of Tenant&rsquo;s light, power and water in the Premises as may be reasonably required for the purpose of cleaning
the Premises. Landlord may remove Tenant&rsquo;s extraordinary refuse from the Building and Tenant shall pay the cost thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.02
Tenant acknowledges that Landlord has designated a cleaning contractor for the Building. Tenant agrees to employ said cleaning
contractor or such other contractor as Landlord shall from time to time designate (the &ldquo;<U>Building Cleaning Contractor</U>&rdquo;)
to perform all cleaning services required under the Lease to be performed by Tenant within the Premises and for any other waxing,
polishing, and other cleaning and maintenance work of the Premises and Tenant&rsquo;s furniture, fixtures and equipment (collectively,
&ldquo;<U>Tenant Cleaning Services</U>&rdquo;) provided that the prices charged by said contractor are comparable to the prices
customarily charged by other reputable cleaning contractors employing union labor in midtown Manhattan for the same level and
quality of service. Tenant acknowledges that it has been advised that the cleaning contractor for the Building may be a division
or affiliate of Landlord. Tenant agrees that it shall not employ any other cleaning and maintenance contractor, nor any individual,
firm or organization for such purpose, without Landlord&rsquo;s prior written consent. In the event that Landlord and Tenant cannot
agree on whether the prices then being charged by the Building Cleaning Contractor for such cleaning services are comparable to
those charged by other reputable contractors as herein provided, then Landlord and Tenant shall each obtain two (2) bona fide
bids for such services from reputable cleaning contractors performing such services in comparable buildings in midtown Manhattan
employing union labor, and the average of the four bids thus obtained shall be the standard of comparison. In the event that the
Building Cleaning Contractor does not agree to perform such cleaning services for Tenant at such average price, Landlord shall
not unreasonably withhold its consent to the performance of Tenant Cleaning Services by a reputable cleaning contractor designated
by Tenant employing union labor with the proper jurisdictional qualifications; provided, however, that, without limitation, Landlord&rsquo;s
experience with such contractor or any criminal proceedings pending or previously filed against such contractor may form a basis
upon which Landlord may withhold or withdraw its consent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
24</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><U>JURY WAIVER</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.01
Landlord and Tenant hereby waive trial by jury in any action, proceeding or counterclaim involving any matter whatsoever arising
out of or in any way connected with this Lease, the relationship of Landlord and Tenant, Tenant&rsquo;s use or occupancy of the
Premises or involving the right to any statutory relief or remedy. Tenant will not interpose any counterclaim of any nature in
any summary proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
25</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>NO
WAIVER, ETC.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25.01
No act or omission of Landlord or its agents shall constitute an actual or constructive eviction, unless Landlord shall have first
received written notice of Tenant&rsquo;s claim and shall have had a reasonable opportunity to meet such claim. In the event that
any payment herein provided for by Tenant to Landlord shall become overdue for a period in excess of ten (10) days, then at Landlord&rsquo;s
option a &ldquo;late charge&rdquo; shall become due and payable to Landlord, as Additional Rent, from the date it was due until
payment is made, at the following rates: for individual and partnership lessees, said late charge shall be computed at the maximum
legal rate of interest; for corporate or governmental entity lessees the late charge shall be computed at two percent per month
unless there is an applicable maximum legal rate of interest which then shall be used. No act or omission of Landlord or its agents
shall constitute an acceptance of a surrender of the Premises, except a writing signed by Landlord. The delivery or acceptance
of keys to Landlord or its agents shall not constitute a termination of this Lease or a surrender of the Premises. Acceptance
by Landlord of less than the Rent herein provided shall at Landlord&rsquo;s option be deemed on account of earliest Rent remaining
unpaid. No endorsement on any check, or letter accompanying Rent, shall be deemed an accord and satisfaction, and such check may
be cashed without prejudice to Landlord. No waiver of any provision of this Lease shall be effective, unless such waiver be in
writing signed by the party to be charged. In no event shall Tenant be entitled to make, nor shall Tenant make any claim, and
Tenant hereby waives any claim for money damages (nor shall Tenant claim any money damages by way of set-off, counterclaim or
defense) based upon any claim or assertion by Tenant that Landlord had unreasonably withheld, delayed or conditioned its consent
or approval to any request by Tenant made under a provision of this Lease. Tenant&rsquo;s sole remedy shall be an action or proceeding
to enforce any such provision, or for specific performance or declaratory judgment. Tenant shall comply with the rules and regulations
contained in this Lease, and any reasonable modifications thereof or additions thereto. Landlord shall not be liable to Tenant
for the violation of such rules and regulations by any other tenant. Failure of Landlord to enforce any provision of this Lease,
or any rule or regulation, shall not be construed as the waiver of any subsequent violation of a provision of this Lease, or any
rule or regulation. This Lease shall not be affected by nor shall Landlord in any way be liable for the closing, darkening or
bricking up of windows in the Premises, for any reason, including as the result of construction on any property of which the Premises
are not a part or by Landlord&rsquo;s own acts.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
26</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>OCCUPANCY
AND USE BY TENANT</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26.01
If this Lease is terminated because of Tenant&rsquo;s default hereunder, then, in addition to Landlord&rsquo;s rights of re-entry,
restoration, preparation for and rerental, and anything elsewhere in this Lease to the contrary notwithstanding, all Rent and
Additional Rent reserved in this Lease from the date of such breach to the expiration date of this Lease shall become immediately
due and payable to Landlord and Landlord shall retain its right to judgment on and collection of Tenant&rsquo;s aforesaid obligation
to make a single payment to Landlord of a sum equal to the total of all Rent and Additional Rent reserved for the remainder of
the original Term of this Lease, subject to future credit or repayment to Tenant in the event of any rerenting of the Premises
by Landlord, after first deducting from rerental income all expenses incurred by Landlord in reducing to judgment or otherwise
collecting Tenant&rsquo;s aforesaid obligation, and in obtaining possession of, restoring, preparing for and re-letting the Premises.
In no event shall Tenant be entitled to a credit or repayment for rerental income which exceeds the sums payable by Tenant hereunder
or which covers a period after the original Term of this Lease.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
27</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><U>NOTICES </U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">27.01
Any bill, notice or demand from Landlord to Tenant, may be delivered personally at the Premises or sent by registered or certified
mail or by any nationally recognized overnight delivery service and addressed to Tenant at the Premises or at the address first
set forth herein. Such bill, notice or demand shall be deemed to have been given at the time of delivery, mailing or receipt by
such delivery service. Any notice, request or demand from Tenant to Landlord must be sent by registered or certified mail to the
last address designated in writing by Landlord.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
28</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>WATER</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28.01
Tenant shall pay the amount of Landlord&rsquo;s cost for all excessive water used by </FONT>Tenant for any purpose other than
ordinary cleaning, pantry or lavatory uses, and any sewer rent or tax based thereon. Landlord may install a water meter to
measure Tenant&rsquo;s water consumption for all purposes and Tenant agrees to pay for the installation and maintenance
thereof and for water consumed as shown on said meter at Landlord&rsquo;s cost therefor plus fifteen (15%) percent. If water
is made available to Tenant in the Building or the Premises through a meter which also supplies other Premises, or without a
meter, then Tenant shall pay to Landlord a reasonable charge per month for water. Landlord reserves the right to discontinue
water service to the Premises if either the quantity or character of such service is changed or is no longer available or
suitable for Tenant&rsquo;s requirements or for any other reason without releasing Tenant from any liability under this Lease
and without Landlord or Landlord&rsquo;s agent incurring any liability for any damage or loss sustained by Tenant by such
discontinuance of service.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
29</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>SPRINKLER
SYSTEM</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29.01
If there shall be a &ldquo;sprinkler system&rdquo; in the Premises for any period during this Lease, Tenant shall pay a reasonable
charge per month, for sprinkler supervisory service. If such sprinkler system is damaged by any act or omission of Tenant or its
agents, employees, licensees or visitors, Tenant shall restore the system to good working condition at its own expense. If the
New York Board of Fire Underwriters, the New York Fire Insurance Exchange, the Insurance Services Office, or any governmental
authority requires the installation of, or any alteration to a sprinkler system by reason of Tenant&rsquo;s particular manner
of occupancy or use of the Premises, including any alteration necessary to obtain the full allowance for a sprinkler system in
the fire insurance rate of Landlord, or for any other reason, Tenant shall make such installation or alteration promptly, and
at its own expense.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
30</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>HEAT,
ELEVATOR, ETC.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30.01
Landlord shall provide elevator service during all usual business hours, except on Sundays, State holidays, Federal holidays,
or Building Service Employees Union Contract holidays. Landlord shall furnish heat to the Premises during the same hours on the
same days in the cold season in each year. If the elevators in the Building are manually operated, Landlord may convert to automatic
elevators at any time, without in any way affecting Tenant&rsquo;s obligations hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
31</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>SECURITY
DEPOSIT</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.01
Tenant has deposited with Landlord the sum of $186,682.00 as security (the &ldquo;<U>Security</U>&rdquo;) for the performance
by Tenant of the terms of this Lease. Landlord may use any part of the Security to satisfy any default of Tenant and any expenses
arising from such default, including but not limited to legal fees and any damages or rent deficiency before or after re-entry
by Landlord. Tenant shall, upon demand, deposit with Landlord the full amount so used, and/or any amount not so deposited by Tenant,
in order that Landlord shall have the full Security deposit on hand at all times during the term of this Lease. If Tenant shall
comply fully with the terms of this Lease, the Security shall be returned to Tenant after the date fixed as the end of the Lease.
In the event of a sale or lease of the Building containing the Premises, Landlord may transfer the Security to the purchaser or
tenant, and Landlord shall thereupon be released from all liability for the return of the Security. This provision shall apply
to every transfer or assignment of the Security to a new Landlord. Tenant shall have no legal power to assign or encumber the
Security herein described.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.02
Effective as of the second (2<SUP>nd</SUP>) anniversary of the Rent Commencement Date (the &ldquo;<U>Security Reduction Date</U>&rdquo;),
the security required to be maintained by Tenant under the provisions of this Article 31 shall be reduced by the sum of $31,113.67
(the &ldquo;<U>Partial Security Refund</U>&rdquo;) to the sum of $155,568.33 provided that (x) Tenant has not been in default
of this Lease at any time prior thereto, and (y) the net worth or ratio of current assets to current liabilities (exclusive of
good will) of Tenant as of the Security Reduction Date is not less than the net worth or ratio of current assets to current liabilities
(exclusive of good will) of Tenant as of the Commencement Date. In the event that Tenant is entitled to a reduction of security
in accordance with the provisions of this Section 31.02, Landlord shall, within thirty (30) days following receipt from Tenant
of a demand therefor, at Landlord&rsquo;s election, refund to Tenant the Partial Security Refund by either issuing a check or
credit against the next installments of Fixed Annual Rent and Additional Rent accruing hereunder from and after the Security Reduction
Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.03
Simultaneously upon execution of this Lease, Tenant shall deliver to Landlord a good guy guarantee (the &ldquo;<U>Guarantee</U>&rdquo;)
from James F. Tripp (the &ldquo;<U>Guarantor</U>&rdquo;) as security for the performance by Tenant of the terms of this Lease
which shall comply and conform in all material respects with the form annexed hereto and made a part hereof as &ldquo;Exhibit
C&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
32</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>TAX
ESCALATION</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.01
Tenant shall pay to Landlord, as Additional Rent, tax escalation in accordance with this Article:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) For
purposes of this Lease, Landlord and Tenant acknowledge and agree that the rentable square foot area of the Premises shall be
deemed to be 3,011 square feet.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) For
the purpose of this Article, the following definitions shall apply:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
The term &ldquo;<U>Tenant&rsquo;s Share</U>&rdquo;, for purposes of computing tax escalation, shall mean 0.271 percent (0.271%).
Tenant&rsquo;s Share has been computed on the basis of a fraction, the numerator of which is the rentable square foot area of
the Premises and the denominator of which is the total rentable square foot area of the office and commercial space in the Building
Project. The parties acknowledge and agree that the total rentable square foot area of the office and commercial space in the
Building Project shall be deemed to be 1,112,424 sq. ft.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
The term the &ldquo;<U>Building Project</U>&rdquo; shall mean the aggregate combined parcel of land on a portion of which are
the improvements of which the Premises form a part, with all the improvements thereon, said improvements being a part of the block
and lot for tax purposes which are applicable to the aforesaid land.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
The &ldquo;<U>Base Tax Year</U>&rdquo; shall mean the New York City fiscal tax year commencing on July 1, 2016 through June 30,
2017.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
The term &ldquo;<U>Comparative Year</U>&rdquo; shall mean the twelve (12) month period following the Base Tax Year, and each subsequent
period of twelve (12) months thereafter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
The term &ldquo;<U>Real Estate Taxes</U>&rdquo; shall mean the total of all taxes and special or other assessments levied, assessed
or imposed at any time by any governmental authority upon or against the Building Project including, without limitation, any tax
or assessment levied, assessed or imposed at any time by any governmental authority in connection with the receipt of income or
rents from said Building Project to the extent that same shall be in lieu of all or a portion of any of the aforesaid taxes or
assessments, or additions or increases thereof, upon or against said Building Project. If, due to a future change in the method
of taxation or in the taxing authority, or for any other reason, a franchise, income, transit, profit or other tax or governmental
imposition, however designated, shall be levied against Landlord in substitution in whole or in part for the Real Estate Taxes,
or in lieu of additions to or increases of said Real Estate Taxes, then such franchise, income, transit, profit or other tax or
governmental imposition shall be deemed to be included within the definition of &ldquo;Real Estate Taxes&rdquo; for the purposes
hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi) Where
more than one assessment is imposed by the City of New York for any tax year, whether denominated an &ldquo;actual assessment&rdquo;
or a &ldquo;transitional assessment&rdquo; or otherwise, then the phrases herein &ldquo;assessed value&rdquo; and &ldquo;assessments&rdquo;
shall mean whichever of the actual, transitional or other assessment is designated by the City of New York as the taxable assessment
for that tax year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.02
In the event that the Real Estate Taxes payable for any Comparative Year shall exceed the amount of the Real Estate Taxes
payable during the Base Tax Year, Tenant shall pay to Landlord, as Additional Rent for such Comparative Year, an amount equal
to Tenant&rsquo;s Share of the excess. Before or after the start of each Comparative Year, Landlord shall furnish to Tenant a
statement of the Real Estate Taxes payable during the Comparative Year. If the Real Estate Taxes payable for such Comparative
Year exceed the Real Estate Taxes payable during the Base Tax Year, Additional Rent for such Comparative Year, in an amount
equal to Tenant&rsquo;s Share of the excess, shall be due from Tenant to Landlord, and such Additional Rent shall be payable
by Tenant to Landlord within thirty (30) days after receipt of the aforesaid statement. The benefit of any discount for any
early payment or prepayment of Real Estate Taxes shall accrue solely to the benefit of Landlord, and such discount shall not
be subtracted from the Real Estate Taxes payable for any Comparative Year. In addition to the foregoing, Tenant shall pay to
Landlord, on demand, as Additional Rent, a sum equal to Tenant&rsquo;s Share of any business improvement district assessment
payable by the Building Project.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.03
Should the Real Estate Taxes payable during the Base Tax Year be reduced by final determination of legal proceedings, settlement
or otherwise, then, the Real Estate Taxes payable during the Base Tax Year shall be correspondingly revised, the Additional Rent
theretofore paid or payable hereunder for all Comparative Years shall be recomputed on the basis of such reduction, and Tenant
shall pay to Landlord as Additional Rent, within ten (10) days after being billed therefor, any deficiency between the amount
of such Additional Rent as theretofore computed and the amount thereof due as the result of such recomputations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.04
If, after Tenant shall have made a payment of Additional Rent under Section 32.02, Landlord shall receive a refund of any portion
of the Real Estate Taxes payable for any Comparative Year after the Base Tax Year on which such payment of Additional Rent shall
have been based, as a result of a reduction of such Real Estate Taxes by final determination of legal proceedings, settlement
or otherwise, Landlord shall within ten (10) days after receiving the refund pay to Tenant Tenant&rsquo;s Share of the refund
less Tenant&rsquo;s Share of expenses (including attorneys&rsquo; and appraisers&rsquo; fees) incurred by Landlord in connection
with any such application or proceeding. In addition to the foregoing, Tenant shall pay to Landlord, as Additional Rent, within
ten (10) days after Landlord shall have delivered to Tenant a statement therefor, Tenant&rsquo;s Share of all expenses incurred
by Landlord in reviewing or contesting the validity or amount of any Real Estate Taxes or for the purpose of obtaining reductions
in the assessed valuation of the Building Project prior to the billing of Real Estate Taxes, including without limitation, the
fees and disbursements of attorneys, third party consultants, experts and others.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.05
The statements of the Real Estate Taxes to be furnished by Landlord as provided above shall be certified by Landlord and shall
constitute a final determination as between Landlord and Tenant of the Real Estate Taxes for the periods represented thereby,
unless Tenant within thirty (30) days after they are furnished shall give a written notice to Landlord that it disputes their
accuracy or their appropriateness, which notice shall specify the particular respects in which the statement is inaccurate or
inappropriate. If Tenant shall so dispute said statement then, pending the resolution of such dispute, Tenant shall pay the Additional
Rent to Landlord in accordance with the statement furnished by Landlord.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.06
In no event shall the Fixed Annual Rent under this Lease be reduced by virtue of this Article.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.07
If the Commencement Date of the Term of this Lease is not the first day of the first Comparative Year, then the Additional
Rent due hereunder for such first Comparative Year shall be a proportionate share of said Additional Rent for the entire
Comparative Year, said proportionate share to be based upon the length of time that the lease Term will be in existence
during such first Comparative Year. Upon the date of any expiration or termination of this Lease (except termination because
of Tenant&rsquo;s default) whether the same be the date hereinabove set forth for the expiration of the Term or any prior or
subsequent date, a proportionate share of said Additional Rent for the Comparative Year during which such expiration or
termination occurs shall immediately become due and payable by Tenant to Landlord, if it was not theretofore already billed
and paid. The said proportionate share shall be based upon the length of time that this Lease shall have been in existence
during such Comparative Year. Landlord shall promptly cause statements of said Additional Rent for that Comparative Year to
be prepared and furnished to Tenant. Landlord and Tenant shall thereupon make appropriate adjustments of amounts then
owing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.08
Landlord&rsquo;s and Tenant&rsquo;s obligations to make the adjustments referred to in Section 32.07 above shall survive any expiration
or termination of this Lease. Any delay or failure of Landlord in billing any tax escalation hereinabove provided shall not constitute
a waiver of or in any way impair the continuing obligation of Tenant to pay such tax escalation hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
33</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>RENT
CONTROL</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">33.01
In the event the Fixed Annual Rent or Additional Rent or any part thereof provided to be paid by Tenant under the provisions of
this Lease during the Term shall become uncollectible or shall be reduced or required to be reduced or refunded by virtue of any
Federal, State, County or City law, order or regulation, or by any direction of a public officer or body pursuant to law, or the
orders, rules, code or regulations of any organization or entity formed pursuant to law, whether such organization or entity be
public or private, then Landlord, at its option, may at any time thereafter terminate this Lease, by not less than thirty (30)
days&rsquo; written notice to Tenant, on a date set forth in said notice, in which event this Lease and the term hereof shall
terminate and come to an end on the date fixed in said notice as if the said date were the date originally fixed herein for the
termination of the demised term. Landlord shall not have the right to so terminate this Lease if Tenant within such period of
thirty (30) days shall in writing lawfully agree that the rentals herein reserved are a reasonable rental and agree to continue
to pay said rentals, and if such agreement by Tenant shall then be legally enforceable by Landlord.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
34</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><U>SUPPLIES </U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">34.01
Only Landlord or any one or more persons, firms, or corporations authorized in writing by Landlord shall be permitted to furnish
laundry, linens, towels, drinking water, water coolers, ice and other similar supplies and services to tenants and licensees in
the Building. Landlord may fix, in its own absolute discretion, from time to time, the hours during which and the regulations
under which such supplies and services are to be furnished. Landlord expressly reserves the right to act as or to designate, from
time to time, an exclusive supplier of all or any one or more of the said supplies and services; and Landlord furthermore expressly
reserves the right to exclude from the Building any person, firm or corporation attempting to furnish any of said supplies or
services but not so designated by Landlord.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">34.02
Only Landlord or any one or more persons, firms or corporations authorized in writing by Landlord shall be permitted to
sell, deliver or furnish any food or beverages whatsoever for consumption within the Premises or elsewhere in the Building.
Landlord expressly reserves the right to act as or to designate from time to time an exclusive supplier or suppliers of such
food and beverages. Landlord further expressly reserves the right to exclude from the Building any person, firm or
corporation attempting to deliver or purvey any such food or beverages, but not so designated by Landlord. It is understood,
however, that Tenant or its regular office employees may personally bring food or beverages into the Building for consumption
within the Premises by the said employees, but not for resale or for consumption by any other tenant. Landlord may fix in its
absolute discretion from time to time the hours during which, and the regulations under which, food and beverages may be
brought into the Building by Tenant or its regular employees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
35</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>AIR
CONDITIONING</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">35.01
Tenant shall be permitted to use the equipment presently supplying air-conditioning service to the Premises (the &ldquo;<U>Existing
HVAC Equipment</U>&rdquo;) Monday to Friday from 8:00 a.m. to 6:00 p.m. during the Building&rsquo;s &ldquo;<U>Cooling Season</U>&rdquo;
(which is currently May 15 through October 15) subject to and in accordance with the provisions of this Article. Landlord shall
perform such work as is necessary, if any, in order to place the Existing HVAC Equipment in working order (&ldquo;<U>Landlord&rsquo;s
Initial HVAC Work</U>&rdquo;) subject, however, to Tenant&rsquo;s obligation to thereafter maintain and repair the Existing HVAC
Equipment in accordance with the provisions of this Article. Landlord shall perform Landlord&rsquo;s Initial HVAC Work as promptly
as is reasonably practical following the commencement of the Term hereof. Tenant acknowledges and agrees that air-conditioning
service to the Premises shall be supplied through equipment operated, maintained and repaired by Tenant and that Landlord has
no obligation to operate, maintain or to repair the said equipment or to supply air-conditioning service to the Premises. The
Existing HVAC Equipment and all other air conditioning systems, equipment and facilities hereafter located in or servicing the
Premises (the &ldquo;<U>Supplemental Systems</U>&rdquo;) including, without limitation, the ducts, dampers, registers, grilles
and appurtenances utilized in connection with both the Existing HVAC Equipment and the Supplemental Systems (collectively hereinafter
referred to as the &ldquo;<U>HVAC System</U>&rdquo;), shall be maintained, repaired and operated by Tenant in compliance with
all present and future laws and regulations relating thereto at Tenant&rsquo;s sole cost and expense. Tenant shall pay for all
electricity consumed in the operation of the HVAC System, and Tenant&rsquo;s proportionate share of the electric current (and/or
water, gas and steam) for the production of chilled and/or condenser water and its supply to the Premises, if applicable, which
shall become the obligation of Tenant subject to the terms of Article 41 of this Lease. Tenant shall pay for all parts and supplies
necessary for the proper operation of the HVAC System (and any restoration or replacement by Tenant of all or any part thereof
shall be in quality and class at least equal to the original work or installations); provided, however, that Tenant shall not
alter, modify, remove or replace the HVAC System, or any part thereof, without Landlord&rsquo;s prior written consent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 35; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">35.02
Without limiting the generality of the foregoing, Tenant shall, at its own cost and expense, (a) cause to be performed all
maintenance of the HVAC System, including all repairs and replacements thereto, and (b) commencing as of the date upon which
Tenant shall first occupy the Premises for the conduct of its business, and thereafter throughout the Term of the Lease,
maintain in force and provide a copy of same to Landlord an air conditioning service repair and full service maintenance
contract covering the HVAC System in form satisfactory to Landlord with an air conditioning contractor or servicing
organization approved by Landlord. All such contracts shall provide for the thorough overhauling of the HVAC System at least
once each year during the Term of this Lease and shall expressly state that (i) it shall be an automatically renewing
contract terminable upon not less than thirty (30) days prior written notice to Landlord (sent by certified mail, return
receipt requested) and (ii) the contractor providing such service shall maintain a log at the Premises detailing the service
provided during each visit pursuant to such contract. Tenant shall keep such log at the Premises and permit Landlord to
review same promptly after Landlord&rsquo;s request. The HVAC System is and shall at all times remain the property of
Landlord, and at the expiration or sooner termination of the Lease, Tenant shall surrender to Landlord the HVAC System in
good working order and condition, subject to normal wear and tear and shall deliver to Landlord a copy of the service log. In
the event that Tenant fails to obtain the contract required herein or perform any of the maintenance or repairs required
hereunder, Landlord shall have the right, but not the obligation, to procure such contract and/or perform any such work and
charge Tenant as Additional Rent hereunder the cost of same plus an administrative fee equal to fifteen percent (15%) of such
cost which shall be paid for by Tenant on demand.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
36</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><U>SHORING </U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">36.01
Tenant shall permit any person authorized to make an excavation on land adjacent to the Building containing the Premises to do
any work within the Premises necessary to preserve the wall of the Building from injury or damage, and Tenant shall have no claim
against Landlord for damages or abatement of rent by reason thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
37</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>EFFECT
OF CONVEYANCE, ETC.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">37.01
If the Building containing the Premises shall be sold, transferred or leased, or the lease thereof transferred or sold, Landlord
shall be relieved of all future obligations and liabilities hereunder and the purchaser, transferee or tenant of the Building
shall be deemed to have assumed and agreed to perform all such obligations and liabilities of Landlord hereunder. In the event
of such sale, transfer or lease, Landlord shall also be relieved of all existing obligations and liabilities hereunder, provided
that the purchaser, transferee or tenant of the Building assumes in writing such obligations and liabilities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 36; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
38</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>RIGHTS
OF SUCCESSORS AND ASSIGNS</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">38.01
This Lease shall bind and inure to the benefit of the heirs, executors, administrators, successors, and, except as otherwise provided
herein, the assigns of the parties hereto. If any provision of any Article of this Lease or the application thereof to any person
or circumstances shall, to any extent, be invalid or unenforceable, the remainder of that Article, or the application of such
provision to persons or circumstances other than those as to which it is held invalid or unenforceable, shall not be affected
thereby, and each provision of said Article and of this Lease shall be valid and be enforced to the fullest extent permitted by
law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
39</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><U>CAPTIONS</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">39.01
The captions herein are inserted only for convenience, and are in no way to be construed as a part of this Lease or as a limitation
of the scope of any provision of this Lease.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
40</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><U>BROKERS</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">40.01
Tenant covenants, represents and warrants that Tenant has had no dealings or negotiations with any broker or agent in connection
with the consummation of this Lease other than SL Green Leasing LLC (the &ldquo;<U>Broker</U>&rdquo;) and Tenant covenants and
agrees to defend, hold harmless and indemnify Landlord from and against any and all cost, expense (including reasonable attorneys&rsquo;
fees) or liability for any compensation, commissions or charges claimed by any broker or agent with respect to this Lease or the
negotiation thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">40.02
Landlord covenants, represents and warrants that Landlord has had no dealings or negotiations with any broker or agent in connection
with the consummation of this L:ease other than the Broker, and Landlord covenants and agrees to defend, hold harmless and indemnify
Tenant from and against any and all cost, expense (including reasonable attorneys&rsquo; fees) or liability for any compensation,
commissions or charges claimed by any broker or agent who claims to have dealt with Landlord with respect to this Lease or the
negotiation thereof. Landlord shall pay all commissions due the Broker, if any, pursuant to the terms of separate agreements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
41</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><U>ELECTRICITY</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">41.01
Tenant acknowledges and agrees that electric service shall be supplied to the Premises on a &ldquo;rent inclusion
basis&rdquo; in accordance with the provisions of this Article 41 (subject to Landlord&rsquo;s right, in its sole discretion,
to furnish such electricity on a &ldquo;submetering&rdquo; basis as provided for herein).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 37; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">41.02
Electricity and electric service, as used herein, shall mean any element affecting the generation, transmission, and/or distribution
or redistribution of electricity, including but not limited to services which facilitate the distribution of service.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">41.03
If and so long as Landlord provides electricity to the Premises on a rent inclusion basis, Tenant agrees that the Fixed Annual
Rent shall be increased by the amount of the Electricity Rent Inclusion Factor (&ldquo;<U>ERIF</U>&rdquo;), as hereinafter defined.
Tenant acknowledges and agrees (i) that the Fixed Annual Rent hereinabove set forth in this Lease does not yet, but is to include
an ERIF of $3.25 per rentable square foot to compensate Landlord for electrical wiring and other installations necessary for,
and for its obtaining and making available to Tenant the redistribution of electric current as an additional service, and Tenant
shall pay for Tenant&rsquo;s Share of Building electric current (i.e., all electricity used in lighting the public and service
areas, and in operating all the service facilities, of the Building and the parties acknowledge and agree that twenty percent
(20%) of the Building&rsquo;s payment to the public utility or other service providers for the purchase of electricity shall be
deemed to be payment for Building electric current) which shall be paid for by Tenant in accordance with provisions hereof; and
(ii) that said ERIF, which shall be subject to periodic adjustments as hereinafter provided, has been partially based upon an
estimate of Tenant&rsquo;s connected electrical load, in whatever manner delivered to Tenant, which shall be deemed to be the
demand (KW), and hours of use thereof, which shall be deemed to be the energy (KWH), for ordinary lighting and light office equipment
and the operation of the usual small business machines, including Xerox or other copying machines (such lighting and equipment
are hereinafter called &ldquo;<U>Ordinary Equipment</U>&rdquo;) during ordinary business hours (&ldquo;<U>Ordinary Business Hours</U>&rdquo;
shall be deemed to mean 50 hours per week), with Landlord providing an average connected load of 4 <SUP>1</SUP>/<SUB>2</SUB> watts
of electricity for all purposes per rentable square foot. Any installation and use of equipment other than Ordinary Equipment
and/or any connected load and/or energy usage by Tenant in excess of the foregoing and the charge for Tenant&rsquo;s Share of
Building electric current shall result in adjustment of the ERIF as hereinafter provided. For purposes of this Article, the rentable
square foot area of the Premises shall be deemed to be 3,011 square feet.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 38; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">41.04
If the cost to Landlord of electricity shall have been, or shall be, increased subsequent to May 1, 1996 (whether such change
occurs prior to or during the term of this Lease), by change in Landlord&rsquo;s electric rates or service classifications, or
electricity charges, including changes in market prices, or by an increase, subsequent to the last such electric rate or service
classification change or market price change, in fuel adjustments or charges of any kind, or by taxes, imposed on Landlord&rsquo;s
electricity purchases or on Landlord&rsquo;s electricity redistribution, or for any other such reason, then the aforesaid ERIF
portion of the fixed annual rent shall be changed in the same percentage as any such change in cost due to changes in electric
rates, service classifications or market prices, and, also Tenant&rsquo;s payment obligation, for electricity redistribution,
shall change from time to time so as to reflect any such increase in fuel adjustments or charges, and such taxes. Any such percentage
change in Landlord&rsquo;s cost due to change in Landlord&rsquo;s electric rate or service classifications or market prices, shall
be computed on the basis of the average consumption of electricity for the Building for the twelve full months immediately prior
to the rate change or other such changes in cost, energy and demand, and any changed methods of or rules on billing for same,
applied on a consistent basis to the new electric rate or service classification or market price and to the immediately prior
existing electric rate or service classification or market price. If the average consumption (energy and demand) for the entire
Building for said prior twelve (12) months cannot reasonably be applied and used with respect to changed methods of or rules on
billing, then the percentage increase shall be computed by the use of the average consumption (energy and demand) for the entire
building for the first three (3) months after such change, projected to a full twelve (12) months, so as to reflect the different
seasons; and that same consumption, so projected, shall be applied to the rate and/or service classification or market price which
existed immediately prior to the change. The parties agree that a reputable, independent electrical consultant firm, selected
by Landlord (&ldquo;<U>Landlord&rsquo;s Electrical Consultant</U>&rdquo;), shall determine the percentage change for the changes
in ERIF due to Landlord&rsquo;s changed costs and the charge to Tenant for Tenant&rsquo;s Share of Building electric current,
and that Landlord&rsquo;s Electrical Consultant may from time to time make surveys in the Premises of the electrical equipment
and fixtures and use of current. (i) If such survey shall reflect a connected electrical load in excess of 4 <SUP>1</SUP>/<SUB>2
</SUB>watts of electricity for all purposes per rentable square foot and/or energy usage in excess of Ordinary Business Hours
(each such excess hereinafter called &ldquo;<U>excess electricity</U>&rdquo;) then the connected electrical load and/or the hours
of use portion(s) of the then existing ERIF shall be increased by an amount which is equal to a fraction of the then existing
ERIF, the numerator of which is the excess electricity (i.e., excess connected load and/or excess usage) and the denominator of
which is the connected load and/or the energy usage which was the basis of the then existing ERIF. Such fractions shall be determined
by Landlord&rsquo;s Electrical Consultant. The Fixed Annual Rent shall then be appropriately adjusted, effective as of the date
of any such change in connected load and/or usage, as disclosed by said survey. (ii) If such survey shall disclose installation
and use of other than Ordinary Equipment, then effective as of the date of said survey, there shall be added to the ERIF portion
of Fixed Annual Rent (computed and fixed as hereinbefore described) an additional amount equal to what would be paid under the
SC-4 Rate I Service Classification in effect on May 1, 1996 (and not the time-of-day rate schedule) or the comparable rate schedule
(and not the time-of-day rate schedule) of any utility other than Con Ed then providing electrical service to the building as
same shall be in effect on the date of such survey for such load and usage of electricity, with the connected electrical load
deemed to be the demand (KW) and the hours of use thereof deemed to be the energy (KWH), as hereinbefore provided, (which addition
to the ERIF shall be increased by all electricity cost changes of Landlord, as hereinabove provided, from May 1, 1996 through
the date of billing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">41.05
In no event, whether because of surveys, rates or cost changes, or for any reason, is the originally specified $3.25 per rentable
square foot ERIF portion of the fixed annual rent (plus any net increase thereof by virtue of all electricity rate, service classification
or market price changes of Landlord subsequent to May 1, 1996) to be reduced.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">41.06
The determinations by Landlord&rsquo;s Electrical Consultant shall be binding and conclusive on Landlord and Tenant from and
after the delivery of copies of such determinations to Landlord and Tenant, unless, within fifteen (15) days after delivery
thereof, Tenant disputes such determination. If Tenant so disputes the determination, it shall, at its own expense, obtain
from a reputable, independent electrical consultant its own determinations in accordance with the provisions of this Article.
Tenant&rsquo;s consultant and Landlord&rsquo;s consultant then shall seek to agree. If they cannot agree within thirty (30)
days they shall choose a third reputable electrical consultant, whose cost shall be shared equally by the parties, to make
similar determinations which shall be controlling. (If they cannot agree on such third consultant within ten (10) days, then
either party may apply to the Supreme Court in the County of New York for such appointment.) However, pending such
controlling determinations Tenant shall pay to Landlord the amount of Additional Rent or ERIF in accordance with the
determinations of Landlord&rsquo;s Electrical Consultant. If the controlling determinations differ from Landlord&rsquo;s
Electrical Consultant, then the parties shall promptly make adjustment for any deficiency owed by Tenant or overage paid by
Tenant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 39; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">41.07
If and so long as Landlord provides electricity to the Premises on a submetering basis, Tenant covenants and agrees to purchase
the same from Landlord or Landlord&rsquo;s designated agent at charges, terms and rates set, from time to time, during the term
of this Lease by Landlord but not more than those specified in the service classification in effect on January 1, 1970 pursuant
to which Landlord then purchased electric current from the public utility corporation serving the part of the city where the Building
is located; provided however, said charges shall be increased in the same percentage as any percentage increase in the billing
to Landlord for electricity for the entire Building, by reason of increase in Landlord&rsquo;s electric rates or service classifications,
subsequent to January 1, 1970, and so as to reflect any increase in Landlord&rsquo;s electric charges, including changes in market
prices for electricity from utilities and/or other providers, in fuel adjustments or by taxes or charges of any kind imposed on
Landlord&rsquo;s electricity purchases or redistribution, or for any other such reason, subsequent to said date. Any such percentage
increase in Landlord&rsquo;s billing for electricity due to changes in rates, service classifications, or market prices, shall
be computed by the application of the average consumption (energy and demand) of electricity for the entire Building for the twelve
(12) full months immediately prior to the rate and/or service classification change, or any changed methods of or rules on billing
for same, applied on a consistent basis to the new rate and/or service classification or market price, and to the classification
and rate in effect on January 1, 1970. If the average consumption of electricity for the entire Building for said prior twelve
(12) months cannot reasonably be applied and used with respect to changed methods of or rules on billing, then the percentage
shall be computed by the use of the average consumption (energy and demand) for the entire Building for the first three (3) months
after such change, projected to a full twelve (12) months, so as to reflect the different seasons; and that same consumption,
so projected, shall be applied to the service classification and rate in effect on January 1, 1970. Where more than one meter
measures the service of Tenant in the Building, the service rendered through each meter may be computed and billed separately
in accordance with the rates herein specified. Bills therefore shall be rendered at such times as Landlord may elect and the amount,
as computed from a meter, shall be deemed to be, and be paid as, Additional Rent. In the event that such bills are not paid within
five (5) days after the same are rendered, Landlord may, without further notice, discontinue the service of electric current to
the Premises without releasing Tenant from any liability under this Lease and without Landlord or Landlord&rsquo;s agent incurring
any liability for any damage or loss sustained by Tenant by such discontinuance of service. If any tax is imposed upon Landlord&rsquo;s
receipt from the sale, resale or redistribution of electricity or gas or telephone service to Tenant by any Federal, State, or
Municipal authority, Tenant covenants and agrees that where permitted by law, Tenant&rsquo;s pro-rata share of such taxes shall
be passed on to and included in the bill of, and paid by, Tenant to Landlord.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 40; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">41.08
At the option of Landlord, Tenant agrees to purchase from Landlord or its agents all lamps and bulbs used in the Premises
and to pay for the cost of installation thereof. If all or part of the submetering Additional Rent or the ERIF payable in
accordance with Section 41.03 or 41.04 of this Article becomes uncollectible or reduced or refunded by virtue of any law,
order or regulations, the parties agree that, at Landlord&rsquo;s option, in lieu of submetering Additional Rent or ERIF, and
in consideration of Tenant&rsquo;s use of the Building&rsquo;s electrical distribution system and receipt of redistributed
electricity and payment by Landlord of consultant&rsquo;s fees and other redistribution costs, the Fixed Annual Rental
rate(s) to be paid under this Agreement shall be increased by an &ldquo;alternative charge&rdquo; which shall be a sum equal
to $3.25 per year per rentable square foot of the Premises, changed in the same percentage as any increase in the cost to
Landlord for electricity for the entire Building subsequent to May 1, 1996, because of electric rate, service classification
or market price changes, such percentage change to be computed as in Section 41.04 provided.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">41.09
Landlord shall not be liable to Tenant for any loss or damage or expense which Tenant may sustain or incur if either the
quantity or character of electric service is changed or is no longer available or suitable for Tenant&rsquo;s requirements.
Tenant covenants and agrees that at all times its use of electric current shall never exceed the capacity of existing feeders
to the Building or wiring installation. Any riser or risers to supply Tenant&rsquo;s electrical requirements, upon written
request of Tenant, will be installed by Landlord, at the sole cost and expense of Tenant, if, in Landlord&rsquo;s sole
judgment, the same are necessary and will not cause permanent damage or injury to the Building or the Premises or cause or
create a dangerous or hazardous condition or entail excessive or unreasonable alterations, repairs or expense or interfere
with or disturb other tenants or occupants. In addition to the installation of such riser or risers, Landlord will also at
the sole cost and expense of Tenant, install all other equipment proper and necessary in connection therewith subject to the
aforesaid terms and conditions. The parties acknowledge that they understand that it is anticipated that electric rates,
charges, etc., may be changed by virtue of time-of-day rates or changes in other methods of billing, and/or electricity
purchases and the redistribution thereof, and fluctuation in the market price of electricity, and that the references in the
foregoing paragraphs to changes in methods of or rules on billing are intended to include any such changes. Anything
hereinabove to the contrary notwithstanding, in no event is the submetering Additional Rent or ERIF, or any
&ldquo;alternative charge&rdquo;, to be less than an amount equal to the total of Landlord&rsquo;s payments to public
utilities and/or other providers for the electricity consumed by Tenant (and any taxes thereon or on redistribution of same)
plus 5% thereof for transmission line loss, plus 15% thereof for other redistribution costs. Landlord reserves the right, at
any time upon thirty (30) days&rsquo; written notice, to change its furnishing of electricity to Tenant from a rent
inclusion basis to a submetering basis, or vice versa, or to change to the distribution of less than all the components of
the existing service to Tenant. Landlord reserves the right to terminate the furnishing of electricity on a rent inclusion,
submetering, or any other basis at any time, upon thirty (30) days&rsquo; written notice to Tenant, in which event Tenant may
make application directly to the public utility and/or other providers for Tenant&rsquo;s entire separate supply of electric
current and Landlord shall permit its wires and conduits, to the extent available and safely capable, to be used for such
purpose, but only to the extent of Tenant&rsquo;s then authorized load. Any meters, risers, or other equipment or connections
necessary to furnish electricity on a submetering basis or to enable Tenant to obtain electric current directly from such
utility and/or other providers shall be installed at Tenant&rsquo;s sole cost and expense. Only rigid conduit or electricity
metal tubing (EMT) will be allowed. Landlord, upon the expiration of the aforesaid thirty (30) days&rsquo; written notice to
Tenant may discontinue furnishing the electric current but this Lease shall otherwise remain in full force and effect. If
Tenant was provided electricity on a rent inclusion basis when it was so discontinued, then commencing when Tenant </FONT>receives
such direct service and as long as Tenant shall continue to receive such service, the Fixed Annual Rent payable under this
Lease shall be reduced by the amount of the ERIF which was payable immediately prior to such discontinuance of electricity on
a rent inclusion basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 41; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
42</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>LEASE
SUBMISSION</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">42.01
Landlord and Tenant agree that this Lease is submitted to Tenant on the understanding that it shall not be considered an offer
and shall not bind Landlord in any way unless and until (i) Tenant has duly executed and delivered duplicate originals thereof
to Landlord and (ii) Landlord has executed and delivered one of said originals to Tenant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
43</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><U>INSURANCE</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">43.01
Tenant shall not violate, or permit the violation of, any condition imposed by the standard fire insurance policy then issued
for office buildings in the Borough of Manhattan, City of New York, and shall not do, or permit anything to be done, or keep or
permit anything to be kept in the Premises which would subject Landlord to any liability or responsibility for personal injury
or death or property damage, or which would increase the fire or other casualty insurance rate on the Building or the property
therein over the rate which would otherwise then be in effect (unless Tenant pays the resulting premium as hereinafter provided
for) or which would result in insurance companies of good standing refusing to insure the building or any of such property in
amounts reasonably satisfactory to Landlord.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">43.02
Tenant covenants to provide on or before the earlier to occur of (i) the first Commencement Date, and (ii) ten (10) days from
the date of this Lease, and to keep in force, at Tenant&rsquo;s own cost, during the term hereof the following insurance coverage
which coverage shall be effective from and after such first Commencement Date:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
A Commercial General Liability insurance policy naming Landlord and its designees as additional insureds protecting Landlord,
its designees against any alleged liability, occasioned by any incident involving injury or death to any person or damage to
property of any person or entity, on or about the Building, the Premises, common areas or areas around the Building or
premises. Such insurance policy shall include Products and Completed Operations Liability and Contractual Liability covering
the liability of Tenant to Landlord by virtue of the indemnification agreement in this Lease, covering bodily injury
liability, property damage liability, personal injury &amp; advertising liability and fire legal liability, all in connection
with the use and occupancy of or the condition of the Premises, the Building or the related common areas, in amounts not less
than:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$5,000,000,
general aggregate per location</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$5,000,000,
per occurrence for bodily injury &amp; property damage</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">$5,000,000, personal &amp; advertising injury</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">$1,000,000, fire legal liability</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 42; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Such
insurance may be carried under a blanket policy covering the Premises and other locations of Tenant, if any, provided such a policy
contains an endorsement (i) naming Landlord and its designees as additional insureds, (ii) specifically referencing the Premises;
and (iii) guaranteeing a minimum limit available for the Premises equal to the limits of liability required under this Lease;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
&ldquo;All-risk&rdquo; insurance, including flood, earthquake and terrorism coverage in an amount adequate to cover the cost
of replacement of all personal property, fixtures, furnishings, equipment, improvements, betterments and installations
located in the Premises, whether or not installed or paid for by Landlord.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">43.03
All such policies shall be issued by companies of recognized responsibility permitted to do business within New York State and
approved by Landlord and rated by Best&rsquo;s Insurance Reports or any successor publication of comparable standing and carrying
a rating of A-VIII or better or the then equivalent of such rating, and all such policies shall contain a provision whereby the
same cannot be canceled or modified unless Landlord and any additional insured are given at least thirty (30) days prior written
notice of such cancellation or modification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">43.04
Prior to the time such insurance is first required to be carried by Tenant and thereafter, at least fifteen (15) days prior to
the expiration of any such policies, Tenant shall deliver to Landlord either duplicate originals of the aforesaid policies or
a 2003 Accord 28 certificates evidencing such insurance (the 2006 Accord 28 being unacceptable to Landlord), together with evidence
of payment for the policy. If Tenant delivers certificates as aforesaid Tenant, upon reasonable prior notice from Landlord, shall
make available to Landlord, at the Premises, duplicate originals of such policies from which Landlord may make copies thereof,
at Landlord&rsquo;s cost. Tenant&rsquo;s failure to provide and keep in force the aforementioned insurance shall be regarded as
a material default hereunder, entitling Landlord to exercise any or all of the remedies as provided in this Lease in the event
of Tenant&rsquo;s default. In addition, in the event Tenant fails to provide and keep in force the insurance required by this
Lease, at the times and for the durations specified in this Lease, Landlord shall have the right, but not the obligation, at any
time and from time to time, and without notice, to procure such insurance and/or pay the premiums for such insurance in which
event Tenant shall repay Landlord within five (5) days after demand by Landlord, as Additional Rent, all sums so paid by Landlord
and any costs or expenses incurred by Landlord in connection therewith without prejudice to any other rights and remedies of Landlord
under this Lease.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">43.05
Landlord and Tenant shall each endeavor to secure an appropriate clause in, or an endorsement upon, each
&ldquo;all-risk&rdquo; insurance policy obtained by it and covering property as stated in 43.02 (b), pursuant to which the
respective insurance companies waive subrogation against each other and any other parties, if agreed to in writing prior to
any damage or destruction. The waiver of subrogation or permission for waiver of any claim hereinbefore referred to shall
extend to the agents of each party and its employees and, in the case of Tenant, shall also extend to all other persons and
entities occupying or using the Premises in accordance with the terms of this Lease. If and to the extent that such waiver or
permission can be obtained only upon payment of an additional charge then, except as provided in the following two
paragraphs, the party benefiting from the waiver or permission shall pay such charge upon demand, or shall be deemed to have
agreed that the party obtaining the insurance coverage in question shall be free of any further obligations under the
provisions hereof relating to such waiver or permission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 43; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">43.06
Subject to the foregoing provisions of this Article, and insofar as may be permitted by the terms of the insurance policies carried
by it, each party hereby releases the other with respect to any claim (including a claim for negligence) which it might otherwise
have against the other party for loss, damages or destruction with respect to its property by fire or other casualty (including
rental value or business interruption, as the case may be) occurring during the Term of this Lease.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">43.07
If, by reason of a failure of Tenant to comply with the provisions of this Lease, the rate of fire insurance with extended coverage
on the building or equipment or other property of Landlord shall be higher than it otherwise would be, Tenant shall reimburse
Landlord, on demand, for that part of the premiums for fire insurance and extended coverage paid by Landlord because of such failure
on the part of Tenant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">43.08.
Landlord may, from time to time, require that the amount of the insurance to be provided and maintained by Tenant hereunder be
increased so that the amount thereof adequately protects Landlord&rsquo;s interest, but in no event in excess of the amount that
would be required of other tenants in other similar office buildings in the Borough of Manhattan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">43.09
A schedule or make up of rates for the building or the Premises, as the case may be, issued by the New York Fire Insurance Rating
Organization or other similar body making rates for fire insurance and extended coverage for the premises concerned, shall be
conclusive evidence of the facts therein stated and of the several items and charges in the fire insurance rate with extended
coverage then applicable to such premises.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">43.10
Each policy evidencing the insurance to be carried by Tenant under this Lease shall contain a clause that such policy and the
coverage evidenced thereby shall be primary with respect to any policies carried by Landlord, and that any coverage carried by
Landlord shall be excess insurance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
44</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><U>SIGNAGE </U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">44.01
Tenant (or, if so requested by Tenant, any permitted licensee of the Premises), shall be permitted to affix either sign or
plaque on or adjacent to the entrance door to the Premises, subject to the prior written approval of Landlord which shall not
be unreasonably withheld subject to the other provisions of this Article, with respect to location, design, size, materials,
quality, coloring, lettering and shape thereof, and subject, also, to compliance by Tenant, at its expense, with all
applicable legal requirements or regulations. All such signage shall be consistent and compatible with the design,
aesthetics, signage and graphics program for the Building as established by Landlord. Landlord may remove any sign installed
in violation of this provision, and Tenant shall pay the cost of such removal and any restoration costs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 44; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
45</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>RIGHT
TO RELOCATE</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">45.01
Notwithstanding anything contained in this Lease to the contrary, Landlord shall have the right to substitute in lieu of the Premises
alternative space in the Building designated by Landlord (the &ldquo;<U>Relocation Space</U>&rdquo;) effective as of the date
(the &ldquo;<U>Relocation Effective Date</U>&rdquo;) set forth in a notice given to Tenant (the &ldquo;<U>Relocation Notice</U>&rdquo;).
The Relocation Space shall be reasonably comparable to the Premises with respect to internal configuration, quality of finish
and rentable square foot area (i.e., plus or minus ten (10%) percent). The Relocation Effective Date shall not be less than sixty
(60) days following the date upon which the Relocation Notice is given to Tenant. In the event that Landlord exercises its rights
hereunder, (i) Tenant shall deliver to Landlord possession of the Premises on or before the Relocation Effective Date vacant and
broom clean, free of all occupancies and encumbrances and otherwise in accordance with the terms, covenants and conditions of
the Lease as if the Relocation Effective Date were the expiration date of the Term of this Lease, (ii) effective as of the Relocation
Effective Date, the term and estate hereby granted with respect to the Premises originally demised hereunder shall terminate,
the Relocation Space shall be deemed to be the Premises and the Fixed Annual Rent and Additional Rent payable under this Lease
shall be adjusted, if necessary, so as to reflect any difference between the deemed rentable square foot area of the original
Premises and said Relocation Space; provided, however, in the event that the rentable square foot area of the Relocation Space
is greater than the rentable square foot area of the original Premises, then the Fixed Annual Rent and Additional Rent payable
for the Relocation Space shall be equal to the amount payable hereunder for the Premises.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">45.02
Provided that Tenant is not in default under this Lease, Landlord shall (i) at Landlord&rsquo;s cost and expense, remove and reinstall
Tenants&rsquo; personal property, trade fixtures and equipment in the Relocation Space (&ldquo;<U>Landlord&rsquo;s Relocation
Work</U>&rdquo;) and (ii) compensate Tenant for Tenant&rsquo;s actual, reasonable, out-of-pocket moving and related expenses upon
Tenant&rsquo;s submission of paid invoices therefor. Landlord shall complete Landlord&rsquo;s Relocation Work on or before the
Relocation Effective Date provided that Tenant cooperates with Landlord and gives Landlord full access to the Premises to facilitate
the performance thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">45.03
Following any relocation undertaken pursuant to this Article, Tenant shall promptly execute and deliver an agreement confirming
such relocation and fixing any corresponding adjustments in Fixed Annual Rent and Additional Rent payable under this Lease, but
any failure to execute such an agreement by Tenant shall not affect such relocation and adjustments as determined by Landlord.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 45; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
46</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>FUTURE
CONDOMINIUM CONVERSION</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">46.01
Tenant acknowledges that the Building and the land of which the Premises form a part (the &ldquo;<U>Land</U>&rdquo;) may be subjected
to the condominium form of ownership prior to the end of the Term of this Lease. Tenant agrees that if, at any time during the
Term, the Building and the Land shall be subjected to the condominium form of ownership, then, this Lease and all rights of Tenant
hereunder are and shall be subject and subordinate in all respects to any condominium declaration and any other documents (collectively,
the &ldquo;<U>Declaration</U>&rdquo;) which shall be recorded in order to convert the Building and the Land to a condominium form
of ownership in accordance with the provisions of Article 9-B of the Real Property Law of the State of New York or any successor
thereto. If any such Declaration is to be recorded, Tenant, upon request of Landlord, shall enter into an amendment of this Lease
in such respects as shall be necessary to conform to such condominiumization, including, without limitation, appropriate adjustments
to Real Estate Taxes payable during the Base Tax Year and Tenant&rsquo;s Share, as such terms are defined in Article 32 hereof;
provided that Tenant&rsquo;s obligations under this Lease shall not be materially increased (and there shall be no increase in
Tenant&rsquo;s monetary obligations) and Tenant&rsquo;s rights are not diminished as a result thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
47</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>MISCELLANEOUS</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">47.01
This Lease represents the entire understanding between the parties with regard to the matters addressed herein and may only be
modified by written agreement executed by all parties hereto. All prior understandings or representations between the parties
hereto, oral or written, with regard to the matters addressed herein are hereby merged herein. Tenant acknowledges that neither
Landlord nor any representative or agent of Landlord has made any representation or warranty, express or implied, as to the physical
condition, state of repair, layout, footage or use of the Premises or any matter or thing affecting or relating to Premises except
as specifically set forth in this Lease. Tenant has not been induced by and has not relied upon any statement, representation
or agreement, whether express or implied, not specifically set forth in this Lease. Landlord shall not be liable or bound in any
manner by any oral or written statement, broker&rsquo;s &ldquo;set-up&rdquo;, representation, agreement or information pertaining
to the Premises, the Building or this Agreement furnished by any real estate broker, agent, servant, employee or other person,
unless specifically set forth herein, and no rights are or shall be acquired by Tenant by implication or otherwise unless expressly
set forth herein. This Lease shall be construed without regard to any presumption or other rule requiring construction against
the party causing this agreement to be drafted. Tenant represents and warrants to Landlord that it is not a Prohibited Person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 46; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
48</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>COMPLIANCE
WITH LAW</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">48.01
If, at any time during the Term hereof, Landlord expends any sums for alterations or improvements to the Building which are required
to be made pursuant to any law, ordinance or governmental regulation, Tenant shall pay to Landlord, as Additional Rent, Tenant&rsquo;s
Share of such cost within ten (10) days after demand therefor; provided, however, that if the cost of such alteration or improvement
is one which is required to be amortized over a period of time pursuant to applicable governmental regulations, Tenant shall pay
to Landlord, as Additional Rent, during each year in which occurs any part of the Term, Tenant&rsquo;s Share of the cost thereof
amortized on a straight line basis over an appropriate period, but not more than five (5) years; provided, further, however, that
the Additional Rent payable by Tenant under this Section 48.01 in any single calendar year during the Term hereof shall not exceed
the sum of $1.00 per rentable square foot of the Premises. Notwithstanding anything to the contrary contained herein, in the event
that the requirement for the performance of any such alteration or improvement is attributable to the actions, installations,
use or manner of use of the Premises by Tenant, then in such event Tenant shall be responsible to pay the entire cost imposed
by Landlord with respect to such alteration or improvement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 47; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
WITNESS WHEREOF, </B>the said Landlord, and Tenant have duly executed this Lease as of the day and year first above written.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SLG
    GRAYBAR MESNE LEASE LLC, as Landlord</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; width: 36%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Steven M. Durels </FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Steven M. Durels </FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    Executive Vice President, Director of Leasing and Real Property </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Witness:</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Monica Perez</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Monica Perez</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    Admin. Asst. </FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TIZIANA
    LIFE SCIENCES PLC, as Tenant</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; width: 36%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid">/s/ James
F. Tripp&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8/2/2016</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT>
    James F. Tripp</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT>
    &nbsp;&nbsp;Chief Operating Officer</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Witness:</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Saira Suscello</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Saira Suscello</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    Notary Public</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0 0 1.5pt; text-indent: 0; font: 10pt Times New Roman, Times, Serif; width: 60%">&nbsp;</TD>
    <TD STYLE="padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; width: 40%">/s/ Tiziano Lazzaretti</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif">Tiziano Lazzaretti</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif">CFO</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif">8/3/2016</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 48; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
49</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>RULES
AND REGULATIONS</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><U>MADE A PART OF THIS LEASE</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1. No
animals, birds, bicycles or vehicles shall be brought into or kept in the Premises. The Premises shall not be used for manufacturing
or commercial repairing or for sale or display of merchandise or as a lodging place, or for any immoral or illegal purpose, nor
shall the Premises be used for a public stenographer or typist; barber or beauty shop; telephone, secretarial or messenger service;
employment, travel or tourist agency; school or classroom; commercial document reproduction; or for any business other than specifically
provided for in Tenant&rsquo;s lease. Tenant shall not cause or permit in the Premises any disturbing noises which may interfere
with occupants of this or neighboring Buildings, any cooking or objectionable odors, or any nuisance of any kind, or any inflammable
or explosive fluid, chemical or substance. Canvassing, soliciting and peddling in the Building are prohibited, and each tenant
shall cooperate so as to prevent the same.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2. The
toilet rooms and other water apparatus shall not be used for any purposes other than those for which they were constructed, and
no sweepings, rags, ink, chemicals or other unsuitable substances shall be thrown therein. Tenant shall not place anything out
of doors, windows or skylights, or into hallways, stairways or elevators, nor place food or objects on outside window sills. Tenant
shall not obstruct or cover the halls, stairways and elevators, or use them for any purpose other than ingress and egress to or
from Tenant&rsquo;s Premises, nor shall skylights, windows, doors and transoms that reflect or admit light into the Building be
covered or obstructed in any way. All drapes and blinds installed by Tenant on any exterior window of the Premises shall conform
in style and color to the Building standard.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3. Tenant
shall not place a load upon any floor of the Premises in excess of the load per square foot which such floor was designed to carry
and which is allowed by law. Landlord reserves the right to prescribe the weight and position of all safes, file cabinets and
filing equipment in the Premises. Business machines and mechanical equipment shall be placed and maintained by Tenant, at Tenant&rsquo;s
expense, only with Landlord&rsquo;s consent and in settings approved by Landlord to control weight, vibration, noise and annoyance.
Smoking or carrying lighted cigars, pipes or cigarettes in the elevators of the Building is prohibited.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4. Tenant
shall not move any heavy or bulky materials into or out of the Building or make or receive large deliveries of goods, furnishings,
equipment or other items without Landlord&rsquo;s prior written consent, and then only during such hours and in such manner as
Landlord shall approve and in accordance with Landlord&rsquo;s rules and regulations pertaining thereto. If any material or equipment
requires special handling, Tenant shall employ only persons holding a Master Rigger&rsquo;s License to do such work, and all such
work shall comply with all legal requirements. Landlord reserves the right to inspect all freight to be brought into the Building,
and to exclude any freight which violates any rule, regulation or other provision of this Lease.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
No sign, advertisement, notice or thing shall be inscribed, painted or affixed on any part of the Building, without the
prior written consent of Landlord. Landlord may remove anything installed in violation of this provision, and Tenant shall
pay the cost of such removal and any restoration costs. Interior signs on doors and directories shall be inscribed or affixed
by Landlord at Tenant&rsquo;s expense. Landlord shall control the color, size, style and location of all signs,
advertisements and notices. No advertising of any kind by Tenant shall refer to the Building, unless first approved in
writing by Landlord.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 49; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.05in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6. No
article shall be fastened to, or holes drilled or nails or screws driven into, the ceilings, walls, doors or other portions of
the Premises, nor shall any part of the Premises be painted, papered or otherwise covered, or in any way marked or broken, without
the prior written consent of Landlord.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.05in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.05in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7. No
existing locks shall be changed, nor shall any additional locks or bolts of any kind be placed upon any door or window by Tenant,
without the prior written consent of Landlord. Two (2) sets of keys to all exterior and interior locks shall be furnished to Landlord
.. At the termination of this Lease, Tenant shall deliver to Landlord all keys for any portion of the Premises or Building. Before
leaving the Premises at any time, Tenant shall close all windows and close and lock all doors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.05in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.05in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8. No
Tenant shall purchase or obtain for use in the Premises any spring water, ice, towels, food, bootblacking, barbering or other
such service furnished by any company or person not approved by Landlord. Any necessary exterminating work in the Premises shall
be done at Tenant&rsquo;s expense, at such times, in such manner and by such company as Landlord shall require. Landlord reserves
the right to exclude from the Building, from 6:00 p.m. to 8:00 a.m., and at all hours on Sunday and legal holidays, all persons
who do not present a pass to the Building signed by Landlord. Landlord will furnish passes to all persons reasonably designated
by Tenant. Tenant shall be responsible for the acts of all persons to whom passes are issued at Tenant&rsquo;s request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.05in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.05in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9. Whenever
Tenant shall submit to Landlord any plan, agreement or other document for Landlord&rsquo;s consent or approval, Tenant agrees
to pay Landlord as Additional Rent, on demand, an administrative fee equal to the sum of the reasonable fees of any architect,
engineer or attorney employed by Landlord to review said plan, agreement or document and Landlord&rsquo;s administrative costs
for same.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.05in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.05in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10. The
use in the Premises of auxiliary heating devices, such as portable electric heaters, heat lamps or other devices whose principal
function at the time of operation is to produce space heating, is prohibited.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.05in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.05in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11. Tenant
shall keep all doors from the hallway to the Premises closed at all times except for use during ingress to and egress from the
Premises. Tenant acknowledges that a violation of the terms of this paragraph may also constitute a violation of codes, rules
or regulations of governmental authorities having or asserting jurisdiction over the Premises, and Tenant agrees to indemnify
Landlord from any fines, penalties, claims, action or increase in fire insurance rates which might result from Tenant&rsquo;s
violation of the terms of this paragraph.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.05in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.05in"></P>

<!-- Field: Page; Sequence: 50; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.05in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.05in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.
Tenant shall be permitted to maintain an &ldquo;in-house&rdquo; messenger or delivery service within the Premises, provided
that Tenant shall require that any messengers in its employ affix identification to the breast pocket of their outer garment,
which shall bear the following information: name of Tenant, name of employee and photograph of the employee. Messengers in
Tenant&rsquo;s employ shall display such identification at all time. In the event that Tenant or any agent, servant or
employee of Tenant, violates the terms of this paragraph, Landlord shall be entitled to terminate Tenant&rsquo;s permission
to maintain within the Premises in-house messenger or delivery service upon written notice to Tenant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13. Tenant
will be entitled to three (3) listings on the Building lobby directory board, without charge. Any additional directory listing
(if space is available), or any change in a prior listing, with the exception of a deletion, will be subject to a fifteen ($15.00)
dollar service charge, payable as Additional Rent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14. In
case of any conflict or inconsistency between any provisions of this Lease and any of the rules and regulations as originally
or as hereafter adopted, the provisions of this Lease shall control.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 51; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>EXHIBIT
A</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>LOCATION
PLAN</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(see
attached)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><U></U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 52; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><IMG SRC="ex10-6_001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<!-- Field: Page; Sequence: 53; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>EXHIBIT
B</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RENT
SCHEDULE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tenant
shall pay Fixed Annual Rent for the Premises (without electricity) at the following rates per annum:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">One
                                         Hundred Eighty Six Thousand Six Hundred Eighty Two and 00/100 ($186,682.00) Dollars per
                                         annum ($15,556.84 per month) for the period commencing on September 1, 2016 through August
                                         31, 2017;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">One
                                         Hundred Ninety Two Thousand Two Hundred Eighty Two and 46/100 ($192,282.46) Dollars per
                                         annum ($16,023.54 per month) for the period commencing September 1, 2017 through August
                                         31, 2018;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">One
                                         Hundred Ninety Eight Thousand Fifty and 93/100 ($198,050.93) Dollars per annum ($16,504.24
                                         per month) for the period commencing September 1, 2018 through August 31, 2019;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Two
                                         Hundred Three Thousand Nine Hundred Ninety Two and 46/100 ($203,992.46) Dollars per annum
                                         ($16,999.37 per month) for the period commencing September 1, 2019 through August 31,
                                         2020;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Two
                                         Hundred Ten Thousand One Hundred Twelve and 23/100 ($210,112.23) Dollars per annum ($17,509.35
                                         per month) for the period commencing September 1, 2020 through August 31, 2021; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Two
                                         Hundred Sixteen Thousand Four Hundred Fifteen and 60/100 ($216,415.60) Dollars per annum
                                         ($18,034.63 per month) for the period commencing September 1, 2021 through October 31,
                                         2021.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.5in"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 54; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>EXHIBIT
C</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>GOOD
GUY GUARANTEE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>(see attached)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 55; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>GUARANTEE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED and in consideration of and in order to induce the execution of that certain lease agreement dated as of August
2, 2016 (the &ldquo;<U>Lease</U>&rdquo;) between SLG Graybar Mesne Lease LLC (&ldquo;<U>Landlord</U>&rdquo;) and Tiziana Life
Sciences PLC (&ldquo;<U>Tenant</U>&rdquo;) for that certain rentable portion of the twenty-fifth (25<SUP>th</SUP>) floor designated
as Suite 2525-28, as approximately depicted on the location plan annexed to the Lease (the &ldquo;<U>Premises</U>&rdquo;) in the
building known as and located at 420 Lexington Avenue, New York, New York (the &ldquo;<U>Building</U>&rdquo;) and other good and
valuable consideration:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
The undersigned, acting as surety (the &ldquo;<U>Guarantor</U>&rdquo;) hereby absolutely and unconditionally, for himself and
his legal representatives, successors and assigns, guarantees to Landlord and to Landlord&rsquo;s legal representatives, successors
and assigns, the prompt and full performance and observance by the Tenant and by its legal representatives, successors and assigns
of Tenant&rsquo;s obligation to pay rent, additional rent and any charges accruing under the Lease (or damages in lieu thereof)
and the performance of all other obligations of Tenant under the Lease accruing during that period of time (the &ldquo;<U>Good
Guy Period</U>&rdquo;) during which Tenant or its partners, shareholders, agents, employees, assignees, subtenants, licensees
or anyone else with the permission of and/or under or through Tenant (notwithstanding the expiration or revocation of any such
permission) occupies the Premises or any part thereof, provided Tenant has given Landlord not less than ninety (90) days prior
written notice that Tenant intends to vacate and surrender to Landlord possession of the Premises in the condition required by
the Lease and, in the absence of such notice, for an additional ninety (90) days after Tenant&rsquo;s vacatur and surrender to
Landlord of the Premises in the condition required by the Lease. This guarantee is an absolute, continuing and unconditional guarantee
of payment (and not of collection) and of performance. Notice of all defaults is waived and consent is hereby given to all extensions
of time that Landlord may grant to Tenant in the performance of any of the terms of the Lease and/or to the waiving in whole or
in part of any such performance, and/or to the releasing of Tenant in whole or in part from any such performance, and/or to the
adjusting of any dispute in connection with the Lease, and/or to the assignment of the Lease to any other entity; and no such
defaults, extensions, waivers, releases, adjustments, or assignments, with or without the knowledge of the undersigned, shall
affect or discharge the liability of the undersigned; and the undersigned hereby waives any and all right to a trial by jury in
any action or proceeding to enforce such liability hereafter instituted by Landlord, or its successors or assigns, to which the
undersigned may be a party. The undersigned further agrees to pay all expenses, including legal fees and disbursements paid or
incurred by Landlord in seeking to enforce this guarantee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
This guarantee shall not be impaired by, and the Guarantor hereby consents to (i) any modification, supplement, extension or
amendment of the Lease to which the parties thereto may hereafter agree and (ii) any assignment of the Lease. The liability
of the Guarantor hereunder is direct, unconditional and co-extensive with that of the Tenant and may be enforced without
requiring Landlord first to resort to any other right, remedy or security. The enforceability of this guarantee shall not be
affected by any bankruptcy proceeding or other proceeding affecting the rights of creditors of Tenant, nor by discharge or
modification of Tenant&rsquo;s liability under the Lease in any bankruptcy proceeding. An assignment of the Lease or any
subletting thereunder shall not release or relieve the undersigned from its liability hereunder. The Guarantor shall have no
right of </FONT>subrogation, reimbursement or indemnity whatsoever, nor any right of recourse to security for the debts and
obligations of Tenant to Landlord, unless and until all of said debts and obligations have been satisfied in full.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 56; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3. This
guarantee is a continuing guarantee which shall remain effective during the term of all or any portion of the Lease, subject to
any limitations contained in Article 1, hereof, and as to any surviving provisions and obligations of the Lease that remain effective
after the termination of the Lease.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4. This
guarantee shall be governed by and interpreted in accordance with the laws of the State of New York, without regard to its conflicts
of laws principles, shall be deemed to have been made and performed in New York, and shall be enforceable in New York.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
<U>8/2/2016&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; width: 40%">/s/ Tiziano Lazzaretti</TD>
    <TD STYLE="width: 20%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0; text-indent: 0; width: 40%">/s/
    James F. Tripp</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif">Tiziano Lazzaretti</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif">Name: James F. Tripp</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">STATE
OF NEW YORK</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">COUNTY OF NEW YORK</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
the  4 day of August &#9;in the year 2016 before me, the undersigned, a Notary Public in for said State, personally
appeared James Tripp, personally known to me or proved to me on the basis of satisfactory evidence to be the
individual whose name is subscribed to the within instrument and acknowledged to me that he/she executed the same in his/her
capacity, and that by his/her signature on the instrument, the individual, or the person upon behalf of which the individual
acted, executed the instrument.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 20; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid">/s/ Saira Suscello</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; width: 40%"></TD>
    <TD STYLE="width: 20%">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; width: 40%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Notary
Public</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 20; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 20; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">53</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.7
<SEQUENCE>13
<FILENAME>ff12018a1ex10-7_tiziana.htm
<DESCRIPTION>ANNUAL LEASE FOR 3085 OLD EASTON ROAD, DOYLESTOWN, PENNSYLVANIA, UNITED STATES, DATED DECEMBER 6, 2017
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 10.7</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"><IMG SRC="ex10-7_001.jpg" ALT=""></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">1st Amendment to Lease &ndash; Tiziana. &ndash; Bucks County
Biotechnology Center</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><U>AMENDMENT TO LEASE AGREEMENT </U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">THIS FIRST AMENDMENT TO LEASE AGREEMENT (&ldquo;First Amendment&rdquo;)
is dated as of the 6 December 2017 between <B>BUCKS COUNTY BIOTECHNOLOGY CENTER, INC., </B>a Pennsylvania nonprofit corporation
(&ldquo;Lessor&rdquo;) and <B>TIZIANA THERAPEUTICS INC </B>(&ldquo;Lessee&rdquo;) (collectively, the &ldquo;Parties&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">WITNESSETH:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, by Lease Agreement (the &ldquo;Lease&rdquo;) effective
1 February 2017, Lessor leased to Lessee approximately 427.50 square feet of office space being part 3705 Old Easton Road, Doylestown,
Buckingham Township, Bucks County, Pennsylvania (the &ldquo;Building&rdquo;), which space (the &ldquo;Leased Premises&rdquo;) is more
particularly described in the Lease; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, Lessor and Lessee desire to modify the Lease in accordance
with the terms of this First Amendment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW THEREFORE, in consideration of the mutual covenants and
premises contained herein, as well as other good and valuable consideration, and intending to be legally bound hereby, the Parties
hereto agree as follows;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">1.</TD><TD STYLE="text-align: justify"><U>Premises</U>.
                                         Pursuant to Section 1 of the original Lease, Lessor and Lessee hereby agree that the
                                         Lessee will lease an additional office, as identified in Exhibit &ldquo;B&rsquo;, attached hereto,
                                         commencing 6 December 2017.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">2.</TD><TD STYLE="text-align: justify"><U>Lease Term
                                         Extension</U>. Pursuant to Section 2 of the original Lease, Lessor and Lessee hereby
                                         agree to extend the Lease Term (which will currently expire on 31 January 2017) until
                                         31 January 2018 (extension period), provided that, at the time of commencement of the
                                         extension period, an Event of Default does not exist nor has any event occurred and is
                                         continuing which, with the passage of time or the giving of notice, will become an Event
                                         of Default.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">3.</TD><TD STYLE="text-align: justify"><U>Rent</U>. Lessee
                                         shall continue to pay the Rent monthly at the amount provided for in Exhibit &ldquo;B&rdquo;
                                         attached.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">4.</TD><TD STYLE="text-align: justify"><U>Lease Otherwise
                                         in Full Force and Effect and Unmodified</U>. Except as expressly provided herein, the
                                         Lease shall remain in full force and effect in accordance with its terms (as amended
                                         herein).</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">5.</TD><TD STYLE="text-align: justify"><U>Capitalized
                                         Terms</U>. Terms capitalized in this First Amendment (unless otherwise defined herein)
                                         shell have the meanings set forth in the Lease.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">6.</TD><TD STYLE="text-align: justify"><U>Binding Effect</U>.
                                         This First Amendment will bind and inure to the benefit of the successors and assigns
                                         of the Parties hereto and will be governed in accordance with the laws of the Commonwealth
                                         of Pennsylvania.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">7.</TD><TD STYLE="text-align: justify"><U>Entire Agreement</U>.
                                         This First Amendment sets forth the entire agreement and understanding of the Parties
                                         with respect to the transactions contemplated hereby.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">8.</TD><TD STYLE="text-align: justify"><U>Counterparts</U>.
                                         This First Amendment may be executed in any number of counterparts, each of which shall
                                         be deemed an original, and all such counterparts shall constitute but one and the same
                                         agreement.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">9.</TD><TD STYLE="text-align: justify"><U>Facsimile Signatures
                                         Are Binding</U>. It is agreed that a copy of this First Amendment bearing a facsimile
                                         (faxed) version of a party&rsquo;s signature shall have the same force and effect as a copy
                                         bearing the party&rsquo;s original signature.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">10.</TD><TD STYLE="text-align: justify"><U>Recitals Constitute
                                         a Part of this Amendment</U>. The recitals in this Amendment are a part of this First
                                         Amendment and are incorporated herein.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">IN WITNESS WHEREOF, and intending to be legally bound hereby,
the authorized representatives of the Parties have signed this First Amendment as of the date above provided.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LESSEE:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LESSOR:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TIZIANA THERAPEUTICS INC.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BUCKS COUNTY BIOTECHNOLOGY CENTER,
    INC.,</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">/s/
    Tiziano Lazzaretti&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">/s/     Louis     P.
    Kassa
    III&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Tiziano Lazzaretti</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Louis     P.
    Kassa
    III&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">CFO</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">COO</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">29 February 2018</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">28 February 2018</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>EXHIBIT &ldquo;B&rdquo;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>LEASED
PREMISES DESCRIPTION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">Amended December 6, 2017</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt">Lessee: Tiziana Therapeutics Inc</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt">Point of Contact: Tiziano Lazzaretti</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt">Title: CFO</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt">Phone: 207-495-2379</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt">Email: tlazzaretti@tizianalifesciences.com</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Orig.Lease Start Date: 2/1/17</FONT></TD>
    <TD STYLE="width: 50%; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">End Date: 1/31/19</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%; text-align: left"><FONT STYLE="font-size: 10pt">Type of Space:</FONT></TD>
    <TD STYLE="width: 6%; text-align: left">&#9746;</TD>
    <TD STYLE="width: 20%; text-align: left"><FONT STYLE="font-size: 10pt">Office</FONT></TD>
    <TD STYLE="width: 6%; text-align: left">&#9744;</TD>
    <TD STYLE="width: 48%; text-align: left"><FONT STYLE="font-size: 10pt">Warehouse</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&#9744;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Lab</FONT></TD>
    <TD STYLE="text-align: left">&#9744;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Other</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%"><FONT STYLE="font-size: 10pt">Location:</FONT></TD>
    <TD STYLE="width: 6%">&#9746;</TD>
    <TD STYLE="width: 74%"><FONT STYLE="font-size: 10pt">3805 Old Easton Road, Doylestown, PA 18902</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&#9744;</TD>
    <TD><FONT STYLE="font-size: 10pt">3765 Old Easton Road, Doylestown, PA 18902</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt">Room Numbers:</FONT></TD>
    <TD STYLE="width: 80%; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt">Offices 2213,2220,2221,2222</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leased
    Ft<SUP>2</SUP></FONT></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Rent Expense</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">CAM/Utilities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 46%; text-align: left">Office Space</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 15%; text-align: right">550.4</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 15%; text-align: right">16,256.00</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 15%; text-align: right">3,467.52</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Lab Space</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Warehouse</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Other</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Annual Charges</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16,256.00</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,467.52</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Monthly Charges</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1 354.67</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">288.96</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; width: 16%">Security Deposit:</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 1%">$</TD><TD STYLE="text-align: right; width: 14%">1,355.00</TD><TD STYLE="text-align: left; width: 1%">&nbsp;</TD><TD STYLE="width: 17%">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 1%">&nbsp;</TD><TD STYLE="text-align: right; width: 31%"><FONT STYLE="font-size: 10pt">Total monthly charge</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="text-align: left; width: 1%">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 1%">$</TD><TD STYLE="text-align: right; width: 14%">1.643.63</TD><TD STYLE="text-align: left; width: 1%">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 69%"><FONT STYLE="font-size: 10pt">* CAM/Utilities are estimated for the current year.</FONT></TD>
    <TD STYLE="width: 31%; text-align: right"><FONT STYLE="font-size: 10pt">Lessee Approval: __________</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.8
<SEQUENCE>14
<FILENAME>ff12018a1ex10-8_tiziana.htm
<DESCRIPTION>TIZIANA LIFE SCIENCES PLC EMPLOYEE SHARE OPTION PLAN, WITH NON-EMPLOYEE SUB-PLAN AND US SUB-PLAN, ADOPTED BY THE BOARD ON 23 MARCH 2016 AND APPROVED BY SHAREHOLDERS ON JUNE 30, 2016
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: right"><B>Exhibit 10.8</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tiziana
Life Sciences Plc</FONT></P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Employee
Share Option Plan</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>with</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Non-Employee
Sub-Plan</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>and</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>US
Sub-Plan</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Adopted
by the Board on 23 March 2016</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Approved
by Shareholders on 30 June 2016</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><IMG SRC="ex10-8_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cooley
(UK) LLP, Dashwood, 69 Old Broad Street, London EC2M 1QS, UK<BR>
T: +44 (0) 20 7583 4055 F: +44 (0) 20 7785 9355 www.cooley.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contents</FONT></P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clause</FONT></P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="width: 90%; text-align: left; text-indent: -35.45pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interpretation</FONT></TD>
    <TD STYLE="width: 10%; text-align: right; padding-top: 0in; padding-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: left; text-indent: -35.45pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Grant
    of Options</FONT></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -35.45pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Exercise
    Condition</FONT></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: left; text-indent: -35.45pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Overall
    grant limits</FONT></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -35.45pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Individual
    grant limits</FONT></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: left; text-indent: -35.45pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Exercise
    of Options</FONT></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -35.45pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Manner
    of exercise of Options</FONT></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: left; text-indent: -35.45pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Termination
    of employment</FONT></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -35.45pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Lapse
    of Options</FONT></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: left; text-indent: -35.45pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.&nbsp;&nbsp;&nbsp;Tax
    liabilities</FONT></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -35.45pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.&nbsp;&nbsp;&nbsp;Relationship
    with employment contract</FONT></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: left; text-indent: -35.45pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.&nbsp;&nbsp;&nbsp;Takeovers
    and liquidations</FONT></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -35.45pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.&nbsp;&nbsp;&nbsp;Exchange
    of Options</FONT></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: left; text-indent: -35.45pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.&nbsp;&nbsp;&nbsp;Variation
    of share capital</FONT></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -35.45pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.&nbsp;&nbsp;&nbsp;Notices</FONT></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: left; text-indent: -35.45pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.&nbsp;&nbsp;&nbsp;Administration
    and amendment</FONT></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -35.45pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.&nbsp;&nbsp;&nbsp;Third
    party rights</FONT></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: left; text-indent: -35.45pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.&nbsp;&nbsp;&nbsp;Data
    protection</FONT></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -35.45pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19.&nbsp;&nbsp;&nbsp;Governing
    law</FONT></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: left; text-indent: -35.45pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.&nbsp;&nbsp;&nbsp;Jurisdiction</FONT></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</FONT></TD></TR>
</TABLE>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Rules
of the Tiziana Life Science plc Employee Share Option Plan</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>1.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Interpretation</B></FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         following definitions and rules of interpretation apply in the Plan.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Acting
in Concert:</B> has the meaning given to it in the City Code on Takeovers and Mergers published by the Panel on Takeovers and
Mergers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Adoption
Date:</B> the date of the adoption of the Plan by the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AIM:
</B>the Alternative Investment Market operated by The London Stock Exchange plc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AIM
Rules:</B> the AIM Rules for Companies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Announcement:
</B>the announcement to a regulatory information service (as defined in the AIM Rules) of the results of the Company for any period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Board:
</B>the board of directors of the Company or a committee of directors appointed by that board to carry out any of its functions
under the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Business
Day:</B> a day other than a Saturday, Sunday or public holiday in England when banks in London are open for business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Change
of Control:</B> the sale of any of the Shares (in one transaction or a series of transactions) that will result in the Offeror
of those Shares and persons Acting in Concert with him together acquiring Control of the Company, except where the Offeror is
a company and the shareholders of that company and the proportion of shares in that company held by each of them following completion
of the sale are substantially the same as the shareholders and their shareholdings in the Company immediately before the sale.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Company:
</B>Tiziana Life Sciences plc incorporated and registered in England with number 03508592.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Control:
</B>has the meaning given in section 719 of ITEPA 2003.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Dilutive
Shares:</B> on any date, all shares of the Company that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">have
                                         been issued, or transferred out of treasury, on the exercise of options granted, or in
                                         satisfaction of any other awards made, under any Employees&rsquo; Share Scheme (including the
                                         Plan); or</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">remain
                                         capable of issue, or transfer out of treasury, under any Existing Options that were granted;</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
either case during</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">the
                                         shorter of</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">the
                                         period of ten years ending on (and including) that date; and</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">the
                                         period since the Shares were first admitted to trading on AIM.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Employee:
</B>an individual who is an employee of a Group Member.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Employer
Company: </B> for the purposes of rule 10 and the definition of Tax Liability, the Option Holder&rsquo;s employer or former employer
as appropriate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Employer
NICs:</B> any secondary class 1 (employer) NICs (or any similar liability for social security contribution in any jurisdiction)
that the Company or any employer (or former employer) of an Option Holder is liable to pay as a result of any Taxable Event (or
which that person would be liable to pay in the absence of an election of the type referred to in rule 10.2(b)) and that may be
lawfully recovered from the Option Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exercise
Condition:</B> a condition that must be satisfied before an Option may be exercised, which complies with rule 3 and is specified
in the Option Agreement under rule 2.3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exercise
Price:</B> the price at which each Share subject to an Option may be acquired on the exercise of that Option, which (subject to
rule 14(b)) if Shares are to be newly issued to satisfy the Option, may not be less than the nominal value of a Share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Grant
Date:</B> the date on which an Option is granted under the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Group:
</B>the Company and its 51% Subsidiaries (references to <B>Group Member</B> shall be construed accordingly).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>HMRC:
</B>HM Revenue &amp; Customs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ITEPA
2003:</B> the Income Tax (Earnings and Pensions) Act 2003.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Market
Value:</B> the market value of a Share determined to the satisfaction of the Board in accordance with the applicable provisions
of Part VIII of the Taxation of Chargeable Gains Act 1992.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Minimum
Proportion:</B> means the proportion of an Option that may become exercisable due to an event under rule 8 or rule 12, and that
shall be 100% except that if the Option becomes exercisable before any Exercise Condition has been achieved the Board (acting
fairly and reasonably) shall adjust the Minimum Proportion to take account of the extent to which the Exercise Condition has been
achieved at the date of the relevant event.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NICs:
</B>National Insurance contributions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Offeror:
</B>the person who acquires control of the Company under a Change of Control.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Option:
</B>a right to acquire Shares granted under the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Option
Agreement:</B> a written agreement constituting an Option, entered into under rule 2.3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Option
Holder:</B> an individual who holds an Option or, where applicable, his personal representatives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Personal
Data:</B> any personal information that could identify an Option Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Plan:
</B>the employees&rsquo; share scheme (as defined in section 1166 of the Companies Act 2006) constituted and governed by these rules,
as amended from time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Redundancy:
</B>has the meaning given by the Employment Rights Act 1996.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Rollover
Period:</B> any period during which Options may be exchanged for options over shares in another company under rule 13.1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Shares:
</B>&pound;0.03 ordinary shares in the Company (subject to rule 14).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Sufficient
Shares:</B> the smallest number of Shares that, when sold, produce an amount at least equal to the relevant Tax Liability (after
deduction of brokerage and any other charges or taxes on the sale).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Taxable
Event:</B> any event or circumstance that gives rise to a liability for the Option Holder to pay income tax, NICs or both (or
their equivalents in any jurisdiction) in respect of:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Option, including its exercise, assignment or surrender for consideration, or the receipt
                                         of any benefit in connection with it;</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         Shares (or other securities or assets):</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">earmarked
                                         or held to satisfy the Option;</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">acquired
                                         on exercise of the Option;</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">acquired
                                         as a result of holding the Option; or</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">acquired
                                         in consideration of the assignment or surrender of the Option;</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         securities (or other assets) acquired or earmarked as a result of holding Shares (or
                                         other securities or assets) mentioned in (b) above; or</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         amount due under pay as you earn (PAYE) in respect of securities or assets in (a) to
                                         (c) above, including any failure by the Option Holder to make good such an amount in
                                         the time limit specified in section 222 of ITEPA 2003.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Tax
Liability:</B> the total of:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         income tax and primary class 1 (employee) NICs (or their equivalents in any jurisdiction)
                                         for which any employer (or former employer) of the Option Holder is or may be liable
                                         to account (or reasonably believes it is or may be liable to account) as a result of
                                         any Taxable Event; and</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         Employer NICs that any employer (or former employer) of the Option Holder is or may be
                                         liable to pay (or reasonably believes it is or may be liable to pay) as a result of any
                                         Taxable Event that can be recovered lawfully from the Option Holder.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rule
                                         headings shall not affect the interpretation of the Plan.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
                                         the context otherwise requires, words in the singular shall include the plural and in
                                         the plural shall include the singular.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.4</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
                                         the context otherwise requires, a reference to one gender shall include a reference to
                                         the other genders.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.5</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                         reference to a statute or statutory provision is a reference to it as amended, extended
                                         or re-enacted from time to time.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.6</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                         reference to a statute or statutory provision shall include all subordinate legislation
                                         made from time to time under that statute or statutory provision.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.7</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                         reference to writing or written includes fax and email.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.8</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                         obligation on a party not to do something includes an obligation not to allow that thing
                                         to be done.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.9</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">References
                                         to rules are to the rules of the Plan.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.10</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                         words following the terms <B>including</B>, <B>include</B>, <B>in particular</B>, <B>for
                                         example</B> or any similar expression shall be construed as illustrative and shall not
                                         limit the sense of the words, description, definition, phrase or term preceding those
                                         terms.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>2.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Grant
                                         of Options</B></FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                         to the rules, the Company (acting through the Board) may grant an Option to any Employee
                                         it chooses during:</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         period of 42 days after the Adoption Date;</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         period of 42 days after an Announcement; and</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         other period that the Board has decided should be a Grant Period due to exceptional circumstances.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Company may not grant Options:</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
                                         any time when that grant would be prohibited by, or in breach of, any law, regulation
                                         with the force of law or the AIM Rules; or</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">after
                                         the tenth anniversary of the Adoption Date.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Company shall grant an Option by entering into an Option Agreement in a form approved
                                         by the Board. Each Option Agreement shall (without limitation):</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">specify
                                         the Grant Date of the Option;</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">specify
                                         the number and class of the Shares over which the Option is granted;</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">specify
                                         the Exercise Price;</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">specify
                                         any Exercise Condition;</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">specify
                                         when and how the Option may be exercised;</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">specify
                                         the date when the Option will lapse, assuming that the Option is not exercised earlier
                                         and no event occurs to cause the Option to lapse earlier. This date may not be later
                                         than the tenth anniversary of the Grant Date;</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">include
                                         a statement that the Option is subject to these rules (which shall be incorporated in
                                         the Option Agreement by reference);</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">include
the terms required by rule 10.1, rule 10.2 and rule 10.6;</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">include
                                         the power of attorney required by rule 10.6;</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">include
                                         a summary of rule 9.1 and rule 9.2(i).</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
                                         amount shall be paid by an Employee for the grant of an Option.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>3.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Exercise
                                         Condition</B></FONT></TD>
    <TD>&nbsp;</TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                         the Grant Date of any Option, the Board may specify one or more appropriate Exercise
                                         Conditions for the Option. An Exercise Condition may be specified to apply only to part
                                         of an Option and must be capable of being met within ten years after the relevant Grant
                                         Date.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Board may vary or waive any Exercise Condition, provided that any varied Exercise Condition
                                         shall be (in the reasonable opinion of the Board):</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                         fairer measure of performance than the original Exercise Condition, as judged at the
                                         time of the variation, if the original Exercise Condition relates to a measure of performance;
                                         and</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">no
                                         more difficult to satisfy than the original Exercise Condition was at the Grant Date.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Board shall determine whether, and to what extent, Exercise Conditions have been satisfied.
                                         If the Board considers that an Exercise Condition has become incapable of being satisfied,
                                         in whole or in part, that Option, or the appropriate part of it, shall lapse forthwith.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                         an Option is subject to any Exercise Condition, the Board shall notify the Option Holder
                                         within a reasonable time after the Board becomes aware of the relevant information:</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">whether
                                         (and, if relevant, to what extent) the Exercise Condition has been satisfied;</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
                                         any subsequent change in whether, or the extent to which, the Exercise Condition has
                                         been satisfied;</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">when
                                         that Exercise Condition has become incapable of being satisfied, in whole or in part;
                                         and</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
                                         any waiver or variation of that Exercise Condition under rule 3.2.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
                                         the avoidance of doubt, rule 3.2 permits the Board to make a general waiver of Exercise
                                         Conditions:</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">where
                                         the Board exercises its powers under rule 6.2;</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">on
                                         cessation of employment;</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">on
                                         the occurrence of any event permitting the exercise of Options under rule 12; or</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         release of Options in exchange for New Options under rule 13.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>4.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Overall
                                         grant limits</B></FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Company may not grant an Option if that grant would result in the total number of Dilutive
                                         Shares exceeding 10% of the issued share capital of the Company.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>5.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Individual
                                         grant limits</B></FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are no individual grant limits.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>6.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Exercise
                                         of Options</B></FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                         to the other provisions of this rule 6, rule 8 and rule 12, an Option Holder may not
                                         exercise an Option before the earliest date on which it may be exercised as set out in
                                         the Option Agreement.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
                                         Option Holder may not exercise an Option at a time when its exercise is prohibited by,
                                         or would be a breach of, the AIM Rules or any law or regulation with the force of law,
                                         or other rule, code or set of guidelines (such as a personal dealing code adopted by
                                         the Company).</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                         to rule 6.4, an Option Holder may not exercise an Option at any time:</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">while
                                         disciplinary proceedings by any Group Member are underway against him; or</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">while
                                         any Group Member is investigating his conduct and may as a result begin disciplinary
                                         proceedings; or</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">while
                                         there is a breach of his employment contract that is a potentially fair reason for his
                                         dismissal; or</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">while
                                         he is in breach of a fiduciary duty owed to any Group Member; or</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">after
                                         he has ceased to be an Employee, if there was a breach of his employment contract or
                                         fiduciary duties that (in the reasonable opinion of the Board) would have prevented the
                                         exercise of the Option had the Company been aware (or fully aware) of that breach, and
                                         of which the Company was not aware (or not fully aware) until after both:</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">his
                                         ceasing to be an Employee; and</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         time (if any) when the Board decided to permit him to exercise his Option.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.4</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Company shall not unfairly frustrate a valid exercise of the Option by the inappropriate
                                         application of any provision of rule 6.3.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.5</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
                                         Option Holder may not exercise an Option unless he has made any arrangements, or entered
                                         into any agreements, that may be required and are referred to in rule 10.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>7.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Manner
                                         of exercise of Options</B></FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where
                                         an Option is exercised in part, it shall be exercised over at least 100 Shares or, if
                                         less, the number of Shares over which the Option is then exercisable.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
                                         Option shall be exercised by the Option Holder giving a written exercise notice to the
                                         Company, as follows:</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">setting
                                         out the number of Shares over which the Option Holder wishes to exercise the Option.
                                         If that number exceeds the number over which the Option may be validly exercised at the
                                         time, the Company shall:</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">treat
                                         the Option as exercised only in respect of that lesser number; and</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">refund
                                         any excess amount paid to exercise the Option or meet any Tax Liability.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">using
                                         a form that the Board will approve</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                         exercise notice shall be accompanied by all of the following:</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">payment
                                         of an amount equal to the Exercise Price multiplied by the number of Shares specified
                                         in the notice;</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         payment required under rule 10; and</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         documents relating to arrangements or agreements required under rule 10.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Option Holder may enter into arrangements to the satisfaction of the Company for payment of the amounts due under this rule 7.3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.4</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                         exercise notice shall be invalid:</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                         the extent that it is inconsistent with the Option Holder&rsquo;s rights under these rules
                                         and the Option Agreement;</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                         any of the requirements of rule 7.2 or rule 7.3 are not met; or</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                         any payment referred to in rule 7.3 is made by a cheque that is not honoured on first
                                         presentation or that fails in any other manner to transfer the expected value to the
                                         Company.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company may permit the Option Holder to correct any defect referred to in rule 7.4(b) or rule 7.4(c) (but shall not be obliged
to do so). The date of any corrected exercise notice shall be the date of the correction rather than the original notice date
for all other purposes of the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.5</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Company shall allot and issue Shares (or, as appropriate, procure their transfer) within
                                         30 days after a valid Option exercise, subject to the other rules of the Plan.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.6</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
                                         allotted and issued in satisfaction of the exercise of an Option shall rank equally in
                                         all respects with the other shares of the same class in issue at the date of allotment,
                                         except for any Relevant Restriction or any rights determined by reference to a date before
                                         the date of allotment.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.7</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
                                         transferred in satisfaction of the exercise of an Option shall be transferred free of
                                         any lien, charge or other security interest, other than any Relevant Restriction, and
                                         with all rights attaching to them, other than any rights determined by reference to a
                                         date before the date of transfer.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.8</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                         the Shares are listed or traded on any stock exchange, the Company shall apply to the
                                         appropriate body for any newly issued Shares allotted on exercise of an Option to be
                                         listed or admitted to trading on that exchange.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>8.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Termination
                                         of employment</B></FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
                                         Option Holder who gives or receives notice of termination of employment (whether or not
                                         lawful) may not exercise an Option at any time while the notice remains effective.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
                                         Option Holder who ceases to be an Employee (whether or not following notice) may not
                                         exercise an Option at any time after ceasing to be an Employee, except where:</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Board permits the exercise under rule 8.5; or</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         employment terminates for one of the reasons set out in rule 8.4.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                         an Option Holder dies, his personal representatives may exercise such proportion of his
                                         Option as the Board may specify (not being less than the Minimum Proportion measured
                                         at the date of death) during the period ending 12 months after his death.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.4</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                         an Option Holder ceases to be an Employee because of any of the following reasons:</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">injury;</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ill
                                         health; or</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">disability;
                                         or</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redundancy;
                                         or</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Option Holder&rsquo;s employer ceasing to be a Group Member; or</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         transfer of the business that employs the Option Holder to a person that is not a Group
                                         Member,</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">he
may exercise such proportion of his Option as the Board may specify (not being less than the Minimum Proportion measured at the
cessation date) during the period of 90 days after ceasing to be an employee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.5</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Board may permit an Option Holder who ceases to be an Employee for any reason other than
                                         death and the reasons set out in rule 8.4, to exercise such proportion of his Option
                                         as the Board may specify during the period of 90 days after the cessation of employment.
                                         If the Board does not make such a decision within this period, the Option lapses immediately
                                         and in accordance with rule 9.2(g) and rule 9.3.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.6</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Board shall notify the relevant Option Holder of any decision made under rule 8.5, including
                                         any decision not to permit the exercise of an Option, within a reasonable time after
                                         making it.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.7</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
                                         Option Holder shall not be regarded as ceasing to be an Employee until he is no longer
                                         an employee or director of any Group Member.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>9.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Lapse
                                         of Options</B></FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
                                         Option Holder may not transfer or assign, or have any charge or other security interest
                                         created over an Option (or any right arising under it). An Option shall lapse if the
                                         relevant Option Holder attempts to do any of those things. However, this rule does not
                                         prevent the transmission of an Option to an Option Holder&rsquo;s personal representatives
                                         on the death of the Option Holder.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
                                         Option shall lapse on the earliest of the following:</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         attempted action by the Option Holder falling within rule 9.1;</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">when
                                         the Board so decides in accordance with rule 3.3, to the extent that an Exercise Condition
                                         has become wholly or partly incapable of being met.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         date on which the Option shall lapse, as specified in the Option Agreement;</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         first anniversary of the Option Holder&rsquo;s death;</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                         rule 8.2 applies, and the Board decides under rule 8.5 that it will not permit the Option
                                         Holder to exercise the Option, the date the Board decides;</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                         rule 8.2 applies, and the Board makes no decision under rule 8.5, 90 days after the Option
                                         Holder ceases to be an Employee;</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                         rule 8.4 or rule 8.5 applies, the end of the 90 day period;</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                         any part of rule 12 applies, the time specified for the lapse of the Option under that
                                         part of rule 12; or</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">when
                                         the Option Holder becomes bankrupt under Part IX of the Insolvency Act 1986, applies
                                         for an interim order under Part VIII of the Insolvency Act 1986, proposes or makes a
                                         voluntary arrangement under Part VIII of the Insolvency Act 1986, takes similar steps
                                         or is similarly affected, under laws of any jurisdiction that correspond to those provisions
                                         of the Insolvency Act 1986.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Part
                                         of an Option shall lapse where rule 8.5 applies and the Board has determined that the
                                         Option may be exercised, but only in part.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.4</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                         the Option Holder dies, the Option shall lapse on, and not before, the first anniversary
                                         of the Option Holder&rsquo;s death, except where rule 12.11 applies.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>10.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Tax
                                         liabilities</B></FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
                                         Option Agreement shall include the Option Holder&rsquo;s irrevocable agreement to:</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">pay
                                         to the Company, his employer or former employer (as appropriate) the amount of any Tax
                                         Liability; or</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">enter
                                         into arrangements to the satisfaction of the Company, his employer or former employer
                                         (as appropriate) for payment of any Tax Liability.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
                                         the Group Member that employs the relevant Employee directs that it shall not, each Option
                                         Agreement shall include the Option Holder&rsquo;s irrevocable agreement that:</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Company, his employer or former employer (as appropriate) may recover the whole or any
                                         part of any Employer NICs from the Option Holder; and</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
                                         the request of the Company, his employer or former employer, the Option Holder shall
                                         elect (using a form approved by HMRC) that the whole or any part of the liability for
                                         Employer NICs shall be transferred to the Option Holder.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
Option Holder&rsquo;s employer or former employer may decide to release the Option Holder from, or not to enforce, any part of the Option
Holder&rsquo;s obligations in respect of Employer NICs under rule 10.1. and rule 10.2.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                         an Option Holder does not fulfil his obligations under either rule 10.1(a) or rule 10.1(b)
                                         in respect of any Tax Liability arising from the exercise of an Option within seven days
                                         after the date of exercise and Shares are readily saleable at that time, the Company
                                         shall withhold Sufficient Shares from the Shares that would otherwise be delivered to
                                         the Option Holder. The Option Holder&rsquo;s obligations under rule 10.1(a) and rule 10.1(b)
                                         shall not be affected by any failure of the Company to withhold shares under this rule
                                         10.4.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
                                         Option Agreement shall include the Option Holder&rsquo;s irrevocable agreement to enter into
                                         a joint election under section 431(1) or 431(2) of ITEPA 2003 in respect of the Shares
                                         to be acquired on exercise of the relevant Option, if required to do so by the Company,
                                         his employer or former employer, on or before any date of exercise of the Option.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
                                         Option Agreement shall include a power of attorney appointing the Company as the Option
                                         Holder&rsquo;s agent and attorney for the purposes of rule 10.4 and rule 10.5.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>11.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Relationship
                                         with employment contract</B></FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         rights and obligations of any Option Holder under the terms of his office or employment
                                         with any Group Member or former Group Member shall not be affected by being an Option
                                         Holder.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         value of any benefit realised under the Plan by Option Holders shall not be taken into
                                         account in determining any pension or similar entitlements.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Option
                                         Holders and Employees shall have no rights to compensation or damages on account of any
                                         loss in respect of Options or the Plan where this loss arises (or is claimed to arise),
                                         in whole or in part, from:</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">termination
                                         of office or employment with; or</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">notice
                                         to terminate office or employment given by or to,</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
Group Member or any former Group Member. This exclusion of liability shall apply however termination of office or employment,
or the giving of notice, is caused, and however compensation or damages are claimed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.4</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Option
                                         Holders and Employees shall have no rights to compensation or damages from any Group
                                         Member or any former Group Member on account of any loss in respect of Options or the
                                         Plan where this loss arises (or is claimed to arise), in whole or in part, from:</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         company ceasing to be a Group Member; or</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         transfer of any business from a Group Member to any person that is not a Group Member.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
exclusion of liability shall apply however the change of status of the relevant Group Member, or the transfer of the relevant
business, is caused, and however compensation or damages are claimed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.5</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
                                         Employee shall not have any right to receive Options, whether or not he has previously
                                         been granted any.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>12.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Takeovers
                                         and liquidations</B></FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                         the Board considers that a Change of Control is likely to occur, the Board may in its
                                         absolute discretion decide that the Option Holder may exercise all or any part of any
                                         Option within a reasonable period to be specified by the Board for that purpose and ending
                                         immediately before the Offeror obtains Control of the Company. The Board shall have discretion
                                         to determine what proportion (if any) of an Option shall be exercisable taking account
                                         of any matters as they think fit, provided that it shall not be less than the Minimum
                                         Proportion measured at the date of the Board&rsquo;s decision.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                         to rule 8.1 and rule 8.2, if a Change of Control occurs, the Option Holder may exercise
                                         such proportion of an Option as the Board may determine within 90 days after the time
                                         when the Offeror has obtained Control of the Company. The Board shall have discretion
                                         to determine what proportion (if any) of an Option shall be exercisable taking account
                                         of such matters as they think fit, provided that it shall not be less than the Minimum
                                         Proportion measured at the date of the Change of Control. Unless rule 12.3 applies, the
                                         Option shall lapse at the end of the 90 day period.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                         a Change of Control occurs, an Option shall continue to exist if both the following conditions
                                         are met:</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Offeror is a company;</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Offeror declares within ten days following the time when the Offeror has obtained Control
                                         of the Company that it is willing to make an agreement for the exchange of Options under
                                         rule 13.1;</FONT></TD></TR></TABLE>
<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">until
                                         the earlier of the following:</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         time when the Option Holder releases the Option under that exchange of options; and</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         latest date on which the Rollover Period expires,</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">when
it shall lapse.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.4</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                         Option to which rule 12.3 applies shall not be capable of exercise under any rule of
                                         the Plan after it ceases to be capable of exercise under rule 12.2.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.5</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                         to rule 8.1, an Option Holder may exercise the Minimum Proportion of any Option during
                                         any period when any person is bound or entitled to acquire Shares under sections 979
                                         to 982 or 983 to 985 of the Companies Act 2006. Any Option to which this rule 12.5 applies
                                         shall lapse at the later of:</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         end of the period during which that person is bound or entitled; and</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         time specified for the lapse of Options under rule 12.3 or rule 12.5, if either applies.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.6</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                         any Shares, in one or a series of transactions, are sold or a right to acquire or dispose
                                         is granted resulting in the buyer or grantee and persons Acting in Concert with him together
                                         acquiring Control of the Company, but this does not constitute a Change of Control because
                                         the buyer is a company and its shareholders and the proportion of its shares held by
                                         each of them following completion of the sale are substantially the same as the shareholders
                                         and their shareholdings in the Company immediately before the sale, the Board shall use
                                         reasonable endeavours to make arrangements with the buyer as the Board, in its reasonable
                                         opinion, considers to be fair, for suitable replacement options under rule 13.1, or some
                                         other appropriate compensation to be offered to Option Holders.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Board is unable to make these arrangements with the buyer in 30 days after the buyer has acquired Control, then the provisions
of rule 12.2 shall apply to the Options in the same way as if the sale had constituted a Change of Control.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.7</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                         to rule 8.1, unless the relevant compromise or arrangement includes appropriate provisions
                                         that the Board considers to be fair in its reasonable opinion for:</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         replacement of Options; or</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">other
                                         compensation for Option Holders for the loss of Options,</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
Option Holder may exercise a proportion of his Option within six weeks after any person (in this rule 12.7, the <B>Controller</B>)
obtains Control of the Company as a result of the court sanctioning a compromise or arrangement under section 899 of the Companies
Act 2006. The Board shall have discretion to determine what proportion (if any) of an Option shall be exercisable taking account
of these matters as they think fit, provided that the proportion shall not be less than the Minimum Proportion measured at the
date of the court sanction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.8</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                         Option to which rule 12.7 applies shall:</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                         an exchange of options falling within is offered, continue to exist until the earlier
                                         of the following:</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         time when the Option is released under that exchange; and</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         latest date on which the Rollover Period expires,</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">when
it shall lapse.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
Option to which this rule 12.8(a) applies shall not be capable of exercise under any other rule of the Plan after it ceases to
be capable of exercise under rule 12.7.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">lapse
                                         at the end of the exercise period specified in rule 12.7 and rule 12.8(a) if such an
                                         exchange is not offered.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.9</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                         a person, or group of persons Acting in Concert together, acquire Control of the Company
                                         by subscribing for new shares in the Company, the Board may in its absolute discretion
                                         decide to treat this as a Change of Control for all the purposes of the Plan.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.10</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                         rule 12 and rule 13, a person shall be deemed to have obtained Control of a company if
                                         he, and others Acting in Concert with him, have obtained Control of it together.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.11</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                         the shareholders of the Company receive notice of a resolution for the voluntary winding
                                         up of the Company, any Option Holder may exercise the Minimum Proportion of an Option
                                         at any time before that resolution is passed, conditional upon the passing of that resolution,
                                         and if the Option Holder does not exercise the Option, it shall lapse when the winding
                                         up begins.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.12</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Board shall notify Option Holders of any event that is relevant to Options under this
                                         rule 12 within a reasonable period after the Board becomes aware of it.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>13.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Exchange
                                         of Options</B></FONT></TD></TR>                                                                    <TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
</TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                         company that acquires Control of the Company may offer to grant a new option in exchange
                                         for an Option on terms that it considers appropriate. An Option Holder may accept such
                                         an offer within the applicable Rollover Period.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Rollover Period shall be the period starting with the date the company acquires Control
                                         and ends on the earlier of:</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">90
                                         days after that date; and</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">where
                                         rule 12.75 applies, the date on which the person ceases to be bound or entitled to acquire
                                         Shares.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>14.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Variation
                                         of share capital</B></FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
there is any variation of the share capital of the Company (whether that variation is a capitalisation issue (other than a scrip
dividend), rights issue, consolidation, subdivision or reduction of capital or otherwise) that affects (or may affect) the value
of Options to Option Holders, the Board shall adjust the number and description of Shares subject to each Option or the Exercise
Price of each Option in a manner that the Board, in its reasonable opinion, considers to be fair and appropriate. However:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         total amount payable on the exercise of any Option in full shall not be increased; and</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Exercise Price for a Share to be newly issued on the exercise of any Option shall not
                                         be reduced below its nominal value (unless the Board resolves to capitalise, from reserves,
                                         an amount equal to the amount by which the total nominal value of the relevant Shares
                                         exceeds the total adjusted Exercise Price, and to apply this amount to pay for the relevant
                                         Shares in full).</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>15.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Notices</B></FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
                                         as maintained in rule 15.3, any notice or other communication given under or in connection
                                         with the Plan shall be in writing and shall be:</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">delivered
                                         by hand or by pre-paid first-class post or other next working day delivery service at
                                         the <B>Appropriate Address</B>;</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the purposes of this rule 15, the Appropriate Address means:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                         the case of the Company, its registered office provided the notice is marked for the
                                         attention of the CEO;</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                         the case of an Option Holder, his home address; and</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                         the Option Holder has died, and notice of the appointment of personal representatives
                                         is given to the Company, any contact address specified in that notice.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">sent
                                         by fax to the fax number notified in writing by the recipient to the sender; or</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">sent
                                         by email to the <B>Appropriate Email Address</B>.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the purposes of this rule 15, Appropriate Email Address means:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                         the case of the Company, TLazzaretti@LifeSciences.com; and</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                         the case of the Option Holder, his work email address if he is permitted to access personal
                                         emails at work.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                         notice or other communication given under this rule 15 shall be deemed to have been received:</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                         delivered by hand, on signature of a delivery receipt, or at the time the notice is left
                                         at the appropriate address;</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                         sent by prepaid first-class post or other next working day delivery service, at 9.00
                                         am on the second Business Day after posting, or at the time recorded by the delivery
                                         service;</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                         sent by fax, at 9.00 am on the next Business Day after transmission; and</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                         sent by email, at 9.00 am on the next Business Day after sending.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                         rule does not apply to:</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         service of any notice of exercise under rule 7.2; and</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         service of any proceedings or other documents in any legal action or, where applicable,
                                         any arbitration or other method of dispute resolution.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>16.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Administration
                                         and amendment</B></FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Plan shall be administered by the Board.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Board may amend the Plan from time to time, but:</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Board may not amend the Plan if the amendment:</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">applies
                                         to Options granted before the amendment was made; and</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">materially
                                         adversely affects the interests of Option Holders</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">except
that each Option Holder may consent to the application to his Option(s) of such an amendment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">while
                                         Shares are traded on AIM, the Board may not make any amendment to the advantage of Option
                                         Holders if that amendment relates to:</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         definition of Employee;</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         limits specified in rule 4 or rule 5;</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rule
                                         14.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">without
the prior approval of the Company in general meeting (except for minor amendments to benefit the administration of the Plan, to
take account of a change in legislation, or to obtain or maintain favourable tax, exchange control or regulatory treatment for
Option Holders or for the Company or any Group Member).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         cost of establishing and operating the Plan shall be borne by the Group Members in proportions
                                         determined by the Board.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.4</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
                                         satisfy the exercise of all the Options, the Company shall ensure that at all times:</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">it
                                         has sufficient unissued or treasury Shares available, taking into account any other obligations
                                         of the Company to issue Shares and to transfer Shares from treasury, if the Company has
                                         restricted the number of Shares it can issue in its articles of association; and</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">arrangements
                                         are in place for any third party to transfer issued Shares.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.5</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                         decision under rule 8.3 or rule 8.5, and whether to consider making such a decision,
                                         shall be entirely at the discretion of the Board.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.6</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Board shall determine any question of interpretation and settle any dispute arising under
                                         the Plan. In these matters, the Board&rsquo;s decision shall be final.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.7</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Company shall not be obliged to notify any Option Holder if an Option is due to lapse.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.8</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Company shall not be obliged to provide Option Holders with copies of any materials sent
                                         to the holders of Shares.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>17.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Third
                                         party rights</B></FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                         person who is not a party to an Option shall not have any rights under or in connection
                                         with it as a result of the Contracts (Rights of Third Parties) Act 1999 except where
                                         these rights arise under any rule of the Plan for any employer or former employer of
                                         the Option Holder that is not a party to an Option.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
does not affect any right or remedy of a third party that exists, or is available, apart from the Contracts (Rights of Third Parties)
Act 1999.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         rights of the parties to an Option to surrender, terminate or rescind it, or agree any
                                         variation, waiver or settlement of it, are not subject to the consent of any person that
                                         is not a party to the Option as a result of the Contracts (Rights of Third Parties) Act
                                         1999.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>18.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Data
                                         protection</B></FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                         accepting the grant of an Option each Option Holder consents to the collection, holding,
                                         processing and transfer of his Personal Data by the Company or any Group Member for all
                                         purposes connected with the operation of the Plan.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         purposes of the Plan referred to in rule 18.1 include, but are not limited to:</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">holding
                                         and maintaining details of the Option Holder&rsquo;s Options;</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">transferring
                                         the Option Holder&rsquo;s Personal Data to the trustee of an employee benefit trust, the Company&rsquo;s
                                         registrars or brokers or any administrators of the Plan; and</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">transferring
                                         the Option Holder&rsquo;s Personal Data to a bona fide prospective buyer of the Company or
                                         the Option Holder&rsquo;s employer company or business unit (or the prospective buyer&rsquo;s advisers),
                                         provided that the prospective buyer, and its advisers, irrevocably agree to use the Option
                                         Holder&rsquo;s Personal Data only in connection with the proposed transaction and in accordance
                                         with the data protection principles set out in the Data Protection Act 1998; and</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">transferring
                                         the Option Holder&rsquo;s Personal Data under rule 18.2(b) or rule 18.2(c) to a person who
                                         is resident in a country or territory outside the European Economic Area that may not
                                         provide the same statutory protection for the information as countries within the European
                                         Economic Area.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>19.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Governing
                                         law</B></FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Plan and any dispute or claim arising out of or in connection with it or its subject matter or formation (including non-contractual
disputes or claims) shall be governed by and construed in accordance with the law of England and Wales.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>20.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Jurisdiction</B></FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
                                         party irrevocably agrees that the courts of England and Wales shall have exclusive jurisdiction
                                         to settle any dispute or claim arising out of or in connection with, the Plan or its
                                         subject matter or formation (including non-contractual disputes or claims).</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
                                         party irrevocably consents to any process in any legal action or proceedings under rule
                                         20.1 being served on it in accordance with the provisions of the Plan relating to service
                                         of notices. Nothing contained in the Plan shall affect the right to serve process in
                                         any other manner permitted by law.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Tiziana
Life Sciences plc </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Tiziana
Life Sciences plc Employee Share Option Plan (the Plan)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Non-Employee
Sub-Plan to the Tiziana Life Sciences plc Employee Share Option Plan</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;(the
Non-Employee Sub-Plan)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Non-Employee Sub-Plan is adopted to permit the grant of options to individuals who are not employees or executive directors of
the Company or any other Group Member.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event of any inconsistency between the rules of the Plan and the rules of the Non-Employee Sub-Plan, the rules of the Non-Employee
Sub-Plan shall take precedence.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>1.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Definitions</B></FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                         this Non-Employee Sub-Plan, the words and expressions used in the Plan shall bear unless
                                         the context otherwise requires, the same meaning herein save to the extent the Rules
                                         in this Non-Employee Sub-Plan shall provide to the contrary.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                         this Non-Employee Sub-Plan, the following words and expressions shall have the following
                                         meanings:</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Eligible
Person</B>: means an individual who provides advisory or consultancy services to the Company or any Group Member either directly
or through a company or other trading arrangement under a contract for the provision of services or otherwise and whether with
the individual himself or with a company or other trading arrangement, or is a non-executive director of the Company or any Group
Member; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Relevant
Company</B>: the Group Member which is in relation to an Option Holder the company by which he holds office or to which he provides
advisory or consultancy services.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                         Non-Employee Sub-Plan is not an employees&rsquo; share plan within the meaning of section
                                         1166 of the Companies Act 2006.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>2.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Application
                                         of plan</B></FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Save
as modified in this Non-Employee Sub-Plan, all the provisions of the Plan shall be incorporated into this Non-Employee Sub-Plan
as if fully set out herein so as to be part of this Non-Employee Sub-Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>3.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Eligible
                                         person etc</B></FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                         references in the Plan to &ldquo;<B>Employee</B>&rdquo; shall be taken for the purposes
                                         of this Non-Employee Sub-Plan to be references to &ldquo;<B>Eligible Person</B>&rdquo;
                                         as defined in paragraph 1.2 of this Non-Employee Sub-Plan.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                         reference in the Plan to &ldquo;Employer&rdquo; shall be taken for the purposes of this
                                         Non-Employee Sub-Plan to be references to &ldquo;<B>Relevant Company</B>&rdquo; as defined
                                         in paragraph 1.2 of this Non-Employee Sub-Plan.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rule
                                         2.3(h) of the Plan shall be removed and replaced for the purposes of this Non- Employee
                                         Sub-Plan by the following:</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>2.3(h)
include the terms required by rule 10.1, rule 10.2 and rule 10.6 or alternative appropriate language to cover payment of the Tax
Liability;</I>&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rule
                                         6.3 of the Plan shall be removed and replaced for the purposes of this Non- Employee
                                         Sub-Plan by the following:</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>Subject
to rule 6.4, an Option Holder may not exercise an Option at any time:</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>while
                                         disciplinary proceedings by any Group Member are underway against him; or</I></FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>while
                                         any Group Member is investigating his conduct and may as a result begin disciplinary
                                         proceedings; or</I></FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>while
                                         there is a breach of his contract for the provision of services or letter of appointment
                                         that is a potentially reason for the termination of his services or appointment; or</I></FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>while
                                         he is in breach of a fiduciary duty owed to any Group Member; or</I></FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>after
                                         he has ceased to be an Eligible Person, if there was a breach of his contract for the
                                         provision of services or letter of appointment that (in the reasonable opinion of the
                                         Board) would have prevented the exercise of the Option had the Company been aware (or
                                         fully aware) of that breach, and of which the Company was not aware (or not fully aware)
                                         until after both:</I></FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>his
                                         ceasing to be an Eligible Person; and</I></FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>the
                                         time (if any) when the Board decided to permit him to exercise his Option.</I>&rdquo;</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rule
                                         6.5 of the Plan shall be removed and replaced for the purposes of this Non- Employee
                                         Sub-Plan by the following:</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>6.5
An Option Holder may not exercise an Option unless he has made arrangements, or entered into agreements, that may be required
and are referred to in either rule 10 or the language in the Option Agreement dealing with Tax Liability</I>&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rule
                                         8 of the Plan shall be removed and replaced for the purposes of this Non- Employee Sub-Plan
                                         by the following.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9;&ldquo;<I>8.&#9;<FONT STYLE="font-variant: small-caps"><B>Termination
of Contract for Services</B></FONT></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>8.1</I></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>An
                                         Option Holder who gives or receives notice of termination of his contract for services
                                         or his appointment (whether or not lawful) may not exercise an Option at any time while
                                         the notice remains effective.</I></FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>8.2</I></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>An
                                         Option Holder who ceases to be an Eligible Person (whether or not following notice) may
                                         not exercise an Option at any time after ceasing to be an Eligible Person, except where:</I></FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.9pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>the
                                         Board permits the exercise under rule 8.5; or</I></FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.9pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>the
                                         provision of services or appointment terminates for one of the reasons set out in rule
                                         8.4; </I></FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>8.3</I></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>If
                                         an Option Holder dies, his personal representatives may exercise such proportion of his
                                         Option as the Board may specify (not being less than the Minimum Proportion measured
                                         at the date of death) during the period ending 12 months after his death.</I></FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>8.4</I></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>If
                                         an Option Holder ceases to be an Eligible Person because of any of the following reasons:</I></FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.9pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>injury;</I></FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.9pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>ill
                                         health; or</I></FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.9pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>disability;
                                         or</I></FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.9pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>the
                                         Option Holder&rsquo;s Relevant Company ceasing to be a Group Member; or</I></FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.9pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: .5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>the
                                         transfer of the business of the Option Holder&rsquo;s Relevant Company to a person that
                                         is not a Group Member,</I></FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>he
may exercise such proportion of his Option as the Board may specify (not being less than the Minimum Proportion measured at the
cessation date) during the period of 90 days after ceasing to be an Eligible Person.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>8.5</I></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>The
                                         Board may permit an Option Holder who ceases to be an Eligible Person for any reason
                                         other than death, to exercise such proportion of his Option as the Board may specify
                                         during the period of 90 days after he ceases to be a director or to provide services.
                                         If the Board does not make such a decision within this period, the Option lapses immediately
                                         and in accordance with rule 9.2(g) and rule 9.3.</I></FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>8.6</I></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>The
                                         Board shall notify the relevant Option Holder of any decision made under rule 8.5, including
                                         any decision not to permit the exercise of an Option, within a reasonable time after
                                         making it.</I></FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>8.7</I></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>An
                                         Option Holder shall not be regarded as ceasing to be an Eligible Person until he is no
                                         longer a director of or providing services to any Group Member.</I>&rdquo;</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.7</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rule
                                         9.2(f) of the Plan shall be removed and replaced for the purposes of this Non- Employee
                                         Sub-Plan by the following:</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>9.2(f)
if rule 8.2 applies, and the Board makes no decision under rule 8.5, 90 days after the Option Holder ceases to be an Eligible
Person;</I>&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.8</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rule
                                         11 of the Plan shall be removed and replaced for the purposes of this Non- Employee Sub-Plan
                                         by the following:</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>11.&#9;RELATIONSHIP
WITH CONTRACT FOR SERVICES</I></FONT></P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>11.1</I></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>The
                                         rights and obligations of any Option Holder under the terms of his contract for the provision
                                         of services or letter of appointment with any Group Member or former Group Member shall
                                         not be affected by being an Option Holder. </I></FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>11.2</I></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>The
                                         value of any benefit realised under the Plan by Option Holders shall not be taken into
                                         account in determining any pension or similar entitlements. </I></FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>11.3</I></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Option
                                         Holders and Eligible Persons shall have no rights to compensation or damages on account
                                         of any loss in respect of Options or the Plan where such loss arises (or is claimed to
                                         arise), in whole or in part, from: </I></FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(a)</I></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>termination
                                         of contract for the provisions of services or appointment; or </I></FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(b)</I></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>notice
                                         to terminate contract for the provisions of services or appointment by or to, </I></FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>any
Group Member or former Group Member. This exclusion of liability shall apply however termination of the contract for the provision
of services or appointment, or the giving of notice, is caused, and however compensation or damages may be claimed. </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>11.4.</I></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Option
                                         Holders and Eligible Persons shall have no rights to compensation or damages from any
                                         Group Member or former Group Member on account of any loss in respect of Options or the
                                         Plan where such loss arises (or is claimed to arise), in whole or in part, from: </I></FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(a)</I></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>any
company ceasing to be a Group Member; or</I></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(b)</I></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>the
                                         transfer of any business from a Group Member to any person which is not a Group Member.
                                         </I></FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>This
exclusion of liability shall apply however the change of status of the relevant Group Member, or the transfer of the relevant
business, is caused, and however compensation or damages may be claimed. </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>11.5.</I></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>An
                                         Eligible Person shall not have any right to receive Options, whether or not he has previously
                                         been granted any.</I>&rdquo;</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>4.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Governing
                                         law</B></FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Non-Employee Sub-Plan and any dispute or claim arising out of or in connection with it or its subject matter or formation (including
non-contractual disputes or claims) shall be governed by and construed in accordance with the law of England and Wales.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: small-caps bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>5.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Jurisdiction</B></FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
party irrevocably agrees that the courts of England and Wales shall have exclusive jurisdiction to settle any dispute or claim
arising out of or in connection with, the Non-Employee Sub-Plan or its subject matter or formation (including non-contractual
disputes or claims).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Tiziana
Life Sciences plc</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Tiziana
Life Sciences plc Employee Share Option Plan (the Plan)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>US
Sub-Plan to the Tiziana Life Sciences Employee Share Option Plan (the US Sub-Plan)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
US Sub-Plan together with the California supplement is adopted to permit the grant of options to an employee, director or consultants
who are US residents or US taxpayers (each, a &ldquo;<B>US Participant</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event of any inconsistency between the rules of the Plan (and the Non-Employee Sub-Plan) and the rules of the US Sub-Plan,
the rules of the US Sub-Plan shall take precedence</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">1.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Definitions</B></FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
this US Sub-Plan, the words and expressions used in the Plan (and the Non-Employee Sub-Plan) shall bear, unless the context otherwise
requires, the same meaning herein save to the extent the Rules in this US Sub-Plan shall provide to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">2.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Application
                                         of Plan </B></FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Save
as modified in this US Sub-Plan, all the provisions of the Plan shall be incorporated into this US Sub-Plan as if fully set out
herein so as to be part of this US Sub-Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">3.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Limit</B></FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
number of Shares which may be subject to Options under this US Sub-Plan is 9,233,392 Shares (which number shall be the maximum
number of Shares that may be granted as Options designated as Incentive Stock Options (as hereinafter defined)). No Option shall
be granted under the US Sub-Plan unless there shall be sufficient Shares remaining available for issuance under the US Sub-Plan
pursuant to this Section 3 or the Board shall have approved such an increase in the Shares available for issuance under the US
Sub-Plan subject to Shareholder approval.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">4.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Effective
                                         Date and Term of US Sub-Plan</B></FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
US Sub-Plan shall become effective on the date on which it is adopted by the Board. No Option shall be granted under this US Sub-Plan
after the completion of 10&nbsp;years from the earlier of (i) the date on which this US Sub-Plan was adopted by the Board, or
(ii) the date this US Sub-Plan was approved by the Company&rsquo;s Shareholders, but Options previously granted under this US
Sub-Plan may extend beyond that date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">5.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Amendments</B></FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board may amend, suspend or terminate this US Sub-Plan or any portion thereof at any time. No amendment, suspension or termination
of the US Sub-Plan may materially adversely affect any Options granted previously to any US Participant without the consent of
the US Participant. Continuance of this US Sub-Plan shall be subject to approval by the shareholders of the Company within twelve
(12) months before or after the date the US Sub-Plan is adopted. Any Shares purchased under this US Sub-Plan before shareholder
approval is obtained must be rescinded if shareholder approval is not obtained within twelve (12) months before or after the US
Sub-Plan is adopted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">6.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Compliance
                                         with Code Section 409A</B></FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise set forth in an applicable Option Certificate, the terms applicable to Options granted under the Plan subject to this
US Sub-Plan will be interpreted to the greatest extent possible in a manner that makes the Options exempt from Section 409A of
the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the &ldquo;<B>Code</B>&rdquo;), and,
to the extent not so exempt, that brings the Options into compliance with Section 409A of the Code. Notwithstanding anything to
the contrary in the Plan (and unless any Option agreement governing the Option specifically provides otherwise), if the Shares
are publicly traded, and if an Option Holder of an Option that constitutes &ldquo;deferred compensation&rdquo; under Section 409A
of the Code is a &ldquo;specified employee&rdquo; under Section 409A of the Code, no distribution or payment of any amount that
is due because of a &ldquo;separation from service&rdquo; (as defined in Section 409A of the Code without regard to alternative
definitions thereunder) will be issued or paid before the date that is six (6) months following the date of such Option Holder&rsquo;s
&ldquo;separation from service&rdquo; or, if earlier, the date of the Option Holder&rsquo;s death, unless such distribution or
payment can be made in a manner that complies with Section 409A of the Code, and any amounts so deferred will be paid in a lump
sum on the day after such six (6) month period elapses, with the balance paid thereafter on the original schedule. The Company
shall have no liability to an Option Holder, or any other party, if an Option that is intended to be exempt from, or compliant
with, Section 409A of the Code is not so exempt or compliant or for any action taken by the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">7.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>No
                                         right to Employment or other Status</B></FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
person shall have any claim or right to be granted an Option under this US Sub-Plan, and the grant of an Option shall not be construed
as giving an Option Holder the right to continued employment or any other relationship with any Group Member.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">8.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Amendment
                                         of Options</B></FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board may amend, modify or terminate any outstanding Option, including but not limited to, substituting therefor another Option
of the same or different type, changing the date of exercise or realization, and converting an Incentive Stock Option to a Nonstatutory
Stock Option, provided that the Option Holder&rsquo;s consent to such action shall be required unless the Board determine that
the action, taking into account any related action, would not materially and adversely affect the Option Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">9.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Eligibility
                                         Limitations for Grants to Eligible Persons</B></FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
Eligible Person (as defined in the Non-Employee Sub-Plan) that is a US Participant is not eligible for the grant of an Option
if, at the time of grant, either the offer or sale of the Company&rsquo;s securities to such Eligible Person is not exempt under
Rule 701 of the Securities Act of 1933, as amended (the &ldquo;<B>Securities Act</B>&rdquo;) because the Eligible Person is not
a natural person, the services that the Eligible Person is providing to the Company or any Group Member are in connection with
a capital raising transaction or directly or indirectly serve to promote or maintain a market for the Company&rsquo;s securities,
or because of any other provision of Rule 701 of the Securities Act, unless the Company determines that such grant need not comply
with the requirements of Rule 701 of the Securities Act and will satisfy another exemption under the Securities Act as well as
comply with the securities laws of the US state of residence of the Eligible Person and all other applicable jurisdictions. Any
Option granted to an Eligible Person that is a US Participant will be a Nonstatutory Stock Option (as hereinafter defined).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">10.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Conditions
                                         on Delivery of Shares</B></FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will not be obligated to deliver any Shares pursuant to this US Sub-Plan or to remove restrictions from Shares previously
delivered under this US Sub-Plan until:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
                                         conditions of the Option have been met or removed to the satisfaction of the Company,</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                         the opinion of the Company&rsquo;s counsel, all other legal matters in connection with
                                         the issue, allotment and delivery of such shares have been satisfied, including any applicable
                                         securities laws and any applicable stock exchange or stock market rules and regulations,
                                         and</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Option Holder has executed and delivered to the Company such representations or agreements
                                         as the Company may consider appropriate to satisfy the requirements of any applicable
                                         laws, rules or regulations.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">11.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Grant
                                         of Options</B></FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.1.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
                                         Rule 2.3 of the Plan the Grant Date for the purpose of the US Sub-Plan shall be the date
                                         on which the Board resolves to grant an Option.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.2.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
                                         Option which is not intended to be an Incentive Stock Option (as hereinafter defined)
                                         shall be designated a &ldquo;Nonstatutory Stock Option&rdquo;.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.3.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
                                         Option shall have a term no longer than ten (10) years from the date it was granted or
                                         such shorter period as determined by the Board. If an Incentive Stock Option is granted
                                         to a person who owns more than 10% of the total combined voting power of all classes
                                         of outstanding stock of the Company or any of its affiliates, the Option shall have a
                                         term no longer than five (5) years from the date it was granted.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.4.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Exercise Price of (a) an Option intended to be an Incentive Stock Option and (b) any
                                         Non-statutory Stock Option granted to a US Participant shall be not less than 100% of
                                         the fair market value of a Share on the date on which the Option is granted (which shall
                                         be determined by the Board in compliance with Section 409A of the Code and shall not
                                         be less than the nominal value of a Share) (&ldquo;<B>Fair Market Value</B>&rdquo;) unless,
                                         in the case of (b) such Option is structured to comply with Section 409A of the Code.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.5.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
                                         Option that the Board intends to be an &ldquo;incentive stock option&rdquo; as defined
                                         in Section 422 of the Code (an &ldquo;<B>Incentive Stock Option</B>&rdquo;) shall only
                                         be granted to Employees who are also employees of the Company, any of the Company&rsquo;s
                                         present or future parent or subsidiary corporations as defined in Regulation Section
                                         1.424-1(f), and any other entities the employees of which are eligible to receive Incentive
                                         Stock Options under the Code, and shall be subject to and shall be construed consistently
                                         with the requirements of Section 422 of the Code. The Board or corporate action approving
                                         the grant of an Option intended to be an Incentive Stock Option must specify that the
                                         Option is intended to be an Incentive Stock Option. If an Option is not specifically
                                         designated as an Incentive Stock Option, or if an Option is designated as an Incentive
                                         Stock Option but some portion or all of the Option fails to qualify as an Incentive Stock
                                         Option under the applicable rules, then the Option (or portion thereof) will be a Nonstatutory
                                         Stock Option. The Company shall have no liability to an Option Holder, or any other party,
                                         if an Option (or any part thereof) that is intended to be an Incentive Stock Option is
                                         not an Incentive Stock Option or for any action taken by the Board to amend, modify or
                                         terminate the rules of the Plan, this US Sub-Plan or any Option, including without limitation
                                         the conversion of an Incentive Stock Option to a Nonstatutory Stock Option.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.6.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                                         provided by Section 422(b)(5) of the Code, an Incentive Stock Option will not be transferable
                                         except by will or by the laws of descent and distribution, and will be exercisable during
                                         the lifetime of the US Participant only by the US Participant. If the Board elects to
                                         allow the transfer of an Option by a US Participant that is designated as an Incentive
                                         Stock Option, such transferred Option will automatically become a Nonstatutory Stock
                                         Option. As provided by Section 422(c)(5) of the Code, a person who owns more than 10%
                                         of the total combined voting power of all classes of outstanding stock of the Company
                                         or any Group Member will not be eligible for the grant of an Incentive Stock Option <I>unless
                                         </I>(i) the exercise price is at least 110% of the Fair Market Value of a Share on the
                                         date of grant and (ii) such Incentive Stock Option by its terms is not exercisable after
                                         the expiration of five (5) years from the date of grant. The attribution rules of Section
                                         424(d) of the Code will be applied in determining stock ownership. As provided by Section
                                         422(d) of the Code and applicable regulations thereunder, to the extent that the aggregate
                                         Fair Market Value (determined at the time of grant) of Shares with respect to which Incentive
                                         Stock Options are exercisable for the first time by any US Participant during any calendar
                                         year (under all plans of the Company and any Group Member) exceeds US$100,000 (or such
                                         other limit established in the Code) or otherwise does not comply with the rules governing
                                         Incentive Stock Options, the Options or portions thereof that exceed such limit (according
                                         to the order in which they were granted) or otherwise do not comply with such rules will
                                         be treated as Nonstatutory Stock Options. To obtain the US federal income tax advantages
                                         associated with an Incentive Stock Option, the US Internal Revenue Code requires that
                                         at all times beginning on the date of grant and ending on the day three (3) months before
                                         the date of exercise of the Option, the Option Holder must be an Employee of the Company
                                         or a Group Member (except in the event of the Option Holder&rsquo;s death or disability,
                                         in which case longer periods may apply).</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.7.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
                                         Rules 9.1 and 9.2(a) of the Plan, where an Option Holder ceases to be an Employee, director
                                         or Eligible Person by reason of his death his Option will be capable of transfer in accordance
                                         with the Option Holder&rsquo;s will, or the laws of decent and distribution. Subject
                                         to the approval of the Board or a duly authorized officer of the Company, an Option Holder
                                         may, by delivering written notice to the Company, in a form approved by the Company,
                                         designate a third party who, on the death of the Option Holder, will thereafter be entitled
                                         to exercise the Option and receive the Shares or other consideration resulting from such
                                         exercise. In the absence of such a designation, upon the death of the Option Holder,
                                         the executor or administrator of the Option Holder&rsquo;s estate will be entitled to
                                         exercise the Option and receive the Shares or other consideration resulting from such
                                         exercise. However, the Company may prohibit designation of a beneficiary at any time,
                                         including due to any conclusion by the Company that such designation would be inconsistent
                                         with the provisions of applicable laws. In addition, notwithstanding Rules 9.1 and 9.2(a)
                                         of the Plan, subject to approval of the Board or a duly authorized officer of the Company,
                                         an Option may be transferred by an Option Holder pursuant to the terms of a domestic
                                         relations order, official marital settlement agreement or other divorce or separation
                                         instrument as permitted by Treasury Regulations Section 1.421-1(b)(2); provided that
                                         if an Option is an Incentive Stock Option, such Option will be deemed to be a Nonstatutory
                                         Stock Option as a result of such transfer.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.8.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
                                         purchased upon the exercise of an Option granted under this US Sub-Plan shall be paid
                                         for as follows:</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                         cash or by check, payable to the order of the Company;</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">except
                                         as may otherwise be provided in the applicable Option Certficate and to the extent the
                                         Shares are publicly traded, by:</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">delivery
                                         of an irrevocable and unconditional undertaking by a creditworthy broker to deliver promptly
                                         to the Company sufficient funds to pay the exercise price and any required tax withholding;
                                         or</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">delivery
                                         by the Option Holder to the Company of a copy of irrevocable and unconditional instructions
                                         to a creditworthy broker to deliver promptly to the Company cash or a check sufficient
                                         to pay the exercise price and any required tax withholding.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                                         a condition to the exercise of an Option, the Option Holder shall make such arrangements
                                         as the Company may require for the satisfaction of any U.S. federal, state, local or
                                         foreign withholding tax obligations that may arise in connection with such exercise.
                                         The Option Holder shall also make such arrangements as the Company may require for the
                                         satisfaction of any federal, state, local or foreign withholding tax obligations that
                                         may arise in connection with the disposition of Shares acquired by exercising an Option.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">12.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Exercise
                                         Restriction for Non-Exempt Employees</B></FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an Option Holder is an Employee who is eligible for overtime compensation under the US Fair Labor Standards Act of 1938, as amended
(that is, the Option Holder is designated as a &ldquo;non-exempt employee&rdquo;), then notwithstanding the vesting schedule contained
in the Option Certificate, the Option Holder may not exercise his or her Option until the Option Holder has completed at least
six (6) months of Continuous Service measured from the Grant Date, even if the Option Holder has already been an Employee for
more than six (6) months. Consistent with the provisions of the U.S. Worker Economic Opportunity Act, the Option Holder may exercise
his or her Option as to any vested portion prior to such six (6) month anniversary in the case of (i) the Option Holder&rsquo;s
death or the Option Holder becoming disabled (within the meaning of Section 22(e)(3) of the Code), (ii) a Change of Control occurs
pursuant to Rule 12 of the Plan in connection with which the Option is not assumed or continued, or (iii) the termination of the
Option Holder&rsquo;s Continuous Service on his or her retirement. For purposes of this Rule 12, &ldquo;Continuous Service&rdquo;
means that the Option Holder&rsquo;s service with the Company or any Group Member, whether as an Employee, director or Eligible
Person, is not interrupted or terminated and the Option Holder remains an Employee, director or Eligible Person. A change in the
capacity in which the Option Holder renders service to the Company or a Group Member as an Employee, director or Eligible Person
or a change in the entity for which the Option Holder renders such service, will not cause the Option Holder to cease to be an
Employee, director or Eligible Person provided that there is no interruption or termination of the Option Holder&rsquo;s service
with the Company or Group Member. To the extent permitted by law, the Board or the chief executive officer of the Company, in
that party&rsquo;s sole discretion, may determine whether Continuous Service will be considered interrupted in the case of (i)
any leave of absence approved by the Board or chief executive officer, including sick leave, military leave or any other personal
leave, or (ii) transfers between the Company, a Group Member or their successors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">13.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Exercise
                                         of Options in Special Circumstances </B></FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an Option Holder dies or becomes disabled (within the meaning of Section 22(e)(3) of the Code) before the tenth anniversary of
the Grant Date, the provisions of Rules 8.2 to 8.6 and Rules 9.2(d)-(g) of the Plan shall not apply for the purposes of this US
Sub-Plan. Instead, in such circumstances, Options may be exercised for a period of 18 months following the date of death or 12
months following the date of disability, but in no event later than the tenth anniversary of the relevant Grant Date, at the end
of which period the Options will lapse.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">14.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Disqualifying
                                         disposition</B></FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Option Holder disposes of Shares acquired upon exercise of an Incentive Stock Option within two years from the Grant Date
or one year after such Shares were acquired pursuant to exercise of such Option, the Option Holder shall notify the Company in
writing of such disposition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">15.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Variation
                                         of Share Capital</B></FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
Rule 14 of the Plan in the event of any variation of the share capital of the Company: (i) the number of Shares subject to an
Option; (ii) the Exercise Price; and (iii) the limit on Options set forth in Section 3 hereof must be adjusted proportionately
in a manner that complies with Sections 409A and 424 of the Code; PROVIDED THAT the Exercise Price is not reduced below the nominal
value of a Plan Share except where the Board puts in place arrangements to pay up the nominal value at the date of issue of the
Shares (or the difference between the adjusted Exercise Price and the nominal value as the case may be).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">16.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>No
                                         Obligation to Notify or Minimize Taxes</B></FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will have no duty or obligation to an Option Holder to advise such holder as to the time or manner of exercising the Option.
Furthermore, the Company will have no duty or obligation to warn or otherwise advise such holder of a pending termination or expiration
of an Option or a possible period in which the Option may not be exercised. The Company has no duty or obligation to minimize
the tax consequences of an Option to the Option Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">17.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Governing
                                         law</B></FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Non-Employee Sub-Plan and any dispute or claim arising out of or in connection with it or its subject matter or formation (including
non-contractual disputes or claims) shall be governed by and construed in accordance with the law of England and Wales.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">18.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Jurisdiction</B></FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
party irrevocably agrees that the courts of England and Wales shall have exclusive jurisdiction to settle any dispute or claim
arising out of or in connection with, the Non-Employee Sub-Plan or its subject matter or formation (including non-contractual
disputes or claims).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CALIFORNIA
SUPPLEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board has adopted this supplement for purposes of satisfying the requirements of Section 25102(o) of the California Law:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
Options granted under the US Sub-Plan to the Plan to an Option Holder who is a resident of the State of California on the date
of grant (a &ldquo;California Option Holder&rdquo;) shall be subject to the following additional limitations, terms and conditions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">1.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Additional
                                         Limitations on Options.</B></FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Minimum
                                         Exercise Period Following Termination</B>. Unless a California Option Holder&rsquo;s
                                         employment is terminated for cause (as defined by applicable law, the terms of any contract
                                         of employment between the Company and such Option Holder, or in the instrument evidencing
                                         the grant of such Option Holder&rsquo;s Option), in the event of termination of employment
                                         of such Option Holder, such Option Holder shall have the right to exercise an Option,
                                         to the extent that he or she was otherwise entitled to exercise such Option on the date
                                         employment terminated, until the earlier of: (i) at least six months from the date of
                                         termination, if termination was caused by such Option Holder&rsquo;s death or &ldquo;permanent
                                         and total disability&rdquo; (within the meaning of Section 22(e)(3) of the Code), (ii)
                                         at least 30 days from the date of termination, if termination was caused other than by
                                         such Option Holder&rsquo;s death or &ldquo;permanent and total disability&rdquo; (within
                                         the meaning of Section 22(e)(3) of the Code) and (iii) the Option expiration date.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">2.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Additional
                                         Limitations on Timing of Awards. </B></FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
Option granted to a California Option Holder shall become exercisable, vested or realizable, as applicable to such Option, unless
the US Sub-Plan has been approved by the holders of a majority of the Company&rsquo;s outstanding voting securities by the later
of (i) within 12&nbsp;months before or after the date the US Sub-Plan was adopted by the Board or (ii) prior to or within 12 months
of the granting of any Option to a California Option Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 30; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.9
<SEQUENCE>15
<FILENAME>ff12018a1ex10-9_tiziana.htm
<DESCRIPTION>CONTRACT OF EMPLOYMENT, DATED MAY 2017, BETWEEN THE REGISTRANT AND DR. KUNWAR SHAILUBHAI
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><B>Exhibit
10.9</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex10-9_001.jpg" ALT="">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none">SERVICE
AGREEMENT</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 5%; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="width: 95%; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tiziana
    LIFE SCIENCES PLC</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shailubhai
    Kunwar</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated
23 May 2017</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex10-9_001.jpg" ALT=""><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Contents</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">SERVICE AGREEMENT</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom">1</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 9%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 82%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitions
    and interpretation</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; width: 9%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Appointment</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Term</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Duties</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director
    Indemnity and Insurance</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hours
    of work</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Place
    of Work</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expenses</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Salary</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bonus</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pension</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share
    Option and Long Term Incentive Plan</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    Benefits</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holidays</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sickness
    Absence</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sick
    Pay</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Obligations
    during Employment</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Confidential
    Information</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intellectual
    Property</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Garden
    Leave</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment
    in lieu of notice</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Summary
    Termination</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reconstruction
    and Amalgamation</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Obligations
    after Employment</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Resignation
    from Appointments</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">27.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Suspension</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disciplinary
    and Dismissal Rules</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Grievance</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Data
    Protection</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warranty</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deductions</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">33.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power
    of Attorney</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">34.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Collective
    Agreements</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">35.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Entire
    Agreement</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">36.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Third
    Parties</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">37.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Releases
    and waivers</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">38.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notices</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">39.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Variation</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">40.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Counterparts</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">41.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Governing
    law and jurisdiction</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Schedule 1</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(Post termination restrictions)</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><IMG SRC="ex10-9_001.jpg" ALT="">&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>This
Agreement</B> is made on &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
2017</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Between:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TIZIANA
                                         LIFE SCIENCES PLC</B> (company number: 03508592) whose registered office is at 3rd Floor
                                         11-12 St. James&rsquo;s Square, London, United Kingdom, SW1Y 4LB (the <B>&ldquo;Company&rdquo;</B>);
                                         and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Shailubhai
                                         Kunwar</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
                                         2707 Bald Eagle Circle, Norristown, PA 19403, USA (<B>&ldquo;You&rdquo;</B>).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>It
is agreed</B> as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">1.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Definitions
                                         and interpretation</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                         this Agreement, unless the context otherwise requires:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Agreement&rdquo;
</B>means this Agreement (including any schedule or annexure to it).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Board&rdquo;
</B>means the board of directors of the Company from time to time and includes any committee of the Board duly appointed by it.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Businesses&rdquo;
</B>means the development of therapeutics and diagnostics for cancers and immune diseases and any trade or other commercial activity
which is carried on by the Company and/or any Group Company, or which the Company and/or any Group Company shall have determined
to carry on with a view to profit in the immediate or foreseeable future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Commencement
Date&rdquo; </B>means 24 May 2017.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Confidential
Information&rdquo; </B>means any trade secrets or other information which is confidential, commercially sensitive and is not in
the public domain relating or belonging to the Company and/or any Group Company including but not limited to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">information
                                         relating to the business methods, corporate plans, management systems, finances, new
                                         business opportunities, research and development projects, marketing or sales of any
                                         past, present or future product or service;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">secret
                                         formulae, processes, inventions, designs, know-how discoveries, technical specifications
                                         and other technical information relating to the creation, production or supply of any
                                         past, present or future product or service of the Company and/or any Group Company;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">lists
                                         or details of customers, potential customers or suppliers or the arrangements made with
                                         any customer or supplier; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         information in respect of which the Company and/or any Group Company owes an obligation
                                         of confidentiality to any third party.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Duties&rdquo;
</B>means your duties as referred to in clause 4.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Employment&rdquo;
</B>means your period of employment under this Agreement which shall be deemed to include any period of garden leave served under
clause 20.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Group
Companies&rdquo; </B>or <B>&ldquo;Group&rdquo;</B> means the Company, Rasna Therapeutics Inc. and any holding company or any parent
company or any subsidiary or subsidiary undertaking of the Company, Rasna Therapeutics Inc. or such companies, as such terms are
defined in s 1159, s 1162 (together with Schedule 7 and the definition of &ldquo;parent company&rdquo; in s 1173), s 1161 and Schedule
6 of the Companies Act 2006, and &ldquo;Group Company&rdquo; means any of them.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><IMG SRC="ex10-9_001.jpg" ALT="">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;HMRC&rdquo;
</B>means Her Majesty&rsquo;s Revenue and Customs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Holiday
Year&rdquo; </B>means the period 1 January to 31 December or such other period of one year as the Company may notify to you in
writing from time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Invention&rdquo;
</B>means any know how, technique, process, improvement, invention or discovery (whether patentable or not) which you (whether
alone or with any other person) make, conceive, create, develop, write, devise or acquire at any time during your Employment and
which relates or could relate directly or indirectly to the Businesses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Material
Interest&rdquo; </B>means:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         holding of any position (whether employed or engaged) or the provision of services as
                                         director, officer, employee, consultant, adviser, partner, principal, agent or volunteer;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         direct or indirect control or ownership (whether jointly or alone) of any shares (or
                                         any voting rights attached to them) or debentures save for the ownership for investment
                                         purposes only of not more than 5 per cent of the issued ordinary shares of any company
                                         whose shares are listed on any Recognised Exchange; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         direct or indirect provision of any financial assistance.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Model
Code&rdquo;</B> means the Model Code on directors&rsquo; dealings in securities set out in the Listing Rules contained in the FCA handbook.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Pension
Scheme&rdquo; </B>means the scheme referred to in clause 11.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Recognised
Exchange&rdquo; </B>means any of a recognised investment exchange (as defined in s 285 Financial Services and Markets Act 2000
(&ldquo;FSMA&rdquo;)), an overseas investment exchange (as defined in s 313 FSMA), or a relevant market (as defined in article 37
FSMA 2000 (Financial Promotion) Order 2005.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Schemes&rdquo;
</B>means such schemes as the Company may operate from time to time, which you are eligible to participate in and which are referred
to in clause 13.1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Termination
Date&rdquo; </B>means the date on which the Employment terminates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Works&rdquo;
</B>means all works including without limitation all copyright works or designs originated, conceived, developed or written by
you alone or with others during the Employment which relate to or could relate to the Businesses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                         this Agreement, unless the context otherwise requires:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">words
                                         in the singular include the plural and vice versa and words in one gender include any
                                         other gender;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                         reference to a statute or statutory provision includes:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 72pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         subordinate legislation (as defined in Section 21(1), Interpretation Act 1978) made under
                                         it; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 72pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         statute or statutory provision which modifies, consolidates, re-enacts or supersedes
                                         it;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0"><IMG SRC="ex10-9_001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                         reference to:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 72pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                         <B>&ldquo;person&rdquo;</B> includes any individual, firm, body corporate, association
                                         or partnership, government or state (whether or not having a separate legal personality);</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 72pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">clauses
                                         and schedules are to clauses and schedules of this Agreement and references to sub-clauses
                                         and paragraphs are references to sub-clauses and paragraphs of the clause or schedule
                                         in which they appear; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 72pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;indemnify&rdquo;
                                         </B>and <B>&ldquo;indemnifying&rdquo;</B> any person against any circumstance include indemnifying
                                         and keeping him harmless from all actions, claims and proceedings from time to time made
                                         against him and all loss or damage and all payments (including fines, penalties and interest,
                                         costs or expenses) made or incurred by that person as a consequence of or which would
                                         not have arisen but for that circumstance;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
                                         where otherwise stated, words and phrases defined in the City Code on Take-overs and
                                         Mergers or in the Companies Act 2006 have the same meaning in this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">2.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Appointment</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company appoints you and you agree to serve as Chief Executive Officer and Chief Scientific Officer of the Company or such other
position as the Company may reasonably require from time to time on the terms of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">3.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Term</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Your
                                         Employment with the Company shall commence on the Commencement Date. No previous employment
                                         shall count as part of your continuous period of employment nor shall your prior (and
                                         continuing directorship of the Company.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                         to the terms of this Agreement, your Employment shall continue until terminated by either
                                         party giving to the other not less than 12 months&rsquo; prior written notice.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">4.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Duties</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         shall carry out such duties as attach to your offices of Chief Executive Officer and
                                         Chief Scientific Officer and any other duties for the Company and/or any Group Company
                                         which the Board assigns to you from time to time. It is agreed that your duties shall
                                         extend to acting as Chief Executive Officer of the Company; it being agreed that this
                                         appointment is included in the scope of your duties and compensation and the Board may
                                         at any time terminate this aspect of your duties, but so that no termination shall give
                                         rise to any termination or this Agreement either expressly or by implication and no termination
                                         of the role of Chief Executive Officer shall give rise to any right of compensation for
                                         loss of office.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Without
                                         additional remuneration, you shall accept and hold for such period(s) as specified by
                                         the Board, any office(s) including any post(s) as director, trustee, nominee and/or representative
                                         of the Company and/or any Group Company.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                         to the terms of this Agreement, you shall:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">devote
                                         such of your working time and attention to the Employment hereunder as may be agreed
                                         with the Board from time to time;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">perform
                                         the Duties faithfully and diligently and exercise such powers consistent with those Duties
                                         as are assigned to or vested in you by the Company and/or any Group Company and in all
                                         cases you shall do so jointly with any person(s) appointed by the Board from time to
                                         time;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT><IMG SRC="ex10-9_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">comply
                                         with all common law, fiduciary and statutory duties to the Company and any Group Company,
                                         including, but not limited to the seven statutory duties set out in s 171 &ndash; 177
                                         Companies Act 2006, so far as they are in force;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">obey
                                         all lawful and reasonable directions of the Board;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">observe
                                         in form and spirit such restrictions or limitations as may from time to time be imposed
                                         by the Board;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">implement
                                         and observe in form and spirit any relevant Company and/or Group Company policy, procedures,
                                         rules and regulations (whether formal or informal);</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">use
                                         your best endeavours to foster the Company&rsquo;s interests and save where this causes a conflict
                                         with the Company&rsquo;s interests, those of its other Group Companies;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">report
                                         to the Board any relevant wrongdoing (including any misconduct or dishonesty) whether
                                         committed, contemplated or discussed by any director, employee or worker of the Company
                                         and/or any Group Company of which you are aware and irrespective of whether this may
                                         involve any degree of self-incrimination; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">keep
                                         the Board properly and fully informed in such manner prescribed (with explanations where
                                         requested) of your compliance with the Duties and the affairs of the Company and/or any
                                         Group Company.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">5.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Director
                                         Indemnity and Insurance</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Company shall indemnify and keep you indemnified from any liability incurred by you for
                                         negligence, default, breach of duty or breach of trust in relation to the affairs of
                                         the Company to the extent permitted by the Companies Act 2006 (as amended) and the Company&rsquo;s
                                         articles of association from time to time. If the Company&rsquo;s articles of association are
                                         amended at any time to preclude the Company providing this indemnity to you, the Company
                                         shall indemnify and keep you indemnified in respect of any liability incurred by you
                                         as a result.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Company may also, to the extent permitted by the Companies Act 2006 (as amended), fund
                                         your expenditure on defending proceedings brought under the heads of liability set out
                                         in clause 5.1 above.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         provisions of this indemnity shall survive the termination of this Agreement howsoever
                                         caused, but in relation to each head of liability set out in paragraph 5.1 above, shall
                                         automatically terminate and no longer be of any force or effect upon the expiration of
                                         the relevant limitation period for bringing a claim under that head.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Directors&rsquo;
                                         and officers&rsquo; liability insurance is provided for all directors of the Company. The current
                                         indemnity limit is &pound;20,000,000. Further details of this insurance can be obtained
                                         from the company secretary.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">6.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Hours
                                         of work</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
shall work such hours as may be necessary for the proper discharge of your Duties. You agree that your employment falls within
Regulation 20 of the Working Time Regulations 1998.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">7.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Place
                                         of Work</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Your
                                         principal place of work shall be at the offices of the Company&rsquo;s subsidiary in
                                         the United States of America at 3805 Old Easton Road, Doylestown, PA. The Company reserves
                                         the right to change your principal place of work on giving reasonable prior notice to
                                         you.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"></P>




<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         shall travel to and work on a temporary basis from such locations within and outside
                                         of the United States of America and Europe as the Board may reasonably require. There
                                         is no current requirement for you to work outside the United States of America for any
                                         consecutive period of one month or more.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0"><IMG SRC="ex10-9_001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">8.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Expenses</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Company will reimburse to you (or as the case may be procure the reimbursement of) all
                                         expenses wholly, properly and necessarily incurred by you in the performance of the Duties
                                         subject to production within 30 days of the expense being incurred of such receipts or
                                         other evidence of expenditure as the Company may reasonably require and in accordance
                                         with the Company&rsquo;s policy on expenses in force from time to time.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                         you are provided with any credit or charge card by the Company, you must take good care
                                         of it and use it solely for expenses incurred by you in carrying out the Duties and in
                                         accordance with any applicable Company policy. The loss of any such card must be reported
                                         immediately to the Company and it must be returned to the Company immediately upon request.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">9.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Salary</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         will be paid a salary of $300,000 per annum (on the basis that your Duties will involve
                                         working hours of approximately 50% of a full-time position but otherwise subject to adjustment
                                         to be agreed with the Board), subject to deduction of such tax and national insurance
                                         and/or social security contributions as the Company is required by law to deduct and
                                         which is inclusive of any fees you are entitled to as a director of the Company and/or
                                         any Group Company.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Your
                                         salary will accrue from day to day and is payable in equal monthly instalments in arrears
                                         on or about the last working day of each month, directly into a bank or building society
                                         account nominated by you.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Your
                                         salary will be reviewed by the Board on or about 28 February each year, save where you
                                         are working under notice of termination. There is no obligation on the Board to increase
                                         your salary. Any increase awarded will be effective from the date specified by the Board.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.4</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Company may, in its absolute discretion, pay additional remuneration to you, whether
                                         by way of bonus or otherwise. Any such payment shall not form part of your salary for
                                         the purposes of this clause 9.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">10.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Bonus</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Company may award you a bonus of such amount and subject to such conditions (including,
                                         but not limited to, conditions for and timing of payment, subject to clause 10.5) as
                                         the Board may in its absolute discretion determine from time to time. It is expected
                                         that that bonus eligibility will be equal to 35% of the salary figure set out in clause
                                         9.1. The Board reserves the right to award a nil bonus.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                         bonus awarded to you shall be purely discretionary, shall not form part of your contractual
                                         remuneration under this Agreement and shall not be pensionable. The making of an award
                                         shall not oblige the Company to make any subsequent bonus awards.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
                                         clause 10.1, you shall have no right to be awarded or where an award has been made, paid
                                         a bonus (pro rata or otherwise) if:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">you
                                         are subject to any capability and/or disciplinary procedures; and/or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">your
                                         employment has terminated (whether lawfully or unlawfully) or you are under notice of
                                         termination (whether given by you or the Company).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0"><IMG SRC="ex10-9_001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                         you have been notified that you are under investigation in accordance with our disciplinary
                                         or capability procedure then your eligibility to be considered for a discretionary bonus
                                         will be postponed pending the conclusion of any such investigation and any subsequent
                                         disciplinary hearing or capability meeting.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                         earned bonus will be paid in accordance with the Company&rsquo;s bonus payment practices in
                                         effect from time to time for senior executives of the Company, but no later than March
                                         15 of the calendar year immediately following the calendar year for which the bonus is
                                         being measured.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">11.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pension</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Company will comply with the employer pension duties in accordance with part 1 of the
                                         Pensions Act 2008.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                         contracting out certificate is not in force in respect of the Employment.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">12.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Share
                                         Option and Long Term Incentive Plan</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         terms of the Employment shall not be affected in any way by your participation or entitlement
                                         to participate in any long term incentive plan or share option scheme. Such schemes and/or
                                         plans shall not form part of the terms of the Employment (express or implied).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Board has agreed to make an initial grant of 4,000,000 share options in respect of the
                                         Company&rsquo;s ordinary shares to you on execution of this Agreement. The options will
                                         be subject to the rules of the Company&rsquo;s share option scheme and will vest in four
                                         equal instalments on the anniversary dates of this Agreement and will be exercisable
                                         at market price as determined in accordance with the rules of the Company&rsquo;s share
                                         option scheme.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                         calculating any payment, compensation or damages on the termination of the Employment
                                         for whatever reason (whether lawful or unlawful) which might otherwise be payable to
                                         you, no account shall be taken of your participation in any such schemes and/or plans
                                         referred to in clause 12.1 or any impact upon participation such termination may have.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">13.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Other
                                         Benefits</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                         to clauses 13.2 to 13.7 below, you shall be entitled to participate in such benefit schemes
                                         as the Company may operate from time to time and in which you are eligible to participate
                                         including:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         permanent health insurance scheme;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         life assurance scheme; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         private medical expenses insurance scheme.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Company will agree with you as regards how participation is shared between the Company&rsquo;s
                                         Schemes and those of Rasna Therapeutics Inc.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Participation
                                         and entitlement to benefits under any of the Schemes is subject to:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         terms of the relevant Scheme as amended from time to time;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         rules or policies as amended from time to time of the relevant Scheme provider;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">acceptance
                                         by the relevant Scheme provider; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">satisfaction
                                         of the normal underwriting requirements of the relevant Scheme provider and the premium
                                         being at a rate which the Company considers reasonable.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0"><IMG SRC="ex10-9_001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.4</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Company shall only be obliged to make any payment under any Scheme where it has received
                                         payment from the relevant Scheme provider for that purpose. If a Scheme provider refuses
                                         to provide any benefit to you, whether based on its own interpretation of the terms and/or
                                         rules of the relevant Scheme or otherwise, the Company shall not be liable to provide
                                         you with any replacement benefit whatsoever or pay any compensation in lieu of such benefit.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.5</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Company, in its absolute discretion, reserves the right to discontinue, vary or amend
                                         any of the Schemes (including the provider and/or level of cover provided under any Scheme)
                                         at any time on reasonable notice to you.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.6</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                         other benefit provided to you shall, unless otherwise agreed in writing, be at the absolute
                                         discretion of the Company who may, at any time, withdraw or vary the terms of any such
                                         benefit as it sees fit.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.7</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         agree that the Company shall be under no obligation to continue this Agreement and the
                                         Employment so that you continue to receive benefits under this Agreement. In particular,
                                         you agree that the Company may terminate the Employment notwithstanding any rights which
                                         you may have to participate in and/or obtain benefits under any permanent health insurance
                                         scheme which the Company operates from time to time. You agree that you shall have no
                                         entitlement to compensation or otherwise from the Company and/or any Group Company for
                                         the loss of any such entitlements and/or benefits.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">14.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Holidays</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                         addition to the usual public or bank holidays in England and Wales, you are entitled
                                         to 20 working days&rsquo; paid holiday in each Holiday Year (pro rated to the nearest half
                                         day for the Holiday Year in which the Employment commences and terminates) and pro rated
                                         according to the scope of your hours as compared to a full time employee.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holiday
                                         must be taken at such times as are agreed with the Board. On giving at least 5 days&rsquo;
                                         notice, the Company may require you to take any accrued but untaken holiday where you
                                         are under notice of termination (including where you are on garden leave pursuant to
                                         clause 20).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         may carry forward 5 working days&rsquo; holiday to the next Holiday Year with the consent of
                                         the Board and provided that such holiday is used by 31 March in the next Holiday Year.
                                         Save as provided for in clause 14.4 no payment in lieu will be made of any unused holiday
                                         entitlement in any Holiday Year.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.4</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                         termination of the Employment:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">you
                                         will be entitled to pay in lieu of any accrued but untaken holiday entitlement; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">you
                                         will be required to repay to the Company any salary received for holiday taken in excess
                                         of your accrued entitlement (which you agree may be deducted from any payments, including
                                         salary, due to you from the Company).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
payment or repayment pursuant to this clause will be calculated on the basis of 1/260 of your salary payable pursuant to clause
9 for each day of holiday. It will not be calculated on any entitlement to bonus, commission, allowance or other payment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">15.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Sickness
                                         Absence</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                         you are unable to perform the Duties due to sickness or injury, you must comply with
                                         the Company&rsquo;s sickness policy from time to time in force.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT><IMG SRC="ex10-9_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">15.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">If
                                         at any time in the reasonable opinion of the Board you are unable to perform all or part
                                         of the Duties, you will at the request and expense of the Company:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">consent
                                         to an examination by a doctor nominated by the Company; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">authorise
                                         the doctor to disclose to and discuss with the Company, his or her report (including
                                         copies) of the examination and your fitness for work.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Company is entitled to rely on the reasonable opinion of any doctor engaged to examine
                                         you under clause 15.2 as to your fitness for work. Where such doctor considers you to
                                         be unfit for work, you are not entitled to receive any payment in excess of any sick
                                         pay entitlement pursuant to clause 16.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">16.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Sick
                                         Pay</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                         to compliance with clause 15 and clauses 16.2 and 16.5 below, you will be entitled to
                                         your salary (pursuant to clause 9.1) and, subject to the rules of any applicable scheme,
                                         any contractual benefits for a total of 45 days absence in any period of 12 consecutive
                                         months and after that such remuneration or benefits (if any) as the Board may in its
                                         absolute discretion determine from time to time. Any payment made to you under this clause
                                         is inclusive of your entitlement (if any) to statutory sick pay or any pay required under
                                         applicable United States federal, state, or local law (in either case. for which your
                                         qualifying days are Monday to Friday).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where
                                         your absence(s) exceed(s) 45 days in any period of 12 consecutive months, you shall have
                                         no entitlement to any remuneration or benefits pursuant to clause 16.1 (whether or not
                                         the Board has exercised its discretion to provide any additional remuneration or benefits
                                         for any absence(s) in excess of the 45 days referred to in that clause) until you have
                                         returned to work and remained at work for a continuous period of 13 weeks, unless required
                                         by applicable United States federal, state, or local law.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
                                         the absolute discretion of the Company no sick pay, except for any statutory sick pay
                                         or any pay required under applicable United States federal, state, or local law, will
                                         be payable in respect of any period where:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         hearing is pending which relates to any aspect of your conduct or performance or redundancy
                                         and which could result in the imposition of a warning, dismissal or other sanction (including
                                         any performance measure); or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">you
                                         refuse to consent to:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 72pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                         medical examination at any time by a doctor appointed by the Company; and/or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 72pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         provision of your medical records to that doctor; and/or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 72pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         results of such examination being disclosed to the Company and the Company discussing
                                         such results with the relevant where the examination is germane to your ability to perform
                                         the Duties.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         refuse upon request:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 72pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                         obtain a medical certification from your GP or another person responsible for your clinical
                                         care; and/or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 72pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                         provide this certification to the Company.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.4</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
                                         the purpose of clauses 16.1 and 16.3, any delay by the Company in terminating the provision
                                         of sick pay and/or any other remuneration and/or benefits will not constitute a waiver
                                         of its right to do so.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><IMG SRC="ex10-9_001.jpg" ALT="">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.5</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                         your sickness or injury is or appears to be caused by the negligence, nuisance or breach
                                         of any statutory duty of a third party, in respect of which damages are or may be recoverable
                                         you shall:</FONT></TD></TR>                                                                    <TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">immediately
                                         notify the Board of all relevant facts and of any claim, compromise, settlement or judgement
                                         made or awarded in connection with it and all relevant particulars that the Board may
                                         reasonably require; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                         required by the Board, refund to the Company that part of any damages or compensation
                                         recovered by you relating to your loss of earnings for the period of sickness or injury
                                         as the Board reasonably determines provided that the amount to be refunded shall not
                                         exceed the total amount paid to you by the Company in respect of the period of sickness
                                         or injury.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.6</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                         clause 16 is without prejudice and does not limit in anyway the Company&rsquo;s right to terminate
                                         your employment pursuant to this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.7</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                         clause 16 shall be interpreted and applied consistent with all applicable laws, including
                                         but not limited to the Americans with Disabilities Act and the Family and Medical Leave
                                         Act (if applicable).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">17.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Obligations
                                         during Employment</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Save
                                         with the prior written permission of the Board, you shall not during your employment
                                         (whether during or outside normal working hours):</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">hold
                                         any Material Interest in any person which:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 72pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">is
                                         or shall be wholly or partly in competition with any of the Businesses;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 72pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">impairs
                                         or might reasonably be thought by the Company to impair your ability to act at all times
                                         in the best interests of the Company and/or any Group Company; and/or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 72pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">requires
                                         or might reasonably be thought by the Company to require you to make use of or disclose
                                         any Confidential Information to further your interests in that person;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">take
                                         any preparatory steps to become engaged or interested in any capacity whatsoever in any
                                         business or venture which is in or is intended to enter into competition with any of
                                         the Businesses;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">carry
                                         out any public or private work other than the Duties (whether for profit or otherwise);</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">directly
                                         or indirectly receive in respect of any goods or services sold or purchased or any other
                                         business transacted (whether or not by you) by or on behalf of the Company and/or any
                                         Group Company any discount, rebate, commission or other inducement (whether in cash or
                                         in kind) which is not authorised by the relevant Company and/or Group Company rules or
                                         guidelines. You will account to the Company for the value of any such inducement, provided
                                         that it is expressly agreed that you may continue to consult to Synergy Pharmaceuticals
                                         Inc.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         shall observe relevant rules of law, requirements, recommendations, rules and regulations
                                         (as amended from time to time) of the London Stock Exchange plc or any other Recognised
                                         Exchange, the Model Code and/or the FSMA and the Company guidelines/codes relating to
                                         dealings in shares, debentures or other securities of the Company and/or any Group Company.
                                         In relation to overseas dealing you shall observe all laws and all regulations of the
                                         stock exchange, market or dealing system in which country or state such dealings take
                                         place.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0"><IMG SRC="ex10-9_001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">18.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Confidential
                                         Information</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         shall not either during the Employment or at any time after its termination (howsoever
                                         arising), directly or indirectly, use, disclose or communicate to any person whatsoever,
                                         and shall use your best endeavours to prevent the publication or disclosure of, any Confidential
                                         Information.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clause
                                         18.1 does not apply to:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         use or disclosure in the proper performance of the Duties, as authorised by the Board
                                         and/or as required by law;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         information which is already in or comes into the public domain other than through your
                                         unauthorised disclosure; and/or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         protected disclosure within the meaning of s43A Employment Rights Act 1996 provided,
                                         where at the relevant time you are employed by the Company, you have fully complied with
                                         the Company&rsquo;s procedures relating to such disclosures.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">19.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Intellectual
                                         Property</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         shall promptly disclose to the Company full details of any Invention and/or Works (including,
                                         without limitation, any and all computer programs, photographs, plans, records, drawings
                                         and models) which you (whether alone or with any other person) make, conceive, create,
                                         develop, write, devise or acquire at any time during the Employment and which relates
                                         or could relate directly or indirectly to the Businesses. You shall treat all Inventions
                                         and Works as Confidential Information of the Company and/or any Group Company.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
                                         the extent not already vested in the Company and/or any Group Company by operation of
                                         law, you:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">shall
                                         hold any Invention and/or Work on trust for the Company and/or any Group Company until
                                         any rights to such Invention and/or Work have been fully and absolutely vested in the
                                         Company in accordance with the remaining provisions of this clause 19;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">shall
                                         subject to clauses 39-43 of the Patents Act 1977 assign to the Company all patents and
                                         rights to apply for patents or other appropriate forms of protection in each Invention
                                         throughout the world;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">hereby
                                         assign by way of present and future assignment all copyright, design rights and other
                                         proprietary intellectual property rights (if any) for their full terms throughout the
                                         world in respect of the Works.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">shall
                                         execute any document necessary to assign to the Company any rights referred to under
                                         this clause 19 and at the request and expense of the Company, do all things necessary
                                         or desirable (including entering into any agreement that the Company reasonably requires)
                                         to vest such rights in the Company including without limitation applying and joining
                                         in with the Company in applying for any protection for or registration of any such rights
                                         to enable the Company and/or any Group Company and/or its or their nominee to obtain
                                         the full benefit and/or substantiate the rights of the Company and/or any Group Company
                                         under paragraphs (a), (b) and (c).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         acknowledge and agree that the patenting and exploitation of any Invention shall be at
                                         the sole discretion of the Company.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19.4</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         irrevocably and unconditionally waive in favour of the Company and/or any Group Company
                                         any and all moral rights conferred on you by Chapter IV, Part I, Copyright Designs and
                                         Patents Act 1988 and any other moral rights provided for under the laws now or in future
                                         in force in any part of the world for any Work the rights in which are vested in the
                                         Company whether by clause 19.2 or otherwise.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><IMG SRC="ex10-9_001.jpg" ALT="">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19.5</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         irrevocably appoint the Company to be your attorney in your name and on your behalf to
                                         execute documents, use your name and do all things which are necessary or desirable for
                                         the Company to obtain for itself or its nominee the full benefit of this clause. A certificate
                                         in writing, signed by any director or the secretary of the Company, that any instrument
                                         or act falls within the authority conferred by this Agreement shall be conclusive evidence
                                         that such is the case so far as any third party is concerned.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">20.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Garden
                                         Leave</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
                                         any period of notice to terminate the Employment (whether given by you or the Company),
                                         or if you purport to terminate the Employment in breach of this Agreement, the Board
                                         may for all or part of that period, in its absolute discretion (and notwithstanding any
                                         other provisions of this Agreement) require you:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                         perform only such of the Duties as it may allocate to you or such other projects or duties
                                         as may be required (whether or not they fall within clause 4);</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">not
                                         to perform any of the Duties;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">not
                                         to have any contact (other than purely social contact) or deal with (or attempt to contact
                                         or deal with) any officer, employee, consultant, client, customer, supplier, agent, distributor,
                                         shareholder, adviser or other business contact of the Company and/or any Group Company
                                         save as determined by the Board;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                         disclose to the Board any attempted contact (other than purely social contact) with any
                                         person with whom you have been required not to have any contact pursuant to this clause;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                         take any accrued holiday entitlement (in accordance with clause 14.2);</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">not
                                         to enter any premises of the Company and/or any Group Company nor to visit the premises
                                         of any suppliers and/or customers of the Company and/or any Group Company;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                         return as requested by the Board any mobile telephone handset, SIM card, laptop computer
                                         and/or any other Company and/or Group Company property, including Confidential Information,
                                         the Board may require; and/or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                         resign immediately from any offices you hold in the Company and/or any Group Company.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         agree that any action taken on the part of the Company and/or any Group Company pursuant
                                         to clause 20.1 shall not constitute a breach of this Agreement of any kind whatsoever
                                         nor will you have any claim against the Company and/or any Group Company in respect of
                                         such action.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Without
                                         prejudice to any other terms of this Agreement and save as expressly agreed otherwise
                                         in clause 20.1 above, during any period in which action is taken on the part of the Company
                                         and/or any Group Company pursuant to clause 20.1:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">you
                                         shall continue to be entitled to your salary and contractual benefits save that, should
                                         you work for any other person or on your own account and fail to be available for work
                                         at any time, your right to salary and contractual benefits in respect of such period
                                         of non-availability shall be forfeit, notwithstanding any other provision of this Agreement;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;<IMG SRC="ex10-9_001.jpg" ALT=""></FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">you
                                         shall owe a duty of utmost good faith to the Company and/or any Group Company; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">you
                                         shall remain an employee of the Company and be bound by the terms and conditions of this
                                         Agreement. In particular, you agree that you will not work for any other person or on
                                         your own account and save, during any periods of holiday taken under this Agreement,
                                         you shall remain readily contactable and available to work for the Company and/or any
                                         Group Company.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">21.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Payment
                                         in lieu of notice</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Company may in its absolute discretion, terminate the Employment at any time with immediate
                                         effect and pay you a sum equal to the basic salary you would have received during your
                                         notice period pursuant to clause 9.1 (or, if notice has already been given, during the
                                         remainder of the notice period) less income tax and National Insurance contributions
                                         (<B>&ldquo;Payment in Lieu&rdquo;</B>). The Payment in Lieu shall not include any payment
                                         in respect of:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         bonus or commission payments that might otherwise have been paid to you during the period
                                         for which the Payment in Lieu is made;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">benefits
                                         which you would have been entitled to receive during the period for which the Payment
                                         in Lieu is made; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         holiday entitlement that would have accrued to you during the period for which the Payment
                                         in Lieu is made.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Company will make any payment pursuant to clause 21.1, at its absolute discretion, either
                                         within 28 days of the termination of your employment or in equal monthly instalments
                                         in arrears until the date on which the period of notice referred to in clause 21.1 would
                                         have expired.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         shall have no right to receive a Payment in Lieu unless the Company has exercised its
                                         discretion in clause 21.1. Nothing in this clause 21 shall prevent the Company from terminating
                                         your Employment in breach.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.4</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                         having elected to make a Payment in Lieu but either before or after the payment (or any
                                         instalment of it) is made, it comes to the Company&rsquo;s attention that it may have been
                                         entitled to terminate your employment summarily for a reason within clause 23 or otherwise,
                                         then the Company reserves the right not to make the Payment in Lieu (or any outstanding
                                         instalment of it) and/or to demand the immediate repayment of it or any instalment which
                                         has already been paid.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;<IMG SRC="ex10-9_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 36pt">&nbsp;</P>




<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.5</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
                                         anything to the contrary herein, the following provisions apply to the extent the Payment
                                         in Lieu of notice provided herein is subject to Section 409A of the Internal Revenue
                                         Code (the &ldquo;<B>Code</B>&rdquo;) and the regulations and other guidance thereunder
                                         and any state law of similar effect (collectively &ldquo;<B>Section 409A</B>&rdquo;).
                                         The Payment in Lieu shall not commence until the you have had a &ldquo;separation from
                                         service&rdquo; (as defined under Treasury Regulation Section 1.409A-1(h), without regard
                                         to any alternative definition thereunder, a &ldquo;separation from service&rdquo;). Each
                                         installment of the Payment in Lieu is a separate &ldquo;payment&rdquo; for purposes of
                                         Treas. Reg. Section 1.409A-2(b)(2)(i), and the Payments in Lieu are intended to satisfy
                                         the exemptions from application of Section 409A provided under Treasury Regulations Sections
                                         1.409A-1(b)(4), 1.409A-1(b)(5) and 1.409A-1(b)(9). However, if such exemptions are not
                                         available and you are, upon separation from service, a &ldquo;specified employee&rdquo;
                                         for purposes of Section 409A, then, solely to the extent necessary to avoid adverse personal
                                         tax consequences under Section 409A, the timing of the Payments in Lieu shall be delayed
                                         until the earlier of (i) six (6) months and one day after your separation from service,
                                         (ii) your death or (iii) such earlier date as permitted under Section 409A without the
                                         imposition of adverse taxation. Upon the first business day following the expiration
                                         of such applicable Section 409A period, all payments deferred pursuant to this paragraph
                                         shall be paid in a lump sum to you, and any remaining payments due shall be paid as otherwise
                                         provided herein or in the applicable agreement. No interest shall be due on any amounts
                                         so deferred. The parties acknowledge that the exemptions from application of Section
                                         409A to the Payments in Lieu are fact specific, and any later amendment of this Agreement
                                         to alter the timing, amount or conditions that will trigger payment of the Payments in
                                         Lieu may preclude the ability of the Payments in Lieu provided under this Agreement to
                                         qualify for an exemption. To the extent that the Payments in Lieu or other benefits are
                                         deferred compensation under Section 409A, and are not otherwise exempt from the application
                                         of Section 409A, then, if the period during which you may consider and sign the Release
                                         spans two calendar years, the payment of such severance payments and benefits will not
                                         be made or begin until the later calendar year. It is intended that this Agreement shall
                                         comply with the requirements of Section 409A, and any ambiguity contained herein shall
                                         be interpreted in such manner so as to avoid adverse personal tax consequences under
                                         Section 409A. Notwithstanding the foregoing, the Company shall in no event be obligated
                                         to indemnify you for any taxes or interest that may be assessed by the Internal Revenue
                                         Service pursuant to Section 409A of the Code to payments made pursuant to this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">22.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Summary
                                         Termination</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Company may terminate the Employment at any time, without notice or pay in lieu of notice,
                                         and with no liability to make any further payment to you, save for the amounts accrued
                                         due to the Termination Date, if:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">you
                                         commit any act of gross misconduct;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">your
                                         conduct (whether or not it occurs during or in the context of the Employment) is such
                                         that it may in the reasonable opinion of the Board bring the Company and/or any Group
                                         Company into disrepute and/or is calculated or likely prejudicially to affect the interests
                                         of the Company and/or any Group Company;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">you
                                         are negligent and/or incompetent in the reasonable opinion of the Board in the performance
                                         of your Duties;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">you
                                         commit any serious or repeated breach of this Agreement;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">you
                                         are convicted of any criminal offence (other than an offence under the road traffic legislation
                                         in the United Kingdom or abroad for which you are not sentenced to any term of imprisonment,
                                         whether immediate or suspended);</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">you
                                         commit any act of fraud or dishonesty or corrupt practice or a breach of the Bribery
                                         Act 2010 relating to the Company and/or any Group Company, any of its or their employees,
                                         customers or otherwise;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">you
                                         become prohibited by law from being a director, you are removed from office of director
                                         pursuant to the Company&rsquo;s articles of association or you resign as a director other than
                                         with the prior written approval or at the written request of the Board or pursuant to
                                         clause 26;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">you
                                         become of unsound mind or a patient for the purposes of any statute relating to mental
                                         health so that in the opinion of the Board you are unable to perform your Duties;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                         bankruptcy petition is presented against you or you become bankrupt or an interim order
                                         is made in respect of you pursuant to section 252 of the Insolvency Act 1986 or you make
                                         any arrangement or composition with your creditors generally (including an Individual
                                         Voluntary Arrangement) or have a County Court administration order made against you under
                                         the County Court Act 1984.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;<IMG SRC="ex10-9_001.jpg" ALT=""></FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         rights of the Company under clause 22.1 are without prejudice to any other rights that
                                         it may have at law to terminate the Employment or accept any breach of this Agreement
                                         by you as having brought the Agreement to an end and any delay by the Company in exercising
                                         its rights under clause 22.1 shall not constitute a waiver of such rights.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">23.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Reconstruction
                                         and Amalgamation</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Employment is terminated by reason of any reconstruction or amalgamation of the Company and/or any Group Company whether by
winding up or otherwise and you are offered employment with any concern or undertaking involved in or resulting from such reconstruction
or amalgamation on terms which (considered in their entirety) are no less favourable to any material extent than the terms of
this Agreement, you shall have no claim against the Company or any such undertaking arising out of or in connection with such
termination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">24.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Obligations
                                         after Employment</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Without
prejudice to the other terms of this Agreement, you agree that following the termination of your Employment for any reason whatsoever,
you will be bound by and you will comply with the terms and conditions set out in Schedule 1 to this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">25.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Property</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
any time during the Employment or following its termination (for whatever reason), as requested by the Company and/or any Group
Company, you agree to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">return
                                         to the Company and/or any Group Company or irretrievably destroy or delete:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 72pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         documents, drawings, designs, computer files or software, visual or audio tapes or other
                                         materials containing information (including, without limitation, Confidential Information)
                                         and/or any copies or extracts of the same relating to the Businesses; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 72pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         other property of the Company and/or any Group Company</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
your possession, custody and/or directly or indirectly under your control;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">inform
                                         the Company of all passwords, pass codes, pin numbers and any other similar information
                                         used by you in relation to any information technology systems, vehicles, rooms and/or
                                         any other secured property of the Company and/or any Group Company.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">26.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Resignation
                                         from Appointments</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
                                         any time, at the request of the Company and/or any Group Company, you agree to resign
                                         from any directorships, offices, appointments and/or trusteeships which you hold with
                                         the Company and/or any Group Company without claim for compensation and your resignation
                                         shall not affect in anyway the continuance of this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         irrevocably appoint the Company to be your attorney in your name and on your behalf to
                                         execute documents, use your name and do all things which are necessary or desirable for
                                         the Company to obtain the full benefit of this clause.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">27.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Suspension</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to investigate a complaint against you of misconduct and/or poor performance, the Company may suspend you for so long as
may be necessary to carry out a proper investigation and complete any appropriate disciplinary and/or capability process. During
any period of suspension you shall continue to receive your salary and contractual benefits.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;<IMG SRC="ex10-9_001.jpg" ALT=""></FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">28.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Disciplinary
                                         and Dismissal Rules</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         are subject to the Company&rsquo;s disciplinary rules and procedures in force from time to
                                         time a copy of which is available upon request and such other procedures of this nature
                                         as may from time to time be adopted. Application of such procedure is at the Company&rsquo;s
                                         discretion and is not a contractual entitlement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                         you are dissatisfied with any disciplinary decision to dismiss you, you should refer
                                         such dissatisfaction in writing in accordance with the applicable Company procedure.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">29.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Grievance</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you have any grievance relating to the Employment (other than one relating to a disciplinary decision or a decision to dismiss
you), you should refer such grievance in writing in accordance with the Company&rsquo;s grievance procedure in force from time to time
(a copy of which is available upon request). If the grievance is not resolved at this stage, you can appeal in accordance with
the appeal procedure set out in the appropriate procedure. Application of the grievance procedure is discretionary and not a contractual
entitlement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">30.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Data
                                         Protection</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Company and any Group Company shall process your personal data (including, where necessary,
                                         sensitive personal data, such terms being defined in the Data Protection Act 1998) in
                                         their paper-based and computerised systems. You consent to the processing of such data
                                         both inside and, where necessary, outside the European Economic Area for the purposes
                                         of:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">salary,
                                         benefits and pensions administration and employee management;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">health
                                         administration and for the purposes of health insurance/benefits;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">training
                                         and appraisal, including performance records and disciplinary records;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">equal
                                         opportunities monitoring;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         potential change of control of the Company and/or Group Company, or any potential transfer
                                         of employment under the Transfer of Undertakings (Protection of Employment) Regulations
                                         2006. In such circumstances, disclosure may include disclosure to the potential purchaser
                                         or investor and their advisors;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">promoting
                                         or marketing of the Company and/or any Group Company and/or its or their products or
                                         services;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">compliance
                                         with applicable procedures, laws and regulations; and/or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         other reasonable purposes in connection with your employment about which you shall be
                                         notified from time to time.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         acknowledge and accept that in order to fulfil the purposes set out above, it may be
                                         necessary to pass your personal data (or sensitive personal data, as appropriate) to
                                         regulatory bodies, government agencies and other third parties as required by law or
                                         for administration purposes.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         acknowledge and accept that the Company and/or any Group Company may monitor electronic
                                         correspondence (including email, voice and text messages) which you receive at work and/or
                                         on Company systems and/or property provided to you by the Company and/or any Group Company
                                         for the purposes of your work in order to ensure the integrity of its information technology
                                         or to prevent or detect criminal behaviour or behaviour which contravenes employment
                                         legislation and/or other Company and/or Group Company policies.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;<IMG SRC="ex10-9_001.jpg" ALT=""></FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30.4</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         agree to use all reasonable endeavours to keep the Company informed of any changes to
                                         your personal data or sensitive personal data and to comply with all relevant data protection
                                         legislation.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">31.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Warranty</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         warrant that you are not bound by nor subject to any court order, arrangement, obligation
                                         (express or implied), restriction or undertaking (contractual or otherwise) which prohibits
                                         or restricts you from entering into this Agreement or performing the Duties.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         undertake to indemnify the Company and/or any Group Company against any claims, costs,
                                         damages, liabilities and/or expenses which the Company and/or any Group Company may incur
                                         as a result of any claim that you are in breach of any order, arrangement, obligation,
                                         restriction or undertaking referred to in clause 31.1.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         warrant that you are entitled to work in the United Kingdom without any additional approvals
                                         and will notify the Company immediately if you cease to be so entitled during the course
                                         of your employment.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.4</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         warrant that you have no previous convictions and have not previously been reported for
                                         or been subject to investigation for bribery related offences including, without limitation,
                                         offences under the Bribery Act 2010.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">32.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Deductions</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
agree that at any time the Company may deduct from your salary or any other sums owed to you any money you owe to the Company
and/or any Group Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">33.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Power
                                         of Attorney</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you fail to comply with any request(s) under clauses 19 and/or 26, you irrevocably authorise the Company and/or any Group Company
to appoint a person in your name and on your behalf to sign any documents or do any things necessary or requisite for the purposes
of giving the Company and/or any Group Company and its or their nominee the full benefit of such clauses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">34.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Collective
                                         Agreements</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are no collective agreements which affect the terms and conditions of your employment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">35.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Entire
                                         Agreement</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Agreement sets out the entire agreement and understanding between the parties and supersedes all prior agreements, understandings
or arrangements (oral or written) in respect of your employment or engagement by the Company. No purported variation of this Agreement
shall be effective unless it is in writing and signed by or on behalf of each of the parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">36.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Third
                                         Parties</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
expressly provided in this Agreement, no term of this Agreement is enforceable pursuant to the Contracts (Rights of Third Parties)
Act 1999 by any person who is not a party to it.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">37.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Releases
                                         and waivers</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">37.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Company may, in whole or in part, release, compound, compromise, waive or postpone, in
                                         its absolute discretion, any liability owed to it or right granted to it in this Agreement
                                         by you without in any way prejudicing or affecting its rights in respect of any part
                                         of that liability or any other liability or right not so released, compounded, compromised,
                                         waived or postponed.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;<IMG SRC="ex10-9_001.jpg" ALT=""></FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">37.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
                                         single or partial exercise, or failure or delay in exercising any right, power or remedy
                                         by the Company shall constitute a waiver by it of, or impair or preclude any further
                                         exercise of, that or any right, power or remedy arising under this Agreement or otherwise.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">38.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notices</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">38.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                         notice to a party under this Agreement shall be in writing signed by or on behalf of
                                         the party giving it and shall, unless delivered to a party personally, be hand delivered,
                                         or sent by prepaid first class post or facsimile.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">38.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                         notice shall be deemed to have been served:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
                                         the time of delivery if delivered personally to a party or to the specified address;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">on
                                         the second working day after posting by first class prepaid post; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2
                                         hours after transmission if served by facsimile on a business day prior to 3pm or in
                                         any other case at 10 am on the business day after the date of despatch.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">39.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Variation</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
variation or agreed termination of this Agreement shall be effective unless it is in writing and signed by the parties (or their
authorised representatives).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">40.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Counterparts</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">40.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                         Agreement may be executed in any number of counterparts, each of which when executed
                                         and delivered shall constitute a duplicate original, but all the counterparts shall together
                                         constitute the one agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">40.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
                                         counterpart shall be effective until each party has executed and delivered at least one
                                         counterpart.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">41.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Governing
                                         law and jurisdiction</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">41.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                         Agreement shall be governed by and construed in accordance with English law.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">41.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
                                         of the parties irrevocably submits for all purposes in connection with this Agreement
                                         to the exclusive jurisdiction of the English courts.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>In
witness</B> this Deed has been executed on the date appearing at the head of page 1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;<IMG SRC="ex10-9_001.jpg" ALT=""></FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>





<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule
1</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Post
termination restrictions)</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Definitions
                                         and interpretation</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                         this Schedule, unless the context otherwise requires, the following additional definitions
                                         shall apply (in addition to the definitions contained in the Agreement to which this
                                         Schedule is annexed and of which it forms a part):</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;the
Business&rdquo;</B> means the business of the Company or any part thereof and any other business or part thereof carried on by
any Group Company as at the Termination Date and/or during the Protected Period and in respect of which the Duties have been materially
concerned or about which you have acquired Confidential Information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Customer&rdquo;
</B>means any person who at any time during the Protected Period was a customer of the Company or any Group Company and was a
person with whom you had material personal dealings or in relation to whom you have acquired Confidential Information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Garden
Leave Period&rdquo; </B>means any period during which the Company has exercised its rights pursuant to clause 20 of the Agreement
to which this Schedule is annexed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Goods
and/or Services&rdquo; </B>means any goods and/or services competitive with those supplied by the Company or any Group Company
at any time during the Protected Period and in relation to which you were materially involved or concerned or for which you were
responsible during that period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Key
Employee&rdquo;</B> means any person who at any time during the Protected Period is or was employed or engaged by the Company or
any Group Company in a senior managerial, sales, marketing, technical or supervisory capacity and with whom you dealt during that
period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Prospective
Customer&rdquo; </B>means any person who was at any time during the Protected Period engaged in negotiations, with which you were
personally involved, with the Company or any Group Company with a view to obtaining goods or services from the Company or any
Group Company or in relation to whom you have acquired Confidential Information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Protected
Period&rdquo; </B>means the 12 months immediately preceding the earlier of the Termination Date and the commencement of any Garden
Leave Period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Restriction
Period&rdquo; </B>means the period of 6 months following the Termination Date less any Garden Leave period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Supplier&rdquo;
</B>means any person with whom you have had material dealings as part of the Duties during the Protected Period and who has during
that period supplied goods or services to the Company or any Group Company on terms other than those available to another purchaser
in the market during that period, whether by reason of exclusivity (either de facto or contractually obliged), price or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Obligations
                                         after employment</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         shall not for the Restriction Period hold a Material Interest in a business or venture
                                         which:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">is
                                         or is about to be in competition with the Business or any part thereof; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;<IMG SRC="ex10-9_001.jpg" ALT=""></FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">is
                                         likely to result in the intentional or unintentional disclosure or use of Confidential
                                         Information by you in order for you to properly discharge your duties to or further your
                                         interest in that business or venture.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         provisions of clause 2.1 shall not operate so as to prevent you from being engaged, concerned
                                         or interested in any business or venture in so far as your work for that business or
                                         venture shall relate solely to services or activities with which the Duties were not
                                         concerned to a material extent or in relation to which you were not responsible and in
                                         relation to which you held no Confidential Information during the Protected Period.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         shall not for the Restriction Period in respect of any Goods and/or Services:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">deal
                                         with or supply any Customer;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">deal
                                         with or supply any Prospective Customer; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">offer
                                         employment or any contract for services to or employ or engage any Key Employee.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         shall not for the Restriction Period in respect of any Goods and/or Services:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">solicit,
                                         facilitate the solicitation of or canvass the custom or business of any Customer;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">solicit,
                                         facilitate the solicitation of or canvass the custom or business of any Prospective Customer;
                                         or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">solicit
                                         or entice or endeavour to solicit or entice any Key Employee to leave his employment
                                         with or cease his directorship or consultancy with the Company or any Group Company,
                                         whether or not that person would breach any obligations owed to the Company or any relevant
                                         Group Company by so doing.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.5</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         shall not for the Restriction Period:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">deal
                                         with or accept the supply of any goods or services from any Supplier where such supply
                                         is likely to be the detriment of any Group Company whether by causing the Supplier to
                                         reduce or alter the terms or quantity of supply to the Group Company or where the value
                                         of the Company&rsquo;s arrangement with the Supplier is diminished; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">solicit,
                                         facilitate the solicitation of or canvass the supply of any goods or services from any
                                         Supplier where such supply is likely to be the detriment of any Group Company whether
                                         by causing the Supplier to reduce or alter the terms or quantity of supply to the Group
                                         Company or where the value of the Group Company&rsquo;s arrangement with the Supplier
                                         is diminished;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.6</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If,
                                         at any time during the Employment, two or more Key Employees leave the employment of
                                         the Company or any Group Company to provide Goods and/or Services for the same business
                                         or venture, you shall not, at any time during the 6 months following the last date on
                                         which any of those Key Employees was employed by the Company or any Group Company, be
                                         employed or engaged in any way with that business or venture in respect of any Goods
                                         and/or Services.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.7</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         shall not at any time after the Termination Date:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">induce
                                         or seek to induce by any means involving the disclosure or use of Confidential Information
                                         any Customer or Supplier to cease dealing with the Company or any Group Company or to
                                         restrict or vary the terms upon which it deals with the relevant Group Company;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><IMG SRC="ex10-9_001.jpg" ALT=""></FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">be
                                         held out or represented by you or any other person as being in any way connected with
                                         or interested in the Company or any Group Company; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">disclose
                                         to any person or make use of any Confidential Information (except as required by law).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>General</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         have given the undertakings in this Schedule to the Company as trustee for itself and
                                         each Group Company in the business of which you have been concerned or involved to any
                                         material extent during the Employment or which benefits from each undertaking. You agree
                                         that each such Group Company may enforce the benefit of each such undertaking. You shall,
                                         at the request and expense of the Company, enter into direct undertakings with any such
                                         Group Company which correspond to the undertakings in this Schedule.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         agree that if the Company transfers all or any part of its business to a third party
                                         (&ldquo;transferee&rdquo;), the restrictions contained in this Schedule 1 shall, with effect
                                         from the date of you becoming an employee of the transferee, apply to you as if references
                                         to the Company included the transferee and references to any Group Companies were construed
                                         accordingly and as if references to customers or suppliers were of the Company and/or
                                         the transferee and their respective Group Companies.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         agree that if you have material business dealings in other foreign jurisdictions on behalf
                                         of any Group Company, you will enter into undertakings providing the same level of protection
                                         for each such Group Company with such modifications (if any) as are necessary to render
                                         such undertakings enforceable in those jurisdictions.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         acknowledge that you have had the opportunity to take independent legal advice in relation
                                         to the undertakings contained in this Schedule.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         obligations imposed on you by this Schedule extend to you acting not only on your own
                                         account but also on behalf of any other firm, company or other person and shall apply
                                         whether you act directly or indirectly.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         warrant that you believe the covenants contained within this Schedule to be reasonable
                                         as between the parties and that you have no present intention of ever arguing that the
                                         restraints are unreasonable or otherwise unenforceable.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><IMG SRC="ex10-9_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>




<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 35%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Executed
    </B>as a <B>Deed</B></FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 22%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Kunwar Shailubhai</FONT></TD>
    <TD STYLE="width: 33%; text-align: justify; font: 10pt Times New Roman, Times, Serif"></TD>
    <TD STYLE="width: 9%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">by
    <B>Shailubhai Kunwar</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
    the presence of:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
    of witness:</I></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Edward J. Lukins</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Name:</I></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Edward
    J. Lukins</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Address:</I></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dashwood,
    69 Old Broad Street, London EC2M 1QS</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Occupation:</I></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Solicitor</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Executed
    </B>as a <B>Deed</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(but
    not delivered until the date</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">appearing
    at the head of page 1)</FONT></TD>
    <TD>)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">by
    Tiziana Lifesciences plc</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">acting
    by <B>Gabriele Cerrone</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    director in the presence of:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;/s/
    Gabriele Cerrone</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
    of witness:</I></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Tiziano Lazzaretti</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Name:</I></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tiziano
    Lazzaretti</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Address:</I></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">55
    Park Lane, London W1K 1NA</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Occupation:</I></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 23; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.10
<SEQUENCE>16
<FILENAME>ff12018a1ex10-10_tiziana.htm
<DESCRIPTION>FORM OF DEED OF INDEMNITY FOR BOARD MEMBERS
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin-top: 0; text-align: right; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.10</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TIZIANA
LIFE SCIENCES PLC</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Name
of Director or Officer]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Address]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Date]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dear
[Name of Director or Officer],</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Tiziana
Life Sciences plc (the &ldquo;Company&rdquo;) and your role as a director/officer of the Company</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
you are aware the Articles of Association of the Company (the &ldquo;Articles&rdquo;) contain provisions, at Article 138, granting
an indemnity to the directors and officers of the Company from time to time. We are taking this opportunity to afford you the
direct benefit of this indemnity in the form of a deed for your benefit (this &ldquo;Deed&rdquo;). As you are aware the Companies
Act 2006 (the &ldquo;Act&rdquo;) imposes certain statutory limitations on the scope of this indemnity. For the avoidance of doubt
the Company will maintain directors and officers insurance (&ldquo;D&amp;O Cover&rdquo;), which is intended to operate for your
protection in addition to this indemnity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
defined terms used in this Deed (to the extent undefined) shall have the meanings given to them in the Articles.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Without
                                         prejudice to any indemnity to which you may otherwise be entitled pursuant to Article
                                         138 of the Articles, you shall be indemnified by the Company against all liabilities,
                                         costs, charges and expenses incurred by you in the execution and discharge of your duties
                                         to the Company and any &ldquo;Associated Company&rdquo; of the Company (as defined by
                                         the Act for these purposes), including any liability incurred by you in defending any
                                         proceedings, civil or criminal, which relate to anything done or omitted or alleged to
                                         be done or omitted by you as an officer of the Company or an Associated Company provided
                                         that no such indemnity shall extend to any liability arising out of your fraud or dishonesty
                                         or by you obtaining any personal profit or advantage to which you were not entitled.
                                         In addition, the Act prohibits this indemnity extending to:</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         liability incurred by you to the Company or any Associated Company of the Company;</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         fine imposed in any criminal proceedings;</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(C)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         sum payable to a regulatory authority by way of a penalty in respect of your personal
                                         non-compliance with any requirement of a regulatory nature howsoever arising;</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(D)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         amount for which you have become liable in defending any criminal proceedings in which
                                         you are convicted and such conviction has become final;</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(E)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         amount for which you have become liable in defending any civil proceedings brought by
                                         the Company or any Associated Company of the Company in which a final judgment has been
                                         given against you; and</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(F)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         amount for which you have become liable in connection with any application under sections
                                         661(3) or (4) or 1157 of the Act in which the court refuses to grant you relief and such
                                         refusal has become final,</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">however
the D&amp;O Cover in place is designed to provide cover for these specific areas which the Act prescribes that the indemnity cannot
extend, and for which it is possible to obtain coverage on commercial terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 1; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Without
                                         prejudice and in addition to any indemnity to which you may otherwise be entitled pursuant
                                         to Article 138 of the Articles you shall be indemnified by the Company against all liabilities,
                                         costs, charges and expenses incurred by you in connection with the Company&rsquo;s activities
                                         as a trustee of an occupational pension scheme (as defined by section 750(5) of the Finance
                                         Act 2004) established under a trust provided that no such indemnity shall extend to any
                                         liability arising out of your fraud or dishonesty or the obtaining by you of any personal
                                         profit or advantage to which you were not entitled and you shall not be entitled to be
                                         indemnified for:</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         fine imposed in any criminal proceedings,</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         sum payable to a regulatory authority by way of a penalty in respect of non-compliance
                                         with any requirement of a regulatory nature howsoever arising, and</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(C)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         amount for which you have become liable in defending any criminal proceedings in which
                                         you are convicted and the conviction has become final.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Company will, upon a reasonable request from you accompanied by actual or estimates of
                                         costs from those appointed to defend you, provide funds (either directly or indirectly)
                                         to you to meet expenditure incurred or to be incurred by you in any proceedings (whether
                                         civil or criminal) brought by any person or in relation to any investigation or action
                                         to be taken by a regulatory authority which relate to anything done or omitted or alleged
                                         to have been done or omitted by you as a director and/or officer of the Company or any
                                         Associated Company of the Company in respect of which it is alleged you have been guilty
                                         of negligence, default, breach of duty or breach of trust, provided that you will be
                                         obliged to repay any such amount no later than:</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                         the event that you are convicted in proceedings, the date when the conviction becomes
                                         final,</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                         the event that judgment is given against you in proceedings, the date when the judgment
                                         becomes final (except that such amount need not be repaid to the extent that such expenditure
                                         is recoverable hereunder or under any other valid indemnity given to you by the Company),
                                         or</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(C)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                         the event that the court refuses to grant you relief on any application under sections
                                         144(3) or (4) or 727 of the UK Companies Act 1985 or sections 661(3) or (4) or 1157 of
                                         the Act, the date when the refusal becomes final.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.4</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                         indemnity does not authorise any indemnity which would be prohibited or rendered void
                                         by any provision of the Act or by any other provision of law.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.5</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Company hereby waives (to the maximum extent permitted the provisions of the Act or by
                                         any other provision of law) all and any claims that it may have against you as a result
                                         of, and in connection with, your tenure as a director or officer of the Company, whether
                                         actual or contingent, direct or indirect and irrevocably waives any such claims or rights
                                         of action and releases and forever discharges you from all and any liability in respect
                                         thereof.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.6</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         agree to give written notice to the Company as soon as reasonably practical after receipt
                                         of any demand relating to any claim under this indemnity (or becoming aware of circumstances
                                         which are reasonably be expected to give rise to a demand relating to a claim) giving
                                         full details and providing copies of all relevant correspondence and you agree to keep
                                         the Company fully informed of the progress of any claim, including providing all such
                                         information in relation to any claim or losses or any other costs, charges or expenses
                                         incurred as the Company may reasonably request, and shall take all such action as the
                                         Company may reasonably request to avoid, dispute, resist, appeal, compromise or defend
                                         any claim.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.7</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
                                         the avoidance of doubt:</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                         a company ceases to be a subsidiary of the Company after the date of this Deed, the Company
                                         shall only be liable to indemnify you in respect of liabilities in relation to that company
                                         which arose before the date on which that company ceased to be a subsidiary of the Company;
                                         and</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 35.45pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36.55pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
                                         director or officer of any company which becomes a subsidiary of the Company after the
                                         date of this Deed, you shall be indemnified only in respect of liabilities arising after
                                         the date on which that company became a subsidiary of the Company.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.8</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                         Deed shall remain in force until such time as any relevant limitation periods for bringing
                                         Claims against you have expired, or for so long as you remain liable for any losses,
                                         notwithstanding that you may have ceased to be a director or officer of the Company or
                                         any of its subsidiaries.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.9</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                         dispute or claim arising out of or in connection with this indemnity and waiver (including
                                         non-contractual disputes or claims) shall be governed by and construed in accordance
                                         with the law of England and Wales and you and the Company irrevocably agree that the
                                         courts of England and Wales shall have exclusive jurisdiction to settle any dispute or
                                         claim that arises out of or in connection with this appointment or its subject matter
                                         or formation (including non-contractual disputes or claims).</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
WITNESS WHEREOF,</B> this Deed has been executed as a deed by the Company and you, or such parties&rsquo; duly authorized attorneys
on the day and year first above written.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>[Signature
Page Follows]</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executed
as a deed by</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 40%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">for
and on behalf of</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TIZIANA
LIFE SCIENCES PLC</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>In
the presence of:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 40%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Signature
and name of witness</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executed
as a deed by [Name of Director or Officer]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 40%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Signature</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>In
the presence of:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 40%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Signature
and name of witness</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[Signature
Page to Tiziana Life Sciences plc &ndash; Deed of Indemnity]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I></I></FONT></P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>17
<FILENAME>ff12018a1ex21-1_tiziana.htm
<DESCRIPTION>LIST OF SUBSIDIARIES
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin-top: 0; text-align: right; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
21.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Subsidiaries
of Tiziana Life Sciences plc</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="white-space: nowrap; padding-top: 0; padding-right: 0; font: 10pt Times New Roman, Times, Serif; padding-left: 0; text-indent: 0; width: 49%; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Legal
                                         Name of Subsidiary</B></FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0 0 1.5pt; text-indent: 0; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0; padding-right: 0; padding-left: 0; text-indent: 0; width: 49%; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Jurisdiction
    of Organization</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tiziana
    Pharma Limited</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">England
    &amp; Wales</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="vertical-align: top; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tiziana
    Therapeutics Inc.</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">United
    States of America</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Longevia
    Genomics S.r.l.</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Italy</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>18
<FILENAME>ff12018a1ex23-1_tiziana.htm
<DESCRIPTION>CONSENT OF MAZARS LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM, REGARDING THE FINANCIAL STATEMENTS OF TIZIANA LIFE SCIENCES PLC AS OF DECEMBER 31, 2016 AND 2015 AND FOR EACH OF THE TWO YEARS IN THE PERIOD ENDED DECEMBER 31, 2016
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
23.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent
of Independent Registered Public Accounting Firm</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
consent to the reference to our firm under the caption &ldquo;Experts&rdquo; and to the use of our reports as of December 31,
2016 and 2017, and for each of the years then ended, in the Registration Statement (Form&nbsp;F-1)&nbsp;and related Prospectus
of Tiziana Life Sciences plc dated August 23, 2018.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 40%; padding-left: 12pt; text-indent: -12pt; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Mazars LLP</FONT></TD>
    <TD STYLE="width: 60%; padding-left: 12pt; text-indent: -12pt; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 12pt; text-indent: -12pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">London,
    United Kingdom</FONT></TD>
    <TD STYLE="padding-left: 12pt; text-indent: -12pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 12pt; text-indent: -12pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">August
    23, 2018</FONT></TD>
    <TD STYLE="padding-left: 12pt; text-indent: -12pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>ex3-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex3-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !% 2P# 2(  A$! Q$!_\0
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MXK9+S+Q^8C32.,D98Y&,X]36]_PS3/\ ]#/%_P" 1_\ BZ]/^$O_ "2SP_\
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M_P#?E/\ XJC_ (:'\)?\^>J_]^4_^*KHO^%.^ O^A?B_[_2?_%4?\*=\!?\
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*$\ +U/-%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>ex3-1_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex3-1_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  M (D# 2(  A$! Q$!_\0
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G0(N>IQW/N>M0XMSN]D=\,33I8.5*'QS>O^%;+YO<LT445H><?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>ex4-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex4-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" %J R\# 2(  A$! Q$!_\0
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M"<8RSY/R_)FG:/:.[Z*^\O(+ON_O?=^9](']L/\ :[^;'[4O[2 QZ_&[XJ]
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M_P &[*DA\YP*:?VP_P!KKG_C*3]I'[PY'QN^*W(.3E?^*HY'=3]TKG/;'SB
MN!PN-XZ_9QG/TEPN> 2,LF =OS&FD)ACA#\P)_X]AD]\_O>"3USAD(QCYB*:
M4;_"M^R_F7D.[[]^_<^DC^V'^UW\W_&4O[2!^Z1CXW?%4YSSQCQ1R#C*[?\
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M& ,<M_Q5&0!G]X?NC*X')S\WC: F G!.,?9CC!S\N)B#@G(V[BY)0X*XH&W
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MP/7!^;RR#G=@U\X84$X"\IR?]'Z 9Y_>^OS8.%!'EYP:3"DCA/N>EOG&,_\
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MXP<$CC/NQ(Z?>.5Y^[VH&<C@CC [\9Z\2=,<@Y49P"@J%Q-F3?PX?_P"K_\
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M^?V9]_\ >,/LE_V!>73MZ']8 ^+'_!N"V<>._C ,KN.?#7[90^7YA_T*& 0
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M!'_$@_;&!^;.W_F4\@'!([;?FZ'-._X6)_P;FG/_ !6_Q>ZC/_$@_;%7\O\
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M;I.<U($]3S\V<Y4#:,D<L=I')(;?M4K@J'.'_KMFZT<,%I_TYK^?_43Z_CZ
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MU_K2X?\ $*.&K_[SFW_A5AO*W_,O_+NK;:?T<?VY_P &\_7_ (2WXM?-D?\
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M!_;_ /P;RD9_X2[XMD-C!_LG]KSGDCC_ (ICCD'/3)Y.3S3?^$B_X-Y,@_\
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M P <X^ZO+84Y+?\ A*/^#=__ *'#XM]!G_B3_M?<#;NY_P"*7XPO+9P5! ;
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M5?O;_H)\O33T(EX7\.I<RKYLXNU_]HPR<;VOS)X'SW\_+7^F,>,_^#=G@_\
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MW.,2 '((SRX#G)VXZ#.S!?/(;Y2O'R@DYDRP)/((.06QNY4G_EJ3V!&2N0N
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M6U*FZT93IRI^T_(<;<KS'T^8G[/C/^UE.3D\"3<QSD'-/4H .8\Y.23;D]2
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MNJ^=T*G,N52BN5RW5O+<E\!2,9R' 4Y 8<+M!'/0^6%."22&&:FSM8'"E5<
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MK#K'(41?E+4DGO\ UT_/U_S*4;M7ZN_GJTUZ+\;ZWW(E PH&TCLW[L9."<@
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MO<\L.#QO)*D8C63YU4#D6B2V<JW0;>)"!QD;-H8?=^[Y9)$ 8'## "H(Z8.
MV2)<9 W$XVXW[.<G]YY'5=V:7*K;:_EHO,5E=W77S6MV];6VUM:UME9:%79R
M NT],$;03R#E0 #P^6!C*KORS?*3F+RUZA0"?NE4CXP<XC.P@'.2H3!WE@6S
M@U<V,< [L'J2LF.,9#Y3KL"D[L$1%2!NJ,;R=O+,02X.[<0!_$NW.W;PY?:
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M#&Y(%+MEVS43!0#RA&_K_HX&3ST:/ + [EW9D*LI+<\:+(6&>=V< YE'<'#
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M8)]1G.7PI)!J&[Z[_IT[%;Z+S\_/S\^GE;L@4#<!CDY8X0^F6.'[*,GC.T
M< 4]4)Z#KPQ^0D=#C:7RS$?PY EP%4Y1J>J[L8PP)) R@P.!P6C;^,-Y779+
MEF^0@5)V7'/3&"%SDD#:"GR%B"(R2?*<.[<2##MM?[OO_#;_ (!2BO\ @[_S
M;>>^K_%W&A<'( 'S'H%<@]MG[SY\<[,\3Y8D_NA4H4 ,3QC&-OEM[ @F==V
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MW#YP:^T/^"=Z ?MB_!U@% )^()P/+!/_ !:SQL"0!*QY8G(7S , DKD@?&I
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M1?/:EX4\4:)I'AOQ#K7AO7](T'QG8ZEJ7A#7=4T?5;#1O%FGZ/JU[X?U:_\
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MMI?M==NJ:_+L"@NS?K^&CO\ UV1"<=.0!MXW,0-@P@Y./E1FV[@3M.T8*TH
M!R<Y&20=S =^1GG;T'4,2"02,U,57D@1GG VF$9.=QV[&.P,5W?)\L> @($N
M:;M0DG Z C!1!NPQ&T*0%/)?"_,C@PXW,*%4DDDEIKK9K>W1)+1_\'4.5;V:
MV:MIT\K+JM6O^!'@<8&.!T!/ /?)R>OS'.U\[@H*Y#=HP!ZC'&Y?KM9&5AU
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M/!!^7.#C#9 12 =XW#-E1A,\J3G)(D =5Z_<1OD#'#CE"S+M? 8U6 Y ZGL
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M!#N&/F&%R50D\AN9A&QXW,7.0P_?8R=N0/W9P!SG!.U-F"6W8>800<Y&><D
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M[*E&?\__ (,_9V^,?Q!M?C--X3\&2WEW\ /#6K^-/B[X=O\ 6_"WA[QIX/\
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MNA2#^$8E0#AN/E)R"R$@KDX(2-=VPX:0+M\W*1Y;RR"JAQL!+@%N#^^VALJ
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M'A<2:\/9[W_L?,N__0'5[_\ !_$_!<< =. >FWCID=>5P3G;N0QGELC-  )
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M&8#QA2#EMJ\N5 .>=S!".,8;.%:3;\P!R)2"V,#<5PYRQ7 4@ESM5B&&,D
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MVPEO;N61+&&VMXFVQ*@Y?Y@'!+#,B$,K.Q()4@%?(/(Y' 8-("A8<[9URS.
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M_3".B[R]YWUT=FEKHEJDU;7=.R%&W*D;.%QG$' '! Q)G Z?*"O7GTD0+B,
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MUK-*_P"JMK9Z)+S=]%JMWY#PBGLJY.2#Y?!YS]T[6<C (1F=E";5R*DV C:
M.7W, $P2>#NR<'KSDB1SCCY:4 Y503DX'!;U( !**02>$W! 2&&_ R)$Y4$
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M7ZO1:Z:/6_6WIN4HN]WTT2TLE?;O?57=AH0=\8QD@;." 2/XQPJ'Y0VTE\P
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M%"]ER<E2QV9?)^<'GY2S9\P.$4."2<-FG 9(P 3G _U:D#N/O953W(_=J.K
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M?,R@)!+D[R "RGJJQ_H/O<X/&!STZ!>NW"&+#;3BITPJL,K\PQD&([MOS<
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MG-S;+/T+$X]NG.4)2]K7J5*<946X2J8NG[*<::332JTYMQIJ4=6IP3=V\:>
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M -]XBT?4-(O8=;\,0^(CXETI/L]SJ.G6ME?6,USZ1X0_8A_:5\;:1X2U/0O
MF@B^^(/ABX\<?#[P1KWQ1^#OA?XL_$/P?!%K,EOXC\ ?!KQ9XYT7XL^.-)U>
M'0=8E\-WOAKP7J\7B\:?-)X8?50@)%AL3*I*DL/6=2"C*4%3DYI3:Y&]-IW_
M ';3E[1V5+VFJ-(XW PITZT\7A8T92G:K*O!4Y2I:5(1=]Z23=5.,/96;K>Q
M2N_E=59@Q^9@N2#L92=[9Z+,@_NG "X;*9; +3XR>A&4Y.R0@$D#C$W.!S@
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ML;28Q]X#,84JIQ(^ 14=.NW_ +:_3OI\M+%*_2R5MK6:TLK+2*5TKWOT;L,
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M?GN9W2=+ZT2,V\GXM^%/'/C3P,OB%?!/C#Q3X.7QCX4U?P+XO7POX@U'0/\
MA*O!.O-:OKG@[Q(-*U*S37?"VLO8V3ZMX>U7SM(U)[2V>[LKAK>$I8T[X@^/
M-+\&:W\.-,\;>+].^'OBC5--USQ/X#L/$FJVG@SQ'K>B;AHNKZ[X7AU.+1-8
MU72!)(NEZCJ5A-=:>)':TGCRQKJI8U0I0HRI\S5''493Y8<SEBW[DHR?O1C#
ME?/%:SNK;GD5LKG6Q$Z_MG%SQ658A0YJJARY>JOM5.FER3G5<KTY.RIV]Y'Z
MC?\ !1+P[XL\?>!?^"8'B'X<Z5KGBSX;>*/V%_@?\(_ <?A*WU'7=*O/CMX/
MUK7_  _\8? FCZ=I$=T9OB.?'-_IS:]I45I_;]_J6JZ7:B*[-K"D/Z>Z->:3
M_P /^OV+/#S7^FZO\3? WP6^%7@']H+5],#W37WQP\+?LO>+++Q9_;&MK;Q0
MZ_KFFZ;_ ,([HNI:@7EN+.73?^$>O#;:AHEYIUG_ #??"W]IG]H[X(:7J.@_
M!;]H#XV_"'0]8U,:OJ^C?"WXJ^-O &EZIJ@MH;(:GJ&G^%?$VD6=[J/V.VM[
M-+RZ@EF%I!$GVCRXT5>#\#>./&OPW\5:5XX^'7B_Q1X!\:^'YIY]!\8>"=?U
M/PKXHT2>ZL[G3[B?2/$&@ZA::OILMUI]U=V4DEC=1M+97-U:RR-#/(C="Q].
MG4C55*HW+$8*O5BY0LOJ?LURT;)N]1QT<TN2'N)23N3+)ZL\-5H.M1C&E@\U
MPF&E&%3GD\TG)NIBDVHI4(U+<M%S]K47MFZ;2@\%2=G.<D'=Q(6^]@;MZ[NG
M ,F%*98>M?TW>+!K%A_P<1VOC*SN6T?PW\-=(^#'Q"^)_BVXG-AX>\%?"+PU
M^Q3\-I_B3XH\8ZW)MT_0?"5OX8GO]-UC4M7GM=)D74H=,FN/M&HV\4OX'?$/
M]J_]J/XP^&CX/^+?[2?Q]^*7A&2\M-2?PM\1?C%\0_&WAQ]1L3(;+4)-#\2>
M)=5TMKVS,DIM;L6\MQ;B23RG3S&#2^-_VLOVIOB;X0G^'WQ*_:6^/_Q"\!W?
M]GFZ\$^./C)\1/%GA"Y.CW,%WI(N/#>O^);_ $68:7=VEK=Z<9;(O9W-O;RV
MT<4D4;KR8;%4*%U%5YJ.(PN)A=4H7EAO;-0GRSGRPE*<??@W)14DHMN-NO%8
M#%8SD<I86FI8''X"JD\14M3QRPT?:T^:G#GJ4XT9_NZBC3E.5-NIRQFG^F7[
M,GB#X,W/['O_  60\1ZUX*\8Z]\%]1^(/[(NI:-X.^'_ (OT;X3^)E\.:G^T
M%\2I_"-KIGB+7/AW\6-&\/PZ7%/I4E[8/X)UE9M-MIM)MIM.FFBU.U^8?^"?
MEYX.O_\ @I9^R;=_#W0?%7A;P9+^TA\)O[!\/^,O%VG>//$FFVJ^(-(CFBU?
MQ=H7@GX=:-K5PUTD\T<]CX+T"&&VF@M7M));>2[N/D?X5_'[X[? Q]<D^"GQ
MI^+?P>?Q.NG+XE?X6?$;QA\/G\0KHWV]M(37&\)ZYHQU<:6VIZDVFC46D-DV
MHWZVJ)]JN!)?\2_M"?'_ ,:>/?#7Q8\9_''XP^+OBGX-M]+@\(?$OQ1\2_&.
MO_$#PI!H^I7NM:/!X;\8ZOXBN/$>A0Z1JVJ:EJNFQZ;J%BMEJ-_>WUJL5W=7
M$DA+&4DL%.5.2GA:D)24844II8N>)DHSYN>*Y9J,8./*G:7-RW0WEM:*S2$:
ML'3S"G.$'.KB92HMY=0P$7.BH>QG)2I*I.K&HJDH2<5'FU/VE_:HD\'1?LD?
MMXZO^RAX?UFQ3Q%^VOJ7AS_@H'I'Q.\7:?XZ\?\ A[3O#?Q1U#4/V</&?PJN
M_#VA?#_1?#OP7\3?$/5/%^G:Y'JWA#5_'R^-;_3/"S>)-7\.:"NLZKY]^S5;
M>&/^"A.A?LZ?L7?M+_"SXE>!/B;X,^#/Q @_9E_:X\$/J%CIT'PE\,P>,M<\
M-:7\9?AKXDT?_A'?&?PE\/\ B;2O&.B_\+1\%^(?"&M17NC:'X2NKAK\^*?$
MUU^/VC_%GXJ:#>^/M1T/XF?$'1-2^*>C:YH'Q/O])\9:_IM]\1]"\4S?;?$V
MB>/;NRUJ&?QCH_B*Z=KKQ!IOB&34+#6)B\FHQW$K%CW9_:F_:=D^'B?""3]H
MWX[R?"4: OA<?"V3XN^.V^'0\-01;(O#@\$GQ0WAK^PXXT18](&EMIR1K&@@
M 7 /K]*53VE2C+V;HNE5PT50="K%8BM74;22='F]I[252FW4IXISKTFU-TUA
M')Z\,-["E7I*NL1[>ACIRQ*Q6'G+!X?#.5X)QQ/LU0E2A2KQC0JX%TL/7BIT
ME6?AP+XCR9.K$[OM70'JV5SZ;B^T8V;3WK]5OV@+?5/$G_!*W_@GGKG@S[7J
M/@OX;_$7]J_P9\9VT>:>;3_#7Q>\5_$;3O%O@2/QM! V;7Q!KWPO:VD\-3:G
M#\VC:?<06,Z1ZA)'/^5"+B11M"A2_!2)BGS$#<RS8R&8#*;\L?G"<@>M?"[X
MY?&SX'SZM>_!?XP_%3X07OB".SM-?N_A?\0/%/@&YUNVL)+B2RMM9G\*:[I,
MNIQ6<]U<M:Q7CSI!=W$\T*()9&;AH584E7A.,G#$471<J?*IP?M85HN*G:+7
M-149P<HWBW9WBK^UB\/.M+"5:4J:J87%+$0C54W3J7H8C#RA)TKS@^3$.=.I
M%3Y9P5XN,VU^UOQ-L7\*_%K_ ((2?#/QQ#]E^/W@/2_@>?B=I5_9WEOXM\+>
M"?%'[26F>(/@KX.\7R7=G:WNEZAH'A>ZU22'P=J@CU'PU%J),]E;VNN6=U?_
M  ;_ ,%%-8^!=[^U'^T[8> OAS\7/#7Q'M?VI?C9_P )?XJ\6_&GPGXW\$ZY
MY'Q$\:Q:U_PC'P_T7X!?#_7?"IU'Q T&I:-_:?Q+\9#1]/BNM"O?[?NYXM?M
MOB ^-_&L_C8_$R?QAXHG^(]QXME\=R^/Y/$&I/XVD\;-J[Z^WC";Q8^HG76\
M52>(@VMR>(FU ZN-;<ZP;O[6QF%+7-<UKQ3K>L>)O$VL:IXB\2>(M5U#7?$'
MB#7;^XU;6]>UO5[N:_U76-9U;4+J>^U+5=4OY[B[U#4;^XEO+B[FFOKB66>X
M>1NC$8V-:G5I1IJ*E7I3C*:A.4:=+ T<)"\G9JM+V2J5)P2B[N*323?#A<LE
MAJU"M+$.;I87$4IQINI2A*MB<SQ.8SM#FDI8:#KRI4:51J2Y8U'K*256UM[B
MZFAMK6&XN;FXFCM[6WM(YIYIYY9?+MX+>)%=Y)997*6RHK2/*63:685_4!H7
MP>\$Z9X3'_!)N?XV?!X^,M9_99U&'4O@W?:/\9+3XC#_ (*%>();']HS1=?E
M\=VWP=3X01^'-$TG2?#'PB@<?$N'6+CPIIL^D:IIFH^(6?0G_F*T;6-6\/:M
MI7B#P_JFH:%KVB:E8ZOHNMZ1>W&E:OI&K:;=17NG:IIFI6-Q!>:;J%A>V\%W
M:7MG-#<V%S!;W-M+',%D'70_$OXD'Q__ ,+9/Q \;'XI-XC_ .$P'Q*/BO6Q
M\03XL^U?;SXJ?QE_:/\ PD@\0F_ NSJXU ZE'>JLXNA*6DJ,)BZ>$]K*=)U7
M5<*<US\B6%M/V].-M74JN44N:]-*G#F3:-<TR^MCE24,2L/'#QJUJ-J?M)/'
MITOJM67-HJ5#V<Y-4W&M)UJBA**>O[6_\$V6\/?"7]F3XSP?%*RO+70_VT?V
MH?A__P $^?$]O=VBQ:GX,TK5_A9\2[OQ%XFN(+TV&I:8?"?BCXB> ]7U!HGD
MO;9=$6V&GW$X%E=;O[9WAW3G_8(OOV:-*TK2+?Q3_P $Q?B-^SQX=^)5WI\U
MOJ-M)K?[1OPW\67WQO&E>(+!;E-4-A^T=;WOAV[@EEM;7[/I%M/<R+="RLC^
M'?B3XI?$OQ9HMWX?\5?$3QSXGT"[\8ZU\1+K0_$7B[7=9T:Y^('B<*OB7QW/
MIFI:K=6$OB_Q"L8CUOQ/)"^MZJ8RM_>S*R@2M\3/B3+;>/[.X^(/C>XM/BQJ
M-IJOQ3M9/%FO26WQ-U6PUZ7Q18:GX_@?43%XPU"T\33S^(;*\\0KJEU9Z_/<
M:M Z7TK7#Z_VG2CA/J_L9<OU:>%C-NG[3EDIUYO162>-^KU_BNHTYPBO>BUS
M/):LL:\>\3"-1XZGC'2C"K[/VE)4L+!IN<6W'+7C<*KQ2E4KTJLO@G%_JU_P
M41U7X(VW@C]B'3O%7P\^*FM?%&X_X)E?LJCPOXQ\._&/PEX;\ Z1%-HOB=-)
MCUSX;:A\"O%_B/Q'+9WL=_<WTNG?%?PK#JMG<6]G!'I,UE+?WMW]B>Z^%%K_
M ,$W_P!O*3XVZ+\1->^&;_&G]CZ#Q+:?"?Q/X?\ "?CRWL)_%/BB)M3\.:CX
MM\(>-?#]W<:7&S7T6A7VEV<.N)#_ &4_B'P[]I.KVGY_^'/VTOVQ?">@:-X7
M\*_M9?M+^&?#/AS3+#0?#WASP]\=_BAHN@:%HFE6L-EI>CZ)I&G>+;73]*TG
M3[*&&TL;*RM[:WT^U@@M[>VBBV1CQ73O'7C?2/"GB/P%I?C'Q5IO@;Q?>Z-J
M/B[P98:_JMEX3\4ZCX?EEN- O_$GANUU"+2-;N]$GFGN-*N=4M)Y])GED%B\
M;SN6YY9A2^MRQ4*3;GAJM"5.=.@H\U3"4,-&4W&=Z\5*FY3=10FX-03NKJZ>
M4UW@:> G7C%0QN&Q,:U.MBG+EIYC7QDXTU4II8:7)6C&G[%U::J1E4E>+2?[
M._M$0^)]/_X*J?L4:#+'X3E^"_AGQ!^QSX>_9%UOP*^I76@>)_V3-/\ B'I2
M_!O77U?5]1U34]?\22:?)J^F>--<O9[<WWBG2_$+V-C9:4-.@7J?@C9/KG_!
M0/\ X*W^#_"OGR_''QS\/_V^O"GP TVVO8;+6-:^(%]\3;Z\U'1_!\_G6^H_
M\)W?^!M/\3QZ#'I,JW!T==<64K&V\?BNWQ;^*LMK\.K"7XF_$&6P^#]Y/J/P
MFLI/&7B$VOPNO[K5K/7KN^^'EJ^K>5X(O;K7-/T_7+RX\,1Z7++K-E8W$DKW
M5M%-'EGQEXNE\8O\19_%GB.;Q]/XC?QC+XXEUO4I/&#>,)=5_MY_%<OB9KPZ
MTWB636F;6)=;:];5'U5A>B\:Z F;1YE357G5&HT\=+%N+G&\83P4L'*E"2BK
M2I*<GAYN*484L/&<7.,F6LEK/#>R=>DI+*X9;3E&E5Y:E2EFD,QC7K4W-WC6
MC0BL93C.\ZN(Q<J4N2I32L2>"O&$'AR]\93>$O$T/A&P\2Q>"]2\53Z#K,/A
MNR\83V%WJL'A.^UQ[0:7:^)IM,TR^U%-"GNH]5-GI]Q,MJ;:">1/Z+O@5\._
MAC\*? ?[/W[!OQ*^,_PN\#WO[5OP=\7:E^T-\*_&F@?&:7XDGXP?M0Z?X2U'
M]FJ\M+2W^$?BKX8^%?%/P;N?!'PIN].L_&?Q#\(7>F:UK'BO4KG0--O;W2KK
M4_P7^(?[27[1?QATBT\/_%OX^?&GXI:)9W(O;71/B-\4_&WCC2+6]10AO+?3
MO$WB+5+.&Y0 1F>*+S6)1P^V.N0USXE_$?Q7XW/Q0\4?$#QOXD^);ZEIFLR?
M$/7_ !7KFL>.GU?0DM+?1-4E\7:AJ=SK\FI:-#ING0Z7J!U$W-BNGV0LY88[
M6 1\V&QN'P4JE2%*I7<XTH?OI0A:E*;>*A:BV_WU-QHQO+EY'/VB=XQ79F&7
MXO,J5*E5Q%'"JE+$55]5C4J_[1&FHY?4OB81LL-54\1)J$9^T5'V+7)-O]>?
MV$/%_CO]DW]GG_@J=JVJ^%M*N/&'PHF_9?\ !'Q!^'7BVSTW7= \0:?)^TA>
M?#KXK_"[Q1;21ZKIM]H?B[PSJ'BOP)KTUB;@KI^K7ESI5[%=1VE['U?[;VA_
M!C2O^"9?[-FK?L[Z[>:K\'?&W[5GQ5\;^#-%UF:YE\8_#R+7?!5L-8^%WC9+
M@/*/$?@'Q+:ZOX?MM16[U*W\3:!:>'O&%KJ-W:>(XG'XYZI\8_B[KY\?MKWQ
M4^(VMGXLOH\WQ4;5_&_B34C\39O#E_#J7AZ?X@M>:Q.?&4N@ZE!;W^D/XC_M
M%])O(8-1L!!<0K(O,KXE\1GP[%X/.O:W_P (BFMOXF'A5M5O#X=7Q))IZ:5+
MKXT-KL:5_;DFF0QZ9)JOV=+]M/BCM_M#0A8J7]IQ6$>#C2E*G]4KX:E.I*'M
M*4JV->(YTX*SC.BJ=.M3VE5IQJT^5JSQ625)8^.8SQ$(5O[0PN-KTZ4:OL:\
M,/EJP?LI1J/F4Z>(E6K8:K\4*%:>'J\ZD^7WK]C3(_:Y_94&6Q_PTC\$,#]^
M$&?B=X8^[\FT#. <$_,?FPO _4SX.W]GX3_;F_X*Y?$+QC#<1_"+P_X%_;M\
M._$B^NE:+0K^7QY\2]3T3P)X#FN+Q[32;GQ+X[\9Q:79>#=!GO[>_P!<UFQ=
MM-#_ -F7$]O^&VAZQJWAS5]'\0>'M4U'0=>T+4[+6M$UW1[V33=8T?6-+N8[
M[3=5TG4[*[@O=/U/3[V"&[T^^M9;>YM;J**ZMY4EB1QZQ\2/VB/V@?C)IEAH
MGQ>^.?QB^*NC:5J']J:7I'Q(^)GC+QSINFZH;>6R_M'3[#Q/XAU2TL[XVTTU
MI]LMXHYOWLB>?Y$C*<L+CJ>%I1BX3E4I8J6*I).'LYMX*KA%"KS/GY4ZSJ/D
M4G.,73:7/*2Z\?EE;&UIN-2E3I5\#' U[JK[:$8YI1S!U*'(O9RFXX=48^TE
M!4YR59<[A&#_ $0^'VI_"G2_^"2-C-\7O!?Q$\<:&_\ P49\6Q:?IWP[^)WA
MWX6:K::JW[,W@5EOK_6?%7PB^,5KJ6GK:BYB_LN+0M+N/M<]O<C5A%9R65VS
M_@D:= NOVH_C!G^V=%\+W'[+'[2?'^A^)]?TG0)/"R_>+#PC8>(=8L-.?"EO
M^$7L=8O82P&C07'^B_ 'PV_:/_:(^#FB7/AGX2?'KXS?"_PWJ&K3Z]>^'?AS
M\4?&_@C0[S6KJSL=/N-7N=)\,:_IUA/JUUI^EZ;9SZB]O-=36NG6D$DWE6UL
MD6<WQQ^-=QXUU_XFS_%_XHS_ !&\5Z5-H'BGX@3?$'Q6_C;Q-H5YI-OH=UHN
MO^*VUHZYJ^CW>B6-EH]QI]_J%Y:/I%I:Z?+!]EMX84UIX^E"KEM9TYN6"IT:
M=2'+1C[54H8J+:JJ7M))O$1:A4@E%1G:5W$QJ91B*N'SG#>WIQAF=;$UZ=3V
MF)E[%UZF7S47AW#V,7%86:G5HU)2J.5-N/+&2?TC\5_CO\(;7]EKP9^R)\$(
MOB9XJ\,V'QGU?]HCQM\3_BIH?AWP'K6K>/-2\*S?#FQ\+>$_AGX2\6?$JPT/
MPCI/@VQT2[FUS5/B/KNK>(?$UWK!;3- TRRTR"?[+_;?\%_$WXB?\%2_ VI?
M".SUO5]/^+E[^SCXN_9BUKP]_:%]H=[\.X/!7@8Z)KO@V]TJ.\@M_"G@^]T;
M7KC5[ZSA%IHO]BZWK6II#&MU<O\ BS&..V">IV DL6ZY?"$[0 0Q:+:!Y>)
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M:\G+$3J8]T\JEE^%JXJC)/#4YX:I*56%?#S6(E1;PLU4@HSA[1^V=G_AL/\
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M5<JX+ \$0F15^9'/S+M)E5<!20Y;</NK<<!>$"#8K%=S?NQR@!D8< TB@;4
M5.=Z_<A!&3G<,3D G[I9"^T9+ $U(L>0"P !<G 6(9R 0<"<XROSL<A@B':N
MYJR[^K6GK*_]+6W?KIT:6CO=-6>MW=I73WOOZZJPJ^8X.WS.2I #7(&"5 "$
MJ,CYB%*G8%W$D*":D*8+D&3)"=#<+CJH /.!U0L,>6AWL"I!(-H!P /FSTC'
M.<Y.)LDX.]C\I,/R8W\4_9N+@#/W<[E1@.,'?B7+ +@OT+0[$7+*:7;HM.NG
MV.VG1;:?@/757TM;5K7M>UET3TM9[:)64EL$9<_)QS,@^88P#M^3<!@E>8@-
M_60Y4;V( +_=R2QFC!W=<D@!2QQE3\\.T <2<R+$O.[!P"""%Q@8W!N3G(QY
MG9E\L#[I-2X/]T]NH!'; .#SG!W8R&(!!(!-+R^_[@3?17U6U]KZ=K/^NA$J
M'&69B?FXW2#DD')PPQD@'##]WCRQ][!D  /5N_WF<\$DG(8GN,\C"\Q#&XBG
MJ.,D'GMP6 )SSAOO$8S@L&RS@_*#2A<D$@@GYMI*'!QT)5R#AB#P6R,SC(')
MW]?\_P#/_@]WROJ[>5V_+97[:^OF,SSU)_[Z/<'/Y_-QP3^Z[8I!]&[8^5L=
MNC8VD!B3D$!F)B)RA G"@G!&/E.,[0N>XW&0<=5!Y)3$NW)X3C(X!Z\_*?X0
M.2'P<\*QR/+0>=]XD46_KMOW] 45M[SVM;3\]?EIZV(PI. ,GD 8W-R<[ ,#
MDECA>[G(.  2G';=QR,))SM(Q@[<,3E@H/S288@?)4HP<9QSG)(09YQALR*%
M!  8Y 10KCER:?A>>1]XCD1#<#CK^^^3=_%CB(A0K9<T[>7XZ;V_K[]BN1+>
M+^4OZ7IHB$+G)&2 <?=?MD+PP&00'*DCYU!8'Y1E-O. 1['YCP 0.",_=R!G
M (RYYXJ8JGS<@]\'RESD@G.)CMSP6"@[&"Q\!S33C+ #<.Q*J.IR3\KD#)P2
M QVL!$,*Q%+Y?UH_UZ^?F')_=:]):^GGMT2V\R(C'3_V;H0,<XSAEXW= #YA
MP<BC)XZ]./O#VZ]N../NC]X>#FIL9SG P#U**>#G.#(.>2_&2),PXVC@(Z="
M,9) 1AT!."7YXP><;GS!_#1_7X7_ $)<5W:\K-_BM_GY(K%0=W+<YY#R <C'
M ! 7( !VXV8WG[^2PQMCAV)QCEI$R6'/.[Y"^!GC=%@D ;SFT5Z<*<ABW3D_
MP@$'Y@.H) WL2@!$>*CY('& >-IP=N,D*=K-N R<MD[R#@_*<GS_ .#K;\EK
M\NNQ9K5.ZZZ^>FE[Z]UTMMLJWSY .\_>!YF )ZDDXVC=C=DG]WA4!Q)FF@N=
MIS)@DY'[\9)^8EACC."Q!XC(\CHX%6_3(X]\8P>><$YSSNQG<V&&0I(B:)2P
M8!%.XG!52!DX(P",9;!."1YP5^0#@OT\NWE*^GS^1-^^FW?RUW[E9@S D&3)
M?N;C!X!*D'D*X&X@?() (<;@,QL77>"9<Y!!!NCD'!/*J3@_*7"=&V@XP14K
M*%RI !W^D?/3G_6]-V!S\QN")=NP4THI#?*#\V1A8NK97&#-C))9!G@7&Z0@
MH15=?GOZ2B_+^NMD-/RT^7K_ %V^^\#J26(#AAG@K<8R7.[HC9+,0[&/!\\C
M<#@DQ,'^Z?- R& 'G+DAL@@8"ER_' \TW+9"[3D6'C WG*XP#DK'V "G+3#<
M"08UW;1N4LQP%8L*JP(90<+D$>2 -R%2AQ< E>"%R0NW=(6)QA)VUOJK:^=H
M6M==V_/?3<.R:NF[-Z;NW1I7^6W9E5HR00!(Y.7^[.V6!)PY*8)4KM ?+;RR
MM\IPL&'!8E7 8#;N#@8VE03N )((;890!MW*,[15PJHQE58&/^(1@9.5_AE<
MA<8!(!5%42Y!R3$X 4'!YWG<$C4JP 'W%F)4?=W$!BOWL')-;0J-^[*[;T6_
M:3Z279;;VTW=\I1:_P +D[Z:K23?739=5=V^5,J1C86' '.]OE .&.>J '/S
M8C=#AFPJXB<,57 ;<JMMP90<?*",C.\)C"D JZN\@.%8"P %XXZX&%4+D -E
M )& 7/103(&&TQJ"!3&0?> Z=<;-S9!(*[G W#!VLQ4KN:/9EQG5VZVLG>[Z
M:VOZ:[MV2;Z$M;Q=FG=776]UNO5^FSML4_G.QAYG<*#Y_P K=\ +G)W!2P&/
MEWX4EA4(+$@KYP"LN.;DX//0JG$@&W>1\^S!7DFK++G&T*0QP554PV6+#Y2Z
MY4Y,B;]I6)73#2$"H2HP&X.&*EE6/!R&VY+3#J1O(. 4 4LIW[:33;36VBTT
M=^;5/YO5V?=:LB2WTUV3LM5[[71:KU5[/5O0K%&Y!]=HRMP 3UPX,87<RJ'=
M>&VHA"C;BH)%SN8AL]PP8,3D!C(S 88'Y79B"LC+LW D5;>/@;@I)(; \L;>
M"VW<)E+<?."H*ON4,P.0() ,OQCG.1Y9(/..%E?D!]H"EMX,C':8<F)+KKK>
M^^]U?\7OYZKO#UNWJ^OG\.M^M[N[ZO75,@.22""IR 20X(Y^Z<G*K\O*G"@K
MR=K$&N^]3D;LD9',K'8&)Z#/3ERN0"<0\C -EUP20%50.<D$ [L=W.1@X&TE
MY(P'*#DU$ZJ<$@YYS@(3P"%SEN'5_FP0 /EDX'6X2<GRRUWM?R6JU]-%TOZD
MO3K:[5VGM=[I-V\VWTW93=2JLX,F2%  \]L'.6P0IXPP.5^\24'W*@<$D\.2
MHR,B=AWSM^4X."&!4YWX_ND5<V*< A2K!,X"8'S$ 8,@S\PPA[2[W.0<5690
MI(^3&PD<(<D[AA290=QP=N0%4J6+8K2+MZKIM=:>5[JSOKJM=F9RBMUI965E
MU=D]NC7F_-%8[B"/F.4Z'S3EMW Y4 N9 <='-QDD!>:^O?V 0W_#7/PG^]T\
M=[N7.3_PK3QIA7&!C:<D&0!BQ91G: /D1D'7 QM&[(1<%3M'24D(VT#&-BKF
M3=D#=]??L" ?\-<?",C@ >/1CY1S_P *T\9YR [8X(P%+Y7#'&[)];)[?VME
MC7_0PP?_ *D0^7_#_=X/$O\ R3N?]_[&S.__ (25?/Y[:?>?@4N, \#,G4X(
MQA2<J$R0..00&7:?*)X$PR6 )SSW.[&.23^[&X <R ;-T12/YRAID><9'4-D
M$;MPR %)PV,GGR\Y??A"Q&:D') (;&<X D/? P"YR<C,6_<6E,B@A54#Z"^L
MG;1\R_"6J_X?OJSXO?E773>UF[_Y7O=?F2$Y).>KG)9ADGK\X$)!QD&51]\%
M%60[":FCX3ORYR"1N!!*CD18<J0&#X/F7 $18JV3" >,;AROW?.S@YVE<R9.
MWGRLDH6,@9< "K"9*I@8& ,+YFW'W 5^?(!&$7H _P#I)&236<M$O6V]EOVM
MY;;:6=D:O9?Y>7YBDCGMR,[2&P221C]T>5;+QCYO,N"\!PJBG C)Z+P#E&W8
MZE2@\KYB#EHLY\QVD5AB,8.2#P3G'3S%W;CM."' &0-@8;?+D#7)^_RH#-G
M)^7)VATR""&VDO\ (6"X7&&A;<^<ORXV6O\ 6T?\O^',WO8F@^YG'!( PW
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M_8L\'?L__M2_M0ZKH_C7X0_"OP/!_P *9\=7GP7_ &=O#GQ2^)'@'X??'/\
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M5@9<A/5N_JOT\ME;YG3%_#%[*',^C3FG:^EG9<W>^SLM21?O X!P#G:<@ \
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MI"$D8K-7WOOKKIIIW^\VBG:^R=W\K-1_)^NFMK2;E  49R @P=Q/0 @X,1.
M#D'(_=8BV;EYG0#*,.AW#.5(X!'00#E@ 6^[M*HN6 %)&C$Y"DDQDD_O<@@[
M3D>8 3G!<,&<.6 ;"@"U&C *2#@;N?WI')P"0TI+$J2JD@YW;\C&#,Y7TNM=
M&K[W4E;?\EKVL7!:^2Z^=DTOPUU^?050,*.K-SU!. "<%A -P7 +':-TH5/X
MBRV%7 P.K9.21D)N*_-A!M9B&+ @E'PJLR8%1Q D*,%2 3G,@V@$CJ)!N&,K
MCG>Y\[!VY-D# QD9P23\Q(QD8;)^;  [D."K')!J'9)NZ6DK7>KNG9+;9]-]
MD:N[M9?$[O>Z5]ETN^_:_D"CD#J 0,9 SD]"=C!2W4G#[6P.A)J=%QM3. #S
MR1QD@%3Y;$9.53ES'('<KAQAJ(1C(QD-G)?@!22#A@<,O^M*_P#+)M_\7%A
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M-P!*9QY:AU898"HF4#[IX 4  $D\  K\N<%23\VW:F<DN!FQ(&YR'P-VXGS
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M/.XNKD%S_%LSO,;#>& ).Y@6$$<[C@!AT=N-PV,!M)+##8.,NV2PX7,IRH.
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MOKTZM+OJ]%M_GKT5KR*J*5)V ^6, >0?W>,YW<'8?X&!VD*Y;'%61L  P"V
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M^R_O=V_YJR;UMZ>F]K#?Z+^O4=M7#DG)&S@#!8EB!M_>#DG*QDE1','F.Y7
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M0<9R>IN5)') )$?7<5&<4_(R_8E1C*#IE0<_Z3SDD #Y".OS#-1_*NY01M!
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M6/)P0<( 2"=I"@9<+*#@<8RUU6D6[I=5?O\ .[>KW14=6N__  >EOZ\MF3H
M#R,@KGE1WY(/[\8&<MG=D$X$8&*G100,=3QP &R>>IG #-@G/R!0KJ0=RBH
M%!'S#[F<L8C@\=<P'I_$.6)Q\_RU.,  ':"% (9HPHZ;@Q\G@9 WD@D2>6H(
M#&D^B7=?FOUO_ET+5DGYIO[U+_)$T8SR-O!R<IU4HP5@?-/R@'(4A2(R(_O
MM4RC).03@;<8!R,KG=\XXYY X<^6HD !(CB.5;GH><["0>3DX08DSDE6WCS"
MZ@!0!4R <GY?X1@-CY">JD+DX.-C<KN',> 30OA3Z6U7R25NFZ*23E:\5J]7
MM\3>OKMLUKZWLIG.1@$?[.>O. #(V0!N8##%W+1#;@,+,2@8.,?,1@CL"?\
MIOQC)Y^<L.< #-5DP<$MM)QSN & 0 0JJF,'Y5*.F) 9&RI&+BX 3#9Y)',6
M03R0N( ",E@-H0COZ4DVDUTNK+YIO]/^'>O1!-J+_P 4F_.7,EYZ]N_97N]
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M-;_PWX<\0P6BW5]XG.L^)G75_%7A'28?[7U7P-;>--0M+[1X?#UWJ5G^F_\
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M3A4Y(UJ>(E5E2J5W1\K_ .":'A0^*/VJ=)\7R3R2Z%X.;PQX1N+<0"==6O\
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MK1_$EJEU"BI(8U9(VV/*F]-R[]I/1<Y4!03] #2\3>"+.\LY&C@B9PA"@(,
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M8\%LY86^"I!J7##'#@?-NW";C@;MX+8QLV^9NS^Z\LQ\DU&=ORX"YQUS"?\
M:R,,<C."0/D+?Z.6  IP !3A1C=T\@].?EVN<D9SA-WF-F%L;*^D>UK]^OE/
M^M3XJ*M*7_;O;K9_UZ?=:53EB1(23G<PE&1RQ(C)^7(16;'R,JK !B3!?\Q
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MV=P^ZQR9FP!SAMS$$CE@LF/,5C&H^6H5"Y9AL_@'R" 'HN#]_<'+;=AP56<
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MLL:6'_"/W^IW?BC3]1W32236,7@R;P[JOPUUZ:5#K5[9ZK9DJ\4M[C]+\/\
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M+;36;K?S0N&EBM"$C\9^*HV9(G\B7,*6\\?'EL@A;=)&;8B#]0OVS9!<>.]
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MGA?5=,\)_M)Z7J5IX)>=O#]Y=:=\=[_3?MUGN(5FNY+5]1G>+$,E]=73VK;
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M2 GL&P"7P!D]A;MP.A"^9N;:20%.)8FP4R6 RQZL<'#+T\G!(9@#M+[WRVW
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MD%5&+ Z+G_GH!D*YQG.-O^D<[>?+XRQW@D[0!4FFGYW_ ":\^_I\KFNWRO\
MF[_BR50VUAGJQP"SXY.T[CY(!8\B3)78A$J@BIE!RQ))S@$%F)_N_,"B=>%8
M,%VJJ2)O+FF*"H&0.)#D!7  !W<%I7!.TAB65R\>(S@@K4T8.[KMPP.<'((^
M;^)W!.,%0V\2*5C&PH2,JG1+HDK:W]-=?GZE1OKWM^;MHOG;9Z]]43XY"Y&<
MY).[ YY+ +N(&1YBA0I&W#D]9A@#!./F)PY9L<@-G$.T[20) I968KM?:I(B
M4'<@ .05^Z&; #=5&\$E3]W+%6)(*#: )U!)(  4$8P'(&.%Q^_!V@$A&W+N
M&XF,_P (K+Y??O\ U;MT-7HO*W7T_I;_ 'EE6(+98YSP 7.02<#=Y)*G!&'7
M?E\Y"@<6NF!G  XVM(V ISE?W.&VD_)U,CD@CY.:JJ6+$*>2%4;7&3T(XG'R
MG@<;2H)?G-6L$GUR,<*RY)Z!?WWRYP0G(\L[FS\P(REU:WM\KJ*2\M[=?5VV
MW@K16F[_ #Y/T_IEA>%7!&< D LP&<8ZJI;&.#@,Q^4H*E0D!CU/ ZG..3@?
M+]XX+98IA0Z_-N05$H(4 XR#M.U2HXV@8^=NOS#!SM.#N.<U,JG;C@YQG.0/
MF(.,[\@9QO)#%9%C52N]@<)W<O.T=NUHMOSW?KTN7';YNVCZR:6_XWWOL3ID
M \]NS.!C"8('D'[P'[K=MV1\,05YL)\H90PYP>&D((*8QN\@\*053;E?*8$O
MB-28 "!T/8G*.#RP8,V)\*[8!*G*[RJ #<#5@*200N&,8X*/R3R %$P Y.>H
M3&4V@'%.*T6NEK].W]/3;\2UM?9=_P##%:]]6WTZ?,EB!^4D88 X(9R<'()
M:( ':!A KAHRSY!4$VH\JBYY!&<<G:>"H.$)P,*KD!F:/&]4.YE@4$!0"3D
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MIHGV+4OZX?BEJMW^S7^RUIOPZU+QWX%U_P :^.]-B^'UU#\)-/O_  _X)O\
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M6EX W;@V%ZEB[ L%&XF)0Q4\DLT:A?+ !*/B]*"",!U'/"J6(P3A23,REMW
MX.92%W%?E-5U) PJX88)&_).20 3*_0ME<B3<Y*8&T$^%3EK;1)W7;K)K576
M^G^6A_O!-;2\DNEK6F^NG9:/L_-57SM;IDC!R2JL,]"Q0$ DE6.%PWSAC@$U
MWR-I!.0I!'S#)9EY?$3%,X(D4!EB?:-^'W59(/=>P#+C( (/)&\\ 9SDN/+R
MWEDC%5V#$#'9<X.22!U&1,NYE! =PRK(3&PCPG&_]=.O]?=ZW,VFU*+TW6MG
MK]_EI^#*;*P8$;F R0N7# C&"08&1<[4*J"V)B06 !802'(0 D@ERI5V&2&
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M\[KDNAPH45;3 50-N,_P,@7J?NG' )&!V0Y8_>JL=WS?>.<8.9%X;*'H/ER
M5.W_ %*@W!P')J[V0D$[HR2760#DLI8# / 4;CS\N!R<@-_$G_=UW>]_ET_K
M4J.S]5^3W%7AG!VE@0#@QYP&;! 08V;L^402&<'.0>7CL??CE2>6."N .C$E
M N!ORK<"FKG:,[CP#E@RYR,<A@-K'H00"F0PP5.'#OZY]6[L1\Q/0GH2V"A!
MD')!K-_$U_>C^:_#L=*Z+LFOFK^GWD\>W##Y?NJ /W7.2Q 4F,MQT&#N'7<,
MU)\O!^0_+_TQQN(/!_=_>.._[T<_/DBFIN&_&_!12?EG4<J#R-@^7!_B)08
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MD*2<"L&M6^C:5O+16_KKJ]1JUHJVC3Z=^5->K;V_ =@#@,"#@#B/YMORG[H
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M,T]5Y7_7^O0<?BMVNOPEV_4D7 W -SYC!@3&VWRR/]8-F)"&8AB27G< DLJ
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MV%[_ # 1;%"@*HW!<;2KG!<,WEG(()R8DW$$_O<X (/VD>Y!X!&[^)A^[3
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M[067A=H$T7!!!'S;AA0G;/"%% 'S$D,F"CE@Y(Q466)8'<1EB<F506"E1NW
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M@$H3&-A)&W]SY?EL#+)GS!5L[V&,2,#$<[A<E6.WHP('5<;MPWF+ QGI58L
M!F3H1('\X@],^:  2!'L\SS>D6SR^0:^2C\4?5?G/UW_ #?H?[73^%K>RZ]=
M&[]=7KLM]-RGP0,A1TP!LVEER5"@*!G@,"@$G5-Q)),# %B&P>,$$1YRP; P
M5(+ ;O+#DN0958EE&+4@.]OO[F7)W>9O')^^'&0-P!RW[O<5(;'2!MP8 %^4
MSC,@ZDYPPZ*VWEES'$RX! E%=7]7^??_ (/SZF5[MM[N[>^MWKOW_P"#JMZ9
MVC8?W?&X8S 20%7)8%".0<'(X090#%0,P(SE >221;L<8)RR^5D\88C."HV
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MBYI_ZA57Z]?ZM<_GV'7G'<\A.A&W'+C QA" 658QY^XYR7J!N7'!R1PL8;#
M*>DWREE^5]N[8NV0E2YPB<%B2P&PGCD'H?F)CX7!#%@ 3%L@$9)(IP/*>Y('
MS\]B06\@9QG+GY=T91/G*&OJY;OT7;^67<^&A\/W_FD6AC8AP!R#TCQG;C!Q
M*P^YEE()/V8/&!O8"EPNT_=(W9R!'MY4#D&3D>7\W9OLI$97S 12 @JO0'C^
M+/)(R1^Y&X;OWAX'[\+!D*Q%.['J<-SS@YSUQY77=^\VX(^T9@W;!6:^+YOO
MW8GM\A& ^?.T9QG>$..,-NP_S83#39V[H"B)EP15\8 3C^ 9R$+ AI,%MLC#
M=SD D;B=G1031)'S=>-N0IW=SC:3&?N'YX_O>;,S0MA4!J^,$1X(^X!A6SP7
MDP%;REZG[K9;:V6S@A13W_[=7ZE1V?JO.VCV!>GY9W%2>!DAMK$9 SOVDAEW
M*#D EW7/3@G)(''/(.&.0!C<5W!H\ $$&FKC'&!]W[N6QCD $HNX XV'"[F&
M"N&P'CIUR,C.,?WNWR@'!Y7[N7RAR!63?OV_O+Y:K_/_ (<Z5_\ )?BY?Y?\
M,6!@[B1@[4/*PDY*C.<3'G.>@W9_@&#A_P N1D#[OI%UP?\ IM^I(<\YCX +
M4/WL?W(Q@/D#Y ./]'''IST&3)_>>,\<Y^0 ?/\ 7'6#CO@8)'3S>14SW>_7
MO_7H*/POUEW[OH.&/EX7ISA82>F.AG7)&<+O*%LLX#;>9SC:O'&\=H2#RO0&
M8=>0-V,')^[S42DX3D\ #E\?PG S]F;;D D9\S:F1N!88F[+C^\"2'P?X>H^
MS\<8R,MA0#C)(JGT^?\ [>=,/AJ?X>[[5"\G '4\'C@#&%Z').#CH 5 _P"6
MF":6+&P\#&T=EZ;Q@$AB5'?]UYH[,5'S4U/NC&1SW/\ ND_+@'TW'(!X_=\4
M^+[K<G[HSZ?>';:I<=,@&$!L$!L$5@^G^)+\D2OL;:1?W7C^'X?B+]!]#@#D
M_1B%/4G:78$!"HSS8CQM(VKCY2"5A^\=W/S3+@$@9(.[=E?+7J8#G)^@!Y!Q
M]3M&X\\X"9;#;B,XG0\'G'W/XN_S]_(;H<Y7'+<^:P8!2;LF_G^&G];[VT9J
M]5\W^OS_ .#YD@5<M\J]1GY8.3ST/GC!QR=Q7C@#-/XW/\J'@$\0X/ P.9AV
M!*!@H" J"<TF<;N0.G\8Y^;U^S?+WR/G&<C(ZU)QN?GMW8>@[?9R%)/).7 ?
MC"@UBNOG\]W%^7?^M+U"_N^O_P K\_ZL. &[E4'R#[RPE0!AL,!,&*9Y;"[2
M<H">!4X51M&U0H4C#+$=H& 5;$N, X$H489VC(X4XB4_.,$\1K]U@2#ZJOV;
MGD# S\S\E!G-3@]!T^7C#!B, [0O[@;]HR(B<>8K,Y!,8I='Z?I+^OR-^WR_
M3NR>(+M4X486;KY98$2("2HD*[P2%EVYS(?-'W *GXST&/HA'7;S^\)//R;@
M23_Q\XXYJQ'YH\9Z-]V0<81\8/DKD!?E7E?,B+/R0,V@>>HZ#H3CIV'E#(V]
M 0/]'RF[=BK:_)^75]O70S>Z]%_[;YZHD&/E&!T'7:!S\O)W<9'REC]V,>?U
M-68PI3D+SN^\%RP)5> ) $'12K%!_JYE)+$57!^[R!P.3R!P#R F<!?F89):
M'$(.X'-F'[O4YR20I#,#\O+DQG#;3D$!PT3!"JM'FLI?#Z?AO_7_  #27P_]
MO1_,1@"OW<DN.T63EL$,YD.T9.R1R,"0F125 W60,,P^<8V@!PHP.1\A5F^7
M.551E0Z[]P5P:@;&P@[=NY22S'8!ZL!$"R!>J[OWD.7VACD6 /F;(QG:>)/,
M!P@']Q,';@'[H6+8P0G(&<O@7^)K_P!)T_JWXAT^3_\ ;?(FCQ@=3EGQ]U5&
M0H(!WD@,<K(4$GE_-(VT'B5<'(^4GL&"(?F)#<B7";P,.5RT:*&VYD"F*/!P
M>!DMU.0<*I.5"<A1@R F/?&%4;SUG4X#<@'=@EFW8 .3O_=X=1P9  OF QQJ
MY*L1E'XEZ_J.'Q>E_P I?EN2KMV'A<%WRS>6">%)+J)/W>[ 9\[6BP$V\D5;
MCQ^\!X&\YRJ,. "2Q\S#84JSKD%XBD0^88JHG"MC(PS9RP=E(QG.(@'8$@R*
M WF.4(D(4D75(*X.>>&"L&/WL?\ /(98?>3.29BZM\H4FG\3_KM^GR^^QT+_
M )=/HH2?WSC'31^NZN_F3* 2?E)&Y P)C(QSD-\_S<8W''S*57/RD5.,;ONC
M@GH$XQCD R?,5ZE<8(Z$$577''W/O1X.[UW?=_=G(!SM)SEBXQ@"IQG</J>A
M 8^FW]U@-G[AS@G(VFLJFT>_-_[;+^OS'_EV79?IIZ>1*.IP,>F A(P#P"'.
M2 0%QD/&=YP8\58  &-HX5?^>3X(SR&\[DCMC+/W P:@!)W=#G'(/KDC;^[&
M >67.W8OF1XSBK"], C[BCY7P,X., V_&<_(/EV9PSM6:W?I^G]?\$U73S;V
MO_=_K_AB5,;1E5QCN(2.B!O^6V"@R-YR';,?R85JN84<A5R,G("9RQ&<9(!R
MP'+E?W@W8(P#43A>H!X.0XY( ((!MN".=B8.[,F9"4&;$>,$C;P!T<G@DJ ?
MW0PH' ;;(6C^;*GYJ$US-=V]=.EO\QM?E^?,6$'WN!D,N2-N#QD!B6&1GJ7"
M!02<XP6LQ@8[=0#]S.-H4#/F#Y>=@&!&%VW!ERN*K)_$#V88). /EY)7:V .
MK "0L,C R M@<*/O $J.H(()4' \HXW(<,Q+;("P\HD 4I:.RZM+1^CV_K<V
MI;Q])/IY_C9:/_+2T@&$P!R&(SY>>ISR)20<GD*&'."5Z">,*53&.K8P(P!G
M.1D2D D!MS*7VQ!\D,X%1C *Y/4OU(!^\W51 !GU'R8/][',B8VIR?XL<@KU
M&>?)4D#AB!Y>X[8_F!+4I?+>_P#Z3_7R.B-^6.^R_)][_P!?-NS#@JW"_P"L
M!QMC'\. 2 ^.0 0N=RQ!%*@YJR@!/0G!XVJAYYSG+@%@""%Y$HV1<$D56B/R
MGDY\PYR1D'J23Y(R2>6 ! D)3=@"K4?).,GH/OA>KD #]V<DL<1L?N3')^5,
MB%\2_K^OZMT*CN[VV\OU_K7IJ31X#)\H[C@1N!C)X+2#=@DE<L!(Y:+I$*G0
M+D?*/OGIY6, <Y/G99!SD'B1=XW#8*AC/S)@YSG&T[,YR!@>4^W)!5.&VR!Y
M#PXJ9#EEY'^LR.3]05'D<,<9B7/# AD(?%#MIZQ_-FSZ^KW)1@L>!RV,;8^0
M<Y!Q(S;2AY"JX,!V@E@:M)_%V]/NG&.O*EN0,$!-^]2JD*0<5L_,1WWCHW^U
MQQY2Y 8E@2R9EW18P!BRG)(XPV ,-D#EL #:N>^P_NPK%@=X49R?Q??_ .W%
MQW7JOOM+[NA:3 '_  /L$)!&"& ,G+*2Q0 EI26!0[,+*@&&^53\RC&(F/'
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MI^J71.)H&HVY^&GB&76&B;5]3M-6^)$-U=FVECEUW1+=;HP7EG%"DEA>^*M
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M NK>7]]_VG6!U'X<E91.I_8Z_8Z*SJ0!.#^R?\*MLZXAQ^]S^Z&X!69I-FT
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M(#(58''RU5?[X.%.0I) B&6Y!(S,"[-R'W$*A&\,0P8VW/SY.#@-]]PC#YB
M ODOQC@,6DS'N;AANJLY^=.>@'WF^8\=@(/D"C[S$-YD>S"@@@"^&._P]7?H
M_/\ KY&<MGZ2M^/W%5\9QA<;NFZ/:03SRKL5!QA^2L2JA#_O37UM^P<<_M8_
M"SKU\<G)55;_ ))OXQY(5B%!)/RJ6 ;=SC&?DDGY1DCAV)SR0!L_UG[L;P.-
M^&(=2@6-2I)^M_V#_P#D['X5_7QSP6W$?\6V\8=6VC<W][A1@!@.2!Z&3?\
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MIL Z8J88#9)7&Y@/]6>,=QCYEQG<O ([5$U=+K:5WIM[KWV95];77WZ]'W_
MG'\6<GUW;QWY+_/QEL>8#DB8*5PK&K?S?-PWW>XF''.<@RD[?[V_<!C@ U3^
M4;AP.F/]6W3'0*,L54@'9PZ%)3G82)QLQ_!]P'_EV8Y .?FP=Q&3D*=[#);)
M%9KKZ+\BU]GKJ_\ VW^O3R+29/4,3QP1,&Q@8)_>@@MC ((1,-\H,E3IR#SP
M%4\)(,\MR,N3@_>V(4 7]V01@540H%_Y9[>0<_9MHX7=D@8/;S2?WA'E8/WJ
MN*H4')!!(SQ&!G)(9OE5=[$Y_>]9 =H P2E\3?2[_3_@_P##%WT:]/SE_7J3
MQY!. 2=ZX.6)S@XVX8 L#]W9MRPY_BS8 .!A3G<H.TR;LB12=P$@ P1N<+MD
M9P8A( V:J(5&0=N2<D?(#MP1D[OF"DC;ND!VG&,@+BW&5P 2G  ( B!"GY?F
M./GC!PI#%H6.)&&WFE)>\NUU=]+=_P #:GO'_#/RO\7KO^5O)EU 3L(#8^8C
M)E. 2>I:4@G!&"X)/)7'%21@[4.UL[CU\W/7C(:4D'G:BN7!=A)P$ %9"H"$
M>63M;&!;@G&[.T+R.^0G /#=ZL1[-L?,>-S8QY'4Y'&T;=Q&X$QGY(_,8_-D
MTI>O7R\O\OZN;16D?1='U3Z_\&Y:B!V=&^^<#]X1@#'&9"< C!/1FS(!\V:L
MIR3T!Q_%OS@DAL8?A&&1+DY5-\HP6!-2+!4@;#\V[(6(+C:/3@8094?>$(4L
M<FK4>,GE1SV$;#(.3N)&-P !* ?O4VQ#+,14+=?\#M_3-%N_3OV73\/ETV+$
M>=R<$\M][S 3P,Y"2+@[0!)C&(1$P&YCFPF>.'!,O *RY+8(QGS1M<DA3CE&
M,;A@1FJR;0R9*#KPWDN..>2PPV,[LG/F!A""?*Q4R;-PQY?WFSS;\*!\V[C+
M1@9,A^XZ9SGRS3?1[ZK\WZ_U]YH]V_4L#.3UQO&3^\P#OV\Y<KG("98.0X,Y
M/S'-E.ISCD#)PPQG(Y!+84XP=Y?:<NFTL,5%V[\#9G>,<0@@>VT;B-N ?+X-
MOMQ\PS5I.^,#.,?</(^\04XR!C<(OOIMWY.[.+WZ=?GJ]OZ_4N&ZUZK\I?A]
MZ>NI:3<<'#8W/G(DVX_=YW8<$ @#S,G:J^7\O(Q, ?[I^^QS^\W=B2X\P#J0
MTFS:H)5 N, 0*1M_@'[SC(B.&4#!P1\S+DY5?GE+$<F-L2KM(_Y9_*Y!7,&5
M;HOS=7(;(!?)=VWYW T[:?U_E^9JFMO+UO\ U\WY]K@ZR>_ED?+*1@?-D9<@
MA?O,!@2#Y#FK* @'((("XW%V((4'@;B&E&=P./F!$;;@I%55 !< H2?+P5,
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M:-6$X.G2CS5:\X5X<BJ4H2<8MN4X^T3/1?VP/BK=^$?AA\/SX7NWMO'7Q?\
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MSU)(0OSG&&-3.>V.F>/7( X=@,?=R#)D?O, C%6H@"AR/XL_=4X^11QFX0G
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M6SDJ@80O\K!021/&3D$D@?.!AY"N=P*C:J$L<KD;-[)* &&,DP+D.O')W Y
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M &K?$J>)[@RW5E%HGPX^&_@+0+:\U'4%U&/3_P XY_\ @A;HUSX:\1>$)/\
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M"_\ !+J**2":%%;X_P#Q@4)Y\31>7B/]G7)A)).2>6^<#*[3R?AO_@@G\8]
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M32[>:6TL98I/MK*0(9MK _N7\;?V6/A/^U=I'[+GCQ/VPOV;_A1K'P\_94\
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MUVV6UNA!(3G!S]S@_O-N#N^Z'17"8R?G 7 <!CQ4#D[AC(^3.1YAP.Y4!#G
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M@"I"&RYVR=L#_2!Z$XVL!GH<IM( *,>:PB_B]-[^GF$=ETU7Y4GW7;Y?D\D
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M[3$0."=K>7MWG$[!BN1#\V0OSDEV.";@L2"H./F[;MNX#>K,C@C(R+5KM?\
M66OS_P"!=:7&^M^_XO3\7^.^ND+,!NR<C=@ O&W!;< /]'P,G)7 4)M8;1O
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MQG/ Y)SDUDU^7^93W2ZW_3^OP)TV$*#L(W$G!C PS;<C+ @'!4Y(,>PRC"R
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M@V 49004/S\Y,&=P3&"-^ P0$8SN%J"H7?Q5>)F95Y/RNP;<TN?[QWG[-\P
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MK$@='ED+/@K'P8'S<+QMZ>23D':,?-S@Y6/?@NY:;D+FD+@8&1@GY<-(,@#
MV_N3M!&1$#PJ;R7#.,H7ZX;.0"H5G!/;Y3Y/ Q\R ;L1%E;:S#);;^MG'^OO
M$VEY_/UT^;VT%)4%\;,@#O 0,#:/O.#A<[07P"";@,1R(L_," @ 7:,"/<1R
MH;(&=@&%&W,98>8K[B*&8MDAN.,!2PZC([$#"@8*ESY8(V\\!/0YXQCC=C.,
MAL;,'@Y+9#8Y\L 9II?U\K/[_P"KBT;U>SVNM;-V:=^EORVT&DX"$ $A20%V
M;C@9P@4D_-]T^7N4 EB< TQMNU<@, V54!!DY.-F&P&;  $9+*0&."QI=PP"
MQ..1\^>O')# 9&#N8N8_W)''&3 S%N20?EQR6!(.00Y,:GYAP^[:(U"%6.[%
M/_@ZW??_ ">^F_WS+7R7RTV_R^Z^O9#@\@J22""/*&3SM*#<5#L-QB'^M51*
M"OS"F_*HS\N.,X,0&<$+@LR@?*6\HRE6$>]<;MH+LGGGDJ<DEUR#R0W[L% V
M,O@;8BJ 2#S#4)8LRX)P02,^8O.,DD?9WV%CRRH9%5L '!)I='Z/\$_\M$*_
M?3?;SOW\_P"K:-GRL5)V9)/)^SD8 X&6<M@)C8).D60O.*C+*"  FW?S@0<\
M;3QNR5VX4+]V1"5&2I)?N8;,-SDD_,X/4D ?N,!G(.,%@KY0[0,5"S8/4CY\
MCYG!(R<8_<?*220AZH0^5&X9TLE?SOU_O3\_S3$^SU\M[K3UZM?.U]7JQR,G
MA0=V<JL1QP>%\O(95S@%3B3KC*Y$? )( X&0!M;V/&3DC.T=2X)E_@R)@<!N
M1RY*[2ZE@3\I7,.!N!)C+;2JAPRC< 868CH,CC."PP,'!7* D'&$7C9$7R<C
M!'_P_P#Y+ZZ_/==[F<[:=K7?IZV6^MMKVMJ1D+D851QD@%&()8G!*L0&4_+@
M'<9 K$=<03%2-ORYR&^8Q#J?EX=A\Q;!0]3,0WW2:E8[5S@XXZ;B#@[0,A2<
M<[2<?ZO,A.159BSESD_,P&"9.PV ?Z@X& $P,@18F!SBA:O?JNO_  =N]^AC
MOKZ^EK/2SO;?OW\QK$*'8%5R,!P85!P.!DN,C+':K$8EWL04((KD)E\K'_J\
M?\NW(P5.,R9*@@J2W[L8+YX)J64D%U!Z;3\K2$@[>?NVSE?E ^[N!1"S!"Y)
MC8E01D8;Y5)+C.\D98&( !8U#-ASMAYV,SC>=-?+\H/^OO6S8-V>ZUNWI9\M
ME97[ZW5]'J^]ZYV\$;%&U1D^2."53Y=S*I#XV!5)CR5E4L9!FJ^W@8C.,,,+
M%QS@,%0G8,J"/+)PT>]@OF9:PV' SS@<@LV 1M.Y@8"I7;AB=R2& J@CW+@U
M2Q.[)(W'+YR,D87+;E&<!0#N\L9PRA@2:VI+1OK>S5O\3]=[_I97;SFTY-Z^
MZM/\3N]/*S=_P5KLB<@_* ,C! 'E[@Q/R%.<"5B"4*G<'4JV,$&LQ1L#]UA0
M<?ZK&>F8\N-H55! ;;((SC!?A9W<LS9R2P( /F9(.,@GR\C<WRR$@"(JK!R7
MYK.XW9+MG 'S"16P3A3M$#')?.0NY VU"Y# #5;[JZUT[VU:ZZZ].O7K#M9J
M][WNM^U[Z6W7XV>I!(H(3B,?-DY%N"5!0G>Q;;@+RH?&X';C)J!]I(P ",@G
M;&3QDY*@X.,Y"D!9<F/)$?%IB?D'(.7'WI0%VGG/^CYP">-BN=YPVU5R*9;/
M.6VYSG>Q;.3@J=A"Y;<(V^9ED5W9=I4DF[^?5_?)?Y*UW]VV;=W:]]'K>^KE
M-]_EU_0A8KNQ@97@\J1T^[D'YE ))?E60GDD 'Z[_8-X_:P^%(P02?')'*=%
M^&GC $XW9 &5!V@GYHP0%!-?(A)/.,DM@(,@\X((!4+@]1R6+!D*@;2?KG]@
MUL_M8_"CD$9\=]&;_HFOC'MY8 QSL5F7<K.W)3%>GD:_X5\L;:TS#!)+UQ-+
M7O?3M\^IX'$[_P",=SY=?[%S5_=@:ZZKN_\ @['VA_PZ(_X(2\?\;'?VA#QD
M?\73^ '0>N/V6@3\F%^;+!!N!#?/2_\ #HK_ ((2G&?^"C?[0;$AAEOBI\ L
MX( 8''[+@  4 <@84 ]\G\OR1\O*?=)_Y=SQC(./*Z8^;C"E<1;<#% *_)RF
M?F[VYZ9+=(AD 8+!=NX$(=VVOWG^P<JM_N='T2DNDNU9/I^/H?RI_K/GZU_M
M3%^O-3Z7M_S#>2/U#'_!(S_@A,O3_@HW^T$/FSS\5/@'U&.>?V7.!C )Z%3M
M/RL05_X='?\ !";D_P##QK]H'@G/_%TO@$.0<GC_ (9;' 'RG'RA/DX7BORZ
M&W Y3&\=?LYQCZ18)'!( #/D#=\M&5PPRH^<CK;G!'7/[K!(S\V06<D'<=M+
M^P,IO_N5'=7=I][+_E\'^L^?W_Y&F+[?%2_^9>GZ=#]1C_P2/_X(3\Y_X*-?
MM ]MP_X6E\ L'![C_AEOOPKXZC"-P *D'_!)/_@A2.G_  4;_: XY_Y*E\ >
M.H'3]ESJ#P!ZX!!/%?ELQ4;\E!C;G)MSC''.8CD@G&6W;R0XQMS1E23@KPG(
M_P!'Z$8Y_=>ORY.5)/F8P*?]@92]?J5'[I6VC_T^MU_ /]9\_P!_[4Q=_P#%
M2OT_ZA?/\/N_4D?\$E/^"%.X'_AXU^T!V8#_ (6G\ PN%R%''[+HZ$D==Q/#
M9P )?^'3'_!"LYQ_P49^/XW[2?\ BZGP&;(7H"'_ &7V!#'&=P)8C&3\P/Y8
M94$<I]SUM\XQC_GEG&<@$87=F3:,G*KM^3!4YW$<VXZC'&(N,G*C:5VD>8<Y
MI/(,IT?U*CHM+QEI\3T?M>Z]?,?^M/$&G_"KB]-O>H]+_P#4)Y?EV1^I@_X)
M,?\ !"O@C_@HU\?\D!0?^%H_ /)_\U=SSCDGAL#.<5)_PZ<_X(5@#_C8Q\?<
M!0@_XNE\!NN.&X_9?Z]2,?(><#%?E:&0A0"ARV!C[,,GMC$( S_#@ H1G(W#
M"DJ 3E,;SWMQR>F,P_*3@X'WD (W?-@M\/Y2[)X*B^B]V2ZM=*RO9+_*P_\
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M_N?]1'2_X(/];>(]O[7QG3[5'R_Z@U_2^[]8S_P2P_X(:$\_\%%OCP3C.?\
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MK_PE876_2KVD_P#H*LMNEMWJ'^O_ !DM5Q%F5U_?PVF__4O\O^ ?NFG[%O\
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M&KUY?^HO7XF/_B(?&W_129G_ .!X;R_ZEW]6/WI_X9$_X(T=/^&^?B-P,_\
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M+W*?ZOO]GZ=3G]T>,?-SE0N8MM'^I_#>_P#9&$U_NU>MG_T%=Y,7_$0^-?\
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M?]"O@^F3\WE@#&[ I1^QY^UUA?\ C%K]I#OG=\$/BKSD8^8?\(OSGHV[!\O
M7+9%?WQ44>WEMRK[WV:_4.1?TEY^7F?P-C]CS]KK _XQ;_:1/S$G=\$?BL<@
MX&&_XI?)!_C!X(P!T;"G]CS]KK!_XQ;_ &D.6)_Y(C\5<X/]['A?OCYP/E)"
M;2<5_?'13^L2O?E7WOO<.1?TD?P.?\,>?M=?/_QBW^T@<GC=\$?BKW.><>%S
MUQEMF<L%/W1F@_L>?M=$M_QBW^TCR./^+(_%7U!SQX7QD]6VYS)STSC^^.BE
M]8E_*OO?]W_Y%!R+^DO+_(_@=_X8]_:Z_P"C6OVD,;?^B(_%7.<YSSX7'/?)
M^;S><;>:0?L>?M=97_C%O]I'IS_Q9'XJ^I.>?"^,CJN[&).>F,_WQT4>WEK[
MJU\WV:_4.1=_P1_ Y_PQY^UU\F?V6OVD.#_#\$?BKVR0,GPN#@=5W8 ;=G@C
M(/V//VNP!_QBW^TCPP_YHC\5<X]L^%^V?D!^4$ON() K^^.BCZQ+^5?>^[?Z
MAR+^DO,_@</['G[76&_XQ:_:0'(QM^"'Q5&,'^''A?(ZX7;T0L&ZBE/['G[7
M?S?\8M?M(?PXQ\$?BI@8&.!_PC'&.B[?^69(;#8%?WQ44>WE_*OO?]W_ .1#
MD7])=+>7D?P.?\,>?M=9_P"36OVD/N8_Y(A\5<9QC/\ R*^,_P .?O\ E<8S
MQ0/V/?VN\C/[+7[2'0YS\$?BJ03TYSX8Y'8YY\L*!SQ7]\=%'MY6MRK[WV:_
M4/9K^DO\C^!S_ACW]KO"_P#&+7[2!Y.=WP1^*Q)SQ\V?"^3G&&W?P!0N<&C_
M (8]_:[P,_LM?M(<MW^"/Q6Y![-_Q2Y)!Q^\'W3A<'@U_?'11[=_RK[WW;_7
ML'(N_P""\_+S?_!Z_P #A_8]_:[^;_C%K]I#D\9^"/Q5Z'DY(\+]^KA<@L$Q
MD4I_8]_:[^;'[+7[2';&?@C\5?7/;PO@9QE]F<R;2>,FO[XJ*/K$OY8_>_+_
M "\M_0.1=_P7EY>7F?P.?\,>_M=\_P#&+7[2'W?^B(_%7.>#G_D5SS_%D?-Y
MO.",FC_ACW]KOC_C%K]I#[O_ $1'XJYSR<_\BN.?XLGYO-YP!@U_?'11[=_R
MQ^]]K?U^0<B[_@OZ_K<_@='['O[7?RY_9:_:0[YQ\$?BKZY[^%\'&<IOQB3<
M1Q@T@_8]_:[X_P",6OVD.#V^"/Q5Z Y&,^%^W5 W 8OG YK^^.BCV\OY8_>_
M/_/S_,.1=_P7GY>?D?P.?\,>_M=X./V6OVD.&[?!'XK< =E_XI<$ 9_=C[HR
MV3R*#^Q[^UWAO^,6OVD!T Q\$?BMQC(^7'A?( SA=O\  6#8R*_OCHH^L2_E
M7?=]T_T#D7?\%Y>7E_73^!W_ (8\_:ZR<?LM?M(=.,?!#XJ  XQQ_P 4Q@#L
M,<^7D?>XI/\ ACS]KK/_ ":U^TA]S'_)$/BKC.,9_P"17QG^'/W_ "N,9XK^
M^.BCV\OY5M;=]DOT#V:_I+_(_@='['G[7?R_\8M?M(?Q9S\$?BI@Y&.1_P (
MQSGHV[_EF %RV131^QY^UU\O_&+?[2)^8_>^"/Q6(.?[V?"_(X^;/!&-O.17
M]\E%'UB7\J^]_P![_P"2#D7])>?^9_ X?V//VNR#_P 8M_M(<L>?^%(_%;.#
MV./"^><?.!\A(3:3BC_ACS]KKY\?LM?M(<G^+X(_%7OR02/"Y.#U;;D%MN.
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MQ^^7>X<B[_@O\OZ\C^!S_ACW]KO#?\8M?M(#D8V_!'XK C''RX\+Y&,X7;_
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M/_Y(.1?TEY^7F?P.']CS]KO!_P",6OVD/O'!/P1^*IX/KCPQGGG>%^4D+MR
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MO"_\8M?M('DYW?!'XK'(/'S9\+@GIAMW5-H7.#7]\=%'MY?RQ^]_WO\ Y+\
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2J:W?5-?J"@E9WV:>RZ?\.?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>ex4-1_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex4-1_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  < (X# 2(  A$! Q$!_\0
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M?%$[VWC?5O#WC'Q%/-%+=6<@>T_X13RC'7Z(_MA:'XID_81^/WA?6?VE-!^
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**\6G;SB_P5O_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>ex5-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex5-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  H 'T# 2(  A$! Q$!_\0
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MPWDN)P/]H9YAL#3<L;C\?C%.$:M:56G;%8+#X?\ F:^#_P#P6,_;(^%_Q9\
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MQO\ 8OMR>'/$*6BVM[8:O8121-JWACQ%9XTW6[.*YBN(62RUNPE:^TJUA?\
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=F(J9AC<14Y;1YJN*QF(G:*C&,)4Z<8QA0HQA_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>ex10-2_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex10-2_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" .M NX# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M!L(/"NIR:+8RZYI4>G3ZCJ6G277V/6M,D:WF7\O=2_X(7?\ !3"Q_8(^*?\
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M&IQ^)WN=5UN?7++Q-:^.O#EWIEW:VD$VGZG:(8B 6OC/_P '7_B/P9_P3#^
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M"P\*Z-XL\*:/H'A[0+'7QX<U'5-<U34+S]M/A!_P;4?&_P#9Q^+WPXE_9_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M)#:6&F:387^JZIJ%Q:Z?IEC>7US;VTORK^R!_P %2?\ @G]^WOJFNZ!^R/\
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MW\0:G;P:'J/CVYU+P=:Z?JEA!J>B2_"ZY&GW,FDZN&G_ *WZ "BBB@#\-/\
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M1OV'M/\  ?@OX._ KXC?&SPYJ7PV\<,^EPR^%;ZPL/"_A+XAW^L:#9:3X?\
M^%@^)?$?AGP#H/B:U14O/B)XD\/>'+'0KZ_\4:=;Q '\-?P,^%G[5<7@?X^V
M'PV^"7[0NMZ1\5OV?-+M-?N/ OPMUS6=.U3X:Z?^T?\  CQ/'KNLW<GA?4K[
M_A!8_B'X+\(V USPA<V-ZWC$>'=&NM5.AWFOZ7?^B67[$O\ P4LE_8K\1_'&
MR^"'Q]3]B[P;\8=1M/$UTD=W;>'=$^*VD:+<Z7K?B:_^&C:A%XR2V\/:98W7
MA_7_ (BGPB_A+PY?QS>'-6\1Z?K$K:?)_HQ?LV?\'67_  29\9_#?]GR?XL^
M/+K]G_XC_$?P[XD'Q!\#VGP_\:>(O!_P U7PPM_.NB>*O%NB^%K=;[2O%<EI
M$O@N[\'Z)KWVV?4+0Z[9>'0;AX.9\)?\'8W_  3&UWXI_M7^"O'>MS:%\#OA
M0VA6/P;\<Z=X4\:^)M;_ &I?^$@+VGC4>&/AP?!MH-%LM.U::Z,9\9:KI,GB
M'1YUU1[:)[BXM(0#FO\ @SE^'OQR\#_\$ROB7?\ Q9TSQQX>\(>-OVHO%GBG
MX,Z#XX\+:OH?VSP?<?#?X7V^K^./!VJ:U,DVN>"?%?B>#4K.R.FZ=;Z);^(O
M#7BB_L[W4K[6M4-K_6A7X8_M!?\ !Q!_P2U_9:UG]HOX>^/_ (LZ_IGQ%_9?
MLO %KK?PFA^'VNZ#XU\9:OXZT:TU+2_!_P ,_#'B6W\/WNJ:UX3@O=-LOB#8
M:C:Z#'\/I[AHM>-JFGZB;/\ 07]@[]N[]GW_ (*.?LZ>'?VG?V:M9U_5?AWK
MVLZ[X:N;3Q7X?NO#/B?PYXI\-7,4&M>'==TN=[BW6^LUN+.Z2YTO4-4TJ\LK
MZTN+34)M\B1 'V31110 5_/7_P %R_\ @NGIW_!)3_A2?@+X??"&Z^/'QY^*
M,VI>/]=\%WMEXCT[POX/_9Z\+V^N6/BGQY=^*-+A:&7Q(?$UKIUKHNA0+=64
M.BZ;XKUCQ;?>%X(_"Y\1_P!"E?P1_M__ /!,'_@KG_P5L_X*N?MO_$#P</$'
M[*/P&^"'PNN?V6OA#XL^-VG:C8^&_B_\,/%7A1['QAX<^$46GPZQI?BG0/B@
MVO\ C+Q+XB\9Z3<VUIH$6L:+X3\0W]AXLLKO3M( /Z3/C#_P7P_X):_LVZ)\
M#-0_:._:0N/A'JO[0/P+\!_M!^ - N/A!\;OB')=?#[X@6L\FEW-SKWP<^'?
MQ(\'0ZE9W]EJ6D:MI,7B>YO-/O\ 3YDF5H)+:XN/!?VAO^#G_P#X(Y_L_P#@
MOPMXLMOVA_$7QRU/QOX3\,>.O"?@/X%_"[QMK_BO5/"7BC5M1T>/4;[4/&^F
M_#_P!X3U;0;K2-4/BGP-XW\<>&?B)H/V&2UN_"(U&:TLKC^!76_@1^WM\(OV
MH_\ @G_^R!\:?V#W^.G[0GA?X&?'_P" GPX_9>^)^KW/BS_A8G@WXEWGQ^\-
MV?B6?^Q=1L;#P5X7^&5OXPU_XD^#O&VD>,E\)>$[?P)#\2KKQ9H>EZ+JE]IO
M,>&O^"2O_!1SX%?M2>,/V._@_P#L]^ _C[^U%XK_ &-=$\=?$[P%XD\,^"[W
M4/@/X;^,MG;6OB&U\,:O\7=8T'X>ZI\2/!\<\'AQOB3\.=3\;:-I=_JNIP>$
MM<&MZ9J%QI8!_9G^V3_P<;>/O FM?ML:U^RGX0^$OQ(^"G[/?[)/[*7[2?P.
M^*.I7%X1\7$_:4\9?!R-+CQ3HOBCQ1\.]3\/:3H6@^*_%GA:?PCHNG:C\3+#
MQ3Y8U7PY!?:'J^D:?]1?%/\ X.F/^"8/P&_: TC]FOXM:S\7T\6V%CX/M?BO
M\4?AU\.K?X@? SX5^,_$'A^/6-<\(ZQK.D>)F^)OB*_\'W<BZ1KP\ _"WQB;
M;5)#I<37.IZ;X@M-(_F U_\ X-:_^"CG@'X>_M&?"7P39MXXU#Q5^RY^RKXP
MT36!\2O"5K\/_&OQET7QWX?O_C#\"K6345M=9M7^'$AUW4? .HZO::1X:UG1
MM'LM3EU^TO=;C\/V/JWC3_@W*_X*R_#OQ5X[_8\^ 7@W]F=OV5OVDOCCX>^,
MT?[4/BC4=(\5_&3X!WOP:\/V6O\ @LZU\0M2LK'XHZ/=7%]K7B/P1HEMX%TG
MQ)%K^HWWBQ]3NO#'ASQ)=ZA=@'[*>+?^#RO_ ();V#_$;2?!7@3]J3Q%KOAC
MPW\3;WP#K/B7X=^%_"'PR^)?BOP=X8U_5O OAX>(-/\ ''C+XD^#=*^+7B+2
MM(\):#XCUSX.R3>%KCQ-8:QXYT'P_I.GZU-IWY[_ +&?_!W?XW^/O[3?PZT[
M]I;P]\(?V8?V<O 7P;^/WQ$^-4VE7T>K>(OBQXW\,Z;XG\3?#CP#\.M1\:ZC
MIEKI.H7>BVN@^%O#7A@WT>L>.?'S7+W'B&PT[4[+2+'\^?V%O^#5/_@IMHW[
M:GPG\5_M+?#SX':7\$?AQ\8_#WB;XE:UXL\>:%\0M!^(WA31-5N=6UBVT3P?
MIL=QJOB.U\2KIR:8+?Q+9^'MO]MVMW?6Q@@OHH>&L?\ @U>_X+*_$O3OAM\,
M/&?@S]ESX<^'?A-I'QNM?"/Q"@\3^%8M1UNZTWQ/>:GX>T[QWK'A#P_+XM\4
M6OQ UJ);KX9Z]XCTS5+[PQX0U61/$T7A\VT7AR( _JL^&W_!U]_P3>^)/[//
MQF^-5CX%_:NT_P ;_!*RU#7O$_[/R? W6O$7CM_!3:WH.A>'/B!=>._"ESK?
MP-\)>$M:O_$^CZ?=W'COXI>%]6TK58M7M8='U:RBT'5/$?V9_P $@_\ @MW\
M"O\ @L+)^T)8?"/X/?&#X1ZQ^SUJ'@B3Q!;?$X>$)['7O#7Q,G\:Q>"-3TF]
M\->(=2NH-<DA\!:U-XFT"^TN&QT7[1I2:1XD\4+<WDNG_P P7AS_ (-YO^"M
M?[5G@?\ :Z^-G[>\?P)\5?M9>-/@'X,^ W[-,NK>(_ ?A^?1KK3?B[;P^(O&
M/CNX^$OP_M/"I71/A=I&I0^$M5EBUWQ5J&D^(_#FF27-@N@G1[#^HC_@GY_P
M3\^+/[)G[?/_  4/^/'B:/X>CX1_M-?#']@[0/A@W@J5;"]BU[]GOX1>+? '
MQ+MM;\,)IMG'I2RZ]>VNJZ9J$<UPNM6>IK=3"+4%OX( #^<3X&_\')?[60_:
M:_X+,_!#XX_$7X1:1_PIGX+?MR>-/V'+K7-$\(^$]+\-?%?]EZV\9+X)^&-K
M9S6]M?\ Q0U/QOI&D0Z]'H^N:_>ZM=ZGX8U2"QAO+?6EL;/]*OBW_P '3/[,
MG[,OQY\&_LW>/O@_\:OBEH_PXTWX2>&?VO\ ]J[P9:^'[[X:_"+QKXZ\&^%=
M2U"_L_#_ (2CU_4/%D>@:]K-_I?CS12/ ^OZ'KNA>)/#WA+PSXPUC2X-(NOC
M#]L[_@V0_:!^+?[&7[1O@_P7K7P(\8_M/^*?^"COQ5_:Z^#WB"2?5/""P_!G
MXRN]EXK^%WB'Q;>Z/<7$FJ6\@T?Q1:6=X)_#]M=Z-?0:?)'?ZJ]U+R7C/_@U
MR_X* 7'_  N[X4^ _P!O/P G[,G[7FN_"'QO^T1X1\<^&?$NJ>,+?Q7X-U6'
M5;R[T69)M7LM7UKPDTNHV?A_Q&^KZ:_B;3YH[/6;2R55DB /[B/!OB_PM\0O
M"'A7Q_X'U_2_%?@KQQX<T/QAX/\ %&AW<5_HOB3PMXFTRVUKP_KVD7T!:&]T
MK6-)OK34=/NX6:*XM+B&:-BC@GI*_*C_ ()C?LH?MA?LFW/[2W@?]HCX^0_%
M/X"Z=XY\#^!/V$_AQ!/;ZO)\'/V9OAMX/.E>&K#6_$TOAW0->U3Q9JL&J:=X
M8\16VM-JXCG^'-OKNG:F]OXF>VMOU7H ^+?^"D/Q1\=?!#_@GO\ MQ_&7X8:
MY)X8^)'PI_9(_:(^(O@'Q+#;6=Y-X>\8^#?A-XL\0>&]:AM-1M[NPN9]+U>P
MM+V&"]M;FTED@5+B"6(M&W^<;_P3_P#^"XG[>OP<^/?[+7Q'UO\ ;E_:B_X*
M"^'/$/@+XR^,_P!JS]CS1/ 7BCQCXK^&^A_#73O&NI:=H2>(/B58+X:UE=4\
M.>'M(^)GB#XH_#G5 OP_\'OK=OK3:AJ6E7&C7_\ IG?M1? C1_VH_P!FK]H'
M]FKQ#KNI>%]"_:!^"WQ.^"^L>)=&@M;K5O#VF_$WP7K7@V\UO3;6]!L[J^TJ
M#67OK6VNL6]Q- D,S+&[,/QU^!__  0+^!'PE_X)8^*?V 4U+P18?&KQ[\&/
MB'\(_&W[9O@'X3^&_"'Q:\2V/C7XBZM\0;2+5M35KOQ+JGARR$^A>%M3\.ZC
MXGN(-8\-:*FGRRPJT1@ /Y3OCQ_P>=_M0_%SX"?&;X7^"/V8_!OP)^)?COPN
M/#WPZ^-'@?XJ>)M2UGX9W5_J$4>L>(K?2;_P]9?;M?@T!KJ/PS>V^JZ?!I&O
MFVU.^LM7LXGTU[G[-O\ P>>_M(_"7X<_!3X9?%C]EKPK\:G\ ^'?!?A7XC?%
MG6OBYXHC^)_Q*BT2&SL?$_C*[-UX>N=(B\8^(;:&ZU#_ $IKC3DU:<&;=:Y1
M?KG1O^#'[25NW_X2#]OK49[/^S[\1IHWP6M[6Z&IFTD72Y'DO?&=W"UA'?\
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M%W8.H7Z0HH **#Q^GZG%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M'?BAX/\ !/B*73M6L!/)I>NVFE7&AZC-8ZI:66HSWFE:C!:_PD?&+X7>(/\
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M&?@?^V#\=/"'P_\ A-X0^+7[2OQ/^!WPBT;QOX._98TWQU#X,O-(T;XP7_\
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M_!'[_@FOX)_:Z\ :R/&T_P /_$?Q"\4?M7?$OX>?L=>$?$'PS^&7PM\:Z/\
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M/@_X-Z+J?AWX9:1J"I(POCX1T/5]0TNPU&[\[59[.=8M0OKL6]MY/Q7\<?\
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M_P 8>*);.STV3Q%XGO;&V@N-<UHZ=86&GC4=3EN;M;&SM;-)5MK:*-. T/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HK(T+Q!H7BC3(=:\-ZQIFOZ/<37UM!JFCWUMJ6GS7&F7]SI>H
MP17=I)+!)+8:E97FGWD:R%[>\M;BVE"30R(NO0 4444 %%%% !1110 4444
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M]DWX8>(8_A#X[^#O@V;P[XM^(?Q-MO&&A:9<>-?'WP[\'_"EO&5OJ5F;#2_
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M_P!I2:**;XG?\%9?V#?AYXU^-?P7C_:,^'FN?M&?!7X=:I\0M5^ UIJBVGQ
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MZQH/B^7Q?X[OM3TGQ-I']K:)XUN+R?P?'X L?&6LR3^#M8_86OR4_P""K/\
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M_HGCO_@J]\3_ (/_ /!0O]DW7_VR_P!NS7/^&./BK\'O$/@S3+WX;:1\-/\
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M /"_BGPKXI^,WQ3'PLGA\2V_A_XPW/P]\,Z?\/K+Q-?K;ZS>_P"GM0./_KT
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M[;\(>%M:U+2+C0?#^B-H2?G)^R]_P<"?M;?M(?LY?\$@_ 6L?&B"?]I#XO\
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M>%M*M_ $%AI?@#Q'IT:M?:C>ZCXM\+Z?JD6A1VP!]G?\$J_^"$_Q#_X):?\
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MPXL_%"Z%<6'B"S\<Z[X$\0>(_B)XDA33?,7Q.VH^!5.D6.FS6NDZ-%JUREM
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M+Q=J'B@1RW.G>%[#2/!W@+4V>2]U&22YU2_T6RM(KA;JYGLOD+PE_P %^O\
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M6^GZ[?IIEW8W4=A=6=?]NW_@NG^R?^PO\1_$WPKU7P+^T#\>?%7P@O?A[?\
M[4<WP&^$OBCQCX5_97^'OQ*>R3PQXZ^,/C9[&T\):9_;;:GIT/ASPY9ZQ<:I
MK5Y/)IS/I^H1):S>6_'S_@OM\-O!US^S[-^R1^R#^UC_ ,%$- _:,^!.N?M
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MEC<N3-:K]HGQ"ZCS7^\=B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBCKUH \J\#^*/ VM>//C!
MH7AFW@B\4>$O$/AJP^($L6M>']2DN=6U+PCI>KZ,\^FZ5XCU?5M"=- NK&-;
M7Q)H_AF\ND47ME97VGRP:E/ZK7SG\(]/CM/C%^T[=IJ.LW;ZEXV\!3RVFH^
M])\+Z=II@^&7AVV6'0_%%A&E_P#$*UG6(7-WK&LM)<Z/>R3:#;,+2RB4?1E
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M!7P^\,3?M6:I:>,_&^I)8+X:;PW'J7Q0\)1:3<WEXT]KKTM_:7=II]Y:QBX
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MOKXR:3^S;\;Q^V;\3/VX/V>K;Q-IOPJU+Q):VOB?]ES2_@EX,OKW3/!/PN\
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M$SX8>(-?\7?"'PG\/_%5Q=Q>*?@5!HL=QH=SXC@\,7\UEHUI>ZIX!CLUL?\
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MXJ?%/P1X_@T^V^.WQ==+K4];TZX*:/%X9O+6'PLFCZGX;7Q$?&G[9C_@B?\
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MO+#2=)@N;V\@B< ]QHK\1=5_X.$?^":VB?LZ>!?VDM6\>?$JTT'X@?%7Q_\
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M_P"S!)\&/!^J:A<Z=JE_IWQ#\1^+)]1\"ZC;>'K#P5XSC\3WGZS_ !L^/?\
MP5B^"7[*W_!6?]D7X>?MHZA\0M8_X)H?'K]F_P 7ZI^UQ\2?#6K>'_C5XQ_9
M&^-/P_\ %_Q(\7?"_P -_$71QXOT;6OCEH/BH_#C1X8M2T7P@EC\/[[Q/,GC
MGR/$'ACP[X5_8GP__P &U7_!-_PYX!^(?PNMO^&@=8^'_BSX6ZW\+O!/A?Q7
M\;?%'BG2_@/9^,?&)\<_$;7O@AIFL>?HW@35_B/K^G>%;CQ>MEI3V.IMX6M)
MFMA<WU_/+]>?LY?\$</V%_V8OV3/C1^Q?X#\!^*];^#'[0]Y?:E\9T\=>/\
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M=J/B?XC?%3X@^ ?"NB:#HGB;5[?3O GC+Q]X:NXM9UKQ*]LG^AMXO^%/PO\
MB$VH-X^^&_@+QNVK^$=9^'^JMXO\'^'O$K:GX#\1W>GW_B'P3J!UG3KTWOA'
M7K[2=*O=9\-W)ET;4[O3-/N;VRGFLK9X_(?!G[$_[&OPXL=<TSX=_LE_LT>
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M&-SI"^'[CQ8FC:<GB:XT%+I+U-$FUY;8:K+I"7L4=VNFO=-9+=1I<"$2HK@
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MQO=6\-RV4&O:?;W"2W>D3:E:+?V$=_"I+V[W=FRW,"R &2$AUR*V* "BBB@
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M!\"?%_B-(O#TNL?#_3-+\20^)M<TZ>6*[70].T"__P"$8OD\1K/9P^%>)/\
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ME=PQW%O)'*BL.FHHH */\_Y]/PHHH /\_P"?\\=J*** "BBB@ HHHH ****
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MX*9Q^"/^"G_PH_8#/PMOHOAYXS\#3/XN_:4\075UHG@'0?CIX@TK5/$WPO\
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M/A3QQX#\7>.-:M?&&K1V>A>-M _LV'5-5_M72]+_ $(^+O\ P4'_ &8?@_\
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M?_!3'QE\>O\ @GQXF_;4_9?\%?LQ^ _^":'[&'Q%^ WAGQ';?%70OB'X@_:
MU?XV>$O@UX%TQK/PMX7U+6[+X?ZMX"\._ FTU#X@&^UF[LGU;Q1::3X9N=>T
M\R7>B_T[?7&>?RS_ /6&?>@ HK&L=!T[3=3UK5[1;P7WB":RGU0W&JZK>VS/
MI]HME;?8M/O;VXT_2$6W4>=%I%K8Q7<H-S=I/<LTQV: "BBB@ HHHH ****
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M?%#QCK?QM^(7CDV'ANW\.^&X;[PCXQAU=;>VUK4))Y&LS:^(=+@AG^A_!/\
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ME=4#R,!&CL-92&4,,X8 C(*G!&1E2 0?4$ @\$9H _"OXB_\&Y/_  2S\6_
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MPZ7>K9ZE']I\2MK_ )6GR#^R;I&^LQ],8Z?3 _+T_"OE'XFZ@(/VN/V5-/\
M^)S_ ,3#P%^TS*/LGA70]3T3_0K7X/G_ (G/BR]T^?7?"MQ_I'_$ILM#U'3[
M;Q(WVV/6(KY=*L5M^B_:G_:U_9W_ &)_A%J7QX_:B^)NE_"3X3:1K&B:!?\
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M1^T]K-C\,X/$_P ,M+T:X\-^!U\=:NOQ&CEUR&XLXWT^'5+R^BNH]6M9C!\
M_%7]D+_@JM^WO\)_VX?CI^TK^Q#X$^!OQ ^*/PR_X)G?LQ?#']F+0/BGX8^(
M7B'QWX7_ &;/VV_AY\?OC7\2/$6L:CJT?@S3/"EUI6L>.+K2- U+58]770-(
M?PU/9>(+[2H/%/C?YE^+/_!!3]N[X1>(O^"P/@KX0Z=K'[0/P3^,/[&'A/X2
M?L8WNI:]X$\.Z[!::_\ M3^"_C+_ ,*"T[0KO7-*M-/M/A#I.E^,%EUR:V\-
M^%KZRN]&;P[:VUW?3>&M& /ZZ/V1OVJ[_P#;8\%>/+CQE^R1^T1^S?X>BTOP
MW;VVB?M*^'/".@W'Q)\+_$+0-0OFNM$TKPWXN\472:?!IB1VNN67B&'1M0MI
M-4M[62R,HNDM_@[X<_\ !2W_ ()IS_$G]KO]E7X4?"7PS%XB_P"",_@G7_B5
MX8\&:!X!\$Z5H&E0^ O"'BKP#\3)/V;;6WC2/POJ'PPN=?U#X+^.=2M[+PVU
MK>>/)M*M)M4T?5=3E;EO^"-OPL^*?[,'[/W[6&C6'_!)[Q7^PSJUEJ\/Q(^'
M_P ./&G[<2?M6^)OVC_&LW@G6(3H"?$_7?#RW_PVT/2+KPSX8\.Z5;ZJVM:7
M;ZAXRUKQ!%I\<RZM)JOY6ZW_ ,&_7[:/P^T7X"?M-^ _CQXZ^+?[8/Q@T']J
M+P7^W)\,OB7KGPQ?X3^#[+]NWP)\2]9^*U_\)-?T[2-+UJ&'P1\7/%]GI/BG
M4KG4?'VI>.SJ<_Q1\(VGPZM_#H\%:@ ?H8__  4F_P""0W[=_@G]B/2?B1^R
M_P##KX[R?MXZ-^T#\>=)\!>-/A'\*?B;;_##QQ^R7\$O&?C?XGR_%JYUB"ZL
M[/XF:/X?TG6/ >@W%G'J&NZC!KL,B/;^$M3>]D\Q_P""7G_!5;]GV7XW_LZ?
MLOZ+_P $IM3_ .":_P ._P!L#P+XK^)_[)GCNU\+_#SP[\/_ (PV]YI]KXN-
MGI-M\/\ PWIEI9ZMXQ\+:=:>()(GNW=I-.L5OHO)ETJ[F^<_@K_P0&_:A_9;
M_P""A_P<^/OP'\5>$?#7[-WC?]ACXV>"?VAOA!INMW5CH?A'X_\ C+]F;P]\
M*_$G@S0+.XEU&QU#PW\7OC:G@OXT6?B7P[IN@Z;I<?PKU_1=>L; V/@L^-?7
M?^"=7['O_!7/Q_\ $#_@G?\ #W]O;X&_ G]FC]E__@E9X3T:[^'%U\/?'>D^
M._BW\?/B]I'P<U'X2>$]5U'4;/5_'NCZ3X$TOP9XHU"+Q=HU@?!EY-XPM;ZZ
ML]5UW39])T_PP ?U,1>!_!<-I9V$/A#PQ%8:?K]SXKL+&/0-)CL['Q3>ZA>:
MM>>);2U6T$-KX@NM4U'4-2N=9@2/4;B_O[R\FN7N+F:1[NH>&/#>K)<QZIX?
MT/4HKS4-+U:[CU#2;"\2ZU;0Y;2?1M4N5N+>19]0TB:PL)M+O90USI\MC:26
MDL3V\)3;&>OK@X/!' X]SD=\=?8"@Y[?GZ<'DC(SS@8'K0!S[>$?"CV'B+2G
M\,>'GTOQ>^HR>+--;1=-:P\42:Q:"PU=_$5F;8V^MOJEB!9:BVI1W+7UH!;W
M)EA 2CPUX2\+>"]+71/!WAKP_P"$]%2XGNUTCPUHNFZ%I:W-RP>>X73]+MK6
MT6XF94::<1>9*R@NQ.".@S[8YQ^O!_'K[=^AI?\ )X_SW[\\?7- !TZ44#IT
MQ[>GM2'CGL > ,D_3]>,<_S %HHHH *0_CU'3ZC]/7VI:0\]L\C]"#G\.H]Z
M /F;]F#6?"FLZ3\:9/">FP:;#IW[37QXT;7E@T'0M %YXKTSQM=6WB'4I8M!
MT;18]5GOKY7GFU[4X]1UW5W)NM7UG5+IFN6_'3]M'_@M3KG[.7_!7#]DO]A?
MP79?"_7_ ((^)=5^'W@G]KOQ7J;W=UX[^&_Q _:/UZ\\(?L\Z/X<>S\3V$%L
MLFNV^EZAXM#>&?$HTW0_$,-_KTOAJQ2SU"Z_7?\ 9-\+V_A?1OCO!!K^F^(1
MK7[5O[0WB>:33  NDS^(/'=UJ$F@7H6ZNO\ B9:.9!:7I)@9I5W&V@!"5^+G
M[3/_  ;+?LB?MC>+/VK?CI^T%\1/'6M_M=?'_P"(/BCQE\//VBO \>L_#U/@
M=IL&D>'-$^#GA>'X4:=XWO\ P+\08_AII7A?3--U_P 0:E%X?U[XB6MQJMV;
MKPCXAN+#7]+ +'CG_@YN_9#^&/QT_:+^ ?Q$_9\_:R\%^)OV8K7XH:G\1=5\
M1_#[1-,TC^POAQK<N@6'B'38[CQ*FJ3Z+\1KQ](?P#?RZ?%!K-MX@TB<M#'<
M%ER?!/\ P=,_L#?$=/AKX3\"_#?]I'Q;^T%\3/V@'^ .E?LS>&? ^A:_\6+3
M4%ATQXO&TDND^)[OP7J'@^]O-7M-*LY=(\4WVJS7MOJ\C:=%IVDW.H5\V6__
M  ;%_M'>)O$G[3'B+X\_\%?O''Q\;]KGP1%X7^/$?C#]D_3H-1\=:IX8T Z1
M\)M:U+6_^&B]1U"+3?A3=Q:?J7AWPCI3:9HS)I6G6$9L8K.TF@]5_8-_X-@_
M 7[%7BG]CCQ;>?M>^*OB=J?[*'[2GQO_ &F+T6'P7\/_  _3XD>(_B=\./A5
M\//"'A=)I_'GCN^\(>&O!,/PQ&J:_'+=^+;OQM+XAOK?2IO #6ZW=P 9O[.W
M_!R9IMKJ?Q9^&O[67[/OQ0T[Q_X13_@HMXJ^&7Q"\#>"[7P[\)/C)I/[#DOQ
M"\=:C\+O!M[KGBW6;G_A.+/X1>"+L^)?&&KW6F^"8O&]A<:,]Q8RW<$4>%X
M_P"#E>R_:>^&L?B+X(?#2P^#7CK1/AG^WG-XT\(?&=[#Q59R?%G]FO\ 9DUW
MXS_#?1O 'B/PUXKT*P\6Z5J>KZ;'/XBLA;VVIZKHUKJ5GI1T\6SZR/2O!/\
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M'_P<$_MS>'_CU_P4)^-_COX-?#Z'X9_L>_L:P>'O$O[.NA?%;6->\#:]\?\
MX5_M@>-_V?-3^,W@?7]0\!V.O:3H_B/QGJVO>'-?TN-K5]1^'OA;P;K&IOJ7
MB"QTVUTV'_B)[_:\^+WASXL?LNV/[*?PN_9C_;9\+>!/VBO'7BOQ7\0OB^!\
M(?AK\+OAC^SM??%G3-9T35X-(\0W6H?&Z:_86VG>#]8LV\+V\MMHZ:OJ45WK
MES8:#_0'J/\ P0*_X)0ZYX@^(OBWQ)^RKH_B?Q3\6;KXMWWQ"U_7_&_Q%O\
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MPN9[6XC#*6BE8!@3D '^9)\&M;\&7K^!OA'X;_;-^.FA_P#!*7]N#]OOX(_
MSXE?$K6_CII&J?MI:EJ7PM\+>+= M?BGXPUF#Q-I_AO]G']G3XT?'*ZBUF]T
M+XA>&]9UV'PKX:LO&6FZQKDO@Q;#4_);#XF^'_B1?_M;^&O$_P"VW^TY\&/@
M=_P3W^#'[2?Q*_X(^_'6\\?MX/\ $?QCC\,?M-?;O"5EKOB.UL=!UK]HB_N?
M&KC1/"FM> [6+6?"MWJM_=:SJ,>@^%;#3-(_T3_A/_P28_X)I_!#P]XR\)_#
M/]B7]GG0?#7Q"NO#E[XUT2\^'ND^)]/\1W/A$:D/#,NI6_BQ-<64Z(VLZO)I
MX78L$VIWTZKYUU,[^T:[^P[^QGXGT7P1X;\1_LI_L\:]X>^&>GW^D_#K1-8^
M#W@+4=*\"Z7JNJR:YJ>G>$;"[T*6U\/66H:S++JMY;:5%:PW.H2/=S(\[LY
M/\H'XZ?M9?\ !0KQC-XD_P""@WQZ^-][I'[26M?M*S_ 6\^$.F?$#QS\-_VA
M/AWXJ^'O[/6D75CXF'[-^HSZAX,\.?!;5T\4V5S?QGX=6TES\1-#U'2O#E_X
M1TV[U*RU#^@?_@G[^S;^S?XJ^)WCW]EC_@E=^UE\8+7P-^T1_P $5Y/$W[2O
M[2ECHNN?$"3X:?M*>)_V@/A[JFO2WUX+WPY=_ ?XB_$;X6>%?BAX$U?P5HOC
M#1M.^TZ?X0UC5=!\7ZWX.M;^7^YO_AD[]EX_%.\^.+?L[?!-_C-J-[)J5_\
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MI>C:SJFB>'YY-(\-^*KK4[>Y^0/A5X^^'_CC_@LEX9\26G_!+OXQ_#']D?\
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M^/'P _X.(?VG/#?Q3_X)_:E^U3\0_AMI?PL^*G_!*CXL?'+X@3>(K/PY\+-
M\4_'[PIXV^.OACP1XO\ $>J7%]K5U>S>-A\$?#F@V'AWPC=>&4U7Q/XYU*\T
M'PKIZ36/AV/R?QQ_P<8?M^?"G_@E1\)OB=KMSX:TS]M;]J/]L[]KKP;:Z_X_
M\(>'O#'@SX$_"?\ 9Y7P9K'C#P!;:-XDN;"/3O'FGZMX_P##'@GP%9>,M"\1
ML+)O$@\02'Q#INBQZA^S7Q _X-DOV=?B3\.M ^#?BS]H#XO^(/AMX/\ V5O@
M#^S-X2;6K;P[-XWTR#X(?M!^./C@?$<OB2PLM.M9;+Q#IOC_ %[X=VOAR'2;
M>+PYH'V"YL]1NKW3X'KZ>\/_ /! _P#8WUSXP:C\4?VB=*F_:+\.V'Q/_:>^
M)OPX^"/C\7E]\'? OB+]I7XS^'_B[K7B]?"\VH2KKWQ!M!X=M?"&J>(=8DNK
M/Q%X7&GZ5J6E2P>']&:W /R]_;$_;5_;V^+'CS_@D[XS_9(_X*6_"WP%^S3_
M ,%-?B/\,_A'I\7AGX5?"V]\0_";Q+8?#OPNGQ7N=1^*GB34;G1?'WCW4O'V
MI>*M'T/X6'P=X$N$\>6_ASX?V<8U.Z$4>S\-OCW_ ,%LOVT/&'[=>G?L3?MA
M_!K3-'_X)S>.M-_9P\*>%/C+\ _"UKXY_:Z^,OP_\-^$-0^)VI^._$-GXDN?
M!_PLTOQ?XC\/^(K;P'J5K+J=L;/Q)_9/B6+PE#)=^*=)_4[PO_P0P_9,\&_#
MK]BWX;>'-?\ B-I.C_L(?MD^(?VR?@@]CJ.DVXMM?\3?$G4/B5J/PTUBS&FM
M:7?@!+^XTS2;)8XX=>M=)T.RB75C)<:@UUYS^US_ ,&]'[(/[5_QT\>?&BW^
M)7[0O[/.F_'0>'1^U#\(OV=_B-=_#GX5_M*R^']<AU@W_P 3_"^G1_8-1U;5
M$B,.HZ@+=C+J!7Q(L"^(C<:E<@'\HW[0/_!>G_@J-X\U?PY<^$/VH_%?PC\4
MZQ^Q_P#L?^+/A_\ #'X%_LI>%/B5HGQ5^/G[06FZ6]UIGB7Q3XE\0Z59_"+3
M]2UO77BT_6[^[\6O<M:Z7X>\->"M4O)+N8?NE^U)^W%_P6B^!_[4'A?]DWP[
MX"T >.?^"H_P3^%/B/\ 8V;4-+\.>,H/V%_CEX-\/_#/1/VS/ 7Q%\;>'I(=
M!^('A?X5>$Y/%GQ9M_&]KX<\1:,WB;6O",UGH,V@:AXDL;3]3=7_ ."&7_!/
M[5O"/[2G@3_A7>KVGAC]IK]G3X!?LS^)].M-=GMT\'>!?V;/#\6@_#"[\!+;
M1V\&AZW92:5X4\1:I=/!=)J_B;PQ:ZK?1RKJ6J6UW]6VO[!OP<M/'7["?Q(_
MMOXDZMXP_P""?G@3XB_#/X-Z]XH\9W_BC6/$?A'XI?"OP_\ "KQE'\3=6UA+
MC4/&.O:EI_@[PEKS>)+NXBU(Z[H\UPSO%JEW$P!^<?\ P5&\.?M$^//BK_P2
M5_8:\%_MA_&K]GV+]HWX@_'O1?C1\<_@U+X?\/?$[Q3=? +]DCQG\4M)O3<O
MIG]EVECX@\5>'9[G7-(M[.WTV9=0298$GTO3V@_%+6_V[_\ @I?^R-\4F_98
M\7?MIZ-\9M:_92_:7_:B^&4/QH^)/A+P=\//#GQ0\*^%O^"9/BK]I/X=0?M
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M[\6:5?Z7IVH^&],L60:[JVMV4^MZ1-<Z;I>E7EW%INHV>L-$-)G2]/9>*O\
M@H5^Q'X'\<? +X;^*_VG?A)HOC3]J72=(UW]GK1[OQ/;E?BSH_B&[CL= U#P
MEJ<"2Z/>6NN7\T6G:+)-?V_]JZA)'86'VB\=83_EI>%-5_:T\!R_"_\ X*5?
M$#]EGX?2Z+K_ (N^*/PW^#O[-GC/]CSQYXJ_8VL8_AW\"-*\,:_J,?PCT#Q?
MINFV>M_$MK6U^%7EZ_H>HV4-WXG\1?$^UU[0]9\!>'-0\/\ LEK^S]^VK\&/
M'/\ P3,M+CX#_'%OCOX?\+_L@>(?!G[*'B'X-ZW:K^T3'X2_:Y^,/Q^TC_A&
M?C3IFD^)_"7P<T'PYI'B?PY9>*K#6&\-:OX4AN[O_A)?"UOI.@Q+, ?Z<W[3
MW[<7[(W[%\?@*7]JG]H+X:_ I/BCK%]H7P_'C_7%TI_%.I:2+!M773HEBGD^
MQ:2NJZ4-6U6=(=+TIM3T];^\MWO;59?I[3M2T_6+"QU;2+ZRU32=3L[?4--U
M/3KJ"^L-0L;R)+BTO;&\MGEMKNSNK>1)[:YMY9(9HG22)V1U8_P%?\'./P"^
M+7[4?[=/PHUH>'OVLO#/P]\0?LE^+/V:OV?+'P5^SM-\7/"WQ/\ VP?#GQU\
M?ZEXC^&M[::IXX\(R?"[PS\4/"=_\-]0T?XZ:?I.KIXGT+0[&\M+&^T/PAKD
MNC?VC_L!^&_B[X-_8A_9-\(?'OPQI?@KXU>%_P!G[X5>'?BCX2T6S\.V&D^&
M_&NC>#M*T_7]&T^R\(SS^&+:VL+^VEMHHM!FDTQ0F;5C%@4 ?7=%%% !1110
M!X;\3K*WF^)?[/5]/\/M;\8/9^.O%L5KXEMO$U]I_AWX87-W\,/&!'BW6O"L
M6JV^G^)]1U.WMKCP5H%[?:+JL_AO_A*-5FL;W2#J5R-03]I+]I'X,?LC?!3Q
M]^T)^T#XYTKX??"KX;Z)/K7B/Q!JLJAW\M2MGH^CV2G[5K?B/7+LPZ9H&@Z=
M'-J.KZI<6]G9PO+* ,[XRPZ=#\1?V7M4GTF]U#4_^%SZ[H&GWUKIRZE!HEOJ
MWP-^+VJ:A>WQF\,^(X='M[@^'+/3DUZ&Y\(:C#/>1:);^+X;'Q!JGA?Q7Y/_
M ,%)OA+9_&_]@+]LKX<2?#BQ^*^N:Y^S#\>(_ O@JZ\,6?C"^U7XBCX4^+X_
M I\.:'=V=Z9O%T7B673SX7GL8/[4MM;:TETR2&\6&0 'Y5_M?_\ !RY^QE^Q
MSX@^ OAKQA\(?VE/'&I_M"?LX?!G]I3PC'X#\$:-=+8>'OCG:W]]X*\':FVL
M>(=)$_C9K.RAEO=/T@ZE8Q3:C:6,=_+?I=VUMZ?J/_!PS^P[8_M7ZE^Q_:>'
MOCQKGQ)MM.U;1-)U30_AAJFH^%?$WQY\/^&-&\7>(_V9]"U&*3[3<?%WPWIF
MN6EGX@LYK2#0M)U\#0+C5EU*ZT^&\\\L?V7OC5\:/#?_  0-^ ?C/X$._P &
M_@?\ _AY\>/VN-0^(NB8T[0?&G[/7[/OPT\(_"?X(^+?#6HZ6)+CQA)\8/'\
MWCG2]'O]45=(U'X4ZQ=WN@:A'9SS6?POX]_8I_;%^/'_  6N^$?Q9US_ ()I
M^%/A=I?[-G[<*?%1OV^O OQZUOP_\(OB-^RTOA?Q[KNE>'[S]FG7M1UO2]6^
M/?C36-:\)S?%#XP^"I;?4=3\8>&K#0-=\*:%IEQ?ZY;@'ZZ?\$^O^"UGP+_X
M*!_%'XV?"+1/@A^T9^SKXO\ @#\.-"^*/Q#L_P!I/P3IWP[DTOPSKMU<0P2S
MV<FM7FH6/E6MN^IO<ZE:6=E-II-W:W$\<<I3Y:\8?\'-7[%^C^ ?#?Q'\!?
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M4^)?B_\ '_Q3X+^-?BS]H/X@_$3X^>-I_B=XQ_:%^)?BOX.>*/@%+<_&^_\
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MEUJ&GWNMZOJ.D:S!:ZHU[I<MYX3L=$TF"YL9K"[L9]9M=0U"[]KH _"76O\
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MKRYGN8X5GFD=]C_/^?K_ /KHHH 0YQUQU/3/'/&/\DT'/./3C/3//7]*6B@
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MF%=3,UE97MW/HWVV,WD5K_:-L9_XW_\ @X,U[]H3]GS_ (*A_LL_\%!?V?\
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M9X2O/$7G1/?Z]\*_$&J6\6K3:;NT2ZTB\8I_:-LLGYK? _\ X),_MC?LT?\
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M;PSXH^*>MZCX:^&WA_6];T_3=7\=^(-(T6]\1ZIHOA6PNIX[G7-3T_0--O\
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M6.GZKKNA:1'-ID.K7.^ZN/%5_P"#<+]M?0/AWI7AOQ7_ ,%;Y/!.E?%CX/\
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MD$>J>&;R\\9:YIW[-VE^&-1N;O1U\4:/XULM8N[?Q';3Z9HOU'^R+\.?"O\
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M8V]U?64\/B?P_:H=,>UO##KFGZ/=ZSK.MS6NDV^N7T?^K\+>W41!8(5$!9H
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M)M%\&>&?A]J6IW<RR^+--M]-\-^"M.TG6M)T37K"T\0K+-=W)M[IYI)_<O\
M@FK_ ,$)_P!D?_@F_<:KXDT[5O&_[37Q-#V6D> /B9^T9)H_C+7?@Y\/-&O+
M+5- ^'WPFTTV*:#X$T^QUJRAUN^U?PYIVFZMJNI0V!>:VLM+TZRM_P!L** /
MPB\7?\&YG_!-3XA_%_XF?%?XB^%/BSX^T_XG^+OBS\0M0^#_ (K^+OBO5/@K
MX:^(?QH75)/&GCKP;X DG6P\/^*/[4US5]<T;5+:9IM*U:[CN8=ZV5I'%]._
ML4?\$?\ ]A_]A7PC\0O"_P -?AU>?$>]^*OB;PIXI\>^,OV@-33XR^,-?O/
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M1T5K8"YH _S%KS]CK]M?QQ+X-^'7[.?PE\)?%KX76_[&O_!0[]HO]C?]G?\
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M,\3S^$-;US3[NVTFV35KG6-.]ZH **** "BBB@ HHHH **** "BBB@ HHHH
M^3-)T?X6-^W'XU\0R?$_1]1^.,7[+_@#1(/@[:ZN_P#;7A/X0R?$_P =Z@?B
M#J_A\7TZ);>-/&Z7&@Z7KCV&GM<CP9>:;%+?_8)S:?%'[:/_  6 ^&/[%O\
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M]JCXF? KX"?"GQ!X&_9O_P""@?PC_9+T+Q#\3?VB_"'P]\#_ !7^&7COP_\
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M!S-G_P %C_\ @I;^TQX=_9YT']@?]@?X:^+?VAKGPU\=],_;>^!_[07CN_\
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MA /V>HHHH **** "BBD)QCW('YT >#>$YM3;]H?XQ03Z%X/M=)B\"?"1]/\
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M+39/!GB6\\7HFN7?ANYNO#MIKO@:.,00Z_=Z]>KH<6@ZI]._I_GVKX2_:O\
M"<]]^T+_ ,$\/'*76@QP>$_VD_'F@W-IJUUX T_4;H>-?V9?C:(9/#MSXO\
M#VJ^(;[4K6;PZGVC0/AQK'AOQ1J&FS7FI7MU?^&M#UJPD^[: "BBB@ HHHH
M**** "BBB@ HHHH **** /-A\+= 'Q??XU#4/$?_  E+_#>+X7-I1UJ<^$1X
M?B\43>+!J"^'=@MU\2-J,S6S:UYIF;3%2Q,?EJ&K^7S_ (.Q/C7X\N/V9?@?
M^QE\"9/B#KOQL^._CW6_B;<>#/@OX1\8^-?BP/ 'P7\+:QJ6G:S96/@O5+*^
MT7PQJ?Q1U3P5X;US6;VSU&**PN=1O;&VFNM&>TNOZ5)?C?I=M^TUIO[.-S<^
M$(-7UGX%:K\:M&M9?$VIKX^U.P\/>/=(\$>(9;7P<WA8:-+X3T:;Q'X;%[XD
M7QL=5BU?6[/36\*BS<:O6L_P"^$\OQ\A_:=G\(6=Q\;[7X4?\*0L?'-Q<WLU
MYIWPR?Q7/XWNO#FFV4EPVFV":AXEF6_U*]M;2+4-06TL+:[NY;6RMH(P#^$_
M]K/]GCX!_P#!0#6/^"-O[:]A^U!^U/\ $#Q/_P %0/C#\,_@I^U)J/@_XG6?
MP^\/:-J/PX^".G>$OB3X=^'7@/PY\/M&TCX?ZQH?Q#\&ZW'JC/INMZ:U^=:O
MK:&ZL]2M;N/W?]I#XF?M\?LBG_@L?\'?V+O@OX2/[%/PS^-G[,GPR\5_'7Q1
M\<M7U'XN_ SPWI7[('['?P];0?!?AGX@:UXC\0>/IH? EOX=>;Q/J5[J'B"Z
MU#6=1U"XU"_U2U6>V_L/T_\ 9%_9DTG5OA]KFD_ [X=:7J?PI^)7Q&^,7PWG
MT[P[9V">"OBA\7FUB3XF^.?#UK;)%:Z=XA\:2^(=<GUV]A@5[NYU2]G(26=W
M.1/^RY^SE\2/"OQXTCQ=\ M#CT;]I7QS)K_QX\-^+-,M7;XI^(? T>B?#[P]
MXM\1P:?JVHVUS;7WAGX<>$+WPU)'=6UPV@6^C7&I:?I^KRZC91 '\$]Y\.(/
MCU_P7W_;$L/$?AVVU'X7_";]N'X-IXDF^)__  4;N/V:?#6CZ0-:TJV\4GPU
MX/U2WB\1?%&YUJ73;KQ5!X$\$75K>^'H;6S\*6FHSQ:E97DG%2:Q\<S_ ,%D
MOA[\:O$GAS]J72++Q?\ \%[M,^ _A_\ ;%U#]I+QM;_![5O"GA_XYZ/X7U#]
MEO3_ (*:!X<NM2CNM8\&/J?PUNK^7Q9!X-3PKK/_  CE_HMIX<BUF2/^X[QW
M_P $?_\ @F1\3?BUKGQW\?\ [%7P-\5_%_Q+XNC\>:]X_P!7\-33^(-5\81W
M<%\NOW<XO4BDO_MEM#<,WDB-Y$R\;98'WRX_8C_9+N]+M=%N?@#\-Y],L/VC
M_P#AKVPM9-"C86/[3)\21^+G^--E+O\ .M/',WB*-=3N-4MY(Q<R-)#<126T
MLL+@'\"-SXW_ &6?CW\!/VT?^"CO[0O_  4;_:K_ &9O^"Q7PF^/_P <M=\'
M_L^-\4].L]2^"WC7X7>-]5M?@7\!?#'P;GTC0K7XE:'I_A31['P3K-]H][H6
MEQW\WB73=0T/9HVI6.N>:^'?BE:?\/4_ ?QT^(?Q(\3?$SX^^._^"A&@WGQ8
MNOA+^U9\2_#O[3_[/EW+XLT_P;<?L1>,?@EXCBLO 'Q+^"7PU^*$TOP^\#?$
M#X32:;X;U'POXKU>S@G3PHNE>'?#?]X?Q8_8]_8@TG]I'3/VJ_$/[!N@?$'X
M]Z'X:\1^-+7X\>#OA)X6\2^(;?7M'ECM;+19;:WU6UU[6?B3XKE\17H\.:F/
M"VIIM34[S7/%&AV]J+D=EIG["7[%$W[5<?[5<?[&WPXTC]I33M(L/%MI^T#/
MX$\+VNMMK_BEO%.E:M%#J%CJ$T\GQ$TVR:\F\2:[/HPN39>(]+-GXDU*X:YB
MTX _CW_9=^)7_!,WXG?$[X6?\%$_VH?V]OVI/A%_P5N^!W[:]IH7[0_@"[U>
M]'CCQY+J'Q/N?A]9?LP^%?@5X935-%?]GF/P59'PAJ=W\,GAGTOP)#XX;X@V
MLL=Q9V-C]<^!_P!N7]E/PE^PO_P7C_8O\;_'_P 'V_[5WCKXN?\ !:W4/#'P
M9U+4[^]\<>(-(B^%'Q.U>TGLI+JSNM,:S3PWX3U>6R-WJ*6D-II!L55##%:5
M_59=_L[?LZZ#\4] ^*FG?LT_#2\^*?B'Q3JQO/BMHGPT\!)XL\/7VI>%/$=U
MJ?BWQ)XJN(+'Q"EKK$%@WA*XOM-DU;5KS5_$VE6MU9_V7<ZGJ6GW8OV4_P!F
M*#Q3XG\<1?L]?!6/QGXTL?%.F^+_ !6GPR\'#Q%XGT[QM:2V'C*RU[61H_\
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M\->)O'WBK4?^$7TW4+OXD'0KB;0-&M/&UE>Z-<R6]E.-<FU#2DO_ *L^._\
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MY^S]KU_X%A\6:1\+Y/AOX3U+4;+XB_%%_"7P[\,W,?B-=/2^\<Z#XJ6]OO
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M_P!CW_@E%X:^)FB_LPZ+XPEUKXPZIHU]\1/&?C[Q1<^)/$&NV'A6Y\0R^"]
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MB-0^'W[4_P"V5\ ;IO\ @KEX(_91^"'QLTK]JCQ)X-_X)X_"/2+/6K'0=*\
M_%?]GG6)O$&@ZJ$TRPTWXG>-=6NI+[P-K7A^'Q5;^*/!>K:9JMQ:'^M/XN_\
M$S_^"&?[3OQX\*>,O&5GX/U/XUR6/@WPQX?T[P9^T1\3O!]SXAT3X)6GP6^#
MWA#P[)X1\*>/M+TO7]&\"1^)OA!X2CM)-+N(+:[\=Z<+]Y;GQ3)-<_9?Q<_X
M):_\$Y/%/P8_:.^$WQ)^!/@S3?AC^UI\9=)^+'QJVZQK>@7>O_&7Q+K_ (8T
M;1?$6@>);358-7\":QJ>O0:+H]E#X,O=!M96U?4--%N;77=5@NP#^:+XK:I\
M5/VI?A;_ ,%4/V]K'_@MU\>/V:_CU^S;\>_V@M"^%G[)O@W]I;6_AC\!_P!G
M_P ,_LP_&"^\"_#OP_\ $_X0Z1>F+X@WGQF\(^$M+9;T>$(-$\4>)?'=E#KU
MOXGU2;6;1O@?QY_P4&_X*/ZC^VW^SY^T[\2?BA\?_!B^%_CQ_P $SOAA\4;7
MP5\;]-\%_"SX;>&/VC/V1_@)\3_CM\"_$W[#=^IDOKCXP_%/QG_PE.C>/M8.
ML1LWPY\1^&=4M[N^\#>'=4\+_P!)?[2O[*?_  ;S_&C]JBP^*7QW\ _"QOVF
M8O'&O:EXP\*:3!\5/">J^-?''A#5K;6M7;XZ?"7P9%IVF^,-0^UZ/'K:)\2O
M#ET/%.E+-JD?]M:/=RSR_2^J?!#_ ((G?'_X[>)/VF-=^#WP!^('[0'AS4?"
M?Q!\=_$;6?!'B&;QCX,\7>#_ /A'/"_@*R\>6UY8P_\ ")_$6V;2=.T?P?X%
M\1Z=8>+M3E\,ZW!H^A7DGAS7?L8!_.\WQ+^'7[0'A[]IG_@I)\7O^"R?QN_8
M[_;L_9O_ &X_&/@U?AMHVLQ:W\,/#'PF^ WQ6UOP+\)O@MX,_8BT^ZTS6?C7
M9^,?AIX^U);2XFO=937_ !S\2?&=KXT:_P!,UCQ[<ZQ^VWPA_:2^"7P.^$W_
M  5:^#NK_M4Z1JW[1O\ POO]IKXA>'O!'Q(^+1^%OQN.J?&'X#>#_B!\,/!_
MAE;[Q=X;\=^'1I<5]9^$O 4_AW6]/UOPA8:)IEI;:II&KZ2D\/T!\:?V//\
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MIWEYX-OK.X\1^'](U?P[I[?Z: Z @8SSCZ\]N_K[UXC%^S1^SK#\1KKXP1_
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MTR^TFP6QMX[NUUG4;C7]5@U^[GU)+N\M[VSTSPY#:V4]OITEA=S6LFI7>Q0
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MLY/4=.1R"",'!S[4M% "$=#W'N0,'KD#@\=,CKZ4N .GH!CM@>@Z#_/H***
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M;A[:'4=5\*Z:NH:U8>0_M)_\$7O#_P"W'\;_ /@G%X$_;$^$FN>-_@%^S?\
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M9]_8D^/'Q]_:Z^(_C/XQ^!?CU^PYIFL/X0^.?[*^M_L]^'-#\0_%H^.=&OO
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MGX,4?MK_ +'/P*_9X^"NE7FJWMM=6OBSX5>!_P!H?3]5UCQC=C3)K?0]'O\
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MYXK\2_!3PY^R!^RI\2_VH?#WB+P<EM'HKZM_PG?A;PAHMS))?:3JEI.LNO\
MA_1C)K=B\UEM_LY_\%>/^"E$7[9G[&WP-_;M_8Y_9^^ _P )?VZ%\5'X+MX
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M\#LUI:_\)_XD\*?$#P[%\/O!VL7WAG7[+4/#%]XMUC5]0MVUJQL<33_V@O\
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MZW\>+#Q#I?A+Q))KGPF\,>)/#S^%_"?BM-:U#QEINC:KJ>G>!8?&.F^$-/\
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MQ%\2?"#]E_\ :-^+'@Y[-/%_PR^!7Q;^('A5]0M!?V*^(O!O@'7_ !'HQO+
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MC'X/\2>-;".WMY?$%]K?@5=?\-322Q17&GZUXN\1^*TN;NZU&ZL;CZ$^$/\
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M0^,3X ^'LEMHNEIX?T'4O%/B;5/$6O06L:1ZSKLTFJW,"W=Q=/. ?SP? O\
MX*A?\%0_V]?@1^RU\"/@9^TO\-?V9OV@_"'[!'[1'[;WQW^+GQ!TG0O'^O\
M[0^M?!;]KKXK? 3PC\+_  5H$&D:8GA?2I$^!?B+6OB%KVGKKYC\,>,K6T73
M[YO#S7^N_P!;G_!/+]HOQ3^UU^PW^RG^TYXWTG1M!\8?'+X'^ ?B/XGT?PZ+
MH:%I^N>)-$MKW4K?25O9KB[CL5NGE-O%<3S21(PC:5]NX_G3!_P;L_\ !/67
MX/?LY_!_58?C7<6?[.5A\9?#VG^,-!^*FJ^!O&OQ/\!_'WQU<_$+XJ_"KXN:
M]X,M=&N_&/PG\0>(+[58[7P)+);:7I6F:]XEM[)EN/%'B*]U3]M? _@CP?\
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MII6M>((K94U75=$T2Z\.:3?78+;I['0[W7?$UUID#*5 MI]>U1U(9C=,&"J
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M^(-.ROB'_P %^/V?/#WP@TCXC?"_]G']K/\ : \<>+/VD?CC^SQX!^!7P?\
MAA%X\^)WCH?LR>-?#/ASX\?$S0X/ FJ^,=$3P1X6T'Q$OB?P[+J&JVE[XI8Z
M;I5U#X=@OM0UG1/EW]L3_@AUK7[=OQ\_X)&:!^TAHFC>)/V8/V4/V0/BA\.?
MVEM-T7QGJND:IJGQ*M_AM\//"W@'0/#&J:6+#5Q:W7CF$>+(=>@@-I-I'@#5
M=,UBVMWUC3+:]^#_ -E7_@B7_P %0?V%O"O[-GQX_9&TC]G.W_:=^!'CW]M/
MX9W7PQ^.GCO6-1^'FH_LY_&;QE9ZQ\.O$FF^(?"FFO>2>,8/[&N/M-EJ$\2R
MZ7K.FW%R+:^MKNWC /T(M?\ @YH^#VL?!W7]=\-_L+?MP:Q^U-X<^/B_L^:I
M^Q%_PJS4D^.</BF?PKXK\>VNH_8K'3]4N$M(/!GA._U/7]'FT2+Q5H%]%=VT
M^A7&E0V6O:GIZ1_P<<^&M4^ 'PV\0R_L*_M&:1^VQ\0/VD_%_P"S(_\ P3]\
M2W^G>!_B[I/BGP1\,M)^,WB#Q>/$/Q"T'PA%-X%T[X<>,?AO?WEYJ_A7P]KU
MOKOCO3=,3P_/H\</B:_^3E_X)O?\%I;[Q1X$_P""C4%K^R9=?\%'O'W[3MM\
M9_B7\*?%/BGQ!HOP'^&7PB\*?LO:G^SU\*_A]9S:+INK:MKOCK2],\1Z_>>,
MK^TUN[TZ34)K!+'4KV"QDN+CQG]IG_@@Q_P4)_:,N;+]KCXJ_#'_ ()Z_&W]
MK[XW?'/XF>,_VI?@KXPO/B7X>^#T?P^;]GGP!\ _V?M,\$?$[2R_CQM7^$@\
M&>-?B,ZZ=<:!IVI>,OBO:R:E8Z];^ ]+EC /Z.?A9_P51^ _CG_@F=!_P5%\
M8>$/BU\+_@G8?##5?B1XN\)ZUX!\0ZQX_P!&70=0ET'5]-T'2M-TY1XPTJX\
M1PO9>'O'>GBS\%:GHLL/B[4]8\/^&X=6O]*_/;]D?_@X3NOVBOVDM'_9P^*_
M_!-[]L#]DK6?C+H'CG6OV0=>^.FD2>$[+]I/4/!GA2]\:P>#K.7QGX9\"^&_
M"'BKQ1X?M8;C19;+Q=XW\&17%U''JWC'3[>;3[O4>H^ /_!'WXPS_P#!"\?\
M$O/CY\9(_!OQ7O\ [5XDT#QY\/-8UCQUHOP>\0>&OV@]/_:&^"_A?P_?^,XE
MO]>\'_#S7O#'A'P[?6B0:9]L\/6FHVFBR:;<26M_%YI^S]^P3_P6#_:2_:9^
M"?Q/_P""LGQS^!C_  8_9$T?Q%J?PF^%W[,4VH:3??&WXO>)_ACXM^#>H?$S
MXD^+(]#T#Q#X-E;PAXM\0:L8O"6I6;6>MZW&OAJR\.1VLTM 'K7_  2@_P""
MV_Q/_P""GWQ%TS0$_87L_@Q\,-3^&>H_$5OBKI7[9'P4^-]]H@AOX],T71O%
MWPF\)Z)X?^)7@N7Q'>K?6^GW7BO1M(DCEL6$]BJW%N[_ !QX:_X+T?\ !37Q
M!^VQ/^Q?J/\ P2&O/"/C?POX<3XN_$JPU;XUZ3?:]X,_9UN_'WB3P_:?%RY6
MV@M/#TNG6VBZO\,K:_M;;6;R\/B"Q\:26UFUKJND:?X?_6#_ ()+_P#!)[]G
MW_@FG\ OA5:>'?A;X"T?]J6]^!O@7P/^T=\8/"D>HF]^(GBRTAM==\4PO=7E
MY)!=Z/;>+WN4TN\BL-/N+^QL=/N;F"!R+:'O/$'[",5]_P %$_CA^W1I-OIN
MGZUX[_X)XZ)^R#HRVVJRP'Q)XDOOBMXX\=^*-5\8:8UI+%%_8NEZ+\(M(\+Z
M[9S?:);*Y\56&I6D\>G:.\0!^$_[ /\ P<O?'7]H[]K?0?@9\?/V5OA+X4^'
M/QW^&?[1/Q'_ &:?$OP=^,6@>+O%\<7[/W@?XA_%2\TKXU:&/%_B35/"*^)?
M!7P^U72;675/"G@[Q%9^*1IUU'X-U/P[J]W>>'.J_P""$G_!QC\:/^"K_P"U
MC\2/V?\ XP_!_P" WP;T70/A3KGQ&\%KX-\1^*I_&FNW>D^(]+LYM(2#Q1KT
M\&OQ:9H.I->ZO<Z+HMI+$UHVH206=E/]F@O_ +%7_!NKXY_8@^+W[,7Q:^#?
MCOX?>'-?\1?L@_M1? C_ (*)7MU?^*?$<7Q9\8_%WPG9R_#N^^&5CJUG,GAW
M1]"^)EMH&O:V]B^@S-H?@]].A^UC6Y(7^%OV _\ @WN_X*M?L[> _P!J+X':
MOK_[!7P;\,_&_P#9.^+W[-9^-?A3P]XC^(7Q2\86?Q/UK3]/NT\6SRZ3H=Q%
M8?\ "&W?BJ.QO(&2YTJ[NM#9[._FTY?( /TO^ O_  71_:<_;D_9X_:W\>_L
M5? 7X&W/QP^ /Q\M]:\)?"O]H;Q5XI^%-AJ__!/;Q#X<?6? O[4WB#4/$6J>
M%[N]O?$"Z-XBU'5(O#JIHF@Z;)HMK%!K-U<6]SJF7^Q!_P %G_\ @HI\<O 7
M[&/QQ_:'_9?_ &8_AS\!_P!N#]K[X<_L\?!WQAX!\=>)M8U35/!]UX._:PU3
MXN>++W2+[Q;J=SX?U/POXC^ OA"S\.?V];6MCJ6D^(M;N)+:YDCMI;#Z-_8H
M_P"" 7PB_P""<7[7UQ\;/V.?BMXZ\%_!'XA_LW^*_@K\<OA7XLUJ3Q)XE\2^
M*WC\)+X%\?>%?%L&F:?<Z#<65YIGB'Q)XA@2XA_XJ/5+:7P^FG:2HTRUVOAG
M_P $8/%OAC]B+_@F'^RKXG^/&B3^)?\ @GI^V5IW[55_XTT/P8+_ $SXCV^E
M^-?COX@M?#5GIOBUM672=473OC%:-)J^J66L1MJVA7#Q0VYO;>_L0#Y9^'/_
M  <;VGQ,^&_@75?"O@GX:>(OB7:?\%:/#'[!WQM\,^&M8O=9TCPO^S[XTUWX
ME7'@OX^>%)[3Q/+=7UQXW\'^!Q9>#M7U*0^"]:\?:?XET9!%9VUI(>F_9C_X
M+,?MX_%3]I+]EFX^-?[,?[)WP._8G_;5UB[U3X!ZMX\_:H^%?P__ &O&^$/C
M*#4C\#_B1K7P4\1?&'5;WQ(_C;5(?#WAV7P_X'\/ZI<W_B#Q;I&E:5<P7\EC
M:ZMZ#XU_X-Z?A5\6/VA/^">W[5/Q*\?VJ_&C]D_6[D?':\\": OAC0OVA_#.
MBZC\0?&WPZ1T/VO5]'\0^&_'FN^%]+U74K_4=0GUCX:1ZYX<AO=/O[#PW?VO
MSKX9_P"#<7XR:A^U-^R/XF^,7[<$/Q$_9'_X)Z_$_P ,^._V.? \WPH\.#]H
MKP]X-\#^)_!OBOP/\#O'GQD-A:#6?AOX7O?!MA8V_P#HVHW5Q:27UW9VNC:C
MJ+7%F ?UA=**** "BBB@ H/0\9XZ>OMV_G11CI[<_H1_6@#S?5M8T ?%/P?H
M%[:^,4\1MX3\7ZQX?OK32_$3^!;FRCO/#UEK]CK6M6$$OAJU\16QFT>YT73?
M$<]GJ-W97&J7/AI;]+/7Q8^C@8SU[#)[X'_Z_3G/;%<)J%WX7?XB^&].U70-
M.?Q5;^&O$.H>$?%&H1>'&OH;2>[TFU\5Z)X;FN;S_A*$FFAAT.]\1+I6GC26
MM(](_M2]\\6$%?S?_P#!S[^T#XR^%'P)_8]^'7P^^,WBCX8ZW\8?VIM-L/$O
MA_P)^T'8_LP^+/&_@'PYX-\17VKVS?&:\EMXO WA[3-7NM$FO]7U.[M]!EU"
M;2K#4EG>XMO* /Z?**_@7^ '_!9O]N;]F[_@FSX4T_PIXV^$&H^-/ ?_  4K
M_;*_9!TWQY^W5\4)/'=UI7PA^#'PAMOCUX5\-_$'XU>$-<FTCQK\1[*]\0W7
MP^\/>+-+O=6T#Q<MGX8TK095TV\L=03P+P;_ ,'3?_!1WXV?M_\ [#WPILOA
M]X"^!GPQ\=:E^RSX/^*_PVUGPD-9OOB7=?%E/"6I^+OB)I^MZBZ:SX8\.^,=
M)\6PZG\,[#2KF0:?X7.A:M?7>JWNH7:@ _T9?\_Y_*BOXCOB3_P4._X*X^'_
M  9\>?!_[-WQ4^ NB)_P3_\ V=OB;^VU\5X/'.A>(O'OC?XT?!8_M+?&:W\/
M^"I_&WB2?4[;0?$>@_ WP)=:_J<-K8EKO5WL/#>GZA8QF*[L_P"S_P"'7BP^
M/?A]X%\<FQ_LP^,_!OACQ8=-$_VH:>?$6B6.L&Q%SY</VC[)]L\CS_)B\[R_
M,\M-VT '94444 %%%% !0<]L=#U]>WX>M8^MZ_H_ARU@O=:OH["UN=0L-*@F
MD2:02:AJ=REI86P$,<KA[BYD2)691&I;,CHH+#\ZO^"QUM\2[W_@EU^W!8?"
M'3?&>M>/]0^ ?BW3])TCX>:5)K?C;5;"_%M9^)M/\.:3!:7US?:E>^%IM:MX
MX+.TFO"LCFT47"QL #[4^&_QZ^!OQDU/QIHWPA^,WPG^*NK_  WUM_#/Q$TK
MX;?$7PAXYU/P%XC5I4?P_P"-+#POK&J77A;6U>WN%?2M<BL;Y#;S!H 8Y OK
M/^?\^OX5_F0K\6_V??!W[6_[37CW_@C3\*?"GAOX/>"_^"*/[8.E>/O$/PPU
M/XI_"KXX?!?5-,^#NDZUX@^*OQOU?XEFP?P_\4_ ?Q>TS0-+\+/\+KF^UCQ;
M=+:Z([V=S>7FO6'N/[6/_!1W_@H?^R=_P4Q_X)^_LCM_P41^._BOPWXDT?\
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M$7]DM_V;OCS^QQ\6?C)\*/ _P"_9V\$:SX3^)O[1O[:?@C2/#$_C7]H7XH_
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M)\/>)O#'@O4K/4_"GA?XA^#_  7KV@>%/B-X>T*33[:PL-&\:Z1K=C'H<:Z
MT3:(L>GQV_BQ_P $<?\ @G=\:/VA/@=^U#XS^ <,/QA_9S3X.0?"?5_"7CCX
M@>!_#VA6G[/VNV^O_""POO WA+Q-I'@O7[#P-=VD%GI%IKFA7\"Z-&NBS++I
MBI;* ?P]?\$H?VJ_^"BOCC]H#X@>/_VD_P!KW]J[Q1X>M?@_^VO+J6L^./\
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MX?T;5(7U>.WAU9XM0TZVNXVU.*TCAM8M19)@;V.VBBMTN3*L,:1A5'R_<?\
M!/\ _8BO/&/P\^(-]^RG\"-1\;?";P3HGPW^'/B?5?AOX;U/5_"?@CPSIFB:
M-X:\.:9=:A8W#&P\/:3X>T33=#-P9[C2++38+73YK>+S%;Z_4*  H 4 !0
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M\,^-?$,2%BZZAXCT'2]1?S"CVJQQQLP!]$T444 %%%% !1110 4444 %%%%
M!112'OVX//'&/_UDC@CKGW %S_A^F?Y4=:\W^%7_  L&3PM/>_$\6=MXKU'Q
M1XRO#I&E^(=,\5:-H6@?\)3JUMX1TO2=?T[P-\/I;ZU'A:WT>_N(M7T.[UG2
M]3OM0T:]\1>)!IT6LWGI% !1129X!Z9QUZ\^HH 6BBC_ #^5 !10>/T_4X__
M %^U!X!/IZ=: "BBB@#Y _X*""%OV%?VPQ<:?X4U:/\ X9I^-1&E>.M,\;:U
MX+U.1?A[K[0Z?XLTKX;3V_Q OO#M[,([;6(/!<R^)FL)9SHP>^$"-];VCW4E
MI;27T$-K>O;PO=VUO<O>6]O=-&K7$$%W);6;W4,4I>.*Y>TM7G15E:V@+&)?
M)_V@OAQJ'QA^!?Q@^%.DZMJ&@ZI\1_AMXS\$Z?K>D^(;GPEJ>DWGB;0+[2+?
M4+#Q19Z)XEN_#]U:2W2SPZO;^'M:FL7C%Q'IEZ\8@?V"@ HHHH **** "BBB
M@ HHHH **** "CIUHHH ^5_V@_!-KXK^+/[#.NW/B'3]$F^&G[5'BWQMI^FW
MM_X?M+GQ?=7W[%'[87PY?P]I-MK6N:3J.J:A;V'C^^\5R6'A.Q\3>((]*\,:
MGJMQH<'A;3?$OB/P_P"1_P#!1S_@I7^SA_P2\^#?A+XX?M+7/B@>$?&/Q2\)
M?"[3;'P5I5MKOB3[7XCEGFU7Q$FC3W^G2WNB>#="LM0\1>((["2YU:2PL_LF
MCZ=J>K7=E87'U3\3_A-HWQ0UCX.ZOJ9@@N_@Y\6['XLZ!J20W US3=9L/ WC
MSP1(/#NI07ENND3ZYHGCO6?"?B>:YMM4M]8^'GB'QIX3-G;S>(8M7TO\*/\
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M;5^V_P#P;\_L3?M'_L?_  ;_ &U?!/C;]ASXA?LE>&_&7P\TZVMU\=_M)O\
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M#FJ>%+P^&+JSUG6I]6TVVT/7)K?3F>]T^_T/7-9S++_@Y(_97?X=>.]:UO\
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MO6_!/BKPKX_C\'>-M)\9>"FT^:SMH[K5M3^>?V4O^"U?_!63XK_L^^"_VO\
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MY_D:/\_EUK^';]D3]HC]M7]E'5OA/\%/@!X#_:K^'GQW_;$^.OQ?UCQ'X?\
M^"SOQG\4?$_P[X!_9/\ V//AO9>,-;^)GAGQ+I]]X>O? 8\67'Q8BT3Q5+I?
MA[Q L^H^"KR_BBETG0[-G^>/V9O^#I/_ (*'_M):W^V)X+\(_"G]F7_A-M'U
MKX/:I^S6U])XEN_!OAN+XC?M??L__LQ?\(/XKUJSOM-NO&F@ZA8_&F/7[+Q^
MEKH=]IUUIDEW+HNH6FH0:=8 '^@A17\3>O\ _!<3_@JQX+N-'_98\6?\.Z?
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M"9W[9_B#X V_BQOBM8? #QB_A1?A_IEUJ_C2U2XLHK76[OPGIVGE+R?7M/\
M#4^KW>EM9AKBWN;>*X@C9X56@#[JT+Q[X%\4:QXA\.^&?&GA/Q%K_A&Z%CXK
MT/0O$>CZOK'AB],UQ;BS\0Z9I][<7NBW1GM+J$6^I06TIEMYXPI>&54ZRO\
M+)^&OQZ_8>_9D_X*%?"GXC?\$9=%\0?\(]\%?^"<?[<?QL\=_%OQ9X@^)^M>
M)/%'Q1\-_P#!/_\ :,\767AOXM^#==@T;0-)\.^$/B7X=^']_=Z59Q7NAZGX
MV33[G3M:C_XDL5O]?_\ !6#_ (*)?\%,?^"9J_\ !,WX+^$_^"C_ ,2?BC\1
MO%OPATS]I+X^^+=?T+PDD/B37/B+XKT*X\.^%M2AG\.QR7OPMT'0=%O-*T?2
M;C5&NM1CN?$FHZS/#)J=G;:< ?Z*?C#QEX0^'OA;7O'/C_Q7X;\#^"?"NEW6
MM^)_&'C#7=+\,^%O#FBV,9FO=7U[Q!K5U9:3H^EV<*F6ZU#4+NWM+>,&2:9%
M!-;5E?66I6=IJ.G7=MJ&GZA;07MA?V4\5U9WMG=1+/:W=I=0-)!<6MS Z36]
MQ"[PS1.DD3LCJ3_G&_M[?%__ (* _$#]FW]I/QYK7_!2'XF:A\(_CQ^UY_P5
M$_9/UK]G#6_#7P]USP3H_P ,?V;;3XD^.O#NB:;K-UI-CK.CW&OZ/X6TWPS)
M%:RO=:7X<OK?4;/5V^V/I]K\X?%O_@H3_P %*8O^"H/['/[,'[!O[3OQM\=_
M";P;\(OV,M'_ &8?!_B6S\::WX6^(_@+7_@!\#_B9K?C/XN>&=)CT/Q)\5]&
MO=6\/WWB7Q?XCUVXEFLO#NCZ[;6=_H^A-K=O. ?Z>9\0Z -?7PH=<T<>*6T@
M^(%\-G4[(:^V@K>#3FUM='\_^T3I"Z@18G4A;?8A>$6IF\\A*V*_AV_X( ^*
M-:^+7_!8+]H3XS>(?CS^U+^TQX_\2_L4&+XZ>*?CC\,O&'PHTKX(_&*;XXVW
M_"0? _1_#=_?:SX>@\"VLFGSZO\ "/3[>ZT/[%H__"1!/#UEJ<6KV]M_<30
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MRTAL&M+7ZH^,'_! _4M3_:R^!_[2?[*7[:_CO]CCPO\ LS_#C3?A7^SW\$?
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M;P9HIL[CP]=ZY%!K5UH<UL8Y-)N=7@AU2>P:WEU"*.[:9% /7Z*** "BBB@
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MQX$UOQUI^B7^CZ)?^/- >VEC\6Z7X>&I3ZKIN@W\\>C2:Q%:W>JV>I16L5N
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MM^&-0\ >$-&TYS-)<VOB#P;X5O="C@T_P]I7V'\Y_P#@CQ^T)^W[\%_C-/\
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M.M+'+IOA'49/#4X\-:QK?A6PT;6_$?AVRTG0O$.HZII6BZ/:6/U]10 4444
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M^?PEX4N+9;.X\,>'KBS2ZU2^2UFT739;9+W6Y+J76KQ8'MFB6ZU>2^O9-4N
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M'P/KGA?R-)\2>*[OQYI6M3:5J-]XEU35?"OPP\.Z-/<WD7A:T=0#]P_V./\
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MOQ&_9_O_ (;+\;]&\?OI]Q-XU\9>%="\6SS7NJAY=$N=9\47R:X/M-KJGV4
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MZ9K,]OI'PA\,O^#D_P"*OC'3_B%\6/'W_!*KXY? W]E'X4_'73/V=_B7\?\
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MC>"O&?BC2YEN/&?A2_T?PO\ ##P[\0OA-$T-[-!JK:)X6\0:5J^KZ+KFI3.
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MK/Q3^S_>/K\NEZNFHCQ;X"FCL/%5_P"%[ZU'CKP]:WD4.H275G;_ '[^P/\
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M_P!GBB\7PS>R6NJO#;S?E+\??^#?G_@H%\4?%OC#X\>$OVZ_@9X?_:0_:7^
M_P"TS\!/VQ]6U#X.^+Y_AMXN\%?M(ZC:VNM>'/A)X;O?$'B*3P-I6G>!],T;
MPM%J4<%KK[7.G?V_)=W.J7EU,_U]?_\ !!>_\3?!OX^?"#Q;^T2?LG[2'QN_
MX)[?$WXBZ[X1\-W_ (3UK^S?V,O@K\'? 7Q U/2=5TG5[?4;3XG?'+QW\/\
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M^+?B;7_%OB6Y\?>$([:37?&VI7NL2:!:Z3/HVF3O!#HT=AI=M%IE 'S=I_\
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M?!5IXA-QXHTG7-;TOQ%,=1\S6].UC5+'4FNK;4+N*78\>?L+?L2?%3PI\.O
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M]9V4]Q:6=S?R@Q6,%S/''#->2 QVT<C3."J&OCK_ ()I_&#X@_M!_P#!/O\
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MB6]LM*B\:ZU:^(;R'PJWB;Q!+>OHTFORV,.K0F34-,>?2U%R*/PK_P""H/\
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MS9_$VY\?_L'7/PKT#5]:U?3/VU-+O/%%V+KQ/:^ _#7PRF_9F_:<TKXGZ_\
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MH"@ / /?V'6O@SQ]962?\%//V3=16SM%U&;]@W_@H992Z@+:$7TEE;?M!_\
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M7@+_ (-_OBAXO_9E_:,UOXA?LD2>&_VU%^!/_!*KX7?LW_%:;XN^'?\ A*/
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MC-<P7 !^%7C+_@X:^,_C/_@G_P#$']K;]CK]@O1/&'Q(^$WQV\?6W[4/P?\
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M\0?#7XR?!D>%_#'@CP3X7;P;\+UT/3=)T+4?AO<:9'KWVJ/7=#U_39]3@U(
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M\!_#CX6QZ7X%AU7P]X7\%:7K&E>(?#U[!'HA /:_%'_!7?\ X*0_%>Z_9O\
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MU#_@EC_P3GU3X'>$_P!FF^_8Q_9]F^ G@CQAJ_Q$\._"I?A]H\'A"W^(6N>
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MZ666/Q3/I0\1,VH:K OVY_P2D^#O[8FM?'K]N+]O+]N?X">&OV8/C+^U#=_
MGX:^%O@GX0\7>%?&NFZ'\*_V?/"6OV6D^(M=\2^';&*[\0>+/$WB;QQXD:XU
M?7+Z:]30=.T'1[:RL--TFRC< _;ZBC^E% !1110 4444 %%%% !1110 4444
M %%%% 'DGQU\*^(/'/PF\9^"_#>B>'O$.I>++&S\.S:5XHUJT\/Z/+H.L:KI
M]AXINI-2U'X??%/3?[0TSPS/K&J:+I^J> O$&E:SK5GIVCZG'86%_<ZK8=CX
MX\,>"O&O@WQ7X0^)/A_PMXL^'WB;P]K&A^-O#'C?2=*UWP;K_A34]/GM-?T?
MQ5HNNP76BZKX>U#3);FVU>PU:WFTZZL))X+R)[=I%.GK^FWNL:+JFEZ;K^J>
M%K^_LI[:S\1Z);Z)=:OHMQ*A6/4=.M_$>D:]H,UW;,?,ACU;1M3L6< 3V<R9
M0_#O_!4+X&?'']IW]@W]H;]G/]G3Q$WA#XJ_'30/"OPGL?%8U*#2X/#/@WQ[
M\0_"'AKXLZ_?W,UW8RW&D:/\)=1\<:AK.EZ;/_;VN:3;WNB^';>\UZ_TVSG
M/QU\-?\ !:C]E7Q=^QE\1_V^OV1O^"<WB;XXQ>#?VO?'VJ_&+P-\/_ASX/\
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MGK%\2=:\+ZL;*S\9^");W4$N>C^,_P#P3/\ ^"U7AOP?^RG\;/@)^V5^SO\
M%C]O/X6_$3]L3Q?\5O'/QI\/>(M#^&%CHW[6WA;POHT?@[X0Z+<>&OB B^%O
M@_=>$M.G\%6&KZ+X;M9;Z#3[N]TB30GUSPGJ8!L_MB?\%TOCS\$O^"HFO_\
M!/3X5_#']D>STGP[XJ_9?\*R>.?VBOV@7^&7BGQ-=?&^UT7Q/XFN/!/AB=],
MT[Q!_9OAW6XO#^CV@U>WN+/Q8EE=7?\ ;D6MV.@)\GZU_P '*'[3_AO_ (*2
MW_[(4_P)_96\2?#"V_X*,^-_V(+;3?#_ ,1_&<?[2J>&?#7Q/U3P%9?%#4?
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MM!O-.AUZWLM:CO[*W_)?Q-_P0E^,,OC[Q?\ $[X2_P#!0WQ3\%?$7CS]J/\
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M4Z=%\0[76?%EYX\T_P $^!O$&BM<^((='\%3>$[>#3M#FO-9UC5KCR/XU_\
M!N[\5?A=^P]/^RIX$MOA]^V3KWQO?]AG]GF[^('B3PS_ ,*NN_V0M ^!WQ*_
M:T\;>+/VQO!UNWCO4=7\6>)M(TG]H6'P'IW@31M=T)Y-+U3Q!<>)[OQ7X-OM
M>\*W/]G=&.ON<_H!_2@#S#X)_"W2?@A\'/A3\&M"O9]2T;X4_#OP;\.],U.Z
MMK2RN]4L_!WA[3_#\&IWEKI\<-E#>:BE@+V[CMXUB%S/(5S]X^GT44 %%%%
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MP4H^%OPU^*6NZOX!U'Q+XF\:_!V']G_XW:CK?A3Q;=>&[6Y\1:M\/O#J>"M
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MNI:MIWAU?%M[IEAX>TR?4;N^M_#3ZGHJ:T]K!!),;!]6TY)E1@]W"H+CVB@
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MM,?M$?M/?&C5_C'^T1^T?X]T'P]X1\2>./$<\"Z?X3\+VWA[0+F\T[PQX/\
M NBRS6WA7PK;ZC=V&C7.N:X="@T;0;W3/#NC_H7%XG\-36^AW,/B+0IK;Q*#
M_P (Y<QZMI[P>( MC/J;'1)DN#'JH73;:YU!OL#3@6-O/=G%O%)(H!NT5S=Q
MXR\(6EEHNI77BOPW;:=XDU:RT#P[?W&N:7#9:]KNI2S0:=HNBW4ETL&J:M?S
MV\\-EIUC)/>74T,L<$,CQNHAU[QUX(\*ZAH6D>)_&/A7PYJOBC4+?2?#6F:]
MXATG2-0\0ZK=W$-I:Z9H=EJ%W;W.K:A<W5S;VT%G817%Q-<7$,,<;22QJP!U
M5%>;:[\9?A!X8\0'PGXE^*OPW\/>*EET^$^&M<\<^&-)\0";51"=+A.C7^J6
M^HB74A<0&PC-MOO!/";<2"5"VI#\2OAS<^+IOA_;^/\ P5/X\M_,,_@F'Q5H
M4OBZ$16:ZC*9?#:7[:S&([!EOI"]D-EFPN6Q"0] ':T444 %%%% 'D/QV^"'
M@;]HOX8:W\)OB*?%$/AO6=5\&>(X=2\$^,?$W@#Q?X?\6?#CQQX<^)?P^\5^
M&O%WA#4](US2-;\(>/O"'AGQ1IQCNY--OKK2(]-U[3M8T"\U/2+[SG]N+XH>
M,_@A^Q5^V!\:?AU=:;8?$+X0?LN?M _%#P)>ZQ9_VCH]GXR\ ?"?Q=XK\+W6
MJZ?YMN;[3;?6])L9KZS$\!NK9)8!-'OWB3]M3PQXF\;?LJ_''P9X0\6Z9\/]
M=\6^!KWPS'\0M8UZ]\.6'P\TW7;FTTO7_B!)J&FV\^H7$_@;0+K4_%=CH5E)
MIMUXIOM(MO#,&N^'9-777M.]<^+OPM\&_'+X3_$_X*?$:PN-5^'OQA^'GC7X
M6^.]+L]0O=)N]2\&?$'PWJ?A+Q/86NJZ;-;:CI=S>:)J][;PZA87$%Y92R+<
M6LT<\<<B@'\0?[(__!;O]IK]I.QU/XGQ?&+7/AW\*/\ @F1^Q/\ !?XSZQ^R
MQX]T34_^&J/^"C'C30/@_#X;^-/Q$\1>,)O%UQ/KWPQTSQ.NN^+-%NM,U&^N
M/$U_/X%U_P <:)&VHZU/HGZ@_%?_ (.$O&UKXNFA_9D_9B\%_M&_#'Q+\0OV
MA],^&_Q)L_C9IW@^QUCX6?L8_LQ? ;]H;]JKQQ'%J>E3Z3XHUOPOJ/Q8\6?#
MGPMX?TO7M&TW4-?^'EUCQ'J/]I/'8_?GQJ_X(^? W7OA1^SGIGP*ATKP#\</
MV,OV;O&'[.'[-GQ'\6Z19:SI6H>$O$_P1O\ X'II/QZM_#MAX?\ $WQ"\.6N
ME:A-XO;3=!U_PE(_CT+KSR2VD^HZ3?\ .?L@?\$6?@/^S1^S[^P_\/->O[CQ
MS\5/V*?@;^T[\.O#'BR,#3? OB'QW^V5IWAZV^/7CC7O"-M:VD_B.WG70[GP
MYX,TWQ#>WB:1X-UB[M=636M=M](UO2@#\C/#G_!Q=^W9X1\+_&+XH?M"_L,_
M"'PO\.O!7AO]B[X\:%9^#?B=J.J:]X:_9._:G^,^I^"=1^*?Q%UFRU?Q7ILN
ML^&?#UCIWA^;0-,T31=1\/\ C;Q+8^(?$&DR^%]+O]*EZ+X@_P#!>+_@I#XF
M'[(FL_LK_LK_ +)7CG0OVZ?C%^T#X=_9Q\._$+XG>(=%^(VL_ _X9_$ZY\'>
M!OC9XQ\/6WC+3?\ A#_"6J^&])U;Q%XO\2W:W.AZ:&T_[ "9X;.\S?V-_P#@
MV%^,W[+W[,__  40^%'_  W=X=A^)G[<_P &K+X!V'B?0?@2/$7A#X<?#B'Q
M7_;/B/3Y-'\9^,Y+S5G\>>$]0\3?#R4Z:-#O/A]9:\/%WA75;WQ-I6F26WZV
M^,/^"!__  39^*VH_LZ^)?C=\(]>^*WC/]FCX/?"/X)^!=:O_B-X^\%>'+KP
M=\'H(1HMKJGPK^&WB/PC\*?LNO7RW.H>*](LO!MKH^O/?7-M?V,]JPBH _F;
M_:X_X.=_VZ/'_P 2O^"AO[)/P%^ 7PF^&LWP-\>>-? _@/X^6WQ6U;PSXK^'
M6@_#+X\:/\.;[QYXODUZXM_#VOKXAC@)OK313X9M?#5CK$\E[-K6G:9=WD_Z
M"P?\'#?[3WAK_@M['_P3(\6? OX/ZC\([FY\&?#:#Q9IGB.[NO'T7C2\^#9^
M(EY\28O$?A[Q)X@\&:CX;\0ZUJVGPQ^"QI%OJVE>&["V2XU33?$TNK62?K]X
ME_X(.?\ !*KQ9K'[3GB/5OV5M!'B7]KS5[[6OC7XDT[Q?X_TG7K^ZUCQ WBO
MQ#;>#-5T[Q1;7GPUTCQ1XB;^UO$^A^ 9?#VD>(+E+==4LKFWL[.&WETS_@A/
M_P $P-#_ &KK3]M?0OV=;C1/VB+'Q.OC*V\6Z3\4_BW8Z/'XG_X1\^&[C6#X
M)@\;KX,>[O[%YKG4F?0RNH:O=7>L72RZC<S7#@'P;_P1F_X*V_MQ?ME_M$P_
M!O\ ;2^%7P5\$:-\6?V.=(_:^_9LUSX)6'B&\?7OAZ/C+XG^&NKZE\1[Z]\9
M^*;3PKJ5\Z:/9:3X9OK'1-09]%O-00W/]H26UE_357Q]\'_V!OV1/@'XY^&O
MQ*^$?P1\+^"?''PA^ ?_  S%\//$.E2ZLUWX<^"!\4+XTD\#PK=:C/;W=M-X
MG#:O-J=_#=:S)<S7 -^(;B:)_L&@ .<''7MGIGWK'T30['P_92Z?82ZM-!-J
M>KZLSZUK^N^)+P7>M:I=:Q>I'J'B+4M4U"'3XKV]FCTO2(;F/2="TY;71M$L
MM.T>QLK&WV*X_P $>'CX8T>ZTTW&C71F\2>+M9$NA:1-HEB@\0^*-7UP6\MG
M/K.NO+J=M]O^SZQJ O8HM5U2.ZU*'3-'BNDTJS /\T3_ (* ?%_X>>./!/[0
M?[;>N?&+]H_XK?\ !3OX>?MP_&CX>^%]-\#_ +5;_#*/]@GPY\-_C>V@?LOW
M_@']GOQ+X>\4:WXM\"^+M4TZQ%YH?A/5+%K?5/$OB#7K;4='ND5T_1K]JS_@
MKE_P5M_9N_9>_:@_:AU7]K_X4:/X2TO]L+XI?L)_#'X::S^RIX:\3?&?PCXJ
M\%>&[SQ1JGQ+LO$&F3^!_A_'XMT+7KW2_!KZ+X_T?7_"NG^%[.\U[_A'?$'B
MNR&@:Q_7?XQ_X)H?\$_?B#\<H?VE_&_['G[/WB?X^P^*/#OC9?BSJ_PV\/77
MC-_%_A*>PN?#?B6?56M-]SK>DW&EZ=/;:C<++<F:RMY)'=HE(ZCQO^P/^Q;\
M2_A]XS^%'Q _9A^#'C#X;_$/XO:]\??&_@OQ#X'T?4] \3_&KQ1<"Z\1_%#5
MK&X@DCN?&FN7 ,FIZX=MY>!F2=W1W5@#^,/1O^"TO_!97]J#]GWP'\:?@=^T
M=^R5\(;3X2?\$XO&_P"V+^TW>ZG\#M;U&#Q!?>$_VLOCE\ []= T_6_"WCN\
MA\3Z+X1\!^$M7OM%T2WT_P '7?B!=<OM)O\ 5;#5K#P_H7P]\6O^"O?_  4;
M_P"":W[(VN^%O@S\?/#OQ2^(_P 7/^"IW[:?B+XL?M0'X.^$EMEUKP!=?"'7
M-0^',GA/69-;T3P_=?&[4/&%]\4K_1+OP7X6O/#GP^O=$T'P)JMX+CQ-'X2_
MT-Y/V*?V19+WQ!??\,V?!B"X\5?"Q?@AXC%G\/\ P[8VFM_"%/&.I?$(_#G4
M;"RL8+&X\)2>.-:U;Q3/HTEL;6YUK4+R_G226=R8O%'[$'['OC70M?\ #'BS
M]F3X'Z_X=\4_%O2/CUXDT74OAOX7GT[7?C/H%EI>FZ/\3M3M3IWE7?C*QTS1
MM-TN/6YU:\?3;4:?*[V4DT$H!_ QI?\ P5K_ &K?^"E'[3'_  3!G_:+^.WA
MGX*77A__ (*<?\$XK/6O^"<MM\'Y_"<WC%X?%FG:MHG[87@[XI:_I4_C/6/"
M^O>(]0U:QU+X6ZEXB;0?#"WG@R^L;OQ1<R6%[#_I&5XC>?LT_L\ZC\2Q\9M1
M^!_PHU#XM+#X4MXOB3?^ ?#-YXVMX? KW$O@U;3Q)<Z;+JMF?"\EU.^A/:W,
M+Z8SYM6BV)M]NH *^3OVA[GQ?;_&;]@Z+PW9_:=$O?VHO'%KX_G_ .$>T+6?
M[/\ "J_L3?M>7MA<C5-6TR_U'PD9/'-GX.LO[<\+WFBZU>"[/ABZU&?PYX@U
M[2-4^L:\-^*W@)?%_P 0?V9O$C7_ (4LV^%GQE\2^-H[;Q!)XA76-4?5/V=O
MCM\-?L7@9=&\1Z)I<WB2)/'[ZG?1^+-*\7:(/!FG^*Y;30K'Q/%X?\4>'0#\
M-/\ @Y@\>?\ !/\ ^&O[''PY\9_MZ:#\3?B[9>&/BE)XC^ O[+7@/XD^(_AY
MX=_:(^,&FZ'<1V.B_%6YT$ 1_#CPQIU]<W_B?Q,TT&M>&=&U+4X/"0U+Q%K]
MEH.L?Q^:%:_\$YKGX/3?";XR^)?BU^TY=^#OV%9O#?\ P31U+X)Z-^TGI/P]
MTC_@H1\3_C7\3?%_Q-^&WP"O?%6JK=:Q_P *]\9ZU\'-$L=/\6ZSJ?A?7/#>
MA:]XDM/"]SXM\5W8UG_3_P#B!\)?A;\6+33K#XH_#CP+\1[#2+J:]TFR\<^$
M]"\5VNF7=Q$()[JQM]=L;^*UN)H0(I9H$CD>,!&)4 5%IGP?^$VBZ9X/T71_
MAA\/M+T?X?:G/K7@/2]/\'>'K/3_  5K%RUR]QJOA2SM].CM_#^I3R7ET\U[
MI4=I<R/<S2/*SR,6 /\ , ?P+X>\1?L=>(/#?PF^$/[3>D?\'*>G?M*?M$>(
M/VI?&'PT_P"&@_ 7Q=\->#9_%/CKQU\4==\8:EX5\7^'O@]X8T#QQ\*_%2:9
M8_V+HUCI_C6TT_7].T2TN[AC=:M\P_L._!;P!\,['Q3XKU/X)_&W]M7]B:]U
MC]A;4/\ @I;\6OA_X%^(?A6W^#7@B\OO%/Q"^-'[(&H>$K3Q%IVL_$*\TSXX
M_P##.GCWQ-\2/"&L:%XI\-S_  (&@&WTKPS\1?$^F:W_ *WMEX+\'Z9XA\1>
M+=-\*^'-/\5>+HM,@\5^);+1--MM>\2PZ)9OI^C1Z_J\-LE_K$>DV$CV6FIJ
M%Q<+96C&VMQ'#\E&A^"O!WABRU?3?#?A/PWH&G>(-6U/7M>L-%T/3-+L];UO
M6BIUC6-6M;*U@AU'5-5\N/\ M&_O$FNKT1QK<2R!%  /X!?'G[$?[/7B_P#X
M(_?M2_'+X ?!+XY_#3]GWX._\%.OA)\9_P#@GKX>\57WQ*BO?%?@+XA?%[]E
MSX$^-_&FJ>"/'5K-XSU3PS/9:E\0;7PO8>(;>34-)&G+K*:IJ1EOKB]E^.'A
M7QAKG_!PW\8O$EO\*M0U7XHW_P#P40_9"UOP#^S5\3OV&/"WQ%E^+'P2\#?#
MSPG\._'?[3&A?MCR:9>:]\'?A_X&T71-7^*?AKPGHWBFUT3Q;<Z=H%WXKT5]
M>T>72['_ $#CIVGM9II[6-FUA'Y0CLFM8#9H()4F@"6QC\E1!+'')#A!Y<D:
M.F'4$/-C9->+J)L[4Z@D!MDOC;PF\6V+%S;K=%//6 NS.8@XC+$MMR2: /YF
M/V:_^"1O[%7[3?C[_@J'\4/'G[*_PH\'_#+QO\8]>_8O^"'PY_9P\(^!?V?]
M*@^ '[-<6AP_$._T'6/A/IWP]U:U\=?&S]I!OB1HWQ.\2^(M3BUC5/#_ ,/O
M"GA"T\0+\,8XK*^^W_\ @@)\*/%OP5_X)0_LR?#SQCX.USP!J>E3?&*^TWPM
MXE:"37=-\)Z]\</B-KG@IM3DMW>&>YO/">H:->M<H0MV+A;I0$F4G]B;6TM;
M*,P6=K;6D+37%P8K6"."(SW5Q)<W4S1Q*B>=<W$TMQ/*<O//)+-(6=F+2QQ1
MPHD<2)%%&NV.*)%CC11C"JB@* ,<!0  < >H!)1110 4444 %?G1X1UV3_AZ
MG\9_#)T/PW'$/V*_A%KR>(XM9\5WWBRX9_BSX[T\Z/>:/=?$;5?!F@:#;>7]
MLL9=(^%_@_7M<OI[R75O%'BRTTRPM=!_18C./8@_X_F,C\?6OA;PWX6\7W?_
M  4<^*/CJYO?"DO@;2/V2_AMX'TJRT[3_$ \7V?B35?B;XN\2:K+XGU/^P!X
M5DTVZL++3CX;L3XG;Q!&8=7F&A+ISM?D _G(_P""JO[,_P"WS:?M<_\ !3SP
M-\%/V K3]L3X'_\ !6#]FS]E;P;I?QEMM;TW3-/_ &6_B7\'/#OB_P"$>G:_
MXKL-<\/:U+K-UX9DU2^^),T/AJV@U'3K"7P7J6D>((]4AU;3;7Z3\&?\$SO$
M/P8_X*B?M.?'G2_V*/ _Q)^ ]W_P1EL_@E\1]#GT3X9V_P +OVO/VKM4^(G@
M3QAJ7ABW\&7?AB&;Q'?^,M.^$=S#\0O%7CS2_$=U-JFH^'[O6IU&JZ79-_4=
M10!_%/\ LX/_ ,%B?$'PK_X*:_'WXC_\$^_B[\-?^"@_QE^$?PW^$?P*^(E_
MXK\-R?#?P'\%/%/Q;T/X=6?P<_9X^!>F0:?X?\+']G/X:>*_%GQL/B#Q?XA\
M3:GXT\9>'_/\1C^S+FXTV^^G/^"L?P!_:?\ V;?@;^RU^P+_ ,$P/^"?OC7Q
MW^RH?A3??#+]H_QY\ =;\(>"?CIJ7P!L=>%[XE_9PT7XKZ_HFKZIX4F^.VMZ
MCJ_C/XL^.WL=>USQ7?:IX@O#;1ZQKVLZE??U>44 ?PF>'_\ @FW^US\3O^"C
MGP0\6^"O^".WP4_8IO?!'Q:_9>^.ME^VA+^T5^T%\3M'\*_!/X7_  O\,PZK
M\ _$GAB^^(&CZ#XI^)T^F:;X>^%^JMH_@+PKIFG:KX>\0>=;:PU_'\1Y?[L@
M<YZ'G'TX[Y[YXX^OM2T4 %%%% !1110 4444 ?)7AKX@>&V_;K^-?PK;4O&*
M^,(OV2OV7_B!!H^HW6M2?#Z?PW/\8OVO?#ESJ7A&SEU.?P[:>,;;5+:SM?B+
M=6.C:7K5_HEW\+HM4U/7K'3='M?#GI/[2GPTUGXT?LZ_'KX/>';_ $W2O$'Q
M6^#7Q.^'&AZIK+72:1IVK^-_!>M>&M-O]4>QMKR]73K2\U.&>\:TM+JY%O'*
M8+>:4+&VM!X3\!:;\<-6\<PZ5KC_ !1\9_"GP_X3O]<-GXIO_#=IX"^&?B[Q
M/K&D:5'?M#/X)\+:Y?\ B'XLZW>36:7&F>*?'UAIL$TL.NZ3\-H7\.^K4 ?R
M._![_@A3_P % _&7P!\(?LK?MC_'?]CO3_@9^SA^R5^TY\%?V1=(_9F\+_%9
MM?\ #?Q?_:/^ GB_]GJ]^)'Q=U;X@:7HMUXN\/:1X8^(/CGQ'JNAZ5>6-QXC
M\7^(1?;M)L]*LK(_G?\ LE_\&FO[</[(AT']H#P%^T3^RI?_ +:/PT^,/A;Q
M3\)IO$US\1_$_P"SC9_#^+PCXNT;QG;^./"NH_!F+Q%XC\97>IZ[IH\.&**W
MT;3].M[^>:5=0F@"?WY44 ?S&_"__@@7\0OV9OV:/C)XT_9R_:+N+?\ X*E_
MM!?"/P7X*^*G[0/CKQ!JD7[/UUK=A\1_ WC_ ,7Z)X8^%^B^!KRR\/?"Z[TS
MP78?"_2O!\'@Z3PZ_P ,;&T\(KX1T30;J?2+;\\_A?\ \&X/_!3_ ."GQ8\9
M?M%_!C]JC]@OX.?%7]IOX=?'3]G+]JSX<_#?X!MX4_9ST;]G3XJP>%-/TG3?
M@-X \)?"CPFNG>(]+31+;Q3+97%MX)NH_&?@KPQ/JOC[QCHGBOQSI=S_ &_4
M4 ?S:?&S_@A3XS^"_P"S_P"/=)_X),?&JW_9M_:I^+GP.^!O[*OQ'^+WQ,\6
M>,X?#-O\!_A=H%YIWB[4?A/H_A30/%<GP=^*WQ'U2/3=3U;7_!FF6NGZ7<ZC
MXMU[PA#X0\<:W+XN?XZU;_@BS_P6NTKX1_ &P^#?[:_[&GP4^+GP@^!OQ?\
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MJ\OA;P_X:\7*?['\5Z2  >T44#H.W'3IC\.U% !1110 4444 %%%% !1110
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MD/ GQ8\??M*>,M>T[2O"GBO6]1TC2/AIJ-IK_AC3;#1&UG1_[QM1_P""/_\
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M M<B:#6O"M[?WUU>7::1J\3>7J=M:S6_V]5B%TTODQ;/:_#G['O[+WA+Q'\
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ML]<TO0=6U#PYKMOXF\4WFC^%+6+P3J4=K/I-OXJN9[S5WO=$32]5_!WX1?\
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M51H]_-%9:I]AFG^P7<B6]UY4KJI\@^%'[=/[*_QFOOVA+#P;\9/ N_\ 9?\
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MQ=J/A7QCH-U8R7^GW7A:7Q)I>D:O##KESJVHO(NH^%M'\06.H: VM^*>"/\
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M .*NA_MO_&S]FWP;X/U_X6?LD> DOM"^%FIV'[->D>#8AXK\<?M<:\=.\8>
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M_%]CX)USXB^$]-U7Q;:Z_!J%OI?\Y_[*WQS^,7Q0_::?_@BG^T1^V?\ M=_
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MM/TWQ'XET;0[BXU;4=,U.;6O$VGV<_F^&O#MT59(@#O/^""WBCX7^$_VD_\
M@J/^RI^RU^T/XT_:B_8D^!WCW]G;Q)^SM\0M1^(MK\9_!'A75_BC\-];UWXQ
M>!?"WQ<74+M_%T47C6V5X'TJ;5=#2/2[NX;56UFXU*2__I@K\</ G[<__!+K
M]A[X3_&;X;?!#P_I/PO^&?[,VJ? +3I?A_\  GX0ZCJ:_$GQ'^U/\)],^*'P
M.;X4Z'X$TW4-2^*_BOXJ>#K=(H-4E6;6[V_T2X_X2"_2VMX+^3 ^)/\ P7R_
M8-\!?!;X0?&;1%^.WQ3D^.'QR\=_L\>!/@]\._@KXMNOV@+KXE_"S24U+XGZ
M1=?![Q%%X=\7QM\/[N^\/>'_ !3!!9W.HZ?K_BK0;'[#*D]Y/9 '[745^2?C
MS_@LS^RK\(_V(/"/[>GQH\)_'_X,?"OQK\7=-^"FB^"_BG\)-7\&?%Y/&6I>
M)]6T!7U/P-JUS#+I6BV^F>'O$7C.75+^^@BG\+:+=36*W>JSZ?I5XO[8?_!:
M3]C/]B[XK^%_@UXZ'Q@^)GC/5O %G\8?&4?P%^%?B#XLZ?\ ![X*WL\*Q_&#
MXKWGAT/_ ,(QX"6Q>ZUI]5CCOY!HVG7E\;<*UFMV ?K717XW_M3_ /!;S]EO
M]E']I?Q'^RQXA^%7[6'Q6^(/@:?X36'Q!UCX$_ /Q!\3/!7@36_C9;1ZG\._
M#GB/Q#IMY;QVOB#Q!HDT&L:=IB6\DFI6\WV72WOM1MK^SM*OQG_X+@_LN?!3
M]L32OV/==^''[1FK:E9_%?X6_!CXI_&W1_A'KD_P%^#OC_XT^#+#Q7\-O#/C
M'Q\ ]LOB#7+GQ-X$T6718;=+NVD\6+?0F\ATF]B8 _9JBBB@ HHHH *J7_\
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MB_PMK&H,=7U31O/T;2]8M[S5[3S=*AFDOS=6<<D0TB\$>F:H6^R:C-%;2.X
M/C#_ (*>Z!^V=XN_8H^,'@K_ ()^0Z#!^U;XRC\+^'OAMXH\3:OX>T32? $5
MQXNT6\\6>.DO_$BRVEMX@T+PC9:X/!%_9VM[J>B^.;KPWK]G;'^R9)8OY;?@
MY_P3G_X+P_LD:/\ LY?%'X(_LS_L'WWQ;\&_"/XR_LF^,O!%WXOG\83^)['X
MQRZ-XW\5?MB_&CX@>.?$<4?B;XB>+/B)IDMSXIT;0)]1&K6-K#I>M:-J6C:E
M;Z5I?]R'?\^.W;_#]31CI[<_H1_6@#^#+X<?\&]7_!5+X;_L_P#C[_@DPGC3
M]FOQ!_P3]_: ^.OP>_:&^+/[3IBFL/C#X"\5V/@SP%#\7]&^&WP\?5IGUF"7
M5O VC^&/"EQXBB@AGM=&AU\+X?'B+5;"P\V\!_\ !L#^W>]_IB:OI_[,OP@U
MC]ACX3?%2Q_8X^+'PN\2WD7CG]J;X\7/Q9\7_$CX%_$KXX7+:1<P>&HO ;7^
MDQ:L^M:-<?:+'3?#WA9-"O\ 2Y]:U#1?]!8\@]O<=:,<Y_#\L_XT ?S._"O_
M ()M_P#!0_X@?LR?\%8?BA^V#K?P,O?VZ?\ @HW^R5?_ +/GAOP)\*=2U32?
MAK\/H=#^!/BSX4>%[+7_ !'<)/I1U'Q/JNMVFL^+]1T2RU"SA@B2SBU#4+.S
ML;.S\+_X*5?\$!?VI_VP/C%:^(OA9\5?V2K#P!\2_P!D[]G+]EKXRZC\9_A#
MJ'C+XG?#JW^!WB.XU2_\<_L]:\]AJ4GAS5_$=MJ,YG\C4?#%]>V]BF@ZEJ#V
M=]]LL_ZU0,>I]2>_ &?T[48&<]_K]1T_$_IZ"@#\N_V,/V-/C)\$_P!MW_@I
MS^U5\8_'.D>+K+]J_P"(?P"T/X$Z/8"2XF\#_ CX$_"J?2]"TF6:?RO[%EN?
M%7CGQ3I>H>&K*TCLYK[PFWC:6^U*]\9S_8_:?V'OV6/$G[*^A_M*V?BGQ;I7
MBW4/C[^V?^TC^U%:G2+*\M+?PYHOQI\81ZOH/A2XEOI9)M1U/1](L;,:IJ")
M;VTM_/<16D(MH8I)/MO Y]SG\1C'\A^//6EQSG\/RS_C0 4444 %%%% !7!:
MK:>)9/B'X1O+*Q\"R^%K?1/$L6N:AJD-ZWC^UU&8Z=_9,'A2>,&QCT:Y"79\
M1K<L)G,>G_9P<28[VN!U;3M&F^(GA#4[G4/!T.N66B>)H-,TW4=&TJY\:WEI
M='3?M\_AO7)[V+5],TJU\J#^W;33["ZMK\RV/VV:W\B'> ?D_P#\%&_^"1NI
M?MP?'WX/_M._"?\ :[^+O[(7QF^'?PX\1? /Q7XC^&6C>%M=M?B%\ ?'6JWF
MH>,_!6JV&NVF'U&6#6==&@76JS:QH.E:CJ,6L?\ ".2:E96]W77V'_!(_P"$
M_@CXB?\ !.WQM\'?&VL?#6/_ ()P_LW_ +1?P ^%,L.@:#KGB?Q7_P +L^'?
M@WX<^&O$7CCQ!=V\']KVWP\ATSQKXQAT,VD<&L>-?%K:B;G3[0ZU9ZW^M_I[
M?KP>O\_K10!_/!^S/_P0$M_V?OAQ^T%\.=7_ &__ -JKXE:)^TY\!?VC_A3\
M5=)U6V^'6AZ%J'Q"_:@\/:;H?C_X\,FC>'(/$'B7XA:-]@?_ (0FX\>^(O%?
M_"/:;<3:/:7$5A/=Q7/TC_P4&_X(W?#;_@H#\%?V6_@3K?[0GQS^!G@S]E2Y
M\.ZAX.@^#<WA#2X=>U7P=X=T;P]X.U37M(U7P]J&AK>>%(]%CO/#XL-.MK?2
M[B[NELX(8VC6/]CJ* /YY?'?_!O;X%^*'BOX9:_\0?V^_P!O/Q3HOAOPQ\!=
M!^,'@C5/BM97GA;]H[4_V>M:EU'P7XJ^)=C?:3>+:ZY<:=%HNC:L_AT:=#=#
M15ULQ_\ "1:GJNJ7?]#5%% !1110 4444 %%%% &3+H>DS:Y:>)9+"!]>L-*
MU'0K/5"&^U6^D:O>:5?ZG81MNVB"\O-$TJYE4J6,EA 0P 8-H7$$-U!/:W$:
MRV]S#)!/$_*2PS(T<L; $':Z,RM@C@GFO+=1N]37XY^#K&-?&O\ 8TWPG^)-
MW=M:Z29/AT-3MO&'PIAT]==US^UHQ:>-3:W>IGPII/\ 85X=1T(>,[S^UM-_
MLO['JOK% 'XG_LJ_\&^'_!+[]CG]I!OVJ?@]\%M<?XL6>J>)-8\)S>-?'.N^
M+_#'@&_\56^N:?JLW@_PSJ#KIUH5TCQ#J.CV!U1=7?3;(V\MD\.HVT5\,EO^
M#<S_ ()'P>$?VC_!&B_LQV/AO0OVFAX1C\6+H?B'5XK_ ,"P>"[JTU+2K7X/
M:G?2W][\.+6ZUBT&KZU;Z3-)'J]U--;7BOI:V^GP?N-10!\$^!/^"8/[!_P\
M_93LOV+-#_9L^'%Q^S[!X)E\!:EX7U?1H-0UCQ-I%Y>IJVKW_B?Q@1%XIU?Q
M#KFO*?$.JZ[)JT>H3:VPO8);?R;:.'YY_P"'"?\ P2*/PQ/P>;]B+X5OX!'C
MYOB;%ICW'BQ]1M_&,GAJ+PC/?6OB9O$1\3VVGW>AV]M#>>'X=83P_=WEI::K
M<:7)JEI;WD?Z^44 ?)WBS]AG]D[QO^R?'^PUXD^"7A&\_90A\.>%?"</P5MT
MU#3/"L6@^"?$FC>,/#-E&VF7MGJ:-IOBC0-)UX7:WXO;K5+7[7>7%Q--<-+\
M;1_\$%O^"1\/PQU+X.Q_L4?#-?AYJWC;2_B+>:&=0\9M(?&.CZ)J7AS3]9@U
M=O$YUFU>+1=7U&Q>TM]0BL)DNFDFM9)DBE3]>J* /S.\7?\ !''_ ()F>//B
M%\'_ (J>+/V0?A;K'CGX#>#/A?\ #[X6:O+;ZS!#X;\(?!>-8/AAH\FD6>K6
M^C:VGA&UCMK+3[K7]/U.]DT^QTW3[RYN;+3;"WM^^^"7_!,']@/]G+XZ^+OV
MF/@K^RU\+/ 'QT\;:OK&NZS\1=)T>:36[75?$::]%XCN_#8O[J[LO"#>(8/$
MVMVVN1^%;71XM4M;Y[6\CFMXX8H_O.B@ KF=+OM 7Q#XGT73--NK+6(#HVO>
M([L>%M7TO3=6N=;M)M,T^\B\33Z5:Z%XIU6'3_#45AJ<>EZKJNJ:#8VFBVVM
MQ:=;WFBI<]-6/:Z;>6^MZOJDNN:C=V.HVFD6UGH,\>GKINBS:<=1-Y>Z?+!9
MQ:C)/K0O;87ZW][>01C3+3[!%:;[O[0 ;'7I1110 4444 %%%% !1110 444
M4 %%%% '#_$ZQU/4_AM\0=-T5;AM9U#P3XJLM)6TO]9TJZ;4[K0[Z"P6VU3P
MXDOB#39VNGB6*_T.*35[-RMQIL;WD<*'RFT^&GB7XD_LD1?!WQ[?#P3XN\>_
ML[GX9>+M4TF2W^*+>%-=\3_#@^%=:U.Q;XT^#KNS^($VBWM]<7D*?%?P'?VG
MB>:W$7CCPO?P7FIZ;/\ 06H64>I6%[ITLUY;Q7]I<V<EQI]Y<Z=?P)<PO"\U
MEJ%G)#=V-W$KE[:[M9HKBVF5)H9$D16!IUE'INGV.G137ES%86=M91W&HWES
MJ.H3QVL"0)-?:A>237E_>2K&'NKRZFEN;J=GGGD>5W8@'^:98? G]IR]\!_L
MR?M.?LV^%WU?XL?LA?\ !OO\*-=G^'/B_P *>(KKP[\3?AW\4_BE^U+\(_C9
MX6B72X;+5IO&_ASX>^,+CQSX4TNPU;2YYKW3(I9?M]M+%IM_][?L>?\ !-7X
ML?MP?M$?L]WMCXN^ WPQ^'WP1_X([_\ !%6X^(47Q_\ V(/@M^UGXH\4:Y>?
M#76M6LO#?PN3X]>%-0TWX5W4&E>!?&>@>/\ Q/X?U:+4@-;\/V5[X5UV^M-+
MUKP9_=Y!ING6RJMM865NJ6J6*+!:P1*EE&6,=FHCC4+:QEW*6XQ"I9BJ L<R
M065G:L7MK2VMW:"WMF:""*%C;68D6TMRT:*3!:B646\1/EP"601*H=L@'\?O
M@?\ ;G_9]_X) _\ !2G_ (+/>#OC9X>^-.J^(?VBOBU\$_C1\$])^&'PJ\?_
M !-T[Q9-XB^"MYKC^&U\1^$? UGIWAFXC\2^)M/\.V>F36FHIH_GI;IK7B!K
M"[OV_(;X4?LX_P#!0?\ 8LT']NFX_;-_9)O=!\$?\%1O^";O[=6L7EGI7B*]
M^/WB&Y_:+^%?P<^+'[2_@WQM^T-'J47CW7O!GQ+AAU]_"=G+IMUX'\,P^+M)
MT>[C\/CQ38R2VW^CE-HVCW%S]LN-*TV>\W1M]KFL;66YW0[?);SWB:7=%M7R
MSOS'M7:1@8I:I)K!U'1K*TT+3-4T*_.I0>)+^^U=K2XTFU^QEK/[%I!TB_BU
MX:E='['>03:CI*6<!^T[[WFVH _S3?V,?@5^U%H7[3'_  3^\$_M*ZM\8O$?
MP1_X)T?&[]CGP1\!_'%CX4\3^&K&\\'?\%$M-T;XR7FC2W&E2ZCXWTV]\!:-
MJMW9:!XJ\/\ B&&7P5IV@V&F2CPC<>'[>"/YK^'W[!W[==K^S^/@QJ7PV^,]
M]^R/\2]4T[_@JGH>JQ?#+6+:;P/\?OA]XJ^-G[-G@_X577B#5GU+6?$X^*-A
MK?P]U'Q';:E(_B.?2HO _B?0]*TJSFUO6]?_ -5A=-TY'$B6%DCJUNX=;6!7
M#VL36]JX81@AK:!FAMV!S#$S1QE4)4V1#$L:1"*,11A!'$$41QB+'EA$ VJ(
M]J[ H 3:-N,"@#_.Z_;'^%'_  4VU[]LS7?^"]GPS\":CXD^!'[)_P"V=X:\
M&?#'PI=Q_%OP%^T%=_LI_"36?"?P:U2QT'P$;FUMKCX"?$^3Q;\0])^((T98
M]1UVWN?B5XS\8:=#\/M3OA=_N(_[!'B#_AJO_@OWX7_9R^#FH?#I?VT_^">_
M@@_"CQ!=6%EX4\%ZE^TC\7_@W\?/!>OQ^%_%%E!;Z)X?ODU_4?"U_P",6TG4
M9TL=8U:_U^[O7;4FDK^H'RHO+,/EQ^24,9BV+Y91@0R%,;2A!(*D8()!&#64
MG_"0_P#"03^8-&_X17^R+;[*4-]_PD']O?:[C[6)PP_L[^R/L'V3[,8S]L^U
M_:!*/)\HD _BQ_9_\8_$S]JN]_X)-_LH_#W_ ())_%+]E_\ :0_X)^>(/ NJ
M>//VC_C_ /![P_X-^$O@.V_9^\ ZQI7C+P?X,^)?@_2;[QQJ'AGXU_%.PT:X
M\5:5:VGA*/69;F;4IT\1WT$5Y+Y3_P $I?V"O^"EWPL_;G_X)M_'C]N?P_\
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M)$FNFMX0(8#<2!IC#"!%$6V1@( *LT44 %%%% !1110 4444 %%%% !1110
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MT3PBWB'PSJ7C7P=J=EJEY^@?[)G_  3^_P""$/A7X0?$?]I?X:?MF^+OCK\
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MT_9T\1Z?%81_$/X3>*O"WBZ^EN?'&MZ196VMSV&DVWAYI/[/U!WZ?QY\2?\
M@J!_P5 ^+_\ P4,^)_[-W_!17PO_ ,$U/A?_ ,$W/C9XU^ 6A^!]?\.Z?+\.
MO$VF>!-'_MSQY\;?CK\5=;E:+0M*DT2#4]526Z\(:CH'@_1;".;@)J.L3_7W
M_!//X%?\$6?V$OA6/^"DOP3_ &V?&WCCX":-H7B7]GCX;_$W]H#]I77O&7PP
M^!GA3Q;X[\/7>O\ P3^&G@S5+/0X/"D^K^,/#?AW4)-(OM!O_%%S9V5IK4$_
M]DWEWJ-]RWQP_9*_X(._\%(==TW]NIOCUXGO_!O[4/Q;^%G[./QF'P&^.GQ$
M\"_#+]ICXHZI-:^'O@Q\,?VCO!/ATQ:G!K%KXBM/#L/A::6/P9<'6(/#T]WJ
M4]K+!<L ?B[XX_;4_;-_;Q_:A_8^'BSQM_P51\-Z3\6?V!OV,OCY>^&O^"8/
MPYEG\)^ OBYXT^)7CGPCX@^+WQ T[6O#.IC_ (4P;07FK:CJK:AKNDC6K6Z\
M*3:G=1^&8M-T_P#>;_@X _9B^.6M?LV:K^U?\._V[OVG_@-;?LO?!BYL(_AE
M\'O$%EX0T?XF>/?$/C[P+IEMXZ\:ZKIL-K?W$BZ!<ZY8ZCI:![<7::!=:')H
MB0>(+;Q#]7?'OXQ_\$K/^"7W[3OAKXW?'_XLZ%^SM\4OB9^RAX;_ &=_AGI.
MM2>(D\#0_ +]G+Q/JOB.P\*^#-"T+1KS2['4K+5_'=G:%+V>34+ZVM=#TS1X
MX$CNH[SRG_@H+_P5N_X(R0_#_1OV:?VO?V@=.U?P#^U%\%OAW\8=+T[PMI'Q
M#U"R\1_!_P"(5]!K_P ._%;^(_!^EB?1;;Q"FD1:Y96LMU:ZJND1Q7E[90VE
M]:&Z /YG?^"LU_\ &+]A+QG8_L[ZM^V[_P %=?'?PW^!?[!VA?%[PS\:_@[K
M^E:_'X9^,GQ[^.?Q3T?0O$'[87B,#P]:Z=\+]0\11> _ '@VY_MO2=5F33?^
M$8T/4FU:YB:YT/VLO'__  5$_:L_:L_9;_9P^$/C[]JKXX:QX#_X)0?LL?%S
MQO9_L5_M7_"WX)3^+?&WQ"TBSN/'/Q2\1_$GQI!+X,^)>GZSJ\]M;VFJ:%9_
M;Y$NHKW2+AK$W4UQ_2I^UG^W%_P1%_9R\;6_Q<_:'^.WPMU#Q!^VM^S)X?\
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MT^UM/#][>:6\VI'7M-.BBYU:*VMDG&C^(OMKN+ P::)O[3@["LR[UK1M/O\
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MN?'NL>,_$BZUXBUI8->M]$.F:+IOJM% !1110 4444 %%%% !7/^+-7G\/\
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M/[/'P%U"+ROL:?VS]L/Q TEQ(-0_X3O>--\E65K/_A690W.R?_A-XF7^PKD
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MN=2@UOPOXDU>V&I:AKMCJVO^+K^VM;CPKHMQXFO #\_OB5^PI\'?V<_V2O\
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MA0:UX*\(^%?#NI>([*Q^G?AE^SA^TU^R=I7_  6*\(?M:> OB#^UW\'OV6/
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M@6UKHGBW6;RTO]4U^Q1I#'J%]>6-AIEG<3RDL&DM]/M(R% 6%<<@'\B/Q/\
M^"$?[;/BK]N+]I;XT^?\/-2^#/[;?QA_;#UW]I+PWH&L>"8_#OC3X-Z'H'@/
M7OV&O WBGP/\1](\575CK.H?&#1O$GBGXC:OX/UB_DF\[2]3OYO#;1P:)IV/
MX:_X(+_M\^#_ !W\.?@S-8_L?>-/V??'FC_L ?&#XO\ [1&I>%%N_CY^S]\;
M/V$_@]X7^'$WPQ^"FI7>I:/XB\3>#?B<OA6^T/2=5U98-"T/PU\3/B(\.E^#
MKW7?$G_"5_VK48_3C_/Y4 ?P\^._^")W_!7G4_AA^SGX&^'TW[*=CHMC^Q=\
M%_A3^T/X7\8>(;S3]3N]>_93_;/OOVKOA7\*O"?C;3--\>W%IK/B_4]1TF#4
M/B+I5K:>#-1BT/6;?Q)H?AUD\.+>>ZVG_!N5\9OB]\;_ (D_ +]K3XC?#SQW
M_P $S?!.L_M&?'']G%?!WA+P=X3_ &E+[XY_M666O2:@GCKXC^'M#T'Q9KDG
MP&\2ZJ_B73-6\2ZG-X5^*>IZ-X"?Q1X3N/#6F_\ ""^$/[$:* /XN_C[_P &
MV_[5/Q?_ ."1O[*'[%O@WXQ?"'3?VB]/^-6J_M/?MB?$7XZ^(O&'CF3QG\6/
M$WP[MO!%O9^$/'UMX$\=>*[4>!/"NB^!_A=;-HI\,:/K?A+P5:7-\^JS.1=_
MU,_L+? ;Q/\ LM_L8?LK_LV^-=8T'Q!XO^!'P!^%7PF\3:[X6;4'\-ZQKO@/
MP9I'AO4]2T)M6L].U1M*O+O3Y;BQ.H6%G>&WDC-Q;0R[D7ZK[]?7C\N?P_K0
M.G7/OZ^] !1110 5EZ;K6DZS)JD6EW]O?2:'JDNBZLEN^]M/U:"UM+R:PN1@
M;+B.TO[.=DYQ'<1-GGC3)P.F?_K\>_'J<<#FO%_AB;B?QQ\<;Q=1\1:GIG_"
M=Z5IUL^NZQJS6>FZAI_@W0#JNB>&?"EWX+\+Z5H.@V375I=+K.CZQXW/B[5=
M0U6^U'Q##/91Z1IP!^37[?W_  1S\=_M3_%SXC?&7]F_]M#4OV3=5_:!\(>
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M^?>O'&%F/V@(6\WPM]N/P@O!Y'V*R/C8VH\9Z;^]74?^$7_M%?"XE*I)9?\
M"9BS;53#.WAF29$U2'V.N=/A?2CXL7QH?MO]MIX>E\,+_P 3&]_LX:7-J,.J
M/G2O._L\WOVNWCQJ!M_MBP;K=9A"[(0#HJ*** "BBB@ HHHH **** "BBB@
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ML';GD<9QGD?45R_@>Y\67?A+0;GQU8V&F^+YM/BD\06&EMOTZUU$EA+#9O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>ex10-2_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex10-2_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" /O NX# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M+J6HZ9>2V\5MXCO;;5KBPT_^PO#TFIZY-=:MH\5OITS:I9>=X+XB_P"#B?\
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MQ9H\[V^I>!?"7CW4TM=&U[QA"T-P;32[,M'K!M;F'1;K4;B+R6_7R@ HHHH
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M^'O$MOKFIRVFFWND_P!M?!+Q[X2N]"N+>Q\6:=K%I8MJ&D6]M>)-7XC>(/\
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MC<>)+F,Z!_G9?'[_ ().?\%4/ ?[,7[/_P 3?'/[,?[1$OP9O?B3XO\ A/\
M#3X<7WP^U6]^(?PO\8^/?BK=>&/#OA?7? 6G:9'X\6Y^,/C6"T@\'ZRWA=?#
MWBKQ!K'AG2- OI-2\9>%M.U;]5_V./\ @F7_ ,%*?%OP'_X*"^'/VG/@5\=/
MAMXE_9._X)>>,_AA^RGX \2? ?QEX@M?%,OQ5\8:?\7O$7A_X1:KH<O]FZA\
M3O$GA[2=?\%ZVG@B\U7Q()OB%<Z#XPTBYCTG7/#-X ?N'X[_ .#JWXA>'/\
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M(7QI^(6J_%C1KNSUHII4'A^[^-6L:-H'A^[@U.1=-TZ">YU&2_N99T\UT?\
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M#'AO6Y8]OB*'7=;UO3[R:RN;S^QM O=!F\J[\.Z587>M7>I>(+G4KV3\%?\
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M7AWQ;I,&GZU\6+2TF\2W$6J2>&?%WQ%MO[1UW4O^$9T^VETA;?P_%[)\)_\
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M#^&WA:ZTOPWJ?C_Q#?ZG>+:_#[P?XMUSQSJ7]IZ5ILVAV-QJ=A',OTM^QO\
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M3PM'>>/]0G\/^'(O#T=O?ZCJ.F?/_B[]M+XR?$OQA\=OV@?BM_P4*_:4T?\
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M_/\ G^0HHH /\^O\Z*** "BBB@ _S_GU_&BBB@ HP/3W_$=#^&!110 4444
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M[/,5H;;]M_\ /^?7\:** "BBB@ HHHH .O6BBB@ HHHH */\_ETHHH ****
M"BBB@ HHHH Q[/Q#H.H:OK&@6&MZ1?:[X>&GMK^BV>I65SJVAC5K=[O2SK&F
MPSO>:8-2M$:YT\WL, O;=6FMO,C4L-BL6R\-^'M-UG6_$6G:%I%CK_B4::OB
M+6[/3K2VU;75T:V>ST@:QJ$,*7>I#3+1WM=/%Y+,+.W9H;?RXR5K:H ****
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M.O\ 5Y[O3O"<E^NNWEO%I6E:GJ<DT%B\::?I]Y>,PM[:61 #T6BBB@ HHHH
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M/Q;^)7PYT:T\":)K?BKX3_ OX-ZC:?&#Q1X*\=^'+C2-.\7>()+GX7?":_\
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M6C_$*:/XAW>FZC\1OAI>>,YGU;P[\1--\#>(M*8ZA_:]M)':/';6.E6OB_\
M\$BO OQB^)_B"/\ 9[_;L^./[*7P8U7X'_ 3]GSXL?LS?LMW?PF\/Z;J'PB_
M9X\2?%_PYX)\+6'CF#PW>_$WX=:>UWKOQ3\&7MSI^KG4;G6-.\7Z=>ZA?'1D
MT;P^ ?ST_M5?\%IOVY/$^B? C]IJ]^.OQL_X)[? W4_V3?@A\:_AUK>B_LLV
M/[4G[./[4O[3ND> -;\?>,_@KXZ^+7AS5_!_B'X$P>/-6\0>'_ 5OX7U#P+X
MPT"XL=,E\>>(=1\+:7:V45U_35_P41_:R^*,GA;]B[X&?L<_$KPEX%\7?\%+
M_'>I_#+X9_M8S:-_PLC1/@_X,;X*^)OC,OQ2\(> H=5\-VWC_7/$?AG0X=-\
M$R7GBK0])T>[UFU\3W:ZNFGQ:1=_-?Q!_P"#?C]G+6;S7OAU\"OVGOVDOV;/
M@C\0OA'\&O@]^T]^S1\._&7AW7_!WQS^#7PLTG1O!G@73]=;QAI.L^*/ VL:
MSX9\%:]X8U/XA>';R#7_ !!#?>);-;S["NHZ;-]B?MC_ /!.;]CC]MKX/?#/
M]DS4_&&L_"?Q1^RTOAK6?V<]9^"'Q/;PS\9/V<M>\+^"4\._#SQ'X=5-2O-:
M1-"T-='OK./7())-1M]-L9QJ$9=KMP#^<+]JW]L?_@IK_P $K- _;J_8W_:!
M_;F\3_M4^./$'[&'AK]J3]EK]J#P5^SSXGT_XD_"+Q'%\7/#'PV\;Z=\0+'P
MO!X[\)^ OA[;:9'K%];>)/&>LW^AS:B-*@L=:TGQ!XH_X16X_3K_ ((7>/?C
MA\=O#'[2?B_Q3^WG^V/^USXDT'2-%\!:3XF_:3_9(G_9=^#/PC\?ZCJ'BP:W
MX$TKP!?>,M2\7?$WXP>%(/#7A;QMXXUBU\0V7A?PY\.OB?\ #+0K*YL/&VM^
M/=&\/_0G@7_@B?\  /4_@'^U'\*?BW^T5\9?VG_C'^T]IG@?X4_'G]JOQ_XA
MT'4_C<OPW^%6K>#M9\*?!C1[C3X)M%\$:)I&G^'[!M0L;6QCU/5M8UJ[\8Z\
MU_K5Q;7,?Z@^%_VGOV5+W3-=@\*_M(? 36K#X?\ A^77?&%QI7QD^'FK#PIX
M<TNXM=*O?$?B^ZM/$4PT?3+?4+BTLM0UO6&MK5-1NX(+FX6XN$5@#^:/PSX+
M_;Z\%?M<?\%2O!/C/_@JO^U7\0?"?_!/3X!?!K]I[X9>&E\/_"+PSI/Q%O?B
MC\-OCG\1O^%??%;R_!>L7U]X3T#7_A3H^G@^%+WPO=ZWX:U'4-+OVCF=;L?!
MO_!$;]O[]HC]I7]M;]@?X=>'?VT_VP/VB];@_9^^*'C_ /;&^''[4L?PK^"/
MP0T/PQJ^FV^C^&_^&=-/T1/$7Q+^.>N>"_%5M;(+O5+&[TK5=)M;76[7Q;X)
M@G\4:'X>_K$\$_ G]B;X\?$C]MSXI_"SXL^'_BKXI_:_^#WPQ^!O[2?_  K+
MXP^%?&FGZ+X(\(^$OB?X*\##2K3PM<ZI)X'UC5-#\<^-@FHWEQ*NJW6G+=V=
MNKZ7>>9Y[\'OV?/^"9"_%W]EOPE\*_'/PB\3_M&_\$YO!.O_ +.7PLL-'^*7
M@S5?C;X4\*^'/ -IX*\6^ OB#HNE7<7B'7QI&C7=OJVN6NIZ1$-&\27=WJY6
MPO+_ %-+@ _ '_@A9^TA^U;\:/$?P_\ VH?VK/B=_P %7]?\+ZC??M.^+?%?
MQ+\6:;\ )?\ @F%JW@[P3)XE\(2>)M2\4R3>'OBKX0;PKI/PZM]!C\-QZ/KU
ME9^._"VHZ_I6KPV7B?5[2U\Y_P"":_\ P5$UC_@H_P#\%%O^"H/['.O?M9Z[
M9?!7]OQ/C9<_L=>.? -WXQ^&OQ/^#/ASX)K8^ ? TOPOTGQO\.K'1[/Q#\5/
M@+);?$VVATK7+C4]*U?X7^+/$?C/PUI7B?Q3+'=?HK^SA_P1'_X)Q?";XB>&
M?@Y\/_\ @HA\<?&^K^!M7\<_VW^RK)^U?X$UGPQ=^.O$'@#QEX!^-^KS_ 33
MUF7PUXJU6;Q)+KEW)9Z)#K'@+4]&"VEQ#)/>7)^DO&^I_P#!!GP3X%_X)H^/
M?%GQI_9Z\ ^"?V>/&%^?V!?%2_%";PS_ &MK'P?MV^!_B2T.HP7EOJOCC1/"
MVOZ)IND>,+OQ6]SIG_"9>'M)&NZA))+<VFH@'XI_!3]C[XI_#K]D3_@L7^UE
MK/\ P4*_;R^)?C#]B70/^"FGP ^$'A+Q?\;M0M_!<L_@G]G_ ,4>%?"GQ0\2
MV6CPVE_JGC;0[/Q/K&K:3%%?VFBZ5XKA\/>*--L+;5O#VGSCQ']H[_@I9^U%
M^S1\5/\ @I3X=\=_$CXK']F?XT?\$[_A]\)OAA\3HO%4UY%\$_VY;[_@GSX<
M^*_PQ^PW!\36&L>!YOC"3KVF)XCL-(OVU[XBW'AJSL7ANEUN]L?[.&_80_9K
MU+X)?M8? _3='UFV^%O[<6J_%?Q5\;;31?%%V)-;U#X\>&(O#?Q#U+PKJX^T
M2:%'XATO-U;FP>6WM+JYENK$1QO'&G >.?\ @E=^Q3\1_AK^TO\ "7Q9\+IM
M2\$?M9R?"27XN:6^OZH6N(_@/X?\+>&?A';>')I99#X?M_!&E>$-%CTY+=9)
M+QENUU>34;>\N(& /XY?VLO$_BW]M3X._MT?&3XB?M.?M3^)/BM^Q1XO^ 7[
M'O[/W[%W[(WQHTGX4>*;[3+;P+X>O-(_:8^,TGBD>)+SXB7GQ?\ &_C/Q9:7
MFI>'?"5QJ]E'X,U+0](^VDV-]X7_ +4O^";?QPO?VDOV _V/?CKJ.E7VB:G\
M3?V>OA?XEU+2M3UT^)]1M=0F\,6%M?F^\0/INBOJUW/=6TUQ<7LFEV,DDTK>
M9;JX;/SG^UI_P1!_X)I_MH>/K'XI_&7]GJSLOB+#:^"M%UKQ;\,/$_BGX6W_
M (S\&^ (8K30/ 7C2T\$ZII6D>(/"J:39Z9H<T5QIJ:RFAZ)X?TBQUFRLM!T
M:&R_3#X:_#7P%\'? '@WX5_"WPGHG@3X<_#WPWI7A'P3X-\.64>GZ%X:\-Z)
M:16.EZ1IEG%\L-K:6L,<:Y+R2$-+-))-(\C ';T444 %%%% !1SQ^OTP>GXX
M_#-%% &+I,7B*.[\0MKE]HMW83:TDOA2'2M*OM.N].\.C1-&BDL?$-Q=ZSJL
M.M:T?$D7B&^35=-M= L1HE[HNEMHQO\ 3+[6-7\N\1_M'_ ?PC\5!\#_ !+\
M6? VC_&#_A5?B+XX-\-KS7;1?&,/PB\)ZC;Z1X@^(=QH:.][;>%K#4[@6(U.
MXCBBN[BWU!+'[2=,U'[+[77\:_\ P5:_9D^/?Q _X*R?M&_M2_LJ)JTO[4?[
M'/\ P3J_9X^*_P ,/ $UIJTNB?M!_"SQ1XY_:V^'?[1'P?BTK3[5KSQ#JOB_
MP9>VVD^'+S33<#3_ !+:P:4#;:I?VE[IH!_6C\%_C=\+_P!H3X4?#_XW_"+Q
M1#XK^%_Q5T*S\3_#_P 4_8-5T2/Q-H&I&3^S=5LM-\0V.E:Q%;ZA#']JLUO-
M/MIY[5XKA(3'*C-YQ\/OVR_V8_BQXF\(^$_AC\9/!WC[6?&^G?%#5= C\+7Y
MU2TN-/\ @QXP3X??$NYNKZ%#:V">&/&\C>&+H7DL33:Q;W-M:^?]GF=/\S7]
MJ/X0_P#!77X5_L^?\$DM \,?#_\ ;'\0>'_ 7P5^&_CGX&ZQ\.;3XN6FD_![
MXH7OQ,\4^*-3\-:GI.C:$=3T/Q]9>'[GX<Z6#XTTZS_X1'3= 2S\(1W>ER:N
M%^Q/V0O^"<UI^WT?@K\-OC/X,_:O^'.KV?@G_@KKX_\ B?\ %#PF-=_X1O3/
MVFH?C'X#3PG+\.O'VFZ)<>$?&G@2]234+1]!TNZMK+X@^(O#^M-'*\@8Q@'^
MD])<V\31)+/#$\Y*P))*B-,PVY6)68&0C<N0@8_,OJ,^(_$K]I;X'?"+QA\*
MOA]X_P#B%H^C^.?C9\0-%^&'PR\(VT=_KGB'Q)XQ\0:-XS\0Z99MIF@V>I7.
MC:9-HOPZ\=7[^)->33/#<*>%M6MY=66]A2UD_P RS]HC3/\ @K+\0_VS/^"3
MM_X>\ _MGS>&? 7[-W_!.Y_A(+S0/B9K.@>&=8'@OX?)\5=0UC7M4TU=/.MZ
ME\2]&\6R^,;KX@20ZK';VMII6I22^%=,\/S/^H4W[('Q6^$W[(?P"_:2\+_!
MG]I;0/VG_P!HS_@H-^WE\8?B3KNJ^$OBA<?%?1/!W@3]G_\ ;W\)?LPRV_AZ
M/3[K7_AYX<T_2O&AUOP;!):6MW>>)?B)J>J6=]=6NI:+#9 ']Z6G?$7X?:MX
M>U?Q=I7COP;J7A3P_/K=MKWB;3_%&B7OA[1+GPY+<1>(K?5]:MKZ33=-GT&6
MUNH]:AO+F%]*DMKB.^6!H9 M+Q%\6/A;X/\ "<OCWQ9\2_A_X7\"P7T^ES>,
M_$?C+P[HGA.'4K74+K2KK3Y?$>I:C;:/'?6^IV-[IL]F]XL\-_975G)&MQ;S
M1I_ED?\ !(3]B7]LCX@^$_BW\+/C#\ ?VF[CX!?%7]K/_@G!X.^)GPY\3^&/
MBWX4TKQMH7BC]IV/6/BOJ=[ID]GI,IT&Q^#.B_$:?XB>/1<65CX7T._AEUS6
M+1M7T^4_47[1_P#P3N_;C\-^ ?VL?A1)^Q-^U-^T'^P/^S_^U+_P46\._LZ?
M![P1XS\8^&K'X;7WBS29/%WP*^/?A7X<ZQX57QW\1/"/P[ENDE7Q+=7WC?3/
M'*W?B/0?#H:XU=M7U0 _T6/A3^U'^SY\:M*^%^H_#OXM^"M8OOC+\*_!?QJ^
M'?@^]URRT+XCZY\,?B!X7M/&/A7Q4_PTUV73O'FF6>H^';V+4)8]5\/65S8A
M+B"_@MKBTN8HO??ZU_G->%O^"7/_  50;_@L/_P35^/?PL_9M^('A+PW\'OV
M:/\ @FU9^.?BC\6[:TL/A3X$D^$W[(_PJ\#?'#PE)<6/B*_O;:]TF71_&'A(
M^$8[/3M9F\?S7R1Z)+H]W;Z]J?\ HR_Y_P _G0 4G'3\?R(_D2*6N.^(GA[5
M?%O@#QSX5T+5[?P]K?B;P=XG\/:-K]WI5OKMIH>JZUHM[IVGZO=:)=LMIK%O
MIMW<PWLVE7++;ZA' UI,PCF8T ?AHG_!R-_P3ZO?B?X/\&Z#X+_;,\2_"OQ?
MK5GX5B_:RTG]D_XCP?LS:+XRO/%FI^!%\):OXEUN/1_B)<:K#XSTU?#%Q=^'
M?AAK_A^/6;ZWL1K;RVFLC2OTM^(?_!17]A'X33?%NV^(W[7'P \)7OP%FTNT
M^-&G:E\2_#1U/X8WNN:GI&C:+IWC/3+>^GO]"U35-6UW3=-LM+O;6/4+F_EG
MM8;=YM/U!;;^5W4OV4?^"V?CC]FOX%_\$M+SX#?$3X.Z_P#LD6B^ /AK^W=^
MS=^U7IGP*_9G\:?"1+J#X>?#GXD?$WX=^&[(>//B-XQ\$>&-'U/Q7>?#.SN-
M-UC6M7;1_%7BFRT/5-<:6;RGXW?\&^?[;'C7_@F-^VI\/++X4?"[5OV[/C1_
MP4V7X\ZKXNB^*E]KMU\:OV>?!_A[4-)\'2:;\0OB+JU]K-JQ\5_$#QUXTBT;
MQ[JFG>(KQKO5[SQ%<W&L3:7;  _J_P#'7_!6#_@FU\,O"GPH\=>/OVUOV?/"
MW@SXYZ%?^)OA%XHU7Q_I<6A^/= TG5O["U;5M!U)'DM9[+2M9)TO4Y99(1IU
M]'/;WODR03+';_X>@?L.V"?M17_BOX_^ _ /AK]C[Q_X*^&WQL\:>-O$OA[2
M/"6D^)_B'H6FZ[X1@TC5H]7O#JL.L_VB^CV0%O;WESK>EZQ96MG.EA)<-_)/
M\*/^"-G[8.D?L=>!_@K\=_V-K#Q-XO\ @)_P29_X*T_#SP]::C/\-/B5I47[
M3_QK\7:5KW[-4_PUN++5M6C'Q,U-8=5N/#FJVEO::IX3NE>X?4].GN]/FN/C
M!?\ @W<_X++?#[]@/X__ +'.D_!WX$>,Y/BC\=/V=?C/JOB_2OCO97/B?Q)/
MX&\$>*M*@\,:39>*K#2= TK1_AO-XHU+3=;U-M1TS5=<OKF!-$&N>';97B /
M[6_VE?\ @L9^P!^SA^S7H7[2FH?M*?!GQ;X<^)7PY^(?Q#_9_P!)TOXAZ9:R
M?'\?#,Q6OB+PY\/-2CMM3BN->M]>N;3PM<64]KY^F^);D:1J4%M<VUZMM^@?
MP?\ B5I?QD^%'PT^+>AZ=J>D:+\3O GA/Q]I.E:TMJNL:;I_BW0[+7K.PU1;
M"YO;);^TM[Z."Z^RWES;^>CB*>1-K-_G6>"O^#<?_@I=^SS\$?!.B>'_ -D#
M]G/]I_Q#^T;^RC\5/A5\??!OQ?\ BQH=X_[+WQ<\2_&36=>\!_$[X/Z^^J:
M/"/B[0OA]:_"^XU:[^'^I:_9:OK>A>-]&U::[TZ^L9+_ /T+/V:?AYKOPC_9
MV^!7PK\43V-SXE^''PA^'7@?Q!<:9+)/ITVM>%O">DZ+J<EC/+%#)-:/>V4Q
MMY7AB:2(HYC3.T 'MM%%% '(_$#QSX<^&'@/QM\2O&-Y-I_A'X>^$?$GCCQ5
M?V]E=ZC<6/ASPGHU[KVN7D&GZ?#<7]_-;:9I]U-'9V5O/=W3H(+>&69T1OYK
MM4_X.,O%/AOP/\0O&7Q1_P"">?Q<^ FA_$+]E3XV_M5_\$ZO&GQ%^(>B>)O"
M/[8WA+X)^!=3^)VO:1XP'@/PS?W'[/'BH_#=-%\?P>&/$E_XF-QI$VIZ+=ZY
MHWB"X\#6OCK^CKXP?#JP^,'PE^*/PDU34+O2=,^*7PZ\;?#G4=6L(X9K[2[#
MQOX9U3PU>:C9Q7&8);JRM]3DN+:.<&%YHT64;"U?R2Z'_P $#_\ @H_\7O"_
MPU^$W[7W[3O[-?C'X<?\$]_@Q\;/ '_!-O5/#WPYO-7US6O'7Q#\+:=X(^'G
MBW]I;0_$>D2^&]5\*_"W1_!OA'5K7P6NG^*+?Q%JOD6'BB;Q!H>GZG8Z\ >P
M_L9?\%T_^"@?_!1?]BKQ9^T!^QU^QA^S+XQ^._PF^/7PL\"_$SX#^(_VG?#6
M@2M\%9/ASK^O_%OXR3WOBOQ'X'O/A=::IXYTRR\-_#*Q\5IXE6TTE]<U>4_$
M%/#M\3Q'BS_@X,_X*3_#G]C;P%^U]\1O^"3WA/P3\-XP?B5\1/BMXW_:T^%_
M@GX0^./@SK_BS7=-^&GAK]G62\U76?%_CGXQ^.]#L'NK*RBTO6Y)K#2-/\=:
M!X&\1^$/B;X8&A]]X2_X(U_MXZK^S1_P4,NO'/B#]C'X6?M8?\% /AA^SQ^S
M!XH\._LY^!]0\%? CPS\#? FO'0/C3\1[G[/X>TVYUKXV?$WX<^-/B3?1QP>
M&=,\.V6N0^&M*$GV/?=V/T%_P5]_X)B?M^_M=^!/AA\!?V3/C+^S1'^R\/@_
M9_!+XC_!/]I+X3:+K%EX1N].2PTW1/C_ /"WQ%H_A75]6TWXH^&O#\,VE^'K
M;2SX8L] B^TKIDS)JLR68!^;\/\ P=!_M":W_P %)?"/[*VD? _]D_3O@(VA
M?"/Q1\6?&</QNTSQSK'PZ,W[.7@KXN_M,?#KP_\ &FR^(_@_X&?$SQY\&_B'
M>?$;X2Z%<:#;6.G>,/$_@V#2;2P:_NY)%U?AE_P<R_'KP;?_ !Z^-'[3O[/G
MPL3]GWXN_ 75/VCOV /!OP__ &E_@'JGQ)L]$\.^)_AE\+_#7PN^-.C:)XBU
MS6?#GBWXE^)/B_X2\:>,]7\:7WAS5OAUI&@_$.V\*_#WQF/"NJZ=I/;Q_P#!
MN/\ M/:C;?#+]@WQ?^U3\,=?_P""3/PS;X=?$K0;"T^$'A73/VI]%^*/A+3=
M?O\ Q;X5T+7+GP]JVC-X3^)GQ:\1^(?BKXOUKQ-K/B;S(=?;PAIOARQTS3(8
MYOGK]G?_ (- M>^$?B+]LS4_&_[4WP^^(?\ PN+]F_XF?"CX"WDWPBDM=,\)
M^/?BK=WPN?&7C_P6^L-HLY\"Z?INC2>$SX<E6*S\1ZXWBW2-.T35/ OA^"^
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M".R(S*#M+*K$$J*YG3M1U2?Q9XGTVYU#PM/I.GZ=X:GTO3M.N+A_%EA<W_\
M;7]IS>)[>29[:WTZ^^RV7_"-/;PPR3_9=:^T-+Y46SJ>M !3(XTB18XT5$0
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M@UK5/!FC:1J>ARVMOKVI:5/<:[I_-?M+?\'",7P_\?\ P:\*_L=?L!_M+_\
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M\1-?\<7.L1^'&7Q]I'ABPT+3]"N]6N[,>%=0L9]9DT#4;K6M+M?U9_X)C?\
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M_P!GCXU?'_XK>-M?UZ/3;M=0MM,L/ASIFG+I^IZCIA==9L1HBW#VFI1GY?\
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MEXQ_X*%7>GZ9%\0?%5P+]FO]4\!>%])LKR^_M*\U*ZUCQ*\T-I>V.@Q6EK
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MA.>T\(> OAA>>'O#NH^)M,\0ZR;'QSXKC673;>^^QJ ?1W[#W_!4;7_VT?\
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M_%.D:Y=^)]"BU+P+IGP;T#5K_3-&\1W2ZU!$_BF.]U*^MU;Q!J&LQ7FK1:@
M?DU^S'_P47_;B^'/_!4KP3XB_:J_: _:[\'_  F_:6_;C^*'P4B^$FN_"'1?
M'/[ ?B'X57]C\8=!^#^F?L__ !RN/%'C'5_#_CI/BK;_  7\+IHGAC2M"O-2
MOM>U2+Q%XB.A:=>64_TO^S?K_P"WK^V#I_PA_P""TG_#X2Q_9_\ V9;']I6?
M6OC]^QYXVTB7P9\!_@W^SIX'^)P\&:S\#?$ES>WFK:+??&'4? \L6D^*=?\
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M>)+#Q#J'BS6-2M_#_B1-5T'0]3:QU30].T_4=-L+JW^_J* /YY/B/_P;,?\
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MW/'Y8_+G\_:BB@!.<=><=<=_7'],TM%% !1110 4444 %%%% !1110 4444
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MJ?M7_P#!9#_@FM^Q&?AM!^TQ^U)X6^'NI?%SP9H7Q%\ Z!;>%_B'XS\3ZO\
M#_Q)=6UKI'C2[\-^!/!_B76_#_AZ]^T33V=YXBL=*?4(M+UQ--AO;G1=2M[?
MB/VF_P#@N7_P3&_9%\1_LZ:)\:OVEO#MCI/[4/PXOOB[\,?&_@RQU#XE>$1\
M-4,</AWQMXED\ 0^(O$.B>&?'NHKJ>C>!==/AVZTK7M7\.>*K,7EL?#.M/9?
MS6:I\=_V>?\ @GY^WG^U'XE_X+,_L4^//C7X+_:6^%_[+OAC]BKXOZU^S9%\
M6O 'A_X2>#/@79647[-G@_1O'3W-MX7^)]AKEV^D>/M*T%=*UG4?B+IFO^+M
M8T_2-,\4:=>7/RS\$]/^&G_!,3]I;]@\?\%(/V!/B;XI^"OQC_X)V?$'X0^
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MN6VC2R^#=(\37>J:+8:AUO@C_@Y>_P"";7CO]L/2OV-K*;XZ^&_%'B#XHO\
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MA/JGA*T&GB_ATF&.^\5^ =2TC4C]ON;^*[\3VT^FVDVE:;_:X!_5?17YN?\
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M90 4444 %%%% !1110 445XC^TQ\;-*_9J_9Q^/O[16NZ3?Z]HOP&^#'Q/\
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M9:GJ5KMOSH-]J-GI^I7.@W5W#->Z))J5A9ZE_9=Q:+J%M#>+/&OU;0 4444
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M#>W&HV,%E<F%;>[FN[>*UN&N1FW6&X>18I3."#"(W8R@Y3=0!>P.N.?7\_\
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MK[W6C>&X!:I?B)]+\7S^(= N]1T:_P#@;]JW_@M5^V#_ ,$G/%W[ O["_P
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M<R&\_P""ZW_!26U\0?L^ZG^U3_PQM\0OC#\#OA)9_#'5X/@]\/\ X[^-)Y/
MWPT3X=Z;K^KP:=X U7QI%K+7GB1+CP7X?\7R^'=8N=#_ *._"_\ P;U_\$U-
M#_;%\7?MP:_\/_'_ ,3?B]XM^-OCK]HM-"^)?Q!OO$'PM\,?&+XA>.G^(FL>
M,_#/@&TL-*L(;VS\2M%/H]OK-QK5G9PVE@DUO<S6%I<0_0WQ'_X(Z_\ !.KX
MS?#SQ9\,/C+^SKH?Q3\,>-/VF/C#^UYK;^*]>\4IKH^.GQSUFYU7XA>)M,\1
M^'M9T+6='T[4K>73]!3PUIMY;: VB:!X>COM/OM0TF'4J /\^#XM_M*?'?\
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M>$[3Q+#J]Y?-J-CHWC29]9MK"9S:&4)!+#+;1QQ+]0^#/V;/@)\.=3\!:MX
M^$G@3P5=?"SPIXB\#_#F+PMX>T_0M/\ !/A3Q=JEMK?B?1?#6F:;#;Z=I%IK
MNJVEO>ZH;*VBDO)X\SR/N<'V^B@#G_"?A/PQX$\,Z!X+\%>'M&\)^$?"NDV.
M@^&O#/A[3;72-#T'1=+MTM-.TK2=+L8H+.QL+*VBC@MK:VACABB1510*Z"BB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BC_ #^76B@
MHHHH **** "BC_/Y=:/Z=: "BDR 0.YSC@]NO/0?C2T %%%% !1110 4444
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M'M[R&SLYX;FY>.&5';_)L\<? 72?VL_V%OV-OAG\2?VW?V:?@UXR_9)\;?\
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M\3/B)X'^(-O^T!X3_:/TOQCX8\:^-)OB1J.C:UH:?#SQQ8Z!J-[:6YO;VSH
M_MR^(W_!R!_P2A^'_P"R]X=_:N@^/.H>,_!'C+X@^./A7X/\)^%O!GB*3XCZ
M]X[^'&F^&=:\9:./"NJ6>F3:7;:)H?C?P-K-SK&K7%GI)L/&GAEXKN2;4E@C
M_8+X$_'#X9?M*?![X=?'GX->)K;QA\+_ (J>%M-\8>"_$=K%-!'J6C:I%OB:
M2VN4BN+6ZMY5EM+VTGC2:UO+>>"0;HR:_@Y_9C\)?M\?LCZ3^RS_ ,%+_P!K
M/]A#XE_MPZ+\:OVC/^"@'Q"\?V?@+X.>&-&^./@OX?\ [4GP>_8L^%?P9^+6
MH_LY^%H=,\ ?#_Q!\2+'X"^+Y9/!FLZ%K7AG3O#>LV.E:QJ/ASQ;XGT:ZE_K
M>_X(Y_L_>+?V:_V!/A-X!\;>$-=^&^NZUKOQ,^)W_"K/%'ASX?>&?$OPJTOX
MI?$3Q)XXT3X=>(;/X8Z7HOA6[UWPOI&LV=EJ^HP:5I]W/J/VF*[L;)K=;.W
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MX+_:?_:$_P""B4WP"TO]KW]H+]F'P'^RMX%^&WP/;5Q\+OA]\*?A3H'C[6O
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MOVD=;TOX-ZWXOTIAX/\ V5;SQ[+\=M?\9>+/^$82/PK;1_#"'PIK4UXNH_\
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MPIMWAT73]%@FT+1_%OC"X\7ZAITL;G6=6TC1;749IM&MI]-N?HV]_P""(?\
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MWG\^^D\Z"&**3='&BKWU%% !1110 4444 %%%% " 8Z]3R>N,X'3VXZ4M%%
M!1110 4#..>O?'3-%% !1110 4444 %%%% !0?PZCK]>?Q]/>BB@ HHHH *.
M_P#G\/RY_.BB@ .>WMU],\_IT]Z",@@]#P:** "D Q].WL,#^N:6B@ HHHH
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M.-8X]+6?^"C/[<W_  3 _:2_:U_8K\7Z3^UO_P %7O&?PK_8S^&^H>#/B_\
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MO#=AJWA*2*U\26M@=2N_$7BBSNI]/@ /V*_;X_8T_P"#?Z;P!^RW^RY^U_\
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M/]EG_@G;\:/A1X?^(?PJF_8+_9GMO'W[-_[1,1U[5/B?I'ANZ\2ZN/!GQ(\
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M% /QV_;1_P""K/['_P"P]K/[8/@GXN? _P 6:MH7PF\'_LZ?$W]H*[\)^"_
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MT/\ :W\,6O[('BO0?$6K>*M%TG6YYOV<_!D=WX<\53W4^BV=J;!]4N[+57L
MK_A[_P &W'[26B_";]JK]D_7-,TO6/A+\>_CW_P2_P#B?KOQ+\3?%'3;+5?'
M\OPK^!_Q&U#]M/Q7+;Z/>>,O%?A:Z;XZ^.M5L/"^C7":C<:C;ZG#=:'>7&AV
MTNH0 ']"_A?_ (*__#+Q5_P5>^('_!,&Q^'FJEO _P"S+I/[0R_'FW\2Z/?^
M%=8-_P"'O#'CF;1K;1+6-Y5T1/!'C'1-0LO$XU:5KO5H-0L3I$6G?8M7NOFO
MX0_\%Q?B7^UG^RI\=?VDOV)/V#/B/^T)KGPU_:%T+X9_#SX*R>.-.\$_$3XD
M?!CQ#I4NH:3^T'>Z?JN@7$GA;PYJSVMX-)TKR=96\BB95U?[39ZE#9_C'^SM
M_P $%_\ @IAX*TGQ;J7BG5]/TGX\?&C]G;]J;X!?&KXR^)]7^"7CG2M%L_VF
MOCA\"O@-;ZM\,Y?"^I^%/B9XYLO W[%7PX\9?$]?#GQ0UO0=.\*^(]1T+1?A
MI+!XN\0>*O#&E_K?_P $VO\ @B3\3_\ @E3^W1;>+_V?OVC_ (B?%K]C;X@_
MLVWO@'XP^'/CYJ?AO4_&^C>.O!.OVL_P;TWX=R>%]$TFW/A_3;35O%,US!)H
MWA^UT"PEFLXM3\12:NEKHP!Y#\/_ /@XH^/?B7]D_P )?M/>)O\ @F;\1=)O
M?VB/B!X/^$'[#WPG\+?$2[\9>*/VIOB+XN;5;L7&C:I:_#RRTOPQX'T'2/#7
MB6?6=9O$OM9AO["TAAT"33[UM4MNNTW_ (+^_M$^!M#_ &P-+_:R_P""8_Q&
M_9;^,'[./[&>I?MK?#_P!XP^+.DZSI7Q<^'7A[XI:-\)/$5E/XITWPD@\*7L
M'BGQ-HHT[R=*\0R7%E!K%S?6VFQIHQUJKX4_X)*_MKZK_P $AO\ @F9\)? 7
MQ&\,?LN_\%#?^">GB/2OC-\.[;QG<Z%X]^%$OQ$MKOQ[HVJ^ _B1K7@RT\;P
MS>'M9\%>-KZUN]8\(1^)H(;B:6Q>QU*WN&N[*OXK_P"":G_!47]OKX8_M:_&
MK]N?Q?\ LX?"#]I+XZ_L2ZC^Q+\!OV7OA;KOC6\^ /PF\$^)_BAX$^+/Q"^(
M/QA\=>3\0_$&I_%/QKXG\#:;I$,/PVDUWPWH/@G3-*M[K5O$>KWJ1^$@#F/V
M2?\ @XH_:!_:)TO]O+2/$'_!.K5M)^*?[)/[,M]^U?X,\+> /C/HGQ%\*>.O
M!(U/2TTKP!XL\>^&]#U32_"WQ&U/P]JTGB71;/3K?6KGQ!IGA3QR8] TF^\/
M"PO?O[]@;_@L]X%_X*:?&KPCX5_9'^$?B7Q1\#-.^ MI\3/VA_C9XIN-4\-Q
M? SXMZ]J1L?#'[.DNDOX;NM(\9>/;RUMM4US4[S1_$\6EV&A6":A"]VE[:JW
MB_\ P3'_ ."/OBW_ ()E?\% /VK_ !%\#M*^&_A/_@GU^T/^S1\%(+SP#_PE
M'B7QIX]G_:<\$:[K$-XVFMXLL+K4-'^'>CZ+XC^*EW>Z?=:[-9:BOQ \"VVF
M6UP^@:S8^&_N#_@EM^P=J?[ OPX_:3\%:U8_"6UN/C)^VC^T9^T'X;_X5)8W
MEIIUA\,?B9XLCU+X9>$]?.H>&?#$T>N^#?#,46B3Z58P:CH&BQQI9:#JEY9#
M?0!^?O[5O_!6_P#X*$_#;]I?]K[P5^S%_P $^/!_[0G[./[ ?C3X.:7^T?XY
MM_C1;Z=\8=6\*^/?@]X0^-GBW4_ 'PVO;+1[47/A?PCXFO/*FFU37K>271#<
M3Q;;V2VL/*_V@_\ @XN@\$_!']IKXV?![X7>#-;\)Z%\6/V&/@O^RUXG^)_B
M/4O!/AK6;_\ ;0_93TS]J:T^*/[0,MS]FF\$>"?!?AO59-/O-$T.6YU22?24
M6ZU2U_M>2;2(/VM/^"97_!:[Q1^UE_P4&\4_L5?M2_L6?!/]EC_@H)K'POA^
M($7Q"T[Q]XD^.VB^'O#W[/7@'X#>,[W2+:+X):WX;T[69--T/Q--H&FV7CH6
M]Y#<:;<-KOA?4[JYGTW,^*G_  0 ^.R?"K]I+X:?LT_&[X(?#.U7XX_L2?%K
M]DV+XI>#-3^-NBZMX>_9 _80L/V1V^'?Q^T;Q?X;N=)\.0>-=9%YJK^(]%TO
MXTFP\-6\,C:!/K.I&WT8 \:U?_@Y.^-NN_\ !-;0/VK? _PL_9D\-?&G2/\
M@H/X!_88^)FJ>,OB#XJ\1_LNP67BWP/XK\5S?&G0?&?AM],\3V/@F-=(TJ^O
M);Y-3&B:(=8N8Y?$$L%LLGWY<_\ !5C]I#P7_P $JO$/[96I67[)/[1W[0WQ
M,^,Z? K]B_PG^RUK_P 3=0^#_P ?_&_B[Q];_#SX?:783^.+>P\8W'B)I;#Q
MEXKU7PN[Z%/>:?X5F\/1ZEH^JW7VF#\P?#__  ;8_MA_#7]BRY\/_#3XH_L:
MI^VOXV_X**? W]N3QMH6J:+X[TK]B/PGI'P%TCXL6?A'X:>"/!$'PP\0W_B#
M3)M7^(:ZIJ^F:U\-/#6BZEH]Q<>$/+M-.T#3;[5?TV\/?\$:_P!H;]HC3O@3
MX;_X*?\ [57PO_:'^#OP7^+/Q ^+Z?LQ_ [X P_ GX3:QX@UOP1%X.\ Z6=7
M\(>*?#EPOAKP7J6I>+?B,]K=^#+OQ7-X^UN.\TCQOHND#4]*U0 ^)OVF?^#B
M+XT#]F+_ ()H?%#X"^&OV>OV?]0_;O\ #7QNLOBG\:OVMA\59?@M^S7\8/@!
M<V?A'QU\-=3L?!^C)X@DEN_B)#KUAH.KZZ%\[0+/3]0N-'6"]N]3TWV?XN_\
M%Z_'5I^PW_P3@_:8\)7W[(W[.GC']M;QU\4_!GBJ\_:I\4?$'Q5\(_#D'P;T
M7QKIWB+Q5X3U#X(17WC6]\)>)_'_ (;T&P\/:[J7A\#0['QKX:TSQCI^C:SJ
M $?FOCO_ (-D?B-X=G^(%]^R#_P4-N?V;-+OOBK^U9XL^%7PD'[,WA;QU\*?
M /PC_:F\)>!_#_BKX(3KXI^(6J>*-4>5OA[H-A>?$6]U&_M+'2);R?PO\,M#
MU>XU2ZUOL[7_ (-TOC9X,_9N_P"":?PL_9__ ."B*_L]_%W]@'PE^U'8W/Q<
MA_9C\-?&'_A,?$O[6WC+PYX[\>-X5T7Q+\0O!]AX0T3PQJ&F:OH/ANYO+/7-
M?O=&U&"ZFN](O(YH)0"E^V?_ ,%TOCW^R=\(?^"=>IGQI^PCXAUS]M'PY\4/
M'GBC]IMM(_:3N_V2?#?AWPMJWA71O!=CX8TK0K&]^+B:?XCO/&NG1ZC\0/%E
MGINE:6=(O7N?#\$5_#):?MY_P2__ &K_ !E^W)^P-^S+^UC\0O#OAKPIXS^-
MW@2Y\5>(/#O@YM1?PSI5[!XFU_0Q!I/]KWE_J26[6^D0S/'=WMS+%<2S1F5@
MH-?F)^T1_P $5_VQOVB/@Y^S-H6O_P#!5*\T[]H;X%>#/C!\)?'WQND_8V^'
M&M^"?V@/@Y\4?$O@_P 56'A'QY\!M1^)?_",1:SX1U3X?>#[BV\1-X@U2SU&
M]TP:R?#UCKBPZC#^L7_!/_\ 8P\(_L"?LK?#?]FCPGXCN?&T_A1=;U[QO\0;
MS0].\+3_ !"^)7C76KWQ1X]\9IX3T:6;1O".GZUXBU*\?1/"FE3W-EX;T*+3
M-%6_U.6REU.\ /LZBBB@ HHHH **S9]8TJUU*PT:YU&R@U;58KN?3=-EN(H[
MV_AL%C>^EM+9F$L\=HLL37#1JPA61"Y4,,Z5 !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%'Z_Y]Z "BL+3]>@U#6M?T--/URWN/#_\ 91N;
M^_T34K'1-1.K6;7<7_"/ZS=6\>GZZ+-(S#JG]F3W/]EW;):7IAG=8ZW: "BB
MB@ HHHH **** "BBB@ HHHH **** #(]?;\?2BL779_$-O;6;^&M*T75[Q]:
MT*#4(-=UZ^\/6UKX>N-6LX?$NJV=WI_AOQ1+?ZUI&A/?ZCH6@S66G6/B'5K:
MST6_\2>&+.^FU_3]H=!QCCIZ>W?^= !1110 4444 %%%% !1110 4444 %%%
M% !17#ZGX=\5WGC[PMXGL/B%J^D>#]$T3Q-IOB#X:0:#X5NM&\9ZKK$FBOH/
MB/4/$5_I$_B_2+OPA'8:I#8Z?X?UK3]*U9==N&UNTOI+'3C;]Q0 4444 %%%
M% !1110 4444 %4M2T^UU?3M0TJ]$YL]3LKK3[L6MY>:==&UO8)+:<6VH:?/
M:W]C.8I'\F\L;JVO+:3;-;3PS(DBW:* ,_2M,M-%TS3M'L!<BQTNRMM.LQ=W
MU]J=T+6S@2"#[5J.IW-YJ-_.(HE$MY?W5S>7$FZ6XGEE=W;0HHH **** "BB
MB@ HHHH #GL,^W^>_IVSW'6L?2;C7IVU8:YI>EZ8D&L75OH;:9K5UK+:EH*0
MV[6>J:FMSH6B#1M4N)FNX[C1;9]:M;2."WECUV\>Z>"UV**  D#D]/\ /Z>I
MZ#J>**_EV_:^_P""JWQM_8W_ ."QWQO^'_CCQM;1?L7^!O\ @G2WQ0M](\97
M?A7PK\,O"G[0[:7\3?%/@*'6?%LVBKXINM:^*]YX#'@31/#]CKUQ<75W>)+I
M>C7,L$F/YBO$'[2W_!3WQ1^PI^PYX/'QH_X*%:I^T9XJ_P""E/[?OPU^*W@3
MX'_$_P")-_\ M(ZEI7PV\'_ G4]4^&VG(NH:CJ-_'\-I[_QA<Z5HVL0WWA_P
MLL^KW<=I:VBLT0!_I_4?Y_S_ )_D:_@L_:1_9K_X*@:7_P $9O@E^V1\3/V^
M?VY_V9?C)\$_!7PL^&4OP2UGQGXU\.>./%7B7X[_ +<VC_#E?B!\>?%-OXPB
M\1^(=0T_X9?%/PM<:!I=Y8VVM:2^@KI<]Q;6;O9#Z7_X:J_X*-?\$A/VS1^Q
MWIEA\?\ _@LAX8\+?L07/Q,U.[D\:W,7Q3\ ZQ<_$KQ?KTOCKXDS7R^)K32?
M#4L(3PSH@\27FI^*-0T+3%AT#5KR.UDTZ, _L\H_S_G_ #_,5_$O\"OBG^V%
M_P %,]"_X)J?L->)/VTOV@_V((/B+^P9K7[<WC?XPZ%XQN-(_: _:4\:>*?C
M%XOT7P?\./A=XMO['0[[7/ OPX\'6$WC+4-)AU*]U9OAWK'@BXUN\\1IITFN
M7OSQX3U']N#XP>.? /\ P25UK_@HS\>-4T+X$?\ !436O@'H/_!0O]GOXC_$
M(?$'XQ>#OB%^RA\>_P!I7Q-\-?&_B^^UYM.\9^-?@!XI\/:)X3\;Z&_B37+7
MP!/XEL/#K6,>G^&_!^J:P ?WWT9Z^W^?\GZCJ#7^=7^U+XA_X*)_ _1?CY_P
M3Y^"W_!1G]H+X^Z;X1_;@T*;X<?M&#X_:=\/_BM\0+F7]B/QI\8M:_9WM_C]
MXL\7MX8&N>"_&_ASPPNJ?"'2O%FD7VNZW=7>CKIT6N>*/#FD+^KW_!*C]O[]
MHGX?_P#!"O\ X*&?&7QYX[^)OQ'_ &GOV&]?_; T^(_M4W.J^)?%OA7Q=X$T
M;4=9\#^#_'>N6UUKVL^+[GPUJ M8-<TV>'0;0ZM%>>&O[3T'1,>(=/ /Z]L_
MY_/KZ=.I^G6F"2,G D0DG  9221U&,]>#QUXK^ 7X8? OXV?"/X2?\$VO^"C
M'[.7_!:7]J#]J7XJ?%_XV_L"> ?C5^SUKOQ?/Q3LM2TOXUZE9GQ[\+=3\,P>
M*_$&L7-SX%N=2\?K<>'O&WAK4]0TW1-)\4:C=16.I:#<:C%SG_!&OX!ZU\;/
MV[?#'[2GB_\ 8<_;A\9^-(OVZ?VE_%>K_M?Z;^T?I'A']D[PM+X9^)GC::YL
M]6^%-]X8FOM9'A5_,\,77AS3]?MVU_7?*M+-4MO.MK4 _P!!TR1@D%T!'4%E
M!'U!/%)YL6<>8A.0,!U)RV"HP#G+9&T=3D8SD5_'A_P60_X(N?LR>)OVS?V3
M?C[J/Q)_:1M=5_;Z_P""A7PB^ OQG\(Z+\6+G2O"^F^&M?\ @W^T%XN\4ZEX
M(BBTV2ZT#4-6N_A[X!L[6W9[W3](M=(U=[:!IM>D:T_G\_X*A?LO_&#PG^TY
M^W3KOPG^&?Q(U;X+_L>?%/\ 9*_93\&?M90_M"^*O!"_LIII/P-^$1\"_$GX
MO>&O 7AZ]\0>,=.T6YE@UGQ7\8KZU%WI6IW5AYURM]_9,$@!_J#7>K:7I]Q8
M6E_J6GV5WJL[VNEVMW>6UM<:E<Q0R7,EO80S2))>3QV\4L[Q6ZR2)#')*RA$
M9@Z[U33+"?3;6^U&QLKG6;Q].TBVN[NWMI]5U".QO-3DL=-AFD22^O(]-T_4
M-0>UM5EG6QL;R[9!!;32)_!A_P %:OA(W[2W_!7?4[O3_ 7[(?[4'@CP]^P1
M^R-XTT^?]HG]L[Q!^S'X1O3XI\=_$VWT_P =?"CX@^$/'OA>/QAI'B/1I;^^
M\7?V9+>2:CX,>.?1-5LM5U#38M6J_P#!9W]H?]K#QQ_P4X_98^,/[)?P1\>_
MM#_LR?\ !'71O@'\6_C?<?".]\6^*/A98>.?'.@Z-\:-4F2[L[PQ^)-.'P'?
MP?<:+XQT:WU>6]\/:Q?0:C?R6TMU;L ?VSZ[^UE^ROX6UG5/#GB;]I?]G[PY
MXAT.]FTW6]!UWXR_#G2-9T?4;9MEQI^J:7J'B2WOM/O8&(6:UNX(9XF.'C4\
M5Z7HOQ)^'7B1$D\.^/O!6OQR>(9/"2/HOBK0M51_%<6DOKTOAA&L;^=6\0Q:
M%')K4FB@G4DTE'U%K86:M,/X[O%?_!+C_@E/^W'_ ,%A?@;XOT_X6#XB?!C]
MM;]A#XI?M^^(;VR\?^+[*#QG\14_:._9]N-"UO&E:\HTG1=9\,ZOXI\)>)?#
M>ES6UI-8^*/$D=O-:ZS#8:KI_P 0?&S0/C?IGQG^#GPW_8>A_P"$0^/'PR_X
M+8?\%*?B=\!--ETK6+GP!XANOV<_V1? GB?0O@AJMS8ZI97%_)\1O#/@J\^%
MDFGW=\;N7P_XMO'NKJ6"]O$N0#^_37_B)\/_  II'B;Q!XH\=>#O#>@^"[B&
MU\8ZWK_B?1-'TCPG=7-KIU];VWB;4M1OK:RT&XGL=7TF\AAU2:UDEM=4TZX1
M6AO;9Y;/@WQOX+^(WARP\8?#WQ?X7\=^$M5:\33/%/@W7])\4>'-2?3KZYTS
M4$L-;T2[OM,O&L=2L[O3[Q;>ZD-M?6MS:3A)X)8U_P U;PW^U?\ LY_M@>+]
M,3]L/4O&'PL_X)]_M8?\%4O^"@O[3?Q'\*>,]<\0^!=#UWX\^"?@#^RO-\$O
M@E\??B)HUPT^@_#NUU/6M<T^;3;*!O$-A#9:)>:;'I"6PDLOWU_X-9O%OA34
MKW_@I'X+^%_P<T/X-_";PK\4O@'X@T/1/A)^T#X^_:#_ &8Y/&/Q!\$^.M9\
M6V'P8\1>+M.CTW3-7T+0;+P#9_$6TT[7-=\0F2;PI8^*FLH=)\.K<@'];E%%
M% !1110 4444 <UJ&@W%YXET#7TU-+>VT6TUBWN-,.CZ5=2Z@VIQVZ131ZS<
M6[ZOI0LS S-!IEQ##J D"7R2K%$%Z6O,]?TC5KGXF_#_ %BV;7QI&F:1XQ@U
M,65R(_#YFO[;35L#K=N=<M#-<AH9CI;C0M8\J3SB;C3=V^;TO(R1W'4?7I_^
MOZ^AH 6BC/./J?RQ_C2$X&?3TYH 6BBB@ HHHH **** "BBB@ HHHZ]* "BB
MB@ HH)P"?3FB@ HHHH **"<<_P"?8?4]![T9YQ]3^6/\: "BBB@ HI,\$^F?
MT_SQ1D9QW]/7C/'Y'\CZ4 +103C\P/S.!_.C_/\ G_/\C0 4444 %%%% !11
M10 444?Y_P _D: "BJ]W=VMA:W-]?7-O965E;S7=Y>7<T=M:VEK;1M-<7-S<
M3,D,%O!"CRS32ND<4:,[LJJ2.#\:?%_X3?#?3- UOXB?%#X=^ M%\5WUMI?A
M;5_&GC7PUX6TOQ+J=[:2W]GIV@:AKFIV-IK-_=6$,U[;6>G2W-Q/:127,4;P
MHS@ ]$HKE_$'CCP5X2N-*M/%7C#PMX9N]>U71]"T.V\0>(-)T:XUG6_$.HQZ
M1H&C:5#J-W;2:CJNN:M+%I>CZ=9K-=ZGJ,D=E90SW+K$>:@^-7P;NM<\=>&;
M;XM?#*X\2?"_3I]7^)?A^#QYX5EUSX>:3;6R7MSJGCG28]5:_P#"6G6]G)'=
MSWNOV^GVT5LZ3R2K$RN0#TVBO,OAS\:_@W\81K#?"/XM?#+XI#P]_9_]OGX<
M^//"OC<:'_:XO3I7]L'PSJNIC3/[3&FZB=/^V^1]M%A>FV\W[+/Y?IM !111
M0 4444 %%%% !1110 45^7/Q/_X+4?\ !+CX*?&OQ]^SS\7?VROA3\./BU\,
M;Z+2O&WAGQ?-KNCQZ-J\D%E='26UFXT8:)=:C#;ZA:RSVMGJ$[Q!Y ^&M[A8
MOU&H **/\_GTK\R=6_X+"_\ !/;0_P!MI?\ @GOJWQ]TNP_:=^W2:-<>%KG1
M-?A\-6'B&+PO/XQ?PWJ7CR33U\)6&N#0K:24V5UJL06^:'2'E759X;*0 _3:
MBOSH_9-_X*R?\$_?VY/BWXS^"'[+'[1?A;XO?$3P'X7?QEKNE:!I_B""RE\.
MP>([OPK>:EHNM:GI5EI.OP6.J6]H]T^CW=XBZ;K?A_58FET_5[2X>']H[_@K
M+^P9^R=^TY\)_P!C_P".WQOL_!OQY^,R^'7\(>$SX=\3:K:P1^,=<E\->#Y/
M$>N:7I5WI'AY/%&NV]SIVCG4+J,R2VTLUR+6U,<\@!^CM%?E3I__  6L_P""
M<&I_MD^)_P!@ZV_:"TU/VB/!VO>-?"WB/1KS0M<T[PIIWB7X=>&M1\3^-= ;
MQS?V5MX:GUCP_;Z/J^DW>G6U]-=R>(M+OM#M(KB^A\MO'OAW_P '$O\ P20^
M*/AW]H/Q5X4_:@MY-$_9F^'G_"T_B5=ZGX$\=Z3YG@E_'GA_X86NJ^$TO= B
M;Q5)J'Q \9>!/">FV&F![^^U?QUX5BMK:2/4)9;4 _;>BODO]CG]N']F;]O3
MX8W/Q9_9B^(UMX[\,Z5K<_AOQ+IUWIFJ>&?&/@[7X88[R+2?&/@OQ#::=XD\
M-7>H:9<6FLZ0-4T^WBU?1KVTU/39;FTF$@^M* "BC/UZD?S_ $X_E10 4444
M %%%% !1110 4455MKZRO3="RO+2\-E=R6-Z+:XBG-I>PK&\UG=")W,%W$DL
M3R6\NR5%DC+HH=20#\-_^"@?_!)/]@;]L3XY:CK?[7'Q0U/3?$W[4>L?LY^#
M?"7PY?QS9>!Y_%,7[+UU\1/&5SX,^'ZVU[I^LZMJ_C[1O'.OZ?XRNX6U'5=)
M\-0B3PI'H>N>1KMMY/\ M,_\$*O^"<G[0_ASQI\/-?\ CE\>OAU<?!O]IWXW
M?MS_ !$O/ WQ5\.:7K_@?7/VM/[(\2?$S3=4O+[P/>SZ)X!U;PE\.[FS\$[9
M#K.@V%MJ%]J.M>)"UY!=?BO_ ,'$'C?]M'X]?MXI\2_V#_@[\;_B7IO_  1V
M\-^ ?%OQ*\?^"/$^IV'A3X9?'CQS?>'_ (S&[7X=16NF:[\08=-^#FGZ1:?$
M.?P;=ZO;0>#_ !5=KK>H:)9:7>17COC?_P %E/@E\&M/_P""N6J#Q!\1OAM\
M3O\ @JK^RU\!?VH_V!/%]QX!L?&?AWQSI?BC]C;X<_ R/P'*OA_4/B _A/X@
MZ=\6O#WQ,\&W7A[Q7HR>&=!U#PEK/VGQ2+B71SJH!^K6IZ+_ ,$#OV;_ -BS
MQ!_P2W\5?MZZ#X6^&NM^*OAA\;/%VH^+?VBM.U[XQ>(=;T_XC_#K]HKP?XFN
MO%VIZ)JGA^WTWQ)>^"O!YGM_#GAO3--N?"\MVMA!I^M7\VM#[:^)_P :_P#@
MC3\,?VBM+_;)^+?[17P&\(_&']KS]EOP]\)O#?BSQ=\3DL;7XC_LZWGB*^O=
M(O\ PM9W5R'\/Z9K>H:M-87?B719="CUJUL[5=0EN9=#@N;/^?/6/^"?G[+'
MA_XF?\&Q.G_'W]B2P\7^./CWH/BKP5^U#X(O/AQ-J_C?QSJWPS_9&\):9\+I
MOB]X=O[NPDO? 7P9\01:+X]^)6EZLKZ-;^"?#/BC4_%.@>)+2/4](U'QS7/&
MW_!![]F/XC?\%1_@]_P5+^ &MP?M(Z9\4_B?X(^ _@S6_@S\0O%.OG]E >%X
M4_9W\*?L=W4D=]\,OA!+I-I/?:;X)U^UN_A99V=Y+HUQ<^))M"LWOK, _>S]
MMO\ X)7_ /!&F/\ 8\^ O[/W[0_BUOV??A=^Q'X#N_'7PA^+_A/XC:=X#^*O
MP^^&6L^*M+T3Q;J]SX]3P]JUMK?AKQYXU\4Z&/%]YJ6B:A<:WXLU*PUY;F+Q
M!=2:I-Y]\9O^"/G_  1>MOV</V*O^">.K?%GQC\"?#\WBSXA_M(? 6?P#\6-
M$\*_&G]HWQQ:?#NRMOBE\6_%WC75/!6O3>.-:_X0O5M!O-4U&QLM BT30;/P
MSX:\-VVC>"=!T?PO8_S?_M/?#']N'X<?\$^_V>?A)^T-XOUN#4?VD?\ @GM^
MR7^S5I^B_$/PQ>7%K\#/AAXC_P""@;7_ (1CU*S@U'0KZP^*VB?"[7_@!X7^
M*C:QX)TFXMKOPGI>BIXB\7:JS7.AP?L=:U^T/^T%^W#^QM^T%^T@=?LY_P!C
MG5?$_P#P22^%>HWVB^+QIWQCT;X$_L<_MB^/?BG\7/$'BOQUKU_JVK?% >-+
M/P^?$MAI^EV.G:3X?\=^&-$O99]1\/)?ZL ?T>2?L0_\&[EY_P $G_#7P?U/
MQK\(==_89L?BYJ::)^T;)\694\>#]J7Q+!?>#KGQ_J'Q?T Z=J,_Q@N&6*R_
MLC6]-D\%W6C:-X>\/W_@>[\ Z5I.@Q?J1\ KK_@G+^P!^RA\0?A;\,/&_P +
M/AI^SG^Q_J;^ /CWJVNZU:W4?A7Q[K,6@R>(-0^-WB"\@\_6?B!XTN?%6AZA
MXEU;61-/JMQKMG"B06(M+*W_ ,U3X>Z-X]TW_@GY\0/V./B!8^.M!^!WPV\%
M:'_P5[U;Q?X)T?6-"\2>*_'7Q7D^"W[,/P<^!7Q(\+^-9M-T;1_!/AWXC>)[
M[Q9;^-+BRO\ 4?'FA:+=ZI\.-&GLKVPUQ_V;_P""FG[:NB?#35O^"Y7_  28
MUCX!?M$ZU^U#^WO^U=\-O'G[+(\(> 8->\._$RS\2I\!QIMO:6L^I:3XE=;I
MOA_J$6BZGX;TCQ?9:W=W'V.%K*[T^[A(!^[7P5_9&_X-Y?V2/V@OVROVP/A-
M\,?!_P +OBO_ ,$_M>GC_: :X\0?&.[\*_ ?Q;XTT;5O$<7BKX=?#3Q'XBU/
MP=IFH>*=,\7R^%O!-QX T3^Q_"\^CP^&/AKIWA"[@U)=1Z_1/^"JG_!&3_@D
M?</^Q5=_&3XA^ _%3ZQ+\;O%/A_QSIGQ=^*GCK_A+?VF-0E^+VH7_P 0?&6M
MQ>(-53QAJ<WB^'4=>TW7-2&K:2ES =90W<UQ=W'\O'_!5K]EW]KYOC=_P6Z_
M:E_9Y\+?%#4_"WB+]ISPI^R_^T!X9TC0O&6L>&?%_P  OB%\*_AQXHB\<OX3
MM-*LK37[GX9?$?PUX:72O$'A>_\ &^IZ*WC*[N-?\+^'],32M9UFI^T?XQ\$
M_ '_ (*S?M6>)_BQ\;O^"I_PKTO3/#/["]_9:3^RQ^S=X6U_3?'</@WX%Z)>
M:QX+\0Z;\0O$O@ZQT7X;^&;$Z/8_"6+Q%X)EN)+#7_%MCXF\+68T"&?Q$ ?W
M[_M667[)5]\*/!/[4?[4:V*_#']D/Q+IW[87@KQQJ>K^+]'L_A[XK\*>"O%.
MCZ5X^;3O"^IZ?+XDFMO"WCKQ'I]IX7U^QU_2+V\U>!SH-QJ]KI<]K\;1?&3_
M ()-?&'X Z3\8[_0O!M[\#_^"RGCW0/@QJ^I:[X5\2>'=,_:$\?7WAWQ+\.O
M#]KXVT^Z.G-X3\1RZ5X&U#PY8>*VC\/ZZ^KZ7H$L&JMKL.B747R?_P %@_C!
M\7?VO?V6OV)/V//V._ =U-\2O^"EVNZ3X_T/4OC_ .%_&FC?"7PG\%_V>=#\
M)_M!>.?"/[1]O\--&\77&DK\4IO^$(^&&I^!M4T*X\"^)O#_ (A^(&FZYK>C
M6FGVDMU_.W:_\$S_ -IGXN_#3X._\$I_VM/V=/'/A;Q=\*O^"I'C75[+]IO]
MFBPGA_9R\*> OVGOV?O%?Q:UK6O /@^9O T^F>!? 7C;1O"LVGPZ)\+M,\!:
M/H>B>(O!>E>+? NOW;G4 #^E7]K32/\ @@5X<U3Q;\0?VI?V;_@#KVI_\$T;
MSX+_ +*U[9Z_\!KCQ/:^$;?XG_"WP_J?P0^#>F> [?1;G1/C7X>T[X?^(]-?
MX?\ A+4- \<Z9X O6U"Y\*V&AZW;7MT/H'_@EM^T_P#\$@OVH_#_ ,>? O\
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M^ARQK#MO_$/A?6_#WBS2M;TZ+D2V-]X<UB"1BA:S=E4KY=_P5N^+WQA^ O\
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M-J=_-JFI-8V=O:-J&IW*0Q7&HWQMXXS=W\\=O;QS7EQYEQ*D$*/(RQH!?HH
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MGT?6=3T31-!T_0-:U87>E:7KMU!JXTRTMM+1]3:_M/SL_:7_ ."+6G?LG_\
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M !.\:_#WQ%XEM;'Q%HO@:'PVT<%CJDWB?0HAX?LM?\/Z=HOBOPIJ5?2/CO\
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M?QJ\<GQI>3V>D1^,=-\":+^R1\)OA?H/@2^OUTFZ\'^-_AYJ$^K1-::I)?
M_I7T[_@GY_P;FZ/_ ,$V?CK;->^%M:_8J^&_[0^IZ_\ %_XLZG\0OB9KGCSX
M1_M :'K/A3X+75I=>+TBE^*7A75;.[;0O#%EI,UF^GR:)XGFUO3;>;0O%+ZQ
M>?IG^P!\._\ @F-^PK\/?CA^SQ^R%XS\&^&?"/PBTK0_VB/V@=;\2^/-7\16
M>E>%OBIX,E\;>&_BIXT^,'C:X?P]K'@W4_AYH[ZW8^(K;Q/>^'])\*6(N[JY
MLK,^;)_GCW'@#]L/PW\#/VIO^":FF^+_ (@6'P-^/LO[8?\ P4Z\8^+==&N_
M\)5<?!_]B33_ -IS1K<>.[._.BW7BO2_V@?B/\#OA9KM[KIO_$>F:E?KX U_
M2+&;4+>[DN?V"\7?M@/^S3X._;8_9O\ 'W[/WQ^\6?$+_@I7_P $;/V.?@W^
MQ-!\'OA1XS\=Z?\ %[Q&?^"?\?PUUK2;(V^C6[W>I^"M1\;R:QXPC\+Q^(+?
M2-'T._MG0ZNL=I< 'ZX?LX?\$R?^#;KX=_&WQ+^T/\&[/PUK'C;]GWX6>$/V
M\+OPQKOQ&^+7B#PQ\-?@_P"/=$A^,GPX^.'AKX8Z_)B\\.:-X>MM*UO0)-&T
MW6[SPHC>'=-UNSM=7U'2+2\^L?!G_!23_@AG_P $S4\3?"O3OVH? _PHU#XZ
M>(+W]M/Q%:ZGX>^+/B;6O&UY^U9##\5]/^(-YK6F^ M5>[B\3>'M6TB;P]I-
MW=MJ>@>%8M!T5K*RMK6SMA_+_P#MF?LG?MD_!/Q_^V!\8_@7XID@^+_[ G_!
M+[_@GY^SC^U'\'M"O]4UGP=\4/@9\2_V,_%GPE^.,0ATFT6?Q9!X#\0^&K+Q
MGI4EW;VEG#I>@W7B-7LKG3 T7Q!^V+\1?AE\$_VL/@A\8_C5JOQD^%/_  D_
M_!+;_@F0_P (O#D'[+'P3^-]]\8_#=I\*OAUX?\ 'FFZ5_POS2_%'@3P7K.D
M7_A3S](\:Z'8ZO<1ZEH?B'P==7=EJ4UUI<P!_I(?%[1_V5/VG/@3\,OCM\3;
MG3_&/P)^%VL>!_VTO OBV>7Q#8:!9R?"[2;[QUX3^(6I:+'!;WFM:3H^DW-U
MKG]@:]HU['YR6U[_ &0NM:=ILUK\*^-/B)_P2"U_X-^-?VV=7UWP/JWPH_X*
MNK\,OV3/%/Q:LM-\16EQ\:H?$-UXD^#/@GPW%X;U+3=/\4:9+IFI:GKT&L:I
M#X9AU7PZ+2?Q9X@:TT;P_-JVG8W_  4M\6?'C]HW_@FA\)/@Q^R]X ^)/A/X
MC?\ !1:]^#W[.UMXG\1:!XMT^X_9G^'_ ,5O".J>-/'WQ'^-=M\.M/MM7\,:
M/I/@+PEK7@74I+2VTK2(?%GC/0K*^C329IM.G_DP^/7_  3X_;/^'OP7N?\
M@DC\6/V>K._^&]U_P5%_9]^)GP;^(WP2\)_$G_A1%CX4_:Y\)?$[PSXG\->&
M?%WB..*YFM_A#JNEP^(;C2]>\5R7^FBSL=$U:[-IKEB)0#^GG]NSX=?\$ _
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M/&L.K74GA;Q#X92]MV&I:!K&I:@VEW&FR:3>R6FNW\CZO'/IVFQU\T?L*?\
M!![QU^RQ\<OV>?VA_$_Q4^"T/C'PK^T5\2_VE/C1X%^!WPC7X5?"*VUGQ+^R
MAK/[-?A'X?\ P8\%6-S+9Z!H]I=>-?&'C7Q?KM[]DCU:\DM+?1_#FC[IV< ]
MB\&_\'+/_!,+QE\9_CS\!X/%GQ<TCQU\ O!'Q[\>ZPFL?"O58-.\8Z7^S/\
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M03:9]@TJ:#Q$=9^(7BOXE^'O#&@:))?: \>K_LVFLNWB*?P__8VM)'#HUMK
M\0/:P#P[.]S>W5F=(@O1=&Y;6;86HO+FU:R2%+*ZM94NI'D>*/\ &+_@LI_P
M1_UK_@JUI7[.W]@?M7?$K]G76OV>/B'-\0-#TO1[5/$WPXUC7'M0NF^,-1\$
MM>:5#-\2O"-U;PP^#/&%W?7G]@:'J_B_2+/3XAXFO[E@#\KM+_;]_P""P7[1
M>E^./VI/AAX[^!_[//AW]@/P-^S/IW[07[*WQ1^'/B<O^T1XK^,OPU\!_%_X
MMZGXLU:?3IO$GPF;2[#6/#WASX>6FE6'VO0[34/&FHWFH(7M&O*NH?MR?\%>
M(O ]A_P4(^$/QR^&GQ:^#_[3?[2G[4/P)^"O[ NN^ /A_HWC#PKH7PM?X[^$
MOA*W@?XF7E]X?'Q$^+Z^)/AGJVMW?PVM)-/U'XN06/A30M#U#4-?U9]&C^T?
M&G_!NE\./B%^U)X5^/WBC]KG]HZ7PIX@^$7PG\#?M=?#+3_$^HV5A^W!XN^%
M5_ITQUW]HFY?5;C2_&7@[X@:;#J.G^.O 6LZ%JNFW4-X8-+N-.BEN/,Z;X6_
M\&X?[)_P@^//Q&^,7@CXT_M%>&_"?BB?]I#4?AK\ _#GBW3=(^#/[/VN_M.^
M$]4\!^.O$'PA\(2:9J&FZ#JUAX,UBZ\.:)<&T<QZ9;Z1:7HO+31M.MH #\IO
MV,_'O_!7CQ1\,/VHO@K^TK^WI^TQ^Q5\?M*^&OP>^._Q2^('[<'[/?P]LOA_
M\*_@C>FZO/C1X\_98^+&A>(M3\.ZTVA)KFB^'+O1=<70/^$.UA4TO6W\->,M
M$UW0])YL?$__ (+<?%C_ ((NZM\=OAM^U#\<;^V^!?Q%_:(\0_#SXM_#CX$^
M+=9_;#_X*!?"T^+_ (?Z1^S!\1/"WA"]635?!GP"G/C[XB>)?B#K5SH*>)X?
MAM\.?"^O:?IVO^'Y+K6[_P#2R\_X-BO@+XA^#OQA^%GC[]M;]MWXFZM\9=,^
M#O@S7/B/\1/B@/%WBG2_A+\%=>U;Q3X8^$.E1ZW#>V7_  @;^)=5_MH:+=+/
MI^F7=E9RZ/96,JRRR]SJ7_!NKX"U;X=?!CPC>?\ !0O_ (*(KXU^".M?%:T\
M,_&:T^/^OVOQ-G^#_P 8-#^&^B^)_@&_B!+EKW3OA=;GX8:+>Z5X?TFYLM-@
MEU3Q ESIUVNHQFU /RF_:6_X*#?M\_%74?\ @F+\2OV&/^"A>C_\+1_:>T']
MFSP1\!/V'IO@KXKN/&OQ9M?$_A76?"'[3O[2O[4Z:]X8U*#3_A]X'\=Z%XAU
MG0?%MKHDO@2+P3H&N_$#0]5O/^$=O;\_$_[07_!6?_@J?X?_ &T_C#^V+XB^
M)_[1_P &?^"9FG?M#_M6_LHZ!J]K\/M"\8_L]^$OB!X"\&_%'X7_  >MH]'T
M^?3->\:65UXWTGPSXO\ %OB75AH=D/&#>(-!T_4M2G\,-:'^D75_^#<O]G+3
M?V@/#'QF^!'[3G[7W[*'A+PSX5^%OP]3X+_LT_%_7?A3X1U'X=_#:>UO+KPA
M?:[X;O+/Q;+:>.-234M<\4W;:J]U-XCUW5_$-LT.KW375>D:/_P;S?\ !/\
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M\6?A]\$OB=X8>;X5^#/'NOZGHGAC6_$'C?2?$/@'XHQ:[%KOAW3=3TG3QH!
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M"_\ :0\.Q1:6H!_F-Z%^S'X'_:!TC]H7XN?$G_@JY^SYXXL?V#;7XSI^SO\
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M_9U^"?\ P3J_;,_:F\/>+O$_P!\8^,&_:;^&W[,=K\"/A$FA?LV^-?VY-/\
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M_ID?$3]D[]ECXO>'/!G@[XL?LT_L_P#Q/\(_#G36T;X>^%?B)\&OAUXU\.>
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MXL6YU;P-_8EEXGN_%%WH#:WKC:5_=;2$^G7!(]./?\10!^%G@/\ 9_;X$?\
M!0[]OX?L8:+\.-#^/?Q7_94^$GQ7U'7?C/H'QEU+PSXM^,'BCXT_&2^.L_%3
MQ])JTM]X]T=-,E;1='L/AKJ%M_PK_0K'3?#EW:6[16D<GX)_\%7?C=\4/@#\
M(/"W[-__  4Q^'\-K\7?VM-)D^%_[?O_  5$^#G[)WBGQ-\)[3]FKP;\8?B9
MXC_9_P#@O\$IKB+2_ GB#X]Z_P"&+2/Q +RXMO#3_"5?$-O<7VC>*O$-A<:C
M%_>!1],=_P S_P#7ZT ?Y^+>%_&?B/XX_'#_ ()5Z/\ L2?'WPY^U5\=/^"P
MOBC_ (*)_LJ?MFZ_X'L+'P)X!_9@L/B[\(=:A^/%C\4=-O;7Q!=Z);_!;2=:
M\&ZY<>&)KBPTK7?&VC?#^[%GXYN3X6TW^H']F3]B_P#9;\%?'G_@J#^S7X4^
M"/@_P_\  GXU:-\%;KXI_#73[?5(?#7CBZ^+/PY\=6GQ(GU5'OFG,GBRUN9H
M-6_L^ZM5*R%HU@F9G;]C:/3CM^7M0!^1_P#P1^_9XG_9@^%G[4_PJTSX4>(O
M@Q\,=._;D_:%O_@CX&U;PG:^$]!M/A->WN@#PY?> 89)I/$6L>"K^XAU*;2M
M=\2JMS?R?:3ILMUI,=I<2?KA110 4444 %%%% !1110 4444 %>"_#OQ_P"*
M_$?QL_:(\$:QHOB&Q\,?#F]^%D'@_5]2L;*WT+78_%?@5->UY_#5[!IEI=ZA
M'INJ-]CU=K[4=5:UU &"V:RAQ;#WJN(T#4H[KQCX]T]?&$NMR:7+X:67PJ^F
M6-K%X*^V:*+A(H=0M[*"]U4>(5_XF\C:A=WQLG/V:U:V@'D@ _,?]M;_ (*5
M?"K]@WXF_'6RUWX&:EXF\1^%OV&/&/[9.L>+_"#>&]-U7QYIOPA\=:-\-M)^
M'&OWES!;ZD9X[[QO;3Z-K=]<ZI9Z+ID^L);Z>)66"[^ -:_X*9_\$PO&WP ^
M"7C[PM^P[\'OBU\&?A__ ,$[OVA?^"FO@+PVOPS^"6H:5\"=<^%7Q!^'/ASX
M@?!CP9H=QX>OM \&_&<?%/QYJ-M\0]8\.G1K?2]7T ZX]QK[ZO:S+Z=_P5I_
MX)X_M1_MB?&'XSWOP6\*>&[KPU\3/^"7GQ;_ &5-&\6>)?&FA^']*T_XN^/?
MC_\ "WQ9I-AK.GO-=^)HM$M_"F@ZWKNH:WI^@:E:Q0:<]A;K<ZQ=6.FW7YJ>
M.?\ @WX_:2^!?QN_X*.W'[+ULGQ"^ W[77_!,W]J7X?_  M\(:GX]\"^&=$^
M%/[57Q[^+7PW\6^(?@]X*\)7-IX)TWPI\+]7T_PQ'=^#/$*V$]I;:9X>33?'
M7B"#6+?29M6 /H;0_P#@X+^,7B/X"?M4?'S]K'_@DSXM^#WP*_9=^"/A#XY^
M&?&OB_XD:?\ $?P5\0_V@=7^(_P.B_99^'&@7L'PJ&GZ?=^+O%WQ(\->--&^
M*NC?V^/AS+X5;Q -/_M/2)FTS]8?^"B'[<_P7_9H_8 \$_MG_%CX Z5\<_$\
MUY\&/%_[./P!O=*TOQ-XE\1_M*>.]+34/AMHO@+4K[PSXAET7QAX9M-0\1ZT
MWC30-!F\1Z1X9T+Q-?Z!8W>H/!I-[^7/[0'_  ;T>"OAU_P1Z_; _9=_81\&
M:I#^U#^TK\,_V8I]=TSXN?&OQ!X@T74]>_9Y^*_@#XP7WPX\)ZUX@N[WPIX/
MBU:ZT7QS8^&FC31O#=_XL\0:3'XF\4Z'X4MXM6T#YK\2_L!_\%N?^"HWB#]C
MC]G+_@H#\*OA]^P1^R;^RM)>^-KSXK_LM_M Z/J_Q;\2>*_"GPU3P+\,H=&T
MBV\=?%?3&\5Z=K,D6J6^L:KX;TO3='\.77C466OVFM7>E:?JP!^E_P"TS_P7
M(^!7@#]E;_@F9^TCJGP,@^)_P3_X*4^./!'@+Q'I&K^(M&U>X^#UGXJT6TU/
M7;?5]$L?#OBO2_B!K'@SQ4)/#6M>&8Y=%/V_1[R1[B"^M$TX_-_Q>_X.*OA_
M\#/BO_P5T\'_  ^_8GU37YO^"?/_  B>O^,?$^F^*=)\-:A\=_B*_C?X;?LY
MZQK'C"WT3P3K,OA?1/#=C!HND:7X_P!6O_%NIW/@CP;X7TBYTG18$TW2M-^
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M:T#P=\(KK6KKXMZCX:^$-OJ6I7WAWP_+976FZKXE:\FET.W\/>, #Y%\9_\
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M:PFTZ6WCDLI;)K?]PUI);-$]LT/[DPE#'\FV@"]1110 4444 %%%% !1110
M4444 %%%% !_2BO(/B_\0=!^'</P^N]>\::AX3'B7XF^$_!NDZ=I7AZ+Q)J'
MCK6O$4MS:6'@N*R.G:C=VD.H,'OKW5[!;2?2K+39[N:_M;1+ACZ]W/48X]CD
M Y]_3/;D4 +1110 4444 %%%% !1110 4444 %%'?'U^G&/\?YT4 %%%% !1
M110 4444 '^?7^5>3>%O@]H/A'XL?%3XO:;KOC&XUGXO6/@6T\2^'=3\176H
M>"].G^'^DWFB:5J?A;P[.AM_#NHZCIMTD'B"6PD2+6)+*RN+F$W$/F-ZS7F>
ME30ZA\5O%L]IJ"S+H/A7PUH.K:<;SQA'+9:G>7>IZ]:RKIEW.G@>:&YTN\MV
M&K:-:2Z^9%?3]7OOLMM8VD(!Z917\??_  7,_;R^,7[ /_!7?_@G1\>=#OO'
MFI_LZ_#WX/\ BF]_:>\)Z)?ZU/X3LOA/X_\ BGHGP\\1^,-5\.6=TFEWFN:2
M-3T^YT"ZN[&]O&U+3[.UM50MOC_#?XB_M:?\%"OB;_P3^^.'CKXB_'CX]3?%
MKXI_\%F/V.?'O@?2? 'QX\0> YM&^#?[2/[+OC#]I[X<_#[X3>(]3\67&F_"
M'P;J?ACQ+X \1^&_"[:K;Z%X+U>TT9]6M3JFC718 _TS**_S[K']@/QQ^T'_
M ,&_GQP^*GQ?_:-_:'^$_P 9?V0C^V9\<4\'^'_VI/#/QQNOB/X,EL=)^)WA
M'P-^T4?#>LZI/;7&J'X5?"A]/TV_\3$Z-%X%TWQOI?A>VU+Q#*1]"_"CX??M
M(?\ !)[]J'_@FG\ O^">'@#XE_MR7G[0'[(7Q2_:)^*OPT^.?QM?0M/T'7?&
ML/P4L?B#\1?"FN7-O%X;^'FB8\-Z-8VNBWMAK,5YK6L6\4VH7%Y.+@@']QE%
M?YZO[/'[3_C+XUZCK'[(/[=OQ0^(W_!/[P'^V_\ \%8O^"D.L_M@W'ACQO\
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M2Z?X.\::9X_71O@GX@M9_A%X%\9Z3%::7?WWPZT:/3]83PW=:5HS?5'_  5
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M4M-\)7MEXBM-?\ )X>N=.\#V'BKQ-[-7S5\"O!D/A?XH_MGZY%;?$.!_B/\
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M/^$FT"S5;;2M3M(%"#V')STSGICT[DDD#'(X&3W&>@,\XP>F<]OI]?\ (Z'
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M:1'?:Q8_EG\7/^#HKX_^./"?P,\%? 3]@#XI_#/X[?M):A\!/B;\"1XJ\8>
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M^_@TBUM[!/HS_@EU_P $3OAE_P $ROBW\8/C%IOQ_P#B_P#M'^+/'?PU\"?
MWX9ZA\9;EKC5/@;\!O VL:MK5G\)O"MW::M-8ZGX=OKL^$"PN-'TY=*;P39-
MH=KIJ:SKL-\ ?MK1110 5_/U_P ' 7A?XP7'P0^&?Q/T_P#X*5>.O^":/[,?
MP5A^+/C?XZ^//A#J>OZ7\8_BW\39]$\*Z+^S?\*_ T?@W6/"?C+Q-%JFIWWQ
M)DUCP5I_BZ+1]<E?1]0U;PMKM]H.@ZYX/_H%K\P?^"D__!)']E7_ (*KVOP/
MTO\ :HO_ (NMX?\ @-XB\4^)?#?AKX;^/U\&:'XCO/&$/AJUU6+QI:G1=6EU
M1(;/PS!9Z1?:;<:-K6C6VK>((M-U6W&KW)(!\+_$'Q=_P4JM/^" 274_B;Q/
MXV_X*!_&?X=^"OAYX0\=:IXO\*_L_P#C_P *O^T-\5M!\ >!/&NM^,/"+>"/
M#O@;XC?#_P"'7C72=<N[VQU:TN$\8:6L=QX@U;5)9KJ^_EQU#XO_ /!<'X#?
ML\7/[ /B?XJ?MJ^(OV[_ (B_M?0V?Q!2^_;%U'Q)\5_$_P +=,_9X;XP_#GP
M!^S7\7-0\2^(]:^%;ZO)I6MZKXWTWPEJ,_B/XB30Z1H6G36%A)K&GZC_ %HG
M_@@-^S!#\1/".BIXQ^(VM_L8:=^S/\5_V?\ QC^QYXS\2ZQXG\.^)M0\<_%O
MPG\7_"?CVV^)%WJ*?$+3-=\!>)]"?5="UG^V9_'&AZWX>^'E[X5\;:#IV@:Q
MHWB'U-/^" __  2E7X>ZO\-)?V9KN\T#6OB5H7Q>NM5U#XS?'34?'MO\0O#>
M@W/AC2?$&E?$R]^),_Q"T=X="NI-/GLM+\2VFG7D4=JUW:3RV=I)" ?Q=?%#
M]MO_ (*<?$G_ ()8_LK?'7PY^U7^VG<_M$_ /P)\2OAWXV\,_#[XZ:]\(O'=
MHWPW_:,^+FK:A^U=^T-X>TK4KW4_VK/A-%\(OAEHO[..@ZQXETK1;^Q^+GPS
M^/.I_$+7_'&J2WPU7^CG_@L7X[\%_'#_ ()3?LF?M8_$C_@HK\>OV+?A<GP[
M\*_%K6+OX-1>)? WQE_:@^)/BKX;>'M=^&7@#3? ]EX@^'8>_M_&]G-XZET[
M4],>Q\./IJ:Y;6_AZUTX^(-*_13XE_\ !!3_ ():?%G0OV9?"/B[]FNV/@C]
MDOP?XN\!_";P9HGC?QWX?T2;POXYUV3Q9XFT[Q[/I'B&UU[XB#5O&%YK'B_4
MYO%FM:E-K7B/Q+XJU'7GU5O$NM)>\;\4_P#@@A^P_P#M!_%CXW>-/VB=-\4_
M%3X6_%3XF?#[XL>#_P!GF'Q!X@\ _#/X3>+O!?P/C^">J7?AX^"->TC6+^+Q
M79(_BN\M/M6E6%GXB<3_ &.]V+)0!_#A^UOXO_X*R>./@5^SS\(9OVK/'WB"
M;]CK]@CX5_MMW/B[0?VN?#7PNTW0;#2M4\9^/])UK39]/U#PWJG[0'QN^%_A
M70= \,>&;W1_%GBSX@>#M<\/S+H<SZUJ\]L?UM35O$=WXA\$_P#!3[1O^"A_
MQ6\3?MR?!;]I[]A3]E^V_9N\4?%'1=#TK7/V?_'/@KX$0_$;X/Z)\/+S1?%&
ML?&3Q%\;=-^)4OC6Y\1W-C;%O$JZ[XHN'U#QMX=BU\_TD_$+_@W[_P""1'Q0
M\)_!WP3XO_8X\(7'A[X#^&+GP?\ #BVTGQ?\2O#EW8^'KS7;GQ+=V/B#5/#_
M (RTS4_&CW&NWVH:C+>>,+O7+YIM0OD^T^3=2Q-Z9>_\$6O^"8U_^U/X=_;.
MF_9.\"Q_M!>$]8\(^(?#WB:SU+Q98>&]+UWP#H]EH?@S5[;X;67B"W^'"WWA
MJPTO2/[(F/A4FTN]'TJ_C O=/M9XP#]15.X(Q4@E0<'JI(&01QR,D9P".1QD
MBG4>G/\ ]?@\?U_"B@ HHHH **** .6\<7YTGP5XPU1=<LO##:;X6\0:@/$N
MHS6UMI_AXV6DW=P-=O[F]L=3LX+/2?*%_=3W>FZA;106[O/97<2M!)YA^R]X
MUTGXC_LY? [Q[H/Q$\2_%[1?&'PM\%>(=)^*OC#2--T'Q+\2;#4]!LKJU\<Z
MOI6C^"/AII-G=>*H9$UL+IGP^\&:?)#>QSV?AO2;>2.SB]HU8J-+U(MI4NN
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MZ9X9U>X@N(?$\&B>#[;1_#MQH/B+1/$EUITOBWQ!XHU;5/3Z "BBB@ HHHH
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M?#FD^(_B%!H9UN]T;2[#3IFT+22LB:?9%Y?@+P[^Q=_P78_X*SQ?LQ?L@?\
M!3/X*> /V//V$_V?/&/P_P#B)XS\4?"W6/"-A\;O%UW\-?A]XB\+> ].\%:O
M9^-?BD^GZ_%=326>K:G;6OA^VT:+Q//K\0UF?1]-T8@'Z;?$?_@O5X$\-_\
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MA]A^WVTFO1V:ZJ\%]_9>F?;(6NC'<_V=8^<K_9+?R^JHH :%4,SA5#,%#,
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MWBBVDMKC13J>G7"&3XZF_:G\!_L^_P#!O?HGQ<_9S\3>._CC%XM^!&G?!?\
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M^4>$_P#@L[_P4"_:P_8O\1?\%(/"?[37BWX*_#S_ ()J7W[%'@SXW_ 7PYX
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MG@IK*7PM;)J$WA^"Q&D+%&@!^!WPC^,O_!47]K[]I']H'_@CEKG_  4O\?\
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M^&?ARXA?X;67Q7^''PVOT\9VHT>ZTKQ5<0ZY%K6D:$T^C7FMK_I+4?Y_S^E
M'^:?^QA\3/BAX9_;F_X)_:K^R3\)OVTOB_IM_P#L>?MD?!S_ ()Y?%G]K:R\
M4^&/!7Q_\0:1^T1\6?B-X+UCQ_\ \(%KVIMJOP ^$/AGQ+X5TOQA9:KK.DV/
M@[Q)!X4^(.J:+I'@V'PHEU]E?\%'/B+X3U3XH_M<_L,?MM_L<:7XB_X*M_M_
M_!+]DG4OV<OC-\)OAEK7BOX6K\8- \%_#/P9X5\ _"3QIXA/_"?:+X:\%?%*
MS^)&O>*O'WAX7GAB6WTWQ'HOBDW_ /9=IX?F_OF_S_/_ #^%'/;_ #R/Z9H
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MZ,O\_P"?\\=Z/\X]** ,.WD\1'Q'JL5S;:0OA)-#\/2:)>0W5V^OW'B*6_\
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MF6]B^',/PVTKQ%<%'\,O<(MT^DZ<&9EM-:N+M+2*\]F^'O\ P<1:?\5)]-^
M>C?L=ZMIO_!3/4_VM[O]EI/V%O&GQ)?PUK7A+P_9PWFOW_QT\<?$[4_AB(-(
M^&>D^%=+OM7U@Z)X5\0W,&HI9:?9F_M]0L=5N/@+X#_\&\/[0'[*-]_P3_\
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MKK'[*?PHT?PS\'O^"?7[2W[?'P>O_"/[1-GXLU7Q)IOP!BTB:'X.?%;1M/\
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M(:;:>);[QC;:K8^-8M>L=?T0 X7X%?\ !S9^UC\0_P#@GO\ MS_M8^(O@/\
MLS>(/BE^SGX<_9H\5?#7P1\']2\=^)?"FGZ!\;_B)K/@?Q9J_P ?GN?'D^H^
M&?\ A!?[+M9+K0M%UBS\36M[XB\/R:CI(T&\N-<L_P!<_P#@B'_P54^/?_!2
MBU_:2T[X[>!/V;M'U+X':_X$L='\<_LN?$Z3XA?#CQ5;^--#O-6GTIFO]?\
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MXAMDM?''AF\=]/TW6_&?P^TJXRMN4NS>>,=%2&Q:YN$ENI8H["Z^I;8 6UN
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M56%Y:&Z-@+JW^W+;)>-9>=']K6TDD>%+IK;=YRV[S1R1+,4$;2H\88NK 6:
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M)OVGHK;X!?"_XCZKXBT[]L#]AC]D;]IW]F7]HWXQ_#J\L?"NJV/[.7Q:U/\
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MQ^@/]: "BD)QVS_^K-&?Q(QG\: %HH_+.!G_ #Z<'%&><>@!_//^!H ****
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MZNB6<NGZ,MW!;11W TFPGGNIK+3!*KBQM)KFXEM[811//*R,[:E(2!GVQ^O
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M,=-UFP\9>(;KQ+X-@\%OI/YL_#3X">#OB1\+_$GQT^!O[/GBO]F']AS]O/\
MX+4_L%R_LL_ W4KRZ\,>-=+T#X7Z5\1/A;\;?'FH^ ?"-Y?P_"?PSXY^):ZK
M>V'AJRUF6\A\.Z=J&GS6-OX3M/#ESJWY1?$']FK]I7]G3X7O^P[>:KXEU']G
M3Q;I_P &O^"U?A.U^'_P_P#%USK$?Q#OM0T[]GOX@_ WQEX>TW1].\^T'BGP
MI=ZMX2T\'Q-J-CX;^'_@+7M'T;2_$/CKQ7HNE ']4G[+7_!'G_@B%\'?BG^W
MG^R%#\1/C5\9/%5E^S?\*M"_:Q^%G[0/Q>UJULO#7P$N=>\,_'CP5KWA_P ;
M>"_#?PJUW2=%M=8\,^%]7UN\\->-_P"S=&%E9Z=JUE8QWLT=U[/_ ,$4/V:/
M^"//[.,WA#QS_P $ZO&7Q=^,7B?]J'X5^,M5T'XI?$;Q/X[\7WME\(OAAXUL
M-+UGP+J>G_V-X3\!_#FU\/\ CS46_L[2=4\':7XTU'4;[4"VI:C8;$B_"+_@
MJT_[2OA;_@J+^VIXZ_99\$>,/&_B#]N_P!^SM_P2PUOX<>+/#WBGPYX<U3PY
M^V/^RS\.9=(^(%J]W<>&+'2_%G@2/P[XN\-75K\2Y=/T;P1XD\3Z%KVLNEMH
MOB/19?:?V3_V@+W_ ((>^%OV5O$'Q'^ 7[3/B']E>U\??\%0_P!GRXO/!WP?
MG\=?$B32/#'[4=K>?L]:RT^H:IX!T2&V\5>'?#NO:G>:_P"8EKXFM(4OM%TQ
MK -=6@!^H7QJ_96_X-QOVF_VW_@]\6/C3X%^&>M_M0?M4^-OB]X8\':/J/BO
MXL> /!WQG^*7[.?Q*3X?^/F\=_#S1O$GAKP#XB\3VOCKP9J_A(VWB_1I-#^,
M]Q+K,&L:=\0+J6QGM?I+QS_P41_X)!?LHQ:9^W3JNAVOP]TK0_'6J_\ !)NT
M^-NA?!OQ9I^G^ M.^ L?Q%^*L_P3\(^'[+28?['^$VE>,/#NO:1)?_#GPR-#
MUOQ?H_AO2-8N+[3_  +HK^&OYWOB/^P'^U;_ ,%$/"?_  3%NK'P#XN_9]^,
M.L:5_P %2?VY/@7XDO[3QE?W?P'N_&_[2?AW]I3]DSPG\>O&5UX5@N_#TE[J
MGB^YT:PM-#TW1],B%WH>L>&M%%ZNJ:5-^;OBWX:_M6'_ ()Z?LU?M-?M.>-?
MVC/@CH%Q_P %O_VQ/%WQH^'?P*^":7GQ<T3Q[\1OAOX?6Y^+G@+PCJOBNRL]
M6F^&/CKX1_&CP99I\3T\-^(=*O/B?KFE:.;K0M.MY]; /]$+]F7]IK]FC_@J
M-^R5J7Q/^&$7B3Q?^SS\9[#XD_"W5;7Q=H/B/P#J'B30$EU7P-XPM$A:73-;
MMM+U:SDO8;'6=)O;>9K:X$]G>VU["_D?&UC^W_\ \$M_'OAG]H?]K[2YK3QI
M/_P1\F^+GPFUSQ2NBZMK/B+X>1IX>T?2?%W_  JFSN=0GMO$=MXZA\/6O@C1
M?&D8:;5)M.U/35UFSTRZU.:Z^7_V9OVVO$^C_P#!!KXI_&;]E/PK^U1\6/'?
M[/WPS\>_#/X0>(?VI/ACX8\)?%OXS_$FSO(M%TSQ)8_#;X>^*_B5>7UGH_B;
MQ3!I=AI6IQ65_P"(=1\.SV'V>6QN!J\OX,ZE_P $3/VX_P!ABV\>?L]^#/&N
MA_'W1O\ @H!_P3[_ &H?A1\2]+^!_P"SSXMT63P]XI^"WAIOCE\-_B)\7$O?
M&Y@UOQWXT^(&LM\'-'\16P?Q-,WB*RTC1O 6OWABTZ@#]N?BCX#_ ."#7QO_
M &??A9I%Q^SK?_%_]GK_ (*.^/\ ]IW_ (*)VVI?#[Q7\7_#\7BWXQ?"KX=>
M)_B7\9/%/C/6]#^*?A/QMX<\06-I9>)_"=A\++2_M_!OA#Q3!J?AFR\*>'$M
MYUC^??\ @EM^V5_P00\#?M2_ 3X-_L@?LP_'G]FOQ-XITWXO^ ?V4_B_\9](
M^.4'PP^)G_"W=8^'?B3QCX=^'?B#XJ?$SQF^J:O\37\&^"=0\.W^LZ4E]:6=
MG#X?T;4M$B\63Z3KOQSX=_X)=_M??L=_\%!/#OP(^&'P?^)'Q%_X)_6W[-G_
M  4'^-O[-7BS3OAKKNO7?[/_ (O_ &I/V</%OAOQ/^RCXB\?6MYK,T*V'C?3
MO#%MX,T/Q7+9:KXPOM0L]:TG[9X@OO%^[T/]D(?MJ_MJ7'_!$/\ 8Y\=_P#!
M+/\ :/\ V3=&_P""9/B[X%_%GXF?M@?M(>"O$GA[0KS0?V9?A-9^$[_P)\.;
M+6?"_@]X;OXZ^*K;0;2326UG6=4T6'3-$U:;0M:TS0];UC10#^NCQA^R!^R[
MX[^'_C7X4^)O@+\+[GX;_$OXJ^%_CA\2O!6G>$]+\/\ A[XC_%CP?\1?"'Q8
MTCQO\0M/\.PZ5#XXU>Y\>^ _">M>)O\ A*1JMIXU@TD:%XRMM>\/7NHZ5=['
MQ1_9G^"'QID\:R?$[P+!XK;XB_";4?@9XT%QK?B73X]=^%.K:O+KVH^#YX='
MUG3HK>UN]4FEN)=1L4M=:*.UJ-2%F3!7NU% 'B/BS]F;]G'Q[K_C3Q7XY^ /
MP6\9>)_B1\.$^#OQ#\1>*OA=X(\0ZYX[^$D=Z^I1_"_QCJNK:'=WWB;X>QZ@
M[WR>#=:GO?#JWC&Y&G";#UXY\#O^"<G[ O[,WQ$UCXM_L^?L:?LT_!KXFZU>
M3W<GCGX=?!OP)X6\2Z.EYX4T+P7J&E>#]3TO1;>X\!^&]5T'P]8C6?"O@EO#
M_AG6-:N_$/BG5-)N_%'BWQ5K.L_:-% !1110 4444 %%%% 'EWQIUZZ\,_#/
MQ/KEEJ&K:5=6,>EM%?Z'>Z)IVJ6YGUS3+1S:WOB/P[XKT6 R)<-#*;WP_J >
M"26.!;>Y>&[M_3%8B%7.YR(@Q VL['8&(&T(I=NV%123P%' \!_:NL_"U]^S
MA\9(?&FJ:GH?AR/P-J][>ZYHOA+4O'FJZ)/IR)J&EZQ8^#]'\)^.M6\0W&EZ
MM:V-^NG:7X0\0:A*+<FRTV:X6,KU7B;1]<\9_ OQ#X?T745F\2^+/A/JNC:3
MJ]W]OT-9==U[P?/8Z?J-UYEA!JFCB2_NX;F?S-,AU#3PS;K".XA-N #\V?#?
M_!8?X">)/"_['%Y!JOPIM_'_ .U_^UA>_LOZ7\,W^//@JX\0_#ZZTF_^)=GJ
MFO\ B:*UM9;Z?7%O/A_I?A;3O!4&E07=_P#$'XB^!O"/]K02:NE_5B;_ (+J
M_P#!,))OVJX(/VD;&]?]B^VM[OX^O8>#_&=XGA^UG\?:=\+Y+CP]Y6AEO&\5
MAXYU;3M"U1_"2ZNFG3744UVT5M)',_XM? 3_ (-L3\//V<?^"7/C&T^%/P0\
M!_M]?LZ?MG_ 3XV_M6?%VQ\:^/++5->^#/@[Q]KGB3XFZ)HNHV^H_$/P[XZ^
M),UM:^#KOPS>W>G>&M!DU.PN+G3+CP=;37>F7OD?PD_X-IOVT-.U>U\)?$[X
MR_LU^&?"'[/?A30?A1^S+\:/V>]!UWP!\9OBCX)U7]K+X:_&7Q;XX_:@TJ7P
MX=!\6>-?"_@#PMXAE\(>'=3U#QEH^H>-]4@LO$&N:E9VMOXH !_0!??\%VO^
M"76G_LFZ'^VQ<_M,:9_PS]XB^*^I?!#3/$,7A'QK-X@D^*>D6"ZUJ7@^;P7'
MH#>*;;4K3PW-9^*IC/I:6Z^&M1T[6/.-K>P,WLOQD_X*,?"'P7_P3]MO^"BW
MPZU&T\8_ ;4-!^&OC^Q\1:Y8^(O#T)^&/C3QWX9\,ZSXINM)?2G\1VL^AZ)K
M.H:TFES:4EW+/8):S1Q*[NO\??\ P61_8F_:P_X)XW]O^W'\-OA[X6^*^KZY
M_P %6_VOOB1\+O@WX3^&VO\ Q?\ @]I?PC_:U^ _PF\ ^#M=^*GA:RT+P]%X
M=^)%IK_PPU7P[H>CV5OJ6B#4?$]DFG^)[Z_N%T^[_?#X1_L*?&_]H;_@W0^
MO["NHZ#'\'OC/XO_ &:O@SX*\4>'OC?H7B/PH_@>XTCQQX;\1>*M.\9^%AHL
MWB2POK;1-+U"$>'9])M+F>ZDM].NGTV.66YMP#Z)^!__  6!\#?&VW_:M_:D
MMO#6B^#/^"5W[,OA74[#2_VT_%>MZA;:A\<OBEX4UQ;'QP_PJ^'EOI<U[J7P
MJT0.OAC1_$MY-;Z[XO\ '3VNE>'M&O%NI8K'Q*?_ (.9O^"75M^S7\)OVFY/
M&WQ,G\-?%3QMK'@B3P5I?PUUG6?B#\.[GPKJFF6OC36?B+I&E/=Z;H>A>%M'
MUC2_%%S?6^KZ@=6T;4;)?#\6JZC<+8#X3^(W_!O]^UY\/M6_;)^"W[%WQ^^'
M?PX_8T^,NM_"G]J[]F#X8>)Y=0U#PQ^S_P#MD? GXC:!\1/#_@;7/A7K7A/Q
M?HNM? GXCS:1<Z9K6NZ3XE>30YV\*ZEXC^%/Q%M_!$&DZ]]&?L6?\$@/VM/A
MA^UE\'_VMOVGM7_9;\4>)?&OB#]J3X@?M4?#CX1:-J^@?";PGK_Q1^''PP^&
M'PT\(?!_PCKGA.[3Q=H;Z3\.8/$?CK5_$]UX9>S\2:C<?V3I6JB$ZI?@'U!^
MTW_P<1?\$SOV8= _9Z\2ZW\2?%OQ*TG]I+P1X5^*O@VY^$_@K4O%">'OA'XK
M\277@^U^(WCUKE]+7PGI=GXJL;SP[=:+J)7Q6VM65]IEMH4]Y9W$,?[>Z9J-
MGK&FZ?J^G3"YT_5+*TU&PN%5T$]E?6\=U:S!)521!+#*CA'174, ZJP('^;#
M^VU_P2,_X*F_"'7OV>/^"=_[-?[/OCCXR_#OXY?L@_L9_"G]HCXZP^#-,U[X
M(Z7\6/@K\8O'WQ:U*XT7XR:;HEK>?"'P)X"\4^,=5TNZE^(D6B^(?&WAF"/5
MAX:U.YN] 1/](GP=I%WH'A+PMH5^]O)>Z+X<T/2;R2T>22U>ZTW3+6SN'MI)
MHH)I+=IH7:%Y8()&B*EX8W)4 '1T444 ? ?_  4=_;1U?]B#X!:5X[\"_#27
MXS_&KXG_ !4^'/P)^ WPF6^OM)M?'/Q7^*&OP:+H=EK&M:=INK7.C^']*LEU
M+7]=U"*PN)H=,TJX6")IG3'X8> ?^"X'[4?['/[0_P ?O@]_P53\6_L-^/-"
M^$/[/'CO]H#Q6?V%M8\<>)?B+\%]6\'^.?AEX"T?X._$#PGXDN[FTG\3?$+5
M?BUX9/AJ6]U#0WTW[%J4NMS1P-*-,_;S_@IW_P $^_#O_!27]F#4/@'J/Q'\
M2_!KQ?H_C'PI\3_A1\8/"$=Q/XA^&WQ-\#7KZAX9\26%K;:KHLMRL4KRVURL
M6I65W%;W#W&G7EIJ$-M=0_A!HG_!MO\ M#^+/#7[9WB[]HK]M7X<?$#]I?\
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M]MXH2%-7N["Y^TS6VM7>H+;WT.GR6D%G]7_M?_\ !"SXD_M?_L?6G[+GB_\
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M6V;_ +;?P;_;F^)?C/XH_%2\\?\ CGXV>/O@[$VD:3X'^)VNW%EI;ZGX!O\
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M8?&^UL[C4H[N#7M51Y-6BTR[M;]='\3W=YJNAZGIVGP>']$\/\WX+_X-A/\
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MI?4-'<Z-J%K:7-QKVOZIIM[_ $4_LP_\$=OV-_V1_P!B#XZ_L#?"+3/'EO\
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M(+X(TP1^$[V\T/2(?$OAS^RM-TMSKFG7?B&R7Q ^NZ.=9%[I%YI.E@'\]?\
MP4^TS]IGX5?\%%/V0/CLWQKL_''@'QTW[4?PD^ 7[-C^&QX8\+_"673/V)?%
M'C[6OC4WCJ+6Y;^]_:%OOB'X2\2:7X;\<W&CRZ7X+^%VL6GAOP_I-EJMWXNU
M;Q1_(_X2U+3_ (+_  !^"7Q;_P""6/[<?[17B/\ ;Q_:8_8,_:@^,/\ P4VL
MK'XT^'O%'A;X6^$OA?\ #/1?B=\2_%WC/5K_ ,&:SXB^'7Q&7^RO%O@KX<W#
M6MWX[T_Q/XET?7O#'Q1\!:YH$%SXU_TV/B/\ ?@_\7?%OPQ\<?$KP'HGC+Q+
M\&[[QCJ?PVOM<BDNXO#&H>/_  =J7@#Q;>6MB\OV">XU?P=K&JZ#)+>6UPT-
MGJ%T+8PR2F2O _AG_P $U/\ @GY\&;;XC6GPG_8U_9R^'EM\7O 6M?"WXH1>
M$?A1X1T0>/?AQXC##Q!X'\4&RTR)M7\,:V&_XFVCW1DLM0VQ&ZBE,,6P _RE
M[_\ :H^!_@GQ!\#CH/P4_;!\?_\ !+%-:\):K^T[^Q9\4_VX_&OBSX2?$+XO
M^)-!UO5;RXT/Q!\$Q\)K'POXV\.6<ECXS\+6&NZ='XCGU_PAIDGC.)-#O]0T
M4_7'Q$^%'P@_:T_8_P#V3-%UK]M;X5_L8^ / WA/]NSX_P#[+?[)G[1NG>.-
M6AO]!O?VA/$][\-?!%I\9]<M1HVK6FL^#- T7X:Z-JOCOQG>2M+X-OIM&TV^
M.L:Q<2_Z4MO_ ,$Q?^"=UI\(]2^ =M^Q3^S1!\%]9\76GC[5?AE%\(?!B>#M
M0\;6%D^FV/BJ[T5=*%K/KMII\DMC;:BZ&Y@M)9;>-UBE=6Z+XJ_\$]/V%OCE
MI'PTT#XP_LC?L]_$K1/@UX>MO"7PITKQC\*_".N6/P]\+V:VB6OAWPE;WNER
M1Z+HELMC:>1IEDL5G$859(0Q<L ?Y_?@S3O^"<7Q3_:,_P""8_@CP-\/_@Y^
MQW_P4S^)/Q ^''[5G[5/QBT_Q;\1?@U^SA\$;/S+SQAX-_9%\ ? #3-=N_ ,
M.I_%7PS)X)A\.>$O"VG>&KS0X-6T&34O'>L:CX@\2Z28O^"7D\WPI_X+<?L[
M_M&> /VG?@)\?OV@/VKOVM/VG/@M^U9^SUIGP8\7:AXR^ ^E:NFMZ_XO\6>#
MO$/C'3)[[3M MHD2STOXJ^#]=\/745M9:SX0U*7Q;X)N_B1H<O\ H#'_ ()W
M_L)GXV0_M(G]D7]GQOCW;:_8>*;;XNM\+?";>/;;Q'I6G6FDZ7K=MXA.FF_M
M]2TW3;"RLK"ZAE22S@M8$MVC\I"/3_ G[+7[-OPO^)_Q"^-7PZ^!/PH\$_%W
MXL7]MJGQ*^)?AGP+X=TCQOXVU&UBOX8;[Q#XDL["+5-0N?*U345EFEN2]Q]L
MN#<&5I&- 'O5%%% !1110 4444 87B?2/#>N^'M8TGQCI^CZKX6O;"X37M/\
M0V]G=:'<Z8B&:Z758-05[*2R2.,RS_:E,"HA>3"J2-*PGL;JQLKG3)K2YTVX
MM;>?3[BQDAFL9[*6)'M)K.:W9H);62!HWMY(6:)XBC1L4(-33P074$UM<PQ7
M%M<1207%O/&DT$\$R&.6&:*0-'+%+&S))&ZLCHQ5@5)%-MK:VLK>WL[.W@M+
M2UABMK6UMHHX+>WMX4$<,%O!$J10PQ1JJ111JJ1HH5%"@  '\R'_  <X_L#?
MM%?\%%/@]^Q+\ ?V>K;21JOB#]J36;#6]>\3:MJ&F>#O"QD^#'Q \1Z1J_BU
MM)L-7OX=*F'A'5=%M-3CTB]BM-<U72-/E>"36(6?^.CXIZY^V_XF^,'CC]M7
M4O!7[7^K?%K]IW_@F!JFFVNBZ'#X^\3?'#X3>"O#5I\-/V4;OXF^-]?G>Q\1
MZ;\/_C'XO\"^/=<75-*LYI5L_'KQ7UCJ,U_JMU-_K&UF#1-&&LMXB&D:8/$#
M::-&;7186@UEM(%S]M&E-JGE?;3IHO/]+%B9_LHN?WXB\WYZ /\ +!_X)O\
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MSXD?\%(?V(?VV_"6F^ ?#TG[/7@K]H;PI\6?%#V<EO\ $3Q[H7Q$\):1X?\
MAYX,ANK*!1J>C>'=7G\1:\&UFY,6E+/=0V"&34Y$(!Y?_P %5?VH?VQ_@3X1
M_93^%G[$$'P;UW]KK]IGXZ:-\,M#\-?$RTUO5_"X\-V'A'7/$GQ#\:W%AH,<
MWB/3O!7@Y--M+GQ)XO\ [)N['PY87UFVI1QS7MM')^1G@W_@MC_P4'^$_P 0
M/A+^RA^U_P#!WX96G[52?\%4?#G[*/Q@O_A+%_PD?@;6_P!GO6?@OX1^,6G7
MOPRTE+]=3NO'/C71?'.@WOA"XU*XL;J+3[FTMO$.AZ/XAGU#0](_5C_@K?\
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MUT'0M2^'[MX3NM**:9H)TWF? G_!KAKQ^!7[2UI\<OVQ[CXM?M1_$[]F^_\
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M%X;U#6+FXOO#GCC1?$?A+6[=8[(B33->T/5+"\4F%[21V3'J/PXU*VUGX>>
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MM^&&LXX?!-MX?31/#/A[1K2&_O&UM;._U::WL=Z?:0#V*BBB@ HHHH ****
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M.F6=[XDTZ[\46&L7MG8:MH[VGB#5]=U75FU"XABMK!D/RQ^P;_P64_X)+?\
M!6O]M+5?@GX1_8_T>Z^,OAC3[O6/A5\7?C/\&/@==WWB_P (_"R]EGTG5?#F
MK:S<W/CSP[<Z+#%IVN>%?#-O9W6M:1:7+WAM-';2=2:U_(C]F;_@B]^V;^R7
M^VE^R-XD\&?#"WU3]FKXX?L??M4ZIHGPSU73=1N?"/[/_P"UU\:?^"?DO@/Q
M[X%^.L,NHW>H:1IWQ,UWP%X/TM_$4^OQZ'JS6%QX>A.@:^BV^I>=_P#!!+]@
MO]L3X)_\%//A#_8_['O[1G[*?@GX > O%9_:[F_:,U2Q\<?!G6O%7C7X:Z#X
M:>]_9OU&?PW:64'C/QSXDTN#4Y-9\%^)?$]]H7@^&X\+ZYXAN-%B^S7X!_2A
M_P %2/\ @LM_P3T_X(Y16'PO\=?#NP\<?$OX]ZMXG^(?C#X!_!7PYX&L]9U+
M3?&LMW'XO^+7Q>M;O^S-%+_$#5(KJPDO_$@N_$/Q"O+?5IMFHVFD:M=VWQ'\
M<_\ @N!_P16_9V^#W[$/[5?A+]D_X=?%/XZ_M/\ A#P9XQ^$'PJ^$'P3^#\_
M[0/PJT/PFMQ\-;+^WM<;1;*Y\)S_  ^\:>$+OX*>"[71;^277-9\(ZI8_#B/
M4O#/A:_U"P]._P""B?CG_@HC_P $\?\ @I-KW[>O[,W[%=[^V]^S[^T;^SQ\
M$OV=_B3X6^'NJ:POQ.^'WC+X9>/?']WX9OSI&E:?JMS'I&O7?Q.M(?[=_L36
MM%L[.#4VUN[\.I9Q7=Y\,:'IG_!=/_@G+^T?IO[=8_8*^#'Q\^'W[1/P#O\
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M^/?_  0E_:1_:2\'_'#PH/ /AKX<_&_P#_P3<_X)]?#KX#?&ZWUJ+3=0U/\
M:0^"GP8U7X9?&SX6:/\ $JQ']MVGPU\;>![O5OAMXM@M/L7@_5_[2T;4]5LK
MA1JIE /M_1O^#@GXT_&GX2_LNK^QK_P3F^*7[5W[4'QJ^#<?QZ^,/PE\">))
M]/\ AK^SE\/-:UCQQH_@0^-_C3J_AJU\,#Q-\1G\#ZMJ'A7P]?\ ]C75W96L
MT$;SZM=Z/INH_NC^Q+^U)I7[9O[,?PM_:(TWP5XV^&UWXWTB[MO%GP[^(/A3
MQ+X1\3^ OB#X7U2]\+?$7P3>V/BC2-&N]2'A'QOH^O>&UU^PMIM&UE]+DNM-
MNYXBVS^1'4?^"+7_  5J^ /[/O@CX-?!WPA^S;^T9\,OVCOV$?A#^S9^V]\#
M_&7C^Z^'=WX:\8_!W7/B!XE\)3> /B?:SVE_<+ILWQ&*2:UI*-;7>L:%J4,N
MG/I5WI.HC^BC_@A[^P+\1/\ @FQ_P3O^%7[,OQ;UWP]K7Q)L]>\;_$'QC;^%
M))[OP]X8U?XA:]-KS^#M,U>Y(F\01^&;>2#3;C7C#;1:I>Q7-Q:VZVA@=P#]
M<:*** /+?C<MP/A%\1KNT;P\MYI'A'6?$-G_ ,)==:%I_A9[SPW:/K]I%XCU
M7Q-9:CH.B:)-<:;'%JFOZI97%MH%D\VLE ]BC+VWAG4Y];\-^'M:NH]/BNM7
MT32=4N8M(U.'6M*CN+_3[>ZFCTO6;=(K?5M/225ELM3ACCAO[8174:(DJJ/&
MOVM+Y=+_ &5OVF-2;3]+U9=._9^^,U\VE:W:O?:+J:VGPY\27!T_5[*.>UDO
M-+O1']FO[6.YMGN+226%9X6<2+VGP6G%W\'/A+=K:V5B+GX9^ YQ9:= UMIU
MF)_"VE2"UL+5I9F@LK?<(K:!YI6AMT2,RN5+L ?B-I__  <??L">%[?X$V?[
M0&J^)?@YXN_:)^(_Q-\%^"/#5O8KX]'AC0/ 7QQU[X&Z;XV^*%YH#1W/@O1_
M%&M>'[S6K%YM*O$31X;VX@DO([":4^F_&W_@X"_X)^_L_:I^U%IOQ%F^/%K;
M_L??%OPE\$/C/XATCX*^(-9\*6/Q'\:OXA70] T3Q):77]E:K<S1>%M;NWA>
MXL[MK*RDO+:UN;<,Z_SA_M%?\&F/[6?QYOOA#XPT7]HOP3X/\7^&O%OQGC\>
M6GBGQ!KNKZ7I?A[7?VA/&OQ#^'>J_""7P[X8M[S1(V\&^*TNM2T77+N>\L/%
M<,\D.I);S(D'ZP_\%)O^"*'[6_[<G["&D?LF> ?V@M&\"W?A?]L+XB_%_5'^
M+%]?^+T^,?@2\_M.P\#>*?&WBO2K&_UZV^(41NY_%6KHD4L&K:WX@UV35I6N
MEM)U /IWQE_P<N?\$HO!OAG]F3Q--\5OB'KZ?M7>&I?%/PZT;PU\*_$=]KVB
M:=;_ ! U/X67,7CRSNSI]OX=O8?B!X>\6>&Q#;WFJI<7'A/6KZSEN=(DT?4-
M6_0W]BC]K/Q!^U3XG_;HTW6?"VE^%M,_9:_;E^(/[*/A%;"ZN;R\\0^'OA]\
M'O@5XSF\5ZY-.(XDU/6_$OQ)\0RPV5I;P0:=HL6D6$K7=[;W=_=?QZ^(O^#1
MC]K/Q-X1_P""?VB+^U/\%?#NL?LT^%_%G@OXEZG:Z#XJU:*VM+S]J3XJ?'?P
M_P")/ EM=Z=!'X@U$Z+\4)M/O='\0+HME!JV@VZBYN[/4)Y;?^P#]A+]D7Q7
M^R?+^V1?^+_'&D^.-1_:D_;:^*G[5-G+I.DSZ4/#VC>-/ 7PF^'FE:!J:RS/
M#>:T]M\*U\1:I<6$-IIUM<^(&TFS@DATT7EV ?>E%%% !1110 445\P?M,>"
M_BMXIG^ 6K_".*^GU7P-^T+X!\3^,;>#XHZW\-].?X8/;:YHOCR75]/TO3]2
MT_XE06NEZHEQ:?#[Q#%;:9J.H):ZI%J-GJ.DV;. >5_\%+_VM_$W[$7[&_Q0
M^/\ X$\'V'CSXB:3=>"_!GPU\*ZS<&S\/:K\0_B7XTT+P#X.C\3WB75G/9^&
MX]=\06<NM7-K.MS%9)*T(W?,O\\<G_!4_P#X*+?\$Y/VWO ?P&_X*4_M*_LO
M_'O2O&GP/^+_ ,?/BC\*O@M\%?&_A;QO\%_AK\-_@9\:/C%HOB_P5XJ72-)\
M-^.+/7?$WPFUWX:ZGIEYJ6JZOIPL]/U-=/V:BE^W]/O[77[*'P:_;=_9Y^)?
M[,?Q\T*[U_X8_%'1/[)UN#3=1N=)U?3KJVGCO]&U_1-2M6#V>M:!JUO::MID
MLB7%J;NUCCOK2\LWGM9?YMOAU_P;$^/;:Q^*%G^T#_P4F^./[1ZM\!?CI\'_
M -G.'Q_IVI:E!\)=?^-OPJU_X)/XX\47&L>+M7U?QS:^!_AEK=YX?\'^#!J>
MDZ%HC:QKDNBC1[>]NK.^ ///VC?^#I;XT?LF_L\?LM_%OX__ /!-'Q7\./&_
M[49\7^,?"?P_\2_%VTTP?\*8T&/PRGA_QO%(_A&;Q#:W_C"YUR]?3M(\1^'-
M G@TNPM-7$5U9ZO9R'OOVK?^#E?XX_"[7_B7J7[._P#P3<^)/QO^!'@CQ)\&
M?A+;_&NZ\6-H#WGQX^.'PPT?XA>'OA?I/@VQ\.>(+_Q=XDTMM=M=/NM.\*3:
MO+++!&US_9]MK6A7.H>X_P#!3C_@VU\ _P#!2&#]EO4=9_:?^(_P\\3?LY?L
M[Q_ 6:)+ ^*/!'B5?#G@9]-\$>*M&\'ZAJT%KX)U!/'4%AK'CF/2)Y#XO\,(
M=':73]7LK'7$^H=,_P"")OA6Q^"4OP@?X[^)I)(OVS/V<OVU-+U]/#&G1FS\
M<_ KX<_#KX?7WA:XL?M^VZ\->*HO!-]J4,L<]KJ.D/J]M;F6^&FF6[ /Q:\2
M?\'67CS]D7]B?_@GIX@_:1_9DU3XI_M9?M,?!N_^-7C^"S\2:1\/_![_  <C
M^)/CSX=_#_XG:5+IFBZQ NO_ !9B\#7WB"R\(1:?96_ARPMWNM0N/)U;1XIO
ML;4?^"TG[3'[3'[=G[(GP9^"'[/7C;X-_LA77[>/A+X"?%+]I'4_%/A357^)
M_C2']E;5?CMK'[/,WA6&UN=1\.V[6WB;P_XJGUZUN3_;6C^&H((KRPDO=3TJ
M/Q#XS?\ !HS\.OC5\+/V#OASXF_;#^(5QJ'[*?P]\5?"KXD^,M0\,C5]3^)'
MP\USXNZ_\6O#OA'P+I]]X@?3_AOI?@"X\=>/O#7AM"NNPOI6IZ/++9P#2!8S
M_H?\,/\ @WV^$WPJ_;N\/_MB>'?VH?VB6\#^"/BIX?\ CKX'_9CO/$$%U\)=
M,^+UEX UKX4ZYXOU+3)2UCJ&IZC\.D\%>'+/7XM*M/%<%GH.HV=_KNHZ=J%C
M9Z4 ?T&T4 ?J<_Y^@P/PHH ^/?VVE\0?\*M\#R>'_%/ASP+Y'[0/P#GUWQOX
MHN]0T_3?"GAB+XF:"VO:G%?V%E=1V>IS66[2M*EU6YT;1FO]2@AU'6].AE\Q
MOI'XA7OC33_ WBR\^'&C:9XA\?0:#J3>#=&UK4!I>C7_ (D:VD32(M7U#!:V
MTM+UH9=0>,><;2.9(")FC(\5_:[T+2]?^"FH6VL)I45C9>,/AQJSZQJ&KSZ!
MJ'AF73?'GA^YM_$?A76+2[TV\L?&&F3JA\/O::MI%Q->2_94OT$[0S_3= '\
MA'PRTS]I#]HC_@EA^UOXK_;*_P""@GQ;^">O?LK_ /!1S]H3XL?M3?'/]G.3
M5+;7?$_PB_9G.IZKJGP>^#MM+Y6H>"_"ESK%MX;U'P9I5GIU_)!<^&M,TF_T
MCQ FHZA;WWX<?\%4+G_@MEI/[/\ _P $]?@O+^T#^UE\9?CI\2/@S^T5^W5\
M3M&^&MYJ^C?%+X:_#*=_ D&D>#?'>M_"&XT8>(M(^%O@SRI?$$IL[;1K;QQX
MJUC2M%LY5.DBX_N^T?\ X)U?![P]^SA^TC^S;HGB/QQ:>'?VH?BC\4?B_P#$
M/Q)-?V%WK]KXO^+'B>T\3Z\= 5[!+"PTNSFL;2RTRREMKAHK:-VFGGFD+KXE
M_P %.O\ @B]^QU_P5?O_ (,:S^TI9^-].\0_!;5KO^R/$?P^\1'0-8UKP3J[
MBY\0?#_5)+BWO[--'U;4(+'4DU.ULH];TVZM&%C>QPW=S$X!_,S\:O\ @X+\
M0_"SXQ?\$@OV1?A_^T3\3=0\+?#_ ,!_L ?$/]M3XNZ]\.EA^(_[3EK\>/A/
M\(_'NC:!&+W4=>&DZ/<?#OQ_I_C?XGQ37W]JZSXB\26F@Z;KU]/X:U2?5?,_
M%?[&?[2/[+_[:/\ P59^/,/_  4Q^-OC?PQ_P36_8Y^+OC_1=:^)7Q/\0>!H
MO"_[6O[;?P8^(=S\$?A=X-TOQYXU\0^#+GPII7@W7O".JMXCFU#P[+J?Q-G\
M ^$-&\.ZA<6+7=E_81J'_!*;]A9K[]FC5?#G[/7PO\(:[^ROXD^#NN?#KQGH
MO@?PV?B9=:?\!/ L?P[^%7ACQ-\6+JPF^)?B'0?"OAFQT*PM[35_%5\E[;>'
M=&L]36^LK..W&GIO_!,K]D^7X,_M9? #Q_X+O/BO\*?VU?VC_B1^T_\ '?PE
MXWUB_.GZY\0_B+XF\+>)7BTA] FT6^T+2/#5SX%\&?V%%87B7L=WH$>I7-[/
M=74^0#^:3_@TK_:/_:2N/&W[;'['7[4WQ7\:?%_QSX$MOAO\8?#VM:K\?_"7
M[2/A'P_H_B&&Y\/ZMI&A?$/PGXY^(NER7=_.NDWUYI^D>*KS3K62&6.YM+'5
M5NQ-_:_7PS^P/_P3E_9._P"":?PCU'X-?LG_  \;P=X<U[Q!/XI\5ZYK.I3>
M)/''C+7)%,-M>>*O%E^@U'5H](LR-/T.Q<QZ?H]GYL=A:P/<W<D_W-0 4444
M %%%% !1110 5\P? :]T)/B=^UQH-GXNNM9\1V_QWT3Q'KOA?5?"&G^#[_P?
MIVO_  *^$6FZ!_9C0QP:CX\\(:\WAC5[S1_B3J"3PZEKT'B_P387TP^'MS;6
M7T_7A_PSLM T#XE?'S0M-UR\U;6];\8^%?BAXBM)].\'V%KX?/BOP'H7@K2M
M$M)?#EM9ZYJ@-M\+I-9FU+QM%>:XS:LEA9:O=:#8:9I^D@'X-_\ !;S]F6]U
M[]J3_@F%^V!K_P 8?%K:3\)?VX_V3_A1\,O@996>EVO@.V\1_$3XD>([KXE?
M$GQ)=3>?J.O^)]4TO3? &B^%H8DLX?#%KX:UDHUY_P )/>+!\\:Y^R=^QI^S
MY_P42_X**?MS_#W]D72_A?\ #S_@D_\ L??$+Q9JNL>"]'UVWUS]H7]J']H?
MX.Z]\<OB1XMT;Q+KNH3^$;V\^%OP0FM?!=GH:72:GHWBCXSZGK6M0VNG2^%*
M_K$U3P_H6N2Z3<:UH>D:Q<:!J<>MZ%-JFFV6H3:+K,$,]M!J^DRW<,SZ;J<5
MO=7,$5_9M#=1PW$\2RA)9%9EGX;\.Z?/X@N;#0-%LKGQ9?KJGBFXL]+L;6?Q
M+J:Z3I_A]-1\02PP))K-^F@Z3I6B+=ZBUS<#2-,T_31(+.SMH8@#_)4_8F^(
MG[2W[(8UC7O^"=>D6/[7/[2'QE_8<T7X;-KG_!/[P'\=/%?C/]DJZ\3?$OP]
MJ?C+Q-\?_ 4/PK?2?B#\8Y/"$E]X2\&^-&N+GP]X6\77-OJ>DW%Q=Z!%_:7Z
MZ_ GPE^S_P#&S_@B5XB\(?$K]C3Q9XG^)>C?\%!/B=^Q1^Q]\8_VP;/5/^$D
M\*?$7]M?X^S>'[GXB^*8=%OO#NJ:AXN^#]M<Z1-\4[E(+][CXO\ A^\L(+/R
M[+5K.W_OJ^#_ .SE^SW^SU;:Y9? +X$?!KX'67B>YL[WQ+:?!_X8>"/AG:^(
MKS3X9;:PNM=M_!>AZ)%J]S8V\TT%G/J"7$MM#+)' R([ ]S;> / MEI^C:59
M^"_"5KI?AW7KGQ5X?TVW\.:/!I^A>*+V[U2_O?$FC645DEMI>OW=]KFMWMSK
M%C%!J%Q=ZQJEQ+</+?W3R@'^5S_P4L_X)_?!+]F#]M3QA^S+H/Q:^$&GZ[^R
M1\+/^"<VE^ _AEXE\ >.(_C3^VMX\O?!NHKXWT3X6S_"SPQJVG:)K'BSQ!X@
M_M'QA9>(;VPO-7O=6\!BUUO4+_1;Z];_ %3_  :KIX0\*))ITFD2+X;T-7TF
M870FTMUTNU#:=*+W_31)9,#;2"[_ -*#1$7'[W?4&J>!/ ^N>+/"GCS6O!OA
M35_'/@.T\26'@?QGJGAW2-0\6>#+'QE#IMMXOLO"GB*[LYM8\.VGBJWT71X/
M$EMI%Y9PZY#I.FQ:FETEA:K%U= !1110 4444 %%%% 'GGQ=M]0N_A1\3[72
M=4M=#U2Y^'GC6WTW6K[5ET"RTC4)O#>IQV>J7FNL571;73[EH[NXU9F5=.AA
M>\) AS7S=_P3FT3Q?X;_ &%/V4= ^('B+_A+?&VD?!+P/IWBCQ0DVHW</B+7
M+72DCO\ 6K74-547VK66IS*]Y8ZU-N76K.2WU:!Y+>]A=OL?4K@6FG7]T;NS
MT\6UE=7!O]0(%A9"&"20W=\6FME%G;!?.N2UQ !"CYFB'SK\H?L%>+_$OC[]
MD#X$^,O%_C/P1\1/$GB+PA-J.K>./AOK&M>(/ GBBXEUW5U36/"FL>(M3UG6
M;[1KJ!(FM9;W5+YE4&*&X>WCBP ?,O\ P6S^!_C7]I;_ ()H?M!? #X=^"M<
M^(GB_P"+WB']G7P'I7A#P]=2Z;J&J1>(/VH?@M9:K-/KL>CZ_%X5T32=&?4-
M9\2^--0T;4-&\$^'-.U7Q9KD']C:-?NG\6WP?_8H_P""I>G^+OA1^T;\<_@I
M\=]9^/GP/^%'[5__  3]\&:#H'PZ^(DI\+_!']FG]DWXF>$/#/[1'@;Q)8Z*
M]O!J&M^/]6\/>!/A9J>C2^&-<^)]_9V>L?#73/&FHZCJVJ6O^D_1Z^_Z<=OY
M_7- '^6#_P $MO\ @EQ^W!\5?V5_VR/V=?B]^Q[^T#X%TGXN_M9?\$L-8U&3
MXU_#GXR_">/7_!OA;XL_'G0_B/;Z4VI:/H>J3Z;IGA3XBWOB3QGXUCL?$&@^
M"-&TE5U2WTGQ#XG\':]I_P#2?^TW^SS_ ,% OV,?@1XW^,_QQ^'&K?M]3:7\
M4/!/P*_8W^"O[#'@[Q/:^(?^"<?P"USX2_%SX8>(_P!H'X(^%=0T+Q/?>+OC
M4VD:WX'\%6NM:[X=\0ZIX8U$)XIA\8:;9ZMX@1/Z[Z* /X.OV?O^"=WQ*N/^
M"+_[*&H_$#]F?]I34/C3^SO_ ,%1/"?BS]F/PY\4? ?C6'XY> ?V?/B#^V/\
M$9?%/C+Q+\+-*2]U#PM'>>"/".JZEXD&KZ3#I>@V$FO:_9"+1]4MM8N_V._;
M7\(?\%!OV3OCA^V-_P %"M2UCQY^W5\ /#^A^!#^Q!_P3B^&_@OQ=X[O?#'Q
MOO\ PUX%\%Q?$OQ/I'AOPSJ.J0:-X0\2VWC'Q7<RZ#;Z_=P6/B&[U*"XT/4$
MCO++^C>B@#_/@_9JN?VI?@IH?[(7[?VL_P#!+?\ ;O\ BU\7=3_X*+?MB?$7
M]O'P5K?[/5QX4\6?$_XF?MB?LV6GAC6=?^%'PD>SNO$VA? /X>'Q)J_AWPUK
MGCO0M(\!ZQXF77=-N_%-GJNK7NG:1[!\:/\ @CG^T[I'_!.#]C'5=%_9 \%W
M/[8>O?\ !6+X/_$[7_ -EH5EK]A^S?\ LP^+_B=\:[_PK\,O& T'6_$6D^'?
M@_X0\7_$KPGJOQ@MOA3;Q>'],L-5;6_%"ZCH7@6;Q'I']W_I[?KP>O\ /ZT?
MY- 'X?W'[(:>!_\ @NO\*?VB?A9\#;S1/!'B7]B7]I.Y^/7QETS1+PZ1KGQ<
M\>?%[X1_\(IIGBCQCJ$DG]I>(;O0?"&IG0_#%K=SC0-#T]WL]+TS2I4>3]P*
M",_H?R.:* /!/&WQ5UKPC\??@;\,UT&_U#PS\7-"^*T5UKL;>$K'2_#WB3P-
MI>@>)=(CN[_6O&FE^)M5U'6=('B*WTSPIX+\#^++FXM;;6/%&NZIX:T;PK.=
M4][K\S/VHO$QC_X*-?\ !+;P.;RP":G+^VGXW_LY[2)]5EE\)_ 6Q\-1ZE;7
MYU19[;3K&/X@W%GJ%D-"N8K^ZU72[AM;TQ],73M<_3.@ HHHH **** "BBB@
M KS;Q?XWL/#7C/X7>&+GQ;X2T&Z^(&N:_I&G^']=LK^YU_QI/HWA?4_$,NF^
M#;FUU2RM+#4M*M["76M3EU&QU:*;1[.\@@@MKEX[N+TFOD?XY:!XZU;]HS]C
M;4M#\)_#'5_ _AKQE\6M3\<>*/%GBFWT[XA>$[B[^$VNZ1X8'PN\*76E,OB6
M?6[V_O++Q;?66OV6HZ!HD2NFAZS8ZC?WNA@&C^VM^T_X1_8S_9:^,W[2OC3P
MUJ/CC2/A?X2FU6U\!:+<Z9;:[X_\0W=W;Z/X8\$:))K$JV9U3Q/XAU'3M)MQ
MY5[<J+F2:UT[4[B.*PN/YS?''_!T)X&^'?\ P3\_8/\ VS]-_9KUKQ)!\=_C
MIK?[/_[2W@V*'5_!WAWX+^+OA[X/M=2^*MOX2UP67BB?6;C^UO$.B>*?AMI[
MZ1J__"8^"=/\4Z5K-SX7\7Z?=Q:;^K?_  5?_8#^(W_!1Y?V4/V?K[5+'2?V
M1]/^.(^)?[6;:5XL\0>'/B5K&A>"?#NHWOP^\.>#1I=[I=D;;5/&$\+:KKDE
MU<ZQX9N+;2M6TC2KSR[PQ_A%\&O^#9;X^_ +]KKX3>#?#G[08^*7_!,[X1?M
M5?#W]HW0?AU\8])T/Q'X^N-6U;X4^.M'^-\%S#I>N^&]'M=,\1W/AWX=?#W5
M-3L-"74?$P\4:)K_ /PB5M;?#35M6\6 'Z/_ !B_X*>_MT^)OAW^WOXB_P""
M=W[-_P"S?^T=#^R-\;OA!%X<TO5-6U_3;7QM^R_XY_9,7]H'QEX]CL[7QEX=
M'BCXDVGBC4O#FA>'O"?AZ33[N\TC4KNT?P_J6OZ?B?R?]@C_ (+ ?\%#OC?X
MD_X)S7_[6G[*_P"S?\%OAS_P4:^)/QJ/@#Q!X0U7Q1+XAO/@]\(_V;M<^,6A
M^/\ ^SM1\=^(_P"P[_5?%.A16<#^+DM7F\*2P7]CI%N9K/5I?IC_ ()8_P#!
M'3QM_P $TOA3_P %%O@5I/Q%\&>.?AY^TG\1-<\0?LZ:F;GQ';>(O#?@O5/A
M8_@[2/#?Q3L9_#[6>E7WA?4YUT:WNO">I^+;75/#NFVVM^1HU]=OX9L,'2/^
M"/OQBU;X2_\ !&3X/_$3QE\+Y?#G[!WP:_:"^$'[4DOA'Q=XZL=6\5Z7\;?V
M1_$?[.K3_ ;5Y?A]9W%W=V>L:^^H-JGB^'P#=Z=I:+JEC!<ZI#'I3@'IW[?'
M_!3G]I+PO^TAX>_8*_X)>? 3X>_M5?MFK\.E^.7Q5_X6?XJ'AKX(_!OX0RWS
MZ1HX\3>(K'Q/X7:^^(/B_56@DT/PU'K^G/9:)Y>KW2W:ZGI]L_@7Q5_X*I?\
M%0=;\ _L._#O]G7]@+X;>&OV\_VEI/VO=7^*/[/O[0/Q$N8O!'PZ\'_L>?$>
M'X3^+-1T/QX/$'PJFU:]\<:YK7A?QGX,EBL]9T6^\%:E,]AJ6LPFQ\0W?F7Q
M,_X( ?%G]D'Q7X(_: _X(8_M!Z?^S3^T19^&->^&7QDTW]J3QEX[^)'PQ^._
MP_UVZU'4;+5_&VIMX6^).L?\)QX"OI["+PD1X3N=)-AI.AHKZ/=:']IU7N$_
MX(V_\%&/"$/[(WQP^'O_  5'M]:_;?\ @AXC_:9\0_&3XL?'#X.ZU\5? /Q/
MM_VL-2^#6E^*_!_@_P *ZI\18T^'/P[^%?@'X/Z);^#?!&CZ9%I7BKQS!?>+
MH6^%]SXHU%=, /OW_@E;_P %&/&?[<GPN^-.A_'KX/1_ K]K_P#9+^*NL_ _
M]ISX+:%J*ZWHFG^-]-L9=7T;7? %_/J%[->^&/&6EPW3Z/;WNJWT]MJ&E:M;
M+JNJ:;#9ZW?_ )1?L*_\%S/VYOBS_P %>-3_ .">/[8O[*'P\^!FB^/_  %K
M7CCX6^&K/Q+I7A_XP_#+1;6'6O&/A"7XNV&L_$7Q5I?B3QAXH^'XTE-?\!^#
M9K77] U)/^$@TW2+_P .RWYT[['_ &5/^""7PT^"RZ+\0_C5^T[^T-\8OVFA
M^U!XM_:V\?\ QD^'?Q ^(?P#\)_$_P"+&LZ]]L\-ZAXK^#.G?$/QWX9N++PI
MX:C'A"'3I]5O+/4=%U+Q!87<7]FZP^GP^0_L6?\ ! 'QQ^SC^VC\'?VLOC_^
MVM8_M?#]G^#XN?\ "K(O''[..G>$?C6VK?$:T71]"\0?$CX_:?\ %;6];^)V
MK>"/#CW^F:6WBCPU/9QG4KR33+72$6RCL@#._;T_X+E^-OV3O^"Q/[)_["&D
MZ+\/U_9W\5ZM\+?"W[2WCC7_  KXQU#QYH/C3X_1>+++X5Z)X0N]/URRT[^S
M3+8^'-6OM9LO#?B&UM&N=0L=:O-.2 *?F[]H?_@XG^*O[/?[2_\ P5O_ &:/
M&GA/P5H&O_ /3[P_\$_/%5YX+\0W7A/QYXP^&WP[\'^(OC+\+_'NNGQ+86GB
M7Q\^G^+O#?COP%X?TR#1#-/JU[X5U359I-3\$6NI_6GQX_X-\_A?^U3X/_;9
M^(G[1ESX2^(/[=/QY^+7Q#\;? 7]J.VU3QAHUW\'_!6E7VCM^S9X%TW1&M]0
MTOP7IW@'PUX?TOPAXMCT/1?%DVJ+/KGBN'4M0UW58$TVC^V1_P &Y?PN_;:^
M'G[1&G?$WXTR:)\7OB;^USJ7[6OP7^*&B>!+^[C^!^I>+/@U\ /A)\0?AKK&
MB/X^TR3XH>%_&4'P)TC4]2U>+4?A_JZW<7A^]LH]/N=$G35 #XT_:4^+O_!Q
M>O[8O[.?P(^%O[7/['/PP\._\%([+XO>/_V;]-U#X2ZY-J?P'\&_LX?"[X;>
M/_$^C>//^$R^#VLZ]IWBKQEH^O6L>IZ4\/Q!L8O%5_XHCL9_"&G'3/LGYW_M
MA_\ !P__ ,%/?AEX6^+OPU\*_$/X.>%O&/AC]O7QO^Q;<_&&U^"\NM7?A_1_
MA+\*O"V@^-/B)X=\(VD?B8R?\))\0]5U[XHV&FS^&/&.N>'M.MM(\)Z?::W'
M;W4.I?V*^.?V!?\ A*_VIO\ @FI^T7IGQ.31=)_X)Y^ /VD_ ?\ P@MUX3O=
M;O?BI;_'WX1> ?A797B>+KKQA#/X/?P?_P (.-;N%O=(\:3^(AJ T]KK29+=
MM2N/P]_:<_X-<K[XN^)?&?C/X+_M_>+O@AXN\9?ML_&G]M$>(M0^"-CXUU3P
MOK_Q9TGP_867A3PS=:%\4?AQ):KX7GT[5Y6\0W374^KVU_IENFF:5/I=Y>:T
M ?*/["?_  6._P""GO[?O['_ .SW^Q[^SIX^^!:?\%(/'GBC]HGPSX^_:-^)
MNB:S;:/\,O@-\ M#\'1Z/\6/'G@[3O"'B&TM_BU\1?$/C$>%=#%SX0.G37?A
MRZU[4/"#W%W??9)/C9^V7_P7<^%WAC4?^"7/Q%_: ^!&@_MS3_M,?L#_  [^
M&?[;7P[M+"]T#QG\'OVK].^-.B0VWC+1;SX</=>&O$>B>._@K(^O^+X?AM9>
M)-7T:?6;:V\+?8[[1O%6M?3^A?\ !IQ\(M"_9[TRWTW]LOXQ>&/^"@NF_%+X
MB_%R[_;]\!>'Y_"7B#Q'K?CB_$\/AGQ-\-(?'=[=ZCX.TJ.WM]4E2W^)=EXL
MOO&%[XAUJ/Q79Z%JZ>$;+TKQ#_P;+:7J'[*_B7P'I7[?7Q]E_;A\<?&SX!_'
MKQ=^WGXWTRY\9^,Y_$W[/WAKQ#X:\(>$_#?@U/'6@ZIX6\!Z./&GBS7/#45G
M\2+CQCI>O7>BR:UXP\3Z+X?L=#H _/7QS_P4<_X+!_\ !/*WO/V2OVYOC_X;
M^)7Q'^&?[;'_  39OM:_:(^"GA'P3XM\8>/?V1?VDO$WQPN/B+\/O"^@>(?
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MK]I!K<%GXEF= #^RG]AW]CO_ (-V/@W^V1\!X_V,_@OX33]I_P",?[+GB/\
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M\1^(K+X8^*/AOXGNY8K1[W2K?QGX7U+Q=I=A=ZP;>0 _T"/V /\ @I'\!/\
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MNYOY;:V@MY+Z\^S_ &R]>&)8VN[O[';6=H+FY93-.+6TM;82NX@MX8ML:V:
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M5C!XFTB33Y/!GPEM?$TFCZ!-I/CR+QK_ '\^+?\ @@%_P3 \1>,_BIXNT/\
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MPV\->'(=:-]/XD^'VC?'<>.7U0:[:B7PQI]QXBT/2UM]#TJ&WD_<CQG\-/\
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M9<^$?B7\?/BY>?M$M^Q:_C9M6AEBU^Z\%6_[0>FWUYXT?0I4^'.M?!_P[?\
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M8^"_\$?/C-XM^'7_  4#_88^+OB:;XZ^-+GXU_MF?M/? SXB?MA?"7]H:_\
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M4]U/?R:#HVKZNL$4+N=/TR^N?]5:S,G\57_!-;_@F_X*^*OP"_;,_P""6?\
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MO!/A;4[DZ?-I1GO='T6VM+B0Z;<7%W/9;Y(R?L\MS.\7W3(V,T ?3U%%&?\
M'V_/IV_#\: "BBB@ HHHH **** "BBB@ HH_SZ_RHR.?89/T.?\  T %%%%
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M0-&TVZN9+O08=2U.VOF^@J\)A@C@_:5O)9];^)%[<:A\%H7TW0I?!FFI\)=
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M(/#OAO7%\969\ ZKJEEIR>,Y-)\26NF[;SP]J=O!U<G_  7._8.T+]NC7_\
M@GIXW^(%UX:^.7ACP#HWBC4_$4]I:R_"MO%7_"!:_P#$KQM\.[CQC!J$]KX;
M\3^!/!^C6>I:VOBM='T]+_5G\._;DUS1]0M!^8LO_!);_@HQ:_M8?M'_ +:6
MF7G[-UOXB_;]\._M ?#C]J#X*:1;1>'-#^'/PLT"^\++^RDWP_\ %.F6J2^,
M_BYX@LO!T&L?&KQOXA$5AJ'B+7;F)-.:W1]2AA^,_P#P0Z_;W^/O[1_[5GP[
MUW]JKX<>!?\ @G3\>_&WB/\ ::TSPUX<^'/@J+XW:3^T%\4?A9\0O 7B?1M+
M\:P^#KCQCH]OIVI7OA[3_'_C.'QG!J/C[X22:%X!TN6TT>T\1>&5 /V'_P""
M=G_!8O\ 8?\ ^"HFM?%3PW^RGXV\1ZKXB^#]OHE_XJT'QOX>B\':U=:/KMUJ
M%C:Z_P"'-)NM4N]0U[P_:WNGBSU/6;2W^P:;=ZCH]O=31S:M9)-^I5?A1_P2
MD_X)L_M;_LS?%+QA^T1^WC\?/ 'QO^,FF?L\_"C]CCX$Z=\)-&OO#7@#X:_L
MV_"J1-7339M-O=)TF?4/%/BGQ1#8ZQJFH7"W;0RVET\-RL>IM:6?[KT %%%%
M !1110!XO^T9\;_"'[-7P%^,/[0/CV\MK'PA\'?AUXL^(>O7%Y+<P6[6?A?1
M[O5%M9)K.SU&ZB-_<00V,<EO87DJ27*,MM,1Y;?R;:I_P5__ ."C?[,OCO\
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M^'TVC:OIE[I&FZ5H::1;S^*I-':U[C_@G?XH_P"">?PH^"7[;&E?M;7O@?\
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M-SILVC:: >2_\%6I%B_X)<_\%)974LD?[ W[8DCJK%694_9X^(K,JL""I(!
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MXW12Z;I-DVI6-GXIUOQ:SQZ-I^@SV^IW,^9I;"S6:-KF#]9"<?F!V[G'?_\
M7Z9/%?GG^WE>M;>+?V!;3[+X&NAJ7[>7PN@W^//$']AVMH;;P'\4[\7'A6WN
M-#U#3O$'Q!6.UDC\):%-K7AK49KM[B]T>ZU6YL7T+4 #L_\ @H=^UA=_L/\
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MJZA>Q:CXNTB?7_A_H>A^+?"/A?4['7;S2+;QGX9@UC6M7T>&TU76_G[X,?\
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M7PQ\1O'N@_"*\US4;Z]\!:L_@ZT\/_$.\>]G%GHNKV[Z3J&B:,\4=]&=<O\
MR#XO?\'*VN_ G]DS_@E=\:_'_P &O"4_CG]MB'P]\6/VC[KPW;>+-8\#? 3]
MF31?BGI_@CXJ^._#GA+3M<U'X@:OXB72[Y1X/34;FYT.#6K>X6\FUZ=K;0[K
MY=_:N_X->_VJ?VD/VGOVE?C3<_M _">X\*_M,_$_]J[QG\0].F^)_P 5_ ][
MXRT35/AAI]S^P]I_BSPAX-^#=QX1N9_A?^T';-XH^*5DE]=:<_A.VL+W09?%
M'B"/^SXO1?V?/^#5FZ^)'@B;PM_P4R^*OAWQ?J7@/]F3X:_L[_L[ZU^R=\2O
MBKH%O\-;#0%\:ZEXJNM;T#X@^%+#1/%;KXK\0Z3XBTVXN[+^P/$MYI[OJW@/
MP\D;V^H 'V)^W!_P5&_X+#?"O]M;P)^RG^R+^P?^S)\5/#/[2LNL:Y^R)\5/
M%_QM'B"S^(7PR^&O@O0O$'Q4^(_C33?"'C3PW;^$_#KWOC#0)?#%[J.I:0L6
MG6-U:VT7C&\U_3+G3O,/%7_!7#_@MEXO7XW_ !G_ &3/^">?[-_Q_P#V2?V9
M_%VN_"_X@>-XO'/C;0/''Q:\?_ O3M-TW]I?4O@;H&M^*-#\2ZAX'L?B%#XM
M\,?#W45^&_BR=H/#L[SR>*=3M]1TZS^Q?V9_^"77[4G@7QO_ ,$9O&_Q[^)7
MPB\::K_P3C_9G^/GP6^+-YX1\3>/H;KQ/K_C7PUX4\%_".7X=J_@#PK!XF\+
M^%_"?ABUTGQ-_P )LOA.XN&M[6[31M<N#(Z_%^J_\$:/^"O'[-'C']I/X1_\
M$Z_V\OV=]%_84_:]\>^/_'WCGX=?M%^!O%;?$/\ 9_F^+^L^)+?X@:'\#=.\
M*^$?&?AC6D3PSK-I=V.LOXC^%<>L:Y8V%O=>'=&NM.N?%VN@'YZ_M<?\',7[
M;^G?%RY\2?LCZG^QCX6^!/B/]F#]G7]HC1/!7[5VJ0^%_'FEZAXW^'7C+4/'
M_P /O NHW?C+X;ZC\4M4B\76)@>2RT5KO[1HGA:#2;&PL_$UW!J?Z+_$?_@X
MM^*'[+EU\'OCA^U7^Q=\5O"_[+O[:?[)G@_XK_LDZ+X?L+#4/BG;?M)V&F3#
MQ;\!/%<T%],E[H'Q!N-3\)Z_\//&=_H&@ZU9>&=9T_6+WPE>MJESHOAZ^W_!
ML+\#/$NA?M2_!_X@W?@WQ!\,O$O[*G[(OP1_8\^,&H+JOB'X_?!7XI? /P;\
M8=&\=_%#Q#ID^B:!X8M--\8>(_'OA_4SX9\-^*=2LO$&D6%WIEY;^%;O2- U
M,?H]K_\ P3:^)/Q%_9E_X)8_"?XS^-OAC\7OBG^PA\9_V<?BI\2_&WB_1=8.
ME^.(?A!X1UOP[KL/@>'1M/TBW35A>7>A7GAFY\7^&IX;\>&[._ULV/B-UUN$
M ^>_VFOVQ?\ @I7^R]_P1LLOVHO&VD_#"V_;_P#C+XS^&<>@?#'4_"S6'@/X
M#WG[3'Q6T7P]\-_@Q-IFJ'PW?:CXG^%'A;Q1X>\+>+-6\=ZIJ41^(\'B:[U'
M6-:\,V=@)?S=_:$_X*H_\%I?^"97@3]J#X7?MIC]E'XW_M&7/[-/PV_:8_9/
M^(/PG\*ZFGPOTG3_ /AHSX:?L]_&GP)\3])%Y\.?$%WK.A_\+3\)^)?"-S%X
M<@\/O?/J\E]XUU32E&DZ+^^O_!8/]CGXZ_MV?L/^,O@!^S5XS^'_ ,/OC7=>
M/OA)\0/ GC#XF:KXBT7PIH&M?#'X@Z)XXLM2N-1\*^#_ !WK$-]:76BPW&F"
M+PQJ$$E]#"ET(H"\B_CG-_P0@_X*+?'']F/]H:]_;,_X*/Z%\6_V[_C+^SO?
M?LO> _$EKX.O=1^ OP7^"_BKXR>$_B)\7/"4=[)H?@_Q?\1=2^+>B^!/#>EO
MXPOO WA&Y^'<DE]::-H/B-X;37B ?$/_  4._P"#@K_@H#^S5^WIK7PT\(?$
M']E+P'\-?A/JO[*,/B7]G[QKX*\3WOC3XI:5\3?#OPXUGXPZGH'Q/FM+KPRR
M>$=?^("Z%?Z+HWC31_&.D^%[9O%NG>&M9TSP[XFUY_3_  __ ,%F?V\?&7_!
M9OQ'^QQI/[7'[-NB?!S1?V]M/^"VC_!"X_9G^,'C3XJ>,_@:OB723->:)\2_
MAS\*O%7P]TYM<\+2ZF++Q7XG^(>A1Z08)O%.MOI_A^V;/K'[0O\ P;#?%CXI
M?%O0O#'AS]N@:E^Q'\6_BKX8^*/[5WPA^(OPLT&^^)>BZSX/T/P<M]=_LX^+
MX++6(M-'Q0N_ 'AOP;>Z1KM]X8M_AOX3B36[[4OC7<64O@_5_4M<_P""'_\
MP4G^"_[6OCOXN_L(?\%%/A9\#_@+\9OVD?#?Q<\>?">Y^!HT3Q'X.\"I>Z;H
M.M^#O#'BI!\0M0\:2>'_ (9Z!I7A[P]I]]J_P]TOQ$;K4-.O+KPC;1#4[X Z
M?5_^"ZUV/^"ZOA3]BO3/$^EZ=^QY_;>O_L@>(TUOPUX3T[QIJO[<VAKJ>MZG
M?Z)>:CXCM?&R?"72(M5\%_#Z;Q'+H,.CZCXYN7@T:#5=.U&RUF3\_?\ @G]_
MP7:_;T^+G_!2KX8? +XU?M ?LM>)?A3\1/VEOC%\"=<^!C?"/QG\-?B]X/T'
M2-8\:Z/\-?%F@>.K_P -Z)\/_&M]J6IZ!X<@@TCPAXZ\?:J=,\0%O$'AZQN'
M?4M%_7/QO_P;O_LU^+?"GB7XA#Q%IC?\% ?$O[0>H_M'W'[=NI^"]:?QA8>-
MM3^/K_&/['I'@+1/B1H6FZ;H^B^&FB^%_AVVA\0LUAHMG:ZG</>3B6R?D?AM
M_P &_?B+PM^UC\#OB=\1/V[?'GQI_9'_ &:?CAK/[27P1_9-\;?!GP)!K/AK
MXNZK'JNKVMWJ_P :](U.SO->\)^'O'GB+7/$FA>')O =N]II1TGPY+J,TNGS
M:W>@'YT?\$ZO^"R_[?\ ^U#_ ,%3M%_9K\?_ +4O[.]W\,X_VC/VH? 6L_L[
M:/\ LT_%ZR^+5UX#^$.G_%>'PQ*OQ6T?X3:I\(]-1[[PYX7U"ZU+4/BOITT5
MN3;:M,FHW(T._P#!?^"='_!PK_P43^+O_!1']G7X$?M8_%/]E_P[H'QJ_:-^
M*_P*^)?[,B?!KX@>!O'GP5N=&B\56OA]]/\ BMJNE6?@+6;BS^(&BV/PXT'3
MK;XF?$#Q'J5[-+IWB/1)-7OK/5[;]I?V2/\ @C#^VQ^R;^T?;?$#PI_P55NY
MOV:KKX_?%KXS>*OV8])_9(\&:7_PE'A[XQ^+O$GC/Q9\.;SXHZS\2_%.M06.
MIZCKD:7.MIHC75G/90:QH-KHVK6FE3V$?[-W_!N!\!O@5\?_ (%?%;QA^TM\
M<_CW\,/V2?'_ (G^(7[)W[/OQ+TGX=3^$OA1J_BB^N->9]?\66_AM_&7Q%N/
M#WBZ>'Q7X7NM2U'2?[,UC3=.O)X;Z[CN;FZ /Z.**09[G/\ ^H?UY_&EH **
M** #TZ=>?R/3W_IFORX_X(L_$K4?BM_P3(_97\3:I)X;EN=*\->,OAU$WA73
M_%FFZ8-/^$GQ.\;?"W2H[FW\:6=EJ\OB"/3/!]HGBJ^LX7\,:CXF75K_ ,&7
M5YX1N=%NIOU'K\W/^"1OPNO/@Q_P3Z^ WPUU#QQ:_$2\\-2_%-;CQ38:OX@U
MG3YI=4^,OQ!UI](TZ;Q3\/OACK]AI_AIM1/ANRT#4?"@D\-V^DQZ#%XA\8VV
MG0^+M; /TCHHHH */\^O\Z** $ Q^/4^IP!D_E2T44 %%%% !117,^,_&?A;
MX>>%M;\;>-]<L/#/A+PW8OJ>O^(-5E,&F:/IL3(L^H:C<[66UL;8.)+N[EVV
M]K )+BXDB@BDD0 Z:BHH)X+J"&YMIHKBVN8HY[>>"1)89X)D$D4T,L9:.6*6
M-E>.1&9'1@RDJ0:R-8\2:)H%SX?M-7ODLKCQ3KB^&] C:&XE.HZV^E:KK:V*
M-!#*D+G2]$U2[\ZY:"WVVC1F;SI(8Y #<HH_SZ?SK"TOQ+HFMZAK^EZ7?QW>
MH>%[^#2]=MEBN(VT^_N;"VU*"WD>:&..5I+*[MYP]L\\060*SB0.B@&[17F.
MI?&7X::1KNM^&=1\4V]KKOAQK9=:T]K#5Y)+$W9\&BW#R0V#V\IE_P"%@>$-
MOV>:7;_;41?'V6_%KV6E^)-$UK4O$FD:9?I=ZCX1U:UT/Q%;+#<1MIFJWN@:
M/XHM;.1YHHXIWFT+7](U$26CSPK'>I"\BW,4\,0!N45P^I_$CP5HP\1G5-=@
MM!X3U?PSH7B$M:ZA)_9NJ^,IM(M_#5I)Y-H_G/JDVO:2B26OGP6YO%-W+ L4
M[1;=QK\%OXAT[PXVGZ[)<:EIU]J4>IV^B:E/X>MH["6WBDM=1U^*W;2]/U&X
M-RKV.GW5S%=7T45Q+;1R);RE0#YN_;LN;"S_ &,/VI[C5/$OA_P=I:_ 7XH)
MJGBCQ1X=?Q;HVBZ9-X2U2'4+R;PTGBSP*=;NULY)DTG3V\7^'XKC5WL5GU&*
M'S WM?PB2T3X3_#!-/FNKFP3X>>"ELKB]MH[.\GM%\-:8MM-=V<-S>Q6MS+"
M$DGMH[V\C@E9XDNIT196^:O^"D6EZ]K?[ _[8.D>%TU^7Q!?_L^?$VVTFW\*
M^"O$/Q'\1W=W)X9OA'9:-X'\*75EXA\17]]A[2&QTJY6Y4R_:-D\4,D$GMG[
M-?BG2_&_[/'P+\7:)!K5KI/B+X1?#O5K"U\2>'M;\)Z_;6UYX3TF6.WUGPUX
MEL-+U_0M2@R8KS3-7TZSOK2='BG@1UQ0![91110 445BZ'KD.O6U[=06&M:<
MMCK6N:(\6N:/?Z+<W$VA:I=:3/?V5OJ$,$MYHNH2VC7FAZO;J]CK.ES6NI:?
M--:7,,C &U1110 4444 %%%% !16-J4_B"*^T*/2-,T:^TRXU">+Q->:EKM[
MI5]I&EKIM[+:WFA:=:^'=9M_$6H3:PFG6$^F:AJGA>WM]-N[W58]6NKJP@T;
M4DU2?Q##?>&X]%TO1M0TVZUJ>#Q==ZIKU]H]]H?AY?#NO75MJGAS3[3PYKD'
MBK69O%=MX8T6?0=3U/P=8V_A[6->\3Q^([K4O#FG^$?%(!M5\QS:SH@_;+T[
MP^==^*0\1O\ LR:UK*>&DN++_A2CZ)%\5-!L9==N;0R?VB?BE%?RPZ?97"Q&
MR7PG-?Q/(L[(K?3E?$6N>-/CW9_MS^!/!FD? +0=9^$>L_!WQS>>+?CF_P <
M=,TN'P5H^E:_X.D\,Z8OPIG^$L_BWQ/X^\7^)[[7+3^SM-\;6?@;P[X3\/1Z
M]J?BBZ\0:Y:>&;  ^W:**Q-8N/$<,VA+X?TK1-3MKC6XK?Q-+K&OW^A3Z1X<
M-AJ,D^JZ%;V7AGQ"GB+6X]5BTFSBT#4+GPO83:?>ZCJ;>)H+C2[;2M8 -NBO
M--=U7XPV^B:A/X9\"?#75_$<>LZ_!I6E:Y\6/%'AW1+WP_;:'J]QX7U/4?$%
MA\&/%%]IFL:QXD@T+2=>T*V\-:O9>&]$U+5O$&G^(O%5_HMGX9U_TN@ HHHH
M ***Q+J+Q&VNZ9-9ZAHD/AF.SU!=:TZYT>_N==N[]_(_LJ?2]8AUNUL-/L[;
M%S_:%K=:%JD]]YD'V:\T_P F3SP#;HH^O^?Y44 %%%% !7SW\'[N\N?BC^U-
M!<VMI!;V/Q<\)6^GS6^F^)[*>\MG^ OPANI9KZ[UW0M)TC5KA+R>YMTO/!^H
M>(]$AM88-/O-5M_$-EK.CZ9]"5YC\-?&N@>+9/B!I^C>.7\<WW@GXC^)O"7B
M0R:.FCR>$M9@>VU9/!12/3=-AU&/P[I6K:9:P:NGV^3487CN+K4;NZ,[@ ].
MHHHH **** "BBB@ HHHH *.E%(?KCD?S''X]/QH 6D[X]N/7W_I^M>-?&O1X
M=4T3P??7GQ5\:?"?2_#/Q-\!^)-6OO!4EI%<>,K73]<BAC^''B&:?2-8NH_"
M7C*_NK33?$/]DKI^I2V8,4.K6,3S2U[-0 4444 %%%% !1110 5\&_MN>"KG
MQOXF_8=MHEUZ*T\*?MM_#'Q_?7^CZ8NHV-J/"_@OXE-:P>(C)IMRFG:5JMWJ
M$6G)J0U/1IK?4[BP6&743*VDWOWE7RY^U!\7O&/PC7]GD^#H](D;XG?M1_"+
MX0^)QJ]A/?[?!WC6371KTFF""]LS9ZND>FP-97\OVJ"VQ(9;*<-A0#ZB'X]3
MU^I_3T]L5C:G9:O=7V@SZ;K9TJST[4Y;O7+'^S;6^'B+39-*U*TBTK[5<,LV
MD^1J=SI^K_;K,//)_9HL&7[/>3LOYK?\%JOB#X[^%/\ P2H_;G^(GPP\<^+O
MAI\0/"7P)U_5_"OCSP'XDU?PAXQ\+ZK#?:5''JOAWQ-H5W8ZQHFHQ1RR)%?:
M;>6UU$)'\N52Q-?Q\?LY_P#!4;]N[]I?XR_\$)O 6E?M(?%D+\%/$GP?^"?[
M>^C6'CGQ=X7LO%OQL^)GQF^.?@+X1>$OVD;6[UO_ (3_ .*GC+Q!\(?V>;7Q
M%\5;?QE-KNBC7?$-SK]M8:7K7B:_AA /]$KKZ]CZ'U[_ *BO.+;PAXNL-=TN
M[L?B5K,WARVU&_O]8\/ZWHNC:O=:PM^VNS#3X?$'DV5WI.G6,VI:0NG0VMM)
M+!:Z!%:RSW!U"\EK^#[_ ()/_#'_ (*C?MB_'JYU;XA_M,_\%AO#_P +/B-H
MG[=/@?5?CV?VA?%%U^Q[X,O-:\%?&SX/>"O&/PPTSQ5\18?%^K:_\-_B%K'A
MC5_AAIMC966LZ%XV\-:7XETVYTO2/"][J-GZ?HG[-O[9?[.]U_P6F^(^J_\
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M[&/Q;^!7QK_9BT3]J/Q?\1[/XJ^%==_:;L/CI\7;OP]?1Z3X:T7Q!%\4-/\
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M/AEXKT3Q'K6G/\3O&=@^F+XH\9:F-8&M7-]J_AJP\1:#<%N;_8;_ &5?@O\
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M5^-_P%_X+F?\$^_BO\2?@Q^SEXC_ &@/A]X7_::^)WP<^%WQ(U'P9;:G+>>
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M9NIM-N]-T^/0]'U+64/V9]&_:BTWX0?M6_M<_P##.7Q#^+UYXN_:V_X)T_\
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MRUO0=/O?"-I9Z[!JOBFYT:&ZA:^T&+_A-[:,?-/C;]EG]K;P#XJ_X*V_!/\
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MU^PTPZOHEYXENM)U6>QTK4H;S6UN_P </^#;#X[_ +,^L?%OXY_!SX=^.?\
M@H+\7_BYK'P<\->/[SQI^V)^S[\,_A%X%\#^ /AUXAT/PG?^"?ASJ7@GQ5XF
MU-M=\2^*?B3IVK:S:ZE)%;>(=%\)Z/*$2Z\'-/>_G1^U-^SS^VM8?MA>/?\
M@X4\6^#-1\6_#+]E'_@HOJWANX_9C7X;^,[_ .,DW[+GP%\36OP*;XJ_"WQ;
M>PZ<OB;P3>6-EKGCW3?#]Q-X?\":/J]WKFMGQ#/81:BC ']-?B#]H_\ X)0?
MM;^*OVQ?&OC3PCIWQ!\7?LC>*/%__!.?]I77]0^'?C*3Q'9>'_B9XET3PAXN
M\%3Q>'X/[8\0?"N]^(8N=!3Q1-;-8^'O$GA;6_$6C7>E626GB#4/RD\0Q_\
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MWH?@[0=#F\.H^A2M;:==W_BJ]\S7M,6PDNM-M?/@L$^3/"?_  <2?LQ>./\
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M?'MA'X@\.7D7AFZ?Q/H>E77IWP"_X)H?MKZ1\"?^".'PU_:%^)WPJ\7^-_\
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M=/MKFPU.^DU6_37KJ?68=3U.+48;+1$@LKZTTMK&>33WU*^ -FBBB@ HHHH
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MB7::/K/C/X1%?"'BNY\.7D_AU?B+9-XJUW4=)\1_8X+WP_K5[I]Q#>R^:P>
M-:^&O_!.+X)_\%P?#G_!7O\ ::^(W[;/B/XL_"3Q3XU^&&@?$[PUX\^"5_\
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MA""36;*YUZZU3P[KD5I;_P""!M]\&?\ @G/\!OV@?V\_BWXC_8U\1_&;P_\
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MH/%LFLQ:>NL:@NK>*M? /IZB@9QSU[XZ9I,XY[8)SUZ?J<]L ]/ID 6BBB@
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MU?Q+X3@N[_\ X175=;TZ&VU6X\-W%Y<7VB&\&FW[_;;>=0 ?4]%%% !1110
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M37FKZ?IEVFJ:E'<7%D-)T>VL&M;32-,@M>;^+G[('[*?Q]\4^%?'/QN_9O\
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M\2>(+[5-:TFUM?[#M9;O1_"#:G'XE\/^&8[JSU71?%?[!_L5?\$C/VOOA?\
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MYK':?"C_ (-.? 'P]^ W[3/[-M]^UOXSO/A3^TI\'_@=;ZUHFE>#K2UDT?\
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M[]M3X1W]KX?M/ 7@BS1Q9>$M<\':?_PA4UCK%M)INI6NHZ*\$/\ :2__  3
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M+^+_ ,>/V>O@;^UM\+?&'[,'Q+_9H\ ^'?'/['^OS_"/Q):^+#\0/V@O _\
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M'\":,TOABSU#XWZ[XEB^'$7[0FAWC0:AJFM:!\)]4@MYM4U?4X-+UC_4+HH
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MTAACCBABC2*&*)%CCBBC4)'%&B *D<:@!%4!57"J !0!)1110 4444 %%%%
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M)^&^K:9I'BVQL=1UFRO-8AN?#>GZ=/X?C&N7P!O_ /!1;_@MG_P4S^ 7C?\
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MVJM(^).HZQ\.O$_PE\ _'FX^#']C+X2\!7FLVFL>#=,U;P#_ ,+#U27Q'?\
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M_I110 4F!TZ<YX]<Y/YGKZTM% !28]>>HY]">GTX'Y<TM% !Z>W^!'/Y_G2
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M41XB;3EM?]):\&G&V%O^^:3RCNH [RBO+M)^./P5U_6_%?AG0OC!\+M:\1^
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M8W6G-H]S9PSV<,D=K<:4Y+Z;- K".6P8[K-U-N23'D@&Q1110 4444 %%%%
M!7Y5_P#!;"]\#6W_  3/_:+L_B5K5YH/@;7[KX,>&/%&HZ5966J:]%H/B#X^
M?"_3-:'AK2-3T3Q/INM>)AH]Q?R:!H^H^&?$NG:EJL=K::AX>UNQEN-,NOU4
MK\WO^"NOAK4_%G_!.C]IG1])^':?&"X&@>"M9N?@\=6T[19_B_HWAGXI>!O$
MOB'X3:?>ZH6@EU?XFZ#I.I>!]%TNWMM2U;7-6UZRT30M%US6]0T_1[X ^Y/B
M;\.] ^+/PQ^(/PG\42:C#X7^)G@+Q7\.O$4VCW$6GZO%H'C+P_?^&M5DTNZ>
MVN(;+44T_4[EK*Y:TFBMKH12-;2HAB/\XG@G]B#_ ((:?$K_ (;%^&/@WXP^
M)_$OQ#_8C^&?[(7[/?[4OCJ7Q_=WWQ#^#GPZ_8'M_!GB;X?^%]'UK7?",WAG
M3-$U+5_@?I5E\<8OAEHL>C^)/B!X&UK1;VWT+Q?I,\%M^\_[4_[0_AO]E;]E
M;XV_M,>)[22WT'X,_"/Q5\1I=+N-+UVY+SZ%H,][I&BWUAX8TK6]:M;>ZU46
M&EZC<V.EW8T>VFN-0NEBL[*XFB_S>;7]FG_@IG^Q$GBBZ^/OP?'Q$U;_ (+Z
M?L8_&?X/:/HG@7Q7J][\3=3_ &J?C%?7?QO\ C]H#PY\59? !\/?'?0M6\7Q
M>%O$44;WNA6?AO6O$D.@W>N^,M,UK3& /WV^,G_!+O\ X-^/%O[1'P6_X*,?
M&GX]_M!O>?MS^)OBY^V_\-[77/%.H:+\'O'?A_X-^!+[]J?XLWNNZ?I_P<L/
M%G@CP#X?^'VCWOB&]TWQ#XP\.^(KFRC&@Z3JTVLS6]HWW]^RQ_P5L_X(>?M$
M_M[ZK\3OV??VDK[4/VJOCS\$+;X7>(&\0>#?C-X(\$ZE\-?@%8>/OC*=4UR\
M^('@K0_!7A&[\(^'G\9ZCJ&NWNL:-!/I%J;:\2>YMX'K\C_^"9?Q_N/V^/VF
M?^"(W[/7P_\ V4_VAK3PO_P2S_9Z_:7TC]N'QQ\<_AQHO@CX;Z%=?%;]E3Q!
M^S?H_@RTT_6M<U27Q:?$?C]7T1/#]W:VGB75-)?6M2'@VX\/^%?'NI>%%^+W
M["_QC\,?LY_\',OACX ?!"7XD?$#Q!^TO\+==^%C_#KX>VGA75/%/PDU^T^'
MWC_]H7X2_#>^C%CJ%U!9_"+5/%O@GQMX2^&^KS:[XCM[NXT+PUI-SXD\0Z9H
M$P!^D/[,/[77_!!#]L*+]F+_ ()P?"+]IW6_B]=? ?XR1?%WX+>"OB1<?%K3
MCXZ^)'P\\2^*_%6EV$GC7XA>$M"T#QOI%MJ^OZMJ7A+X?Z%J5KH%QH5AH^C>
M$M#'A32K#2$R=$^ '_!M)^W!^W;X.\06/P7^'OCK]L#XVZ-XP_:,\-VUWIG[
M1?P_\'^/++X%?%SXC? OQKXJU#P*^I>%?@;JE]:_$WX$_$*W\1:'K'AF6[\>
M?V!?^-]9TOQ%IVO#7=4_-3X%?M(_L8_\%<OC?_P3'^''[ '_  35\??!KXH_
ML#_$[X=?%WX\^+YO!O@3P'X4_9M^'/PY\)%KSX3Z;\2;?Q1%-\5X?%GQ(T;P
M_P"%=%TWQ[X6\.>*O%UII=QXJA7P1JH\0ZGHOY1P:?\ &'X4>%? '[;7AOX2
M:T_Q[_9 _8U\9?$/2/#VL>$?B)>VEI!\3O\ @ME_P4L^'?Q?\#7>G>"M(\;Z
M9;2:W\/?B)=6LNI^(]8CT+0]&DFUBS\8M='3)-4 /Z+?VC]/_P"#9S]H7P1^
MT3_P4!^._P %KOXI^'/"_P"V=X$_9W^)?QK^V?M(6NIZ[\<[31/"WABTTKP1
M::/X^T/4D^$_@?PUKHGU?0O#NFZ-\.;^U\'W^I:#X;\3:C8^&9-1^G?VO? _
M_!##P!_P40\:_$7X]_LB:7XA_;2_9K_9/\:_\%"-8\:>%_"VMW/AW4_ 'P)T
MG5-2U'4]?\(>'O&NE_#KQ;\5]#TKP_;7_A)OBKX)=[B2#PW)HWB3[=INGK8_
MS2>&_P!@OXQ>(O\ @B5\=_V%/@KX6\:^+/B%XT_X+8?![P3\/9M7\&^)],DG
MMO%/P.^'&L7?C/7K?2=&U6^TSP'X+BOM5U'Q?XPM+"\TO0/#_AO5]:O3%'87
M4<70?LI?LQ_\%7/&WBS]H_XS?M2_ WXJVWQ-_:P_X(P_M[_LW:?\.Y/A9XXL
M?B%H^F_ KX!^$_@I\ ?#OB[P9J_@73-;\/>-?BCKMM)+X.N[[Q5XEU;XN7]S
M?75E#:3AK8@']A'[9W[2_P#P3:^.'PF^&_PQ_:A\!0?M#_"3]H']F#XC?MV_
M"CPSJGP^O=:T?QW\,?V=_!?ACXR:GJVD?VE+H=[X=\:-X1\2:1JN@:5K,OAV
M35K6YU'0M2O(%GOM.N/D3X5>./\ @A[\+OV9_P!DCX"?!S]G?PSIO[+_ .W?
M\-?C-^UGX,MO!GA<:]IS_P##$?A'P=\;_'.L_'+QC:^+]2^(5_\ %'X>F?2M
M*TJ#4-7\9:Q9>)_#%_X0FO;&VL+>WG_+SX7VG[4_[:O@+X$V6D?L)?M7_ 2[
M_P"":_\ P1A_:K_98^,5E^T)\.[[P+XE^(OQ]^,_[*/ASX9_#GP#\ O 307'
MC?XGR:ZWP^B\3KJ8T/0A;:9XDTG2]2L-.U^[TC3M;^0_V;?^"9?[>W[*O[0'
M[.'P53X0_&SXA_LG:=_P3P_;H_:#^%.L'X7_ !!U'6O@?\;?VT?V&M%\ _%S
M]F/XGZ])H$.@>&_'R?&GX364OA#X=6%P+W5)_'%OK$5E%KWB36]$T0 _IA_8
M9_X+^_LC?\% OCQX$^ OP/\ @Q^V+I-_\1M-\:ZMX7^)/Q%^!]MX:^$%QIW@
MC0-2\17US-XTL_&6M1V\6I66E2VVC,;!DGU2YL=,N6L[R\BB/O7[8O[7/_!/
M_P#8P_:3^"'@+]H#X>>&X/BY_P %);^#]G*\\<V_@?P%J,'B?POX>B;1] \.
M?'?6]:U33=;O?AO-?>.KCPMX?L)].\4:<U_XAU&Q_LZ"UGOY1_.9_P &Z/PX
M^,/[-WQ+^!_A/XW_  2_X+G3?$K5OAEKOP\A\,?&S]GW4/A#_P $^_V<[2\M
MK/5?%VK'Q)XS^)VAPZ]I]YI7@;P5I_AF&]\(+XG&NVY@T#P;J.LWYEL_0O\
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M#;PQ6]O%'!;P1I#!!#&L4,,,2A(HHHD"I''&BJB1HH5% 50  *DHHH ****
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M3Q5X&O?#GAC5-?ADEU>TO]#\6^+-9BL&N/#U[KFG^(P#^@[_ ())_M%?%/\
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M^)=WHOQ@T+XU_%GX1:;\/M/T?PGX*U2/1-8C\.?#?Q!XO\-_$""325LXGOM
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MA?$7Q)IGP\O-'U;X@WVI^(M5\+MX6M].M_#-^U_<Z?/HMM9_V?(;=5 _<V@
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M5_'?BK3FT+PSJFJ+?>&O \5O=2^,O$%H;47&C>%(K6XD\0ZE';:0D$S78C8
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M_%[QSXZO?%<]Q=?#/X?>&M0M?-AOO#NFWO@[5OB\[>&O[(LX?B'H_B']A/\
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MS:?M6_ WX_?L_P#Q>^%'PQ_X36R\-6'P6^'7Q^^&MS)XO\,?$$Z;:7&J>-]
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MM1CNFMG /D;_ (*V_':?]FS_ ()L_MD?&'3OB%=?"SQ'X9^!GC2#P9XXL?M
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M'[2?_!4G]G27]EZVU&V_X)E_LXS?&2#Q++XZM]'U/XYZAKFE^!=4\7?#_0_
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M9\8:7I7Q%MK74/%.@::N@W^A:79W'V6]\:ZC FF:IJGW?^V)_P &X'QJ^/\
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M'?!6B:O9ZEJ/BWPU8:4NL6'A#0=8OK2+1)KJWUUM5:WU,Z7<6>FV'/?M:?\
M!N_^T+^U'\3;7QK<_P#!3_Q[H.A?%#X _!7X&_M>Z'KGP5T+QOJGQQ'PVTZ]
MTSQ7XI\-:MJ_C.'3_A]/XH.MZ[KGA[3/["U^+P?KUQILXN]8M]*LHH0#^B+]
ME?XLZA\>/V9_V?OC3K5Y\/[[Q!\4_@U\-O'?BB7X4>)[7QI\-(O%OB7PCI.J
M>++'P'XLLK[4K?Q#X5TSQ'<ZIINBZLFH7C7EC:PRRW$DS2,?>Z\@^ /P,^&O
M[,GP4^%?[/?P=T"'PQ\+_@UX$\.?#WP1HJ%9;BWT+PUIEOIMK<ZG>+'%)JNN
MZHT$NJ^(=<NE;4->UV]U#6=1EGO[ZYFD]?H **** "OG_2M+^'Q_:=\9ZW96
M$.G_ !//P8\$:/XAO9OAOI^GWGB;P9#XO\7:AX::Q^+$NAQZQXFT[POJ]WXB
MM[SP19>([K2/"UYXCBU>^T>SO_$EI=W?T!6!_P )/H7_  E'_"&?VC'_ ,),
M-!'B@Z3Y5QYO]@G4&TH:AY_D_9/+_M &V,0N/M 8!S"(B'(!OGG]/T.?_P!?
MM1110 4444 %%%% !1110 4>G'_UN#S_ $_&BDYR3CL,>Y&>.WMW'X4 8GA^
M'Q+!83IXJU'0]3U,ZYXFFMKGP_HU_H=A'X;N/$FJW'@W3I[+4=>\0W$VN:1X
M0DT/2O$VLQW\%AXB\266J^(-*T+POI>IV?AG2=RO,?A=\/1\/;'QBDMQ;W.H
M>,_B;\0OB%J<MG=^)[BQ#>*?$EW<:+!;6_BGQ%XFN=-GL_"T&@V>MV>D7EAX
M8F\1P:QJGAOP[X9TC4;;0;#LM)\2:)KMWXAL=)U".\N_"FMKX=\00I',ATS6
MFT?2-?6PD::*-)9&TC7=)O?,MVFAV7J1^;YZ311@&Y1110 4444 %%%% !_G
M_/Z_YZ?F7^PC\5?B1\1/VC?^"H?ASQM#'<>&_A)^V)H'@+X:Z^US?"ZOO"LG
M[//PA\476ARZ6^HRZ19P>%]>\0ZE:VE]I&D:.^K1W;RZTVL:Q;W>K7'Z:5^=
M/[%/P+\>_"SX_P#_  4D^(/B2"ZM/!OQ_P#VK]$\??#JWUKPS9^']?DLM"^
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MAFRU2>&_L=.U*'Q;KEI<64UL)8'^D_CU\,/V6_\ @IW\</\ @IMXX_X*%_\
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MS+8? K]FGXE?LX:-^UQ\2[*V_P"":O\ P4Z_8?\ #7C/X._LHV/[/>I?#_\
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M+IH]%A-S\:5^'GAT?%.<P^&[6P\.Q&;QS_;LACT"QLM%0MMTNUM[%;>%/?:
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M:YXOL?'/PZ^&EGX>NK3XI7Z:IHVM^(/#7P\:YU?6;".:!;67A/A-_P '9?\
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M);>*]7_X27P=X2M?[3OO[+N+&TTV]N-/,%_J(N+0 _7_ /X) _MD?%C]N_\
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MX(^)_AO3?'T9TO5;GQG!#XV^(6@KXK^+D&F:EHOAV_\ "?B'1M+^(<6N8?\
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M6D7FA64FFVL^O^+;/Q5=Q2[-<NI9/";:9<:99P:A'>'@_B__ ,%S?B#\(O\
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M\0?!KPVDWC>"^N[O6;/XM?&+3H;K3O$43ZC:2^!8K_Q'HD#/ILVCGTOXZ?\
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M35?@QJ<_PD\3ZO<VFMZUX_.OZ*OC+0;2#2K*+4KJY\6I%=7?A?\ LR;^@?\
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MB^T\+VWB8>*]7G^&7B6>_OM<D\)V5]JKZ*OAZRU"^O=5FO+&=;I(X. \4_\
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M9Z\ >(O#_ANPT[5_"/P/AUG3?$47PLT*]@C6:Q\%1Z[I&F:LFAQ,+1;^R@N
MGF*2?>: "BL72W\0O?>(AK5MHT&G1:S%'X3DTJ^O;N\O/#QT#0I)[KQ'!=Z=
M90:;K2^*'\26D-CIEQJUB^@6VAZB^H)J-_?Z9INU]: "BBB@ HHHH ****
MY_0_GVKX@^ 6D6UE^V'^WUJD7B'0]3N-:US]FI[K0M/?4VUGPT=/^"%G:0Q^
M($NM-M=/1]6C']H:9_95_JBM8D&]:SN<VP^WSGL,_P"?\BO"?A[I/A*R^,W[
M0FJ:+X=\1Z7XHUF_^&+^,]>U7P/H?A_P_P")IK#P)!::!)X7\9:?H>GZSX_C
MTC2%33M9FU_6?$#^&=14Z)ICZ99*+( 'NP.1GUYHHHH **** "BBB@ HHHH
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MP>UO0-#^*?BGQY#X>TZVUW1EE\/:1J]_KWBRU2\\*:?-HVLZ=:?)'C_XA_\
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MP[XA^(_Q TE_!?A/P3JWAZW\&^$M4\,P:OXET&]O;>V\.^)M%DH _P! )/\
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M5]X3O+G4=/\ %6IZOX6TK6+N'Q=8V5C?:SH<?_",Z/JD0!G?M^?\%&/V;?\
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MO]LK]DOPWX]\/?"SQ!^TI\#]&^)/BW5[WP_X7\":C\3?"-IXL\0Z[IOBG5O
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MG\1]:BTRQTS3VO)B]]>:=9_RN_%OXE?$74?^"X/[1/P3^%/P \,_$SXGP_\
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MOQ!=3Z5;?&?QWXZ\:^,O$EKKGQ!L[;Q+>W>E6&GV$TMCI6A:<UD ?Z)E%%%
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M+9P6>LI;6.GW%Q?3V-K'!_+)^V/^S!%KOQ _8O\ $/[1/[*__!2?Q!:>$/\
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M]7^'?C<^'++PRVF_L_QZ/X2M]!\3LEOJVHRW?Q3ET/3X%TBP>35+#3M7N?\
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M4CQKXFT'0M7\5:S!JWB@:)I/AS^UYKCQ;K_B&^BF.C:'IEHT-M=0VKM;O=-
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MW@?PE<?L8^!]-LO 'B@^)-'U+1-5\2Z7XAU*VD\;WWCJY\)^*]=AU<ZAXO\
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M7P;K^C>&[+5?#&DW]KXAU^VO=-T2[L;.ZM]<UB&>&2/4[U9_H*B@#RB#X#?
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M_P 4[/P#XHLM4TO1_"R0W=IH,O@C1?'DP^URZ[X1\,VJ:7<:Q):?\'2WP_\
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ML^#M%ETG3+/QYX:\2:KJFE> /&'C70O$(@\-:3X@O;KPZU[?+<^(/"'X]_\
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M_P (S;_%BZ2Y\036<ZZA=VKW\D[Z<EE;P?(7PI_X(=>)_P!FCQY\.X_VG/\
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M?AQIGA30P#]1_P!E7_@AAX@_8I^+_P"SS=_\%#_^"Q4WQ$_9P^!'BK0_B?\
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M*_NIO'6E>%+"[T'PW>6G@73]2CT?2X-'C\.Z)+I?@\V?AS3_ .BJB@#\+/\
M@HK_ ,$%/V6OVZO@EX=_9^^']]I'[%?PTB^,4WQS^(NA?LW?!CX4>'[?XM_$
M:#PQ?^%/#GB7QD(]#TZ235_#&EZUXB@L=1AE:6YM_$&H6]\DZBU>W_/O1_\
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MUH5E>6T.H#1K.?5=*BU[Q1)JUU>Z1?Q0W-D-0M#J=S^]-8?AOQ)HOB_0]/\
M$GAV^&I:+JL3SZ??+!<VPN(DFD@9Q!>0V]S'B6&1,30QL=NX J5) -RBBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
HB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>ex10-2_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex10-2_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" /. NX# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBJ6I:EIVC:=?ZOJ]_9:5I.E65UJ6J:IJ5U!8Z
M=ING6,$EU>W]_>W4D5M9V5G;12W%U=7$L<%O!')++(D:,P +M%<9HOQ'^'GB
M7Q;XP\ >'/'O@O7_ !W\/8_#\OC_ ,%:+XIT/5?%O@>+Q;IO]L^%9/&'ANQO
MI]9\,Q^)M(_XFOA]]:LK)=9TW_3M.-S:_O:[.@ HK,UO6]&\-:-J_B/Q'J^F
M:!X>T#3+_6]=UW6[^UTK1M$T;2K66^U35]7U2^E@L=-TS3;&">\O[^\GAM;.
MUAEN+B6.&-W7,\&^-?!OQ%\,:-XW^'WBSPSX[\%^([-=1\.^+_!NO:5XG\+Z
M]8-))$M[HNOZ)=WVE:I:&6*2,7-C=SP&2-T#ED8  Z:BBC_/Y=: "BO//'_Q
M=^%'PHT?6O$7Q2^)WP]^&OA_PYIEEK7B'7?B!XT\-^#=&T+1]3U9-!T[5M9U
M/Q'J>FV6EZ9J&N2Q:-8W]]-!:7>JRQZ=;S27;K">_AFBN(HIX)8YX)XTFAFA
M=9(IHI%#QRQ2(622.1&#HZ,5=2&4D$&@"2BC.?U'Y'%% !1110 4444 %%%%
M !1110 4444 %%%% !11UHH **0D]@3^0['U]QC\0>E+0 45GV6KZ5J,EU#I
MVIZ??S61@6\BLKVVNI;1KF/SK874<$DCVYN(OWL(E"&6/]XFY>:9I6M:/KEN
M]WHNJZ;J]K'<36<MSI=]:ZA;Q7EL0MS:23VDLT27-NQ"SPLPDB8@.JD@4 :=
M%)G\N>?<'&/Y_E3(I8ID\R*2.5-TB%HW611)%(T4L>Y"5WQ2H\4BYRDB,C ,
MI  )**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHK\D?VI/^"YW
M_!+O]CGXS>'?@%\<_P!J7PIHWQ.UGQ'+X8US1?#FG:YXUMOAIJ$&H6^EW$GQ
M7U7PMI^IZ?\ #ZWMKV=H[K^WY[>ZM8[34+JXM8K6QN9XP#];J*X70?B?\.O%
M'AKP7XQ\/^./"NJ^%_B/IVE:MX!URUUW3CIWC'3]<M[2YTBY\.3O<(NK+J$-
M]9M;)9^;*YNH$V"215.[J?BCPUHHNVUGQ%H6DC3X[2:_.IZOI]@+**_>:.QE
MNS=7$0MH[R2WN([1YMBW#P3+"7:)PH!NT5R%S\0O -G):17GCCPA:RW]G9:A
M8QW/B718)+VPU)=^G7UHDMZC7%G?K\UE<PAX;I?F@>0<U\S?#G_@H#^R'\6/
MVC?CK^RAX#^-?A?6OCG^S9X>T[Q-\9O"!:[T]/!NG7OB'4O"]Y'=:OJ5O::3
M=7GAS6++3X/%%M9W<YT%/%'A*2^9%\06.\ ^R**Y6P\<^"M4AU*XTWQAX5U&
M#1[-]1U>>P\0Z3=PZ7IT:RN]_J4MO=R)8V:1P3.]U<M% JPRL9 L;$=!97UG
MJ5I;W^G7=K?V-Y$EQ:7ME<0W5I=6\@W13V]S \D,\,BD,DD3LC*002* +5%%
M% !7Q=^WK^WO^SM_P3E_9[\3?M%?M'>*1HWAO2?^)=X7\+Z:;>Z\:?$CQ?<Q
M.VE>"O VBRS0R:KK>H.A>5RT=CI-@ESJNJW-K86LLP^T:_EY_P"#GG2/BWX=
M^&O_  3W_:;^&WP)\9_'W0?V.OVX_ G[17Q/\)^"[">^N4\&> +=/$ERFK2V
MNF:Y/I&C:Q_8DVD7>NR:)JEAI7VI)]0M9+?]W( ?3O\ P38_X.'/V(O^"DOB
M#XU>%O"UEXV^ NM? _X='XL^)8_CE)X7\/V-]\.]/<Q^*?$UAJ>GZY?VD=IX
M0,NGSZY'>/!+%8ZC#J$2R6L5S)%]\?#K_@J!_P $^_BS\!OBM^T]\//VM/@[
MXF^ WP.N)+3XM_$>U\1-:Z1X"NA;6US:6^OV>I6MEK5O-K*7=O#X:CBTR9O%
M-])_9OAP:IJ"/:K_  1_\%&?VZ?VAOVXO W_  4 _::_8V_X)2:/\/?V6/C_
M . ?@-\ _B=^U)\3OA5\0O#_ .UEXEM8M3\&:7%X;TNU\(?&[7?AEX@M-.\?
M^ X= AD\'^!M6CL/">DZ,/'$BZK-#;VOXT> ?V5/VA?"G['?[;_P]TSX ?M.
MSR?$?XQ_LJZ#\-X?$7P%\;^'-9\87WP_\=?%KP_XJT^\T?26\4Z/8:QH/B'Q
M%H^D7.ECQ%JICU&_MH8+AII&1 #_ %<K[_@J!_P3[TW]F^[_ &O+O]K+X/I^
MS99>)-+\&R?%R+Q!)=>&9O&&LK;R6'A/3UM;2;5-4\3M!<"[NO#^F:?=ZMIU
MC;ZA?:C9VMGI>I3VOU]\/?B/\/\ XM^#M"^(GPM\;>%/B-X"\3VK7OAWQEX(
MU_2_%'AC6K5)I;:6;3-;T6ZO-.O%AN8)[6X$-P[6]W#-:SK'<0RQI_BC>/\
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MG1/"WAKPQ+X0T;2M=M])TC4(= \(Z?I5[,]E=VU_#>ZU<7%HU_JUU=MU%_\
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M4-/L+/2K"RTS3[>.TL-.M+:PL;6+(BMK.SA2WMK>,,21'##&D:9).U1DD\T
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M8 _>FBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HYS[<_7/&/ZY_"BB@
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M#FG^,K+Q3K>EW,^L6=NWA9M"@T[P]J]K/KL&I#1=.UC_ $\*,#T]?UZ_GWH
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M CTZTL/Z(,<Y]B/SQ_A10!_.?^TW_P &V_[(?[4?[</PI_:^\>Z^]_H7AWX
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MM*O-^J:;BR.IZWI.I2[(]5<R:=$%TN7)NK3^%+]MSXF_L6_LT:Q_P22^*/\
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M U'PSX@^(>C32>)-'\$^ ;CQ!XNDL9[S0; :_P"']*TS6=7UV;4-,TZE9_\
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M<:?KWAW6K5+JPOH8;N"UO+25D<QW=A?VMKJ.GWD<]C?VMM=VTUO$ >E4444
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MU/71XA\<6_QH\-Z=KFGZCJ\>KZ)JR>+M5U^]MY9K+3A::G^PNK_L _M!:_\
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M3T\:+)XN^&EG8Z>/ &J:-;:_!X>_X0Z]MVUKPY:Z3;Z1K]WJ&N6FHW]S]7T
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MLEW<QQ17%TD$:W-Q%;F7[/%/.%$LL< ED\E'9EC,DFP+O;(!_%1_P<O^ _\
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M0T[Q'\8-5\.:E'8R0:=K)T1;'1M+DAU/3-12\U>.Y65M,MM4*_A(_P#P4_\
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MQET?7W\)>&=:MYOC1K/C_5_"=O-K>IV&IWNF^$?%^OQ1ZCX?\2:+=O6\9_\
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MRCP[;:/H.N>&/$.J7<_AKQ7'K&C>O?&C_@Z#_9+^!'Q<_9)^&/Q%_9>_;/\
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MW)JFD?"2;Q%^QO\ L_?MJ:AXA_9D^,6D>+--T+XQZE\"/$?[+_[07Q7^,OQ
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M=NV(NHD(83%"$)#$.MO,R87D0S$$B-RK]PW%<C< I(R,@,6 )'4 E6P3P2"
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M:/S%CN]4L;:1HB[)YBI-.C%"\;)O V[D9<Y4@;5 ',>"O!?A+X;^#?"7P[\
M>'-%\&^ _ 7AC0?!?@KPAX<T^VTGP]X5\)>%M*M-#\-^'-!TJSCBM-,T70M&
ML+/2]+T^UBCMK.QMH+:"-(HD4=/110 4444 %%%% "$9_,'IGH0?_P!1['FL
MZ\T?2=0N]-O[_2].O;_1IIKC1[Z\L;:ZN])N+F!K:XGTVXFB>:QFGMV:":2U
M>)Y86:)V9"5K2HH 3!XYZ=<]3Q_//-+_ )_SZ?A110 4444 %%%% !00#P>G
M^?T]1T/0\444 )CMD]1CUP,<$G.<X.3UP?QI?\_Y_P \=J** "C_ #_G_//>
MBB@ [_GQV[?X?J:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I",
M@CU!'(R/R[_2EHH **/ZT4 %%'IQU/Y<$Y_3'XT<Y]OUSSG^GZT %%)GIUY)
M'3TS^G'![\>M+WZ>O/Y<?C_2@ HHHH **** "BBB@ HHHH **PM;\4>&_#7]
MG?\ "1:_HF@G6-1M-'T@:SJMAI9U35]0N8+*PTK3A>SP&]U&^N[FWM;6SMO-
MN)[B:**.-GD137T_QGX0U;Q-XB\%Z7XH\/:EXP\(VFAW_BOPM8ZSI]WXA\-6
M/B9+Z3P[=Z]HT%Q)J&D6VNQZ9J,FCS7]O!'J,=C=O:-,L$A4 Z6BD)QD]O3'
M.?\ Z_&/Y^D-S<V]G;3WEY<06MI:02W-U=7,J06UM;P1M+/<3S2LL<,$,:-)
M++(ZI'&K.[!5)H GHKR#6OV@_@/X;\,^#/&GB'XS_"S0O"'Q%FM[?P!XHUCQ
M[X7TWP_XUFNX#<VT?A76+S4X;#7FGMP9XQID]SNBPX.UE)[/QGX\\$?#GPOJ
M'C?X@>+_  UX(\&Z3]@.J^*_%FMZ;X?\.:<-5U"STG3#?:UJES:Z=:C4-4U&
MPTZR,UP@NKZ]M;6$O-/$C '645X-J_[4W[-&@>$_#_CO6_V@O@MI'@KQ:^IQ
M>%?%NI?$[P99>'/$DNC%5U>/0]9GUF.PU632W94U%+&>=[-F1;@1LZ@]%J7Q
MW^"6C^-O#WPUU7XO?#/3/B'XNL],U#PKX'O_ !QX:M/%GB6PUHW@T>]T'P_/
MJ<>J:M:ZL=.OUTRXL+:>*^:TN%MFE:%P #U>BO#?!O[37[/7Q#^+?Q ^ G@;
MXS_#CQ5\:_A5;6][\1_A9HGBO2;_ ,=>"[2YN6M(;GQ!X;AN6U/3X#<A87DE
MMPD,DUL)C']JMO-]RH **** "BBB@ HHHH **** "BBB@ KD-2T+7;OQMX5\
M0VGB'['X>T71?%>GZUX:\G4G_MW4-;F\.2:+J7GPZU;:7#_8*:3JL82^T+5;
MJ;^V";"^TI8[M-1Z^C^M 'Y!?\%Q/VS?B'^Q1^P)XY\9_!3Q'X.\*?'GXK>+
M_ ?P ^#'B3QIXW\)>!-+\)^-/BWXBM?#"^.WU7QJC>'OLW@73;F]\1ZE<ZI+
M8Z5H>GV<_B/6-3T_2])NIQ_,3\3?^#EO]HKX6_LH?\$3OVD;#Q#HOB6SUKXA
M_M-?!_\ X*%^$M+M/"_C'4_B1KW[-MI\#/"$^H6]_8^)KF^T+6O$/@KXKWGQ
MBTO3KO5_#(U?7M<\+Z^]A_PAZ:++J']8/[?/_!-?X1_\%#_'_P"S#_PTEK1\
M4?L\_ WQ1XX\8>)?V=[Z+['X;^+_ (Y\0>%V\->"-1U[7]/NM/\ $,$/@IKK
M5KR'1=/OXK;6);[9=JRPA7_,OX9?\&TO['OP8_X*!>#_ -J3P+X_U33/@EX/
M\9>/O'GA?]AO4($U7X/^'M7\:_!_PC\/=0N-$L]:UG4;B9-4U/PU?^(_%PU&
MPO!XCTFW\*^&KQQI?A2W,X!^._[7W[97_!2WXQ?L??MZ?M]_L3?\%*=8L?@E
M^R+^W[X_\,6>EP6/A]K_ .('[/OQA\!_L@1_"#P]X+U;PCX8O]!.L?"KQEX]
MUZTO/#NIZ98&^'BCQ%=7/B:WUC14T;6_T^\!?M9?M _\$H_CK\!_ O\ P4>_
M;O\ B+\;OA#J/["GQZ_:G_:/^*'Q)^$ T*RT;Q=:_%?X&^"?AIX%^'N@>&[3
MQ'XWFU7PGJGQ#N/!NH:=M.IZ]J/B+1+R_P!)T<7,6E:5Z[9_\$I/^";7[+W_
M  3L_;R_9!\6?MC^$/A#^R!^U%^U/:^./$/CKQ#\4_A5\/[7X%^-K'5_A*\?
MP;TWQOXEU:'PO:ZAI_BSX+QZ9INBZ[Y7B"TL[FYT.:UN+_3VN7^O;#2O^"7O
M[:O[5?PW^)T'[6_[)7[8.N> /V=M>_9ATOX-1?&CX#_'2V\7)\0_%6@_$74]
M8\;^$--U[Q!:>+_$&L#X.V>K:78W>@!(;OPMK?B#3H UC<M9 'XS>.OVE?VK
MO^"V_P"TM^V=)_P31_X*W^#OV/?@?^P=:_#^Q^#UAI7@:]L-'_:-OO%7@74-
M6^(_Q8^)GC+7/$^E^*_#_P /_!_C/3M4\$:)XHM/ACXO\&7'AZ*S\2:7I<[Z
MC_:>N>7^)_V@?^"D/_!23]H3]H/P]^Q__P %9_@U\ M/_8R_X)[_ +*OC[Q'
MXC_9^\06_P 8_P!F#]H_XY^*?!7BSQ;\6/$L/C'5K31?%7P.TJR\4Q:AX3O[
M/5_#_P 4_$VDZ'X9T2_\3:/8:W>ZGX;TC[Q_X*-?\$"O^"1/[:WQ>^(7QFUO
MXY:#^R?XI_9^^&?@SP5^T;HWP7^(7PG\%^"_AQX3LO!^FM\*=1^*W@S61+H/
MP:M[/X:Z=86_AY;RR\*:#K_@RPTB_6PN8+'^T+CP?XS?\&^W_!$O]L*V/[7W
MP\_;1TWPI^R_\(/A[X'^%'BB_P#@3^T+\'M5_9C\ Z-\&]!T^W\06L_CQ+W7
M?#7P[EUK3=0LO%GQ%M[GQ' ]UXW\5>(OB9KCR^)?'FKZE?@'Y-?M8?MH_P#!
M;;4_V//V5_\ @K!X3_:M^,8^&NO>%O UZGPZ_9Y^#^@>*?A%\._B-\/;W7/A
MM\4/&O[3EU<:SI=[X$^%WQ'\/W>M>(/!&O/X<^,'A7Q/XLDO_#OBY_A+<0_#
MF]UC]P_^#EG_ (*;^(/V4_V._@-\$/A=\:]2^"?[1'[7NN>%X;SXA>$[O58=
M6^&7P9C@L;3XF^.[S2_#FB>(/%4NBW4NO0Z-91^&8(_$LDT=[)X;>[U734M)
M:WC+_@CM_P $/?VIK[PI^TG\/?VQ_!S_ +,/[+7PA^&OP3^.WA;X+_M6?##4
M/V;O$GPH^"NKZ-\0O#WA?]HKQ=X9\0SZ;HFEG4-+\+>*_%CZKK^BOJE]I.B^
M+II;378;37(_U_\ #O[.7[&7[9?[2/P7_P""@OPY^,_A']HKP[\#OA3XP^ ?
MPVT3X9_$/P'\6?V=K/4K[Q3HWB'6_$,I\/3^)M%N_B!X=N-'T&VMC#JD-SHM
MQIFBZA<1'4=,TJ:U /X\M/\ ^"['[>!^)O\ P29_:3^&_BCQA^T!\.]%_8HU
M_P#X>'?"/X=:1<>,-/EN/@Y\3=3T+]I/QMX@\*_:=)N+#XV^%OA7IW@#XQ7X
M>]L/[%7Q+IFIPB#X=^)&>Z]C^/=_\2_VIO\ @A-\//V_/AM^V9^U7\-_$OP\
M_:V_;#T[X;:GX7^('C7P_;_$'P!^TA^WFOA/P?)\6-+T?PYXNUK4&^&W@_0M
M)M? .@7WB+P%X;\-#5]6T>^\;:/82V\,W[*_#3]B_P#X(V_ 7]KCXT67C[]N
MGX+>+OC[\8?C;^V-?^)_V<_B'^T[\$O"_B>Q\4_\% U\-Z7\4/A0WPQTGQ'H
M7CB2YO?#]KI_AOPAI$MK!XF%MJZ7,1N=0N+:X//_ !%^&'_!$_\ 8;_8OU3_
M ((U_'S]M32_ OAGPUXIM?BCI?@CQ#\3[JU^.7AR?XF_&+Q3\;/AI81:;X*L
MFU+Q3'H^KV*6\'A_4]%UF?4?#I\*:CXQTJ1?&WA>_P!: /P?_P""CGB7]LO_
M ()?:O\ M3_LN>"_V]/VB_BDO@[_ (([^'_'?_"R?%'B+4=,\1ZAXA^(G_!2
MKX.>"Y]<-J=9UM-+\2Z3\//BCXU^'6E>*].O;?6H?#FK>3#<0744<J_%O[-W
M[4/_  4<^$?C:#_@G;^T+^U?^TW^S%XA_P""C_Q-_8]TGP5XH^+7Q'T3XH>+
MOA-^SG\17UQO&7Q-T3XGSWFB^'_#>L?%".^\-^&O#VG:)=Z+XC2VLM1T_7]-
MTZ5[6[UC^V#_ (*!_L#_ +!?[7/Q3\1? [XZ_'?5?AS\;_\ @H'^SGX ^!N@
M^"-'\6Z)IWBSXE?#;]CCXX:)^U7=WWP[T;6-/O"VNZ9=R31^+7MO,>\\&2WU
M];:>7\.7E_9?F%XD_8E_X-F/^"?/[,7QY^&_QO\ 'NF#X5_M._%/Q/\ !GQ?
MXI^(&L?$[XF>.O#/Q(_9\N?[8E^'_@?4_!GA#6?$'PX\2_"1O$UK=6U_!IUG
MJFI)K4,-YJ6N:5K"Z?< 'Y3?M<7'Q:_8=^+'[1W[&/PI_P""O'Q3_:'_ &;?
MB]\._P!DCXKZAX]UCXR6>N?&C]EY/%'[0WPP\$:GJ?B3XQ:7%:>!M!M/$_P\
M\7:OX]T;4-%U#1-.U/P1+I][XY\':=I>F^'/%OC?I/VD+[XL_L<ZO_P4D_8\
M_9^_X*J?'']L_P"#J_L ?#7]O;0?$C>*;GX@?%+]GGXE^%?VF_V<O#O@W1KG
MXO\ PW^(&D::^F_$;X6>)=0\7^)KS38= T";X::SX4UWQ-\*_%>CVFF7_B_]
M.?B?^RQ_P;/?\$^_V7-8_9B^*?QJ'P^^"W_!0GPU\._COIFOP^-?B;\1=<^*
MOP\\"W5CJ_@/Q#X.^)GP^\'>+)+7P)=76J6NKZ38F_CT_7FN'U'3(+@0S3P>
MZM^QO_P;M?\ !/[_ ()TS:[XUFTCPK^Q3^WKKGP.U4_%;QCKGQI\5ZM\9[S2
M/[:^//P#M4U#PYIESXLTK3-$M-,UOQ3H=D^@Z)9M9PSV7B@7DCQ6K 'XD6OB
M3]J/QW_P7<^,6O0V7B#XJ?#[X=?M7_L2>$+'QWXX_;LU#X"^#/V:-%GUCX8W
M/BV?4_A)#\7? =[\5M$^(^@?$3Q#X*\'^')].NM.\2_$WQ7I?@O0(_%^N>)=
M2^'?B;YC^!'[7'[3J?\ !6?X"_&3XS_M!?'R>3X\_P#!7WQ'\"-4N_AS^U'X
M)T[4=.^'?A[XF:Q\*/"7P!\=_L#:SKGB'Q/\)/ NH^)-5T6'7?$OBOQ)XA@A
M^%*ZYH/A*;4/&D-AXCU;]HO"WA+_ (-9_P!N+_@I9\,/B=X2^)4O[1'[6GQR
M^+$&L^'? $MO\:Y/A)K7B[P3X#U+6-)MO%OA+Q5X%T+P?_PC$&G>#[9+31-4
MO;C2]7URWTC2=4LKW3;Z[LY_H7QWKG_!NY_P2:^,?QL_;Q;X*VO@;XV^!?VC
M[_\ 9PUNV\'^ _%?B;4/ ?QJU'P+:_$'Q/+\)O FH7\/@WPK;:[X&\;V6M:E
MXET%[*VM],O?['\._P!EQ37NDW !\>_\':G[7?Q;M_&W['/["W[/>N^-=1\8
MZN?%7[5/CWP5\%O!>N?$;XJM=_"YT/P1&L>$].U/2[.Y^'FI^(=/\;Z]K4Q;
M4;W3$\#2:W-IMQ8V"V.J_ ?[:'_!8;XC_P##Q#_@GO\ \%$?@7-\3_B?\!+C
M_@C]X8\3?M.?#7PCJK:#=^'_  KXR^/'Q]^ W[1%Q9Z+-J=KX:T'Q_X+^+FF
M^%["R\0VMOJ6G0>+O!/@Z]N(];\,:3#"W] T7_!;W_@AI\,O!J?\%([NR\3>
M$_%W[<^K3_!S4_$NN? ?QL_Q:^*GASX!WNC^ ]9$\6I0WGAB;X9> +/7]#EU
MY_#'B%]-U+SHK*YT_6O&NAW^BZ5P]O\ M9?\&[_[!7[._P +?VY?A#<Z7XV^
M%7CSPO\ $?\ 8$\%ZS\'?#?C+Q]XDO=!U;XC>-?V@_BI\.]=\'^(1HFH_#Z[
M'B_XA>*_'NLQZO;>#=1U7P]\0-"ET>PU;PEJ'@:.V /YA_V,_!_[-G[>'QQ^
M!OA3_@HU^UQXW^"?PFM?^"2/BWQ3X.^+'BO]IG3OACK_ (>\?^$/VCH_#/@"
M6X\6^*[C2_#OQ&\7:'\/]9\4W%QHM_H-U-XL&CW>N7.A&VTJ6.T_M7_X-[_B
M!X^^(/\ P3:\&S>*_&'BOXK>!_"/Q?\ CGX _9Y^/'CJP\1:1XR_:$_9U\)_
M$/5;'X:?&'Q%HWBS6-8\0Z/>Z_&VJZ1!IFJG3;RTT[P_91SZ192;_,_+_P",
M^J?\&T6G_L ?L5_MT_&_]G_3D^ _@R>3X>_LK>"_$G@W5+7XS_$+1M#UKQ)H
M^H^$[[X=6GB*UN?B7X,\(WWB*]^(&N:AXKU'4-*MS8Z'J&HZS>ZAK.FZ)XC^
M_P#3_P#@X8_X)(?#S]B_X8_M*> /&U_!\&M2\>2? KPQ\&?AK\/=)LOBCX#\
M0>']'NM5/AZ\^"5AJNE77A_P]I?ARTLM4M[S1(KO0H](U71FM)B+IHH #]^Z
M*^+OV#/V\_@3_P %&_@-'^T;^SJOCE?AU+XR\2^!5'Q"\)R^#/$']M^%18'4
MV&D2WE^6L&74K5K6[2Y99BTL;I%-#+&OVC0 4444 %?%_P 0?^"AO[&?PG\2
M?M->%?B;\>_!7@;4_P!COP+\,?B/^T7)X@N+JVT_X<>%?C'+K%M\.)-0U"&V
MN+:_U[Q1>:,]EI_@W27OO&,EUK'A*(:"?^$V\('6_M"OX&_^"A'[!/[97Q._
MX*?_ /!9#]H'X8^%[KQ?\./@U%_P3I_:JNOV6O&]FP^!?[=WA;X7>"M--UX+
M\?\ B#2]9L(GA\ #X>?$;7=/\":I>V]YKVM6ME-=:9&A\/:G( ?V^? K]H/X
M3_M(?"3X>_''X2>)+C6?AO\ %3P[!XM\"ZMKOA[Q+X%U36_#MT]PMIJW_"*^
M.=(\.^*K"UO$M9KFS?4M&M/M=D([ZW$MG-#._HVI^,/"6B:-K7B+6?%/AS2/
M#_AK1]0\0^(M=U/6],L-&T#0-)M9K[5-<UK5+NZBLM*T?3;*WGO-0U.^G@LK
M.UAFN+F>.&-W7_)C_: \=?\ !0S]MK_@HOH7_!5+]F/]A#]OW7_A'J/B+X:^
M)?ATO@WX&_%GQYX;A\%>"_#.C^$_%O@?X?>+](^'?C3P%:^#KZTM/%?AW2K6
MQL-7T72]+U6:&\TJZ?[9;2^&^!/!E[#_ ,$U/V]_%_PA_9R_:Z\$?%/Q7\3?
MA/J_Q%U71(KR'X+?#?\ 8LUWQOXT_P"$;\%:G?7VL:7X^\:>%M5\?:/#HNL:
MY)X1U/PW+J?@VP.N:AI303PW !_K3>,_VJ/@UX"^/_P+_9H\1:_?Q?%3]HSP
MK\5_&?PML;+0]4U'0-5\/?!;3?#^K>/KW4O%-G!+H>AC3['Q-I,EE'J=W VJ
M/.T=EYDD;*>-^#G[=W[*WQS^)GQL^#'@7XO^$U^+/P ^,FK_  ,^(?PV\2ZK
MIWA7QU%XVTC2]#U5KG0/".MWEIXB\1>$M2378]/T#QAI>FSZ!X@U;2O$&G:1
M>7<^B7ZP_P":A\+?V,_^"D7Q(_8H_9E^$7PZ\%?M?^$?C7\-[/\ X*DR^/\
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M?AMH7_"X[6[MGU_X@>+?$'P\LKKP]K7BF33H[BYMX]/M[N*[MHV6  T?BO\
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M/Q<^(Z?!3X,Z)\4OBY\:? ?B_P +?"_Q,FD>%;+PC8:WK.J>(+7QIIOZF?\
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MO6= T]+C0K?6]5TBT;Q/<?U$_P#!1+]@+X3?\%(?V=9?V>OBQKGBWP7#I_Q
M\"_%/P'\2/A]J']D^/\ X:_$/P!JK7FC^+O!NI,3#9:V=(O->\.&ZGAN#;:;
MK]_<6:0:E#8WMK\\?"'_ ((P_LH?!G]C[P5^Q=X=U7XJ:E\-_#G[1GP[_:K\
M2^(=>\8-JGCCX@?&KP!XI\(>-_\ A(?$&MW-G((+'Q%XL\$Z'JFLZ78P11^1
M'<V5M+$EPT@ /YX_^"MGQ(_X*#:?\?\ _@HI_P %"/@/_P %!;W]G'PW_P $
MQ/BI\ ?V;OA]^S*/#UW>_#OXH:5\1_AE\&?B+XD\4^,]1UCQ[)X8DU[5=<^,
MNH6EY8S?"[5O[0T+PUIMC#J>GSV/VT_'?@CXY_\ !:_PG^US^WK^R_I/[4/Q
MN_:$U[]I+]C7XZ?$C]G[4]5^$<O@#X8_'3X[7WA'X/WGBW4_V(_$&IZSJ_@.
MQ\*_"7PCXEU.\\(>--/\9>&?#VL^&O#T"VW@O2_B#XN\)^'KG^G7]J'_ (-Y
M_P!@O]K+]O;P_P#M]?$W3?%5UXO:^\*ZS\4/A)+=6>K?"#XT:]X,TF'P_H.L
M^-O#VKVUW<P7">'=/T71]1L]&O+#2=2@T+3[BXL/MT^KW&I^>? G_@V0_P""
M:GP-\7?M*Z_!H_Q/\=:!^T1\,_%WPAM/!7BWQO<KHOP@\"_$%A+XWL/AK-H4
M&D7=EJ&KSV^EBPU746O+C0K+2XM.T]1;7>H"Z /Y(/\ @G-+_P %6O'7[<VG
M?\$:/VT/VIOVF?V6IOC<=0^)OQ6\3R?&#^T?CU:>&/!'P?\ %'C'P/X-^'OB
MC4M;\:>&=.L/$NM:;HNLZO:Z?&NIZAH]EJ\37D;!K:7^W3_@AA\8_C_\7?V%
M8M/_ &C_ !A<_%'QY\"/CS^T!^S#I_QGU"QGTS5?C/X3_9^^).K_  XT/XB:
MO8R0R0IJM^FBSZ/J5S;Z[XJDO[_1+F]U7Q%>Z[-JJ0_#OP__ .#4;_@F-X3_
M &?/$7P*\667Q$^(^JZ]\7?"_P 4D^.6LZKIFC_&S1++P\VG6MU\/=&\7Z'I
MUJ++P5K^@P:II&JV"V>?-UJ;78/+UK3]*O+3]Z_V7?V6O@5^QE\$O!_[/'[.
M'@2S^'/PF\#17BZ#X9L[W4M2VW>J7DNI:SJM[J&KW=]?WVJ:WJMQ=:IJEW/<
M$W%]=3RJD:N(U /H*BBB@ HHHH **** "BBB@#^/[_@[MG^)>F?"/_@GOXG^
M&,FJIXC\$_M4:_X_T6UL;V::+5O%7P\\ R?$#PYHL/A.R\):M?>*_$=]_P (
MMJ;>&+2+Q5H%I%>6]S;7>B^(?[1@U?P?_/A\-?\ @JQ^UMIOPQ_X+\_\%!?A
MAJOC'X)^-_VA6_X)^?\ "M_'VH_#B)/%V@R>+/BIX\\,^#K/09H+_6]!\,:1
MKGP6T;XV&S\7WOAO6O"]QJOA[2;;3OB/X6\<W'@[P_\ $#_3)\;?!_X7?$C7
M_ OBGQ[X"\+^+_$/PSN_%5[X#U;7])MM1N_#,OCGP;K7P]\9Q:>UPCK]B\4^
M"_$.L>'=>TZ=9M/U33[L+>6LLEM:20?/GC'_ ()Y?L.^._A_\2/A3XB_9:^#
M'_"M/B[\/?AQ\*?B'X%T+P9IOA#POXB\ ?"#Q'XB\7?"KP\VC^$4T.RTQ/AU
MXG\6^(-<\%ZAHT6G:MX=U+4/M&E7]L]K9?9@#^'_ . /_!9+_@I[KW[%O[)7
MCW3/C?JGQQ^+_P"VS9?M#?\ !-GP/%-INAZ'8_"+]K[Q%\5/A_8_LY?&[XA>
M/(=4T[P[HGC&7P=\2=8;3XO$6C"2:S\+:#K\UAJV@G59;/\ ?"VUW]O'_@H3
M^SO^V?\ \$]OVB/@]\>_V._A[^S5X=_X4AXW_P""@<OB?1)O''[<T7PQM7L_
M$GB7X8?#OQ!\//#UO\.M'_:#\-Z1I/Q-UOQKX>\3?%7PUX8T?Q=??#S3]8UO
M4+I]>M?T9\;_ /!)7]E+Q#X^_84\0^#/#=I\(_AK^P-\0-<^)WPR_9^^'OAS
MPQIWP:\5>-M1\,6_AW0_%?C?PM<:7<0ZIXS\'7=CIWB?P[XZ8MXRMO$EA%JK
MZX]W+<S3?IS=VEK?VMS8WUM;WME>V\UI>6=W#'<VMW:W,;0W%M<V\RO#/;SP
MN\4T,J/'+&[(ZLK$$ _RA?\ @H;\2]/\*? +_@F-X%UCP/\ "#XV2^/_ /@A
M%\*O#'@CX>?%RZ^*$>J_!+QOXA^-OQ5L8?C;\#]'\/:IHOA*]^-7CQ;.Q\/:
M)$C:_JM_:?#J6'Q3I4.D)X936/Z)_C!^V+\4_'G_  3R\)Z1_P %N?\ @FA\
M8/V7?V0/V2O!7P/^)>N:A:_M,^%4/[>?QP\%6MAX'^"?[*=[\![SP[9?$2\\
M/>/=?UF;XY>-]*N/'5XO@!O@G;:EX_OAHL=U%<?US^.OV7OV9_B@W@5_B7^S
MM\"_B(_PNLX].^&;^.OA)X \6M\.]/BDTJ6*Q\"MK_A_4#X1LXY="T26.VT
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M?A;=_#OQ7JUCJZ6E_I7A/^SE\1:IXI@N#J?C+3;K3QXC\4OV!_BU\(?V1?\
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M@U*TBM;>)_Q!T;_@V4\$_$CPMK?Q=_;?_P""B.I>._CMX(\+?#?X3_!7X_?
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M/B*PU;0;#4[U]4U#PUI4\_V2ZNWT/U/Q#_P1K\86GAO]I3]HG]NG_@JIX?\
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M$%_-\,'^+D&@(]K:QRZ'%8ZMK[Q?V-X5T^"Z< '[<+_P=)_"76/ VBP?#_\
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ME+/:SQ3LVGW_ (9U*[T^[M=0C\/>(M9BM92\YCD_.OP+_P $1?B)??LD?\%
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M^"GAO]HGQMXY\ >!?!7B'5_BMI#?8+SP]\,K[Q9J^FRZA(NMP^!M;L=,\/\
MB#]!/VS/^"''Q1_:7_:O^*7Q0^'/[9VK? K]F[]KGX7_  (^%7[=GP8\/_#?
M0-5\:_'/0?@#::IH?A>7PY\1-5:]3P1J-WX5O;?1CJ=EHYNM.:W:X3[<HMH+
M;%^$W_!!OXO:-\?M/\>_';_@I%^T#\;/@]\#[WXK3_LB>";ZRT+3/BQX#B^,
M/PW\7_#+6&^+/QY%G-XT^*$W@SPWXEBT[P)9WACT33+"&]TY=*MM'U"[TBX
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M:2=!^&'B'PQXI\#Z7#?>'=3TK6;:UT/7?!OAR\C2WU&+[4NG"VOC<VMQ=0S
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M&L^*K/7I?#GPHT.ZU;X@:WX2\.ZMXWLO#S^&K.ZOK;]1?C/_ ,% O@M\%?\
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M$_VR?C3\'OV&_B5^T3I/['?[9OQ(_93\;V_A?Q]X:T*WTKPK\+?V</ 'QO\
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MGMX>M'&L7EG<7,L&F-XI\#?^#JWX.>(-8^+OA7]HK]G*7X:>.=+\&>"_B/\
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M?K^P?_P6Z_X+"_\ !1KX/_LU_L[_  B^(WP/\ _M._%C]M3QC\)-3_:#\4>
M;2?3A\)/!O[/GB/X^^(FO_!MK;SZ(=7T'0O#OB.>U_LVSM;OQ-)IF@^'TN='
MDO=0UAOZVO\ @D1^T7\:?VI/V$/A?\4_VAM5\.>(?C';^+/C-\-?''B;PGI!
MT'0_%&J?![XQ>./A<OB2VT<,8]/?6K;PG!?SV\2QQ>;,[K#"6,2@'Z84444
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M[Z:"UL;?3Y;RYMI8?XG_ (7> OV7_@/XFTCXS_M ?L\?&+]J+]E']N#]A?\
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MZSH>NVEA%Y4\.E&UM9M5 /UO_; _X+5^$OV8O%>EZ!\/_P!D/]J/]K+2;/\
M9Q^'_P"U'\6/$OP#\)V^I-\!/A=\3M=O=)\'7OQ@\&ZZVE_$'P9J6I:;INJ>
M*WT/6?"UEK]IX5TC7]<N](@TWPQXINM$\)\%_P#!R/\ LN>)_C1\%?!?B']G
MG]JCX8_ 7]IC4_BII?[./[6_Q'^'3>&/A+\88_A%X4\/>*?$_C'P_P"';Z:/
MXFV?PG1?$VD:;+\6M3\'V_@?1)KFYU+Q1JFAZ#X8\?:KX-^--?\ ^"6/_!5W
MX*3^#-0_98TW]F3QC:_&K_@CG^S3_P $\OVI/#GQ<^(_BCPZOP[^)/P@^&+_
M  YU+Q=\-KSPYHE]9>,[/2H;^^O])OM?T]9;UIM1LHO[.M+E1<>+ZS_P0>_X
M*/\ Q=_:4_9XUSXWS_LESZ%^R=I7AGX9_#C]J#PIXO\ BC:>,?B+^R_\./AU
M\0/#FD?LS_$7X!72WGA.#1?B?=^-;7PKXT\9^'=;T35M%\*IXLOX+77-7\0L
MT@!]-?"O_@[(_9U^,G@[QCXM\"?L8_M,^);C0M?\"?#_ ,)^!_#'B;X)^+?B
M9\1OBY\4_&]CX*^&GP\\+_#GPUX^U+QE-+XKO&UF>TU\:+/IT]QI$&C:-'K>
MKZUIUH_[+?\ !-O_ (*&7/[=&@?&[PC\2?@KK7[-'[4W[*GQ%L?A+^TW^S_K
M7BC1_'T?@7QCJ&B1ZUI.I>'/B%X7B/A3QAX0\2PQ:J="U+2KN6YQI%V;R!+6
M72[_ %/^30_\&]O_  4;\>^(_ 7[0/@O]FK_ ()__L&?M$_L6WOPP\;?L[6O
MP$US7M9\(_M&_'OX=?%WP'XCF\??%QO$9\21>%_ L/A_1=4\3>$M(M;&6]EU
MJS7P[K&D6NG:P]WI_P#3U_P2D_9%_:U^".J?M?\ [3'[>'BGP'K'[5O[:/Q@
M\->+O&'ACX3ZMJ>M_"_X<_#SX4^$_P#A!OA3X-\*:AK-E8:C.;'1[G5);PR0
MLB02Z;"\UQ?17US, ?K_ $444 %%%% !1110 4444 ?DA_P7&_;<^+__  3P
M_P"";GQK_:J^!-KX3N_B;X%U_P"$6D:&GC32I];T&.V\;_%?PAX/UF:738+Z
MP,UVFCZS?BP>:5[>WO&BN9;:Z$/DM^-FA_\ !T=X?\8?MN^!/ASX2\,_"C5_
MV/- _8:\:?M.?M!?$+1+WQ!XJ^)6B_$WP-^SMXH^-WBOX7>%-0T76#X(MM0\
M+:S9>&_A_JFBPVGCBZ?5KV\,NOZ?>2-IVE_T*?\ !1W]C)/V]OV7M7_9V?Q+
MI'AA;_XF?!'XBO<^(= 7Q/X>U>'X/_%SP;\3;GPKKNBO-"+K1_%=KX7F\/WS
M$S+#'J!EDM;J)9+>3\8;K_@V"^!VD>'/%WA+X<?M%^./!'AKQ-XK_P""BWB6
MTT ^"?#.I:7X;L/V]_A%\+/@W!X8T>&*YTQH=(^$?A[X4:5=Z6Y<7&OW6HW=
MO,=.M+6T10#H_P!E3_@ZD_X)\_M&:7X,UOQIX9^+'[.GA[Q9\<M/^ ^K>-?B
MA;>%I?A[\,M?\2^$+OQ+X"\2_%/QEI&ORV/A/P5XZU33=6\(Z?XD2#4].\+:
MEIEWKWQ&G\%>"(9_%,/W'^S5_P %A/A;^UQ^RO!\8/@K\/X;[]I[QC\,O$_Q
M0^#7[ >N?'/]GNP_:?\ B;X8T^]N-+\)^*T\)?\ "RQ-X5\!>*[N)=0;Q9XH
M@TM-(\,QW.OR6%W;MI<6J_SU_&[_ (-9?%?P _8#^)?[+?[+'C+4?VE/B3^U
M+^U7^RU/XK\?>/=,\%^"K#]GSX8>!]8\26'B3XEZ7H]UJ$]YKL6CV?BR^N?%
M]IX=UJT\3ZEX?"V>C:9JCV\UG=?UI?!/_@GW^QI^SO\ $6P^,7PB_9[^'?A/
MXPV/PE\"?!!OBQ#HZW?Q#O\ X;_#;PIH'@;PEHFI^)[UY[^]N;/PGX6\.Z#?
M:W(W]MZSIFBZ79:OJ%[:V%I#" ?S)_%__@NW^U9H?[$G[$.N^/OBO^S_ /L,
M?'[]M+XC_P#!123QG\;/BU\/?$?Q3^&O[.>@_LD_'SQG\,_"7P@\/>%? .D>
M+KSQAXTOM6N_ /@>?QCK'AKQ#I!T'2O%7BV\M[S6;O383^D?[ '_  6#N?V]
M_P#@GAH]]\/_ (T?L76__!5+QG\,/CIX=^&/[.US\:?"4,_COXT_"RP\=VGA
M?QD/A'?:]I7Q1T_P+XPM?"$7Q1O]'DT6*;1_ ]Q>W\]U:Z1:2W=M3_:6_P""
M WAO]H[]G7X'_"BY_:F\<^#_ (G_  %_:!_:W^.OA/XH6'P\\#:SX3UH_MA_
M%OX@_$WXA:'XI^!^MPW/PXOM1TB+QS%HWA;Q5;:?::EX?6QU%M(@L+;7[FUM
MO7OA3_P0-_86_9X_9R\0?#7]G;P'HOPI_:3U7]E_Q[^SIIO[;6E:*S_'K0]3
M^(G@2Z\%^(?BSI.IV^IV4>A^.;TW=Q>/J?AB?0=3@L+O4?#UAJUGH^J:C;W0
M!^&WPR_X*9_\%RM<_:!\7_\ !+^/XO?LR?$?]J;QE^T7X9^%_@O]NG1O"W@>
M3X ?"<_#?X&2_&[]IOX52^ ]#\&V5YXQ^(/A?2&T6TL;Z_\ #U] =2N->T*Z
MM_#EY]BO=#X;4/\ @LI_P6I^-?PIUCX>^!_$'P#_ &4/VD_V'OA7^VAK/[:'
MBOXE^$OA[XA\%?&OQE^QQX\^'_P^\0Z7X#U=+KQOX.\'>)9YO$NH6^OV-O8Z
M-X(U/QVFGCP/XHF\,>)+/2/#7Z3_  <_X-GI_A-\,?"WAR#_ (*3_M3Q?$OX
M&_$#6?BE^R9\1_!NE>"O!-O\!_'_ (RAO1\3?$MYX=M+2_N/B?J7Q8EN;6P\
M?3>,]?N?[7\/Z>FB2(UK?:BMU7U/_@U>_9YB^'O[+W@;X<_M0_'3X)7_ ,)_
M!GQ-\%?M%_$'X0)I/@CXB?M<:=\7M:'B;QHOQ'\5Z-+::E]B?4E30-'T'69/
M%>@Z;X%CMO#QT^XEMVO[D _-3X/_ /!R%^UK\4?V\OV=/"&C?&?]G?7?AU\4
M/'W[&?POUW]GU? NF^&_A/+HWQL_9D\,^./CK\3-3_:^DU7Q!?>"/B%\.OCI
MXHC^'OA?X3BT\1F_U33]0T'7;'3]1T1[7Q)_>;7X.?L]_P#!O;^QU^S1X@.D
M?#GXB_M#/^S7)\6O"GQWO?V/O$7C[3]8^!&M?%[P+8^&E\&^./$5O)X?B\8Z
MUJ'AWQ!X2T#Q58V=QXH32IM5T?28-1L;[3M/BM&_>.@ HHHH **** "BBB@
MHHHH **** "BBB@#\A_^"X7[<WQV_P""=W[ ?C#]I7]F[PYX%\6_%K2OB/\
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M^%[T7E];Z7\0(]?TG7?!_BKPG;3ZI^O_ /P2._X(M_MM?\$\_CI:?$#XW_\
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M%+6Y\8^!KG3;F\CUS0CH'BZW@.O6@N-':+7[.-+MIKVT#_QL?M'_ !SBM?\
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M  UX=U[1?ACX[3P3+X[L],\=ZAXM\,:UJ.F:?XXEMOV>_;!N/VTO&'_!!?\
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M&OQ$NO",5@?%?BRXT.0 _P!-0SP+*(&FA$[<K"9$$K##,,1EMY^52<@= QZ
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M$/@G4_A5(D^C2.T]_P#8==UG3-2U#2'TUI-WXA?\$V?^"XG[)?[3/[56@?\
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M_:$U*PU0ZM#%?:@;[P[X3D\-6>GZ7:B&:ZUN_P#M,%CI^M?JG_P5'_86\?\
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M=&\>>*M-\'CQ1J^KP>![74TC\'1:&-.TK[#RWC3_ ((2?\$??'NI^&M6U_\
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M^!K7Q7XE^&/A7P#J?B&2RUOQ!IFE#2-3TC1=-UP7'[5^./\ @I5XV'_!M/\
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MYDOIK.:\VSK_ "Q_ ?0/CU\!O!'@;Q]^RCXR^"OQ#^(GCG]D+]IN\^)?@O\
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M^*.E:1K.D> _AM\:O!'Q)\$#7O"FF>,X;/2M0L=0^'FI:S_:<>HW%E<?B/\
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M"C?B*Q\?_ [1?V"?VD?"OPK^&/[(/[>M[\;?@O\ 'WPI;?$G]F[X??&'QO\
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M,OQ^^(YT;6;;2CJ^B>#[#2M'\<>%O&'BL>(;2VOO#T>E7OAG6M2TR[MKR.
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M(_[$7BK5]/\  'B>VNV^-WB_XH:]\5M(\<^%-<:Z?S? \%_XIN/!GBC7-?\
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M"/#WB*'PEHK6G@6VUU[#1;VS=-0U/Q/:72K9?US $=\CW^I/7TY 'ICO2T4
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MT-_"'A/X?_%?P#X4\<>'I]2T>\MOA1XGU*/5+G6_!_B.^T^76_ZB/^",^I>
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M\&Z\9OV1]#\<_%#PQHWQ%\8_$+Q7'X?^*/[5N@>&=>.O?#_0M=34_BAJFC^
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M^/'Q)\'?M>?$7X7?'+_@K)\ /B-X'^*WQ)^'WA'X??MG?''P+X$^%/B#P?\
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M6SGO-3-C8Z=:W<D<5K8Q21>Z:?\ \%B?^"57PA_:9\)?L*Z+\6/!'PW^)'Q
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M;8Z7X,\7W]]<?9O&%K\._#.DZ'H]Q>S:FUO>:GK.MO?2W-M[1_P51_X*=_\
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M#I.J^"?'^J:5JXT^2:Q\4_8KC3O$D<$^E>';EOI/]M7_ (**?\%!?CM^U_\
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M_$C1/VCM*^$W[+7@OX;^'-=U#X=^'+XZG8WOB;Q5X8UOP')I?Q2T;2O %O\
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M[XD:[XF\3>!/&/AR\^$WQ%UN#PKHFN^&M//A32_$=S] Z_\ \$+_ (@^#_\
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M'_AG3-6TKQOX4N;'7=*TJ?5O'7AEO"]U9Z-JFG]-XM_X('6GCG5;#Q+\;/\
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M&5_H.L^$[G5]>UC9JFH7-N(Y+CS-.,<0!_79XF_85_8 ^,7[+?[%/[$?A/\
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M('BGXA>+5U3Q?X<L)]1O!;27VLV.@KI>L?#3PV_AG3/AG#I3 '],/C#_ ((
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M3?LQ67B[P"]UK3/XP^/GCC_A6^L>//B);SW/B7Q1K?BZ?QYJ?B._,%A>6O\
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MCJV@:/<:+87OC>]MI]1\-'PWXF1M%^S%$?Q*;'4)%A_![XS?\%_?'VO?L_\
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M 6NKZ%>ZAY&J:3?V5J;K^)?_ (*=_P#!<SX__ ;_ (+Y_"OX%>!_CEH_A/\
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MNK>?15>:T^R:M(VH#U*RT5;+5M:U<:GK-TVM_P!G;].OM1FNM(TP:=!+ O\
M8NGN/*TS[:)?-U'R<_;)XXI9/F05\XV_[</['M_^S_X]_:JT;]I;X+^)?V=/
MA?8:YJ'C[XP^$?'_ (?\7^"/#2>'41M5LK[5O#%[JR/K:236MK9>';5+C7M6
MU"_TW3=)TV^U#4]/MKF+X@?MU?L8?"?XC:!\(/BG^U1\ OAK\5O%-MX5O/#O
MPW\??%3P;X/\<:O:^.;QM/\ !\UEX8\0ZMIVL2IXDOT>QT<_8Q]MO$DM8=TR
M,@ /JRO.;_X<0W^OZGX@/C3XC6CZG/83MI%AXQU"T\/V1T^[\%WBQ:;I,:F"
MR@O#X*BMM0BB)6[L_$WC2W?Y?$EYAWQ8^+GPO^!'P[\5?%OXS^/O"?PO^&7@
MC3)-8\6>.?&^N6'A[PWH6GQLD8FO]3U&:"W22XGDBM+*U1GN]0OI[>QL8+B\
MN8()/D/XV_\ !5#_ ()[?LX7OP/TSXX?M5_"[X<ZI^T;8^%-9^$&E:_?:DFK
M>)?#/CB2]@\*^-=0TNUTRYU#PAX"U>ZTZ^L8O'?C2V\/>$;?4+6XL+O6;>[@
MEB0 ^T+?P3I$/B9O%D]UK>HZNDNIMIO]HZWJ-Q8:+!K-IH]IJ=CI.F":.Q@L
M;H:'87/D307!M[S[5<6CV[WMWYW8'/;VZ^F>?TZ>]?,GBG]L?]FWPE\9;C]G
M?4/BEH5Y\<[?X(^*_P!HMOA?HHN]8\2+\'_!L^FVNK>+KF2RMY-%TNWN+G5K
M"'1+36M6TV]U]99KK2+>\LK.]N;?\B/"/_!SY_P23\<^%?B_XP\,_%7XDWND
M_!;X6V?Q5\3+<_"?Q%I5WJMC?^(K?PO;>$?#,6K26,6H^.9-3OM.*:+>3:99
MR6E^ES%JLBV>J#3P#]XM.\'1:=XFU[Q-_P )#XNOVU\,)="U/Q%>7OAC2@;/
M1K+;H6AR 6VE KHXN/\ 1VR+S4M9N/OZE+CSW3?V=OAAI7_"&6]I9>)!H_PZ
MU71O$'@?P]/XX\8W.B^'_$FBS^.9HO$203ZV]UJNIW\?Q"UVRU9-?N]7T_4+
M&UT"WEL0- THVWXQ^*/^#GO_ ()&^&_A+HGQHM_C#X^\4>#];\:?$CX?1P^&
M_A9XC;7['Q9\.]-?6H].OM'UPZ',(/'6BOINJ>"M5LY+W26@US1K?Q;?>$]0
MNI+*#]J_V?/CEX,_:7^"?PQ^/GP\L_%FG^"/BQX0TCQKX8LO'7A;5?!?BRWT
MC6;<7%K'K?AK68HK[3+P(<E3YUK<1F.[L+N\L9[>ZF .S\:>"M*\<V.D66JW
M6MV)T+Q1X;\7Z9>>'];U#0=1AU?POJUMJMG%)=Z=-"]SI6HK#-I.O:1=K/I^
MLZ)J&H:9>020W+%5\&>!/"_P_P!/U+2_"EA/IUCJ_B7Q'XNOX9]5U?5FEU_Q
M7JMSK6NW<<^LWVH3VT%UJ-W/-#IUK+#IFGQNMKIUG:6L<<*=?10!P,?PT\)V
MVG:)IUA;:EIB>&8/$$/AZZLM>UH7VD-XEM;VTU.Z@NY[^>2YNC'?W$EG+J7V
MW^SYS%+9K"\$13A_!O[.7PP\%ZG>ZS;6?B+Q#J5YI/@/0DF\;^,/$OC2"PTO
MX:7]IKG@V+3-/\0ZG?:987>E>*;1O&7]KP68UJX\57=SJUQJ,KK:QVWNU!./
MT'YG% 'COPG\+^$],L[G4]#UCX@^*-0LKG7_  K=^(_B5?>,;CQ'-%:>*M7U
MB?3,>*[32VOM)TW5-4O+70=6M=.EMI=%BLK33M4O=+MK4KWR>#O"D=G:Z?'X
M<T5+&R\07GBRSM%TVU%O:^)]0U:_UZ]\000^5Y<6KW>M:IJ.JW&H(HN9;^^N
MKIY#-/([7](T'0_#]O<6F@Z-I6B6EW?7NJ75MI&GVFF6]SJ>I3M<ZCJ,\-E#
M!'-?W]R[W%[>2*UQ=3LTL\CR,6.KUZ4 <UIO@WPIH]W:7VD^&]$TZ\L1XF%E
M=66FVEM/:+XSUN+Q+XM6VEAB1X1XD\100:WK80J-2U.)+RZ$MPBR#FM:^#GP
MM\0V>D6&K>!/#=Q;^'[R&_T'RM.BLY]%NX/%.A^-5FTF[L1;76GF7Q5X:T+6
M[M+6:*.^O-,MC>I<1!XV]*HH Y?3?!/@[1AH@TCPMH&EKX:&KKX=33M)L;*/
M0EU^;[1K::1';011Z>FJSGS;]+58DN7^:4,0,:>C:)I'AVPATC0=,L-'TJWD
MNYH-/TVUAL[.&:^NY[^]>.W@1(D:[OKJXO)V509+B::5RSR,:U:* ,S1=%TC
MPYI6GZ%H&FV.C:+I-K%8Z9I6FVT5G86%G H6&VM+6!4AMX(E&U(HT5%'  HT
M_1=(TF;5+C3--L=/GUO4&U;6)K.VBMY-3U-[:WLVO[YXE5KJ[:UM+6W,\Q>0
MPV\,>[;&H&G10 5!!;6]K:Q6=M;V]O:6\"6UO:P0I%:P6T2"*&WB@C58XX(H
ME6-(HU6-$4(BA0 )Z* (H((;:&*VMH8K>W@C2&"""-(H88HU"1Q111A4CCC0
M!41%"JH"J  !4M%% !47D0^=]I\F+[0(C )_+3SA"7$AA\W&_P HN YCW;"X
M#8R,U+10 4444 %%%% !1110 4444 %%%% 'EOQ?\:Z#\/\ P?I^O>)/%'A[
MPAIUU\1_@QX0AU?Q+HM_K^F3ZW\0_C#X$^'_ (8\.PZ?ITL-S%K?C+Q+XFTG
MPAX7U=Y#9^'O$VN:1K^I)-IVF7<3^I5\[_M,V=]/X%\&WVG&.2ZT;X^?LWWQ
MT^]FB31]2L[WXZ_#_P /ZG'J]K/X?\2PZ@=+TS6[SQ%X?MVTZWEM?&>B^&=6
MM-<\-7NFVWB+2_HB@ HHHH **** "BBB@ HHHH *\[^+UUHMC\)_B?>^)/".
MN^/_  Y9_#SQK=>(/ ?A?3)M:\3>-]$M_#6IRZKX1\.Z/;SVMQJNN^)+%)]'
MTG38+FWFO[^\M[2.>)YED7T2LCQ!KNC^%M!UOQ-XAU&WTC0/#ND:EKNN:M>.
M8[32]'TBSFU#4]1NI &*6]E96\]S.X!*Q1,P!QB@#YL_;!^(WQ"^%7[''[0'
MQ%^"OA#QWXD^+'AKX&^-;[X0^$? ?A"W\8>.9OB/=>%[JP^'EKIG@[4/,L]6
MNM,\47FCW6I:??I<6<=C9WKWD%U;Q2P2?PW?!/\ X(;_ /!57]@?6]#_ &DI
M$\-_M"2_M8_LF?&K]FS]I/X8?".VD\+^/OA[JGQS^#VIZGX=UOXKVXT9;3XT
MZQX=^,5QIEQXE\7-/+J5YXO\/:+J&JZT=.NX[VV_N^_:A^*.N?"#]ES]HGXT
M^"ETB]\2_"[X!?%OXH>$EUF">^T*[USP3\._$'BS05U6UL[NPNKO2)]0TRU6
M^M[:^LKBXLVEC@N[:1TF3^&32_\ @Y]_:P^(O_!.?]D7QA;^+/ ?PN_:Q\5_
M\%'Q\ ?C1XMTG0/AOX];QA\ _#>E>%/B=K/BWP_\$M:UCPWK_A2RU!?BMX.^
M%<T.F6/B#3+JS\%:]>?\+7\&^*O&.B:79 'VI_P2T_X)7_M:?\$_O^"K/[,F
MG7?A/QE-^P^/V3?B_P#$_P !17$C:_I/P"^/OQP^&O[/>F?M"_"[Q!X@NKO4
M];L;G4/&WPUTB?0K'4M5FT/4UAO-8\.6%EJ-[XJ+_9G[0G["7[3_ ,3/V'O^
M"P_P[\,?#2[\0>-OVG_^"CG@'XN_"+P7/JUIHVI>*_AKX*^-?[*^MZ[K7VW4
MYK:PTVTN?#_PZ\7:AIK272M/:Z<"BK)- C_EI^RK_P %O?VX?VA/^"@6I?LW
M^//^"AGP#^"?A[7?^"@'C3X3^&_A O[$/Q8^)'Q9U_X?6GBOX8:)\-O 7P]\
M2>"?"7B?X<:%X3\>[?&^B:MXH^*?Q"L_&'PFN5U_QAXK\1>+?#FH>%X_#GK?
MASXU_P#!P?J/[87[0G[)VL_\%(/V?K;4_P!@#X-^&?C]\7O%'A[]CW3?&L7Q
MG\#Z_HOBW7++1[?P;H7A&W\7>)O%<J:#X:TV^\.>##X'NYV\2ZO_ ,([J.I:
MGX?L8/$@!W_[7W_!(G_@L)I?QL\!?MZP?M;ZE_P4&\8_ G]MK7/V@/AK^PUK
MOB/5/AO\,=#^&&HZG=Q>&+'X?ZYK=W<:%X9\5:'HEU!H.MZ+8>%[?2X=$2>X
MTK5-8O3=Q7_4_M&?!_\ X++_ +57PM^,/[2^H?L"_ [X0_%&/]H;]A7QEX,_
M9*T3XE_#V?QQ\1=7_97\7>+_ !+XL^.WQ&^.N@>!?"'C7Q7::[X;\2>"OA%X
M3\%W'Q%TC6?"?AWP;JNMZ#<66E6]YX?^(?Q3\)O^#I'Q7\9?#W_!+[X(?#G6
M?B_=?'RQUSPS>_M_^,/&WPF^$V@:+\:](\"?#'4]=\;^'OA?KNG:QK6FZ,WC
MCQ/I%TK:M9^ /"5Q;6<EG<V9T95N]-G]W@_:<_X+Z^#/V#M2_P""T^I?MN_L
MN>//@KJMC8?M >%_V#H?A)X%O_""?L_^/]3\/R6WA'5OC;;VWP\\<Z5\2?AO
MI&OZYI\W@C3-8\9^(7\1^#;/1#XC\9>)-9O/#]L =MX_^$G_  6^^)7B#]KO
M]O+0/V)/AE\/OBK\<]=_9(_9U\:?L->,/B=X1^(%G\2?V8/AUX0^,NE_&;QY
MX9^,%KI7A'Q%X'\;>)H/BQ:?"G1M1\):_P"'=3\-_#KQ=\;M6DTW6?%%E\./
M$.A^H?L1?L"?\%%_V-/^"+W_  46^%_P^^%]EX+^-W[1GB#XR>(/V3/V.['X
ML:WXTF_9K\$?%>.#P1<>"M,^+%]XE\-W5WXUT?PU?ZOXLT'Q3_PDUM.WB'3-
M$UO7)KC4Y]2L)/A3XN_MB?\ !;;Q%^SA\6?^"N'P@_;>TFQ_9M_9P_;-\5IK
M'[$GCGX1>!/A7K-A\%?#FL2^!=>T;6_&WB/P5H/B3QU#%;^+X].M/A_XNTBW
M\3/B#QYX6O9OBCX5\':5/A?LX_\ !:W_ (*,>,_^"K/@GX7VO[32^/\ X,_$
M[_@H3\5?V<X?@G\3OV>/AOX0_9NT;X)QZSK%QH=SX+_;'\&1VGC'Q3\6]#\.
M61M_!/@^7PKYFL^([71H/$%_KEAX@NK1  ^+O_!M-^T)^Q9\.?&_P[_8*U'Q
M[\>(?VK/V ?''P:_:SM/%^L?"^W\/3_'KP]XJ^$'C#P?-\--0U'0_"GB+PSX
M+\5^*]+\1:CI>C7\VH:AHFF>'H(-?\7:JNHO;V_WU_P1I_X(\_M5_P#!,+_@
MJ/\ &#Q.W@7PS?\ [''Q&_9!T#PQX2\6V_Q3U?7)?A3XFO?%/AGQIK?PFT?1
M?$0UC7];OXOB+8>-=:U&6.ZTWPNVE>(X_%%EJ\FJWUSX</NO_!1;XK_M@?MX
M_P#!2!?^"1?[(7[7E]_P3_T#X1? &Q_:7^/'[0/AB#4S\9O'>L^()38?#[X<
M_"J/1O&'@_4+GPKITVIZ/J_C[['XB\-WUS;R7[/>7UGH::/K7\^/[3__  4K
M_P""H_P^^ GB#]DK]H?]LGX]Z)XM_8Y_X*D^#/V2OC+^U%^R-X&TR'XO?M#_
M  F\??#+QYXQ\-V/@36+?4OAQJFI?$CX02?"+7KKQ'X;DN])F^)-G\8/AS:>
M.->2_P#"5]J?CH _8'3O^".'[9L'_!*/]NO]E+4-&\+P?&?XX?\ !4S2/VD?
MA7I5AXD\+ZCX>U;X7W'[4/P4U>Y\1^)]?U31=0U#POI]CX$T/Q7X[N(_"EUH
M7CDP:!9Z*]W=Z?J^M^$?$'YZ_&G_ ((D?\%$?C+^WG^T)X3^'_[-?@/X'^!/
MC#_P4#^(/[0VE_\ !4J/4?#-O^T/X+^%.H:#XGAT_P )^&= \&>*_!VC:5X3
MU6[\17LVK:3X;\'Z'K_C#49;"3Q1<WU]8W&N77[3?#;QWX]^#_\ P;R?MB?M
M#:'\??\ @I)\1?'VO_LV?M3?$GX?_%3]L+2?$.C_ +5W@G6I? _B#PS\/O$/
MA[0/!OB'QKK'PZ\#>';_ $_2/'6D>*++Q1=6GAO0GU7XGZMJ>@:-!>MI7Q1_
MP5)_;V_;*^!OAKX ^)_V;?C_ *O9^*?%W_!%'5?B%%'JWCJUE\.^(OBSXI^-
MO[*/PZ;XGV6GZOK=GX>\3?&NWT;Q]XIL?AUJ5W'J^L3^)M7^S:1IVI:A<K9S
M '+7O_!,7_@O%^T#\&/@S_P1\_:FU[]EBS_X)O\ P<;X/^$O$W[4?PEL!9?'
MCXA? /X7:W>Z9X*\'Z+9>(-7O/#]GXL\-^%O#'AS3O,;X8Z#JMM80>'=3\2^
M(?'.JS^(CXCX#P;_ ,$L_P#@M+XT\/?%7_@F5XP^&7[,O@+_ ()R?%7]N+QM
M^TGXO^/TM_"GQTG\(>'/VEO"GC6WM?"=MX#N/"'PWTF^\96/A/2]?\(Z);_L
M[^%]+71IM2,MOX=C2RTJU_,GPS^WU_P47\!_L%_\%8X/%7[6?_!0OP)X^^&&
MA_L(^/?@WI7[3'B?7[;X]^"_#?Q9US35U_QIH_Q8AU+2=9TWP]X^%W<6^B^%
M=&T6VTO6?"-]I.L7.JSZU87Z3?T\?\$&O 7[7WC7X.?M:7?[57B?_@J5X6O?
MB!9^!/ W@?7?VYOC3)J/CG0(G\&>(;[6O&'[/?A,>"=-?PA;QWGBZRNY?B=)
MXD\01>*-3T[0O#D'AW1+SX<:UJ'B@ ^3/C)_P2G_ &Y/%'[#_P (/A9\./V<
M/V>_BC\0/A;_ ,%AOVC/VE5^#G[7-[9>*_@KXK^ /C=/CMX=\%>)OB/I&AZM
MHK>*M.?3_&GAG6[SP[IVIZ=JS7S07*631VMQ95\N_'__ ((F?\%@?CIJ?P9\
M?^,_V:?^".^O^'OAW\!/BS^S=X6_8UT+1?C=X2_9V^#GA'QMJ=[JC>/_  ;I
MEM\2X-1T;XM:AJ6LZKK>@^-O GC+1-0\+:QY>J30RZHEM>0<CXH_X)S_ +2_
MA#]HK_@JMX8UC_@KY_P4:\36'_!,[]EOPK^U;\/K^/XNZUHOB?Q[XX^,WP8^
M.7Q1>SUWQ"=?U>WT.'1O&GP4\ W>JW^EZ%<7?BO3(]5L&&@W;V&JVGBW_!-#
M]NS]M+X^_M*?\$!OAU\7?A-^T]\-/A=X8\*?M">#;3]H/Q]\0O&>L> /VT;?
M0/@E\8-1T;42+OPYHFG:L?AHT-II>C6&H^)/&EQ:P6\%ZLUM)%;F, _H(\$?
M\$;/VB_"7_!$/X-_\$FE^/VB#7_$FOZ/IO[27Q36/Q#.OA#X3>,?B-JGQ/\
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M>D+I'B>\US4;Z._TZTLOZ;_^"5/[9W[17[9GPZ_:BG_:G^#G@+X%_&;]F?\
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M:\OFT^[M);$WMT;<SO\ I T:, &1& ;< R@@-S\P!! ;D\]>3SR:?0 4444
M%!&?7KGCO_\ 6_GT/&02CGOCH.??OQV'IR?TY ,?1=,O-*MKB"^\0:OXDEFU
M&^O8KS6H- M[BSMKN=Y;?2+9/#NAZ!:-I^EQ,+2QEN[6ZU62W16U/4]1NB]R
M^Q7.>&/%6D>+K*]O]%:^:VL-8U70K@ZAI6I:1*-0T6[DL;X16^J6MI//:BXC
M86U]#')97L6)[2>:%E<]'Z^W^&>/S_/- !1110 444#/?'X=_P .W.>,GZT
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MQO&%CX=\%:)J'B+QKXH@US7WT"QT_4-3\::G97$=W-0!\50?\$-_@1>_#?\
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MQT'1A9_\)%::5INO_NTAL&X'P9_P<#_\$'M;^-FJ^(?!-TMY\1M TZ[UV_\
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M-WJ(U_0[RW2%[JUDN.2'[+O[ WP:TW]BWX;WVK>&/ ^F?L)P>)=*_9UT6_\
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M%_A76M(C\-^+_!GCOXG:KX1A\?:#9Z7XU\0>*+3[Y_X-\/&/Q=_9$_X)Z_\
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M6?B5;?$BXU7P]\;[;XC^,O&5CIVHVC^%=%M;33_#6H))8W$?B%+RZU&-K&:
M _"G]IG]G#]J+X,_L/>&]"U'X-_M\:'KWP[_ ."_WQ7^)6KZM^RE)J7ACXY1
M_!?5?@O\0]$D^+O[,'B73DU^30=+O[+46CLM;UK3= TO6/%MSJ6C7%Y;0:DV
MLCQ'XD?"K_@J3^TYX'_9&\7? S]D+_@K[%\-/@'I'[4'PWM/C#XL_;&@\(?M
M]_$?4/B3XBT^?^T?&WQ(\56-W?>%_A/>>'+'0-'O/AII?@FV\,W%W8:QI>B>
M(-5M(I-7O_UA@_X*]_\ !>+P1^V]\;OV7OC9^SM_P3ET'PW^RG\!M<_;4_:!
MOO#=G\<[CQ#<?LD^#2-;U[_A6.M2_'K4](UKXN^(="5/"WA2UO/#DGAFP\=Z
ME97'BHZ;X;L]6N+3J_\ @GK_ ,'*=I^V7XC_ .";/[.^C:KX#\0_M3_M _$7
MXYZ;^V7X4OOA;X_\.Z7\-O"7A7X;?%KXG^!Y/A!KD'B*Q\-2H+K0_!?A>.\U
M6\\=7]]HEEKCZK8VNNS)K0 .\^ OP9_X*'_LR_\ !MW\.OV5-+_9S_L#]LOQ
M]INL?L]Z3X.\$Q:7X+/PG\.?'#XI^(M)L_B[\5]2^'FIZ=+8:IX<\$:\/$GQ
M&\3Z7/>>);K7[S^U/$\6J:Q/KT]Q^/GB;_@A;_P5*_8W^!'[6?[&G@71]%_;
M"^$W[9/[(/[.GB3Q7JWPV\/^'OA_X5\*?M/_ +.'Q_\ ACHND_#32#/J6AZY
M=6\OP:?5+_4OB9K>B^%]1^)%A<:SK^MV;>,?"5W>3_7'_!)'_@X$_P""B_[>
M_CJR\"?$3QI_P3HTJVM/A%^T#\5/$GA3PSX$^/5C^TP-#^&'A_Q!=6%[I4$O
MCG6/@KIM_%XCNO"KZ=HVMVD]SK'@.WU36I8)[ZTN9)N-_P""0G_!P'_P4F^/
M'[0?@#X _'G7OV5OVH?#7Q0^#G[1/QMU;QK\._#>M^'/C!^SFGPQ^&UWXG\-
M:)\9=,\$VGA?X;V'AR3Q'H5IX=GT3_A'&\0WNH^-Q,?BB@T[2-!O0#Y0^*W_
M  0\_P""DG@2/]O;]E3P[X-\>_'[X!>"O^":WA?P[^Q=HUIXH\!^'CI/B#XB
M?MP_LM?M0^+OA#X9\0WVG70\87_@/Q5\%/BSJ&LZ;K,L/B3QGHVB^&=.TS4_
M#=]\0?#-[!^TW_!.;PY^WK_P4!_;R_9=_;?_ &I?V,=7_8J^ G[$G[-7CGX)
M_"'1/%6O^']2^)OQ,^*?B*UTKP9XNU_Q"-4\+:'XW7P&UCI^K?V/I":=IVE:
M;JNG6]Y;:CJ\FI7MW/\ $7_!*/\ X+G?MT?%SX<?MG_M;_M8?M&>!_B?X$_9
MT_8L^,GQ^7]EW0?V7=4^%<FC>-;+Q;H2_"Z73/C;+X.\/>"_%/A^:SM=6\-P
M^&F^+5WXOUF'Q+83Z;IWB[5-#UW4]#]^\'?\%(?^"TO[(5C^R%^W'_P4-\5_
MLK?%3]C?]N/Q5I/@VV_9_P#@-X>73?&'P%U3XQ>&=4\7_!/4_#_BW1-#\3ZS
MXJT5UT^QL]9BF\9?%R\T_0-1O!?W%_KD$.J6X!_8[17\//\ P1V_X*^_M^_\
M%!_VVO@1X4^)G_!03X-6'AWXE3?%KXH^-/V1/AS^QEKDS^%O#O@S4_%LQ^"0
M^.VN^"M-T_3CH^@V_AO6$\4P_$7QEK5GHFK^&+'5M;\2^*=1U2)?[A0<]C^(
MQW(_I^1![T +1110!QGC#P=:^,CX<@U%]/ETS0_$>G^([K2M4\.Z!XBM-5GT
MH2S::@77;&^;2+O3]1-MJ=CK&D_9=6L[JUC-M=1!I,]=--'!&7DDCB!>.)&E
M=$5IIY$@MX@7>-6DGGDCABCWJTLLB1H=[J*\H^)GB/Q!H7B#X26>B)XD:T\1
M_$*+1O$!T'19]6LTTAM"UF\9O$=S#X*\5KHNC?:K6W#:G/J7@N);HVUO_P )
M,C3+I]]\>_\ !47]@?Q/_P %%/V<="^#'@7]I_XD?LB^/_!'QD^'7QN\"?&/
MX;::^O7>F>*_AW+JITVQ\1>&8/$O@F^\0Z'MUJ;6+"TT_P 9^&;G3/&6C^$_
M$;7M]:Z)<Z%JP!^$.H?\'3/P^_9%^',-I^VY\,O&/Q+^,6N_M$_M9>!/#UK^
MS7X;\+6/AVR^%7P.^,%_\.?!^N>(+OQ?\2&T6?7M9EL=1L+NW\.>(-7(DT66
M_O8-.6_LTG^C_%7_  =5?\$_O WQ5U_PGXM^%_[4EA\'?#^B?#?5[O\ :9TK
MX86?BCX3Q77Q9^%?A;XM>!O#FHQ^'/$&H^)]%\3:IHGBB/3)]%U31[:^L=9T
MO4X+B%8;:2=/D/\ :G_X-#/"?[17@S]GKPWI'[?/C+PEKOPE\)_$)/B5XY\9
M? A?BEXA^-OQ7^*WQ*U[XH>._BC>_P#%\? ]OX-CU76]>FM;?PE:+KR6UI:P
M3W.OW^IS7]]>>0^$_P#@U,^.?Q2\7_M,?#+X^_MBZI\&/V0-3@^$FE?"CX7?
ML[6,%[I_QI\=_!?X ^'?A3X"_:/^*_A;Q*\.@^#M2MM:T>3Q-XN^&5G9^(M:
MUG4-?\6>'M"^+.B6=KI/CW7 #Z;^$_\ P=__ +'OQ1^$'QZ^(B_LT_M ^'O$
MWP3\+Z7XBMO!=Y>^!-1B^(%_XO\ BKIGPW\!^%?#6KZ7KMU?Q:UJ5KK^CZ]X
M@EO_  [;Z;HLD6M:=9W>LK::??:M^XG_  2Z_P""C&F?\%+_ (%?$#XN0? O
MXF_LY>)OA-\<O%'[/WQ#^%OQ873QXFT?QQX4\%?#OQUJ$D(LC'.-,DTGXE:+
M;Q#5=/TC5$O[344DT\6B6EU>?S+?!W_@RK^&GPQU'6?$/C3]N+Q;\7]5CM_#
M+^"-,T7X10? [3?#OB+3?&?A[5M2\4ZUJ(^(WQGE\4&U\,V.M6GAOPY)H^F:
M?#XDO--U76;W4M/LIM*N?ZVOV5_V2O#_ .RMKW[66K>'?&6N^+;7]JG]JSQ1
M^U7J-KXBLK"&]\&^(/&?PH^#OPYU[PI::CIWDPZWHZ:E\*9_$.C7LVFZ;?6&
MG^(8?#UZ-6N-%?Q%K(!];T444 %%%% !_G\Z\-^%?B&75_&?Q?TW5/"6I>'?
M$V@>(M'MM<U$>+-0\3>$_$4-WIUQ<>';[PE;ZC=QRZ&(?#G]FIXDL8_#GAR%
M?$4U_#!_;MO;0Z[>^Y?Y_P _I_GKP_AGQGX;\2>)/'F@:+'G5/!.JZ7I7B6Y
M0:<T,NI7^DPZG;P":SN[BX:XM+*>%;B'48;.YMS)&$A>%TD8 _F:_:+_ .#?
MSX-_M3?%K_@J#\9OVYOBA\)O&7QG_:VUW0Y/V+_&-UJNN:!XB_9:^'_@+P5=
M>&? 37J1:EX1TW69Y+]=(T?Q!H\>@Z]IDNB>"[6]NO$'B'6?$&JP:?\ EM^Q
MU_P01_;=\5_'S]LC2_VO/B3XCC_9\^&?QZ^#/QMT'P0=)MKJP_X*,_'7X"Z?
MKCZ5\3+F]DU]O&7@+P;XE\-WWB.&\T;PWXGTQ].U?XG:%-:Z9-IG@JPMKCYU
M_P""L?[)W[2__!0'_@N?^W7\,?A]^RQ\<OCC#\/?#7[%N@:?XE\%_M!:%X$\
M/_ ?P5K&A?#?4M:\6ZMH%\MWI/BG0/B-X<G^(/V3X>P:YX-\5:1J-[J7CJ.^
M6>TO;"^\(O?VP?C3_P $V_VBOVAOVJ?@1XT\!ZWHGP2^-W_!33P!\$/@!\:?
MBK^TCKOPMT.'P7\0_P#@G]\%3I.GI>^+?#^N?&74#X$\6:0F@>#-5\/?!F>Q
MA^'0\6:[XO\ %,_ACPKHUL ?I_\ L2?\&W_[0G[7W[,G@_XI?\%'/V@/$7AS
MX@R!+_\ 9W^!FK>"+7Q'>?LJZ+XE_:S\,?M!_&*^UW4-0U'1[CQ3\2OBCI&@
M^-/!":?XE@UK0O!=O\3=?U?5(?%UY!IFF:1] :=_P:[^+-(UO]FR\^ W[9=E
M\%/!VF67CCX=_ME^(/@]::]X9\8_M&_"K0_VI_$'QR^%5EHNJ>"KOPU#H'CN
M#1WT'P;XVUTZO;KX?\0^$- UK1AK]OX9T[1J_$/PA_P<F?\ !7W]H+]FZ/X?
M6?B[X<^#_BG^T5^UG<_"GP9^TMXGT[X&?"CX)?#GP1/\,B=;^!Z2^)=)QH^I
MW6L^//"_B=?BWXVUZVN/!6D:-I=H?$NLW6O:K=Z)_8Q_P;8W%[=?\$4/V()]
M2N[B^U!M!^,*WEW=7CW\\]Q%^T-\6X)'>]>6<W(!CV)*LTD;1JAB<Q[#0!^&
MWQ=_X,R- ^*W[6GQ0^+&J?MO>,KKX-?%35O'WCW4+?6/"PU7XX:3\2?&T>NZ
MW]KU/Q7JU[JVA^/M#M_'E];:MJESJ<6@>*-=T&\O=.NM8BUVS_X2;6?I;2O^
M#5[Q/9?!'QCIDO\ P41\56'[8.I?M ?"GXR>!?VT_!OP.L_ _P 5_ OA?X9?
M"'Q/\'!\*++6O#_Q/M?'$'A?6=!\77FHS)X:\?>%K/\ M30O#<^J:5K3VL\L
MG]?]% '\E'@K_@U&^$/PA^"'[5_P4^$/[5GCW2[']KS]FSX+?!KXB>(/&_@7
M3/%NH6/Q!^&OQO\ !?QB\6_$W1H+/Q'X>B@TCQRGA#^P+#P/<O<S>%9-2DU-
MO%.O"'[%+_5+\._ 7AOX6?#[P+\,/!UK<67A#X<^#?#'@+PK97E]=ZG=6GAO
MPAHEEX>T.UNM1OY9[W4+B#2]/M8I[Z\FFN[N1&GN99)G=SV5% !W]N>/RQ^7
M/Y^U?YAOQ[U3]C'X:>'/^"MWQ%_8H_:H^,FK^"=3^'FE?LM_M5>)_C+\9O#M
M]\=/VU/BK\9OV[?@GXR^)WC#X)?"G4HU.L^!_A/^S;IOQU^'EW\3/%/A_0+Q
M=/\ $,]_8MJ,.I^*_%-[_IU6UW:WD;RV=S;W44=Q=6DDEM-'/&EU8W,MG>VS
MO$SJMQ:7<$UK=0L1);W,,L$JI+&ZC\W/"_\ P1T_X)>>#=5^(&N^&?V'O@#I
M6L_%'PCXV\!>/-3C\'137NO^$_B*-GC;29)[N>=[%?$4&^VO;S2S97XL[BZL
MH+N*TN[F*8 _AEOOA[K'A[]EO_@O)^SS_P $]_VT_C/\*OV(/V4="_97_:'\
M ^&O#GC>7Q[:_$G0/'WPQ\?6/QB^$VJ>/]"US3+OPS#\1[[4="OOB98>'-6O
MO#^IZAX6@\/:SX:U+1KF[Q^@W_!Q!_P64^(OP:_:P_8[_9!^&6C_ !2M?@#\
M#?B5^RS\?OVG]1\!6206OQ]LM.\4>"?B=X,^$_A'66M[>TU[0TT;11J4-M;^
M((?#/BGQ3=Z5;W@O8O#JRVW]=G@;_@G1^PU\,?V?_B)^RQ\/OV7OA)X/_9^^
M+;7K?$WX7:#X;AT_P]XY?44M8KF7Q(8I!J&J2+%96D=J]Q?.]E%;0Q61MT0+
M7NWBKX!?!+QQX1\/^ /%_P */ 'B+P7X3N? 5YX6\-:IX7TBZTGP[<_"[6-*
MU_X=R:+:/;%--/@O6-#TJ_\ #RV@ACTZ2SA2!%B\R-P#^2G_ (*8?\% OV*O
MV^/V);'XE_\ !0[X#_\ !0S]C7]F'X(?M'^%_L7P5\<^$8/ASXP_;D^)FH?"
M3XI:MX9^$GARZ\,>+M5N-%\->";NUT7QSXL\6:[:6FF6+MH]KHFKVVKM<7NE
M_P [G[=?_!0+XE_!?_@F-^PG_P $S/@UKJ^-O!MCJ-]^TK^T7>^!/B%X@^,&
M@>#_  GXQ^.6N?$3]E?]BYOC+8O!HNJ7WPQ\':GX<E^+>BQ:#?:9;^,X/AOI
M/AJ_MGT#Q!I>H?Z7_P"T_P#L;_LO?MI>$O#W@3]JGX)^!OCEX/\ "?B1?&'A
MSP_X[TZ34M.TCQ*NEZAHHUBTBCGMRMW_ &5JNH66YF9##=/\F\(RUO#7[%/[
M)/@_X)Z%^SAX:_9U^$6D? KPU<:->:+\+K;P5HQ\)VEYX?\ %EEXZTJ\?3Y;
M:07E[;^,=.M/$DMW>O<7%YJT(NKV2XD>0N ?Y_O[5GBK_@FU_P /I_A;X]\.
M7WQ.^&7[3EC\;-#_ &Z/VL_B=\1O%FHZFW@'XKZ%\.+/Q]X)_P""?OP ^%VB
M:/X,C\7?$#Q'\59_!O@G4_'.L;_$7AO7KFY&D->VVD:OI\?YL?\ !,;X\_&_
M]A[XBVW[27[,^AZ9^V7^T_\ &O\ 8L^,_A>U\"_L[:3X\\>>//@-\1O&?Q#A
MO-$^(7[5TM_X<O+#5O&B6<M_XCMK70KG7?MT>EZ-X?\ $$MC.FHW!_U%-!_8
M-_8P\-_%7QS\<-)_9C^"Z?&#XD>-K3XD>-/B1>^ ]#U?Q?K7CFP*267B=M:U
M>UOKRQU2UF5;J"?3)+(1WA>]51=.\Q]J^'_P9^$7PHGU^Z^%_P +OA]\.KCQ
M7J$FK>)KCP1X/T#PM-X@U.666:2^UB31=/LGU&Y:6>:0S732OOFE8$%V+ '^
M<#^S)X9^)'[3_P#P;X?\%1/AW^T-I7[3WA+QW^RG^T]\??VH_C/\2/&=S?:;
MHOQT_:(O_".FV&I?"SX@:WJ'B:/QAXE^(?@+Q_%9?$?XL:3XR\.:B@UBZ\*&
MYNVUS4OM6E?WD?\ !*.%K?\ X)G_ +!D+P26SQ_LH? Y6@EADMY(C_P@&AG:
MT,JI)&><A612 1QC%?7;?"#X42>&O&O@Q_AKX%?PC\2-:\0>(OB#X7?PKHC:
M!XXU_P 5W"W/B?6_%FD-9&P\0:IXBN8TGUF_U6"ZN=3E1)+R29E!'?6=G::?
M:6MA86MM8V-C;PV=E96<$5M:6=I;1K#;VMK;0JD-O;V\*)%#!$B111HL<:JJ
M@  L4444 %%%% #555W%552S%F*@#<QP"S8'+$  DY/ IU%% !1110 4444
M%%%% !1110 4444 %<=XG\)MXDU+P=J UG4M+'A+Q$-?:VL9IHH=9"Z=?6']
MG:DL5Q DUF3>"Y\N:.XC\^")O)W*'7L:* "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ H_S^?2BB@"O=H\EK=1QKOD>WF1$RH+.T
M;*JY8A1N8@98A1U) R:_S$OA5_P;&?\ !5K1X/'C^._ NI6O@77/AOH?[56A
M?"GPI\4?@P\^L_M8^"/'GBGP-\,O@IXU-_\ $5-"M/%?@[P3\0O'_P 1+CQK
MI6HZI\.K_P  Z]<>&K3QI:_$#4Y_#FB?Z;'A_2+W1O#6BZ%?:_JGB+4=+T/3
M=(O/%.K)IZ:WKMY8V$-G<:_J<>G65CI2ZIJ4\<FHWB6.G6FGK=SR"VLX+?9"
MOD]]\)/&6MZ/I>EZS\;_ (@0W&A37#Z;K7AB#P]X<U6_\C5?"NI:#>>*BFE7
MUCKVIZ='X>U/3=32*QTSP[X@T_Q;KD5_X<62/2Y;  _CM^*?_!'/]MG3?^"G
MGQ=_:QL?^"<W[-'[3VF?%']MWP-XS^&/QC^*W[0=U'I_P:^'FH_#G0M.U#XB
M?$?]GJU\6^%= ^*'@_X9>,KJS\4CP_\ :-2\<OXM\ >(-+T?POXH\/:]X5\2
MK^U6F_\ !.;X\:;_ ,%G?VL/VW+*[\):5\#?CK^PII?P=T(:;>2FZUWXLI>P
M:/+;?$&SOM3NM7T>?0=.TJVU33=8\,>']3T+5-'U0VL_V#6M.FM;_P#4C7/@
M7\0/$FM>&]8U#]I;XO:-%X5\0^$]:LM%\%VW@7P_I.N6GA3Q'KNI2:5XSBN_
M"NMW7B&#QEX:US_A$/'$<5UI>GZA;:5H^N:#IOASQ!8KJ#9OA7X,ZWX??3].
M\1_M/?%#Q9JME\5(/%6F"^U7PGI5Y=7$4$.O/\/M5LK+2A_;.CZAX0M-=CU#
M0Q%;0'1M2N/$6EZ;I6HZ/I>KV(!_'U\$/^#9'XD_#+X0_P#!)_Q9IGPK\(>%
M_P!J[P7X^^(EE^WWXYL/B#I<#:!\+_'O_"T;G0+FVTA=>U_PEX_\6_#S3/%V
MB>%#JGA*2>YUIM$T>%;9]$%U=Z=U'P9_X(L_\%]O WP0E_X)@W_[6/[)^B?\
M$RKBZ^*O@#6=2L/#Z:Q\3];^#7C_ .(?B_XA^()[32;GX=C7-*\5^.-2\2Z@
M5M6\>2KX.EUI[:VUR_LM'@:\_K^N/A/XHLM,T*\U#XW>*M-;07\8:YXKU&-H
M;32-1O\ Q'=:KJUUK<4.JWNH?V):>&'OV3PYHVH:AK'A'1M)LX;271+A+>&:
M'7O/#WA:R\':+KK_ !@\0Z5H'P\\:Z]\0-<\<S>.M._LV_-EKWB6X\;^'O&^
MJZB)M"/@JUN-2U[1+S0I186G@V#3;&ST=]#G\-6!M #^0#Q9_P $8_\ @N=J
M'C_]L?\ 9K^'O[2'P!\!_P#!.K]M;XWZ[=_$A?$_B._^)WQ7TKX.:U'HWA2?
M4M%T_6OA[;7-CXMD^'OAS2+6;P_HOBS0]-O-6A2UEU>TLVDU"/R+]G7_ (-B
M/V[?A%^WS\$_%M]\4?V:])_9>_9__:DT3X\>&/CEX8M_$;?M4^)/ ?@C4-)U
M/PQ\)-1EN]._M6'0+_1])M/A_+HE]X_O_#OA_1GU'4+6+5+1;70+O^VSP#KO
MA;7H_$7Q-\-_&NS^(_@'4UNTMY]-\0>"M:\!>&&T/4-6N-8?3?$'ARV4!K*.
M=--U3^U-:O5LH-'MQ,L%R+N6;A?#&@V_Q;F\;>+_  Y^TUJGQ"^%'C2+6-$T
M/2/AKK/@HZ)X9AU'P])H6MVND?$/P=#<ZY/JFGWUP-;T/4+;6;'5/#FH^4K2
MW82)U /QD_X+!?\ !-+]O3XR?M4_LS?\%!?^"7WQD\)?#/\ :P^#7A+Q#\&_
M$FG?%+5[>P^'NK?"?7/[<U=Y%M9/"'BU-6U&;6=5DL-2T74K,:;=V4EGJ,4U
MM?:3%Y_Q[8?\&YGQV^,VH>!_B%^W'\?O 7[0?Q<^/'[=?PG_ &N/V]9VT:^A
M^'%[X ^ 7P=^+W@CX;_ KX4>$6LK!]2L]5O_ (J:IX;\1:S?7/A71])\)2Z>
MF@>&43PM;V6O?TG>._"WP_\ B#KOCNZT?]I;QAX%UGP,MH_Q.T_P#\6?#\,/
M@J"*VT;6K%?%>AZO%KEIX%1['P]'J$DT]IHDNH:7>ZZUS-/8ZE<L.;E^$'P+
MU/2O#'Q'_P"%W>(SX2U#5O$'Q1BU_2_C2UAX#\9:UJ7A_P -ZEJGCG3KO3M5
MAT.QM[-O I\<HO@VZTKPK:S:OX_O;C3)-(\5:Y!( 4_$'[ O[.UK^Q#\9OV"
M/@UX&T3X"? SXN_"/XR_"@Z!\-+"WTJU\+P?&OP[XCT7Q/KVC6US'>P?VJUW
MXDO=8+W<5U%->X\Z*2(F,_SE^"?^""O_  4G^*^H>/&_;@_;2^%7Q$UCX(?L
M-_%+]C/]@GXA> O#NN>']:\._P#"[? R^#?$WCWXG+I&F>&=9D;PIX<N=8\&
M6-H^J^(]2\16.J'5+J^L?LBV-S^^K:7^RGXIT;7?!FD?MT>(Y--U?X8S>&[F
MV\._M@:7-XBTS3_!MS%X^U/XDZ7XEB\0WGBG2_$^D:%X8NG\1^(XM3&EGP;;
M:X^N6+V4NIW3>*^'/V*OV6O"/Q.\&VD7[>G[0]]\6+3Q)X;U?PUX7\0?ME&_
MU?4O#-[H]U<V?@'2?AQ-J$>FR>'_ !BNJZIXF.L:=X:;QM>OK6H3Z)XJM-+F
MM[>W /R-^$__  ;9_&?2? '[;]Y\5OV@?V<1\;_VG?V7?$G[-'@W5/@/^SY!
M\'/AMIMOXV\0Z#XE\6>/OBCH'A][.Y\6^)I;OPSI5GHL6D0:58:9;S:I<20W
M,EY!#:?JU_P2_P#V(_V^_P!DCQ1XT7]J']IO]F;XD_"B^\%:=H_A/X7_ +.'
M[*7@/X PR^.(;K1;=OB#XW\0>&-&T74-?U/2?"^@#PYIUO<1WW]HQ:Y=W5]<
MVS:-IT-Q]2^*? ?[,NG_ !(L]!\2_M8>./#7Q!L/%/B"^3X?7?[7>LZ!J<NL
M?%.RTE;30KSP1/XOMKRZLA;RZ;=> - GT]XM);4UN= @']H*TGH7C3QA^R5;
M?%^+P)XZ^,_P\TWXO^)/ACK7PONOAGK?QFL-'\0^*?!-Q?>%[VXM=3\#2^)K
M.YOM;LI_%FC-HNMG3XO$MK:>.+M-,O?L>OS!P#X-^./_  2E\5_%3]KO]OC]
MJW3_ (]>3-^UY_P3/\4?L$^!OA[XA\/7FH:)\+-9\5VEW%?>-'U"WU5;B[\,
M+J%AH6M'P[I-OIMU<ZGK'B^XN;MY9-,D3RC]FO\ X(7?#W]GO1?^"4,^GZ_\
M-C\2_P#@GH/B7>_$WXK>'?A7IGASQI\>Y?B7\,_&O@V^\.2ZUI]Q;ZC;>&]-
MUOQQ<:K9W?B2YU_519:#IJ1?9KZ_U&XK]7-3U+]G+X*_#+7[[7/C!HG@#X6?
M OQ!;ZIXOU77/BZECH/PZ;2=,MYK;P;XOU?5=<8Z3H,6E7]C)%X-URZ475O=
MZ>RVLYN;8R>)1?'K_@FPWP?L/VBT^/GP"7X)^)_AI=_ K3OBI)\9K*/P;JO@
M/P_X>U[Q#>> +76)?%"VKZQ8^'=#U_4I;>/;XS:VT^Y;SI)8T4@'\^_[)W_!
MN[_P4+_9,^,.C7/@+_@HW\-;/]G7PI9?$KP/H?P\'P*T:[\8ZO\ "+Q3IWBC
M2M"\&^+_ !0-%TVYU6XN(-6TR?Q-??VB2E[;3W&E O;V'E_<?P__ .#>3X(?
M _XT_L<_'WX!>,1\-/B#\ ?V5/B)^S)\=KC3--FM=*_:?M?$'P'U7X2^"_%'
MC;2]'FTVQ77=#U_5V\2>*-8FMKJ]\76.CZ!::C&=7T?3=;L/W.^#$WP4\3>%
MM*^)7P,USPIXP\%^,M"T]=%\9^"O%*^+_#>O:%;:KK^O6#:;J]MJFJ:=<Q1:
MKXIUZY:6VE\]9KZ2VN'V6EM!;>2Z9\?_ -C[4/@O\;&\(_'[X<VGPF_9JF\3
M>!OCCXI\'_%&T\GX':CX/L(]8\4:7XO\4V6K7-]X2U3P_IUPM[?2ZA>1SVT#
M.QD(CD" 'X%_L1?\$!?VQ? 7@C5_V<?V^?\ @I!XJ_:1_8@A^ _B/X)>&?V2
M? >DW/A_P&]AXB\+ZKX4T>]UN[\46>H75I_PJC[98>-_A?/HBQ:OH_Q*T#PI
MXG75+6+PS_9VL=G^S_\ \&WT_P .OBS\&4^-_P#P4!_:1_:+_9&_9.\51^+_
M -E/]ECQ9>+I.A^"M0GMM1AN+7Q9KVFWZS:I8Z0+[[/H"^';7P_-!9&6S66R
ML)KC3[C]UOB3^U!^RM:^&=6TWQC^T/X$\*Z5JG[/OB+]I6;6],^(5IH=]#^S
MIX9N]#LO$/QJTK7M-NUEM_ VD7GB/0;:Y\564YM(I=7LXTF8W SQ7P(_;E_8
M+_:V^)B:'^SO^TQ\%?CA\4/"'A76-6_L7X=^/;+Q%K6D>$]0O=*L]8U&XTO3
M;QHOL$E\FDV\EU<V\C03-"D3Q><X< A_X)\_L'_"G_@GK^RG\#OV7_A],WC"
M+X,Z!XFT^/XD>(M&T2W\8^(]:\>>)KWQGXZUFYNM-LXFLH-=U^]5([".>8P:
M+I/A[2KR\U%M'M[IOMJ:]L[>:TMKB[MH+C4)9+>PMYIXHIKV>&VFO)8;2)W6
M2YEBM+>>ZDCA5W2V@FG91%&[+RFA?#SP=X9C\(1:'HR6,?@+PI%X(\)JM[J4
MXTCPO#;:9:1:4INKR<WBI;Z/IL8N]0-W?D6P8W1>6=I>AO-&T?4;W2=2U#2=
M-OM1T"[N+[0K^\L+6YO=%OKS3KO2;N]TFZFB>?3KJZTF_OM+N+BSDAFGT^]N
M[*5VMKF:)P"S+>V4-S:V<UW:Q7=]Y_V*UEN(H[F\^RH)+K[+ [B6X^S1LKS^
M4K^2C!I-JD&K59EUHNCWNHZ5K%[I.FWFKZ&+X:+JMU86MQJ6CC4X%MM2_LR^
MEB>YT\:A;1I;WWV26'[7"B13^9&H4:= '#ZYX>T[QG>^%=5MM>N(T\&>*KC5
M-FCWD4MM?:AIT.H:+?:/JAB=U*VES+<17=JQ\ZWO;8Q2HDL;JO<?_7Z^Q_KU
M'M69I6BZ/H4%S:Z)I.F:/;7FIZKK5U;Z586NGP76L:[J%SJ^MZM<Q6D4,<^I
MZSJUY>:IJM_*KW6H:C=W-[=RS7,\LC:1ZCGN1UZ\'\^G]: ,=O$?AY7M(VU[
M1EDOYYK:P1M4L0][<V]W;:?<6]HIGW7,\%_>V=E-%"'DBN[NVMG59IXD?'N_
MB'X L-&M_$-YXW\)6V@7DMC#::W-XBTA-)NIM4U^Q\*Z=';Z@UW]DF:^\3ZG
MIWAZU$<K>=K=]::7'NO;B*%FO\.?AY)-I$\G@/P8]QX?O;O4]!F?POH;3:)J
M.HZMIVO7^H:1(UB7TV]OM=T;2=:N[NS,,]SJVE:=J,TCWEC;31'AGX<_#WP5
M:Z-8^#? ?@SPE9>'+'4-,\/6?AGPOH>@VN@Z;J]^VJZKI^C6^E6-I%I=CJ>I
MN^I:A:6*007M^[7ES'+<,9" =G1110 5Q=M\1_A_=MIJ6OC?PI<OK'B?5?!.
ME+!K^ERMJ7C'0DU!];\+6*QW3&Z\0:2FDZHVI:1"'O[(:?>?:((_LTNWM#SW
MQR/T.<?CTHQ]>N>I[8_3CIT/.>IH Q- \1^'_%5C/JGAG6]*\0:=:ZUXE\-W
M%_HU_:ZE:6_B#P=XBU3PAXMT.:XM)98H]5\->*]"UGPYKM@["ZTK7-*U'2[V
M*&\L[B&-=;\1^'_#,-A<^(M;TG0H-4UK1_#FF3:OJ%KIT6H>(/$-_#I>A:)9
M27<L2W6K:SJ5Q;V&F:?"7NKZ\FBM[:*25U4[0[]>O?WY_+G\.@H_S_G_ #SW
MH P];\3^'/#;:,OB'7M'T-O$6N6/AK0!JVHVFGG6_$6IQW,NG:#I7VN6+[?K
M%]':74EIIUKYMW<);3-%"XC<CXW^"7[:'[-WQ(\5_M-Z?\/_ !3X?D\)_ CX
MO^*_AY\3_B#H7@OQ)H_P^T?XE^!?!VD^(?BQ%XW^)DFEQ^!C?^$8YK31]9\3
MZAJNGZ5+JVGW7A>VU35-;T34+.S^X\8^G/YDY_Q_/VKB_"L=J=4\9W&FZ]X;
MU33KCQ"4DT_P_I^G6USH>N6VGVD.N6GB&_L+VY;4]=GD^R7%PU_;V5_9VS6E
MM-'*@BD(!Y5\/_@M^SOH'[07Q_\ C_\ #OP]X1C^/?Q/TWX5^ /C]XIT>\@O
M/$5\/AIX9N-4^&^D>)X4GG?1M1M_!?CO3+E(3'92ZOX<D\(W=S%<V]EI5P/D
M3XX_L8_\$L_AC_PD?Q ^/'P6^"WP\\&>+=(_:%E^)7BKQEH,WAWX)7]K^T1J
M?PGC^,UW\5O%-[##\+_#6M?$+Q%X(^%Z^&KGQ;K&@:[J7B;1X(OAV\NL)J<=
M<7_P4P_X+)_LV_\ !+_XD?LG?#'XS65]KWB#]J3X@-X<*Z/K%EIX^%_@&TO=
M+T;5/BUXNCN;2ZW>&;'7M;TW38;0RZ?<ZFD6O7FGSSQ^&]5CB^J[_P#X**?L
M)Z9\<-._9JO/VM/@/'\>]7\2:!X/TSX2I\1?#]QXWOO%7BJ*TF\/>';?1;:[
MEN'UC54U"R-IIX_TEC<Q1O&CL%H ^2E_X)'?\$?=%^!,/P#/[(7P<;X%>*HM
M>^.0U.7PUXBU7P=:76A>%K30[SXDZA\8V>[T7PAK"^$?%D!T"[U7QAHUYK^C
M65[JN@6VK6G@W5;S1?I7]C[Q]^Q%\.?@?'\(OV8%L_A%\&OV>_!UUK,_@CQ3
MX#^)/P77X?\ @RXFU3Q5J?B/4]&^-'AGP=XAATJ[%U=^,M7UZ\MY89-,\1:/
MXKO+L:1XL\/ZCJGQC^U1_P %^/\ @G]\!?V=OVG_ (W_  M^+'@K]ICQ=^RA
MXA\!>&?B)\#O WC;3O"GC^YU7QO\5-)^%4D>@IXML;<:['X=U"^U;5-9G\/6
M6MV]K9^'[S[5+9PS079VM&_X+N?L%:'\)H?C#^T)\5_!?[/_ (9\0_M*?$7]
MG#X=B_\ &^C?$VX\;77PZU'2-,U7Q^H^&D6NCP_X0CGU:*XU6_U=5M/#NGM8
MWNJ:A'%JMD) #]G8)H;B&*XMY8Y[>XB2>":)UDBFAE421RQ2(2DD3HRM&Z$J
MRD$$@@UR_CKQQX:^&WA36?&_C&]N]-\,>'K>.\UO4[31M;UTZ98M<0V\NHW5
MCX?T[5=2CTRP\X7>K:G]C-AHNF0W>KZM<66E6-Y>0?EU^TI_P7/_ ."7_P"R
MGX^^.7PD^*W[47@VU^+_ .S_ ."KKQ=XX^&^D1:GJFN7&I0P1R1?#KP[?V]D
M?#^M_$V>2XT^"?P19:N^LZ5)?(=:@T\6FI&R^7_V=/\ @X@_9"^*?@C]I7XU
M?%;Q+X6^$GP"_9T^#'[&7C^\^(-SJ&O7>K^*_B-^UMI_QPU]O@[X?\%W>AV>
MNZOXN\!:=\,]$T">UT*'5GUOQ /'&LVWV?P9X?BUMP#]W- ^('A_Q)XH\4^$
M-*M_%IU+PA:^'KS4M4U'X?>/M#\%:G;>)[!]1TN3P7\1=<\-:=\/_B)Y=K&?
M[:C\ >)O$TGAFZ>&Q\2)I-]<06TF[_;MDNOQ^&3!K/\ :4FC2:ZMR/#OB!O#
MXLH;V+3W@?Q:NEGPK'K)GF22+P[)K*>()[)9=2ATM].@GNH_Q*UW_@Y"_P""
M/'ACP?\ "KQKK_[66EV.G_%[P(GC_P -:;:^#O&OB#7M)TW^U+[1+S1?&FE^
M%]#UR3P?XMTS5M+O;._\-ZX]KJ*>2MY;QW&G7-K>3_M'X$\:^&OB3X(\&_$7
MP9J']K^#_'_A7P]XV\*:J(+FU&I^&_%6DVFNZ'J M;R*"[MA>Z9?VMR+>Z@A
MN(?-\N:*.1610#BOAKXO_MG0_#MWIWP9\8_#FQ\6ZY\1;^_T_4?^%4"/0KNT
M\6:Y))XJ\0R?#[XB>+-'OH_BW>";QQX>U'PU?^)M3O[7Q';WWCJ'POXCN-6T
MRR]&N=6NK?7](T2/P]K5W9:EIFMZA<^)[9M%'A_0I](N-$@M-(U=;G6+;7FU
M/Q$FKW5SH?\ 9&A:MIPM_#VMG6M1T:8Z-#K'#?!47Z_#3PX+]/A9&HDUT:2G
MP5,S?#0>&/\ A(]7_P"$0_X1PS)&/,/A7^QCKHME&GCQ&=7&F%M.%JQ]2) S
MST_PSC'7..<=<4 <>^O^)+?Q*FDW'@C4)]"O=6BT_3?%&DZQHMY;6MHOAF]U
MJ]UGQ3I>H7.D:CI&GKK%FGA33XM#3Q9J%[JFH:=>W5EIFCO>WUAIF]U_^W+V
MR&@VQT*'1XKRQUPZT@N+S6FGE271Y-'^P&2TMXH$AN%U4WLZ2-,T/V-#%O?>
MHH \?M_%?QD?0KR]N?A!H-OKT/AGQ)J5EH2?%2VGMKSQ/I\'A^3PSX8DUG_A
M#HDM+3Q'/?\ B*"[\0&PFBT >'K29]-U)=<1=/U?#7B+XGZA%9/XG^&FC^&Y
MIM$\27E[%9_$*#Q MEKNGZK8VOAG1(Y4\,:8+NV\2:3-?ZK=ZP$@70)K&+39
M+'4FO!=0>ET?Y_/I0!XWJ?BWXT6WB'X>6&E_!S0-2\.:]X9UC4?B+XAG^*]K
MIUW\/?%%IX=N+_1?#.EZ$?!MT_CFSUCQ'';>'KCQ#!J7AZ/2K6X?76TR]2 Z
M=+QOBKXB?M.Z9XM\+Z7X3_9J\(>*?"&I>&+'4O%7BV^_:"L?#=]X7\436%_/
M?^&+/PQ)\,]6D\1VEC?P6%A%XACU?2X[V._DO1IENMFT$WTM_G\^E% 'EV@^
M)/BI>^)]+TW7_A?HNA>%KG2O&=SJOB>U^(T&M7FEZMI'C Z5X*TJ#PZOA73Y
M-2M_&7@['B^^U(:I:#PG?9\+36>L2@:N<$>,OCH5F)^"7AM637O%UE"/^%P6
MQ$V@:5XG\-Z;X/UTL/ O[JY\7>&-0\2^)K[12K/X7NO#=IX?EO\ 5YM?CU'3
M?;LC\R1T/49S_(\]/S%&1DCN.H^O3_\ 7]?0T >#>"?%_P"T+K?CR#3O&_P6
M\$^!/ATGA[Q-=7?BBR^,#^,_$LOBBU\26=AX4TJR\,6W@+0K1-)U?PN-1\0:
MOJUSKHN-*U!K'0H-.OA]IU(/?6/VC;^\NX[+P7\+/#MC%XH\,FSN-:\7:_K]
MQ=^"EU[5['QFDUOI&B:6MIXI?0+/1]?\*.)KG2/M&N3Z)K*))HC7^J>[T4 >
M2>)KSXWPZI]D\):'\.+W3+WQ:8[?6=<UG7[.30? UOX.TBYDN-3TBSL)Y-<\
M4:EX[77M+M8-.O\ 3-,T[PT^CZG=27E_'?6,F'/XA_:(U&+18M+^&OP[\-7,
MU]X@77KOQ%\0=2\0V=AIMKX,BN_#<NFVNA^&-,N;Z\U?Q_?+H^H0S3VD.E>&
M-"U'6$EO=0U;3=,MO=Z* /S@_9Y\8?\ !1'6O&OQ_P!)^,=C^R)JV@:1\;/%
M6F_##4OAK\1/%.MS^$_AGI^@6LWA?0_'_AS_ (1RVU:Q^(&MWU]87^K6%WJJ
MIH%I#J1C.I6^I:-)%]A^'G^.IUFP_P"$JA^%*Z =O]IMX?E\6MJX!TK3"_V$
M:BHLV/\ ;9U=5\\X_LQ=.)_TIKD#JO"MY976H>,H[3Q3J'B.2S\2RVU[97L%
MO%%X6NA86,AT"P:#3K%I[2..2.\$L\NH3>;=R*;QE58H^RZ=* ..@;Q__P (
M[X3-Q'X1'BPOX:_X3A(7UC_A'XXBMO\ \)?_ ,(LSC^T&=&^U?\ "._VJ K
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MPC>:59IX/LK&UL] TM+6Y\,W-K-?\!?\$G?V:= MO^#A7Q;=^-_VB?&FH?\
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MO?#/[4_[47[2^D^//@)I/CC]G'XB_LF^./A_X:^)GC?Q;:?&/QGK?ASP_P"
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M1+*]\6ZWX,\*>!_#GA'1O!'A7^B7]F3_ (+N?L(_M):%^TQ^V=JW_!)CP_\
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MM)H8WR6W+@\_Q0?%7_@LQ_P5U_8=_;#^//A[]K7Q%^RGXLT;QC^S;^UQ\<?
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M:);'4]/O6GM$OX5M+VVN6FL7E:%+V(0R.9+1YD>)+E 86E1HPY=2  ?SY?\
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MP[INEV0!^,OPN_X.+O\ @H3^T)^R[^S]^SY\/_C)\+OAY_P4,^*O_!37P/\
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MO%=S_LQ4-O;P6D$-K:PPVUM;Q1P6]O;QI#!!!"HCBAAAC58XHHD54CC151%
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MK>VT[7)M..H:?;3W"WT%M,D5Y#',I!_S7OV8_P#@V]_X+,?"7XAZ+\;O%W[
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M\<_B#\7?B=?V7Q'\$_#_ .#/QJ_X*^?L_P#[>?Q$T3P3JNK:5X@U'X%?LY_
M_3;'1? 5Y9)X5;1M1\6^,OV@_!7@7Q7=6!EBTG2-)MYO$TFN7OB73[/3W]E_
M;B_X);_$+]L']H;XSW6@^.=$^!OP9^-O_!/KQA^RWJOQ#\&1&Y^(WAOXA>+_
M -HGP[\8==UJU\$6L/A^PUO3/$VEZ;K5CXDU"X\8:?>ZG-X@U1;E99+J664
M_-']H7_@[.^#'PQ\/_MJ^,_A%^SM<?&;P5^S-^T=\#?V;?A/XDD^)\OA;3/V
M@/$/Q!TKXVZQ\0_%D=[8?#_Q=:>!O!WABT^"6LW'P^U%I?$]U\1=-U*QU*[L
MO";-]@;]//\ @D__ ,%;=4_;Q_X)O>/O^"@/QT^'/@7X0:3\-_$7Q>MM?\-_
M"SQMJOQ0N8_"WPD\/:9X@U+4=9T-M"LM>\)^+KV.ZOFL/ TSZ[?ZAH \,^++
M:]6T\866FV7\WWPY_P"#5?\ ;>_9 N_BK\0/V8?BW^S=\7OB'X0_:-^ _BC]
MG6Q_:!L_%.D^&O$?PM^'\-[XF\<^)?&/A[P];:QIOAKQSX@\1ZE9?#<Z0FIZ
MQ#>_"&3XK:>FKZ1JGC30YK/]??\ @F_^P-_P4M_X)^_%GX#Z);>'/V6[_P !
M?M?_ !S_ &LOVH_^"H-_\*O".D^#_AE\)9=2\!^ /#?[.?P'^ FG2ZGIVO7&
MF:3X@/B3Q%!)HO@*WL&O]0\2:7KNL3Z#I=AJVN@'G_B'_@X/_:=^-G_!/#XC
M?M8_L7_L)W ^*&C_ +0WQ/\ AEI'A[XU:OK&L^!?A5\&_@A\,A\8?B?\<?VC
M[K0F^'-CX%>Q\*VMWHNG>#&^(6GP3:O>+J-CXMUMM%NO#NI^(:)_P=.>/_BG
M^R/^RQ\4/A=^QS=Z7\<?C?\ M'6/P:^)+ZQ)XG\=_ +X6>"_#WCWX4^$_&'Q
M#G\4:"GA'5_MGB\_%+1M)\#^%M9O-.F\/:Y-=7&L:CXHTW2[#_A*OL/]I?\
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M?ANTL#X>35@MY;Z0]I;M'!%%%;P_H!XK_P"":G["/C_P%XC^%OQ!_9@^%?Q
M^''BKX]>,_VG-4\$>.="_P"$K\,Q_'3XA17T7C+X@Z3I.MS7EKH6IZ__ &KJ
M\UY:Z/'8Z7]IU?5+F*QCFOKAW^D_@U\$_A'^SO\ #GP[\(?@7\./!_PG^&'A
M.*ZA\-^!? FAV/AWPUHZWUY/J%\UGIFGQ0P)->W]U<WMY<,K3W5U/+//))([
M,0#TJX@BNH)[:=2\-Q#+!,@=XRT4R-'(HDC9)$+(Q >-U=2<JRL 1F>'M!TK
MPMH&B>&-#MWM-%\-Z1IN@:/:27=[?R6NE:1906&G6\E]J-Q=ZA>R0V=O!&]W
M?75S>7#*TUS<33/)(]K56":7J3F6. +87C&>6ZGL8H0MO(3++?6W^DV<<8&]
M[JW_ ']NJF:+]XBUQOPEN5O/A7\-+M-5L-=2Z^'W@RY77-*\3:[XUTK65G\.
M:=(NJZ;XR\4%O$OBVPU ,+NS\3>(F;7=>MIHM5U<F_N[@T >@T444 %%%% !
M1110 4444 %%%% &/H>@:3X;L9=-T2S%C93:MK^N2P":XG#ZIXGUW4O$NNW9
MDNI9I0U_KFKZC?-$'$$#7)@M8H+:.&&/_*'^,?[0_P"V#^S'X&_X*C_L1:KX
MJ\3?%31_^"CWQ,^/7C_X6^'OAH?$NMWNA^//@;^W3\0OAO\ '_Q)J^AP:EI%
MUX.T7XG^!/A;\6I?$=EI=EXP@\4Z?HO@%_$"6EO#K,=O_JZZ/XATO7]/N-5T
MB6XN[.UU+Q%H\A:QOK*<ZEX7UO4?#NM6T=I?V]I<R+;ZSI%_:P7*Q&TU".*.
M]TZXNM/NK6ZG^3/!W[$/[%EWIOPV\6VW[+/PO_M/PKK?Q0^)W@6_\>?#S3-7
M\>>#/%G[1.NWGCGXQ:FNI^*H=6\0Z1K?C[Q!J]U=^,;-M0,<LJPZ:8DL-.L;
M6V /\^7]K7X-_"7XT_MO_"O6+GQC_P $Y/#?A'Q__P $R/\ @GK\7=#^('_!
M0?\ : O/AM\.=>T[P1\-]!^$VJ>'?@\?AO:ZCJ]GKFJ/I(&K^#?B1I,>MZC8
M^%-1\5:.H\(7&EB\_6G]OO\ X)B_\$W/CK_P7&_X)EVD'@SPQJWPJ_;U\!_&
M3XY^/+SPSXX\4'PI\:+[X>^#=&\>_#1/!K>%['Q!X?C\+>(?"?AL6S:9:3^#
MO!FK> [K6)K#Q):^(CX<LM9_I^^./[$__!/+XD^//A_)\=/V+O@1\3/%4'A7
M3/ W@'Q3XL^ 7A/QE%I.B>#HI)?"WP[LM>N= OAHT-A817\WAG1[E[72;6PT
MZZM[>>V"6UM-L6/Q$_9W\8_&73_&<'[-7CS4_BC\$OA-XC3PC\6+_P#9XO(+
MKP;X:U73O#NJ>*/A5X!\::GI\%W9^)+Z*;2K#4O"7AR6.VOKFQN]-2ZG2SNH
MP ?P%^(/AM^UYX9^&O[4UE\-/$'P:TK_ ()7^%_^#B#3O#FM?#S6]96U^/WA
M[XG>%?C-X T"&ST:+2Y/$'A7Q3\-H?#]_P" M-33D^(OBK5XY/"<.J6FCVUK
M8W=VO3:=HG_!(KXG:-_P6*U3_@L[>W/P;_X*=>$/VKOVDM7M)-0\0?$5]<EL
M?&XT[1O@OH/P2T+PK>^,[;X@:%X+\7Z;<6]M;:=H^KZ7H/P^U/0_$=]?-\.7
MAUS3O[ZCX<^"W@/Q/J/[.>@?LDW\_P -+;2/$W[3_B7Q-I'PR\,W/P@N/B9>
M>/+GQ5(A%U<&]\8?'3Q/XQ&H^-]T6C7U_%>P6FLWNLPWT]@J]!XP_8L_8X^,
M7Q6\-_M)?$C]ECX&^-OCCI5EX<ET/XJ>.?A-X/UCXE:,GA_S[KPW%_PD&K:1
M=:Q;7?A][ZX6PWW+3:8Q\FW=$@A6, _S8/V9/B__ ,$Q+S_AX!X3_P""T'PR
M/PV^+GC?]F?]D:;]G.\U/1_B1\2OCC<>,_!WP.U6"^;PK\1OACX;\7:-X F\
M8G3OA7K4$'Q$M=#1K77$T?Q9?WNF:;J%E8?F-+XMU6U\)^/;WXZ^+/!J?M++
MX<_9F\"6W[/'[07PM^/^B?M566A?"S3OAW??![5?V1/B-\-?@[JW@OX4W/B'
MX92Z1X:ATOQ[XC\%W-SI%Q-XEL[;7+S4]!C/^M@W[)'['WQQ^++?M%_$G]C+
MX2W'Q]\$^)?[ TSXG?$SX/>!-2^(N[P-NTOPSX@T'Q=/8:E?7VBQZ887\)ZD
M+T3V5D(((8K*2SCBBF\?_#+X+1_$;P1^T]XA_8P\.^,OC5H$_C'05^*5M\/_
M (=:_P#%SX=>$= M=:UN/7;+79M_B2_A\13>%-'@\.:5X;O+SQ!]OU[2+5+:
MU+7PB /YT_\ @N_XAOO'C_\ !&_]JG]L;X%_&?0/^";^F>)[#XD_M^?!B\TS
M5O%%O\'_ !1\1/!7A"_^'OA[X\>!/"TMGX@U-_ 'BG4=9\+Z_?1:5+907MIJ
MVAVMG<:]KNCZ%JOX-_M(?#7]F3X_7O\ P5:^-/\ P21^$WB"#_@G?KWP4_90
M\-ZKXM?3_C%\,O@'\1/VR?#?[3'P8\17OA?P-X+\6^ ])DNH="\)_$G2;;Q1
M\&/$/AG^T;JRO?&/B_P;K'A_2_%&@BY_T3])^(_B[Q_X+\)GQI^S)XWTF+QS
MXBUCPSXM\#>+KOX>:TWA+0K"SO[NU\1>*X+;7M3T75-#UJ>RM;*TL],FU*^2
MYU"U:[M(88YI(^-\%>.]=TGPQHTFG_L>>(/AAHEYK(U[Q;H B^'<$WA];2\\
M;63Z]!H/@F\U1?$GB;R? G@N[L+;3T^VR6?CCPRQO8I=$U6WL0#\^?\ @EK^
MP-^T5^RE\ /VHM)^.WPT_8J^&'Q(^-(%GX<^'O[#?A#4?"7PS.D:)X OM'TG
M5O$^K>+O#OA?7M4\;ZWK>N:G:7J7XET31M+T[2S87,;7FHJG\@/[,OQ^\0_M
M6?#/_@G+_P $V/ /[/'QDO\ X\_\$X_"G_!07P+^VY:+X7TS1? O@[X2?$'X
M4_$7X6^+M5TOQ]X0\<7^NCQ?8I?-I]G=1Z=H=YKOC>?3M!\/+XFGU.&QU3^]
MGQY^U[\7O!K:V=-_81_:<\<P^'O#]UXBOY?"<WPJE:_BBU/Q!:VFC^&H=3\?
MZ=+XA\17FFZ';ZPVDVJQ-:PZ]H]C-/\ ;YIX(/,- _:H^-]EXPUG6]-_X);_
M !P\+Z-JWBFVT_QSX^_M_P" ^G^+M3T?2;35AK7BR3PWI7BJ?7_&46EWMO96
M_AFQ&HS7WB?3]3EOM/-E);?8;H _SR/^"+OA_2;+X^V\/P]U+5?'5[\./^";
M?_!1/0/VE-%N/V=]?^$/B#]G77=0^$7BS4?LWQ4\>6.N^(M ^)6BZIXWU.?P
M7X*\4^*[S1=4M!IHT34? OA?5/\ A'H9OU\_X-+OVE?V8_"7Q-\%?LT>$?CY
MXF\5_%?XJ?L_?$37]>^#D'[$OA3P'I_@[XA^&O&&B:]XAN?&'[4^@^)O&'C/
MQK"W@C1(1X(&L0^'OA_JEBCP>()/#?Q&D\%>"=3_ *SM$_: ^-">*=%T_3/^
M"9?Q$T67XHZW\3IOB?XHF\3?!/2;'2?!?AOQ%-IW@;Q%XPO+;5);GQ=XG^*G
MAV^378_ _P#I&H>%[B;5M)UW49#:M>76E\.OB_XQT+QU'IFC?\$V_B#\-3JW
MAL:C)XRT-?@;IMM9Z4^HZQ8GP]XCO=$\16LZ:Q=:OX974+;0].FUF#^P]0\.
MZYJ,^GS7J6,(!^5_[7'[&/[/WAK_ (+X_P#!-'XCZ=\-OAD\'[0_[-__  4%
M\/>.O %U\.? Y\,:_P"+?ACX=T7Q]'\2-=CN=*D3Q)XN\37OQGO[/5=0UR*[
MEM;'POIAMITBDNXQ_'E^S/\ LI_\%%K+_@GE\'_'_@S]J*%?@UX4_P""MGPG
M^%OPS_8[?X9^*/BMX0N/V@- ^)3VT?Q*MK[1O#/B32/B'X2T/Q)IUW?ZGX1^
M&FA?%'3?%&FV6H--:OJ:'19_]-S5_'?Q(U/P[?>-]%_9EO[_ .(7@_PM>ZOX
M4T#QCXC\%:-J]_>:QI?B%]2\(>'O%5M)K\.BZIJ%_P"'/#&F:I+,UKI-Q;Z_
MI]U/=7$>DW$*?$UW^U)^W_I.M^$_#WA+_@D?<2-?:[>W/C+Q++^TY\$- \(^
M&/%NK:_J6E:KXJTNXM],NM9\2:7J&CW<WB*_\11:-I^O7L&JWNG3Z;+=^>;@
M _D0_9$^+OPC_8O_ ."QO[0_PV^+/B[]NKX1>-_BY_P5-^,#?#WX1_"K]E?P
M9XY^%'CKP#XE^*FD3>%_$4OQ@^*EGX?_ &C=+L=:O]22R\<ZE\*? TUKJOPZ
MGLIM)NM;TCQ.;P)\ _V:?V@/ WQ"_P""./[6_C31O$GQF_8QOO\ @IE^TYJ<
MW@?X._ 39\7_ ('?&#_AK[XZ:!\/_%_BKQYX'^'/B#QY\4/@OXDN=(T3QQ:V
M?B'4&N(EAUSPEHS6^G7/A^>U_M'T7XF?M]>,--MO%?B']AGX*^$=?T87L%AX
M9\5?M':1XD\275MJ$ECYJZ1XET/X>W6E:! +JUM;_4HK@SG4(=,MH8XH[A+2
M9/8_"_Q"_:LNM1\0:?>?LP>"/"?A;0_%UKX;\(3'XVZ;/=ZWX+T_7-5T:^\5
M_P!CZ=X-%OH5N^CZ?IFN^'/#[W,MW/8:I%8WQTV[M9H@ ?P%?\$P=0\;^%?V
MS?&7PBMW_P""D<OQ7^+O[0/[:GPE@^"_A+X(>%]*_9$O/AI\1?#7QCDT37_'
M/Q+\3ZA#XNB\+K\1)]#\6_$/3+?1M&T;3[32K+QT^LZCJ/A.RLYI_!5O^U7X
MG_X)@>"?^"02?\$)?VCM'_:CAUZW^&]C^VGXD^%7B+PSX?\  'CJR^.^E^,U
M^+6H>-?"WP?G\2P:)X!TSQ?H4<_B.'QIJ>CG0V&N1ZCJ/AZ$6+?W.:=\0?\
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M=W-9W<-C<I97LMM<16E[);B[2TNI(F6WNGM&DA6Z2WE997MVFB$X0Q&2,,7
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MI=QXOO\ Q+);QFVMO"EEHL_B2ZU1DTBVTN75'2T;HHW$D:2*'"R(KJ)(Y(I
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M7PW\(>$_&FO>!M5T_2O#O@_PC<:E)X^U#5?%-^-&'B/3_#5I9>$M7GN&\1^
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M (*"Z%\9/B]^V=X=_;OTO0_BW^TE^QY^P1'X6^&^H^!/"6EZ-I\OQI^(&E^
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MZOJM\(/#T^IWOB/3O#=IK6GVU\ ?UG7'_!U]_P $U-6\7_#NT^&^B_M">/\
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M M*T'1?#GASPQX3LKVXUC7#9Z=H\5Q=:KKE[+=W,T45G%; 'Z4T444 %%%%
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M%H'A/4;:^NK[2M(M]4L=/ /\]+XZ_!W1?B]_P<L_M"S>,/CC^S9X#\+>#?\
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MGQ D>G#P[%H\LAU:Q751K$UY"D>A%G_M*33S90S-)JB)Y?V&&X$=H[%A/,@
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MU3PUX/U/[4EYH4<LX![#17C-C\"?!=I)\4%N-2\=ZMIWQ>T9?#WBW1-6\?\
MBRZTJWT=-$G\-I:>%(DU2&Y\%N-#G-@;WPM=Z5J#O'#J4EV^L)_:)VM5^%FC
MZM\0K3XE2>(?'5GKMEX4U3P=!INF^,=8L?"?]E:LQEN;J;PG%-_8=SK<-R(;
MJQUVYLY=4L9;>)+6YBMFF@F /3,X]?R)[@=OK^63T!HKP7QU^SGX$^(X^'K^
M*=:^)LMY\.+2&QTO4-$^*?COPE=Z[;QMI$TH\9CPIKFBVGBM[F]T/3=1N)=6
MM9I6NHKA8WBM-0U"UNO1U\ >%D\$2?#E;*^_X1&32)]":Q.O>(&OSI=RDB30
M_P#"0MJA\1K,RRR!;U=6%]'D&*Y0JI4 YC3M%UB3XV>*/$]SX>LK+1X?AYX6
M\,:7XC'B5+O4M;F37-?UJ^M)/"D6FK_8]AICWBQPZO=:O+<:K<S7$,6FV]O8
MK=77K5?B3X._X))_!C0/^"BGB_\ :?UWQ'^T3\0]1\2_#D3WMYX\_:Y\8ZBB
M:Y:_$O3O''@ZV'@#P\WAKQ*_@;P/?1^(-(^'^F:WXGUGPAI,%]XFTF?P[/;W
M&F26WZ??#;]FGX._".6]F\!Z%XBTV34?%EUXXNSJOQ)^)OBQ9/$E[:7EE<7:
M)XO\8Z\EO9O;7]TB:+;K%H<+NDT&FQSP6\D0![Q1G^O8]O\ /X]J\:\4_ +X
M7>,](\+:%X@T?7+K3/!GQ!N?BEX>AM/'OQ!T>>U\:W>LZSKUQJ%Y?:+XIT^_
MUG36U/Q#JTR>&-;NM1\*PPSV]A#HJ:?I^GVMKV,WP^\*S^"]8^'TME?MX4U[
M3M<TK5+)?$'B*._FL?$@O!J\4'B"/55\16$DXOKH6]UI^JVMUIV]/[-GM/(@
M\H [2FNZ1JSNZHBC+,[!54>K,2 ![DBO)-'^!?PST'P]XB\+:7I.MPZ)XJ\,
M+X.URWN/'/CR_N;CP^NEOHHM;74]0\376JZ5=?V=(T)U;2;VQU@R$79OS>*M
MP,W7?V<?@UXHT_5-(\3>$)/$6CZWH]_X?UC1M=\3>+M7T;5-(U/4M3U>]LK_
M $C4-?N--NUEU#6+^X26:U>>WWV\-M+#!86$5L >SI=VLC(J7-N[2/<1QJDT
M;,\EI*8;M$ 8EGM9E:*X506AE!CD"N"*L5XC/^S;\"+CQ3#XV;X6>$(O%EI?
MZ;JMAK]GIHL-2TS5-,\9>)/B&-2TFXLGMSI.H:MXX\7^)O%/BF\TT6MSXRUG
M6KZ]\6RZW)*"OMU !4?FQ>88O,C\U4$C1;U\Q8R2 Y3.X(2" Q&TD$9R*DK)
M30-"BUR?Q-'HFD1^)+K38=&N?$*:;9IKEQI%M<27=OI4^K+"+^;3;>ZFEN8;
M&2X:UBN)9)HXED=F(!K4444 %<MXW\=>"?AEX1\0_$#XD>,?"OP^\!^$=+N=
M;\5^-O&_B'2/"?A'PQHMDN^\U?Q#XDUZ\L-&T72[1/GN=0U*]MK2!?FEF0<U
MU-% %:SO+34+2UO["ZM[ZQO;>"[LKVTFCN;2\M+F))[:ZM;F%GAN+:XAD26"
M>%WBEC=7C=E(-6:!_GO01G]#^1S0!C:!XC\/>*],CUOPMKVC>)=&EN]3L(M7
MT#5+'6-,DOM$U2\T36;*._TZ>YM7N](UG3M0TC4[=93-8:I8WEA=)%=VL\2;
M-'<__7Z_T'3IWS10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110!R&B>!/#&@>'-5\)VNG&^\/:WJWCC6M6TS7KJZ\10:A<_$3Q/KWB[Q7;
M7?\ ;DU^T^DW^K^)-66#1Y6;3-/TN:'1;"UM])M+6SB^*/B#_P %)_V6_A+^
MWU\&/^";OBO6-5TG]H7XX_"Z3XE> TCTJT7P4=%MKCQS:Z;X<U'7_ML;:=XE
MU0^ /$+:)H;6)^UJVG);OYFIVL<GZ#5_ =^U!_P2A_X*A?M"_M5?M*?\%B=-
MM%\->/?A3^WSX8U3X'?LHZ[\./'WB?XS>,/@C^RYX_C^%?@_Q1X"\4-9:=X@
MTKPEXT\-2ZUX\L? OARTM_"?Q#T3[)XJ;6K<0>&S; ']%'Q2_P""R7_!,#X@
M?L^_M7_$[Q_'J?Q6^%O[&W[37@#X#_%GPQ??"Z3Q5?O\4Y_&6DV'P_\ $>C>
M&;Y9!-X/N/&2:I9Z1XHUL:1IU[=^%O$EC''<F6WL]4XZX_X.+?V-E_:4U3]D
M_3/@K^VCK_QDTSXHO\*?[!T/]G37[V*]UAOB!<?#BRUVTF^WQNWA/5/$%K,=
M-\03Q065U:JSAEE5XD_D=^(W_!$[_@K/??#O]K/XZ_"+P-\5?#3_ +8W_!0W
M4_A+\5_V2[CPQ;:3J_Q2^ %M\8/"GQ&^$GQN%_<WMY<^%OAWHGQA7Q,/%-[X
M];P7I>D>#=*T+QV_B+4?!>I:I<O_ &Z>%OAE\1]._P""RG[1OQCU#P)XRM?A
M)K?_  3R^"_@C1?B2GAW69?"FI^,]"^,7Q(UG6O"FCZSIT0>_P#%&F:3?V.I
M7&B:5<?VREK=6DT,:M-;LP!]3_"G]N+]GOXM_LN>*?VPH/$MQX,^ O@K4_C?
M8^+/%GC^Q_L--"L_V??B1XV^&?C_ %J_M5DO'32XM<\ ZW=:9(GF7-YI[6<B
MVR74WV5?R@^!'_!S'_P3C^,OB+XP:)<6OQM^$.F_#'X;?%SXQZ'X@^*7POO_
M  O8?%GX=?!#1=%N?'6H_#ZS$\VHZGXEL-2'C'1(O!\MK'K$2?#W7;O4!8*@
MM8/R4\!_\$5?^"HO[1?_  3*\$?#*]_:>\8? +X>7WP,_:OCU+]@O7]+\0>$
M;WXG_$;XF_M3_&_XZ?#+Q/\ $CQEXTO]9\3^'I?&&B^(/AA=7&C?%KP]-\2/
M!4-I?>&O&TGA_7]:\9&P\Y^*^E_\%Z?^"B?P'^)7[)?CC_@FSX#_ &/]=_9M
M_9>^-_@OQU\=K?P)X7U?QA^TI=:OX%GT&[^ ?[.7BSQFFI^"=,TK]H/X@:)9
M:_\ $3Q'\*O%^J6TVCV5KJ%E\0; W6F:5X[ /U3_ &8O^#JK]ASX\?$#1_AW
M\1_A)\?_ -F34_%?P_\ '_Q)\$:[\8=%\/:;X/\ %_A[P%X>\?\ C)HM(\1'
M6K2UEO\ Q)X9\#"+PL8TET[7_&>M6/@C2]1O-7\EKKZF_P""6/\ P7S_ &9O
M^"K'QD^*WP/^%7PL^,OPR\8?#G0&\=Z4WQ'TK24T[QC\-IKW3+/3/%EM<:3?
MW3:+<:J-9TN^L]$U%'EFTZ]CN[:\N8UDV_AI^RY\(/\ @IS_ ,% ='_X)S?!
M;QE_P3+\(?L=V_\ P2K^&]Q\2;?]H']M3P1XN^S_ !N^-/A+X<^*_ WP)^"O
MAG2)M!T'QS9?!7QWXMD\.^-/V@M"T9/$DVE:?X8MM877M&\3>'OA[H7Q)^R_
M^"*7[)7[>5U_P4K_ &I_^"@G[77[&FD?L<7/C_X/VGP-\<Z7:>/[75M#^*GQ
M?\#ZQX4\/7WCOX0?#V);_4O!GPKGT#P/:/IDEQK.H^%=66[M-0\"Z]XATRXN
M3IP!^N?BG_@L!^SAX8_X*H>"?^"4\L%U=_%KQ9\-+SQOJ'CI=?T&W\)^&_%"
MZ-JGB?1_A;=V$T_]K7_C;6O"^F'78+"R5I8+.^T\R0/YSF+YK_9^_P"#A3]D
MO]I'PGXAUCX;^!_B _C#P?\ MP?!W]C3QY\/]3ET*PUOP^/CQ\2M;^&_PS^-
MRW[79TW6/ .KGPWJ5U=VEI/_ ,)#I5[I]QHMY9(7TF]U3\*]%_X(R?\ !4#Q
M1XKOO^"SOC/6]9T']O\ UO\ ;[\*_M G]@;06M-*T#0OAUX;^*\GPJE\#7_Q
M-LU,.J:GI/PNNM6T?1?$.GR3^"]4^#WE^)]6\8^)IM<O;L=)X5_X(7?M7:=\
M2OV _P!K;X.?!;6/AKXS_P"&_/C+KG[<GPE7QGX \$6/B3]G/1?VXOB%\?\
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M--UK_A4OBO5K[SK:T.G:6MI< ']'?Q0_X.5?A!9);7W[+_[%W[6G[9.@:#\
M?@W\?/C-XC^#?AO2YM&^!EC\=/!'A[XA^"? WCF]$VIP2^-;3PQXFTR7Q38:
M/+>VVAZD\^D_:;N]T[5H].H>*?\ @Y7^'&MZU96W[*G[$/[3O[9?AL_LY^!?
MVD/%'B#X*R^$[G4/AYX:\877B?2]3T+QYX3FN;CQ!H&M>"M>\*:IH/B/?;S0
MQ:A%&T#2VE[I=UJ'YI_L5?\ !)__ (+X?\$<K>[^'G[ U_\ LF?''P'^UG\.
M_A]<?&35?BWK-OHC?LK_ +0T'PYCT_Q)XS!GN-/U3Q[X(\"^*[W6-/\ !MQX
M4TGX@R^,]*CTF;Q1\*=*:VN9KSA/@M_P2D_X+4?\$H?CCJ2_\$XOV:_@Q\:&
M_:'_ &-OAQ\,/VE_VB?B'\9/ ]IX3T3]I77[WQKX@^)7Q#\#>$_%7Q/\"^*I
MO#G@#Q;XBT9]'AO?@MK%OXB\)^&-/@L/#=OJFL^([6X /U4U#_@YP_9]\2>%
MOVC?%WP4^#?BCXEZ3\!/^"='@?\ ;=NVO=>@\*D^/O%_Q(\.?#JZ^ ^OF^TJ
M>2TE\,7?Q!\"W^M>,]%M]:MD-OXSTZUTNYOM*TF/5\K5O^#DK4/AG^SK\?OV
MM/VAOV#_ (A_!SX/> ?$?PI^&OP4\.7/Q>^'_B7XM_&'XK^/+/4]3\1Z+JWA
M?1XY-/\  7@WPOH^FS:W!XYU#4;ZWU:TBDTVSTV3798]-'P'\0?^" '[<'P]
M^'G[6_ACX<^'? _Q<U;XA_\ !'SX+_LE:1KVD_%70M)U3XO?M-VO[0OPZ^)7
MCT:9HGCC2O &A^ /"/A;1?!&M6\6H^(-<M+/Q!IEQX1U>SGF\3:YXL\->#?'
M/A/_ ,$(?^"PWBS]E#]HS]G*R^%__!/;]@OP[?\ Q<^'/CFR\$^''\3_ !5T
MS]L;5OA?XHM)=*A^+7C+Q!XR_:#U;PQ\#K;3H9O%GAGPS=:1IVMZYK@?PYXX
M^&FF:1K5S>Z, ?TJ?\$9/^"R/P]_X+#_  F^)?CWPA\&/B#\&/$7P9U?P1X9
M\>Z/XHGL]<\*ZCKOBWPU/K$S>!?&.GQ6L.NV>G:EI>LV=S:7VGZ9KECII\/:
MIJ6G60\0VUO'X_X)_P""]7P8^)/_  4Z_:Q_X)U>"O#?AR^'[.7P6\:^)/"?
MQ-O?'AM9/C+\=OA?H0\5?$WX1^$_#2:!-_Q+_".D+KEG?Z^-4GNUU/X?^,+F
MSTG4-$?2K]_,?^"&/_!)G]K7_@F5\.?V\%^)NO?LV^%_&O[2_BCP]XE^"_PQ
M_9[UWXJ>*/@]\);_ ,)>$/&.GV%\-1^+FDOXE%MJ>O>*]*MKK3KJQ\47D&D>
M$[2?4-=UUKZWTO2OSK_9[_X-4?B-\#/%GP8_:QT3]LZ[B_;J@^*.B>//C]I\
M4(M/@O=>$?B'I7B+1?VB_!7@J^T+0]+\;:G-K$/C*_ET'6-=L-)T?Q%HEI=>
M$-6\,^'AXE'B300#ZB_9*_X.54_;'^"_[(OC;P!\'O /A;XQ?$O_ (*6?!7]
MB#]HSX(ZSXUUW79? _P\_:"^'GQUU7X<?%SP5XLM]&T2XQ=^*_AWHETZZKX4
MUJPN;7P[XZ\$B.RU'4='\8:-X9^RM_P7^_X*AZ1XQ^ 7Q#_;Z_8:^$A_8?\
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M+UO2/%EEI'B;[7H]@^KG\(/CO^R9X2O+WXP_&^XF^+?[*?P9^,NO_$WXN?\
M!*CX%?$/X,^+O&^K?M%?"W7/CC<Z+X6^&FC7?@[Q9XQ'PK\2:-X4U719X]5\
M6VVK^%/&EWI5Q;:+XMUN6XT_4-1 /]AG1/VJOV</$OCWX9?"W0?C3\/=6^(O
MQF^%=K\</A3X+LO$5E-XA\?_  AO;=[JT^(OA?35?S]4\*7%M%)/%JL"M;O'
M&[ X1L>0?$S_ (*-_L8?"3PC^U'XW\9?'3PK'H/[&-]\/]._:2DT1KOQ+>_#
M.Z^*=KH5WX!CU33]!M]0N[G_ (23_A(;.UL3I\5UC4+;5=/F$5WI-_%!_/\
M?#/]C+4O"/\ P5U_X)5?M,?$6]^-\O[0O[9G_!.GX^0_M4:#XLN+73O#OP1\
M0?#;]F?]G+P@O@OX8^#M%\-:/9_!#1--\7>//&;S>$HI9]*TOQAJMU!HUMIP
ME6PKE?V1_P!D[]DC_@GMX_\ ^#C_ .%?B3X/ZU\7/V.?@=\(/V(OBEXK\*?%
MK2C\89_BQJ7A?]FCXG_'WX@R:X/%$VCZ+XV\27GC*_M?$]WHD-]HVG:?J&J:
M4ELFA6T]DR '[%:)_P %Z?\ @D]KWP-U?]HFU_:_\!VGPQT3QW9_#:]OM7L?
M$6D:])XNO3H[QZ=I_A34-(@\1:JD-AK=IK-Y=Z;IUU;66B17^JW,D5GI]W+%
MZ5\3_P#@L?\ \$T?A!XN^!7@WQK^UU\)X+W]H^WAO/A1K&B:XGB;PEJUE<W]
MAI=K>ZUXL\/KJ.@>$K2ZO]2M;:"X\3WVE1,QG9F6.TNW@_BA_;F_X)[:3^R+
M_P $T_\ @F!=Z9I6I>$/%G[5/C7]ICXS?M1_$C]F_P#9S_X7XOA/3?VJ?V:[
M[18?!G@_X4ZEJG@JV/A;PO\ #_QY'\,O!D4_B;PW=>"1]L\7>&]5N/$6CVM[
M=_,/BC7?V5O 7['_ .R9^R#\0/\ @G7\1O 'Q&^*OPX\$:C^WC^U_P# S]DB
M/7?CG;?L_P#A_P 6:MXW^#'A_P"$6F:_XG/@VP^//QS^'=OX&UCXT?$#4?$A
MTOP3=ZTUGKOAKQ[XET&[T#0@#_2)_:Z_;6_9F_85^$*_'7]J+XHZ1\,OAG-K
MVC^&+#7;NVU'5Y=7U_7A-)IFF:/IFB6FH:CJ=Q-:VMY?O]DMI(X-/L[J\F=(
M(6>NN_9E_:;^"7[87P6\'?M"?L\>-['XA?"?QY#?S>'/$UC#=6?VAM+U&ZTG
M4;6\TZ_AMM1TR_L;^SN+>ZL-0MK:[@9 9(5#H6_B%_X*Z?#3_@KC\8?V$?V?
M(/\ @I;\+OAI<?L>7'QS^$WB_7K;]A+X>^)?B-^UI^S;X"M? FNZ9HB_$?PQ
MXD\=V?PR\2^)=33Q7;^$M>C\):UKG@S1O%>C//%XZ73=6T>'5OWB_P"#8?X
M_$[]G;_@E!\.O"OQ1\">,/A[=^+/BG\6OB3X*T3Q_I]IH?C*\^&GC'7X+GP/
MK_B'PU;7]_/X8U#7=)MEU%]$U&2*]MXIHIS&UK<VMQ. ?T)4444 %%%% '!1
M-J7_  L^_0^$M+CTD> M*:+QV(<:S=ZD?$.M"?PE+<?91G2]/MEM]8AA^VMM
MN]3N'%JF[S9.]_7_ #[5QJ:WJI^(-UX<<0C0X_!VGZU W_"/>*4N'U:?6M3L
M;I1XKDM!X)N88[.VM&/AVTOW\56+R?VEJ%I%I%_ILTO9 Y&1T/(H **** "B
MBB@ HHHH **** "BBB@ K,UK4)M)T;5M5M]-O]:GTS3+_4(-'TM(7U/5IK*U
MEN8]-TY+B6"![^^>-;6T2>>&%KB6,22QH6==.B@"O:3M<VMM<O;S6CW%O#.]
MK<!1<6S2QK(UO.$9T$T)8QRA'=0ZL%9A@FQ1^.>O\^GX=** "BBB@ HHHH *
M*** "BBB@ K#\-ZQ<:]HUIJMUH>K>')[IKM9-'UR.WBU.T^S7MQ:(US':W%U
M %NXX%O+<I.Y-K<0LX21FC7<ZU@^&AXF&BV0\8OH,OB,-=_V@_AJ/4(=%*?;
M;G[#]CBU2:XOE8:<;1;OSY6!O1<M#M@,2  WJ*** "BBB@ HHHH **** "BB
M@_S[^GO0!ROA;QQX1\;CQ"WA#Q#I?B2'PIXIUCP3X@NM'N5OK+3O%OAXV\7B
M'P^]]!NLY]3\/WEQ_9.NVUK/.VC:]:ZGX?U+[+K>D:I86?\ +%X^_P"#AGQC
M\$?V[?\ @LA^S3\4/!_@VZ\.?L8?L_-\4/V5M+TB2*V\1^+_ !3\//#.BZAX
M^\/^(H+^_M;CQ?=>)F^(6E>-)AI6HZ,G@KP/\,_%)AL=7GU"2\M?Z#OV0;CX
MMSZ+\?!\3_A#X.^"&@P?M9_M"VOP3\%>#X-#MVU;X06_C:6*T^*_BN+P^19#
MQC\>_B$/B'\<]6>YCBUB:#XBV,VO>?K3WUY<_@=\?/\ @VC\(_M/?M%ZU^TA
M\7OCMX7U#Q7XA_;S^+W[1GB=!\*_#^L7?C/X!?$+X=?"3PCX5_9Q\::Q=G3F
MU^T^'FM_"99_#T-Y82>'+;1/'GC6W;1[G7-2N=8O@#\K?VC_ /@X^_;G\'^!
M/V$/$OAG]HC]DCX*'X]?L :)^T+\1M<^+GP#^-'BO1O$WQP;XX_%OX;:_P"#
M/ VG?##P=X[UO0HK;3O!-EY#ZY9P>%F?3[ZXM_$]V]W;"X^\_BY^V#_P<(-X
MY_X)\^%O@O\ $C]A.'1?^"@?PR\*#X3^)?'_ ($\0Z<UW\1[']F&X_:4^)>N
M^(M)T.S\77'A/P?9Z?'=^$?#T:2Z]JFHZYI*WLFBV&CZG%<1^NZ3_P $"/VP
M/@.W[/.K?L6?\%%O#_[-WB7X4?LG2?LN>.M9G_9T^&OCZV\=Z?J'[0OQ&^/=
MP^F:/XMT'4=%T'1T\0^.M.T[38O[/NO$YCT&V2_\1ZD+B7SOT:^(W_!,/XB_
M'[_AU3X@_:<_:6NOB=X^_P"">/QHG^/7Q)\>:9X4T_P%J'QV\<:/HES)X*FM
MK3PL-+T3P7I&E>+K+PM>^(=(MM*ET_Q%X5TW5?#KPV9U9KV  _FY_:M_X.A?
MBI^R?X__ ."J_P"RWX\_X2_7/VA_ 7Q/T+X;_L>^(O"7@_P$_P ._AYXL\%>
M$]*\(?%_4/%VJZA?Z5J^H^!;KXE:!?\ B_P/H-SX/\0Z_=^'M=O-%U_7K2^(
MO8_T?U?]O+_@KQ_P4.^(/[67A;_@F3KW[-_P2^'7[#>GW'P:^*FJ?&WPGXA\
M6_&;XV_M*Z1X,U'Q/KDWPO\ #FA:7JWA/PKX&U+Q+HQ\!>%CJ>LW.LK:7Q\9
M7MC<3ZC;>%_#?UOXJ_X(8^&_%_P6_P""KOP^E_: UOPMXK_X*A?M*:K\8O$/
MQ'\.:):O_P (!\/)-;LM4T/X:1:/<W< U=0E]XQTWQ+?KJUI#XBMM;L89(+>
M&QE@N?"?CE_P;J7C?M*^-/C]^Q-_P4$_:._83M/VC[+P_9?M@^&/A+X@U+3K
MGXF_V%>V>LZKXR\#:_8:WI>I^"O%?B+Q%;#5[Z66XU&ST:Y\0^+[+09M.\,^
M+=5\+7 !^;OPS_X*Y_\ !9'_ (*<_M.6GP3_ &)M5^%7[*'B3PU_P3CUK]I;
MQ=X!^-7PKU:[A\0_%'PYXO\  /@GQ/HG@K7]?L8GG@UWXDSZ;X<\'^(=6AC\
M/>$O"GB7QZVKR^(-:TG3!7Y9_M._\'3_ /P4*\;67P6\1>$/&D7[+.L?#SX:
M13>(M \(_"?P3\1/"W[1/[1?@_Q[;:3X[T3Q9/K?Q$DU+P+\(FT:R0VUQIEM
MJ6H3ZA)K&E6^C2V&HV6O:;_1YX__ .#<7Q]X ^-OAGXK?L&?\%&/C#^R1/I/
M[)/_  S-JFHSZ3IOC?XD>+5TOQ7:>.K&[U?QQ)+I$[:%XN^(>F>$]8^(=M96
M%OJM^NGSZ98W:V.LW-C)#<?\&M/PW\'7NCQ?LV_MU?M(_LV^&-?^!'_"B_V@
MO#W@/1_!L]E^T59ZAX2\;>&/%WC'XFV%W"NB^*O$?C1/'_B+[?)XLTOQ$^B6
M<NG_ /"/W=CJ^C:9J]N ?7?[??\ P4&_:M\,?L0_L #]F/3O@II/[6W_  4U
MU#X*_"OP9\1)/B%I&M_ KX-^+OBO\(#\3O$_CCPGXIN5NM+^(WA_3;6TU6T^
M&U_%<W">)_.T34=-LM?O+RQTB_\ S>^,?QV_X+6?\$X;[]HS]FWX_?M2^!/V
MGHOBQ^P5^U'^TW^R/^U5IW@KPK\/?%G@;XK?LS>'/AOJWQ4\&^)/!-U9^*(S
MIGAO1==LKGP['<V>H:;K\_C6PUFTU^TU*/Q!X>\&?N)^UE_P1]_9(_:__8N^
M"/[$/C^/X@Z'X"_9E\-?#S1?V>_''A;QA=V'Q'^&NI?"OP'#\._!'B2+6O*-
MGKVI6OAZU@@U9=5TYTU-_.G@;3;UX+RW^./@Q_P0)^%7PSTG]ICQ+^T%^VU^
MU/\ M=>-OCA^RYXF_97LOC3^TMX[M_&GBSX$_ WQ.VL7_P 0=.^&OB+Q1=:Y
M+X<@UN2_DN;N87]MIFFP+JB&TDAUK5O/ /A[_@VX_;[_ &AOVX?C-\;C\1_V
M]OC)^UGX5\!? #X7ZWXC\'>,?V3O!OP;\$>!/B?X[U:2:YTC3?B9I'COQ-J_
MB'Q'X332=?T&YL_[!\/Z)XNM)6\0Z5=7UMH92+TSXO\ [</[3VI?L>>"/BS?
M_&K6OA9XLT/_ (+S> O@-\9+?^S_ !K::EX;_9[L?VA)O"(^#OC/1_!GA#Q5
MJOPKTO6_##>$-1NX+W5O$-GKNFZI9FQ\;7NI>.=%\*#^D#X6V?P5^#WP]^&'
MPW\$>)O!UAX:L/A]I&F> W;Q!X;6]\6>#_A_X1T2V'B&WNK-[.+Q)'I_A<:/
MJ>L:YI\$EG#97MKJ$S6]G=6Y/X10?\$?_P!B7P+^U]JG[6&M_MR_&/QK\#D^
M*M_^W/J/[#?B_P"->H?$_P#9ZN/B1-HB>(K#X^7'@I?$NK:WXDLO"NHZCIGQ
M(T+Q+JVFZ]8:3IEMIB7>I3^#[:.% #\ ?V$?^"K/_!3GQ1_P6B^"W@7]HC]H
M[XG>&]%^/7[4OQI^!/BCX"^.O@]96G[/#_"_X8>-/&7A_3=.^"OCOPUJGB2R
M\2^,M+\?6_BCP!<:WH>C0:/H5]X?M1XD^*'B&&=X-.]Y_P""%?QT_;?_ &IO
MVWOV>=?^)_[4'_!33QOX'TF__:2\:?$_PYXN^ NFVO['&L0^%M(UWX4?#ZWT
M_P#:+'CR-M=T".R\*>"K&]TEOAY>W%W\3X=4L]/_ +,N[SQ%XIE_6C]BS_@B
MM^PM\ ?C+X'_ &I?!O\ P4#^*/QX_9T\&_$7XO\ [3G[.OP'UK]H/PYJ_P"R
M_P" /')U#4_^$I^+'AL>%?$,?A[Q1<_#2UFU'3M;\1@1645S:B\\:/<W%G)&
MU[_@GY_P1?\ A1^RE\;?AKXQ^#/_  5P_:R^)7PN\.:[XA^/&A_LE^&/VA=/
MTSX"^,K;QI%:^)XO$NI_#GP/XGET+Q#X(O'\;>&_$E[=+HLVE>)X-:T*]OKV
M6'7+>XNP#X _X+#?LE?\%29_^"FO[,.E_#'_ (*H_$WX3_!S_@H=\:/&GPH\
M!^$O!NE>(M$TO]FRU^'GPQLO%FE6+Z#HWCG3;;XB_P#"2V^F^(YKG5()?"5W
M:ZDD37TMX+M)(/S"^/W_  5H_P""CG[(/P1_X*O?L.?%S3OVJ/B%\4_A_P#%
MOX-^ _A_^W3X'U&]OO#/P=/@.#X1Z7KE]XO\2>';"\\-^";/XK>$?#FC^,--
M\/66L1>(WU3XLZKH7BRX.N&;5;O^]3]HK]FCX0_'?XU_L9_$;XB>.-:T'Q?^
MS%\:?%GQ5^$GA#3?&)T?2_B!XUO_ (0^-?"%WIFL^%)[W[%XIF\-^&_$&H>+
M[.YM=+G\3:%;:7J"6&JZ9X7UWQC9:W\K?&C_ ()O?LE_%'X=?MP_LD^.OBSK
M.DZ__P %-_'6K_'3Q?H">./#NF^/X]1\&Z;\,-,BU/X9>%+G%]J/A3P7=> /
M!5QXF"Z?J%M=_;Y[#6[VU@U6W" '\L_[2(_;F_:J_P""UW[2_AGP+K7_  4:
M^+'PD^'/BS]D&WT*X_8U^+'@_P $?"'X4:1X[^''PX^)[Z;\3?#'C'4/%5GX
M4\,>*/%OA^X\5SZ9K/B?0?%.A:/;ZJOB3P]?27MKID_YX_M-_&S]N#PQ_P %
MN/VC/B3\)/B;^U'X8UK6_P#@JUI'[*_PJ^*=Y\4;7PG^RPNEV'B"W3Q3\!_%
M#^-K*/PAJ&LZ?X-B^']Q;:-#XDL--\,^$3#<>)-%NI_$?AJ\/]9/[3/_  ;$
M_L1_M6?MA_$7]J?XA?$OX\>%O#OQ%\)>"?#%S\"OA3XHM/ W@K0?^%?> /#_
M ,./"S>']3%KJU]I7A_1?#OARQM=%\$:?96?A30;5(]+T73K'2(([ _5'Q4_
MX) _\$W-=_9V^-_[*7Q5T_QEXC\ ?%_]H:X_;O\ &F@S_$'6]3^*%E\2[/2_
M O@'5?&G@Z#PU9OXMC\+S:-X8TOPGJ-G::/J]NR^(]9@%Q%J6I64]D ?ROZ=
M\ OVY/VA?^"XW[0GQ%\-^&?^"B'B#X)V_P#P5.\,?#34_C)\*?B??^&_V>/
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MXL\'_#D:EK.E?#KQO\.-2?PM\/O!>I:9#JUSX>U7Q!%I4USJ"W]WJ#_UU?\
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MSJ/C'=J$,"71/BF_\&>$;S7R92=5N?#.A37OG2:79M" =?W]O7\\_EQ^?M2
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M=JGB7P;HMKH_BB/6;"]U:/5;369;'3]%@GTN?4(_&_V>_BC_ ,$/_B+\*/V
M[#]@W]D&XU'_ (*'ZS\.?&VD?%/PC\._B7\8OAAXS_9ZTGPS^S]XM?X^?%CX
MW^-SHL?A?]H7P]X>U'PTLVB>!/$,]L/BOI'B"[GBBT>6[U3P_. ?V:^"?VTO
M^"<G[2_Q)^'_ (3\#_'[]F/XT?%.[LO'FL?#72]/\1^"?%WBR"T^&NO^"]?\
M<W7AEIC=:AIKZ'X@T;P3XIG6RDMI;N;PGIOBFP6ZA\(-J.E^F? []M_]D/\
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M_ +X;?#+Q]\-? _Q!\:7$F@IXO\ '\?C'0?B)X'MKV73M0O=7N[7Q/XAMK\
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M%KM]I\]A'-8:"Z:U>+#IDD=T_P#"+^V5\3?V2O O_!$#]A'_ ()O_"?_ (*
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M)I4=WIFI^'--CM+R'4K&_P!2TF0 _/+]MO\ X.7/VM_A7^V?X _9O^$OA?\
M9?\ A-X/\7_L\_LM?%%=>^,FE_%?QKJNH>,?VA_AA\/_ (DW'A;07^']E<Q-
MJ.G?\+"M_#WAV#6],T/P]<GP_=ZIXA\5Z/!?QQ6O,_MQ?\'-_P"UQ^SW^V=^
MU7\!OA=IO[+=SX:_9D^,_@;X)Z#\*/'?A/XVW_[1'[0.L6;Z1X6^)6I?"I?
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M^)_B%IB:SX,T&S66V4:UJNO:0QU*ULM$;49XK*&ZN+M+>*SNFA /YIOVD?\
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MVMQ-& ?G#%_P1!_8'\#I^VKXC^ 7PAT#X)_%?]MGX:_$+X<^,OB!H5HVJ0>
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MSP?'JT/A=OB1X+\/>-K?P^NO1VT.KR:58^)+#4K&TN-0BL[:WN+J&W6Y:!#
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MBG1?#&OZL-8ETTZQ%I)T[2KN\&IR:0+NP.JQV'D_:GTT7UD;Y8C;"[MC+YR
M'3T5YG\&?%NG^/\ X1_##QUI/Q \._%G3/&/@#PEXET_XH>$-.71O"OQ#L=<
MT.QU*V\:>'-'CU36X]+T7Q+#<IK&FZ>NL:I]CL[N*V_M"[\OSG](E61HI%AD
M6*5HW6*5D\U8Y"I"2-'OC\Q4;#%-Z;P"N]<Y !)7SIJ_[(O[,>O_ +1/A_\
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M#]K/7O$<^D36?QO_ &F[WXP^$!I=Q/<3V_A>X^!7P)^&Z0:RD]M;K:ZN-?\
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M5\,7\WBA-3GTN2^UVV\!>&],L5MHW@T^*XZC]G[28OA1\,?V;O\ @J-\2_\
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M[F>VE\*V6GZ->Z98ZK<BS_F[_P""E5G\2OB;\*_^";?PET'Q;/J=QXI\+_\
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MEC^W/I/AKXKZKX-^!$O@'P3\2? <D?@ZT\9/I!\/6OC#1O#/@/P[9PW4VO\
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M:]K^JVOB74(M<U!=,U*(7CW#@'Q'_P $K/\ @KW_ ,%<O'7_  5 _9M^&O\
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MUXQ^._P2L-<,/Q5N/#PETJX\=ZSJ6E^,[Z74P^J3'3HO%OBY[:X2R\;75K$
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MB>+_ !?)8Z=^%NM_"?\ X)E?"CPYXI^#?C#XFVG[3&O:O_P3IU#PE\!_C_\
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M>^*=%T>.RGT?PU+<W&NZMX4<>*XM1\0:?K7AJ^MHH-,UWPW?W,?NO@'XJ?\
M!LK_ ,$B-?T+_@HG\$_&OA5-4_:[M_$6A?#*Z^&%WXO^,5YX?\/:/="W\?CP
M1\.A'=:[\*=$.M06VE^+7U^VTV_.K&'0($CCCN-/B_FB^#!^#_\ P38_:>^
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M\1?LW?M">"_B;JG_  4H\-_M.:O!X T'Q8?^"=1,GC#Q#XA^(WQ/;Q!XD/\
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MQ/\ %5&U:P$?@?PE/9:?KB7L]EJMC8>([;1+JZBLWCM[Z#\%_P#@J5_P;_\
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M^%/QZG_X+^>.6T>/0-(NH-5\&?L:CP7<7_A:?3KW2_$=SX:F^%5CXTFLI/\
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M4%I<V TQ;'1KEO$"-#?6YNI?#PU2+37:6'4GM)K:YCB /YG?V8O^#4G]C/\
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M>()_#OA&Q\?Z;XS^)6N^#? NOZCI_P )]&UP:[<16]A82WECJ6NZ7%)\K?\
M!$__ (.$/B;_ ,%A/VFOB9\)4_9,TCX'_#OX7?#O4?'FI^*[#XK6'Q!U&>34
M?$-KHWA#1=7L]5TKP!J=FUQ ]])/J'A?P_XNMY;ZS,>IIX;LY[2:Y /ZC.<G
MICMQS[Y.>?R&/>C_ "?\_P#ZZ_D>T+_@ZA\'^.?^"M,7_!//X3_LP7'Q@^#N
MK_'Z/]GCPK\?_ _Q2T&3Q%XH\1VJ0>'-;\8>'_"%]9P^!]<\ 6OQ"M=?_L77
MK7XGP#Q+\-[33_&6G1KJ-_%X<?\ K@SSCV!_/./Y4 *!@8'0<"BBB@ Y]?\
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M$M*NM*M9Q<17/B7QGXE,@L-,T[;<>-/&.O>,;R#[/I-I96C_ &6ZUZ:V-])
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MQM??#R3QYK-D->\16>B2:;X'2_74W.MSVF@_FOI?_!RU^WGK]O\ LWW?AO\
MX(3?$#Q-8_M>:+)K?[-VJ>'?VU-'U71?BQ';>%M?\:ZCI/AK6H/V71IDGB71
MO#/AC7-5USPS<W,&N:1#9K%?6$-S=V4%P ?T#?"*R_91^(W[1_Q]\9^$/V9-
M0T'XL_%CX=Z3X0^._P 7_'GP6NO!J_%OPW\/[^[\#0_#V_OO%]C:7/CR'PXM
M]=Z!XF;3],OM&:RTS1M$UW4[Z+2O#5K9P?&;]G_]A?Q#X*\%?"KXI_L#_#_X
MO?#;X'7H\%_"GP#>?L9^&OBEX$^'=A<Z?\/[:3_A5WAJY\"ZOH/AKPFUCXLT
MBQN;WPM96&DE?"/BRUE)'@G5%L_&OV(/^"IVD_M8?$+_ (*#^"?B)\([+]G.
MQ_X)]_%#2OAMXV\3:[\5;+QG8^('?P[XGU[Q5JVH)'X+\)6GA'_A#Y/"FJ65
M_9P:IXMM[Q(I;V#5(XXC$_YF?#3_ (.,OCS\:?B1X*U[X-_\$B_C[\5OV%_B
M?^U>W[,OPO\ VU?!WQ7DCM/B!8S^.KOP5I7Q&T7X2^+?@CX4DT^QU&6UEEDT
M_P 3?$;0?#^E:S#?>#M4\=6OB73;VQB /Z"?'W['?[(GQ.^&/A'X-_$W]EG]
MG?XB_!WX<-I]SX!^%'C7X(_#CQ?\.O!$NB:9J>D:1)X-\":UX9U#PYX>GTO2
M-9UC2],.B:5:2V=CJNHV5IY<%]<1R^8O9_ WQM\(9_@;\0?V)M6MO@18_#>1
M-$^#7BG]GWPAXP^&>H?#WP[9WFIZ?X+M/AGH%KXG\.:+>10^%=)&A_#+5]$T
MO6/[4G\-Z=8:)_::)#:_@[\8O^#CK]I+X$_%SXJ:CXT_X)?:YJ'[#G@']LAO
MV1IOVT;#X^WVG>#/"]]H7C)? GB_Q?XOTB'X'^)9I+>UOX+[6+2T\_PYI5O+
M]A\%R>(M0UR]L]1N_4OA#_P<"?$[QS_P4P^$G[&OQ*_8=\5? GX-_M$>,?'O
MPW^#GB?XD^._"NF_M'6?B;P'H@O_ /A)OBG\#K76+Y/!W@'Q??6>I?\ "$:O
M;:YJ5IXP\/7&F>(_!6K^+85OK2( _>/PS\9M1U#Q+<_#\?L\?&/PO#I_C*\\
M&PZGJ7AGPW:>!+CP_:#7'D\=6&OV'B"YT<^$I[73+66VM&:+Q#=R:]I=E!H,
ME[_:,%EX'I_QS_X55H^AZ'\+_P#@G9\?=/L;[^PK*R\.?#[X>_!;P=I6DZ1X
MK\1?9;J;4!)X_P##NAZ/;:3>+XO\0>)]+EECOK*RT:#5)K*67QWX('B/X._X
M+$_\%GM1_P"";7Q;_95^$?P^^'VG_$?5?B+XMT'QO^TSJFI>%/%OBS3?@?\
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M7[3-S\=O%/Q._:7_ &6_B[XO^'/[(_[9GQ@\#_L7>&O@'\4=#^,.O?$/X$>
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M@70!%J,VF_RE^)O^#BKX\?#+]H__ (+??LH?%CXA?"WP=XQ_9T\"_M%>*?\
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MTU>.YUC7/#>J:=9_"DW=K8W=GIOQ"\61:IX:CNI&\,3:9+JGB/2[FT +W_"
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M1"=KJK @ 'SI\0?V-_V2?BUJ>O:S\4_V8?V?OB1J_B?2?"NA>(M4\=_!_P
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MOB/Q?H/CCQ?<:5:Z%X;\7N;3Q%H5CXOL+=-*\/:WIUM]4?MG_'^Y\-_M<?\
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M_%?64L$=S'VU !113))(XD>25UCCC5GDDD8(B(BEG=W8A5554LS,0% )) H
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M?$/XP?%?X5^-?$L7PFNO >IVMKXNU/5=>L[._P#ACIVN:!;>']+O/#NMV?\
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MXR\,>*M/\5>'M1\%ZGXEUGPG:?!33-<6WU+4/B[;>#;F'Q4P!_0XI.T%@%)
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MJ_@Z>^U+4'O-9\1:C86UOHZ>C<Y/X$?RQTQVSU)YYP,9",@C.,^GIW_,<>U
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M_P""9OPI\/?L!^'_ (9Z#_P3S^(WP*TK3/V[_ /B:UTWX+_%']E+X-W?A3Q
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M8;>/P_I/A361\38KO3M8\,S+=32:GJ=E=P:]OABNK2R6-]P!_+K=_P#!,?\
MX*Q?M2?'#X0_MX?M/_!WP!\,?BQ\9_\ @KA_P3O^-GCCX$>$-;T?5HOV>_V:
M/V,_ _QMTR;QEXN\1:+?:I'K=UK]SXTM='L]*LI-?UZUNY-(U#Q#J-C8:KJ
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M&36=2T'Q7875_I.IV,VE:)X<UX:1#J'G/K;ZNUGILT'](_\ P2C_ ."+$_\
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M$L.G^#[>WTB.'PU8)XB\"^"M>6ST9+*W&L>$?#&H^7]KT'3)K4 \V\)_LR?
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MX*^&=<\)?V;\/AX?N]*NI]<O_#7BC5[G656#_A'IO"?AO[7X?O/UC_X.7/\
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M>IZ;-H=['I<'@G6KNPU>+1]0M-?33=2U&""QL[[5;&S-O:^(M&$<RWWY\_\
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MXCB^-NKZ)X'N%\._&S1->^)_Q1^.6C>&/#D\UY8:O:R?#WQO\4-7\$:+XO\
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M7[3O[/-K\+/V$_AS%?ZMX0_:.\(:WK7@KXG_ +3VH^--?\7>*_C;X@^$VE^
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M6G)I>J7EMILNM:"NMSR:1)?:5*Z:[ID[I>2W=MJ$%PD4H /Y"O@?_P %T_\
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M#FNV-MJFB:_I>H:+K.F7D23VFHZ5JMI-8ZC8W4,@9)K:[M)YK>>)U*212,C
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M=5MHM?\ &.H>)[WQ'/;:5HFC^%OZ4?$7PR_:V^&/_!Q#^RA\3_C%^U5>^/\
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M^*_Q3\*Z/X+_ &1/^"D5[H?[0W[3G[,'PF\/V7Q!U*X_:5^%-AXAT[Q/\-/
ML/BKP/\ "'PQXQ\8:_X]\$^ -22RLO'EH/ %QJZZ=KD1G\1:]_<I#J/[1<7C
MVVLKSPO\(KGX;7?BS7XWUW3O%?BN/Q;I'@BVTO29_#=W>Z'>^&H]-OO%&IZM
M_;UCJ=E8:K_96G6RZ-=PWEV9;Z&#C++QU^T\OC?XC:=J_P )_ D?@/P[XZTG
M0/ GB32_$VOWFM^-/#/B33=-N+7Q#/H4VC6\6E1>#;[5;>V\:W!OY[>X2PUX
M>'8[N72HEU$ _P V/XD?"?Q)\)D_X)5_"_X-_LO_ +<'PQ^.'P]_9W_;6^$?
MCGP+\$O@JOQ,^+GQ'^.8\9^*/A]\?O$VC^%OB!X;US2O'WP@^(OPRO?'ZW@;
MPRB0>#938?V/;V.G7=S7[075G^TU\&?V@?@%_P % _&G_!$CXY_MG?L\?$[]
M@GX+_LH7OPI^('P4\+^,OVP_@1X[^ VO>,M%BU;Q/\"H? ,,7@9/B!8Z;I.N
MZIJ>D_"_3?";:#?:/;Z9K'AYR-#U'^P#Q9=_MGH^O_\ "!Z!^S#=1*W@H>%C
MXM\8?%:QDG1]*U(_$7^WQH_@C45MFMM<&CQ^"O[.-V+[2I-2FUTZ?>0VL$W-
M?$#5/V[]#72K'X7^$/V9?B%<:CXGF.I:]XU\9?$/X=6/AOPG<7"3I'+HNC^%
MO'%[KFKZ7;3R6,$UI>6D.L+8)J%S;:/+>FRMP#^/;X)_\$W?VM/VCOVCOA3\
M9/ 7P<_:3_X)&^!/VO/VG?VZ/C-8Z7\)_AKJOASQ[^RM\-K7]G7X??"WPY8_
M$:74K"/1_A+K7[2WC?1/$OB(>%]6TOPF]M)=ZU#X$L(=(U+PM?Q?VG_LL_!/
M5_V<OV?/A7\$O$'Q6\>?'+Q!\/?#$.C:]\7/B;J4VK>.O'^MRW5UJ.J^(_$%
MY//=2?:+V^O9S;6IN)UL;!;6R261+=7;D=+M_P!MF)_#']L:A^S-=1VZ^(-0
M\8&RA^)=L^I7&HC[1X=\-: LD$HTO3O"LE[+IE[XJOFU*_\ %UOH%EJW_",^
M&)_$5YI.@^]7C_$ -K8L+7P<T:>%M%?PU]KO];C:7QJ;C7_^$AMM<\C39!;^
M%HK9?"S:+>6!N=6GGEU];ZPMXK;3VN@#LJ*XV6#Q[?>&?%%I_:/ACPWXKNH_
M$%KX1UNTL-1\4:1I!FMYHO#6LZUHEY<^&[C5Y[&X>&\U?1+;5=.M[U86LK;5
M[83?:HMG2&\0%-1.OPZ/%(-6O5TE='N;VX1]!$B_V9)J+7MM:F+5FB,AOX;9
M9;.-PH@GE4D@ V"<<GIQ_/DGV'!SV&2:\]^'6M^)/$-IXKU/Q#;/IT8\?^,]
M'\-Z7<:1K.E7=EX;\*ZO)X3M+FX.NZ1H=WJB>(;W0]0\6Z;JUMI[:1<Z+XAT
MR+1-5\0Z3;V?B+5?GU?"'[=CZV5D^-G[.D'ANXUP,TD7P2\:W&NZ7X;T[4S#
M!%;QO\58-.U;6?%6B(M]J4MP^F67A+69Y-/TZ/Q/86Z7\_7>&6_:!\4ZI\1X
MKGXG?"#1X?#?Q=\3:-H6F^&_AUXI\2S6'@ :?\.=8\(:1XNO]=\7>%U/Q 72
MIO%-]XCO-"M;KPYN\:^'H=-W-X1O#KX!]+UGW6D:3>WVF:I>:9IUWJ>BO=R:
M-J-U96UQ?:3)?VS6=\^F7<L3W%@][9NUK=M:R1-<VS-!,7B)0^)ZKHO[2B>-
M_AI_8?C[X2W'PYAO_%$_Q?&K^ O$=KXTO=/$'A&7P5IWP]6R\77>B6DSW=AX
MWM/%&I>()9?+L_$.AWFDV,USX=N;36KEAX5^.M_9^!W\2?%;PMH^HZ#K>E7W
MC*#P7\/]]AXYTS2+SQ);WNFK/XEUW4;GPS9^,-)O/#5_?VUA!>:AX8UK2;RU
MTOQ!JVG79D8 ]PHKS3PGH/Q5TX^)O^$R^(WA?Q2+^\\0R^%/[&^&UQX4/ARQ
MO?$.NWOANTU0S>._$@\2SZ#X:N_#^@ZC>1C05U_4=$O_ ! EKHR:VFBZ3PO@
M?PQ^TE=>'?B#IGQ:^)_P]M]9U>QCTWX>Z[\)/ VH:7=>%)7M]4FN?$NJQ>-]
M:\36&LZBMWJ6F:=9Z(=-338[/PL-5N+VYN?%=QI7AL ^A:*YCPAI_BO3-%AM
M/&?B33?%>N)(_G:SI7AIO"EI/%LC5%_L=M<\0^7*'621Y5U$H_F!4@B"#=Y[
MXQ\#?%SQ+IR6>A_&YO EY#/XSN$U3PY\.M O9YO[3@DC\!VU[!XHU'7[66R\
M'RN+C7H[6.QNO&KQ1QPWGA6+S$D /::*K64=U%9VD5_<Q7E]%;01WEY#;&SA
MNKI(D6XN8K,SW1M8IY@\L=L;FX,",(C/+L\QK- !7+>,?!^C>.M$'A_7XGFT
MX:WX6U_9&MLS?VAX/\4:-XOT9R+NWNH=D>LZ%822'R?-$:,;:6WN!%<1:/B'
M18?$>@ZYX>N;W5]-M]>T?4M%GU'0-5O="UW3X=3LI[&6]T37-,EM]2T;5[5)
MVGT[5=/N(;W3KR."[M)8IX8W&/XUT/Q-KOAY-+\(>,9_ NM)KG@_4#XABT73
MO$DS:-H?BS0]9\3>'VT_5V6T9?&7AG3]7\'SZH6^VZ+%KTFN:=NU+3[4$ ["
MBN0L?"DNG^+=5\40>*?%<UIK<4QOO"5]J4.H^%X=0-CX9TVTU+2+:]M)]1\/
MFRLO#<@72M$U.PT"\O\ Q#XAUK4M)O-:OUU"'C_%OPHN_%'BM/%%I\5_BQX2
MMG3PC]M\*^%_$FFVWA:^N/!FJZWK&F72V>I:'JE[IC:O<ZU':^,;71=1T[3_
M !KI&BZ'HWB.SO\ 3[6X@O #U^BOG>Q^ %_;:]IGB:^^/7Q_UG5-'M?%9LK>
M[\:Z79^'9-9\6Z-<:'<:YJ?A#1/#>E>%M=?0K22WN?".@:WI.H>$?#FL6B:]
M9>'_ .VKB\O[C.T[]GSQ-:^#I?",_P"T5\<29K74;277K/7]+;Q#)-BWMO#F
MNC7?$FD^*=<M=?T>STW1[C58=-U2P\&^)M=BUJ_O?!EMI/B75?#[@'TSCC';
MI1Q_(?X#\SQ]:\(D^!KWMIK.G:W\8?C;JMEK7BM?&,@M_'DOA74+#4H/%,OB
M&STS2-:\$6/AG5]+\)VVE1Z9X,D\&V5[%X;U+PWI0N-8TW4?$VL^)?$.M=U\
M./ G_"N_#(\-GQEX\\>,-4U;4Y/$7Q'\0_\ "3^)9CJM_->"P;4!:6$$>EZ7
M'(FG:396]G"EM86T(E-Q=-<7=P =%>Z(E]K.AZTVI:Q:OH2ZJB:;9W[6^D:G
M_:D$-NS:S8A&74&LA")M,9GC-I/)+(-QD(&WW^OZ=./\_P!:\:\0_ GP#XQB
M\3V?C(^+/%FE>*Y-5>\T77O'/BZXTG2_[;T'Q/X7U1/"]K!K%L?#"7/A[Q?K
MVEJ-#DLC;P7%M-:M!=Z=IUQ:X?AC]F_P;X:\46_BR;QA\:/%U_8ZY9^(]+T_
MQ]\:OB3XR\.Z1K-CX3C\&0W>F^'-;\17.C6ZMI7VJ[FM6LY+.;7]1U'Q$]N=
M:NWO0 :WQ1^%5YX^\9_!'Q9::]J.ECX3^/[WQ;=Z7#=P1Z5X@L]0\*ZYX=EM
M-4L9],OS>RV;ZI'>Z6\%SI<]E=QF=;MUW02>U_Y_S_G^8K\Q?BU^P[;3_$3X
M.:OH'B']HSXA>'M6^+&MS?%U/$G[4OQJEN= \#ZSX:\17MHOAZZN_'@&A^%M
M&\:IH-^?"WAK3[6]O)H-)CM-6TFQTIH;GL?AC_P3-_9S^%FC3Z;I7B7]I/Q%
MJFM_#/2/A3X]\8^,/VI?CQK7BWXG^&O#WBS3?%WA^_\ 'VHQ^.K&TU/Q?HDV
MGS>'-,\::;IVD>)K;P+J^N>!1J9\+:I/I= 'W['J%A-+%#%?6<LTPNS#%'<P
MO+*+":.WOS%&KEY!93S0P790$6TTL<<VQW53<Z^W7_\ 7_6OA/X>?\$X/V4/
MAOX>UWPW8>$_&7BBS\4?#[Q'\+/%.H?$7XL?$[Q_XA\0> ?%&NV7B;5/#VH^
M)?%'BO4==2!M9L4ODO+&_LM1>>>[FNKRYFN'EKZ<\<_!CX9?$G2_$>B^-_"T
M.NZ9XM\.6'A+Q#:RZCK-FNI>'M-U--7L=->73=1LYK=;?4HTN1<6DEO=NP$<
MMP\.8Z /2&N;9;J*S-Q MY-!-<QVIEC%S+;6[PQ3W$<!82O;P2W5O%-,J%(Y
M+BW1V5ID#3@Y)X(^O?DC^F?H17D&H_ +X/:MXH\+>-M1\!:->>+_  5XPU_Q
MYX4\2S->G6M!\3>*K*&P\27>GZB+L7,5AKMO:6']JZ 9&\/WMSINE7L^EO>Z
M5IUQ:]7K7P]\'>(7\6R:UHT=Y)XZ\,Z;X-\5LUYJ$)U?PSH\OB*73-,<V]W#
M]D6UE\6:^ZW-A]EO7;4G$MRX@M!  ;L7B#0)KUM.AUO2)=1$RV[6$>I64EZ)
MV6_9(3:K,9Q*R:5J;+$8]Y73K\A2+.X,=BSU72]0EN[>PU*POI["3RKZ&SO+
M>YFLI?-GA\JZCAD=[>3S;:YAV3*C>9;SQXWQ2!?([;]FS]GNT^+:_'RU^"7P
MLMOC:MG<6"_%>#P+X;A^( M;N"ZM9X_^$ICTY=7WM:ZAJEHLQNC/#::UKUK#
M)'!KVL1WOI.B>#O"/AF\UG4?#?A7PYX?U#Q%=&]\07VB:'IFDWFNWANK^^-W
MK-U86MO/J=T;W5=4O#<7KSR_:M2O[C?YUY</( ='5:WO+2[-P+6ZMKDVMQ):
M70MYXIC;7405I;:X$;,8;B,.ADADVR('4LH##-FLS3=$T71FU%]'TC2]*?6-
M2N-9U=M-L+2Q;5-8NUB2ZU746M8HC?:E<I#"EQ?7)ENIEBB625A&@ !I'GC'
M'/\ A^N36+)XDT"+Q!;>$Y=:TN+Q1>:1<Z]:>'WOK==8N-%L[JWL;O5H-.,@
MNI=/M;V[M;6>[2(P13W$,3NKR*"GB?PWHGC+PWXA\'^);%=4\.>*]#U;PWK^
MF/-<VR:CHFN6$^EZK8M<6<UO>0+=V-U/;M-:W$%S$)"\$T4JJZ[E '':U\0_
M ?ASQ)X?\':_XQ\-:+XK\5QSS>&?#>IZS866MZ_%:WNGZ=<R:1IEQ/'=Z@D%
M_JVF6<K6L4@2YO[2%B))XU;5UCQ-X=\/W7AZQUW7-*T>\\6ZU)X<\+VNI7UM
M9S^(-?AT+6_%$NC:/%/(CZAJ<?ASPUX@UQK*V$EPNE:+J=\4^SV4\B2Z_H6E
M>)]'U#P_KEI]OTC5K=[34+0S7%N+BW<@M$TUI-!<(K[0&,4R,1\I.UB#J1QI
M%''%&-L<2+&BY)VHBA5&6)8X4 9))/4DF@#\_?\ @H'\9VL/V#/VDO$_P3^*
M?P?TKQSKOP8^)5A\,?%OCOQ;X"L_AU%K4/@WQ)J>IZIK^I^,M3M?"3^'_#?A
M;0/%OBCQ&^K7+6=OX=\,Z[?3Q2PV$R5]B:)XE\&>'=-\#>%9O%7A.*_O],T;
M1O#EC9ZI8PIK4T&@F[MX_#]F;J6:XM[C2K&XU"PAA:<MIL#SH\L43R#Y _X*
M<>&_AI_P[Y_;QU#QUXGUCX3>%=<_9@^*[_%+XG_#[0[&]\?V_A#1O 6M#4I+
M*T_M_P &3>+=230%OM%TOP[=^+=&;5HK]] M-3L3J <?4WP4\'?#;PE\-/A[
M#\+_  MI7AOPO'\,_AOX?\.)9:;)97Z^!O"_A>TT_P ":+?7-_=:EKES;>'=
M"F6STVVUK6-6N]/CEN(VO9YIKB>8 Z.X^)?P]M-.\3ZO=>-O"UOI?@K7E\+>
M+]0EUS3DLO#'B5X=(G70-<N6N!%IFKM#K^B2#3[MHKHKJVGGRO\ 2X=^9XD^
M,GPE\'^,O#'P\\5_$GP/X<\>>--3T;1?"'@[6_$VD:;XE\3ZOXCTWQUK.@Z;
MH6BW=U%?ZI>ZQI7PO^(NHZ;;V<$TMW:>"/%$\"M'HM\T/I5% '%6?Q(^'^HZ
MQ!X>L/&GAB]UZZU7Q'H5MHUKK>GS:G<:UX/CLIO%6E06:7!GEO\ PY%J-A)K
M5JB&;34O+9KM8A-&6?I_C_PEK.HQ:7HFJMK\\FL^)/#MS<Z!IVJ:[I&CZ]X2
M$8\0:+XDU[2+*\T3PMJEC)(MNMCXDU'2KF]O!)8Z?'=7D4L"=E1_G_/YF@ Z
M4444 %%%% !1110 4444 8MGKUC>ZWK.@0PZPE_H5MI%W?3W?AWQ!8:+-%K2
MWK6:Z-XCO],MO#WB&>(:=<#5;3P_JFIW6A.]FFN0Z<^I:>MUM5BVGB+1K_6]
M:\-V=_'-K?AZVTB\UFP6.826-MKJWSZ3+)(\2P.+U=-OB@AED9/L[>:L9:/?
MM4 %9.JZW9Z,VE+>0ZM*=8U>UT2S.EZ#KFN+%>7<5Q-%-JCZ)IVH)H>DHEM(
M+G7M:;3]#LY6MX+S48)KNUCFUJ* #_/^?SHHHH *1B0K$ L0I(5<;F(&0%W%
M5R>@W,HSU('-+10!QGAKQ!XEUZ:WN=0\$:AX4T6]\)>&]<M_[?U?2)/$]GXB
MU6?6!KG@[7- T.;6-*L+KPS9VNAS3:OIOBG6]-U2\UB\LK(B+2#>ZAV=%% !
M6.^@Z4^OP>)VMY#K=MH]WH,-U]KO1$FE7U[9:A<VYL!<#3GDDN]/M)!=R6C7
ML2Q-#%<)!--')L$9!'KQ6,UMK;:_!>)JUDGAQ-'N[6?0CI#MJ,VMO?6<EIJR
M:]_::I!96UC%>V<ND'1Y7NI[N&\&IVXLS:W(!LT444 %%%% !1110 4444 %
M%%% !7Y"_P#!:'_@J:__  29_9>\)_'32/@O?_'OQK\0OB[H7PD\%_#VUUN?
MPY9W-]?>&?%OC76M7U?6K+1_$6HVEEH_ACP7K-U%'8Z#J+W=_P#9+6<Z?9RW
M&I6GZ]5_.]_P5"_X(_\ Q._X*Y?MH?"W3?V@/'FJ_"']@[]FKX"^)-4^&6K_
M  8\=6EK\9_B'^TU\8O%%CI7C)/$6D:QX.O],T+P=X)^'?@328XI9)KNXFNO
M$>G'0-7U&+Q+\0- \'@'8>,?^"Z_P:^&OQ2_X)&^%O'B>!8/AU_P4^^&&M:W
M=?$7P[XMN-8MOA/\1KV'X9:5\-],N;1K*UG?X>^+?'_C#Q!X$O?&NK0V4&BZ
MEHYU&_\ LFD:1XCOK#\X?VL/^#C/]NS]GKP+X<^,OA;_ ()Q^!O'WP,\0_M
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M^"FNO?&3]M?PY\2/B1XXD\<^+?$%S9:KX:O?#O@CX.>&?@S\,D\):U?Z_?\
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M>'M*U[P_X.E34_!>GI>:3<Z%8WD]Y9W$UC:7MB ?RY?M#67[4_[$WQB_;O\
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MS_LT?L<?%_\ ;)_X+'?M2_$SX]_L1?M)?&KX9:G^W!X8T'Q5XH\'_M1GX,_
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M?FNHO$IUGP7H_B/3= \.W[21:AXD3Q!H7B[5;&PTO5XM,T[^Q#Q9_P $CO\
M@FE\6],35?$7[!/P8U;5O"/Q.^+?Q.\)Z'X]\+7.G:+)\2OB!=1R>,-7GTJS
MU&]TV?P1XWUG3+#6SX:N=-O?",-QM\0:=X3L]8=YG^G)/V&?V./$?PF^%?P>
M\<?L?_LN>(/AU\(].>/X=_"_7/@A\-?%_P //AE>ZK;Q'Q"OP^T'Q)X3NM/T
M(:G="5]1U'3M.T^_UMLW>JM-<RR&@#_.8\)_LV>&/%]WXM^"_P"Q)IVF?M8?
M\$]?&G_!9/X._#/]BCPE^U!K7C'PO\(?B5XWB^ 7Q>UGXKZ++XDTA-)\:/\
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M\1V>DV%KKOB&T\/)?1Z!:ZWJ\%O'J&JV^AQZIJ<>CP7]Q<1Z8FHWRV2P+>7
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MQQXV^-/QR^&^B^"O#&D1:O\ #72_"6H>(O&6K7-AXI\,:5H8!^V_Q'_X.6?
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MTR/1P#_3RI"<#/7V]3V'XFO\[/\ ;A_X+F?\%K?V>_V7/"W[4NG?'/X(>'_
M?[57[8/[17A3]G[1M/\ @%H+_$/X=_!OX 7R^%5T'Q%8^.M#6#1F\1ZUJ@GU
M'0_&_AKQ!\3--O?#L4MYXE\-QWNH>&77]KC_ (.#_P#@K(=0\$?&[]EOXM_
M;2/@S\,OV)/V,_C_ /'KP;J7AGX9:OI7CSXB_%"_70_B=:> K;Q5X;@^)FN:
M&OQ$.H_#OQMIWPY\3ZS8_#B;P[JUG<>-?#WB97MK4 _T3**_RY-4_P""]/\
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M#?C!\>?&<<\_A3X-_#7QK\3/$%K:2VT%W>Z7X+\/:AX@NK"SFO)(;.*\OX[
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M^%/PQ^)5Y\%]:D^-GC.+0;#4-;\;1:1X6\.1^%!$UHD>KOIVOR:/]P?L0_\
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MC2SU[QYX:$%E\0]-\*Z7X6F\3ZIX^T/0I=_]KC_@HG_P6F_X)C^!OCA^S/\
MM#?'+X(_M"_M-_%3]FCX<_M _LT?$?P)X2M?#&K^"=5A^*FA?#[XS^!-&T#6
M-(T;3/B1J>CQ7RMX0T>31AXH\5273:EI&A^9'=>'K;]51_P;G?"OQ5^R-^T;
M^S_\>/VQ?VHOVCOC?^T-H^A^$V_:\^,7B-_&WQ/^&'P]\*_&?PQ^T%H?PO\
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M7A./Q9X]\'_ >QL="\2WWA_5O$7A/PMXG&I-?Z/I-ZOA30O FI:U] ?M=?\
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M7A[2]!\1WT,&EV=UIAOHM:@\/WUC9WEE%INI06\R@'\.GQ>_X. /^"V_@/\
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MXK\8>+/'.KF2[E,TJ/K_ (TUK7]=EMD=BMK:2ZB]K918@M(H856, '24444
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M;7OQ'\!6>D(T&II8>*;I(K.V_!?_ (.1-=^/6J?LP?!K]@?]E30KWXW?'O\
MX*(_M&WGAQ_@[JNM:M'XC\0_ _X<:))\2_B]'X>\0QZIX=T3P/\ #KPWJ%G\
M.] \::SK^MV6G^&_"?C2]N;>>VF9]9T@ _?%=?\ @CXFTWPMK,'Q(M9=+_:
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M-[:^)'T/3]0_*OXT?\'07_!/SX%?#_PQ\3)_@_\ M6>+]!^(7QP^/?P=T-/
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MU<>&CK-]J6D:5H5QH$FHVNCSZ3>RQ7-[& ?V#4F!G..?7ZX']!^5?Q)^,?\
M@Y8_:E_8C_9@^*_Q8_:H_9(C\=_&?XD?\%&OVU/@+\'_  3;?'GP7)\/_A/X
M,_9ZF\*Z)JO@C5O%O@?X?W-SXJB^$7B?6M)\#:;?V?A[29/C/':>)_B._B7P
ML+[3+;5_/]4_X.+/VH/^"B-S\(]%_9F^ $_PA_9YTSXZ?\$S_!/[3_Q<\._$
MS5C\0_AA\5_V@?CW>WNH_#P1WN@>')/&7P9\>Z!\-/%'PHFU/1_#>F2KK.HV
M6IZEXI_L[7M/\+WH!_=:,XYZ]\=,T4@.?3J1Q[$C\QT/O2T %&.<]^GY9Q_,
MT5^>'_!6SXE>//@Y_P $R?V[/BE\+_%&J^"?B'X$_9B^+/B/P=XNT.<6VL^'
M->T_PM?26&KZ5<E6-MJ%E+B:TN54O;SJDT>'12 #]#^X_P _Y'7MU(ID;I("
MR,C@.\99&5EWQ.8Y5RI8!HY$>-U)W(Z,C ,"!_G9_P#!/3]L7]KK]GCX3_M+
M_MY:'J?_  45A^!/P:_X)ZZEXE\9^'_^"C'Q<LF^&WB[]LGQ]XGO/"G[.E]^
MS1K;?#'PY:?'/P!>6-Q=WDFB:CX>\*ZG:ZOJMO:3ZOK]X?!<'B/I?^";O_!2
M_P#:&^-7_!.'XC?\$W_A;^T;XBU[]J+QU\?_ -GOX9?#3X\^(-,N]!^-EG\.
M?VQ+^'Q_^U9KO@KP=KWQ M/&GCCQ1^S%K\_QJA/B#3FL],UCPGI5MXGTW4-*
M?5-&TW2P#_0J'3ICV]/:J\EU;136]K+<P17-WYWV6WDFC2>Y^SJ'G-O"[!YO
M)0J\OEJXC0AGPI!K^ ?X ?\ !TG^TM?_ +5_[3G[-MSX-^ NE?L[_##P=^T]
MI7[/GB'Q]I/Q+^&7Q1TJR^!VB^/H_@?:^+!XN\2:S?ZIX^\7PZ3X.T3Q1X.\
M7V.B:WJ'B57TZ'6?#FM7%W'=>%WG[+/[7OBGX^?L2_#?2?\ @H_^UC^T9_P5
M@\":Y\/?VG/BUX2T%?$/AGX#?\$_?V4OBOI,/QH\=OX_N_'.F"]^(7Q"U/7_
M !?H.D:?X<N?&7@S4->T[QCX;\"#X=2B/PY:ZL ?Z-R7-O)/-;)/"]S;I%)/
M;I*C3P)/O\AYH@QDB2;RY/*9U42>6^PG8V*\.I:==6K7UM?V5S8QAV>\@NH)
MK2-8E\R1GN(Y&A58U 9RS@(N"V!S7^3S^TC^TQ\=_#WP0?\ X*4^#?\ @H+\
M8_A9^U1^W1\:?VDO@#^T[^R)J7Q-L];\5^%?@=!XGU"32Y/#D?@G3-9U?X3Z
M#\-_"MIIG@.[MOB9X.\)?$%-;CF\2?#;2/[-AU6PKUG]N+XD^+OV1?B]XD_X
M)Z?\$X/VM!\5_P!@G]K[PU^QY\3/$.L>+_VA=?D\$_"KQ/XF>\T/7/AYX^_:
M+G\1>'(?AKIWQ;U#PM!K/Q"U#Q/:?"V?3M)U.PTY_#/A"'P[*[ '^I5#JVE7
M*Q/!J6GW"S/.D#07MM*LKVR&2X6(I(1(UO"?,G5,F%,NX5>:2VUG2+T7)L]5
MTV[%I&D]V;:^M9Q:PR"4QRW!BE;R(I!;SE))=JMY,VUB(WV_Y.OPI_:SF\*?
MLL:)\!O#WQNUW0-2_9%\5?MH:[^UM\1_"'COQ9\4;*^T#]J3XK_ ;]D2'Q#^
MS9\4/"OB#3-&O_"NB_!G5=7\;?#N]NI?BQ/JGC/PIJ&OPW]SHGQ"TO1-&_8S
M]E?X)^'?'7@C_@XI_9W_ .";'[<WC'P_^REX:^ 7['_Q"\!_%N_35OBKX]NK
M>3P/\4OB'XS\+^$?B%:?%;3[N'PCX_\ !_A;QO\ #WQDVKV&C^*;*^\7Z8]O
MX=\*#P7KWA_QF ?WOV7Q"\!:EX*E^)6G^-O"5_\ #N#2=2\02^/+/Q#I-SX.
MAT+1DNGU?6I/$T-X^C)I.EQV5])J&HM>BSLX[6Y>XFC6"1ES=4^+GPIT3QGH
M'PYUGXF> =)^(/BJW6[\,>!M2\8>'K'Q?XCM76=TN-#\.76H1:QJL$BVUPT<
MMC:3)(+><HS"&7;_ )JO[='[97QD\"_\$ _^"8/["GPZ\/\ Q2T#P)\:/V4_
M'/QQ^,7Q%\$_#Z_\0:5XA\/>"/C3K^GZ'\+]1\36OBS0(O"W@]]2GN/$_P 7
M]6N-)UN2VL)OAS816=_I?BC7(1F^/_'?[)W[0GB7XE_&J7QA^T;\,_\ @KG\
M,?C9_P $]_!G_!,CX-ZGX=O? GC'6/A/8?"_X :=\-M#A^&7AS6_B-\)_"GA
M;Q7)<^,_B0VG2_$[5+WPO9>(?#=EK/BJ_36+V/60#_2,TC]I_P#9L\0>(W\(
M:%^T#\%=9\5QRZG!)X:TKXH>";_74FT6.XEUB-]*M=;EOE?2XK.ZEU!3 #9Q
MVT[W'EK$Y&Y\//CO\$OBW?ZGI?PK^,'PO^)6I:+:6]_K&G^ O'GA?Q=?:597
M4\MM;7FHVN@ZI?SV5K<7$,L$,]PD<4DT;Q(Y=<5_G??M$_L4?LBZ=\>_^"^_
M[0/[//AN']ENR_8EL_A!^SWX%U.\N/B+>>&O"GQ>_:3\4:W9?M$?'V2#PIJ'
MC_5M%\&:+H\?C+P)X4\">"?!^KM9?#_5](\26GAK0?%%K=:/>_JU_P &M_[/
M>F?L<?'S]L[]FCP?\4_V6?VM_"I^#/[-_P :=;_:U_9JTK7]=MM&\<?$*+Q%
M;77[-FN?%/4+>TTW6;+PO8Z._CO0O#L-K!J45MXCDUS5[?1M<O\ 6_!?@\ _
ML^_S]?\ /M6+X=\0:/XLT+1_$_AZ]74=#UW3K;5-)OTBGA2\L+V))[:X6&YC
M@N(Q)$RL$GACE7.&1""*VJQ= UM-?L9K^/3=:TI8=7\0:0;77]+N-(OI'\/:
M[J.@2:A#:70$DFD:M)IK:KX?U%<V^L:%>Z=JUJ3;7L1H \^T;X^_ OQ%K?BK
MPSH/QF^%>M>(_ MIK.H>-=!TKX@>%+_5_"&G^'KL6&O7WB?3K759;O0K/1+T
MBTU>YU2&U@TZY/DW<D4F%KD/"_[7?[*_C7X>3_%SPI^T=\$M=^%UIKX\)WGQ
M L?B;X/D\(6?BB2411>'KS7VU=-.M-:E;F#3+B>*\N(F6>&%X660_P"6S^W1
MXB_X)>>-O&7[1_A;]@OQ7H'[-_PQ_96\!_$KP/H'Q2L?B5\>_'G[4G_!43XA
M?',R7-W;W5OJ7@6X\/\ _"D/AQXJTO6M,\;R^,_$-I?:EX#NM,\4:)J>MQZQ
M9:%X;X'X(^*/ _A;PS\7/"/Q5U+X,_'3_@GSJ_[=?_!+;Q;^UE^T+\ /!'B#
M3O!7@[2?!?P^_::N[;X9?#_]GOXE>$?@O\2+_4_'FCGQAIOQ;^)O@;3K'4=#
MTKP#K=M:V?CBT\;Z=;7(!_J@2_MU_L86_ACP'XUNOVJ/@':^$?BAXFUKP=\/
M/$EW\4O!]KHWB_Q+X;&O#7M(T2_N-5BM[RYTA_"^O)?LCB"WDT]XI)1)+;K-
MH>-OVUOV0_AOXX^'_P -/'G[2_P1\*>/_BK=65G\//".M?$CPM9Z[XKFU318
MO$6DG3+%]2\TV^KZ)/;ZCH]W.(;35K>YM3IT]R]S DG^7_\ 'OQ5_P $JO$G
MP2_X*>:)\%/#S? OQCX]^.?B75/V$M=^(_[.GQ>^*_P_\=_LO>!K[PS=2_#O
M]FGQ=H/B/5_#OP#\6>/_ (I>!=8O]1^*7B;PAK<USX?UK1/!.L:YX5L=8\6Z
MAX4^6+CPE\3_ -H'XV^*_B!^TG/XH^%?[2VO^%OV*O$'P$_8[TS]G7XV^/\
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M/P0T/X$ZSH/AZU_:'U#XR^'[S3$UGX=0^#8_%<WAXZKI6BZWH?BS5=5/B_\
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MV/B'1/#^J2W$?BX^'M2L--.I>X_&;_@X:_8Y^%_Q:_X*!_#3Q3\-_&_CB/\
M80\7?!?X.:%?>#-&/B[6_C_^T-\89/%FEZG\%/A_X:FTBVNM#U[PGXM\%ZOX
M5O\ 4=7N7TK6KKPOXFO],GN8+30(=>_*75?^"#O[0GQ@_P""-'_!)#]BWXY>
M"O$.A_%+X#?MA>(-;^-OASP;X@\-ZY9^#/@E\7OC'\4_$/CG6=9OX]1LXKJ[
ML/ VL:"\!\-:P]QI.K:M(&CU$VTL0\I\0_\ !N%^TY^S_P#M8_M9_&C_ ()G
M^&])^%MA^SW^T;^PO\3OV$O"OQH^)OB+5/ 7Q/@\#?")-?\ CQJ7B2/4;S6;
M/Q"FC_%'QAJ>F>';SQO%;:IHZZ?XRTCPQ>Z5;:K;WEX ?H/\._\ @X@T2"']
MI"^_:Z_X)B?&K]C[]I;X=?L_^,/C+\$?A_\ &_X?Z[X%\0_M)? ?X)/K/B7Q
MEX4T/Q;XZ^'/AO4]*U?P#9OXM\3V>D2V.J>#996\0_V9J%MK4-W9ZCGR?\'-
MVA_ O4/'H_X*1?L"_$S]C/Q6/@CX3^/7[-OAKQ'>?\)1XP_:"T+Q#XAL=/TW
MPSH4H\*6FF>%_%NGZ;J']MZA;>)-8TL^';C1]<T3Q!!HNO6\%C-\]^-_V O^
M"T__  56N/CA^T'^WA\*?A%^S[XX^%_[$G[47[+O[(OP*\%_$?6-/\/^+?B]
M\?);OP/XE^)'C#2-7\0_$?P_H'AR\^'%SK%A_P )#8:GX<U_Q+/9_"VYOUO=
M)\+WMB?,/^"AG_!'7_@NW_P5T^''A\?M877[%WP<U3]ESPC%;?L\?"SX1ZWX
MAU+3OBSXH\4WNCZ=XUO?&?C76M0UB7P?)IWAC0-.;2Y-D^FWEZIM3IEOYLNI
M( ?O=_P1G_X+':3_ ,%9M!^,XN?@;-\%_'OP+_X5S-XHMM-^(GA3XJ>#M7T;
MXMZ+J7BGP<^A>+O"KM"NIP:+IPC\4Z!?)%J/A[7%N='U2"SUBPU'3;#Y(^+G
M_!?#X[^'$^-GQQ_9W_X)5?'OXW_L,_LZ_$?Q[X"^,W[30\3^#/!.I:AK_P )
M?%5[X2^*WB?X>_#F]ENO$OC'PAX<@M;6(^,HH'TZ&\L_$>G:_<:*WA36TL>2
M_P""&G_!*7]LG]BS]M']K#]I?X\?"7]FG]ECX6?&KX3^#?!OA[]F_P#94^(O
MC_Q1\+T\;Z1K&DW=WXRL/#?BS6->&A1VNGZ/J.%U#6]1G@U'Q=JL/AV#3-)G
MO;8^5>/?^">O_!=GX??#W]J#_@G=^SIX@_8U\2_L+_M'?%WXUZWI/[0/Q&&L
MZ;\;/AG\,OVIO&=]XX^*>AP^"=-U :5K%]X1U;Q7XU?39;ZSUC4-2N=3D-EJ
MD6G#1M/T$ U_CY_P<D>,X?B5XD^&/[&'[,?[/OQ7\,:I\*O@=X]^'7Q!^-O[
M9'P%_9HMM?U+]HCX;Z5XX\.V[?#?XV>*_AIXD\6VVD:MJUQH.O1^#Y]0DDO[
M!X+B[L)M1L#<?M=\</VW/&WP@_;0_P""=7[)VN_![2[BW_;;T#XZV_Q"\1#4
MM:U#3_AUXD^%'PK@^(47A[0=>/ARS\-^+H9;R'7-)O[6YN+'5[G3)K+6X]$L
M;1Y#)^</[,G_  ;T_LH>$/CU\=+W]I3]G#X7?'#X1^%/ W[&WPY_9(\4>-]6
MUC7_ !C8:+\$/@;IO@_XC7FK:7%JD*Z$-9^(%C_:T-C>3ZF+NW$:"9K&WAA'
MT5_P5\_8I_;1^.7Q%_8C_:[_ ."?VN?#&#]I']A[XD^,O%^G^"?BYXF\6:%X
M4^*7A+X@:5HOA;Q-X$=],G/AVQMM7T Z[;>(;Z^CTK5[O29TL])\16%W%;
M'YS?M,?\' _[27PV\%W^H?!O]F#X&0^(XO\ @IM^U7^P[I_A3X\_&7P7\&M%
ML?AE^R)X7^'U]KEWXI\>^./&W@WX8^'O'WC+4O$7B./3;-_&4OAW2+2*QT[2
M4\4W^9;SP;]I?_@YN_:AT/P'_P $^=7_ &:/V9/V;M$\0_M?_ 7XJ_&OQ!IW
M[0GQ^\'^ ? OA*T^'OQ:^(7POL= TGXG>-O&?PB^'EI$]E\,-8U]+W6O$,1\
M0RZWHNA>&K6:]@"ZKC_&_P#X-U/VZ#\'_P!F[XAVGC[]F?\ ;0_:,\&_'?\
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MTW_@A7^VO\5X/V6?#G[7GQ(_X)Z^-OAK^SU^W#X,_:3U7X7?!?\ 9AT?X/\
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MZLOB1XGTWQ[JFO\ AS7)OAYI'C#1]?L/#'P]U;0?#OQ-OO#^G:0S_#PSK"]
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MD6$'PX\.66EZK'J-O/K%GH@\2)I%H-+U'2;U4\V'_!>#3]*^!WC[]M'XE_\
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MQW^GW7B?PG)9:'+I?B*&[LOQS_:$_P""27_!4/\ X*9^!O&_QC_X* 7?[/\
MX1^)_B^X^#?PC\*?LS_!/4K_ $NQ\&_LQ:9^U=HGQ<^+-KXF^*]_>>(;/6OB
M5_PA6CV]IX+O-*B%G*D<C:M)%J\JVT?])G[&?[!?[)G_  3Y^'WB;X6?L?\
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MXM4L9+_X?>/-0LM,\;W6F7U_-=>'==TRWDT>7-WK#ZGRWC3_ (,__P!E?6O
M7P^\%>!/VM/V@OA,^A?"B?X4_%74/!6A^#-.LOCY8V_Q%UWXA^']>^)>@:<F
MEV6L:QH]QK%GI4QU2;6+?4+?PQX5N5CL;C1;>@#^N+0YY;K1-'N9W,LUSIFG
MW$TN%4R336D4LDK*N%!>1BQ"C +8 Q6K_G_/Y"N=\'^'Y?"?A+POX5G\0:]X
MLF\->'=$\/S>*O%,FES>)_$TNC:9;:=)X@\1RZ'I6A:++KVLO;'4=7DTC1-&
MTM]0N;AM/TK3[0PVD/0Y!_E^.,X_+F@!:._\_P!>GO3#(BLB%T#R;MB%E#.$
M&7*J3EMN1NV@[<@G%"2)*H>-TD0E@'1@ZDJQ5@&4D$JP*L,\,"#R"* 'U\[_
M +6?@GXV?$;]F?XZ> /V</'UI\+/COXS^&?BKPS\*?B5?M(+;P+XSUK39K#2
M/%3F&RU&97T.:?\ M"!XK*YE6XAC:./> 1[OJVKZ3H.GW.K:YJ>GZ-I5FJ-=
MZGJM[;:=I]JLLJ01M<WEW+#;0+)-+'"C2R*&ED2,$LZ@Z- '\C/PJ_X-V?VU
M/AU^RAJ?[/\ +_P4KT9O'/PV_:9^$7[7G[)?Q3\+_ U?#6H?"SX_>%-8\=K\
M4OB'\3IO^$FU#Q'\:M:^)GA+QS/HTC^,?$-\+:XTZU6_;4='ENM*FR_%G_!L
ME^T-INK_ !"^.7P8_P""I/Q"\-?M;_M/^#?B)X#_ &UOB-XU^$/A+7OAW\;O
M#7QBT-M.^(FEZ)X TBYT<>$[4W$UPOAXR7NIWVGVIM9[:^T_4K7[5-_7U10!
M_)=X4_X-9?!G@+Q?<_"OPO\ M;^/U_X)W>-V\#>-_C;^R _ARPTO4_BC\8_A
M[\.Y/ >GZ_<?%6RN;G7M"\,^);B:]\2>)=-TN&'48;K6-1T[2+RV@@TRZLX-
M+_X-4_A_XWT&;PA^TY^V7\9?C/X.^$_P9\2?";]B#1+2QM/#=S^R.=;^(FN>
M.-(UG2->6\N];^(D'@V%?"NE^'M&\5WAL8[,>); K%8-X6C\._UL44 ?R)7W
M_!M1^THW@?2OC58_\%3_ ([O_P %38O'\ESJ/[<FHZU\1Y$M_@C-X;U7P[<?
M!30O"%MX^BU2WTJY>?3M;GU.]\17(;5!J033X[>YB2/HM?\ ^#9+QG8?&+]F
MSXI_!K_@HO\ %SX2:[\+/"?Q8U3XJ_$F#P'X:\4_&KQM^T-\;Q<S_%OXZ>"O
M&.JW$5OX+UGXB7#Z?8ZA;O:W^H>&=*T:VF\,ZQ;ZWJ&JZI=?UEUQVK>/O"VB
M/XCCU*^NX6\)VFAWNO"+1-=O!:VWB2XN;71WMS9:;<+J;7$]G<)-#I1O9K (
MLFHQVD4L3N 3>!/"D'@/P1X.\#VNK:[KUMX.\+>'_"L&N^*-5N]<\2ZS#X?T
MFTTF+5O$.M7\DU[K&N:BEHMYJVIW<LEU?W\UQ=3N\LK,>KK#L?$FCZCK>M>'
M;.XFDU?P]:Z->:M;OI^HV\-O;Z^E])I3PW]Q:1:??-.FG7AFBL+JZFLC&BW\
M=LT]N)7>(?$&D^%='O->UR>:UTNP$)NIX+&_U*6,7%S#:1%;+3+6\OIMT\\2
M-Y%M)Y:L99-L2.Z@&U11_G\J* "BL6_\0Z3INK:%H=[/-%J?B674(=&@2QO[
MB*YDTJQDU*]$UY;6LUEIXCLX9)8WU&XM$N7 @MFFN&6)DN_$6D6.N:+X<NKB
M:/6/$-KK%[I-NMAJ$T,]OH(T\ZH\U_!:R:=8O -4LO*AO[NUFO?,D^PQW/V:
MY\D VZQ]"U*]U:QENK_0]1\/3QZKKVGII^J2Z=-=36FD:YJ.E:?K,;Z7?:A:
MBP\16%E;>(-+BDN$OX=,U.TAU6TT_4X[NPMMBO(/AE\4K+QGHGAZXU(WMEK?
MBJ_^($NEZ1=^$?%?AR]L=-\)^,=7T4Z5K]EKE@ITGQ%H=G;V6F:X)[H:=J^M
M6VH:AX4N-5\/SV%[* >OT444 %%%% !1110 4444 %%%% !0> >_L.M%!Z''
M!['KB@ HK$N;C74U[2+:TTVRF\/36&L2:SJDNH/%?V&H02:6-$M;33A;NE]!
MJ$4NJO>7+W,#6+65JBQW'VQS#MT %%%% !1110 4444 %%%% !1110 4444
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M[OX?:]I%_P"$/A+;Z+X6U7Q)XW\%#7-%U#4/BAX6LAXE+++I: ']1F>OM_\
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M;^-WPFD\:^%K+3/ R7W@SXAG6(==\&Z9IFFZQX8\1+K%OKME;ZG)?QC^G:@
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M (*1_#K6_'4_[27[##?$8R1_!GX5^ OARWQ:U+XS0_'WPM\-_%O@#Q7X*N?
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M0?\ *-\0_M4V?[(6G?LW?##X ?M9^/\ Q1X%_P""H?[&?P!\4?\ !2J_TO\
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MXKO-&^'%[KOBI?#_ (6@^(=_;Z%:II5Y\0[;0=-A\67FG7&HFU@F::&/]OJ
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M]DW2K;4_!OP3\5?M:ZC^U!XCU3PI\0_"OQDUCPK\3?%]Y\7;/P%\']7\-_\
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M^R+KNJPV/BOPWXM\6Z]H_A/5M3\6^']9M=)\CQ58V<.K0WE]IVK>3>(_A_\
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M'V[QA/X4\,^#=?\ %DNH:CH#>._&UI9W_C7PAH.CW^K1ZKX+TK6]0DOK35-
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M*?A#XO\ A+5?'OC[0]?M]=N- MM0\,S7.K7S>([:Z7XD_:8_9%_;=^.6J?\
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M'[4>GS:OH/C3XLZ!K7@SQ#?S>-/#U[X,\5S:;!'X-M-(U/Q79>%M*T6P_P!
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M-)TW4KC1KU=3TB>_L+6\FTK4DBD@74--EN(I'L;U8)IH5N[5HIQ%+)&) DC
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MB.FBPC=QK8TD7/\ 8R3A;!M0%N+YEMO,(Z"B@!JJ%5550JJ  H  4 < !<
M=  ,#M2[5Y^4<D,>!RPQACZD;5P>HP,=!2T4 8,R:^_B.W BT%_"3:'>K>M*
M+UO$A\0#4-/.G);KL.F'0O[-.J-?&5_MPO\ ^S_(4P&X8;*PQ1AC%%$C$8RJ
M*H)&2H8J 2 W/?')'-2T4 8&@1Z[)HUC_P )A#H)\1-$RZL- %Y+HID2XE>!
M+%M41+YHEA,+M]I0$7'G% %VFMT(BEBJJI<[G(4 LV ,L0,L< #)R< "G44
M%&.<]^GY9Q_,T44 %%%% !01D$'H>#110 4444 %%%% !1110 4444 %%%%
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MK/=-?/JGE&+8=0>]9[M[TK]I:Y<W!D,A9JU:* #'.>_(_/&?Y"BBB@ HHHH
M*JRV-C-=VM_-9VLM]8QW,5E>RV\4EW9Q7ODB\CM;AD,UO'=BWMQ<I$Z+.((1
M*&\M-MJB@ IB11Q;_+C2/S':5]B*F^1SEY'V@;G<\LYRS'J33Z* "BBB@!JH
MBEF555GP78  L5&T%B!EB   23@#'2G444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
'!1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>ex10-2_004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex10-2_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" 00 NX# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^_BBBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MCP+\+?#EUXS^)'BO2/!/A:R:&*^USQ#=QZ?I=M)<G9!$]U+A%ED8[5!R6;(
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M<)JE_;S*EQ(Z,L2  ']+J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MAZG_ &+IMJ]]I&FH;&Z.L2V]PJ1W#6PGD@"JC '^D!\0_P#@I]^P[X'^#_Q
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M=;_:B'@&V^(.J?#_ ,::9H2>'-6\31:=H^D6+WFFI;7UTUB91:B S7'&%!;
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M2M/T+X^^!$GU-]4^(>E3S0IXHL-,OQ']DTRWU?35FLX6EA>: 2[@^*^T]?\
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M  KU35=9TWXF^(=.U#3I]>U75-7U;2-'LX)1_8\ES?3&&2'SY!)%]GA4(D:
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M^I^+[@ZYKOB+P_XJ#B^\.WVH21Q$Z=$EQ<Q1+"D1C25L294$?EGXI_X-)?\
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MJ.FZRIL'5K.;2;V>>X6PDC\E I5&)C 4#@9]"\0?\$B?V*O$'[(/PY_8=NO
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MKF\O]1N!>7^M7VKW;17$4WF"18_GPZE3Z]_P40_X+X?L1_LH_ GP#\1_V/\
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M>G6XN+B.WT?0X+%8;"")DB1'8)&@XK](JJPOP[D8W%2%SC*$X#[2>.,D#J%
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MMS;P6TUN(XRG^LNL&Q2BLRKOWC& 6)8LX?"C(8GGKGJ?2FQP&/S#&0AD;<V
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MZ7XDN/$-KJT<MKHU[9P)IUY;PQAA/)!>([3(1'OC(7(R*_J3H *:74#.<\X
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M0W_X1;5[BTL[R"PUXB[V:?=26M_9RQK.REQ-$H/F,5K$\4?M-_L[>"?!6O\
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MSDBCAN6(PH K_0)0G>RD#^(_[6,@ D>AYVYYP/3!(!*.1T(]CC/Z$C]:***
M"BBB@ K/U2\M["QNKZ\GBM+*QMY[V]O+B3RK>TM+:&26YN99""!'!"CRR9P
MBDDX!K0K'UJ?3X=-U.3571=,BTR^EU02H[I_9L=O*]Z2B*S/_HXDRBJS,H(5
M2>* /P#O/^#ES_@FCHO[2<?[.WB#Q-\1]$TN3QC?^"8/VC-9\*Z9IG[-]WJ6
ME6YN+Z\M?B-=:[&TNEP.IM9KE-+9DN?W;QKE2>0M_P#@Z#_X)NW?B+XR^'+7
M3OCV8_A!H'BWQ.GB ^ M'A\/?$K1?"NMP:-)??"K4)_%,9\60Z[-<07GAYEA
MMAJ5A(EP#$K*#_$Y_P %<OV@_"O[7?[:GQH^!/A'P%\1XOV=_AIXEU_3?V8_
M"7P;\,C3]%UGXAZGI9MKGQOXDD\1:.;KR=;U:2%-7CMW2/[/;2&S*R%6KOO$
M'PX_:K_X*]_ ;]GKX:_!+]EWQ%X0\7?\$U?@CJWA;XB^(=7MXK.V^)/B7PUJ
MUG=6'AK18XX+"<7%W86KEIK][I%>U8@X*"@#^OO6/^#J+]@#0-+\;1>*?A7^
MU7X \=^&_"WA[Q/X5^&?Q+^%^C^#O%WQ/'BO4[72-$M/ NGW/BVX?5C)+=QW
MUW.HCB@TR.XNT,SQ/$-7QE_P<W?L6_#7]ESX:?M+_$GX;_&KPE-X]^)&H_#>
MX^$U[I.A#X@66H^'DOAXKUC2;*3788-9T;P[<V]I:WMSY]J1-JM@FP/*H/\
M)_\ %[X>_MB?\%GO&7PE_;>E_8CU*]\#_L@>$?!?[*'Q'^%VB7G]FS^._$OP
MZUJXU&].GW>IFUF@W:7XBM8[R9A+%%-"\-O(BHL:?2_PX_X(X?M<?'_2?VB6
M^(G[%R^!/@SX<^!O[27B/]D/X-^)=8.IZEX%^+7BWQ1X'N?#]M9:G!>>7+K$
MMK8ZI]BGF9K?RVG\[+;: /VM^('_  =A_ 7X5Z-?7WQ _8X_:=\":KXLT[2M
M>_9_T+QMHFF^']1^,?AO5KR.VM=<M4FNYVTVTG,JFVD@74DFE94#@'<+4_\
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M(KOX%_%SQ7H>@>*==UB[\(7TD.EJ!J^@1MH-S<V4<4UDD%U*ZR.D$.0!7<>
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M'-?[8/@[PY\4/@SJW['OP^^$7[6'PZ^.EK\%;JQ\9>*=2@^'VB:;+I6J7_\
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MIEP;K3X/"5[/ISRZ'#9W3&XMHK(Q)%*6= K'-?361QSUZ4!E.<$'!P<'H?\
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MIG)_CI_8N_X.*?%G[1/QC_X*2?"C4/#6J177PI\.?'/QU^S=>206HM[/PO\
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MTNWNA+'J<NM_V7++FXCN8M)F:2U_>I&3E:_2K5/^"EO[#6CZ/\1/$%_^T?\
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M4/\ V@OAC_P2FU']L[]KKP_X%@^,&K_#RZ^)/PX\"^&?$5K>G6M$U[P\=6\
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M9N])N-7AN+Q+U'*P7*HLD2+MQ)N4 _T_G"L"I)W+C<"I)D7MA?O,0H],9SG
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MM4MXKO3=7TK4H6MK_3;VVE5HY[:Z@=X)HI%*R(Q1LAB:^*_"/_!,K_@G_P"
M-$\=^'_"G[)GP6T71/BG#+:^/-,M_!VG"T\1V4UY!?RV6IQF+$MI]LM[>X-J
M/W?FPQ'&$ H _P ^+]CO]M+]K_\ :?\ '7[.GPF^(?[7?Q^^%?QTU+5M0TC3
M/AOH?@S2] \+^$O@'X8\-1W/PYU+PO\ ;/#<ZZC"+^!;5#-)?7%S91[WEE7+
M'Y?^'G_!9C]N_2OVH?VCM&^-?[4WB_QQJUWX9^(_PJ\+:?XMT30U\/\ BG6-
M.OY]!T>P\266F:3IR6-K<Z-!<M)<1_9G^T^3N<,V#_IZ67["O['VG_%/PO\
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M(\$U]MTF!C&.!QCZ4 ?YTW[3_P 1_P!L+]KW3_V7?V3/V?\ X%?M5? OXG?
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M=I6EVES>RVX2-9[B*65'W'=@C/WW:?L#_!]?V8/CG^R??:CXOU'X>?M ZO\
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MN))$$L5G;0PIY0C"[%8#>-U>TX&<XYQC\#VI< =!B@#\B? 7_!$S_@G=\/\
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M3=/T"SF\+Z3XLTO3M/E262PN9HK+58;'6%EF#:?JT<]DV9(GP ?T)!R-JO\
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MA/Q7XCLKR\'C?XP?$G5=9@U;0-/CL8G-O:Z5:>#O#$FM7,[*\5OJEK]E1W!
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ML<UWJ%S_ &1;SJD<9A07+@-\@#?OK;J53D.,_=5QRJ@\+W&.<C)SR<C@X_B
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M04U:ZM&TK6?&/C/1]0\8:L^O^,M8TAY%GU.SO-*A342+K[*\:BWK]#/V-O\
M@AYX$_8P\&^ ?!'A/XT:]XGTKPI^SK^T9\!K^XU_P]:+>ZM=?'W7?"&N'Q-;
M-;7D<5@GAMO"TL"Z7Y<_]H"_#"ZMO(Q* ?SY_LT?\'6?QU_9^^ 5YIG[='[.
MWBGQO\5M2\!ZOXQ^!GCS3=2L;'2/BG!;W6J6%E?>)H(XX6TG1O[3LTMY[C3(
MIYEACDD6,R *>K\8_P#!Q'^T/^WI_P $\M3^)/P472?V-?C[X3_:Q^#WPDNM
M9TK5O^$G\,R>'_'9DF_M47VO6MN8(;2-"+\7,,:1D*48CD>VV?\ P9W^#?%O
MAO7--^-?[?/QD\=ZIH>B?\(U\%Y=$\)Z5X?T#X?:%+J5WJ-]H^J:3J&H:Y/K
M^F2FZE$,%EJ.C+#.[S;W#>6;S?\ !KOKW[-7[*WQ-^''P3^-<'QYN[SQKX8^
M-6G?#OQQX+M=$M_%OC_X=65P?#'A^_U>/Q"+6/PKJ<SBVUBR^S+=7$<F8;Z$
M[J /BK]DW_@[6^*?P_U+X$_LV?%GX/O\:]0TB77]%^,GQ_\ %OB6V\+>*/$>
MJV_BCQ-<2:MX9T.PA/AUM-AT>&PL[&2\OK9KB2,^8@'-?H;\$_\ @Y>^/7Q=
M_:K_ &;?AIJO["VG^%?V7/VN?CGXA^$'P7^-MQX^N;O7/$EOX<UR+0=9U3^R
M+:"336NM%O)H%U2%+D0+NQ;22KR/E3X3?\&<?A?QQHOPW^)?QH_:%\:_#?X@
MWCQ:Y\1?A5I^EZ'XLT31[^3Q%=:E>^'] \0VUW:K%HTNERQVEI$T-S):^;ME
MFG964_M)X-_X-^/@GX(UK]@T:9\8/&=MX(_8'^-7QD^,W@3PUI^DZ;:7_B._
M^)?B6S\3Z+H6KZH_G16VE^';VRCBOFM+%)=6MF=$DLMY) /Z#$<QMY8QY,:[
M1G<&!#;%R3P5P"<DG/4=JM@Y /3(!JHI$FX-AD=\*&7=DGYCA@RY0$8Z9&1D
MCD5<H .<^V#^?&/ZUYM\7O%5_P"!OA/\2O&NF6PO=2\)?#[Q?XEL;-MP^U7N
MB:!>ZE;0$HK.!+-;(AVJ6Y& 2,5Z35+4=/LM6L+[2M2MH;S3]2M+BPOK2==\
M%U9WD+V]S;S(<!HIHGDCD7/S(Q&>: /\B?XR?$OP)\ KC]G?]M#PS\=OC/XG
M_:B^*W[0&I_M!7^@^%O%$6I>&/AK_8'Q"GOI/ 5YH]QXD:]FU.>\C'V6UOM%
MCMI;$F(KY.(J_HV3_@OS^WIXS_8@^/G_  4OM%^"WP_^%&IZ'J7P ^%7P&U'
M7]>G\::'\6?#R6L&I_%;1;U=":TU#495UJUU Z%?SII\9L&B0[7P?W!3_@V_
M_P"":"_'S7OC_P#\*\UIM7UW6+;75\$M<Z(W@+2-1@!+RZ1HYT/[3:_:I2T]
MSNOY#),Q8;<XKW&/_@B/^PZO[*7BC]CF7PIK=S\)?$OQ.?XJC[1<:.^M:'X@
MN=1TC4;ZVT*Z_L<6MKIFH)H\6GWL#V4TDUE<W,?G!BKQ@'\G/@7_ (+@?\%0
M_P!L'X:_L@:#\%_BAX7^"WQ!TWX(_&+Q]\:/&VO7?A_6=,^+O_"H]1FL[C4)
MM)LH;O5/"VHZC!;AC;W5C90-,[&W:6W"2'Y!^&7_  6L_P""@/P^_9C_ &[?
MVQG_ &E/A^/B%\0_C1X3^$.C^ Y=9MYO'>D^-/#VD>&8I/B;X:\+W-L]G+X1
ME\*:/<: _E6\$0O[AYBC2C>?[@/@G_P0T_X)[_ 'Q!XM\3?#SX30:?JOC#PU
MKGA&^FE73F6S\/\ B&'[/JNG:>L6GQ>1!=1!1(C%U8@E@0<5X58?\&V7_!+Z
MSU?X@:Q<_"J^U:7X@6L%O+:ZE)HT]GX:N(K^VOY-2\-PIHL?V*_NFMC;7,\[
M70>VN+B,(K.'4 _C)\,?\%K?^"GG_!0#]DKXA_LU:Y^T)X=^%FJ^'_A#^T%\
M3/B7\:?'/]F^'+?XY> ]'TZQA;X+>#ITLH+.+Q:MM?2VNGG2YQ?3-)(K;:_O
M>_X(I^.?#WQ%_P""7/[&'B?PW->W&G2?!W0]+>;4IYKB]DU/0UDT;5VEGFDE
MDF)U*RNL/)(Y90I!.>/./$7_  0:_P""<'B7X$^%O@#>_!;38/#'@_Q%?^)=
M$URSM],A\3V]WJN/[4MC?_V>UNUEJ&R(W4(M TABCR^!@_IY\#_@E\./V=OA
M5X)^#/PG\/6GA?P!X T>#1?#NBV4<<,%M;19>64I$D<9GNKAY+JX9457GE=@
MJYQ0!ZS1110 UB%!;V'4\=<#/8#)Y/IUZ5_G<_\ !=7P[_P3$N/V]-+_ &<-
M/T;5?A_^T3\9]7T;7/'7[5EUJGBL77P7B2#7)[6RT;1A(+S43XCU!$LH3 B6
MD2S-]G<Q[Q7^B)(GF*4)(&1DC@G!!QR""",@GU&,'FODCXI?L#_L9_&[XH6/
MQK^+7[-_PM\?_%C3K33[&Q\>^)/#L5]XBM;32M_]G6\5Z9%Q'9>;)Y V':68
MY).: /\ ,1_:/_9Z^"_@S]@CX,?"?X-^$?B)XO\ ^"K_ (=^+?CG4_VF?^$6
M7QEJ_P 5=$^%-RNKW'@GQ)K8L9;AX-#\1>")?"=U9[KH/Y5]!;R*NW;7/_'#
MX06>E_ +P%XF_P""9FB?%6\\6P_LEZII/_!4"XM['51I7AXN_A@ZQ%XU?7YE
MC&K'5X]5DO[=5>^MKF.9;,&)IC7^J'X2_9._9L\"_%/Q?\;O!_P7\!>'_BUX
M^T:P\/>,_'^G:+%%XC\1Z)I=G::=I^F:G>LS&>TL[*PL[6&/8H6*VB7)VYJ/
M2?V1_P!FC0=!^*7A?1O@IX!TSP_\;9+J3XM:39Z)%#9^/WO9)Y;L^(XU;_31
M/)=7#R E S2N<<T ?Y%O[.'P>^%7PM^.O@J\^*?PU^('Q\_X)_V7BSP_XI^(
M7Q>71/&FB^ =<T[4/ <BSV%S-8VHT,+I/BR_338=2:4N]SIZP[]LQ!_1/X/^
M$O@Q^S/\(OVA_B3I7[+<GBM/VF/'GQ1^$O[.FM^*],^)Q_X4+\!OB!-<6DGQ
MG\1Z7'H=]X;_ + TWPI=VM[HNI:69;VXDM6\^6*/:]?Z8-E^R7^S9IWP6E_9
MSL/@OX!M/@5/8)IDWPMAT.!/"4MA%>)J$=LVG@Y,27L:7"KYG$BYS@X'9S_
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M,M#\,_$#PAXQO/!&D6WB*.WNK6/5-!U$SI;1S07\"3K*LA_?)(268L,T ?Q
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MN"VBDA7D@U^7/@S5?^"A?BV\_P""-_Q$^(W[.NF^"O!'PO\ ACI/A[X >+/
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MO#/Q)\3:.-,@T33X=<U2RNK76/$%QK5JHVSZC,TLM]*\S!I/E'GG[5_[(O\
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MR"QUWXD_"?6="MO <&GZ_92>'+]))-%LM+U.*UNWU%]5999%LX4@>X,:S(6
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MO%5YH%O^T#8>*K*;Q)XAT63Q%/X;T#QOINA1R-/I7AS5)(A=K<:UI\*B":-
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MI6H:E=_'VVM-0TW5+/1WTFYT'Q&FI_Z8UP;J54;1A((K%K0+=H1\L@C4X8<
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MV6^4FXMCDC;GT!Y_GDY]?I3@JA0H' &,>QZ_GWH _APC_P"#/#Q!K^F^,?\
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M%2P8!5\H[1R[#&%E!Y P3D 9%:&Q000,8)/YC!_/C\J7:H!  PQ)/N3U)^M
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MAB^R--(#"T:,"0 H_06B@#RWQY\&OAA\3_!3?#/XB?#[PCXW^'DD%M;MX/\
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MNW_Z"6<&/G_6?UG2=#\1:;)I?B/2=,U[2[D)%<Z5J=A;:E87 _@\^VO(YH)
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M]1O9O%W@#X"^)/B7\$]6UK2]=TRP^*_C/POX*U?Q9XA\$Q0:MI-I%H=]HO\
M9;VD,FM26\6M3GR].,TC+&?TG\4?M/?M;?&C_@F-X*_:L_9+\!Z9<_M!>(_A
MWX=^(-M\,?$%SH:0ZPA@5O$.CQ:EK-S9Z/8S)%Y]]#-/.@Q ;:,-+(BG^9WP
M=_P:L?$KPG\-/^"AOA&&'P9:^)_%GAGPAIW[&GQ-TWQ)>Q^,QK'AG58M1\4S
M>)%BCCC\/VOQ#LUN-$U9(9)XC87<B(@4XK^OK]C?X"^+O@;^Q#\%OV?_ !G)
M9W'C7P;\%M.\&>(I+6<RV7_"0'0&M+^.&Z"(9H%NYG03[0SJN\_,#@ _D_\
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MZS?^ _VE?V4/#_[.OBWXO>*_B%XFUP> Y/%GQA;2]<-]*-,TB;5O#-I)I_\
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MT+5K>26QV(R,QD=:^:9?^#BW]I'X_>--5\3_ +)7@[P=;_!C]F/X>_#WQ_\
MM@:/\1?#5UI/C=;^]N3:>/?!?@9KB:*+^TK2YMKZWTV\E4V6_P IBS*/E[?X
MB?\ !'O_ (+<>//@S\%?A9??MG?LV7&@_ 6]TVX\-_#^3PKJUMX4\62:+]JL
MM,UCQ==1:-(VHRQVMS_:=QIM_I>H6]WK"+/-<><!<"A\0?\ @W2_;9USQ_XH
M\7^&/VU_A7HVG_M#^%_!.@?M5:9:_"*/0H?$]QI%U)J6OOX:ATV^\B$75_<7
M7V9V6T>>-U$PC ( !]*_\%X/^"N'QG_8_P#@U^QSX\_9LU_P[X*B_: O;CQ%
MJFJ^+M#U3Q#<6.D6?AV/6K;2Y=$T-AJ5TDMU-!87<MO&]LK,7D81C%?F)XG_
M .#ES]H_XM?!_P"$WB+X*W7A'PK\2_AS\.]/\>?'ZYNOAIXH\7?#WQ;XBU^]
MN-.T'PE!J7AHSV?PZB-SI4S3W_C6:VTZ2.^C6-_W$XK[>^,G_!)7_@I/^V_<
M?#6W^,OQ6^"?P:\9_LG6^L_#'X:>+]+\/W7Q)\-^/_A9XMT*ZLYKZ?P[J^D^
M';32?$-@MAHMD?+.HF+SKJ6._P#,B19> ^!G_!L=\=?V:/A!J?PH^#/[8?A/
M0+']H_2X?"'[;%IJ?PP_MJS\<^ DEG-MIG@B:\UII=*O],.I:S<VE['%8RF:
MYB ,?E))0!\[?&S_ (+*?\%IOV6/$7[._P 7/VD/#'P-\(_#[X]>(?ASIWAO
MPCH'AW5?%/AW4O 'C"_M(K[Q3>>.M)N9?"/AK7H(K@K:Z5JMW%J<R8FCB:($
MU_<_HMZM_IUA?%%5[[3K&_9D V'[5:03'81D%=SG&#T'&>M?RG^,?^#<'XB7
MGBSX1_!3PQ^U_>O_ ,$]_"?CGX8?%[QM\#_&_A_5/%?C35_'WPUEM8I-,T#Q
M1J?B&XFTCPWXILX9#+!#*D.CS.(XK"[1=]?U;Z=:Q65M;6=O$T-I9VL%G:1$
MY\JWMHHX(H_^ I&!DDY&.G2@#1HHHH **** "OFJ_M]>_P"&K=*NU\3:H/#:
M_!;4(9O!XL]1;1Y]5/B</'KDE[L_LM;Z.W'V1;<R"\:'YU0H,U]*UY[<:1.W
MQ(MM>'B9!!%X2GTU_""VT?FS.VH^<=;%T9_,"QC%J(3;E">?-SP #MP>5!&5
M4J&+ Y=NH/.3B/@C/.!P>:MU41R[@@$9;YB?X-N/EP>[*=IP, Y()ZU;H **
M** "BBB@ HHHH **** "BBB@ HIK!B,+CKSGC(P<C.#@^AJ(,QWL3C!!4#.4
M&"I9@0.QW%?;!P: )Z*1>5!SG(!SC&<\YQVSUI: "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ J*7.T$9X8'@$D 9R0!U('('?&.I ,M12LZA=@4DNH.
MXX^4YS@],CMG /3(H _.;_@K7\2_$7P<_P""<_[6WQ%\)^,=9\">)?#WPGUJ
MYT7Q3X>M+J]U?1[Z?R[2"6P@LX9KD22O-Y+3Q(3;+(]PS(D98?PN?L9?\%WO
MVY?C9X0_8.^"FC?%S7=/\0>"_CQK/A+X^Z]82O<:AK_PKN-.\*M\/I=?N=0C
MG-Q<:GJ5OXMM[V6%BVV(96+=N'^C3\9OAGIOQP^$OQ"^$&O7MUIFD?$?PEK?
M@_6KW3PC7=MI>O6<NG7QM6D^5+AK6>5(W(.QF# 9 K^?#P7_ ,$8/^"4?PX\
M'>+K[X)_&3PUX*U7X"ZM\,D^,OCVV\:>%=47P=<_";4]5UF>#Q]$)+>'PYJ6
MNPZQ-;>(+K5)X9YK6.W612L2"@#\\_!7_#S3]MKX$?$W_@H5H/\ P5/MO@!H
M_P /_'?Q#L/"OP"TNTL#X?L;'X2ZW?>'FM/$$M[?+<R7WC6#3Y93&?*_X_PU
MO$2L;#QKX!ZE^U=_P66_:*MYO&_[8OQ7_90A\*_L@>"_'&WX9>)8/#_A&+Q1
MXIN_$_A/7=>U/3=<FCGO;?5K*R260PSJ\#2>=%)$P60?H9^UG_P2T_X(H?$*
M3PM^U#XA_:NT[X5?"#QSXNT&\\9>%_A9\;_#OACX-_&O4-!LYM)ACT_0].NT
MT==7;Q%;V>O:_JEFM[/<R:7>17042R.ODOQC_8+_ ."+O[8GQ[GN/"/_  4.
MC^&*>#/A)X8^&FI^#?AC\</#/A_1/$'PU\%PWFH:O;2ZA8ZG;G4HI-'FU ZK
M<-&R62"6Z9#L8T > _\ !-?]K7XM:Y_P4F^!7PI^+O[1_B/QAHOP+^ G[8/P
ME_X23Q+XQ@T[P3XRF^$^O:AX,\)^*8#=7<&G:EJ.H6>BVNH+=W5S?S&YFD>W
MF*DFN<_X)/?M3?M/?$#_ (*H_LX^#/$?Q]\=^*_A/J7P3^(7Q.^)'AO6_%EE
M_P (T=4O9_%.DZ9KE^M_(!=VS7,5A;6-M92ADE2.;;Y:D']<_P!L[_@B%_P2
M7^*'[*GP2\0^*]3U/X9_!?\ 9Q^'NEP^ ?B9\/\ QAI^D66M^"_$$UE<1:QK
M?B&UABM_$]SXD:[@N6UN2X!OVNC<9D\[)Y;PM_P3!_X)!_MO>*+7X8_#'Q;\
M0/A]\5?V0_"MA\$=1TOX6_$F#X>_$#4O!7AD6SV_B'6+?1H_[5U[0M3NM61#
MXBG06MY=_NS^\4!@#\BO^"]__!8SQWH?_!0WX%_"7X%/XT;P'^QIXFTWXE>.
M-=\ :YJVJ>"?B1K.OMIT5GH_CB'PJLA@T7PW:P:UY\5[=K#/)+G:C(*[7XD?
MLD_#SQO^V;_P3Z\.?";]M;]ISQ=\$?V]Y/%?B+Q(Q^(NL6EM!9V6C7$XTSPS
M%%<P2VMM8ZH)&02Y96C"%R!7] 1_9/\ ^"8G_!'KX!_&_P =^)TT_P &_#GX
MQ:+8^$_B/>_$77-)U?6O'DEGI^JI:Z99RZQ#;RZOKU[;W>I3F/,\T\_[XH&4
M-7M?[&/P+_8%^(_P4_9:^)O[.FEZ#XG\$?L^VNLZE\$?%5Q=:7J>N^$X-=-P
MVJ6UWJD43R6T6R>=_LZ20K&N6;@<@'\!W_!3O4OVS?V??VHM/^$_[.7Q]^.=
MSI'PJ^(/@SX/^$/+\:Z[+J'B3Q1X.\1SZ1X;U;Q;?1W;:>NKZ[)%$98KWRX;
MQ]VZ.5,J/KKXH?\ !1CX[_M2_ WQQ\4K;QE\8OV=]"^./_!0CX;_ +-WQ]M-
M/\0:CJNK>&?!GASX*?"WPKXWN+C5--@BM/#^EZUXHL=0UB2[MX]/@MI+]S+=
M,QD9OZ@M6A_X)7?'CX:_M1?'S08M7\<:'\-OVF;#Q7\<M0\ 7.GZIK$'Q&^!
M^MW>L:=XDF33XYY!X/%U+>W2WDSK!>VB2MO"QDU<U/\ :!_X)#^ ]!^-GPPT
MBU\(^)_!G[5/PBN_VHO']MX1LO#GB#P[XG\*:HJ_#G4Y-'DL5DMAK%I<^%Y$
MU"QB$TUMJ=M<32L)U95 /P=_X)O?M&R?!_\ X.&KC]B+X*>*OB\OP'GTGQ7X
M6UJPUOXFK\0O"?C>^\$_"K7O$-KXQNM[ZE#9PZGJMM%>VB6-W;RQ78A2Z>7.
MVOD#_@X5_P""J7Q<OO\ @I+X#'[,7CCQY;>%_P!C_51H'CN7P&_BV'PQ)K1O
MK>;4/^$H^P!M(FNXK2>]M(S*6"+@;<@+7[9_\$X?VV/^"$G[/OQWTCX$_LB?
M#/Q8GQ!U8Z]JMS\;M;\!VFK6GAG3(],O]4\176N_%0V\9T/1-)TE+V/4GN+A
M(;*S62&9A'N%?I/^SI\4?^"3=]^SI^U?\:/AMJGPTG^#_BWQAXOO_P!H2\\3
MW'A2\CU/7H-3U'2;J]O4N1LDAU&Y1[G0)9V<7$4UC<VY):-J /XGOC!^WK^R
M#^T)X6_:_P#VO_VLOB7\9OVA?CK:?%+4[/\ 96_9H\3ZWJ/AGP-X.^%&J:ZR
M?#GX@>%@]C9*9M'AD5WO;9FN[FSC_<3A]K5Y3^U-;W_[8/["_P#P1T7XN_'&
MZ^'<_P 4[W]L"\O]5\=7OBGQ/H%Z?"?Q5\,Z/X,TJ:TN=25Y4T/P_<7.GZ9J
MES(TAL'E03L9]Q_JP_9B^,/_  0O_;K\6? WX36O[-NJV7_"@/AM=6_P\\<_
M'[X1Z5X;\->)OA_X,T06CP:]XOURQCM/%>GZ9I4;:G;&XD$$"L;U66/E>)^-
MO_!03_@W[_:@^)GP_P#V3?B-\+FA\(?";QSX@^#7PZ^(>E?#G1M!_9]\(WNM
MWZ-J=UH'CM+8^'+#P_JUQI"W$>IV<D$%TD7FDOD$ 'Y\_'_PA\4I])_8-\!?
M\$L_BA%IWQ9_9(_9ML_C;/JOPB77=-\#_%K3+_4=5T;Q9X?@T_6KZ\7P_#9Z
M5X5U>ZN1K=S-;W37\W]F01W#*Y\7^)GP@_9@_;R_X)+:?_P47^(?P-L-#_:+
M\8?MI:QI/B/Q-J5X\FL7>C0^)HY+[P5),S0PKX:N7FEMQ"L*W8@)S.S88?U#
M^ ?V_O\ @E5^S-\._P!J2Y^$7@_P_I^A?L9S?#OX)_%L_#WP9HEWK6L>&O%^
MHVNF^$)M-;3%2?Q'X/O;_7I95O"PL9))KV5 3O!\S_:9_P""DW_!.'X%? 6Z
MT.S_ &</#OC#X=>'?C-\*M'U[X-Q?"_2?)N-5^+,,FK6?BGPGX+@MG@UG7TA
MB:226.W64WFU)'9V!H _EF_X+.?!S]G+P3^V!X:_9M^&WB[PO\(OA_\ L^_L
M1>$M2^#WP3\2:-X\O/!&M?&C4V\0>+M3L? MW9ZA9Z5I/C!+75HM:C\0O)<(
M]TD=LCR.@6OZ%_A/^W5KG[//_!N#!\>Y9?&_A+XH>'OA+IOPU\(:YJ\^IZUX
ME\0?%7Q);6>E>&-1L?M-M/??\3+4;Z*"W62.;88F=Y,<KY1^U%_P74_X)[>/
M/#?PO_:!U?\ 8AM/V@?V?3?VWAM/BAXW^#<.N:U\/O$N@:A-9ZKX;ECN-.OX
M-'O]#L8XKFWLI+N.1%GB4HBN*]"\9_\ !P'^S+J'P.\-:G<_L<^)]2^&WB/X
MK^"] _9Q^&WBKX8W=J_Q)TO1=0L;K5_%7@?PI<6(M[^_\'VM_I^H:-_9$$\8
MNI,"2+ 8@'\U_P"Q;?\ [9G[+5]\?_@1^V59_%CP5I?_  4,_9Z\4?%3P9HV
MO,/$GAWX@?%-_$>B>(-+\36\FE6-S=Z5JUEX)T;6A_9E_?1S+';R^7;J"@KZ
MI_X)Z?$']H6]T;PA^PQ\=DU^+X=>!/V(/VTOB/\ "/XY7OA[7+J*V^'?Q.T>
MWTVUT"VTB"U^U3?\(Y=6.H7*:;'*VISM,0D0#(#_ &L?L1_M:_LP_P#!3+X2
M:;\:OAQ\/IY=+^'7B[4O#%MIWQ(\#VFFZWX.\6Z98W.DZM!IEI?12RZ>]O;7
M5[IDCPF)O(GFMW4!V4_;UAX*\%Z;+I$]AX4\/V-SH-K=6&ARVFD649T>SU$@
M7]KIKQPJ;6VN\*;N*$K%(1EU- '^:M\ K+]F;XH?!O\ X)<_LY_L%^*+GX2?
M\%%/#'[27B'1/C!\9?"7PR\8Z1XG3P9HEYXDL],\9>([S5=-CLO[/\26D&EW
MXTZ_N&ELGOQ;W*K-%@_Z7_AFQU+3-"T#3=:OFU76+#1M+M-6U=PJR:MJ=OI\
M4%_J4B*<*][=0R7##L9,#@5R>@?"CX7^#]<U+Q3X7^'7@GPYXBU>2YDU+7M$
M\,Z/IVL:D]Y<FZO)+F^M;2.XE-S=DW$K,[>9(1(V2:]%C8.XVKM"[N"-IQCC
M@ #&6)!QR2U %FBBB@".7[A''/4M]T#(R3T_ =2>@.#7*^(Y[*V\-Z_>W>IW
M.F6D.E:G)<:I9Q&6\L+>"SG>6\@@"2&2XM%!E@58W+LB+M8X!ZN10ZLIY!!R
M#C!P01DGIT_KVK'O[5-1T^_L7E>W:\MKBR,\#;)8(YH6C\Z&3'RO",NC@Y$@
M(/2@#SSX-W^F>(/A9X6U;0?%^M^,=-U'10^G>+?$-FUAK.JIYLZIJ5_:2V]K
M+#,9$*E'@C.$!*8.:_S#_P!KRV^,7[1?Q8_; ^"5OX0_;+@^.GA#XK?$SQC\
M4_B=JWC36K[X5:Q\'M$\=W%G9:)X6\)6>GP@P7.DZCX=6SA2YO _V:5XXW$;
M^7_J/^$- 3PSX<TWPX-1O-6ATNV2U74-1G^U7E]%YC.9KBYSF5V#MO..%&"<
M5J_8;(O+)#IUB[.-DI-I;*\@)^[*WE[GC(4'#,>@X/! !_+3\5_V=Y?V6O\
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MS\^B_&.;1]1?7/%^H)X2^&USH$FAWT.N36HMT=Y;74/.TI"\D+;"@8EO$O\
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M #_-B_:5_8<_;C^'GA7]KKQE^SMX5^(MI%KO[6'PR^$?[4.@:7X2AOX/B/\
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M.I)QZDY]>>: '@#&<8)Y/ SD]<X[^M  '0 ?08I:* $P,YP,C.#CGGK^?>C
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M6%YEW8YQA@?KCMU'6F"/"JH8_*6(//4@CIGMG/)/?UX 'HH10J\*H 4>@
M]_\ (IU(.  3D@#GU]Z6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH 8Z!^&)VE2"HXSG'.1S^&<'C/?*>4I8$Y.T@@Y ]1@A0,@#&-Q/3
MZYDHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH .^/K].,?X_SHIKNJ+EC@=!
MP3S@D=/I_3K5>.:4_P"L0(5Y;OD9 X ^H/...U %JBBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
, !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>ex10-3_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex10-3_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" .; KP# 2(  A$! Q$!_\0
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MDI-6N[71]",QRK*&V\%F&#T/W2,YX#$$ $]!V%*91T"G)*CE2.""1D$#JH(
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M-)K9JZ'T444QA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MA=(>@STZ'/49'3/:I%E5ANSM'S=3C@=\>V,8[<]N:')+=I=]5I^($M%1F5
M=PQG'')R0>/_ *_/]1']IA.<-G'^)'X<@@^F#Z&F!8HIBR*R[@1CGKQT)'0\
M]J/,3^\/S]<D?G@_E4\RZ-.S2=FM+_U\^X#Z*9YB9(W#(QG\3C_/U%()4)(W
M8PQ7GCD=>O\ /\>E.ZU?:_X;@244W<I;&X9P>/8$ _D<#\?>E!!Y!!&2./4<
M&CFC:]U;O_2 \X\>^/-.\ Z-_;>HV=[?QRZMI.AV5EIL<4FHW>J:Y?+8VEM!
M'/)%&H7/F&9Y5CV"1@?E..%3XUM-]WX=^.P5<Y AT#"C8&\P[=3)"E@% /5\
M#:1@UG_M%")?"'APR/,@_P"%J?#K:80DV]I->B"/,KA_W<9^=N54;%XQA:YQ
M'5(S'),\D?EHLLO^CNB3,[.+;R0CKYBL7G,P7*H1'D C/TN393@L9@8XG$4I
MSFZU:C%PJRHI*C[.,KJ,97MSJWO>\G=6LSXOB#/L=EN8?5<.Z2@\/3K/VD.=
M_O&XIQ?1WB[JS:O=NUD^Y?XRS))&@^'OC=MQ)(0: 2$""0,\7]I,Z(6+0AMJ
M*&0C>"A #\7;LXC/PU\>$[_*"FY\/L9-BAI2RQZRP;R&4P/Y>XE@44MQ7$)<
M.JW*0NQM'D,BQ,D5E<R311H"6\A8'5_M*R2;V+K)"\:D=A&KO&X$TLAE(6VD
ME78H,PES(D:[&A!-P"JQ@%"I52I4$5Z*X<PLFW%U(0M=4W)R;\G+1JZNFK-^
M;;]WR5Q5F:BDYX>^C:E0EHGI=/F7-JGHEU3V1VP^,Q+(DGP[\;1F122IBTG,
M;*&41;?[31F88QP21N$A!4$U(/C$ OFOX#\:1DE(A&)=%7,A!SAAJF6P' +9
M*[LJ "C9XV2Y8-:W=N(H+I))"Y"1 R(0S2',,,9%Q@%F4DY7<.20:<=1N&=I
M("TB!W>-BL:1;9%4N(VPV -N0N3-N+E<,P-)<-X![X65V[.^+JK76[]V+5G>
MZCO;1I#AQ5F+U5>@_P"Z\/*R6RLV^779WZ]&M3KV^,Q1V1O 7C$, HC_ -*T
M B=C-)%(A,>IF.%XA'YCO,8P0 F[>"!$GQG#*X/@+QDAPHB\Z\\.1O<,)"GE
MP[M60?.!O+#@HQ)(/-<F;UX&5WMX93.QE \L!4+PK!N,<2B"10B*!&5><R R
M%?,9C4;W3;$=9KBW=HK>-)X456B<OMA9YHA'($V*0JRD*&8X!+8H?#V Y$HX
M>JV]%?$MQ3NTK\B4[7T75W5]+FG^M68]9X;JW>DK:>DUKVTWTNVSM7^,,BJQ
M/@'Q<X60J2NK>%\ALC=G&MKR.#TW?*#[TT_&F,!BO@CQ9(5>2-1'?>''>23C
M,:!-6+DIG'R@A<,2<#GE1J!>0%9+Z>,/O>8W#MN(P-I6238QW*=VT94<DCY:
MJ2WLBJT;*TD8N9+AQ)-=SBY5AF6 6\DDD3I;>7%\SQ%-\@V#Y1B5P[@8NSPT
MT[*TXXF;4='JXRYK]$E%)_S/6ZREQ;F'26&;;MI0DU;RM)-7\[]$M;,[J3XP
M7*A?^+>>-0S+E(FN-!668NJX6!6U(F4*,%Y48+ K+D@, &_\+ANRVV'X:^,[
MD)&[,_VK001<J,K:'?JH9I78!%E7*D@ $HQSQ2S* ;QY+F5+FW241;HH;<1!
MOEMDC1(Y%=-Q9D3#3@J' Y (]SW%WLN)&B8H0\CJHA16#QKEV#*8E!'ED%4&
M$'!%4N'L'9\_/4LKM.;@O/:+;M>W]ZS?=*X\49FDIR="<9-)0C1=*2O_ #2D
M];ZI:]NAW3?&"Y52TGP]\7($!9G:YT151\;O+,HU$?,P[Y) )W$'D8M[\?K'
M39[&&^\"^,8GU&_M-.LFAFT*^DFOKWS##"L-GJDTH(,; R2HJL3EF/5>?5U\
MMRI,<DLCSS$3/,J/@*&,8<P 7:,;LAE("KL_B&?'OC!<'[-\/;<K%.R?$;PY
M$8)K?3)1/=$W#+,([FVD3<4YB(C:2+:5B*DC.M/AK+:DN7ZO.GS.2TQ56RM%
MM-N;Y;*71Z6V:=KJ7%F/LVE2AY.ESWU7\K2>VU^SV9]+GXOW6P_\6W\81(,[
MFFN-!C8("QG+B75%W/%@F*-69YR"$ 96S+#\5M1N899H/AQXQF@M3ON+B"YT
M&2)(QNW2AO[54F- $D7*QR2*X?R]V[/FQN=@FD0*\H!:%WCMYHGN-Y1(HS<V
M\Y@NK5Q_H^"I@<MY)0L$'\A/_!2[]OI-%_X*1Z5\2O"/QJO]&\-?\$\-2^%N
MF'X762>+;C3?C;XA\=>,1#\=-.FDL4N/"C_\(%X$NR\Z>+)"QOK=$M)8;K#G
MLP' ]+,:V(HT8?P,//$*4JE5)RBTE3O2<)<]6;4*<I2:3<ISY80E%\5?CG%X
M3DEB/8<KERI12A)W::;BWJKM*32NEHKW/[-E^-3^8(Y/A_XNB9Q^[W2Z*J30
M^8RK+$_]HK\K(B/&"JR*TFPHDF:1_C-<1@)_PKCQ>96 RDUWH*;V5]H1&;4P
M90X_>LT:_-NP3DE1_/[^T%_P5#_:*T?XO?M,>%_V9OAM^S_XT^'?[-_[)WPZ
M_:\O_&GQ*\=:]X=U3Q3\//&&EZOK.I^'_#UII$8M)M8DL=)-OH^L2EK33KJ4
M1:M(][JNE12>?>,O^"MO[1GB?Q!\2M2_9W^"7P4U?X;_  G_ &)_@9^W3XDN
M/C!XMN_#GC&3P/\ $[PQ#XIUGP!'!;V'V:/Q+IMM<MH]AK5ZWV.RFLX[[5?-
M%_:I73#@&=1?N\%["4849U54QFD?K,Z%.C&:E#FI.K+$T5"-2TY\TW'W:?O:
M?Z]S7+[L7S)2C*,N9-.*FW%Q5GRPO*5MDFWV/Z3[7XL:M>Q+);_"GQTZN\ZV
M\AF\/A+GR\DF.=M5VK$P#*)2PQA@0K'B$_&:YRP'P\\4%D=T"?VCX:5VFBF>
M"=2AU=8U:*6%LF-F#'<%.XR(/XU/CQ^T[H?C77O^"E/[0M[X7\2:]\/_ !I^
MR)_P39^('A_X777Q!\9^"CI$_P 2_BMX9M(S::[X8N([G09+&^U6-M7O=#M+
M-=<M+)[74GEBO"A_53X<_P#!0?\ :%^)WQM^(6D?"GX6_ BV_9;^ 7[0'@?]
MDSXAW?Q.^*Z^!/B]JGBN]\%:3XN\0^-?!2>(X[;P]<:7HC>*?#NBZ#X5U CQ
M!XXDAU2\TUY+BUN5*J^'\L/%3=*;CR4Y33;IQI.M0IXFG#VCG.,ZKA4Y/9J$
M?>C*49*+C;.GQ[.<Y>_1G3@DYN*5^5RY%+=-+GTU=WS1\V?NH_QJE59&F^'?
MBQ%C+8D>ZT Q!%1I1,\W]I"&- "0\DKF&-06E;;N-31?%K4)0\LGPW\80PQK
M!)=2R3Z&%M;.>-62XGC.I E!*MS&6B,D'DQK+;WDL4\1'\X_@G_@KI\8O%O[
M;N@?L[>'O!OP+\5_#/XD?$[XL_"+X:>)O"%UX[NET+Q?\/--DNM)F\9?$*ZT
M*Q\#>)CJFL?9H?%WACP1+?:AX4M+J(7%W</(%;X/_8X_:?\ C3XNT_\ 8!\;
M?M.V<OQIU'QQ_P %&OVO$\(_$:#XK?$^3Q=H5[X2\%>,=;\::?>^#UNH-$\9
M>'= O=(30/A+\/M4A?1-/T&+3;*PT^RN8K:,ZOP[J0E%8B,:2G3A45&6(BZ]
M>$X5:E/V--<DYRDJ4H6C/FA.[M*%*KS3'Q!]I4E[-1E"/,W)1LH<G-=3E\,7
M9<UI7<HI\KNXM_V0#XT,8HIQX#\1^7.JD%M5\,;E78SB0#^V"VS)PLO 8DA?
MFZ0_\+KW!7/@+Q?!&7";Y+[P]$A9NIC9]4$<D856<R*<* P! *J?Y[_@9_P5
M;^-_C/7/V2OB)\1_@O\ "SPK^SA_P4 \3^/?"WP&G\#^.=8UCXR>#;W0-&UC
M7O#M[\6M&!B\/O9>)+/0I(-:3P[*DOAF]FA297 61F?LZ_\ !4G]IGXG_$K]
MBZR^)7PH^#'AWX._MI^(?CI\//!C^"M?\2ZE\2/"'B?X,_:Y)O$6L?VY9#0[
MGP[XCAM&M(]-LQ<W-I-%-<RWN&C4\?\ J/349U)X.HZ='VLW-8V5TJ:J\Z4H
MWIRJ4O8U8U(0TBXZ]GI4XZKPY4G0AS35/6'-)2<E32<$^9I2E9ZVNFDM&C^A
M6'XRWDD)F7X9^,);41++<W2W>@/9V[2S>6D/V@:DJC>'#I+(L";"RL0J;C8N
M?BYJ=MY9F^&GBV(/$LT):^\/J'B^VVUME$74'>1)$N!)',5>WD),?GQ>8)!_
M+#_P52^(G[1WPM_X*5?L=?%?]G*'Q%XG\4_ _P#9T^(/QH\:?"+2]>O;2/XG
M_"?PQXGM;?XG>&H=(\W^SM;UBZ\$W]Y<Z>DMM/J*SV,?V6XCGBC \C_8\_X*
M/>*+6T^(MA^S+IF@^//B%^WQ_P %&?B#X5_9[U/XZ:KJ]M\,_ASX3?X?Z3XP
MUC4_&4RLVKRS:9I<R:3IW@G2IH?[9U(K#;6SW#VZR]J\.W4P<<?A:<:E*I0A
MB>2-=.K3C.=6$_;MS;I<D*52NY<DH2I1FDN>#OE5X_JT:DJ$E"=52E%RA%0A
MS0CS-J#UDG%JVJ5U+K>W]>S_ !EN8U9Q\./%;0QNXED^V:#$L1B=57>;K4(B
M-[*02"R=<MCYAR'@GXX2ZAH?FV?P[\62R?VWXF0V\6J^&WFD,&OW:.XV:HZX
MW'.PM&55!C<&(K\Z?V$OVR];_:?\,?%*R^)_A[P3\/OBS^S]\?/%7[-/Q#@\
M+Z^EU\/O%7CSPQ8Z?X@LM>^&VL:T]KJMWI-WX<U*)+SP\4_M;2-3-]97L=PD
M =?LOX>W$0\-;#"9F3Q)XJC>.>-;U9I_^$EU%ML;7(F""&4M(7B,;LDB([%$
MC%>;5X5P6&5>A6PM:-2'LG*/MY**4[3C)VNI*7,IIP<E9K5;QZJ/%^85^65.
MKA7!KXG0;<7=-PD[_$H-.W]Y6[/V31OCRFNG41IOP_\ %\T.E:AJ&EZA,;WP
M^JQ7^F);RW4 C>^5I B7*%G4!%F$D0^>)0-\?%;6IU$D7PK\:7 (!Q:7?A^X
MC4R1F:%V>._RJM@"02;0K/\ =D(%?,_P[E2.7XGSE_.E3XO^-;=98QY+6L%K
M::"X#);^7%]D\TO;SQ+&!=)"JRJYW2-^!?\ P5'\$6?Q<_X*+_LH?#_4O@M\
M8?VD?#%]^S-\7O$%W\&O@M\9A\#M=O=1TWQ%H0M/& UB?Q5X2TZ<:,DQB:WN
MKV2[>TN3"B$1@#; <'X+,,7.E1]IAXTL-B<2W.<ZG,L/3IU:D4_:X:,9S52*
MI\U6A3;=Y3A%29.*XRS'"0H5&L/4]M5C134(P2E-U(PLVI\J_=SYWRMV2?+[
MR:_J'D^+>JPI(TGPH\=#R95AE(FT%_)E:$W 4M_:602"Z[@"3Y>4RPX'^+6M
MQ6HNI?A9XUBBW&,B6_\ #<0$_1[=Y#J0 $;>83-O"+"8IV95="/Y0OC)#X+^
M -WX)^"WA/X ^-_@?K8_X)%?MQ>-]'M_'?QS\;>-_BA\)K=O$ U#4? E[J&F
M^+]6\)>*-5DU<KJ&E^)TU&^U?PQ;3)I^CW]K;R31R>9_"3]MBX_9<^&^N?&3
MPS\-='\:_%WX/?\ !&O]@+QS?^.O&'Q(^(>J0?$4>([/2_#\FDZ_X5NM6N_#
MVGRPS74NJS^*=-L&UW4C=HFK7MQ#%"D?;2\.WB:*Q&$4ZL9RARMRE%N%2*:Y
MW[:<*5YM1OS5EJVVU%2EC+Q!K1DZ;I45-17-=)OFYFKI:<T5%7NE%_\ ;I_7
MU)\;Y$C#GP!XA62-XEE@.K>'#+"FTR.=HU!O,\@JKO&#E@&);:I#.E^-DD$B
M1GX?^(@7>'_6ZUX;@EB61MOF3V]SJR7"LJ$28\N5MAP2I7:/YQ_B%_P5U_:
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M8JZ@$D(FY& J:3XV:G%$TMQ\,?$L2HRY+:SX<>-C*PBCV,MX761V=5\MXX@
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M8J.>6 F2>!HT#E#*H:X5E:$[7S(LC^<1*(F#,7$@(!)!( L@R]M)X/1WY?\
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M^&*Q!XG>1 I#>8J\A1AR.:XN>\/[HQ7B12,T, B=MVX+*#,AC(V+%+9J$\L
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M5@BH%**1*-X 5B 6P%<C:PYQE#+*LOVAGF61O+$ZEC*9&F*M+$R;D ("HV4
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MRN[%F=I 2RB/#<%@=6+RY(XTQY.VV5F21RL16.26$L4<F)Y+L0AI#C*K&O\
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MZ1[#3X+RZFL[#3Y62R* OYGND2RRNT10*0UU+M2$1DA) T96ZE=VCP&D(54
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MSQ4<8'G0>9MB>:6"(IY1$?G,\>\HTG*Q7$2F*$!_-.+G8K,T2L- 5DD)ME5
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M=7[<I-*-U[TH*34=M6N:_6W;1ZZ==-"UECN3:QRB58H;@,K!O* >=AE3"H#
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MOAC\4_VL_B7X)^)?PHA_9T_8\_;B^$/P/UGX7ZOX'1?&7Q'\(?$K4M+TF_\
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MNIR:<I7LO=2NDDD[M:/WG;7A>-5$S O.$NTD02SR0RDLQC5V/RH020A&0"H
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M^H7*^24GT3:6FVU][+E6KLM+7W:?R4*<74DG&/*Z;LK:7N]]5JM'T5EKKO\
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M'YM%\$ZA=3W5]X*O[O3=5L[SQ!X:8W-W?RZ7K<M[9SW<TL\BN[LU>$_MG_L
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M.=X"2I<CG>I!2C&7Q.-TG**NGR7C9N*DE>U[Z+^LR%)-Y7SXV;S95F(VW"Q
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M/_H[M$LS<*\:JP@#<,K2X^48KUJ"TE AF,4/F++9?:(F:-%9)XB)@)BY&&4
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ME5TA1S<7"._V<'S(O+83@&VE W>4$0EB9=X7"L5TII(RBEXHI4*IL1S,QGR
M8V#@-&?+8C#;MCDC@?>%*4P2 A(GE>"-C! $8)(>"[7.711"A*E'+'_2! -H
MW@T1F];-ZJ*6S;=^KT>J?5VWF]FARBE%W23Y4G>^[235G?N]-M]>IP$GPC^&
MO_"R'^,J>#_#;?%:3P>/ +_$%[.V'C!?!$5Y+JL7A ZPV)_[!BU2XDU**P93
M%'=7,T@!:0X\7\2?L5?L@^+O"UIX!\2_LW?";7?"<'Q NOB]8^&]0\(6K:7;
M?$[5[P7]_P"-[>&,0R-XCU;4 +K5;J.=/[395^UB6$!3]06T<[^7-<#R$#,Q
M87/FF9"0%$\ CN)4N-XV2H.D(A;R^02R5-_V@^=N4E&F@<PJD,8?YBMT.(9(
ME4,\3*LL"8=\;L5TT\165HK$5()\J]VK4BK4VXQNXRC_  US*'P\O,U%0YY-
M\WU;#OWG2IN7M)5&VKMSG%<]35NSDE[VBO9:62M\J>)/V'_V/O&7@FY^&OBK
M]FGX(>(_ ,7C76/B6O@C5O 6BW.C#Q]XAG^U>(O%ME;F,7%AX@UVZ8-KNI6-
MQ;RZH"T-]YL3F,]G:_LW? */0?%VC6_P3^&VGZ)\1/ ^B_#'QUH,?@[38--\
M6?#SPU9W=CX?\%:Y9P0);77A?2+&_O;?3=+V1PQ17=T &,SEO<KNS-Q:[6CB
MDG\XC;:0PH$#2@HL,[2Q,IE4F.=9-V]1+@$D&@M=0Q10RQ116VY&E$<K0NOF
MRB%UA:-F78BX:1MV5/.%&<=DL96JTN66)K.+JZTWB:UFO<E-QA[;WE.<(S<W
M!.4H0;F^6#C"P^&;YO8T>9\R;C&+>KLU=6M=)7:M+35Z7?SYK'[)7[,6NGQ:
MVK? 'X0ZA)\1_A]X5^&/C R^ M"N#XJ^&?@^RT[3O"G@'Q'<+;B:^\,^&K31
M=&M-&TG>+73;+2=/MX-D=G B\I-^Q+^R(WC]?B=J/[+_ ,$9_B%<:IX5UBX^
M(%W\.-!'B?\ MGP2]BWA'58M3>-KVWU+09])TU]/O[-8[F$6%F9FE$28^JFC
M9H[<7,-Y.! PN(4AN$MP9 RHFZU8+%&"$D%G,\5TQ_>X"$9KV[1B^8+YTH0Q
M1B&/[.-S,FP>=]JEMI8XD(V(\9NG8@_*"/FBGC<1&+Y*U9QY>7W:U5-)<T(P
M456CRJ,'\-N2S<DI7?+E+"8=RUP])RE9^_37O6;U?,U=VZ[[7/%;G]FCX WW
M@[Q'X#O/@U\+I? /C?QRWQ+\8^%I?!6F)X:\5^.VUK3O$4GB[6+)[?[-J7BC
M_A)=&TG7%U66#[7'JFEVUY$Z/#N/=^&_A%\+_!_B?QCX[\'_  ^\,^&?'GCZ
M;2'\>^+=%T2VM=8\7/H5FMAHL_B.ZML-K%SI^GB.RL[J[5[B.W"1M(8T KT&
M6UEA$K+(D D:2."-HY)S'(J"298H8AYLD;,?O["K==^&&ZG=)&BVK(@B,L(+
M%)+FV"QB8/F6$;)?M1*G&2!*&,2 @D&'B*M2'+[>I*#DY\GM*CCSO=N+DTV[
M14K75XQUTBC:EAZ7M.>5"DI148PGR>_:-W;GT=M5I%WZ-NUU.\D-S*L/V261
M$FAXERSK+&K)+(R)EE#8!58@VX;CM^Z*EF>"25 D\D8G9U2:&UEVR-&"&MY9
M)(TDBC^0A9 L;LP()*Y-1S2),\<3222*F);4!+:. SMRH4-<23&1?^6JS;9(
MV'W3N JPZF)HYUNXHF*SK<0*A4M-M_<K 8U*PR,V5FEY4QH(T =EQSS>D6G4
M3?,FES/7FT;?+>Z2Z*RO9[:=%1WOKTTOV\K6T_JX6L=DDK>4H5XD'ER2&**X
MWRG+!FW,7R1P44LJM@$$C%D*T3!B I!6((JN%" /L:-B#"YE)9I#(RMO&[;P
M355)0\<"SH27:0HPDD :9D#1JGVI4EAA/W8V<$1;MS?+MPUKM6>! EY]G1?,
M=V^S)"#\SRM/-(1(SHZ_NC$NV1&+@=-V<5*33O*[7O2=W>U[ZW6[M>RNGNE=
MWB-[:_Y#Y\*LL3S1+YLKY+W>#$\I$85E1C"J\@MAO+8\*V2V+<$L3SQJ9FCG
M=#<2VR,D<,40000P#>4V&8B22,AA+PQ "9-51()%GW^7<6-Q(R3%DCW&$KG]
MXCXDFMV&XQL/F@'[U\J@-5Q+:VQEGNY)RLL08SI9SS!)'=(T3<L4B-)%$ (P
M%\UXR[#!!4R[N\6W=*VUG)Z7TVMWNKNRUW)E%MNR;VV3?0M2R/$\4EM"K3/(
M5\J*9%:- %02W+QNPD49 'F$MG  P!6C97*H+B1HB]QYTD3-:P.9;IP=DL0D
M!'FPJ=R1PN1'<#Y/NM5$AA+.RR(\;^68)(U@<S@*#B4;8Y(U(X\IXQ(L@)(V
M@[;HN8RHP@B+DL"849$F;!(N8H6:>XB#@><UN#),A?R 9"JC*M9TG%QLY:\U
MI*6^BO9O5JR5K]US*-K@K-MOE7))-2T7,XS5G>RNVUH];M*VJ.B_9]"QZ5\0
ME "F/XE^(_E%R+G:66Q*QY!*P'HQA'R@ ,>,U]&1MP02,@D<GDCKD_7-?.W[
M/\,<&E^/!"DBQ?\ "Q->EB#6\5N\@ECL7+,L3?/G:=KN/."'YEZ5]#Q%BI(V
MGYCZXX ''J!C&>^.W2OSG.;O-<<TU=5YN[3?Q1HIMVE=-VMJ]TUJTV?LV376
M5X%--)8>"2:MITLM':VU]78^<?VD+;5KKP#IR:!ISZMJ\/Q(^'UQ8Z4EQ%:M
MJ,UOX@M7:U:YG'EP@IO<RG</D^8%0PKQV5?CQYK,OP'25)+:25E;XC:+'B\#
M_*-BV97#*SY8-@DIZ\?1GQ:#G2_"3)&TAA^*7PW>6)'$9=6\1PP2!=Q!=8P_
MF[(R2RQG:-BFO6B%+%2H;.0>Y*[I2%X&0 4!ZG&>@KLP6;XG+<#A:%&%*2E7
MS"I)SYF^:5;#\O*XRCLDK:1UW;NTO,S#(L)FN85ZN)G43I8;!1BH/7E<,2Y<
MW2[;NFFG:Z/A2V7XYR!9&^ 8MY%=WB@N?B)HK&) BQC?+'9LRNTB/)'&B,NQ
ME+$$G*I#\<_)02_ N25_*E:9E^(6BGS)4G*.Z&2T4%[NX!OHO,5%-@ZR2HLS
M;!]Y>1&#QPQ#8.1C=QS@C)(Z@]>"3D\TU;>$$\ E><@DL2I."Q_B96S@-GGC
MH,5NN*<Q5K4J">E_B>G1:R6E[.]VV]SFAP9E<7)\]=J2T7/9;]M]/5+6UNA\
M#06?QTAWB/X&WRE9(R93\1] /VA2<R.5^Q_?)PH&<!,@GBFK!\?9'W#X'W$*
M_:&M8MWQ T4R)'(&DENY52T$8B)\J)0-Q;:68909^^FB0X^9L')7;C@*!EB3
MC=DA3\V[HO& :'2(+O8-\P[,2#R3MZXPV6P.@YK5\69DKOV>'DWU<-==+:M^
MFE]++N'^IF5/1SQ%WNE4=KZVMUMV6NMSX)%O\>A&\7_"B-Q$Q4!/B'HBPR@*
MLLY+-996.0R-%#.07EE60RJ%Y+H8OCVTK6TWP&2WM5$B0R)\1="EC[."5-BD
MAC7[J896+<C( K[T%NCKD;@).2I.,!N<>H PN%SC(S@9;,GD1'=\I^]SR?3&
M!DDX(/(& >..*A\59D]?9X?1[<C^=VY>;O9)VNKVL7'@[+(*RGB&O.>JUZ62
MLGUW;>OK\(+#\=6ENR_P0:/Y(UMV7XAZ.89F*!MK@V@,4<42M%N57;[4Z1_-
M&2XJK;?'EO-EE^!"BX98R,?$/0I&>.92(8@S6>P/:.F^]!RJL8_);+,:^]6M
MHF8J>0Q8L#SR<'!SU'5L=,\XSC"_98\Y.3T[X^Z>  ,<>OJ0I/()(N*<Q2MR
M8?9JWLWHM+*ZE=V_'K?8I\(Y8]>:NGW4_P!+M>G7N?"1B^/D,H*_ BV,$IMU
MG,'Q(T4S2RE0KS21C3UBBBPN^49W?.2IW9)L7=C\=87,T'P1LIFE"12_9OB%
MI496)3O;BXT\K(23A9>-H^Z,#G[G-O$%QM.T$,1R0>>A[D#!X[;B1SC#?LT+
M,W!P6W;0S  Y(R!G'.&' '''K4?ZSYBFK4Z&E[>X[='=IS:^^]DO.R?^J&4M
M[XC9?;>_R:_/Y'PQ#9_'-(Q&/@=:^69#<LI^(FE0EI&4 81;,K]HX/F X3;D
MKR17EOQ(TGXS75OX%@UGX6RZ8UKX[T.;3S'XXTG4(M3U&![AK;3)EBM(VMC>
MJ9#]L?<D7EIO5A7Z;R6\80-AMZA #N.>JKZCIG@]CSW(/AWQJ3,7PR9/.!'Q
M;\(L/*DEC!V3WB8D:,,2A5FWB7*/GYP>!6^'XFS*5>*5/#IR<GK#HHR>C<I-
M:1^??MSXCA/*J=*=23KOE<?MMM<TH05M5HG)-MNZ2>^QX2EM\>8F;_BS2>4L
MUO+_ */\0-#XC1WEDB"36;,I=G6.0ECYBJ9$ !"JAL?CVXD>3X+Z9+*+8,IE
M^(&D%VF:02O$TD5B'.U<PJQ4\8)P<D_1?QFO/C!:_"[X@W/P%TOP)K/QFMO#
MFJR?##2OB5?ZSI7P^N_&I3&B0>,[S08Y=;308YWDN;W^RECN;B*'[/%- 7,Z
M?D1H7[<O[4?B7Q(GP%\%?$+X#?$#Q?K_ .V/I?[+7A+]J_3?@GXJL_A9<_V/
M\%/&GQD^,MS#\(;/XW:LOB+Q'\.+[P?'X LKG3?B];:!<:IJTKZTEGJ6D2V-
MYKA\[SC&1Q%;#TL/*%"2=6HZ<E"$*DI>]*HE)6;HU.5*3JU.2?)":A.4<,3P
M_D^%G3HUJF)<ZC:IQIR<Y2FVE&,(QDI>]>-YN"IQ5O:5(7C%_=4UA\>&=)8O
M@S:I/#+9RP^7X]TH^1+'+Y@G!>Q43&W&\A92%D\XQ\!=]>._"[X"^)_@EI_B
MC2OA-^ROHO@C2O&OCSQ-\4?%5AH_Q"T^W&I>/O&4L#>)?$%S-<V\QNM2OUM+
M*:66"2"&2:#"1*K;:^3;'_@H-^V5\1-,^-ND> /^%"^%_'_[&/[/GQ)^,WQY
MEU[X:>-->\-_&#QEX0^)/Q>\(^%OAWX)T.U^+5IK/PM\.>(O"7P?UCQ'JWB2
MZU[QSJFF:]K^A:=8VE[INF:F;R2X_P""K7C8_$?5->N?%OP&\)^#+/XZ_LS_
M  3\)_LH^(=#U63]I#XE^&?VD/AS\)?'&D_&[3?'J_$6TTJPT@77Q(U<^'-)
MTWX7:SX;O/#W@/6Y=3\7PZO>"VTGTGBN)H2G1C2P$)1HT*DZ<,5"7-'$IU</
M=4Y33<HWJ\S_ '>'3YJ]2A*2C/RJF5\+I4L77_M.JY.<*+EA*ZM[/W9)QJ<D
ME)2]RG2UJ8B::P\*JC)Q[J[_ ."=GPTU#XBS_%Q_V(?"<7Q N?B+8_%2VUM/
MB3+!#IWQ TN6.XLO&=EI%I=0:5I'B&=X(VU&^LK59=0VI%=,\996Q=>_X)J?
M"CQ7K'Q'O]8_8=T&2;XJ^*;3XB^,[J+XJRZ; WCZ'4[Z^F\5>'H;*YC_ .$1
M\6WE[++<W>L^&FT^XO[>\2WU!KF+R8H.[T3]N;X[? _XS_%CP?\ M@>.?V>]
M?\"_"7]FSQ#^T3\>-6^"/@GQ;X=MOV6K]?%&GZ7\,_A/JWBOQ5\1O&$'Q:\2
M?%S0)=5N_#-DWA;P-XH;5-.M[J#PQ=Z3K>F6Z_,<W_!7G]H?6O@OX6U#6OA)
M9?!SXQ_%+]MGXV?LY^%O"OAKX7>-_P!I'QIX ^'/PK^%4/Q?TZ[U'X2>%?$_
MAS4?B)\8]?\ #LFFZ9=:5:^(/"7AS0;[6)+JYL3%I$UO<=5/.N-)N-?#R]I"
M%/"488C#XJ<X*.(=>I0I*4YTJD6_JU6?*E!.*I54N7$T?:Y3X?X.HZ8B=2$J
MKQ-9X>M"5*LYX;V"KOK34J<L334X2JN4&YQDKTJO)]6>&_V,M&\"GX03>$?V
M.- TQ_V?K[Q#K'PADA^(L$LW@S5?&KM_PE>I:5/<BXN[O4?$#O)-KUQJ$UT\
MTCGTRW!ZQ_P3G^&][X0\)_#Z7]B;P^GA3X>?$;7?C#X*TK1/B8=)&C^/O&&I
M?;?%VIZ;J=I<0ZI9/XB:1CK=G'/]BNH@Z*B1X%8_Q'_X*S>+/!OP#_9<U;X=
MV'PN^/'QT^-5SX<UKQW/H>G>-_AO\.OA_P#!M_C!%\*O%'Q1\1^#/%VJ-XZ\
M$:\=6G'A>T^'.MZU)>Z9\1M-\3Z/_;VM:1H']H3^^_%W]JW]HWX'_MI_ +X1
M>,M=^#6H^ ?VB_BWXG\&^ /AMHOP\\?VWB'3_@UX0^%VO>,=5^+OB_\ :&U/
MQ#IG@"S^*4OBSP]<Z/H_P/TOP3-+XETF]B30M2NKJTOM2BS6><7T9T*E2#A/
M%QQT\.\2ZE/ZPL%'$_67"I*7.^1RK?O&[2E4;3DZGOZPR'A*5.<L/.K.E2K8
M:$G14IRA+%*G*G%Q35FU5@Y1CS<NMKKG1N>)/@5XM\:?$/X<?%OQC^S!I.L?
M%#X07&O7_P .O&MU\0=+%]X9NM?LS9:]/HL%O MI')K5J5ANEN$E_=1SF)TR
M ?*KK]@GP+>>%_BUX.?]B#X:?\(]\=?%UKXZ^,&G+XRLHH/&OC#2X7?1?%L!
MMX5DT3Q-IES/>2:3JNE/93:?=2M=P.L\CLW2_LB?MC?'[XM^(_V9M5^+MS\)
MYO /[:/P4^)'QO\ A3H/@'P9XD\+^*/A79^#;S0-1T7PEXE\4:W\1/%]C\2E
MU;P)XCM+W5=;L_#?@2?3_$4-Q%:6LFFRQJGZVP()%C/!8JA<@(N&(&=HW,,E
M2=AW,<M]XE0U>5BN)N(<LK4,)7="G)T8R2C7Y[JCBL;1LH1J*7[O$87%*,7&
M"52E.I3C%RYI^EA^%^',SI>TI0K2A2E"ES5*;A*7-0HXB#]YZJ5#%4)\VZYU
M!I2C)+\7=%_X)^>"/"FD^'O!_AW]B_P5;>'=$^(6F_%Z"2Z^([7^I2_%+0;I
M[C1_'&NZS<-)K/B#7=.>25+*;5+ZYBV,D,D+0HH'V&VG_'V-R%^#=K.TS3,M
MR_Q TPR!S_I$AN3]F4*LV]XH!$I*W91&Q;[I*^[S;1D9 VG'7)R#QU]>G?Z^
MM!MXP2P7<V!@G'.&W$' &02.1C'/ &!CEK\9YQ6=.=;V$Y0OS2E%SG:/-:SE
M)R;;;;2LM$NB4>BAP1D]!3]G[>*EM%3:BMK-K2[25EHK+2V]_A<6?Q]P$7X)
MZ8$>.T )^(NFF423;4N?.!T_;-#;0@8E!1@[; '3YSY]X&TKX]6VA74:? NU
M*/X@\57!$WQ&TK:AF\17R2!$%AEK?RT:;"X,4LJJF1FOTI\F-0, @EU(QG"X
M8#')/RY8Y'1LGZUQ7A1$.CNVT<ZSXE8D9)+'6[]!QTVJ.NX@#@\D#$0XLS!4
MFHT\/><X-/DDFGSM-M\[2NNR;3OM:ZU7!N5P?-&IB%:,D_WG>-E9*R6MNC6G
MJ? ?@.R^-<<GQ#ET7X4VFJ-=?$7Q$;ZWF\;Z1:+I6K_9M-LKO2&FDMI#=6]K
M:06*6]W"D;-YTNY"P)'/?$C]G#5_C%K_ ($\3?%7]E'PCXWUGX:W&NW/@6[\
M0>.](U$>&W\4Z+<>'O$:Q6#6:6SQZOHD\FG7:S"X26!FWJ2_R_</PC5!<_&$
M(N2/C;XP.U-A(=],\*.Y\H'$;L3YF[*E@QN'PTQK\VOCU^W=\9OA=^VS%\"A
M:W'P^_9]T*+X':5KWQMUO]D_XE_&+PAJ?C7XOZ]J>GP:!K_Q7T#XT?"WPS\+
M=,;R= \+:1KLOAKXAFV\4Z[%<Z];Q6PCMW[J'$6=XG&8F.#IX:-7#8:KB:DH
M_NIN%&EAVZ=.4IQG4JU(UH\D(-SGRU7O"3EQXGA?(\)A:<<3*M-5<0J,.:7,
MU*K.:BK-Q2C%)IRORJZO\21R?@;_ ()T_#CX?CQ+_P (O^PO\.[)/&'A75?A
MYKUOJWQ!3Q1:-\.=2NGNK_P#H]AX@6]M=#\'ZA<2-/-H6DK:6BLD1"YAA9+7
M@?\ X)W?#7X?^&_B)X5\.?L,_#]?#WQ3\+?\(5XZL]4^(QU^?Q!X+LDCATKP
M:UWKSZE=Z=X9TR!(H-*T;3Y[>VTT6L+V8A*Q%-;X[_MU_M8>%/AC\9/C!\'_
M (=?"#7?ASX)_;'L?@18>*O&6J:]#-X>^%7AGQG\*?A+XN\6V_AW1%EO/B3X
MS\8?%/Q'\0M)\-Z?;WO@WP]X3T;P]::OJVIZOYPLY?1/VQ_VFOVD_P!F_P",
MGPGDL?$WP5M_A7\5?BU\+/A%X#^&VN?#WX@ZCXB\9S^+=6ATSXC^*?B-\?[;
MQ-H_@#X&VOA2&YMH_ &GR>%_$W_"6:FD5C<S3WFK16.F]L>*.**D(1>(P\GB
MXUI>QEC:LJM6>"IT*SIU8*MS7C&M&5*55*-J=2:?+"TO/J<*\*X=N4Z.)<<*
MXQ]K#"5)4H*K-K2I&"B[U5R.,.:4IN,(Q;;DO$O"?_!./X9^#M \<>%_#7[!
MWPVLM&^)7@NP\ ?$"UU'QU;ZO'XQ\(:-<1W^DZ'X@FU>749;N'3+Z&&XTV2(
MV]Y8744%S;7<4EM'N]K^!W[,&L?LZ:#=^'/@[^S)H_@73M7U.37-:2+XIMK6
MHZGK,MFE@-1U+6]:CU+4M2E@LH8+"V2YN-EK9QQQ0;44K7&?%']K+]I=/!?[
M0GQUTWXG_L[?L]?LN?L_>.OC;HFJ_$_XA?#/Q7\3_'.O_P#"GKG3/"FC^%=*
M\$6_Q'^'VE:_>?$'X@0^(--M;C1]8B\4:S='P]X'\&^';GQ'KD6L6WFEK^WG
M^V;)X*U[]H;Q9X2^%/P^\&?!CQ3^R_\ #_XT?LVW7A/Q+J_Q O/$/QI\(_"S
MQ)\6;K3?BS-XOT>/P_JGPXN?B7#:>#O"\GP[O%OVT6YM?%6JO<WN_3=8YYQ;
MBZ;I\V&K.K*A2GA:>+]I_M5916&P\KU>2=>HJE-))U*>&]I"G5JT)S5,B?#7
M"U"LL3[#'JI25:<JRPM50H8>"DJM>I))\E#W+1FE.=:7N4J52<9QAJ-_P3#^
M!DWC6X^(5W^P'\*+SQ=>^)YO&>I:K=>.3J*:AXKFOGU%M=NM'OEET&^O_MDG
MVEIKS39=TJJQ $2$W?B1_P $Z_A]\4?'7B'XE^//V'_AWXG\:^+Y?#FI^*=8
MO?B"]N=7UGPR8AHNN7VF:=)9:=)XGT:.TABTSQ,8&U*.%Q;F5;8-$.;\5_\
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M<>922:4TE)WBDV[:;I;/HC\PO%^@?&J34/AQ#J_POL=+EA\:"33H!XVL[_\
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MX_M)BX^$?A:5%@8)+#\1HK=5F&]HP$;26#,7."<KTSW!K[B%NDB!7R5()VD
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M(DL3_(HCVJ5P1D@\66\,_'YU1?\ A7W@>-PUMYDB^.KILI&0701C1RISNP)
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MR+P &';M];D;]W#,I9FP%0@!2"W(SR?EP2>",<9-(RJI5PI1F) &&;YU^7
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MJ/"^42>M&I)I2W<X_#+D<4Y:7>Z76/O)W:/DP>!OC[B%GTWX2,1\LN[6_%#
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MWCFQUT::FL1>/=5;4!I#2R:6DYL]/=H;&:Y NI84&4+W 67/W@0>/H924W
MOEF.5P ,G&.O48]OZGQ_X6(W]J?%!'\P _$+52H8Q'8&T_3@VT1JH4'((#+D
MG)).!CV15"C ]R3ZD]2?K7GXN3JXBI4J6<JC4IOHY-)WWZ7M%7T6FIZV"CR8
M>-*FWRTVX1<M^2+?*M>;I;K\D>+_ !:2W?2_"JW9553XH?#=X=T1F N(_%-O
MY( X,? *JW1"01C->L/(L3,SX0 YR1@EAYG [D]&4<9 8C)W5Y9\78XI-(\.
M/*-XA^*/PP94& I:7QOI%J#(&EM\A5NF<$.V75,+)NQ7.?M-_&C3?V>/@/\
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MFGSX>HHTJU.2=:R<*KIOWE1<DK)\M2D[6DN;^BT70(1U#,A)9)?+.TEI-O#
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MFW;W:<4^:;EU5[I)WY'6=.&*J<LI^Q@ZR@E>514X3?LH+>4Y.-HQ75I=7?\
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M5.*,#2GR2I8AMKVL7&G>+H*DJSFFY)\\:<E)T[+5J,93D^5_U>_;(<+MD(V
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M*_#&@>&;_P /K;Z%HWP@\)E_!ATOP\D\HTG2YKFTM]:RXOH3"T9KZ,F^)?\
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M66)C4E#$TJU>G9J&(>'IQHQ<.=-QI58J4JD7S*<VFDG%M^7_ /!.'Q+JE_\
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MT.$M/ X9L!_BIX.08(PV;F3 RP/MD8YQ@=*]OE?>$PLN=ZL=T4BJ  ,C+*%
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M\5^$_ VGQ^#M#\1RZ6'TO6_$'C'38=&N=??3<VD=SJ5TL5BL4R^2_ G]C_\
M:(\+_%/X"Z+\0F^'\?P1_90\9?M"^,? 7B[1]=U/5?&7Q9G^,UKKNF^'M/\
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MM+>RN#;P7LTGAW5=;TB:TU&.,W-A/:ZE=++;RH[-DE1Z_(S+ Q)^8(N"1U)
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MD*:GJL%M'?WRQ)&B1K=7$H1455 "C&P+@L>(Y.F0-CG(8L%)4*<!E4MEMIR
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MI;N35->M]#&M:MH7V";Q4VI:_P"?=U^IA+$%B'50"4*;@ N[()P=H 4YX."
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M@CQ=GX*?$GX066O^)-%O?">J>+O 'BO1M-#>,(IX+&WU29+G^E'=Y87<&R_
M;>J,,C<?F++G[HVJN201P >(!(^/EF55))QOA8$\ X<O]TDG;SC*L.A)K2EF
MBP\:?^RTFX4_95.2KBE*M!0Y(.<8\RC^Z24X\DHU+6G!2M-8U\IJ5I2G+%U'
MSM2451P[C=3=6,K3M)253WU><73G=P=FT_YHC^SS^U9H7QH\5>./CO\ #;]N
MS4?%WC+]F3]B;3_$NL?\$]/CM'\#_A#?_&3X<_!C4O#/QTTQ?"_ACQ5X1@EM
MM(\;D0^$!=6=S90Z%<6FGZ8MK9VJPM^Z/QO\/>)OB5^R9\9?#/A[PWKEMXS^
M(G[-_P 1-!T/P=K5W!!X@@\3>*_A=K6EZ5X<UC4([F2W.N_VI?6VGZA>7%W=
MPKJ!DN%N2H5C]'JT@92TS%02Q!"(I0$ DX8=&R"> H !(/%3"ZB7JT62"5#2
MPH",YR&,@!7UVD\KD<%2>;%8YXEX>2I*$L/[.T_WD?=IOW$FU%0<8I*+4IMJ
M,?>OMTX3 O#^V;<FJLJM2S5!1]I6G[2K+W>:3<ZEYMOE<I3DW>[O^,_Q8_8Y
M^*'QB\1?\$I]+UN?XO> O#_P-^$'Q5T3XV^-?@O\6-:^$WCGP)KVH_ #X:Z#
MH>C_ /"8>$[VV\23Z=KWC'PY>:1J-GH]W%;7S6T;:C'<6:,C_%OQ+_86^/?P
MW\5W,WA[1/VV?B?X%T+]NGQ7\2[?QM\.OVD=6A_:BUOX;^)?V4?!GP_M=>B^
M+^M:OI7BF^T>V\::=>>&[S1[_6GN)/#\'V%YGLXDC/\ 32LJ$';(K;@-H61/
MG.2&48<AN%4'&6W$!CSRAFBV $@D$9.^-FP"N3M#'H/F(/(VDX+9KHPF>XO#
M*K%*,Z%2,J/)-WFZ<YXB=2S]FZD(SJ8JNWRS]YU92:=VSFQ614,3R/VDZ=2%
M>.(O2LN>K"-"$933GRR:CAZ,4G'E_=1NO=27X,/^RG\8?COK'[%>GV-Y_P %
M!O@'X7^$GC+]K&3QU\4?B#\?]&U_]IC0K7QG\.O"X\(W,?Q&\0I\2IM8\&^(
M/$7VC0M)\.W-M*ENFEF.ZCAT^TAMY_G#QK^Q=^T/\/&^$GAW5_AO^UC\8=2^
M%'[8GQ8^(OQ,_:7^!GQ[U_P=^T;^T;X1^(/[-GBSP1\./BS<^-9O&VCWGAS6
MO#MM<>'OA/\ $#P-HLVA^&;:VTN(^#M(TO0M2N;%/Z=1-&G/F(C8;<3)$A.!
ME@JM(-Q3.X%=RKCCAJC8O(/EF0 EB-KQEOOY.&W98DCU) .W.>:UHYY5PSA%
M48RH0C.G"FE-*,:DJ\IQ]O2BZ\HS>)K7A)RIM-7I)4XMK$Y3'$1@YUJOM:=5
M5%-J%1RE%4TI1IR;A"2C2A:4(J:O4M/EJ2Y?Q \'^#_C;X!UK]G#]IOPK\ /
MVL_B&GP,TO\ :+^!_C;X5?M)_$O2OB?^TY<>#?C-JWPR\6Z;\8_AWXM\1^(-
M2@UBXT75? S^%+S1K[Q!%J=WX,U)M-T^*/\ LT>?QGBO]DG]H[]J'XL:O^T3
MXB\)?$_]F:U^,7[4G[-=S;^$? GC?0?!WQG^'/P4_9R^%?Q8\,?\+H\<^)]&
MM=?TV+XI_$/Q)\3=1T.?PY;C5'T/X7^%_!6AW.J7.H2W2:9^^67C(>66,KP6
M)E0-QRI)##* \;LX((8 @#$I8,3L96^[M(8E=AZ,"FY0#DA>1NVL5S\QJ(YY
M.,Y5</0AAZR@Z%.J_;UW1PW/.<:%*GB(U*<HJ56=ZWLE/WW&]G=S/*85HTZ>
M(J5*M'VBK2H-4J/M*RY'&K4JT'&HY1<$^3VDJ<[6:NH\GF_PG^'J_##P+H7@
MD^-OB5\1)-%61&\9?%GQ5+XS\>ZP]S=R7/FZ_P"(!::8+XPR2/%;Q0V5K;6U
MLL<,=LJ*-WJXAA('W3U^A'0C (SPIQSC.3R!BJ8N8U0!FB&,.JEU$F\D%#L)
M\P[LG"D;R<J$^915@3!=RJA)# 8$;J0I3<"=L8]6 (X+9 QG%>7SW;G.5Y2;
M?-R<JN]VHQBK;[6COT;LO;2222344DDF^:RMLVVV[+35O32[W<@@C#9VENQS
MZ$M@DY[$N1@#J/2HY@I!0@%2<;<<A0C XP0><>F1\V&4X(07+$9"-UR2590!
M@, -RC@C[W<9Y^\HJ"290K$J0X5WW+N'R.K?,&QA0"=V6Y7/W1T$0MST^75*
MI.323MJG9W:LKWUU?G?2\R2Y6M%=-)::MIZ;KK_P.Z\S^'$4T>O?$]I?*Q-X
MWDDC$2LH"#1].5@=SOSN0L<8!/88 KV#K7D/PZ:(^(/B<D0C_=^-)0XA"B-7
M?2-.8[V1W!E8L&;(4DMT[UZZ""..@X^F.,5TU]<1=6_A1O\ >K?FSGPG,J/O
M*SYZF]KOWGT6GZ[7/#/C9!>W'@ZT@L-7BT&^F^(/PVBL]8EM[>X33YKWQWH>
MGB9(+F2.TEF$5VRQPS2A9F=46,LRBJ$O@KXUM)(%^.*A3N 4?#7PL&+ \G+:
M@I(3CC:RDD'D@@=%\6&C30-&\Q]BR?$KX61MCY58?\+%\.L@8[9,_,JG! RP
M7E!R/5 B[]Q .">V2!\S,">^>&![$8&0#NW=:<:&'Y(PT=>?[R,7\=2C+1N,
MDGRQLUM?YF"HJMBL4YSFER8:'+"3CMAZT?>2<5JW?K+3:S][PQ?!/QEW.9/C
M5!*6*[=_PT\+XCPH&U?^)GRI(+'<<[B>0,"I%\%_%]=P_P"%PV;,XC*[OAIX
M<4JWDK&< :D"QD;$F 2,L5! ''N>V/:/D5>0P4=SR1G@#YAGGJ,XQD&I?W9!
MP5(&&R3P,C.<_09Z_EVQ]O5MK&GZ<L+*ROOR+33UMWZ]:HP2M%R2VNI2;]'K
M;YV6OJCP+_A"_C01NB^-5M&RX;Y?AAX:PZ$\[P=27* #((965]IP1Q1'X)^,
MW'G_ !JM+AHW=]TOPP\-*3"Q!2( :D2"I+$,N#MQD?Q-[XP1MI.#V!QQR.>,
MCC!YZX![=V[$"J> H/RXR0>P8]". >^,=SQ4NO4_DHO372.^JM\'?1?Y[+V$
M5M*:WZRT?E_EJ>$2^"OC(5<)\9;>,%F=9/\ A6OAE]JLQ94(&IY,2JP4@KNP
M!D@Y)1/!/Q@('_%XK-FP<O\ \*S\-!" IP%7[>&!W<Y?C!Y"]:][V1GG .02
M>N2",'OGL ?IBD\F+M&IZ#\.A]>Q/UZ52Q%;90I>;<8NS\KPOMJNG<)4(RWG
M45K6M)]&GJ[Z^GF>%?\ "%?%UE<M\8K=< !MGPW\,J%3).5#7[,&9SAFR5VG
M 7<V^G2^"_BX03'\8;.,E/+"Q_#?PVR[MI$CC=J!;+!TR <#!W H17NBQH,_
M*!G(Q[=,?CU]B32^6G]T<'/'X?X4G6K=(TNFZC_\B5[&*22E/3;WGU_[>?\
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M:-%UING4<;PC5J4Y2BW)Z?NY3;DHV@HSNE%M?I>G@KXOI$(U^,NQU4)Y]O\
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M37,\16MM1NDMJ<-[]U"Z3332W3;M9,Z5@Z2OK5NMG[2?76Z:E=;_ .>IXJ/
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MX '6&/X8^-R.?CE\1'PY4%++P8@.&.%"MX?;YL8&X/\ /N)PIZ]MXJ\<>#O
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MCY_B;>Z?I\GC;QK>V&EK-K6FK::RMS96/C$I<>)+6U479EF_;2$C:3W/)8Y
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MF,_VB;OKK]@_XA^//VG-.\>_$KX=>.=9\)>+/V^_VG;[XCW-W\4_$<6AZO\
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MLL?PN_:,\!>/=8LO"GB+X;65YK]KXC^'WBB;2]7CT.2_\<V&J/8P7,+3_/\
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M%XC^)M]X0U/4="T;0]+FM=+TZ*>_U6_%LD1EIQ_M^?%/QSK/PL^'7PU_9?\
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MOB#0K#24M[2QL/&.N?#;X=G7KGQIXJ\.:=K%K;:+K.E^&]4U-KBT73+7]'O
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M%< -CYB%;Y74[<!1BF!,[_+^<N0TKACG=@A2Q.22H 4%CRH4?P@5*XS&%8#
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M*JS[/[G_ )#NNZ^]?YENDR/7_//^!_*J'VIBRL4"YSMW%L@' ^=1]TX&3D8
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MMU-=&Y*?<,!"-M/=/O'G))+$ 8Y"],@@'T]/@C]AS]B'0?V*=.^.FDZ!XO\
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MC@A8!C%'D!#G )SCJ0.?O$'/4 '@'!JPMO" 2(T4L!N 4 <<KGUV],GKCD5
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MM:^,>=IS\2[Q@$+%LG2M.7:>,9QRH  '!+8RU>RF5!;JH8_-AR5.'VEV8XY
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M&%B8$$"0@,&4*HPVTC#'(R"VX#'*DX)')42J2&^9,%L%E8,"%W'&2 %R3@8
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MM;)I245[SM[UG;5KUCX1?MH_";XP^/-:^%MKH_Q3^&OQ(T3PQJ?CEO!OQO\
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MQ+TO^P$TWR%DLO[&3X?1S1WLEQ+]M_M4!43[,6D_-;Q+_P %7_$5_;_ G3O
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MS&MG,:(WO?Q+_P""FGQ-\,_&K5O@S;_#']F[X4:KH/[/_P !?C+X@T[]K_\
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MG/+)]B>%?^"B_BCP[I_['?B/]JSX?_!GX!^#_P!L2X\:ZCX7\;M\>[*Y\->
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M*?QU\(WVM>/O^"I-IXYT;X:?##Q1\6[3PWXH^(?BO]C5O"VH:;)X?T][^_\
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MMS*9&WG/J"QHN1CAF9ON\*,#*G QEL$D=<$YP< U@\J<8#<CD;1]T @A&?)
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M]@/]I6;]J?X!V_CO5-:\-^*O$WA'XF?%'X->+/&'@6QNM-\$>-]<^$WC"_\
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M;_5Z7\LN]^>5]G^AXW#\&OAY Z2QZ5?I,C*8R/$7B7Y3\WE?*VJ'[@+( $R
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MMIO=IJZ6ASSG26*Q\*JYH2P^ CRV;4E*EB=/=5[O5\MT[6LT? \G_!*/X?\
MB.UU#PK\9?VCOVE_CI\,-*\!>-?AS\(/AAXZ\9:-;:#\'-!\>>&+_P &:KJ&
MCZMX6T'0?$?C'Q-IGA:_GT'PYXB\>ZIX@O-$TII[.U.V\O&FI?"+_@D3\&?A
M?XA\+>+]3^+?Q;\?>*?"VL_LZ:I:76JVOPX\+Z$EK^RQXCU_Q#\(M!TKPEX
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MX.$GS*GD^2SJ2K_V?AU5J2<YU52J0J2D[-R<X3AK*RYDM)))24EH_BKX$_\
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MM4];?_:GJ,KJX"$%!D$8& WS)@CD';EAGH1SD9&!X;\>4_XI;PTY8 1?$SP
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M!Z@$DY'W@=R\_,*&\5_%=6D,?PI\.N%C!C<?%:W4R3D\0,H\&8C;C[Y.&9<
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M_7/$L#SS'7?$6OZQJ]XS7%[(:]KCUKXT&1_,\ > 5CVHT;#XCZRS,Y/SJ_\
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MUXSNGU7Q=JNG:UHOA*TUW2K_ ,4ZJ3<ZN=/OHH]08M)=ARH4U-=_9 \#>+_
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M$\=:U=ZCXB\8?%#Q!XMTS3].T&_MIO%%AH-K8'31K,,=Y8VMG<QI*OE7QO\
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M<'''WU*@MGJ,GL?!]'_:/^ GB36_&_AKP[\=O@GK_B7X9V%WJ/Q&\-Z+\5/
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M2##!B&0JZ,K?+^Z>-E/SY/\ ,)\<'^'_ (9^(_[3O[1^O:]9_&3P)X-_:?\
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M >&_&^HIXG^&'C/1_P!G^V\??$7X2:=^TM'JGA[4?!^M?$WX9?#[Q!\2-?\
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MT3+KMP&#$L.I!R1@YY(^7 Q]2.1UKE/">#I$O3)UC6P,D<XUB_!&!V)X8\D
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M6?$VJW<?P[28>,](\!:Q9>'?$47AGQS>6TNF7\FGP2WEOI]AJ6GW,_E6H_\
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M5E!X9\7:UJ7B6X\4^#/C3:>-Y[F;X/\ @7P;X6\8Z6]@NKE[K^MX6TH"$/\
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MM_"&CWMUK6I:ZI73Y[9;4&8(/+X:]_86\:>/_AC_ ,$COAK\3O"UEJ/AW]F
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MH :3XV?$5W6*:/>8O#J@MO5S*Q.FG>?*W*K;I ZR%204VBQ'\+/%_!_X7/\
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M!B@*[OB?X*#ED#?*UZP(4$9P0!@@@\#=@YS[",MYIVL"LCKRI;(21N5"D\G
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MY(WPEOR/^2L_%@$*1YO]OVA4,0V'VC2S@   @XR2 <8("2?"*\E5 ?BK\7%
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MH<T:51I.,%.I&3Y;Q<%.#DM;-I*[9:E!2<>:*DDI<K:3:>BLF]=G]SW.L+
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M"OQ,\:Z;J6H@7%M8SZO%ID6M36,$NH2O+^DQ!:WDD9F5A#)NV[5(/D!OO;6
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M\!D-P=J*0 2'0X/H&!./?' ^OIFO$_CH^SP)%,-A\KQEX(=PQVA5/BO3AU!
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M[7F5]_[3PMZBC"HI4I33@XI224H)/>WO<TFG=)>SG[1T;,_;9;F+>-K2$>8
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M<IIJLJ:YJ;?OK"GPCAE3C[3$XIU%1E1<H8B4;7L_:I73<^>[BM(QLFG=V?\
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M,YWM)DY0?(J$AE 7RDB5L':TJ>859V<R1P6:PPJ&G:9@22[E4\Q\L=VV-41
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M?ZI)-K/ARWM[9I-9MQ7.^,/^"C'Q6^%GA/X@>#/BI^SWX2\&_M2^ ?B#\"=
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M8+_P5IVM:5J6EV>J:/H>LW-E/J6E6MS!O^*_^";\7CW5;N\\6?M+_&_5]/\
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MK>7\IP8V'5U;'0L>3G/& 3N4]!XU\-X[A?&_QH282^4/%.CF#*X 5_#MJ'"
MQJZ_,HW$2/#@CREC);-)O@+X1C*DZM\3&$1:7$OQ0\9M&<GS?WBG5&XCPT<>
M5)"D]>=GF7@3X*>$KOQ;\4]/;4O'2QZ7XCT>VMI;7QYXHLIV4Z+#+NO+FTU*
M.XOYX9'?9-=&0(KHB';OSOAX814<:EBJC:ITK7P]12YGB:=TKU)7?)JW=>[S
M.5K._-7EBO:X1K"0:YJKYGB(>Z_J\[67*M.=12?>UDG9GUO):0N3NBFR^""
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MB/%?B#QM^U#^TWX\^)?CKQ3JOQ7^*G['?_!-?XCZMX<\6ZI=6MSJ]GJ/PO\
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M\[)W>B/<XY-H"^7*2"3D G.5YYQST^I.,=P)3-)C/E$YQQE<\DCD;N#QD\G
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M_.G;Y?$^@2E4CJJ<6[67O-WLGI:WGI;U:>Q[>[.P*K$1C!R,;>"" ,'.022
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M^(.J"1/L9D^:-O)'EF[64_;^&%R4CQY8CP>8\+_ G1WT%H1XZ^+:)!K'B"0
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MN:<F^:3T_-/XW?\ !+#XG?$'X,?"OX0_#K]I_3? ^C^"/V@?$_[1_P 1M/\
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MHP).50 ;=Q9CU=FR:CC^ /A>+[0!K_Q$9;J6%YC)X[UF3(MU)C$8W?NE7 &
M?G7.3FL71PTK.6*K2T5F\/#2R5]Y)KOZO9=!2Q,.:4<-13=VX^V[6V?+?O\
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M+#TDG96]K:UNBM'9:Z+3=)IMGM)M[4ALQ(6D.Y]RAM[$J2S Y!(( !Z*<8P
M"!HH6P!%'PV0,\Y!' &W'.U7*A@,HF<$ CQ>3X">"FR);_QN%\XN(T\<:ZRQ
ML%.0FZ=3M?YMR$LHV@C&2"[_ (4'X%\S>;GQH7,IE&?&_B'"3LA#N@6]"@D
M C#+NY5,Y:FJ.%_Z"ZC:;2_<QDUS*/,D^9VO&$;ZZJ$;W223C4Q2E=86DGIJ
MJUW%1YFK62=ES2LKW7,[)<TN;V<01J1Y<2A2<\%5 /(+!0F"P ^4\, Q((P0
M$^S6Z9*PIEVRYW$%G9 I;*JS,2ORDG!(&#FO&V^ _@GR@JWGC=<;ON>-]?5B
MI+%N?M!QSDXXYQAB.:8WP%\"2K$#<^,XS''(BD>-?$"DG+;F=ENU$C<8#$$[
M1C.,5+I8/F][%U4XNUWAE+XDV[M.Z;BW=7;UL][&LYU(P;A"$[I)PD^2+5[I
M)VNTI)-7T5KIW5SV80V[9W1QY"L-Q(+'/)8]VS@$L1DL<$'.:/+@= A"@ ,5
M4,/+^;ECM7@#)"AP 3DX/RFO$#^SQ\/7"QB?QHHC141D\<>(]R@,P!#&\W;C
M_$6R#D@\#F9/V?\ X>HY"_\ "6@>48&0>-?$87R4EBDMOE-[\JP$210L,%(K
MFZ1S)O4K:P^&5VL36NVI.2P\7)MI)RM>[=DKK71)7TBHY*IBFDGAZ:6S7M]-
M;N6J6U]TUKKZOVIK>W+!S'&Y"Y#NV2H))P#M;(.< 9)P2O3@J(84R%C@7<V7
M&[ 8DEF9L*=S$LQ(/0LWKFO&&^ 7@!IGE)\6KYOE90>,_$ C/E,2FU1??+L^
M^W.' )(Q@5"?V?/AZZJKIXL9%=Y I\;>(PP9W+]4U ,P9MIVDX0#C<."_9X5
M-R6+K\TFKR^K<DFTE:\DVV^5)/5626M[H'/$M*+PM.48K1.LFDMU9235NETE
M9K9ZW]M*1@$%4VL K(SDC8&SL(V'@MG()'(!R>R".)>D4. 0>750I*DY7Y00
MPR,GC( ([BO#U_9Y^'.Y7_XJW*EF;'C;Q,J[I"K2LX&H'=YTBB1P,*K ! JD
MBK3_  $^'C-*AA\3-F(Q +XQ\2;?+E5@Y!.H[@S@89]N8S@KC)RO88;F5\35
M<HMO^#'1U+Q=DFU&4KM.^LM;[M-JMBVKQPU)[:NLG[JNXW:2;Y9:K9)WMK=O
MV@1VX)94CSPN[OM.>00 3QR23N+'ECCE/)@<#<N> %]N,9 /(;L& W'"D<UX
MFWP ^'!A@@:#Q,51?+5AXQ\3*['#C<[+J>3QN*GDE67(&*1?V=?AG$!LM_$Q
M01[5'_";>*R&9P%+$'52=P+ !BQQ@'@"E['")J^+JQ=TU:A'FLF]8I25_>:7
M1K=6L)U,7O\ 5XZ:INLN967=1YNO39.^KNCVQX+:3"R1QNNP)A@IP@8.%?CY
M@'7<02-IR03ELKY<6[?@ D[@Q/)SPS=2"2,$MG) 7!R,#Q)OV>_AKOWM;>)X
MWVCE/&?BD!CMVD@-J9P0J_-UP"QQEL57;]G/X8-N#6_B@$'<N?'/BKYBISR%
MU0$9!W8&2>G'2JY,*FH/'8B+2ERIX5)6UYFKSM9INZV;;ONV2GB-?]EI-M0E
MK6C;W;.*=X+X?LMJ\6G:RW]V\J$ X"MD-][I\P8$<AC\Q=@WJ'8]R&!';J2=
MJ!B2"P !.3@EN03D*HPV2,#&>M>%Q?L[_#.*(PI:^)F"N2-_C7Q6S;I3N(W_
M -JDB-=A('.",>JEY_9X^&.9&:T\1R>8JJ$D\;>+"NP_,$*KJJA.=QW9)#$\
MXXJ70PTK6Q=62:<8WI1C>*LW&W-I'FC\*TO%/H-U,6M?JT-=[UD]VHV^&3:?
M-%*SM=V>^GN/EP'DA"Q( 9N6PN2@0X."N6P.!\QR1U*[(3GA0A&" < D^N>"
M<*"2>!GKU->'M^SQ\,I0C/9>(-@4JBQ^,_%JYS@;AG6,94$8<$ G)V@J"0?L
M[_#)4:);#Q&8W,;MYGC3Q9M81I\N)!JV0N)/X#EG# X*YIQH89-M8NM&5U-M
M48N7-R\JN[W<E%J*N[I66S#VF*2UPT+;6]NK/5\M_=V777=NVJU]S&Q,A<*%
M7"JNP!54#"\9  ((&#CZ@@E@YS\PR<DGSC@YR2,%0022O./N]",8/B3?L^?#
M2=V=K7Q'NDC\LC_A-/%2#:WRG"+JNT-M! ()Y!;"GFF']G;X8*[2_8/$(8-#
MQ'XS\6A56-7"[5;6"?F7YI 1\Y4!NF0.GAM&L97D[VLZ"B^9VT4;^\]]=XZM
M;W;53$IV^JP5]W[=)+;2_*O/5JW;6Y[@5R"/,]O^/EN/_'1^(]*7 92IVGY2
M!^]))(  R2BDDX'(/S8X.>:\5;]G?X:2N\C67B-",+F+QGXIC$F ?F9?[5()
M[!A@8P, CFJW[.'PN!>9;'Q&\D;R. _C;Q=M>9><,J:PI92<!@"I(R$(.&*:
MPNJ>(K+:[^KZJ[25US-+56U;=WW*<L1O["E=+K5>_;F44FO.SW^9T/@R.'_A
M9/Q4VHF]Y?"C22 $-*QTMAEV" .RJJC()Z8;;@@>O)A000X(8]F.<<#[FX#I
MC&<XP3C.!X'\)O"FA^"O%OQ)T30UNX[*&Y\-N(KJ_O\ 4Y%,NELS,+K4;BYN
M67)PH>3 YP!BO?!(%R"K=3T&?SY'(Z''Z'(%XE6K+V3<X>R@N>=X/X8M+D3:
M2NW;=I:!A')TY7IQIOVM6\(2YUS<UG>3U<KI<UW>[5]CQOXV1!_ASXB 7<3J
M'A:4ANF8?%^AR @ D#;Y0(;'!^;:6!SZV#F?D#@S<9/59"J]>F1)T&.G'6O)
MOC2ZQ_#CQ'+O:(+>>&\O&Q#X/BG2!C(21@&R%==F"I.XKR1V'C/Q%IO@WPSX
MF\8ZVURFC^%-"UWQ)JAM%WW']FZ':S:I?-#&'4RR+:VTGEPDCS79%'!R,HIR
MPF&25Y2Q>-LEHVV\)9.Z=[[*VEVG= I*.(Q+D[1CA<&Y7OHE'%:Z)O35V?:V
MAV?FKDC#$ XR%)R<#@#'(&0/3) ZD4Y6!&1V'0_+C'?GH",$'IC!KX<^"?[9
M>E_&6PLO%=W\%/CA\'/A=J7@ZU\=Z1\7OC1IW@SP5\/M3T"^B@N=-;[>_B^]
MO[!M3T^YAO[/^TM/LT>T999)(V)6O;]*^/\ \"-8U#P+HVD_'+X1:MK/Q,TF
MWUOX;Z9IWQ.\&WFH_$71+CSS!K7@.PM]:FN/&&E7)M+T0:EX>34K*1[6YB29
MGMKD1.5*K35I4:D9IJ-10INHX.*YI1E*"E'1)\UI+E=^9*TFM*>(HU8J<*D7
M!K23;BFKV5N=0;YM'%J+4KI1E*ZO[H7 !/4@9P".A)Y_(9IP8$9!&,D9SW!(
M_GP/K7D6A?&+X2>*O$6J^#O#'Q6^&WB/QAH%D^I:YX6\/^//"^M>)=$TM+AK
M.74-8T/3=4N=5TZPAN8VLYKR\M(+>*:.2.26-E8+C0_M&_L^R>"=2^)4?QY^
M#$OPUT/6_P#A'=;^(<7Q3\#MX'T;Q&+F*S_L+5?%JZ\=!L-:^U306B:3<W\=
M^;F:*!H%=D#2HU6I/V-9:Q23I23M+9J+BKJ^R>LK-1Y[65>UI7M[6G=MJRJ0
M>VO235[:M7O%:R44>[;A@>IQQU()]1[=_3FE!!&001ZCD5@:=J>G:I::?JNE
M7]CJNG:G;VE_I^IZ==P7]E?V5]"MS:7EC>6KR6]W97<+":VNX)'@GC(DC=D.
M1MB3)(P0<;@,<[<X!Q[]?8=LYK+VBDY1:E'E=I73AM=N2O:3M9*R3WWO=&GG
MW)****V6VC;ZZMMZ^H 1GC_#^N:1E##!Y_SC_/\ C2T4P()1A%&1@/'CZ"08
M'?H, <\G.:\,_:%8I\-;QUR3'XG\"O@ LI8^,M&!& P)Y)Y+'!&!D<5[G<?<
MSG^),=^=P(..YSC _#O7B'[0*@_#*Z+0M-_Q4?@7,:A=Q*^,-%.3O( "<DXY
M'..:5.2CB\-NKS6ME_>OT;OYJUNYG5@YP<5U4E9WL[Q:5^MKV;[K3J<'^VIX
MD^)W@W]C[]KCQC\$I;M?C-X5_9F^/WB;X1"RLXK^Z'Q0T+X3^*]5^'[6EA<1
MS0WUVGBNRTJ2VMI%,,\X6*6-E<J?YQ/$&F?"SPYX U[P%^S#\1-'O/V;O$G[
M/W_!/#XK_&SPO-\:_$VF^$_C9XY\9?%J6QUKP!XD^*3>*-3A\ ^*_P!I'P5=
M7%MXXU&>71[/QA<:;86WCO4H-+O)[A?ZW6@5C(<*P!D 4HN,G=A>1@Y7*2!C
MM8$JP;C/@^@?LQ_LX>%?!'C+X;>&_@!\%?#GP\^(\MW>?$3P'H?PM\%:1X/\
M=7FH-F^N/%OAG3]%@T?Q#+<N[&8ZG:7 0N/+8$@UZ>5X_#X&=252C.OSU*=1
MP_=>SE&T(3]JIIMS@J<I491:2E-OFA**9Y&9Y=B<QH<E+$_59J/NU*;JQJ*<
M6^1<U-V]E*[52+3O%13BUS1?\T][X$\!?&W]DO7M$U[X5:3I?C?5O^"@/B_]
MB[]@73;;X\_$CQ+HGP7T+XC7OA]?$<MKXF^&/Q \+:7\1=#^$GV'XG>./#.@
MZMJFN>&]%U/0X]!TB^.A01VA]0_:R^(O[1/[/7[2W[#G[//@?X5_M6^&_P!B
MW]E;XV?LH_##P-KGAXCQ /VP/&FKZ>UG=3>.OB/+X]TKQ#JVD>!-(B*Z9X3U
MU6T[XD_$BYUO4/%<$UAHVBV;_P!&^@_"/X5^&=!\%>$_#WPS^'F@>&?AM=07
M_P .?#>C^#?#^FZ%X OX+2^LH-0\&:=::='9>&-02SU'4+2.^T..RO$AU"^A
M$Y2ZN%DZG5O#/ASQ NECQ!X=T37?[%U:P\1Z+)K.CV.IC2O$.D,YTS7=)^V0
M3G3M9TYW,FEZK:>3J%D26MKB(EL]L<XPT*]2H\NHUZ$_;^RP]:<[4*E6A##J
MO3<5)>W5&,HMR<X<U:K42]JHU5S?V3C)X:C1CCZV'KTU25;$TXK_ &BG"O*O
M[%\UG"E*4KWC&$HQA3IZ4OW:_!O0_@9\,/AQ^V?^U9^T1^S=\"O&_BO7?V(?
MAWK=QI'PO\$_%KXGZUK_ .T#^U)\;O!UUKNOZ5>V7C/XAZIX6CT3P=X)U"W\
M.^'/"0LX="M?$7C+6?$2Z?\ VCH'A?\ LWY3_9?^)MY\5=%_;H^&_P#P49\8
M?M$^"==\1_M3?LM^)O$+_$^]O?@S\*/^$_\ B/\ !WX90>%/V1M6A\(:MXD3
MP9\#CX@-A97&E6]EHMYX^^&UWHGCCQ1XDOO%>M^((+7^H_3?"OAO1;O7;S1_
M#>A:3>>)[]=9\3WNDZ+8Z=>>(M8$,-D-5URXM+>";6=36SM;>V6^U!Y[H6L$
M4(F\J*)!R_B3X1?"[Q;I7CS1?%7PP\ >)=(^)HL?^%F:5KG@WP_JVG?$;^SM
M.LM&TW_A.+6_TZX3Q5<:9H^EZ5IFFSZV+Y].T[3K&QLY(+>T@B3&EFM-4ZD*
M^$=:JX82%#'JLUC<-]6DVVI.#IS3<JM1<RYYRE"$ZD:5.,8[ULJQ$JL9T,6J
M-%_676P4X>TPF)E74$I5$G&HI+DC%\CC"%G.,)3G*_\ *T/%7P+U#]F3P;\%
M/C7XDLOB#\=_#G[0W[9?P _9S^$X_:3O? _[(/A[6(/$FEW,/Q%\._$6\UK1
MO&E_\'?V9],US1?#_P .-<UCQ-/X]\.:M#KG@WPY9V^JG2'T?]DOCG\6/C_\
M!_V'OA9X)_9BN]5_;)_:3MO 'P ^%M]\6O!-GX5^(^M^']/\2^%K/1M9_;%\
M1^ Y/%=N?%^FWFFZ3K'C_P (Z!)K1T_QUK\FEZ=>ZY)HTNHZBOV1J?['7[)6
MN>%O!_@C7?V5_P!G77_!W@'2)M"\"^$];^"?PYUG0_!.B7D\MY>:5X:TS5/#
MEU9Z%97MW++=7MMIL-M'>WDLUW=)-<3.[^O^%/AO\/O [0-X(\!^#/!KP>'O
M#'@R&3PKX2T/PYY?@_P1;RV/@_PG$VCV%FT?ACPK8SW%AX7T%6&E:%;SR6VE
M6EK"[K3Q&99?4K8:K2PU6?L:\L35H8NM2J4<14DU9)8>-*I3ISC&7M:<6^:I
M*3]I..IGALMQ\*>+I5L307MZ7L*.(PM*K1K4()OE;]K4J1JSA#EA"L[:1TIQ
M=[_G9_P1W\:>)?&O["G@"7Q1=?%[6]:\,^//C/X0N/&7QT,3_$;QXGA_XL>,
M-.C\3^()(=5U6&/662,:=X@L+9K2PT;Q#I^L:)IUA;Z?I]L7_4]-N%8X^8B0
MALC&5V@X8G@9/IC@=%K \,>%?#/A33#H_A?P[H/AG2!>:GJ*:5X=T>QT+34O
MM:O[C5=6OAI^FV]K9_;=5U2[N]1U.[$7GW]_<W%W=R2W$TLC]*44XR 2 !D^
M@]NG_P"NO(Q<J>(Q>(Q%*C'#0KU)5%"$Y2<.9I^S3DK.*:=G9:2<4N6R7L8.
MC/#X3#X>K5=>="G&FZS7*ZCBK<[2M9RW>G=O5CZ0_3.2 <^YI:0G&/<@?X_I
MFN>HO<:]-=&UK%6\[[?AV.D:WW>P^=1CVW@$?CS_ /7KD?"F/['N,]/[3UTG
M)QTU>^X)P" Q Z,#G')Z5UQ^[_P-?_1@KD_" SI-P?35=<X]0=7OL\>O''O3
MI7Y(^EWWNV_N$_A?H>>^"WC;XH_&Y$(C9-2\ ><Z%0[LW@E&4OZY01[0>"!\
MH7&:_"K_ (*P6FAZE\>+GQ_X@^)'[._B"R_9A_9_\-?$"S_9;^+.I_'7P]XU
M\>ZAXJ^*MC!;:SX!U?X3_%?X4:7%XEUZ32XO!O@W5M3M/B<NG:_=FRU?P;);
MZG]IK]U?! 6+XH_'(ADR^J?#P_> 9!_PA5N@&/X2$0L,C[A9^  :TO&?P3^#
MGQ&\2>$/&/Q#^$OPR\=^+OAY>2W_ ($\5^-/ ?AGQ1XB\%7[2"0WGA+6]:TR
M]U+P],9$CG#Z5<6LGG1Q3*1+$DJ>C@\73P>*=6K1]M">&E2<$H<WOQP]W&4U
M:$I0IRAS1DJE)2E.F^:*YO,S#!UL9A:=&A75"I#%>V51\[C:,L1[LHP5Y).K
M&;A+]W-T^2:Y).WX&?M1KXD_: _8D_X*I_M6:3\9?C1\']"2S\5^#O %I\-_
M&6DZ%)JOPJ_9/^'&L>%U\&:IK6N^&/$&L>&?"WB;XWZ[\3O$_C:Y^'EYX,\9
M>*;6TTS0KWQF_AQ#97-G_@J0/@[/X$E\>Q_$"UM/VF/@K^SY\'/BMH=GXT^)
M_C/P9JOP]^%NG>);6\UKX@_LG:#I4>G^'?$O[0WBG5[5?"D+Z]J.HV.HSG0O
M#6OVTVBZG-HNJ_T!GX<> 9?"=_X"E\!^#I? NJVVHV.K>"3X6T,>$=5LM9N;
MFYUFWO\ PR;+^Q+RVUBZNY[G48+JQDBOY9[B6Z6:269FYOQK\#?@W\1-7\%Z
M]\0?@_\ ##QWKWPROX-9^&^M>,/ 'A?Q1JWP_P!6M3']FU'P7J.LZ5>W?AB^
MM6@A>&?1I[)K::VMIX&2:"!D[\/FU*E6HU94*O)1QDJT*=*K23^J_5<!AH82
MHZM"?MDGA:]2<I.*G+$QFXMPG3J^=6R6K4I8FDZM)U:V$G3565&:4,9/$8ZO
M]:BHU&X)+$THQ4;U8^SJ<K490E'^?7]H/XN_LQ^.=,\8_M/_ +2%WK_Q,TOX
MG?M+:Y\,OV2/V8?$/Q;TOX<_![XY:_\ "WX>_P#" :+J/QA@\1ZCI'@>Q\%?
M#[Q+=>-O&&N^*]>U:V\.>#]0N9-8U/3?$WB'3O"6F0^!ZQHWAKP9\-?C9'\:
MOCUX;^+WQV_9E_90_9+UW]BOXD>%/B]XDU&'1?$/BCQM\1+OQ#<_LZ>()/&-
MUXD^(%MI_P 0-+T/X4ZCXHOKCQ!XJ\2>"O"WA_PKXUFFTS6+_2;[^GCQA^SG
M^SS\0-)T?P[X]^ WP5\<:!X?O=2O?#^A>+_A5X%\2Z/H-_K5S)J.KWND:9K&
MA7UEIEUK-_+)?:E=65O#-?W3R7%V\L[%JS)?V6_V:YI_AK<-^SQ\#1-\&DE'
MP@=?A/X&5_A6)KD7LT/P^6+0T7P?%)>%-2,&AK8P?VC'#J*@7L$<R;T,ZPM"
M,*3P]9T5.4JL*E:A*$Z4:L94<-";I0J4J<Z$/JV.=+EJ8J-6M)R<8T:%.*N3
M8^K)3EBZ'M(P<5+ZO5@YN5.\Y5HPJN%1.LY5J2:DZ#C34%=U:C_GHT/7KB7Q
M[X-^)=K\0[GPA_P4&\?_ +</Q[^"'Q+\4V.K?VQXN\/?""R^"GC.\@T36OAM
M+J&HQW?P@^'6FZ;X1\9>&;*VT**TT7Q+#%J.C7%OJ_B#5?[9])_X)/ZY-:_M
M.^ ?"?P^\->%/#O@_7?V!-*^(?[0>O>"/CW<?&_3_C]\7KWXF:7I?@[]I+QA
M)<:S>ZE8>-?B3:Q>-]2@\0>,[2V^+7B'2=1N/#GC=A:> ]&LM/\ WYLO@W\)
M-/\ B1J'QGT[X4_#FQ^+^L:1'X?U?XL6/@;PQ:_$W5-!A\EDT74_'4.F)XGO
M-)*VL %C/J,UJRV]NGE_N(PEWX>?"'X4?"F7Q)_PK#X8?#[X:#QCKUYXF\7?
M\(!X)\-^#AXK\37<DEQ?>(?$I\/:?8'6M:NKBZN9I=3U$7%Y-/<7$TDTDDSN
MRQN>87%8?%4(X.H_K"<Z<ZE6E+ZK-VIPHT94Z=.I/!X.@O9X*C7Y^24I5'&G
M->TJ7A\GQU/%X3$SQ].-/#M.K0IX>:]ORJ;YG.K6J*G4K3GS5ITU&\8J%ZD&
MH1](@92"I8Y.T]@"=H;Y2N.!@[>20HP#M&!/*1Y9_ \=<;ER1Z]:41H.BC_Z
MY&"?KCC/6DEQY;]@$8^F,#(_(XKY?>37DV[;J4G*Z;ZQ6V[UZ6L?2GAWQQ5'
M\,: D@?8WQ$\(!O)9PQQK$6,%%<[5.-W 4 $YS7LO5E)&?WTIZ9YP2.0 <]
M6SD$ >M>)_'J8P^%-#=91#_Q</P4!(9UMPH?58"V)&>-</N(9=PWYQ@]*T?C
MC\6/#?P&^#_Q@^.GC1M5/@GX)?#'Q]\7O&<>C68O]5D\)_#7PMJWC+Q%;Z/9
M,\:WVJ7&DZ1=):6WF1_:)VCC$@9E)Z9TY?5\%%+FE.KBH1BMY2E+"I)/35.2
M26MFTDCC@XQQ6-<G:,:&&E*3VBE#$N[ZV^UVT:9[&' VXX!*Y!# XQE3ZG)]
M3T&3D\%YD0$DGH2#T(4#N<>H(/<X;TS7P7\./VV]%\7_ !+\$_"WX@_!?XZ?
ML_>(?B5X<\5>*/AM??&#1?#-CX;\<VG@W28/$GBO3[35?#?B7Q!%I6L:%X<N
MH==N++Q#%IC#38KK8_VFUEB'MNG_ +3_ .SEJG@+Q!\5--_:!^#.J_##PEJL
MFA>*?'^G_$OPE>^#?#>M0SI:R:-K_B&UU5]+TC5!-<6Z0V&H7$%S,;F PQR)
M<0EZJX7$TI*,\-5<G+EM"FZR;G4G3C'GHJI%N4X3Y4I-N4902<U*,:I8O#5H
M*4:]+2',G.<:;M&$).7+5=.224E=RBK7BW:,HM_0Y920@R&*Y&,XZ],C@'@]
M1CN01Q4:R-QU.UMI&TC=D,1LW#=SA2&R%VC/3FOFX_M(_!VYO-,NM-^)'@C4
M/ 6H^"/%_P 0I_BQIOQ&\ W7PUT_1/ >JZ=H/B![[74\2 F/3K[485O]4MX9
M]&T>6W>TU>^LKMH;>3F=/_;-_9>U?XG_  >^%GASXU>!/%_BSXZ^%_'_ (K^
M%]SX5\6Z!XAT'Q'I'PZM[.Y\4FWUS3=4FLI;N&&YN+F#3H#-=R0:/K<_E16^
MD7S0I8?$._+0K-0C*4I*A548N$5*47>FO9R45*4HRLTEJM5=_6L->WMJ'-S*
M+2KT6]9))M<Z]UW5FF[MZ-K5?7P<9(Z8]<<]/?L<@YZ$&C<./<9'KU Z=>_/
MI@U\[:5^U!^S;KGA+Q7X]T?]H3X*:GX%\#:RWA[QKXRL?BAX-N/#7A+7_->(
M:+XEUM-8.GZ'J<\@"P6FHSV]U>[X3:),K@MJZ!^T'\"/%GC*Q^'/A7XT_"?Q
M'\0=3\*6/C?3/!&A>/O"VK>+-0\(:K:)J6E>*;3P_9ZG-J<VAZC83PWUCJ$=
MLUO=:?)%?0L;4B8Y<N(L[X;$1Y4W+]S-\K5KIOELG'FCS<S22:;:5KW[>BG;
MV]&]DTO:TTVG>S2=2[3:=FDUHTFVG;W(2 MMY[C.#U!(_+Y3R?;M3P1T!SU[
MYZ'')]<Y'/.0<\BOD[P-^UO\#?B3\=;KX!_#?X@>'_B)XPTCP'XA\=:[=^!O
M$V@>*]!\.1^&_%UKX)U3PUXCN]$U*[ETCQ1#JMW&4TF]@A=H(+F2-W$+[?JJ
M%B2V0>3C&  ".3CDC&6YQR#U&33J0J47&%6G.E.5.%11E%J5JG,HZ-+?D<KV
M2:L]5JZIU:=52E3E&<8SE#FA.,XN4.6]G%M;RLU>Z>]BNW#N<E1F1@3SQM@.
M3DG/ )P>PX]O,OA]A?$GQ;53D'XB0'&00,> _!L*@;6(XCAC!RH8L&>0EF)K
MTY\!Y1D@ 29ZG&%@].W7\SQ7D?@)W;Q%\91M"/%\2H0?+=FWH/ OA)E,N6/E
MB52&(&W:3P,8!FGK'&+6W)3^=XS5UVU36O?3=H4[.5)2TO/5ZM*T6W=+7T=K
M=^B?L.YU4#@*58;CG"NS-Y> ,M@X *YX#*,5,K9W9'S J"/8@<^ZY+$'N*^*
MX?VT?@P/VM-?_8LO=8U72/C9HWPRL_BYI>G:M9M!I/C#PO();C4+7P=J9=HM
M7UWP]9QG4=?T:/;?P::ZW\,+VD5S/#T'@#]LK]GKQMX1^"GB6Y^*7@[P%=?M
M Z?<WOPG\'_$/Q7X>\+>-?%ILM3DTRZ@T?0=1U&*[U*:*]MUM_+M(Y6:\O;2
MP4_;KB&W;:6&Q=.$9U,)7A3G2PU6$I134X8JC.M"4>3FNO9TJCNDU)1DXV49
M)9QQ>&J3E"%:$IQ<U*.JMR249-N225I.*:YM')*UVCZS9MN2B@DD ]>I&><9
MQ@$'Z'/04\N, C)!;:<=CTY]\\?6OGGXJ?M%?"7X6_"OQ/\ %C7/&V@ZKX7\
M.Z7XOO[:/PYXBT/4]3\4WO@>RU2]\2>&O"$$5^$USQ18)H^IP76BV$DU]:7-
ME<Q7,,1MY!'CO^UM^S;I"Z#9^*OCO\*? OB37O!\7CR/P;XV^(/A/PSXNL/#
M_P#PBVF>.;Z[UOP_J>KPZEIITSPQJUGK.IBY@B6+3IS?+NM4+B%2Q$ES0PV(
ME%R<%)4JGO2A%.<$G"Z<.>*;2LG)7:ND[>(H1DX3KTHSC",Y1E4@FH2NHRUF
MERR:=MKI-JZ39].&11U!ZD=#C"L QSC' .?P(ZTX-E0PSSCJ,'!(YP?;GZ5\
MWZI^U-^S3I'A_P '^+=7_:+^".C^&OB#:VE[X'U[5/BGX-L-+\96.HZA#I=K
M?>&[JZUB&/6;9M4E33VN+#SH(+QS:W#PS)(B=!X-^/'P1^(UFVH?#_XT?"WQ
MM8)XQF^'K7OA3Q_X9UZW/CNUM)-0F\&QR:9J=PLWB?\ LN*74TT* OJ4VG1'
M4H()K0B6H<,1&4N;"8E14E#VDJ<XQD_=4G&\5\+;4DK-.$D]4[.->A*W+6HN
M_:K3=NVTW\2U7==[H]P9PH#'.#SC'/3)XZ\ =.N>.M-\Q>>I'R\@9SN(Z8SQ
MR"3T R20 37SQXT_:;_9Q^&]G%?_ ! _:&^"W@FTN=<UOPM!<>*/BIX,T2.7
MQ'X;UX^%_$>A1O?ZS$&U?PUXD#:)XET]09_#^KI-8ZJEC<021)N3?'7X,0?$
M?2/@\_Q;^&P^+>O:(?$.A?#(^.?#P\>:YHT=C)JG]HZ/X8.H?VM?VD^G0RZA
M'-!;2";3([G4HM]G!-.BC'$NS>%Q*BX59N4J4DDJ,Y)N_(KQ<5"IS+W5"I3Y
MFG(<JU&,N7VU*4KJ+49Q;3>B3][1MW2ZRL^5.S/:?-&X#'7.0<YX"\CC! 9@
M&.<#KWIC/M8LR]&(!RV2 H.0HXX!^;/3YL\C%?&OQP_:N@^$WQ*\%_!#PA\+
MO'WQS^-/C3P/XS^*MCX \$7WAC0KBP^&7@3Q!X:\+^)O%VH:WXSUG1M&.->\
M7:%IFC:!8SW>M:G=3R&&WB@C><<!\3/^"AGP4^$?P8^"_P :?'^B?%OP]HWQ
ML\6VOA72/!^K>!=1TGXA^#IH[V[LO%FM_$3POJ1MKWPWX8^'/V.:]\9:W*7L
M[+2I+74[=KRUO+:27IHX3%UUAI0H5']<I\V&@G#VE6[J6BH\RFN94II2G"$)
M.$E&4[&53&86E]8<Z\80PLU3Q,Y*2A2;4&N9V2=U.#M%R:4H\R3=C]!)CAR0
M<D;,Y/0J6P2%Y(4@N0,$G@#!(KQOX?JW_"POC*QW'S-:\,N$,<JC9_PC\05O
M.)*-D\LD:AHR!YA.[CU<31SQ1S0R+*DJQ2QRQ,'22%MC1RQR(2I5X52:-P2
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MF^([6Y%_!<337FG7-K<&U,MP8E^N[SX>?M-6W[6_[9'CGX06OA?P4/&W@?\
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MV5O!'PL\5_#WQ;<>%?V?OAIX1\6#Q%)XIN;K4;/Q+H_B+0[SPOJL-G-:V?\
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ML93GRRJ2;<HR<FYQBX\_+!>ZD[_S<M_P2N^->D_"7P-H'PX\"?"OX9?&'5?
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MOQ/>ZHUUJ44"3""W^W1^U1^U5^SM\,M$_:"\#3?"72/A!H/P^\":]K&G^(_
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M\+_'_P &>$1\'/'OP:\2:)'X@U33Y;JR^'>I^+]2U"S^./PKT/2/$NDZ7?\
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MAW]HCX7?%._^+'PA^#_P_P#$&@>"_B7^P1\2M ^%?A_XB^'_  #<>.)O@=\
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M?$?Q%:^';?3[_3+_ %[QG\)/$FE>"[*TNXM.U'1[S1M2NKC$X>OMS]K_ /8
M;]J#XD^+?B18_&+6?A=KVJ?LIZO^SSX2U/0_#=IJ&J> O'4?QR\!?'7P+\:]
M&U*XNHV?4O _B3P-;6L6BM D%TM^9VOK8#;)Y"/^"7FO>"]9M->^#GQB\*Z#
MJ&C1_LN0Z!IOQ!^$=MX\\,[?V<OA-\0/A;J,VNZ3%K^CR:K>?$#_ (3^;Q/<
MWJW5M/INI6DF/M,EP\]>Q@8<._5Z4L93C+&?4L/3J2J\T\/+%X>KBZTJLDFX
MQC:KAZ*ARS4?95)RO&HCQL?7S_V\XX.,)82.,Y&[?OEAU3I<U.#?+ROG56KS
M1G>4)P@G%KF7*?$']MS]KG0_V,?B#^V3\+?B#_P3O_: \(_"FU\8:[XK?X:W
M_P ;;[POKUCX>.E6^F^'?#'B5=>O!IWB."YO)9-;GU2VO+(K):VMO;0B26[3
MW/Q3^W/K/[+/QC^"WP<_;R\=?LP_#&/XK?#/XW>/E^)WAC7_ !9X,\&C5OAY
MXN^%GA_PKX-T*T^(6HWMW/K&K:/X[UC5-;:6Z9/^)/$VG1B,W&?0_B!^RO\
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MB5V\3_"O5=*\5:U>ZY9ZQXJGU67Q))IGBBQO[>\TFW@E]A_94_9-OO@#??M
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M>,= AGOK>Z@U.SM?T5U?]C_XK?$A_@O)\>_C7\.O&0^#'[4'A#]HO0K#X=_
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M/8\8^-P,OPP\8P+AY##I#; %^8CQ!IF2!_$V1@*/F8[5 +X%>M%<R' ; #L
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MM!)WM;F=]/-Z:^6A[,9&(X##DY#@^@(^Z#D')R,$'IV.$\UB ?+9F.X$@,"
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M/ISW*:B=.1[W[*;>)I%L?":[_8R^--[XDT;X/^,/!OQ U+P@($\0Z?X3\?\
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M6VL_P(?UMM_NL-OUE*WR5D_QT?9'JW[HC&80""0WF'!4]2#G)!Y*GD ].13
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M*6,BKNEA[+514ZFFJ::C&*L];JR3NW=ZL]>::U_AGT]0HX'G1C;RPR"#N'!
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M;._-*Z;5+-,NK2DJ6/P53DC*4U'$PE*'+:_,E&,4M5=N::ZQN??QD4$#J22
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M6G->^"M9CT7P!X=\->)+*SNO$4?]3 C4@$HIP#MW '&?3()QWYS][T I54
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M?&-S\)O%GC+5;6#0M"^)FC>'IK>ZUOPG?S03Z+<SPV%])#>S&VK.. S%QE?
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M_'[X6?"[XDR>!?&FK?&6*U^-$^OIHNJ^,KW4?'$O@:RUCP?H^L#P[J=Y\/\
MPGX>;QM96,,NJ06!9X!_1-Y:#Y@BC=N)#&0J%)SG(."K$ C(W$=,# #E2(L2
M43+NA8[90_)W !AP,9.W!"+D@!1@+ZF'SS-,+3Y</B)QA[7VME"FX.HW>;Y)
MWMS:WM>'O2M&+DY'!7R/+,14C4JTZCG3CR1E[6M!):/>$H^T^%?&IZ)*3>S_
M #7^,W[!.K_%J\^/5XOQ6@T)OC-H7[(VC1JWAQ;J+0W_ &7?B9H?Q%N)YU-V
MD&H0^-VTF329+$)%#86]U))^].]*\4^.?_!,7X@?$RZ\<+H?QY@M?"GQ$_:X
M^*7[2?C/X9ZUI?C#3_!?B[1_B-\&/ /PIT3PQXKN_AYXH\,^*M8N_AIJ'@_5
M?%OA^P&MV_ACQ'-K\MCXGTZZM[.V:/\ 9=8HB0=I8 DKM=L=P=R.X#@9!^8,
M-P'0BGJD(X"/@L",D,=P+,#DR9!&X@X)!!4$\A:RIYSCZ3A[*7)[*4*D'"G3
MO&4/9\KYKJ_+[*#2>BY;I7D;SRS!U*=2G4C[2%524^=J\G.]W=1BUJY;;W:=
M];_B=X*_X)/:MX,_9@^)O[.C_'*QU"3X@?LO?"W]FJS\46G@E=.M=*@^&'C7
MQEXELO%L^F1ZE+YTVKV'BF.PFTY+EHK::U9_M%U&WFMU/[+'[(?B33_^"C_[
M77[7>N^'/'?@OX?76E6_P\^$/AGQP--M[?6O'7BNV\'/^T'\9/"6DZ;J>I_8
MM ^(!^&OPVTK3+Z^%AJ6I#2-3N6M5BO&#?L,RQ[77(^8,ISP%)&TAU'WMR\$
M D'"XX&0V&.WB)9%4Y5%41KP @ 7"G   X50"% VA^Q)9SCJRQ"FY.6+@J=:
M<H02M%4+:+1>[AZ<;Q?\[27/*^-/),%"6%=.T88)6HTTY<T4W4;7.VYO6I*3
M?-=M*[:1-"C01C+>9C"+@':N $(51E@JA  .3U.1G%7 <@'&,@'!ZCVJ$3*W
M;!+$$'&?EP#QVS@9P2.1R<T[SX^>>G7_ #^?Y'TKS(P4;6WUN[W;;=]WKO=Z
M[WU/9\M/E_6FQ+14/GQCJW_ZNHSSUP0?Q!Z$4>?'_>JE>VK3??;\._X7\@)J
M\0_: (7X7^()" <WGAQ2-PSM/B'2X\L&)1E&XDAU:-\!7#"O:3/'C.[L#TR1
MG./EZYXZ=>@QGIX/^T>2?A!XDD#. +KP^Y$*Y=E7Q!IS%%4I*23TX0'CJH)K
M2E_%A_CC^9C6;479-Z/_ (;S76W4]M24Q1)'M)"A5#+M 9  2R!0%"A!N( "
MJ 0I  JHE_(63_1V8AIAE?G*O&N"G=E8#<SHP^0@!L')7B/B/?V-C\._'E_J
MWC2;X<:/I_@3Q1=:I\0H;BPLY/A_IL'AS4)M0\=1SZG#=Z=!-X2LU;7HYM4M
MIM/B:R#7,<L1:)OY?/@MK/[%%A^S;^U9\4M/_:;\>?"K_@GYK'P_^!.B7VG:
M=\?;WQ?^U)^T9XCT7QO)_;GQR\9Z3J.M:QK?P<N/VF;E[;X>6GAO0[?PAXH\
M>Z/J5[XFU2W^'*6VEV2]>"RZ6,6(DY5(*&(IQ4H4)5KNK4]GR6A+^+-7Y(?:
M4)N56A33J'#C,P6"5&\%4C*A6FU[:G2FO9P@U/EJ7YH1O[S3O%RC'DFW:/\
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M;5OZ3XYF?H,@$@?[0&SG/0'+>O<'UP^0GR6/0E?3INXQCKQG'K^-5(CL4@R
ML'P<+M&#SSSG:-J@MQR03SS4[RJRL-PR<%1G_=^G.#TQQZG(KRKZ22=FG);=
MK_FEHWK:SL>MU>]G9J_HK_U^AX1^T*C'P# $!;/CCP7@"-Y"#_PD%DCDA"I
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M[:'[7'QG^ /[>W[(?@W1O$?A[3?V9=7^$OQ*\<?M,:3K&E6PNSH>H_&;X#_
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M4;0=NTC;G>R@<D&I7^+OA9=A^P>,@&C#?)X-U[]WR=ZR8@)5Q@2;>JI(O)#
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M3P!J\FI6EA=RPS:A:6>HM8M=VUK>W%G9SW=JD@M[B2V@E>(R(NW#\+ZW\$_
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M_M^_M$Z/H'A'XV?M%>$?@9\1?V__ (<_#OQ%X,\"?%?XD?!_QO\ #F\\'_\
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MLI--VOS4]GO]LT1+%T#K@>XXYQZYZ_UI#-$>/,3G@C=@XP<XP"21Z?K6>%#
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M7B"'5+.QU"X@UVXTCPSX@NO!@@5]"_MGQ/;WVHRRZ6+V.?T'P?H_[&GB1O\
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M.*YZU;+UA93G1Q,8TJBQ-6JL1&"YTY1A6C24$HM1IMN34E[/^=CXX>.OV/\
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M[?G[;?Q-^,OP2\3ZKX[T_P  7]QX\_80\+VGPK\4?$?P+X*\&_%+X=_&W0O
M%Q\6]>7X+W7@W5_BAXMUSQ=9>(O%FN>%/%7AG5+#0O .I:'#;:U#::5IFK3+
M_4]9>&M*L((H-,T'2=.M[>.:VMH;/2K2Q6&"5DCNK6..WM8@EM=06]NDT058
M)5@A1HY8XHS5,^!O##:IINO2>%_#IUO1+5M/T/6!X=TLZMHFF/\ NY-+TG4/
ML37UA8^26A6"SN8(-AVF':>;I9W@J5.I1EEU"K"5*%&A*<*;J4TU*%64IJ*4
MY8AM<_/%\G+%TW'7F5;)L=[:G7AF$XR==U\7!SJ3IU%&I&K2I4XRE^ZA0UC%
M)/FBVJE])+\:?^"HGA+X9^+/VB/V6%\4^,_@?X7\=^&? GQLO?A]HW[:_P *
M+7XC_L6?$6PU'5_ 1\8>'M4U[6IX]&\ ?M!:+9Z'IVI>#=;2VGUJY\'WGBVR
MTV*]@EOK23\]/%MIXA_;7^!W[.7[)_[/?[(=I<>'?A?X1^-OQR\:?#+PC\3-
M/\)_"KP%\1I/$_C+P!^S1X_^$'B[XFPZ4U_\/;?XCVNO_%SX::=H]O92:?H%
MAIJV>F0V4=KYO]4WB3P?X<\9:8-'\7>&-#\5Z.)EN!I/B31+#6]/-U"V;>YE
ML-6M;R 30D;EN5C\T/\ ,, EZN6FB067E"RT^UL_+@M;0-:6-O:L+*PBD2RL
MD:VBA/V2S#@6D99H;=&DC@MX=^1GA,\IX:AA(+#.>*P+D\)4DXJ%%)SE'VB@
MXSQ$8NK-PC4E'V3FU3J3C.<8[XK*,3B:^(Y<6Z&$Q?)];IQG>=?EC&+5*6V%
MDHTXQ<H*3J6]Y*23?SI^QM\;=2_: _9L^#OQ*\3Z;<Z#X\U'PM'X>^*GAJ]1
MA>^&/C#\/Y[CP5\7/#5X #&QT;Q[H>MV5E=J7BU.R$5] S6MS!(W;^!@W_"Y
M/C;GY@;/X>,JYX0'3-5P ,!1@_Q[=QZ%L# ]=M;"/3T86T$,$333W<T<-JEL
M'N9Y&GNIV2&-5DFN69A([;IIY3)<32R2N:\=\"QN/C3\;G$9V-;?#T)M0N[!
M=,U,$D*Y;;SA=R(P 8@,/FKSU.+_ +3J4Z4Z5*K&,Z=%N.E\33JM*2[.;C%\
ML=(QT7*[]SBXK+X5*D*M:G[2$I1E:4OW$J5W!)VTLW=O52MH[KG=>\2_LU>!
M?VG?"FG:[J_@+PW^U5^T/\-Y_#7A&*_NIK?XB_$GX7? '5]6\6/H&A._FQ2^
M'O!&M_%/7==O-/MY+1I+SQ+-=/;Z@[+]E^;V^,'_  30_9H\<_%;Q!'XO^"O
MPX^(?PC\;W_@_P"*;>'H=6O?$'@WQW^TS>6?QDUG0-3T/0K#5&M]7^*NKB+Q
MWJ>G:?87!N-2DFU"\:VO+NXA'RI_P4M^$WQAU7]KGX!?M'_"_P"$?C3XDZW^
MRA^RI\>OC%X @\.6C[/$/Q(\+_M)_L@ZUJ7PBL+M()A#XK^*GPBLOB-H6C6%
MT@&IP)>36,-PFG:CY'Y\Z?\ LS_M#?#?X@^)/BIXC\$_M(>"O$?Q/\9_L=?M
M,?&+XE?![X577Q3\<:/\6_B)J'[5GC'XP^&_#WA6ST3Q"FMS_":S\1_#GX:Z
MQ>0:1J%KI6D6^C1/9P2*D,/T&79/A\3A:4Y9JZ/M,)SU,.IP57VT*TH1P_+S
MWE36'C"O&3A.2JS=.%)SC9^%F.=/#XNI065SG.EBJ=%XB=*4J,J<J5.3KQG&
M*5*4:DITY*]K1<W4<+I?K.G[3/\ P20^''P*T"TB\4?"CP5^SYX/^*UU\4?#
MUG_PKSXDZ)X$\*?%GPSXP;XOW?C6V1O",$6C:EI?B_41XP%[-]ETJ._G+1JT
M;F)?J;X3?'+]D/XK_%2'QM\*?%OA'7/BW\5_"NN>&K76H-&\3Z+XM\<>!_@9
MJ.GWVN:9;IXATC26O=%\!:M\4]+DF>."..*Z\3LD-Q=/]H2/X<^+]E\0_B__
M ,$KOV\_A]X6N?VL?CG\1]8^#?QAT3PI;?M ? 75?A!\2O$FOZSX&9-#\)>"
MO"MQX-\&_P#"0V!O(Q':7UEIMY+]NNI;=[J5UBC7V#]J;]G_ .+?Q8_;5_8Z
MU/X?^,_BS\'O#/@OX$?M,Z;XI^+GPTTCPQ>#1-2U^Z^"H\-^"=:N?%>E:Q86
M8\3C1=;U"UCAT]KF:;PVJM<0X1JX?J.#J4Y<^.Q="M[7-H574K>UI-4\%@\1
M2JJFH*O:K6DX2BX2=Z:G'FES0CWU,;B*;H\N%PM2$Y9?%*$>62^N5L12<.=S
M=->RA23AJHRE5<+4XOFE9_:*;_@F!?\ A3XCW'[0,'PKU31YOVBY;'Q[90VW
MC;4O%FI?M->'? ^B:>]EI>C^"@?'&K^/M/\ A]=:%;W,'A2TGA30I87N#Y3,
MQ\DU_P +?\$8[_X&_"SXC>(K/X2:S\'?#?Q%N_AW\.]6U*Z^*NO:@/B%KFLK
MXTO?A/XDT"6\O_B%KXN=7TR'Q5<_"+X@Z=?Z!%<65MK?_".P1[)Z^9?A!\$_
MC?\ LG?M+>(/VBOBM\._CK\=/AIX2^/?[66C:CXPM? D'C;XM6B?$KPM\&=2
M\*?M%Z;\/?"5A!>>*_"FJ6OA+6O 6I:GX)T6;Q!I264+'1[FPGN6BE\:Z'\4
M-7^.K_MP:7^S=\?M)^#&L?MT_LU>+;/P#IGPFU[4/C+K?A#X-?L[?&WX<^-_
MVDO$'P:T8W7B[1[+QEKOB_PKX=T6ROM&3QEJ'A3POI&OZUH]B]W::='Z"P.%
MI5Z="&<8BK36%5?ZY0KJC252IAZTYX%4JDHSC4<Z:IRK7]G)RNX-<E_/^O3J
MTYU995AJ2GBJE*6%Q&'3KJG1G!+&2Y8RA*E3;<W#FYDES0FI.2/T0TCXU_\
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M9)(2D+U^-WASPQ^UE8^*_P!FSXG?&WX>?MJ_!+7;K]D7XL>$O$FJ?L5_L_\
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M[A:=5-<RL]55;=[)^]?6VE]3YM\/_!^QN/B+\2=-/Q"^+< TVW\"LUY:>/\
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M?\)S\9QUP%^+_CE54DYRH&JYST')Z9 ZTA_9X\+YD+>-?C.WFIY;;OC%X\
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MB>^\-^+_  ?XMTG0?&/A+7K6WN;6\?1_$VA:9?BQNK6]2W>TN8)Y/:)7Z.I
M!#'<N&!4@/\ EM8O@D;F^7&#FL98C%PDJ52M5C55U)5(\C6L6TXRA>/-%NW-
M=M25FTTWI3P^%DHRA3IRBU[LJ<N:+33M)2C-JU]VGNNZ=OGSX5^$=#\%?$_X
MG:5H)U9;)=&\$W1AU;Q!XC\13+/<0ZK-,_V[Q%JFJ7(WD)^ZCD2-,81$4XKZ
M/0  @=-S8_$[OYG\O7K7CWAL;?BS\20 ,GP]X(SAB2Q6#6%SS\P!!4( -N"
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M;\VCUGZK0U4L-AE:RTPM.5E;2_/[S>BO?EC&33C>QYBWP=^&+?$5?BZ/ASX
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M])C%J]E%WFVDJM!6<G=1T>EFF[V5[.[ON$QC;M&Q0X8L%)9>=N>1PP8'!.<
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M&W\2>']&\)0ZQKOCG5]9N],TR*PNOE/0/^"BW[9?Q9^%\GQ,^&7AKX"Z!#\
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M1VAI9K5.3;TT3/5_]&*@[X>/E*E(SN4*R' (RH<'!7(4 DA03RH: (J^:H4
M?\LE*A0!A<E #RG' R!W"<1-,H"C:RX 4+\IXXP!@>@Z9&3CU)I6D<C<K@#
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M1@TY/V?_ (>(I11XI";;E47_ (3'Q'B(7$;1KY7_ !,/W?V0,S6.W M'):(
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MK["L2D?\)/XBR1"7*$D:EG/[QPQS\P/S X4AZ_L^_"]/,":1J:+*%#*OB3Q
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M;W_B_P 3367Q^\.?"8ZIX7^(VNI!(L,>BZ?HWQ+TN?PZC6%SJC2Z<DMZ2'C
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M'R@U[?6U=N4HMZOV=/5];1T,L$E[*:LK*M525M$N9V5O3\#P_P#: C,GP?\
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M+Q;X+_:B^'7@SX7?"6__ &<(OA]'XHT+Q=IGB'X9>/?CAXPUKP>W@[4;_P
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M;L_$WQ%L/%^G6<2_$W0O$-O?:A#IFO:)J%O-ZU^UQXO^(G[17Q0_94^+FA?
M'_@HK\+/"'PRO_CWH?C.Y^$OA+0/!?QUTBX\9>"-.C\-7EC%=:WK=D_A'5KF
MWN;#4I$66Z6]2Q"K&8W)^KOC%\<OV]?!O[3WPX^!?P]\'_L:WGASXSR_%;6?
MASX@\9^)?CDGB/2_#'PSMM'U6\B\<:?HGAMM-_X2765UEBXT>\DTZRO89XV-
MT&9SYQ\1O^"M7P]^&_P'_;*\;Z]K7P'TWX\?LT_$#XL> O!_P,USXQQ:/KGQ
M$N?AU=Z)IVC75QIVHP0^*;-_$USJLDL5EI>@:DXMEMVC:8R3%'#&YA)X7%K
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M?LZ348O"QI1I)-5.6\9^\^6>DO:0_0*W<,K8<L 0 3CI@9QWVYSC(_2I)O\
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M(4A,D8QMVJCC!/7Y650>K#'!Z^*^$) OQQ^,\:\L-$^&TFW /RR66K 8/'#
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M_P# JY\0Z5J&D6.C^(%M='NKK4;:WUB2]T6WMWU!Y'GNKB$LH-7X5^%OCO\
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MWII?Y_UK\PE5]Q88*E<9!]\T^JR.4 W,2I)'1F*XP!R!C;WR>@[Y!IQF&UB
MV>0"%;'?!!VGC'.X KGO@BJ=2*=M?DG;79_,"9C@$^@->*?M$ -\'?'.=V#I
M-N04V[\KJNG2+@."  4Y[D$XQC(]A5PO<R989)887J.A.<XQ\IR>G'! \A^.
MC2R?"CQL%1II&TV%HX 1'Y@34;(^4I89)E4':H&YW.Q<G%50BWB%HW><;63O
M=R;U5MT]K7;TTM8QK3C&$[RBO=>E]==/.WD>M0DM9P_>R8(/F&.2T498#'3(
M.>/XB2*N,O&<].2>1TSS\N&.,]VZ#DYR:S[=LV]L-VPF&/*NW(W1*=C!L,,,
M< , 5X& >3;215Y:3@G W[@!QZM@<E3][&,@ #=SG)QYI)MK]Y-:)V=FNKBT
MKJVVC5[ZIVTCM=.ZY8V>O;OI?U]4MB0+R<\YSD';QN.3V.<=L]CQCI0JD*H_
M4>A!QUR>.G4\?I$\J KM(;L"KH-[#(*IEAE\*<C/ '.. R>8#DG=@'!^8=\#
M!;.T]>VY2 <'@XKETMT]$ONLEWTZKO>X-N^U_P#MY+9=KW2_!>2T)5Y+84J,
M]^_+9XS[]#QSTR!3U!&<G)W$_0'D#Z#/?U]*C+J #OVX ### =,\ C.?3N>G
M44@8')\PG)P,9). /[O?U]/RJ7-QDTX3Z)-M)/YR:O?OWT\D)I;6UZ76_D3T
M5"2%&3(>/4']<9_E^%+YJ[<[E+#L"3SDCH,GL<]0,9.,4XU+NSCRJS=[J2TZ
M-K9VUL^@TTR6BH_-0\9;IDC8_KCGY?T/4<XQ2>:N<?-C@CY&RW)R -N<+\F6
MZ#(R1FJYE:^OP\UK:V]/T]1DM(PX'U'\\5'YB\$\@@@X!/S E2, 'C((R>.G
M/-0AE#%O,RA;*H3A2"%YZ8( ;<",@X^4D<UG*<:B<%JY)VO%VTMOIIK;I^-@
MNK;K[U;\R8X\LX.1NQG.?X\8_H1Z5R?A-=VCW Z9U77!GD\G5[\#H/S'<\<\
M5U E0X0J%8M]W//WQR,=<\'\AZ5RWA0XTF;C ;5M; .&!R=6O><[>/8DJ#N
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MO!=[HGC7PCK^F>'O&6BVR2>'==TO5-8TV^N]+FFNK(/$OEGP[\7?\$_OA/\
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M7?\ 8]O*RRI';$,^5^U]^SG_ ,$T?A3XTTSXL_&O]EB;QO\ %?\ :$^*-S'
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M$-SX4MY<O'<>)X?#%]-H-O( RN(WU*.W$AW*2I"JRG=7\G6A:]X#G^ 5G>?
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M\+VUOX=\'6>JZG%8"V&D'Q3XGTZ5Y8[?1A'+^>W[./QG\2>*?C3_ ,%+8?\
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M5*YYS\N(?^%*>'@29/%/Q08-*TI4_$?Q+C]Z ,%8KH;5CSE%#  @DDD"LO\
M:!_:,^$G[+OPTUGXQ_'/Q?9>"/AKH.H^'=+U7Q)>6]Y=):7_ (HUNR\/:1;)
M9Z=;W5Y=S7NK:C9QR"" I;69N+V<I#9SLLFO_M%_"'PW\6?A9\#M;\<Z3IWQ
M2^-GASQ1XK^%7AJ2.Y9O&F@^#;;3KOQ'?Z1J*1'3BUE;ZG:726MQ/'<W-NS2
MVT4D8+#)2Q,Z=.<83]E+VJC4Y?=?LTG*WN).24DVDWRQDI3Y8M%?[-&K-2J1
M]I&*YXNUX^UTBN767O/1)6YY)J/O*25P?!/P]'N7_A)OB@Z2-N??\2?%+%'4
MXPI:\&%P2[ A5/3G.#*_P4\.M*)&\1_$E<D_*/B1XI495<)@)>D!2 <G  ."
M3DX'RE\4?^"G?[*WPBDNI/%5_P#%G4-)M/B)KWPFN?$O@[X%_%'QKX7@^(OA
M_P >?\*VO?!%QX@\->'=0TV'Q$_C;'A_3[&283:O<R0-8K-',F?>OA;^U%\+
MOC)K5EX6\)S^+-)\7WOPVL/BVGA'QWX!\7> O%&G> M4\8:SX$L-9U?1/%6E
MZ?=Z7/<^)/#FKV\.GW\<5X;.%-3\K['-&6MQQ\5[\:D*4H<KE9)2:C92:=#X
M]87?/97AI=ILA/"S?*JL)M3C)6G%M-WM%1C._)=2?*T]I6;:=NM_X4EX>9)%
MD\0?$EQ)A3&_Q*\5NC@G(#8O@Q ('*,I!4] 078OP-\,H92OB'XF":X8228^
M)GBO:=JK'&%'VQ44"-%155 & 4LSEV<\WJ'[5?P5T7QIJ'P^U+Q3)#XMTOXK
M>"_@I>Z2FCZS(+?XE?$;PG<^./".@K>+9&VG_M3PO:3ZE+?(YL[,K'!<2I+(
M@/*?M)_MN?L^?LFW/A^S^-?BK6=(O?$&E:YXI%IX9\#>,?'\_ASP-X5FM(?%
MGQ&\:)X,T?6)/"7PY\+RWENFN>,->CLM(L%=B9W\F;9'-CIRI.#K>TDW.+IT
MXSDX4H*,Z=O9M2CRN*;Y=&TN:\HA*EA8N<INFY0BX2JU)14H\_,][I1YG+JD
MY65K6;?J!^!WA$C_ )#GQ(9N',B_$SQB,LIW,,?VGLSU.%7:V N 32CX*>&4
M:(+KOQ+*HXD4'XE>+0I;8XVD#4 " &?<' '0X)P%X[Q%^UI\#?"/Q+\%_"'6
M?&L3^.OB%JGA;2?"5AI>DZAK-AJ%YXVT3Q3XH\-DZYI4=UHD-MK?A[P7XAU6
MSGEN8U-C9I,,"ZMP_J/PO^*7@WXR>!/#OQ(^'NJ+K?@[Q2EY-HVK-8WNFM-%
M97MYIUS*]G?QPW4 AO=.O;<K-&#(Q@=#LDR8E+%T8*=:-7V,[2A&K&,7)SE*
MU3W:-+5N,HQ:NER-.[BQM4*LK4:M+VU**@ZE.TY1A'D4Z;O*?V7'F4KO5-.T
MM>?N/@AX4FE>:3Q%\2@VP1X7XF>,$ $>]$VQ1:FBJPWR%@ 3(2"[9C3$*? S
MPBD9A37?B20[JREOBEXT=@8@%4)(=4W%'<;74, V6) QD^8_%3]MW]G3X-?%
M_P /? WQYXSU&S^(.O0^')KJ/2?!_B[7?#?@F#QMJESHO@>X^)OC#1]&O?#/
MP\@\<:Q;7FG>%O\ A*-2L)=7N+2?[*GE1^:?)=5_X*@?LH:#XK\1>&-;U3XI
M:78>$?B?=_!_Q;\3;GX'_%./X+^&?'FF>*#X+U:WUSXL?\(\W@W1M&T7Q.!I
MNL>)M2U.WT+2I"L]_?6\!W+4:.9S:]G0J5*;E&5.3C-I1J1M"RA"\I2<9<J]
MYR6D8S:N*I5P$92C*M14TW%P<X1:?+*+;5[Q:<FU>RC+XFM$?5?_  I'PBH3
M.L?$@_)ER?B5XPP2N&4%CJN=HW<?Q'H0 IIR_ SPBH;9K?Q&V22&3+?$OQF?
MFW(2!G5/EW<%8U.U<9.0S54^/WQ]^&/[,_PD\9_'#XU^)(?!?PU\ VMM=^)M
M?FL;O5I+&.[U"#3[>*WTW3(KF^U&ZGO+V""WM=/@N9I,F0)M! P/$G[5'P/\
M'>+OV>/!'B'Q_I6F>(?VJH-:?X"6EU:W26GCN70= TWQ7J-E::KL73[2_FT3
M6;"73+*_DMKG49',-HDDZNBE*IC:]&%>F\5*G5E6I1O1DHQJ8:+G62YJ$6[1
M3DVV^6'+-14&FYG3R^G*=.2HQJ0A2G5]ZTN6L^2FY+VB;YI66T5*6BO)V?2R
M? KPHR3*^N?$>)7<LYC^*'C4$!BK+\_]JJR $*/W?R[?E& <5%)\$/!LJH)-
M>^(C% -H/Q0\<* 0!C#1ZPA;<,$LZDE3G SBOF3XM?\ !3+]ESX06OCR]\5W
MOQ6O-"^&?Q'\6_"'XC^*/!_P-^)OC/PWX#^(/@^+P7<:EX?\3:SH&BW=GIMQ
M<0_$/P?+H4\V;/7DUN!M*FNE60IKZS_P4+_9L\*>"O%?CGQM=?$7P#IG@SX9
MZW\8/$.B>.OA!\0O"_C+3? 6B^---^'MQ?KX/U+24UVZO+OQ?K.E:5I.DPVC
MZEJ8NXY[.%[?$BW*.9>SIU(X?&5Z;?L7*G0YZ;J?NI)/EBI<W[VE&]U&,ITW
M-1C*+E-1X)SES5:";MS1DY12Y8J"VK0M94[WU?NR:TO;Z'7X$^$&2+R]:^(I
M$<EP5Q\4?'! ^UPBWE&Y]89WW*NU%8E86!EB*L=U2K\"_!Z@H-8^)+(96F)?
MXG^-78,%V;(F&KAE08RT2D*"Q;#$\>$>!O\ @H-^S)XQT;XLZS?^)_%?PL7X
M%>#K/XB?%/1_CA\./&_P=U_PW\/]4&LPZ5XWBT+QOHVEZAKOAC4;_1-2TFSU
M+P]%JOFZU"NCA3J-Q%;U3\!?\%$?V;?B"WBR$WWQ)^'NI^$?AGK?QGF\/?%_
MX2^/?AEXE\1_"3PW91WNL_$+P1I?BK2+"?Q9H.F6SQ-J4>D)-K%B\]O'J&FV
M?G+1[#':PG1Q3=/FO!T8*4'5=W%[N\;IMIRARN+:>[M?4K75:BHSE!IJ3<;T
MI.5DI5'L^9MOE:L]6](_0C_ GP>ZE#K/Q)*MM;CXF^-0^Y<L03_;.!_$" ,,
M< \'(B/P(\(3,&DUCXE!1"$01_%+QJB;>Q,?]L@"4]-^,X!.<X!^;_AC_P %
M)/V8OBGXET+PKI^H_$KP7K/BSX?^)OBCX$@^*_P<^(WPM@^)7@CP9HMOXF\4
M:M\-[_Q?H=C8^,IM%\-W%MKU]H^DSS:LNASMK"V[6$$\B8EY_P %-?V:9-2T
M?3_#-C\>/']UK?PQ^%_Q?C/PU_9W^+'CJWTWP)\8]$G\0?#R_P!=GT'0)8]'
MO];TJTDG?0[PQZKI[CR;VVC96:JE2S+6,:&(F[-I2H\GLVW)<\9<T(M^[*-W
M)Q;A*/*YWBLZD\OH+G=;#P<H\EYU8PC4@KOEDY*JY13]ZRC%I-7:3;?U7%\!
M_!MJX,6K_$H!V#$M\4_'4HWJ3L8A]:Q@Y^91P1@$@YQ8;X'^#]N!JWQ'(CWL
M GQ,\:!MSN3+O;^V"6PX(4$G"\)D-BOF/XF_\%'/V</A!JUSI?BU/B[<S^&_
M!/AGXC_$^]\+_!?XA^)-(^!O@;QIY\OA[6_C=J.FZ5/%\.OMEI9WFIW6FZH7
MU?3])M9M9OK"#2XFN6^K/&?Q@\"?#_X5^)OC;XH\2:=8_##PIX,NOB#K'BVT
M>35-/7PC9Z,FMRZM9"S22;5%O+%TN=)M[2%I]4ANK 6L4DETBO#AF%-TE4HX
MBDZKA&DO9^]B7)^Y&\N9WJ1<>5<L')24H1E%QG*J=7!U(3G2J4:\:;O+V4X3
MIT(Z\]IQ4(**U3<D_>34I*2<8YP^!G@X%L:S\2"_+['^)_CC:,L5 "IK&4X
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MTM9=_7[O(ZPHHHH **** &NBN-KC(./4=#D<C!Z]J\2_:(B27X,>/TD+HO\
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MTZ*-M*<'M.,;+F7*XIV<FE+1MKWF[2]U\SO&\FVGP,GP/^"DWA_0?"LOP?\
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MJ&C:Q96VI:7?VDZ,RSVM[836TMM*"X*R1E&PV*\J\+A1\;OBVX.&G\.?#PL
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MW9EALLA45?%5*[J5(*G4G!S]ER4IQG#VR34%3HRY)0E+E]FXMQG%ZKSGP?\
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M2&8R(8I=]_K(\L1Y\S?%C:78$8P,C(S[%%M12O3#'@9QT'3_ .OSFO&-"/\
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M.[*(?%VU(PX;_A#M;$;G<4\O)T]6+_*'VC:<,,.2 H&^,'A%?/S%XL81^?\
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MNH?#>A>&=-E@TJP\-3ZP^J^(F^7_ /@F1^T1\:/'?QM^"6O?&SQ?XOUCQ/\
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M_L;_  D_:>\4>&O%7Q*G\9"]\+_!K]HCX'V%OX=UV'2+ ^$OVD(_A4?%^IS
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M\?\ Q(FTG[26\8_$_P 11^)?&VK--<M<;=5U:+3]+M[A;7(CM-ENBI"JQ[
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MTE67/RA@2.X)!J;R9"!G+@'Y@79>>Q&.>.AR3E<@Y'%- &+,#&4$8.,D<!0
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M"YI9AAIX>$5*6.3KMTTIR<H4DO<J<_O*?,HJ,5&*C.,8GP+HWA?P-^S=H?\
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M7%\6_AA;ZMH/B'PYK&G:)JGC7PQX>UO3]7\.WFBVGCW2XO!OB".]OVGM5']
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M=Z997=O9R0!1!-917$+Q6SP*@%NT*H8P %("K7CK_!?2?,B9OB'\<Q+'*9Q
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MN8#^Z(SY*Q$@TDWP)\ N)5FO/B/-YNS8\OQD^+,C0"W01QK:AO&1$**@$6%
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M3:7\9_&/CJ\UV+4?#FMZ+IWB9KWQ#X:U/2)_$C>)=')TI;FWO+.2'V7]B_\
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MYHM+Z6>VO(;?Z80MY7S#&49F)"@JNP=5R22P'(&[(/7.!7YV?LR^&?B[X_\
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M_!-W]IOQ-\4/#VKZU\#[GPWX6\<0?L;:O:>%_AI\>/AUX(^%_P"SCJ7[-O\
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MSC'W"%.2#7Y>^$O^"N7[*_BSP+XQ^(C6'[0GA?P;X=^$K?'#P9KWC+X&^*M
M;X\?"4^+-!\"Z?X_^!6FR)>:GXPTS6?&'BKPIHFD:/J]CX<UZ\B\4:-K,FEK
MHUU'J]*-'$5IU/94?:J%247RKWHIM.+CIO*\M+2Z2ERQO)8RKX>C&FZU6%)>
MRBX\T[1:LE?>SL]+R:?2+<O=/U1^88WN@/IM''' 7@8((P<GG  (&,.#D<%L
MXX.,JH.#DD#+#CG=G&1G /-?F@G_  5 ^"P\+V]X?AG^T_-\6[SXIW7P:A_9
M43X+75Q^TVOQ T_P)I_Q4U&S;P+::W+X>@\,Z9\+M5TCQWJ'CZ?QP/!NG:+J
MVG0W_B-=6OK72:S_ (C?\%3_ ((?#OP+X6^+$/PN_:]^)/PA\6_#VT^(Q^+/
MPI_9K\9^-/A]X0LG\0:EX2UGPQX\U:&6TG\)_$+PMXFT;4=)\6^ M6LTU[P[
M?)%87%D9P5=RPF/4HQ6"K7FE[-.5&#E=:.,92BY*6\;2Y9V?LY3?,HI8S!3<
MI+$T?=YE4<7\*A:4N9I>[RW3GS6Y5;GY%*#E^H <H,J^>",!^,*N?XAG.T;\
MC );N!D@<MGA5.2% '0?*<D$_-M[XQ]T\$$8_/OP[_P47^!?B3XPV'PB@TGX
MS:7::IXYO/A-:_%[7_AO=Z1\#1\:=-\)7'C?4/@S+\09-0D:S^(&GZ%::BD]
MM<Z-_8-QJ^E:EH%KXAN]3B6S;A-#_P""KG[,VHZ/X^\0:EIGQW\):/X;\#Q_
M$WP#>>*/A!KD)_:0^'?_  GVF?"N/QE^S)9Z1-KVH?$^QF^(/B7P)X9?2[NV
MT3Q#9'XA?#[7=0TBQ\-^+M+U>\J6 S&G/V<L'6C-<K<>10:FW9WY:M25[V]U
M1O!.\U33YB(YA@*FL<71::4E:<6^5O22OR^ZVMWI+50E-WBOT]!W':"<CCIN
M7))SD8S@= 6.< $D'-2Q.XD*,HP?E('WAR.3[?,!D8!Z\D''S5^SI^TYX&_:
M0TGQ=>^%M"^(G@3Q1\.?%J^!_B;\+OB]X.F\!_$[X>>)KG0]*\5:;IWBCP_-
M=7MD;?7?"NNZ-XDT#5])U;6-&UG2=3MYK/4)95EAA^F%=0[NPV$D;SG< !@8
M)P" >.,!>G9E)PE2G"7LZL91DOB7/)J75W5_-7MS)IIJ34DWUPJTZJYZ;3@W
MRIVN[Q;3UM=*Z::LK---)W2L+A2P&3\W.3P,@'CV [?K3ZK&=,L-R@94#/?*
MY.2.F<<;L>G6IPV>>,<G.>JX!##VP<'WIK_+3MI^/R+_ *WZ:?YCJ1L\8_O#
M/T%-:6- "SJ >G/7\J9]HA_YZ+^O^%345X26NMO71IZ?=T\]P'G[I[_,,#CK
MYG!_/'7(XZ=<\=X43&AW !!*ZKKS$XZ[M9OR /H"1[MR*ZWS8V^4.-S'('/(
MSN'48P0,G/'/)YKE/"A7^QYPQQG5-<^7 #'_ (G%\#_,?3..*Q5U3:6K<:6J
M:LK3DN_F[]Q/2+[V?Y,X'27=/CE\0%SN1/AS\/)(U.WB1=9\8C=D#(/R@X)P
MW0 <UZWL8KG>IQCC:&!*YPRDC!W!3C( !7"@Y!KQW2W#_'CQ^N& ?X9?#T_-
MA02=<\8[=@(^:13C*/@ G!/RG/R]^WQ\=_VBO@)X+^&_B/X+:#\.QX<U?XU?
M!OPA\5/'WC_Q#>"^\*^$?&OQ1\)^"[JR\$^!+/0KZ#Q3XD\10ZTUM;7FIZYX
M>TSPW ]Q>K%J-['#;#LA2G7Q-"A3M[25"F_?Y4G)Q^%MZK:2LD[RV5S"K6I8
M:C.M5?N0DV[Q4OA=Y6UE=1U;5K6WT/T&:38H5 &+*3SE6P H!P-W&#E@<G.0
M"!@"(W)?Y&P'4<ID]C]W)P<[3D],<]U.?S*^/W[2_P"TEIWQ*_:YT7]G#0OA
M[XHT_P#9A_9O\!:E?Z?\2+R_\/>'X?C7\39O&GCZZUW5?$.G:+K&J:KHOPM^
M#GA#P_K]WX*T8VUYXEU#XBZ582W.E1!-8M?G?X\?M6_M@:)_P3^^!'[8_A#Q
M]X.\&V2_LB^ ?CM\3KC1_P!GWQG\;?$WQ%^,GB3X=:!XLTKP-;^!O!_VRW^'
M?P8UR]NM4N/'?C]M3%UX'T9H[]]3TW3;&XU*3>CE^)KNA2C4PD:V(J>PI1<F
MI^VJ4G5I.<%9Q@TTHV=IST;C&-21S5L?AJ%*OB9PQ4J%&BYS]G2O#^)"#E!I
M>]R\UW%)\L6M+N,3]ORZ-G 52>?G9@ R\$\8 (4DYYR%[ C 2,898SN)QDL/
MX0<D#).[*XXQ@@GG(/Y$>*/V@?VLOC1JGB?2?@1\3_@-\%_ G@7X;_L]ZY\<
M/CAXBN=)\?>%?A38^/O!>O?%KXK^-_AEJU[*/#'CV[T#PM#X3T'PNWCB_P!)
M\#VFC^(KWX@:I<ZJ='AT6^^9?!O[<G[9WQQ\$:''\+_B1X!\,7?P[_9H^)O[
M75W\4-;^"[7-O^U7\-=!^+GB3P#\#%LOA]J.OV^H_"7PE\7_  7X5U;QQKNO
MV,4^O"2]\/3^$;*UT6:=)=*>68Z5_P!]A4J48>TC.HXSCSM4Z;E9Q49.I[SA
M!2DJ<H5)1A1O,SGFF'A)+V6,492J*,HTM).FG*5KI[07VN5-QE!.55<I_0?Y
MB /PF2K!2K-G.,<#U&!G.3UYZ"E29U+,55=J@J,<$,"2P.3G"@?,1U YQD5^
M4NA_M@_M"^)?VFOV/-,O/!W@GPK^S'^T'^SW\1OBK]OL]<N/$GQ+\5>+_"7P
MT\&^.-0LI-+71X-(\%>"_#=QXG.G:1/'XAU'Q'XJU(7$EYI]AID,;'P+_@G1
M_P % /C5^U'\8/!NJ_$;QE+I'@#]H;X;?$SXF?#'X8^+OV<_%GPOT(VOA+Q'
MI<6BZ7^S=\==0F-O\?AX0\+7Z1_&,>+M'T&[U#5+F#QQ\-(;[P!*PM<Y99C_
M &.*Q*E0G1PT(1J.,D^6K*K5<HJ,6[RC2H5$XVG&,5&<FI2YHBS/!NOA<-^_
MC7KU*DH4Y4Y).$*=+64FHI0YJL+237-.7+&\59_O) Q.0RA2   .BK@$+UY(
M)/0 8]1C$D[;8G.,_*1UQ][Y?ZU4MIE";V<,K8*L3DE=H^[ZJISP"^ ,9X%2
MRRH\;*IW$A2 ,@_>7)YQCVSSP3VKCBUJM.9.TE;:6SOZM/Y'J)JU^F^NFCLU
MOMN>'?M#EF^$7C%-CD(-';"$!RIUK3\8) &006R=V00"<UTWQ,\/ZCXI^&OC
M[PSHR02:SXC^'WBGP[HZW<H@MI=3UKPMJ.E::EU<;72WADO;F..64I($1F?8
M0.>;_:#$B_"7Q@0RK(4T?:74%%/]LV"Y8$,#@A@#C!4# !YKV2!59(U?;Y@B
MBP<?*'$*;BBGE-HWX&%(#L<C/&\Y\E#"3O\ !BJ]5;?%3I4)Q;7VDI1UB]'9
MIIW9SJ,77Q&EW.A3IS[.$HUDTENM)MJ2UOL]$C^?CX>?\$E/$GP;\%_LFZI\
M-9;:V^(6@?LE']F#]HC1/%WQ)\;>-M#\ :]XM^"-EX2U3X^_L]W?BO5=8B\(
M^//!7C:QN-)O;+0+73=+\4?#G7M6TJPM-*N;&QE/QYJG["?QY_9W^#EA\7OB
MYX+DL;[]FGP[^S/X6L(_$7QAUOXW>$OC-;_"OXTV'B2?3M;\$>!OAOIA\$_
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M8U_XIMXS\3ZKJGBSPUIW@O0)_$-CIWA26PN)[O0[K2GNQ/JL,EM#^T1^V?\
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M6UK^P>E_LY_!PV=IJ,_@NU\^6VM[Z:<ZKKZ+YTEND\\^U=56-<RLQ*+A!O(
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M_P!-L1D,1B[MP JXVG(DXQA<XX 'X#S!OV?/A))*9'\&Z<7V",'S=1Y1 NT
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M#Y])\#/A&SLK> ?#AWLNYA8D,N\;6)PY*[ER<C!9AS\QW5$OP-^$(5%'P_\
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M$W6CM:HE:ZTZ?B>4_&65[?X7?$N9"[R0^"/$CQYW;BPTRY.Y%CVY"OQ]TX)
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M\)KHDVJ>'K*+Q[X*M?%&G3>&[_Q;\/Y/%/A_3-;ET_2]0O[6XU+3DN5\+_\
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M&2#@D8W@<#.06V@9R,_>)! G%N_!$S9Y/()&6!&1DC& >,8P0#DC(,<!!BA
M5EVB(+YF=^. 0X('4#&2.20.Y(M[Q\O(^;CKCD#/OZ'\NM<2;E=N2<79JR:L
M]5+>]DWVMULD>GHNW9JT>NJO9)7VVZ=R VYZK(ZC'(QEN"& SG(Z8(SV';(+
MA H.,DCW[8^F.23D]^*G+#!Y!_$4;E]1^8HY(O=SZZ.<OTEY7WT_ 'RM6?+9
M>2]>EMKW(&M\_=D9#GL!S]>>?7D]SZFD-N .'8= ,G@^WU/'/7C/7FK&X9QD
M?F..G!]^:0LH&<C'4Y].OX8]343CRQ;7.WT?--I;:[_+KZ,--O=]+1V^Z]B
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M\6_LK_M$?&[X1_MH_!+XCZS\"/#WQ \:37NI?L)_$7X=Z=>VGP_^'&O>+I/
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MG52^M5E!+$59-Q2TE&-+EM6A*DU5^)7_ &BOVY?B-\)_B5^V]\*_&OP-\+?
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M.$D5_IUA?65W;3VN7\3T[_@G?H/AKPUH/_""?'?]H'PA\9=&^)OC;XO:M^T
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M=[(B?MEC8^S49)T'=SE:UI/IO97OYO2VC9Z##XJ\-LLCIXAT%D1B=[:SI95
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M?#'R[8SK<L?'?AE?L[1EA,LSG4@L*PE7+N_RH%=V< $CL6T/05(8:'HP894
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M;.]GTS66D4I@L@4NN Q*OD8(93GUYEPCCH-HZ#)'!!P#G/'8]<X/4UXYX56
M_%SXJ.LFZX&A?#3[0@)V;C8:^8Y-N,*"H&-NWA<XZUA1BW1JQ5[N$TEMJYQB
MK[JWO*_W&T[WI]/?O\E&3U_#0]?-S&C*A90=JL23@;2=HVD!@6)P-I*]1DU"
M;J,LDH9=GS -GY6 '\;XQ&5YVJ2=[''& Q_,K]HS]O:?]G+]LGX._ _QMX$L
M1\ O'G@;1KCQ]\<HM3NQ<?"+QMX_\?V_PU^%+>*=)>%].M_ /C+QI=V'@J\\
M3M*O]A>(M?T&75&ATFXN;B'D=(_X*@^#] \/NWQ%^'WC76?'$/C+]I)[SP9\
M%_#VH^.)O"7P._9U^+\OPQUWXU>-7NVM)=&T%+Z31[;4%5YC>:O<W=MH=E/%
M8W#Q]T,MQJH8:M[!RC7PZKPY91:Y'*I!+FNDM:,E)2:DG9V<9P;X?[5P<:U>
MA4JQC4H5G2E'5OW8TY-RLKK2?1-.S2=XR2_6N6=(@3N4\@$9P03QGT.,CY<J
M>.OHV*XB=5PRCJ/O@C:H)!S@9W( ^, [#N'&*^"K[_@H)\ KSP;K?BGPQJ^I
MZ_/:?%[3?@9H6DP:7,UYXA^(?B7X?V/Q,\(W%E#$5G;P=K/A#4K3Q''X@CQ&
M-&CO[K:3:R*?F73O^"O_ ,&?!_P\^$GB'XQ^!_B3:>)_&/P%^!?Q^^*L_P +
M?!NL^.? 7PKT#X\ZW/X)\%W6J:XSQ:E<:?K/CRR;POI4,-C<:EF[LS+;+;%I
MZ(Y;FLU-PR^M/EJ^QY>:%.?.HJ4E:I*"7*MU=R;E3C&+E-(J6:9?"HZ4\72Y
MU2C6M'GDE2J2Y82O&,D]4[V>B3;Y5%G[(&X4] PP220 1A6'?D8;IQT&2.@-
M(;E,=&SP<8.3GD 9&#N ;'/;\1^8U]_P5+^"6F>&](OKCX9?M#-XVO\ QO\
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MYK6GVUE9V2ZAIT;PB6XM8;G?\$_L>?M=^-O!/[&_P;_:&OO@+X2^#?[&6O\
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M)"FMZKK>K737EC810?N)M90,1' &" ZYP @& %SCHN#D +P>@9KQDDGR\'8
MK;EW<Y?&%SD*<+M/!Y8$9-8_VOCI3C-U,/-PUO+ TF^;E<$[.R<N1^SYI)OV
M:4$[1A*-0R'+J?,H1Q-*,TD^3%59224U42C)RTC[2T^792<I6;E-2^/OV4?V
M?O&?P:NOC-XX^+?CK1?'WQE_:$^)EI\1OB/J_A+P_=>$_ .ESZ+X0T/P%X2\
M,>#-"U/4=6U:WT[2?#?ANQ-Y>ZIJ=YJVHZK<W-Q+*+<VT,?V; V5"]" "/4K
MDJ#[@[>O3GBJ4<)1H^"<,'(*J<;@,CIA>1@8RV,G/0&ZK?O'+ KT )88/"G
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MO[3O_!+SXB^-/CKXIE\$?''X!_$Z77/@+I^FZ=X>\+77C'2/@OX4\2ZIX_\
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M7D9]@_8;(?C@X&3MPV!MW 9;: =S$8Z$@YZ\GEDDY0 <JP95;.1G Z@KN+$
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MFIV%O=ZYYEQ8:A/>0F%;B*)I".5T+X]_M%?LX_#O_@F3XR\1^-_VD_VP[_\
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MK>BZ6=GI8\:L#'_POK5U\TF=OA58.T0/!C'B:=1*R\(K9(5<C)4DYP*]J0L
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MKS*1E!("< Y/M(T^S'2WCSZ[%)SS\Q.,ECDY?.X]VH_L^R&,6T0P21B-!RP
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M,/"7P]T31XUU/Q)XQ\<6VGZUK]CHT<,,>G^#M$U[Q;KUSIV@Z-?W<7"^(O\
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M /.37L+6D'00H0< G W#U;=]XNP^\Q)9NC$Y&%%I .B $=#^)ZYZDYP2>2
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M2,7>[;::W7\BUTOZ6/'D^/\ \,WCDE&KZV$1XT=O^$)\9D%I7*(04T$JV6!
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MV0H"D!L@*.3R%Q/'\??AS-'"8YO%>V5',0;X>^-T;]T65]ROH:%<,#PR#J,
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M .T.3_>QM)S@_,QVOQQ5C[0H8@JX(4LRXSP N2.G0 ^QP3GIG\.H_P#@I/\
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M^*GP;B^-?A3XQSW*P7]KI_A>V\#G6K[4M)FBGN[75_#%[I<MX7N8'/S!H_\
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MW5XUT#0?&&I2^$O'-XX\[PW<P3S7L21V=PT?T/\ M&_L4_#[]J?XO?!OQO\
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M_>4W2CS4UTT7F<HXE2INU6FUAYSJP3BY-16MVK1BVWRI-/W9<\OWA\B>-O\
M@IM\6/AW^R-\.OC)??L_6'CC]H;2?VF+#]FG]HC]GSX=>)!K=UH'B[PZ-=UK
MXD6_PHU 2+%XTU6#P+H<OBSP-;"6*+Q.DT=E:-)<R)&VI\5/^"F7B35_&-IX
M._9:TGX4^/M(\>2?\$_C\(?B5XOUC73X6UFW_;-\8?'_ ,-W^IZ[IFBQ0ZC;
MMX%A^#^F78T>'R-4-]JNIZ?J,,-]I\MK%Z]IW_!,#X1>"OBGHWC;X2^*]7^$
MG@?3?CG\*?V@KKX,^$]!T:;P3J'Q0^&7A_Q=X3N=86^U![K5M.D\;:'XGL[3
MQ##;2^9'-H%G/:@/-<[O)-:_X(]>!='^(?QF^)?P/^.OC_X,:I\5?C=^S?\
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MGX'M=*N_#NDZU>^'I;6<:AX[T;PWJ6H>'M/\2W5U+)%I%]-;RV\KXD7FK?\
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M;F+2=<U#PU;:DL]RYLM2.G*MR.?R8^)&J:S^T1\3?CMX,\,?%WP;\0-&UO\
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MW<2>$OB@2'=2J>!=7(&UA&6!"D%7(+H0<D$=*</C9H+1F3_A$_B>!LNI-O\
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M=P.,9P?NCKSQ[G-Q=.*DE3TE=?$UK=+3337KOT,I1J2=/W_AFFUM=--;I/\
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M!\8[?*Y\!?%@YE:+/_"$3A6*1><9/^/W*Q."40[=V\8*C',K_%RW&P_\*_\
MBK+N(&$\$SJT9"Y#-NO4&.0HQU8\\KFO8"B_*,'J1U;H&X[]J,!A\V3SCJ>F
M5]_<TKT_^?;?:\Y:?@_EL-.3W=K)[.^B^25_ZZ'C;?%^%)1$/A[\6L,JMN7P
M7(4!<G/S_;P<CA2""HQG))X1OB]:B/S3\/\ XM$EV!1?!EQORC'^$WN &P ,
M9SGG"_-7LA523G)^8#DGIEN.O_ZJ0(O7'/S<Y.>%X[]LT?NVKN'5+XI;O16_
M5Z/L%YKK=)-ZR:=HV6ZC:[OINM-4SQR/XOVCEP? 'Q938!CS/!ETN\G@*#]L
MY8D'/91RS+W8_P 7XQPGPT^+\RXW%E\%N5!!*N%9M0&3&!G;M)?>"F1T]FV*
M2.O )'S-U*')Z^Y_'GJ!0(HR%RN<G/)8\A@ >3U )%%Z=_X>W]^72_WK3:_^
M0N:4DU>W9WUUMY+;4\<F^+(6V(7X<?%AV9H$)/@R3$2RRJDDY07OS)"C-*T*
M',J1F)/G*Y\LL_&6J6_Q4\1>-Y/AK\49M)O/!FD^'8$M_";O?'4+#6S=7 :U
M:\*M;K#,LT5X)=DJB6,1AH=S_6^Q1N(!')'4] 5 []LFFM%&F2J@'YAGG./+
M9L<GIGG'2G3G2@JD517O)*_/+9-2M:UM6O-Z>;(=.<W2:FER.6][V:DE9JSO
MJM_-[V/'_P#A:P#,C?#KXK!E4,?^*-9E)**VU)!>D,X#!3T^967C!-)#\6//
ME>(?#+XN(598PTW@^.)&WP)<;D<ZD,*F?*8\$3;E . U>QM%&O*K@ELY!/4@
MY[^YI?+1F((R 3@$GN%8]^Y8DGU/TJ7.G9M4^5N^O,Y6U6MG9/=NS+]E.R7M
M'I;2[LTKIKRO;IY]7IXR/BQ(S2*/A=\604(4"3PK$@F8Y*K&1JA4@$?,SE5[
M9YP5C^*4S,Q'PO\ BEA02"?#5NN< $$;]8!)8@HH(5\YSA""?8_+0(?E^\I#
M<GGE1Z^G7'6I-BG8<<@Y[]2#G\^_XCH334Z-F_J\7+5.;G.[2=[.*7+:ZYEK
MH]-B%1Q+::Q4HP_Y]J$&K6VYFN?I;S3UU29Y /BG=NGF'X6_%=#D%D/A[3@P
MW?[(UECVSP<9ZX)P8_\ A:-U)*!_PJ[XJ  )N\SP[9HJ(9#EEE_M@AVR /(5
M2SY!WA6P/83&A))7)R!G)Z%B,=?3BD\M"3E<[ &7))VD,^",G_9'Y4E[*_\
M"5M7;FEO>]^OE9V6RVM9[VGI[RTM?1N_G?H]MENO.YXTOQ5G<,__  J?XMH$
M!.&\-:>"RKTVK_;1)X(  !YQGG)I?^%I73?=^$_Q4#[%F*R:#I\>8A<VT$VU
MCK# RQQW!N/)(1WA@F4<C!]D6-"PXZ*".3P?E.<9ZD\D]SUI!&BE<*!D#/7G
M)R>I]3FH3PRE_NL=_P#G]5MV;MTW;LM+M=D-JJE=5-.W*M+VLD]-O3O:QXS_
M ,+4U'YMOPC^*Q/[X;5T/3"=L,BHC9?68\&9&26-5/\ !(KE7C84Z;XG:C&L
M^/A-\4Y1';RR^6FC:4=S*C%;>,MK0#23#Y RDJ@/) !Q[(T4:JY"@$'(.3['
MU]23[Y.>II6BC"L @ 5#@<\<-[]^ASU'%#GAU_S"4]=_WE2^D4^VN^^COK=V
M1#A5>JQ$X7W4(PL]?[R?>]E;YGBS?$S45,?_ !:'XIYE#'C2=*.P*D; /G6F
MP6+L@4$MN4E<\E4/Q-U/!*?![XIRG'"KIFB*R[DW+GS=>3822 W# 8Y(&:]J
M:&,H?D'WB>ISG<!G.<]%'Y5%'$A)!7((W$$G!.$&3SZ$C_\ 4*T52BX\RPM.
M[O\ \O:JV>O??7H+V=;_ *"JO7>G2;Z>G;3R;33W/&1\3]9"AE^#?Q3^:0H%
M;3]"!,2J296_XJ#" D,B*V';@C 895OBEJRM"/\ A3WQ4?SF!VKINA*(4Y.)
M2VOA.&'(0DXR2<@"O:C&G3:,.Q##GG!"C//8 #\*0QH,_*. 2.O!W%<]?3CZ
M4KT&W?"4[NSNJM56>UU=._IHM]V]*C"I':M)ZW]Z,=][Z+UO:WWGBS?$W60>
M?@W\3S@ DI9: 1R!A21KX!QWP?O9 ..:4?$K7%5';X._$T!@P=5MM =H@"2H
M;_B?@'#$X&>">K 9KVM8T5F 7'(/4GDY)/)[DG/KFF"-, ;>"1D9/.20>_HH
M'T ]*2K4+2_V2F^6^OM:J=E;:VE]]=//<3IU6[JO):[<D-VK]5L^M]5K;6S7
MC*_%'6&"E?@W\4P7#@;K'0%(XSAP?$'?) (W'( ')HE^)VL1$*/@[\4)28]X
M"V.A8#*>8V8Z^%#<!@22&!XYR*]B,,>?N]AW;N!GOQ3VBCR/D R2#C(S^\1>
MQ[ D#TZCG%-3H-RC]4IO76]6M=6>EGUVZE3IU6E:O*#NUS0C%\RMK>,DTM[+
ME=K+5'C2_$W7I54#X-_$LEM[8EMM C5=I+'>XUXGS&P-J[2I. &YS4/_  L[
M6=[JOP7^*C!&(#"Q\.!&7!(9=WB-6;<0V<;L' !Y 'M"HIW@C( D8 YP"-N"
M!T'3L*62- 4P,99L@$X(#< C.,<GC&*ISHQMRX2E[ST_>5E9<K;77HNWSZF:
MHUUH\74:2DO@IZ-ZZ64;6^=SQ)_BCKJ$LOP3^*SLID)"VOAD8$<9DC"_\5&0
M?,=1& /F!^]D&G#XH:^F"?@M\4""BG(M_#CDNZ-(4VCQ"N!'M,;-@8=E4*S<
M5[0L2#)"\AG R2>"T8(Y)'(9A]#BI%BC"\*!\D9XSU);)Z]Z7-ATF_JE/F2N
MVJE:^W1WT=[O;KVLANE7E:V*FO6G2OJTUK9[+39[M^1XNGQ/UYC\_P %OB<F
MX(0!;>'6 #C+ X\0C:R\Y![XY%"?$O77R'^#OQ,AR\2I)+;>&]B"=@!+(O\
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0.4Y))N4W>3M'W=7K^5C_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>ex10-3_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex10-3_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" -G KP# 2(  A$! Q$!_\0
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M]4[W=MAKC-;_ %*Z_P >NE_ST_JY]GKJ]D?NZE9%0"<+?6C8 R"<F7.!QUZ
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M!/!8+@ Q0> / F$:+P9X<MGEFD:*+^SX)M\D\TD#@XR1-/;*\TA!4%EW +@
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MFDHV:NKMO16Z]+ZI;'Z;K<?:BLD,9"L?+BM(XXY_,:2/[2ACF9R\T4 W&?:
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M?#'7->^)^F^'O!GAL0V>V\NEG,W??M5?\$_?VPOB1\0_^"@FD?#7X6_!W6/
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MUT:UZ)Z:6M=ZO6RNW330+$JQ6_V>"(2O-#+*MS'$'(,;EE(.)/\ 7*%(()8
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MQ&2J32-,&\D+A6PXPN!FO,Q42SW$[H @952#R)MKJ4"2(6?]TK9*L C.#N4
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MO,2DH54 &.-"23'C.T%CDE6X&?Q'_P"'V/P\T?X1?%?QKXK^ _BJP^)/P?\
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M+^QI^QGHG[*6@?$*)_B1??%3Q9\4O$6DZ[XC\6M\-?AM\+-+L++1+"UT32-
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M1+6[UN^NV<^#ZL(N7]IQ]U-W>%BK-:IKWGKI\_E8_/[P7\6?A9I7@KPM#/\
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M$^X^-6L6'A?]LSX2W/PY^)7PE\/)I-I;>$/$6H>(_#/BZZ^(G@#Q2(+EM/\
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MJ?F_#\9OAP9V'_"1/$\32S",:-XICCAV_+(WFSZ?*A><J7B3C:V5+%0<RO\
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MIOCR26-D4O/\,_$<DD;S2(AAD!CB?S+;(FG,4+!;9"XCD8[7E/Q<\-PS,/\
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MU1+[5]268B!X85^'4_X)-?!QOC-J_P 8[SXD?$F[^U>/?BY\08/#QTOP);7
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M7-#^$_P=\"^!=)_9ND^*W[/W[6OC+X)^!O%OPL\):E?6FB_ 3XC^*OAGX_\
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ML.>$/&_PZN_^$<G^'_Q(\0_M'>#_ (4?%3]H3_A8&D6'AN74-4FL=2^/FH^
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MM1T9_"GBB33[JV&DI4^/>B?MU_ S]BCPC\7]4_:7^/WCWXS?"WX967Q#\?\
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MR2$,5+ !&"D,V=X"1EF5N2HQE?YF? _[9'Q*_;<OO@Y\8=?8Z#\(/!/[:_\
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M+X5?!#]D3X3?%SXK>-/$WAW]JC]JG]GGQY^S+\7]5U34)O$;/%^V78P_'/\
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M4I.-JEW9JTHJ6]FN+$X3ZW&G[\$E";A)\K5.<H*U2/-?WOB2:5W"<HWM=/\
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M,TJ\L+JPOM1URSOX]/NYU@F/]"PAN'CDW^8QE 9P'E4$J%PK9$;;B!L+,-Q
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MM20Q[,;0FZ,E42?;.01S*B9'ED(?H'RE9G!08./FQR>/4D^XZ<>N33A$B_=
M'((&!@8QG''<#\\$8Q0L3B(7]G5<>;63M%M[V6L&ENW>ZZ&BPU%)6I1B[*-X
MREI&.D8[K9::=VM4?/B_ ?2&8./B#\6Y,2L[(_C[40CQO&5^SR*8QF(3JMX
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MP=XLG7QC\3B8M UF\"W'C;5KF-Q;:?<7 MVA.[S8#M"30XW2Q.8R68D5]/\
ME1@A@B@KT(&".O<?4UR/CI0W@OQ@.5+>&?$* J2#M_LBZY!Y(QP3MR21V.,$
M,5BU4IOVS2C.#?+""O:::5G%];7>MEU02PM+E:2=VI)-RD_LM:W;T[]SYZ\
M_!+0]8\"^#-6?QO\4XWU#P[H=Z4M?'>JVUNK7&GVSO%#;L L,"<I' !^[B!
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MI/ #<1M"OCG5]\\TFUXQ,\8(V6TL(>"YW_9H98566X4&1&_*_P <?LS?L_\
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MWV6EMD>,'X&> _,A82>,$,<PG 'CWQ<VZ17W .&U?#)EL8. 02,C)-,;X$^
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M<?$'QF@ 4E@0%UL8(R0<8SG&"<T]?@;X"4!0/& 7"YS\0/&3'Y2I(&=;;)(
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M,9)]^Y)IG[K;E0A *YR!@ MC^A [9&*GZQB;W]K77I6CTV_Y<_U:PWA<._\
MEQ0_\%+_ #_K\O#_ /A0?PSWM)]C\4^8S(^1X^\<':T9!4KG7B!@Y. ,,0!@
M@U./@9\.%.Y;+Q(^!C#>._&>,=3P=<;DX^88!.0.<G'M>(\@83) P,+SD$C'
MX FEQ'W"\9_A'13@]NW ^M'UC%+:M7^==?I2B_Q%]5PW_/BA_P""E_F>'_\
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M))^[&*;T=HKX;;6VLD]%:R[(RSH\;7LMZ(K1;J:".WN+M8%%[/;Q[I(89+@
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M9_$'X>^+O$"?!/6I- _X*+^ ?VMO$%Z[ZO-K5]\.O!G[%NJ? '1M'L9[CX?
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MAMO@XDR2M>_\)W+\/H)_'ODM#';+X>@P"]Q(B#\Z_P!H/]@;]JGXI?M"ZO\
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M?MP_%K6OVHOC;\*-5_;#T;X&)\/_ (S>"OAQX0^'>A_L#_%CX\6>N6>N>"/
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M9R6WP[DO[:&VNYXH(O6?%O[0_P"W!K/P*_:%_;M^&OC[X/Z5\*O@9?\ Q?\
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M I;:UMX%E$5M;P++,UQ+Y421B261<O,^Q5W3-P7E?=(P^\Q-<6OQ \%!M_\
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M/V*?$GASQ[X(OOB)X_E\.>-_AOXY^#&A:#:?M!7HB^$7PO\ B9XLT;QO\3?
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M6GBZ>8JHZD\7#]YAZ/M7#&J,(U8<RFJ:DO=C2;BX-*'.E4]HYSE"$/)OB_\
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MDE^^IZ23]Y?'H[:;:GTWY<9SE$RW+# )SSU]?O'GW]Z0Q)@!51< [<*,#/.
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M(=QR5V*Q+@'GE5 W+GYE^\,'.<9INMB$O]ZQ-M++VLV[]][M7V_$%A<.TO\
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M3!^CO"RHOQ4^+Y1&4R0_#W>X1EWJN@W(27S7F6-XD!*DA0-R.JL\JE*_,?\
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M >"< #!-=<3$ !\X ZY+#&,_[7&.>,C/& 32,\0!^^2"&Z..<A1R,]V7*DC
M*DKA@:+U>M;$?^%%==?.=_+I^0O90U_=Q\_W5+\/<_*_F<@? ?@<<KX+\'@<
M$D^%]&4%0#C)-EG"84>HP!DX:D'@;P0O(\'^#E.>WAG2 /F!#$8L<@G(5LD
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M3O2;][WGOHDE9MW7HBZ;I@50UAII4LK*HLK4H1\O/$0V.#R, ^H+$$!B:;I
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M (@_\%5_B]X;^$OQ<\7Q^ ?A?X+\;?!K]FKXO^*OB-I^J#Q=X_\ #/A+X_\
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M)R^ /@YXS^&/Q!@\6:IJGBCX<Z[^T+XBBL_"_P /OAI\+_ NJ7W[0_@SX7^
MM?@'@+P%X>TK1M)M/#WAWX3^&X_##1RWNHO<3ZNVN:K=0306\7UY^SS\%=%_
M9U^"OPU^"7AC4M7UWP]\,_#=OX7TG5-=6"/5KZTMI[F:.XO4M8X[<3@7#QL(
MHD41JI"#G'BXZ67<LXX2I.+A5C&%67,W5I.,^9RC)<L6I*%DOL.3E9I)>U@W
MF7[N6*A&3J)^T@N2+I3]VT4T_?AI.\FE?W5'=W]TCD,F,CDEE8?W05![=,L
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M/6KV"]\.:*UQ906;$SRW ;XA_P""K'BWX:>)/%'Q.^*/PJ\/^'OV;]%_8O\
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MI<L;J2M:1V]O_P $]M6\3>*M2^)GQN_:$\5?%3XQ:OXX_9KUN7Q=I_P\\,^
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M7PN_:7NM6^,%EX\\'I?3>+;'0M \)V-[K'B:YUVTM]"E\.B)VN?L-Q 7\/\
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M%0A.+Q+5.I/FI+1256?/>TK*::BWR/Z!B_8%U/X9:C)/^R7^T1\1/V9T\0^
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MK::OQ6>",_#IIF<,?B=X<CB*HTN+A_MB(6900@!V[G8@ ':6YP?7+<AL?P@
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M.>@^@QTS33A0>.  ,XR>3@G'?'!/]>E>(K\3_'PZ_ CQZ!@8)U[P">X&-O\
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M? T)R0I'Q%\/.2N["DXLC@')W9W-G(PW&#_A/OC)N(_X4=  ,G?)\1=!4'D
M@!;(D<$D9'4,>O)'0QJ?,JOLY):N&*HTU*^KC+DK0DDT[>Z[.VJEHE+KY?))
M.%.<6_\ EY0G/5)V=ZE"4?=Y=.:Z5ERZ\K/66TB*..XCMX;2U2]:5KF&.VA2
M&YN+A4MY[B[0Q^7>RRP_+.US'*;@+$+E9TAC5,V7P;X=N<&]\/>'+R1XT1I+
MC0M-G\Q8U"(C?:+-T7RT588@56-$0+$D<?EQ+YA_PL#XV;R#\"+=PI)60?$O
M06B)8D$@&P!)PV &7Y=IQTR7S>/_ (UJL97X&0.S AP_Q*T*,*5X4*&T\*^X
M@%<C!.01P )5#&0OR247--2MC^:U[>\N6O?F3O:TDUT>]B5;!3Y'-4JCIR4H
M2>#C[LK622="U[==[+5Z(]1NO"7A^_U/3M;U#P_H5YKNE)-%I>O3Z997.LZ3
M%=(HNH](U:XMVO\ 2UF1522.PEMT:/:J["@9=JWLHXI9YPD(FG8N[1P)$9"N
M(U,DB*))9EAVP-+*\S,D92,B,E3XRGCGXTNC%_@GIT#JH*(WQ'T;,C' D0M'
MI<@&P8W'@8SP,FJ4OCSX]QR@0_ O1IDW'YW^*>EQ\'/S;#HC 9P-H&3\V<\F
MLY4*\DKRG4<4HJ,\9)PY4_LIS:6MWRJT>9N5FWJ+%8.#;@J5*3;;<<-.$W>[
M?,X4E=MK>[YDDKVT7T> , GG./O<GG'&3SU_R*,#G ]L=CCVZ9SQG&>.N*^>
M&^('QYS&$^".C;6R7+_%+2D,;8/R@?V$Q<>ZC'?H0:<WCOX\EGV_!/0"%0D?
M\73T\*SA<A3C0#M+[@-S$ $ C;G+7[&HE9QC>W6I36V^[7]=.AHL=A9*ZJ_?
M3J7W:32<-;V_ST/?WVE@V<'<0W&XD8"D8/. >3MXRO?%>-?'3:?ASK:;_)4:
MIX-W2%6."?&_AIQ@J"6W,=IZA?3 P,:3QQ\<<Q>7\%]#E8Q1R2J/B?IRB.>1
ME66'+:)AA&-TA<'#8Z#=BO._BCXJ^+M[X1U&VU_X4:-I&C/J_A07FIVWQ!M=
M9GAME\8Z!Y-Q!IMKH(EN&+%6:-FB"Q[G,B[5%72P]5XBA)J*2YT[U*>B:C9V
M;OT=O^W;)W5\*^(I3P];V;<](M6A-7O)-;Q277Y/L?8T>/GP,'S'!^NXG]0<
M^V>.*DJ*($*V<_?;'T.#@>H!R/KD<8P):YHZ:=G+JW?WF[IO=6=_*]EL>BG=
M)VM=)V[:+3Y;&>Y;>HP#B1<C;N'6([\9PN,L<\#E@""0U>.?!<(?"%YY0=5/
MCOXE,QD"J"Q\<:ZQ*%<YM\C$>?G()+-D U[#,V7A W?>3.,8W%X6))))/\0/
MOD=3D>3?!<!?!]W^\1@?''Q*52K C:?&FMD@DXY7!0@\[L\';3BDZ$W.4H^\
MU>#<4^632NM8J^FB7?316PG%RK4E'D?*N9\\(RY>SYGJMFW9[V6QZ@T;D D@
M9SU'(W8ZC:3E<LQ8=1T')(E\F<@%AR&ZC@Y.5..!G((7@@=\9&*8+D]%@F95
M.)=H+B-@K%HRV JLFT"42&)49E*EADU9CG,R[C%+&0$')5F(*[\[0VW.2 2"
M0P;*L0!GG]ERMJ]:_=2O[LM4T[+IJUO%K9)V>T6K2Y5%/FEHH16M_-.[36_;
MTTI&.Z4\@>O!(Z8';H!]U3@XQDX/REPBN>#A6ZX.6(R!DD#=U  _#OU(<UQ)
MN&Z)MK2>63M"HP8L69&8Y(+.C*6VL[)(D:%P%:Z"X'S(" HZ* 0!@EAT.<#I
MQR " .:N,$U:]2-K[RAWUU=-ZW6U]=+60.+NW>.JV27:UM)I)ZK:*WVW90VW
M8SM4 D<8R=QZ\YVD\[@5Y&,#J"2;+Q1T+!<8P#A<!@,?='RCY3VXY'3$\\S*
MVWYB3Y9C"@L 6+HIPH+-AH68A1R&&2!NQ:BD!C!))+$?)@  N"=I'_?1/Y$
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M%GXN;RH(TGX8$1*ADD&[3?$J"5IA*2(VW$_91"L=NT,ER+B8W3)#\-_MM_\
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M?G";3Y753E:]G&ES6M>^D5LM4TO)ZAF0CA9>>G"'(Z$D8QC@Y!XR3ECV0%B
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M.1[C79:18O+<2D-(B@C?Y0(0RXQOVY;!7DDAMNX+DB3L<1.#NVER,\@>G.6
M(("N%*E@V ?O')1@])4G!M-WM+9-*Z:DU;56N[W36Z3+LVM)QD[VLXP=G975
MK75]--]5NFAH4DAR65>!AD7)R>1P0,=R<Y![''#D4;N,L=N[:$3<P/)&-QP
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M\D9D_P _Y_*F*N$"]#C]3S[_ (]?:GXYS[ ?EG_&O,3ND]5ZJS^:Z;'KJ_\
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MOV=?A#\6+']C*?XEZ;J?A4?LY6OP/N+N_P#"_P =/'FLZ$/&MMXANO%/A_\
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M/%XBKBKX6G[5N4(QKTU3II*4?90O\,*<8JG2@F^6$(IMJ[EZ&%=+!8>AA/\
M:)RH\ZE*>'J.K6Y[7KR<(M2E4DY5*D[QYISD[7?*O? PR #P,AB>.>O3USU'
M'7V%.!'JH]@1_,''3VKPLZI\>2Z#_A%?AD4+89E\3>(68(%).T?V.N[8=R]<
M?Q*.>)O[0^. 5V7PU\.&)^9%;Q%KVX-P-I(TD#IN.<DG...0<EAIM7]KA][:
MXBDN;SLKJW6^G3T.F6,IQ:]RM+OR4:DFFWM)64NR=DTK>\^K]NW+Q@C&3W'&
M,Y/]/QI&=!C<X )XSW((/7UQV]\]J\-DU'X\;PL?A?X9^4$RS/XC\09#J5Q\
MJZ/C;CL,D<#@@X=+J?QZ3/V?PO\ #/<%7Y7\2^(%RY4\[ET?_5QL2& ^9^2,
M$T/#R_Y^X=^F(IO\;V\B7CZ2WIXK_P ):W_R)[6TV ",.&;:<$@#[H SL(.=
MP.6VCG@^G)^$6+:1=@?+_P 3SQ$<,,G(UV_50IXP68$C )7US\U<&NI_'9B/
M,\,?#=02J[?^$DU]V^Z-WS_V0J@.Y94XPBD9&<@\AX-U/X^-I$YN/#7POC!\
M0^*MZ+XA\0,\< \07Y@VLFDF.1SG<Y!PI(&,Y%3+"RE"7[W#+2SOB*2?7I?7
M6R_"VH?7Z5FU3Q+LG_S"UNS?\O9?IOH=WX<11\4_B@0_S/X=^&C,K8W1QK;^
M*E!4\AHG;S%)QYGF>:,;0I/RU^W%\(-9^(WA7X)7G@7P%;^+_&'A7]J_]F#Q
M->:A9Z=ISZ]H/P_\,_%[0M=\;:K;ZK=RV=S9:)HVCP7.J:K%!?;)+6&=1;W<
MKQV\GI&@ZA\;%^)WQ(:#0/AXUZ=%^'(GMKC7M=CM8[)+/Q=]DN5N!I&^65[M
M9H[B''RV\,<@!+9KN8;_ ./TEO-]J\*_"7SLLL,:>)/$;P21%3Y;2G^R=V),
M,"A5@%VD\@BNI4JV&Q6%K4J^&]I1A0J<JQ,&I1G@JE!Q:C*,KKGNXW<;+5M7
M3XZM;#XS#5*52EB%3JQ<9*6&J*4>6O1J*46Z<N62]D^62MKIHI7C\'>*/@;X
MZ^)WPD_X*B^-?&WPMEO?B9\=+_XS^$O@9X1UG3M/U?6)/ WP=^!6J?!OX$WN
M@Z7JMR^G6NJ^./&%S\0OB)X7E%[IDTEE\3K/[3-IUPUPD?D7[8?ASXR^(?V:
M/A9^S2W[*'QY\:0>,/V;/AK8^'_B/\"O%.BP7?A7]H;P;8:)8:;\)?VB/#5Y
MJ>FC2O@];S3Q^(=5\1:KJOC#P5J8TSQ#HFK:79:E:Z1<:[^J$5]\>AN27PQ\
M)51S"(A_PE/B1O-&YC<*^_2LF..9E5%(*E9=@3866EGN_CJCGRO"GPHEDE3]
MXA\2^((FW* ,L!I/EG: $:0+NV+'&6*HH7;#XK$T*]*JJF$D\-6HUH0^M1:B
MZ.'I4HI6M:-J2C)\J?)S)N[3AGB<-A\3AZ].4,2EB:>(I*7L*D)1C6KSJJ33
M6E6*J7@[N/-9*WO*7XV?$+4_VT?A)\ _$_C/PC^S1\5M<_:7_:D_:?U^/QUX
MT^$O@7PEXZ\6_LN_!CP1X M_A5)\3OA]X6\2^)M%TZ\\=Z]\/O"JZ-\%-"FU
M*ST6;5/'PUSQ5/%HFE:EHFL>6^)_@S\5=!^"_P 2OA!\$?V-OVH8/"'[97['
M_P +_@)\,S\2K3P)=^,O@'XUT'Q5X_T/QSJ'[5NHQ_$?48_#\]R?&M[\<]7\
M5:1J/B>T\5WVHZK;:0S:[=0:2O[R/>_'9(HU3PM\)X9?,A#F3Q3XA>,<X0YC
MTF,M(S,HY8^:DI1]PRM,$_Q\C!(\-?!YANB<L/$/B*$>86R[.XTHMO2,AX)<
MEUQE3G&.R.9XA5ZE>.'RBG&O7G7EAX3:P\?W^'Q%"%.//*2I4I8:%.,?:.,:
M-6NG[25650Y)970='#T'5S:I##THT(U*CG[>3]ABL-4JUY^RO*HX8N4]VIUJ
M6'?-"-&"/ACXX_LK^,_&WQK\2Z?X3\-Z=HNA?$'_ ()O_M ? 37/B[]ETG3_
M  \GQ<\=7GAG0="N/%MY8^?XCO+N[TV*367OI](U80Z5ILA:19T6VE\3_P""
M8?PT^,7@KXB>&%N_@5^T?\"? 7A/]C3X>?#/X]:;^T/XN3Q!I/CK]JSPUJ?A
M73X-5^"T,WC#Q1+>^&] T'1?'D?B/QWHEEX4\&>*;#6_ ,6C>'VFL9ETC]79
M+OXZ!%*^&OA1N#$J7\2^(%54(.]E?^R3M!15R1M)0E23DBH'NOCVI=H/#7PD
M)E#Y_P"*D\1G.V8^8ID&CDB..=L,@X,K[@NXG'//'8N6%G@[X#V<L+'#IPG%
M-NF\3:=7=.4EB924U;DG%.*D[WUCE^%CB\/C.7&JI0Q$\1SRC)*+G"C"4:>J
M?*_J]-SBH^\YS4G&+4I>[6X/"G"X$G+<G!<D?+@ <,"#G[O0 \U-.^<(#@Y1
MA@ _\M0H.=W?L,>N3GBO#A?_ +0&YE7PY\*60.5B \1^)@3$<!2Y_L?E]RE=
MO3Y0.%/"B^_:!*(?[ ^% ;GS ?$'B?8J*[E=N-(Y.1N&[H7P#7ENA)_;HK1-
M_OH[N]ULWHV_16>NMO7^NTXV7L\2[)>\L/4E=='=*S;T5N_8M?%V%YH?  0X
M9/BCX2FP6*'8+B\)R4=20V3A6R,= >,>R1#*DEL;@N3LVY+/\W?@,3@#)(P2
M68\5\A?%+4?C?'9>$#?Z)\.$F/Q \,#37TW5_$%S&=1W71M(M22ZTR-ELYG4
M1R36^^2%B)/+VJQ/I[WGQ^)00Z'\*/*9I=P?7/%#&-?/8% 5TC#,B#:3\HWC
M&!M K66'E'"X!^VPK]W%Z1Q%.]U5I<UTKO\ .W?8Y*6+IK%XZ]/$V4L,O]VK
M+5T6KJ\;6TT:ZWZWM[J-H!/<8;&0 2%&!QG)&T<C/-/^4\9!YSP>X.?YCFO#
M3<_'I@Y.F?"V,AAL/]J^)G&, [7SIJ$'L #]T G.,%?.^/6S*VWPL1\CC[5X
ME*CDDDL+,'!^4DXP-O0]!FJ#O\='_P &+[W[OEIKJOPZ_KE*Z2IXB[=KNC.-
MM/[]K]O=UONCV\#YA\Q^5<8R/FX.2>^1_GK3CM(()&#[UX:DGQ^SS%\+D)0F
M3%YXDSYG&X#%F<JK,>N22V<C&#(\GQ[QE(?A<'&<DW_B;#')PW_'D2@V[C@<
M+R.<XI^P?_/RB_\ N)_]J-XK5_NJMN_(M?\ R='M15,<=1TR<\$!2.>@(QD>
MH)ZYPJA1U.22"3G'(&!G& 0,?R[8KQ(R?'W8PEC^%T;8 1A>^)2 3C+.?L0;
M:F2 H.3O#'@,"WSOV@-N1#\+02.5-]XD.&)''%D<@C/;(],9)7U=R_Y>X=65
M[RJN*WV34&]^CM]X?6=?X-;73X5]UN?\?O/;RZYP& VMR!WS@'H"3USTZD<]
MZ>"I4=,$#C@C#<#IQ@C\*\-,OQZ"C-K\+BY4LZB^\1X9AC;@FQ!^7+98J.>2
M.F(5E_:$623]S\*9(FV^6!=^(T:)%4?ZPFRPWSG)V@8Z+D$D-X9J[]K0;?15
M;]._(E;^KMH%BXW2E2K)O^XFETZ3>W5;]=CW$G!7K]Y QXR>0PST^[D'@D_,
M>".*\Q^#\:P>!=,C# A+_6EW;$CZ:Q?$Y2,;1D=1\I.>3D@5S32?M"%^!\)E
M4L@*?:O$Y;;E%#!OL6T,,9QMY.!P:XCX8S?&J7PA:OIT7P[AL#?ZWY:W<NO1
MW 9=6O%8/&ENP \U7F(+%WCV1D!CFKCA6Z-6]>BFZE*_--V7+=[\B2V;U3W;
M6BL\I8J]:FO956K5'%\L-6]M.=+;M9]-SZK$H/#$+C:>HZ@@GT/)X((&"& W
M#DR"5"<;E]N1SU_PKPE7_:%*DJ_PF)8X51<>)LE02J2;OLN/WJ8D"C++DJ>U
M3AOC_P $R?"L  EL2>)0<\, N;4<$$+NZ G//:/JNZ]OAMDK>U;?X4=KZ/5Z
M:FWUFV]"NO6$5UM_S\/;@Z GYN< 'IU&>3CH3GN!VI,IVD '(&", _,?T##'
M3@>AX\3+_'[?E7^%>P]09O$N[!R/^?;!'RL<DY[@X!RV0_M $JL<OPKB&]=[
M/)XD?*_-N55%L/F'R\Y(P3D<'+6%MO7PZ=^M7?HUI1MT]VUW9+7<7UK_ *<U
MO_ %_P#+/QV/;2Z<%6&X= ",N"1P3P#NX/U/O3PZ# R!QTSP.-V..^.?Z\UX
M?,?CT%@$5Q\+M[3Q^=YA\1%'@4J9(XRENQ#S#,8DP4B9@Q&!S$Y_:""*L5S\
M*S( 4\QSXC"L_F,P=8A;[D4Q!(MA;[QWY"@TGA&_^7^'M>ZO4>Z?=TO^&Z-:
M@\5;>C75K;PCU_[?O_70]S+QEAEEX/0]P0P./J<=0.G%/)S@G&0>03TYZC /
M/Z8R#CFO#@/C[L9Y+CX7"0J  H\1,,EB61MT'/R< D'A<GG-0*O[0(.))_A;
MQ<981Q>(CBT).$R802ZXR2<%F.3D9R_JKT2KX9ZV251NW_E-;>;O:WS7UN*^
M*C73;T7(M7MTF]/6R\SW5V;.U-N,,3DKR#T&".Y.#SR,GJ1B"1F)57*C$B'Y
M><DDA<].H#<C.",=#7BX7X]F61EN/A='#C,:O%XC\UN<+YK>6H!(SD#A0!UR
M!3'@^/YC5%U'X5I(0?,W6OB%T49.[:H"EAN"XR!DXXSTB6'=I1]I1O9IN,V[
M7U=[P2V_0?UQ:-4:S6_P)-KO9S2WLD[>6^IZQJ*DVES@%@+.^7@A>3:SG<,D
MD' PQ9<DG)7)POFWP10'X1_#Y2V]3X<MEW[GD+H\TIRV]8B-N6R-\C!5*[I&
M DK"O(?CWY%QY^H_##RS;SX"67B(L4,$BN24+!750)45D(8XBR"V3POP@M_C
M&GPO\#1:+?\ P_&D+HD"6(U2UUZ345MDO)A''>,FV)[F-/DF9/W1<$Q?*<UN
ML-_L]9\]&7^UTK*-25_]WG9WY%9Z:M/H]'9WPGBE"O!.C4]S#2C*4::DGSU%
M.RBY:QY=VDK2;NFG=?49M3&6 D(4JB.JC*E$8E5&XDB, D*ASAB4QC:6E19-
MH'VJ<L[C+<*Q8D,4"C."41TR =O+C!&\^1/;_'MD)CU;X7K)C&6T_P 0$%@<
MA3^\RN3R,\ DG/3*+9?'S $FM_#%)",MLTKQ X'*]"TP)P.JC/ )]<\SH-M-
MUH2;O=3G-K71V:<6MEK9O2U][ZK%QY5R8>K%:RYJ=."=]U[KNWH[K7EM)W3Z
M>P); CB9L#D[D)9V+L[,R[MK.S,P)*@Y8G:2U->U*H@660NH(#;U\Y 2S#;(
MV%55!C4A0%*Q_,H+.U>0C3/CP6^;Q#\- N!^[71-='((&"QNQD<DXP<X&?0I
M_9WQY+2*_B3X9LA50H71-=#J<\EV-V!@*=ZC<#VQD9H6'5M*T;)6Y>:Z5T_=
MOO:_5OF=]&N@\3*]WAJK;M[W+"[Z+9\M[)NVU]UJT>NK$0W%S,$.[**/W15L
MDA1$VX$CY23QD!EPS?,+"8Q@7<P09 7G80I.Q5&[&!GD*!YH!!W#&/(9-.^/
MC%!;^*/AI"$^:7/A_7)"X8<; MVNT*#RP));Y3@=1=.^/BNH;Q7\-7B);<W_
M  C>MH[83A<?;B-N0YQD@#C(XQ#PKM)JK34V[)RE4Y8IZV7O/IM?73HU=4L3
MK_ KJRM?EIMRU6MDM-K[J*;U/7EA6-6BC>2*(YSM8QM&#WC*%B,D$D,"7+,<
MHH I1$%.\22Y Y9F4.03ABI# ;FX;(P,A<KSAO'ETOX];E8^*_AHL8)#*OAG
M62Y!W  .=00+R6QG:&W=@>96TSXZXE\KQ7\.5=I 8MWAK6RBKMV@2*-0^]N4
M'(( ')Y(I_583MS3HSY=(-SJW7FWS[\UWNTEI>]TDL1*-^2E7@I?%:%)1?=:
MQTM:[:2U=]=&>M&/C)N)W/S%7.?-#;BP567<#'A]H7D#*KDJ7W-\L@D 84E1
M@;?GQG+,O0AL(,,2,#Y3M!+^0OI7Q](('C#X;JRHQ,G_  C6L2;6!!'[LWZA
MAUR0PYY/. 1=(^.N8@/&'PX 5";E3X0U4G.TX,1&ID$,V&.<, 23@X%/ZI2D
M_?>'J6N[RG56[U::DVKNSTTVT5R7B)M.U/%4EWC&C)-[7:<5?O:_;=)6]C95
M>-XVDE PIV<$ ALX*,P &Y2-F3C'/0$H+<LHW7%TR9R(BRLBXW#8=S'S W4%
MB0K!2-O(KQP:7\?MFQO&7PUWD9)/AG60,#N$.H>I7O@#'!X-2'2?CV47_BL_
MAV).2P'A361&<=?^8F",9!)P....M-X6UG&KA[:<K<JS2^>O1*S2;NNE]*^M
M=51K.35FN6EJO/3J[^[:VK:N>N&.4KY8N9\&-$+%V9\)A';+E=XD..=@8,S?
M>5E 8ML%&\NZCDLJ.Q. 0Z9).&*. RJR[!CG@ #QUM&_:"52&\:_#-<$_./"
M6KYVC@_(-2('S;23EL;0.,5*FC_'E'0R>-?AVZ#.Y1X0U9<\$\$ZF<Y;!X!^
MZ >>:EX1MMNMA&G)23;J\T7?:*2MR2LN9WOT:T3*^MR5U&CB/>E!VM2OINEU
M3=D[:?),]D^SN"'623*C<GRH0F 5 4DAPK(Q.U2<%BR$/C:;)E5%^T2C;M#.
M,*S,HVLS("4R2"Y"X1RV5 5,'QW^R/CMDG_A-/AX,DE$3PAJ:@$9W!V;5 5W
M<\@ @GH0PPATGX]@$/XR^'0RC>7M\+:LRCYAC>#J.3QC@!@"&(&0"']46MZ]
M&/?][5DI6NH\T?9JZW<;--623LF+ZS%.\</4;CS6:A"[YKIV]YIO5W71K963
M7KKVA).)I$$8*QL,-A7# A6))7JHROS*OFA?]:YI88&B62);JY*E1@EB60;<
MD[GD^8O(6=OF+*QV%S&H!\;;1OC\L3&/QW\//M P5#>#=32':S98^8-4))*L
M&Z8RQR!C(!HO[0"QJ7\>?#YI2,Y7P=J052!GY3_:18AF(9L^I[9%"PD(M_O<
M'%U(\DVIUKR3C%MK1ZZ)]'T3LM4\3)63I8F2@^>+Y*;LV[)?"W:^B_%;GM$<
M)1$7S6(4.[A0$CD8[LF2(;4<L26(!/S8#90 T1P!)"#)(VXDN9 "P)50!D;0
MN[DJV !C&T8./(8](^.^UA/XX\ [ONH4\(ZIE>!D%#J6"&RK<9P3P3@5'_8W
MQ[WJ1X^\ M$/O"3P=JD3\]P?[5*@\@ $$XZG)-5#"17+)8FE9)I+GJ2BUM>T
MH-+9:\W-IOK8'BI7TH5U)Z-Q]G!ZMMIM)-W;;Y--=$D]3W4NF, @G.!SR<8!
M&<>@P<?EW+E=, [AP#D]L@#)/OQU^M>%?V5\>@6QXZ^'YX^0?\(?JK8YQ\Q7
M4P>01D \9+9QFDBT?X^<"7Q_X")#*[3+X.U$,4)YB6$ZF$V@AE67>7*]5X&:
M]@NM?#KLY2J)7MHM*;U:3[]>A7UEO:A6W5_=CL]/Y[=%Y][['NCL"#@\;&&0
MP .X*0..03T!'3)/:O(/C,B/\-/$:NY6,_V /E=('Q_PD6C-GSF;8N2,X."P
M) 8'.,V32OCQ@!/'O@-?FW/GP?J#*$ /((U(8)P" >,$XXQCSKXH:7\7+/P-
MJESXC\:>%]1T>*?13J=AI'A2XT^]NH'\0Z4B16UW/?S+ XF=79FB8LOF* N0
MRW1PJ>(H/ZSAURR;LI5-=%WI+5[)Z;K5)W65;%-T:J5&JGRK>,%9-M7O[32U
MD[IH^N(P1N]"Q.>?F)/49ZC&.<\]?825! 3M8'DAVY]1P0>3P<<<8!()ZYJ>
MN5*UUJ[-ZOU?X'=&[BF]&TG;>UTC.E8%HE4#*E5<,,$ /$=R_=SV (ZYR PK
MQOX**!X2UM3C>/B5\4V8*I0H3XZUML%&8C< ZDAB<D9'S' ]CE3]XQ))VM%V
M'!+(,G(;@;,@ #DD>F?'?@SM'A3Q 1MQ#\1_BGPJD;MOC?5LG<<;F;@%@J@D
MC:JE>;27L9*5I+F@GS7?-?\ FV3=[6M:SWZ'/)VKTMDW&]_M+X=M;ZJ]VM%H
ME>Y[&L;*$0@.0PR,@9*]=Q) R$(7:1@G)()(-*L98@D#!4\EG4-T'3"\,.V<
M$#H>2.9@\7:%=7WB/3;;6-$N+_P<;,>*+2'5[&:Z\-R7NC1:_9Q^(K=)6DT>
M2[TFX@U6W%^(//TJ>"_B+PR*1>L=8M]5T^SU32+VPU?3]2M(KO2[W39Q=6&H
MP3HDEO/:WL+S0RVL\;AHKB%W1U8,"JG)YW#EVA"SU3]G>WDWS1?3S>FJ.A:N
M6KO=Z\SO=ZNVC[>5KFP(N" H.<$ N_0@$ #)QG<<!L,3GL#A7B<  (C9QD;F
MX P 20<GG)8G )))SBN6\+^-?#7BRSL=4\->(O#_ (AL-1M9[_3KO0M:LM5M
M;W3H]3ETO[?:36DLOGVD=Y!<6,MP/W4.I0W%B6,D!ST\]SY",\FU%578LSA=
MJ(@D=VW]%1=Q?.%&,N53<:'#5?NXMM)V]C%M[WO[U[NR5VTE>S:LB9;.\WH[
M-N?;JW;KI=6\]7NW$FX?(I)'4L^3G'(Y^[P<E?EX/2FDN!G:A&2,J9#EQ\I'
MU')[C"L<X!SQ<WQ'\'VWA>U\=W'BSPM'X,NX;.:/Q>=<T]/#<MM?W5IIEG/#
MK;7+::ZW.HW<%E:[;DI<W-Q;V\;-=2B(4-6^*7@70=<?PSKGCOP7I7B:WBTB
MZG\,:GXDTFPUJ"U\2:O_ &!X>N)K&YO(M0C@US6@=-T65[51J=^'L;,2RKM:
M_8OI0@VTFOW45:S:Y6^;SU5K*RNT1&<&T_;=&W^\=I6ZK2UEO;HFM&E=>BA7
M9\%8Q@9QOD!Z$Y]""<$$'#$9!)ZO$<IP0J?]]2>YP>#W)/KR1G!(-:"5RIWJ
M0K,BJI0QMCYU!;[PRW$NS=N5.75:M[I/FVKAC\HR6SR&3(4@8&\8Y[!FR,X$
MRC%63ITHRUNO9*=VI..DE))WWLOGV*MS:\\FGU56_P M%Y^5][,CVRY_U0^N
M93ZXP1G(^A_B [G $E+8$:K]?.QZXW$*/7UR>, G%8FB:_IGB>P35-!U;2]<
MTN62YMXK[2+R+4+)IK&6:ROXDN[9VA=[+48'@N$#!X9X##+LD&T;_F,3DH02
M2-V206VD  *.I&W P2<D8R#0XQLK4:<GK=\L8VLET<[I]K7MO;J59?SSVO\
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MOJ_BV+6?@I%X@^#7@NS\4+HD+:IXB\,^/_%MGX>U@+::-J6FR?97Q._X)3?
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M<IO[3AS)CALX^4%BJ[2Q&,# !4C:"",Y7@YQ4QC( ;;[$9? Y(SP3D\<CKZ
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M>%6DW93IU%.-T[22E>5W=-:2NVNXT%80=X9LDG(VG&-['D=BH.,@' ]3DO\
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M<HX\M96F9RX96C"&8,I0J6&VK"W]LZ%F0D;1(255,H %8@DJNU "'8X5!C)
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M.C^)M?UK6+^\L='LO^$A\10ZCJ.JS>7%:7>KW,UVZ^?=!HOU3_:R_:9\<?\
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M8_$'[1'_  B&E^!OC_J'C&[UO4-._:2\<0ZO?Z[X^^)&CPV]U\1?!6FF?7O
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M.M7'B2\\*V]RVG^*KF)[2YZKPG^U/:77C3XJ?#/P_P#\%!?B_KO[$NE_M;_
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M< 8YZ\$GN<8'<\\XI9CA,YXWHIX[%]K?H3_2HK>02'<"<LA)&XE 2V2$R &
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MRR7$<\BVTTL61"\L2/+;K(I$JV\N"\ F4NLJHZB4LI?.&+2R6$BE681X/R%
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M48Y$4Q2%^+\6>!O'?C#]H'_@G[\3=$\"^+]/\%?#[P;\89_B#)XYO[2Y\9>
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M/?@98;>1G<0, G:#D\=>WN/6N,\+,/[+E4@D_P#"0>(Q@#)&S6;YNG)SS_+
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M#/R@>Q(]:<K $@D!AC/(QC!Q@]3P!GTSD5\Z7/@;]H"6-U@^/WAZ!V92K/\
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M_P"?-;M\,/\ Y9K_ %W/H@LI(R1WR,CC!4,#ZX/?C!&.M&4Q@,#G_: . /\
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ME+71]&I1MHDT[.ST:3%*O4TMA*DG=77+1>R;:5IIQ>UMG>RTNSW<VL)54*X
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M:;<Z&+66^&LP:A;3Z4;&!3+->OJ*2FP%G'LF+W!G\I$@E=Y%2%V3G/"7Q1\
M?$&QN-5\"^./!/C31[6XBLKG5/"WBWP_XAL+:]G<>39S7>DZA>P6]S,1LAM;
M@Q37!(,:,"%/XG?#[_A =?\ ^" WAZS^(>N?%@?#C6OV6UB\:>/OA)X1NO$/
MQ#TOPWJ7BB:/5/B7%X/GM-+:_P!'\/VA?QS\0O"EQI]M"/ D7B.RN+ Z=Y\8
M_-;Q[X]\,Z[HGQ(\(:7\9?V3=3_X0WQ)^P3XO\:?MO\ _!-G6-.^&_PKU+P.
MO[3^@>&]&^&O[0'AEO$'C[X0^#O'EO%J,WQ$T37O#6J7)AT'3_LFIPZ;X>0:
M3JO-A<C5>IB(0KU.>GC*]"+]G%1:IQB[7LHR;;;4%.%:7-#DIXA-QAU8C.I8
M:G0J3H4I1GA:6(JOGDG%5)32Y>5WMRQ5FX.F^6;E.FTN?^PUKZ$<#8@17=BW
M[M!&L+2.S/($5%5/OM,8PI7:Q4 L'1W7F(CQ(DL4R1R1SV[13021S*#$\4BO
MB1&5AMD#;75]RY4AC_)-XI_;0^+OQ5_:2^,WPI\+?M4_%'7O!_QO^$W_  4\
M\%WWP[O?&_PC?QWX%?X&_#KQ!-\,6\+?L]^ /A_?^//V>==TJ\\.ZL_A3Q%\
M2/&.I^-/C%H$MYK=_P" +)[K3VT[B=$_;8_:'\'ZE^SWX1^'_P"UAX=TWPW\
M/OV<OV ;G]GF#Q]^T-X0TZP_:ATOXF66GV7QAUFZ^$/A_P" GQ&^(G[4=[_P
MET&O_ X6?PTU;POK_P +KWP5#>:G8:3JEWJGB;4.N'"^-E+V3KX2%51C-PJ\
MT;4Y\KCSW@VIN3<91Y5*"C.4DHPE;#_6G ."FJ&)G3E.<(SIQ4N:4&E)QBIZ
MQLTXR6D[KEWBW_8@)_G4>6IR"5.[AD"Y>4 @_*&^4D@NK[00 XRDUT+?:WE!
MHN1M D+'J>$CBE)*1)G#8W$;4)/3^?S_ ()E_M8?$CX@_M9_%7X6_$O]I;7?
MC[J_B?P#\3?&EI8>$_%/A+QA\,?"%W\._C!8^'/,\:?"6X^''P^^/O[$GC.T
MTSQ';^"M$^&/Q/MM4\%?%>'0->\0>'_%%]XI\.W$-[RG[0'[2_QA/[4WQ'\&
M:7^U=\0?!'QOL?VL_ G[//PU_8F\+KX*@3QC^R9X\\"6%UXP^/&E^%-;\*77
MBC6-1TJPU7Q-\4+/XY6M_J'AWP-J7@"'P3>N4U2YTBXXUD6*6+J8&IB,(IPI
MX2LZB:<?98N:I0G3M&3G!2C4=:<HI46KW2:9URSO"_5*6.C2KN%2KB:$:+7+
M+VF$INK.[DT^:44O9P3<I-M).29_0;X<\;>%?%]M=WOA'Q'X=\46.GZC=Z/?
MW/AW6=-URULM7TZ7RK[2KZXTJZO((=0LWQ%<6+2BXM9/EN%B=65>@OD/V6ZX
M"!K2[D(P#M#P.A4<;<@C.%S@=>, _FY_P21\&6'@G_@GU^SO8V7B'7_%9US0
M]=\4W>M^)1H[ZO-?^(/%_B2\OEEDT?1]'A>."Y\PA[ZWN=2!:5+R]N&7C]*;
MT_Z+-C!_T"["E@-I_<')(4@$9SN51]WI[>=B*=.CBJE&G.514,3.E*;ARQDZ
M52*NKJZ;[._NO>]K^EAJDL1A*5>4/9RK47)PO=*\=%?FL])6EMKJKK;Q[]G]
M(S\$?AAM7 'A+3-O(4@J95 !//#*>YSN&<J"1\&Q:K\?[;]OW]I7P+XP_:'6
MS^'^M?L7VWC_ .$.DZ=X8L-(\*? 42?%/QCX2A\7WMKJ6KW*^+_&5M96\.M>
M(/%&K#3].FLK6WTFVMK33;60W/WO\ ,#X*?#+!0;O"NG_<SY1.Z3<8P?F4*[
M#:I/W2R]0!5OQ3\$/A)XUU7Q+K_BKP!X?UO6O&?PTN?@[XKU6\MY&U+7/A?=
MZA>ZK=^!=1NX98Y'\/W&IZC>W,EGNCD>6ZE&_#XK2&)CA\7C(U(\T6Y)2]G&
MJZ=YP?-%27+'^'):/WK\KO&4T85L-*MAJ,*<W#DC\#JRI*I[DU9U(/FWDF^S
M7,O>43\$?"WC'XWCX4?&32/@3^T)\>/'_P +/VBY/@;^R7\ /CS\:/$>H:QX
MG\;?M"?$7Q7?^&?CW^TG\%K76!%KOA/X3>%OAW<:[KOAR>/R-(U#Q7X5FO/!
M-N^BPPZI+X5\4?\ @L-\2+_]I#]H7Q+X#\3^)_!OPS^'_P"R#^UUH'[/_P $
M=<^&?Q#L?%GB'XN_!KQ)\.+:T^//Q%&N>%[72;EO%::AK]Y\.=,CNIM.\.^#
MO#%[>^-KK2-7\90V$O[Z_"C]@+]C3X'ZMHNN?"C]GWP+X+U7PY+:W'AV?2QK
MDPT*ZL]/U'2;*ZT>UO\ 5[VUTRZLM.U74K2TN;*"&YMH[J?R7B.&7W_Q)\)_
MAGXQ\4:9XT\6^"/#GB'Q/H_@KQO\.M-UC6=,CU&ZM_ GQ'F\-W7CSPBT-T);
M:?0?%DOA+PY_;5C=03QW?]CVT;_()%;TZ>:Y5"M*53+\1BH5J?+"4E"C*E44
MZ3C-1HQG3FY4Z?LY.4%I4J.$(MJWD5,MSF6&]C#&X2C4C5YXN,:]1NB^=RIN
M=:2DK2:<7S27-"/.];G\]5EK?[8&B?#?X]?LR^#O'GQ4\,?M.>,O#?[*OBWP
MC'\6_P!L#P?XZTZ/P?\ $?QW<Z/XV^(?@+XY#PY:ZCX$\>>-H-(UW3-9^$NE
M:'J>E6FHK9ZA\);K7-'8,OZ-?LB^)]?\5?L8_%_P#)\1/''PM^+'PF\6?M*?
M!;QM\5/BI\3(OVAK_P"&?Q0\,:AK=_-X]TCXF>(;#PQ#X]\!^#X=>TKQ)X=A
M\1:=HDGAZ"R@\$^(+:RO-"OD3W70_P#@GU^Q=X>\ ^-?AAHO[//@:W\$?$:]
MT+4?&&ER#7;RZU2]\)2B;PI)#X@U#5[GQ%I"^$9"\GA.#0]7TVW\,,9?["CL
M1(^Y;K]AK]F:W\/>$? .D_#;3=)^%'AKX=_''X6W/PKTNXNK7P3XJ\*_M$#P
M_'\2H/&EN;I]2\4ZKXFN]'$TNM:AJ<NM&_UC6=5O-3EO+EW,XC,L#7@Z4:56
MC)8OV_,L/2BXN32E&4N:;<.6/)2HRO3B^:;JM2<%>&R[,*$Y595J%=5,)'#*
M,L1B&K1C+WX6C'EJ.4N9UH)3Y5&*A:*F_P =[/Q!^T%:_![XBZ_\*?BM^UEX
MZ_8Y\0_&+]G#PCI_Q U_Q?JVL?M5_%_P3;1:W8?M%?$G]F;^UKVU\;V?A3XC
M:I)X-LO >AZ6(?%&M)I_C;Q!\/-)%A<:3#J/F^K_ !0_;*^/'@#3-*^%?B7X
MTP?"O]G;QU^W#K?Q#M_&?[3MG^S3^T]XE^''PHE\(:;\+M!\5:YI^B>.O$&N
M7_AT:IXTM[C4[VR&D6>LZ?H.B_$75M UA+A&_;GP[_P3M_8K\,^ O&'PTT#]
MG/P1IW@7Q]'X?7Q1X>AG\2/:WS^$[F2[\*WFG7%QXAN=3\.ZAX>N)&NM U3P
M]=Z1J>G3>7+:74#I&J;'B;]@#]CCQEX3\#>!/$_[//@&]\(_#5-53P9ID4&K
MZ8VG6OB&<W'B;3;S4M(U2PU7Q%I/BR\VWWBW1?$]]K&F>*K[;?>(+34KL"6N
ME9WE,/:1>$K3J-MTZM2A0<:<5&4)5:D(UJ4:E>6M-R;A!1E&=.GS4XI\;R?.
MI2C%XRA3H>TO.-.MB.?DT:IPJ34Y1BG&-KPE-S4VY2C49[/\ /'OA[XK? SX
M*_%3PE)XBF\*?$WX1_#7X@>%[CQ6S/XLE\.^-/!6A^)-%F\4/EB_B.;3M2MF
MUV60EYM3-TQ'3?[*D6XD<#:>O/S8'!)&,C+$]02"0<9JCI6FZ?I.G6&F:18V
M>EZ3IMK;:=8:;86\-I8:=86$,-I96-C:6R);6EA9VL45O;6UO&D,$$<<42)$
M@4:T1!W <8(]QT&<=NF,XR1D%OF.3\T]9RDG#DJ5)SC&RNH/X?LZM)I2>O-9
MMN\FE];%<L::=W)4XPE*[>L$KWULKM-KU2O9$)MB>"5VDGH"&.23R1UQDD#.
M,]\9RHME/S;(\X_N$ ]#T.,X(&,BK=%-I/LMMDE^27]=BK)_T_\ ,JF$K\Q*
M@*.2JX<D9_B)SR<9ZY&0<YKE/"ZG^SYU8AMVN>(<,!\RYUJ_8X(YXP-W/4@8
MXR.S?[C>P)_$<C]0/;UXKC_#!Q83'.,ZSX@P>,?\A>_[GC(.2 <#\B1,W:G-
MQ=_=E*^CU2[V?K9W3M9JSL%E>_7YG#Z*[_\ "XOB2A*L%\!?"LA3A26_M7XB
M<G(' [G[J8^F?R]_X*<M^TCJOBGX?CX.Z[J%G\+OA5\(OB_\;/C?X8\#_M4K
M^S1\2_$VDZ!#I_V'^Q;K2O#OB37]8M-'T^#6IK&XN+/2O"#^(7T^PU[7=/@N
M/,7].]((;XV?$U#\PC^'OPH('<%M8^(Z/D]3E,=1ZE<'<!S'QN_9._9O_:.N
M/#EU\<OA#X2^(]QX3>[30KO7X;U)[>SU!E74M&OIM/O+)]:\,ZI(B2:KX4UI
MM0\,ZH8XVOM+N&B4COPN(I87&4:]:G[2,,'AW)<D9Z3@U)N+E!7<>91;DN23
MC)1ER*_F8W#5L3AIT</-0E.JW)RJ5(? VTXSBIRBW)0NE%IJ+3TDW'\O?$/Q
M9^-7[1'@K]K_ .*W[-_QI\9_"7X=?!?]D?X2^"/!?B#7+.W\6ZU)\2-1^$.J
M?M._&#5ETV_U2QTF/XJV/P[\<? GP7_PF]V;Y/#GB"Z\4S6YGU+3[BUAX_\
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M6="=&G'X9PJ.?-&HG#\J_"OQA^,/B?QYX1_:8?XH_$FP^)OB_P#;_M/V34^
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MM=6MM$N/">K7OVA(+37HM9O;32SI,SI=K?7$4#P[GC#?SYRZC^TM)^T#?_\
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MI/XZLW+EA'2[;5[^5WLG;]AR\8)^<?* [;\!0!R3GG"X.[.2%')(&27K(H+
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M1K6SYH+I?2]K)ZI-VUT;U1V6D*&^-OQ*51EA\.OA8VP',@!UCXB%20<G&Y2
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M /"C/!Y,Q-SXVS-Y08_\)KKW C_YYD7P\O?MS(0-S[L @CD_X45X/PX%SXR
MDW%D'C?Q!L'((5<WF1R. .@&,XP*2A0V=66EM72OWMIS+U^8^?$VNZ4+]E*Z
M^^U_P/9MX)R)&P6(&%SW(P#GMT]!S3BZ@C#,&&W.0#N&3Q^.3MP>O3G.?&/^
M%&^#U#!;OQH/O\CQIXAR-P*L /M>T*PW<@'DE@<G-,_X41X*RFZX\985MV3X
MT\2]C\B8%Z%94R0O<@_,2<$"HX9:JK*^]_9V[_\ 3QK37I\EJ+VF*_Y]1_\
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MT%2K5*#=2FN:-12?2=^76*?+9I:IM+8\?_9^8S?!CX?L"=C^'X%!(B+;DGE
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MJ,8U:D:N(=+EJUYQE&=2;:DY2BJG))-QI+5I<M*RY5*5_P"1GX9^&?V<]?\
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M5RL]W?W%W_9T*Q?J3&N57DM\F/F')S@$[@<G@;<XR."<D8JJHC4#&TINPR@
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M&?PW<:4WF:CJNCVM\+!8YI?[+7E92;?L:EY.*NURJF[2BI*\$W):75W8:S'
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M9XMN_ WB-=8\066I7>J:7X<TSQ1876G7GBB]T:'1K.93]JN(4220?F#\8?\
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MNC1;3CRN4/>YE&S<LJP')3A"E&C[)_NYT[PFMW93@HSC\32]Y\O/.RCS2O\
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M<6>KZ7\M_!C]L_XR_M9?$SP5X@NOVC/VPO@!X/\ BA^RI^P[\:?!WPQ_9?\
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M;LO-4[6^2[&BAB96:="5NJ=5+;SF[OMKUOW.(;XZ_!X$[_B1X2&T*S;M5B4
M,2J[<@;B6& !@G!/:G'XY?"'YPWQ(\)IY;*K!]3A39N7<O#%>",<C"YZG. >
MU;0=$;:#HFDD!@,-I=BP# !E=0;?DKE^.!TQWJ4:1IJ[U&F6&U@ 5^P6H5D(
M&(MHAP%W'>?EP&P#M&:RYL$WK&L[K_IR[[/_ )]^;DKWO:VB0<F*[T5_X-_^
M2^3^3V.$'QR^$#+N3XC>$W!?RQC583ER"=H R2<#L#@]>*J3_&WX22)-L^(?
MA9C)'+&BKJ*,9':(HJ8"D$!F'7;AB-V.,>@_V+HXRPTG2E+*S%O[-L@2SY4N
M#]G)W$80;N3C+#;R(I]#T@VMR5TO303:W))33;($^9#-N^80#)?:N\DD%QU(
MR*TA]3C*+5.O\4;\OLKV4KW;=-)6LUZV=F3.&*M)1=%7A+K4WE[O\W;5>:Z)
MZ?-/P0^,/PNT3X4>"=-U?QUX<TG4;'3!!=6%Y?16\\4J7ETK(R 'Y6/[R.0,
M"48,0-U>:P?"G]@>R^+FJ_M!:;HWPJL?C!K8\4WL_CNTO[V.\LM3\;Z(GA7Q
MGXOTS1'OSX5T7QKXJT"/^Q?$_B_2-$LO%/B+2HUT_6-4O[8M$WT!^SUHFDS?
M!CX?7-WH^C_:)=%&]ETC3D8#[1,A)/V8%W*1@NQ+-(0S.6)4+["=-TI05&DZ
M8(RXB"C3[7:^WYVC;-LJ1X"&.)06+EPP!/RUUU:V&IXG%>Q>,A[2;C-1E37-
M&-GRM1II34G9N,E*+Y=4VFSFAAZTZ-"-5862I1YH\ZF^6>JYT];35W[T7&R=
MU*ZL?GD_[//_  3QNYOA?>>)-)^&GC/Q'\)]%\)Z#X2\3>+M;U#4M9N;/P/J
M9UWP2OBI)+Z'2/'A\)ZXW]M>%(_&=AKEMX9U7RKS1H+*50Z^A>'?AG^PSX<^
M,E]\>O#OAOX0V7QAO]0U_5IO&4-U.MS;>(O$UO;VOB;Q3IFA2S3^&]'\8>+K
M*UALO%WC'2-)T_Q1KUE;Q6VLZGJ<"I /LIM+TV-MTVC:9Y:;&0MI=H75F8+D
M 6Q(\L'S'E!PH^\ %.)#IFFLK22:+8J,+N9],LMXWJQ=9=ULP!15568@*P=<
M%ADC.6)C)2A]8Q;@Z?(X+$QY8P<N:R@Z=EKKRI<BU?)I<4< XSIU51PG-"7,
MI/#RYI26BDVIV<K6M-VERV7,GHOCJ_\ #W[)@^#FD_ [1=<\(>"OAAIFNZ-K
MNA>'O!6NS>'+?3-0TCQO%\0UETB[CD:YMDN?%HN]0OTW[KAKJXC"K'( <SPA
M\-_V'/A_\7-2^-GA31?@[X?^+FLMXHO9/%UOJ%T][IMYXTNK2X\::AX:TJ[N
MY?#_ (4U/QHUE!+XRU;PIIFA:AXFD1VU>;4?-G+_ &FVE:*C11_V'I8._,2'
M2;&/!;(+0JUK\S<@_)SRQ8X4@BV6G0&55TNP@554R_\ $OLD=^%#+*#;(,,'
M"H[%5*%NZG$+%4XJ<56Q$(5':<76IQA5<E&RJ.--2FI-<S4I-.:3=GI+5X2I
MSTJSAAYU*+FZ4G1J3Y>?FYFHSJ\ETI6BXJ$E%)7=['R+XW\,?L9?$?2_B;H7
MCBU^%WB;3?B_J_A[7OB7'=WUPMQXA\0>#;/3++PCXAFU*TOK?5--\0^%+71]
M+7P[X@\.7.EZMI$NGV,MA/;S6T5Q'VGPKUC]ESX(^$]-\"?##6?AUX(\%Z0;
MR:TT31M0$-JUWK-_]OO]3O)9YKF\U36-9U"6>^U36M3N;S5M2NY))M1O9KF5
MG/T4VFZ<R'&C6+/M)2)M-M,E=Q'R@P#*NN0<,><':5*%HGT;2 V)-"THH<+M
MDTW3V8<!H@R_9LML;<?E(923M!(;%3K49TY0G4QLH2Y6Z<L11:<H1C&R7)=K
MW6D^6[245**5DH82<)TIJ.#4Z<:D5-4IQDG5UGO+1MMNU[.4I:.YR@^-WPE$
MAB'Q&\*F11DJ=2BR%VARV,X P0?0*.2>@KP_'GX-S.RP_$KPE*RRB$I'JD;$
M2,-RHR@%@V/<CISD@5W2:-I+.2=(TQI/F5G6PL"2%  3)MU? ^X%()PN<X96
MJPFGV,:[!I]DBE3NV6-L@W$GHOE$ X4@':0>#GO7.ZN%NDOK%WM?V:3[_P#+
MM:VT7GO;1F_+BK;T%Y_OGOY.=W^%NQYX?CY\&F>WA/Q*\*;[M96MU&HKF80D
MB0HP4#Y2-IR1D\*"Q%.?X[_!Z,(C_$?PO&SQ>:BOJ"JYC.X@LK(&4X4G8X#[
M1DKGFNZ_L;2F5%;2=*8*/EC.F614$N'P@:V.T!PKGD9D <-D59&GVJKS96A?
M!+,ME;#<S9R<&(_=Q@<<[L\D52^JM/W:[>J;4Z23[ZND[_+3;71CY<1_-1].
M6KH_5S5SSU_CG\'XR#)\2/"XRJD ZG'RKME&&T9Y.0IXQM.3D9'&^&OCY\%/
M[.NP?BAX.(_MO74!_M1 5DDUB_Q$<@-NXPRX&".>U>[R:7828#V=A(@*Y5[.
MU<9(4  >40&#_-\H&,\G!XY+PMH^E1Z9<B/2=*C!USQ"[&.PLEPPUJ^W2LHM
MP#)T(+ DX7DD9HM@_9S3IXI:-.TJ+5DKMKFIIM[6[--=4R4L4G\=#W?>ORU5
MW:37/M>UVONN>(V?QG^%"?%/Q?JTGC_PR=-N_!G@/2(-1%\DEM+J5MK'B^:X
ML%E5'?SUCN;>780 JR!C@,<:?C7QQ^S5\3/#\GA/Q[XF^'OBOPW+K/AS71HV
MMW(NM,EUOP9XDTWQ9X6U&6 &-'N- \2Z)I&LZ<[/^[U"PM9PK&),]7INDZ</
MC7XWVV\0D;X<_#Z1HUMK<0;WU[QO")5(A8)(5LBDH/S31.%R%A7'J!TVQA7;
M;Z;8;A\L:-96N $B*J=L<&_* 9;'+8&TD$ [U_J?M,+.$<7"I#"86=*4:M*%
MI\E:-U)4^9+EFVDFK-<UU:SQP\<3:JJD\/*#K5)22A4_Y>)>Z^:33BG!6TO9
MRWT9^</B_P#9E_X)H?$'XL:W\<_%WP_^"NM?%WQ-K6A>)_$GQ ;5=?L-<U_Q
M#X8TZST30]5UB72-;L[74;K2-)L;72K5;FVEC6QM[:SQ]F@VB3XG_LW_ /!,
MCXT?\*_D^)WPZ^!/BZ7X8?#YOA7\.A<75_9'PA\-EELW3P7H[:-JFGQQ:#')
M9V0-KND4R6T,@)(R/T9%EITZDR:78AHP "VGV\Z([*),._V>0( 'BD"[E9EF
MX!*N X6ULL:QP:9:KL*E(!90*JP*Y1G58HAM5B&("YQ\@ .5H^LV4.2OCVJ4
M523>.49*GR.G+WN5<O/!.G)1C&*A>"IJ'NNHX=I/FI89RDKR:H.=Y7O[TFUS
M6]V6O.VVI*:=V_S_ +SX,_\ !.]_'VB_%*_\*_!"7X@>'K+1+'3O$4UQ?2M;
M/X=\*3> O#FL/IC:BVE7OBWP_P"#[B7POH/CG4-/N_&FB:!))9:9KL6#&O+_
M !%_9K_X)?\ Q2U/P_J?Q(^'/P#\2ZCX,\!>'/AAX;N[]]2M[CP_\-/#*M'X
M:\%V8L-3LD'AK2HY'2STHDP1EFED2X=\']+&@L&4R?V?9L 5!/V: 94R(FYG
M6,K&%#JXWLF5RVW@X6*VM)-Q?3;8! 2Y:S@P!\^P$^5N9 %R2F0,Y#GG#CB^
M2:<<1CX34)0?)CO9RE!Z2C.48*4HM63@I<C25X-)D+"2]].&$LY<R2I-ZWUM
M%W5VM&WS--NTO=1\.P^"_P!@F/XRZ3^T!;:/\&!\9-(LK72M-^(GFR'6K==.
MT5]!LKH0"9].N=>L] ?_ (1Z'Q1<V4GB.'0FCTR+56LT6W1/B5X6_8+^,NF?
M$GP]\3=)^"/CC2_C3)X0?XJV&OKYJ^/9_AQ;QVO@>?Q$+?RY;J;PA:0JFAOY
MT!M8RHC8/'O/W L%F8R\>GVOE(<9%I; %RVXDY1BA.Y5(DP3GC@YI5M[%6WF
MRLB)#Y:NMK H>52$,2#RRL@,GRC #H5D5@22##Q47*G5=?,.>A!0IR>87<:<
M9PJ*'\-\D5-*2C#V:4DI*TK25?5YJ,X0AAHTZC4I16'G=R2LVDII-N+U<E.Z
M;3<DW%_&_P #-*_8G_9E\/:QX/\ @5)\*OACX:UK59?$^J:/X6U2^6VU#5UL
M8;-M5O#?7M\\EV;"RL[4,+A%$$*Q!2J*:]XD_:"^"H"(?B?X48M$DJ ZB6+Q
MG8R. D1X+$85B0RMW'%>IBRM0C*-/M8L?,$^PVY&/,5S_P L]V70["' /S9*
MAC@/:PLW3+65IL.,'[-"%Q&2V-R(".H3.1N.<8QFIE4HRFYU'BJDI2<G4J5X
M5:CV^*<J3;6B24G9)<J>NFJIUE%1C*C%12C&,:<Z<59WNHQ:2771:VU2W/E7
MXM_&SX3:UH&DV.E>//#FIWMOXW\%Z@T$-X3)#;0:W"T]TXDCB'E01;V.QF+'
MY=N2"?67_:'^!\9=F^)_A)5S$#_Q,"?FF7S(PP6/&YPP) P5)(;#<#'^.UE;
M'PGHC+#: Q_$3P(0_EI&T.-?A+,DL,?G(X)55:,J?O L5+$^V"PM'R%M;4C=
M*Q#P6_(,C*F#Y>05 R.1COD\57^R_4\(U3KI.6,6LZ7+I.GN_9M:Z635DT[;
MZ91C7]M5:J4&Y1I)QY:EXJ$7%?;NT[^]=O6UE>Z/+!^T/\$G *_$SPNP+F,"
M.[EE(<?>7:L);@#N!@<GTIK?M"_!2)XXW^(_AY9')1$::[+/MQDA3:D[E+8)
M/7%>K_V?;]#9VHZ<B*($9).>% )(.">0.M/_ +/MCTAMPP  ;RD)')R09 <G
M !!;.2<\G)K)>P6T:ORG37HG^Z3-;8C9SHJ^VE5^;T=2W7:^OD>2C]H7X)S1
MK.OQ)\/,@$IR)[CY3" 9"5^S;F**/G&,],!LFHU_:$^"+8V_$CP\2P4@^?=
MD-P6#?922"V IQSP#UKUS^SK?G]W!@X/$$*D?>#8*J""P.3C@]<C"BI/L%J$
MXBAWX '[E  1\V,!1P3P2!GD<C@B>:CLJ5=[J_/3T\G>G\KKMOLAKZRO^7U"
MW;DJ/3KK[76[UL].AXT_[1/P/C8K)\3/#XVA"0TMX>'<H.EKR#T [G.=H.:F
M'[0OP4C+*/B1X=!5<N#+=@!21RNVU8,2#TW$@X!'.X>OFQMN,1PGDYW0H<@
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M45X\K\2?$-*$U1C&-2<ZU6C&,)N$_:4ZKISYG4FZ,(<R:C>U[\S2NE+^B/\
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M\'_LS?MN?'SQGIO[.L'A7]H[]H3XP?%3QQ^SUX]^,O[1?@7XQ? G0?AU\/\
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MEA5HRCR*LFX3C>C)R4)J*DI6?*W:2CHTU971Q0_:4^$[!_\ 3/%:A(DN&+^
M?&:$J04; .B_/(#\TH +!"<=0"Z']I/X3R R1W?BM."S*_@#QHC$ELD_/HJD
MMM<'J6,;*P.&Q7O"Q*<'(QC!R>"#N^8AB"!D?+P3VYXIOV=07 D<@ J&+YXP
MN/O$KOYRK_>(0KR!BN)O".Z]C6T23O-)NUDU=QTM;71*VFK.Q?6VOCHM/5>[
M4LT^J2EV?=]UN>&2_M(_"Y8I&:Y\82X:-&\GX?\ C.1AYK! =L>C-N50Q,C$
MD1K\S844Y_VCOA>N4^T^+\JQ5D'@'QH9$7[IGVC1LK;G:'63!7<K,2,Y'NA@
M49)9FQN. 0'P 3_L@J=I/3Y@?08J-HP2VTL#@;0-I&WD$J0P)#'&-S'(*G@9
MHY\%!+FP]=I_95>G#5VNW*5.<?=T;T;V] MC/YJ"6[]VIY:I*6CU^3\FVO"G
M_:/^%H,)^T^+FW-*!(/A[XT9<A"02XT4K&&7+I\I$JH2HP,5P/Q)^/'PYUSX
M=^+]+TVZ\1F^U70-3LK.'4/ WBZTMS-Y>(4N);C1XXK991S')-($FP2&4<'Z
MS"*%/SEBJX*_,N2QQ@D*,X4':1PO; (%>7_&1 GPM\?EBS"/PIJ8VR"27>%A
M(.55FF+D<87<&W9PR]-L//!SQ%*,</7C'VD(W6(IS5Y3:?O1I12NK*SCKRW5
MKI1PQ,<6\/6O*@[PE!V51-0D^65O>6JBURMV7,UIW]2T@DZ=9Y&";2T.,8QF
MUA!'4]""/0# '3 TAT[?ATK,TA=NG6(&<"QL5'&"%6UBPISCIDYXSR>AQ6G]
M:YDTVW:WO2279*<EO\OQ^2[H:1BNT8KUM%+IIT*<Q5#%MXP&P<C*D%5(/!Y(
M<\'^(+@9&&\D^%YM8X?'RVI8JOQ3\;BXX'S3OJ0>8XP>06+C@ $$;=N%/J,O
M##.00[^^"?+( R"-V&QC\<<5Y'\+_,2/XDO(RNH^+7CDQ;8\,D?VZ,;2#G>X
M8,=QQG<,XR"!2Y,)B96:4(T+WT5O;VEIJN7ED^;2R5^JN95/]XPD=??G52M;
M=4)273JTO/72QZ9#K>F76HZCI<&L:9/JFA0V-QK6FP7MI+J.D6VIK=3:;/J]
MC%,+O3X=0AM+J>PFNH[2.ZBMKF2%Y8X)76:RO[+5;*UO-.OK+4;2\BBFM;[3
M;B&[LKBWE/[J>"ZMY)H)HI0I6.6.9HF. OSL-OXI_%+]HGX>_L4_MQ_MM>)_
MC]I?CGP_X4_:7_9\_9OU;X,>)_#7P\\8^/\ 1_B#KOPC\._&/P=XU^'=M+X1
MTC5C8?$&TN_$WA^\T[PU?K;G5-#O3J<%PL<5QL^.?"UK^UEX#^'GB74H_&G[
M1'PYUK]EZ'_@F=HGPY^$_A\&V^'\0^+/B_0;/XXV?B7P_!H%\WCA1X6\0WFE
M>+[.34[JU\*F%KBW.GWUO]NC].CE%2I06(E-4(58T/J[FM*RK1A9T6F^:-.<
MU"HTW&GKS*/PORZV<PHU50A2EB*D*M>&(=)K]RJ$Y)^T23Y74A'GA%KWW:,'
M--,_IKTKQ#HNN0B?1-;TC6()6U 1SZ1J6GZC!+)INHS:/J0CDLI9E8:=J]K=
MZ9>G</LFH6LVGW/EWJ2(NB\C,&.&$B X5BR)N4 C(!RF1M=F8L!_$V 37\@N
MK>./VEO /B?Q_P#%;X::U\4=(^/>I_L;_MNZ!\+?#2^&-570;J+P;_P5-^(D
M/CG5-(\&Z5X?CL[[QYX2^!\S^.]$M+2U&M:W=VD&MZ9#K,EU.D_I7@;]HKXQ
M)HFFI\0OVL/C/JW[$]W\9K;3M>^.7P=\(_&2Y\4>#=6N?@YJ'B72? ME\7_B
M/X5/C_QOX4\1_$XVBZX;'P5':^#?%DX^&LVK7%F7M['T'PM7DN>&-P\8IIRC
M::K5)0@YU(TTG^]DG%0C3A.$J\U4A13<)<OG?ZUX>+E3J8+%J=^6,K6A!2FJ
M<74<H^XFI<]YQ<8QY)2DE.*?]2UKK^C7^D+KMCKFE7VAO:W%]_;-GJ=I<Z,;
M*!K@2W0U6"X:P:WA^SW!NYOM*0PK;3/^Z,<V><\%?%GX7_$;3[_5?AW\3OA_
MX]TK3;F"SU34?!OC;PSXIT[3;NZ++;VNHWFAZC?06%S/(K)#%/)&TS!EBA=B
M /QD^".A#5_^"$EEX7\3_#/XX_$33-9_9J\86WB#X>^%$3P!\??$_A+7_&GB
MYM<FT:PU33E:P\>GPM+>>)SH5UI,IUZ=)-"BTSS+\QS?E]\7+GPSXI^&7QPL
M/AEXVL?B9\-/"'PU_9=\6>+_ -JWX$?LU>)_V3?&/A*P\,_M4?#I&^#7Q+\/
MZ#82^"?B'?Z=X3OM<^(=S?Z'X.T/Q3X!F\-RQ>(+)-.N%LUY<-DZKO&*-:HY
M4L75AS.GRPA#]W&'*W)*\I-J%).,Y2;4/;2YHQ[,1G#P_P!4;I^TCB,-3G[-
M)RJN;G-R7)R.5U!)5)I-*\5-4DU*?]CI.P,VXH5&#)(56- JN'8.RE  "7).
MW*A@-H&%2&ZBNHHKFWN(KFWECCEAN()HIH)(9@TD,J31%XW21&3RW21TD'S*
MVTG/\I-W^T?^T1\5_P!M#Q1\-O#WC_XZ6GP[^+&M_P#!0/X*^,? DVL_$;5_
M%OAKP5X8_9P^)^N_ OQ5%;+\+M#^%/PCE\4:OX-T[Q?\$;C0_$/BKQIXJT76
M(K_Q!K.H7=Y-I$7BGP]_:+_:2\*Z!^R-X*\"?M!^+_ ?@W0_V0OV,6_9YA\0
M^$OCCXUU7XI?$]_$NM>$OVC/".K>$?!7A>#3_'?BCP5XMT:;X>>+/"'CW4O#
MI\'^#(+/6=/,AANM2KJCPSB>?V,L5AW6]BJ[4TXN$9*5Z<[1DU4C**3]V47&
M]1SY(3E'&7$=!+F6%Q$HWG!V35N635XZ)<MK.+33=U%13:1_9')( 2JS 8QP
MVP<# )#,02"2%;:V=P5MP'#)O+(Q5RQ^7+*N0"V<X)WJ 3E>02  < \5_/M^
MP!\?_C+K/[</Q!^&/CGQS\7_ (T6?C'P=\<]8\27GB'2?%OP_MO@)KOP^^)^
M@6N@Z%\7/@UXH\/ZIX5\!ZKK^F:XWAOX0^)OA+\7O$&C?$/PUHVLZCX@\'6U
MQI=MK*9O[0_Q:^.=O^U_\1OAYHOQ,^/6A?'&Z_:)^ O@S]GOX*^$=.U>/X.^
M-/V2?&&@^&Y?C)X]U&XCT.XT"6^T6T_X61K/B/QOJ>L6FK>$/$N@^'M+TN"3
M[3''>\KR'$PS"KA)XBBH0P6$QSJ<LI.$<34Y:LG'E4_84%[]63BZ<(\LTY4Y
M1F]Z>=TY8&GC%1J1<L5B\/[.<6FHX:/-2G*]U^_E:--Z^TE>$;331^^?AKQK
MX0\8QZG-X1\7^%_%::-J]UH&N2^&O$&E:]%I&NV#A;_1=4.EWMY'8:Q:+DW>
MFSBWN[7YA-#&P4CIK@ V<F1UMYSM7H6,4F1Z9W9..QSM&!Q^8O\ P27^%$/P
MB_8=^%.A1P>*H+K5O$7Q6\1ZO%XXM(K7Q2NIZA\7?&L?FWJKI^G7;B_ABBOE
MDU&&>\N/MT]ZUVT=TB)^GLAW6;X7D6\@ZYXVN,9! !. 1V&0".P\G$PA1QE2
MA3E*=.EB8PC6:<8U6G+FY%>2Y-.C=M+GJT:LZV&A7J4_9.=)R<'=M<T6U>]F
M[1>^EV_(\;^ ;LWP<\!,^5(T@C#QJC ?:KA<E58QA=N!DIDAN,.<G\_IKOXM
M^&?^"D'Q1T#Q[^T_XSE^&/C#]ASXD?$7PEX1AT/P7X0\$_L]Z?X9^,'AKP[#
MXG\/VC:7K9\4>,M(LKR_U;6O'_Q#O=>AO95T^VT_PYHV@V\^E#]!?@&CM\'_
M  2H#AQ87!VR??'^G7F 23GM\I)/0?+TQV%SX#\,W'BI_'5QX8T6Y\8?\(M<
M^"O^$DN;.WFU@>#]0U*#6M1\--<R(3)HU_J]K!>7.GMFWDEA61UDQL.[K>QQ
MF,YHWB[J"E%2:DYP3<.9-)Q<;Z:V;3YH.2EC"E.MA<)%.22=YRA-PO%0K63L
MTVG)J*OM)*7NM)K^<76/'WQ,^#'BCXV_LS_"[X[?$_58/VM?A-\ /"/[)'Q&
MU_X[7G[34_Q U_XV>/[CX<?$W]K?_A(M9?3K_P"$7CVW\*:OJ_BNP^%?@J\'
MPJN+7PCIWB;PPFA7/]H:78_65S\"M&O?VY/B?X5^$?[0G[27PF\(?LX? P_$
MWXZ>/M<_:Q^-OQ)\/0_$GX]Z5XXTOX2>&+#X=?&'XA^*OA;X6\,_"'P?X6\2
M_'#Q0K>&X;&_NM3^%.D%8_"^G:U8W?Z1>"/V0/V=/AEJ1UKX?? KX:>$M77Q
M1:^,(=0T/0+6SNK;7K2*_LK;4;">6.9]/DL;+6=6%G:V0@T^W^VW:VMI#)>/
M+7HMY\'/ &I-\19M3\ >$+VZ^,FGZ=I'Q=EET^(K\1-+TG0)/"VF67B8LCRZ
MO96/A^>72;>TO)"L6GO);*6C=J[ZN:X6FHSPM+$*^$]EB92HT)NI652%*5>G
M2=*<4UAXSY(-RO5E[;FLXPAYU++,94YUBY4N6&-E5PJIXG%0FL,Z4OW5:<:D
M):UG"33;M3BHQ5[RG^'/[-VBZ;\0OAY\8M;\,_M4_M)> ?V*O'R?"'X>?!SQ
MY\3/VDK^#XI_M5?%+P]X@OK7QC\7_"GQ&\?0^*/$GP6^&_[3VH6T7@>UB\#/
MX/'BZV74/%_PXT3P3!<:;'-ZU\!/C?\ &SX:_P#!-[]NC5;W4M=UK]H#]D;5
M?VV]"\/^#M=\>:K\8IO!&K> _#E_\4?@Y\-O#7QB\06\WBKXS:#X3\%>*_ U
MO_PF/C"WO?%5I?RWOA+6C#<>&C&OZ"^&OV#_ -D;P5X>\;>%?"'[.GPJT/PU
M\0],TK0?&V@6N@!-(\0:)H,\-YHNG7EFTL\,4>DW<%O=:.]K'#)I<\,3VGE-
M$CCI/#W[)?P2\(R_#@^#OAKX:\)6'PEMOB3;>"?#VA0M;>'8D^+EIIUC\0Y-
M<TDNUOXBO/$<-B8KF\U>2[FVW$UQ*9I6,=%?,\!+GIPI5IQGB<+7@YX3#\T*
M>$BL0X3JPY7S8ES]A6CRM55;FY8TUAI.CE^+A*G5?(N3#XFDXK%8I\\L1[2E
M"3IRGRMT4HU:<FTZ-WR7G+VJ_GSL?$W[0OP_^'WQ!^$NH>,?C?=:[XH\$?L9
M?'WQUX5\ _MJW_QL\3_%OX)^./&NK^$_BE9_![XF>/\ PU\+_&GP>_:B^-.H
MPPIJW@7P;XZ;X<^,/#]G$OP5A\)^)K^[N9/#?VAO^"G7[1/PU_9H^-WP,^%^
MG?M-_!"#P[\2OC<?#?Q_\?>$_BA\=?&OPL^#OP]'A"?0/@C/\5-#O/B/#%\6
M/%GBK5]:\*W'C[XB_$%/^%,> ]-U==6US4O&]AHD:_TTZ-^Q+^R[X>\&^./A
MSHO[/WPML? WQ.:P;Q[X9C\-VSZ5XB72)/,T6*_AG$\RP:%,3=^'X;*:U@T*
M=5DTF*SG)D'HVC_ 7X6:)\+YO@KI?PW\'Z;\(+S2M2T74/AS9Z9 /#%[I^KF
M:34[?4[':(]3_M&::>34IKH2W=_<3&ZN+N61B*]&EG^2T_;NKDLL=5G7P[HS
MJN.$IT(?O)5'["A[:%5+FA2Y*KJ*,80A.;@[0\VGDF>2C2I1S1X.A&AB%5A&
MI5Q52K4T5)QQ-:4:M-WYI\R<9-R<HQNO>W_A1XSTWXC_  W^'?Q&T*35AH/C
M[P)X-\::&/$.B:QX:\0_V/XJ\.:9K^FG7O#FOVUAKWA_5OL>HQ17VAZYIVFZ
MYI=S#)8ZQ -0CF1/2XP'SN<[L!3@X/"AMN".Q)(P,CG/H*MM:M!$J+$B(L<<
M:HF<;43:BDGDH@.U%S\B(BY;[U7XE"@X !)Y/K[?A_\ KKY)WE5E*-U2;<Z:
M:2LI:*#5E)<N^RN]6E=I?7P3C"G&;O44(QE)._-**]Z3MH[[W2W>^FJB( @[
MGX.>O_UJ<0>@)'?@=LC//8G)QS[@'!IU%$X\R=^E[:OHM'I;?MK\]"RHT2*
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ML\065]>Z7XW\ CX ?&G0]$_:4U2^?<--T7XFZ1K'P;T:XU"=KJ$ZW9:[#-<
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MX2L?&]I::S97T4%WIMUINK>*VTG4M)U[0? 4=]:Z[XGL=2&J:;*T#^8?R?\
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M):>9Y!^SJR-\'O [QYV/I]RR[@ V6U*[!'WY.?E8L0Q! &TX)KVLODA@V5/
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MG-NO%\^)DE3JRC%_69^TJ-QO;GDVTYQ49I<O+--<Q_-5X5_X)O\ [6^FZ/\
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M"UGXXQ^'/CU_PFWP=U[X,_#3PS!\/W^'OCVV_9*TVVN?A3<:_P")-1T9]?\
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ML_&_5(OVY+/XKZ?XQ^#'QKTVPU"+P=\&_A!H%Q+H5C^S!IGP\^WPZ?KWP?\
M&GP^OO%.G?%&WUM+K5_$_CCQ;/\ $);R'Q!X;\(7&D_K-:QG8OF@!@J J Q1
MI0F'*&3#E6^41&0NRQ@$L7+$\&8PR^-/"O!QC4<:=-8I34G_ +5&3YIT;/\
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M&I3J3C4DU9J::_>0E9*4)I\W)%M7BK_)_P /?^";?PB_9PUOXV^._P!D4O\
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M&\8#37&JWMAXAMK/QLFG2_VG'>RP 18OB#]C'X1^--+^'OP3O/V=?V/+NT^
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MAZ7+K>C6\VKW @T][C4+"VBNI)IXHCY-\)?VS?V6OCK\3_B/\%OA#\<_ ?Q
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M #+'G'3FO*?A?&@T37U60,!XV\6;MN$Q(^JRY5@&8LX (8D(>2H# G'JD?\
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M9ZEK^F>$[C6#JVI):V[-']&>&_ OQ6_9,^)-O_PC7P _:/U;X!^"OC!^W?\
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MRPLM8O[KPKXXT37KE-.D73+GQ->6SZT+*)KV&)._\,?M9_L5R_&K7/@I\1?
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M!1XQN\"V**YD+1IJ?B)'!.YW58AJK!%&"PC *^9N5/[Q&_9Y^"A^7_A!+!2
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M-T34/CIK/BS2_AE\,OACX+\.>)/A#+>V]YH_PV\7>*/$?BOQ'XOM;G0]-O\
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MP&^-7B'P'H&M:5X \,:A\'?#_P 7?'1N/%]]X=@CU"X\#:_%?2V>G7MN_?\
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MG/V;93B*V PS^L>TGAO]EP_*K8BE!.4)3>K3C&I[6$N:+E&4;N2]Q?%>G?\
M!+CXQZI^UEX9_:6^(/[0>@^)K7PQ\3_VC/'5FAT?QQ/XDO?#_P"T;\$/B3\)
MH_ ,<.I^,;CP)X8\/_"B]\<:1_PB%UX6\(V&H:YHFBQGQ/=7&I2/=2^-P_\
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MKQOI.HZQJMKHE[XCT?2-=^(5RUWJ,8TKPSK6D6]Z#=V-R*Y;X ?\$XK+X!_
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M3:!(B\LOFKXR\1(^,%$;B2,-C:R^8AW!2,^.?M%_LQ:A\=;K2-9\._'WXW?
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M>$_B/X.^'9U]M+^)1\,6-W-JVHVE_J7A_P .>"OA!X/^"G@WP9HMZNEPR?\
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MVA>))+"[MIA8V%W#\+^.?VI?BE^R[^VK^W_X@L?%VMZ_HOQXU2S_ &??V?\
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MNK0^'DCCM;<20RBY8AMRXKPCX>_\$^_@AX+\&^']#\4:'I_Q \<^"?$_Q_\
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MG@FMI-"\--!>AI=7U4W%'XQ_\$H?A/\ &[X2^+?AOXS^(7BVV\5:W^TCXO\
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M_B1XDUO1KW1_%.K:=HMR;+2;W4;RYD'8>"/@?XV^,W[2?QJTB]\%?!S]N9O
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M_2[QS^P_\*_BGI.C:9XA_8UT Z?H6J_%ZYBN?"G[0VK^#[JYB^-_CS5_B/\
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MH8%<;QLSM4<!0OS#C->)_LYY/PJM50$$^-?BLPXEC W?%'Q:2J[U62.-2PC
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M?3W%S-))-(S5WAE2-,R2*A88R[I$6;#?*/,D W!OO%>,#:<$[A)%*LF&@;S
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MHK:=V3C-7OCYJNDP?#JZ\W5=-M1_PD7A"5IGU+3(<I%XKT:255^TW"!_E!W
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M_P#/_@B]E3;NX1OO>RO]]MNZV\CRJ7X(_!HJS-\*?AT6XY_X0SP\IQG[N18
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MW?\ "#^%MQ#D%OF_LG/S')8 A6))8,>:5O@]\*9 1+\-/A[+N #&3P/X68D
MY .=*P0.P(XS]*](HHYI=W]X<D7]E'F__"G_ (5 %4^&OP^C4YW*O@CPOALH
M4;(.E$'<A*GCE?EZ9!9_PIOX499A\,_AX&; =AX&\*[F 7:%8_V3DC'KG X&
M!Q7I=%*[[O[W_F')'M^+_P SS/\ X4S\),AC\,/AV64DHQ\"^%"R$IY;E2-(
M!!>/Y&(QE"5^[@":'X1?"ZW9&M_AOX!MVB55C>'P5X8B954,%6,II0*(N^3
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M62]K5M'5)5:J2?=)5$K^>K=[MMZC<(-MN$6W'E;<8MN.]FW%NRZ+9=$CE)/
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44 %%%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>ex10-5_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex10-5_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" (R D@# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HJ
M.>>&VA::XECBB7[SR,%4=N2:CDO[.%RDMW CC=E6D /RJ&/Y*03['- %BBL6
MZ\8>&+&X-O=^(](MY@%8QRWT:, P# X+9Y!!'L14/_"=^#_^AKT/_P &,/\
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M<6C1W*R1QK:W#QK%\P:/)RV=S%L_,2&.6!4*9H-+N;AY)#HEU+,T[+'&FD.
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M87^T R.K-(7DVC #8PNTY#$X*DC> /%\,*>3X6U#[0NUF9?LZ+()&41*5!*
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M00,#O4L7P\\<0?O+7PW)"'\G[7;/<P21WA_Y:M+F?YC][  3B1\,G"GZ0HH
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M\LG9A2&(:/)QD!OM.OCC1K&^U/Q%#I5A/_IL]Q+&)/.EA@+B7[S?\M3PS#+
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M1]:]OKP[X4L[76B%(8\_9;(3<#<H\O4<,?FZD;.F>".!SCW&@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH Y/XFF%?AOKC7$<DD
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MA/.3&3DDDUZQ7DWP*MY+?PZ^Z,(KVL+9"!=[>9."2!D9& I.<_+RJG);UF@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ KY.\!02-\38+RUDA-C_;*J9(1L1F+OL"Q(2JAEWD#)VA"0<#!^L:^5_
M=S;P_%-X%CD6ZEU@_NWN8V\N/S3E1A"'8$ DHX! ! ;' !]44444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'B7PC\IET14:0R
M16L"R120C]WE;UT82;SG=YLO&T8"@''?VVO#OA?;K]H\-S)A6:ULY),OG<1'
MJB#H<= O'MSSDU[C0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 <G\369?AOKC+-Y+"WR)<D;#N'S<<\=>.:ZRN/^*G_ "2[Q#_U
MZ'^8KL* /+?@F-WA\NJ+Y0M(1'*$5?,#2SRM]W@!7E>/ X_=DX7<5'J5>6?!
M5I9-#2618UWZ9: [8C&25DN$!P0,C8L?(R"VX@GFO4Z "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OD_P0N_XLPP
M^9=R6D.IXCDDNF4C9-A01DY!\P?*3U/4C<&^L*^5?!\:'XU,TT*O.^J/)%,U
MQYC*!.P9MP.')^[]WD$L,8Y /JJBBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH \0^$A1+O3R,GSK2PP5RPR(KX'.!\OW2.>_N
M<5[?7B/PCC>*\L69<K+9Z>RD,#@>3?#)YXY4CU_"O;J "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#D?B@H?X9Z^K.J VQ!=LX7D
M<G )_(5UU<?\5/\ DEWB'_KT/\Q784 >4? ^+R]$=BX9FL;3@1K'M7,Q VJQ
M'<G=@%L[F^8D#U>O*?@@T+Z$[16OV<?8[< -"L;,/,N,$D<OUSO.,Y. *]6H
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH *^5/"L44OQ7M9(;2ZBFM];D\Y)(BH@5IL!';+;,=AEMS%E) ^8_4\\C
M0V\LJ1M*R(6$:]6('0?6OE'P]8ZLGBVTUV/P]JT>GSW<%S9I):F& %IU>.)9
M FS8Q8JN/+3>8V. ,4 ?65%,A9WAC>2,QNR@LA()4XY&1P<4^@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \.^$4P6]LHWD 'V6
MP2)2W<PWS$*/^^FX]S7N->(?"(J][9_(%*6FGY*D_,?)O>3S[X].!WYKV^@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH X_XJ?\
M)+O$/_7H?YBNPKC_ (J?\DN\0_\ 7H?YBNPH \L^"\*6^DK$ET+C_B56<C$E
MBR-)+<R,IRH'!<^IY.21MKU.O*?@G?R7VCQEWN2$TBT11/-YF L]W'\N  !^
M[P!C(  );K7JU !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 445@-/?7GC"^TY+^2VM;:PMIU6)$+,\DDZDDLIXQ$O'N: -^L/PS
MK_\ ;MM>),L<=]87<MI<QH<KN1B R]]K 9&?<=JN?V==?]!F^_[X@_\ C=<K
M<Z'9^!#8:WIT,C6=G%);ZCM1-YM22ZN<;0?*8#ISL+=2!0!W5<\? GA)KQ[M
MO#>EM,X;=NM4*G/4[2,9/<XR:Z&B@#"3P=H<.S[):26(0$!;&YEMEP23@B-E
M!&2< ].,=!44.E^(-(W?8=675(,LPMM5^5QGH%GC7( /]Y'/;(KHJ* ,G2M?
MM]1<6LT<EEJ2INEL;CAT/?:>C@?WE)'(K6K/U71K36(HUN!(DT)+6]S"Y26!
MB,;D8<CC@CH1D$$$BJ6A:I<FYFT35Y(_[6M5WAU&T7<' $ZC''/#*/NM[,I(
M!NT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!XIX1\.7WA+
MQ>NG6]P+_4+6&WBE$]_Y=O)NAN3& @M]RE0C<[FX<]3T]3FU74[,P_:M#EF2
M0@/)I\RS"$9&2X?8Q'.?D5CP>!QGF3#*OQ<%P5989/W8(4 .4@)Y(;+$>9QE
M1C<<$[B%[Z@#.AUW39K@6YN##.2 L5S&T#/DD#:' +<@],UHU5U'3;+5]/FL
M-1M8KJTF&)(95#*W.1Q[$ @]B :RWLM6T=))=/NY]3@!!%C=,K2!=PW".4D'
M."Q D+9( W*.: -ZBJ&D:Q::U:/<6I<&.5H9HI%VR0R*>5=>H/0^X((X(-7Z
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH X_XJ?\DN\0_]>A_F
M*["N/^*G_)+O$/\ UZ'^8KL* /)/@7%<1:(_G.-IL+7RX]@4JIDN&SPQ'.[M
MC.,D9))];KR/X#S6\_AZ0V]PSK#:00O""Q2)Q).[8)[DOD\#'&,C!/KE !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5S]G_ ,E#
MUG_L%6'_ *-NZZ"JMSIEA>2"2ZLK:=P-H:6)6('IDCWH M5A>*M1FM--6QL8
M4GU/4BUM:1/M*[BC$NX;@HJ@D^O ZL*N_P!@Z/\ ] FQ_P# =/\ "N3^'_AZ
M6UEN=3O(9(3"\UA9023-*8X4GD)<EBQ#,Q/&YOE5?F- '9Z=9IIVF6EC&[NE
MM"D*LY)8A0 "2>2>*LT44 %%%% !6!XHL':VBUBS@1]1TQO/CPHWRQC_ %D(
M;MO7(';=M)Z5OT4 5M/O[75=-MM0LI1-:W,2RPR $;E89!P>1QV/-6:P_#-L
MFG0:AI4,7EVUE>ND ";5".%F"J,GY5\TH.F N,<5N4 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110!YUY<P^-(E+2>24VA=T>S<(.3C[X.".ORGM
MD@X]%KSL),/C.[_9_P!PR*/.9WY80'Y57&T\')(.1\N1@C/HE !1110!SNM:
M/=QZG%X@T9Y?MT"%9[$2A8M0CQPK9X$@_@?CT)VGC5TC5+?6M*M]1M1(L4RY
M"2H4="#AE93T8$$$>H-7:Y>*%= \<.$#+9Z_E\ ?*MW&G/TWQ+GH<F(G([@'
M44444 %%%% !1110 4444 %%%% !1110 4444 %%%>4?M 2SQ^!=.%M-<1RO
MJL:K]GSN9O*E*KP1U8+_ #P<4 =/\5/^27>(?^O0_P Q785\;++/=1P6VH/.
M?M,<>^WGNS;Q2(VU\^;.Q"O@QE2!@[]Q^0?O'74RSV]E]K%S&C68E5)C%&_E
M^>Y!$LA#3,<[BR;>5V8 &5 /<O@@6_X1Z+S%D\QM-MFW2(5)7SKI5P,D8 48
M(QD<D<YKU6OFKX26-];>/M'NK2RO+*R+7-G>+]G;R694E91YH+!V! RQV>B@
M@&OI6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M$'H0:=6-X1P/!NBKYQF*6,*-(6R694 .2><Y!SGG-;- !1110 4444 %%%%
M!1110 4444 %%%% !7D_[0$PM_!FD2L\B*FLPEFC8JP'E2YP1R.*]8KR7]H,
M;O!.DJ6V9UF$;L$X_=R\X7G\N: / )X6M9Q9HLDTUT8[BUFEM51BI)#"2+8[
M-SR &Q\N0&R*M1K;:6EO<>0H%W'((6>XW.67"!050EHRR8+*%#99%<;7JO(D
MUI:*\%K+%)/ TT5S S.7522S;]VU6RB[MN?3Y3D5)I]\(/$C74+6BRB.Z1SY
M;D3[U81[(TVXSO14"8VD!B HX .W^%GVJV^+>CV)DC'E6SF:([3M7R"4PP=]
MWWN.<J"PP!P/IROF#X0RF/XJ:5;+.%C6"YPDBH&)92Q4,&8N0>YQ]T^AKZ?H
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M[_P+G_\ DZO4** /.;+P5'8,YAT65BXP?/9INQ'&^\..O4>Q["M"'0YH3E-
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MC!?'5P+8@$,+&VW _-D;?*Z#"8.[G<W3:-S!X;\<;DSXZGVE%+G[';9#9&X
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M#SW#^%[O[3,96\^!E;<[#:UE;.,;^?XL_4FNM7P[8VX4:>T^G!=NU+24I$H
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M,"S C"AI&+ DL2&-?7E?(G@RTCB\;6-S!;Z:+?\ MFR>!9MRSQQR3*5\M-[
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M+([%F8X ')/3H!@#@5?HHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH XWXIK$WP^O%N)E@A-S9B25G*B-?M466)'
M(P.<CFNBU[_D7M3_ .O27_T UB?$?)\%S ,Z[KVR7<DOE,,W40R'_@/HW8\]
MJV]>_P"1>U/_ *])?_0#0!R'PY)_M;Q&C,6938X8A1P;2,@< 9QDC)R<8]*[
M^O//AG.+C4_$D@ADCR]FO[V-D8[;6-,X/525)!'4$&O0Z "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OD'PI%!9>
M+M/M+6"_61==MHXKN9#@(+C BD"R;"-P1SC.64@$?>/U]7QYX*BE_P"$TT6V
MOO,CN;+4+7$,@;?&XNHHV5P5^5N !DC 3;W% 'V'1110 4444 %%%% !1110
M 4444 %%%% !65XBT"V\2Z0VG74LT*&6.59(=N]&1PZD;@RGE>A!&*U:* ,>
M'P^HAVWFJ:K>REPQF>[:%N,8&V'8N./[O/.<YJW#I&GV]PEREI&UR@(%Q(-\
MN#U^=LMTXZ].*NT4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M*X"X(5,D<''V17QIX!5)/$_AU1$KM'JMI()3D>6QG4$9&0=R@8W$?<.!DY8
M^RZ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .
M;\<^=_PC<?V?R_/_ +3T_P OS,[=WVR'&<<XS6KK@!T#4@6"@VLO)Z#Y36=X
MR_Y =M_V%=-_]+8:TM:)&A:@0^PBVDPW/R_*>>* //\ X0-/(WB&:XA\IY+E
M N6=BR(&C5CO9CR$' PH&, #%>G5YC\'X5MEU^UB;]Q!<1K"GE[ BLAD(49/
M&YW[\D$X484>G4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %?'/@22/_ (2?P[&I<RQW]HN5#D,C7,;$Y(P%5@%V
MX W,2&/2OL:OCOP3:7">(_#5PS2?9SJMF#B0JK.9H]N0V-V%W#"C(VY^Z1D
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MV_8@*8+-L^; &2<>G?I0!R&L_%SQ;<L+#4+?0HQ!/;7+I]EN(Y$V2QR(2'<
M GR^20"&X;'(FF^-'BR_$VF26>DB:Z8P0VK64PGE5OE&4$Q*LV<!>>2/X<L.
M! NX+VRL<1V&#)+$98GBD!9\Q2SQ;'!X8;5C7N,<\F;1M0>*_BD6SL8H#/L8
MQM*!=EQEM^XNWE890RHH9U(0 %S0!ZM\)?%L\FNV>C%M)>TN-.41)IUM)%M:
M,N2^&(&W.\,=H)D?Y5*AFKVVOF/X.RHWQ2TW+RB4V$RR),54I(!AE" G:!C@
M87@ ;>,GZ<H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MB">5#.H)07,.%4Y ,@ #$$X"#) VYH ^Q:*\YA^-GA&>2-5.H*)-I$DMMY:
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MZ/?&B@_NB=X(!"A<$*6_A# KN /3?A)O/Q%TY3<1.GERR1+;I$N8_*P/.DB
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M?_@NA_\ B:Z"B@#G_P#A!/!__0J:'_X+H?\ XFC_ (03P?\ ]"IH?_@NA_\
MB:Z"B@#G4\ ^#HU('A71""2?FL(CU.>Z^_3MTH?P#X.D4 ^%=$ !!^6PB'0Y
M[+[=._2NBHH YT> ?!PD:3_A%=$R0 1]@BQQGMMP.O7OQZ"G?\()X/\ ^A4T
M/_P70_\ Q-=!10!@+X&\(HP9?"NB!@<@C3XL@_\ ?--3P'X0CA2$>%M%*(,*
M&L8F/IG)7)/ YKH:* , >!O"(! \*Z( PP<:?%R/^^:BC^'W@V)YG7PKHQ,K
M[VW64; ':%^4$8484<# SD]22>DHH P3X(\)&-8SX7T0HI+!?[/BP"<9.-O?
M _(4-X(\).J*WA?1&"#:H.GQ':,DX'R\<DG\:WJ* .?_ .$$\'_]"IH?_@NA
M_P#B:/\ A!/!_P#T*FA_^"Z'_P")KH** .?_ .$$\'_]"IH?_@NA_P#B:/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%><_&34;O2_#NB
MW5M/)#$NMVXNB&(1H</E9.Q0G;D'@\4 >C45BZ,UMI=P_AX7L<DL$8FMH&=G
ME6V)VKN+$EL,&4'/0+GFMJ@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M%% !1110 4444 %%%% !1110!'/!'<V\MO,NZ*5"CKG&01@CBOFFZU6_\*>
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>/:AI_
M]O\ [3-F+JV>.'2-*6>,NIQ/@G:RD=@\O7CF,CZ^PUYUHK#7?C?K^JPF-K;1
MM-BTK>IW!Y7<RM@C@%"&1AU!H Z/QAX)T;QQI:6.L12$1.7BFA8+)&Q&#@X/
MY$$' XX%>.V/P<D\/:K!;:GX;@UZUGDGCAO;6ZD4Q@KB,W$1P.I',;#;\Q)8
MA:^A** /F+PHEAXH^('@.PT9[8PZ3IT$]\RVZV[&=&,CJ2%!DPPC]03D]V)^
MG:X_Q-96V@RZ)K5I#;6EGI]_F[1(U1!'./*:0G@#:65BW]T-FNO5E=0RD%2,
M@@\$4 ))&DL;1R(KHX*LK#((/4$5Y7>^$M:^'>K+K'@B*6\TB5]VHZ1(Y?8F
MX'_1U'.<,YQR<^N<5ZM10!C^'/%&C>+-.^W:->QW,0.V11PT;>C#M_(]1D<U
ML5X_X\T'4_ FNM\0/"NX6@=&UC2H?W<<Z#(,A X/WCDD$J26]:]*\,^(;/Q5
MX>L]9L!((+E-P2089"#@J1[$?0]1P: -:BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH YWQNWB9?#$X\(I$VKLZJADV_*I/S,-YVY YYS
M]#4/@/P9!X(\/&P2XDN;F>4W%U<2')DE8 '\.!^I[UU%% !1110!%<VT%Y;2
M6UU!'/;RJ4DBE0,KJ>H(/!%<=X9U67P[=1^$=>=83"!%I%Y,P47T*X55ST\U
M<@%>K?>QBNVK,U[0--\2Z8VGZI;B6'<'1@=KQ..CHPY5AD\CU(Z$T :=%><_
MVIXK\ R"UU*SOO%.BM(([2[LT,E_&-KG;*G23&T#?E?4Y)P-G0/B7X3\0IBW
MU>&VN@=KV=ZP@F1L9*[6ZD8.=I(XZT =7)&DL;1R(KHX*LK#((/4$5XYX4MI
M_A_\:KWPK#O70=<B:\L8B25CD +$+Q@8"NN.I 3)X&?2M2\8>'-(L);V^UJR
MC@C&6(E#GZ!5R2?8 UYK93'XO?$72]=M8I(O#/AR5FBDE1D>XN,A@RG&-N50
MXSD!>0-X% 'LM%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 5AZSX-\-^($D&JZ'8W+2##2M"!+^#C##Z@BMRB@#C
M=*^%'@;1;S[79^';;S@, W#O.%Y!R!(S '('(&??FNQ5510J@!0,  < 4M%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445@>*]0O-.L(Y
M88G-F6VW<\4H22!#@%QN&T* 6)<LNW:#T)( -R.:.7=Y<B/M(!VL#@D _P B
M#^(I]5-.@CALK<J)"YA12\^XRL ,C<6);/)X)XR:MT %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 -6-$)
J*HJD]2!C/)/\R?SIU%% !1110 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>ex10-6_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex10-6_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" /A S0# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OSU_;>_P""J?[!W_!.
M35_AOH7[9/QQG^$.K?%RP\3ZG\/;2#X4_&GXDMX@L?!L^BVWB282?";X=>.H
M=,_LV;Q%HZ-%K,FGS7(O ]G'<1P7+0_H57\VO_!2[1]'U_\ X+L_\$.M'U_2
M-*UW2;[P7^V_%>:7K>FV6K:;<H/#/PV=1/8ZA!<VLI1U5XV>(M%(JR1LKJ&
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M\_4__$6?VRO_ *'NOV5_X4%\"?\ HBOPE_\ #<>#O_E-1_PH+X$_]$5^$O\
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M%\"?^B*_"7_PW'@[_P"4U'_"@O@3_P!$5^$O_AN/!W_RFH _&K_B)X_X(?\
M_1Y^I_\ B+/[97_T/='_ !$\?\$/_P#H\_4__$6?VRO_ *'NOV5_X4%\"?\
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M5_\ 0]T?\1/'_!#_ /Z//U/_ ,19_;*_^A[K]E?^%!? G_HBOPE_\-QX._\
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M_;*_^A[K]E?^%!? G_HBOPE_\-QX._\ E-1_PH+X$_\ 1%?A+_X;CP=_\IJ
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M]_\ !T#_ ,H7/VJ_^NWPR_\ 5C>'*_<[X:?\DX^'_P#V)/A3_P!,5A7X8_\
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M62U2=0BL\EO$!*)4 >>XBMP '2.1B7D_=!DC\UM@^4/O'X8_&[_@XW_X)9?
M#XTZO\!/'WQONCXZ\+?&ZQ^ OCJ]\.Z/9^(/"GP_\6O;6O\ PDFN^+-6M];M
M[ZW\!> -:N)_"WCCQ1I^DWYT7Q)I6L:6FG7<FFW3H ?NSGG'?_/Y^G&>:6JE
MO+*[R),L8EC:0$PEF54\UC"KLW\;VYA8X'+>8<1\(+= !1110 4444 %%%%
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MHGBBQO\ 3;K3KN\LI46"9@/P,^(?_!1W]H;X2?\ !-?_ ()C_%Z+]J[]M/\
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M1:V%W;P:[:_#2_U6;4KB35;O5'>V\^R /U)\!_M>_%C]M[_@UL_;L^._QO\
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M[_X.@?\ E"Y^U7_UV^&7_JQO#E?N=\-/^2<?#_\ [$GPI_Z8K"OPQ_X.@?\
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MI\.A_#'P=X'\/M%;RZEJ-S]NNM%?5YY;Z6.ZO)+:&SM[;\A/^"3^#_P<=?\
M!,8$GG_@G'^S)R"5(_XTLZ1D[@P8$<X(.03D$'FOTT_8Y\.? GPM_P &H/\
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MN\<NS1NP2)"@14$+RK)A<;BS3-*S.Q59(_)DB5M\DCZ-)QGI@GGL.G Z<_\
MUN#Z4M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110!_/W_P '0/\ RA<_:K_Z
M[?#+_P!6-X<K]SOAI_R3CX?_ /8D^%/_ $Q6%?AC_P '0/\ RA<_:K_Z[?#+
M_P!6-X<K]SOAI_R3CX?_ /8D^%/_ $Q6% ';4444 %%%% !1110 4444 %%%
M% !7\XO_  49_P"4]7_!##_L3_VX/_46^&]?T=5_.+_P49_Y3U?\$,/^Q/\
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M/XS'AWQ]X:O[26#Q%X7TL7%E)>?DK_P1$_9M@_:1_93\(?"_PCH?P_L?B_\
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MPY/4T +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_/W_ ,'0/_*%
MS]JO_KM\,O\ U8WAROW.^&G_ "3CX?\ _8D^%/\ TQ6%?AC_ ,'0/_*%S]JO
M_KM\,O\ U8WAROW.^&G_ "3CX?\ _8D^%/\ TQ6% ';4444 %%%% !1110 4
M444 %%%% !7\XO\ P49_Y3U?\$,/^Q/_ &X/_46^&]?T=5_.+_P49_Y3U?\
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M =M9WFN6NCWGB?3M+@\0>*IK:\630_!VBO>^)O$7V>\31M,O)+2=$_EPT?\
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MFU:+1Q:6]KM-T+?S+HW4L-G9VSPVD/T10 4444 %%%% !1110 4444 %%%%
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M-7MX/!OBGQ=I(T::^\0M8Z?))JD=]<OIUS=W%E;)<0*?Y?/^";'@OPE\3_\
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M76D:#XK\2:)??#W7?&'@7Q)X[M]6TKP]97L4E^?$7A/PG/9W>HLJ6T4+1V*
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110!_/W_ ,'0/_*%S]JO_KM\,O\ U8WA
MROW.^&G_ "3CX?\ _8D^%/\ TQ6%?AC_ ,'0/_*%S]JO_KM\,O\ U8WAROW.
M^&G_ "3CX?\ _8D^%/\ TQ6% ';4444 %%%% !1110 4444 %%%% !7\XO\
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M6#S7MY%\NX6-LA;] !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?S]_
M\'0/_*%S]JO_ *[?#+_U8WAROW.^&G_)./A__P!B3X4_],5A7X8_\'0/_*%S
M]JO_ *[?#+_U8WAROW.^&G_)./A__P!B3X4_],5A0!VU%%% !1110 4444 %
M%%% !1110 5_.+_P49_Y3U?\$,/^Q/\ VX/_ %%OAO7]'5?SB_\ !1G_ )3U
M?\$,/^Q/_;@_]1;X;T ?T;1?ZI/]T5)Z?YQP:CB_U2?[HIY/!QUY _SZC^E
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110!_/W_ ,'0/_*%S]JO_KM\,O\ U8WAROW.^&G_ "3CX?\ _8D^%/\ TQ6%
M?AC_ ,'0/_*%S]JO_KM\,O\ U8WAROW.^&G_ "3CX?\ _8D^%/\ TQ6% ';4
M444 %%%% !1110 4444 %%%% !7\XO\ P49_Y3U?\$,/^Q/_ &X/_46^&]?T
M=5_.+_P49_Y3U?\ !##_ +$_]N#_ -1;X;T ?T;1?ZI/]T4\CD'N,C\^Q_$
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** /Y^_P#@Z!_Y0N?M5_\ 7;X9?^K&\.5^YWPT_P"2<?#_ /[$
MGPI_Z8K"OPQ_X.@?^4+G[5?_ %V^&7_JQO#E?N=\-/\ DG'P_P#^Q)\*?^F*
MPH [:BBB@ HHHH **** "BBB@ HHHH *_G%_X*,_\IZO^"&'_8G_ +<'_J+?
M#>OZ.J_G%_X*,_\ *>K_ ((8?]B?^W!_ZBWPWH _HVB_U2?[HI^.N.I]><>G
M'''^<TR+_5)_NBI* /X!O^#RWX?>,?BK\??^":WPN^'GAC7O&OCCQU9_%'PQ
MX/\ !WAK3;C7?$GBCQ+K_BWP;I^EZ!H>E6^;C4=5U2[GCL].LXF'G74L43-!
M"7GB_#_]JGX61_M*_P#!._\ X(J?!#]C+]GZ^^,/Q4UGX<?M2^(M<'P5^'?Q
M<G^(VI>,?"NK?#NW^,GAFX\#ZEXP\;6?B;[-XDA?Q7XD^(NC:;I6D:E-8Q3^
M%= \*Z#'-HMW_3=_P<V:=X?7]L3]@SQ_=_M>>!_V*?B)\#?@W\=?C?\ L]?%
MSXA^%==\5^&-6_:$\!?$'X87?PV\#7T.B>#_ !\NC1ZE=3WFLS:[K'A+7='L
MK;0ITN=,OY)XK.?X1_X)X_ S_@E;XM_8$_8%^%O[;?[:'B7X$?M!:%^TE^UW
MX!_9/^,_[-/Q(^*?P^E^)>B:W\6M \'^(+7PA\0H? OV+3_ 'B/Q1>>&KZPU
M/QUIG@C7,RQRM+8:5+K4,H!^YW_!I7KVCZU_P2+\-VNE?#K0OAU-X9^/7Q6\
M*:XNBWWB6\NO''B+1M.\%+K'C_Q*GB75M6^P>)M;GF%IJ.F>'FL/#=C#I5G'
MINEV;FZ#_P!-=? __!-S]DW]D_\ 8K_9GTCX$_L<7NFZW\*M%\0ZEJ>J>*['
MQS#\1+[QEX_N],T33O%GBCQ/XDL=4U+1V\6:G+H]G_;>FZ'!H6DZ?+#"EEX?
MTZ&16N/OB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#^?O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MH **** *\EQ$D@@,N)V!9$P68ACL4D 8"[F !8J"1UPK8_E5_P""M'_!0/\
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M\-WUGKX!_K]?\/*/^"=/_1_?[%7_ (E/\#/_ )NZ#_P4H_X)T#K^WW^Q4/\
MNZCX&?\ S=U_E2?\.Y?V/_\ H8?^"Q'M_P :EM _^C,KYO\ VJ?V1OV>/@=\
M+$\;?#K4_P#@H'J/B63Q;H.AI9_M.?L(:5^SA\,)-.OX=3NK[=\2;/\ :,^)
M=ROB,KIT2Z3H$7AH'4[5M4N3JMC_ &:!<@'^P_\ #O\ ;?\ V+?B[XNTSX?_
M  G_ &O?V7OB?X\UH73Z-X)^'GQ^^%'C7Q=JZV5O+>7K:9X;\-^+-2UF_%G:
M03W5T;2RF%O;0R3S%(T=A]09'O\ D?\ "O\ $'T#PK^R;\4_CA^SYX1^$Q_:
MM\&>&=2^!OP\L_CC?_#SX<Z!\=/B]>?M(6GA;5+CXM:C\'/AOI?B[X8_VC\-
M=4UP0#0M*OO%=CJ&CZ,+Z:XENXH+:U;[L_X85_9L_P"BE_\ !:O_ ,58V?\
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M$! ]>_8]SGTI"02.#P1V(ZY'IC@$FO\ "_\ ^&9_VZ?^C?/VMO\ PU?Q@_\
MF>I1^S-^W2Q 7]GO]K<DD!0/A5\822QZ* /#Q))/  Y/\@#_ '//.3(&)<G'
M_+&;'+;1D^7@<\G)&%^8X7FG(ZR*'5LKEUR05(97*LI5@""K*5((!!!&*_QF
M/V??V;O@GXR_X)O?\%-OCK\8OB-XY\&_M7?LP:K^S]H7P5^%VH_%>P\*3:Q'
MXU^+7A7P7\4;?7?A9KUDOC3Q9?\ A_1=2UG[3'875G;^&;E)%U.S>6*,K_KF
M?L2N\O[&7[(TDDC322?LQ? 1WE>1YFE=_A5X3+R/*[R-*SL2S2.[LY)<NQ)8
M@'T]1110 4444 ?S]_\ !T#_ ,H7/VJ_^NWPR_\ 5C>'*_<[X:?\DX^'_P#V
M)/A3_P!,5A7X8_\ !T#_ ,H7/VJ_^NWPR_\ 5C>'*_<[X:?\DX^'_P#V)/A3
M_P!,5A0!VU%%% !1110 4444 %%%% !1110 5_.+_P %&?\ E/5_P0P_[$_]
MN#_U%OAO7]'5?SB_\%&?^4]7_!##_L3_ -N#_P!1;X;T ?T;1?ZI/]T5)4<7
M^J3_ '14E !1110!R_BOPSI'C#1=7\/>(M'TKQ!X<U_1=2T+7]"UJV2[T[6-
M&U2W>VU+2+^TF22WN+/4[61K:X24!(T.]XKDE5B_C/OO /Q(_P"#<_\ :Z^)
M7BSQ3X:USXF?\$&?VN_%L]AXYTS0;!O'-O\ L4^+?B7'+I?GZM\,DCN_$5QX
M"B\67EAX3.K:5_;.EZI\./$-OI(M_$_QDG\/^'O$O]K!&>M>:?%OX1_#GXW_
M  [\:?"?XK^"/#WQ$^&WQ%\/WOA;QUX(\4646H:%XF\/WX(N+"^M)E:,NCM]
MIM+J,PW=G>1PW=G=6MW#!<P@'\-OCC]EV[_X(X_M)^*/^"KW[(7PG^'G[;/_
M  1O_:ABT7Q3\8?A9\-] \*^.];^#'PWO+F#7;7XA>&-+\:6YAN=$\'7VI>,
M9O TNE>(X]+L'GO-*^,5]X02'0[I/Z__ -G2R_8/_:K^#_@SX[_L^^ _V<OB
MI\)?'VEP:OX2\9>'_A5X3M+:]LKF..?[)?:-JWA2PU[PUK6FB5++6?#/B33=
M+\1Z%J$,^GZWIMCJ$,]M'_,%\6O^"5G_  75_8@\7>-OV7/^"1_Q>\(>(O\
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MCMK6TLXD@L[.UA58X+2S@C1$M[2VB5(;>!%"0Q(D:\*#5^BB@ HHHH ****
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M-9\._#WPGH6MV;36PM;AK;6M+T6UOHEEMWEA:..5'DCDEBEG>"3[/%[!110
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M-$^!WA'QUX@^#GBOQM\5K/Q1X@^*WB'XG^*O"6O_  D^'?B#0AK'AZ\F\(^
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M]_\ !T#_ ,H7/VJ_^NWPR_\ 5C>'*_<[X:?\DX^'_P#V)/A3_P!,5A7X8_\
M!T#_ ,H7/VJ_^NWPR_\ 5C>'*_<[X:?\DX^'_P#V)/A3_P!,5A0!VU%%% !1
M110 4444 %%%% !1110 5_.+_P %&?\ E/5_P0P_[$_]N#_U%OAO7]'5?SB_
M\%&?^4]7_!##_L3_ -N#_P!1;X;T ?T;1?ZI/]T5)4<7^J3_ '14E !1110
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M\)PW6IV$OBF2?PQJD2>&H[[1;FSUJR;7BPTH7>C7EGJUN;OS]-N[6]2">/\
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M\//$WA'Q3';6^IVUM//9V6O6EO?+']GO$GMFEBD^E:AG \EN.FW'_?0'\N*
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M^U__ ,$B?&7@3]JGXB^./A1^S1\(/^"=WP'G_9\\-?$N_P!=_9WT3XR>*?\
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MPG0!]04444 %%%% '\_?_!T#_P H7/VJ_P#KM\,O_5C>'*_<[X:?\DX^'_\
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M^H^';;1KNQ06DNH:IK,"Z=LU2XMK*-9U=Y5#,\8!^U7^/]<=L_YZXHK\ZO\
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M_!T#_P H7/VJ_P#KM\,O_5C>'*_<[X:?\DX^'_\ V)/A3_TQ6%?AC_P= _\
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MQX"\$>(_%6G6.IFRFM;K^SKB]TJWAO1;W,%P\$DJ0RQOM=?Z_*_BO_X/;?\
MDQ[]D+_LZR__ /51>-Z /E7XI?%C_@LU_P %Q?C#K/[&7C']F?\ 9"\(2_\
M!-+]M#]E_P",?Q[O_AU\3=7TV^T?4M3C^($N@:7HVJ>*O&7B'2/&&G#PUIOC
M)]5&B(E];ZIIVGPAR9_+K^_="2N2 ,DD8SR"QP2" 02,%@1P21DXR?Y9O^"%
MR/'_ ,%:/^#BQ)$>-U^-?[&.Y)%9&7/AG]I0C(8 C(P1Q]T@C@BOZG/\_P"-
M !1110 5\E?M6?L-_LS?MKP_"F/]HSP3XF\577P.\?0_%/X1ZUX.^,'QH^"W
MBCP#\1+6T:QLO%_A[Q=\$/B%\.?%%KK>GP.QTVZ?5Y3IMQB\L%M[Q5G'UK10
M!X?\ /V=?A1^S!X%N_AS\'M)\4:9X;U/Q?XL\?ZQ<>-?B;\3_C%XOU_QMX[U
M>?7O%_B?Q+\1/C'XQ\>_$'Q'J^N:O/+?7M[KWBC4)#+(5B\J,",>V/+&F-[!
M<DJ,]R 2<>P .3TXJ2JMW#YR(I<H!+$25!W$"1#MR& "MR'#!D="4=64L" ?
M"'_!2[]K;X!?L<?L8?'?XK_M!>.K7P7X2N? GB7P)I(6VEU/7/$'B_QKH=]X
M?\/>'?#F@V8-_K.J7=]J$<LL%LOEV.GPWFIW\UI86ES<1?XOOAN?XL_$+P3K
M?P:\#^%_#.O^&_"E]XY_:-U>?3/AS\,Q\0K+3?"O@?R_&.M:C\7)O#<7Q8NO
M .A>#]$EU>7X97/CBZ\ Z=JPU/Q)IG@V#Q1J.HZA<_TA?MI>%_\ @HA_P6C_
M ."X?[47[&WA;XT^&?%=Q^S+\=_V@U^ OPO^-6I-I'P \$_#KX'^/I_#UMI]
MOX'TKPMXE\,ZAKVI:5!HMKXCU+7/#.HW?C^.&6V\7ZC>:?'#9H_]L#_@W4_X
M*L? O]FG]H/X[?%V7_@G]H'PT^'FK_%']J;XA7'P@T?PMX)\=(=2T2WA\4>#
M/ ^I^"O@'X+U/1_A;;:99*OA#X":=XBT/X-^&+^XO;WPYX6T6_U"6Y< _I&_
MX,NY'D_X);?&3>[.%_;:^)NU2?E3S/@[\ W=54?* S$OC P7; &XY_KPK^$[
M_@Q_^+7CSQ!\*O\ @H)\$M3UBVG^&?PO\9_LZ?$/P1X?CT/0;2XTOQC\9-+^
M->B_$;6KG7K33(?$6KMX@TGX.?#:Q33]9U?4=+T6'PQ$VA66FSZGK<^I_P!V
M- 'YZ_M.?\$LOV)_VQ/%'CSQ=^T#\/OB3XIU#XI^"O"'PZ^)^D^%?VGOVJ?A
M%X)^)'@OP#JNIZYX+T#Q_P##GX._&OP#\/O&=KX:U?6-1U+2IO$GAC4[RWO;
MC[0+HO#;^5]G_#+X:>"_@[\.? /PF^'.D2>'OA_\+_!'A+X<^!M!?5M:UMM$
M\&^!M!T[PQX7T@ZOXAU'5==U1M.T/2K"R?4]9U/4=7U$P&[U2_O;V:>YE[NC
M/^?\_44 ,\M?5_\ OY)_\51Y:^K_ /?R3_XJG;AZ_4]AUZGI[4 @].>W% #?
M+7U?_OY)_P#%5#<1IY>X@L8WCD3<SMM=74AAEL@]5.",JS(V49E-FH;C_4O_
M ,!_]"6@#_&+_P""J'C3XB_LJ_MC_MY?L#_L]?%OXV_"[]BWPU^T=X^TO3OV
M8]$^.'Q=O?@Y<V\%_IDGGZ]X,U[QKJ^F>*=3GGTO3KBZU?Q/'J^J7,UA8--=
ML+&S$'^PG^SA_P F\? ;_LC'PN_]0?0J_P <S_@NE_RF!_X*)?\ 9T'Q%_\
M2Z.O]C/]G#_DWCX#?]D8^%W_ *@^A4 >ST444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?E+_P7,1'_P""0/\
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M<W"I?ZW=);B7R+98;=(XE^@** "BBB@ HHHH _R^_P#@O-_P4?\ VS?V)O\
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M&;^SM"T+Q7IYTN6W\26 LK@:O]IED2Z66U@6.)YON#]B'_@H!_P43\0?'?\
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MD8^%W_J#Z%7^.9_P72_Y3 _\%$O^SH/B+_Z71U_L9_LX?\F\_ 7W^#'PN_\
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M_!D'/,/"G[?, ED\AO$?P1F,(=A&TJZ=XPC64H"%+A)'0,02$9U&%9@W][5
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MW]Y\0!^QE\-+OX>2Z#::K!?^'=7N;KQ)_8[Z=!JEM>Z3?M)%#=P7-C//&_\
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MFZK9?%;5XO$^FI:>)'TCPU-JDFA6(!_6I_Q$!_\ !&S_ *2$? C_ ,"/%?\
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MDDT ?Z77_$0'_P $;/\ I(1\"/\ P(\5_P#S,T?\1 ?_  1L_P"DA'P(_P#
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M)^'NJ3^,-1\,P:=="[^(?B=KE9+;] /^(=?_ (+.<?\ &"7Q2Y_ZB'@O]?\
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M "@X_81_[ 'QN_\ 6F_C50!^[]%%% !1110!_/W_ ,'0/_*%S]JO_KM\,O\
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M./&A''//;:W8C< ?6M%?)+?M\_L,*<_\-G?LGX .1_PT;\&QSQA?F\:CYLY
MSA>>6&.7C]OC]A?)!_;/_9/ ]3^T9\'<' '3'C,GJ2O('*GM@D ^LZ*^2_\
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MV\OV&Y]+U*"']M#]DUIIM/O(XE_X:.^#J;I)+>5$ =_&:(F6(&]F54ZL0.:
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M$=*CTF7QA8?$RXU[2-/TW5@#_1A\R-$#&1?+P!YC.NW)8*HW9P2S':/5N.I
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MT6_TNS /[F@ ,X[G/XT444 %%%% !1110 5_%?\ \'MO_)CW[(7_ &=9?_\
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M  S\4_B=\&/ _P "/#'Q4CNM!M?BWIG[0WA#Q?J'P7\9_$CQ#J]MXP=%\/\
MB3Q_\*/&VKQ^)],U34?%-_H7B'2=0U#P?8ZC?:MI.D@'H'_!NC_P6@_:Z_X*
MVW'[:=K^T_\ #_X%^!KS]FVZ_9[L?"]A\%?"/CWPI/<S_%-_CU%XLB\4Q^/O
MB9\2&NKK3Y_AAH$.D+92:%#8-<:P^I#41);1VO\ +A_P7%T7Q!K'_!;;X_\
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M6C>,(?!TOC#09-7U?0].T[1]0-Y):ZAHNHV=O'IFN6M]%:P6D?X#^!_VA/\
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M73-5LO!=U$L-O>Z?>W1D2>XMI8?Z6/\ B$2_X(W<?\4=^T'S_P!5QU;CZ_\
M$E_QH _83_A[%_P2R_Z26?L ?^)D?LZ__/&H_P"'L7_!++_I)9^P!_XF1^SK
M_P#/&K\>_P#B$1_X(W?]"=^T'_X?'5O_ )2T?\0B/_!&[_H3OV@__#XZM_\
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M&.*WFU+4K[1Y/$^C>+/&/@7P;<:AX7U>"'3M$O= M=8L)KJ81VD/XZ_M ?\
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M=OX:L_#GB;5[F[?PKJ&HV^B:W/IWQ#^VM^QG\1?V-?&7P.\.^+M0\">(+O\
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M40M'%L73O 850H2(+'&+U(X@!'\L,7DVY=G;RPTCL?S-_P""!'[4'C[]L?\
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M7BE=1\6^'?%MA/HXUG5I/ 7B&ZM]5UOPMH%OIVG)+!^MW_!F[O\ ^%Z?\%'
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M*[_18M>^&OA#P;IC7'B#Q8NKZAI]G=6MUJ&IZQ?7<%K<CSC$ ?B5^PA\ O\
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MO/A9KMIX@\,^"]2TU?#>FMX4U&7PQX0U2UT;1=2L7:#6X-%M[[43=7-S>27
M!3_X*8_M^_\ !4GXO?LY?$K7/VD_^"-'P9_9*\*?&S5=)TWX@?M91?L9_$GP
MSXRU:#Q;;3(]C#\4/BM>^(["QU'Q;9PQ^1XCMC'KT26<,FCZI:7)CF7^R+_@
MM?\ \%CO@5_P2YM/#G]I_"";XU?M>:EX&\3^+?V9/#FI>%+V;PEH$^L7T_@?
M6?$VM>/=/LKO4_#UE9RB&X\1^&]&?1=9\8:#9II-CXBTN74$OX/XR/\ @H7_
M ,'!'_!0/]J3]B2]_9+\;_LFWW[+?PZU<_#[P/XO^)_A5OC;X9O_ !+X7T72
MKK2;OX<>)KKQ5;6FCZAH'CG38+@:SH%[<XU*"RE5XKV)+@5_<=_P6;_X*_:)
M_P $F/ /PLU&P^$^L?'7XL?M ZSXR\%?";X?Z-K]C8"/QKINAPR^'=3\3Z1:
MQ7_B_6?"UWXAU32=&GM?".FMK-Q+FQLY'U&YLHW /\^[XB_MQ>"_^"PG[65O
M\</^"OO[07Q(_9U^"WPTT[P3I_@#]GG]FW]G_P ?_$'P]?:#96EE;>,/#W@6
M^UCQ)J7_  K_ %_Q'J5J^N^(/&OC:'X@7]W_ &IJ>EZ9Y&EZ1X:TN'^S'_@A
ME_P4A^ 7[1O[7O[4W[&/[#_P.^&'PN_82_9S^!_P.\8_!KQ7I'PX\8?#OXT^
M/-=N?!'PU\%^*)_C+;>(-7-GK.M:/K%OK_AVU\0R^';76]<TK0-$U&77-8M)
M?MM]\"Z5_P '&_\ P6<UC]EWQ)^U]9_\$L/A,?@]X4^*=A\&]7$^K?&2U\>?
M\)QJ-CIFHVMO8?#NX\OQ=J>CFWU:S$WB*PTRXT6UN6DL+F]COXGMJ_8/_@A'
M^W;\+_\ @IEX3^.G[6VM?LQ_";]GO]M"Q^(MQ\$?VE;WPE#9CQQXULO!NAZ!
M<^"+K5GUF-?B3!X:T'PHWA#P6T/C#9$OC+PIX@L=+,%KIL5C" ?T&T444 %%
M%% !1110 5_%A_P>UX_X8@_9!SG'_#5E\#@9/_)(O&_097)]!N&:_M/K^+#_
M (/:P3^Q!^R  "Q/[5M\ H!)9C\(O&^% ')R>,#D]J /A3_@@)^WS<?L5_&3
MPO\ L\?\%*_%7AO1?!W[=_[#W[&&G_LA?$;5=9\(W'PO\'_ KX?^)/VI-(^%
M_P )?B[>6<.GZ9X:NO'LWQ)^(DIO_%5^\UCJ.BC2-?BG?Q#:'3OU,_;,_8X^
M./\ P19^.GC?_@K1_P $TM U3QO^SEK=_I^L_MW_ /!.SPO9W4W@S4/AQ/;V
M^@^*_C'\$H=#TVZN/#!\(XTCQUXA2Q\.ZM:_#HPZWXGU;47^#FCZ[X5@^/O^
M"+/PA_8U_P""NO[,/[0G[,?Q COO&W@KX;_\$\O^"4WP1\>7DFC7GA_7OA;^
MT!\-]8_X*-S7&K^!+_5X#'/K7A.T\;Z?<V'B*T2;2]1CU;5=+S);37<9^E/V
M4_VEOC;_ ,$'_P!KKX,_\$EOVQ?$%Q\5?V%?C#J#Z=^PS^V%KL@TWQ%X%N-?
MNP?"OPF^)7V6]N-#L=%L?&4FH> T%Y<Z;;>&5U+0/$2+I_PJMKF+20#],?C#
M^SW_ ,$\O^#CW]@KX<>+[G6-2O?!7BB]TOQ!X ^+'@F;POI_QQ^"'C#0M8LS
MXS\$32ZMI_B#3M+U*6W:Y\*>+/#&O:->Z?=V7B.WUVUTZ+5T\,ZK8_''_!/W
M_@H7^TE^PC^TCI'_  26_P""N'B/2U\1-':Z+^PE^W-KC:GH_A']JOPG;WRZ
M%H7ASQ)XHUZ^U'0C\1+NUNO#-O:2)XBOM<M_$.M6O@WQ?9ZGXBO--U?7O)?V
M^OV3/VAO^"+_ ,:/B?\ \%:O^"76CZ?XV^#7Q+OM(TW]KS]@NYL=2D\ >*-2
M^(EW8> O"_Q2^'&D^$HSK]XUC\2/$GAS6KS3/#.G76L6DFL:Y?6\L?@Z[\0V
M8_2&XT;]@K_@X]_X)PZ/JVK:=JFH^ _&L-[=Z1=PQZ2/C)^S;\:+#23:ZD+"
MZFM;NS3Q!HM]<7%K.S01Z/XYTZ,16]O=Z)=QR$ _!O\ X+/ZWH'_  ;P_MB?
M!_\ ;5_8 \67/P_\3_MI>)/$]W^T3^Q9<>%I9/V=/BMX9^&6IZ3JVO\ BS2-
M1TZXL)/AQJ']L^-K/3;;P]I-M=RVI\17E]X9U'1-$L]<T'Q5]6>)OVJ?^"6W
M_!RQX4\!?!3X9_$3Q!^S)_P4A\#>"M*^,O[.WCS4],D\/^.?A9\6/#<,?C#Q
M+X#\ >,;NY\*7OQRT+PE>0:QJOBW0/#-OIUW!X2T_6_B1X>CT>[T=KVT_F/_
M ."WDG[:>B^)OV:?^">W[?\ :^+?C-\<_P!DW5=:\/\ [/GQY^&]C+X@U#]I
MS]F;XH3:*M[JWB&&\DUW6=3^*^BS?#7P>?#,*37&KF+7O$T'Q$,VI6VCWFI?
M)G_!.OXO>(?V0O\ @J+I7QG_ &$O@C\0OBK?_ 3X8?M ^+]*^#7[34UIX>^(
M]_IGA+]EWQQ/\?[/Q#!\/;"P!UOPW8VWQ"U3P=H.F61UC4HM)T'1=0M5U:XN
M  #^]/\ X)F?\%B/%FF_&FW_ ."6W_!4_3K/X1?\%#/AAJ*> _#/CJ_FM-'^
M&W[66CM:00^"?%OAG5];M](T:'QE\1-)N-.MM TC0+_4K#XEZS:76I:1#HDA
M_P"$=T[YJ_:V_90_:)_X(1_&+X@_\%(?^"77PZO_ (M?LK_$;4+WQ#^W?^P;
M"U];^&O#&BZ5?/J=Q\8O@M=^'M.O;_P/INA:5/XBFUO5[OPYK>C_  SMK:;7
M-<TS6_AZ$\.^'OL[5/AA^P+_ ,'-/_!.WP1\3-?\-W/A3Q#?Z?J-CI7C/2K?
M3+SXW?LO_%CP]<W=MK?A1+R:**:YT"/6#/<S:%=M:Z=\0-(GT35(HI(;:WU/
M3_Q@^,/_  7]_;N_X)<? G]HK]A[]L#PWX/\2_\ !1#X'?\ "&>$/V;/C[JF
ME^)/$/A+]H7X:^(Y-1T;_A;NO+:K-IU]XZ\&:9::)XJ8ZY=K:^+[NZN-!\36
M$>NV6KI? 'R%_P $(_C%X"_:(_X.B/VK?CY\*=0O-7^&/QGNOVV?B=\/]7U#
M2;_0KS5?"'C/QK:Z[H6IW&C:I#;:GILE[87L,S6E_;P7<#.T5S!%.DD2?Z1[
MPQR89T1G4#:6!QE3N7CG@-R,@XK^-O\ X-??^"1'[/?[/?@7X6_\% I_CMHO
MQC_:6^,'P$\.ZU;>"/"7B+PVGA_X%^!_BYH^EZPWAW7M#T>]N]=OO'4UE!::
M-X@N/$HM;6RU+3[JVTRQ@OH]2D?^RDC.??N.O'3\C0!^+G[0O_! ?_@EK^U;
M\:?'_P"T!\>/V:KGQ=\5_B5JT6N^,_%0^(GCS2$UO4TT[3]+6X73-&\46NGV
M8BM-+MXA%!:P1@ R!2\\@7QO_B& _P""*_\ T:5==,?\E5^*/\O^$OQG_/2O
MZ!\=>3S^GT]/Y_C2T ?S['_@U_\ ^"*Y_P";2KOO_P U6^*/<8_Z'#_)YI?^
M(8#_ ((KC_FTFZ_'XJ_%'W_ZG#W_ $ Z#%?T$44 ?S[_ /$,!_P17Y_XQ)NO
M;_BZOQ1XZ?\ 4X=?T . !1_Q# ?\$5_^C2KK_P .I\4/_FOK^@BB@#^??_B&
M _X(K_\ 1I5U_P"'5^*'_P U_'7M_05YC_P40_X(<?\ !/32OV#OVDO$EQ\/
M_BSXJN?@%^S-\9O'7P>TKQY^T9\</%_AGP!XE\ ?!_73X2O_  ]X?\0^-=9T
M:Q_L.WT?3;*TM$T_[,^GV4>FR!;8L4_I6KYZ_:U^$VM?'O\ 9<_:,^!7AS5=
M+T'7OC3\#_BK\)]%UO6HKF?1]&U3XA^!]<\*66K:I!9,MW-8Z?<:LMW<Q6S"
M:2.(HAW-D '\Z'_!G62O_!(V[RD@#_M9_&QU(BD9"J^&/A@C$.B%%7>2J[F&
MXJX7)1L?U9;AZ-_WP_\ \37\''P9_P"#8O\ X+!?L\>!(?AE\!O^"PUI\(OA
MY#JFJ:[%X.^'5U\9?"?AU=;UHV?]L:H--T;6+6V?4+YM-LHKN\9#<31V<,+N
M(XP@]1'_  ;Z?\%Y"<?\/U/&7X>,OC\<#N>/$?:@#^W W4 1I"Q54!+;XY$8
M %@249 ^%*-N.W"A220 34H=2,@-C_<<'Z8*Y'?.<$>E?Y\/_!/;Q5_P6%\(
M?MP?MG_\$Z;+_@KGX#T/XZ_!GQ5X<FM+C]KWX=>/?B3IWQ5T"QO?#WA>VUCX
M1:Q\0+[R= BU/Q#XR\*Z=9>#[)Y=:\;&_77-'BU"UT^:=>$_94_8R_X+9?\
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M]$M_K%W+, ?Z#N\<GYA@$G*L. ,GM_\ KZ#FH5NH&94#,6;/'ERC: )"6<E
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M+#2[B>[\0Z?=W2SO!'<Q6)0.TPBCD_KVMVD>%&F $G(.T.H8!B%?9(JR1EU
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M99_$_P#X23X;Z387FC7_ (JBT:YM_%GC!K#2=):\@T/6OC%H3CX]:/I'B*<
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MKSXO^(_ACI=Y8>)KZ[TS5= A\(2>"HK&6ZLO!,%K;6^B/:?DA_P2K_X)C?\
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M;_@V[_X(K?"'Q[X9^(O@S]@KP+J?B#PY<:J;73OBA\0_C-\<? %Y#J_AW6=
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M:G^,?[%7QJ_;*_9^_:4_9G_:-\0^)?VJ[?\ ;U\/^-/%K7%O\9]5\!>'-/\
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M_P#\/[?^".HZ_P#!07]G_MC_ (G>L=_^X)P?;Z4?\/[?^".AY'_!07]G\_\
M<;UG_P"4E?Y0/_!0+XC?LG>-_B]+%^R!^Q=;?L??"&P.KS>#['4OB#\;_B'X
MO^*/@O6;^*?P3XU\37/QB^('Q$LM-NFTNVEN+&Y^'NI6'AG6+34(I)$U)8F
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MJVT.V^*=OXNN;J\\(VEZ^E:-XGU.YO?%!M1/+=:O/=7U[/< 'U]_P;_>$/\
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M[X,U'6M4BTCPOX/T+0O%(O[SX>^#Y_L7C;3?$FF6G]C-%::?$FIZI]J^X_V
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MPAINIZ[J-WH6A)H>BZ5-=7\\\DEAI>D:;96SEH8+2!4\M?MS_A;/PR_Z*/\
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MFJ /[!O^%L_#+_HH_P /_P#PL_#G_P LJ7_A;/PQ_P"BC_#_ !Z_\)GX<_\
MEEU_STYK^/C_ (@IOV0/^CV/VLO_  !^&'_S-4#_ (,I_P!C[<-W[;'[69&1
MN LOA@"1G! )\,L 3T!*L!U((XH _&[_ (.-OB]\+)_'W_!3[X96_P 0O"=W
M\0?&7[9W[ _C[PGX1L=5CU#5O$7@KPA^RG\8]"\4^)]*:P2ZL)M+\/:UX@T7
M2]6>2^AN+:\U.TB%N^Z0Q?Z&?["]W:WW[$_[(-S97-M>6[?LQ? >-;BTN(;J
MW>2W^%WA:"=$N+=Y89##<12P2[';9+')&V&0@?YVW_!-7_@E[_P3R^(NF?\
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M5AUK6K&'2OAUX9ET;P_-IFD:G#JVIZ?=ZY?\AX(_X-V?^"V=W\%/'^H?$/\
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M^H(E[X6LM)@TN]T#Q'[1XO\  /[(/_!RE^P=X ^-GPSU^?X!_M5?#*^:_P#
M7C?2;O3-2^//['_[0OA'5P=;^''C^SLKKP[J6N>"]1\16[:A91ZE;^"[K7O"
M&O>'_&>DZ5X/US4_L]OX9_P31_X*A_M&?L9_%WPE_P $F?\ @L?I/B'PE\>]
M.NY_"/[//[9.IZU%XG^"?[1&C6,,4/@S2KGXGS6>E75MJVN>'K&WOO#OB'Q?
M$?$6N7]\NG_$VV\ >,I;31=2T?\ @IG^P9^T'^PI^VA/_P %O?\ @F[H*ZY<
M:7IUOJ'[?W[)7AJ>;2+WX_\ @"W1K#QWX\\*Z7%%?Z'JOB2Z\/1V6NZYH5O9
MZ=K\_BS1)_B7H7]O>,]8U>"[ /0_^":O_!3;]I;X0_'2\_X)9?\ !973_"WP
M]_:QTBTTO4?V8_VDKV^N='^''[9?@N_N;S1+JQM-3U>SMO#<_P 1M/U'R[&P
MU'PM]GT[QYI]W?\ ABZ\'>&M;\#3W_Q ^?\ ]KG]E']HW_@A=\:_B+_P4I_X
M)<_#V_\ BI^RQ\3IKSQ%^WK^P+<27%MI.@Z=H\]QJDGQG^"&I^&;#4;[P9!I
M^D7WB2?4$O\ 1O%5E\-I3-J>JV'C+PKJ6F>&/ _UKX]T;_@GM_P<_?\ !/G7
M/^%3>(7T[QWX U"Z'@35_&VBQZ+\:_V1?C3>:1)-9Q>,= TG5I;VW\.>+%M;
M:VO!X8\1^(_A_P"-K?PW;S6.J:IXA\%W=CHM/_@D1_P4O^*_ASQM<?\ !*O_
M (*CS:A\,O\ @HG\&$MM,\">+/%5W::CX._:Y^&4:+9:#XQ^'7Q"L((M&U_Q
M=;VUM!!/HVLR:?K?BR&_T[4;%-7\5V_COP[X. /YU/\ @MG_ ,%B= _X*2?
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M/^)<,NDW;7&A_9SH%XC66H"0RU_1VGW5S@9 . <@>P;N!G /&[&<#H/X*?\
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M:W_@W5-1L@LA%S;Z7X@TF^:$^;'=0[2U?AC_ ,/4O^"EO_1_'[7G_B07Q/\
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MZC<Z7IOB+XR)J.HP6-U-8:>]S^S/\:H[9;V\CB>WM6N'^6 3R1F4\1@D<?[
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M%M&\97%]'X_\&?M*^.(/$NH/HOB'3(=*TSP+IGBHOK5MKND:S-HUWHE[$O\
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MAG@UO7/$NKQ"XFAN;Z 7^MWMP]O<PR$VRR+:0?VEI]Q?]U?Y"OX.O^#++5O
MVN>-_P#@K!JOPU\(:MX"\"WEW^P^_ASPAKOC(?$'5]#LH[#]K.&6UOO&0\,^
M#O[=D>\CN;A+D^&=)\F&:*T6"1+=;B;^\5/NK_NC^0H _P QG_@Y ^ /C[]J
M#_@X>\)? WX9_"WQ;\:_%7C/X._ Z<_"SP)K&B>'_&7C3POX2\+>+?&_C_2O
M#.N>))(]$TC6%\!>&_$MY9:CJ'G0V<MJLZVE[*D=G/\ G?HO_!O_ /\ !32U
M\>^-=2\1?\$SOVG-0^&MQIOQ%7P#X?TOQK\(;;Q5H6I7EIJH^%USXBU<ZW<6
M?B*W\.7KZ//XOL[+3=.E\2V]K?6>G2:7)=0S1?T%_P#!0']HSX,?LF?\'?7[
M.O[0?[0GCFP^&WP?^'OP @D\8>-=4M=1O;'15\3?LN?'OP;H7GVVD6=_J$IU
M'Q-XBT;2HA;6DQ6:^C>0+$LCK_:-^RW^V-^S-^V9\-[?XI_LT?&OP5\8_"%V
MD\C7'A36X9]:TN--3U70D7Q)X7_T?Q)X4GNM4T/54LXO$&EZ=-=1VSW5H9K7
MRY: /\AKPC_P2Z^/WB[XS?M<?L4Z+\/[/Q3^U!^R3J/B?QQ\5?B/I7Q$TR'X
M%_#GX+_ WPGXT?XPQZK)?^&DU_7]7U?Q1J/P]TKP?J.F1P2V^H0WFF7NB3MK
M":EI/QG^SI^R'\;_ -JY?C=J/P<\/V&K:%^SS\$?B)^T1\8?$.JZI9:+I'@S
MX9?#KP_>Z[J5_=>9ONKW4]:N[6U\+>&]'T>RO[B^\2ZMIT-U_9VD&^UBQ_V/
M/#O_  3/_99\(_MF?&[]MW1? $1^*/[0WP/N/@%\8O"4FC> ;;X0_$'POJ^N
MV/B+Q3XE\6^"--\"VE[XO\=^-&MX=.\:^)O%WB/7/^$BTJ)-'N=/:RC06O\
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M\/:#HL8\#KXDN;F#3)+RTM[VSGF&D%-1>SFOV^N?^",GPPO/^"BW[:7[)?\
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MQ)$EEHFJ>-M8UV)+SPKJ%W<W,LFGQ:C9VH @_P!*X     !0      ,  #@
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M9X0UBWU;Q#<ZK%#X<L],T_5GU.6"Y@!AG$$4X!^X&>GN,^_;_&EK^>7X1?\
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MAM\._ \=U!!)YT.ER>(UU:_2.;^S;&\:&54 /V6HKY&_X> ?L)?]'H_LI?\
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MM;97N;FYG=EB@M[='GFE98XE:1E!_P ]GX/_ +1W_!SS_P $\_V&/#^O:?\
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M&5#,,JI(5)HI&9$D5V3;N"G)4-NVDXZ!BK $\%E9?O*0/\=+]COXS?'/P?\
M!GX.:3_P2-\*_M\:3^W)+?:FO[=GBWX*/XK\7?"+QSX<G^*GBB]^ \$_AWP+
MI6K:MX9L[#0)]$TKQ+JVNWNCZ7JUXFO0K!)*]]>W/^D%_P $>O'G_!83QSX<
M^*=U_P %7?A1\&_AK?67B>W@^%DG@R73+#Q?J>GQ^%_";;IM \-:CXG\/-X3
M66X\0!-<U+Q);^+O^$BCU/2Y-%C\/PZ==R@'[8 Y .",C.#U'L<9&?QHH P
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M[PQ=:Q=3Z#=^.-.\'?MCR^&M)U9---NLVDZ3>ZK;:8S/91ZQJB0)>3?ZD5%
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M+\6/!%GI\=PHTN[TOQKXG_X*X?##6M2N[NU)>^L[GP;8Q6-P/*BEO80;EO\
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M/BI[ZTL;/4KS3X3XTL_#^LBRTRYXO_@B\=W["'_!?TGO_P $^+(YZYQXSO\
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ML:OH&E:)=C3-8U&!S?Z?-J%O#--:PW)\N73HI[;\=O"W_!*/_@K_ .#-.O\
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MG_!7S5]:\&:R?^#?S]C[1X?!FMZUKLVA:+)X1@T?QP=5\"^+?!5KH/C6.?\
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MPOJ^NZ'<KJ7AW7='U: V6J7)C@OXH;H6]['<6L/Z[T@!!ZY'N![>GT/;O[4
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M4_\ 3%85^&/_  = _P#*%S]JO_KM\,O_ %8WAROW.^&G_)./A_\ ]B3X4_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MKD?'P_XHCQ=W_P"*6\1C\]$O\_RKKJY'Q]_R)'B__L5_$?\ Z9-0H _QW+_X
MK>$;W_@F]\0?A1JWQ%T6]^*TO_!8CX3^,]'^'E_XDM;GQLOPK\+?L_?&3P8?
M$MCX?NKQM77P1H6LZKHOA6+4+>S.B:=?W%GI*3P2/;P2?[*-?XZBDG_@DO\
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M<_:K_P"NWPR_]6-X<K]SOAI_R3CX?_\ 8D^%/_3%84 =M1110 4444 %%%%
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M7/\ X='?\$J_^D:_[!O_ (B3\!O_ )@Z#_P2._X)5C_G&M^P:?I^R1\!L_\
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M4)%XO^/T:#)"1_ ?644%B6)"KJH R22>.223SG+_ /B+S_X(W?\ 0Y_M _\
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MHVB_U2?[HJ2HXO\ 5)_NBI* "BBB@ HHHH "0 2>@&3]!7X5_P#!9W_@IO\
MM&_L.6GP:^$7[#/[.FB_M<?MD?'%O%GB3P]\'FM?%GC36/#/PP^'5I!J7B;X
MAW_PH^'%WI/CSQ5I-Z[7?A[2KS3_ !!H%G9:S:3.TFLRK)I3?NF3@$^G/3/
MZ\>XX]NM?A1_P5J_X)R?M _M$_&C]E']NG]B[QIX:\,?M8_L3WNOZ[HG@WQ?
MK/BG1_#?[0G@Z&_TOQ;9_L_ZUJNB>)/#NG>&=%\?^(-+N]!U_P 0:M=PVS:7
MK;6MW<16:R/& ?B:W[./_!YG&7@A_:T^ MY':L+?[3'XH^!S>>(%$8N-TGP<
MMIPMRO[Y?M,,-R5(-Q&LH.?2_P#@@?I/[?\ X;_X+._\%,?"_P#P4=\:?\)U
M^T?HO[-O[/T?C;7?#]U'/\.[^XNM!^%5]X6?PPNA:'X=\%-?V/PZN?!VG>(K
MC0M(LII]<M]0GU!]3U.;4M3N/MO_ (:>_P"#H[.1_P $QOV!5W'<<?M)8&3C
M);;\8\$X !."2  ,@"H/^"3?[?O_  4E^/W_  50_;Y_9)_;]T+X6?#&]_9Z
M^"7P/\::=\#?A-+I/B/PK\.O$GQ \,?#O70^G_$(76J:_P"*CK?ASQ/;ZYJD
M5WKFJZ?H^MZUJ.E6,_V2RL<@']-=%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<CX^_P"1(\7_
M /8K^(__ $R:A775R/C[_D2/%_\ V*_B/_TR:A0!_C;'X/?#V;_@GW\2/C])
MHEPWQ7TW_@K_ /#KX.VGB/\ MO7!:1_#S7?@I\8O&NI:(?#8U#_A&WNIO$OA
MO2KY-=?2CKT,,$NGPZBFG7-Q:R_[.]?XS+>(?&*?\$X_B-X43X=2R?#^Y_X+
M)?#OQ%=_%O\ X37PS'!9^,++X$_&+3M/^'1^'+Q#QE<RZEHFH:EXF'C6WE'A
MFQ32CH5[$=5U&P9?]F4G'8]">!GICCCN<\#O@T +1110 4$9]1].M%% $,RY
M\L@X(EC.< \!U9A@Y'S*I7(P5)W Y&#_ (X:?![]E7]HW_@MW^T;\-?V[/VB
M?$O[.?[/GB?]L7]J2R\6_%S3ETBXO;%M&^*GC6#P]X>N?%?C'[?H'@#3;];6
MVTE/&VN:-XOTOPXB6%M<>')[:Y%Q8_['5Q-'$J-(P4"1222JX4??<EV4;(T)
MDD89V1H[D84U_F#_ +('_!-7]H/Q/_P<#ZKXW_:;_P"">W[86N?LL^)_VW_V
MC?$Z^,O$W[+?Q(L_@AJ6G>(OB'\0=4\$^*/'_B3Q[\-;SP=J/PFU*&\LKZ^N
M9)K$7=O<Z=<6&J6ZN97 /Z2_^#>+]FG]A/\ 95_:D_X*2?#;_@GE^TG??M3_
M  *U#X/?\$]O%VJ_$C4/'_P\^)$UE\1M5U[]N[3_ !#X237OAEX1\%>'[>+2
MM&T;PS?II5SHHU:U.KM-=W4L%U:1P_U9I]Q?]U?Y"OY3O^"#_@OP;\.?^"L7
M_!Q?X&^'WA;0/!'@KPM\?/V1M(\-^$_"VDZ?H7AW0M-M=-_:G6+3](T?2K>T
MT_3K&)BYBMK6WCCC#$$,Y=V_JQ3[B_[J_P A0!_$!\=O^5V#]D+_ +()JW_K
M&W[2M?W U_#]\=O^5V#]D+_L@FK?^L;?M*U_<#0 F/<]_3O^';M1D>H__4<<
M^G/'UXI:_G>_X. OV^OVJ?\ @G[X4_8=\8?LL^+/A5H6L_%;]KC3?AQXYT_X
MY:UX3\'_  K\4>$#X5U371X>\=_$;Q=JGA[2?AIX3FO[(C6_&K^(_#\VC6$C
MW4NMVMI'*K ']$&1ZCKCKW_R#0&!.._/'?@@$_3D'Z$'O7\7/_!(W_@X6_:U
M_;*_;\^$_P  ?VB? W[,G_"N?VNK3XR:?\*]-^ 'Q<T7Q!XL^ WB?]FOX?>+
M_%OBBZ\?^';?Q/XP\2Q>$?BTOP]UJ[\*R^,+;0[CQ#;:IIOBGP-K6I>#[/4+
M/4O[1_\ /YT %<9\1_\ DGGCS_L3/%'_ *8[ZNSKC/B/_P D\\>?]B9XH_\
M3'?4 ?X4%I_R7RT_[+%'_P"IO%7^\E7^#;:?\E\M/^RQ1_\ J;Q5_O)4 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110!_/W_ ,'0/_*%S]JO_KM\,O\ U8WAROW.^&G_ "3CX?\ _8D^
M%/\ TQ6%?AC_ ,'0/_*%S]JO_KM\,O\ U8WAROW.^&G_ "3CX?\ _8D^%/\
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MP9\93_@L;\:=X(\W]DCX[E/E;YO^+T? X@D '8,*V"^T<8SN90W^H#0!1^V
MG$<%S*0&(*1ML;:KG'FL%CR2H7!<$.V& VFOES]J;]C#]FK]N3P%:_#']JOX
M/^%?C/\ #O3?$FG^+=(\,^)I]7L'TWQ#HP\J"Y@U;P]?:;K-I&[J\=]96FIP
MV>I6^^TUFSU&W;[-#_#W_P ',7B']NK2?^"DGC6V^ UM_P % Y_AY=_L@?"R
M#P'+^R[>?%#3_AGI_P 7)?&^NR:K>^-T\,^&]:TO5]-/@U-9M]4TW0;W0/%
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MC##XS\%WOACPA\4='^)VJ^#_ !5XMTRZU75=$\.ZGJMWHVF?V[%I=_8_N?\
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M^#F_]B'XX?MM?LO?LX_\*<^#7CGX\6?P._:6T+X@_$WX1?"OQA8^"_C+XO\
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M8?\ 8G_MP?\ J+?#>@#^C:+_ %2?[HJ2HXO]4G^Z*DH **** "BBB@ HHHH
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MLZXH _ 7_@V'_P"46VG?]G2?M:]_^JV>)??\_P O:OZ&*_G=_P"#9&XDMO\
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M"[* /5/^(R;_ ()6_P#0D?M4?^&[\,__ #?4?\1DW_!*W_H2/VJ/_#=^&?\
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MA\&_M3Q2ZAI&JV,.[X=>&1$\U_I]U8QB?'CQB(E:Y$K%,,OEAEWL%1OY^/\
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MGI,UEK_A7Q;H]GKOAW6;$3)%,;;5-(U&SO;<2QQR>5<()$1PRK_CK_M*?\$
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M-HO]4G^Z*DJ.+_5)_NBI* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MK^?/_@Z(_P"4+G[4O_7]\+O_ %8WAZOZ#*_GS_X.B?\ E"Y^U+_U_?"[_P!6
M-X>H _)7_@A%<3G_ (*,?L-@S3%1_P &TOP3BVF5R!$G[55U(D0!8@1I( Z1
MXV*X#!0W-?VY1?ZM<=,#'KCMG@=/\\U_$/\ \$(O^4C/[#G_ &K4_!7_ -:G
MNZ_MXB_U2?[HH DHHHH */\ /X444 &.OOS^F/Z4444 %%%% !1110 4444
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MK#'))<7]X\5M"L4C2RJH4M_.-_P>O?\ *.K]F3_L]C0?_5&?&ZOTN^.2(?\
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M@9"Q+0-!$Q9\\;_.,BX7"A5 ^\"2 6JC\Z+<5WC<&VD#)(8@D!L#C('!. >
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MTRV\021>-O#F@>'](MM83_2O#,=IJL]S8?Z%/_!V2<?\$4?C.2 X'Q2_9Y+
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M>&O&WAS1/,U/X.ZWJWQ"U+Q):>%YY] TZX^+NE7,-EILNL2I<?TET %?%O\
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M]9#Z=7;/3&<DD\YY)-?YB/[6_P#P1&_:\_X)->&/V"W^*/[:6B_&+X!>(_\
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M7_$>@:;,VLK<6MY8:.=0T4?;5U&XNS[9_P '9B$?\$5/C7& !CXJ?L]H,MD
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M?$29\MB\>=H'RL50LOIE5SQP*5[6"08=,\@\$K@KG!^4CID\'(P2#P3F<
M#@   >PZ4 +1110 5^>7_!6;XB^,_A%_P34_;9^)WP[\6^)_ 7C7P)^SUX_\
M3^'/&/@K4'TKQ?X<O])TMKH:IX8U&-E:SUZWACE.ESAXPEX829(URZ_H;7YW
M?\%;/"GC+QS_ ,$T_P!M;PG\//!OB_XA^.-;^ 7C6U\+^!? /AO5?&'C7Q;K
M"VL=Q::!X8\,:':7VK:WK6IO#]FL;"PL[FXEFD7;"X!4@'\W/_! O_@H7XP_
M;%_X*O\ [57@CP1\;/VWO&'[)GAO]C'PAXL^'?PK_;9\9R>)O'&@?$6U\5_
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MZ\.:]-X?U;P[\1+K4]$EO[-EG;3[V?3+"XN;92%E>R@WY174_P!(=>1?&OX
M_!/]I#P=%\/OCY\+/ _Q?\#P:U8>(X?"?Q!\/:?XFT&/7M*CNH=-U9=-U.&>
MV^WV45]=I;7'E[XEN)0I&\T ?QI_\% OVN?@C\&?%O\ P3^'_!.G_@LA\<OV
MAO'/Q*_;U^ 7PW^,/@2S_;\F_:"AN_@OXDU1(_$/]L^"[;6;UM-TK4=6_LK2
M;V_DM3&PU!M,=E^T201_V]6G^MOL+A?M.W& ,%8(QA<*%,>T(P822MYDDD;&
M(Q&&+X7T+_@EG_P3B\,:[HOB?P[^Q'^S1HOB+PYJVF:[H.M:;\)?"5IJ.D:S
MHUU!>Z5JFGW4.G++:W^GWEM;W5G<Q,LL%S#'.C"10U?>@C1=Q4;=W)P2.<EB
M1V!+$LQ'+,2S$F@!]%%% !1110!_(U\:O^"U_P"S7_P2@_X*C_\ !3WP'\?/
M@E^UI\2M6^,_Q"_93^(GA?4_V?OAEX"\8>';/0M$_8P^"?A">UUK4O&GQ8^'
M5S%J[:OI]\RVNG:?J5G':I"[ZBMT\UI!TO\ P:G^,+?XA?!C_@I%\6-.T#Q9
MX>\._%O_ (*7?&'XF^%M,\::,F@>)K?PUXZ\*>$_$&AIK6FI?:AI\&J1VFH0
M6NI0:3K&LV%OJ2S6UMJ=[#%]J/\ 5\J*N=HQGD]>3@#)[DX 4$YPH"C &*8T
M$+/YC1J7QC=@!B"I4@D $@@C()(RJGJBX ):*** "BBB@#^"7_@E9I7@/4K3
M_@Z-N?%FG^"=1U.U^)_[7;^%Y_$=EH5[J5M?IIO[1CN="DU6WDOXYHG$/G_V
M<1^]6(N"XB8_OW_P;+?\H./V$?\ L ?&[_UIOXU5_GI?\',/@KP?\/\ _@LA
M^U-HO@;POH7A#2+N?P1XFNM,\.Z;;Z78W/B+Q1X1TK7O$FN3VULJ1/JFNZU?
M7FJZI=[1)=WUS-/+EW)K_0M_X-EO^4''["/_ & /C=_ZTW\:J /W?HHHH **
M** /Y^_^#H'_ )0N?M5_]=OAE_ZL;PY7[G?#3_DG'P__ .Q)\*?^F*PK\,?^
M#H'_ )0N?M5_]=OAE_ZL;PY7[G?#3_DG'P__ .Q)\*?^F*PH [:BBB@ HHHH
M **** "BBB@ HHHH *_G%_X*,_\ *>K_ ((8?]B?^W!_ZBWPWK^CJOYQ?^"C
M/_*>K_@AA_V)_P"W!_ZBWPWH _HVB_U2?[HJ2HXO]4G^Z*DH *_SE/\ @X0_
MX)S_ /!3[XT?\%A_$G[47[&_[,?QL\9:7X/\)_ ;4OA[\6_A_I>EO::;XX\$
M:+!?0ZCH]_J&H0*-4\/:U;1RK(MN_P!FO;>)L!A&S?Z,LLGE;?XB[%5!( +[
M2P&XX"_*C'ZY^E?G_P"-_P#@JW_P3=^&OC+Q7\._B!^VK^SSX.\>>!O$&K>$
MO&7A/7OB+HMEK?ACQ/H5Y+I^LZ%K%E+,'L]4TJ^BFM+^UDQ)!<120O\ ,A
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MJFB:M8Q-(\<AN=-G/E*OEN?Z<Q"P 7S"< #)4$G QR<Y[9R3G/>O\\3X-_\
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M1UZD[E8EE/8ANA!^E $]%%% !1110 4444 %%%% !1110 QVVH[=U5F&>!D
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M?\(3Z?J^FV]]9'3X/&=EXEO]?71[FPL3I\ 4LS36P^])O^"8/_!WG/-*R?\
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M  ]X<T;3K*V^'L4,-KI.AZ5IVG6S;&F\FU0RRR.S$_Z$>>OMG_/I^O\ 7"T
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M4+G[5?\ UV^&7_JQO#E?N=\-/^2<?#__ +$GPI_Z8K"OPQ_X.@?^4+G[5?\
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MB4VEZVD>'M!TJSN)='L];T6TE\JYFFN1+.)8?Z^*_D"_X+Z?\$M?V^/VPO\
M@HI^Q1^U?^R3^S]\&/C_ .#OV;_AUH47B?P=\;_B!X4\/^!_%7BCP[\6-?\
M&J>#/%7A/6M:\.ZQKGA;5])U*R74I]+U![>\@EO=/DEL+BU O@#Z+_X-I/\
M@I;^UI_P4@^'/[8>N?M5_$[PS\5+WX.?&;PQX)^'WB+PO\/O"/P^LKCPU?>'
M]3NIK[[!X1M+>WNDUB:S@U.%[N:_DMDG,-O>208 _IRK^=__ (()?L4?M?\
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M.LOVD/@E\(OV@_AC_P %#?BI-\.?C?\ #;P7\5_ DFN_MW_$W3=<?PCX_P!
MLO$WATZSID?VR+3=6_LC4;-]1T];J<V5S(]JTK30S"/U?_ATC_P=V?\ 20CX
M@?\ B?OQ0_\ C%?J_P#\$%?^"[WP'_:K\6_!/_@F%\#/V:_B_P##[PM\"?V8
MK?3/ GQ-^+?Q4\#>,?$NL^#/@?H7A?PGI,'BC2_!G@/PAI)\3:QIDMG-=WVG
M)I^F1W,4\PT^.&6"-_ZVT+%5W<,54L.."1ST)'7(X)'H30!_GC+_ ,$D?^#N
MHL __!0GQ^J9&YC^W]\40 O<DK:NPP.X1B.H!Z5^/'_!1OXO_P#!?W_@EO\
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M_P!IK31K7A#QEI^F0VNA?$<> ;6R%^FO6R:#>7'AN]AF_P!'=L[3LQN(.WG
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M'% '\C?_  09_P""I'_!0?\ :V_X*!?M!_LN_M<_M.?LT_M)^"/AS^REX?\
MC'X>\2_LQ:?X"U#P2/%NO>+_ (2P1P6OQ"\&:!X>_M&^\/Z+XWU?P[XU\/W<
M,\&E>*+::T@(FTMY)_[!T)VC.<@*#G)R< D@X&X<]<#G/?@?.GPD_9"_9<^
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M_#GP9U:3Q9X[U7QS\5O&>IZ'X$\ 0V>BWUL^F'Q+K=A<:[=7$=AH\-Y<.RJ
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MA=_ZL;P]7]!E?SY_\'1/_*%S]J7_ *_OA=_ZL;P]0!^1_P#P0B_Y2,_L.?\
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MK_A!-8\2^&'@.K:7I0\7>'7O9K;R1J]@9DG3[>KR?XR?!OP'\?/AG\2O@O\
M%?PZGBWX6?%WP3KWP\^(GA9M8UK0E\2^$/%&F7&C>(-&DU?PW?:/X@TI=2TN
M[N+*:_T?5K/4(;>4M97-M<*LH /\T/\ X,]-%^&TG_!3+6=;U/QOXFL/BUI_
MP$^)^F>$_A[9^"+/4_!^O^$9T\,2>)O$VK?$?_A,;:]\/:II-^FG0:3X>M?
MNM6>OQ7MS='Q'IQM!#>?ZB,;;T1QC#J&R&##YANR"I8$$G@@D'J.*_G0_P""
M8O\ P;?_ +,7_!+G]H^R_:>^$GQH^-WC[QM;?#;Q5\.)]$^(2^!X] NK#QA_
M8TFHWTB>&]#L+I;ZWGTI)+=&NI[0+(\."L4,B_T7QJ0BAL[MJA@3G!"@$<
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MP-\*_AYHWACQ7X/NM"\5Z)H8F\(?\)-XME;7H=9NKB:"QTJ]M;598G /5/\
M@W8_83^&7[#O[)VNVWPA_;;E_;)\!?'?Q%X?^+/AW5=(2Y\,_#OPMHEYX<O+
M'2)O"/PTU:^O_$7A+Q#XR2.]NO&%_KLUM=:]9>%O"]LFEV;>&[IY?Z&*_/O]
MAK_@F%^Q-_P3AD^)I_8U^!EM\%(_C*?!)^)4=K\0OB=X]3Q(?AX/&A\($M\3
M/&'BZ?3#HX\>>(8L:/+81WQO2][#,UM;RU^@E !1110 4444 %%%% !1110
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M#QMJ$6I:K:2WO@KP9X#T5]/M[J(M8(-!6ZA6:5)KNX00K#]XT %?RP_M9?\
M*U[_ ,$LO^S"_P!H'_TR?M65_4]7\L/[67_*U[_P2R_[,+_:!_\ 3)^U90!_
M4]1110 4444 %?RX?\'>_P#RB*G_ .SH?@-_Z%XRK^H^OY</^#O?_E$5/_V=
M#\!O_0O&5 ']1]%%% !1110 4444 ?RW_P#!H7_RB8O/^SL/C[_Z*\"U_4A7
M\M__  :%_P#*)B\_[.P^/O\ Z*\"U_4A0 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '^0U_P '1_\
MRFC_ &GO^P5\*_\ U76@5_H#?\&RW_*#C]A'_L ?&[_UIOXU5_G\_P#!T?\
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M%* 4 (##S(N& (YE3L1CZ=Q@'J,U_F,?"K]G3_@I?^UG_P %E_\ @L-\*O\
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MLK JQH GHIGF+ZG_ +Y;_"CS%]3_ -\M_A0 ^OY8?VLO^5KW_@EE_P!F%_M
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M_G\_\'1_/_!:+]I\C'&E?"H=1W^'6@$<=2,=QP.,]17^@-_P;+?\H./V$?\
ML ?&[_UIOXU4 ?N_1110 4444 ?S]_\ !T#_ ,H7/VJ_^NWPR_\ 5C>'*_<[
MX:?\DX^'_P#V)/A3_P!,5A7X8_\ !T#_ ,H7/VJ_^NWPR_\ 5C>'*_<[X:?\
MDX^'_P#V)/A3_P!,5A0!VU%%% !1110 4444 %%%% !1110 5_.+_P %&?\
ME/5_P0P_[$_]N#_U%OAO7]'5?SB_\%&?^4]7_!##_L3_ -N#_P!1;X;T ?T;
M1?ZI/]T5)4<7^J3_ '14E &?J.XVY";%DR1%))NV1RNK1QN2GSKL=U;S%QY6
M/-) 0D?SO:1^WK_P;P_L-?M:_M.>--'^+?P%^!7[7'BSXA?$'PA^U!K5AX>^
M*!\5Z[X\LO'^H:EX_P!.\22+HVI:"U_/X\L[O4M6NM%@AAO-426X29XY#G^B
M:]BFEA/D>7YJ9>-)F9(6D0%XA*\:/*L9D5 Y0C"%MR2KN@D_'CXI_P#!O[_P
M2#^-OQ-^(?QD^*?[%G@WQ9\3/BMXU\2_$3X@^*)OB)\;],G\1^,O&&KW6N>(
M]=GTW1/B=INC6-QJVK7MU?W5OI6GV5B+F>>2"VB#E: /,OB!_P '#/\ P1MU
MCP#XYTG2_P!O+X82:GJ?@WQ38Z;%'HGQ&AEEU"[T*_@LXH9?^$/C$<TUR\<<
M+%T E9,R)RX_F-_X(&Z[?>)?^":?[1VL7^M:IKK7/_!;/_@E4EK?ZIJFHZC*
M^G#]M3]D6>T6-M0N)C''LN6?<JI)('43,XBA6/\ I4^(7_!N%_P14T+P#XYU
MO3OV$O!-MJ.C^#O%&J6%Q_PL[X_2>1>V.AW]U:S>7-\6)(F\F>*.0*\;J2HR
MIK^9S_@W\MK>R_X)D?M'VEK&L-I:?\%N_P#@EC;6L"M(XBMK;]M/]D"*"-7E
M=Y76.)5C5I)'=@H+L6R2 ?!/_!1O3;+_ (*%?\'0.K_LZ?'B+^RO ?BG]K'X
M4?LH:G>?#-F\.>)O^%:>'KK1_#6G7]OJ7B,^,[.W\83Z;<!=5UB+3%LKMUE%
MEH^EP7$D _U.K32HK> 1P3*B([I8HEM:P0V-J"RVUC;PVL=O&UE:HH2W@E$B
M':)'#S!9%_ROO^"F>MV?_!.+_@YWUG]I/XTBY\8>"?"W[4WPG_:UU#1OA6BZ
MGXMD^'GB"32/%%KH5M:^,)/!FAR>,[>QM&@N;"7Q!!H#W$L,<?B18VGDM?[$
M?"G_  5^^/?BS_@O59?\$Q_#>C?LY:W^RAK'P;M?BYX;^*/AO1?&>K?%/7+#
M4/A/:^/='GTSQWIOQ:N/AQ?:+?ZA=0SV=];?#RX2Z\./!;QR2SRKJI /S)_X
M/&_V.+>'X/\ P&_X*$?#W0/!WASX@?"/Q[I'P_\ B-\2+-KW3_B3KNEZO=BZ
M^$-@GE-)INMVO@_Q%:ZE=_VAJ0_M>T6X@CAN)=/@MM/M/ZM/^"<OCWQG\5/^
M"?W[$7Q,^(OB34/&7C_X@_LG_L^^,_&WBW5?LW]J>)O%?B7X5^%M8U_7]1-G
M;VMJ;[5M4O+J^NC;VT$)GGD,<,:D*/X]O^#PS]MK1O'B?L_?\$X_@_\ %F+4
M/B/J?C;1_%OQZ^"%I8:=+#:2>([#2;GX&OXH\57.F26VAZZUSJ3:[;:#9^*K
M"YBT37-(UO7=+N-(U+3KE_[&O^"?GPR\;_!7]A/]C7X/_$S2(- ^(OPM_9>^
M!/P^\=:%:ZEINLVVC^+O!_PR\,Z!XBTR#5]&N[[2-4AL=6L+NVCU#2[V[T^[
M2-9[2YF@>.1@#Z]HHHH **** "BBB@ K\3?^#@/X8Q_''_@G!XM^!TVKW.@6
M_P 9?CI^RU\)I_$%GIO]LWF@0_$?X]^!_",NN6VCM=:>FKS:4FJ_;H]-.H6"
MW;0&%[VU5S*O[95X-^T;^S5\&/VL?AAK'P8^/G@J/Q]\-=?O_#^JZIX=/B'Q
M9X4FEU/PMJ\&O>'M1M?$/@C6_#GB;2[W1M9L[74;*YTS6;65;B!,L!@T ?Q+
M?\%/?V$?'G_!"#]FW]D#]K3]FC]N[]I?5OVF](\:_!3]@?6?BA\3]8\(:;\#
M[#]F9%\>?%-_ (^%_AWX?WOB3PO\,M/\9>#-,UD:3'\1O$&L06#^(RVL:YJ%
M_;7<73/_ ,'!7[=UO))!%_P47_X(*R1PRRQQR1>!OVR%B>-)65'B']KIB(H%
M\H%0_E!2^7W,?Z,?%O\ P0,_X)2>.]-31_&_[+^I^.=)CNQJ,>E>-?VC_P!J
MWQ1I4.IQVUS:P:G!IVN_&_4K2+4(;>\N[>*]CCCNX8;JX2&=%FD#>>M_P;8?
M\$2G)=_V"_ ZNYRRQ_%#]H!8U)Z[%3XL1JJ]2 (T"C@#I0!^+_P\_P""SO\
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M$RQQ?I"?^#A#]O"-,_\ #Q7_ ((-E8UY6/P'^V0S%44\(BZN 6.W"HN 2<#
M Q_0AXD_X-W/^"/'C?59-=\<_L::5XRUV6&VMY-<\4_'#]IGQ)K4EK:0I;6=
ME-JVM_&6]U":VL+:*.WLXWN?(AA41P6ULBA6P#_P;8?\$3%5EC_8+\"GS-JL
M9/BC^T$2%#I(=A_X6RS(Q,87<C(=I96+1NZ. ?D=I?\ P5>_X+1ZYX:LO&>A
M_&G_ ()<:WX.U/1HO$FF>+]%_9 _X*5ZMX2U/PY/9KJ,'B+3?$^GZ)<:%?\
MA^?3B=1@UNTOYM+FT_;>QW36S"2O ?\ B(1_;Q )_P"'BO\ P0;('(!\"_MD
MJQ'/&#K(P>.A(//..<?THVO_  0V_P""9=CHL'AZP^ 7C+3M L]+_L*Q\-Z=
M^U3^U_9>';/08K?[#;:'9Z-9_'>WTRRT:'30MC%I%K8QZ?;6>+&"W%I&L9\<
M'_!MA_P1-D9WF_8+\"*68%%A^)W[02!5:-&=6Q\68U8B<S;"L<:B'RDV H:
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M^P^,WB.S3Q!I%Z;#P#>^.-2N?"EMJQDM8YI9M9@EMUT^*[$:_:#%7WO\.O\
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MZ-;W%K:7&L7FB^#?[:U.UTJWN[ZRM)]2GM4LH;F]LX))UEN84>AXU_X+I_\
M!2_X:>(;GPC\2_VV/^"*7PW\6V4-O<WGA7XA_!?]NKP-XFM+>[C$UK/=^'_%
M4^DZQ;1W4966U>:QC2YA;SH6>/!'[X>#O^#>G_@D#\.]4N-;^'W[(<7@+6KK
M3YM)N=8\$_'G]I_PGJMSI=Q<6EW/IMQJ&@?&O3KN;3Y[JQLKF6SDF:WDN+2U
MF>-I((V6OXJ_X-XO^"/GCK6)=?\ &W[&ND^--<GA2UN?$'C#XX?M+>*-?N+:
M!8TM8I=7UOXP7NHR1VJ1B*WADO)%MH<PV[1QLZ. ?SD^,?\ @OY^W3K?@[QA
MHUY_P4/_ ."%5S::KX2\3Z=<6^C>"OVQ8M:N([S0[^W>WT62?6/LZ:S.)/*T
MA[D-:#4GMOM2/;B53^/'_!/K_@F'\//VG_VL?^"1?PK^/'B[]IKPG+^VW^RE
M^U[\9?BIJ&A^-IO"?C#P^W@/XJ_M7:!\-Y/AEJ/BGP;JU_X>\#^+_ OPR\"^
M(;NQU6+Q#:^);?Q+?ZY83VNF>*(XYO[F?^(:[_@B/R/^&#/!1^4\#XI?M! G
M.1PW_"VR0?\ :/(.",$9KO8_^"!'_!*2VU/PWK=G^RW=VNM^#?#J>$?".M6_
M[1?[5MMK'A3PHEO=61\*^%]4M_C='?\ A[PW)8W]]8IHFDW%KI=O:WEW";*X
M@NYX" ?SA>%OVHOVYO\ @D)I'Q6_96^$WQ__ &-O@E^RO\(OVK/CWX)^"OB+
M_@HW\(OVN-7^,'B[3KOQ?KFMZ=JNL_&/P-X8\%_"7QO'XJLY=6U_P9/X45M1
MO/"MKON#-;VER5TO^(A#]O$_\Y%?^"#.>P_X0;]LGG_RL8_,U_1AXK_X((_\
M$KO'^EV>@?$']F/4O'6@65V-0M=$\9_M*?M9>+M*L]22!X8=4T_3?$7QPOK&
MSU&"&XO-/%Y!!'=O8WD\:W<%O-<64_GI_P"#:[_@B.!_R8;X(ST!/Q1_:" S
MC(SCXN?X9]!G% 'X^^"/^"NW_!8KXG^'[;Q=\,/V@/\ @E)\3/"-Y/<VEIXL
M^'?[*/\ P4>\<^%KN\L9?(O[.U\1>%=+U;1KFZL)_P!Q?6\%\\UI.##/'&X(
MIWC?_@KI_P %B_AEX>N?%_Q,_: _X)1_#7PA97%G:7GBWXB?LH_\%'_ OA6S
MNM0E%O86MWXC\5Z5I&BVUU?7!6WLK>>]CFNYR(;=))/EK]T?"?\ P0C_ ."7
MO@G0K;PWX0_9T\1^"M M);FXM?#G@W]J#]KKP]X=M+B]9)+V:TT?1_CKIFGP
M3W4J*][<Q6D<M_.IN[@":1E5_BG_ ((0?\$M?'.CS^'?&_[.?B;QIX>NI;>X
MN=!\7_M-_M;^)=$N+BSD\ZTGGTG6_CO?V$TUK+F6VE>W,D$N)(F5P#0!_-Y_
MQ$(?MY'C_AXK_P $&>>/^1&_;)_^7%?EK_P4Z_X*;?\ !2'_ (*)?L1_M.>'
M?BCJ7[$'Q'_9-_9U^._[,=CJGQQ_9P^'/QRT&R\?_$CQXWC6Y\)Z3\.?%/C_
M ,8:IINI:;X7&F:@?B):7WAZSU;3UU#0(+22V&MPSW']G8_X-K_^"),9#I^P
M7X'9E.Y5D^*7[0)0D'(#[_BQ*I4_Q!HG4C@H1Q6ZG_!O#_P2 A\+W7@6#]C7
M1H? M_J<.O:AX-@^-_[3%MX6OO$-O;&SAUVY\.P_&)=&GU:.R$=I'JDUG)J,
M44<&+IELK>( 'X=_%C_@L)_P7+_9[^,_QZ^%O[3^O?\ !,C]F/0O@SXL\,>%
M=+^,GQ8_9W_;9TCX&?%K4?%V@CQ+8P?"CXCVGB76=%US[%IK.MQ9ZEJ-IJQD
MM;Q4M[G[)<RIYK_Q$(?MX_\ 217_ ((,_P#A#?MD_P#RXK^CWQA_P08_X)7?
M$33#HWQ!_9L\0>/-'.HKJ_\ 8_C7]I?]K/Q9I0U51<A=3_L[7OCKJ%F=147=
MTJWP@%RHN;D+(!/(&\R_XAK?^"(__1AG@G_PZ/[07_SVZ /Q=^'7_!:+_@J_
M\8O[8/P<_:I_X(_?&%/#9TX>)I?A-^SA_P %!_B7#X9.L_;O[&7Q%)X(M]=7
M1)=:72M8;18M3-J^K+HVKM8"<:;>&'8\>_\ !7__ (+!?"G0#XL^*O[0W_!)
M[X7^%!?VFE'Q1\2/V5O^"C7@+PW_ &G?+/)9Z8->\7:;HVDG4[N&UO)K/3OM
M@O+M+2Y-O#((92G[C^"_^" __!*#X9PZK:_#/]EF[^'MKKTEE<:Y!X%_:+_:
MJ\&)K=SI4=];Z1-K/_"-_&NP&JMI-OJVL)I;7PF?3?[5U,V!MSJ5ZTNCXM_X
M(/?\$M?'>C-X>\<?LW>(/'>@R72W[Z#XV_::_:U\4Z$=2M[:]M[+4?['U[XY
MZGIYU"S2_O([2_\ (2\L5N[A[.>*1SN /YP?^(A#]O+_ *2*?\$&?3_D1_VR
M2/?D:P0?PZUZ?\ O^"Q?_!:C]JO]H+X8_ 3]E/XI_P#!)C]I>_\ &D/B74?%
M_C?X7_!C]L;5OAE\&[#PUIXU.U;XP^*IO%NDQ>%8_%\<5Y9^%HTE-WK%Y97=
MK:%+A$W?M$?^#;#_ ((E.2\G[!?@97;[PC^*'[0"IP-H*JOQ8C5<@ E50 ,3
MDL<NW;>#/^" /_!)OX;27A^&W[*D_P /AJ+V<FI-X%_:)_:I\&2ZE+I\QN=/
MFU!_#?QKT\WS:;,QDL1>><UO++++;26S;A, ?Q@_\$S_ -O[_@J=_P $X?\
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MQ]N+&_T_4+8FWN;:[BEMW4D7%O=1GR: /Q]_XB:E_P"AU_X)2?\ B9W[2O\
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MH **** "BBB@ HHHH *_G%_X*,_\IZO^"&'_ &)_[<'_ *BWPWK^CJOYQ?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#^?O\ X.@?^4+G[5?_
M %V^&7_JQO#E?N=\-/\ DG'P_P#^Q)\*?^F*PK\,?^#H'_E"Y^U7_P!=OAE_
MZL;PY7[G?#3_ ))Q\/\ _L2?"G_IBL* .VHHHH **** "BBB@ HHHH ****
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MV7/AUXLN(K'3=4O-9T9=(\=>'=?\/QP>)M/T6[U&/2QJFFVMQIURERWXR?\
M!0__ (*I>,_^"D?Q1_8QN?\ @J]^RMXT^!OP3^&7PO\ &WC;X?1?LPZ/XP^%
M?CWXF?#OX_-X,A\(_$/1M7_:/T_XF:'X@^&=Y=?"@7/A_P 1^$M):V\1:5+X
MBL=)U^YU"W1=/_N?OY/V/)?^"2W[$#_L$2:-)^RA)^V!_P $JY/A5_9%PMW=
MPP'_ (*5_LW/XIMO%\C%]0@^(5MXPDUZ+XAV6OF#Q%;>.E\2P:W9VVK0:BM
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M +,I_9B_]4UX.H ^_**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MWE^RIXH\01:%:M)+!I\'B#Q/J^I^(M2CM7\FYU6_NKH*IEY^.OC=_P '$/\
MP5$_X+#?"7X@_P#!/CX,?LM_"ZT\0_M >&;O3?$:_"2QUO7?&MU\.=(=-8\9
MZ?%'XXU#4=&TW1;S1("NMZZD,&K:5ICRWFDZC8W2221_T0_LF?\ !-6/_@F-
M_P $AO@)\*/%T?A.?]H7Q_\ \%'/^"97Q%_:)UCP3XPUKQ;X=O?%VJ?\%)_V
M;1X4T>V>_O9=%M;SP7\/F\.^#-5E\*:;I>B:WJ.BW6LQ_P!IR79U.Z /S?\
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M7B3Q+KMW?ZUK^N:SJ%Q<:AJNL:M>W>HZC?7$]W>7,UQ+)(P!]OT444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 ?S]_\'0/_ "A<_:K_ .NWPR_]6-X<K]SOAI_R
M3CX?_P#8D^%/_3%85^&/_!T#_P H7/VJ_P#KM\,O_5C>'*_<[X:?\DX^'_\
MV)/A3_TQ6% ';4444 %%%% !1110 4444 %%%% !7\XO_!1G_E/5_P $,/\
ML3_VX/\ U%OAO7]'5?SB_P#!1G_E/5_P0P_[$_\ ;@_]1;X;T ?T;1?ZI/\
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M^"4FEI<W;O)<RQ:;^V=^R!:QS2EY9F#3(BLR!RB/N"$@U^1/[&OQN_X+/?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?S]
M_P#!T#_RA<_:K_Z[?#+_ -6-X<K]SOAI_P DX^'_ /V)/A3_ -,5A7X8_P#!
MT#_RA<_:K_Z[?#+_ -6-X<K]SOAI_P DX^'_ /V)/A3_ -,5A0!VU%%% !11
M10 4444 %%%% !1110 5_.+_ ,%&?^4]7_!##_L3_P!N#_U%OAO7]'5?SB_\
M%&?^4]7_  0P_P"Q/_;@_P#46^&] ']&T7^J3_=%25'%_JD_W14E %2[C9_(
M<%]L,XF=47<SJL<H"8&6(,C1MA>24&<KD'^(?]L/_@SRU?\ :K_:P_:5_:<C
M_;QL/!4/[07QS^)WQDA\&S?L^W&OS^$T^)'B_5?%A\.S:U!\6=+CUAM(EU9[
M%=2CTS3UN8(8YFM8R6S_ '!_U_SQ6(OB#2;F>^L=-U33-0U/3PWVO3;.]M[N
M^M2D_P!FD6YLK:5[F I.#"_FQILE#(V&4K0!_CR?"?\ X(\0_$O_ (*S?'G_
M ()?)^T!_8Q^"3_M!1#XTGX=B]3Q!-\#/!6I>+%9_ I\90#3T\0W6FC3Y%B\
M47LND0L]WC4GC%NW[F?\&]]@NF?\$O\ ]H73S*MR]A_P6Q_X)3Z<UUL\MKE;
M']L[]C^W20J7=D5]C2+&9'\O>RACR3Y'_P %!?\ @G=_P6U^ '_!8;]K?]L/
M]ACX%?$/7S\8/%_Q/\6> ?B_\)O#OA/XC:&?AK\;K/5M#U+0[I?&ND3Z3:>*
MYO#[W5KK-A'I5U=:!+=V\NG:M*\MI?M^H'_!+;]@']H']AG_ ()+V>H_M*:+
MJW@?XD_M$_\ !6W_ ()M_$>_^%?BCP]<:%XR^'L/A?\ X*0?LU_#F"'Q,3/+
MI][+XLM_#EOXSTF72DCM(M&UVQCW2.20 ?%W_!3G_@N[_P %P/V??^"@/[6_
MP-_9\@FO?@E\+_C3X@\+?#G9^RGI/C..+P_I0L9;!1XFE\)WLVLR02L9DU&:
M[GF>3;*DH41!/A>/_@XT_P"#BF^<6T6B7MZ\Z_9EME_8HTF[,@N"ML8$@_X0
MB3<)_,2W,2J?-W)"5;<%/^I=>WMO96MU>7%Y;6UO:J\ES/=7$,%K:PQN!--<
MS2.D<,4$9+RM(Z! /F(Z'_/[_P""W7_!U-HOCWP%JG[.'_!+?Q[\1?#6J:EJ
M_BWP]\5/VG;*QN/!NH0>'M+EGTFSM_@1JMK?S^(;&+Q;"MYJ]K\3;2+PQXET
MC2QIM_X9?2M6WWUF ?CLW_!V%_P6I2 2GXR?"7R=Q82#X _"Z1%E+2$L?^)2
MZI<,P,OS 2LLD<X!2XB>7_3H_8%^*_CCX\?L-_L>?&[XFZC::O\ $;XO?LR?
M WXE^/-5T_3+31;#4O%_C?X:^&_$GB*^LM'L56STNUNM6U*[FM]/M%6WLXG6
M"%1'&H'\37_!%3_@U+?Q58^&_P!I;_@IQX=UOPLNF^,4U+P7^R-J:36NK:EH
MO@_6]3TB:7X_2K$B1:;XMU#3H]3TCP?X:U659_#-MI%YJVK2VFO7>@6W]_OA
M?PQX<\$^&]!\'>#] T7PMX4\*:/IOAWPSX:\-Z1IV@>'O#^@Z/9PV&DZ+H>B
M:1:V6E:/I.F6-O!9:?IFFVEK8V-K!%;6MO##&D:@&]1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110!_/W_P= _\H7/VJ_\ KM\,O_5C>'*_<[X:?\DX^'__ &)/
MA3_TQ6%?AC_P= _\H7/VJ_\ KM\,O_5C>'*_<[X:?\DX^'__ &)/A3_TQ6%
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M^#]>^&/Q'.OZBWB#X::W\/=8TF33XM)TV^U#43IQU";Y3_X(@?MQ_P#!'/\
MX)[Z7JOQB_:^^&_Q#_:#_:>UGQ!X?U/PCI.K_L[?!_X@^ OV>G\ >)1X@\*>
M,/A-XK\:7=UXPL_BI?ZDJZG=>.-%N?"\NC&RT6QBTZ_O]$@U:3^^KXU?\$"?
M^"2/[1OQ9^(/QW^-?['&E>-?BS\5_$U[XR\?^*KSXK_'/39M;\1ZBL2W=\VF
M^'_BGIF@Z=YJV\6;31M-L=/1]SQ6ZM)(S>8_\0T'_!$(=/V#_#_X_&/]HD_S
M^,'7W]>: /@%O^#RW_@ET%8CP#^T^Q .%'@#PR"QP< %O&849(Q\Q R>< &O
MZ@/V?OC/X6_:.^!?P;_:"\#VVKV7@SXW_"_P)\6/"EGK]JECKEKX=^('AG3?
M%6C6^L64<MPEIJD.G:K;QWULD\RPW*21K(X7<?Q\/_!L_P#\$06!!_8/T##
MJ<?&7]HM3@@CAE^,*LIYX92&!P000*_:3X5_#'P+\%?AE\/?@]\,- A\*?#C
MX6>"_#/P]\!>&(+S4=0@\/>#_!^C6>@>&]%AO]7O-0U6]CTS2+"TLDNM2OKR
M^N%A$MW=3SN\K '>T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?S]_P#!T#_R
MA<_:K_Z[?#+_ -6-X<K]SOAI_P DX^'_ /V)/A3_ -,5A7X8_P#!T#_RA<_:
MK_Z[?#+_ -6-X<K]SOAI_P DX^'_ /V)/A3_ -,5A0!VU%%% !1110 4444
M%%%% !1110 5_.+_ ,%&?^4]7_!##_L3_P!N#_U%OAO7]'5?SB_\%&?^4]7_
M  0P_P"Q/_;@_P#46^&] ']&T7^J3_=%25'%_JD_W14E !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M2?\ B5OP'_\ F^KV/_AE;]F#_HV_X"_^&?\ A[_\SM'_  RM^S!_T;?\!?\
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M'_\ F^KV/_AE;]F#_HV_X"_^&?\ A[_\SM'_  RM^S!_T;?\!?\ PS_P]_\
MF=H \<_X>9?\$X/^D@/[$G_B5OP'_P#F^H_X>9?\$X/^D@/[$G_B5OP'_P#F
M^KV/_AE;]F#_ *-O^ O_ (9_X>__ #.T?\,K?LP?]&W_  %_\,_\/?\ YG:
M/'/^'F7_  3@_P"D@/[$G_B5OP'_ /F^H_X>9?\ !.#_ *2 _L2?^)6_ ?\
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M  3@_P"D@/[$G_B5OP'_ /F^H_X>9?\ !.#_ *2 _L2?^)6_ ?\ ^;ZO8_\
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M/[$G_B5OP'_^;ZC_ (>9?\$X/^D@/[$G_B5OP'_^;ZO8_P#AE;]F#_HV_P"
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M]&W_  %_\,_\/?\ YG: /'/^'F7_  3@_P"D@/[$G_B5OP'_ /F^H_X>9?\
M!.#_ *2 _L2?^)6_ ?\ ^;ZO8_\ AE;]F#_HV_X"_P#AG_A[_P#,[1_PRM^S
M!_T;?\!?_#/_  ]_^9V@#QS_ (>9?\$X/^D@/[$G_B5OP'_^;ZC_ (>9?\$X
M/^D@/[$G_B5OP'_^;ZO8_P#AE;]F#_HV_P" O_AG_A[_ /,[1_PRM^S!_P!&
MW_ 7_P ,_P##W_YG: /'/^'F7_!.#_I(#^Q)_P")6_ ?_P";ZC_AYE_P3@_Z
M2 _L2?\ B5OP'_\ F^KV/_AE;]F#_HV_X"_^&?\ A[_\SM'_  RM^S!_T;?\
M!?\ PS_P]_\ F=H \<_X>9?\$X/^D@/[$G_B5OP'_P#F^H_X>9?\$X/^D@/[
M$G_B5OP'_P#F^KV/_AE;]F#_ *-O^ O_ (9_X>__ #.T?\,K?LP?]&W_  %_
M\,_\/?\ YG: /'/^'F7_  3@_P"D@/[$G_B5OP'_ /F^H_X>9?\ !.#_ *2
M_L2?^)6_ ?\ ^;ZO8_\ AE;]F#_HV_X"_P#AG_A[_P#,[1_PRM^S!_T;?\!?
M_#/_  ]_^9V@#QS_ (>9?\$X/^D@/[$G_B5OP'_^;ZC_ (>9?\$X/^D@/[$G
M_B5OP'_^;ZO8_P#AE;]F#_HV_P" O_AG_A[_ /,[1_PRM^S!_P!&W_ 7_P ,
M_P##W_YG: /'/^'F7_!.#_I(#^Q)_P")6_ ?_P";ZC_AYE_P3@_Z2 _L2?\
MB5OP'_\ F^KV/_AE;]F#_HV_X"_^&?\ A[_\SM'_  RM^S!_T;?\!?\ PS_P
M]_\ F=H \<_X>9?\$X/^D@/[$G_B5OP'_P#F^H_X>9?\$X/^D@/[$G_B5OP'
M_P#F^KV/_AE;]F#_ *-O^ O_ (9_X>__ #.T?\,K?LP?]&W_  %_\,_\/?\
MYG: /'/^'F7_  3@_P"D@/[$G_B5OP'_ /F^H_X>9?\ !.#_ *2 _L2?^)6_
M ?\ ^;ZO8_\ AE;]F#_HV_X"_P#AG_A[_P#,[1_PRM^S!_T;?\!?_#/_  ]_
M^9V@#QS_ (>9?\$X/^D@/[$G_B5OP'_^;ZC_ (>9?\$X/^D@/[$G_B5OP'_^
M;ZO8_P#AE;]F#_HV_P" O_AG_A[_ /,[1_PRM^S!_P!&W_ 7_P ,_P##W_YG
M: /'/^'F7_!.#_I(#^Q)_P")6_ ?_P";ZC_AYE_P3@_Z2 _L2?\ B5OP'_\
MF^KV/_AE;]F#_HV_X"_^&?\ A[_\SM'_  RM^S!_T;?\!?\ PS_P]_\ F=H
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M72/#?A[QCJ.LZK+;VZO<S0Z?97,L=M%-<NBP0S21_P!-OPR97^&WP]="&1_
M_A-E8=&5M!L"I'L00:\]/[*O[+Y5U/[.'P%*R1R0NI^#_P /2'BF0QRQ.#X=
MPT<J,R2(P*NK%6!!(KW6&&*WABM[>*."""..&""%%BBABB0)'%%'&%2..- J
M)&BJB*H50    2T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
D0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>ex10-7_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex10-7_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !2 ?D# 2(  A$! Q$!_\0
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MNJLCQNKJRL,JP9&8$,I# YY!!% $M%%1/-$C!'D16/0,Z*3QDX#,"<#K@<4
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MQT8JM/WL3B::=6?+&')'W9=Y69J&=DN "?(; /0X67@].OU'M6G7A'QG^/\
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MDMI3+!8Q:!\6+7P[J<U]%Y.CZ\UBJO=_T ?L>?\ !2W]CS]N+0]-N?@?\6]
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MT[XI\8Z3K^C6%U>V.N^&HOB!/?P:II,@AV75KJ%A;BZLY5*QSI)&R-LD!/\
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M?\$6;OX,^%M7_;F_9Z^*?Q#\8>,O">LV_BKXV+\2?$7A6'Q/J$336\%EX_\
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M7AS5Y[ZRFU"RATW7=8O;32[R2\L+>:[MTM[J0SVT3S0B2)"U>C^'/$&A^*=
MTGQ+X9U/3-:\.Z]IMGK&A:SHU[;:AI.L:1J-M%>:?J>F7]H\EK>V%]:S17%I
M=V\DD%Q!)'-%(\;JQ_F#_P"#DB[\(7?_  3C_9PN/AQ#;1>!+SXL^ +CP1;Z
M9936%G'X6F^&OBJ70HK*PEM89;2U&CO#'#;2FSD@AVQM&S1M&OUI^Q]\"?\
M@I7JO[*'[.6J^"?VZ_A5X5\*:A\$/A9>^&?#-[^R7H>M7.@:)=>"]$FTO1KG
M6S\3K!M6ETVP:ULWU,Z78G41')=-9V[S[%Y)\*X6/"V5\0SS>C@:N8YOFV6O
M!YA2KJG&&7*@X5(5<'A<54=62JM5HU:5.G&4&J<I2O!=D>)\:^)\SR".45L;
M1R_*,IS%8O U:3J2GF'MXSA.GB\3A:*HQE07L9TJE2<N=*HE9-_KWI7[17P%
M\0_$:^^#^A?&+X6ZY\5]*FU&#4_AIIGCSPQ?>/-.FTB(S:HEWX3@U&378)-.
MAQ+>I)8J]I"QGG$<*LXQ?%G[27[./PZ^)FD_"KQQ\8/A1X)^*OB+3["^T;P7
MXG\9^&?#WBW6M-O[F_ATZ73M+U.]M-1U"WNKJPU*.T%M%,LTUO<+$#)D-_(%
M_P $Y],\>:)_P</_ !DTGXH^+=+\>>/=/NOCI:^)/&VB^&(/!^F>)=;MM&2&
MZU&S\-0:EJT.BBX422M90ZA<JIAD)94W :'_  6M^'7A7XQ_\%O?V/OA-XSC
MN+SPA\1/#?[.G@7Q;9V>HSZ;>MX>\4_&#QAH^I16M[:SK<6-Q/9W<ZVL\2Q.
M)MK1[R"#[T/#[ 1XDP^2ULWQ'U2KP6^*IX[#82A5E&I'*99I.C0HU7A_;4'&
MG-0]HZ%>=-P<O93;MX%3C[,'PYB<ZI91AXXJEQBN%Z>!Q&(K4Z<X/-J>61KU
MJ].%9TL1>K%S5)8BA":GR^TA%<W]LDD-AJ$*^=%:7<,JAE$B0W$<B<X(WJZN
MAR2#C!!SQFO#;KXG_LUZ7\2K?X47GCGX*V/Q:NI8(K/X>R^)/!-M\0IKB[L5
MU:WCA\)-=IXCDDN--*:C%ML")+,&Y4F%3(/Q'U_]G+_@J1_P30,?B+]C;XDZ
MM^W?^S)I%M%#+^S1\<K\7'Q8\&:):R1!;7X>^-;1[2YUF.UM!-#96MI&C6@D
M2VMO .O2*;M?QM^&W[2T'[6/_!P9^S]\81\/_&_PFU/5]7\/:+XH^&_Q!LFL
M/$W@_P 7>$_@MJ^@^)M!O8G6)I(;/5=,N!8WDMGIEU>:<T-Q<Z;83M-;Q\63
M\!T\VIYOCL+GF$Q>4Y?D>9YM'%X%TX8R.)P,*<\-E^:93C:E#,,!/$QE-*LJ
M6+PTI4I+#XR;<82[LWX[JY5/*<%B<DQ6$S7'YWEN53P>-]I+"RP^-J3A7Q^6
M9I@J5; 9A3P_+%^R=3"5XJI'ZQA(>])?W;7=UI.C6=Q>W]SI^FV-I&UQ<W=W
M+;V=K;PQJ-\T\TK)%%&BK\TCL%4#D@"OF'6?V[OV+?#FH-I.O?M8?LX:-J22
M/";#4OC7\.[.\66-E1HGMIO$"31,"ZC;(B')QC(('\XO_!?30_VH%_:0^"/B
M;XG:;\6_&'_!,O3[GP-=?%O0/@_-JT=A90V'B.2?Q_\ \+ AT-XI8-1N-$\J
M3PYK.MF#3(8&-EH^JV.L?:6C_0WX(>-/^#?1/ =C)\/KC]@+0]&N+.WGEM/'
MNE_#?2?%N7@CP-:A^)UJGBZ2Z16"3'4C)*&WDNP)=N*/"F'I9'E&=3J9OG"S
M6G4JSH\-X*ABZ.5.G6=#ZGFN*KPQ<\/F,[.M'#?4:4%2<)*O6Y[Q[7Q3B:V=
M9ID].GE64?V7.E!5N(L57PU7-%6I>U6*RO#4982%; P=J4L0\;5J.JIQ="CR
MI2_8?P/\6/@S\9++[;\//B)\-_B58PC<\WA+Q3X<\76T(;Y"S2:5>7T<>2?+
MRVW)^7VK0\=>+OA5\+M#_P"$G^(WB7P'X!\.K>6]B->\9:MH'AC1A?W D:UM
M/[4UF:SLENYS#)]GA,PDE9"(U)%?Q5?\%+;S]D[Q!\<?@2O_  1,T;5)/VNK
M/Q-JESXLUO\ 8RL=?TSPA%X9N(HK.W74;CPHEOX0:>769H&N]1TY$T1-':_3
MQ-?/:M:0#])_^"X,?Q=M/^"*WPRM_CP]O>?&L:Y\!8/B=-8/:M#)XX33KIO$
M/E-9-]DEG6^CN3,]F#9R2I-);GR-@KL? ]*6,X2HK,,3A8<4YE]0_L[,L)2P
MO$&61]HH+%5\OA6E3J8;$)J6$KN&"59)N5*R4GQ/CBI#"<557EV'Q=7AG+OK
MSQ^78JIB,AS.7LW)X6ACZE"-6&)P[3CBL/SXUT=.6K>\5_2/X*U_P3XNT&R\
M5^ -6\,^(_#6LQM+IOB+PG?:7JVBZK#;SS6SR66JZ0\UE>Q0W45Q SPSRHDT
M<J9#*PK8UF[T2RT^XO->N--MM,M$,]W<ZI+;0V5M$@R9[B:Y*PQ(@()D=E50
M1D\U^%/_  2!_;4_9#^'G_!.7]E_P7X__:=^ ?@GQGHWA#6K36?"?B?XL>!M
M$\1:1=3^-O%%U;VVI:-?ZW;W]A<S6L\%RD-S;Q2O',D@4AP:_,C_ (+::A\?
MT_;D^$&N_M%6WQ<U_P#X)8"3X=W_ (A'PM'B&7P-)HQGC;QFGC.?PXT<:>*;
MK4)1-IKZK=VEQ=>'!;IX3N$OX[N1.#"<'5\3Q-F&0UL5/ 4\%4SOV.*Q>%J4
MJ^90R>>*4*&6X>M+!TL9F&80P\%A,/3Q:A4G67)4JI1IU?0Q?%]'#<-9?GM'
M"T\=4QD,F5;"X/$TZE#+9YM3PSE7S'$4HXNKA,OP$Z\OK>(J83VE.G2DY4Z3
M<IT_Z8M6_;1_8<T#47T;6OVFOV9=)U2(B-M.U'XN?#2UO(SDJB2V\NLB6$GG
M"R*I )XYY]K\%^,O@O\ %"R-_P##_P 4?#7Q]IZG#7GA/6/#/BBS!4CG[1I$
MUY 1N(VL'P>&4D$5^1WPM\0_\&_LO@BVD\&3_P#!/*TT&XL$>2#Q?9_"FQ\1
MM#Y9F)UJ'XA01^+OM( ;?_; %T&#1N P*U^#O[?$_P"SCK/[4GP.M_\ @A9I
M'B-_VG;?5-<D^(6K?LK1>(+3X9)I4@TN#15U!55O!"0I*=0.L7EC#:>"%T*6
M2+Q'+?>='!!WY7P9A<WQM7+XT.)\DJ4Z6(J3S//<KP='*,,Z%&M63S2O&. G
MEU&JZ#HPJ1Q.-;K5*2C2KW49>?F7&.)RG"4LP=7A?.(U:N'IQRW),UQ-;-L1
M[:I1I..64W+'1S"O35;VKHSP^#3I4ZEZE&UU_<=!H^@Z<YN+73](L9%#$SP6
M5G;.!M(8F6.-& **0W/W0<\"O#_%O[6_[+7@2^FTOQK^T1\#O"FI6QQ<V'B/
MXI>"='O+<XW,)[:^UB&>)E&"V^-0,@$[@0/P;_X+ZK^W]:?LB?!"7X3R>-;K
MP6FD7<'[7,?P?^VC4Y+U_#^B[+W5(]%C;7)?AL+M?%)U<1 :':DZ?-XAB: 6
M,UK:_9#U#_@A</V9M,O_ (2V/[&T_P 3[?X<[)=,_:DG\,67CF\\>PZ+)+)8
M^,;SXJ_:=7CMKOQ(CKJEWX96XT&.%I)]#4Z;'8QIPX;A2B\APN>5JV/S3ZYC
ML5@EE_#>&HXVME\L+4]E&OG&)K1KQP-/%^]4P<?J,G7H+VBJ\JE$[<5Q766?
M8G(Z.'P.6O"X+"XUX_B'$U,'1Q\<3#VLJ.54*,J#QD\(VH8R4L=!T*[Y%0=X
MU#^@'X<?%OX#_$B?4;WX3_$3X5^.+F[>*YU6Y\!^*O"WB&XN9!"BPSWTNA7E
MU+*RP*J1O<,2L:A4^4<4?'WQ<_9X\'^(K?0OB;\1/@_X7\4RV=M/:Z3XX\4>
M#](UR6PNI)4MI;:SUN\@OI+::4RI$8HS$\GF*A+;A7\2/B[]IKP/\-/VIOAI
M:_!7]@7]AGXN_M!ZG>1MX5C_ &(OB;\:-:L=,UF"]LI;,O:?#I_#7A276IC'
M/,)=-M]5N[6PM+Y]4NK:QE4W']??QT_8S^#?[<_P%\+>%/VN?A+X=U'Q;+X-
ML;N6ZTMC#XA^%_C35M#M9-<D\ >*HI#JFG#3M9"E8VN+C3=9CTZT@U[3]5L_
M-M9*SSA7#\.XC*:V98C'4LKS2C*JI4ZF38G-Z-.#4955@:&(H\^'2E^[EBJ.
M72Q#C4A0CHIMY)Q1B,_HYK2P%# U<SRNNJ,N>GG-'*JM64.>-)XZMAZSC7;5
MJJPE;,HX=.$JTKOD7UL-%\$P6T>K#3/"\-K;Q+?QZB+'2HX(8$'GK>1W8B"1
MQ*J><LZN$ 7S P"Y'->#_CA\&_B#K$_A[P#\5/ASXUUVTM9+R[T?PIXT\.Z_
MJ=M9PRI!+=3V.DZA=W,=O%-(D3S-&J)*RQL59@#_  X^'M$_:D\1_MWZA_P0
M_O\ ]M'XQ_\ #+%CXZU;PB=4BM=*3Q@? .B_#>[\<IX/&K2"2_;29M)M8_#_
M /9L][=^&$EB75#X6-H\FD'^S3]E+]BW]G#]C+P,O@3]GWX;Z7X*LYX; >(-
M;W7&I>+/%UY8P-%%J'BCQ+J4MWJVK7"O)<2PP272Z?8/<SQZ99V=LZPKGQ)P
MQ@N&L/@UB,XEF.-S3"T,TRJC@<'5HX59/BG)X?%X^KF$X5J.*Q,8\\<!A:%6
M5)1G[?$_P^9\.\48WB3%8OZME$,!@LLQ5;+,UK8W%QJXO^UL*H_6<)@:."A*
MC6PV'D^1X_%5J,*TI06'PW\1Q^I+RTL[ZWDMKZWM;NVDV>9!=PQ7$#[761-\
M4RM&VUT1TW X=58<@&O,/%]U\%O MA_:?CN?X9^$=+#^6-0\4MX9T.R+D! @
MN-3^SQ%RI"A0Y.T@8QBNB^(:^+_^$%\9+\/GTU/'1\,ZT?!KZR)#I">*/[.N
M/[";5!"/,_L]=2^S->>6#(+<2;,L *_BA_8FO?@;XB_:[^/&G?\ !=*_\0CX
M_P!@-%C^%5C^U'?:[I7PRMM$EN=477&TF)IK;P1!;2LNG-X?>1T\(/9273Z&
M+B\D8Q<W#G#;SO"9OCWBJJIY/2HUIY;EM#Z]GN.]M4C"4\!@'6HQE0P\>:IC
M<4_;1PU.,)2I23NNGB'B6.28S*<#]5I>US>I5I0S+,*_U+)<"Z,)SC''X]4:
MDHU\2^6&"PL71EB:CG"%6+5I?US:'\</V+_$VIKI?ASXK?LTZ[J[20P"PT?Q
MG\--3U%GGD\F&,6MGJ$MV3+,QBB'E;9)"8U)<[:]$\6ZU\ /AU=Z2WCO5?A'
MX(N[YI;G0G\4W/A+P]=7DED\(GGTLZH]K).UHT\'F2VQ=H&FAW;"Z9_,+Q5X
M+_X(.+INBWE_;?L 6GEZEI1\-W/@[5?A9I_B.358KN-M*CT:X\#WD'B6[NS>
M"/R8K5YGDG*H48L%/XY?\'4\_D:[^Q+'8%%@>P^+Z>6^%C9#=?#J,1W".R2+
M$(XUC<MY>W!1G+G='Z7#W"N&XBXCR?(Z-7/\JIYG_:*J8K,\OH\\7@,-4KM8
M6-!X>&(?-#V6(37^SRDOC?N'G9]Q3B,@X>S7.JE#(,TJY?\ 4'2PV6YA5E3D
ML;7IT5+$SG#$SPZ<9^UP\H-_6(QW@KR7]8=M^TS^SE<S0VUK\>/@[//<210V
M\%O\2/"$DL\LS".&**--6W222N0D2("78A5!)Q76^.?BS\+/AJ=&7XC?$+P+
MX%/B.ZDLM!'C+Q5H/AH:W=Q>0LEMI3:W>V2ZA/&;JW62&U,LB>?&&7]XH;^7
M/X2_!_P"=1^&4U_KO_! >1(KKP'=7\=AX>6;QY!"9=%>YCTYC\0S!)XP".XL
M96C"/K3PR,$3Y%YO_@ZBV2>#?V-K5I#'YOC/XCQR>20B)&VF^$%F(;8)(T\J
M14=W<0B-DRJ.=R:8'@W YAQ5DW#E',L52IYG4QU&KC*N&I.5">$H8NKS0HRP
MV7QG"3PLE4YIU'&,_=J-IMYX_C+&Y?PUF_$%7+L)5GET,!4HX2EBJJC7CBZV
M$I.,ZRQ&.E"<?K2]FHTZ?-*'O4TG8_K2T/P_X5TA]0U'P]HV@:;+XAG34M4O
M=&T_3[1]:NC$%COK^YLHHVU&<PLJI<SO+)Y6U0^S K@?B#K7P(T75]-'Q1U7
MX5:7KFH6Y32!XZNO"EIJEY:6\@C9=-_MUTNKB"&:[5"MMO1)+D*0&E^;\%;/
M]F/_ (*:_L">#?!/Q'_8A^,VN_MA? ^/PMHMWK?[)?Q]O['4?%&A:/=Z=:WP
M'PP\<FZTB>:/3(RUKIFA64VBK!#.GE>'?%EZ!;G\(/\ @K;^W+I'[:G[0_['
MTM_\,?B!\#_BG\+[RY\'_&+X1_$?1[O2]:\&>)[_ ,7^$;JVMHKNZMK"75]'
MOH(;J6UDN]-TJ_\ *C'VK2H8KE/.Z^&_#R7$.:QH8+/,-B,J=#,JN(S'!14<
MPP,L#A*]:-',LFQN(P^-PGMYT8T(XA2QN!FW+V6*?+RKFXAX_7#^5SKXS(L3
MALSAB,OIT,OQC;P..AC<51HSKY;F^#PU?!8KV$*L\1*A+ZEC812=7#1<N:7]
MT_BC4?V7O!FHC2/&MY\#/"NKO;0WW]F>)IO FBZ@]G<2.+:\%GJ8M[AK>>6V
MD$,_EF.26W<([-$VWG1X]_8RW1D>,/V;-RCRHR-;^&NY59C\B'SL@%D/R*0"
MRG@E>/%?VUOV2OV7_BK\)?BS\6OBC\!OAAX^^)?AWX'>,(-&\:^*?"&DZMXD
MTRWT'PUXBU72K>QU:]LYKNUCT[4+Z[N[$*P>"ZN7ECQ*<C^<G_@V\_92_9L_
M:(^$/[0^N?';X&_#7XL:KH'Q'\,V&AWWQ \(:5XCNM(M7T"\EFM-.DU.QF^S
M6\LL@EE6WF >18GD0,L3MYF5\/Y7CN%LZXDJYCG-'^PL5E6#Q6$H87 U(8BM
MFLZ]*G/#XB>,@H4J7L??6(@JTE)J$=$CT<RX@S7"<39/P_2RS)ZT<[P^9XO#
M8NMB<?">'I99##U)QQ%&G@JD:E:K[=*+PU5THR4>:6I_6EJNM_LY?#;4M)N]
M;U3X-^ ]7O;8W^B7.HW7@WPYJ-U9L/)-WIDUP;*YFMW5S&9[9FB*L4+$'%:^
MF_'WX&ZS?V>DZ3\8OA?JNJ:C=Q:?I^FZ=X[\,7U]?7T\BPP65K:6VI237%U-
M*RQ16\4;222,$5"Q K^0?_@Y#M8+?]LW]AO0[)O"5E9'PM::7';>,8YU\%6U
MD_Q(TJSA3Q/#:%'3PK% 3'JRVQA<:2MZL;IC%?=W[,WP<\':+\<_A/J%TG_!
M#N)=/^(.C75M_P *+M;UOBU)=V]]&UL/A])?>-+N./Q>+R"(:;NL+QQ=@,45
MTVOT5N#\%1X;R3/:^98V=;.L!F&,IX2.&I<F'6#Q=?"P@ZDJ&,J5HU?8J<G"
M6&<;NT7&/M3FH<88W$<1YUD=#+,'"CE&/P."GBZF)K<^(>+PM+$SJ*E"MA8T
MW2]I*$4XXCGLG*2;E2/Z#/B'XS^"6C3V6C?%7Q1\,M)NGC.I:?I7CW6/#-G+
M)"3)!]NM+/7IT+(2DL1N(HB/DD3?\K"N6\.R_LN^-;G[+X4D^!7BJ](W+!H/
M_"!ZU<'()R([!+B3[H+9 Z G(&37\GO_  <-6U]J7_!1G]AW0M,T#1/%EYK/
MACP780>%O$X"^&?$LUW\7-0M8= \22&VO"N@ZH[BSU63[#>B/3Y;EC:W!7R7
M^1/VAOAW8_$S]K[X?_ ;XW_"+X"?\$;-<\)W%_J.F?%7P;X?\3OI'Q,@N;FP
MM;&ZT#QIX?G\-> [G3+589-0TCQ!J%QX<M]-FEO+#4=<@U&"#2:]G*_#C#X_
M*,BS*>=XC#2S;),RSNI"EA\+B:F!HX#%5\*U0RJAB7GN;>TJ4H\_]DX.M5H*
MHYU*,H4ZDX^3F?B+B,#FV=Y;#(J6(659UEV2T:E2MBL/2QU;'X:AB8NMFE;"
MK),IY(59*"S7%4J5=TXPIUE.I3@_[][.VM;.U@M;&&"WM+>)(;>"UCBAMX88
MU"QQPQ0JL4<:(%5$10JJ %   JS7"?#&P@TCX>^"M(M_%5WXYATOPOH.G0^,
M]0OHM3O_ !7'9Z5:0)XBO-0MVD@O+G650:A+<Q221S-<&19'#!CW=?D\DU*2
M;;<9SBVXS@VXSE%MPJ)5(-N-W&HE.+;C-*<9)?JM-\T(2LH\T(RY5*,E'FC&
M7*I0]R25[<T/<E;FA>$HME%%%26%,81GA@A[8;:>/3G^5/KF;[PAH.I737EY
M:22W+A T@N[J(,(QA?DBF1 0 !E5&<<\UYV95,UI4(RRC!X#'8EU(J=+,<PK
MY;0C1:?/.-?#Y=F=2=1.RC2>'C&2;;JQM9Z4E2<OWU2I3ARMJ5.DJLN;3E7+
M*K223UO+FNNB9LFQT[S/--G9>;C:)3;P>9C&,;]F[&,\9QBK"I H 1(E Z!5
M0 =N !@<#'X5R1\ ^%VZV$OT^WWX'Z7(_P *!X \+ @C3Y00<@_VAJ'!'_;U
M7A?7..=7_J[PI?9?\9;FJNEM=_ZGZ>FMNFYTJ& :][%8N]W_ ,P5-KUUQN[Z
M_FSKPJ= $]< #KZXJAJ6D:9J]M)9ZEI]E?6THVR07=O%/&P[?*ZL 0>AQD=B
M#7/MX!\+L<FRN,_]A'4/_DFG#P'X8  ^PS<#'_(0U#_Y*K#$2XPQE"MA<9PG
MP;B\+B*4Z.(PV*XGQF)PV(HU(N-2C7P^(X)KT:U*I%N,Z=:C4A).TH/2SBL'
M2E&=+&8VG.,E*,X82-.4&G=2C.GCX2C)-)IQE%I[,\I^/'[+OP;_ &D?@IKW
M[/?Q:\,OKOPK\2+I":KH-GJVJZ+/)'H>MV.OZ<D&K:5=VFIVBQZCI]L9/LUU
M$TUN)+:0M#+(C?F:O_!O-_P2N602#X":PY 4%)/BQ\4WC<+G&]3XMP0<]!C'
M SW/[#MX#\+D$&QF [XU#4!_[=5\K?%7]I7]D/X+?$6T^$?Q'\?Q:'\1[SP[
M'XML_!MO:^.->UV?PW-<7-HNM)8^'K#59/L N;2XADG956)XR'(#*3[619SX
MI9-A*64<,Y-E.68'"T4Z.6Y'QOG>"PN&P^%H4J,73PF#X1HT:-'#86C0HQ:A
M3I4</2I4TX4Z<(KQ\VRGA''5?KV>4L)C*TG"BL7FF48"O5DZE2<J=)5\7BIS
MG*I6G4E&FI3E.I*;492E)OY3TW_@@O\ \$K-,6-4_9>TF],14AM2\>_$^\+E
M2"/-$OC4QR#C!5HRK#Y2"#7TO\.O^"9'_!/[X57,=[X*_9&^ FGW\)4PZCJ'
MP[\/>(=3@:-@\;VVI^(K35+ZWD1EW>;'.)3R2_)KUWX3>-O@9\<-,U;5?AIJ
M>J:YI^B7T>G:G<7MCXW\/O;WDL"W"PQQ>);/2;F;]TZEI;:.6%'S&[B4%!ZS
M_P (/X3YQ'><EN!K.K#!?.<*+P 9W?*, '(QG(SOB^*_%K$2G1Q^%PM=K25+
M$>(^?S2TLU*E/AZ5/9V:<)*SL]V@PW#_  A0Y:V#P. H2DE*-:APWE5.35KI
MQJ049[)--2AHKWM9OI=,T;1=%L[?3M'TK3-*T^U01VMCIME:V-I;Q@E@D%M;
M110Q*&);:B*-Q)QDYK2!4# *@>@P!7CMY/\ !W3?%ND> +_Q9HUCXX\165WJ
M6@^#[SQK-;^)]:T[3XYI+^^TG0YM634M0M+&.">2\N;2VFAMDAD>9T5&([)/
M GAL#*P7_P!?[8U?/ZWO]*\AXSCF/*Y\,</14USQ;XPQD>>+E)<\'/@R*G%R
MC-<R<HN49KGYHS4?5C'+)74<=7?(^22A@J4N222?))1S!\LE&47R249)2C[J
M35^QR/4?F*AN;>UO()K6[@M[JVN(WAGM[F..>">*12KQ30RJT<D;JQ5T=65E
M)!!!(KE3X'\/*"1'J*G!Y76=7'0$_P#/Y[5X?\.OBE\!?BMX^^+/PQ\!^,=0
MUWQK\#];TKP[\4=&BNO&=E_PBVLZQ;3WVF6,U]J4%GIFHR7%K!-*7T>]U"*(
M(OGM"98U?2.)XZG"K4I<*9)4C0C&I6G#C"NX4:<JD:<9U9+@Z2IQ=24:<93<
M5*I)03YFD\ZLLLISITWCZD)UIN%&-7"0A*M.,)5)0I16/YYSC3C*;C!2:@I2
MDE%-GN;> _ Q.X>#?"6_/+?\(]H^X\D]?L>>I)^I)ZUTL-K9VT:Q6]M:P1*
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M)X%'_"(Z:S #5?$@/0 :_J:@G!/'[T G')QG P3P0:7]I\9M)/A'+&DVTO\
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M[1,R'U$%1T*CZ8%<H_A>W8%3K_B49XXUB0'UX(BS^7!Y]*!X4A/3Q!XH]_\
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MQ6L][:3:;+:FZ^+?AC\=_P!L#XV>.O /_!+WQ%XQ\<^&/CG\ _B)J=]^U?\
MM%^'-3U'2=2\4_L^>$9-,UOX<:YX:\2VDT5[;>(OC5I/B'0=,U$QSG6=+%I=
M:I>-*;J[@M_Z+_%/A;3_ !=X;UGPOJ-SK%A8:YIMWI5W>>&]:U7POKMO:WL+
MP32:3XAT"\T_6M&O421FMM1TJ^M+ZTEVSVUQ%,B2#Q+X%_LE? O]G+4O&FO_
M  N\)W=GXN^)&H6FI?$'Q[XI\3>*?'_Q"\:W.GH\6GCQ)XY\<:UK_B?4[;3H
M7:+3K&?4VL;%"WV6VB+L3Z>'X@PBEGF)Q&6X5UL95CBLGPM+#4OJV69@H1PJ
MQ4JDU%U</'!SQ$JN!=!T<5F,L/BYTJ*H-3\RKP_C.7)L/A\SQ4:.$I/"YMB:
MN)J2Q.99?[1XGZK&$9/V.(EBX8>-/'JJZV&P$:^%C4Q#KJ=/Z&@B:"WBB+O(
M(D5 SR/)(^T8W.\A+.YQRQ8LQY)Y-?SX_M ?#[0?AK_P6)^'OQ5^(=G^T38?
M"SX@_LV/X<T_QWX*UK]H+5_#T/Q6F^)_FZ=X*;5?AKJ=U=>%M#FL(K*>7P5M
ML/!,CW-M?W>DM-<SSR?T-8&,8&/3M4;1(Q4E$.TY&5![@\9''2O)RC-:N45L
M95ITU56.RW'997C[1TI>RQ]*%.=6-14JO[RG*G&I%.FX3=X22C*\?6S;*:6;
M4,+1J34'@\QP69492IJM'VN"JRJ1ISINK1O3J1G.G+W^:*<913E!<WX*_M;?
M!_Q3\3?^"QG[#5W;+\4- \#Z7^S[\8K/Q'XW^'[:YH0LII[/Q+<P>'+[QU86
MSKH$NMK L$IT_4=)U^6SD*Z?J=J\T<U=E^S3=_'SX:?\%4_VAO@)_P )'\</
M$/[+$?P,\/>._"*?%#7/'GQ&\/Z-X[N;OPO;7MKX6^)/C^YU[67:<7^K-/H)
M\2W4>\RA+?;8PBU_;KRTR&V)N4$*VT9 /4 XR >^*-B9)VKDC!.T9(!) )QG
M ))QZDGO7;/B.O4P,,!5PF&JT*7#W]@4N?WI4Y+-*F9TLSA)T7..,I3JU:%-
M0J1I1HU*D4U&3@^&/#="GC)XZEBL12KU,^CG=1P]U3A_9L<MJ9;-1K*,\)6A
M"G6J.<)3E6HTI2BY4XS7\Q'QY^+G[6.E_MK?M):!^T?XT^(/PJ^"%C:Z2G[,
M%UI.I?M%^#_ASX@T5[%VU'5-"\3_ +->B37'B?QS9.]G-JVC>.-6>*QO;F>W
ML]&N(%B6V_8G_@G,GQU_X9D\(3_'WXF:G\6?%%Y=:M=:!XQ\1> ?$GPV\77?
M@R2XA7P_;>+O#GBRPTK7)->MHTN%DU>^TRRN=5L7L;N[BFNWFN[G[K:")SEX
MXV]F1#SSSDC.>?7^9J15"@  <# P ..PX[4LSSZ.8X.AA(9;@\%&E3P4)?5H
M4E3YL%AOJWML.I8?ZQAZF-O.OF"6*J4\3B*DIR@^6DZ6F6Y%++\96Q<LQQ>,
M=2>,DOK$JGM'#%U_;QI5Y1K^PKPP=H4<$WA83H481A&4>:JJOY%_\%T=#UCQ
M)_P3(_:+T3P_I.JZWK-]_P *M%GINB:=>:KJ4Y@^,/@.Z=[>RL(;BZD^SPV\
MMS))'"?(BAEF=D2,L/!_BS\#OVH7_P""8'B-W_:;\1Z_H[_L@!$^%8^!?@:V
MO;ZT;X7VPA\(^?::?+XFBN@@.FB6"W.KQR$%S]IB>0_O6R*XPZJP]& /\Z0Q
M1E=A12O]T@$?E1@^(L1@LORW+Z>&PTXY=GE7.XU*U.E6E5J5*6 I>PY:M"I[
M"*6 C>K1G[22J.RA*$9.<;P[1QV/S''U,5B82S#):>3.G1J5:4:,*=3'3^L7
MI5Z:KU']>:5.M!TU[**;G&3C'\4/V3&_:%^'O_!%7X?M\$O#%['^T+X<_9MU
M^?P/X9UO25?5D\6VZZS-ID:Z!JKQ)<ZF7VW&E:3J 2.]N6M+*X@9IC;'\T?A
M'\</VK/%&D_L[KX1_:@\5:+^TSJ/B/PV?B-X7\67O[57Q0UG5-7$DP\;>%?B
MK\")/@E<?#WX>Z%9N;S3X]6\.GPWI.B6-O#=Z?XCU6)1J<_];HC10 J(H P,
M*,#C' Q4:VT"/O6&(/W81(&)]=P7=U)/7N?6NJ'$U-5\UQ%7*,#5K9EFV,S7
MVDH4JLJ;Q<<9'ZC4>+PV*C6P-&6,E6A34:-25:G";FI0I5*/+/ABI[#+</2S
M?&TZ6797A,K5-2K4X5%A98.7UV'U3%8:=#'5(X-4I5%*K35*<H*/).K3K?B'
M_P %:_CM\2_A#XN_8:TKPU\4_B=\+_"OQ!^/-KX>^+EY\)K"XU3Q'J?@?^RV
M;Q#;Z?I-OI6MW][-:69NKNT-EI=[J-G)$FHV-K<WUG;Q-PWP'^.GC/7?^"C/
M@+P)^R5\8_C;\??V4=1^'?BF]_:0N?B5-XG\9^ _AIXGM=-NYO DG@KXB>-]
M,M]>A\1:WK,:VNH>'X-<U?3FB?4HH].A;2[A] _7?XR?LO\ PC^/'BWX/^-O
MB-I.IZCK_P "_&]M\0OAW-8ZYJ6E6FG>)K0 6]W?V-C/%;:M#$,D6MZDD!+$
MNC'&/?8K6&'_ %4<:<DG9$B[LXSG: ,G R1R<#/05*SO+Z>38+ 4\MC5QE/+
M<VP6+K58X:GAIXC'XR-3"X[EAA*F+Q.)P&&B_JDYX[#JA6<8OVE&,XU:>1YE
M5S;&XVIFDZ6#J9CE.,PE&F\1/$0H8#!SIXG!*<L73PV'PV.Q,E];A'!UY5Z*
MDTZ=:4)TOYZOVQ_VI/%%Q^U5\7_@[_;WQ6^"?_""^ M#?P;K.O\ Q1^,W@O2
MOBCJVHV.H74.H_ +P+\&_AIJX^(6L6^H7-MI%_%XE\6ZP;K6=+:SL?!4UO8Z
MNUUZ1^Q9XS^/7[8O_!)#Q-J7QS\3?$75OC)=:#\;_#,U_IH;P3X^UNX\-W7B
M2T\,:3>IH^EZ>\MSJ%FVGZ/<A-/BDUVT\F2Z\R[O+BXE_<YK:!VWM%$S DAF
MCC+#(VGDJ3RH Z]!BGK#&JE51%5NJA$ Z '("@'( '(/ QTQC&IGN&_L[#X+
M#91AL/6P^+RS&1QKK.O6C4R^E6IUJ=)SPT*D*&8SJ0Q&*I5:M=1K4:?L?<BC
M>GD>+6/KXS$9QB:]&OA,RP;P?LE2HNGCZM&I1JU8QQ$Z<L1E\*<Z&%JTZ5)R
MI5JGMKS;O^#G_!#'6?!<'[%7A+P59_$+QA??%WP)X9\2:=\4?A'XBU;5A_PJ
M[4+CXA?$"\T98?"6K:?8#P[>ZK:3)<3RQ1N-092TKF>WNE7TC_@F+)XZ^-?_
M  3SU2V\?ZSXNTGQ1J7Q!^-NG2ZMX>CA\$^+8K?2?B'K2Z3!9-I>F:>]I+]C
MM+?3]YT^*XNK%BC!1*'/[,);6\;,R0Q(SY+LL<:L^>NXA03^?UIZQ1H"JHJJ
M220%51EN6/R@<DG))Y)Y)S6>8YY''5<YK1P-.E5S?-\)FWM)U%5J8.6&J8VK
M/"T)+#4E*A5GBXI.=-3C3P]*%3V\E[5U@,AE@J644'C:E2EE658K*O9PIRI0
MQ=/$4\+2AB*Z>)K26(HT\)'X9RA*I5K5(NG[3D7\Z?\ P0"U#PEX=_9ZNOA3
MKGCWQMIWQ[\$>(/B[;>.?@'XHU36; ^#M-C\?1?9]?;P/J]K;-8WC-<Z9:/J
ML <&YU#4+:4&YDNH[;UW_@D+\1O'^N_"W]N/7OB)?W>F'PK^U'\7[+0M7N?!
M=EILFG^'](TV"\ANETK1M#TF37A8;C<!Y$N]4U%?+BE<2O&\W[E+:6Z,SI#
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M5BZ]?$5Z^(]K5?M5*M:=&-J,)U8Q51_S6_M/>/O#WPV_X+-Z]XF\5?%SX?\
MP2TBX_8<\-Z(/&/Q2\#W7CKPIJ-Y<?$IY[?P];Z:GB3PQ%!K#K#+J$-VNHOY
M5E:SHUH1=&6'HO\ @EOJ<_\ PWG^V'JO@[3)?C1\/OB9HO@WQ%?_ +4G@#P1
MJ7P4^"UOJNB6L5GIWP[T;X77T']C:YKJ-J&K75]XXT3Q'XIU/4%1Y[DVUO>7
M=S+_ $2S:?97#L\]I:S.R[=TMO#(VW^[N=&;;[9 J6*WBAP(TC15  6.-44
M9P %P !DG@=23W->M5XGC5RN>7_V?%3J9!@<AG5]O%4_9X'$2Q,<8H4\-'$.
MM*JU^XGB?JK48JISJ,8GE4^&'3S&&.6/DHT\^QV>QI+#WG*>-P\<-/!RG.O*
M@J$::=JT,/\ 64V^1PYI2%E)^SR$$AO)<@\Y!V$@\ G(// )ST!-?S&_\$L_
M@M\3/'_B[_@HKJOA+Q!\&="LU_;V^-MM-;_%+X#W7Q2U&[D;48[A;G3M:@^)
MO@H6NCS03"..QBL+I&E6ZFCU F5X;;^GC'&.W2H(K6W@:1H888C*YDD,421E
MY&^\[E NYV_B9LL>Y/.?*R_-ZN7X#-\%3HTJG]KPRZG.I52FJ$<!C*V+O&C*
M+A4E5=54^:4H^S47.*E)I+U<?E%/,,=E&,J5JD%E,\?4C2IN4%B)8W"4<*N>
MI":E!453E4BDI\TI\KY5>3_&[_@I?\9_C]\!Y_V1- \/>+-;^$?[-_BSQ]%X
M8_:F_:!^&7A>SDU?X=Z+;6NG0:/:V%M?Z=XKA\ >%_$MT^JK<^*?[.OVT#[-
M96T>IQRR10:GR_[*WQU\7ZW^WSK'PD^ G[07C[]J?]D^+X%-XJ^(?BSQG=Z7
MXRT7X:?%N77;>V\.Z-X6^+&F:!IAUNZ\1Z LUW>^$Y]2UDZ=%#<7\<EJ+:6U
M3]NI[>"Y0Q7$,4\;9#1S1I*C!@58,DBLK94E3D'()'>H+73K&PC$-C9VME""
M3Y-K;0V\1+')/EPHB D@$L%!) R3BNBGG.'AEGU&65X>=;ZICL*Z]Z2IU:F,
MKTJ]+,:].6%GB)8_ *G*CA94,;A\.Z<HNI0O3E#$\M7),1/,OKL<TQ$*+Q6#
MQ*H6JNI2AA*$Z$\#0J0Q-/#K XUS]KBH5\%7K>T3]E53E&IA_P 3[7]MO4_@
MG_P5,_:I^%G[3_QGB^&?[/TOPB^$WB7]GO2OB+<:7X:\'ZKJ<FA:;;>/+OP?
MK=U86HU:\DUZ'4(9[&?6;B[-]#J%OI]BXB<)TO\ P2D_:=^+'[2.N_MM7WQ#
M\7^*?$^A>"?VF_$OAOX7VOBG0SX<O?#GP^:T@N]"TN+2KC0=$U.W@:VE2>-=
M76;4E!*3QQO@R?L1=:3IE[+#->:?974UNXDMY;FTMYY('!!W1/+&S1MD [E(
M;*J<\"K$-K;P>9Y4,,9E;?(8XDC,CXQO?8!N<C@L<G'H*=;-\OJX#%8>&34:
M6*Q6 R;!O%1K1Y,/4RJ7[W%X:DL,JD*^9Q;^O.5=J4U%Q<H<T0I9/CX8S#5Y
MYS7J87"XW-\7]5=*2GB(9I&2I87$UGB7"5#+).^!4*%TK*:7+%G\^O[*_BS]
MH[]J?Q__ ,%)]-\>?M3?&_PQX;_9\_:2^)O@3X2^'OA[/X)\-?V1I.EW?B*7
M2A=>()/ FJZWJ]KI4>GV%C8Z?-<R6B1I=RZC;:C-+#)%[A_P3S_:I_:<^-__
M  3"U[XW:ZZ_$W]H;PUH?QHT_P +&_TBUTJ;QGXB\$RZY'X,M-5TK0[33K/[
M=>3PZ?I-PEC9V<EZT://&E]--*_[+PV%G;F8P6MO"9W:2;RH(8O-D;)9Y3$B
M&1V).YG+%LG)R:?!:6UK&(;>W@@B&XB.&&.*,%B68A(U5<LQ+,<99B2Q)-5C
M,]P^+C7A_8^ I1GC,EQ&'C3A3@L+1RS 4<%C,)!T</AYSIYO.C]9QDY3<O:S
MG)*563K.<+D>)PU2A4_MC'5)0PF;X>NYSJ2^LU<RQU7&83%2C5Q%>G"IE,*K
MPV$A&'*Z4(Q<E32HQ_C:^*G[3%A\:?\ @EE\1O%?Q5_;P^*NN_M9>,=-U'1O
MB+^S;JEAX"TN.RUB#Q;#:7O@>X^#<'@)/$?A?PSHVD6T>KCQU8ZEI#02Q"[O
M]42WFO/",GZVZI\>KW]F;_@B]\"?B?!<?%RRO].^ OP-TJVU;X0V_A6?QII%
MUK6G:!9PW\]SXZ\-^--#TO1!O^SZ]JUUX6UR]TW3[F:>PLO[2CMY8?VI?0-#
M>>>Z;1M*:ZN8Q%<W+:?:&>XB 0>7/*8=\J81!L<LORKQ\HQ>%G:BV6T%O +9
M(Q"MN((A L07:(E@V&(1A/E"!-H7@ #BN[&\383%T,+A%E3IX2CQ!B<\JX:.
M*H4J;I8G"T<+_9>&^J99AW0P]"G2<:.(JK%XGDDE.[BY5.+!<,8S"5\5BWF_
MM,97R##9)3Q$L)5JSC5P^*KXIYGB/K.8UO;XBO.K&56A3>$P_.IN/NRIQI?S
M#? +]MOX^Z-_P4"_9<^$6F_';P_\7O@[\>M-\7:'XZTK1_C/'^T;X:T'Q%HW
MAB_\4:0UK\1+?X&?"*S\->.(XM.<ZGX4T?6?$=LNG7"W%_HVD0W&E3W-O_@H
MQ:Q_#O\ X*Y_L.>)_'O[2?Q*^#OPM\6^$/BU=:CX[O?$O@SPWX8^&]S8^&-6
MLK71/"VO:_X,N= TZWOM0FL6O(_%A\07ZW/B!&L;K3%N[$+_ $PV^@Z'9M$]
MIH^EVK02R30-;V%K"T,TJ[)98C'$ICDD0[)'3#.ORL2.*?J&BZ/JWE#5=*TW
M4EA+&%;^QMKP1,W#-&+B.01E@,$H 2.I.!3CQ1A*>.P^+P^34<.H9%F&2XKV
M4L+&KBYXZCB*,<RES8"MAZ>,PT:M+DM1E&?U>#J5&Y2LI<+8FK@:^$Q.<5Z\
MIYY@,YPSJ+%2I82&"JX:K++HI8VEB*F$KRHUG)2KWA]9E&-/D@N;\1?V_/'6
MLZ-^VS_P2@T+P]<:!XAT#QA\3->M]3U?6_!G@OQ?J-Y80Z9H%W:ZOH_B35M#
MO[_PY>WC+%=MJ/A2\T">=S#-YTD4$4</>?\ !0S]HKXO_#']H[]D;X3R_$[4
M_P!F[]E_XM:MXQM?BU^T/H%OX>&J6&N:5HZS^$_ DGBOQAX?\0^%_A[;^(-7
MDM+<ZY>V(N;Z*ZN!8ZA8C3+P2?L(^G6<KV\DMK:RO:,&MFDMHG:W8+MS;LRD
MPMM.W,>T[<KT--O]+T[5;:6RU2QL]2LIU"S6=]:PW5K*H(;;+!.CQ2+N4-AU
M(W '&0,>=1SG"T_[)53*L/6CEN6YE@*EY14\36QV)Q=>AF-IT:E&.+R]8BFL
M/&K1K4)SH1=2GR2C"GW5LDQ=19HZ6;5Z,\QS#+L="T)N&'I8+#X2CB,O7+6I
MUGA,P6'JJO*G6I8B$,1+DJ^TBY5/QF_8I_:3^)_C?]M3XZ_!#P1\:=?_ &K?
MV3O _P --%\06?QR\0V7AJ[E\%_%N]U:VLY?A9I_Q$\&Z!X>\/?$2VN-$-WK
MC744%]<:6]N]E->/<6MZTV!\/?'7[0O[1?\ P4:_;[_9XO/VF?BK\./@_P#
MS2O@?J?@WP[\-]-^&6FZK97?C3P(EWJUO%XH\2?#OQ/JT>GMJR7E[<0174=[
M+>M;^3J$%E936MU^VNFZ/I6CVJV6E:;I^F6B8V6NGV5M96R8 4;(+>*.-<
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ME*4Y2=*C5HT%*4YRE'#QE*4FVV4445P'>%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
<% !1110 4444 %%%% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>ex10-8_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex10-8_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  L (4# 2(  A$! Q$!_\0
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M(VE0ZCX5FG=E26S_ 'L;M^17\?Y@5RGPKT4W-_/K4X++;CRH2?[Y')_!>/\
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G(&!@!<\<8Y["NCK.,7S.3/0Q6*IO#4\-1V6LNEY/_(****T/-/_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>34
<FILENAME>ex10-9_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex10-9_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  M (D# 2(  A$! Q$!_\0
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G0(N>IQW/N>M0XMSN]D=\,33I8.5*'QS>O^%;+YO<LT445H><?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>35
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  Z 0 # 2(  A$! Q$!_\0
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M92C@JRG!4]0?2NV@U.-I=#Q<?"=*?/3=KGO>C^.;?44"75N8GZ$H=RG\.O\
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M-J^B6\1P7?[=&7D/JS%LD_R[8H Y7X?_  .T[0'AU/Q R:AJ2$.D(_U,+?\
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J.2Q,:Y)/<U\R>$[Z[OOB[8:3>74]QIHU9R+.:0O",,Q'R'Y>#[4 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>36
<FILENAME>image_004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "S >\# 2(  A$! Q$!_\0
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M-/LY+R[N(H;:, O*[851TZTR'4[2>2YCBN(W:V;9, ?NMM#8]_E(/'K7+CP
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MP370Z+ILFE6<L$EPL^^XDF#+%LQO8L1C)XR3338-*VAHT444R"6P;,]P/,W
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MT>/36O;D0"^-ZYC(5G)8L%SV )!_"LJ/X9VT1BC75+EHH]@ DC1FPF\(-W4
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M>2,%XF1<JP"CN7P1[?6O2,BC<* .8\%V>LZ?HYMM9>5FC<+ )71G6,(HP2H
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M8'AGPL-.GEU.^6)]2G/51D0IV13_ #/>NJ7@TT=*7.*Z(Q25D=$8J*LA^:3
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MI!4$=*6L?PW?G4?#MC=9R7B7<1ZC@_RK8KSI+E;1V1=U<.U<[XDTF34($F@
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M\:1I5;[SCKQ_#ZCWK<[4FK#3N%%%(:!BYHKEQJ>J02123P,83N) 4DX+';D
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910 4444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>37
<FILENAME>image_005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !W H\# 2(  A$! Q$!_\0
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M\!Z.MO/;(;M+>9(PT0G(7?&%"2#T<!%Y]NE41X>\)2R76G/J FO9([A+H->
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M)=V\L\LJ0R0@R[<8>0R$C &#D_E754 %%%% ''_$;_D61_UW3^M>=Z-_Q]L
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MMX1TOREQ+>2@&>?'WCZ#T45U5+BD[5=K:''*3D[LX/Q]_P ?=EC^X_\ ,5R
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M>*-Q_J?[WN?2IM(\/):XGNPKS=57JJ?XFM\#%>CA,&XVG+<ELI:M.;31KZY
M),5O(XQUX4FODH7<LD 2-"9'!?<2,9^M?7EU MU:S6[_ ')49&^A&*^0[O3K
MG2-1NM.N5*/;2-$1GG@UZ%171=+<6ZG;5((X98&B,*?(00=Y]ZD>YMYH8-/C
M0JZ8X=>2._)JAL950%R6'\0.-M178C>>&9ION'D%N3]*Y^6^AO9K4Z9KUH7\
MN.+<J@#<[\K_ +M6=9\2S7-RT*#8D2*$R,\]3S]:U_ 7PWOO$LPU#45N;32\
M[E>1=CR\]%!Z#_:Q]*[:]^!VD3WWG6FJ7=M 3D0E1)M^C'G\\TU1;0.K%:'A
MFG/K>HZDMA:6\DTD[[8X4'!/^%>Z>"/A.NF"&\\0W N[A#OCM%_U,9]_[Y'Y
M?6NK\+^!-(\*AI;5))KMQM:YF.7QZ#LH^E=3BMXP2W1SRJ-Z( ,"JNI?\@R[
M_P"N+_R-7*@N8?/MI82<"1"N1VR,54E=$+>YY+:V%Q=0B2()C.T9< DU<,>I
M00V]NUPBQ,X$05@=I/.1@9'KFNB_X0&'&/[0E_[]BC_A (O^@A)_W['^->8L
M-43O8[WB(-;G/7$.I22KON%>25&7 (&%!R1_7CWIEQ8:C.QDN'1B@ +&0< \
MUTG_  @<2?,-1E!]HQ_C7%SQB&XEBSD1N5R?8XJ*E.45[RW+ISC+9["S0O;S
M-%)C<O!P<BM/1=!N-7EW<Q6RGYI2.OLOJ:T-!\*27I6YOE:.#JL71I/KZ"N]
MABCAC$<:*B*,*%& !6M#"W]Z1E6Q-O=B1VEJEG;1P1[BD8VKN.3^=>-ZRI3Q
M!J@=2R1WKM\PPN2 1[?RKVRO#/&LJV7B#4O-!.VX$H"\YW#'-=&)5H)(>7ZU
M'<S-5NW178,JLV/N.&W+C&?EX49]:QY;J1@7DE,J[1]T';D'_'O]:I%M2UK5
MTT[1;=[B<_=$2\8[D]@OJ379V'P9\1ZB%_MK5X;:($9CAS(V,?@/;O6-.C*2
MN>C4Q-.GHV<!<79M6E5S''QD1JV"#_,&H8O"^O:[IKZI8:7<W-JDNQFC0DDX
MSP.I Z9%>\:'\&_#&DS">YBEU&8#_EZ(* ^NT?US7?PV\5K$D,,:QQH,*B#
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MQ]%/%:"M>_9@WEP^=G[AD.,?7'7\*=M#-3]YJQ9EB65>20PZ,.U5/[*C[22
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MRY$*,V&;#MA0<X]#[5T&/6DV@]JKF5MC%PE=M,YZ37;J)S&UFOF*Y4G>0AP
M0 2.IW?H:?/K4\,4\GD)A)3$@);+$#))XP*WMH]*"/:CF78.27<YM-5OY;H&
M.,E&(982N.L.[&<?WN]6XM9,NERWZPE4#;8]V?FZ DX''.1^%))KD2:D]HT)
M&QBK-NZ#;N+8],4ZWUC38X%6/='$H. 8R !MW?J,FJ:\B(NS?O%>/7;B8PJM
MH-\JN57<>64GCIP#CJ>.:0Z_-);^?!9[D*R.I9B,A ,]NN20/I5QM<L0SJ6<
M; 2W[L\8&2/KBF?VK9V\#I#$R>3%YGELA0!:+>0:_P Q7FU^> 8DMXD?S&0%
MI#MX0..<>^/K3?[<NE:8O;(B_NMBN2"@<9)?CH#QQ3YM;MQYS2V_[ZW:01[A
MPVT<X;'!P:OVVJ6MQ<FW1B7&?X>"1U /M0U9; FV[<QG'7+IDC9+%3E5+98C
MJY3CCIW^E*^NS1^2K6P\QG*NH)[/LR#C\:Z#;1MI<R[%\D^YS8UJ\2'S98@[
M+YP:.,''RL ,Y&1US]*W+.8SVR2EHV+#K&25/TS5@+["EQBI;3V*A"4=W<<*
M***1H%%%% !1110 4444 )UK/U:YDM-/DFA ,@*@9&>K ?UK0I"H[T+<4DVK
M(YM-?F5466 -*7=2 =F K 8/;=SG&<5+)K[()Q]E?-N<2\\*2V!SCICYL^E;
MI13U4'\*78#V'/6KYEV,E"?<PQK<Q5F6T&%A\T@R@?Q$  ].U5I=<F8))"5"
M'R2=W"@,S!N2,CIUKI-B8QM&.F,4NP8Q@8Z=*.:/8'";ZG-IXAE):4P_NRD8
M53T4EF!8M_=^45N64YNK6.<QF,N,[20<?B*GV*1@J,=,8I0 !CH*4FNB*A&2
M>KN/HHHJ30**** "BBB@ HHHH **** $Q2XHHH **** "DI:* *MY*T5I-(G
MWTC9E[\@5CIJ]YY);[,K,@B3)8C<SA3G&. ,FMJXE$-O+*1D1J6QZX&:SVU>
M%5@:4!$EA$N[DE<E1Z=/F'-5'T,I[[V*[:S=BXN(ULPQA#9&[#-M .0.X/.*
MC&NS2/#Y=I^[E),;.VW<N[ QGOU./I5P:W9&81AV)+;>$.!\VT?AD&EDU>'^
MSY+R*.21%8  C;N.<<9]Z=O(B_:1F_:4CMTMY+%/L\\SQG+,SG#8W$8R23SG
MM38]8O(7B4H7C:-5"OPQ.\KP0.3@ UH?VW#&)_M,+Q/"P#J,/U&001[4Y]<L
MHW*_O3C/*QD@D+N.#]#FB,4MD$I-[R*=IK-V98;>6$.S'YG8[,@NPX'?  S7
M1 \5FOK5G'($9F&4\P-M.",;OY5'_P )!9!0Q,@R3QY9S@8R?H,BDXM[(J$T
MM&[FS135((!!X/(IU2;!1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 4[VPM-1@\B\A2>+(.QQD9'>L__ (130?\ H%VW_?%%%*,Y);B<4]S2M+.W
MLK=+:VB2*%?NH@P!WJU113W&%%%% !1110 4444 %%%% !0:** *3Z?:2.6>
M%&8R;R2/XMN,_EQ4?]DV36_D&!6B#!@C$D CIC/2BBCF9/)$'TNT:61FA4M,
MI5^3AP1@Y'3I2RZ99RN7EA5B4V?-DX7T'I11338<D1ITFQ:21V@1FD#!L]\]
M:EBL;:"X>2*,([CYL$X/X=***7,QJ$47:***!A1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 1/&DJ,C#*G@@]ZIQ:78HA18%V[3'@DG@XR.>W HHIIV$XIBIIEHA
MA9(%4Q*%0J2, =![_C4AL+9K0VAA7R#_  =NN?YT447#D17;1M/>+#6Z%,EN
M^22,')ZGCBI?[,LP/^/=.I/3U7:?TXHHHYF+DB0RZ)8R+(1 $+*4WIP0-NWC
M\.*2#1+2*,!@\@#%E9FP5Z<#&,#CI111S.PO9QOL:H&*6BBD6%%%% !1110
:4444 %%%% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>38
<FILENAME>image_007.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_007.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !) 4 # 2(  A$! Q$!_\0
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M^)&KPV^J?$;QK?+M#W/B+Q&%;4#9B^RR:<-NEZ:,JH.QI!]4_M&?\D'^-/\
MV2KX@_\ J+WE!T'^<'_P;Z?M>:=XI_X+'Z1X;'[,?[-7AI?BCJGQ)BAU7PQX
M'NK+6_A[<V=U>WEI=>";J]UW4?[& -IDXTT?\?GWAP:_TYDZ'Z_T%?Y*7_!N
M/_RFW^!O_8>^*'_N:K^]G_@N_P#\%8;C_@E1^RAI?C?P-H.G^)OCM\7/$=QX
M#^$MAK&Z;1-"U!=+O;_5?&/B&V'_ !_V'AVRM<#3L[=4U4V*GC=0!^X5Y>6-
MA'OO[VWLH.[WEU:P0?@;QAC'UK/_ .$Q\*_]#-X>_P#!UI7_ ,FU_DV?"7P_
M_P %X_\ @MOX@\4>-O!GCKXZ?$[P=;:[<6VL^*+CQO=?#_X.>%=0O/\ 3/[!
MTFT^W:;IV!]K_P"/#P[IFJ8Q[&OJ;_B&/_X+?_Q>,-'W_P#9<]>/7W_P^F>M
M!G[3R_'_ (!];?MR_P#!O!_P5<^.?[8W[0_Q@^'7[3/POUOP!\2/B7XA\9>#
M=4US]H;5?#FJP^']7U2\O-*T&[\/8_T(^'K$V>GC^\+/(SC(_/CXP?\ !+3_
M (+P?\$W?!^J_M#Z/\8/$%_X4^'\7]LZSX@^"G[2I\<7'AO3[09N]>U;PE?7
MV?L.G=\:9JA'0\@UZ?\ \0Q?_!;_ /Z'#1__  ^>NUY]\6/^#=#_ (+*?"?X
M8?$/XE>-_%VEOX0\#^$=7\2>*;6+XU:]?&[\/:1:F[U6V-IUO?\ 000..<,!
MR*#,_I#_ .#:O_@N?\9/V^-4\6?LD_M7ZA;>)_C+X'\)'QEX$^+%O:VMC?>/
MO#UG<VEGJVE>++2R/]GWGBK3C>#41J.GC3/^)39,NW)!''?\'-__  6_^/O[
M$_BSP9^QK^R7K<GPZ^)'C#P/;_$#XC_%^SCMI_$6@>']8N[RS\/Z!X(^V@:?
M9:YJ!TF[U#5=0*ZIMTJ\L,!<X/X _P#!H_\ \I5]*_[(U\0/_22MG_@[W_Y2
MK6?_ &;[\-__ $Z^)*T_Y>?UV*_Y<_\ ;OZ_><;\#_\ @BU_P79_X*(_#SP_
M^TS_ ,)SX@3PK\3+:W\1^&[_ .,OQ^U[PMJVO:/>_P"FVFO6OAX#4?L>AZ@.
M=)P!D<X KV;_ (A5_P#@MS_T4SX8_P#B1GBC_P"0J_T ?^"7IW?\$[_V+W?[
M_P#PSG\+L_\ A,67],\=>.IK[SK,KV?G^'_!/\P23_@UH_X+D:<OGZ;\1OAO
M-<Q_O8_L_P"TMXHL9_3_ )\?7CGZ>U?*7A']O;_@L=_P0D_:CMO@]\8_'?CB
MZA\+W6CZSXM^"_Q(\1W7C_X?_$/PA>&SS=>'_$-]_P 3#&HV'VP:3X@T[4P-
M*X]Z_P!:7N_T'\C7^87_ ,'BG_*2OP9_V0+PM_Z4F@T/](+]F[XV>'OVC/@/
M\)?CQX2CDA\/?%CP)X?\;Z?;SC$UG_;.F6EW=:7WYTZ]-YI[>ILR0,=/:GD2
M.-YIGV(@_>22?N.!WSZ?7MTK\;/V!_CIX0_9C_X(H?L_?'WXA?:$\$_"#]D^
MW\>>(_L7_'Q+I_ANUO;S[-:9_P"7W4> ",\D9&,FOX%?C?\ \%:_^"Q/_!9C
M]HN\^$/[-.L_%'0=$\2W^H?\(1^SY\ -4NO#EEIW@_[3_HMWXX\0_;M,&M?V
M=C_B;>(/$6IZ4,7@QZ4 ?ZLG_"6^&$^5_$N@(WI)K.F _D;W/\O6OY.O^#A?
M_@E9^VK_ ,%'OBI\!?''[(WQW\$:-X7\!^%/$'AOQ/X+\2?%ZY\ 6&G:A>ZI
M97O]OV8L,G6;S4/LI7+8P;(D@@AC_.58?\&UG_!=/Q19VVO:QXBBTW4M1B^U
M7.GZQ\>=4_M6TN#P!=_8K[DY[<]^#TJY_P 0Q_\ P7 _Z&_1_P#P^6OT 0:U
M_P &Z'_!<3X6V<_B?P-\;/ ^O7FEQ?;SI_@?]K/5;'7)OL?/V6TM;V]TT7U]
M_7\17?\ _!*G_@OG^WI^Q/\ M>>'OV3OV^/%OB?XB?"23QMI_P -/B#I'Q,^
MRW_Q ^">H#_1!KOA_P 0V7_']8:=_P ?^K:?J)U/^U0?^0N"<UPX_P"#8S_@
MM\=F/&&C)_W7/7N/KQ^G/OQ7X&_&?X"_%W]F#]M/Q-\!?CQ<QWGQ<^&GQ&T?
M0?&]Q'K-UKD$^K_9;*\!&K#_ (_?]!NK3ZUT;]G_ %ZG.?[:WB3P]IOBO0-?
M\*ZU;17>B>(='U'0M4LY,>3=Z=K%K=V=Y:G.<YL;HY('(QCKD?YH_P"V?^SK
MK7['G[6?Q=^"-_#+#IOA_P 47&J^#+@@K#>>!O$O_$Y\._9;H\WATVQN[33R
M" ?]#O\ N*_TV\F7RW' ].1G/Z?3\^_'\R?_  <5_L9W/Q ^%GA;]K?P-I$M
M[XI^$$1\._$6+3XB;[4/AQJ]T!:ZGTX'AV^N[LZK?DD_V5>D !5 'UO ><_V
M7G"IU7_LN+LGKHI=.NG;INO*WY'XS\'_ .L_#.(JT</?%Y2FXV6KP-G]<LDK
MMK317T6A_-K\*_%'RPIY_P XS]?4_P"?IZU^KG[-WQ$?3]0MK-YODN,RQ<_\
MO&?_ *_]>U?@Y\._$7V6XMOG_#OC^?(_'DU^C/PK\6/;S6=S#-L>.7S8O3Z'
M'/88Z?A7]+8=TL9A,1A9VMBUIU6SM97?==#_ "@XJPV.X;SO#YO@>:.(RG,E
MS6NKQYE>]K72BGO=:']CW[&&NS>(TNW\S?;V-C]JDZ<F\S:6H'X+>9&>QQS7
MSK^UW\06T37]:TN6YD\VQDGM9/,][J[^Q^O6Q^R#GKTXKTG_ ()>ZD-?^%6N
M>(R^\W.J6.F#/_3EI5E=]>W-Z!].IQU^$/\ @K-K,G@?XD06UN\D">*]"AU+
MS!TPK&QNCZ\@9QV)[8K\0RC*Z%?CS$995M;#-V73W'=J_5KFUW?I;3^Y^+N+
M\9@/H[9/Q32;Q4L9!)V=DGCH\N#=KVTG?[K=3\EOCM\3'UK4+GR[K_1K<_NO
MU[?GZ9_"OS-^*'C#_70QS?G^N!^HR/7 KV#XF>,O+69_.S_+]>A[G]:^#_%6
ML7FL:BEG9I<7EY>77V6UMK<_:)YKF\_X]+6T/KD>M?M^,Q%+"TO9T[+"X-:[
M+96>NG9G\2<$</8_.LQ^OXE/&9IG$]%9RMS2T2>NUTOD?HM_P2<_98O_ -L/
M]M;P'H^H6<ES\/?A?=6_Q/\ B-=_\L(;#PY=65YI&E=_^0EKO]D:?G''^G^E
M?Z(T<*6\4<,2HB11B.*../ BX&,X.,9 XZ$BOQ[_ .",G["<_P"QI^S#INI^
M-;".V^,OQB&G^-OB")(U-YH5E>VWVSP]X.) )!TNQN<:L. =5>_!&0"O[#^:
M,F'&7 R>/Q Z=<<@YSGC&:_EWC#.?[8SFNZ3OA<([1MKWYG>[6_;HK;L_P!9
M?"/@REP?PIAL/4PZCC,9%8['Z:IM+EB]$TE?:_R1=!R ?49KXA_X*6?\H^/V
MU?\ LV'XT_\ J!ZU7V\.@QZ5X5^T9\'[?]H#X"?&7X&7NKW/AZT^+_PT\9?#
MJXURVB\^XT<>+]!O-%_M.VMB>M@;P,!P,@9/RDGY8_4C_,M_X-#/^4N^D_\
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M-4NKRTN;3[%?Z:VBZYI][>W9R 5U, AF4#!_!G_B"O\ VBN1_P -A_"I./\
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M"/A/P)\._'&@^,?$GB37_$>E&RL[:UM-$O=1^QV1-TI-_J(51DX)QAOYC?\
MB"H_:'_Z/ ^%'_A#Z]_\O:]"^'?_  92>/[C6+)_B5^VOX8L=!@EQ=6_@_X:
M:G>ZK=VY[VMW?:Z-/LO0 <Y[=Z /@;_@T'\'^(?$'_!3[5?$.E:;<7.C^!_@
M9XPO_$^H1Q?N--M]9NK/1])^U\_\Q&^N_7\:I_\ !WO_ ,I5K/\ [-]^&_\
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MK35-._;2_9@N;"]B\VUN/^%S> X/-X/W;6[UQ3WZ]<CL#DZ__#Q3_@G_ /\
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MZB* "J%O<PW4;O;302IYGE^9!*)P/J>1GGIG'4BOY@]5_P"%U_\ !;#]M_\
M:B^"@^-_Q(^ G_!.S]BCQGH_PKUK3_@?XCNO"OC_ /:6^-'V0:OXAMO$/CBQ
MSJ/AGP1X=6Z.G#3].'_$VVKSCE?U&_9+_P""4'[-7[%?QANOBY\$/$GQYMKR
M_P#!M_X2U/PCXW^-WCWX@>"+W[7>6=X==/A[Q1K6HJ-<_P!$Q]OR6()Q@XH
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M@XW0P?[#^(EE:#P_JE@206^P C:"#_2W^VM_R9O^UK_V;3\<?_57^):^&?\
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M<_#+Q3HGC;P9K1N/[+\2:!?"_P!+U'['<FUNC;7:C%V 00&Y!(ZDX-?X\?\
MP< ?\I:/VO?^Q\;_ -)17^D/_P &VO\ RAT_9 _[%C5__3M=T ?$W_!:3P/^
MSA\2/^"KW_!)SPA^UMIO@?6/@+K/AWX__P#"9:?\2-0_LOP=-/9Z#>7>DG5K
MLWNFX_TW_D% :B &SP<Y/ZS_ +#GP;_X)4_!+QSXOL/V!M$_9W\,>._%^BP3
M>,[#X/\ BA=5US6/#VC7/^BW-[:'7=1/V#3[Z\!!4  W1W-@@'^33_@]U_Y&
M/]B'_L _$'_TL%?F[_P9P_\ *6/7_P#LUOXK?^G_ ,!T ?Z=/Q5^)_P[^#?@
M'Q)\2/BOXJT;P5\/O"]K]J\4>)_$,WD:)I>GWES]C-SJK8/^@[KI<]>.2#7\
MA/\ P6C\ ?L*_!/PGX _;G_X)G>//!_PZ_X*/^)?BKX0O_A#I?[+'B.TU6X_
M:)U#Q)=?\5!I/Q"^$WA>^.G:W8?V&?MYU#4--TS^RNISDX_>7_@N+_RB@_;;
B_P"R+ZM_Z5V5?YJ?_!M#_P IC_V3O^PMK_\ Z8KR@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>39
<FILENAME>img_1n.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img_1n.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" &6 G # 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%I>KW]W:VCS:QY<1C?R.\_;;_;/\%_\ !-'_ (+F_L?_ !L_:#\5^,_VK?\
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M6A?'[X2W_P!HT>R\2ZCX>U'6/#&O:);R6KSV4-L)OMC0/V#OV_\ XK_M]?\
M!.3]O#]K'Q#^QS:^+OV9?@C^TO\ #;]H+PS^SYJWQJ@\,:SKOQ5NM>L?A_<_
M!_1OB3X/U'4]1T:T\.7&BGQG-XV\8:!>0:R-5.BV&HV/V1&\'_9<_P"""-W^
MQA_P6K\4_P#!0#X >*_A_HW[(GCGX:?% 7?P/O-2\2VOCGX=?%GXJ26,OB2P
M^'N@V?A&?P4_PNNK_34UNR-SXNT?5]"_M%_#=KH=]IFC:=>S '@/_!$/X#_%
MZ\_X*'?\%)8_B/\ \%$/^"E/QU\*?L _M)3_  '^%/PV^._[6OB?XG_#3Q[X
M5\6>$O%5O-K?QE\':[H[:;XI\7:)-:6^H^'=2\-CP9IVFZG#'=OH]RT:*OPK
M_P %I/VK=!^'W_!7+]IGX9?'O_@J)_P4!_89^&/AK]@_P+XW_9N\)?LG?&#X
MW:%X5\9_M-W,6J'P_P"'/$G@'X>^&O&>A/I7B<QNVMW=W%\/X]1EM[:*_P#'
MVE+AZ_I:_P"">'[!OQ>_9)_:C_X*D?&WXC^(_AOK7A3]MS]I_2/C7\*=/\$Z
MQXGU+Q#X?\*V&DZ_83:?\0K37?!_AO3=*\0--JMNT5KX;U;Q9IS1),SZJC*B
M22^ ?V$/B[X5_P""ROQZ_P""A^H>(_AQ-\%?BE^QS\//V>_#_ABSU?Q/)\4;
M/QIX2\7:;K^I:GK.BS^#[?PG;^%Y[.SEBLKVR\;:AJLERT:3Z+;1%IE /QA\
M0_M1?\%!IO"O_!L3J/[2'CWXQ?"3XX?M _M):IH7[4G@[3M1U_X/S_%;0(;+
M1?\ A&K+XU?#CPQ>:%H^HS:SX:?2]?UKPAXCT*VL;#6M6U$/X9T.XDGTVW_)
M+]O#]M3QYX4_;U_X*U:!9_\ !43_ (*0_"/]KWX2?M"?"_3?^":?['WP0^(/
MQL\=_!#XQ>*;Z#PY)JOP]U_X+V'@CQW\.M0TNXU&6PM=/\'ZIK?A#1=;FU6[
MMIO#/C@7$N@WG]@W_!0_]@WXO?M;?M1_\$M_C;\./$?PWT7PI^Q'^T_J_P :
M_BMI_C;6/$^F^(?$'A6_TG0+"'3_ (>VFA>#_$FFZKX@6;2KAI;7Q)JWA/3E
MB>%DU5V9TCE_8/\ V$/B[^R]^VG_ ,%1_P!HWQ_XC^'&K^"/VV_C5\-?B/\
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M PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M=T/Q!\0/!GP:\+6G@'Q3\(-%NY%^.5KXNTC3O"7PNB%GJ.N^-S8W<TME[/\
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MQG^YXS_L$Q?_ *BXD>5_\C/+/^QEEO\ ZL< ?Z>M%%%?S^?VT%%%% !1110
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M^\/?#OPEX7\,:N]S]AU?1K[3(+>RA_13_A5__4<_\IG_ -\*/^%7_P#4<_\
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MWP[^)$MQX:UJ[\726O[-/COQGXB\'^"M(U[3-;UCPOXO*:WX>_JP_P"&7_\
MJ>/_ "VO_P (*/\ AE__ *GC_P MK_\ ""EA\SP%&MAZM7.L1B84:U*O/#SP
MLJ5'$5(1R]U?:QHTERTJ^(P>(Q4J%)PH1J9EC(*%6BX48D^',\E2JTX\-82$
MZD*M.-;Z[AYU:-.I/%\BINKB)1=2CA\33PU.M5C4J*G@\++W:D959?S>:_\
MM&_MI?#+PY^SWX9\ _!+Q!+<^*;?Q#=ZU8^,?@?^UE\?M0\9>)KOX_Q>%+;X
M<:M\47^)%W??LL6EI\/=1F^(!^,G[1FJ^.O IT6\@L_"WAR#1?!D^CW'T_\
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MO:A9^'_#>H^"7^'5]I-W#?ZK<IXFMKOP7))H<Y\6#7)9(G>[:0Z@QNROPD^
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M[ __ "?5^Q9_V=G^SE_ZN'P;7]$/_$+?_P!7S?\ FLO_ .4'7K7P#_X-P/\
MA1WQU^"WQJ_X;*_X2C_A4'Q:^'/Q1_X1K_AGC^Q?^$B_X5_XPT;Q9_87]L_\
M+RU;^R?[6_LG[!_:?]E:G]@^T?:O[/O?*^S2O$\4Y%4PV)IPQUYU,/B*<%]6
MQ2O.>'KPBKNBDKRG%7;25[MI)M& \.>,:./P-:KD_+3HX[!5JDOK^7/EIT<9
MA*M25HXMR?+3I5)6BG)\MDFVD_Z>J***_'S^I HHK@_BGK6I^&_AC\1_$6BW
M/V+6-!\!^+]:TF\\FWN/LFIZ7X?U&^L+G[/=Q3VL_D74$4ODW,$UO+LV3121
MLR'FQN*IX#!8W'5HSE1P.#QF.JQII.I*E@L)BL95C34I1BZDJ6$J1IJ4HQ<Y
M04I1BY2BTKM);MI+YM+]3O**_!__ (;-_:4_Z*1_Y9_@+_YEJ/\ ALW]I3_H
MI'_EG^ O_F6K^<O^)I_#_P#Z%'%W_A#E'_SZ.OZE5_FI_?+_ .1/W@HK\'_^
M&S?VE/\ HI'_ )9_@+_YEJ/^&S?VE/\ HI'_ )9_@+_YEJ/^)I_#_P#Z%'%W
M_A#E'_SZ#ZE5_FI_?+_Y$_>"BOP?_P"&S?VE/^BD?^6?X"_^9:C_ (;-_:4_
MZ*1_Y9_@+_YEJ/\ B:?P_P#^A1Q=_P"$.4?_ #Z#ZE5_FI_?+_Y$_>"BOP?_
M .&S?VE/^BD?^6?X"_\ F6H_X;-_:4_Z*1_Y9_@+_P"9:C_B:?P__P"A1Q=_
MX0Y1_P#/H/J57^:G]\O_ )$_>"BN#^%FM:GXD^&/PX\1:U<_;=8U[P'X0UK5
MKSR;>W^UZGJGA_3KZ_N?L]I%!:P>?=3RR^3;00V\6_9#%'&JH.\K^C<%BJ>/
MP6"QU&,XT<=@\'CJ4:B2J1I8W"87&4HU%&4HJI&EBZ<:BC*45.,U&4HJ,I<C
M5FT]TVG\FU^@4445TB"BBB@ HHHH Y30_P#D8/&O_85TG_U&])KJZY/0O^1@
M\;>VK:3_ .HUI!KK*VK_ ,3_ +AT/_3%$Y,%_ ?_ &$8S_U-Q84445B=8444
M4 %%%% ')WG_ "/7AS_L4_&G_IX\!5UE<G>?\CUX<_[%/QI_Z>/ 5=96U7X<
M/_V#P_\ 3N).7#?'C?\ L-J?^H^!"BBBL3J"BBB@ HHHH Y3Q=_QZ:/_ -C7
MX6_]/EG75UR?B_\ X\]'_P"QL\*_KKME765M/^!0_P 6(_\ 2Z1R4O\ >\9_
M@P/_ *9Q(4445B=84444 %%%% &3K_\ R M:_P"P3J/_ *1S4:!_R M%_P"P
M3IW_ *1PT:__ ,@+6O\ L$ZC_P"D<U&@?\@+1?\ L$Z=_P"D<-;?\P__ ',?
M^X#E_P"8[_N2_P#=PUJ***Q.H**** "BBB@ KE/!W_(-U+_L:_&?_J5ZQ75U
MR?@[_D&ZE_V-GC3]/%FLBMH?P*W^/#_^E5CEJ_[Y@_\ KWCO_36%.LHHHK$Z
M@HHHH **** "O+[#_DLOB?\ [)SX-_\ 4B\9UZA7EM@3_P +G\3#L?AQX._]
M2+QI77A?AQG_ & UO_3N#/,S'^)E/_8WPW_J+FAZE1117(>F%%%% !1110 5
MR>M?\C+X,_Z^M<_],MQ765R6M_\ (R^"_>[US_TR7)K:A_$?_7JO_P"F*IR8
MW^ O^PC!_P#J9ACK:***Q.L**** "BBB@ HHHH **** "O+_ (W_ /)%OB]_
MV2_Q_P#^HIJU>H5Y?\;_ /DBWQ>_[)?X_P#_ %%-6KQN(_\ DG.(O^R>S_\
M]46=E0^.'^.'_I43^<^BBBO\B#W@HHHH **** "BBB@#](?C7K.L:7\-?V94
MTS5=2TY)O@OX9:5;"^NK19670/#H5I%MY8P[*"0I8$@$@8!-?-__  EWBO\
MZ&?Q#_X.M2_^2:]^^//_ "3?]F#_ +(MX;_],/AROY_OC/\ "W]J[QS^VOXH
M\4_#WQ-\0O!GPF^'G@'X/Z^-;'Q@^.&B^&-<8:3\>XO'7P]\"_ 31-)F^"/Q
M5\1^-+EO EGXH\8>)->TKQ=\*Q;^&M>\.6FK:K/I]J?]T^!,3#!>'/!E?^SY
MXUKA3"8BHJ-.C*I&GE_#.#S"HVZE&?-*I&@J%*#ESU*LXTZ4*]:5#"XC^/\
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M8>[@Z\TU*5&A+]?_ /A+O%?_ $,_B'_P=:E_\DT?\)=XK_Z&?Q#_ .#K4O\
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MP]66<U*,*U6I'+DX_O*\E2C&OF,:#JUZE*E'V%:K6GADI4J/[/\ _"7>*_\
MH9_$/_@ZU+_Y)H_X2[Q7_P!#/XA_\'6I?_)-?CG/^UO^VMX/L$T/QE\!KSQ3
MXQO;_P"(OA_P]XA\ _LQ?M"GP9KNM>%?BG\+=,T"^U;3M-\5?$%_AYX>U[X4
M^*/'NNV&K>+?&2:#K^O>#_-T;Q*NR3PO>51\=?VV? W[7OAKX5Z-\*=7\3?
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MH&14D,;2(K_:-RI(T43.H(#&.,L"47#_ /A+O%?_ $,_B'_P=:E_\DU^'?Q
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M'%5,+-IOV3E"3C[:%7EE&IAWRS3J0C.?M'1I4J.)=2I4H?TET5_,AJ'[<_\
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M26-R[+L>I4GM4@Z.+I492>L<1AL53Y8NG[Y12>QZ_P _<?U]/R)6I-0HHHH
M**** "O++#_DM'B;_LG'@[_U(O&E>IUY98?\EH\3?]DX\'?^I%XTKKPOPXS_
M + :W_IW!GF9C_$RK_L;X;_U%S0]3HHHKD/3"BBB@ HHHH *Y+6_^1E\%_\
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M_P!T?#+_ )-[P7_V362_^JK*S^*?$G_DN.(/^PJC_P"H>%"BBBON3X<*\O\
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M.EFTFJ,XSE5JX9U)8F&&JPH58SC3C"%&KB9TJ^)P[I3DH4%0I8B"JSJKQO\
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MA?ZO\7])U?P5X1MO#N@WM]XVETZ?6_"]CJ6@#^TA?OOV+OV;=4\9^+_'NJ>
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M^[T*WUJ33M&\07,=N[>%?%46B=AXE_X*1_L6>$?%>D>!M>^-4-OXNUOX*?\
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M7B3XU:=\6[G5]/\ &Q?1]*^$6O6*0ZM=?5-A^P+^Q/I_PNUSX%#]E?X%ZE\
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MXQ<8**4(9CFE+$YI"@I36$CCGAHR5.G2IT[G7G\O\3_A^?/1:**YCK"BBB@
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M))XN/F76G:EX1M[.7S#KYF3R8=4ODV)(L<GG[I4=HH6CZ'_AE;X"_P#0B?\
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M_B)]0^->D_$[X<_"W_A7]EJW@>+Q3JFH_$3PA9^.SXJT7PWJGC'3?$FI> O
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M-G<:KX/\!>,/%.F6^HQSS:?/J'A_P]J.K64-]%;7%I<RV<MS:1I=1V]W:SO
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M"/P;:)';Z7%J N1>>&M#F+LTE[:&,QF$*%"ONW$DC&#S_P#PPII/_11]1_\
M";MO_EQ7^Y/A[Q+DV!X%X0PF)Q4J=>CPWD<:D%A\1-1<LHRF:]Z$'%WC.+T;
MWMNF?RSQOP#Q3F_%6<YEE^74ZV#Q6(IRH57C<%2<XPPU"E)NG5JQJ1M.G-6E
M%-VNM&C\YJ*_1G_AA32?^BCZC_X3=M_\N*/^&%-)_P"BCZC_ .$W;?\ RXK[
M'_7#A_\ Z#9_^$N*_P#E9\I_Q"_C7_H4TO\ PXY?_P#+S\YJ*_1G_AA32?\
MHH^H_P#A-VW_ ,N*/^&%-)_Z*/J/_A-VW_RXH_UPX?\ ^@V?_A+BO_E8?\0O
MXU_Z%-+_ ,..7_\ R\_ OQ!^PK\/_$WCCQMXJU+XG_&H>%_&GCG4_BR?A%::
M]X(M?AOX<^,>I>!]/\"+\4]$>/X>_P#"PK[7]*LM/37]#\-^,/'_ (J^&FD^
M,9$\46?@2/4]-T232N=U;_@G=\*]0\:Z%XJL/B5\9O#6@>'O#G@W0K+X7^'M
M1^&=M\/I+_X<_"7Q=\'/A]XJN%OOA;J'C0:UX*\-^,]3UCP]IEKXTMO!5IXR
MMM-\32^$I[R"9;G^A;_AA32?^BCZC_X3=M_\N*/^&%-)_P"BCZC_ .$W;?\
MRXKSI9UP;.DZ$W"5%PJ4W3EA<>XRA4PN)P4HSO-N<5@\76PU-3E/V%'V,,-]
M6^J8&6!]6'!?B7"HJL*#C4C%0C*./R9.*4J,W**]GRQJ2GAZ52I6C%5ZM15*
ME:O5GB,3+$_@Q\8_V$O@G\<_!'PQ^&WC/4OBAIG@/X/^ O$'@;P)X:^'WQ'U
M[X9VNFOKO@JV^'$/BRZO_ ;Z!K6J:]H?@)O$/A'3-)U#4[CX?WN@^-?%VG>)
MO!'B&WU*V2PP/A_^P'\._AYXO\5>+M/^*OQMUMO$/@SXB^$=(T+Q%JWPVNM)
M\"77Q6TGP!HWCGQKX3O-.^%^E^*;CQMJME\-?"T5MJ?C/Q)XOT[1K:&\TS1-
M(T_1KV73:_>^P_8HTN]U'7;$_$'4(QH]Y9VJR#P];,9Q=:79ZB793JP$90W9
MB"AGW! ^06VC7_X84TG_ **/J/\ X3=M_P#+BM\5GW">)KXROBYQJXC,(XSZ
M]4GA<8Y8I9I0Q-+&2K<CC&4\3A\PQ5.510IU:4:\EAYX2<:=2ECA>"O$:GA<
M/A\-0G#"X3EI86DLQRODPZPF+C5C&BIJ<X*.+PL*DVJC>(E"^(EB85*D*W\\
MEU_P37_9XFL=,TJUNO'>E:3I%]HMQ::7IFI>%8K3^S?#OP9\$? /1/#4IN/!
MUS<OX<TWX:^"[C2K6P%PLL=UXX\>Z@+K[1KEL=-ZWQ+^P;\%_%7B+QAXIU/4
M_'@U?QWJGQ,U?Q+-;:MH$<6H77Q7U#X/-XF6:&7PO,DT4'A7X(>#/ASHPN?M
M$EAX%EURP>2YU?4DUNU_>[_AA32?^BCZC_X3=M_\N*/^&%-)_P"BCZC_ .$W
M;?\ RXISXDX5J5)UI5[U:E:IB9U%AL=&3Q%5TI5*\7#D5.M*=&G/VE*-*<:D
M?:PE"K*I5JO_ %#\1N7E^K3<?8+"M/,\ME?#QA.FJ,G*<G.FH3G&U251M3DW
M)RDYO^>G2_\ @GOX)TOP_H&B1?&_X]/<>&_BUX]^,.F:O!)\#]%2SUOXE?#C
MQ)\,O%VA:-X+\,_ _0_A;X.\-ZII/C#Q5XBNAX$\ ^%O$=]X]\2>(/&^J>(]
M0\0Z[J][>WF_X)^?"U/B/X1\>:=\0OB]HNA>#M)\!6%C\)=)U'X=6_PSOM0^
M%WPM\5?"/X>>(=227X:3^/3J7A#PYXOU/5-$TO3O'FG>$+7Q;!8>)1X8;4()
M6G_H(_X84TG_ **/J/\ X3=M_P#+BC_AA32?^BCZC_X3=M_\N*RGGO!\X1IS
ME&5.,/9QIRPN.<%3^I/+^3DYN5P6#?L8Q::CRTZT%#$T:&*P^SX+\3)5:E=T
M&ZM5UG.?U_)[MXC$2Q5:27L^6$JE>4ZDI4X4Y)U*L8SC3JUJ=;^>ZY_X)\_#
M^3P7\&_"UI\7OC=I6M? +P3X \#?"KXAV,OP;D\6^&=/^&_B6W\1^'M1.DZC
M\&M0^&FJZM)'IVAZ%J1U?X?7VEW6F^'=#U&/2K?Q99-XEEV_AS_P3_\ @+\+
M_$?@[Q3X;?QK+JW@SQ%X/\4VLNK:YIU\=:UGP5X,^*OA73;CQ)<+H5O?ZHMY
MK7QL^)GQ,U6,7EN+KXD>)I]8A-MI%M9Z!;_OM_PPII/_ $4?4?\ PF[;_P"7
M%'_#"FD_]%'U'_PF[;_Y<5LN)>%EB9XSV]\54Q-3&3KRPN-E4EBJL_:5:[<U
M->TJ55&O-J$8SQ$*>)E!XBE1KTL7P'XC2HO#O"R]C*$J4J:S++(QG3FJZE"?
M+*,JBMBL4E[2=1Q6)Q"A*"K5>?\ !*[_ &#O@MJ*^$!JFI>.]2D\&:3I.CZ=
M<76K:"MQ>6MK\?O#?[27B-]2EM?#%LTDWQ"^(_A#PT/'9L_L,6JZ#I,&FZ?#
MI,TUW?7&GXN_8F^$WC>#Q#!K^M>/YAXF^*GQ1^,6I26^MZ-:S?\ "9?%/X+Z
M_P# .]D@DB\. K8^$_AYXANK/P5!*)KC3-1M=/OM3N]:^S-#+^X<_P"Q1I<.
MOZ;HH^(.H,M_I&N:H;C_ (1ZV#1-I%[X?M%A$?\ :Q#"<:V[LY=3&;=5"MYA
M*:__  PII/\ T4?4?_";MO\ Y<5G+.^$5AUAI2A]7J4*E/V3PN-<9T*]"&"J
M0E=N4HRP^%IT$ISE*$*:]FZ<I3G5*?!?B1[95Z=&HJ^%Q%XU(YGEL9TJ\9O$
MWIOF27OXN<WRQY&ZU2+@X2G3?\V>A_\ !+/X*^'+3P#IFA_$CXI>']#\'-I<
M/B+PWX,\)_LN_#;PS\6M&T?XG^&OBS9^'_B3X=^&/[-W@S1_[.N?$?A'0;'Q
M#>> ;/P%X@\9^'K"'2_&FM^(3%#<Q>D>(O\ @GY\(O$FG^$M&O/%WQ+@T'P[
M\/OBC\,]=T&&;X<W.F?$CPQ\9?B)X:^*/Q&C\=IJWPWU.YEO/$_BSPO93ZK<
M^%;KPHNIV-WJ5AJD5]!=*(?Z!/\ AA32?^BCZC_X3=M_\N*/^&%-)_Z*/J/_
M (3=M_\ +BJCQ%PI"7/"MRR=55G)87&W=2,XU(RD_M*,X*<*;O1@W/DH4U5K
M1JW+@CQ*ER7P\O<A5A!QS+*X.,:UO:M2@X3YY\L$ZKG*NE3I*.(BJ5+V?\ZT
M/[!F@P_M$?"CXBG4C>_#?X7ZA\>/B;<Z?K&K&]\6>/?C-\</C!I'Q7L(_$=A
MIWAG0] M?AY\']8T:WUGX>VL6H7^HS:Y;^%CJ=G'+X(@UGQ#[)J'['?PGU;X
MX_%/X^ZI>^-+_P 8?%CX7/\ "?5=+EUZUB\+^&M$O=(M- UW7/!=E::5;ZIH
MOB[Q)HFE:%I>K:[<:SJ+16>AV<6C6VD_:]9.J_N+_P ,*:3_ -%'U'_PF[;_
M .7%'_#"FD_]%'U'_P )NV_^7%9//.#Y8:&$G.%7#T_[24*=3!XJ2C'-\OJ9
M3CX+W(VA6RBK+*HI6E2P'[FE4IU)5,75<^"?$F5;ZPL+[.M[#!X=SI9CEE)R
MIX#'0S3#749VYHYE3I8Z3BH1G7I45*G]7HTL'#^<0?\ !,3X-W/AJ;2-=^)W
MQL\3>)9- C\,1?$C6+KX/Q^+K+0])\!V_P -/!.G:?I6B_!S2/AM9V?P]\&'
M7M(\,VD/@!;34%\:>,KGQK!XNNM=EEBZ_2O^">7P;MH='D\0>+OBGXYU[3KV
MYU/4?%OBG5/!,?B'Q1J>L?M'Z%^U%XOO=??POX!\-:2K>.?B'X5\*:5XFM-"
MTG0]-/@;PSHWAC1+'18[>2[F_H,_X84TG_HH^H_^$W;?_+BC_AA32?\ HH^H
M_P#A-VW_ ,N*VCQ)PK&L\0J_[Z5>.)E4>%QLI/$1JSK^W?/SKVLZ\YUZT^5/
M$5Y>VQ2Q-51J0E\#>)#I^Q^K-4E!4U".8Y5!*E&FZ,**Y.1JC3I2=.C04O84
M(6C0HT4H\O\ ._X4_P""</P=\*_%WP3\9'\9>.O%NO\ @#Q1X]\4^&]+\>^$
M/V<?&.GZ7<_$#XC>,OBMJ-IH>NZS\ KCXA^#&TWQQX\\0:K8>(_ 'CCPEXYU
M*,Z98^+?%GB:RT;3(+5OPM_X)M_!3X06=Q!X2\2>*X[[[7\0=1TS7I? ?[,]
MAK5AJ_Q \%7_ ("DUW6;GPY^S[H-O\3_ !!X8T+6O$2^']?^-5I\3-9O9?$W
MB"'QG?>+M-U*73Q_07K/[%&EZ5#92K\0=0F-WJ^D:65;P];)L74[^"R:8$:L
MVXPB8R!, .5VEE!W#7_X84TG_HH^H_\ A-VW_P N*QCG'!].G347"--4\30I
MVPN-O[*O]3ABJ=VY3<:RP>#57GE-U%1CS2J)U%.I<(>)=>K6C.G4J5.;!U:R
MEF.5M2E1EBZV$E)74)>SEB<9*,5%17MJD91<9)+\AO@+\&='_9^^%?ACX2Z!
MXG\8>+]&\*+J4.FZSXXNM FUA+._U6]U.UT:RT_PCX=\'^#/#/ACPY;WD?A_
MP?X.\%>$O#'A#PCX6TS2/#OA[0M.TS3H(%]@K]&?^&%-)_Z*/J/_ (3=M_\
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M.,X\]#$UH<T)1G'GYH2C*,9)IM--;IIKU337XI'Y?_\ #MW_ *K-_P"8[_\
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MD9;>;4O$MLK1DO),LOEQ_.UM_P %NOVV(+^2\E;X1WENY)72KGP%=K80Y=&
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M_P#!."_^8C[G_P"&YO%?_0B^'O\ P8ZE_P#$T?\ #<WBO_H1?#W_ (,=2_\
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M_$T?\-S>*_\ H1?#W_@QU+_XFOABBC_5;(/^A91_\&8C_P": _XB)QI_T/\
M%?\ @G!?_,1]S_\ #<WBO_H1?#W_ (,=2_\ B:/^&YO%?_0B^'O_  8ZE_\
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M3_\ +#;_ (@QD/\ T-LX_P# <O\ _E)^*7_#/OQH_P"B=>(?^_,'_P D4?\
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M 6!^_$__ "PU_P"(,9#_ -#;./\ P'+_ /Y2?BE_PS[\:/\ HG7B'_OS!_\
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M;=^*W_0O_#W_ ,%/B3_YK*^.:*/]6\A_Z%.#_P# *G_S0'^OG&7_ $4F:?\
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M_P##*WQZ_P"A$_\ +H\&?_-%1_PRM\>O^A$_\NCP9_\ -%7[&44?Z^9O_P!
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M?_A)O!Z[XID62-]K^(%==R,#M=589PP!!%?KWK__ " M:_[!.H_^D<U&@?\
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MN?\ X[6=11R0_DA_X!'_ .1#VM7_ )^U?_!E3_Y8:/\ ;&K?]!34?_ VY_\
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M?_+#1_MC5O\ H*:C_P"!MS_\=H_MC5O^@IJ/_@;<_P#QVLZBCDA_)#_P"/\
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M;<ZM>:!X:\*^(/B1_P (]<>)=6AL?%8D$VH:CYUX9_8X_:P\$:/^T#IWAO\
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M .6&C_;&K?\ 04U'_P #;G_X[1_;&K?]!34?_ VY_P#CM9U%')#^2'_@$?\
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MV\'?^"6^_P#EQ5U,LXX<KPS-*/+!6^O45[RIP4W_ +B]YJ3OUO>RO994<_\
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M#O\ P2WW_P N*N>6<<-4^7,TFJ:4_P#;J*O/FJ-O_<7?W735]-K6TN\Z>?\
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M  ;>&_\ YDZ/^&(OA3_T,'Q"_P#!MX;_ /F3KYJ_X;0^+_\ S[>#O_!+??\
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M_P!#7+__  JI?YA_JCQ3_P!$[G7_ (;L3_\ (GS517TK_P ,D?''_H6]._\
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ML["(KX@T5]US?W$=K;(0EZ2H>:1%+G"H#N8A035S_ADCXX_]"WIW_A1Z'_\
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MX4>A_P#R=1_PR1\<?^A;T[_PH]#_ /DZM_[;R;_H:Y?_ .%5+_,Y/]4>*?\
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M2W+;SN91I*-6M5YFW65%.-E:/L85(*SW?-[2[O:UM+W"BBBH-0HHHH ****
M,K759]$UA$4LS:5J"JJ@LS,UI, J@9)))   )).!2Z&K)HFCHZLCII>GJZ."
MK*RVD(964@%64@@@@$$$$9K4HJ^?]W[.W_+SVE_^W.2UOQO\C+V2]O[:[O['
MV/+;2WMO:\U][W]VUK6UO?0****@U"BBB@ HHHH *Y;PC')%IVH++&\;-XI\
M8R*)$9"T<OBK5Y(I & )22-E>-Q\KHRLI*D&NIHJU.T)PM\;IN_;V;F]NM^?
MY6\S*5)2JTJMVG2C6BHVTE[:-*+;>ZY?9)JR=[ZVL%%%%0:A1110 4444 %<
MW:/>-XLUV.62Y-A%H7AIK2%RXLTN9KWQ+]NDA4@(;AT@L5G8%F5(X 0H;YND
MHJXRY5-63YX.%W]F\H2YEH]?<MTTD]>CSJ4^=TGS./LJJJM*]IVA5AR2LU[M
MZJEKS*\(^Z]'$HHHJ#0**** "BBB@ KE=9BD?Q%X.D6-VCBN]:\UU1BD>_1;
ME4\Q@"J;V^5=Q&YN!DUU5%7"?)+FM?W9QMM\<)0O\N:_G:QE6I*M!0<G&U2C
M4NDG_"K4ZJ5G;XG3Y6^B=U=JP4445!J%%%% !1110 4444 %%%% !1110!Y_
M\4_BM\-O@CX#\1?%#XN^-_#?P[^'WA2T6]\0>+?%>IV^DZ-IL,LT5K;1R7-P
MR^=>7]Y/;V&F:?;+/?ZGJ-S;:?I]M<WMS!!)>LOB+\/]2T+P=XHT_P <>$+S
MPU\0Y-(A\ Z_;^)-'ET;QO-X@L)M4T*#PEJ27AL_$4^LZ9;W&H:7!I$UW+?V
M4$]U:I+#%(ZU_B1\,OA]\7_"&I^ OB?X0T+QQX0U<V[WNA>(+&*]M#=64Z76
MG:C:,P%QINL:5>Q0W^CZUITUIJVCZC!;ZAIEY:7MO#.GB/[1/P(U;Q1^S=?_
M  O_ &>M-\ >!?&_@-O _BWX :?JL4_A7X9^&/'_ ,)?%6A>-_AUI^KQ>%O#
M^N76B^"I-9\.66CZ\FA^&=4NH?#U]J*V&F7%P8D."^L_697^K_4_80Y+>V^M
M_6O:S]IS7_V?ZO[#V?)R_OO:\_-^[Y3U)?V)_8E'D_MC_63^U<1]8<WEO]@?
MV%]1P_U54%%?VPLX69_6GB75;RUX!X=44L6JK?M.C?%CX6>(Y]$MO#WQ*\ :
M]<^)M6\9:!X;M]&\9>'=4G\0:[\.;^\TOXA:+HD5CJ4\FJZMX$U/3[_3O&6F
MV"W%YX7O[&\L];AL;BVFC3OZ_G<^*O\ P2)_:"U3X>>+/AM\._'GPKF\$6.@
M_#R[\#^#M8UK1]$A\8^*/&,'PW7]K[PU\1S\1OV6/VH?@O9>!_B?XA^$/A;Q
M_87.N_LS_&F#QGK/BKXA:)XN\#>'UU6/Q-)]8^.OV OBQXV_9&_9=^!4/C2R
MT7QK\//!MQ\#_C/J^M_%#4O$M]>_L\_%'PW'X/\ CAX2\#?$[X>_ _X$+J'B
MFPT;3_#-Q\,]8TKX)_!?1X[CPEH^G'1O!NEO*D>YY9^F'Q ^*_PZ^%NCZQKG
MCSQ7IF@V>@Z')XFU2!OM&HZQ!X>AU/3]%FUJ+P[I$%_X@O=,@U;5=-T^XO+'
M3+F&"ZOK:*9T:5<Z7@/Q[X3^)OA>Q\:>!]6_MOPUJ=UK-E9:E]AU+3?/N?#^
MMZCX<U>/['J]G8:A']DUG2=0L]\UK''<?9_M%J\UI+!/)^17A+_@GK^T8W@;
MQ]=_$CQO\)-<^,_Q:^#WBKPE\1?$&D:SXU/AR^\=3_$GX:/X.O;";4O!PU?_
M (1W3O@[\*?"NBZG=7-I_:C>+(KHII][:W,VM/ZC\</V,_B]XR_8)L_V8O#_
M (?^$'Q#\=+\0[_Q->Z5X^^(J>$OA)?:3<?%KQ3\1[2/Q/;>,?V4_P!JCPM\
M2=*6VU'2-/UKX;>.O@-J&A:O-)>W^C^*/"?B?0/"GC&R /U4KCW\>^$X_'UO
M\+WU;'CJZ\'WGCV#0_L.I'S/"=AK5CX>N]6_M,69T=?*UC4;*S^POJ"ZE)YW
MVB.S>UCEGC_!OQC_ ,$POVS?$?QU_:K^*EG\7/!^AZG\:?@OXI\!>"_'_@OX
MF_#SP-=6L6MZ+X#CTWX.ZO\ #V[_ ."=/CWXI:7\)/#M[X?\0Z5X*NO&W[9_
M[0O@CP"NK3^,=-_9MUF?Q!KO@JM_X!_\$N?V@_AM)^R[J.O^(_AY%X;^!5YX
MKD\6?L[77Q(\+>+OA'XPT_Q%\8M.\<>'M'TS4?@S^PM^Q=X1\->'?A.(?^%K
M?"WP3X8_9]\+> =*^*FBZ7H7B/PKXGA?1/B;X) /WUK,O-:T?3[_ $G2K_5M
M,L=3U^:[MM"TZ\O[6VO]:N+"RFU*^M])LYI4N-1FLM.MKB_NXK..:2WLH)KJ
M94@B>1?P-_:,^"/Q ^)__!7/P7<:Q\ -.\>^ D^&M_!X(^-6O?"/XCZGXJ^"
MFL:K\$OB1X,N]9\$?'#4/V<_&GP+T3X227_BO57\>?!Q?VJO@M\8?$WQ+3PM
MXS\,?#"^TO1;V]^-FZG_  3_ /VU?%NDPZWXN_X9O\ >-/#_ ,._"7PWTOPY
MX'^.?Q8\;>'/&&@_#WX*:[\,8;;7_'6H_LU?#36_"-K\5VU230_%UMIG@?Q:
M_@3PQJ^IZAIEQ\0+^TAT34 #]N/"7CWPGXZE\6P>%=6_M27P+XPU/P%XJ7[#
MJ5C_ &7XLT>RTS4-1TG=J-G9K??9[/6-.F^W:<;S39OM/EP7DLL,Z1=A7\Z$
M7_!+?]IVW\6_LRZOX.^$G[#7P.\,_"?]J6X^/DGA[X7>.K;6=8^ WA;4/'/P
MLO\ 7_AA\#/'OCO_ ()[ZGXTO_ >O^ O!&KZ#'X+^$&L?L-Q:3)>6/A?5?%'
MC+X:L/"6E_3?A;_@F_\ $'X8^!OBU8_"RX^%7AKQG\7_ (6?$S3OB3>67B7Q
MIHP^,?Q*UW]H"\^)/A&'XF>,;?P9J?B.?PO_ ,*HO]7^#,?B:?3/$^J_"KPM
MXBO_  _X!\%:IX4L+;1KL _92O+_ /A<?@)OC"WP'AO?$%W\2X/ 5M\3+^PL
M/ GCS4/#&B^$+_6K_P /Z3<^(OB18^&KCX:^&]:UW5-)UA/#GA#7_%VF^+_$
M=GHNMZKH>A:AI6C:G>VOXZ>!?^"<_P"T!I/[9G[-G[0<?@+]GSX#_"/X0^&-
M(T;3?@A^SE\9/A_I_@W]G^PL['QW8^*?AY\(+#7/^"6FF?$OQI\./BA>:[IG
MBGX@Z+X)^/\ ^QUX7\0ZO?R6WB;X>^*[OP1I/B3Q7]!_M"_\$T? /QW_ &BO
M'/QDUGX9? ?4]/\ B5-^R+IWQ!O-9\/BT\<>._!WP,^('Q"\3?$SP?XTU;2_
M"CW?BCPOXU\.ZG\.?#S>$];U^_\ #?C?2O"S>%O'%C!X9T^QMKT _5BBOP1T
M7_@E7\0/$WBP:=\3_AK^RWH7PUC\=>$;OXK7?@7Q_P"/-<US]N'P_P"'OC!I
M'C6U\:?M.^!9?@3\.O#VF>+/"OP_T";X<^&O %_XR^.>@WW@WQUXK^&M_P"/
MM.^&UI_87B'[>_8X_8CC_9,\8ZEJOAC3? 7A[P]XH^$GA_PIXXM?"=YKMUJO
MBOQYX1^('CB^\'Z[K5SK&D6T^K:=X.^%7B'0/AMX0GO]2>X\+>$_#VC_  ^T
M#2].\#^%?#%I: 'Z(45_/#XX_P""0GQ<B\<?LV^*_AK??#FPC\%_%/QA\5/C
M'<:-\2?!/P_\5-\1-;^.8\=Z/\9?"_C;XI?L!_MA^-O$WC_3/A8-/^%FGP>"
MO%/[+/B7PMX*T)?A?X?^+?\ PKK68K+PWY'^Q_\ LV_M':SXX_:P\;:-^S)\
M,_#_ ,>/#GQ_^!7CW0?B-\3_  [\9_V:K?X_:9\+/BY\2/%EQX0^.OQ7\6_L
M5Q^,?&_Q7M[/Q/JD]Y\=/@]JG[:7P@UWP[:?#GPI!X_O-6T/4/B+\0 #^DK2
M/'OA/7?&'C'P%I6K?:O%G@"U\,7OBW2?L.I0?V3;>,K;4KSPW)]NN;.'3;_^
MTK;2-0DV:9>7LEG]GV7Z6LDL"R[$'B'0+K7=2\+VNN:/<^)M&TW2=9UCP[!J
M=E-KNDZ1KT^JVNAZKJ6D1SMJ%CINM7.A:W;Z3?75O%:ZC/HVJPV<LTFG7:P_
MA[XF_P""='[2^J_LM?'+X57/AW]D_P <^,OC<_PC?5_!?Q UFP\6_#C3H?#7
MCOXD>-?%\>D^(OC1^QQ^T)X&&NZ%=>,=%E\!>*/''[)GQ*TW4I]'OWO? W@_
M4[O2=?T/E9O^"6_QATI/"7B*7X)_L2?&[QU=_LH_LF?![X\WWQ7\::WX;N_C
MYKOP%NM=TWXA_"#XB>,M,_9#\>W_ (H^!7Q-T75?".NZCX@UOPO<#6-0^#'@
M;P1KWP);PUJ5OK'@@ _H$HK^?V^_X)U?%7X)_#SQ?^T-H7A/X;>(_P!L/X=:
M5\(Y/V38/"EUX^^)^E?!O5+;QI\0;'6O@/X4U/5_!>@Z]HGP(7P5\5;'X,ZC
MXOT#PYX8O+[X2^#="\1>+O#GA?0OAYX9\->'O;OV\O\ @GW\8OC-^QU\!?V7
M_P!GC3O@'K-_\*?['\WQK\<+GPKH_BCPMXD\.>#;K2="^*WPV\5^,OV3/VP[
M+1/&_P#PE%W>ZUXAO/#7P_\ AU\3;M-2EO? 'QZ^%>LVLUWJH!^OVO:_H7A7
M1-6\2^*-:TGPWX<T'3[O5M=\0:]J5GH^B:+I5A"]S?:GJVJZA-;V&G:?96\<
MEQ=WMY/#;6T*/+-*B*S#$\(>/_"/CU_%<?A/5UU=O!'B[4? GB?;9:E9KIOB
MK2;'3-2U#2U?4+.T2_6"RUG39QJ&FM>:9.+G9;WLLL4Z1?C3^T%_P3N_:!^/
ML_QQ^&/BSPC^R[XK^"/C*Z^/GC_P;X@\>?$+QMXD\3^(_B-\7_@+H7P\T#0?
M'GP>U+]G;4_"/AG0O!7C_18/$D'Q"TKXJ^/M=FMK6QUJR\!Z?K4*6$-&#_@E
MS\0M T/Q-XN^%W@[]F_X*_%SQM?^.;?Q-HGP_P#&'C6S\)/\']2^$?@#PSX0
M_98TOX@:;\&_#>MZ1\#+3Q=X/O[*XTC1/AIHOA?P[8ZS<?%#1_ACJGCFYO\
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7 HHHH **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>40
<FILENAME>img_3n.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img_3n.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" (G G # 2(  A$! Q$!_\0
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M=2FMT\W;)*CI(J?HWXT_;-_9K^'O[1?P._9-\8?$C^R/V@?VD?#7BOQA\%O
M'_"'^/=0_P"$S\.^"-.NM6\4:C_PE6E^%KWP5X=_LS3[*YN/LGBOQ)H5]>^7
MY6GVMW.\<;_P0:!\6M,^!'_!5_\ X*X>&=%_X(+V/_!6S1KC]K_3M-TG7]+^
M"MOX]TS]F+3=%.LZ?8Z+IT5I^RM^T':>%K'7[5XKVSL;:^\%6_V?PI&L,%Y'
M:++8?T%?MP/YG_!Q[_P1)D^R?V?O_9W_ &M7^P;=GV(MX \5G[)L\N'9]FR8
M-OE1;=FWRT^Z #]V_'O[8W[./PR_:4^"O[(7CCXC?V)^T1^T1H'C#Q1\'?AY
M_P (CX[U+_A,-"\!6-YJ7BR^_P"$LTCPQ?\ @?P__95E87<WV;Q3XET2\O\
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M#7[1'[07P>_:;_X2_P"$/[*'A[1?%7Q^\7?\*7_:%T#_ (0+0/$3:HFCW_\
M8/BCX3Z)XG\4_;&T74Q]E\%Z+XCO;?[-FZMX!- 9>[_8I_X*Y_\ !.?_ (*)
M>)?$W@O]CS]I[PO\6O&GA#3%UO7/!ESX5^)/PT\8+H?FP6\VNZ5X6^+?@OP'
MKWB/0[&YNK.UU76?#FGZKIND75]86NJ75I/?6D<W\UFM_&K_ (6__P $9_\
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MOA'PY&T6G>&[7&CVQL=-TZ-[32)?$/C2STJST_2]:@MK'^M>@ HHHH ****
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M?VN_!UU^TI\$?B7:> /&P^#/@W5_C)X9B\(_'GX'Q?$AK>Y\'>&O%+3:R_\
M8/A+^T+75H[#P?\ VK%86RZA;?:?@3X(?M ?\%OO^"&W@S6?^"<GA_\ X)E?
M$+_@I)\)/!OB/Q+9_L:?M-_"A/'TOAO1_ ?B_5[C5_#VF_%>V\!_#CQS!!9Z
M!KFL74^L:#XMUKX47NA2R:UIUEXRU3P;:>'_ !)'_;U10!_.K_P3!_X)Z?M)
M_LQ?L,_MT_%K]K68^+OV]?\ @H(OQ@^./QT\.^%X[?6AX:U[7/ WB>R\#_"G
M0H/#K7UAJ>K:8^LZE+<VGAQ[ZPBU;7E\,:-=:M8:'IVH7GY'?$K_ ()-?'C]
MI3_@V%_9.\&6?PB^*O@']N']CG2/'/Q<^'WPQUCP+XJ\(?&N\CG\>?$"V^('
MPKA\)ZCI-AX[M=7\<> M4BUO0/#D%A#>>)?$&B>$K6&VN4O;<M_<W10!_'UK
MW_!+W]KCXZ_\$.O^"5FN? '0]=^"O_!2'_@GGH?@KXT_!OP9\4=-U/X;^)G\
M3:3-=-XM^$OB/2?&:Z);^&-=\1Q:?H-W80>.[*RTB6_TBVT+7;[0="\0ZMK%
MK\$?M(:5_P %'O\ @NIJW@S]ESXF_P#!!OPE^Q-\8-7\0_#G1OVH?^"E/QA^
M%EO'KVD?#'P+JUO-XD@^"'C_ .)GP2\,^*--M;N[M[DZ#X9\"_%KXPZE?:/>
M#P[!>Q>'M4UGQ0O]_E% 'PQ^U'\&H_"?_!-KX_\ [/WP@\,:YKD7AK]C#XE?
M"+X:>#]!T^_\0^)=8CT?X,:OX0\)>']*TS3H+G4]<US4%MK"PM;2SMKB_P!3
MOYDCAAEN)U5OYA_A_P#LJ?M0V7[$O_!KUX4O/V;OCW:>*?V?_P!L+2_$WQX\
M-7/P>^(<&O\ P2\-Q^)/%T\GB'XN:-+X=34?AOH:07-O,^K>,K;1K!8KB"0W
M 26-F_M?HH _BN_:Q_X)4?&OX0?\'*W[%/[9OP,^%WQ+\7_LQ?'[XLQ?%OXR
MZCX$\'>)=>\ ?!7XP^'?!FI^$_&GB#X@W'AW3+GP_P""=/\ 'EK/H/B33O$_
MB:73_P"V_$.J^+K1+V:6T96_3;_@H!\%/C+XS_X+I_\ !%KXN^#_ (2?$WQ7
M\*/A7X7_ &MK?XG_ !/\-> O%6N_#SX<7'B3P-;VGAV#QYXUTO2KKPWX0FU^
M[!M=%C\0:GISZI< P6*SR@J/Z&Z* /X7O '[7'_!0[_@F)_P4]_X*R:M\._^
M",W[9_[8OPY_:R_:UM/%?AGXI>"_!?QP\&^"K+P_X:FU_3X-9T+7M#_9H^+>
MA>-]&U:'Q(U[#JNGZUIEE#'8,J2W2W!EM_KK_@MWXM_:^_9]_P""J?\ P3(_
M;J_9S_X)_?M(_MP:9\"?@;\=].\5^!?@IX'^)^IV%EJ_Q%M;SPQ:Z1XA\?>!
M?A-\5;?PIJ5G;Z]-K%O9ZEX8ENM4ATZ2".&U25KNW_KGHH _B7_X*(?M'?M[
M)^V7_P $;_\ @JA\/?\ @DK^UY\5?%'@S]F'XWW_ ,4OV5O!O@GXS:OKWPH\
M5?$O^U?",'@7Q_\ $'0_V>]=U'PMX@TVSU8^((K3Q%\*]&U+5+:V,":59Q2_
M;HLW]O']IO\ ;^T?]OK_ ()3_P#!57X?_P#!(;]L+XM:]I'[$7Q$LOB9^S#X
M.\%?&G4=8^$WC'XC>(_B!H+>!?'7Q&T3]G;Q!>^'_$NB:?JMKK[:5K_PNT/5
M-0LI8%.FV$%Q%>C^WJB@#^8#]MKX)?MI?\%;/^"?7['W[=GP5_9]\8?L3?\
M!2;]D[XPZI^T-\%OV;?C-?:A;^((+[PQXKU#PWK'PW\47_Q%\#_"=K>?Q_HO
MACPWXR\/OXJ\)>&]'O EIX?OKZWT/7KKQ$OSEH'_  53_P"#B?\ :_U[X9_L
MX?!+_@D5KW[$GQ1TWQIX-?XY_M4?M$6'C:?X#?\ "*^']<TU_',G@_3?B+\,
M_!NAVVB>(UM;VTNK3PAXW^-_CB7PGJ%Y#X 9?$8TOQGI_P#891_G_/\ GZ4
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M"\1ZU;Z7 [6MO?:O_95Q::<UY \X)DCCD_HIHH _DY^)_P"VM^W%_P %2_\
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M/6=.T/Q+9:M)!J>NV6?%OASPQKNN:KXCOKI?"/AK0_#?AJ*]_J/HHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MGT'Z_P"-'M8]JG_@FM_\K"W]77^9+146\^@_7_&C>?0?K_C1[6/:I_X)K?\
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M2H2_?'_AX7\4_P#I&-^WI_X6G_!-?_Z8Q1_P\+^*?_2,;]O3_P +3_@FO_\
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M_P#],8KTWCU3\A_C1QZI^0_QH_XK0_2,_P"C:>!G_A%QU_\ 1B'_ !#K*/\
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M/?$WQAX?^+W[0NJ:7/JNI>!?#?CCQI^TUI?Q4\>?$>74M!CU"_\ &WB;Q?\
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MFL:]#-LMRS$0Q,*%+ECF%:G"GB:3]B_:T*E*<JN'JQE%5%0KMTX*$74^F?\
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M,M+75Q/\/OBAX&U_^T-$GU/2XO[<.E37T>MZ9K.FZ?VW_#POXJ?](Q/V]?\
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M-*U:X^%4??A/I?\ TYL1@^)9U^"/HKX?-.&,SKY7BLDEC>/Z=>6)CP9DW&F
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M<+^J/_#POXI_](QOV]/_  M/^":__P!,8H_X>%_%/_I&-^WI_P"%I_P37_\
MIC%>F\>J?D/\:./5/R'^-?RM_P 5H?I&?]&T\#/_  BXZ_\ HQ/H_P#B'64?
M]!F9_P#@>%_^9CS+_AX7\4_^D8W[>G_A:?\ !-?_ .F,4?\ #POXI_\ 2,;]
MO3_PM/\ @FO_ /3&*]-X]4_(?XT<>J?D/\:/^*T/TC/^C:>!G_A%QU_]&(?\
M0ZRC_H,S/_P/"_\ S,>9?\/"_BG_ -(QOV]/_"T_X)K_ /TQBC_AX7\4_P#I
M&-^WI_X6G_!-?_Z8Q7IO'JGY#_&CCU3\A_C1_P 5H?I&?]&T\#/_  BXZ_\
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MO@@>+/#G[._P+^$$.MZ1)\<?V/?C1XYL)=1\'?##PC'J5@WCBXT?^TK2ZO\
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MO_@FK_\ 2Y:/^'>?Q4_Z2=_MZ_\ A%_\$U?_ *7+7%?\->?\%'?^C)OV)?\
MQ9#\=O\ Z5K1_P ->?\ !1W_ *,F_8E_\60_';_Z5K1_Q*Y]'_\ Z1Y\%?\
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MERUQ7_#7G_!1W_HR;]B7_P 60_';_P"E:T?\->?\%'?^C)OV)?\ Q9#\=O\
MZ5K1_P 2N?1__P"D>?!7_P 5/P!_\Y _UAS'_H=8_P#\+\7_ /+#M?\ AWG\
M5/\ I)W^WK_X1?\ P35_^ERT?\.\_BI_TD[_ &]?_"+_ .":O_TN6N*_X:\_
MX*._]&3?L2_^+(?CM_\ 2M:/^&O/^"CO_1DW[$O_ (LA^.W_ -*UH_XE<^C_
M /\ 2//@K_XJ?@#_ .<@?ZPYC_T.L?\ ^%^+_P#EAC_"+_@F#XI\">%-6T3P
M=_P4C_;RT32+[XG_ !M\9W=DGAK_ ()UZDL_BKXB?&?Q]\0/'6LFXUK_ ()\
M:I=Q2>)/&OB;Q!XBGL(;J/2=*FU232_#VFZ/H%GIFD6/IW_#O3XI$;S_ ,%.
M_P!O3G@+_P (7_P35*CL3D_\$Y]^2 !SQQCL,?,7P&_X*"?M\_%7P/KWB;PM
M^P_^R!;Z9I?QG_:/^&]U'X@_X*)?&?3[YO$GP<_:&^*'PB\8SP0:;_P3+UJW
M?0[GQ=X'UNY\,WLEY#?ZGX;ETK4=4TG0-3N[S0M.]G_X:\_X*.XQ_P ,2_L2
MX_[20?';\?\ G%ICGZ?UKMQWT;? W-,9B\PS'P)\(<PQN.JRQ.+QF-\,>",7
MBL7BI0HTOK&*KU\JJU*]9TZ%*FZM64JCA2IQ5:$8*,HCGN/IQ5.&;XV$8>ZH
M1QV)C&*LW:,5*R5Y;1LM7=25X/M3_P $]OBB?^<G/[>7R]_^$,_X)L9/?'/_
M  3G..0#\O.0#UII_P""?'Q17*'_ (*;?MXN9ARQ\&?\$V<H#GHH_P""<X5^
M">)< Y/6N+_X:[_X*.<_\82_L2\\?\I(/CK_ /2M/YYIK?M<_P#!1MBI/[$O
M[$N5Z?\ &R#XZ?\ TK.N:'T9? RE)SH^ O@]2J-2INI3\+N":<W2JP^K5Z;E
M3PM&;A5P<IX:I%U'"=!NA.E5P_\ L<F\^QS33S?&M-/26.Q$HMWC)<T9<\9)
MRCS-3A43<8N2G*,)4^W'_!/7XH@!?^'G/[>7&3G_ (0S_@FODY.3D+_P3GVC
MD9^7DGGGBN?\7?\ !-+X@^-/#&O^$-7_ ."H/_!1.RTSQ1I-]HU_?>$HOV _
M /BBSL[^WDM[B7P]XU\#?L >'?&'A;55CD=K+7?#>O:/KFEW&R[TS4;2[BBF
M3+_X:[_X*.9S_P ,2_L2],?\I(/CM_/_ (=:9_6FG]KG_@HX2#_PQ+^Q+E<X
M_P"-D'QU[C!_YQ:?7ICJ<UI0^C5X'X/$4<5@_ CP@PM?#UJ=3#UZ'A?P13JT
M72E!0E3G' +E<*4%3C>G.'LXJG+#5:'-@JK_ +?Q^M\XQSNI;X_$M/F5FFI.
M5U*\E+FY[JW-SM0=/GO@?_P2"3]G#X8>%O@U\%O^"AG[=?@GX<^#(+^+0M!A
M\-_\$[-:G275]4O]=UG4=5U_Q%_P3XUCQ%XAUO6];U74]:USQ!X@U?5-<UO5
MM0O=2U;4;R\NIYWL^ ?^"8'BGPOXL^-VN^'O^"D7[>6FZO\ $;XH:1XT\=7R
M^&O^"==XWB+Q78?!;X0_#VSUJ6WU'_@GO>V>E2V_@CP+X.\.+8Z!;:/I,D&@
MQ:G/ILNOZCKFKZKM?\->?\%'?^C)OV)?_%D'QV_^E:UXS\+_ /@H+^WUXY\<
M?M'^&-#_ &'_ -C^+4_@W\9M"^&_C)]6_P""B7QGM;"Y\1ZI^SS\!OB]:S^&
M9[3_ ()EZE<:EHB^$?BIX6MKB]U2ST"^C\1V_B#38](FTO3]-UW6O1Q7T??!
MO&XG/<7C?!7PLQF+XFK>WXAQ6*\.N#\3BN(*T<S6<JMG6)KY=4K9K56:4X9F
MJF/J8B?U^$,8G&O&,J>4,YQ<(TXPS3%QA1<I4XQQF)C&FZGM%-Q2G[KJ.M6<
MY)\TY5:CE.3J3E+Z;'_!/;XI2 $?\%./V\XPHX5?!G_!-=AT((&__@G/D*0>
MW)&12#_@GW\4U&?^'FO[>6%X"_\ "&_\$VP,#C/'_!.?(X].!VR*XI?VNO\
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M_ M_-?ZCI%]J^G/X;AM]$U'2K+5?$-MK&T?VO/\ @HZ2#_PQ-^Q)QT_XV/\
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M \_,,9'(%1_\.]_BC]__ (>:?MXG^#9_PAG_  38VXPP!W?\.Y@_0G@ )AB
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M*,DTFN62=[-,],_X=Y_%3_I)W^WK_P"$7_P35_\ I<M'_#O/XJ?])._V]?\
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M"; )Z<$+_P $Y]ASQ][CZDYH_P"'>WQ23I_P4X_;T.>,GP9_P384C!.#A/\
M@G/@@#H#G&>!P<^9:9^VO^W_ *VIFT?]C_\ 8/U9%NM7L3+IG_!3#XTZ@BWN
M@:G+HNNV;/:_\$NY0+K1-8@GTG5[<MYVFZG#+8WB074;Q+E^+?V\?V\/!,%A
M<>*OV1/V%M'.K7ITW1K6X_X*0_'>74];U%+:XOI-/T/2+7_@EE<:IK5_#I]I
M>:E<6FE6=U<6VF65]J,\:6-G=7$6J^C-X&)TG'P'\'5*B_JV"DO##@F/L*=5
MR<L/AY+#1]FJCJU+T,/+#1FZLW+#34Y\R6?XZ3DUF^-=XWF_KV)3:AHW.5XM
MQAL_:5)0A=12@W&)["?^">_Q3. ?^"G/[>AW<Y_X0S_@FN<8)(QG_@G/SSSR
M,@].13/^'>/Q-+I<'_@IK^WAY\,<D,4G_"$_\$U2Z1RE&EB63_AW,)$21H86
M=(V".8HRP)1"/'O#_P"WU^W%XMMEO/"W[+?_  3X\26AM[*[6YT+_@J!\7]6
MA^S:E#9SZ?<&2P_X)@W"K#?07]A+:2$JMQ'>VCQ%UN(=_3R?MC?\%$8X[IW_
M &+_ -AU(K+=]MDD_P""DOQQ5+,B".Y;[4S?\$M]L!6WEBN")F3]Q)'*0(W5
MB+Z,O@/"3D_ 7P:C*,;\R\,.!8N-G.<7SK!W255U9I\\4IRJ2C.G4=2M-?ZP
M8UK_ )'&-Y=%_OV)M;EM9IN-O=E&-I)>ZW%)4Y2IU.[/_!/;XI1D2?\ #S?]
MO*0\X#^#/^":X !QDJT?_!.??SGG)&?<4_\ X=[?%0G'_#SK]O1=W/'@W_@F
MP=HX^[N_X)S\C_>]SZX\WU?]L_\ X*#Z+I]SJNN?L<_L*Z/I5DBR7FIZK_P4
MK^-NGZ?:1NZQ+)<WEY_P2YBMH$:21(E:69%9W1,[F4&"U_;=_;\O+[5],L_V
M0OV#;K4O#M[I^FZ[IUO_ ,%,OC1/>Z)J&K65GJ.EV&KVD?\ P2[:?3;S4M.U
M"POM/MKN.&:\M+VUN+9)(9XG8_XED\"6HX7_ (@'X//#PDW#"_\ $+>"?9TZ
MU:G_ +1)8=8%TZ=2M0251_4Z4ZE-<M2IB8W@-Y_CU:;SC')M-<SQV*5USV2B
MV]E-?!"48JHFW2YTYGIH_P""?'Q1D&?^'FO[>*;!PJ^#?^";+ @8.#O_ ."<
M_P HR!]ST'H#3A_P3X^*<AQ_P\X_;T0$<@>#?^";)('_  /_ ()S@'/<'U]1
M7 #]L#_@HK&\L7_#%G[#XDBCBFFC/_!2/XY+)%#,TR0RR)_PZWRD4KP3I%(X
MVR-#*JEC&X7(UW]N7]O/PE"+GQ/^R7^P+X<MC9ZKJ GU[_@IO\9-&@:QT*PF
MU?7+T2W_ /P2^MT-GHVE6\^IZK<!C#I^GPS7MX\-M&\BN7T:O ^NYRQ/@3X0
M5_K,X?6Y5?#+@NK]9J*,H4/;2JT<3[>HJ$)0I*L\94=.#A1M3C[%']OXY<RC
MG&.3BW*RQV)O%-J\I)O1N4HN4YVG>2E.M+2HO4Q_P3X^*,@S_P /-?V\4\K
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MN;NXD6*WBD<XK03]L/\ X*+20K<1_L6_L/R02!6CF3_@I)\<VA=7(5"DB_\
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M_B?%&491<?B4HRBTI)Q7??\ #O3XJ<_\;._V]?\ PB_^":W)/<C_ (=S=?\
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MJ5%36G->7ZHNG\</\2_4^VJ***L@**** "BBB@ HHHH **** "BBB@ HHHH
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M-0U/2_AQI]YIEU?>&O$>H:A?Z%X4F\.>")->DN+B#PI;Z9J_B'2=9\C\0_\
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M<_A%JW@?6O'/Q(U>QL/#LWC:35[/PMXET[Q_'X>TVRF\0>&KB_\ #Y@U^_\
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MT?\ UX[^RI7VU7Q-_P % ,?\*)\!CO\ \-M?\$T<<C_I([^RI_GKBHJ?!/\
MPM_C'_,NGK."_O+]3[9HHHJ[KO'_ ,"C_P#)$?)_<_\ (****+KO'_P*/_R0
M?)_<_P#(****+KO'_P "C_\ )!\G]S_R"BBBBZ[Q_P# H_\ R0?)_<_\@HHH
MHNN\?_ H_P#R0?)_<_\ (****+KO'_P*/_R0?)_<_P#(****+KO'_P "C_\
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M_P"":6?Z?G43DK1U7QPZQ_F_Q>1<$[RT?\.ITE_(_(^VZ***NZ[Q_P# H_\
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MZKC"'LZD6HXB"?/-\TYXBE*-6JU**E*A3^KT*4>:%/DJXRI*$WB>?"?&NL_
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MP7I7PU_:LT+1/%/AP?MN>'M:\0>+/V>;GQ?H>M_#S]MW7M(USQ9H^F^&-/\
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M?U_7^>U]+W:3G[_N;_)/_@]-G8HHHH_KT]>J^:Z/JK!9]G]S_KJ@KXD\>_\
M*1W]E+_LR;_@H#_ZO7_@FE7VW7Q)X]_Y2._LI^O_  Q-_P % /\ U>O_  32
M_P#K5,].7_'#_P!+2_0J'VO^O=3SW@^UUU74^VZ***JQ(4444?U_7W?U9V/Z
M_K^NW1IA1110!^3_ (/^.FI?!;XZ_M_QZ3\-]?\ B3?^,/VWM&M8+#P]<O%<
M:0GAW_@F)^P7X@N-9U*UM]+U?4[KP_86]O/=Z^?#VFZ[XMBTJVN1X/\ !WCK
MQ5+H_A#5_HSQI^W/\+/!9L NCZ[XZ35KWP!I>A7/PXUKX>:];>,;OXE>$/\
MA,O"VJ^ AK7C;PQ>^*/ UU8#['-X^6QL/#<5])EKDV&E^)[_ ,.?.?@_XZ:E
M\%OCK^W_ !Z3\-_$'Q)U#QA^V_HUM!8>';EXKC2%\._\$P_V"]?N-9U*VM]+
MU?4[KP_86]M-=Z^?#VFZ[XMBTJUN1X/\'>.O%4NC^#]8^KO%?[87P[\+2:?:
M6NA>*_'VH:OX.\)_$'0V^&;>%/$?AWQ1X#\8^7I^D>-_"OC'5O%'AKPUJGA:
M?Q9=:7X-CN[S4-*U5]5U[0-4;18_"FIIXABYL-4O9>UC4YLUKT+>SE3J>[+"
MU)8*FURQO3ISFX8N7VL7)J<_[/C3CI7TJ37+*#_LZC4C>5Z$'4HXM?7*CE>,
MO:SC3]IA6XI4<)*$J;^OJ4L/7OVX/AEX7FTBS\0>'O%>FZCJ?B^P\$FSO=4^
M&VE,-7N?C[=?LZ:C/H[^(?B!H;>*]/\ #OC.T?Q!KZ>%XM6UK3? ]UI6J3:*
M-=UK2/#-[ZK\=?CMI'P3^'>C_$HZ6?&&@:IXJ\%Z(QT75+5'?1O%FHP6[Z[I
M$[)-9:L]O82->Z=9M=V%IJCF&-M7L89#=+\Z>//VNOV;;?Q[)X9^)?PRO+O4
MM'7Q&_BSQ!K&A_"KQ3-\/[;X1_$#P!I-KJ'BWPY;^,M6^)^GZ,OC7XC>&=?\
M":QI_@G4]/:WDF\;QSZ3I3Z9J^H>L1_M/>#-(\6GX9V7@?7+'4O#/P@C^)&O
MZ!%JOPTTBZ\ 6<'AE]?TSX?:_I]WXVL-(TCQ?-I=I-#:Z-:ZK-8:=;6IUS4K
MS3/!3V?B>X7M)2PM1QQ%.-6$G4>)A2=:FL/AL+6QN(=>C)J*@L-@L3B;4VX0
MI2JQ]HY^P3T45]<A1]CB'%PHQ>$G5E2Q3Q&+QF%P="5*I%_N9/$U5AX*2E5C
M6J4JU6,(0=_,7_;D^'?A_5H? =C\,_$'A?Q1_P )M\%O#LGAGQ#K/PQ\)6C-
M\??%7P[@CO\ 0Y;#Q?JX\6:UX;L?BIIWB'QGHWA.PUF:WU;?8S:@UOKFAZ_J
MO0Z/^WG\&M2^(/P_^'%[:^)="UGX@QH;34=7AT:T\-Z,\O@GQ7X]!UG7I-82
MPMHX=%\'ZA#=VRR-K<%[JOAN:/19]"U2XUO3<?PW_P %!/A+XGT?6/%-GHOB
M2'PUH/@C7/%]Z+I+.V\7W4^@^(_!GAR]TK1O!EQ+!?ZD/M'CG16M[E[NTO+V
M6>TATS2+Z+6-$NM1T?A9^VM\*/C^]MI&E^!/&3^%M;\>>(/A/>:[XJLO!0\+
M7'BG0=$^(WB+4K>;3I/%=WKK>'_['^&.O73WVL^&]+ND_M3PS;W&CQ7%UX@C
M\,[.<7B()U)TXQG6Q%6C-/\ W#ZSB:%&$JU14HTEAJ.#K)5)2BJOU6-:<:6&
MKMPYG_!2BY<ZC1IRJ./[N>,G@J;O3PT4FX5L2JN*A3C%U:5'$3H4ZDWAX.MT
MO[0'[7GA?]G3QIH'A[QCX6US4]!UGP;?^*;C7_#US9WNI:=-:^*-!\-V]D/"
MTS6VI:U!.=8>=W\/2ZQK,,L<#-X?.C)J^NZ-YW\3_P!OOX*?"WS?%GB/P%\0
M+FUL? ]EK]MXLT[2? ^H_:M(UKP3I/Q0F\-Z;-:>,KC7(9AH=SI'VN\U.RTK
MP"?$=SH=A<^+XTN8]2M_8?CU^TA:?!%OA#K7]BZ3XA^'?CCQ)>)X\\;_ /"3
MFPM/A_\ #FS\,WVK7/Q'LXK71M6L_$FD:5>R:+>>(#/JGA_3M)\$GQ#XM;5Y
MQHD6G7_C?A?_ (* ^$YAX$TGXB?#/QOX$\:^/O%?B#P_I_A6R3_A*5TNTL?C
MG>?!#19=7UF2Q\.P)XCDU#^R=<\7^%["VOU\()>7.BVFM>*-1?PL?%Y"-1JG
M!5TZKS*K@E#V:I5)585JO/@)0E&$H8AT*D*%.M>*>&HUI).2K06LXQY95.6H
MJ:H83$3Y:T:D?93M6EB(I<]Z52G@<4JL;M4JN+H3<E4JX5U.CD_;M^&=Q\:M
M(^!ND>'?%ESXDO/'6N>#-5U;5K-=#T'15\,Z?87VLZRUU*+N2YLI$UG26T1S
M#:VNJV4EQJ5Q?Z797/A63Q9W7[5G[3FF?LS?!C3OC-'H>G>.-%O_ !U\+?"@
M'_"5V_A[24TKXD>,=%\,GQ2OB%=*UZTDL='LM7_MI5%NMMJ$$ 3^T+.*7[4G
M'O\ MP_"JX.O6TWACQD;;1[_ ,1:1>K<GP))#J4&C7F@:4FO6$MOXVN]+E\!
MZW=Z^\%EX[U74-+\(&#1?$EY>:K#I^@:U<V'077[6'PO\*_\(OHXTB6UTV^M
MM#M;";0?$'PQO/#D%I>_%&X^#%K9>%I]*\;-!XIET7Q#9"]UG0O"=O?ZKX8\
M-?9X-:TO3/%]SIW@R\SH5(3HX:;K4I<F)RNI5JN,:-/%815\)C\1A7&JZ?U:
MGCLLPV+PD*L'_LKS'$XGEHU<'2I)UJ<XSKQ<*L+8'%IJ,IU)T,5[/&8..80G
M"51UIX;,<1A*BH>^ZTLMH8=3K+%5ZD.:U[]N?X;V'Q%\7_"G1?#_ (DUCQEX
M/BO9[S[4++2?#MW#HOQ ^&G@'7'LM<6;4C>F&[^*&EW.G#3+#4=\VB>(]*\1
M?\(MJ%I8IJ7N?PX^.O@[XFZGXBT?2;/7=%U#POKUSX.U:#Q1;Z9I3GQYI+ZT
M_B;P-IL<>KWDNLZ]X5TS2[+7]9NM(BO?#<^@>(_#^IZ%K^LPS:D-,XCX]_M(
M6OP2;X0ZV=%TKQ#\//''B2\3QYXW_P"$G-A:?#_X<V?AF^U>Y^(]G%:Z-J]G
MXDTC2KV31;WQ T^J>'].TGP2WB+Q8VKSC18]-O\ Q;X<?M:?#Z?3M"N?%'P.
M?X7^)]6\>^)IU\/VEQX)N+RRU?Q'\>/$/P/75X#?MX-UG7OB1KFH+%XB^)V@
M^$=#U_4?#=OK-[I<NO\ B[4+OP\?%VM"$WRQJUH55[2O@:T9PC0J_7Z550E3
M]C4C!0DJ5>E'V%2-2%10E-27+6HTXK)J"JKEA"%.CB+J<:L7A:\,96I3YXSN
MXTXX.=.G4I1IJG"4%4IQGB,,ZGH/Q/\ VO/@_P#"7QMK.GS1:5XDGMM,TZS\
M7:YX'U#2O$&O:+XC7Q'=Z#H_A3Q;HVD17.LVHL NOZE/YDMWJ>D6-AK5Q%X>
MDM+35;NUX*Z_X*/_  1M-$T7Q&_AOXARZ5K?AOX9>)H(+*'P'JGB."S^+'P[
MU3XE>&!)X0TCQ[J'B:2WL]'TB?1M;U2VTV?28_%-WINC:#?>(5?4[S2:&M?\
M%%? ?AU/A]%JG@36_P"U?%_BK1O#>L:3;>+? MO>Z);:_P##_P 5^.K#Q-I-
MGXAUSP]JOB+PK:MX<BT;7O%5UI?ASPGH$LFOWVH>(4@\(:U&N]XV_;E^!_PI
MT2S\<ZEX#\<7%Y\0?%.N^&;63P/H'@W7[SQMKGPX\7+\/O%MQ9Z_IWBJ#3/$
M%MX+T:V_X2V.2XU3^UM4\$6=QI?A'2]:\=:9J'@&QPC.<J$*KQ,)PJI*,G25
MVJW-4H*E3YN9I2Q<*=*=:"<81FY<]?ZTY:5J-2$ZT/93I5;5N6,I:4U@H8FA
MBZO/>+DH5,!4Q-2TW1J>QM"7L94)+?\ "G[<OPV\9Z7H&O:'X1\>S^']6U"'
M3M1U^6+PA9Z;H4MU\>KO]G6SEO8;_P 76FMR17OCJTGUF/&C1SVG@B"XU/68
M-*\2+;^$;KT?XW_M 2_":Q\#7OAGP#J_Q8/CT:^VEKX1U!9DM++1O#4WB7_A
M(K@6.G:U>:EX6@L(7U'69_#-AK_B?^QH)W\&>$?'GBB?1O".L]'\%/CEX"_:
M \#:?XP\*O)#9:U>^.M+CT'73I\.LW,/@+QIJWP^\0ZBNDI=7-RVA3ZWI,C6
M5Q>P6EV;#4-.76=,T?5+F?2;;Y"MO^"@>@^!AI&B_$;X17O@6V'AKXS^+]*L
MO"&M'Q597?PL^$_CKPOX!\->(O"4?_"+>%;*\^VOXCM;7Q_X?N7T3_A4%_8C
M^T+K7?!6L^$O&_B$JSY%&+K\M9/"XF+E1YE5PU:<Z#IR?(U3C4Q,\)*<J4X5
MZ,57E*,)48.C*3;FX0;A-XO#I0E>5*K1AAJSJ.*G%SG3H4\13G"K%X>I.=&G
M&<X)0?J<W[:OP$\/?$CPU\.K>2TEO_B'IT'BX>./#-WX9G^&.H0WWPFU_P"*
MT?BB;XA7&I:1HNH:0_@GP7*)-<O)(-3$%[X2U%M+'A6_GUW2>;LO^"AOPCE_
MX5M'J/ACQQIUQ\4_$GAW0/#,<<?AO4HGM_%WQ T;X=^&];U&6Q\0R'P_9:IJ
M>N66N6]CXLB\.ZY=>%K;5+_2]+U+4[:TT74;?A']NCP_\0KB6'P'\/-=UZ2+
MXC>$?AXNGW6NZ1H&O.WB2]^).E7GBAM*U>.VB@\.Z5J7PTU9[=KC4(M4U73#
M=K_9MAXHTJZ\)OE^$O\ @HW\&O&\5^WASP7\7+V]LO#G_"1+H<OASP]INL7!
M.I?#G2HM*!U;Q;8:#!>7MU\4?#1TV\GU^/1+FVAU#4)M5L]-O/"EYXIUA)3J
MTX>UE-U*BK0I*%.#JX#ZW*M##J*IN,5'!XC+L'2JTI3Y53EB7A^>:EAYE2JQ
MIU-9IT5*G4JMJ<88F.'JPE.NU*$9IU<+BL54BU3DU"=&%5TXQ56#1_\ @H#H
M6KZ9_:\?PA\<K;:/H?Q"\0^-;5M1T'3M:T71/AWX5M_%U]XAT+1/%$_AK4?%
M7A+7+.2ZT7PKXE$.C6GB+Q-I]_;:5%=Z#8:EXDL>VE_;?^'1^)NH_">UT+6X
M/$^B?$+PUX$U>?7;W1-*T../Q+XHTGPG::KIFL6-_K=IJ]Q+J&M:<;;0+9TU
M*V>ZM])\4?\ "*^(KB'17Y./_@H;\+K/XE>(OA1XB\(^--,\7^'/%?C_ ,+W
M-OIPT;6;!Y/ ?@3QA\1YYGU5]2TS3H;Z[\.>"=2@FT,74^IV6KZIX;:*._\
M#.JS^*-.U?B!^WAX)^'_ ($\7^*]7\!>+-,UGPQH?BS5(O#?BGQ!\-_"UI?:
MCX;^$W@KXQ6GAR3Q=/XSO_#\>MZSX:\?Z)96VFZ5-KNIR:KIOBV32[#6=$\.
MOK5[&&FJBP,O:K$1G]553V5'V7UV4I8#!2Y&TWAXXO%X?&RG%-^S6.G1A/ZO
M@\/5EM5@JD\73H4*N'J.I6ITH.I*I+"3I5,5"3JQGR.K[&689?3YYOE4<)S*
M7/6QT57T/]M3X+_%?Q++X;T/X<^+O&7B;P9XT\ VV@0ZCHG@R%=/\1>.Y_BC
MX?T;Q-I6H^(_$=I'8PZ59_#[QC=ZAXDT%M0$_A76-+?PG<^);[5]2T+3_JKX
M2>-_!OQ&^'OACQGX#MX-/T#Q+H^F^)(=&6/2+;4-$F\4Z=:>*GT[7K#0[S4-
M/T[7S'KD-[JUK%>7.ZYO&NA<7*7*7,WE_P "OVJ_AO\ 'JW\42:%#J_AFX\(
MZUHWAW6+7Q;)H5FCZWX@NM4LM+TW2=0TW6M3TS7Y+FZTJ>UM[_0;S4M!U6Z=
M;?P_K&M/#>?9O,?BY^U@OP)\?>-=#O\ X36+^#H=:^!>B6OC_3?$OV+^V_B?
M\:_&EEX-31/&>D0>$)AX97^PWTZY\(>+;C6->L_&&NZ=/X!U7_A#M8O/ I\8
M50DX1P].I6=:IB\/AYT:D*2I/%552P$_:*$+P@L5]:I8BC2J585(.IA*5!<L
M/:&%5IJK4C&5.GAJDZ52$TYSI0YLRO&2E%5)>P^JU8.=*A*E.G0Q-6I#FJN,
M?N:LO5=#T378[2+7-'TK68K"\74+&+5M/M-1CL]02"XM4OK1+R&9;>\2UN[N
MV2ZA"3K!=7$(<1S2*WR#H/[;O@GQ3XMTKP1X8^&_Q/\ $GB36?!6L?$"VTS0
MV^&=[>:=H.BOK]O<V'B6T;XD07?ASQA<W_AZ;3['P=J,"ZT]WJ>FPW<-E+9>
M+8_"O+V7_!1CX%ZGIOB;5M-T;XC7&G>&-3\.V-SJ3^'M.%C?:?XX>]/P[\5Z
M4EIKM]K&K^$_'EAH_B37-#U'1]&U"_M= \+Z[JFO:3I$4-BNH3*OAE2<Y2A*
MC[&>)D^24X>QC4HQE4G&-)W3JUZ44N2<IU9.WM)*4QRC.G5G3ESPJPE[*<;V
ME&3C5O3YHU&Y/V=&JG&,W>$&DG!J,?NG2-'TGP_I6FZ%H.EZ=HFAZ+8VNEZ/
MHVD65MINE:3IEC EM8Z=ING644-G8V-G;1QV]K:6L,5O;P1I%#&D:JH^??BE
M_P G:_\ !+/_ +/;^)G_ *[0_P""AE9_P5_:W^&?QRL4U'P]IGB[PU9P>!/#
MWQ$U^[\;6GA[1[#PIX>\::/X?\0^!&US5[#Q-J^C27'C30M=N=3T8Z%J.MV5
MHOAGQ-8>(KW0]7L+73K_ $/BE_R=I_P2T]OVV_B9_P"NT/\ @H9_GJ*>+YGA
MZTI.[E";;;YVY>VG3DW)-N[J8>NDY6E/V4YQ3@N<K"N'MZ<8N-H5)0:5DDX7
M4E91BK1YHO2/*N>#O:I%R_;.OQ+^%W_)W'_!4_\ [/:^%G_KL7_@G77[:5^)
M?PN_Y.X_X*G_ /9[7PL_]=B_\$ZZ\O ?[Q_VY/\ 0]+&?P)?XH?FSZ4HHHKW
M._S^=]T[J2LUH[QDG;6,U[C\GK>W9Z7NFMM4XNZW34HM-7C*#M.)1112_I]V
M_-W3UZWD]&^9U(_NPZ[?^DZ==$X-+NK*.MFN1KG91110VWO_ %VOIKMU;Z7Y
MK+D5K;?T_P /R5_)<W.5\2_\% /^2$^ _P#L]K_@FC_Z\=_94K[:KXE_X* ?
M\D)\!_\ 9[7_  31_P#7CO[*E155X2UUL^]KW3?FV];MZW;>K=WI3TG'UV[:
M273LK6Z*VBLD?;5%%%60%'^?Y\_CBBOF?XQ_#+XA>+_&%EKFA6_A_P 6^%X?
M .N:%#X,\2?%#XB_"J#0?&T^IVUWI?CC2M6^'_A_Q+/>ZM-8>;I<6M/::5XE
M\"BP2]\&:PDWB+7(TF4FI4HJ$IQG.49RBXKV48T,154Y*37-SU*-+#02:_>X
MJE*<H4HU9QN$5/FO.,&E'EY]$W*I2IOWFN6*IPG.O-N\G2P]6--2K2HQE],?
MY_4?X_GCUHXYZ^WZ]^^/U]J^+_#'PT_:\BM-!TGQ3\:=%AM;9? <'BG6]!FT
MG4=9U_\ L>Y\<-XYN]!AU[X1 >$+7Q58W/@"PM]&N]4\7ZO8VFEZC-:^.+'Q
M)#J'BKQKQM[X _;SL['PGH=G\8-%\0:C=>#KR+Q/XOGN/ .B6&D>/;;X/>']
M'MM8N;.W^!<MYK&A2?&:/6_&&G>'=$T+1X;_ $AEM/$&IZ9HH'@V^.:-X^[5
MY95:=.-J3YFJE%UO:<JFN6$7%T)\\H-5G32=.%2,J<\KU=Z=HQ<ZDN>5HQ55
MTO<O"4JST5:2IPYX8>4*LX59R=*/Z!?Y_G_];]>O8KX4^(7P[_;KU"_\WX=?
M&CX>:2L?B+Q5>M<:\EO_ &)J/A^[U+19O!>BR^#;/X17VM:2OAS34UZWU">P
M^*=QJ6NZC-:WFJ:O>Z7-!H.B;OB/X<?M::EJ7A+4=+^)OA6U;3]4\)7.OPGQ
M#K&GVALX/ >B:9XW$.G:=\/AIGB)M4\9V6KWVE6.JV6EV5O8ZJ-4M6T2]MX]
M'51G*4J?+3:C4Q%.C*<VH*G"I2J5'B7%KVDL/2G"%&I-*$W.<>6ERJX37)"I
M*\92AAYUE3@TYU*D*DH+#13T5:<8NI!N3IN,H+GYI-+[/]<Y'IQ_/I_+M^2?
M_7_+CV]_6OC_ $;X??M9R7&F6GB7XPZ+;Z6+WP4WB;4-#ET*[UG7(-,U+QU-
MXW?0[>Z^#6F6G@RS\4:;=^ -,@T6&[U^_P!-M-,U&72?&6C:_;WWB;QE%\5/
M!G[9NJ?!WX>:%\*?BE\-M"^,>G>"KBT^)'B_Q-:.="U_QR/"EI9V.L:%;:?\
M/[Z"TMH_&7VGQ 99O#EKI'V.!-+U#P/K>G:E-IVGRJDG"$U2J>_/"0<9*$:D
M(XE474JSBY75/!*K-XC7VEJ%7V,)7A!W*%JLJ:J4Y*+JKVJD_92Y*TZ<7"4H
MJ4G6C#VU)-13A.E&I.$ZG/3^Q?\ /^>G_P!;WQ1_G'<_YX_.OC?3O '[8.FZ
M;8_:OC!X=\3:C);>"+KQ!;WMQH.@_;-4BU'XG_\ "?V.A:[IWP0OX- T672M
M7^%">'I7\'ZI>WP\$ZU97<6A:KXBU+QCJ4E_\+OVHC\$/A3X-\._&N'PY\3_
M  E\%=4T#QOXP:[TSQ0?%OQDMOA_I>D>$?$=]KOC+X6^(+W5_#MGX[AU'Q)K
MUZ?#OA[4=<B^RC4M!U&PNM1\./I3<IJ/-%TKUL'2<9<K<%BH.52M4<7R>QP3
MY:>*G!RES.4J*G&FU.4ERQDY)1E3K3UNYITYJ,:<J27/&I634Z<6[<EW.7-%
MI?8G^?I]?;MQDY[4=.O^?\_SXKXMUGP!^VLGC70I?#OQH^'LWP_M/%TU]JMM
MXBT>$^*Y_"S?%#3]673Q+H_@2STB_N'^%AU/PLMO)'IQL]27[0FL7.K:AIWC
M'PCB^$/@W^UQX?E\07\WQRL5O]4\1^(A8:;J6O:AX^\.:9X6D\"_$C3?#5]#
M:^*/ -KJT.O_ /"?ZG\,O$>L:1:ZO%H]MI/AC4M+T[4I4N]5A\59>VDX3G[&
MK:%'$5>1QC&K*=&24:,(2;YIXF/-*@^:SLHS46VRU2]ZC"56A"52M0I3?M.>
ME1A5NIUJE6G!+V6&:O5<(-M+FI1;E23^[,?Y]^?Y_P"?8_S_ "_S^'2O@BZ^
M&/[;NH^(D6\^*_A>/P.WC#X'ZS;Z79^-Q8^(]'TKP7XQ\#>(/B]!?Z_HW[.^
MB7'C2S^)6E:9XJTJQ\)J_@?3](BNY=.GUVZ\/^*8-)^'OJ7PN\(?M4Z3X8^+
M&F?$[XF^"=;\1:K:7L/P<\0Z991ZA)X7N9K7Q EE?>-+9/!7@_3M:O[6]N/#
M]Y>R:5IMGH>H1V=Q9Z=X8\/PQ.=5TJ-PC6FHNHJ5/&U(J.DZSPCBJ=*E&>LJ
M^.;G+!TY6C.G%5*]2$I.!-.'M'A^:=*BJ];"4Y.K.WU:&*A3G+$5U",FJ6"E
M4E2QOLN:K3J4:SHPK05.=3ZE_G]/ZYX_(T>OM_CCMG_"OE#X6_##XY6/Q:N_
M'GQ<\8:/X@\/:=X/N- \&:%:^([G7K[1=3U:T\"R>(=6NI+3X=?#/0+F35=9
MT/Q//!<_V"^IZ38ZHNF6%XF@WEOX?\-\=KW@[]NO4M"U:RTGXD_"C0=>L[?P
M%;>&=8:]EU73M:O=)U[XE3>.]:\7Z,GP9TF\TZ'Q%X=U/X9Q:?X:\-^(=MIK
M/AZ^<>([73$U.T\;JK-PA*4:52K*-/$3Y(*"<W1Q];!TZ<'4DG[3$T:<,PIP
MJ6:P>(HRFU456E%4(^VYG*<,/%2H1BZ\^63=7 8?&2DXPC/EITL17J9;4DN>
MV,PF);3H?5ZM7[@X]^G^?U_2BODOX/>$?VOM)^(LVJ?&CXE_#;Q-\.VT+6[:
M/0_"^GW,.LMK%Q'X)?P]-.\GA#0;95TB6T\=0W=]9W=H-6.J6][=Z,T5WI&D
M?#_ZTK5Q246IQDWSI\O-[KA6KT=>:*TG&BJ].4;J="O1G:,I2IPFWO..FBIN
MZ<91;G3IU&DU:[IN;IS5M*E.:3<5%A1114@?$O\ P3__ .2%>/?^SVO^"EO_
M *\:_:IK[:KXE_X)_P#_ "0KQ[_V>U_P4M_]>-?M4U]M5,/@CZ?JRI_'+U_1
M!D<>_P"GU[_IQTZ]0?YX_P _Y]:\1_:!T#XH>)/ ']G?!_2O ^K>-1K^CW%J
MGQ&^('Q!\ >$K*PAEE_M'4=1D^'&@Z_J_BV6UMW/V'P7JD%EX;U>]>"[U?4(
METR&WNODSPU^S/\ M.Z-X6;1KCXK?;=6LO#7B/3GUS7/C7\5O%6L?$ :EXH^
M$6NZ#X;\;ZR_A+PXVCOH/A7PAX[^%W_"T?"^E+XCGL?%5S\0-/\ "6C^(?$W
MB30TEU9*4X^RJ-1E&*GRRDI<RP[E)6WA3C6JN<K6<L/5I4^:HRW""A"7M4Y2
MYFZ<4FXI*O9.3M%3JRI0I4X2TOB*=6K*GAXS/TA_S_G_ #]:*^$OA[\!OVI?
M#WQE\&>.?$_QY\-W_P *=!UOXNM+\&+*T^)-Y-H_A7QQJ7B?5O#&DCQS?>/K
M32/B+J&A7E[X5LM/O/&'PRTZS\!^%O"]KX8^'ECI)N_$VL^+?NVJIRE4HTZL
MXNG*;K7H2;]K1C"5%4W6M[D95HU95(TX3FH0I-2FZG,H9R5JDX)J<(J#C5@W
M[.IS^UOR*48S3A[.',IQ3_>PTTE<KXD_93_Y+O\ \%+_ /L]GP%_Z[C_ & *
M^VZ^)/V4_P#DN_\ P4O_ .SV? 7_ *[C_8 H?Q0]9?\ I$AKX9^D?_2T?67C
M?QKX:^'7A/7O''C#43I/ACPUI\FIZUJ(L[[4&M+.)E1Y!9Z9;7E]<$.ZJ([:
MVFD).=NT,1R\/QO^#5SID&LVWQ5^'MQI-UJ%AI=GJ$'B_09K2]U#58M3GTNU
MLIHKYTO)=2M=$UJ]L/LQE6\L-'U6_MFEL].O)X<KXV:K\,9?#2_#[XHV=YJ^
MB?$J'5-#;0++^TX9=7M-.LFU;58SJ.F7>F3:?';VMNDAD75+.YE<I':^:QD5
M?FG0?AG^P+XL\!7MCI\_A.?P5\>H/"_QEUG3-=^)7CC1Y_'"76@:W\0?#WBG
MQ)I7B;Q7I^O0W5[X:&N^+KBQUVVLKN]TO0+S5M6T^:'P;YVC8NI-QQ;A/#7H
MQ:I.=22C&K1PZJ5Z>*:DE3A34<17G4IMU*.'I7JJ%.52M#2%*,G14O;I2<8U
MHPHJK)QK.L\/*BE[TJE5*A&%.HE"LU65)RJ*$']?_P#"U?A?]@&J_P#"Q_ 9
MTLV.KZH-17Q?X?-B=-T"YTJSUW4%NQJ!@-EHMWKVAVNK70<P:=<ZSI4%V\,N
MHVB38$'Q[^"]YKOAOPSI_P 3?!NJ^(?%GB74?!^B:+H^M6NL:E+XGT?0?$WB
M;5M#O[32WNYM$U#3-%\&^)[K4(M<73OL<VC7=A<&/4?*M)/E&]\%?\$^+K3)
M+6Y\4^$_$.D^)K?1/AG%H5I\;?'OBVUE'Q@\5?"FW\/)I/ABP\=ZJNDZAXU\
M4Z)\*M:TKQQI.F6.HW,CZ?XNM_$4=GK>I:QJ%C1OA=_P3\\)SI::#XI\%>%&
MNM5U+Q0VD:=^T'XS\.V4OB/X@>"O&GA1M?OM"@^)%E8#Q5K_ ("USQ?I?AK4
MKZQ77U\/:,C>%IH;7P!I$GAW:;4:M6"E%07M(T'--5'4IK%PG3K4HKFBH599
M7[5X?GJ0]IBZ*@JL:"<QC1=*$Y59\WNNM*%&#HJ#A3JRE3E*?3#SJ58^TFH3
MC3C5Y_J]55(_<WAGQ%I?B_PYH/BK0YI+G1/$ND:?KND7,D,EN]SI>JVD5]I]
MR8)566(7-I/%.J2JDBK(H=5;('R!X]_Y2._LI?\ 9DW_  4 _P#5Z_\ !-*O
MK'P7XF\%>+?#]OJ?P^\0^&?$WABTN]4\.6VH>$M6TW6M%M=1\)ZI>>&==T)+
MO2I[FSAU#PSKFDZAX>UG3#(EUHVKZ9>Z5?06U[9W$$7R=X]_Y2._LI?]F3?\
M% /_ %>O_!-*KK**DU34U35:/(JJBJCIN=Z3J*%X*<J;IRDH-T^:4O9MT_9M
MYT7/E_>*,:BI352,>=QC444JD(NHHU'&E4<Z<?;1A6:IP=:$*TJL(?;=%%><
M_%S2O&&M?#;Q=IGP_P!+T'6?&=YI?E>'--\4^.O&7PV\-W.IK<P20C7?&?P^
MT?7O&.DZ5&%>:\AT/2KFXU>")]$GDM+/4KB\MXG+DA*:C.?*O@IQYIR=XJT(
MWCS37,VH\T4^6SE%<TH5",934924$W9RG91BK2=W*TDE[JO+EE9._)-I1GZ-
M17YU?#K]GO\ :>\/7<.J>+_&6CZW=R>(]<\67EC:?'[XQK9V^G:OX"^)NC3?
M!G0;I? 6FOI'PT/CWQ+X;\8>&-;73Y_$OP]TN&QT&VL?%UY\,?!VO:SG^!_V
M>?VL;77/#/B_Q-XZT/PSKUIXKTS6-6\(^'?C;XM^)GP8TS0XM2^'=MJFE:!X
M+^(WP#L/&\]Q?>%?#.MDWL?Q4\-7TGCB]U+Q9+?HGCG7M,T@IRYZT*<XSA&4
MU&I54>>%).6(ASJ[@ZL5*C3<G246J->-=1<(JE*I1IQC5E&;GR<SIIQ4)5%%
M1D[PYI.DY*5H1G*I>H_8.2J*K6I_I+1115&9^6'PY^*^O_#C]H?]O72O#G@V
M\\87_C#]N'2Q+#IN+K4+&Q\)_P#!+S]A#Q-=266BBYLKG6[NZ2T%K;V.GW;:
MC),R16>G:A-,L<=U_P#@H]\"O#,/ACQ=XV^&VLZ=\2?$_@/X>-XCD\&_\(1X
ME@TJW\6:%KOC32_"P^*NKZOX,\/ZSX:\+7=KXAL=;U6YU;3O#VA>)FU<*'M]
M*\9ZIX>YGP_\;M4^"?QD_;_O]-TKPU?Q^(_V]?!NGZE?^)_&GA/PA9Z'INF?
M\$ROV$==O=1B3QAXC\(V6NF.UTZ=KS3M(UR?Q'9::E[KVF>&O$T&DW]@GN?B
M/]M[X,Q>&_#3?$+PE>WND^)8/A7=:A"D>@ZAHL5QX^\%6WQ2TCQ%8:!\0Y_
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MO\._"OQ2M8=-_P"$?\0Z]8ZE-:>$_&&F-K$=C>7"V.I66LQ6\M_I-E;:U?\
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MMS=V]6[J[ULKWY8WOORQT]V*C^V=?B7\+O\ D[C_ (*G_P#9[7PL_P#78O\
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M84)SM%PIU:6$Q5-SIS<G'T'2_P!NG]G75?"5[XSA\0>*#H^DMXNCUPZ?\/\
MQIXIFT*X^'V@6_BKQ];:HW@G1?$]DD_@[PY?:=J>M&VO;F$3ZE9>']/EO_%,
MQT).LN_VN_V?-/U_3?"NH^/ETOQ)J>N'P[!H>J^'?%.E:M#J?_":#X>QI=:?
MJ.BVMW;V\_C!O[*@O'A-L]O%?:Z95\.:3K&KZ?Y9XR^,_P"Q[X+\-:UXEO\
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M^"]5^&GP_P!3\'>"/[./@OPEJ'@SPY>^&?"']D:3<Z!I/_"+Z#<Z;+I7A_\
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M'_!4_P#[/:^%G_KL7_@G77E8#_>/^W)_H>AC/X$O\4/S9]*4445[9Y(4444
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M5PITHU*GM)TYX;%QP_FO_#R[_@G%_P!) /V)?_$J_@3_ /-Y1_P\N_X)Q?\
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MZ-2,=)0C"Z<9N4:CI2BJM!M32Q#LW?EY7]5J\LU.4)?NW&;C5I2G5_X>7_\
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M.4LVZ<9.,H58M3G"/O0:J<L(5.>G)1UIN-6'+.4::<U4I<KJT:L8?D+^P_\
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MOIC0/BS\,/%5_P"%]*\,_$+P;K^J>-O!K?$;P?INC^(M*U&_\3?#]9=.M_\
MA-M$L[6ZEN-1\)O/J^EP1>(;:.3299M1LHX[IWN(@_H55:IWIZ.2?NU-)1ER
M27K&2<9+>,DXNTDT0I47MSMI1;2G2=E)2<6[)Z24)N+VDHR:;29\2_\ #R[_
M ()Q?]) /V)?_$J_@3_\WE?'_P"S3_P4)_8&T'XT?\%"=5US]N']D#1M,\:_
MM?>"?$W@[4=6_:6^#&G6'BSPW:?L#_L0>#;KQ!X9O+OQK#;Z]HEMXN\)>*O"
MMQJVER75A#XD\,^(-#DG74]%U&UMOV:KXD_94_Y+O_P4O_[/9\!?C_QKC_8
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M+*,I.T8RE&?W:M>%57M:[IJ_,FXI>[JY)-Q2NY)-Q36I\>_\/+O^"<7_ $D
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M3_EJ_P#@5/\ R/B7_AY=_P $XO\ I(!^Q+_XE7\"?_F\H_X>7?\ !.+_ *2
M?L2_^)5_ G_YO*^VJ*+5/YJ?_@-3_,+T_P"6K_X%3_R/B7_AY=_P3B_Z2 ?L
M2_\ B5?P)_\ F\H_X>7?\$XO^D@'[$O_ (E7\"?_ )O*^VJ*+5/YJ?\ X#4_
MS"]/^6K_ .!4_P#(^)?^'EW_  3B_P"D@'[$O_B5?P)_^;RC_AY=_P $XO\
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M_93^.^#_ ,;+_P!ML_\ <A?\$XOPX'_!/WD^GX\<T?\ #*?QV_Z27_MM=/\
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M_P##*?QV[_\ !2_]MOTQ_P (%_P3A_7_ (U_#^GX\TG_  RG\=_^DF'[;?\
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M_P"4CG[*?_9DW_!0 GV_XOI_P33_ /K\^U'_  RG\=^O_#R_]MO'3'_"!_\
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M .SU_ '_ *[D_8"_7U(^@XK[;K\-O@+\'OBE8_M)?MI>!C_P4!_;/T;6M?\
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MHN_[RUI3@TZ55-2IU*E*:L]=*E*I':SY;IM--_;=%?$G_#*?QW_Z28?MM_\
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M[E[?!_X;0^&__1&/V_\ _P 59_\ !3+_ .A)H_X;0^&__1&/V_\ _P 59_\
M!3+_ .A)K*I*E/6.)]E)4<73A*G4A>$\5A_J\<0HRO"=;"/_ &C"^T4J<,1^
M\G&:]TN%.<7%3PRK05;"U9TZM.;A5AAL0J\L/4<90J>PQ27U?%*G.$ZF';IQ
MG!OF7-ZKXG_;EN[&.+PMX(^'6E72Z["LNH^-_#NEWMQ-HDF@_#^6ZQX>\*_M
M$K969MO$VK?$%;.['B_4;NXT7PQ9:3<:3'>36/B[Q-NZ;XI_;#T>^AD\1?#W
MP=XQT2+Q%J-I=P>$[71- \23^%[;XE?$70M)U*P_X2+XS-H<VKZA\-K/X8^,
M[^.[N-+M[:[U;Q)9P:>FIK!X8TF?_AM#X<#_ )HQ^W__ .*L_P#@IE_]"31_
MPVA\-_\ HC'[?_\ XJS_ ."F7_T)-7*K3E[6V(C'VE3VD>65)JBO?3I45+X*
M3A*$>5N;BJ--J7-[252(T*B4%.A4J<E&%/FDZD)U)P27MZDZ=G*O*+GS2Y5#
MFJ3J*GS1I*'EOB?QS_P4'T_P8VN>$?@OX0\0>.-7\,>'=5D\&ZSX@\"Z9H_A
M/Q0GPIT.]UOP_87=O\04?5;8_%J;4](N[2_\4WT%YH=MJ#Z1X_T:!=&U>_[_
M $KQ%^V#!I_A5+[P/83^;,\/C2YOO^%?7WB:TMV\<_$&UDNO#EAI7Q&\.>%K
MJ;_A$K?X>7M@=0U.%+/3-2U&]O[+6/$]A=>%+C3_ .&T/AQU_P"%,?M_Y_[1
M9_\ !3$?^^DT?\-H?#?_ *(Q^W__ .*L_P#@IE_]"347H*=6<<1R^TJ1G&+K
M*I"A&%;$5HT:49M?NE]8]DU-RG.G0P_--N#4KE3JR<FZ#CS.M)J%-QBI5:.'
MHJ45JH.E]752DHODC4K5I.$N=M\5HWBS]OB7P/<:QX@^&_PP@\;7GACQG=6?
MA+2[738K?3/$.D>(/AS:^!])O-2N?C=J5C)-XU\/ZE\3=1UK4;?4]1TKP?/H
M_A^&*#Q!-I;VWQ&],U7Q;^U&GP/\*Z[I?PJ\,W'QSO\ 6(;;Q;X$/B71+;0M
M$T4ZGJ\=[>:?XFN/$%QI\]S%I%MILVEWFW5#?:C>P#4/#.DVTU_!H61_PVA\
M./\ HC/[?Y_[Q9_\%,OS_P"32:/^&T/AO_T1C]O_ /\ %6?_  4R_P#H2:)N
MC.E6I?69Q=6G0IJK#$*-:C[&<IU*E&I9J-7%*2AB9N$E*$8JE"F[W'3J-QE]
M7?NSQ<G'EFH26*;<*<HJ7P8-<L<%9\U)0C*<JTG/GXI_&7[>X\,>$M=_X5=\
M,QX@N(?A?#XS\$0PZ6]UIIU'X:WFN?&'4M'U>?XYPZ/J-_H/Q'AL?!_@30)=
M8M-/N8)KB76/$^JZ5?)XQ\-]_H>O?M167PHT?4M7\(QZO\1[OXM_$"#Q!HUU
M9> (=9TOX07'CSQ^OP_O='TG2_BMIG@>YUBR\(+\.UNX+SXEW%ZFDRZOJ%^F
MI>+(&T*YJ_\ #:'PX_Z(Q^W_ /\ BK/_ (*9?_0D_K1_PVA\./\ HC'[?_\
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M9DU*[\-S&WU#PK8/_P"&T/AQ_P!$8_;_ /\ Q5G_ ,%,O_H2:/\ AL_X;_\
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MIX)F7J?^&S_AOS_Q9C]O_GK_ ,:L_P#@IEV_[M)H_P"&T/AO_P!$8_;_ /\
MQ5G_ ,%,O_H2:GFHN4W*NI1J<R=-S@HJ$J,:,H1E&2G&[C[5SBU4YWR)P@E)
MU)8B5.%-4I14)1GS1A[\IQG*:E*3B[\M^6,/@LO:-3J.T?.?A%I'[;=G\0_A
M:WQ2UB?4? UAX1\%V/C5?)^&R27FI3_"74AXWU+Q+J^B:Y'-=>)A\8-.L99=
M*\)?#L:(VDZEX>N?"GCKP_HL7C_PQK'W[7R1_P -G_#?_HC'[?\ _P"*L_\
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M>G@AOIX[VXUSP!TW_#:'PW_Z(Q^W_P#^*L_^"F7_ -"31_PV?\-_^B,?M_\
M_BK/_@IE_P#0D_Y_*LFJ7+.,<7.#J3QDYRC6@Y?[5AIX:G&#DI>QC@95'BL%
M[-7ABU"K5]K&G&D:4U4A+FE@Z=9+ZGRTZM.HX+ZK4YI74)1<EC*=Z&,C*5JE
M)W@Z=51FN&U'Q%^W<NOPZ$_@WPG-H*^,?@:\/C?PAI'@RWDO/#5SXA^&M_\
M'J+6])\9?&ZXN/#^E:=HNH?$/1?"DFB:+XS\2W%CI#R1K+K5KH&M>+V>)O'O
M[<OASP_:^(X?AMX(U@VOB#P7I6J>%M,T$:]XCE\.:CX=U>Y\:>)M/;2?BO;6
MVJ:U8>+$\.>'O#6A^1H6DPQ7FIZEXFUB/P[)/XM\(=Y_PVA\./\ HC'[?_\
MXJS_ ."F7_T)-'_#9_PW_P"B,?M__P#BK/\ X*9?_0DUI.I1G)R5:$&ZE>IR
MQFG3:KUZ57V4H<WO4J-.F\-0CSQ<*$Y)R<WSO.-*I&G"#P\Y.-*%.=23J*K4
MG'!2PDJTII>Y4JU7#'S]E#D6,BYPC&E.5*/IGP \7?$GQO\ #R37?BMX:F\)
M>*QX[^*6CP:1=>%KGP9>'PCX=^)/BKP_X#U.^T"X\7>.ECO-:\%Z;H.KW>I6
M/B6\TG7IKQ]>T6VTK2=2L])LO$/'O_*1S]E/_LR?_@H!_P"KT_X)I_X5T?\
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M'5/#_@S6O&UIJ6N>*/'U]XFM/$'BE[_5H/[)\.>/9=#C\ 6'B;X7Z9H74?\
M#:'PX_Z(S^W_ /\ BK/_ (*9?_0DT?\ #:'PX_Z(Q^W_ /\ BK/_ (*9?_0D
MT0G0A5C5=6G/D^"$I1=.-JM2M&\>?WW"<XJ,ZC<I1IQC4YH3JQ'.%>:K7ISY
MZU^:HH-.-X\K]G",53IMISUC%<JGR0452I37UO17R1_PVA\-_P#HC'[?_P#X
MJS_X*9?_ $)-'_#:'PW_ .B,?M__ /BK/_@IE_\ 0DU?MJ/_ #]I_P#@<?\
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M %FPW_0)B/\ P.A_D'^J&*_Z#L+_ ."L3_F?LAD^A_3_ !HR?0_I_C7XW_\
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M %FPW_0)B/\ P.A_D'^J&*_Z#L+_ ."L3_F?LAD^A_3_ !HR?0_I_C7XW_\
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MU'^LV&_Z!,1_X'0_R+_U0Q7_ $'87_P5B?\ ,_9#)]#^G^-&3Z']/\:_&_\
MX=>?\$S_ /I';^PM_P"(D? '_P"=_1_PZ\_X)G_]([?V%O\ Q$CX _\ SOZ/
M]9L-_P! F(_\#H?Y!_JABO\ H.PO_@K$_P"9^R&3Z']/\:,GT/Z?XU^-_P#P
MZ\_X)G_]([?V%O\ Q$CX _\ SOZ/^'7G_!,__I';^PM_XB1\ ?\ YW]'^LV&
M_P"@3$?^!T/\@_U0Q7_0=A?_  5B?\S]9O#O_(7\>=/^1KL_S_X0?P:3]>O^
M>W4\$GOD#/\ 3]/3]>W\H?PP_8H_80\._M'?MF:7J_\ P3K_ &4?&WPXTS]N
MC0/AXRV'[$G@CXI7/PP\-7'_  3/_8M^)>CZ1X4\/>#OAMXANO!OA'5_B/K?
MB?6]6ECT%?"P\4^,-7O[N2R\1^+#>:C<T#]C/X!W6O?!JX\5?\$J?V'M'T[Q
MAH_P8D\7>&_#O_!.+PQJNJ:/JGQ!\1&W\8?VTVH_"ZV\%^&]&\->&HY;_5-5
MUOXW>'_%/PMN;>]D\4_"GQ_<W7AKP]KF\,^H5*\**H3A[252"JU*M"$%6IT\
M-4]C*Z<E*I#$0G1FU[.I3A6J*:C2E%X3X8Q,:;J/%4GJE&,*&(FYKEKRO%QE
MR^ZL+54U)Q<:RAADI5JM)R_JRI!@=L9[5_.O\;_V'O\ @GCX=^%NG>.OA+_P
M37_8J\7FZ\?Z!X7U/^R/V#/ ?C/5-.T;_A,O^$7\8:I;^%?!'P2\5^,9QH4E
MM?>?>VG@_6[6"VMYM1D@.G :A%YSXK_9>_8,\#^"]*U6P_X(Z_LV_%76-6\.
MZ%J6D)H7[ 6BZ)+JNMZI\3+7P;K6@:QI5W^RI%KG@3_A%_#NH1>,3J/C3PYX
M?36M'L[N6TM$L+>ZUJ')<1X=T:M987$VIUE1Y'*BJE27U%9ES4X-)RA]5E&4
M9NRG4DJ%-NM[CUCPGB9UX8:.,H<]2G&K";I5U2<98R6!:=1S48SIXB-JL92B
MZ=)QKN]'FG3_ *;LGT/Z?XT9/H?T_P :_EE^*W[/_P"QK\)/#C:_K7_!$[]B
MK4IK:?P%:7MCH_[,'A+4M*3_ (3;PP^KWVL1>+=)_9#U73UTGP;XE^S^!=2T
MNZT^#QWKFKRS2Z3X-BU";PEX=\;;6K_LW_L7Z+J_@_3YO^"''[-6H:7KFMZG
M8ZQXMTS]COX/-H.FZ%IWQ@7X;IXEN+:Y^"L.O>'8+SP>Z_%F.P\7:5HUPFBM
M%ID,MYH2:S\0- UEGM&$Y0E0LX8F>$G+ZU@_9QJTX8V<W*K=4U24,!B)*NY^
MRDE2<9R5:DY<\.&ZE2$)PQM-^TPL,9"#PF-526'J/"Q@U3:YW4<L;AHN@DZ\
M95'&5*,J=6-+^H&D&!VQGM7\[OQU_85_X)\>%OA3X;^('PJ_X)J?L4^+8_$/
MB'X?*[Z/^P=X \:ZG;^"_%FJZ<FH>(;?PIX&^"GBSQD18Z3>"]N'3P=JQTRW
M\V?4K"WBAGN;7S2P_9>_8+MX]/TE?^".W[-OBS5;M]0DM-:7]@'1?"ND:EIE
MI\,?B'X\_M&]E\1_LJ:$OABX_P"$M\&Z;\++;1?$=IH^L7^J>*-"UJTL[D:E
MHNF:[#XAHQIXJ<L'BHO"5:]*M2DZ*K<V%P<L=B>6FUS2]E0C)-).=2O">&HQ
MJ8B$J;WI\*XBK5HT88W#R>(AAZE&K[*NJ%2&*Q,L)2:K.:@OWRC[1RE&-*E6
MHUZDXT:G/#^FW)]#^G^-&3Z']/\ &OY6K?\ 9^_95%_XKTG4O^"#O[+-G?>&
M_ ?B3Q3;W]C^R3X"U;PMXAUWP_K_ ,.],@\(>$]<3]F*SU#7-8UVQ\9^);C2
M8=6\.^$8[F\^'=[+;SW/A37+SQ=X0[#4OV9/V+;3P=X?\56__!$']FVZO-=T
M'2;ZX\(P?L6_"*X\4^'M3OO&GBOPWJ5AJ=F?@[;:<]SH6@^'[+Q;>6<NJZ;:
MWEGJUK:Z1KFHQW^@ZAK16X@IT(U)3P.)DJ;2E[*IA*KNZF/I1<5"HW-3GEN*
MY7!23BJ$WRQQ6%=?GI<.SK4H5H8VGR3I2JQ4\'CJ<U",L$FI4YQC.,VLPPTX
MP:YI0=9I.6&Q,*/].U)P?<<\YX]\^OZ_A7\Y^D?L@?\ !._Q#^SA)\8='_X)
M)?LDW/Q0C\(Z!-=_ .']C+X0?\)?I'Q6\2^'O#VI6'PLU2?7?@_X8FL6L-:\
M4:1I'B+QIK>D^'_#7A73SJ/B;Q;/X>T;1-<FT[Y\TS]D'X&S> /!-YKG_!&/
M]D'2/BAH7Q,\3^%?B5X.O_V(?V?=)T[Q1H5KH\>I^ M?T;Q7X"\._M#>$_#G
MAGQ%8^)/#-UXNU7P_KGQ);P_KVB>,?!UM>6^J:7<FVM9[3^L2PTL)5C4A7P^
M&E)UL*Z3J8FM4H4Y0JQ;A5I1E3A4JUJ<Y4J=#$87$2G*E6YJ+GP[4A06(6-I
MU(2HXFM%4\)BY2Y,)&+J\R?*Z4VY3ITJ56$*E:K1KTZ<'.G&%?\ JSR?0_I_
MC1D^A_3_ !K^:O4_V1OV(]&U+6-/U#_@CC^QV(=&O-7B@U2T_8O\,Z[I_BI;
M'Q@WAFVM?#;>"/V8O&EU;2W&F;/%$>J^)+71=%O;*ZTN*QN9=,D\4>(O!6_\
M /V1/^">/Q5L]23XE_\ !(K]D[X#>('\=2^#_"/ASQU^QI\'(=0\7V]O\.?#
MWQ!U#6;.67X16FEQ6&ES:GXA\+_;K75-3TS4[WPA=W4=]8:GJ$OA;1\H<14*
MD7*&#Q$DJ:JO]YAKJ,JWL8QY6^9U)2O-4HJ5148RK3C"$6UI+ABM"HJ<\=0A
M-U'2M+#XNRJ*$)N,IQYX1LJD5SN2I2FW3A5G-.*_HUSR?;W_ "XSQW[?CVI?
MP_E_C7\N>O\ [)/[,5E\:/'.A:/_ ,$6?V5;CX)0>'/B'X<^'?Q)N/V&/V=[
MR+6?BUX&\+W/B+3[S5-%T]H_BC9^ /%FKZ/XQ\#:7J6I_"+0/#&L:EHO@?7/
M"/Q*\0Z;\5M @M?-=9\ ?L*Z9XZ\,?#C1O\ @BE^Q_X\\2:F_CZS\2VW@W]D
M_P"&UWK?A)O 7B?X9^&9?$4VB3_LZKX6UG0M2;XA->ZA8:+\3[S6? U[8V.@
M>+X[&27Q?JO@)QXBH3C3FL+52JT_:Q4JV%A-0]K4I-SA*TX./LXU9)Q]VAB,
M-6E:%;]VY\,5J?M>;&TK4*DZ=2?U;%*"G3HT:TE"3=JRE[9T*4J*J*MB</BJ
M%-.6'ES_ -:N3Z']/\:,GT/Z?XU_+FW[-?[)RVMMK;_\$*OV4$TB7X9Z3XK;
M2(?V5OAE=^,I_&^J^'?">N2>!(]*/[-=IIU@FG7?B&]T ZOJ>JP7DNJZ1J":
M_H/@Y-,U0VOO_P "?V)O^";_ ,5?"VCW?C3_ ()7?L>_"3QYJDWQ#G7X>>+O
MV,O@_8:ZGAKP+X_OO!-IXHN4U/X2:9%91>*;-=#\36.F+-?+%9>(;>/2M6\2
MZ=:C7[NI9_2A[?FP==?5VXU+5<++6-3%4Y<G+*3J*#P6)G.5-3C"C!5I25.I
M3E.%PS5]JJ+Q]",Y<O*Y8?&*$N>G3J1M4LZ:NJD8I3E!NI>G%2E%I?T&^O!]
M^?;MSQ^G^"U_*]X5_9<_9NO/$/Q5?7/^"&W[+-MX5N=*MO$?[.MSK/[&G[/?
MAN#Q?IMIXUT[P?J5AXYU#PUX:^*7C?P%J&J:!X@\*_$[3=*^(WP>^&WC+2]-
ME\>^%I_!^KW7P[U/6I^BD_99_8\TE/B9>Z__ ,$:OV,HK7P)KT^F6%O'^QO\
M+]&TW7="T>3XQVFH^,[;Q[XA^$%GX7?1-:?X<^&=5LRT,%IX5TGQWH\VN:OJ
M-EJ&BZQJ</B.@H>T>#KJ/U5XN7-5PL73IQA&<XU%)Q<*U-2:J46G*,HSC>7+
M=ZPX5Q%2JJ$,72E4>+6"C%X;%1<JSK3P\7'F=I49UZ<Z=.NI^RJ<JG&2ISA.
M7]/V3Z']/\:,GT/Z?XU_*M\.OA7_ ,$]O'_BCQIH-G_P1G_9,O\ 3/#WCOX2
M>"M"\4^$_P!C#2-;TO6'^(</P>U#Q5=^)H=8_9"\+S_#MOAKH7Q5N/$6HMXC
M=M&UO0?"]QJ<>NZ3'<:Q'X7]<^$G[)O["OQ!U/XP6_BC_@BO^S7\/]/^''A?
M3O$GA>XU?]C+X)6]Y\3[B[U'X@6=QX>\&Q^(OA3X7TB\U..Q\':!J]NNH:WI
M.H1MX^TK2_$.B>&TTZ/6-<NMG]/#QJ3JX+$1A2PV*Q52?M<+*,:.#<5B-8R?
M-4@Y6C2@IU*O+-T8581YWC1X;J5_8*ECZ$GB:M"C17U?%KGJ8FGA*E"+;:A!
M36.P\/:3J0I0JNK1JU:53#XB-'^DP=,<?0=@?7DY[_7VYIP^G^>OOZ_X<5_,
M=^Q;^QA^Q_\ %W3OB%H_QZ_X).?LG^ ?%7@[5/#=YH^NZS_P3T^%?P]\%>,?
M#/BW08[ZU;PE?^,/A_INMZOK.D:I8ZK)XMT"_P#"N@7/PY.K:'X"FUGXH3Z)
M-\6?&OW!_P .O/\ @F=_TCM_86]O^,2/@#[]_P#A7V.!^/?%57S^EAJGLJF%
MJ.7+3G^[KX:I&U6#E;F@VE*$HU:52+M*-2C4BU91E.Z'#%7$0G4HX_#RA&M6
MI*3H8JFINC4E3YXJHJ<O9U8JE7I2E"/-1Q%&3BINI"G^R'.>GZ_T_P#UFN4\
M1?\ (7\!GM_PE=X>3T_XH?QG_P#7[_I7Y-?\.O/^"9__ $CM_86_\1(^ /\
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MB6Q4ZG91&SUO6O%5M;.GAC1Y->\.VVHZ?;:WK5OK-S)HL.BZQ\[?$G_@HO\
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MX7^--6^&GB:2QTW2;^]M[KPO%KND/;Z9?0K'#)IMYI8OK+3;RZ;3H?E_P?\
MML>&5T?Q4^N_"W4OAYHW@C1I9?"GA]M9T*+6_'7A_0?B,OPLU?Q5\/-)O8?#
MGA0?"OP9JEWX>LO%OB36O%GAR_\  L]^+GQ9X3T#P)J7P_\ '?C^:L:>(JU8
M82C.G&,JV,I4ZD^=/ 8G%.CAJ,JE1QA*='ZQE]#]T^?$..(GBE&E[;ZII"I6
MI4:2Q>*C*K5IT\*ZE##RBJ>887!1KXNK"G:I*%&I*AB\3)8A4_8PG2IT9RJO
M"O%\WX._X*4_![Q%?:5X>FT/Q;K'B.[T[Q!>RR_#_0->U_PWJ T#0/B1XE,W
MA6^\2Z1X,UGQ)9WNF_##7K*.[T_0Y+"?Q'<6UAX<U'Q5X<T_7_&.D=?I_P"W
MY\,=0U#QQ8VW@GQ[<VGPX\.>%O%?C+Q-IFJ?"36/!FCZ5XT;PO\ V$)O%.F?
M%"YTS[3;1^*K>Y\5SLZ:'X-T_1M>UOQ#K=IX<70-:\153_P4*^%4>D^-->G\
M%?$J+0O GQ)TCX1ZIXDM++PIX@\,:AX[UG5=4TNV@T+4O"GBWQ!?:CX=A;2G
MN9_$<FCVMO(U_I?AZPMK[QS->>$K&M\)OV\_V<?VE_$<'PZM]!UZVLM1^'^K
M?$^YD^)^A>&K#PM::1X-U'X>271U2ZN=<U31+JZM-2\>^'IM,NM&N-<L+74]
M"\0+J5]HMUIFC-K>B@JLFX8-U%R3<G#$--JI2>+IU/=4E2M@9PG%0C)UYJC!
M07M?82*M>,8V>+CA^:O*E&;P\;*I1DJ=2E%./LDH8F+IJ<KQI0E*,:L72A.I
MY]X@_P""H/[./_"OO'WB;Q-X)\<W_A?POXN^)?@+5-,6T^'GC2U\1O\ "Y=6
M/B:_L7\,^-_$GAN\\/ZN-'FB\.:AJFJ6>FO=:GH-AXSN?!5]J%Q;6'VA\8?C
M5IGPP^#_ ,0OBKI%E8^,C\/M"O-3O-"M=<M[,F_MK.ROET;4+^UMM7.DW;6E
M_:7+QRV4\R6\\$OD&*>*0^5?%;X_^'_V;_%&A> =%^%5C:>$M2T?6/B'XJ\;
M6=]IW@OX;?#'2KSQUI\/C+QS\29M-T#4;G1]!GO_ !+>ZUJ_BK3M&UHKK]]_
M;/C=/#/@9/''Q-\'<!\1/V_/@?\ !C6]5TW5?!7BZ*2Y\:^,-#UBY\.6W@&\
MU676/!EYX<T#5_%&M>$-/\8-\0)=+U>+6="C\):LOA34-4\1:9';ZBUA8>&I
M-&UG4<Z;I^RA74*DJ?UGVKO6=JBP%? 4<=AE34E4A&H\/FE&&(BWB(PQE%45
M*EAIU93+V[J8VDL5"$U2J4XJGAI.6$6-PN,K8!PQ#BGB:E&$\)B*E)QE&=2A
M4=54GB*="77ZI^W5\)='\&3^.+W3/$G]EKK_ (.\.Q6>GS^%=>U^QOO'.L^*
M=!T-O&'A?PUXEUOQ1\/U.H>$-46XMO%^B:9J+RSV.@:;8ZEXZBUOP?HGF'A?
M_@IQ\&M?LOAK>7OA'QYI'_"VO&&A^&_!]K]DTN^GCLO%/Q&T+X9^&]5\2S#4
M+73M N+K6/$-IJ5Y9O?W>FSZ%INNW'A+7O&.H:=;Z9J'M]E^V#X U3Q/X;\*
M:5X8\7W^I^+(/"K^'[6*Z\ Q:GK$_C3X5ZI\6]".CZ)=>.+?5M5T<Z%I%UHF
MI^*K*VD\+:=XI<63:Q/I&D>+==\,\%\-O^"A_P #_BAXBDTG1=+\:Z'H?_"=
M0^ +'QAXVB\'^$M/US4&\ :CX[U'Q'HGAS5/&*>/;CP+X:NM!\3?#[Q3XJO/
M"6GVVD_$3PUK^E1V][H.AZ[XETNZ5"K3J*A7P]652E4I*M3I5U1DOJLEE^-H
M>[-J-7$9EAL3&#IJI6HSK2PE*-10I.6E>O&>'=6ABZ="*?M56JT/;0C#%0Q>
M.P"G"48-PA@<1@*DW)4Y5?J-7%3="=>M&ERWCS_@I+\./ _ASQ#J][\-_'5C
MJ%G\(?$WQD\+V?B[Q!\+/!VB^*="T&3QW::;I$GBF\\?7VGZ3XE\47?P\UVZ
MT3P]'!J^O3>'I(-8_LHW-AXETCP]^@^E:SIVLPS26%]974EI.EGJ<%I>6]T^
MFZB;2UO6TZ^\EV-M>QVMY:W#6\ZPSBWN+:<QB.>,MI\'!Z]P?8X[_AVZ\@Y[
M5+33M/L)+V6QL;.SEU*\.H:C):VL%N]_J#006K7UZ\,:-=WC6MK:VS7,YDF-
MO;6\)?RX8U7G4J?L8PE"3KQ:E*OSIJ;C3H025/X*495%B\3*5.<Y*I6ITZ;5
M*-6I4ZN2:JN49VI/F2HRIQ2IKFJN+A-1C.7+#ZM2M4C%-4:DK1E*G&F7&G:?
M=W-A>75C9W-YI<TUQIEU<6L$USIUQ<6TUE<3V$\L;2VDT]E<3V<TMNT;RVL\
MUN[&*1T;Y+_:$Y_:@_X)6CU_;I^(X_\ .8__  46K[ KX_\ VA/^3H?^"5G_
M &?5\1__ %V/_P %%J[<I;>98%7=E7T3;:3E"JY6NW;F:3E9>\TK[)+S\Z2_
MLG,79)O"M-V5W:=%*[25^6+Y5=R:3:32T/UG'5OK_05^37[/W_)TG_!57_L^
MCX9?^NP/^"<=?K*.K?7^@K\FOV?O^3I/^"JO_9]'PR_]=@?\$XZ^KX@_Y%M3
M_K]A_P#TY(^*X8_Y&T?^P;%?^FX'U]1117P9^DA1110 4444 %?#'_!1#_D@
M7P__ .SY_P#@E]_Z\N_9)K[GKX8_X*(?\D"^'_\ V?/_ ,$OO_7EW[)-;X3_
M 'JA_P!?8_\ I%4Y\9_NN(_Z]2_]+I'W/7,>,_!GAGXA>%M;\%^,=)AUKPUX
MBL)=.U73I9KJU:2"7#)+:7UA/:ZCIFH6<R17FF:MI=W9ZKI.HV]KJ6F7EI?V
MMM<Q=/16%D]]KIVWUC*$XM/=.,X0G%JS4X0DFI0A*'19/=)K5--)IIJ46G=-
M-.,Y*2::E&4HM2C*49^!:G^S)\']:@O(M8TWQKJ=QJ%IX@TV[UB_^+_QANO$
MTNC^*M#TSP[X@\/#Q7-X\?Q+%X9U/3='TV2?PS#JT>@+J]HGB&'38O$#2:F]
MV?\ 9O\ @M<.LC^"HTV?\)-LCM]<\36L$:>,/%O@;QSXABBMK;68K>&&^\4_
M#;P5J<<,4:1:>NB+I^F+9Z7?ZK97WN%%6JM6,_:0J3C/FE+FC)Q:E/V;E).+
MA9R=*G?EC%-PA)QYH\[SG2I5;^UI0G>/+[\8SO'V=>BXOF4KQ]CB<12LXM>S
MKU8)1C-\GR/HG[#_ .SUH]I:K/H?C'6];MO!>O?#H^,M4^)_Q'@\8R> O$^I
MZUK&N^"HM<T+Q/HLNE>$-1U+7KN\F\*Z%%I7AT7-GH5Q'IB7'AO0)=-W4_9#
M_9N7QUKGCZ+X?Q+XXULVMUK>I1^+_&RRW44=E/I&DK-I2^)QID%AIVG17>EZ
M!:16$-CH]D+JRT>*TA,T=?31&>YZ$=N^.>G7CZ>U?#LG[!WPRUK6?B-K/C77
M];\2_P#"Q/%/Q"UV]TBUT3P3H>C0:7\1/$OPR\1ZQH.KQP^&;S5/'$;M\)_#
M&F7%QXYU;7[633Y+^"PTO28XM$CT4ARR3P]64EA98:>':24X>QFL!@JF&]C-
MR4Z-3+UB(SIWA"I'!TZ-1\N(G.2GS4VZU"C&IB'759M35.3J1688R&(=62;C
M.&-E!1FKSI3Q\ZT.6-#E7IUS^R_^SZ^GM9R:!J5M'9^#8?"-SJ%I\4/B3IFM
M_P#"#MX.TWP(-*U/Q+9>-;77[K2+_P +^&-)M+Y]0U28:M>Z%9:[?RW>O:=%
MJD75:%\"/@KX,T/4O"NC>$=+TO0-5^&.G?"W4M#N-5U:[T^X^&'AFX\57%EX
M?>RU35+J)=+TZ7X@>)4N+Q$6[DAUE+2^O)K:UTR&U\9U;]A?X4:IXTT3QQ#X
MA\;Z/J'AOQGXO\>Z'INF6WPT;1K;7_&]YH%[K8U.#5/AOJ=[XLT>&?P]9/H.
M@>-;_P 2:+X7N(=)O_#MCIFI^#/A[?>$.-^(G_!.'X,?$[5K+6/$GC;XN0W%
MEHO@;1TLM%UCP)I&@)-\/_!>M>!M"UK3/"UM\//^$:\+ZM'I>MSW]NO@W2?#
MFD>'];@CU#P;I/AG[9K$.IZ3FL0Y_6*^(DL9+$?7W42K.:Q-.M6K2JKVG^TO
M$8S%8N->+<+JM5Q"<JF)KM9T:;H2IRI4*%*6#IX9X*=&3IN%6A.G1A"ARP;P
MD</ALORR6'G=N,:>'PZ45@*?/]/>&O@?\*/"6OZ;XATC2M0E\30:C-KFGZSK
MOCGQKXKUF6[/@W3_  %)-]N\5>)=9O+ZSM_"5G::=%8SRW&FV<LMSJL%K%K&
MI7VH77,^-_A+^SOX>L-;\9>.=.TS1M-TNR\;^(=;UC4_%?B.PMK:Q\3>+_ O
MC_QG?RJFN1*(;WQ=\/? VIE88O\ 1)],M])TN.VLM7U#3M1\WTS]A;X7:3K7
MP5U^V\9?%1]2^!B10^'9Y]=\,/-XJMX/&^H^/+>V^)%XO@U-1\;0VVKZK>QV
M0U.\#Z>9[G7-/>U\87VI>)KS:^*'[&7PQ^+'B;5_%'B#7O&VG76O:_H/B?5+
M;0Y/!4)GU?PWX)UKP#IC0:[JG@C5O&&G::N@:W<BYT#3?$MGH%U=BYFFTMH]
M=\4P:]HIQ5:C4>+K.4L365:M"$U4HT*N(RN=7$Q<IJI4J8F+QM>=*,N=U\MP
M:K3;Q:G0QE1E&A6IPP.#ERX*C["@I*%&KBJ> S/#+"SYJ4U2P]%2PF"IUN2I
M;!9CC%&G'ZJHU'>#_P!C+]EGP=XG?XA^$_A]<Z'XF\1V\PNM1_X3SXGV\FN#
M4]%\=6]Y_:VC:GXP^R:AJ%YIGQ"\;7>HMJFFRZA->:B=7OBVJZ)I5YIC?"W[
M$?[*/@S49+SPW\-+:QU;4=*^SR7,WC?Q]J=]>Z?;ZAX*U*6\=]5\77TUQ.VJ
M^#/"M_?ZP2U]=W[:E<WUY-<>+/$KZUU_Q1_9=^%/QA\8Z?XY\<Z;+JFNZ5'\
M.H=->:R\-7T-C;_#7XLZ!\9-+M;0ZQX>U2[MK;6_%/AK2;/Q/!!=QQZGH=NE
MO;K8ZA%;:I!XA_P[K^#">(?"_B&#QC\6[4>$="O?#ND>'[77_"4'A8:9>?#'
MQ]\)U$^@IX'%HU]9>'/B3XGGLM4@$&I0WTME:/=R^';1=!;)5'"$94*M2E4I
MT\33ITKR4(4Z*JU<!0A6I\DXPK5J. A4O3Y,-^]Q"C*5&C%Z>RDZBA4H8>=&
MM4HK%U;)5)NK1IT<9BE1LZ<^2EB,=2C2G45;$1]R52-+$.:^N+CX?^&-?\'3
M>#O$5UJOC+0I=7N-0N9M;UZ\N=1DO;/Q:_B6VM)M6TZ:PNA;^']9M[>QL;-9
M46UL-+M=)N1/%#.DG@[?L]_LE_&C2I9/^$5T7QKI$7B[Q7J"7$7B;Q>ULWBC
M3?BCXO\ &GC"\TR[AUVW^TPV_P 2O&OC)-5GTR672"NLZCX0=F\.JNB0\_:?
ML'_"?1O$<VO^$_%'Q \%6E]J_P '=4U;PIX77X;6GA758/@9=_"V]\#:-)87
MOPWU"\TK2%F^$VB#54\.:CHE_>1:SXABAU"T230QH7%>)_\ @FK\%/%?B71/
M%%_X\^-%O<Z!K\GB2QTFT\1^#6\,S:@VG^-["--4\-W_ ( OM(UFV1/B#XD-
MS'JMK>/K-E<KX<\02ZOX1>[\/73<:'/."K2]A4E&+G[&<9*.%Q,J.%J3H0J*
MG5?U"%&K3@ZG-AZTJM*52I+]Y4F7UOV=&<<-AW5=*?MZ3KWY57P4<54PM*O.
MBX_\CB=7#U:BI1H5:$(8NG&,)_5Z7LGAO]E_]EWP[H[_  P\.^&K&'3-5\)^
M+A'X3'Q%\:ZC>3^#_&_A3PQ\./%U]I]O?>+[O5(-*UK0-!\/:9>:OI[Q(FKM
M)K4%W#XEUO4]3O\ :A_9:^ E@VDV-KX>UK3KO3+;1(?"C6GQ0^)UAJ_A?3?!
ML_B"72['P'>V_C6'5/!FC:?'XUUS2[W3?!\^CZ9>Z#J\?AO5K:[T"#3M-M^?
MUG]D?PMJ^M>"/$D7Q%^(NA>(/ $FOW&B:EX;TWX.Z-%+?>(?',_CJXU&_P!#
MMOA)_P (S+?6]Q>ZGHBS6VB6@U+3-6U#5/$*:UXSEC\5P^?1?\$[/@";32[?
M4YO%FOW5A\/O!?PPO]7UN/P%=ZIXE\(>!]#\&:#IVE^)98O 5O;ZC9ZA#X)L
M[W5]+BM;70IM0UC7Y;'2=/M[ZWMK(YHUN65;$54ZE64,1&495I*@JD53J<RE
M"%62P\81G3E'F]K2<82^KU$HZ3C4IQG*CA\/.I",:M"/-[-2KU*,WBHSG.$^
M24ZLZE.%91E"I&LZE:FI1DZGL?P;_9:_9]^!>JGQ1\)O"$FA:QJ_A'1O!<NM
MW/CGQWXNNM8\)Z'8Z1;Z!I]S=^+O%7B$ZJFE:=HFFPZ7?W#7%_:6<<\=M>)#
M?WXNMFX_9J^"]UXLTGQM<^%+V?7M \5ZOXYT+S/&7CEM#T7Q?X@UG2_$.N>(
M-)\)GQ+_ ,(IINI:QK>CVNI:E-9Z+#]MNI]7>X60:_KHU'YX\<_L$^&/$VNZ
M%J.A>.I_#>BZ1X^\+_$&YT#4/ 7@CQ>NH:EH/[4DO[4T]E9ZAK.GI+X3ME\2
MWFH:#X<O?!4'A[7=*M+BRU/Q#JWC.[T/0H=.^_*<ZTZBI8FIB*TL7"=1>^Y<
M]&*J4\3&I2J<SDU/&5L753<7+VD?K%HSK2L.G!SKX>6'I2P]6$:LYJ/[NO6J
M1=&=.=.:YJDXT5RSJ32@TU07M+3F?.OQ)_92^!?Q<UR\\0>/O"^NZO?:C-#<
MZE;6/Q)^)_AK0M3N8/"/B+P&MSJ?ACPMXRT7PUJ5T_@[Q7KWAVXN;[2;BXNM
M,O4M[F286.G&TYNZ_8A_9@NHO D?_"L88)/ACI=MHW@&ZMO%'C6*Z\-:;I_C
M'_A/M+LK>7_A(S]OM='\5F34-(M-9&I6FFV=UJ&@V<$7AW4]1TFZ^KJ*Q4YJ
MFJ2G.-*+3A"$Y049)8I*4>1PG"45CL9RSC54H?6<0X.+JODZ))2DYR49R<73
M<I1C-RIREAYRA+GA+FA.6$PKG!Q<9O#T7-3=*+,W1M-_L;1])T?[?J6JC2=-
ML=-&IZU=F_UC4OL-K%:_;]6OBD9O=3O/*^T7]V8T-S=22S%%W[1I4443G*I.
M=2;O.I.=2<K17-.I*4YRM&,(+FG.<K0A"$>:T81BHQBHPC",805H0C&$%=NT
M(1C""O*4I.T815Y2DW:[E)MM_#'_  3P_P"2!_$'_L^?_@I__P"O*_VM*^YZ
M^&/^">'_ "0/X@_]GS_\%/\ _P!>5_M:5]SUKB_]ZK_]?9?^D4C+"?[K0_Z]
M1_\ 2ZAX1^T5J_Q/T3X>"^^$7@/Q]\2?&0U_1HK?PG\/O%?PJ\$7M[93321W
ML_B+Q/\ %F^L-,TSPE91$7>L?\(K)+XZNGBL[/08A%<:A-%\?>&-/_X*!6WA
M*6+7;OQ=K/BRU\+^)DU_4]6D_9XT!?%SCQ+\&YO"+> ]%\-ZEX@TCP7\31\.
M1\7=/U.UU[4+CX9P?%6>>:;Q#KW@:'P5J5M^G!YZ\_YQ_G]:*SIU'34DHPG>
MI&I>=.,[**PW[M)VM"<L,IU->:I[:K3?+3LY74A*IRI5:L(QC)6I.,&YRAB(
M*HY\KESTUB+T='&E5I4<0H5*L.5?"7@BR_:UC^)'PXG\03?$9/!D/Q%^)H\>
MV?B0_ &XT-_A3>K\4_\ A4MG%JGACQ#<>+$UOP^EO\.V\6I;^%M9U[Q!?ZAX
M=E@^(.G:9I7Q'T[Q#]VT44G-NG2ARQ_=J:<TDIS=249RE-K1V<?<BKQIJ4XQ
M?+*R(4^1S:G.2FU+EE)RC%\U24N1.[BI.>D%+DA"%*G!<M.\BOA?]DG_ )+]
M_P %0?\ L^;X??\ KM+_ ()XU]T5\+_LD_\ )?O^"H/_ &?-\/O_ %VE_P $
M\:UH_P +%_\ 7JA_ZE0(J_QL)_U]K_\ J+5/LSQ-_;7_  CFO?\ "-X_X2#^
MQM4_L/\ X]?^0O\ 8I_[-_X_O]"_X_/)'^F?Z+G_ (^,0[Z_-W0_'G_!3W3/
M#4.GZC\$?A]XCUW2M#\'F+5]2UOP+I-UXNU?^S]$@\666L'2/BQ-IGA&:TNY
M=5N?^$DTS2/%=EXFEL9SI_@OP';ZEI]MIOZ?4#C_ .OS^O6L8M159-*:K0A&
MTKKV4J<,1"-2BXZPJ?[2YMMRC*=*A*4'[**-)P4Y4Y-S3IN=G";@IQJ.G)PJ
M)?%!.FK*R:4I\LH\S/A3XB_$W]NG2-*T^#X;_LZ^%?%GB.\MO!U_<W>I^(_!
MNC^&M)@N_A=KVI^.-(O6NOC+:ZS)XFTGXJ66C:'H,6F6&J^&+[1=6MX+GQ.L
M#:EXPT'.F\8?M[:CI_@JUNOA;X=\,WM[XW\&CQ+>^%[GX?>)9=-\'6'[1-MI
M_C-/$%YXG^*>AVEE%JO[.\2:S::AX-\,^,=;OM:NM<GMM!\%:Y!H/A%OORC_
M #^&,8^G^>E=,<1"-5U/JF%DGB8XA4I0J.G!0K8VK&A!.IS1PZCBZ=!TVYNI
M1P.#4Y.<:TIYRH\U*-+VM=6P[H.HJK]I.;AAHO$SER+FQ'-AY5+VC#FQ6*CR
M*$X>S*^%_B#_ ,I+OV2/^S&?^"B'_J_/^"8%?=%?"_Q!_P"4EW[)'_9C/_!1
M#_U?G_!,"HPWQU?^P7%?^FD+$?#2_P"PO"?^G6?=%>9_&._\7Z9\,?&-_P"
MO#WC;Q;XQM-):;P]X9^'6J_#C0?&6NZBMQ!Y>F:-K?Q;NK+X>:0UV"T5_J?B
M*Y1;+3#>W.F+-K$6G0R>F45SR3::3<7I:4;<RM*$DXW35_<M=J5N9NTFE&70
MM+:)VOH[VLXSC9V:=ES7LFF^5)2C?FC^:OPT'[=7VV#4OB'IOQ,MK2?Q+K>M
M/H]GJ7[,D\VB?#.\\ _%.YM/AM#Y>OZI::]\3O#WQ*/@+3?"OC[4;]="\5^%
M[7P9K/C6Z\+W5_\ %?P[!D>#KS_@I)J^L?#O5YO!MKX)^'[?%[PSJ/C[P;\4
M?B5\(;_XMZ1\.I;+P[H/B#0H-5^''@;XB^ _&7A2"T3Q/\1-4OK3Q;X"^(][
M\1=:LO!7A5O#_P ,O -K<?%#]0?\X[4?Y_.NF-=*HIRH8>I&-2A4A1J4VZ*]
MABIXF,9QC.$JT9*4:,_:5$W3I0D^><JD7RSP\JD*D)8G$WJJKSSC.,)\U2C[
M-3@X14:4J4W*M25*,8*?+!Q=*E!2****YSJ/QV\-?M&M^SQ^T7^W/>ZAX8LM
M6\$>+O\ @HQX.T[XG^++WQ%-H@^%_P /M*_X)6_L$:KJOQ#6RCT+58->L/#N
MI1Z/=>*;>^U'PU8Z'X)'B;Q7-J\SZ#'I>H>W:!_P47\&0VGPXL_B=\-?%_@#
MQG\3/B/J/@/3O"=C=6?BAM#23X^W/P&\,77BW5;F'PQ!X?UN_OVT[Q!XCT&\
M@-KH]O;^*]%\+^(/'^J>&(5UOP_2?VG?!7[-_P 8O^"C!UOQ;\.=&\:_$#]O
M_P "Z#\//"WQ"\9:7X*M?%FH67_!,;_@GE=:G,VMZK>6EGH7AWPW#/::AXM\
M4WPGL=#TV6*VM[75O$VL>&?#FN>UZO\ \%.?@/X=\0W'A'5M-\7WVMV5S=:3
M<ZGX5TK_ (2#P==:OIL?A%KZ^T/6$>TUC7O!=W'XTTS5?#_BC2?#=W+JGA:V
MO/%-SI&FZ->>&[GQ#WRG3<7.IA_:*AB93JU:<I4JM;"T,#EF(Q&$C9S3E0A7
MI4YXF$'6]CB94?J]:2]I2\JHZD82]GB%AE[&,U*>']O"G+ZSG%"-2?OQE*GC
M*RC65!QE%SRWFHUJ3<Z=:/4?^"B_P574?!'A?QE\/?&=WXCUZUC\4MI>B:5H
MGB_3O#SZ'X/\8?%%M7@U'4;W0A?WGAKPQ\/]5UFXT_3;(>/(KZY\.'PWX3UN
M'5H=0@[OQO\ M_\ PD\"/X$;5/#'Q!>S^)OAC5/%_@._CT_P[]G\0:%;:WJ6
MEZ)JK1+XF>^T+2_%NGV-EXI\-WWB>TT1=6T/Q!HMC81W/C-=;\(Z+YKXU_X*
M1_ :Q^%MYXV\=> ?%6I_#7Q=X!T+Q/IVC/IOAWQ+J7B3P=XO^#ND_%35=*\5
M>&6U";0=,E30M=3PM<17&NZQX-O-=N;33];\4:+IVJP79]4T/]MWX7G0=)O7
M\">-/!VB7UAX!G\/-KT_PQT+0X?#OCW4_BAX>\'W^IZPGQ!?PQX4TVYO?A%K
MT-O!JFJ6S^7KG@?2K2&;Q/K\_AK2>:=.I2HUHUJ>(4\+.=+$55.*]G7ITL90
MQ*A34IP57ZQ2P[M3E7YHX>M!RG&O2<>FG6IO%2:KTZM*3JSAAX4/WSHT\1@\
MPI0C7C2;K4J>6UZV%<I03B\51K04:]*=.>OX!_;@^#?C_P"+>J?!VSCU_0M<
MT3P?XI\9ZGK?B2'1]*\*66F>#+WP'8:XLFN2:PUM.?M/Q$TB"TETXW\=O=Z3
MXHL/$?\ PCE_IMA;:P_X]?M5WGP,^*?@WP7??#U_$?A'Q3X%\6ZO/XIT_P 0
M/!KEI\0DU#1-'^%/@&R\,RZ,VG7Z?%3Q)>7G@?3=:O?%6DO;^/-6\!>&K32M
M5D\5R7.F+>?M(6?C7]C4_M$^&_ GA3QE?>(/@_H'CJ/X5:]XXL)?#:Z]XL\*
MZ)XATWP)XN\:Z)X:\9V]E9H?$.F1:GK=GX-U]UTV5=7L/#^HQ3VMO<>>Z-_P
M4&\&3:_\2?#WB3X=^+?#FI?##78O"?B72Q?:/<ZUHOBNW\%_#7Q/KVB>)(-2
MGT'1-"@TB]^)-A;6_BL^(KSP+JOA.VA^)D7BBW\#:K9:L=Y4U2Q;I2PTY?5,
M56PF-PDJL*DYJM2S'V:A7TC2E0EB,(L)B*3Q.%6)P="=2,_KU2E5YX5JD<-R
MU<;3JU9X:G6HXSZG)4XSPV)H4*\JU*G*7/"O/"XN%:C*IA\0L+B,5&C./U>E
M6I\UIG_!33X7VFE^ ;?QYX"\:Z!XZ\5?#KP+XVUKPSX;?3O$6AZ/J/C?X<:S
M\1K?0O#WC+Q0_P /+?QC:6]OX=U7P]::PND:'=ZWXB:QT[3=!>>'Q/'X6]AU
M7]KSX5:IHWA2#5?">LW.E?$CPUX<U*WL/$[>"+72]-;Q3KWB?PX^@?$2ZU/Q
M-+X9\+7FAZCX4U.Q\36.K:G-<6.M+%X0BLKSQM/:^&[CE/BW_P %$/@G\%M.
M\*7_ (JTWQ1JP\5LRV@\"W?@?QM8H$^)K_"8[?$.A^,IO#$;OXG2:[C@U76M
M'NCHVG:Y:O!'XVT+5/!,&5X[_P""D7P:^&GB7P=X1\9>#?B=H_B'QC;^&)QI
MTMGX'EB\-#Q=X0UCQS82>*?$,7CI_!.DVNB^'=$N+OQE<_\ "5S#PS!>Z7K4
M\=UX1FU#Q/IF24ZRI2HT6JSQM2E!T9SAAZE:G+%XGV%"G*KS0IQI2P=JD:BC
M;!TI4J]2IB7*.U7$4:<JRGB8Q@\-B*L(U:#JU*5.T*GMJTXTI1JTH8:52E*'
MLDJRJSYTI4W2EZQ\./VQ?A;\2-?MM#LX+[P_'=:-XPUU-5UOQ%\-;W3[/3O
M\WA&+5M2U=_"7CSQ.=-\/:JGC;1[KP?XMD\SPIXKL$DU73=9.DZQX*O_ !=E
M_'G]JN\^!?Q3\&>"[WX?2>(O"7BCP+XNU:;Q1I^OO!KEI\0H]0T31OA3X"LO
M#4NC-IU_'\5/$=Y=^!],UN]\4Z0]MX]U;P%X:M-+U63Q6]SIG":K_P %!OV<
M)_ VH:UXQL-1M-!O=6UOPQ;:-KVH_"75;3QI-HOQ\O?V=]33PU<VGQ'U3POX
MIT]/%=K!XCG2WU5YK+P3J>FWNLV>F>()+GPS:^T?L\?M6_##]I/2O$.J>"SK
M&B'P_P"-!X%_LWQC;V>@ZOJVLMX"\+_$EX])T>:^?59C8>&_%=G'JMO>6%C=
M6FIZ7KPM8;_0K2QU_4](Q2JPF\+.5"BZCQ-)3<HU*%6%;"QG3K\UZ.,I8G%8
M:M0J4H591JX:E5G2E2]M!NK5M[6C]:ITZU=N.%]K2YO9U,/7H2J4ZL8N-/$4
MI4Z<\-B/WU+GC7Q=/#UE45.6'\?\&_M\^#]6\*^"]4\9> O$'ACQ'XA\$^%_
M$NM^&]$\0^%?%":=JGB'X,ZS\:;JP\+?VKJ/@WQAXV\+Z1I'A[5_#\_CN/P'
MH6DOXB2*&>TLK+3O&%YX2IP?M\?!_P ,:P/ UY\-?''@K6D\4?"/1#X;N[GX
M,Z&9=1^/^N_#U-'N="AD^*5G:>+KW0;CXN^'=:^*%CX.;Q!JNA--J$MC!XEN
MM3\+?\)75\9?MYR_#CQ[J7A/QO\ "#4+71KOXT:S\+?A]XB\/>)KCQ!-XZT[
MPC\&M6^*GC:6/1AX2T\:/\2M%FT6ZM-(^%\FIWL?C'PM=P>+?#?C*]N=#\>^
M&_!;C^UY^S[XZ\0^.)]9^#NJ^(A\(_"?@OXA>//B#-I_P5\9^&/!_A.WO?#G
MC?P]K!\4:;X_UF>]N? 3ZTWCK5K30X+^;P;-X7UW7;"2>:7P==^+%2Y).GB)
M8>/U:<*6(J1H8B5"F\/RRQ[]GSU)5(*EA\1AXJG5</JU2$(<ZQ*]I/.M7]S$
MJGB'"HI8FCAO;89U'&O+%U,%2C5Y*+>(@JE*=*7U:#GBE3C))4JCBH+_ /;R
M^$NO^,?!WAN;X9ZUK#-I%M\1+:ZU>X\#W^J>#YG\7GX>:,;G1],U?Q'-X5\<
M1:G<:P]]HWB&[\+Z_H^CL8H%O=8'BK0O#/L/P0_;+^$7QX\6^/O!_A=M;T2^
M\ 1^#WO[WQ9%I6CZ=JDGCCQ)XV\)^'[#0YSJT[ZM?7VK^ ]5ELY-/BN]%U73
M-7\-W&AZUJMY?ZCIVC^&:Q_P5%^ VA_#S5?B/J7@SXPZ?IF@ZEXGT'7-(U#P
MOX>MO$.D^)O!GAQ?&/B+PO?:7%XNN7M-4MO"M]X7U6VU*\>T\&L_CSP9I^H^
M+-*N[_55T7ZD^'OQT^&WQG77XX]&U/3+;P/XNT;POJLOC[3="TZRT_XK0:S?
M0)X)TV635]2BU#QEX=N;+0M8BO=%-YHE]:>+?"-_X0\1:]-=WB:9-.G.TO:4
M*Z=.E%5DI3I\E:<<L;J^SF^>52$*\80P[DU.KC*%*I:='V+)UZ=2O%T,9AHP
MJ2E&E1E1C452G#ZW55-UW32:]GSN52,I)1HUJL:7)6JM?-7[0O[:5W\"OB/\
M6-&;X(:;XOU/P7\'+#7OA5K<?B\:/JGQ%\;70USQ/XP^%NJ73^"=5;P1HVE^
M"?#EO\2VUG3[KQE?ZEX5\'?$K7/^$+8^ ;>+6/1-3_;@^'NE7FOZ;+X+\=:C
MJ^@KXJ@&AZ-<?#ZY\07^H>$?%'@;PA>PIHFH^.](U#0M-US5?B%H,OA#7_&,
M/AC1M=TR.YU*:\TNUU'PD_BCN?$WQH^(EM\4-=\ >!OA:GC:'PMJ/PFAUV4>
M(8=$EBT'X@:\UIXH\3MJ.H6W]EV<?@'PQ;ZGXKCT)Q>:EXR.BR^'](FL]4U2
MR:'YA3_@J3\'+[XFP_#C0O OQ%U5XOL9UKQ!)I]C8Z/X>M]6\2:SX6TS7-7O
M6NY]+L/!=K>^'-8UOQ1X_P!2U33O!6B^$7T/5M,UWQ)JNK3^']+O"M8F&64(
M86%:K6@XJI&I*A+%16.E0C4Y925+#*I.=7"5:LG"$\0H8F%I0JJM=>I[.6+D
ML3&DH5L1&TZ#J*E*.#P$'1G)>]B/95:V&Q-)*\JE/$XO#\U:,:;P?H5Q^W_\
M-M)B^(%QXB\*>*=)C\ ^.O#7PVN[2V^Q:_K1\4:_XR^(O@"2\U'3-$:\71_"
M$?B;X::W!I'B%KN]NO$$,]E9VFAP^);B'PW+CV'_  4&^"OC3X8W_P 0=8^&
M/Q3B^&]]X*\:^+(/^$B\,^"=5?Q!HG@35?AKH7BF.;P]I?C37?*LH]0^*OAV
M*UOM8%MI-Q9Z3XJUJ^NM/\-Z=I&LZ_U'C3]O3X8^!_&T'P_U3PMXQ;7M1USQ
M9X9T2XB&@/HNHZYX5\1W/AF2WN[J#6;C4= LKJ]@BFAU37=(L+.^BNX;#PV_
MB3Q%#?Z'9YDW_!1#X-V7B#P!X4O])\4W6O>// &G^/+5O#:Z/KWAZ"WU#X+^
M)_CBME:^)9M4TG3]1>+POX1U*QV;;/5YM3U7PK=QZ'_PC>LW6OZ3S0?+AO:^
MSJMJE1DL3&52FG+#X/$8W$UW3A'WK4LLQ>*2A%_5E2H4J:E5AA:-764E]:CA
M757//$5J7L'1C*4EB*L<+AL/"<HRI1?UG%X:E.4I-5US^U=.%:O7I8F@_P#!
M2_X&^(;JUL;+PS\0UN9_%WC/P:UK>+\/='U22[\#> ?B1\0M3\1Z3X8\1?$'
M1/&6O^"+RQ^%OB+0-.\2Z/X9NQ%XME@\/Z[8:'=Z+XW/A#UK3_VR/A]+XH\.
M^%O$7ASQ1X#O_$%QX9M77QCJWPWL[C2'\6_#O5_B=IE[>:?IGCW5K^^\/6.@
M:+=Z=XB\5:!!K'AS2?$A?3HM2O[+1O%FK>&^C^%GCSX4?&'7-9UT_#:P\+_$
MKP?K.C:K<6?B_2O %SX\MKW5?A7X/URQ\1Z=J/AS6?$DDL^G> /BEI'@[5]6
MLM4==.N;W5_"]IJ&H:%)9W^K>0ZO^T]XZN? VL^,M3_9YC\:?#.73O%5O=F+
MQ3HEIY^MZ;\5?#'PY\.^"%T_Q5:Q6/B:X\96&K^)-=&LG^R?#GA^Z\'?V)K]
MQ;?\)-IVHV77R0^LK"RPDZ=:G9XBG*O)J$)XYY=>E5=J?/+$SE0A"I4Y(5:=
M*ES.E'$3.5XCVE)UZ.-@Z5:C6JX2;H2FI>SP$,UE.K!Q@U3C@?9U:48*$Z]&
MLZJ=3$3HTH=%^TW^UOJ'[-FIZK>WWPT3Q1\.O"OP0^)/Q=\<>-+?Q9/IM]X1
ME\)2Z5:>%K>^\-1^%-6$W@?7=1N[K3_&7CZ'6?.^&Z2:3X@U'PIJW@T>+O$O
M@WD8?V^O@;XFOO''@S7_  =XVEB\&>%=>\0_$2+4?#&G7OAO1_#WA.;P /'&
MKZD^LWNGK>>%O#^E?$&Q\3/JAL6.H^%]#UK5(M-C-_X*MO&/1>(_VW?"^@K#
M&O@#Q/)<V^I^*],UZTO=0T6T;3G\#^*?BKX+\1MI\MC/K$&K,->^$VJ-HJ2R
M:9'J.DZII][>3Z1>)<:7'RO@[_@H]\&O'7A+P]XLTWPQXQL]-\6W7P\L=)DU
M;6OA/;:;97'Q+\3^._"&BVWB[Q'!\2[OPQX4U/3]4^'NM7>M>&]0U>3Q7%I&
MH:$FE^']6\2W6J>&-'Y\.N:+G[/VDZ<6E5<W12J8O&S>!K37->3I5JM&AS)I
MU84%*K4IXF#K2VK2C2G*-3%>S552FJ4Z,)Q5/#X"C+%Q7/3:<XTO:8V4*G,J
M:K1@XO"RK07T%^SO^TIX-_:5T3Q)K?@OPWXZ\.0^#M<7PIXEL?'6CZ7HFI:/
MXM2V74[OPO<6-CKNLRKJ=AH%]X;\1W,@SICZ1XOT#['J-UJ2ZWIVB_0]?"/A
MO]OKX>^*O%%OX;TOX;?%>.%O#?P(\5:AK&HV'@S3;71=,_:'\1>%_"7@.TOK
M&Z\:QZS/JL.N^*K6365TC3M4T6+0=.U76-+U[59&T/3]<YS_ (>6_ QM#\7^
M(H?#/Q1DTOP3JWAG2]<>3PQ8VEY;'Q/XB\=^%K5AHMUK46OWE]:ZO\/=8CO=
M!T;2M6UR"&^T^1K 2:5X]A\$%6";<J=*K"G3P\JTO;5%5JNGAZ_U"O7G)*',
MY8R,HR5.G92E>%-TW&1M0G*SA4JPJUHUY49.C1G3@JD\-3QU.A!/GYI1P56G
M44G.7/&=-.7M+P?Z(U\?_M"?\G0_\$K/^SZOB/\ ^NQ_^"BU?2'@/QSX=^(W
MA;1O%OAF]@N].UG2M(U00I=Z==W>FG6M'T[7K73M5&EWVH6MKJ<>FZK8W$]L
MEW.HCN89H99K:>">3YO_ &A/^3H?^"5G_9]7Q'_]=C_\%%J[<NI5*.;X:C5@
MX5:6+=*I!VO"I36)ISBW%RB^6=.I'FA*<)<KE"<X-3EY^:U:=?)<96I24Z=;
M!JI3DE)<T)O#3BVI1C.+<9P;C.$)Q;Y9PA-2A']9QU;Z_P!!7Y-?L_?\G2?\
M%5?^SZ/AE_Z[ _X)QU^LHZM]?Z"OR:_9^_Y.D_X*J_\ 9]'PR_\ 78'_  3C
MKZGB#_D6U/\ K]A__3DCXWAC_D;1_P"P;%?^FX'U]1117P?_  W]=_)+5[)-
MZ'Z3_7_!]%U>R6K:6H4444KZ7TMWNK==+WM?1NUV[)NUHR<3Y/[G?IT2;MJE
M>UDVDVFXIE%'\_3TH)P">F!G--Z;Z6O>[2M9V:=VN5IZ24N5Q=U/E::1?;S2
M:\[[6_FO]GEYN?['-=7*^&/^"B'_ "0+X?\ _9\__!+[_P!>7?LDU]SU\,?\
M%$/^2!?#_P#[/G_X)??^O+OV2:WPG^]4/^OJ[W^"JMFDUL][,Y\7KA<1_P!>
MG_Z72_#7_(^YZ***P.@**** "BBBC^OZ_K_-']?U_7^3**** "BBB@ HHHH
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M  _J_P /= ^)_P#P4@U?XD_"+0OB]H4G_!23X ^#+'2M<T?PIK:Z3XB^+G[
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MT@U:Y\.:!XNM(+>YO+6WM]02X\->*?#^I&?3Y;J*TDOY-(U$V6O:9J^E:?\
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MM;B_X)B_L :9%J^G6VMV5]#9:I'INI:CI\>H6R1WB66HWUJLP@N[A)/KF?\
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M-TW34XPQ"J1G!.,8TXUXX&K2]E&4M<;&K&ZP*I_,W@KX[?L27?QEN;7P9:^
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M-\1> ]+U'R-#TK3[_7-7O/LOV33O#]I<>(;N:+1(7OQN0?L6?\$=9K]M,?\
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MOZ/^'7__  31_P"D=_[#'_B)/P"_^=_1_P /0?\ @FCS_P ;$/V&,@?]':_
M+^7_  L#GZ#FC_AZ#_P31_Z2(?L,?^);? +_ .>!6%LP[X__ ,N_\CHOE_;
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MT<U)X186DH1R^51QBOWLJ,4DUB[N?(W.=JD<,I0C[\X2J\LHN--N;0?V:_\
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MV+>V&E1Z@EAH'AZWTKM?A]^VG_P29^%FJ7VI>"O^"BO[(M@FJV<-MJ^F:O\
MMW_##Q?8ZO=V>B>$/#&EZSJ$OC/XL>(-4FU?1_#/@C0] TRX74HX8+ :@SVT
MM[J=[=RQ3>*<)*I'-(U'0BH.,L1*"Q"]I.HY^[SRHR2I4:<(V<)2=>I-J,H!
M/V5Z;IO*E!8F3J1DJ#J2PKC35/EFIJE&NFYSJMIPFXJ%!>SE&2Y[Q-^RK_P1
M_P#"/C;0_AOKO_!/;]D:T\;^+KS6K#P3X>;]@CX<&[\;7'AJXT:W\1/X7D;X
M1K::C8:0->T^\FUE[BWT6\TI=4UG2]1U#2- U^^TSE=5^!__  1)T?2-$U^Y
M_8A_8J/A_P 1S^"=,T37+?\ 82^'=QIMYXD^)'AJ3QAX%\(2O%\'6GT[Q9XB
M\,K#J\&A:I!8WEA%J&CVNL+INH:YHUG?WIOV@?\ @BS<^//$_P 3;G]O;]E.
MY\<>+?$6D>+-6UNY_P""DEG.+;7_  ^470;_ ,.:7+^T,VC>#!HMG]LT;2;/
MP?I^A6&G>'-:\3>&+.UA\/>*O$FF:K)>?M _\$2[ZRCTUOVUOV);/3DT'2/#
MBV&D?MX>!M#L9;'0? FM?#'2[RXL]&^-EA;7GB2V\ >(-4\)OXONXI_%EUHT
MEI:WFM7 TO2S9PGC>6DG',G.U-UGSXI4U)JDYJ*]GS6@U6]Y7E-RIN,53IOG
MN?U9RJJ$<LBN64*,I^PJ-2Y<0HU*L(RC>//+"2=&,OX4,53=18G$4/9>Q> ?
MV O^"4GQ-T.Z\0>#?V OV&=3L-.\2>*?!^K))^Q_\#+"]TCQ7X(\0:AX5\6^
M']1L[[X<P7%OJ&A^(-*U#3KG"/:W'V=;W3KF]TVYM+R?YI_9@_X)S?\ !/;7
M_C?_ ,%&=)U[]A']C76M*\$?MD^!O"_@O3-7_9@^".I:?X1\-7?_  3W_83\
M:7?AWPO97G@>:VT#0KKQCXN\6>++G2-)CM-/G\3>*/$>O2V[:KK>IW=S](?#
M;]O7_@DQ\(?!^F^ ?AS^WC^PCX8\):3/JESI^D6_[8'P1O5AGUG5;S6]3F:\
MU7XEW^HW#W6I:A=W#-<W<QB658(/*MH8(8_F_P#9@_X*-?\ !/70/C?_ ,%&
M=6UW]N_]C31=*\;?MD^!O%'@O4]7_:?^".FZ?XO\,VG_  3W_83\%W?B+PO>
MWGCB"W\0:%;>,?"/BSPG<:OI4EW80>)O#'B+09;A=4T34K6VW7UOEQ:I_P!H
M<JIX?V;J+$*;:K4/:64;J-Y>V:C%R<:7)&3=FWE_LO/A?:_V?S^UQ/-[)T.3
ME]E6]GS<S3;4/9<TFE&57F<%;E/K[4_^":'_  3$T;3;_5]2_P"">W["]MIV
MF65UJ%]<?\,C? >;R+2RA>XN9?*@^'<LTOEPQR/Y<,;ROMVQQNQ53XKH'[+W
M_!$KQ-HFA^(-(_96_P"":<VG>)$LFT477[.7[-FG:A>3WUI%>IIRZ1J'@BVU
M2/6+."8#6-'ELTU/1)XKJVUBTL;BSNHH?:=3_P""E_\ P3$UG3=0TG4O^"A7
M["]SI^IV5UI]_;_\-=? >+SK.\@DMKF+S8/B'%/%YD,CIYD,D<J9W1NC@,/D
M5_B%_P $&I;75[*;]KG]ANXL_$&C>'/#NO6]S^WMX2N8=<T'P?'I,/A;1]92
M?XZR+JFF^'HM#TJ/2+._%Q!8)9H+=$WR^9SQ6/:K<_U^,N2#H./UN2]HH8CG
MA55DO9RF\*XSA^\A!8BT92G#EWDL&W2]G++U&]158SCAI-Q_=\DZ;4TU**55
M2C+W)-QNTUK]#:A^PU_P1\TFQ_M/5/V//^":^FZ:6L4%_??L^?LOVEDSZIX>
MN?%VF(MS/X12%GU'PI9W?B:P4.6O/#]K<:S;"73H);E,#5_V0?\ @C%H=KI%
MUJ/[(7_!.15U_P 0:%X5TBWM/V9/V>-3U&]\0^(_'UM\+-*TN/2=,\!7FJ)<
M-\1;M/!FH>=9Q1Z+X@AOM/UI]/FTW4!;>;^-OC7_ ,$/OB+;V%EXT_;5_8NU
MO3M-M?#MK;:3+_P4!\+V>C/)X2\'ZKX"\-:I?:/IWQWL]+U7Q'HOA76;[3K#
MQ3JEI>^)(9UT_51JIUC1]'O["_IWQ]_X(DZ-#H-MHG[:_P"Q3H5IX<U?2M<L
M;/0OV]O!FB65YJ&@_$O_ (6_H)\1V>E?'"TMO%UCH7Q#:;7M$TCQ7%K6DZ1#
M=W^AZ=8VWAW4+[2;C>,:GM6I5,X]A]9BHR5.HJCPBK8U3<TWRQQ$L/#+Y15.
M]&G6JXN%Y4Z-&4XE[#V45'^RO;?5VY<R@Z?UKDP\E"/O*HZ#J/&1]I.T^6&&
MGRKGK1A]-?\ #K[_ ()H_P#2._\ 88_\1)^ 7_SOZ^,_'/\ P3F_X)[6G_!0
MG]E_P9:_L(_L:6W@[Q!^QM^W=XHU[PG;_LP?!&'PSK?B;PA\;/\ @G1I7A+Q
M%J^@Q>!UTK4M=\+:7XW\::;X<U>\M)M0T33_ !?XHL],N+6WU_5H[O[+_P"'
MH7_!-#_I(C^PO_XEM\ O_G@5\:^./^"C7_!/6[_X*$_LO^-+3]N[]C2Z\':!
M^QM^W=X7UWQ9;_M/_!&?PUHGB7Q?\;/^"=&J^$O#NKZ_%XX;2M-UWQ1I?@CQ
MGJ7AW2+RZ@U#7-/\(>*+S3+>YMO#^K26DX?Z_>IS?7O]VQ-N;ZTO>]DN6W,O
MBO\ #]J_PBQ'U#EIV^I?[QAV^7ZL_=59\VS^&VDNEM]#VGQK^QO_ ,$B/AQK
MMMH7CG]@+]C#PT;V6_M[37-2_8=^%D7A:YN]*\%>(_B+JMO;^)D^$\FC7*:7
MX*\(^(]<U74(+N32=+_LPZ3J.H6NO7FG:5><I'^S/_P1T::2"Y_X)[?LH:8U
MKXC\#^$-6DU;_@GUX'TZVT3Q-\3)?"$7@#0]4N[GX,I:IJ?B<^/O"$D-A:S7
M=WH]MK#7?B6'1+72M<FTS2US]JC_ ((W^)OBAJWQ@\0_M[?L?ZQXVUWP?=_#
M[5DU'_@H)X4N?!5_X(O]-N]+U+PM-\+9/CF?A>=%U2"^GN=7L5\'"'5=76UU
M[45NM<L+'4;?D[+XY?\ !%#3O&WA'XBVG[>O[+4/B_P/<VE[X<U-O^"F'FV\
M-[9Z+X?\-1WFIZ--^T=)H?B*[E\,>%M#\,7USXCTW59M2\-6;^']1>ZT>]O[
M*ZFD\3S4%6CFEFKXB5*6)7*U5Q6E-.+<W*C'!:OEA"I4K[JDN9UG0Y:OL(97
MS1NJ3JRHN,KTZ7O5.5KD2JSK-QCS2E&C3;M]8FJ?<_#G]DG_ ((Y?%765\/>
M#/V&_P!A6]UJX\-:1XUTS3;[]C?X+Z-=:YX+U_4O%.D:+XKT./5OAG9G4]%U
M#4O!7BBU26VW7-O_ &4+B]MK6TU'2+C4*_B;]DW_ ((_>#M<OO#?B;_@G]^Q
M[HVL6^G:WJFGVM[^P=\.(_\ A)+7P_XA\'^$=1/A9U^$++K[3>*O'_@SP]H0
MT_S5\6ZIK]O!X1;75M-3DL6^!_VK_P#@CW\-/&6L^// /[?O[&OAKQ+XIUJX
MUWQO>1?MR?"K6?\ A.+R=/$S11>)QXF^*NMO<V-E?>+=7U:PL;*33[>VU$:>
MZHUMI=A;08LO[1?_  1=NO$7Q2\4WW[>7[).IZU\9TM8_B"VK_\ !1?1M8T[
M43IEYINHZ!-HF@:G\?KO0?!-WX2O])LKWP/>>!M,\-W?@:Z6>?PA/HDM[>M<
M$/K26']I_:?-]57UKD>)M]<B\#S>PO%J.'J*6/=-S;E3]G0=1N56T1O#J>(L
MLJG%UVL*Y>R@HX=PQ/+[=*4ISJPJ+"*<:=G4A*NH.+C%C#^SO_P1=@U33])U
M+]A7]B_0[G4KCXC6-O)KO["WPTTBS&H?""T\27WQ1MGO;WX1Q6K6O@2W\)ZU
M_P )'X@@DF\+6%RNCZ>VNMJ'BOPE:ZYZKX _8,_X)3?$J#6Y/#7_  3S_8OC
MN?#6HZ?I7B#2]?\ V*?@[X:U?2+[5_#6@^,M+@N].UWX86%QF]\,>)]"U56A
M69;?[>=-OC:ZS8:GIUEY\/VH/^",KFWCO/VZOV,]6T^#5/$NMC0/$'[?7@SQ
M'X5N-9\9V?CK3_%FK7_A+7OC?J/AG5-3\1V7Q*\:6VLW^I:5=W5_'J\8N)7.
MDZ*=.] ^'G[>'_!)OX6:?J.F>"OV_P#]BBR@U:\T^^U6YUC]MOX4^+]7U"ZT
MGPWH?A#39+W7O&'Q9U[7+@67ASPUHFEV\4NH-%'#8K($^T3W4T\+Z[R>]',5
M4=--VEBN2-3VFL;<O-**I>ZYW2E/WDE*\1_[->"_X36O:R<Y-8:,G1?,X1C&
M,W%5$N53FFXSFI2484'&_P I?LZ_L(_\$V)?VC/V\? OC#]B#]C3494_;0\-
M>#OA-H&K_LK?![6-/T+0+#_@G+^PW\3=?\->%XY/A]=Z9X4T,^(/$OC/QK<:
M7"^E:;>>)?$OB'5TAN-<UR_EN_4-$^ /_!%GQ/XJ\'>#O#/["O[%FOZUXZT'
MPYXH\/VNF?L0_"22]G\/>+-5ET70=<DT&;X70>*#H,FHV]U'K?B*VT*Y\/>"
M[:UGU'QUJOAG34^UGQ+X-_ME_P#!,?Q1\<OV]-<^(O[='[*6AVTW[</@SXB_
M"CQ-I_[:/@3X97.N:2/^"</[$WPNU;Q!X4\4>$OBOX5O_$_A%]=T;QQX,U9+
M74M2\+S^*?#&KZ7?P2:_X4:/3/HB/]IS_@C%%9>"]*B_;H_8QBT'P!/\.KSP
MKX8B_;X\%Q>$+74/A1?1ZGX"U?4/"$?QN7PSXBUO1=4@L]3GUSQ'I.K:OKFI
M:;I%]X@O=5N]'TN6SZ&\4L3!UUF,J*O&I"A+$Q?LWA\'*A6A-1?[R#^L0KT&
MG&I5Y*CG""JQ,H_5?8-47E_.YR:E5CAVX6GC.=-<RC-2KJ@X.3BH86=2*4L1
M&AS>C?$;]@K_ ()0_"G08/$GC7]@/]A?2]+N]:T?P]:RG]D7X!O]HUC7[Z+3
MM*L]Y\ 1V]M]INI4C^T7L]M:H<*TPD>)'YR?]C;_ ()!V6CW^MZC^P=^PW8V
M>E_#SQ+\5=0S^QQ\$M0:W\!>$+AK;7M>$NC?#?4[2[6TD ,6G6-U=:K>)(K6
M=C/\P67Q5^VQ_P $H/'?@RU\"^-/^"CO[)VO:98^)H/%]EJL'[>_PU\)^,++
M6[#Q)-XHT>:Q\:> OBWX4\4V$.B7LD=EIMO9:K;Q#1K6WTF\%Y9^='-S/B+]
MJ/\ X(Y>+-*TW2/$?_!07]E?5K73/"7BSP(]S=_\%(=-;6M:\'^-Y[.X\2>'
MO&/B1/V@D\1>.-,NY;&W6TA\9ZKKO]C0FXMM%;3K>\NXI^=+'NE4BY8Z->56
M2I5(QQLJ=*E/+9>SG4IM*5:='-ZD/;03BJ^ H2CAY1K5XN&]\']9I.2R]X2U
M'V\8O#+$7IY@GB(TIN7LU[?*U-8:<U;"XZ<*F)52A"I%^F^(/V ?^"47A?P/
M<?$;6_V!?V&[7P?;:39ZVVI0_L;?!B_NI[+4A;#34L-#T[X8WFOZEJ.IS7EI
M::9HNG:7=:SJ%_=6VGV=A-?3Q6[^;Z=^RK_P1WG\9?\ "N?$7[!'[%/P[^(#
M6>DZA!X4^)/[%OP6\&7.I:?K^L6GA[1+S0-:U7X;)X3\41:EK^I:1X?1?#'B
M'6)K/Q)K.D>%]3BL?$NI6FD2=K=?MV?\$HM5^'>H_"SQ)_P4'_8E\4^#]3M=
M4T^[L];_ &Q?@4UXNGZEJ-QJ-M96.I:;\0=-O=(7P\\UO;^$[K2)K'4?#4.E
MZ1)I-[;7NFVMVG&VO[57_!&ZVU;5M>F_;S_8YUG7-;F\#3ZGK'BC]O[P=XNU
M28?#7Q3I?C;P1;1W_BCXX:O=6>G:!XKT>RUN#2[*6WTRYO'U#[?:7<6L:O'?
M:Q^L>VK\RS/V$JL7A]<7*O3H2HU)2527*J56M#$3HTY2:A1JTJ-:=/EE6HJ.
M+5/ZM17/E/UN-.E&NU"BL/5K*K"->4%*:K4L/*C"M.C3]_$TZM6A&JW"A6<]
M<_LB?\$6%N8K.7]E7_@F1!=RP65PMI<_ /\ 9>M;E(M3LM2U+2A<6]SX0BEM
M)M6T[1M;U+2;>Y2*XU73M"UV^T^*XM=&U2:T]#\-?\$Z?^"5GC/24UWPE^P;
M^P#XDT:2\U331J6B_LL_L\ZC:)J>AZG=Z+KFE32VO@.1;?5-#UK3]0T;6],N
M#%?Z1J]A?:7J-O;7UI<01^$:S^T#_P $1O$'AI_!VK_MF_L+WOAN75M/UN?2
MC^W'\.X8I]0TOPIK'@>U-S-;_&:*ZN+-O">OZSHE[ID\\FF:G:7\QU*SNYQ'
M*G<?"[]M#_@DC\%]-TKP[\,O^"@_[&7A?PAH\'B];+P6O[;?P>UCPX+[QOXM
M?QMKVLR0>(?B=JVH2:HVNW&HOITG]HBUTJPU74-,T^TM[!X(+?.$<;[/]Y/,
M%5]E1TC#%>S550G+$W?\7D<U3AA[+3G<\0_9PL])/#JL^2&6RP[J54G*=%5E
M35>I'#NR;HRG]7]E/$1;BE4]I"@Y)Q9P.D? _P#X(1Z[KZ>%M+_9N_X)EW7B
M!;;QM=ZCI'_#-_[.L%]X=@^'?B#3O"OB]O&$%SX!A;P6VE^(M5L-)BC\6_V+
M)JMY.L>CKJ&URO>WO[('_!%S319'4_V4_P#@F3IIU"*]GMDU'X!_LNV$OD:9
MXC_X0W4YKB*[\(PR6<6F>,RG@O4I+Q($L/&4L'A.[:'Q#<0:;)E:Q^U;_P $
M9]?L/#.FZG^V_P#L-SVG@Z/Q4GA?R?VW/AA976B2>,_$VB^,M?O+#4+#XOVU
M_%J<GBGP[HFNZ7JWVHZGX=U'3;:;P[=Z44(;"U_]HW_@BWXD\,>+?"FH_MR_
ML23V?C6V>#Q#>WG[;OPHUW5=0F/CR?XG07M[=^)_BMKBZK<VOCF?^V8X];@U
M2QGM8;;PU?V5YX2@CT%9_P!N]DG;,W64(.2YJWLY5/JE%U(TKQO3IO'+$1@Z
M[;6&G1<[SC52N*P;Q$5*671PTJT4Y\M&5:E0>,G&4Y1C)1KU88!T:J5-PC4Q
M,*M)6IRIS?=/^QG_ ,$;O^$7\:>-;/\ 8Z_X)SZUX8^'5S#9^/-5\-?LR?L[
M>*8_"%[<:1HOB&WL?$-OX<\!ZI>:9?W'AWQ'X>\0V]E<V\=U-X?UW1];BA;2
MM1M+N:G:?L@_\$9;SPMI/C?_ (8\_P""=EAX/\0IK%SX:\2Z[^RW^S_X=T3Q
M5I&@P->ZIXI\*:AK_P /=,MO%7@B#2A_PD$7CKP])J7@V]\,,GBBQUVY\/2)
MJ;<EX-_:<_X)!^$?"7Q0\#7W_!1S]E/X@>&_B[K&F:MXSMOB7^W?\(?&%_<#
M2?!'@WP%;:5;:[>_$F/7HM(;2/ ^E74UK<:G=2/J=UJLJW"6=W'8V^GJG[4G
M_!&?58M9MY_VZ?V+[&#7;[QOJ%[!H/[>G@;PQ#;GXE:;ING?$"PT:+PY\:]*
M3PYH'C-]*M->\2>&O#RZ7X=U;QHU[X^N]+E\;ZGJ7B"[VDL1&I647FE2GS87
MZO.2Q-.?)[*7USVT4I14O;.F\.Z=U"DJRES5'AV^>BX2A0E6AE5*2I5EBJ<9
M8:JW5<\,J#H34HTXTU!XZ56-1.4I1P<8N,7C7#H[C]CG_@C%::S=^';G]D__
M ()E6^OV.H7FD7>C3? +]EU-3@UC35TY]4T5K(^$A<-K6E1ZQHTNJZ0B-J6F
M0ZWH<U_;6\6LZ8]WWOAC_@G-_P $K/&WAS0O&/@S]A'_ ()]^+O"/BC2=/U_
MPSXI\,?LP?LY:_X<\1:%JUK%?:7K>A:YI/@>[TS5](U.QG@O-/U+3[JXL[VU
MFBN+:>6&1'/@?BS]HO\ X(U>*;GPGJ$/[?\ ^QWX0U;P1XF\4^*O#NM>!_VY
M/A#X;UG3-2\:RZ7/XMBT_4K;XFR76CVFNRZ)I,=XFAR:7/'IEK<^'K.XMO#6
MN>(]&UCM?AG^VK_P2O\ A;X!TCX:Z)_P4U_97U7PQHOPY\)?#/3UUW]N;X)2
M:M;Z1X1T:[T.'6[36M(\?:/J6G>+]:M;L7&O>)=)N+"^N=1L["_LCI]Q:1,(
M:Q?LJCB\R]M&SA&2Q$:52U*<G'G@I2IN=7V<%*:Y:<>>;YH<E[BZ'M**G'+'
M3G%NLXRP]Z,N><4H>T:E77*H5'I!6DZ:_>IDFH?L?_\ !&71IM9@U_\ 9 _X
M)R>&9?#VO?\ "-:T/%7[,O[._A5-/U@SZ79Q0S2^(? >FQ&UN]1US1](L=4C
MDDTK4-<U2QT.QO;C5[J&R=Q_8_\ ^"+@T"7Q7_PRE_P3+/AB%9I)M?'P!_9?
M;2(;>WT*P\5W-]-J \(&UBTRW\(ZMI7C"?5))%T^'P=J6G^+9;E?#M[;:E)X
MIX\^(_\ P0O^).GM:^*_VV?V-]3U))[F_L?%%Y_P4#\'ZKXLT[6+C6++Q VN
MP:[KGQNU6ZO-3&LZ7H]W*^L?VG:7]OHNCZ-JEI?Z!IMII45W7_BK_P $,O&'
M@^/P3XT_;2_8K\9Z5Y:"[OO$G[?'@G4/$FJ7D?@?1OAPFJ:GXG7XV0Z[=:K!
MX,T&PT2PO/MR/I%N^IOHRZ=-K6L27SC'$J,5.>9N2JX93G3IXI1=%2@L9.G3
MJ>\JCC&K4PT*S]G!SI4YRDJ=>1'-!RTIY3R2==Q<JM'FBE4HO#PFH7C.4J4Z
MZJU:+^.E!\MJL4?07@W]@_\ X)#_ !%>_C^'_P"Q=_P3E\;MI<<4VH#PG^S?
M^S3XA%K;SW^K:3#=2/I/@NZ0V<NKZ!K^C)>(7M6UKP_K^D";^TM$U6UM.Z_X
M=?\ _!-'_I'?^PQ_XB3\ O\ YW]>:^ _VX_^"1OPRECG\$_MX?L,Z-+'X2\.
M^!4D;]LWX/ZHW_"+>%-5\4ZWX?TPG6?BGJ&]K#4_&GB:Z-^^[4[LZEY5]>7,
M%G816OI7_#T#_@FC_P!)$/V&/_$MO@%_\\"LY?7ER\KS!^Y'GYEB4E4Y5[11
M23_=J5U!R?/RM.:4TSHIO".-ZT<NC-MZ4I4)Q47?E3E.S<M(\S249.[C96N?
M\.O_ /@FC_TCO_88_P#$2?@%_P#._H_X=?\ _!-'_I'?^PQ_XB3\ O\ YW]'
M_#T#_@FC_P!)$/V&/_$MO@%_\\"C_AZ!_P $T?\ I(A^PQ_XEM\ O_G@5%LP
M[X__ ,NO\C2^7]L!_P"6W^8?\.O_ /@FC_TCO_88_P#$2?@%_P#._H_X=?\
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MRO[#3[%U<BZU*V"AG[G6/@]\*O$O@U_AYXK^'GA#QEX$DU:77I/"/C;0=/\
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MWCCQ+JOA;PO:^(-?\'1: 9(8]6\+>.=/\,?$/1-8FC\&^(/!FD>/-_A9.Q\
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MNZTW5](U.TNM/U+3[FXLKRWFMIY8F_02OAC_ (*(?\D"^'__ &?/_P $O_\
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MP]\,_P#@D_KQQ_P[&_89MVM-<^*GA_5?)_9U_9MNP-1^%_@KQCXWN]/T(_\
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M9@^".MW]MX9\$?\ !0;]IWP9X+\.V]YJ?@>ZN(-"\(>#M T+PGX7TB*1=/\
M#_AG1=)T'2;>TTK3;.TA^R_^'7W_  31_P"D=_[#'_B)/P"_^=_1_P $\/\
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M:]\)-$U^^OW^&UWK,5Z_AC7GEU32M+U/3?">J7^G64=WX;DT6XUK1M6EM/V
M_A-8KX42W\9?$^5?"WBO0_&!?5[SP!XFNM<U/PY\>G_:)TB/4-1\4_#O6]3T
MA(O'4]W:W]]X*O?"FNZ[H=T?[?UC5/$-IIOB&QZ(U8>U<99AB_8K$QA&K&%9
MREA56QL)UW3=>\*LJ%+ UJ=%2E%/&U*-27/@ZDJD2H/V47'!X1UGAW4G!QM"
M.)Y,-)8=3]BG.//4Q5/V_+&">'ISY/9XF*IM_P"'7W_!-'_I'?\ L,?^(D_
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MH6F_!/1[KQCX)\?W-G<ZA9:SIEG\&T\+:/=Z1]D>'1+[P+X>\'S)'>W;ZO\
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M/7]A21[>013K'^R;\ ':&5HHYUBF5? ),4A@FAFV/M8PS12A=DB,TG_#K_\
MX)H_]([_ -AC_P 1)^ 7_P [^O9_@I^S7\./@)+--X"74XFNO!7AGP1>K>)X
M?ACO[7PQXI^(?C&+7;V/0] T1;CQ+K&M_$SQ%/KVI./)O]EC(EG;72WUS?\
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MC&=9)TX29M?\*_\ ^"EW_1VW[#'_ (KO^/O_ -- H_X5_P#\%+O^CMOV&/\
MQ7?\??\ Z:!6-X._;Y\.?$>YG@^'_P -]>\020_$GP3\.%TZ[U_1_#NON_BO
M4_BCH=[XK;2=9BMXK?PUI&J?"W5Y;=[G4(M6U;2VO8SI6F^+='O/![V/#/\
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MB-8=RG!U\5S14&T\1B>9JK7GAJ>CHS<U.M3486YXRYJ4TY0JTJDU_P"%?_\
M!2[_ *.U_88SZ_\ #N_X^_\ TT&C_A7_ /P4N_Z.U_88_P#%=_Q]Z_\ BT&L
M_P &_P#!0CX2_$36]0T+PAHOB 3Z-XV^#7A+5[SQ7+I?AG3HX?C3XY\9> -
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M^%?_ /!2[_H[;]AC_P 5W_'W_P"F@4?\*_\ ^"EW_1VW[#'_ (KO^/O_ --
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MXI_X5_\ \%+O^CMOV&/_ !7?\??_ *:#1_PK_P#X*7?]';?L,?\ BN_X^_\
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M /+!_5X_\_,5_P"%=;_Y ^&/^%?_ /!2[_H[;]AC_P 5W_'W_P"F@4?\*_\
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M )X%'_#T/_@F?_TD2_86_P#$M_@#_P#/ H^KXC_H'Q'_ (3U_P#Y2'UG#?\
M01A__"C#_P#RX^Z:^&/^"B'_ "0+X?\ _9\__!+[_P!>7?LDTW_AZ'_P3/\
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MP'XATOQU<6OQ/U?P[<^/-&3QSH_@6+6-2\-I!<;K:]N-:\"6WC37_P"'H?\
MP3/_ .DB7["W_B6_P!_^>!1_P]#_ ."9_P#TD2_86_\ $M_@#_\ / JJ5*K!
M057!XFO:&&4Y.&*IS<Z5.M#$5*;A1<8?69SI3]G\--4*5.,E""52:M2,E4]E
MF&$IN3K^SYGA*D8QJ5*,J$9Q=9*?U>E"K2U_B>WG4DI2DXQX'Q#_ ,%-_A#X
M7M/%_B#4_!WB^?PAX/TSX0W6H7>A:CX.\1^+K/4OBQXB^,?AQ-'\1^"-$\0W
MUSX+N?"5S\(YYO$L?BK5-,O])AUF=M:TW1H_#>LRIWWA[_@H!\'O$/B3X5>&
M8/#_ (^M+GXOZWK/AKPM?7FE:1%8G6M"^(^J_#*^34$.N#5-(TYM;TF6]L=0
MU[3=&34[*\M-'TR"[\<VNO\ @W0T'_!4+_@F<  /^"B/["P X _X:W^ .!CG
M@?\ "P,#\*7_ (>A_P#!,_\ Z2)?L+?^);_ '_YX%.E2E%157!8RI:6#<Y1^
MLPF_8X65/%\M\/*,7B\4X8F%2W/A84XT(<T6I1NK6IR=1T<?0I<T,1"GSU,'
M6E"4\6ZM"<I.O#VBI81_5*E-^Y6DOK3M5E**^H_AIX]'C[3_ !+-)IYT^^\)
M^//%_@344CD-Q97=QX8U1[>VU*PN/XX=2TN73KN[M2TDFC:M-J.@37%W<:3+
M=3]KI.CZ1H&G6FCZ%I>G:+I-A&8K'2])L;73M.LHBSN8[2QLXH;:VC+R.Y2&
M)%WNS8W,2?AK3_\ @IC_ ,$O=)MVM-+_ ."@7[!.FVCWFH:@]KI_[5O[/5G;
MO?ZOJ%SJVJWSPV_CV.-KS4]5O;S4]1NF4SWNH7=S>W,DMS/+*]W_ (>A_P#!
M,_\ Z2)?L+?^);_ '_YX%9>PQ/+'_9\0I>RHPJ6H8AQE4A3I>UE&]&ZA/$1J
M5H0;M#FCK*2YHW'$4->?$X63]I6G!^VPT7"%2=1PBFJS?/"C.%*<U*+J*G=I
M)N,ONFBOA;_AZ'_P3/\ ^DB7["W_ (EO\ ?_ )X%'_#T/_@F?_TD2_86_P#$
MM_@#_P#/ I?5\3_SXQ*MM:CB=&[7M[BM>RNURW27,II*,;^LX;5>WPUFK6>(
MPS37;6JU;R::[177[IH_SU_SGZU\+?\ #T/_ ()G_P#21+]A;_Q+?X __/ H
M_P"'H?\ P3/_ .DB7["W_B6_P!_^>!1]7Q/_ #XQ#M:R=#$65NW[K3JM.FUA
M?6<-_P!!&&UW_P!HP][VMO[;7M=W>FKM9)W_  3P_P"2!_$'_L^?_@I__P"O
M*_VM*^YZ_$O]A+_@HW_P3U\(?!+QSI7BS]O#]C/POJMW^V5_P47\46FF^(OV
MH/@CHFH77AGQO_P4&_:=\:>"_$5O9ZGXYM;B;0O%_@[7]"\6>%]7CC;3_$'A
MK6](U[2;B[TK4K.ZF^R_^'H?_!,__I(E^PM_XEO\ ?\ YX%;XJA7>)KM4*[3
MJMIJA6::<*:NFJ335T]4S#"XG#K#4$\1ATU32:>(H)JTZFZ=9-=-UU7<]Y_:
M!^&GC;XK> XO#/P]\9^!_A[XGB\0Z/J]GXQ\<?"6U^,L6APZ?)*UW<>&?#-_
MXO\ !MCI?BZ:VEDM-(\675YJB:#%<WDD6AWES/!-:?(7A?\ X)WP>%?"$/@_
M3?B/X;L-/T;PYXIT;PO_ &3\*KN,0OXI\4?!CQC)HGC*77_B7XGU7Q_\-M,U
M#X/V_A2P\%ZUJT.L3?"S5K7P/JOCC4;C0D\1ZCZ)_P /0_\ @F?_ -)$_P!A
M8?\ =V_P _\ G@4?\/0_^"9W_21+]A;_ ,2W^ /_ ,\&LZ=+%TDU"CB8\U2%
M635"L_?IK#\F^'E[L986E-0^#VBE.7.YRBKJ5,'5Y54Q%&48PG!1^MTE"U2%
M>G4;C'$13E.GB:U)SYE/V<^2$J7*JISWPH_8+M_AC\;I/C2WQ-;6[Z\^(WBO
MXDWN@1^&-:TS2K"]\6V7Q-L[WPUX3TN;XB:OX2\.^&;:3X@0:K97$_A#6O&]
MEJ\/C)[#QK9Z3\1-4T?3OT*KX6_X>A_\$SO^DB7["W_B6_P!_P#G@4?\/0_^
M"9__ $D2_86_\2W^ /\ \\"E['%.G2I.CB7"A!TZ2="N^6$IRJ23E["\G*I.
M4VY7?-*6U[(A/!4JE>K"OAU4Q%3VM:3Q5%^TJV2YVGB.52:C&_)&G%M+W(K0
M^Z:^%_V2?^2_?\%0?^SYOA]_Z[2_X)XTG_#T/_@F?_TD2_86_P#$M_@#_P#/
M KXT_9@_X*-_\$]/#_QO_P""C.K:[^WA^QGHNE>./VR? WBCP7J>K_M0?!'3
M=/\ %_AJT_X)[_L)^"[OQ%X7O+WQQ!;^(-"M?&/A#Q9X2N=7TF2[T^'Q-X8\
M1:#)<+JNB:G:VNE*A75+%WH5TW2HI+V%:[:Q,&TE[+6RU=KV2;>FI%7$X9UL
M*UB,.TJE9MK$4&DGAJB5_P!]I=M)7MKIOH?LQXGT7_A(_#FO>'_M/V/^V]&U
M/2/M?E"X^R_VE93V8N/L_FP&<0^=YGE>=#YNTIYL>X.OYO:+^P/\:/#GAN+P
MMH/[:OQ#T;2=/T3PAI/ARVT_PYXF%MX5F\*V.BZ?)?Z39WWQ>O[+48M8MM+N
MXSX=\6P>)_"7AN._@A\&:!X<AT?3$B]4_P"'H?\ P3/_ .DB7["W_B6_P!_^
M>!1_P]#_ ."9W_21+]A;_P 2W^ /_P \"LHT,3!5E'#UK8BG&E53PU:2E"$*
M].%DZ7N2C#%5TIPY9KVC?-=1<=IUL'-TY3K864J4IRIMU\.[.?(YW?UA<T9.
ME3O&5XNVL1OQ&_9=_:!\8:3I^B>&?VPO%7P_M(K?P=-JFJ:9X5\4ZCXFOM8\
M,?"[7O &I_8]7E^,5G:Z=X9\7:[J.E>.]>T2ZTK5M9;6=*N+B#Q9'KUWIOB?
M0<V7]CKXGWVG^"M*UW]ISQ'XML/#7C?P=XPU6'Q1X=\5RQ7W_"#?M$VWQRTB
MQT#3_#_Q;\.:)HLL^BVUM\-;N;Q#I/CC1[/1=,T1_#?A[P]H.FR^$+_4_P"'
MH?\ P3._Z2)?L*_^);_ '_YX'Y_2C_AZ'_P3/_Z2)?L+?^);_ '_ .>!73&I
MCXU95HT*BJ2Q*Q<G]1LGB(UL;7A/D^JN,5"IF&)<*<%"E&'L:*@Z>%P\8Y-X
M"5*%&57#.G##O"QC]:I*U%PPU.UUBN9U.7!T)>VE*553C.IS.5:M[3[IKX7^
M(/\ RDN_9(_[,9_X*(?^K\_X)@4G_#T/_@F?_P!)$OV%O_$M_@#_ // KXT\
M<_\ !1O_ ()Z7?\ P4(_9?\ &EI^WA^QG=>#O#_[&O[=WAC7O%EO^U!\$9O#
M.B^)?%_QL_X)T:MX3\.ZOKT?CAM*TS7?%&E^"/&>I>'=(O;J&_UO3_"'BB\T
MRWNK;P_JTMIGA\/74ZK="NKX;%)7H5E=NDK)7I*[;T2W;T28L1B</RTO]HP[
MMBL*W;$4'91JW;TK/1+5O:W5'[:5YM\7_!VO?$'X;>+?!WA?5?!F@^(]>TS[
M+HVM_$'X>1_%?PCH^H)=6]Q;ZKJWP\E\2^$(/$[:?)"MWIUC<>(M.M8M4AL;
MZY%Y!:R6%U\O_P##T/\ X)G_ /21+]A;_P 2W^ /_P \"C_AZ'_P3/\ ^DB7
M["W_ (EO\ ?_ )X'^?SK"6%KR3BZ&)L[7M1Q$792C+22HW6L%JFG;F2:;4H]
M"Q6'BTUB</=7U=?#M:J2U3K-/2<MTTW9M-7B^)^'7[!&J^!+I=2NOB3\/_$V
MJW'C#7?B9K-QJ/P/NUM-<^(/B#X?_%;P/K,EY:W7Q;U&X@^'GB6\^)USXU\5
M_#2QOK;2[KQ//XV3PMJ?@S0?&MIHOA3L_A%^QQK/@^Y\*WOQ0\??#_XBW6D>
M/=6^*/BF+PG\$E^&&D>-O'UKX0\$>"/AEJUSH$_Q(\?:/X>TOX5Z)X4F7P_X
M<\/6EEI5UJ5I\/O$D\=OXO\  =QXC\5/_P"'H?\ P3/_ .DB7["W_B6_P!_I
M\0*/^'H?_!,[_I(E^PM_XEO\ ?\ YX%=*ECXSE45*OSM12;PM1JFHU*]6/LH
MO#\M)QGB*G*X)N,?9PB[4:;ES-8!JSKTI7<W+FQM.7/*<80E*;EB'*HY*#UF
M[IU:\K)XBHH?=-%?"W_#T/\ X)G_ /21+]A;_P 2W^ /_P \"C_AZ'_P3/\
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M/6O">GZO\>+O7/#FJZ(L5\MZOB+Q9X\AUR>ZMYXAHL=G);7F=_P]#_X)G?\
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M"^*-%U?XGW&L77C#_A(I_'&LIXATC4O#.N#7=5\1]A_P]#_X)G_])$OV%O\
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MBOA;_AZ'_P $S_\ I(E^PM_XEO\  '_YX%'_  ]#_P""9_\ TD2_86_\2W^
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MRT377K?0_?*BOPD_X0K]L3_I*9^VG_X:K_@F5_\ 2\*/^$*_;$_Z2F?MI_\
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M_KMD/_/S&?\ A%4_^7!_;67]ZO\ X(E_\F?NW17X2?\ "%?MB?\ 24S]M/\
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MRO\ Z7A1_KMD/_/S&?\ A%4_^7!_;67]ZO\ X(E_\F?NW17X2?\ "%?MB?\
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M7WFK]MS^F>BOPD_X0K]L3_I*9^VG_P"&J_X)E?\ TO"C_A"OVQ/^DIG[:?\
MX:K_ ()E?_2\*C_7;(?^?F,_\(JG_P N)_MK+^]7_P $2_\ DS]VZ*_"3_A"
MOVQ/^DIG[:?_ (:K_@F5_P#2\*/^$*_;$_Z2F?MI_P#AJO\ @F5_]+PH_P!=
MLA_Y^8S_ ,(JG_RX/[:R_O5_\$2_^3/W;KF;NXG7QCH-JLTJVTWAGQ9<2VZR
M.()9[;5/!<=O/)"&$;RP1W=U'#*REXDN;A(V59I WXE?\(5^V)_TE,_;3_\
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M2.E^"]4BUR^O)O"NJ:%\<_&ND>//!ESHGBNQM]$M;R".]]'_ &\O^2'^!O\
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M4'AOQD= \%'Q-HWPU\5Z18S7GQ9TW3?&NB>$;SQ'H_A:RNM)U+Q7:#2M9O\
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M8>(;B'6M8EL(K2ZTW49_$/AF'7#2_C7^SKX@\*V5Q\6_A8O@G3/A1I7AR_\
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M/^3OO^"7'_9Z7Q/_ /7:?_!0>N[AK_D?93_V%_\ N'%G3EO^_P"$_P"OR_\
M3=0_=L]/Q7^8K\)O!7_)X/\ P5(_[/0^%7_KLS_@GE7[LGI^*_S%?A-X*_Y/
M!_X*D?\ 9Z'PJ_\ 79G_  3RK](XS_Y$%;_L)P7_ *D3/I,[_P!PE_U]H_\
MI3/8?$>F^'M8\/Z[I/BVPT75?"FJ:/J>G>)],\1VUE>^']1\/WME/;:S8Z[9
M:G'+IMYH]WITMS;ZI;7\;V4]E)-%=(\#2+7YB^+/VNO^"5OC'X3:O;_$33?
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M+S]LC]GNPM=+O[SQ?K=MI^LZOX,\.:;?2_#GXE+;7GBKXB:?>ZGX'\)6S?\
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M4BUZ#4M&2&VT>.-=*U&#Q5XHAOM.519W<7B37H[B&1-8U!;BGX;_ &=_V?\
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M&T.WU-DJ^);']BE/#7AS1=6LO@K:^&[[Q;HFG:#X=\/VNB6,5[XJ\1?%*_\
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MDI>TG.;:DIJ2;G.=U)5)J2^TJE2[3G.4RO _''_)WW_!+C_L]+XG_P#KM/\
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M_BCQ-XXU?3Y?@6GPIB6V^ _Q:^&7Q-^'G@GXWPRVNE:+-^T'\)OC/\-[?6?
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M+:ZOI>AZQ966L65K8SZ;9W\$UMINI:C9QQ7<DW[>?_)#_ W_ &>=_P $X?\
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M****/O\ _ 9?_(A9]G]S_P @HHHH^_\ \!E_\B%GV?W/_(****/O_P# 9?\
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M?^+!/VBO_I7]'_"J/^"I/_1N/[ 7_BP3]HK_ .E?T44?ZH\/?]"V'_@_%?\
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MX]?\(_\ 8_\ AVEJWG?\(C_PLG_A%/[6^U1?V_\ V+_;O]F:+_:7]C6'L_\
MPJC_ (*D_P#1N/[ 7_BP3]HG_P"E@445K4X5R&M4E5J9?"=2K+FG)UL2FY>Y
M&]E723M".R6WF[U+*<OG+FEATY2=VU.HK[+I/LD'_"J/^"I/_1N/[ 7_ (L$
M_:*_^E?T?\*H_P""I/\ T;C^P%_XL$_:*_\ I7]%%9?ZH\/?]"V'_@_%?_-!
M/]D9?_T#1_\  ZG_ ,F'_"J/^"I/_1N/[ 7_ (L$_:*_^E?T?\*H_P""I/\
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ME2.M=VYHI*ZLUNFGJ5'*<O5VL.DVG!VG4^&HFI+X^JT\EL>T?\*H_P""I/\
MT;C^P%_XL$_:*_\ I7]'_"J/^"I/_1N/[ 7_ (L$_:*_^E?T45E_JCP]_P!"
MV'_@_%?_ #03_9&7_P#0-'_P.I_\F'_"J/\ @J3_ -&X_L!?^+!/VBO_ *5_
M1_PJC_@J3_T;C^P%_P"+!/VBO_I7]%%'^J/#W_0MA_X/Q7_S0']D9?\ ] T?
M_ ZG_P F'_"J/^"I/_1N/[ 7_BP3]HK_ .E?T?\ "J/^"I/_ $;C^P%_XL$_
M:*_^E?T44?ZH\/?]"V'_ (/Q7_S0']D9?_T#1_\  ZG_ ,F>,?"[]DG_ (*E
M?#7QS^T?XS/P1_8"UH?M!_&?0OBZ-._X;N_:)T[_ (1$:+^SQ\!O@+_PCQO/
M^':5_P#V]]I/P2_X2O\ M86NB^3_ ,)/_87]F2_V+_;.K>S_ /"J/^"I/_1N
M/[ 0_P"\@G[1/]/^"8!HHK2IPKD-67/4R^$I<M.-_;8E>[3ITZ4%95TO=ITJ
M<=KM1NVVVVY93E\G>6'3=DK\]3[,8P7V^D817RONV'_"J/\ @J3_ -&X_L!?
M^+!/VBO_ *5_1_PJC_@J3_T;C^P%_P"+!/VBO_I7]%%9_P"J/#W_ $+8?^#\
M5_\ - O[(R__ *!H_P#@=3_Y,/\ A5'_  5)_P"C<?V O_%@G[17_P!*_H_X
M51_P5)_Z-Q_8"_\ %@G[17_TK^BBC_5'A[_H6P_\'XK_ .: _LC+_P#H&C_X
M'4_^3#_A5'_!4G_HW']@+_Q8)^T5_P#2OZ/^%4?\%2?^C<?V O\ Q8)^T5_]
M*_HHH_U1X>_Z%L/_  ?BO_F@/[(R_P#Z!H_^!U/_ ),/^%4?\%2?^C<?V O_
M !8)^T5_]*_H_P"%4?\ !4G_ *-Q_8"_\6"?M%?_ $K^BBC_ %1X>_Z%L/\
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MO_F@/[(R_P#Z!H_^!U/_ ),/^%4?\%2?^C<?V O_ !8)^T5_]*_H_P"%4?\
M!4G_ *-Q_8"_\6"?M%?_ $K^BBC_ %1X>_Z%L/\ P?BO_F@/[(R__H&C_P"!
MU/\ Y,/^%4?\%2?^C<?V O\ Q8)^T5_]*_H_X51_P5)_Z-Q_8"_\6"?M%?\
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+=FKZS:>[W3W/_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>41
<FILENAME>img_7n.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img_7n.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" %^ ED# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^_BBBOYZ_
M^"D_QR_:I_:%_P""AW[-G_!(7]EGX]:W^R9H'Q0^!7C7]IK]J[]HCP#9VH^.
M%K\$M%U^X\#6?P[^!'B34+:]M_ /C/Q'JJ7AE\?:;!;^)O"]W+H6NZ-JD5MH
MNL>'O%0!_0I17XV_LQ_\$U?VG?V-/CKI?C/P#_P52_;'_:*_9LU7PMKL'QA^
M _[>FN:?^U'XTUWQ3!8ZC%X1\1_"3XWG_A7VN_!R#2I+R.;5M"T[P]KFEZ^]
MF[ZW!JLMQI$GAGRC_@W&^,/Q<^./_!.6X\<?&KXI?$;XO^-1^T_^TQH \7_%
M+QOXF^('B@:%H/Q'N['0]$'B#Q9J>KZL-(T:R5;/2=-%W]CTVU5;>S@BA 2@
M#]Z:*_S_ 'Q=^US^VCJ/_!NO\>OBKX=_:R_:-L/C^O\ P5>\0_"?PG\9#\=O
MBC;?$C1/"%Q\5/#^B:7X*M/B%#XDD\6Z=X(M8;PV@\-VFH'18;"2:W336A=X
M7^@/V@_^"MG[0_Q<_P""?W[.WPW\7_$?X@_LV_\ !1G]E[_@IE^R?^S!^V]X
M+\ >/-=^'7BSQ-876M>(]-/C%CX1U72+O7OA+\<=*TV+4[VU0W'A#5-9MM5L
MH(;O1XM&N;L _N"HK^9[]A+]LKXE?#_XQ_\ !QU\4/C%\1?BA\5OA[^QU^T/
MXA\3_#KP'XL\=>*/%&C^!?!?@GX;?$#Q9=^"/AOI.NZEJ6F^!]#U231+>)M*
M\.6>GZ:)E@G>T=H$QY5^QW^PK^V[_P %2_V8_ O_  4"_:>_X*U?M[?L^_%[
M]I+PM+\2_@Q\'OV&_B[:_ _]F'X(_#S6Y=0U7X4>&O$WPJMO#=Y/\7-2TI;N
M#4/%NK:YXETGQ-XDT26T\%Z]XLU>ZT=?%UT ?U;45^0O[4_[27QI_P""8'_!
M)?XJ_&S]J;X[>&/VB_VC/A!\+-7T73?BUI/PKM?A)I_Q5^+WBS4I?"_PB@G^
M&_AO7=;TS3M2N=?USPW::\WA^YTG2[Y;+4=7M=(\/VSO;6WY3_\ ! CXY_MN
M? OXZ_M!?\$V_P#@I'\:?B)\8/CIXA^!GPB_;D^!'C/XJ>/?&GQ$\3WG@3XD
M>#="L/BCX TOQ)XSU75]0MM-^&'C.;3M'3P_')80VVN6OC+5=.L8K"Z1+8 _
MK2HK\%O^#<7XP_%OXX_\$YI_''QJ^*/Q&^,'C5?VG_VF/#X\7_%+QOXE^('B
ME=!T'XCWECH6B#Q!XLU35]6&D:+8JMGI.FB[^QZ=:J+>SAAB 2OF?_@JYX7^
M+O[0_P#P6/\ ^";?[&/A[]LG]M7]E'X0?&/]GC]I'Q7X]D_8Y_:&\3_ SQ'K
M6N?#])=;\/7MX]C;ZWX8U&XBEL4L9;K6O"VJ7::9/<6ME<V32":, _J!HK^7
MS]ESXW_M5?LD_M'?\%$_^"3OQU_:5^)'[4>E_"7]C#Q-^V#^QY^TK\2=4GN_
MVB]'^&>O6FOZ)?\ @3XM_$*R-M?^,?%_@WQ7<V<_ASQW<O%K5P;"]O;9])T6
M[\.>$?!_YI_\&^'[2/[*'Q]\5_LL6WQ5_P""S_\ P50^,7_!0KQKX9^*T'C/
M]C'XD?'W]HWQ;^S9>ZA'X?\ '\$V]_$?P:N/"DUQH'P]MX/'6@W[?'6XGTSQ
MA8V5W879U*U@T9 #^Z^BOY$/V<?^"F7Q3_8!_8,_X*Z?!3]J?XU>)OC'^U'_
M ,$Q/BEXZ\)_"OQE\9?%NL>*_B/\7/!WQU?[3^R?K.LZOXDUG4?%?BC^U/$^
MM_8%DN=8U&\M=#AL-+AOA!96XC^4O^"AWB+]HK]BG_@F_P#\$1?"/[5__!0K
M]MWX,:I\4_CZ-4_;H_:/^&/[0OQNB^.-EX3^(_AB^^('BO0QXGTC_A+_ !?K
M]G\+[+7(=!\->&Y_"_BG3-/F\/Q'2O"S@I;4 ?W.45_$E\=?VG/A;X4_X)E?
ML^>-O^";?_!4;_@H)^UCX1US_@KO^SE\.?''Q_\ VA/C1\;X/C+Y.O66GGQ?
M\$CXE\3_  ]^!GBJ^^$USHYT/5;GPI)H.I>%[_4-:U1I[N^F:>ULOVD_X+$_
MM8?M-^ _'G["?[!_[&_Q#T7X'?'K_@H5\9?$_@-OVA=:\(Z?XYF^"WPI^&GA
MZT\5_$KQ)X1\*ZTPT'5O'5[IE];6.A1:PCPI;+J<5A/HNNW6D>)]  /W)HK^
M2[]L/X1_M6_\$(?"GPN_;K^$W_!2+]MS]L7X'Z3\6_A7\,/VO/V=_P!OOXM)
M^T18^+OAW\1_%%EX3C\7?!#Q'-HGA[5?A-XQ\*ZOJOVRWM-*6]F\02W6EMX@
MUS4/#_AW4/"WBGSK_@X!_:6\+?#7_@HQ_P $]_ WQV_X*%_MJ_L!_L=?$+]G
MSXW^(OBKXW_8]^+/Q>^'_B.Z\3:;?P/\/KF_\._"_P *_$637+BXUE[#1Y[J
M\^'VM3V>EW5U$E_I,):]A /[%J*_@1^*?[=W_!3]/^"#/[/MKHGQ-_:2U;]J
MKXZ?MRS_  \_8]^+,J^)?AM^T9\>?V3OA7IVM?%#PKX^\47VGWV@^)->@\7>
M'?":VNLZ[XBEANOB/X/GBGUVX\71:]/X@UGWW_@KY_P6T^+7C']FW_@E[\2O
MV&O&7C+2M7\5^&_!7_!07]JE?AGXIU;P]+X2^!/PU\0^&O OB;P)\49-%U;0
MKN;X=^(?BSKWB;P3XBT'4YTT_P 477A--.6TNED38 ?VXT5_*[_P<G_M(W7P
MO\$_\$Q]<?\ :[_:3_8Z^ 7Q;_:H@TSX_P#Q>_9:^)OQ$^'/Q!M?@OJ?@)=6
MU6^MKCX;Z?KVK>('TFSF.JZ7IL_A#Q=%]N1)X/#]Y-B-OR>_;$_:2\4VW[)7
M[!=O_P $3?\ @J=^W_\ M?>*/B-_P4B\3>";?XG_ +3GQM^,K>-?%WQ$T[X3
M>$M=TGX">*9?'WP[^"<GBWX1R7*Z%?V_@OQ1X5UKP-=ZOXIUH7FH2+>:A'8@
M'^@'17\?6K_\%9/$7[</QX_X(&^,OA%\2_B/\%M4^(7[3OQT^#7[;O[./A?Q
M]XI\)+H7Q7\ _#OP\GB;X8?%SP9I^J6">(='TK6Y9_$7@JT\;:7>*VC:I8:B
MMK;ZB]_!!'^R?^RS\7[#_@OQ^T7^S'K/_!3?_@JQXZ^#'[*GP=^"?[4W@[P5
MX^_;/\3^)_#_ (Y\5>-M=\-WVM?#WXJ^&[KP\GA3Q-\(MFM7.GV_A/2] \.Z
ME_9D=M:W7B&Z"2/* ?V$T5_'C_P<%_M&^&_A3_P4B_8 ^'7Q]_X*%?MI_L!?
ML@>-_@)\==9^+?C;]COXM_%[P#XAN?%>C:G$O@&XOO#_ ,+O"OQ$?7IKC6_L
M6CS7EW\/M:GM-*NKF-+[286:]A^5O%G[87_!0R+_ ((#_L_?%_XA?';]I#P]
MXUO?^"E?PA^&_P %/V@-0U?QA\'/CE\<_P!CR[\5W]I\/_%'Q"U70]1T'Q5X
MFL/B!HR3K>:MXC4S^/\ 1;/2]<UNX\4O=CQ)JX!_=O17\'?_  6D_:MT'X??
M\%<OVF?AE\?/^"HG_!0']AGX8>&OV#_ OC?]F_PE^R=\8/C=H7A7QG^TW<1:
MH?#_ (<\2> ?A[X:\9Z$^E>)S&[:W=W<7P_CU&6VMHK_ ,?Z4N'KRS]J_P#;
M,_:#AU7_ ((IP_\ !57]O#]N[_@G3X8^+O['/QG\4_M5^*OV7_&GQ4^!7Q+U
M/QEHOB>\M_A)X@\:?#3X2^"_',<'BWQ-IT7A<^([:[^$[7.D-K6I02:;X0'G
M6^G@'^@O17\B6I_M$:1IGQ*_X-T-&_8N_;U_;%_:3_9C^-7[27[3&A>)_BW\
M;_BQ\5W^(G[1V@Z';SR2:1\=(O$?AKX5:G\0-,\'>)_[6T7PQI_C?P%%::;I
M>FV/]G03PB+4+G[S_P""OOQD^+WPT_;D_P""&OA/X<?%7XD?#_PK\6_VWO$/
MA/XJ^&?!'CGQ1X4\/?$WPK!X?\*3P>&?B#HN@ZI8:;XT\/Q37-Q+%HWB2VU+
M3HY;B:1+=6ED+ '[]45_#?X6_P""J/[5/[%W_!;S]O[Q;\>OB-\2/'__  2^
MM?VI? /[+WQ+_P"$P\=>)?%/@W]D+Q9\2/",6M_"+XB>&/#NM7]]IGPY^']S
MJ^F>(='\;/X=ATO0KJQO7N]5@EUO3_"\-YX5^U_^VM^TYI?[(G_!;GQEHO[8
MW[2?A>R^&_\ P6(^$7P[^&OQ!\"?'OXFV6N?"[X):YJ2MK'A?X2Z]H7B*XO/
M"O@BZTB1KJ/PUX1$7A^_40L-)O%9(G /] 6BOP _X(9_$[]AOXC6?[0K?L:?
M\%0OV^_^"D$FECX8GXC']N'X@_&#QT?A)/>1^,3H,7PX/Q6^!_P;.G)XM:WU
MG_A(_P"Q&\1"Y_X1[13?/8>3:_;/W_H **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ K\=_^"CO_  3F^-OQ\^-'P"_;E_8<^.GA7]GG]N[]
ME_1O%'A3PAJ/Q+\,7OBKX(?'/X7>+7%SKGP2^-MGHHE\2Z1X4OK\SW-IXM\-
M:?KVN>'DU+5Y=(T0>(9?#OB7PK^Q%% 'XU_LO?!__@MOXI_: TGXI_M]_M/?
ML4^ _@[X(\*:OH6G?LR_L*_#CXBZ[X1^,VN>([;4X)/%?Q6^(O[1NF?\+%\&
M7?@YVTJ7P_IOP\U&ZT_6Y(PVH1Z*EKJD/BWYW_X(Q_L*_P#!57_@G=]N_9X^
M./B+_@GUXH_8MD\9?&OXF66J?"G5_P!HW6_VH1XV^)/B4^(M%M+J]\7^$/!/
MPH_X1:TEFN(M4@BT0ZM!&(4M+^_8/.?Z'** /Y.C_P $)/VN3_P23\>?L%_\
M+%_9Q_X6_P"*/^"B,O[6^G^(_P#A+OB;_P *VA^'$GQ)T+QB-$O-8_X5#_PE
M$?C<:9I=Q =-@\'7&@_;WAB'B0V[/=1^P_\ !7W_ ((%7?[=G[3W[+'[9_[-
MOBOX>_"_X\?#+XB_"A?V@[7QUJ/B70O"'QC^%/PV\2:5XDTC4EG\(^#_ !;?
M7/Q1\*'2%T/0CJ^FVVDZ_H-U866JZWHW_"*Z2UQ_3)10!^-G[%7_  37\<?!
M/XV_\%>/%/Q]OOA?XX^$?_!1CX\3^.?"GA7PEJ_BG4M8M?AEJ_A3Q5X7\0>'
MOB1::YX0\-Z?I.N7]IXB,*V_AG5_%5CY)GD_M>*5(E?XE^%7[!?_  7F_8&^
M'.H?LD?L"?M4?\$]OBW^R5X?&O6WP&\9?MM^#OCSIG[2_P !_"WB.XU&>T\!
MZ./A#I>O_#/QS8_#N:]&H^%O$/CNWU>/6M2>6RN_"/A_P;;:9X/L?Z;:* /Y
MZ?VPO^"27[5G[;_PU_X)Z_LK_M3?M/>&?VDOV<_@S\4=2^+/[>/C[7X]7^!7
MQ:_:5U#1=/U)?A[X+\'?#SX/>$Y?!^B>%;>YUO5=*UC4Y?B3X8\3:9H@T_4=
M-OM3\5VIUJ3S#Q?_ ,&[7P3_ &6OV@_V0/VJO^"0_@3P!^S=\6?@E\:?MOQO
MT/XI?&_]HCQ%X/\ C#^SOXK\.ZEX;^(O@VUN_%TGQ\O=)\9?V==M#X8>PTG0
M=*E.IZA<:OJ:7=AHL]I_3+10!_/'_P $8_V%O^"JO_!._P"W?L\_''Q%_P $
M^O%'[%LGC+XU_$RRU3X4ZO\ M&ZU^U"/&WQ)\2'Q%HMI=7OB_P (>"?A0/"U
MI+-<1:I;Q:(=6@C$*6E_?,'G/5?\%*_V$?\ @HM\5/V__P!CC]O+_@GYXC_8
MKL_%W[,?PB^,'PXO_#G[8VK_ !SM_#FKW7Q4E^Q37=GH_P %/!^HZG?P6>C7
M%VT4\_C#0)+?4Q;L]CJ-H)5/[Y44 ?@_^R5_P3 _:=T'Q5^V[^V%^V_\9_A#
M\5/V]OVT/@KJWP*AT[X+Z/XQ\-_LU? #X8V.E:SIOA+X<_#N[\60S^/?$>B7
M5ZWA_7-?\3>)?#EOXBL7M;C3HX?$=X=3\2>)?./^"0/[(/\ P6F_8*\&?L\_
MLF?'76_^"7?B/]BGX/:1XQTC6-:^$NI_M7ZQ^U'?0ZS-XI\3Z+)INH^,?#/@
M[X37,J>-M;LH=4:Z\-Z8J^%H[J.TBEU=8KB;^B>B@#^9?_@I+_P01U_]N'_@
MJ5^R_P#MF>'?&O@#PQ^SWI\?PXC_ &VOA9JNO^-=$\2?&H?!'Q7>>*?AJ^E^
M'_#?A;4/"OC.>_MI[+PCKEQXU\2^&Y_#^B:397>C2:K.J64/UI_P6,_8._;!
M_;"U']A/XB_L4>(?V:- ^*W[&?[3$7[0=I9_M0ZM\4-*^'6N2:5H'V'1=*EM
MOA-X/\3^(]2A.IK$=2L8K[PLQT_<;36H[C:@_;2B@#^;O]MW]A'_ (+!?M__
M +"_@#X<?&WQ'_P38\-?M@?"G]M3X7_M">"[KX5ZO^U!HW[-E[\.?A;IEQ>Z
M/I?BB?Q;X/\ &?Q/N/&UYXMO[U=3LM*L-.T*X\.+:BUUK3]3$KO[5^T!_P $
M[/VW/V\/V9O@9XH_:=^,_P"SQ^S7_P %.OV5?C/K'QG_ &<?CY^QCX?^(GBS
MX&^$-3A*66F>'?$7A3X[[?%_B7PYXTT"*+3OB!IMS*+"+4;;3-0M['Q#HEIJ
MOA+Q#^[5% '\W&N?\$Y/^"LO_!0;QK\&?#7_  5Q^/7[$?A[]DWX'>/_  E\
M8+WX"_L">'OC5+??M,?$'P5=_;O"MA\;_%OQZL+.Y\,^#O#^I0Q:E<:5X&BO
M+#Q1%J&J:?<Z'HFK6OACQ;X=^X?CW^P=\6_BC_P5H_84_;P\.>(?AO8?![]F
M#X)_'SX:^._#6KZMXFM?B/JFM?%+2[NQ\.7/@[1K#P?J/A>^TBQDGC.L3:SX
MO\/W5M$K&QL-0("G]9J* /R__:B_8N^+7[0W_!0__@GC^T:=:^&D7[.G[&UC
M^T1XI\5^%=9U#Q(?B3XC^*OQ7\!P> O!MWX>T2'PK?>$KKPYH6G"\GU6[U3Q
M9HVIQRWCI:Z=J,:[&_)+]FG_ (-Q[CX'>&/^"O\ X.U_XA>"O%.@?ML^ /B!
M\$OV/X$U?Q9<-\"O@EXIU+QO\0]&\'^*$U;PO-%X433?BIXJTJZO+/P./%MA
M-9>&E\41LVO:S>:5!_5;10!_-U^V+_P3)_X*+_&']F'_ ()"Z7\'/'_[(UU^
MUM_P3E\7_#/XA^/=9^.GBWXUW7P5\>>,?AW\-M-\(QRZ7J/@OX9M\0O$VFZK
MK>FI>WZZGIO@#4+BQFE=+RUNR(JZ3XJ_L(?\%5/VQ=;_ ."=7Q(_;$\1_P#!
M/O0_B9^QK^WO9?M"^+[3]FG6/VC=,\":]\"],\+Z)966F>&X/BCX0\3^(-4^
M+#Z^OB!KJRU._P#"_@]M'_L<Q:U'>_;4K^B&B@#^:+X]_P#! ^YU+_@M'^S'
M_P %2OV:/%7P^\">#-)^(C_$G]K/X3>)M1\2:3/XD\<:=H&I:#9?$/X3Z;X>
M\(ZYH5]XF\76NK2'QOIWB?5?"MM_:MC/XCL]8OK[Q)JMI;_>GP?_ &#?B]\/
M_P#@L5^UU_P4(UGQ'\-[GX,?'W]F#X/_  4\'^&-,UCQ/-\3],\5?#ZZ\-3:
MS?\ B71;KP?9^%+/P]=)HUU_9=WI?C76=2F:2W%UI-D&D,7ZTT4 ?DW\?OV$
M/B[\5/\ @K5^PK^WEX>\1_#BS^$'[,?P5^/OPW\>^'-9U?Q/;_$G5]<^*FF7
M=EX>N_"&CV/@_4?#%_I5E+<(VLSZUXPT"[MXPQLK'4& 4Q?\%EOV#?B]_P %
M$/V7/A]\$?@KXC^&_A?Q5X4_:@^!OQKU'4/BCJ_B?1?#\WA7X9ZMJM_KUA8W
M7A/P?XVU&7Q!=PWT*Z1:3Z3;:;<2K(+W5;!%5W_6FB@#\FO /["'Q=\*_P#!
M93X]?\%#]0\1_#B;X*_%+]CGX>?L]^'_  O9ZOXGD^*-GXT\)>+M-U_4=3UG
M19O"%OX4M_#$UG9RQ65[9>-M1U66Y9$N-%MHBTR?.7_!2O\ 80_X*+?%7]O[
M]CC]O+_@GYXC_8KLO%W[,7PC^+_PXO\ PY^V-J_QSM_#FKW7Q3E^QS75GH_P
M4\'ZCJ=_;V>C3W;1SS^,- DM]3%N6L=1M1(I_?*B@#^;O]M/]A'_ (+!?M0K
M_P $Q_VC=&\1_P#!-C2/VW_V)/B9\9/B/\0M*U/5_P!J#3_V5?$%YXQ@LO#_
M (*M/!EC:>#_ !!\7-5M8/"UC%+XI@US7/"DL>OO(^DWUUIS+"GOW[2W[!O[
M:_[6_P 0/^".OQM^+/B/]EK1?BO^Q)\?+[XU?M6Z?\.M8^+.F_#WQ!)J&F:+
M87&G_L]6OB7P?XE\2:JB-I3-#:_$C5O";*'#/JKEBD?[C44 ?A?\'/\ @D;<
M7OQB_P""RLG[5J_#'XB?LZ_\%-_'O@G5_#'A'PIJ_B2\\8Z#X5\/^#-4T"\N
M/%J:[X+T72?"_C32M;NM/U_PAJ'A?6/%L>FZEIMIJHO;6[M(H6_'#P3_ ,&U
M/[9_PA_X)V?MB?L6^ OCC^S?XO\ %WQ3_;:^"O[0'P)\<?$#Q/\ %;3M'D^%
MWP8EBATJS^+L>C?"?5M3T+QS?:=8Z?'-H/@Z#Q9X=1Q-;VWBRU@2"0?VOT4
M?G[^PM%_P5)@MOB!!_P4F/[ A,*>%XOA$?V'C^T008HX]83Q<?B.?CT%S(<>
M'CX</AA0O_(:_M,#_017Z!444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4449_P_7% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 445\]>-_P#D:-4^MG_Z;[2NG"X?ZS4E#GY+
M0<[\O->SBK6NN_X;'!F..^H48UO9^UYJL:?+S\GQ*3O?EEMR[6Z[GT+17R?1
M7?\ V3K;ZQ_Y3Z+=_P 3T\M5W1XW^LG;!]M?;]7:VOL;:WT[_)GUA17R?11_
M96E_;_\ E+_[???1]K;A_K)_U!_^7'_W'^M]FCZPHKY/HH_LK_J(_P#*?_V_
MFK]@_P!9/^H/Y>W_ /N-M]-SZPHKY/K@_BE_R+7A[_L.:U_Z0:/6E')O:UJ5
M+ZQR^UGR<WLK\ONSE>WM%?X+6NM[]##%<5_5L-B,1]1Y_84W4Y/K/+S6G3C;
MF]@[?Q+WL]K6UN?=E%?D_17J?ZJ:)_7][?\ ,-W<4O\ E_U<DEYM+J?/?\1)
MUM_8W_E_YRO_ ,PG:+9^L%%?C/<_$GP79_$G1OA#<ZUY7Q#\0>"?$7Q$TCP]
M_9VK-]L\'>$]<\,^'-?UC^UH[!M#@^P:UXP\.6?]GW6IPZI=?VC]HLK&YM+.
M^GM>XI+A:+BI+,8N,G-1:PZ:DZ=1TJB36(U=.JG2FDGRU%[-MU&H.GXBS3<7
MDDE)*E)KZ[+15H.K1;M@FDJE-.I!MQYZ:E4BN2$YK]8**_&?6/B1X+T#QYX)
M^&6K:S]D\;_$32O&&M^#M$_L[59_[8TSP"N@/XMN?[2MK&;2-/\ [)7Q/H1\
MG5;^QN+_ .W8TR&\-M>?9^XHCPM&<7*.8*454JT7*.'4H^UH2C"O3YE7M[2C
M.<858)MTYR4)^_=1)>(TH.*GDDHN5.G6BI8UQ<J592E1J)2P:;IU8PG*G.W+
M4C%RA>-F_P!8**_)^HM:_P"1!^)7_8L:/_ZL3P-2EPKR\G^W?%5HT_\ =MO:
MUJ=*_P#&^S[3FMUM:ZO=$?$>ZJ/^Q_X=#$UO]_W^KX>M7Y?]TTY_9<E]>7FY
MK.UG^LM%?SWT5[;\/=6O[6NU?_F![.2_Z"K]+WV5];W1\HO&VZ3_ -6ND6_^
M%?17C3E:ZRZWV[*_Q6TLV?T(45_/?12_XA]_U-E_X1;=[_[4K6Z[VNF]!_\
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M\THQ_P!6[<TH1O\ VMMSU*=._P#R+NGM+^=K=;K^A"BOX-OV[_\ D[CXW_\
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MO^@_S_ /^)G]+_ZD]_\ FH>R;_Z$W6W];'^D!17^>Y\+O^1<_:)_[-:^._\
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MX?V2[#Q7J'Q M/"WQ7A^).J_$6R^*.H_%0?M2?M4/\6;SQ+IWAZ3PE::9/\
M%23XT/\ $%OAU'X:D_L.3X/_ /"2#X2W&FQ6]K<>"98[6U$6;?\ _!,3]B75
M?#7Q4\':M\)-=U?PQ\88=&M/%.BZM\:OCSJEGH.F>'OB+>?%O1M"^$0O_B=<
M2? 'PU8?$B^E\7P^&?@2_P ./#_]K0V#R::\.F:;#:*'UIS@ZOU=0Y(.:IJI
MS*I]8P:J1IO2"A]46-G!RC&*Q,Z-.TL-3I3K:-8&TU%XM/GM3E)*35-0KOFF
MFX*<_:^PBXJ4.:BJE1.&*<Z5/S\?\%C_ /@FZ_CKQU\,D_:/CE\?_#;X3:?\
M;O&?A.#X2_'2?6=)^'>I>'?"GBRWO8+6'X8R'6?$T>A>-?#EU?\ P[T(ZE\1
M=*N+F^TW4_"EGJFB:[9:;]4>%OVM_@)XQ\<Z)\,-(\6:]:?$C7QX<:R\ >*?
MAG\4_ _C2UB\5_#74OBWHMQK_ACQMX*\/ZSX6M9/!.CZI)J-WXFLM(MM"\4:
M==_#W79=-^(5O)X67B];_8*_9A\0ZO\ %+5-2\)>.UL?C58?8OB?X&TOX]_M
M!:!\(/%$QTKPMHLFNO\ !'0OBEIWP?TKQA<:9X*\,V]UXYT/P/IGC*\;3WN+
MK79KG4-3GO-JZ_93\(ZA^VAI7[9][=V4OB[P[^SG=?L\Z#I$6B2175OIVI_$
M)_'>I^(=1U]M;FM]1E@5(]$\-Z?'X<L;KP_:ZMXT=M<U*W\5-8:9=)UN?"*O
M&$HRG4CC94G**A&&&QTHSHQDY6Y\7' 4E"<JC5*I5E/V-6-2*QK^P=/$RPZJ
M*<<+2EAH59\SJXR5;!TYT:CY:*A0A0EC<3[:$5)SI4J%.G6HSC57U57!_%+_
M )%KP]_V'-:_](-'KO*X+XHY_P"$<\/^G]MZSCZ_8-(S^F*[,%=XS!)Z.5>$
M7?2,7.G&+<I7^"$ZU3GE;2GAZM2S2BGY>:_\BW,6M8K#3M9:R2K)K3O*%.GR
MI/6I7A2W3D>&45^/_P#P46N/BW_PLO3K2"R_;#G^%[?LK?'&?X3G]CX_M"0:
MC=?MBC6O"<7PYM/BC?\ [.-U:ZS9Z4OA]IV\$GXP76G_  ":]G\73>.[E[BU
MTI[/YU\;_MC_ /!2R\L?CE\*?AMX5TK7/B3\(OA=XRT'Q%XG\%_LF_&3Q9<>
M#OBQX#^!_P (/B+%XCTCXI7?B>X^ WQJ\1?$7QAXP\4^!- ^!7@3P6OC70KA
M-'\:W6GZUH5O/X:U#UHYI32G>AB5.%;$4X0C3YI-8.%"O5=76*H3I-X>K*,W
M*G"C5PM:=:U>--?+1R6M45*<,1AE"IAZ->I.K-TZ<5B:]2A25*2YY8B,G[2G
M-PA"2K4Z]"-.<H>T?ZG?&']G3XA^/?CW\/?C3X"^+WA_X>VN@_"3XC_!/QQH
M.J?#37/%OB#7?!GQ+\4> /$NJ:K\/?&NB_%GX?Q_#?QWI#^ [>'0/$6L>%OB
M1I5G<7YOKCPQ=M9I;S_DUX=_X($^%/#/PP^%'PWT7XL?#305^%_QRTWXYG4_
M#_P@_:"%OXF\8Z;H7A?1;?QS=Z7XN_;C\93:+\6HAX<GEC\0>']7T_X2W$.M
MW4&L_ C5Y]*\-WNC?0OC#X\?MX^"OA-J'B3X*?"\^*?&6K>.?VA/&.KW7Q$_
M9[_:T\3P>*_#_P /?@!:_$CP39>$/A/XN^.&G>.O@F_QH\=Z;_PK_P '>$3K
M=[X;\'ZUJHT'1?A[K'BR#5+75;7B_P".?[>5K\,]'\97OPPT*;XV^ _&G[2'
MAJQUJW^#?[:FC_!O4]+T/PSI2_#?QGXE^ OP8\7_ !>^('B[0O$LFHSV&G6=
MUIWQ6DN=8TV?5/ $OA?4&NM0TW"LLOHR5:KAL2Y8/$QDIQCB)1NL=0S2I]6]
MY2J8?#XNO3Q2HSA3I24\6H1G4I2I+MPE3-_8>RPV-P-*&,=/"U*;GA8U7*C@
M\=EN'EC$X249O"3Q&&>)C*K."GA8WCS<R]V^'G_!/^#P)^VUXJ_;";QMX"U6
MYU^Z^)MU#;1_!5--^-%]!\4-*\!V%QX8\>_'T_$:_D\<>!/A_)X#MHOA-X57
MX;>'4\%:%J=]HCZAK+"/41^CE?SR^.OVVO\ @JKXJ@\7:'\./@!JW@73+C]D
M75/B%X9\9:U^Q1^T)IOQ6C^-NE>'1XBD?3/"-]XV^*GP9T[2]>:UO?"GA3X,
M^*_'FO?'>P\37-C<:_X(U&QBCT_5OH+QC^TA^V!\,?A!)XH\%_#?Q5?:[XL^
M,GQ-N-2\::S^R9^VQ\=3>:9IGPIT3Q)X(@T+]EFV^*P^,_PFT7XP>,C=:%I-
MT_B[1_A)\$9=-N]$\0^&FUW6IKX[T,;AJ.$A&C1Q,,+2Q&,C34J-:=65?$8B
MKC<145-\U=TJF(KXB<:E2RG"-..%515:,#GQ.5X_$8RA&MB,'4Q5>AA*"<,1
M3]E1P^$POU?"PJ3@E3A..&PU-.G3YIQE*4\0J?+4D_V8J+6C_P 4#\2??PQH
MX_\ ,A^!C_2OSL^#WQN_;:\1?M :-X?^+/PB\)^%/@WK]YXQ\,7%AHGPU^))
M\2^!]<\*?"7X3^/;?Q5J_P :K[QM>> /%'A'Q)XS\9>./AGH-IIWPU\/1:CJ
M/@J74M/\7W]Y'J?AZU_1/6O^1!^)7MX8T?\ ]6)X&KNE+GA3DKQ?URE2<9+E
MG"=#'T:4E.+O9/\ =582BY1G3J63]I2KPAX_)[-UH\T*BEEF*K*5*3G!QK9;
MC)\JER1]^'+4I5(V]V<4TW"=.4OE2ORJ^$__  5+\!^+_&GQ+\/?$+P?I_AG
M0_!'B&\\*Z=JWP@\2>.OVEO%*>+!\:/&7P8\/> /B3\-OAQ\&;;Q5\.?B9X[
MN_",GC'P-X,L$\>-K?@^>\U235;)-,877ZK?_6_KQGW_ *>U>-6W[/WPCL_"
MWAGP5;>$?*\,^#OB9)\8?#FF?V]XG?\ L[XC2^-]7^(K^(?MDFM/J%WGQGKN
MJZQ_9%_=76A#[7_9PTP:5!;6,/U.(IXZ6*57#8BC&A"C*/U>M3YXU:\\QK-U
M9RBU."HX"T:7LY<SQ%XQY.:=2I^>8"ME=+!UZ6.P-;$XFK/#.AB*%949X6A2
MP<)5HP;C*+GB,2J<)W@U&@YRDVDH'A?@7_@H[^PY\1O%_P 1? GAO]I/X=0>
M)?A5XNL? ?C2W\77.I_#S3;;QAJFM:MX=TSP_H/B+X@:9X8\.>-;_4=:T+5+
M"P3P5JWB&.[DMXWMY)(;RRDN,KPC^U_XW\41>%?%TGP0L-.^$?Q(^-#?"#X;
M^,1\5(;SQ5=_8/B#K_P[U7Q!XY\!'P+:0>$VU"^\/WFO>"M)\/\ B_QZFL>'
M8;AO&&K_  \UX6.@:E]$_"_X!_#;X-ZEXIU'X>6WC+1X/%^IZGJ^H^'-0^*G
MQ4\5> ])O]9US5/$NJOX'^''B[QIKO@'X;6]]K>LZE?7-C\//#7A>Q<W(@-L
M+6&W@BY'0?V2?@5X8\0W/B/1/#OBRQ:?QW)\3H/#/_"V_C!<_#;1O'UQXDO?
M&%[XI\+_  FN_'MQ\+_".IZEXGU/4];U5_"_@_1XM6U#5-5FU**[_M*]$^"A
MFLOJTIU</&?U>"Q$:+Y*/UA8R4ZTN6H\14JTZF C3HX7ZO5I?5,7*OBL0JL9
M4XT>R=7AV$L;'#X?'3IRE0>&EC/WU?V?U6"JQA.@L#'#5(X^=6<ZF)HXJGB,
M%2I86A]7E.52KY;:?M[_  42ST[1=<\0Z99?$K5M&U;4K'2=(T#XZ:[\+H+M
M9/B!_P (IINO_&5_@1I>D>%KCQ;%\./$XTZSU_P]8Z]J%[HVMZ?X0T'QE-86
M;ZMU&N?MN_ 'P3X?U36OB%XIU/1U\'?"+P[\8_B5J_A7X<?&GQ]\/_ 7ACQ#
MHD.MV0U;XB:-\+(=&M=0U"R<WWA_POX@M_#?Q$UW1GLM7C\"V:7L, Z)_P!C
MG]G&2Q?37^'.;*2_\/:F\/\ PEWCL9OO"[>/)-!F\Q?$XE'V!OB;XX/E"00W
M/]MXO([@:;I(T^KXC_8Q_9W\52ZD^J^%/%5O!K/@KPEX UC3?#_Q>^,OA'0]
M6T/P$+0>!=0U/0/"GQ T71+_ ,<>#!I^G_\ "*?$N[T^7XD>'SINFMI/BNT.
MG61@B?\ ;D:;Y)Y9.KRTE#VGUA4745"HZCG!-22>*]G"4Z<E5K4+3_=3C4YB
MG+AJ52G[:EG%.BHU/:NE.A.LW[;#J#I/D48+ZO\ 6G&E4A.C1KJFIRJPG&,;
MW[/O[4/@']I>Y\4:G\+98]=^'NF^'?AKXI\(^.XFU6S7QEH_Q'T/4]8M[D^&
M]<T'0]9\./IATU[.6UU17OII6?[3:Z?+"UNWVQ\)_P#DI/@K_L8+#_T97RY\
M(O@)\*O@387NG?##P[>Z%!J5EHMAJ,VI>*_&7C#4=1@\/KJ(TM[_ %?QKX@\
M1:M>WL1U;49+K4KF]FU'4[BZDN-3NKV<)*GU'\)_^2D^"O\ L8+#_P!&5V5>
M>.7RC6ESUE@IJO.RM.MRRE.4;**Y??Y(VA!<E.G[K?-.IQT)8>6<T982$X81
MYC1>&A5NZL:'MN6"JNS_ 'CC&$II2:]I.K:T>6-/SVBBBNB%N2&OV(?^F:'F
M>=5=JE6RO^]J_P#J1B_[H5^7WCG_ (*1-X%^*/C7P'??!2>Z\.^"-1^.VC:I
MXYB^( 2WM]5^$_AKP+JG@^+4M&'@B5]-LOBCXG\<Z?X%MK]=3O$\-:]<:&)(
M=<77?*T_]0:^9?$W['7[.'C%?B:OB3X;IJB_&*P\7:;\1=_BKQQ =>M?'5WX
M-O\ Q.839^);=M"NKR_^'W@Z\L[_ ,.'2=0T2[T2"XT*YTV:XOGNN'&T\PG*
MC+ 5Z5)4Z>+=6%11:K590PL<'&4G3J.%*$OKE2I*%I*?U;W:L/:0/0RVKEE-
MU5F6&JUU4="-.5-SO0I\V)^LU8QC4HJI5L\)[*$VZ<E'$1ERN4&_!?'O[</C
M;P;XH\22V?P0\.:W\*/AI\._V>OB7\7/&$GQAO\ 2O'GA[P]\>]=U[2&N/!?
MPY_X5)J.A>.$\ VGAZ^UW74U+XG^"=1U;38W@\/:9?:P;72[S]%*^8_$'['7
M[/7BGQSI?Q"U[P?K]_KNEZ9\.M'.EGXH?%BV\ ZY8?"/4[K6OAE'XR^%5GXX
MM_AAX]G\#ZU>3:SX=OO&WA#Q!?:=J_D:G#<B^M;6>'Z<KHPD:\*5:.*J*K-X
MANC.\6_8J$HSYG&%**C4J>SG1H<LZF%C&O"I7J.O3C2C,:N7U'A/[/H2H\F&
MY<4G"K#GK.<7%_O*^(]K4C%5%5Q-..'I5_:45"@GAYSF4445M)KEEK]F?;_G
MU5\SBIO]Y"Z:M4HOK_T$8?\ NGXC?MW_ /)W'QO_ .QGLO\ U'=%KY(KZW_;
MO_Y.X^-__8SV7_J.Z+7R17VV6:Y=@%_U!87M_P ^WY_/Y6>C=_R3B&ZSW.EK
M_P C7,'_ .5HV^R^MOEJM4CZM_9/_9D;]IWQ+XPT!==\8:,?"6@:'KA@\"_#
M7_A:7B/4AKGCCPQX*_=>'1XP\%F'3-%'B4>)/$&J_P!IS?V9X?TG4[W['/Y)
M6NV\2_L$?&%;GP7'\+KCPW\8+3QE<_V1;7WAOQ9X"TQDURY^)?C[X<:(;;2M
M5\;+KTWA'Q'<>!Q?:'\0M0TK1O"=]<ZJ-#BOSJ%A*UQ\CZ!XW\3^%]%\9^'M
M#U/[#H_Q"T2Q\.^,+,66GW/]KZ-IOB'1_%=E9_:+RTN+JP\G7] TF_\ M&ES
M65U)]D^RRSR64]S;3>I>#/VH/CG\/H=-M_"7C==,MM)\/:)X2L[>7POX-U6W
M_P"$;T#Q!XF\4Z;HUW!K'A[4(M2L!K7C#Q-/?0ZBEV-8L]6GTC6&OM(CM[&'
MAQ=#//KE7$8'&X5894L%&A@,52YJ4JL*&-^NU:E:G:M!U\1/!*FH2ERTJ%2;
M<)3Y8>GEN+X2668?!9OE.92QSQ.95,5F^7XE0KK#U<1EJRS#4<+63PU18;#4
MLRG6E5A%RK8FC3A&<:7-4[;3_P!AK]J/4]=\7>&;7X91+KO@?Q[H7PP\1:?>
M>//AKITL7C[Q+;P7NA^&=)DU#QC:P>)K^_L;B/4%;PS+J]M#IPFU"ZGALK>X
MGBAO?V0OBGX,^(_C_P"%?Q@T^;X9>,O ?P9\;_&.739&T+Q<FIZ=X3\+WOB2
MQTZ'4?#GB.XT=(M;^PRZ=)J-MJ6H/I%RD\=SILUU:S6:TO#/[9/[0W@WQ?XH
M\?\ A;QAX>T'QKXR:P77_%&G?"OX1P:U+8:=:Z-8V^A:;?#P+YV@>%GL_#^D
M6E[X1\/G3/#&IV]HT.I:3=QW-VL_FLOQH\??\)#KWBFPN/"GAW5?%'@S6_A]
MK<?@WX<?#CP1HEWX3\1Z9/HVNZ<GAGP?X3T3PU9W.I:;<S07.LV.D6VNEF6X
M34TN4CF3GIQXIE*4:]7)J5*67<JJ8>-9UH9HZ.&]^'M*DH+"1K1Q+CSTZM2=
M.K&,J=&,(3GU5I\ 4Z=.IA:'$]:O'.)2E2QE3"K"SR-8C&<D)>QH4ZKS&>&J
M8-5.2M0HPJT)3C5KRJ5*=/RFBBBOHXOWHK3>G?;^?#+OK[RF^^J^7Q$K\DM'
M\-;O_P ^<;;[-OA=->L6_7Z.^,__ "23]D7_ +(KXX_]:8^/-?.-?1_QG_Y)
M)^R)_P!D4\<?^M,_'FOG"O/RJSP<+[+$XV^W_0RQ#?5->ZII>;6JT:]O/[_V
ME52W^J999M.UWDV$Y?LVTJ.F^MTFK6;3]V_9R^"K?'WXEQ_#T:IXATLGPGXY
M\5!O"/@T_$#Q3J9\%>$]6\4_V#X;\'CQ#X6.NZ]KO]E_V3I-E_;ECYM_=P#<
MV0A^@/BE^P)\0O!MOJ]UX!\1:1\3X] \9>,_"^N6*WG@_P &>(M,M_">F?#.
M_FO&\+:UXZN=?U/4M,O/B,FA?$+2- L-8MOAIK6AW=OX@UJ6WNHKJ/XT\'^-
M_%'@+4-0U;PGJ?\ 9-_JOAKQ1X0O[C[%I]]]H\.^,M"O_#7B73_*U*TO((O[
M2T34[VR^UP1QWUF)_M-A<VMW'%/'W/@;]H'XO_#6QTC3O!'C*;0+705\7)HX
MM]'\/7%Q8#QT_A:3Q0\%[?:3=7@EU%_!?AEXYVG:;37TQ7TJ2Q:[OS=<V-P^
M<SQ=*O@,=0HX>G1PL)8.O1C4IXBLIXIXNI4FE[2FG!X6%%TI.6E1OV<(1A5[
M\IQG"U/+Z^%SC*<;B<96Q>,J0S/!8IT*^#PGL\$L#1HT:EZ%>:J+'3Q'UB/L
MXJ5)+VLZCG0]0\??L,_M2?"^S\47WC_X91>&;;P?-X;M-:-_X\^&KRR:CXO@
MFN/#6D:!;6OC"XN?%VMZS#;SM::)X4AUK5R89(Y+))$91L:Y^PS\<?AUXCU3
MPS\;= N/A9?Q?!7XF?&?P\7NO#'C.#Q'IWPWT*ZUBYTF.Y\*^*KRRTV>^G@C
ML;F2ZNWOM)%Q#=RZ-=)+%'+R>I_MD_M#:M-XCNY?%WAO3]2\5^%W\%:OK7AW
MX3_"#PGX@7PG-=27]UX?TCQ#X8\":1KGAK2[Z_FFO]2MO#FH:2FIWTLEYJ N
M+EVE/(^(/VCOBSXD\2:YXNO]5\*6?B7Q1X:\9>$O$VK^&OA=\*_!MUXET;X@
M07%MXQ_X2 >$/!>AQ:WJ^N175S]H\2:G'=>(X)+B6>SU:VGD:0\=%<6RY(XF
MKD4%*$E5GA8XAU(5.2+@Z*JU7&T:BDI2J1JRG%MK#4XMSCZ.)EX=4W*>"H<6
M5G&M&5*CCIX*-*=%5&IJN\/AXS<ITFI1ITIX:$)J/-C*M2*I5,+XU?#'_A3_
M ,1-1\!?VW_PD7]GZ%X'UK^UO[-_LCSO^$S\"^&_&GV;[#]OU/R_[-_X2'^S
M?.^V/]L^Q_;/*M?M'V6#RJNK\;>-_%'Q$\17/BSQEJ?]LZ_=V&AZ9<:A]BT[
M3_,LO#>A:;X:T6'[)I5I8V2?8M$T?3K+S([99KG[/]INWGNY9[B3E*]W"QQ$
M,+2CBYPJ8F,&J]2%E"=1.LW*-N6R<)4U\*UCMKS2^3QT\'/'XF>7T:E# RK\
MV%HU7>I2H6PRC"<FZEY*<:TFW.3?.KO:,/?O#?\ R;5\5/\ LJWPE_\ 3!\3
M*\!KW[PW_P FU?%3_LJWPE_],'Q,KP&EAOCQ=^F-FVM-5RX6_5;Q4DM=VMMT
M\;?V.6I+7^S*5GTNYX_E^R]JCIO9Z1::LVG[O^SE\%3\??B9'\/1J?B'2B?"
MGCCQ2#X2\&_\+ \5:E_PA?A/5O%(T+PWX/'B'PL=<UW7O[+_ +*TFR_MRR\V
M^NX!N;.P^_\ Q2_8$^(7@^WUB[\ >(M'^*$?AWQEXR\+Z]8I>>#_  9XBTNW
M\*:9\-+Z6\;PMK?CNYU_4]3TV\^(RZ#\0='T"QUBW^&FLZ'>6_B#6I+:YBNH
M_C/P?XW\4> M1U#5O">I_P!DZAJOAOQ/X1OKC[%I]]]H\.^,M"O_  UXDT_R
MM2M+R"+^TM%U*^LOM<,<=]9^=]IL;FUNXXIX^Z\#?M _%_X:V.D:=X(\93:!
M:Z"OBY-'%OH_AZXN+ >.G\+2>*'@O;[2;J\$NHOX+\,O'.T[3::^F*^E26+7
M=^;KS\;A\YGBZ5? XZA1PU.EA(SP=>BJM/$5HU<0\95J5$O:4TZ3PU.BZ4I2
MNINT80C3K>UE6+X7IY=7PN<93C<1CJV*QTZ69X/$NC6P>%='"QP%"E1G^XKR
M5=8J>)]NE",'3474J574P_I^K_L,_M1^'_%WC+P-KGPS@TCQ+\/_  IHOC?Q
M=::EX]^&EE8Z3X;\1WDFG:#>#7;CQE'H.H7>L:E$^F:=HVEZG>ZW=:EMT^+3
MFO'2%MF7]AGXX^#?C;\(_@O\;M G^$FH?&&=CX?UB2Z\,>-XAIT9FBN;Y(/"
MWBJXLYI[:9(TGTRZUC3KZ..YM[B2-()X'EX^']L3]H&W^("_%.T\5>&+#X@6
M^@Q^&]+\3V'PE^#VGW_AO2XWUF4GP<EEX"@M?!6JSR>(-9DN]?\ "=OHNO7K
MZA*UYJ4[+$8N6U7]H[XLZO\ $C0OB]+JGA33?B/X=U.\UNR\4>&OA=\+/"-U
M>:WJ-Q/=WVL^(;3PMX+T?3?%FKW=S<W$\^I^*;+6;Z22:4FX^=@>6BN*G5PZ
MQ4\CC1>#K+%RPT<0ZT<=+#XZ-&6&]K5E'ZO#$3R^I)U(U)VI8B*HRIU'.'?B
M7X?0I8F6#I<55,1',Z$L%3QD\&L-/*8XS*9UXXSV&&C-XVK@Z><T(QHU*%)2
MKX.<L33K452J]Q\8_P!F3_A4OA3Q1XG_ .$V_M__ (1KQQ\)O!GV'_A&O[*^
MV_\ "T/@P_Q=_M+[3_;^I?9O[#V_\(]]C^SW']IY_M;[5I^/[,/RI7JWC'XV
M_$_X@:5JFA^+O$_]K:7K6N^$_$FI6O\ 8OA[3_M.M^!O!C?#WPO>^?IFDV5Q
M#_9?@]CI'V:"6*TO<_VAJ,%WJF+T>4UZ>64\?3PZCF6(I8C$<U/WZ,4H*/L<
M-&:TC35WB(XB:]W2$X*ZM9>#GM;)J^,<\BP>(P6"5.JO8XF<IU.=XG'3IRYI
M3K.RP<\'2DE.SJ4JC:;?,_7?A=_R+G[1/_9K7QW_ /4-GK\>J_87X7?\BY^T
M3_V:U\=__4-GK\>J^7SAWS;$]OJV7Z_]PL0?HO"__).8%[?[?G7?_H)P?:(5
M['^SU\*(/CI\<?A7\';KQ*?!MK\2/&VA>$KGQ6NBMXC;P];ZO=I;3:LN@KJF
MBMJ[64;-,-/75M/-T4\H7<)8./'*Z[P%X[\5_#'QGX9^(7@;5?[#\7^#]7M-
M>\.ZO]ATW4_[.U6PD$MI=?V?K%GJ&EW?EN-WD7UE<V[])(7'%>>FE>ZO[E5+
M6WORHU8TW?IRU)0J7::YJ<;QE#GC+VU\4'NE5HRFK/6G&M2G5CK%?Q*<)TM&
MGRU9N,HS4)1_0&;_ ()ZZ9H?Q \.^&/%WQIN[7PIK7P\_:1^+#^,/"/PUL?%
M=U<_#WX#:5KGBC0->\*Z%??$SPK8>(1\5_!>F:9XET&*]\4>'8-'BUZTM;J\
MOA#)=-H^,?\ @G!;Z-\$_%/QT\*_&S_A)/#VH_"W2_C1\ O#NK_#AO"_B_XP
M_#_1H?#DWQMFUK3(?'7B.R^'OB#X*KXA\S5M,LM2\?Z5XEM=*U/4=(\0PZ='
M#=3?+>A?MC_M%^'KCX8W%EX[T^^'P>^'GBSX3^ +/Q)\/OAIXPTK3OAQXYM]
M1L_%/A#5]&\6>#M;TCQCH^K6&JWVFO#XTL?$,EKI4L>E6$MKIUM:VT'I&H?\
M%*/VX-2L++0F_:"\3:;X.L?"OB'P+#\-?#NB>"_"GPCG\'>)_#]UX5U+PSJ/
MPA\,^&M(^&&K:-:^'+M]'\/6.J^$[R'PC906$?A-=%_LO36M/GJF'X@]E"-+
M'4/;1AR.M/DC3J*$HS=65".$JS]O7]G"FI0_<X:G6Q:E"4IX>6&^OI8S@_VF
M(G7RO'*C.K[2C1I2J5*M)5*$J?L/K$\?1A+#X>K4G6M+]_BY4<)RU(1IXBEB
M/ANBCZ_IT_"BOH+WBFTHR:O**=XQ?LU)QB[MN,9SJPBW=NE"@VW/VDI_(V2E
M[KE)*247)6E*,:W+&4TE92E35&4TM(UIXA)N'LU$K_6(K_)WK_6(KX+C?^)E
MO^#&?^G:'F?KOA8W[+.]'_$RSJO^@;%=[?J=!1129'J/S%?F3DE_7_ 9_10M
M%)D>H_,49'J/S%+G7]7_ /D %HI,CU'YBC(]1^8HYU_5_P#Y !:*3(]1^8HR
M/4?F*.=?U?\ ^0 6O.]=\"'6-4NM2&J?9Q<^2?)^P^<4\JWB@_UGVN+=N\K?
M_JUV[MO.-Q]#R/4?F*6M:->I2DY4I<LG%Q;LG>+:NK2CW2U6ISXG"T<7!4Z\
M.>"DII<THVDDTG>,HO9O2]O(\D_X5B?^@T?_  6_7_I_]OKZ4O\ PK!N/^)V
M.1G_ )!QS^7V[WKUJBNKZ_B^E:VM_@A_\CIY/==-SB_L7+M/]G6G_3RMMM;^
M)M8\E_X5@<X_ML?^"W_[OR/Q I/^%9'_ *#8' /.G>O_ &__ (_3T/%>MT4O
MK^+_ .?W_E.GY_W=-WMY]W8_L7+O^@=?^#*W_P L]#R7_A6!_P"@V#G_ *AW
MZ_\ '_[4?\*Q/_0:[9_Y!A]O^G_KS^AKUJBG]?Q?_/[_ ,DI^F_+?;_+8%DN
M6K_F'7_@VM;[O:?UU/)?^%8'_H-_^4W_ .[ZXOQ-\*O^$HN8/"PU[["VD1#7
MOMO]E&Y^T#5W;3OLOV;^T8#%]G_LCSO.\Z3S1<%!%'Y1:3Z.KD(/^1XU/_L6
M-&_].^MUK1S#&1E*I&M:=*G.K3DJ=/W:D>2,96<6G93DK--:WM=(Y,9DF6SI
MTZ$\,G2Q.(I4*T?:UESTIJK.4;JHI*\J5-WBU+W;)I-W^>O^&8FP3_PFP.,]
M/#9.<8[_ -O>_'X]*Q])_9 T'0IM:N="UG1M&G\2ZS)XA\13Z3X)L]/FU_Q!
M-8:?I<VNZU+9ZO"^JZO-INE:7ITFIWK7%[)8Z;86C3M!9V\<?V4>_P#O+_[+
M3JV_M[-[W^N.ZBX)^QP]^27*Y0O[*_)+DAS0UA)P@Y*3C%1YEP;PV[K^S8ZM
M2=L3C%>:NU-_[19S7/-*32DE)I6NV_DL_LQ,,_\ %;#CKCPV?_E[1_PS$W_0
MZCG_ *EL_P#R][U]:44?V]F__0;+S_<X>[U;U?LG?5MZWU;E\3;'_J9PW_T+
MEIM_M.,TLDEI[?HDEIT26Q\E_P##,39Q_P )L"?^Q;/_ ,O>/QH'[,3'_F=1
MTS_R+9_^7W.:^M**/[>S?_H,E_X)P_\ \J_X+>NC%_J7PW_T+8]O]YQFW_A1
M^5M+K5:'R7_PS&QZ>-0?^Y;/_P OJQM?_9U,6F7'A@^, 3X],'AI;W_A'^-*
M.GW$/C<WIMO[;_TT2CP@=,^SB>T\MM0%WY[_ &7[-<_9M<;XF_Y#/@'_ +&Z
MZ_\ 4)\754,\S6<X*6+;2?.E['#JTJ2=6F]*6G+4IPE;9VL[IROEB.$.'J=&
M<H9>E*5J4G]9QCO3Q,X8:M'6O]JC7J0OO'FO&THQ:^(_^&%'_P"BH+_X11XX
MZ-_Q5GRGVZ_G1_PPH^/^2HK^/@H_K_Q5E?H8O3\O_05I5Z#Z#^5=/^MW$+U_
MM&71O_9L&]XJ7_/C363V//7AGP3JEDJ25TO]OS+H^5?\Q?:$5\O6_P">7_#"
MC_\ 145_\(H__-91_P ,*/\ ]%17_P (H_\ S6?YQ7Z'44_];>(O^AE+_P )
ML(_Q]AKZO;H/_B&7!-[_ -BQ_P#"[,O_ )K_ "^9^>/_  PH_P#T5%?_  BC
M_P#-91_PPH_7_A:*_P#A%'_YK*_0ZBC_ %MXA_Z&,NB_W;!__*.^OD]>B#_B
M&7!/_0E7_A=F7_S7Z_>?GC_PPH_?XHK_ .$4?_FLJ[IO[(C?#^_M?&S?$$:J
MOAB5=8.G#PF;'[=]CS(+879\27?V=I. 9?LT^P9;RFQM/Z UR7CK_D4?$7_8
M*N?_ $6]./%.?591I5,P<J=62ISC]7PBO";M*-XT$U=.UTT^J:9%7PYX.PM.
M>(HY.H5:$95Z4_KV82<:E).<)6EB91?+*SM).+M9IH^'1^PJY&1\4 > 1CP4
M3G/I_P 59SCN:7_AA1_^BHK_ .$4?_FLK]"DZ+_NC_T%*DJ?];>(5[JS&222
M2_V;!O1>ZEK0Z1A%?+S=Z7AKP7/WI9*G*5I2?U[,M922J2>F+6\ZLW\[+1)+
M\\?^&%'_ .BHK_X11_\ FLH_X84?_HJ*_P#A%'_YK*_0ZBG_ *V\1?\ 0RE_
MX2X/_P"4#_XAEP5_T)5_X79E_P#-9^>/_#"CXS_PM%>N/^1*/_S68]_7%'_#
M"C_]%17_ ,(H_P#S65^AU%'^MO$7_0RE_P"$V#?YT/\ A@_XAEP3_P!"5?\
MA=F77?\ YBS\\?\ AA1_^BHK_P"$4?\ YK*/^&%'QQ\45[]?!)XQSD_\59P#
MZU^AU1O]P_\  _Y/2?%G$+T>92:>C3PN#VE[K_Y<=8RDOGY(3\,^"H^\LE5X
M^\G]>S+1P]^+UQ;VE3@_E9Z-GX!?%_\ X(PR?M"?$KQ=\95_:03PD/'>IC4O
M^$=;X0-KPTK[);6^D&!M8_X6AHPO&E.G&X$G]F6FT3"/RSY>]_-_^(?R0_\
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M\&_<H _XRR7GM_PHELC_ ,S%_P#K[5_2313_ .(@\8?]#F?_ (19?_\ ,O\
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M=[7ER<TFY-R?\VO_ !#^2]1^UDN/7_A1+?\ SXJ/^(?R7_H[)<>O_"B6Z?\
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M_IB_X@?X8_\ 1-+5-?\ (USKJK/_ )C^S:/YTM*_X(<-X'TSQO9-^T^NI_\
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M_LJF 5+VWU9KVOLU.:I\_P "E)1W9]G@X0DI\T8NW+ND^C?4^G?^&R?VD?\
MHHY_\)'P)_\ ,O1_PV3^TC_T4<_^$CX$_P#F7KYBHK^4_P#B(?'W_1:\5_\
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M=/,\SQV88>E7IXG!.-94*T^7VB@YPC./O)3DEHY'SG%>:4>'\BQ^<2POUB.
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MOUO[N5?QGPM6FZ:R#$IRE2DG_:&&^Q5IU;)>RN[^S<5:V]]HMO\ ?!>GY?\
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MUOF='3?_ &:JNE]G/3?KZ[: O&O"M77#V*?IF&&?XJG9^BU7=]/WOKD?'?\
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M54HU(RC4IR:5?#5U!^TP^(IIMTZM.4K-/W9PY:M.4Z<U)<GX%_Y%G3?K??\
MI?<5UR]!]!_*L7P_IJZ5I%G8K*TXA623S&0H2;B9[@?+N;&PR%,Y.0,\9Q6S
MT& /4<<@=N>#S^!YSGN:Y:LDZM22U3J2:?=-Z:=]'IY;GHX:,J>'H0FK2A1I
MQDKK1Q3OKM;5:ZK4=13,\GO]X<#ME>#P?_U>II1T'^<8ST&!SCC&/P/?._\
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MA^'W[37PN^%\NA6?PX\0P^ KCQAX&_:*\%^!/B)HL3ZY]@CTG_A.=&ETF_\
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MRIE-&G4Q%&C1REY7BL<L-*#E4]E&3ITJ^(O*G.OC*^%4JM:G.$/G#0_V@_\
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MZ3J7P^\+_$6>^M/V;-6F\>?%;P7XQNM3\3>(OAM=_#GX30>)/";J\_C3^W/
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M_F'K^GB;_52?[K?^U*_F'K^,OI8?%P3_ -W!_P"G,O7Y-_\ #'HX':IZQ_\
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M&GB<=2A2I5,0YJC&2K4ZEZCI0G-)J$]8PD[\NEKM?F?17[#_ /#*_P !L?\
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M_#6JZ3IE_#'?Z9'JN@:U_2O_ ,,J_ ;_ *$9_P#PIO&/_P OZ/\ AE7X#?\
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MQK\/_P#I;'78UM/^#A_^YC_T[ XZ'^^8W_#@_P#TU5"BBBL3M"BBB@ HHHH
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M'A+#5<7!5XXG'PCS2P]&=1*FW[MI6Y91;_H+_P"%K_%+_HI7C_\ \++Q%_\
M+&HA\4/B6)WNA\0_'0N7B2![@>+M?$[0Q.[QQ-*-0\PQ1O+*T:,Q1&ED95#.
MQ/X2^+/^"N%YX>\._'/5-,^!7@/Q%KOPM/P@G\,>$[?]J;P/:'5-%^+&N^'O
M#T/B?XV>/I?!4WPD_9@T?3=4UJZTZUTCXG_$)_']]>Z:MQJ_@;PQX;U.Q\2-
M]7? []HWQ[\8?C!\&_[1M-(\(^$_B1^QWJ7QDU;X>Z!XR^'OQ8T+2O'*_$OP
MAX?BNM%^+O@-;_2/&FE6NDZIJ%II^J^'-:7P[K%I<PZC)I<&H*J6O3A:V38R
M:AA</A:EY0A.2R^A",%5I9E6CS7PT'4364XJ$X4E4E"I]7C-)XBDCFQV$XGR
M^A]9QN-QU.E&53V;_MG$U)3G1IX"K)04,=-P_<YIAIPK3Y*<KUHTY2=*HS],
M?^%K_%+_ **5X_\ _"Q\1?\ RQH_X6O\4O\ HI7C_P#\+'Q%_P#+&OQ E_X*
MCW'B#Q!XH^%VE_ OQ=H?CN+6/&?P]TZZM_&-@AM?'7PDA\5W_P"T@MI>:M\-
M=>T^UC^!O@ZR\#^-=$U[6_#&J^&/B)<_$3PWH8L[ 0:AYM'PK^VO^T3XU\">
M.+?0]/\ A2?'_P /_P!IC]E#X8^%M#E^)$0\7>,O GQDTGX7:ZUQ\;POP@ET
M[P$OC6S\5ZD@^(/P^\ 26=PR>)K/P3X$L9_!%K?>*.:&.R.I3A6I8.C5I3P[
MQ*J0RNBU[*%#!XFO[DL)&HZF'H8ZE4JTHQ<[4\3&"G.A-'14RWBNC*5.OF&+
MP]2%6C1E"MGN(24L1B*N%HR]I#,:E*-.5>DH5*DYJ%"-6A.LX0FK?N;_ ,+7
M^*7_ $4KQ_\ ^%EXB_\ EC1_PM?XI?\ 12O'_P#X67B+_P"6-?A;<_MC?$/X
MF?'W]BF.T^+GA']G;P!\8?AI=^,/%OPQ\0_%?X1>')O&WC72_C!H'@:?P)X,
MUWXC_LW_ !$\3?%N_P!1W:II6D>#_!6H? 3Q-XATV\CU:#Q-X;U>**T@M?$#
M_@I5\6M!@EFT[X,_!OPA8#X@>!K>P\4_$?XZ^($\+R?"R_\ VGM?_9I\9^(O
M'-[8_"32;;X8:O%K^A0:IHES'J'Q!T+3?#VM'7];:?4M$_X0O7-/K62I-SP>
M'C_MN+P4+9?A:L:DL+C:N!5>-2EAI0A1Q-:A7J8>-9TZ\L/0JUI4U&,?:+^S
M^)W]7]GFN)J.O@XXQQ><X^BZ:E&K-T(^WQ<%BZU.%*]66!=>C3E6PU.515*\
M(Q_<C_A:_P 4O^BE>/\ _P ++Q%_\L:/^%K_ !2_Z*5X_P#_  LO$7_RQK\-
M?!G_  5%^)/Q \3?%#PIX>_9A\ 6&J^%?CUX2^!?@*U\2?M@?#A]<UZ^\4_%
M#Q)\,QK/Q<^'G@'P5\0OBU^S[+9SZ -8@T3Q7\/=<.K0S7=K8:FQM+>ZU+W#
MX:?MDZE=>*/V<OA=J\'A;^T?C'H?CWQ!<^,OC9\9?#7@;Q-K1\.?$O5O!T7A
M'X1Z#X0^">C>'OC3X^L(;>/4-3\*6.G_  Q?0?"LOAZ]OM4\0:CJ5W?/IAZN
M2XJIAX4,-A)?6GA88>4LNH4U4JXO$XO#4J=JF$C*%OJ5:M4G4484J<J$:EJV
M(I4GEB\)Q3@O:K$X[&PG0I5\16IQSO$UI4Z&&R_#YE5JR]CCZB:=#%4HTHQY
MI5JL:T8>YAZU2/ZM?\+7^*7_ $4KQ_\ ^%EXB_\ EC44GQ/^)4SV\DWQ#\=2
MR6DK7%K))XMU^1[:X>&:W::W9]0+0RM;W%Q;M)&5<PS31;C'(ZM^)7QM_P""
MJ$'PB^(_Q%^'\GA#]GO3I/ OBWQ?X80?%W]K1_A+XJ,/@CP9%XNFU+Q5X,@^
M!'CNZ\)M\3?/CM/V?;"WU/Q))\7;>&_U!9_"[VJ6-QSM]_P5+^('B+1_VU[/
MP5\ ?#?@_P 7?LN_";_A9/AP?$OXJVFIW.L-8-IR>*M/^*7PP\*Z':>./A3=
M>&1=WDVGV>LW[6GCFVTXZKX?U^#PO>6_B6N2GF?#M94Y4*6'J.K3KU*<895&
M,YPP]'"UJ[5\'",>2CC:%1QG*,I1E.,8N5.K"'7+).,U#GJ8G&0I?[.Y3J9[
M648?6<1##4'*+Q[E+FQ$H07LE4Y)6E)J*C.?[N?\+7^*1_YJ5X_.>O\ Q6/B
M(Y_\J/-'_"U_BE_T4KQ__P"%EXB_^6-?A;+_ ,%7/$-M\1/C=X.?X _#F_\
M#?P<^%UGXWC\=:%^U_\ "C49?%FJ7/A+X>>)GUFR^&$N@67Q>L?V>5B\>'5;
M?]HVW\$:UX=N/ .F1^-V\,0K>W&AZ7V_P^_;I\;:3^RGK7[0'CJ7X.>,+[5O
MVI/''PMT+Q ?C/I_AS]F_P )>"[WXG:IH/@[7]7_ &BM.^$RI)\+M)\/PV5G
MHWQ(N_A5-J'B_4=0\.6]Y:PS:\=3M]5C,ADZG+A\+*%'#2Q-2K_9M"$(Q684
M,LIPY9X15/:5\573I7BH1H4YUJTJ<)4N;.IE?%U-474QF-ISQ%?!8>A3_MS$
MU95)X_#8[&TY7I8Z<(1I8? 5IXA2DZD9U*5*%.I4E*W[-_\ "U_BE_T4KQ__
M .%EXB_^6-'_  M?XI?]%*\?_P#A9>(O_EC7X3W7_!6PVGCKX]^"KSX5?!_1
M;#X.:_\ #/P]I'Q&\2_M8^']'^'&OR>/O&.C^!K[Q+XZU&'X6:CXI^#W@31]
M7UFVU70O%?B7P?J4/Q \'!/%_A:SGT:ZM)IS0_\ @KE;ZA#?:AK'P=\$Z#86
MW[-&J_M":?81?M!VGBGQIKZ>'+.XU'Q/%;>"O"/PMUO4O"/PLM=*M[?7O#'Q
MF^+DWPSL?B-H&M^'M0\ >$?$,UYJ-GH]4\7P_5G2A"G@;UI0C"4LOH4X7J8W
M'9?'GG4PB5*V)RW&0DJO)*,*:K<OL)QJ.*N6<8T83G.OF5J=-U)*&<XBK-Q^
MH9?F25.-/'MUI/"YG@YJ-%S:J570ERUX2@?NQ_PM?XI?]%*\?_\ A9>(O_EC
M1_PM?XI?]%*\?_\ A9>(O_EC7XMO_P %%)]3N/VA?BMX&T:R^(WPG^"7P5^,
M'BKPSX=\%>+_  MJ^B?%;4_AOXYTO3-(\=Z?\2(M$^R^'_#'B'1+\3:AJ"WF
MO^&_#/A]+WQ')_;7V/+1_"#_ (*;ZS\0_%?[,7A?Q=\)/@UX#D_:'NO%>E22
M^&_VS_A-\?+W2]?T37+_ $K1=(\!:'\!/#OC_5/B7::K::=>ZIXA\9W\/P]^
M'/P].G:GI7B_QE9:LFEVFL13QN0U%0Y<-A^?$J$J-.65T8RG&M_:'U5WEA%!
M/%1RVO.E#F4X1J81UU3^MT%)_P!F\7.GBZRQF-=/ RE3Q4O[<KQE2JTZ-.O7
MI^REC_:R>'A52K2C!P4X5H0<GAZTH?M1_P +7^*7_12O'_\ X67B+_Y8U%-\
M4?B9<PR07/Q$\=W$$J-'+!-XNU^6*6-@0R21OJ#(Z,.&5E(8$@BOP'\#_P#!
M1CXR?#Z"*S^,?AGP%XP\5?$/X\_'73_"NBZA\9])\&7,_@_P7^TK_P ,Z^'/
MA%^S5X>L/V=](U/XU_$S1K[3[_6-0\(>+]:LM8N=+N-&\8:M\3-,L?&J>#/A
MM] ^/OVC?VB?BC^RKI/Q)^%%MX4^!?Q!\<?M(>%OA9\-KN#7[7XL6VH>&H_C
M3%\-+FY\:VWBSX8^&=.\.7'BV_TO6=.U32-$M/$T^@Z!=6NJ:-XS;6YC#I5Q
MQ.43I5:M' 4JM3#QPTJ]"GEV&C7HRQ.)H86--N>&IP=:GB*ZI3ITIRFYTL1[
M.ZHRFS%9=Q)A*].AB\XJTJ6(KXC#T,3+.L=.AB/J]*-6K5A2CBYUY8=0DG*H
MZ7+3A*G4JVA4C%?KY_PM?XI?]%*\?\<#_BL?$7 ]/^0C1_PM?XI?]%*\?_\
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M*\#VUM8^(/#FBZE\-AHWQ<TZ+XV6?[0-_I_Q-?5?A?JNLO:>)/B59IJ/BQ/
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M&U6&S^>_B9_P3:T7XG?%WXA_&O4/VJOVHO#?C;QAK?P<\4>#)/"T'[+<>F_
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MZ*+J'_A.VW_RVK[\HI_ZU\0_]#.K_P"",)_\H%_Q#;@K_H1T?_"K'_\ S4?
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M5TR.BO\ N9QW5)O_ )BNM_UMT/@3_AA?2_\ HH>H_P#A.6__ ,MJ7_AA;2\
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MH?\ V-?A_P#]+8Z[&N.\8#,&A_\ 8UZ ?RO(S_2NQK6;_=4%V]O^-6!QT/\
M?,;_ (<'_P"FJH4445D=H4444 %%%% !1110 4#H,>E(<]>PSGW]/I4/F1_W
MS^#+C\.:SG.$;<THQO>W-*$;V[<\X7^5_D%F_P"O^"B>BH/,C_YZ'_OI?\:/
M,C_YZ'_OI?\ &L_:TO\ GY3_ /!M'_Y<.S[?BO\ ,GHJ#S(_^>A_[Z7_ !H\
MR/\ YZ'_ +Z7_&CVM+_GY3_\&T?_ )<%GV_%?YD]%0>9'_ST/_?2_P"-'F1_
M\]#_ -]+_C1[6E_S\I_^#:/_ ,N"S[?BO\R>D&.WJ?SS_DU#YD?_ #T/_?2_
MXU*IW %3D<CL<_B">1W]:N$X2=HSC)VO:,Z<G;TC4F_PMY@TU_2_S'4445J(
M**** "BBB@ KD(/^1XU/_L6-&_\ 3OK==?7(0?\ (\:G_P!BQHW_ *=];K6G
MM6_Z\5/_ $JB<F*^+!_]AU#_ -(Q)UI[_P"\O_LM.II[_P"\O_LM.K(Z5N_E
M^40HHHH*"BBB@ KC?$W_ "&? /\ V-UU_P"H3XNKLJXWQ-_R&? /_8W77_J$
M^+JTI?Q(_P"&I_Z9JG-C/]WE_P!?,/\ ^I6'.P7I^7_H*TJ]!]!_*D7I^7_H
M*TJ]!]!_*L8[?*/_ *1 W6\O5_\ I<Q:***HH**** "N2\=?\BCXB_[!5S_Z
M+>NMKDO'7_(H^(O^P5<_^BWK6C_&H_\ 7VG_ .E(Y<;_ +IB?^P>M_Z0SJ4Z
M+_NC_P!!2I*C3HO^Z/\ T%*DK'[3]/\ VZ9M#9?X8?\ IND%%%%,T"BBB@ J
M-_N'_@?\GJ2HW^X?^!_R>CMZK\T3+X7_ (9?^D3.4\"_\BSIOUOO_2^XKKEZ
M#Z#^5<CX%_Y%G3?K??\ I?<5UR]!]!_*M*W\:K_U\E^:.?!?[IAO^P>E^4A:
M***S.H**** "HFZM]5_D:EIC]!]?Z&E>UOG^$9,3Z>L?_2X'*>'O^0UXY_[&
M2P_]13PU775R/A[_ )#7CG_L9+#_ -13PU775K6_B/\ P4O_ $S3.7!?P'_U
M_P 5_P"I5<****S.L**** "HV^]_P$_R:G'GCKCK[?A@_G3/7V!Z<8R&/08^
MO3(R0>://T_&42)OIY2ZK^2?3=?J>7:W_P E9^'_ /V*/Q#_ /2_P97JU>5Z
MT,?%OX?#T\)?$,?^5#P77JE=.(_AX+_L$7_J1B3SLN_C9O\ ]C6K_P"HN!"B
MO#_CM^T7\&?V;?"?_"9_&;QUH_@[297EBTNVNFEN];U^\@1'EL?#N@6$5SJ^
MMW:++$9TL+2:.SBE%Q?S6MKNE7\&OC)_P7LUAKN\L/V?_@EI<%G%<-]C\4?%
MS4[N_FOK<2%09/!7A&\TM-/=HP65_P#A-]0),@#0Q^2PF];)^&,]SU.>6Y?4
MJ4%+EEBJTH8;"1DMX_6*[A"<E]J-)5'%Z.ST7SG%'B+P?P<U2SW.*-#%RBIP
MR[#0J8[,I1?PR^I815*M*$OLSQ#H1GO&ZLW_ $JT5_'LW_!;3]M5M06]W?"5
M;=1@Z4O@.Z-A(1&R9:1_$3ZF#O(EPFI(ID51@0[HS]._"#_@O9XSM;FVLOCQ
M\$O#VMV#W$2W&O\ PIU*_P##VH65F& ED3PMXKOM?LM8N]FYPG_"5>'K=G&T
M&&,@I[^(\->*Z%/VD,-@\6TKNEA<=1E6VO:,*JI*;M?2$G?I=NQ\7@O'_P .
M<975"KC,TRY2ERQQ&/RC%4\+NDG4JT'B'1B[[U::2L^:RBVOZ;*1NA^A_E7S
MM^SQ^U3\#/VI/#4OB7X->.M/\2"R2V;7O#\PDTSQ9X8EN@XB@\0^&[X1ZC8K
M)+!<06NH+'/H^HO;7+Z5J-[#"TH^B"<*2.._3W]#^OI7P^(P^(PE:IAL50JX
M?$4I<M6C6ISI5:<NTH349+35.S36L92BTS]?P6/P69X6ACLNQ>&QV"Q$%4H8
MK"5J>(P]:#M[U.K2E*$K;27NRC*\9PA)-'(^+_\ 4Z'_ -C5H/\ Z5I785Q_
MC#_4Z'S_ ,S3H''I_IB_Y'U-=>.@^@I2_A4?^X__ *<B%%?[7C'?[.#T_P"X
M-46BBBLCL"BBB@ HHHH **** *T_^K?J/E?D'!SB3_\ 7]<5_*!7]7\_^K?Z
M/_Z#+7\H%?R=])J<X2X0Y9SC?^W+\LYPO^\R_?DJTKV\^;RMU\'/ML+J]ZVS
M:_Y]]F@HHHK^4_:U?^?U;_P;7_\ FH^=^;_\"E_\D%%%%'M:O_/ZM_X-K_\
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M>'O_ +R_^RTZOS4_X;E\5_\ 0C:!_P"#+4?Z)Q^&!^%+_P -R^+/^A&\/_\
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M?_0?BO\ PV8[_P"5'Z545^:O_#<OBS_H1O#_ /X,=1_^(H_X;E\6?]"-X?\
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MB:;P;J/BCX:7=SX#BM_C1X:M?%$*Z*_B#X//X[T@WMWIJI>LFKZ6]Y]!WO\
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MXK_X)%?#OQJ=1EUO]G3QJMYJNK^)]?GU?0/B7\5/"6O0:OXS\<>+/B-XIO\
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M=*7:OI^I_P :_+/_ (;9^*__ $ OA_\ ^"GQ![?]31["C_AMGXK?] +X?_\
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MMC]3, ]>>.#DY.>O.3D>GX_B8QP%'/7/3@_S]./Y5^6?_#;7Q7_Z 7P_]/\
MD$>(.GI_R-%'_#;/Q6 Q_87P_P"@'_()\0<XQ_U-/L.!Q[4?ZD9\O^76#_\
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M?3M7Y:?\-M?%?I_87P_X_P"H1X@_^:FD_P"&V?BO@C^POA_S_P!0CQ!_3Q0
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M2Y8ZV4GM$^3Z*^@/^&6_CO\ ]"(W_A2>$/\ YH*/^&6_CO\ ]"(W_A2>$/\
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M\-YO-0Q%"?LJF48GDK.G4C65&49*49QJ.BHS@XM3I>UIR3A4F?RK_#_]NO\
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M4R7/A2#0-*FCT_5='_I"_P"&6OCO_P!"(W_A2^#^?I_Q4'(]QD4?\,M_'?\
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MNH7-WJFL^+-1U?4[_4=4O[W4M1U+5+^\O[Z^N[B[N[F:>9W*>8T?9UJ<>*,
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M_P!^Z_ 3^V-6_P"@IJ/_ (&W/_QVC^V-6_Z"FH_^!MS_ /':/^(>R_Z&E/\
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M6_Z"FH_^!MS_ /':/[8U;_H*:C_X&W/_ ,=H_P"(>R_Z&E/_ ,(W_P#+A?\
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M_P".T?VQJW_04U'_ ,#;G_X[1_Q#V7_0TI_^$;_^7!_Q&RE_T3M7_P .E/\
M^9C]^_\ OW1V/W>GI[-T_F/;\S^ G]L:M_T%-1_\#;G_ ..T?VQJW_04U'_P
M-N?_ ([2?A[-I_\ "K!:-?[I+JFO^?WGW0+QLI?]$[5Z/7-*?1I_] K[?B?N
MAX=!_MKQU_V,MB3_ .$EX:/Y>GX#UKKZ_ !=6U12Q&I:BI<Y<K>7&7.T*"V)
M/F(557).=J@#  H_MC5O^@IJ/_@;=?UEJY\ 3G+F_M2"T@K?5)/X(1A_S^Z\
MM_*_S,Z/C12HT^3_ %>J2]^I*ZS.DOXE2=2UOJCVY[;ZVOI>R_?^BOP _MC5
MO^@IJ/\ X&W/_P =H_MC5\_\A34>.1_IMSG//_37_P"OZU/_ !#Z?_0UA_X1
MR?Y5[_==]C9>-E%_\TY4_P##I2_^9/\ @=VE=K]_Z*^%?V:_VE!K_P!@^'WQ
M!O@->41VOASQ'>. -;"[4BTO5)G.!K  $=E>R'_B;#;#.W]I;)-0^Z/X1C(X
M&1WQCIVY[=OSKXC,LMQ658J>%Q<+2C[U.I&[I5Z3;Y:M*32YHM633]ZG+FA.
M*DE?]:R#/\NXDR^EF.75>:$DHUZ$VEB,)7LG/#XBFFW"<;WC)7IU:;C5I2E&
M3Y74TKUY]?UW?X_IWI<_7H.Q]?I^G7V]?R1^(G[+W[8?BS]M;XY?'_P_\<_B
M-X0^#FB? I?"/PD^#>C^/_B,FA?$GQYK?PQ^(^@7US;Z)'^T)9?!?P#'X?\
M&6M>$_$K^(M;_9S'Q0OO$V@:#=>'OC-HGA*#Q#H6J>54J\DHWA-P]AC:\IQB
MY<KP>%EB:=)0C><ZN,K1I8/#Q@FW6JJ<^6C3K2C[5E**NTI2JX>C&+OJ\17A
M0G.4DG&G3P]*=3$5ISLE3I.,6ZLZ2E^G&H^&[^[\=>%?$T4UJ+#0]"\5:9=Q
M2/*+MY]<N?#\UF]O&L+PM%&NDW(N&DGB="T C28-(8NWK^;#2/!7_!>KP/KW
M[+/AFP^)?Q9\5_#_ ,(OXZT;XV:[KOAC_@GY\2/$GCK0;OPCX>7PCJ/Q&UG5
MO&/P/U_3]<\#:Y=ZY'X(N_A?#K]]\5+_ $>+3OC3J7@RT6;XD>-O?OV-;'_@
ML/-^TI\)-0_:I\5_$[2_V=K/X#WNC^,/!7B;X;_L'>(7\4_$ZUU[Q5!'X_\
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M-?:?XI^&M[>0P_!SX4WGAK5M5G\'?O!\#=-\9Z-\%/A!H_Q&EU&7XAZ5\+O
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M:O96U1^?U%?J'_PQ)\+N?^*B\?\ '_42\.\?7_BE_P#"D_X8D^%W_0Q>/O\
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MQE^U?\+O&<?B*Y_:7\8ZG;/X+UOPT5\6?M!?M"?&NQL=6U;]G_X9Z!;>(8O
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M/''@SQ5+J7Q_D\%?\+;31]7TKQ*]UX@U&'_A#]/_ *O_ /AB3X7?]#%X^_\
M!EX=_P#F8K&\1?L;?#31]"U;5+?7_'4DUC93W,*3:EH!A>6)"ZI(L?AJ.0KQ
MD[9$R,@$$@U$<YX5G3^KJIG3=9*E*JX8J%::G26&FIUU64W"M27)7IZ4ZJE6
ME*//B*\G57A3Q#@H5G0X=IT\+"G-4:>(P+HN.&E3K13H2P\Z<K5:%*JGI*$Z
M=*-.4:=*G!_S"_!G]CS]IWP9I&@Q>+?CY\3M6U/PC\$OC9X5\+'QQ^UY\9/C
M;<Q_%_Q]KA;P7XQ\;ZWI'PO_ &;M,^*>A>%_#EWJ<6G#QKX#N];\%7L]E#X5
MEN;C2-'U_3?F+PS^R;_P4-\.Q?!SX-ZA\:OB%KVNZ'I?CSQG?_&G7OVO?VCO
M$FF>"WC^+WPEU#0O[?\ $6D_!_P+H_[2'BU/"A\?Z9I'P?\ BSX9\(>#+CPY
MJ=RDFJW<.@_:F_LO'[$OPN(!'B'Q^<C( U+PZ-P[G_D6#C&>A].#Z+_PQ)\+
MO^AB\??^#+P[_P#,Q5SX@X8G4HU)5LY7LJ;I2A&EB>6M'VE6LW4M6YHU'7=&
M4L12<*SHX>&'A*-*I5YJCPCXA6Q4GA>&ZCQ=9XF+EB,%?#5)4:U**P_+AX\M
M&-/&XF<<-)SHRQ%6->K&<J4(G\[/[%_A/XX>'KKX_/\ &3Q7XX\2Z/HWQ?U[
MX:_!.3QQ=>+GU/4/@UX"OM3NO#7BW4X?%4^_4_$FM7_BO5_#VI^.H+4-X]T?
MP9X:\0#4=1TN72#;_<E?J%_PQ)\+O^AB\??^#+P[_P#,Q1_PQ)\+O^AB\??^
M#+P[_P#,Q7H4>-,AHX?#4/:9C4^KX:CAW4G@*G/5=)5.:M4:JZU*LJLG+I&$
M*-./NTHW\/%^&'&.+Q6(Q+PN34?K%:554:.:8>%&C%T\/2C2I05&T80C0YE9
M7=6MB*CUJM1_+VBOU"_X8D^%W_0Q>/O_  9>'?\ YF*/^&)/A=_T,7C[_P &
M7AW_ .9BM/\ 7?(?YL?_ .$%7_Y:<_\ Q"CC#_GSE?\ X=J'_P I/R]HK]0O
M^&)/A=_T,7C[_P &7AW_ .9BC_AB3X7#KXA\?8[_ /$S\.\#^]_R*_/K@<\X
M[4?Z[Y#TECOG@:B\O^?O];C_ .(4<8:_NLJTN_\ D:T.B;_Y\^1^7M%?I3X>
M_8V^&FKZ/::A/KWCJ.6X\_S%AU'0!$IBNIX%"J_AIWY2)6)+D;B<8& -G_AB
M3X7=_$7CX>W]I>'3CVS_ ,(QS52XUR*$I1E+'7C)Q?+@:DE=;V_>+3SL1#PK
MXOJ0A4C2RMQG&,XWS6@G:2NKKV.C\C\O:*_4+_AB3X7?]#%X^_\ !EX=_P#F
M8H_X8D^%W_0Q>/O_  9>'?\ YF*G_7?(?YL?_P"$%7_Y:5_Q"CC#_GSE?_AV
MH?\ RD_+VBOU"_X8D^%W_0Q>/O\ P9>'?_F8H_X8D^%W_0Q>/O\ P9>'?_F8
MH_UWR'^;'_\ A!5_^6A_Q"CC#_GSE?\ X=J'_P I/R]HK]0O^&)/A=_T,7C[
M_P &7AW_ .9BC_AB7X7?]##X_P#]G&I>'?F/H,^&!C'X^N.U'^N^0_S8_P">
M J+S_P"?OD->%'&#_P"765]/^9K0>[MTHWW:_K?\O:*_2G2_V-OAI?7_ (CM
M9-?\<B/1]6MM/MVCU'P^KO#+H>CZFSSE_#;!I%N-0FC4QK&GE)$-I=6=]O\
MX8C^%O\ T,?C[_P9>'/_ )FJ<N-LB@^5RQU[1>F"J-6E%27_ "\[25UNG=$T
M_"KBZI'GC2RNSE..N:44[TYRA+_ET].:#L^JL]-C\NZ*_4,_L1_"[_H8O'Q'
M_82\-Y_7PU_6C_AB3X7 @GQ#X]//0ZGX<'!QU(\,@X( S@_3/6I_UWR'3WL=
M_P"$,_3_ )^7V]+WMW9?_$)N,?\ GUE2U_Z&E+HT^E'35)];6O9K1_%WP/\
M@GKWQ=UX",SZ7X5TR>)M;U\)@QD8D73M,+#9-JLZ$%?O164;+=70(-O!<_L5
MO-E:K!$KR+:P>7&TTCS2N(8756EED9GED81@R22,7D;<S$DU1\+^%]#\&:%8
M>'?#EA#INDZ;"(;:VC )SC,LTTI)DN+FXDW37%S,SS32L\DC%FS70_T'O[]L
M>W'4_P!?S?B;.L1G]9NG)X3#T8XBE@XI1E4A[6G5@J]26TJOM)4J_(GR0]C&
MG%?')_N'!7!^'X2R]T_:?6<QQCH5<RQ"<O9SE2<90PM"#:Y,/2@ZM%3<?:U7
M5G5G*SIPC_.'X _X+/?&M-*\?:QX@^'?P&^,=QX?_:^^.?P0U#PSX,^(/AOX
M0:M\*?A1\%_$_B+3;C7]<C\(_%K]M/Q9X[^)>L:'IEA>Z7X6^+/P]_8IGU>^
M74I+30K7PG-HWBS4/>M&_P""NWC9_B/^S9X#\9?LW_#OPM_PTM\3/$?A;P78
M6?[3=YKOQ+USP)9_&^Y^!&D>,_AU\.+O]G[P]#\3?$WAO4]-U3XH_'_P)IOB
MW2=/^!_P2.A^.7\=^.-3U:_\*Z!^X0Y[>ASZ]/H<X^H'KQBDW8Z^_P!>,DGH
M,Y[>N?:O!A!KV:J2<XQ>'511_=RG"GA<70KQ4X\TE+$5ZN"Q,:T^:M2EAJR;
MG+%1E0^RFFW5<6H<T<5[.ZY_9U*E2E5H3E>23AAX0KTIT8*%.K3J4HKV:I35
M?^9?X$?\%M/VL_B-X>U60_LK_L__ !$UJP_:2^*?P=NM87XZ^/\ ]GS0=#T.
MU_;4^'?[&?P71=#/P<_:@U7Q3KVL>*/B;H?B/XCZZNK^$]+TCP[I'B#4?#OA
MS4=5&C^%-4^E?A3_ ,%CO&'Q&^/UG\%+_P#93\->%K&R_9<\;?'/Q7XLO?VN
M?A-%X@7QWX"B\;_VYX-^&'P0\2:)X2^.7QB^#G]J>"-2\.C]H_PQX"M=)TKQ
M$TND^*/A]X?N=.U1+#]LKS7UM/$FA>'C;N[ZU8:W?"Z64*EN-%ETR-HFB*$R
M&X.I JP=!'Y!!#^8-O1CD ^M:.G.-/#QDU=X*4)5'&[K5_J\<+#%\O.HPC&O
M3J8N5"S57$-.K-TU*G44)TJCKQA)N5/,*\IJ[:I4)XC"XJC@DFOCHX9U<,\2
MFW*GB8RA"FZ$$?BA^RU_P4Z^.'[0G[0'[/?PV\8_!7X ?!KPC\6_ /[0E]KM
MFG[0_B[Q[X]N?B#\(?\ A1_B+2-(^$CZK\#_ (6Z9X]LF^'_ ,9-,UWQ?HMY
MI&AZWIX3Q1J]M>1Z+\.[>3XF<1IW_!9SQ5XJ^''QY\6?#[]F[X=>+?$OPD^,
M7P\^&&B:%_PTYJ,'A>X?X@ZW\2M,N?"OQE\9Z)^SUXHO_@G^T3\.;3X;7.I_
M%+X!6G@SXG-X0A\6^ TD^(=['XCEN=-_>:D(!_#I[<YK+V<_:*7M+4_J"P[@
MH^]+'?VGEF+>82J-RG-2P&%S'+/JDK4H1S1XFG/VF#HQG7*U"6O-5EB(5%)J
MU.&'A@\VHO"PI)Q4>?%8S+,8ZW,ZC>4JBTJ>,JRI_P X4G_!P'I-]KO[1NF:
M#\(?@%IVG_L_VOP#AUG7?BE^U_KGPQT7PUKWQYM+C5=%B^.'B.X_9:\0^"OA
MAX5ATW1=:M;#Q7X$\7_'&5_%^N?"[P!XST'X?^-/&VN:+X#]>^"/_!6SQOX]
M^*OPC\'+^S[KL?A+XT?$73;'Q)JGQ2^+>E^&?B)\%;'QROPXTSPCX8T#X7^%
M?V=[.P\51Z3X@\:_9O$FF>-?B5H_B3P]!;ZE=CQ?XTF:PT*P_4_X:?LE? GX
M1?%3Q_\ &CP+X9\16?Q!^)$OB"37]0UWXG?%/QMH6D+XN\32>-O&5K\.? WC
M?QIXB\"?"'3O&WC&1?%?CC2_A/X:\%:=XT\26VGZYXIM=7U/2].NK7Z->)'5
ME895@0P/<,K*>O<AC[4XZ4Z$Y1YJ\81G7I\S6'=3ZCF-&IAX2NZDJ$L=4RW'
M*M)QJQ6"EA8?NJM:JXJPG*K7C2FX4?:26'G.*G6]FZN6SA5G'W80K0I4LSPZ
MI)U*;^N0K2;E3ITX?F5_P3G_ ."B]I_P4$?]IJ_T/P;\/?"_AS]GSXZ:O\#;
M>]\'?%WQ'\2M9UO7?#]G::AKA\7Z3KGP8^%.F^$M1TJ'5='L'D\$^(?B_P##
MW7=7'B%?!GQ.\5:%HMKK^L_IL#N3<.A7/'?(S^7\_IU^<OV??V3/@3^R[;>)
M[;X,>&/$>C#Q=+HJZQ<^+/B?\5/BMJ4.D^&+6YL_"G@[P]JWQ:\:^-]4\'_#
MGP=;7VHQ^"OACX1O-#^'?@[^UM7?PQX8TE]7U-[OZ//"D>@/\JT5N6A9-26#
MP<*_:>,A0MC:T=7^[K8AN=-65H<JLDDAI357%-RO1GCL9/"0?Q4L#.M3>"HS
M?_/RE0BXU&G*\Y?'*USC_&'^HT/_ +&OP_\ ^EL==C7'>,?]1H?_ &-?A_\
M]+8Z[&MY_P '#_\ <Q_Z=@<]#_?,;_AP?_IJJ%%%%8G:%%%% !1110 4444
M5I_]6_T?_P!!EK^4"OZOY_\ 5O\ 1_\ T&6OY0*_DSZ3GQ\'_P#=<_\ 3F7G
M@Y]MA?6M^5,****_E(^="BBB@ HHHH *_7[X7?%;Q/\ ";]COX):KX7CTJ2Z
MU77?'.G70U6TFO(A;IXR\87(,20W5HR2;XER6=@5RN.<C\@:_3-/^3*/@!_V
M-?CS_P!2KQI7]-_1.P]#%>*$\/B:4*]"KP_F"J4JD>:$TJV$DE*-U=*44]UK
M%,\[/,9BLOX<XBQF"Q%3"XK#Y7[2AB*,E"K2G]=P4>:$FI6?+.4?A>DFNJ.X
M_P"&S?B]Q_HO@WCI_P 22^_^7'M2_P##9WQ>_P"?7P;_ ."2]_\ EQ7R717^
MGCX=R%M_\).!Z_\ +E]:E;_IY\S\)?&_%]W?B3-MWMBHV^.IVH=DO1+N?6G_
M  V=\7O^?7P;_P""2]_^7%'_  V=\7O^?7P;_P""2]_^7%?)=%+_ %<R'_H4
M8'_P3_\ ;A_KOQ?_ -%'F_\ X5+_ .4'UI_PV=\7O^?7P;_X)+W_ .7%'_#9
MWQ>_Y]?!O_@DO?\ Y<5\ET4?ZN9#_P!"C _^"?\ [</]=^+_ /HH\W_\*E_\
MH/K3_AL[XO?\^O@W_P $E[_\N*SU_:\^*RZG/JHMO"/VJXL+;3Y%.CWIA\BU
MN+JZB*Q_VMD2>;=R[FW$%=@"J02WRW137#N11O;*<$N:+C*U%ZQ;3:?[S9V5
MUY(F7&O%LN6_$6;-QDIQ;Q*?+*-[27[E:J[UUW>A]:?\-G?%X=+7P;_X)+X_
MSUC-'_#9WQ>_Y]?!O_@DO?\ Y<5\ET4GPYD+=WE.!_\ !/\ ]T'_ *[\7]>(
M\V_\*E_\H/K3_AL[XO?\^O@W_P $E[_\N*/^&SOB]_SZ^#?_  27O_RXKY+H
M_P _S_S[U%3A_(*=.I5EE&"<:=.K5DE1UY:-&M7E:]2UW&C)*^G,XWTNU<.-
M>+ZE2%-<1YLG4G3IIO%:)U:U&C%NU"]E.M%NVMDTKR<4_K3_ (;.^+W_ #Z^
M#?\ P27O_P N*/\ AL[XO?\ /KX-_P#!)>__ "XK^676/VS_ -MW1O"C>(FM
MO EQI'_"'?\ !0S6/"6NZ1<R>.O%7BZ7X$_&.S\*>#]6\9?"S3O@YX*A\,1?
M"OPQ+>2:=I?@OXD>,+CXA6EDUSXI\O4Y5%>R77[2UG;>.OA!X1L_^"D_@F?X
M,:YX8^(WB3P[^TKJ'_#+E]8?%;XL>&O$OPQL-+^ 'CKQEI?AC2?@]>C3],\5
MZYKVH^#OA=HGP@^+WB3PQ>:)#I'BG2[SPCXE\4^(N'#Y?PWBJD*=/),/"=3&
MT<#&.(I4<+-5JZPLHN=.O7C4A#EQ=)1E)6JUW'!4F\77P]*?OU\SXYP]*=:I
MQ9C)PIX?$XJ3PF(Q68P=/"*M[:,:N!P-6FZZE1E_L]_;*C'$8J4/JN"QE2G_
M $;?\-G?%[_GU\&_^"2]_P#EQ6?>?M=_%6_N=+NI[;PD)='OY-2M/+TB^1&N
M)-,U'26$RC5SOC^RZI<D*"A\T1.6*H4?\4_CE^W9'\&?B3\9? LO@_X>W<?P
M@^$VE?$8VGBGXTKX(^)/CA];M[J:+6/!_P -V^'/B$:A\%/!\D8'Q8^,W_"5
MY^']OIWBFX7P+X@/AT0:E\]3?\%1?B#?V&@S^"_V?_A'XW2_U.;2KWQ3H7[4
MFM7OPLUUKS]H7X?_ +-OAW7OA'X_TO\ 9LU6;XF>#KSQU\1=,.O>(KSPUX).
MCP>'O&4&C:?XKN-)TL:],*'"//'V> PTI2?+%PR_%N7+*KB,.YN*CSPC%8;$
MSGSJ,HTZ52,HJM%TG$<=XCUZ<)?VSCW"M+#QA[7.,%2A.IB*/UO#PC4J1A3E
M*:II1<9N+FZ;YG3ESQ_I '[9OQ=&,6O@WC@?\22^X_\ *Q2_\-G?%X?\NO@W
M_P $E[_\N*_F&A_X*>^/)?'&GVNI^%?"EGH?Q=^&GP_?PW\/]"^+^A2?&7X=
M>+[_ $SX[CQMXN^&OA?5_@?=I\8/ GAZ]\!:%?\ C7QIXIGT2P^'^D?V5K5Q
M\/\ 5(=1U#0KOZ!\6?M^>*?AG-X1M;WX1#QGX+@^''P5UGQ?X]O_ (E^1\0Y
MO$_Q@^&_Q(\8^'+/3?AWX2^"HT'Q,WVGX7ZE;>+=4TS4O!*6TFN6-WX2\#:D
M$D\/6L+#\(_5WBIY;A*="$(3J3E@ZTE14X2J+VBIN=HJE&C-58J5.;Q%"C']
M_*4(DLS\1%6HX=<08Z=7$1G4PZCFN&C&O&-94+4JE2$(2J2Q#J4HT;JHW2J5
M5>CRS/WX_P"&SOB]_P ^O@W_ ,$E[_\ +BC_ (;.^+W_ #Z^#?\ P27O_P N
M*_F?^"/_  4]^)7Q_O?!C7'PU^$_PB\+>.?@G^T_XEGATS]H?PY\2?'W_"P/
M@=)X=FM++X0^+=%\ ZW\*/B)*/#OB.SU[4M'ETO46TJ,>(-6U59+/P!=>'O&
M_0Z;_P %1K^Q?Q/H$7PLT/QE?^ ?A3X@\67>EW/QQTF/X[S77@CX?^ O$UQX
MK^+'PNT;X,:'X<^&_P -OB'JGC*#2? 7Q+TG6+VS\6WU[H=_I_PW\.Z9K5Q8
M>&Z^J<)VPS>5X:/URG4JX:+P5:52I&E2]O/]U!SG"7L^5PC4Y95)2Y(QYX32
M=3,?$:G/%TYY[F'/@:<:N+MFN&]G0A*N\/>5=TE1;A5C-5>23C2A3E4G-1LG
M_1__ ,-G?%[_ )]?!O\ X)+W_P"7%'_#9WQ>_P"?7P;_ ."2]_\ EQ7XA:]^
MW3J/P_\ V?/&/QS^)_PCM=&D^%/QRU7X)_%[0_!/CW4O'.B>&'T_Q)%X2B\9
M>'/$MW\-_".M^*]"EUS5_"L%W!>>!?"U[I]OJVI7DBS6^BJ^I^7_  Z_;S\>
M?&W7=#7PU\*/$'@#5?#VF_$SPIXG\)ZSXVT&\\,W?[0_@'X0W?B_XA_"#Q3<
MI\(]7\0:OHOPF\5OH?AF/QU\-_%/AW^W-;O=8FO="U&ST:/0K^Y8#A6,Y4UE
MF$J3IPH5JD:>$JR<:&(IUZE.LGI&I&V&KP<:<I5%6HU*'(JB7-A'.?$&5.57
M^WLRC16(KX3VSS/#.D\3AJV$P]6G>,7)157'85*NX>PE&M&:FTI\G]!O_#9W
MQ>_Y]?!O_@DO?_EQ5#5/VO?BMJVGWFFW=MX16WOK>2UF,.CWB2^5(,-L8ZLP
M5O<J<=<$8S_.1^SE_P % OC5\1/%7PCUGQCX5^$WB7X=_&;PG^R_I.L7OPR^
M*,M_I_PS^)GQ?TSXVSWW_"(Z;+\,9;_QG:W.I?#RWTSX@:#XL^(.AWGPIUBQ
MF\.Z%=>/KNTU>_N^Y\=?\%-(O!'Q!^/OPYO_  -\'=/U'X0>/? _@[2-;\1?
MM-6-KX1BT3QAK\?AX_$7]H3QAX1^%7COPK^S!X8@U)+_ $G2_#GB_6O$WQ7U
M37(=.AO_ (<:!X>UJS\4!/"<)T8T*E3+L)1G6=94X/"574A4PU+!XB=.2@VE
M*5#,,'7HR3E3KPG5]E)RPF*C3TCF7B'7K5\+3SW'UW2C35;ES3#N')7QN(RU
M:.DI^[B\-6IUH2C&I1A["M./LL7A75_H,_X;-^+P!'V7P<1WSHM\<D<9S_;'
MMV_K2_\ #9WQ>_Y]?!O_ ()+W_Y<5_,WX]_X*V^-_"/PKUCXM:9^S'X,U;P[
MHOA?X+:BZZ]^TY;> (=6U_XT?\)7?Z,VD>)O%'P7@\#V_P -IO#'@C7/$?A;
MXA>*O%/A74O&RZKX&T33? MGKWC"#3]/XKQ3_P %-/C[\)IOC!\3=:^%/A#X
MB^$_$/Q^^&_PB^#_ (&\2?M(_"+X ?#KX<>'+O\ 9B\*_'C6=5\5_%[XH_"S
MPGI]MXT\30^,--GM]&\1^/O$EIXAU%=5\->#-/\ #D?@<ZO\3X>'X2O.^6X9
MTZ;A[:M]0Q')2G7I1KX:,D[3;Q=-U)T90BZ<84*]2O*E&,%/KHXCQ)K03AG^
M*<IU'0P]+^VL%SUZU+$RPF(HP<8.G2GA)TU]85>4+*=&,/:5*J2_J9_X;.^+
MW_/KX-_\$E[_ /+BC_AL[XO?\^O@W_P27O\ \N*_GJ^)'[?OCBTU/Q;X7'PL
ME\%>'!>:YX;\+_$;PA\8?">N>/W\8>#?#?P;\?>(+63PIKOP4\=_#33_  W/
MH'Q5@TBT\3V_B7Q[)J.H:5J4=EH%E97FE>*8.Y^%/[9'B[4OVT?B;^RMXIL_
M!GBFRE\?^/V\&:CX>\?V-Q\2_AWX1\'?#3X7>(86^(GPBLOA]I;Z+\-M=U[Q
M!X@TKPI\4K[X@^(+[7/&,K>%)-&MX;>":TWIY9PQ5Q,<+#*L)[6=:KAH<V%G
M%/%4</+%2P\E*2E2G.C"52E.HE1J0Y)JHHUJ7-Y\\\X]IX>MB9<19@X4,'''
MU5#,J-1QP;Q,<*ZT7"E*$Y4JLZ:K4(M5Z3GRRBYPJ6_=S_AL[XO?\^O@W_P2
M7O\ \N*/^&SOB]_SZ^#?_!)>_P#RXKY+HKN_U<R'7_A)P/\ X)W]Z<?Y^O(V
MO)KK<\C_ %WXO_Z*/-O_  J7:+_Y\?WK?)GUI_PV=\7O^?7P;_X)+W_Y<4?\
M-G?%W_GU\&]2?^0)?9!/<?\ $X'KV/7TKY+HH_U<R%?\RG ]/^7/9W_Y^=T'
M^N_%_P#T4>;:[_[4O_E'F?4FF?M>_%?2;*"PMK;PDT%OYOEF;1[QY1YTTD[@
MLNK(" \C!<#(&!R<L=#_ (;.^+P_Y=?!O_@DO?\ Y<5\ET4Y</9%)N4LIP3;
M;;;HW;;W;_>;OJ*/&W%T8J,>(LV48I**6*LDELE>ALNG4^M/^&SOB]_SZ^#?
M_!)>_P#RXH_X;.^+W_/KX-_\$E[_ /+BODNBE_JYD/\ T*,#_P""?_MQ_P"N
M_%__ $4>;_\ A4O_ )0?6G_#9WQ>_P"?7P;_ ."2]_\ EQ1_PV=\7O\ GU\&
M_P#@DO?_ )<5\ET4?ZN9#_T*,#_X)_\ MP_UWXO_ .BCS?\ \*E_\H/K3_AL
M[XO?\^O@W_P27O\ \N*[7P!^V?XD;Q':P?$33]&/AJ\Q;W5_H6GW=O?Z4[LJ
MQ7[1/>W@O+2'YENK6*);DQ.9K9I981:7/PM16=7AG(:M*I2_LS"TO:0E'VM*
M#A5IMQDE.G/G?+*+::;36C4DXN2>V&X]XOPV(HU_[>Q]=4JM.HZ.*K*MAZRC
M.,G2K4W2CSTZD5*$DI1E[R<)1G&+7[J>#[ZRU2^\7ZCIUW!>V%]KFF7EG>6D
MJ307-M-X.\,20S02H622&2-P5="58,&!P2:[G(Y.3QGOD=_?.."1DBOS[_8G
MN/'S)K]OY4+_  Z61F^T7K,EQ#XC,<(\K1B%8SQ/:A/[3ADQ;PG[-+ Z3O/'
M<?H"R [CEAG/H/O!QW(S@,2/3 ]\?D&>8'^S<SQ&#C6IXB-'V45.#C=1<:24
M:L5I"M&',ZE)-VDHV?[R,5_3?"><2SS(,'F?U6MA)8EXB4J-52C'G56M*4\/
M.:3K86I4:5&LTG*'/=7I2G+Y2^.O[;O[-?[-GCOPC\./C)XU\2>%_$WC;2FU
MW1I-/^$_QB\:>%K'2AKECX8M;WQEX^\"^ O$_@/X=0ZOXHU33/#/AP_$'Q'X
M8;Q/XDU+3] \/+JFK7MK9S4?!?\ P4"_86^(6E?##6/!W[8W[,FMVOQJTS7-
M7^$T$/QR^'%MJOQ"L_"MO)=>+U\*Z%>^)+36M6OO!<44X\:Z7;:>VI^#I[:[
MM/$UEI5U:7,,2?&/]AW]G?X]_%S2/C;\5?!6D>,/B!X4^%7C'X4> -8U[PSX
M%\07'PSM?&U_%=:SXY^'&H>)/"NL:WX-^(X@1M,MO$VBZI;1C2Y);2ZTZZ!S
M7Q;KG_!$;]E;7O&?PG\<W/CSXR'5_@]J6OZKX<M]6T[]G'QQI]W<^(/#/AOP
MO<1W$?Q-_9Y\<7FA6ALO"U@^M67@&^\&6WQ"@E?P[\5H_'O@VPT+PUH_B495
M>6@JT(\TL1B/;RI2CRTL*G4>&]G";;K8B7+2IUM8THRFZBG.$9QH_13>M5PN
ME&C3]BIR_BXGFBJBG*$6Z5%)RG3^*H^1P]G&4H2J_H9X#_:X_92^*OB+PIX0
M^%_[37[/OQ)\5^.O!-Q\2_!'A?P#\9OASXQ\0^,OAQ::W?>&[OX@^%M$\/>(
MM2U/Q%X(M?$6F:CH-SXKTBUO-!@UFPO=,DOUOK6>%.&\8?MW_LQ_#O6_C;H/
MQ%\:^*OAS-^SSX.A^(?Q1UCX@_!GXV>!_!MCX"FU6VT27QMX.\?^*?AUI/@?
MXJ>%-+U2^M+#Q#X@^%7B#QII7AFYG6/Q%=:6ZR*/EKX*_P#!,/\ 9>_8W^*O
MAW]JR^^+OB[5O%/P^^'!^'VK_$/X^Z-^RA>W$NE27&L:5H>H'XKG]GCPI\2/
MA!I'A_P_XCM/AUX4^%OP-^(WP>^ .D^#M(\.>&[/X1D17$E_UOCK]A+X:^(/
M'?[32^-/VLOCI%KG[=NCV?AV#P=JVH?LS+JG@BW^&\=EKOAZR_9VO]8^ -S\
M1WT/X965EK/B'3?A[XN\3?$_X9Z-J?C7XC>/M4\#R^*_'GBCQ#J,U9U5&+I1
MC.M]5Q_-!N/LUCHU,,\LH*I[E7DQ&&EC*M:3@U&I2C3O&BZ56HZ;BYR59\D/
M:Y?R."<YRH3]LLSJM>]3A]7J?5H8=)2J5%4O:=7VE.E]&Z]^W)^QWX9LO@3J
MNL_M,?!6#0OVG=8U/0O@!XGMOB#X<U/PC\6-0T?0M3\1ZD?"'B[2KR]\,ZAI
MUMIFD72-K1U6+1I=6N-'\/P7\VO:_H6FZAS>D_\ !0G]B[57TZ\'[4/[.%GX
M1\4Z[X4\+?#+XA7'[2'[/EQX-^+_ (M\9/K$.E^%/AI=Z5\3]1U?7/$JWVAZ
MEIJZ+?:+I5[J]_;W,7AB+Q!%8:E-9>9:;^P_\$?&/P@^%/P;\.?';XG:LO[-
MOQ;^)GB'6?'GAWQ#\'-5\>>)?B-\3?"WQ4T#XT>&_BU#%\,-0\!Z/>>-;#X\
M^,=5\1:!X+\"?#G4_"]YJVBS>"O^$,TZTM+%_)/C/_P1C_9<^.-K\/+/Q'XQ
M^+^D6OPTF^!K>'[724^!VN6"P? #P3/X \')'I/Q&^!WCS1_#^KW&BR"2[\<
M^"K#PK\2?#EU]JA^''C3P)I6M^(M,UC>MRJI-8>4JE/Z_6A2J5%"DUE<Z5*>
M'Q4X+F;Q?M/:T_9)TJ4URUI0Y%R2QI.K*G0=50C4>#4L1"F^:*S*&(Q-.IAJ
M4VW?#3P_U:LZSYJE&;K4+N7+4A^E7P\\:?#GXRZ%X>^*O@+4_P#A(]#D'B?2
M=!UW['K>CEC9:]/X?\20?V7K-IIEV/*UOPW/:>;>Z<-_V/[18R/:7*3W'IH]
M^3_GD<#\?3IG!R?)_@C\'_#'P&^&VA_"WP??:YJ6@>'KSQ)>V=[XDN=/N]9E
ME\5>*=;\77ZW5QIFFZ19/'#J.O7<%F(M.@:.QBMHYVN+A)KF;UG'^??VK6;B
MYR4)RG2A[M)S7++V>ZO'51O)RE9:>]HW:[K#QFJ:E5A2IUZGOUU2UBZOPM\V
M\VH1IQ<I:OEV6D44?Y_SG%%%2;A0,=NW%%%*P!2'H?H?Y4M(W0_0_P J8GT_
MKJCC_&/^HT/_ +&OP_\ ^EL==C7'>,?]1H?_ &-?A_\ ]+8Z[&MI_P '#_\
M<Q_Z=@<=#_?,;_AP?_IJJ%%%%8G:%%%% !1110 4444 5I_]6_T?_P!!EK^4
M"OZOY@Q1P!DE7QG/4APOYY_K[U_,M_PHCXX?]$:^*W_AN_%__P IZ_E;Z2>
MQ^.GPE]2P..QGL_[;]I]3P6,QGL^:I@.7VGU7#U_9\UGR\_+S6?+>SMX>=PG
M-8;DA.=G6OR0E.UU3M?EC*U^E[7/*:*]6_X41\</^B-?%;_PW?B__P"4]'_"
MB/CA_P!$:^*W_AN_%_\ \IZ_EW^P<^_Z$>=_^&7-_P#YWGS_ +&O_P ^*W_@
MFK_\K/*:*]6_X41\</\ HC7Q6_\ #=^+_P#Y3T?\*(^.'_1&OBM_X;OQ?_\
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M !M_Z%W3_P#PH-%_^3*7_ADWXVXS_P (YI_;_F8=%[]./MF:_7^BC_7K.?\
MGUE__A/4?_N?_/\ -,_X@]PO_P!!6<_^%=!?EA5^:\FG9K\@#^R=\;1@GPYI
M_/(_XJ'1>?\ R<H_X9.^-O'_ !3FG\]/^*@T;_Y,K]?Z*7^O.<7NZ&6M]']5
METDI+>JWI)1DM=)1C-.,XQG"EX0<,K;&9XO3'071QZ48K:36WPMQ?-%RC/\
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M/PY9?LY_"S7?V5?#M_H/V?3U^"G@WQC\>_">@20+;:'XWAM9M1DU'Y^\:_\
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MM%% !1110 4444 %)^/7CT_#ZTM% "#'8Y[]<TM%% !1110 4444 %'']/\
MZU%% "8 Y_4DX&?Q_P *6BB@ HHHH **** "@=^,<_Y-%% "=^IZ=.W_ .O\
M?TI:** "BBB@ HHHH *0]N1WX]?\]Z6B@!,=AP!CCGW]".O^<TM%% !1110
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MGC3Q)<>,?'MOX(^"G@_XFZIK.I:UXM\-_M2^#_'NI:YXD\1_TW44 ?E5H/[
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MX=_91^.?Q%_;1_;-\/ZS\#-!U3QQ=? ?QIX,^%?[4GQ,\&?%30O%US=W=_\
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4B@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>42
<FILENAME>img_8n.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img_8n.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #& 5X# 2(  A$! Q$!_\0
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MUJ^^'OBF$1W>CW5U/IEGJ$EGIUS8/<W<1DWLSD'Y1\.?L8>.? 7B3Q!\<?\
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MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J%_O_\
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M3?\ JI_B97T57TV<?\B#@S_L7\0_^M7B#&G_ !<1_CI?^F$%%%%?,FP4444
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M%1G**G*211117X">J?.OQO\ ^1Y_9G_[+A-_ZJ?XF5]%5\Z_&_\ Y'G]F?\
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MQ1X:O?AY^T-\'-;D\)_'WX4W>BZ]I,/@KQ#_ &QKVEZ;<Z'-KT>_6?#6N_\
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M%!Y!()X&><?1=;9SID/!JZK+^(;KM_QE>(%3_BXC_'2_],(****^9-@HHHH
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M48Q248WD^6,4E&/+&-E%'=Y#%C1#E1@D!2<GD  #/J0!P?KZFF/]_P#X"O\
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M?A/\3S<+IO@+4M5G\,Z=';B-/[)CM+"%-(1I$LPBR-7WC7SK\;N/''[,^/\
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M8S@ZU6$X)PYTI15US/G=O9+=<S233Y94H74J,YU/>:***_#ST@HHHH ****
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M5U=F[+W=[)OY'U'17@(\9_M$D9/P.\"A2,EE^-TQPOJ,?#$9XY&"/8UQ5O\
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MYX;U'4-!TBZO-)OQ/:SO9(C*L<DZ2^Z(B1J%15155555  55 55 '15   '
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MYKRUBGDL+K: IGM'<P2LN5=D+I\K 5\%>-OCKXKL8?VF_&UQ\-/A[?\ C/\
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M?HT=MKGC"7Q+X=N;S4/%NHB[U?4!XAUQI9EN)8[F+/\ U>^C#BZ>6Q7'_&>
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M/\Z=117(]&UV;7W-C"BBBD 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %0O]_P#X"O\
*-J**:Z^G^0'_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
